Citrus Sinensis ID: 038949
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 678 | 2.2.26 [Sep-21-2011] | |||||||
| P0DH62 | 567 | Inactive protein kinase S | N/A | no | 0.402 | 0.481 | 0.598 | 1e-109 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.443 | 0.461 | 0.506 | 1e-86 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.433 | 0.414 | 0.514 | 3e-85 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.418 | 0.396 | 0.522 | 3e-85 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.457 | 0.437 | 0.490 | 5e-85 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.439 | 0.391 | 0.495 | 6e-85 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.420 | 0.555 | 0.527 | 9e-85 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.432 | 0.406 | 0.503 | 5e-84 | |
| Q8GX23 | 670 | Proline-rich receptor-lik | no | no | 0.449 | 0.455 | 0.491 | 2e-83 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.432 | 0.430 | 0.5 | 3e-83 |
| >sp|P0DH62|Y4407_SELML Inactive protein kinase SELMODRAFT_444075 OS=Selaginella moellendorffii GN=SELMODRAFT_444075 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 395 bits (1015), Expect = e-109, Method: Compositional matrix adjust.
Identities = 192/321 (59%), Positives = 228/321 (71%), Gaps = 48/321 (14%)
Query: 348 SVREAVSLSRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGF 407
SVR+ + L + P PPPLCSICQHK PVFG PPR FT+AEL+LAT FS+ NFLAEGG+
Sbjct: 207 SVRKQIHLRKQSSPQPPPLCSICQHKTPVFGKPPRKFTFAELQLATGGFSDVNFLAEGGY 266
Query: 408 GSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467
GSV+RG LPDGQ VAVKQ+KLAS+QGD+EFC+EVEVLSCAQ RN+VMLIG+C ED +RLL
Sbjct: 267 GSVYRGRLPDGQAVAVKQHKLASTQGDKEFCAEVEVLSCAQQRNLVMLIGYCAEDKKRLL 326
Query: 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNI 527
VYE++CNGSLDSHLYGR R K
Sbjct: 327 VYEFVCNGSLDSHLYGR---------RSKT------------------------------ 347
Query: 528 LVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVL 587
VGDFGLARWQP+G++GVETRV+G FGYLAPEY Q+GQITEKADVYS G+VL
Sbjct: 348 ---------VGDFGLARWQPNGELGVETRVIGAFGYLAPEYTQTGQITEKADVYSFGIVL 398
Query: 588 VELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASL 647
+EL++GRKA+DL+R +G+ CL+EWARP L+ +LID RLR + EV ML A+L
Sbjct: 399 LELVSGRKAVDLSRNKGEMCLSEWARPFLREQKYEKLIDQRLRGRFCVNEVENMLLAATL 458
Query: 648 CIRKDPHSRPRMSQVLRMLEG 668
CI DP RPRMSQVLR+LEG
Sbjct: 459 CIDPDPLIRPRMSQVLRLLEG 479
|
Selaginella moellendorffii (taxid: 88036) |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 321 bits (822), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 158/312 (50%), Positives = 211/312 (67%), Gaps = 11/312 (3%)
Query: 363 PPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVA 422
PPP + V G FTY EL ATN FSEAN L +GGFG VH+G+LP G+ VA
Sbjct: 253 PPPSPGL------VLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVA 306
Query: 423 VKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLY 482
VKQ K S QG++EF +EVE++S HR++V LIG+C+ +RLLVYE++ N +L+ HL+
Sbjct: 307 VKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLH 366
Query: 483 GRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542
G+ R +EWS R KIA+G+A+GL YLHE+C I+HRD++ +NIL+ FE V DFGL
Sbjct: 367 GKGRPTMEWSTRLKIALGSAKGLSYLHEDCNP-KIIHRDIKASNILIDFKFEAKVADFGL 425
Query: 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRP 602
A+ D + V TRV+GTFGYLAPEYA SG++TEK+DV+S GVVL+ELITGR+ +D N
Sbjct: 426 AKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNV 485
Query: 603 RGQQCLTEWARPLLKRHA----IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR 658
L +WARPLL R + L D ++ N Y E+ M+ CA+ C+R RPR
Sbjct: 486 YVDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPR 545
Query: 659 MSQVLRMLEGDI 670
MSQ++R LEG++
Sbjct: 546 MSQIVRALEGNV 557
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 317 bits (811), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 155/301 (51%), Positives = 210/301 (69%), Gaps = 7/301 (2%)
Query: 376 VFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQ 435
V G+ FTY EL T FS+ N L EGGFG V++G L DG++VAVKQ K+ S QGD+
Sbjct: 333 VMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDR 392
Query: 436 EFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR 495
EF +EVE++S HR++V L+G+C+ D RLL+YEY+ N +L+ HL+G+ R LEW+ R
Sbjct: 393 EFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRV 452
Query: 496 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET 555
+IA+G+A+GL YLHE+C I+HRD++ NIL+ +FE V DFGLA+ V T
Sbjct: 453 RIAIGSAKGLAYLHEDCHP-KIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVST 511
Query: 556 RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615
RV+GTFGYLAPEYAQSG++T+++DV+S GVVL+ELITGRK +D +P G++ L EWARPL
Sbjct: 512 RVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPL 571
Query: 616 LKRHA----IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML--EGD 669
L + EL+D RL Y E EV+ M++ A+ C+R RPRM QV+R L EGD
Sbjct: 572 LHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGD 631
Query: 670 I 670
+
Sbjct: 632 M 632
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 316 bits (810), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 153/293 (52%), Positives = 207/293 (70%), Gaps = 9/293 (3%)
Query: 384 FTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEV 443
F Y EL ATN FSEAN L +GGFG V +G+L +G+ VAVKQ K SSQG++EF +EV +
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401
Query: 444 LSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAAR 503
+S HR++V L+G+C+ D +RLLVYE++ N +L+ HL+G+ R +EWS+R KIAVG+A+
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVGSAK 461
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGY 563
GL YLHE C I+HRD++ +NIL+ FE V DFGLA+ D + V TRV+GTFGY
Sbjct: 462 GLSYLHENCNP-KIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGY 520
Query: 564 LAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623
LAPEYA SG++TEK+DV+S GVVL+ELITGR+ +D+N L +WARPLL + + E
Sbjct: 521 LAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQ--VSE 578
Query: 624 L------IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670
L +D +L N Y + E+ M+ CA+ C+R RPRM QV R+LEG+I
Sbjct: 579 LGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNI 631
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 316 bits (809), Expect = 5e-85, Method: Compositional matrix adjust.
Identities = 156/318 (49%), Positives = 212/318 (66%), Gaps = 8/318 (2%)
Query: 355 LSRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGV 414
+ + P G Q ++ GN F+Y EL ATN FS+ N L EGGFG V++G+
Sbjct: 336 MQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGI 395
Query: 415 LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474
LPDG+VVAVKQ K+ QGD+EF +EVE LS HR++V ++G C+ RRLL+Y+Y+ N
Sbjct: 396 LPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSN 455
Query: 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE 534
L HL+G ++ L+W+ R KIA GAARGL YLHE+C I+HRD++ +NIL+ +F+
Sbjct: 456 NDLYFHLHG-EKSVLDWATRVKIAAGAARGLAYLHEDCHP-RIIHRDIKSSNILLEDNFD 513
Query: 535 PLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
V DFGLAR D + + TRV+GTFGY+APEYA SG++TEK+DV+S GVVL+ELITGR
Sbjct: 514 ARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 573
Query: 595 KAMDLNRPRGQQCLTEWARPLLKRHAI-----GELIDPRLRNCYSEREVYGMLQCASLCI 649
K +D ++P G + L EWARPL+ HAI L DP+L Y E E++ M++ A C+
Sbjct: 574 KPVDTSQPLGDESLVEWARPLIS-HAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACV 632
Query: 650 RKDPHSRPRMSQVLRMLE 667
R RPRM Q++R E
Sbjct: 633 RHLATKRPRMGQIVRAFE 650
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 315 bits (808), Expect = 6e-85, Method: Compositional matrix adjust.
Identities = 150/303 (49%), Positives = 208/303 (68%), Gaps = 5/303 (1%)
Query: 369 ICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKL 428
+ Q + FG F+Y EL +ATN FS+ N L EGGFG V++GVLPD +VVAVKQ K+
Sbjct: 403 LSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKI 462
Query: 429 ASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDP 488
QGD+EF +EV+ +S HRN++ ++G+C+ + RRLL+Y+Y+ N +L HL+
Sbjct: 463 GGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPG 522
Query: 489 LEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548
L+W+ R KIA GAARGL YLHE+C I+HRD++ +NIL+ ++F LV DFGLA+ D
Sbjct: 523 LDWATRVKIAAGAARGLAYLHEDCHP-RIIHRDIKSSNILLENNFHALVSDFGLAKLALD 581
Query: 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCL 608
+ + TRV+GTFGY+APEYA SG++TEK+DV+S GVVL+ELITGRK +D ++P G + L
Sbjct: 582 CNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESL 641
Query: 609 TEWARPLLKRHAIGE----LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
EWARPLL E L DP+L Y E++ M++ A+ CIR RPRMSQ++R
Sbjct: 642 VEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVR 701
Query: 665 MLE 667
+
Sbjct: 702 AFD 704
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 315 bits (806), Expect = 9e-85, Method: Compositional matrix adjust.
Identities = 154/292 (52%), Positives = 205/292 (70%), Gaps = 7/292 (2%)
Query: 384 FTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEV 443
FTY EL ATN+FSEAN L EGGFG V++G+L +G VAVKQ K+ S+QG++EF +EV +
Sbjct: 171 FTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNI 230
Query: 444 LSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAAR 503
+S HRN+V L+G+C+ +RLLVYE++ N +L+ HL+G+ R +EWS R KIAV +++
Sbjct: 231 ISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSLRLKIAVSSSK 290
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGY 563
GL YLHE C I+HRD++ NIL+ FE V DFGLA+ D + V TRV+GTFGY
Sbjct: 291 GLSYLHENCNPK-IIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGTFGY 349
Query: 564 LAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623
LAPEYA SG++TEK+DVYS GVVL+ELITGR+ +D N L +WARPLL + A+ E
Sbjct: 350 LAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQ-ALEE 408
Query: 624 -----LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670
L D +L N Y E+ M+ CA+ C+R RPRM QV+R+LEG+I
Sbjct: 409 SNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEGNI 460
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 312 bits (800), Expect = 5e-84, Method: Compositional matrix adjust.
Identities = 150/298 (50%), Positives = 205/298 (68%), Gaps = 5/298 (1%)
Query: 376 VFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQ 435
+ G+ F+Y EL T F+ N L EGGFG V++G L DG+VVAVKQ K S QGD+
Sbjct: 351 ILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDR 410
Query: 436 EFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR 495
EF +EVE++S HR++V L+G+C+ D RLL+YEY+ N +L+ HL+G+ LEWS R
Sbjct: 411 EFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRV 470
Query: 496 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET 555
+IA+G+A+GL YLHE+C I+HRD++ NIL+ ++E V DFGLAR V T
Sbjct: 471 RIAIGSAKGLAYLHEDCHP-KIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVST 529
Query: 556 RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615
RV+GTFGYLAPEYA SG++T+++DV+S GVVL+EL+TGRK +D +P G++ L EWARPL
Sbjct: 530 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPL 589
Query: 616 LKRHA----IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669
L + + ELID RL Y E EV+ M++ A+ C+R RPRM QV+R L+ D
Sbjct: 590 LLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCD 647
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 310 bits (795), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 153/311 (49%), Positives = 211/311 (67%), Gaps = 6/311 (1%)
Query: 367 CSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQY 426
+I +A G+ FTY EL +AT F+++N L +GGFG VH+GVLP G+ VAVK
Sbjct: 283 TAIPSPQAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSL 342
Query: 427 KLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDR 486
KL S QG++EF +EV+++S HR++V L+G+C+ G+RLLVYE+I N +L+ HL+G+ R
Sbjct: 343 KLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGKGR 402
Query: 487 DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546
L+W R KIA+G+ARGL YLHE+C I+HRD++ NIL+ FE V DFGLA+
Sbjct: 403 PVLDWPTRVKIALGSARGLAYLHEDCHP-RIIHRDIKAANILLDFSFETKVADFGLAKLS 461
Query: 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQ 606
D V TRV+GTFGYLAPEYA SG++++K+DV+S GV+L+ELITGR +DL +
Sbjct: 462 QDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTG-EMED 520
Query: 607 CLTEWARPLLKRHA----IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQV 662
L +WARPL + A +L DPRL YS +E+ M CA+ IR RP+MSQ+
Sbjct: 521 SLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQI 580
Query: 663 LRMLEGDILMN 673
+R LEGD+ M+
Sbjct: 581 VRALEGDMSMD 591
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 310 bits (793), Expect = 3e-83, Method: Compositional matrix adjust.
Identities = 151/302 (50%), Positives = 209/302 (69%), Gaps = 9/302 (2%)
Query: 383 WFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVE 442
WF+Y EL T+ FSE N L EGGFG V++GVL DG+ VAVKQ K+ SQG++EF +EVE
Sbjct: 326 WFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVE 385
Query: 443 VLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAA 502
++S HR++V L+G+C+ + RLLVY+Y+ N +L HL+ R + W R ++A GAA
Sbjct: 386 IISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAA 445
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG--VETRVLGT 560
RG+ YLHE+C I+HRD++ +NIL+ + FE LV DFGLA+ + D+ V TRV+GT
Sbjct: 446 RGIAYLHEDCHP-RIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGT 504
Query: 561 FGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLL---- 616
FGY+APEYA SG+++EKADVYS GV+L+ELITGRK +D ++P G + L EWARPLL
Sbjct: 505 FGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAI 564
Query: 617 KRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSKD 676
+ EL+DPRL + E++ M++ A+ C+R RP+MSQV+R L D L + D
Sbjct: 565 ENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRAL--DTLEEATD 622
Query: 677 DT 678
T
Sbjct: 623 IT 624
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 678 | ||||||
| 225442323 | 737 | PREDICTED: inactive protein kinase SELMO | 0.957 | 0.880 | 0.711 | 0.0 | |
| 225444965 | 753 | PREDICTED: uncharacterized protein LOC10 | 0.960 | 0.864 | 0.723 | 0.0 | |
| 147839162 | 761 | hypothetical protein VITISV_043993 [Viti | 0.960 | 0.855 | 0.723 | 0.0 | |
| 255546177 | 682 | ATP binding protein, putative [Ricinus c | 0.958 | 0.953 | 0.706 | 0.0 | |
| 449531434 | 751 | PREDICTED: LOW QUALITY PROTEIN: tyrosine | 0.973 | 0.878 | 0.702 | 0.0 | |
| 449458185 | 751 | PREDICTED: tyrosine-protein kinase Lck-l | 0.973 | 0.878 | 0.700 | 0.0 | |
| 255572979 | 754 | ATP binding protein, putative [Ricinus c | 0.960 | 0.863 | 0.703 | 0.0 | |
| 297738688 | 731 | unnamed protein product [Vitis vinifera] | 0.901 | 0.835 | 0.704 | 0.0 | |
| 224128638 | 694 | predicted protein [Populus trichocarpa] | 0.960 | 0.938 | 0.700 | 0.0 | |
| 351724979 | 700 | protein kinase family protein [Glycine m | 0.951 | 0.921 | 0.682 | 0.0 |
| >gi|225442323|ref|XP_002280107.1| PREDICTED: inactive protein kinase SELMODRAFT_444075 isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 976 bits (2522), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/663 (71%), Positives = 552/663 (83%), Gaps = 14/663 (2%)
Query: 16 VIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHK 75
V+VAVKAS+EIP++ALVWALTHVVQPGD I LLVV+P S +K+WGF RF DCA+GH+
Sbjct: 20 VVVAVKASREIPKTALVWALTHVVQPGDCITLLVVVPAQSPGRKLWGFPRFAGDCASGHR 79
Query: 76 SSLSGTSSDQKDDIVDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNW 135
S SG SS+QK +I DSCSQM+ QL +VYDP KI V++KIVSGSP G V+ EAK+ ++NW
Sbjct: 80 KSHSGASSEQKCEITDSCSQMILQLHDVYDPNKINVKIKIVSGSPCGAVSGEAKRTEANW 139
Query: 136 VILDKQLKHEKKCCMEELQCNVVVMKRSQPKVLRLNLVASPTMKSQVARSETFSLEVSPK 195
V+LDKQLKHE+KCCMEELQCN+VVMKRSQPKVLRLNLV SP M+S+ A S K
Sbjct: 140 VVLDKQLKHEEKCCMEELQCNIVVMKRSQPKVLRLNLVGSPKMESETA---------SEK 190
Query: 196 YLKSKHDDPYMMKGPFVTPASSPEQESLLTATDVGTSSISSSDPGTF----SEICENLKK 251
+ K+K+D ++GP VTP+SSPE + TAT+VGTSS+SSSDPGT SE+ +LKK
Sbjct: 191 HSKTKNDSMKSIRGPVVTPSSSPELGTPFTATEVGTSSVSSSDPGTSPFFNSEVNGDLKK 250
Query: 252 ECSLVSEERQDRFGPDSDSDCEVLCLPSTSSNHDPWMAESLSPREEFLKLLEGSSERTND 311
E S ++E D SD+D E L PS+S PWMA L+ + + +E SS+++ D
Sbjct: 251 EESSHTKENLDLDESSSDTDNENLS-PSSSVGFQPWMAGVLTSHHQSSQHIEQSSKKSRD 309
Query: 312 PSLTSAYEFLLEKLSTLNREPDIGVLNYKLDLKISKSVREAVSLSRNKPPGPPPLCSICQ 371
+ + LL+K S ++R+ IG++NY+ +L S +VREA+SLSRN PPGPPPLCSICQ
Sbjct: 310 KTQPPTSKALLDKFSKIDRDARIGMMNYRSELDFSGNVREAISLSRNAPPGPPPLCSICQ 369
Query: 372 HKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASS 431
HKAPVFG PPRWF+YAELELAT FS+ANFLAEGGFGSVHRGVLPDGQ VAVKQ+KLASS
Sbjct: 370 HKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS 429
Query: 432 QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEW 491
QGD EFCSEVEVLSCAQHRNVVMLIG+C+ED RRLLVYEYICNGSLDSHLYGR RDPLEW
Sbjct: 430 QGDVEFCSEVEVLSCAQHRNVVMLIGYCIEDRRRLLVYEYICNGSLDSHLYGRHRDPLEW 489
Query: 492 SARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551
SAR+K+AVGAARGLRYLHEECRVGCIVHRDMRPNNIL+THDFEPLVGDFGLARWQPDGD
Sbjct: 490 SARQKVAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDFEPLVGDFGLARWQPDGDT 549
Query: 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEW 611
GVETRV+GTFGYLAPEYAQSGQITEKADVYS GVVLVEL+TGRKA+DLNRP+GQQCLTEW
Sbjct: 550 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEW 609
Query: 612 ARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671
ARPLL+ +AI EL+DPRL NCYSE+EVY ML ASLCIR+DPH+RPRMSQVLR+LEGD++
Sbjct: 610 ARPLLEEYAIDELVDPRLGNCYSEQEVYCMLHAASLCIRRDPHARPRMSQVLRILEGDMV 669
Query: 672 MNS 674
M+S
Sbjct: 670 MDS 672
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225444965|ref|XP_002282534.1| PREDICTED: uncharacterized protein LOC100242363 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 963 bits (2489), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 476/658 (72%), Positives = 535/658 (81%), Gaps = 7/658 (1%)
Query: 23 SKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTS 82
S+EIPR ALVWALTHVVQPGD I LLVV+PP S KK+WGF RF++DC TG + SGTS
Sbjct: 40 SREIPRRALVWALTHVVQPGDCIMLLVVIPPHSHGKKLWGFPRFSSDCTTGQRKFHSGTS 99
Query: 83 SDQKDDIVDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQL 142
SDQKDDI D+CSQMM QL +VYDP+ I V++KIVSGS GVVA EAK Q+NW++LDK+L
Sbjct: 100 SDQKDDITDTCSQMMLQLHDVYDPDMINVKIKIVSGSRSGVVAAEAKSVQTNWIVLDKRL 159
Query: 143 KHEKKCCMEELQCNVVVMKRSQPKVLRLNLVASPTMKSQVARSETFSLEVSPKYLKSKHD 202
KHE K CMEELQCN+VVMKRS+PKVLRLNL S + +VA E S +LK+KHD
Sbjct: 160 KHEAKHCMEELQCNLVVMKRSRPKVLRLNLTGSSKKEPEVACPLQSISEASEGHLKNKHD 219
Query: 203 D-PYMMKGPFVTPASSPEQESLLTATDVGTSSISSSDPGT----FSEICENLKKECSLVS 257
D P ++GP VTPASSPE + T+TD+GTSS+SSSDPG I +LK E +L +
Sbjct: 220 DMPNAIRGPVVTPASSPEHGTTFTSTDIGTSSMSSSDPGNSPFFIPRISRDLKMEDALTT 279
Query: 258 EERQDRFGPDSDSDCEVLCLPSTSSNHDPWMAES-LSPREEFLKLLEGSSERTNDPSLTS 316
E DSD+D E L P T W+ E+ LS EF K L S + +D +L
Sbjct: 280 EGNPLLDESDSDTDSEKLG-PRTRLCFQTWLVENILSSGGEFSKHLVEGSRKPSDKALAF 338
Query: 317 AYEFLLEKLSTLNREPDIGVLNYKLDLKISKSVREAVSLSRNKPPGPPPLCSICQHKAPV 376
LL+K S L+ EP++GVLNYK DL+ +VRE +SLS N PPGPPPLCSICQHKAPV
Sbjct: 339 KSGMLLDKFSQLDPEPEVGVLNYKFDLESGINVREVISLSGNTPPGPPPLCSICQHKAPV 398
Query: 377 FGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQE 436
FG PPRWFTYAELELAT FS NFLAEGGFGSVHRG+LPDGQVVAVKQ+KLASSQGD E
Sbjct: 399 FGKPPRWFTYAELELATGGFSHVNFLAEGGFGSVHRGILPDGQVVAVKQHKLASSQGDLE 458
Query: 437 FCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRK 496
FCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDR LEWSAR+K
Sbjct: 459 FCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRGLLEWSARQK 518
Query: 497 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR 556
IAVGAARGLRYLHEECRVGCIVHRDMRPNNIL+THDFEPLVGDFGLARWQPDGDMGVETR
Sbjct: 519 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDFEPLVGDFGLARWQPDGDMGVETR 578
Query: 557 VLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLL 616
++GTFGYL+PEYAQSGQITEKADVYS GVVLVELITGRKAMD+NRP+GQQCLTEWARPLL
Sbjct: 579 IIGTFGYLSPEYAQSGQITEKADVYSFGVVLVELITGRKAMDINRPKGQQCLTEWARPLL 638
Query: 617 KRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNS 674
++ AI EL+DPRLRNCYSE+EV GML CASLCI++DPHSRPRMSQVLR+LEGDI MNS
Sbjct: 639 EQCAIDELVDPRLRNCYSEKEVSGMLHCASLCIQRDPHSRPRMSQVLRILEGDIFMNS 696
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147839162|emb|CAN76926.1| hypothetical protein VITISV_043993 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 962 bits (2486), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 476/658 (72%), Positives = 535/658 (81%), Gaps = 7/658 (1%)
Query: 23 SKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTS 82
S+EIPR ALVWALTHVVQPGD I LLVV+PP S KK+WGF RF++DC TG + SGTS
Sbjct: 40 SREIPRRALVWALTHVVQPGDCIMLLVVIPPHSHGKKLWGFPRFSSDCTTGQRRFHSGTS 99
Query: 83 SDQKDDIVDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQL 142
SDQKDDI D+CSQMM QL +VYDP+ I V++KIVSGS GVVA EAK Q+NW++LDK+L
Sbjct: 100 SDQKDDITDTCSQMMLQLHDVYDPDMINVKIKIVSGSRSGVVAAEAKSVQTNWIVLDKRL 159
Query: 143 KHEKKCCMEELQCNVVVMKRSQPKVLRLNLVASPTMKSQVARSETFSLEVSPKYLKSKHD 202
KHE K CMEELQCN+VVMKRS+PKVLRLNL S + +VA E S +LK+KHD
Sbjct: 160 KHEAKHCMEELQCNLVVMKRSRPKVLRLNLTGSSKKEPEVACPLQSISEASEGHLKNKHD 219
Query: 203 D-PYMMKGPFVTPASSPEQESLLTATDVGTSSISSSDPGT----FSEICENLKKECSLVS 257
D P ++GP VTPASSPE + T+TD+GTSS+SSSDPG I +LK E +L +
Sbjct: 220 DMPNAIRGPVVTPASSPEHGTTFTSTDIGTSSMSSSDPGNSPFFIPRISRDLKMEDALTT 279
Query: 258 EERQDRFGPDSDSDCEVLCLPSTSSNHDPWMAES-LSPREEFLKLLEGSSERTNDPSLTS 316
E DSD+D E L P T W+ E+ LS EF K L S + +D +L
Sbjct: 280 EGNPLLDESDSDTDSEKLG-PRTRLCFQTWLVENILSSGGEFSKHLVEGSRKPSDKALAF 338
Query: 317 AYEFLLEKLSTLNREPDIGVLNYKLDLKISKSVREAVSLSRNKPPGPPPLCSICQHKAPV 376
LL+K S L+ EP++GVLNYK DL+ +VRE +SLS N PPGPPPLCSICQHKAPV
Sbjct: 339 KSGMLLDKFSQLDPEPEVGVLNYKFDLESGINVREVISLSGNTPPGPPPLCSICQHKAPV 398
Query: 377 FGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQE 436
FG PPRWFTYAELELAT FS NFLAEGGFGSVHRG+LPDGQVVAVKQ+KLASSQGD E
Sbjct: 399 FGKPPRWFTYAELELATGGFSHVNFLAEGGFGSVHRGILPDGQVVAVKQHKLASSQGDLE 458
Query: 437 FCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRK 496
FCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDR LEWSAR+K
Sbjct: 459 FCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRGLLEWSARQK 518
Query: 497 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR 556
IAVGAARGLRYLHEECRVGCIVHRDMRPNNIL+THDFEPLVGDFGLARWQPDGDMGVETR
Sbjct: 519 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDFEPLVGDFGLARWQPDGDMGVETR 578
Query: 557 VLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLL 616
++GTFGYL+PEYAQSGQITEKADVYS GVVLVELITGRKAMD+NRP+GQQCLTEWARPLL
Sbjct: 579 IIGTFGYLSPEYAQSGQITEKADVYSFGVVLVELITGRKAMDINRPKGQQCLTEWARPLL 638
Query: 617 KRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNS 674
++ AI EL+DPRLRNCYSE+EV GML CASLCI++DPHSRPRMSQVLR+LEGDI MNS
Sbjct: 639 EQCAIDELVDPRLRNCYSEKEVSGMLHCASLCIQRDPHSRPRMSQVLRILEGDIFMNS 696
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255546177|ref|XP_002514148.1| ATP binding protein, putative [Ricinus communis] gi|223546604|gb|EEF48102.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2439), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/655 (70%), Positives = 540/655 (82%), Gaps = 5/655 (0%)
Query: 23 SKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTS 82
SKEI R AL WALTHVVQPGD IKLLVV+P SS+K++WGF++FT+DC +G++ SLSGT
Sbjct: 23 SKEISRRALFWALTHVVQPGDCIKLLVVLPAHSSNKRVWGFTKFTSDCTSGNRKSLSGTK 82
Query: 83 SDQKDDIVDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQL 142
DQ+DDI DSCS+M+R L +VYDPEKIK+RVK+VSGS GVVA EAKKAQSNWVILDK L
Sbjct: 83 LDQRDDISDSCSEMLRHLHDVYDPEKIKIRVKVVSGSSSGVVAAEAKKAQSNWVILDKHL 142
Query: 143 KHEKKCCMEELQCNVVVMKRSQPKVLRLNLVASPTMKSQVARSETFSLEVSPKYLKSKHD 202
KHE K CMEELQCNVVVMKRSQPKVLRLNL+ SP M+ +V+ +E S L S H
Sbjct: 143 KHETKYCMEELQCNVVVMKRSQPKVLRLNLIGSPMMQPEVSWPLPIDVEASSNDLDSTHS 202
Query: 203 DPYMMKGPFVTPASSPEQESLLTATDVGTSSISSSDPGT----FSEICENLKKECSLVSE 258
+++GP+VTPASSP+ ES +T TD GTSSISSSDPG S I + KKE L +E
Sbjct: 203 QLDILRGPYVTPASSPDHESSVTITDAGTSSISSSDPGNSPFFLSGIYGSQKKEHLLFTE 262
Query: 259 ERQDRFGPDSDSDCEVLCLPSTSSNHDPWMAESLSPREEFLKLLEGSSERTNDPSLTSAY 318
+ Q + +SD+D + PST S + PWM +++S E K L +R+ + +L Y
Sbjct: 263 DNQSLYESESDADSDKQYPPSTRSYYQPWMDDNMSSSGELTKGLLDGFQRSKNAALAFTY 322
Query: 319 EFLLEKLSTLNREPDIGVLNYKLDLKISKSVREAVSLSRNKPPGPPPLCSICQHKAPVFG 378
+ LLE LS L+ EPD+GV+NY++DL +SKSVREA+SLS + PGPPPLCS+C+HKAPVFG
Sbjct: 323 KSLLENLSKLDLEPDVGVMNYRIDLNVSKSVREAISLSTHVLPGPPPLCSVCRHKAPVFG 382
Query: 379 NPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFC 438
NPP+WFTYAELELAT+ FS NFLAEGGFGSVHRGVL +GQVVAVKQ+KLASSQGD EFC
Sbjct: 383 NPPKWFTYAELELATDGFSGDNFLAEGGFGSVHRGVLTNGQVVAVKQHKLASSQGDMEFC 442
Query: 439 SEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIA 498
SEVEVLSCAQHRNVV LIGFCVEDGRRLLVYEYICNGSLDSHL+G D+DPL+WSAR+KIA
Sbjct: 443 SEVEVLSCAQHRNVVTLIGFCVEDGRRLLVYEYICNGSLDSHLFGHDKDPLKWSARQKIA 502
Query: 499 VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL 558
VGAARGLRYLHEECRVGCIVHRDMRPNNIL+THDFEPLVGDFGLARWQP+GDMGVETR++
Sbjct: 503 VGAARGLRYLHEECRVGCIVHRDMRPNNILITHDFEPLVGDFGLARWQPNGDMGVETRII 562
Query: 559 GTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR 618
GTFGYLAPEYAQSGQITEKADVYS GVVLVEL+TGRKA+D+ RP+GQQCLTEWARPLL++
Sbjct: 563 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAIDIKRPKGQQCLTEWARPLLEK 622
Query: 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMN 673
A EL+DPRLRNCY E EV+ MLQCASLCI +D H+RPR+SQV R L +I N
Sbjct: 623 QANHELVDPRLRNCYPEEEVHNMLQCASLCILRDSHARPRISQV-RELVSEIPQN 676
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449531434|ref|XP_004172691.1| PREDICTED: LOW QUALITY PROTEIN: tyrosine-protein kinase Lck-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 943 bits (2438), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/665 (70%), Positives = 537/665 (80%), Gaps = 5/665 (0%)
Query: 16 VIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHK 75
VIVAVKASKEIP++ALVWALTHVVQ GD I LLVV+P SS +K WGF RF DCA+GHK
Sbjct: 20 VIVAVKASKEIPKTALVWALTHVVQIGDCITLLVVVPSQSSDRKFWGFPRFAGDCASGHK 79
Query: 76 SSLSGTSSDQKDDIVDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNW 135
+ SGTSS+ K DI DSCSQM+ QL +VYDP KI V++KIVSGSP G VA EAK+AQ++W
Sbjct: 80 KAHSGTSSELKCDITDSCSQMILQLHDVYDPNKINVKIKIVSGSPSGAVAAEAKRAQASW 139
Query: 136 VILDKQLKHEKKCCMEELQCNVVVMKRSQPKVLRLNLVASPTMKSQV-ARSETFSLEVSP 194
V+LDKQLKHE+KCCMEELQCN+VVMKRSQPKVLRLNLV SP + +V + S + E S
Sbjct: 140 VVLDKQLKHEEKCCMEELQCNIVVMKRSQPKVLRLNLVGSPKKEPEVPSPSPSDIYEGSX 199
Query: 195 KYLKSKHDDPYMMKGPFVTPASSPEQESLLTATDVGTSSISSSDPGTF----SEICENLK 250
K+ K +D ++GP VTP+SSPE + TAT+ GTSS+SSSDPGT SE+ + K
Sbjct: 200 KHQKENNDPLDFIRGPVVTPSSSPELGTPFTATEAGTSSVSSSDPGTSPFFNSEMNGDTK 259
Query: 251 KECSLVSEERQDRFGPDSDSDCEVLCLPSTSSNHDPWMAESLSPREEFLKLLEGSSERTN 310
KE V +E ++ SDSD E L S S PWM E LS + + + G S+R +
Sbjct: 260 KEELFVIKENKELDAASSDSDIENLSASSASLRFQPWMTEFLSSHLQSSQHISGRSQRCD 319
Query: 311 DPSLTSAYEFLLEKLSTLNREPDIGVLNYKLDLKISKSVREAVSLSRNKPPGPPPLCSIC 370
D + S L K S L+RE IG+ +++ D VR+AVSLSRN PPGPPPLCSIC
Sbjct: 320 DRNQASTRNSFLLKSSKLDRESSIGMSSHRSDNDFHGDVRDAVSLSRNTPPGPPPLCSIC 379
Query: 371 QHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLAS 430
QHKAPVFG PPRWF+YAELELAT FS+ANFLAEGG+GSVHRGVLPDGQVVAVKQ+KLAS
Sbjct: 380 QHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGYGSVHRGVLPDGQVVAVKQHKLAS 439
Query: 431 SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLE 490
SQGD EFCSEVEVLSCAQHRNVVMLIGFC+E+ RRLLVYEYICNGSLDSHLYGR ++PLE
Sbjct: 440 SQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEEKRRLLVYEYICNGSLDSHLYGRQQEPLE 499
Query: 491 WSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550
WSAR+KIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL+THDFEPLVGDFGLARWQPDGD
Sbjct: 500 WSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDFEPLVGDFGLARWQPDGD 559
Query: 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTE 610
GVETRV+GTFGYLAPEYAQSGQITEKADVYS GVVLVELITGRKA+DL+RP+GQQCLTE
Sbjct: 560 TGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELITGRKAVDLSRPKGQQCLTE 619
Query: 611 WARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670
WARPLL I ELIDPRL N ++E EVY ML ASLCIR+DP++RPRMSQVLR+LEGD+
Sbjct: 620 WARPLLDEFLIDELIDPRLVNSFAEHEVYCMLHAASLCIRRDPNARPRMSQVLRILEGDL 679
Query: 671 LMNSK 675
+M++
Sbjct: 680 VMDAN 684
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458185|ref|XP_004146828.1| PREDICTED: tyrosine-protein kinase Lck-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 942 bits (2436), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/665 (70%), Positives = 537/665 (80%), Gaps = 5/665 (0%)
Query: 16 VIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHK 75
VIVAVKASKEIP++ALVWALTHVVQ GD I LLVV+P SS +K WGF RF DCA+GHK
Sbjct: 20 VIVAVKASKEIPKTALVWALTHVVQIGDCITLLVVVPSQSSGRKFWGFPRFAGDCASGHK 79
Query: 76 SSLSGTSSDQKDDIVDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNW 135
+ SGTSS+ K DI DSCSQM+ QL +VYDP KI V++KIVSGSP G VA EAK+AQ++W
Sbjct: 80 KAHSGTSSELKCDITDSCSQMILQLHDVYDPNKINVKIKIVSGSPSGAVAAEAKRAQASW 139
Query: 136 VILDKQLKHEKKCCMEELQCNVVVMKRSQPKVLRLNLVASPTMKSQV-ARSETFSLEVSP 194
V+LDKQLKHE+KCCMEELQCN+VVMKRSQPKVLRLNLV SP + +V + S + E S
Sbjct: 140 VVLDKQLKHEEKCCMEELQCNIVVMKRSQPKVLRLNLVGSPKKEPEVPSPSPSDIYEGSE 199
Query: 195 KYLKSKHDDPYMMKGPFVTPASSPEQESLLTATDVGTSSISSSDPGTF----SEICENLK 250
+ K +D ++GP VTP+SSPE + TAT+ GTSS+SSSDPGT SE+ + K
Sbjct: 200 SHQKENNDPLDFIRGPVVTPSSSPELGTPFTATEAGTSSVSSSDPGTSPFFNSEMNGDTK 259
Query: 251 KECSLVSEERQDRFGPDSDSDCEVLCLPSTSSNHDPWMAESLSPREEFLKLLEGSSERTN 310
KE V +E ++ SDSD E L + S S PWM E LS + + + G S+R +
Sbjct: 260 KEELFVIKENKELDAASSDSDIENLSVSSASLRFQPWMTEFLSSHLQSSQHISGRSQRCD 319
Query: 311 DPSLTSAYEFLLEKLSTLNREPDIGVLNYKLDLKISKSVREAVSLSRNKPPGPPPLCSIC 370
D + S L K S L+RE IG+ +++ D VR+AVSLSRN PPGPPPLCSIC
Sbjct: 320 DRNQASTRNSFLLKSSKLDRESSIGMSSHRSDNDFHGDVRDAVSLSRNTPPGPPPLCSIC 379
Query: 371 QHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLAS 430
QHKAPVFG PPRWF+YAELELAT FS+ANFLAEGG+GSVHRGVLPDGQVVAVKQ+KLAS
Sbjct: 380 QHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGYGSVHRGVLPDGQVVAVKQHKLAS 439
Query: 431 SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLE 490
SQGD EFCSEVEVLSCAQHRNVVMLIGFC+E+ RRLLVYEYICNGSLDSHLYGR ++PLE
Sbjct: 440 SQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEEKRRLLVYEYICNGSLDSHLYGRQQEPLE 499
Query: 491 WSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550
WSAR+KIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL+THDFEPLVGDFGLARWQPDGD
Sbjct: 500 WSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDFEPLVGDFGLARWQPDGD 559
Query: 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTE 610
GVETRV+GTFGYLAPEYAQSGQITEKADVYS GVVLVELITGRKA+DL+RP+GQQCLTE
Sbjct: 560 TGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELITGRKAVDLSRPKGQQCLTE 619
Query: 611 WARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670
WARPLL I ELIDPRL N ++E EVY ML ASLCIR+DP++RPRMSQVLR+LEGD+
Sbjct: 620 WARPLLDEFLIDELIDPRLVNSFAEHEVYCMLHAASLCIRRDPNARPRMSQVLRILEGDL 679
Query: 671 LMNSK 675
+M++
Sbjct: 680 VMDAN 684
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572979|ref|XP_002527420.1| ATP binding protein, putative [Ricinus communis] gi|223533230|gb|EEF34986.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 938 bits (2424), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/658 (70%), Positives = 536/658 (81%), Gaps = 7/658 (1%)
Query: 23 SKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTS 82
SKEIP++ALVWALTHVVQ GD I LLVV+P S +K+WGF RF DCA+GH+ S SG +
Sbjct: 29 SKEIPKTALVWALTHVVQAGDCITLLVVVPSHSPGRKLWGFPRFAGDCASGHRKSHSGAT 88
Query: 83 SDQKDDIVDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQL 142
S+Q+ DI DSCSQM+ QL +VYDP KI V++KIVSGSP G VA EAK+A +NWV+LDKQL
Sbjct: 89 SEQRCDITDSCSQMILQLHDVYDPNKINVKIKIVSGSPCGSVAAEAKRALANWVVLDKQL 148
Query: 143 KHEKKCCMEELQCNVVVMKRSQPKVLRLNLVASPTMKSQVARSETFSLEVSP-KYLKSKH 201
KHE+K CMEELQCN+VVMKR+QPKVLRLNLV + + +++ A L+ +P K K+K+
Sbjct: 149 KHEEKRCMEELQCNIVVMKRTQPKVLRLNLVGT-SKEAESAIPLPSELDEAPDKQTKNKN 207
Query: 202 DDPYMMKGPFVTPASSPEQESLLTATDVGTSSISSSDPGT----FSEICENLKKECSLVS 257
D ++GP VTP SSPE + TAT+VGTSS+SS DPGT S+ +LKKE SLV
Sbjct: 208 DSSDSIRGPVVTPTSSPELGTPFTATEVGTSSVSS-DPGTSPFFISDTNADLKKEESLVI 266
Query: 258 EERQDRFGPDSDSDCEVLCLPSTSSNHDPWMAESLSPREEFLKLLEGSSERTNDPSLTSA 317
+E D SD+D E L S S +PW+ E LS + + +E +R + S
Sbjct: 267 KEHGDVDESSSDTDSEHLSTASASLRFEPWIGEILSSHIQSSRHMEEGPQRRTSMAQAST 326
Query: 318 YEFLLEKLSTLNREPDIGVLNYKLDLKISKSVREAVSLSRNKPPGPPPLCSICQHKAPVF 377
+ LLEK S L+R+ IG+ NY+ D +S +VREA+SLSRN PPGPPPLCSICQHKAPVF
Sbjct: 327 TKALLEKFSKLDRQTGIGMSNYRTDSDLSGNVREAISLSRNAPPGPPPLCSICQHKAPVF 386
Query: 378 GNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEF 437
G PPRWF+YAELELAT FS+ANFLAEGGFGSVHRGVLPDGQ VAVKQ+KLASSQGD EF
Sbjct: 387 GKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDLEF 446
Query: 438 CSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKI 497
CSEVEVLSCAQHRNVVMLIGFC+ED RRLLVYEYICNGSLDSHLYGR R+PLEWSAR++I
Sbjct: 447 CSEVEVLSCAQHRNVVMLIGFCIEDKRRLLVYEYICNGSLDSHLYGRHREPLEWSARQRI 506
Query: 498 AVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV 557
AVGAARGLRYLHEECRVGCIVHRDMRPNNIL+THDFEPLVGDFGLARWQPDGD GVETRV
Sbjct: 507 AVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDFEPLVGDFGLARWQPDGDTGVETRV 566
Query: 558 LGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK 617
+GTFGYLAPEYAQSGQITEKADVYS GVVLVEL+TGRKA+DLNRP+GQQCLTEWARPLL+
Sbjct: 567 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE 626
Query: 618 RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSK 675
+AI ELIDP+L N YSE+EVY ML ASLCIR+DPHSRPRMSQVLR+LEGD+LM+S
Sbjct: 627 EYAIDELIDPQLGNNYSEQEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGDMLMDSN 684
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297738688|emb|CBI27933.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 937 bits (2421), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/657 (70%), Positives = 519/657 (78%), Gaps = 46/657 (7%)
Query: 23 SKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTS 82
S+EIPR ALVWALTHVVQPGD I LLVV+PP S KK+WGF RF++DC TG + SGTS
Sbjct: 59 SREIPRRALVWALTHVVQPGDCIMLLVVIPPHSHGKKLWGFPRFSSDCTTGQRKFHSGTS 118
Query: 83 SDQKDDIVDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQL 142
SDQKDDI D+CSQMM QL +VYDP+ I V++KIVSGS GVVA EAK Q+NW++LDK+L
Sbjct: 119 SDQKDDITDTCSQMMLQLHDVYDPDMINVKIKIVSGSRSGVVAAEAKSVQTNWIVLDKRL 178
Query: 143 KHEKKCCMEELQCNVVVMKRSQPKVLRLNLVASPTMKSQVARSETFSLEVSPKYLKSKHD 202
KHE K CMEELQCN+VVMKRS+PKVLRLNL S + +VA E S +LK+KHD
Sbjct: 179 KHEAKHCMEELQCNLVVMKRSRPKVLRLNLTGSSKKEPEVACPLQSISEASEGHLKNKHD 238
Query: 203 D-PYMMKGPFVTPASSPEQESLLTATDVGTSSISSSDPGT----FSEICENLKKECSLVS 257
D P ++GP VTPASSPE + T+TD+GTSS+SSSDPG I +LK E +L +
Sbjct: 239 DMPNAIRGPVVTPASSPEHGTTFTSTDIGTSSMSSSDPGNSPFFIPRISRDLKMEDALTT 298
Query: 258 EERQDRFGPDSDSDCEVLCLPSTSSNHDPWMAESLSPREEFLKLLEGSSERTNDPSLTSA 317
E + +SDSD + L S
Sbjct: 299 E--GNPLLDESDSDTDTLAFKSG------------------------------------- 319
Query: 318 YEFLLEKLSTLNREPDIGVLNYKLDLKISKSVREAVSLSRNKPPGPPPLCSICQHKAPVF 377
LL+K S L+ EP++GVLNYK DL+ +VRE +SLS N PPGPPPLCSICQHKAPVF
Sbjct: 320 --MLLDKFSQLDPEPEVGVLNYKFDLESGINVREVISLSGNTPPGPPPLCSICQHKAPVF 377
Query: 378 GNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEF 437
G PPRWFTYAELELAT FS NFLAEGGFGSVHRG+LPDGQVVAVKQ+KLASSQGD EF
Sbjct: 378 GKPPRWFTYAELELATGGFSHVNFLAEGGFGSVHRGILPDGQVVAVKQHKLASSQGDLEF 437
Query: 438 CSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKI 497
CSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDR LEWSAR+KI
Sbjct: 438 CSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRGLLEWSARQKI 497
Query: 498 AVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV 557
AVGAARGLRYLHEECRVGCIVHRDMRPNNIL+THDFEPLVGDFGLARWQPDGDMGVETR+
Sbjct: 498 AVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDFEPLVGDFGLARWQPDGDMGVETRI 557
Query: 558 LGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK 617
+GTFGYL+PEYAQSGQITEKADVYS GVVLVELITGRKAMD+NRP+GQQCLTEWARPLL+
Sbjct: 558 IGTFGYLSPEYAQSGQITEKADVYSFGVVLVELITGRKAMDINRPKGQQCLTEWARPLLE 617
Query: 618 RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNS 674
+ AI EL+DPRLRNCYSE+EV GML CASLCI++DPHSRPRMSQVLR+LEGDI MNS
Sbjct: 618 QCAIDELVDPRLRNCYSEKEVSGMLHCASLCIQRDPHSRPRMSQVLRILEGDIFMNS 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128638|ref|XP_002329053.1| predicted protein [Populus trichocarpa] gi|222839724|gb|EEE78047.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2414), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/657 (70%), Positives = 533/657 (81%), Gaps = 6/657 (0%)
Query: 23 SKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTS 82
SKEIP++ALVWALTHVVQPGD I LLVV+P + +++WGF RF DCA GH+ S SG +
Sbjct: 24 SKEIPKTALVWALTHVVQPGDCITLLVVVPSHAPGRRLWGFPRFAADCANGHRKSHSGAT 83
Query: 83 SDQKDDIVDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQL 142
SDQ+ DI DSCSQM+ QL +VYDP KI V++KIVSGSP G V+ EAKKAQ+NWV+LDKQL
Sbjct: 84 SDQRCDITDSCSQMILQLHDVYDPNKINVKIKIVSGSPCGAVSAEAKKAQANWVVLDKQL 143
Query: 143 KHEKKCCMEELQCNVVVMKRSQPKVLRLNLVASPTMKSQVARSETFSLEVSPKYLKSKHD 202
KHE+K CMEELQCN+VVMKRSQ KVLRLNLV + V S + E S ++ K+K++
Sbjct: 144 KHEEKRCMEELQCNIVVMKRSQAKVLRLNLVGTSKEPEVVGPSPSKLNEASEQHSKNKNN 203
Query: 203 DPYMMKGPFVTPASSPEQESLLTATDVGTSSISSSDPGT----FSEICENLKKECSLVSE 258
++GP VTP SSPE + T T+ GTSS+SS DPG SE LKKE LV +
Sbjct: 204 SSGSIRGPVVTPTSSPELGTPFTVTEAGTSSVSS-DPGASPFFISETNGELKKEEPLVIK 262
Query: 259 ERQDRFGPDSDSDCEVLCLPSTSSNHDPWMAESLSPREEFLKLLEGSSERTNDPSLTSAY 318
E +D SD+D E L L S S +PW+ E L + + +E SS+R+N + TS
Sbjct: 263 ENRDLDESSSDTDTEHLSLAS-SLRFEPWVGELLGSHIKSSRHVEESSQRSNCMAQTSTT 321
Query: 319 EFLLEKLSTLNREPDIGVLNYKLDLKISKSVREAVSLSRNKPPGPPPLCSICQHKAPVFG 378
E LLEK S L+R+ IG+ NY+ DL +S +VREA+SLSRN PPGPPPLCSICQHKAPVFG
Sbjct: 322 EALLEKFSKLDRQTGIGMSNYRTDLDLSVNVREAISLSRNTPPGPPPLCSICQHKAPVFG 381
Query: 379 NPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFC 438
PPRWF+YAELELAT FS+ANFLAEGGFGSVHRGVLPDGQ VAVKQ+KLASSQGD EFC
Sbjct: 382 KPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDVEFC 441
Query: 439 SEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIA 498
SEVEVLSCAQHRNVVMLIGFC+ED RRLLVYEYICNGSLDSHLYG R+PLEWSAR+KIA
Sbjct: 442 SEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGHHREPLEWSARQKIA 501
Query: 499 VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL 558
VGAARGLRYLHEECRVGCIVHRDMRPNNIL+THDFEPLVGDFGLARWQPDGD GVETRV+
Sbjct: 502 VGAARGLRYLHEECRVGCIVHRDMRPNNILITHDFEPLVGDFGLARWQPDGDTGVETRVI 561
Query: 559 GTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR 618
GTFGYLAPEYA++GQITEKADVYS GVVLVEL+TGRKA+DLNRP+GQQCLTEWARPLL+
Sbjct: 562 GTFGYLAPEYAETGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE 621
Query: 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSK 675
+AI ELIDP+L N YSE+EVY ML AS+CIR+DPHSRPRMSQVLR+LEGD+ +++
Sbjct: 622 YAIVELIDPQLGNHYSEQEVYCMLHAASICIRRDPHSRPRMSQVLRILEGDMHVDTN 678
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351724979|ref|NP_001235029.1| protein kinase family protein [Glycine max] gi|223452396|gb|ACM89525.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 924 bits (2388), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/656 (68%), Positives = 540/656 (82%), Gaps = 11/656 (1%)
Query: 23 SKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTS 82
S++I R+ALVWALTHVVQPGD IKLLV++P LSS+K++WG SRFT DCA+ H S GT
Sbjct: 31 SRDISRTALVWALTHVVQPGDCIKLLVLIPTLSSNKRVWGLSRFTTDCASSHWRSSLGTI 90
Query: 83 SDQKDDIVDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQL 142
SDQK+ I +SCSQ++ QL + YDPEKIK+RVKI+SGS G V+ EAK+ QS+WVILDK+L
Sbjct: 91 SDQKEVITNSCSQLVLQLHDFYDPEKIKIRVKILSGSLCGAVSAEAKRVQSSWVILDKKL 150
Query: 143 KHEKKCCMEELQCNVVVMKRSQPKVLRLNLVASPTMKSQVARSETFSLEVSPKYLKSKHD 202
KHEKK CME+L CN+V+MKRS+PK+LRLNL +S M+ +A T + K K +
Sbjct: 151 KHEKKYCMEQLHCNIVIMKRSRPKILRLNLNSSSKMELNMACPLTLT-----KNFKDNSE 205
Query: 203 DPYMMKGPFVTPASSPEQES-LLTATDVGTSSISSSDPGTF----SEICENLKKECSLVS 257
+++GP VTPASSPEQ S LLTATD+GTSSISSSDP T S+ E K+ + V
Sbjct: 206 HADIIRGPAVTPASSPEQGSPLLTATDIGTSSISSSDPATSPFFRSDNNERQKRGFTFVH 265
Query: 258 EERQDRFGPDSDSDCEVLCLPSTSSNHDPWMAESLSPREEFLKLLEGSSERTNDPSLTSA 317
E + +SDS+ E L + S SS PW+A + +F + E + +R++D +L +A
Sbjct: 266 EGLTNLEDIESDSESEKLSMSSKSSYFQPWIANVICMDGDFSRH-ENNMQRSSDKTLATA 324
Query: 318 YEFLLEKLSTLNREPDIGVLNYKLDLKISKSVREAVSLSRNKPPGPPPLCSICQHKAPVF 377
YE LL+K S L+++P +G+LN KLD+ +SKSVREA+SL++ PGPPPLCSICQHKAPVF
Sbjct: 325 YEALLQKFSKLDQDPILGMLNCKLDVNLSKSVREAISLAKTSAPGPPPLCSICQHKAPVF 384
Query: 378 GNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEF 437
GNPPRWFT++EL+LAT FS+ANFLAEGGFGSVHRGVLPDGQV+AVKQYKLAS+QGD+EF
Sbjct: 385 GNPPRWFTFSELQLATGGFSQANFLAEGGFGSVHRGVLPDGQVIAVKQYKLASTQGDKEF 444
Query: 438 CSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKI 497
CSEVEVLSCAQHRNVVMLIGFCV+DGRRLLVYEYICNGSLDSHLY R ++ LEWSAR+KI
Sbjct: 445 CSEVEVLSCAQHRNVVMLIGFCVDDGRRLLVYEYICNGSLDSHLYRRKQNVLEWSARQKI 504
Query: 498 AVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV 557
AVGAARGLRYLHEECRVGCIVHRDMRPNNIL+THDFE LVGDFGLARWQPDGDMGVETRV
Sbjct: 505 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEALVGDFGLARWQPDGDMGVETRV 564
Query: 558 LGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK 617
+GTFGYLAPEYAQSGQITEKADVYS G+VL+EL+TGRKA+D+NRP+GQQCL+EWARPLL+
Sbjct: 565 IGTFGYLAPEYAQSGQITEKADVYSFGIVLLELVTGRKAVDINRPKGQQCLSEWARPLLE 624
Query: 618 RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMN 673
+ AI +L+DP LRNCY ++EVY MLQC+SLCI +DPH RPRMSQVLRMLE I++
Sbjct: 625 KQAIYKLVDPSLRNCYVDQEVYRMLQCSSLCIGRDPHLRPRMSQVLRMLEDRIVIT 680
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 678 | ||||||
| TAIR|locus:2165041 | 669 | AT5G56790 [Arabidopsis thalian | 0.970 | 0.983 | 0.659 | 2e-230 | |
| TAIR|locus:2091511 | 753 | AT3G13690 [Arabidopsis thalian | 0.952 | 0.857 | 0.643 | 8.5e-223 | |
| TAIR|locus:2035686 | 676 | AT1G55200 [Arabidopsis thalian | 0.730 | 0.732 | 0.637 | 1.8e-165 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.461 | 0.483 | 0.493 | 2.8e-82 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.443 | 0.461 | 0.509 | 6.5e-81 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.433 | 0.414 | 0.514 | 2.8e-80 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.429 | 0.405 | 0.489 | 4.5e-80 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.457 | 0.437 | 0.490 | 7.4e-80 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.438 | 0.436 | 0.496 | 2e-79 | |
| TAIR|locus:2093999 | 700 | PERK6 "proline-rich extensin-l | 0.451 | 0.437 | 0.455 | 3.9e-79 |
| TAIR|locus:2165041 AT5G56790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2223 (787.6 bits), Expect = 2.0e-230, P = 2.0e-230
Identities = 450/682 (65%), Positives = 526/682 (77%)
Query: 1 MKQKGGFSE--LXXXXXXXXXXXXSKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSK 58
MKQKG F E + SKEIP++AL+W LTHVVQPGD I+LLVV+P +SK
Sbjct: 1 MKQKG-FKERGVVVGKKVMVAVRASKEIPKAALLWTLTHVVQPGDRIRLLVVVPSNYTSK 59
Query: 59 KIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSCSQMMRQLQEVYDPEKIKVRVKIVSG 118
KIWGFSRFT+DCA+G+ L+GT+SD+KDDI +SCSQMM QL VYD EKI VR+KIV
Sbjct: 60 KIWGFSRFTSDCASGYGRFLAGTNSDRKDDIHESCSQMMFQLHNVYDAEKINVRIKIVFA 119
Query: 119 SPYGVVAVEAKKAQSNWVILDKQLKHEKKCCMEELQCNVVVMKRSQPKVLRLNLVASPTM 178
S GV+A EAKK+ SNWVILD+ LK+EKKCC+E+L+CN+VV+K+SQPKVLRLNLV +
Sbjct: 120 SLDGVIAAEAKKSNSNWVILDRGLKYEKKCCIEQLECNLVVIKKSQPKVLRLNLVKNADT 179
Query: 179 KSQVARSETFSLEVSPKYLKSKHDDPYMMKGPFVTPASSPEQESLLTATDVGTSSISSSD 238
+ A S S V + +S ++ PFVTPASSP+QE + + TD+GTSSISSSD
Sbjct: 180 EHPEAISRLASKSVESR--RSSRTGK-KLREPFVTPASSPDQE-VSSHTDIGTSSISSSD 235
Query: 239 PGT--F--SEICENLKKECSLVSEERQDRFGPDSDSDCEV---LCLPSTSSNHDPWMAES 291
G F S + E LKKE V++ + F DSDSD E L + S+SS H A+
Sbjct: 236 AGASPFLASRVFEGLKKENLWVNDGSKSFFESDSDSDGEKWSPLSMASSSS-HPVTTADL 294
Query: 292 LSPREEFLKLLEGSSERTNDPSLTSAYEFLLEKLSTLNREPDIGVLNYKLDLKISKSVRE 351
LSP + S T P + F + +L+ +EP+ G K D ++KSVRE
Sbjct: 295 LSPSGDL------SKAHTETPRKS---RFAVLRLALSRKEPEAGKEIRKPDSCLNKSVRE 345
Query: 352 AVSLSRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVH 411
VSLSR PGPPPLC+ICQHKAP FGNPPRWFTY+ELE AT FS+ +FLAEGGFGSVH
Sbjct: 346 VVSLSRKPAPGPPPLCTICQHKAPKFGNPPRWFTYSELETATKGFSKGSFLAEGGFGSVH 405
Query: 412 RGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471
G LPDGQ++AVKQYK+AS+QGD+EFCSEVEVLSCAQHRNVVMLIG CVEDG+RLLVYEY
Sbjct: 406 LGTLPDGQIIAVKQYKIASTQGDREFCSEVEVLSCAQHRNVVMLIGLCVEDGKRLLVYEY 465
Query: 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH 531
ICNGSL SHLYG R+PL WSAR+KIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL+TH
Sbjct: 466 ICNGSLHSHLYGMGREPLGWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH 525
Query: 532 DFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELI 591
DFEPLVGDFGLARWQP+GD GVETRV+GTFGYLAPEYAQSGQITEKADVYS GVVLVELI
Sbjct: 526 DFEPLVGDFGLARWQPEGDKGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELI 585
Query: 592 TGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRK 651
TGRKAMD+ RP+GQQCLTEWARPLL++ AI EL+DPRL NCY E+EVY M CA LCIR+
Sbjct: 586 TGRKAMDIKRPKGQQCLTEWARPLLQKQAINELLDPRLMNCYCEQEVYCMALCAYLCIRR 645
Query: 652 DPHSRPRMSQVLRMLEGDILMN 673
DP+SRPRMSQVLRMLEGD++MN
Sbjct: 646 DPNSRPRMSQVLRMLEGDVVMN 667
|
|
| TAIR|locus:2091511 AT3G13690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2151 (762.2 bits), Expect = 8.5e-223, P = 8.5e-223
Identities = 428/665 (64%), Positives = 515/665 (77%)
Query: 23 SKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSR----FTNDCATGHKSSL 78
S+EIP++AL+WALTHVVQPGD I L+VV+P +S +K+WGF++ F DCA+GH+ S
Sbjct: 29 SREIPKTALIWALTHVVQPGDCITLIVVVPSHNSGRKLWGFTKSFPMFAGDCASGHRKSH 88
Query: 79 SGTSSDQKDDIVDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVIL 138
S + K D+ D+CSQM+ QL +VYDP KI V++KIVSGSP G VA E+KKAQ+NWV++
Sbjct: 89 SEALPEIKSDLTDTCSQMILQLHDVYDPNKINVKIKIVSGSPCGAVAAESKKAQANWVVM 148
Query: 139 DKQLKHEKKCCMEELQCNVVVMKRSQPKVLRLNLVASPTMKSQVARSETFSLEVSPKYLK 198
DK LK E+K CM+ELQCN+VVMKRSQ KVLRLNLV SP K + L P+
Sbjct: 149 DKHLKQEEKRCMDELQCNIVVMKRSQAKVLRLNLVGSP--KKDAGKE--CPLPSGPEAAS 204
Query: 199 SKH--DDPYMM---KGPFVTPASSPEQESLLTATDVGTSSISSSDPGT--FSEICEN--L 249
KH + ++ +G VTP SSPE + T+T+ GTSS+SSSD GT F + N +
Sbjct: 205 EKHSKNTKGLLDADRGLPVTPTSSPELGTPFTSTEAGTSSVSSSDLGTSPFFTLGMNGYM 264
Query: 250 KKECSLVSEERQDRFGPDSDSDCEVLCLPSTSSNHDPWMAESLSP-REEFLKLLEGSSER 308
KK+ +LV +E S+++ E L STS PW++E + R + E +
Sbjct: 265 KKDGALVIKENDGLDDSGSETESENQSLASTSMRFQPWISEYIGTHRHSSQEAEESLLWK 324
Query: 309 TNDPSLTSAYEFLLEKLSTLNREPDIGVLNYKLDLKISKSVREAVSLSRNKPPGPPPLCS 368
+D + S + LLEK S L+ E + + ++DL+ S +VR+A+SLSR+ PPGPPPLCS
Sbjct: 325 NDDRAQISTTKALLEKFSKLDVEVGLSS-SRRMDLEFSGNVRDAISLSRSAPPGPPPLCS 383
Query: 369 ICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKL 428
ICQHKAPVFG PPR FTYAELELAT FS+ANFLAEGG+GSVHRGVLP+GQVVAVKQ+KL
Sbjct: 384 ICQHKAPVFGKPPRLFTYAELELATGGFSQANFLAEGGYGSVHRGVLPEGQVVAVKQHKL 443
Query: 429 ASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDP 488
ASSQGD EFCSEVEVLSCAQHRNVVMLIGFC+ED RRLLVYEYICNGSLDSHLYGR ++
Sbjct: 444 ASSQGDVEFCSEVEVLSCAQHRNVVMLIGFCIEDSRRLLVYEYICNGSLDSHLYGRQKET 503
Query: 489 LEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548
LEW AR+KIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL+THD EPLVGDFGLARWQPD
Sbjct: 504 LEWPARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDNEPLVGDFGLARWQPD 563
Query: 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCL 608
G+MGV+TRV+GTFGYLAPEYAQSGQITEKADVYS GVVLVEL+TGRKA+D+ RP+GQQCL
Sbjct: 564 GEMGVDTRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAIDITRPKGQQCL 623
Query: 609 TEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668
TEWARPLL+ +AI ELIDPRL N + E EV ML ASLCIR+DPH RPRMSQVLR+LEG
Sbjct: 624 TEWARPLLEEYAIDELIDPRLGNRFVESEVICMLHAASLCIRRDPHLRPRMSQVLRILEG 683
Query: 669 DILMN 673
D++M+
Sbjct: 684 DMIMD 688
|
|
| TAIR|locus:2035686 AT1G55200 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1610 (571.8 bits), Expect = 1.8e-165, P = 1.8e-165
Identities = 327/513 (63%), Positives = 394/513 (76%)
Query: 168 LRLNLVASPTMKSQVARSETF-SLEVSPKYLKSKHDDPYM--MKGPFVT-PASSPEQESL 223
L+ N+VA +++V R S P+ K+ + + +K T P SSPE E+
Sbjct: 155 LQCNIVAMKRSEAKVLRLNLVGSSTKEPELASEKNKNRLLDSVKAVVTTTPMSSPEVETS 214
Query: 224 LTATDVGTSSISSSDPGTFSEI-CENLKKECSLVSEERQDRFGPDSDSDCEVLCLPSTSS 282
T T+ TSS+SSSD GT S + ++K+ +LV +E + DSDS+ E L LPS S
Sbjct: 215 FTGTEAWTSSVSSSDLGTSSPVFTAEVRKDETLVVKENES----DSDSESENLSLPSLSK 270
Query: 283 NHDPWMAESLSPREEFLKLLEGSSERTNDPSL-TSAYEFLLEKLSTLNREPDIGVLNYKL 341
PW++E LS + + E S R +D ++ S + LLEK+S L+ + + + +
Sbjct: 271 RFQPWISEYLSTH--CVSMQE--STRGDDKAVQVSTKKALLEKISKLDEGEEAAMSSKRK 326
Query: 342 DLK-ISKSVREAVSLSRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEAN 400
DL+ S ++R +LSRN PP PPLCSICQHKAPVFG PPR+F+Y ELELATN FS AN
Sbjct: 327 DLEEYSGTLR---ALSRNAPPVSPPLCSICQHKAPVFGKPPRFFSYKELELATNGFSRAN 383
Query: 401 FLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
FLAEGGFGSVHRGVLP+GQ+VAVKQ+K+AS+QGD EFCSEVEVLSCAQHRNVVMLIGFC+
Sbjct: 384 FLAEGGFGSVHRGVLPEGQIVAVKQHKVASTQGDVEFCSEVEVLSCAQHRNVVMLIGFCI 443
Query: 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
ED RRLLVYEYICNGSLDSHLYGR +D L W AR+KIAVGAARGLRYLHEECRVGCIVHR
Sbjct: 444 EDTRRLLVYEYICNGSLDSHLYGRHKDTLGWPARQKIAVGAARGLRYLHEECRVGCIVHR 503
Query: 521 DMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADV 580
DMRPNNIL+THD+EPLVGDFGLARWQPDG++GV+TRV+GTFGYLAPEYAQSGQITEKADV
Sbjct: 504 DMRPNNILITHDYEPLVGDFGLARWQPDGELGVDTRVIGTFGYLAPEYAQSGQITEKADV 563
Query: 581 YSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYG 640
YS GVVL+ELITGRKAMD+ RP+GQQCLTEWAR LL+ +A+ EL+DPRL YSE +V
Sbjct: 564 YSFGVVLIELITGRKAMDIYRPKGQQCLTEWARSLLEEYAVEELVDPRLEKRYSETQVIC 623
Query: 641 MLQCASLCIRKDPHSRPRMSQVLRMLEGDILMN 673
M+ ASLCIR+DPH RPRMSQVLR+LEGD+LMN
Sbjct: 624 MIHTASLCIRRDPHLRPRMSQVLRLLEGDMLMN 656
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 805 (288.4 bits), Expect = 2.8e-82, Sum P(2) = 2.8e-82
Identities = 160/324 (49%), Positives = 220/324 (67%)
Query: 358 NKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPD 417
++P PPP + V G FTY EL ATN FSEAN L +GGFG VH+GVLP
Sbjct: 243 DRPVLPPPSPGL------VLGFSKSTFTYEELARATNGFSEANLLGQGGFGYVHKGVLPS 296
Query: 418 GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSL 477
G+ VAVKQ K+ S QG++EF +EVE++S HR++V L+G+C+ +RLLVYE++ N +L
Sbjct: 297 GKEVAVKQLKVGSGQGEREFQAEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNL 356
Query: 478 DSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLV 537
+ HL+G R +EWS R KIA+G+A+GL YLHE+C I+HRD++ +NIL+ FE V
Sbjct: 357 ELHLHGEGRPTMEWSTRLKIALGSAKGLSYLHEDCNPK-IIHRDIKASNILIDFKFEAKV 415
Query: 538 GDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAM 597
DFGLA+ D + V TRV+GTFGYLAPEYA SG++TEK+DV+S GVVL+ELITGR+ +
Sbjct: 416 ADFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPV 475
Query: 598 DLNRPRGQQCLTEWARPLLKRHAI-GE---LIDPRLRNCYSEREVYGMLQCASLCIRKDP 653
D N L +WARPLL R + G+ L D ++ N Y E+ M+ CA+ C+R
Sbjct: 476 DANNVYVDDSLVDWARPLLNRASEQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSA 535
Query: 654 HSRPRMSQVLRMLEGDILMNSKDD 677
RPRMSQ++R LEG++ ++ ++
Sbjct: 536 RRRPRMSQIVRALEGNVSLSDLNE 559
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 794 (284.6 bits), Expect = 6.5e-81, Sum P(2) = 6.5e-81
Identities = 156/306 (50%), Positives = 213/306 (69%)
Query: 376 VFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQ 435
V G FTY EL ATN FSEAN L +GGFG VH+G+LP G+ VAVKQ K S QG++
Sbjct: 260 VLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGER 319
Query: 436 EFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR 495
EF +EVE++S HR++V LIG+C+ +RLLVYE++ N +L+ HL+G+ R +EWS R
Sbjct: 320 EFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRL 379
Query: 496 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET 555
KIA+G+A+GL YLHE+C I+HRD++ +NIL+ FE V DFGLA+ D + V T
Sbjct: 380 KIALGSAKGLSYLHEDCNPK-IIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVST 438
Query: 556 RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615
RV+GTFGYLAPEYA SG++TEK+DV+S GVVL+ELITGR+ +D N L +WARPL
Sbjct: 439 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPL 498
Query: 616 LKRHAI-GE---LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671
L R + G+ L D ++ N Y E+ M+ CA+ C+R RPRMSQ++R LEG++
Sbjct: 499 LNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVS 558
Query: 672 MNSKDD 677
++ ++
Sbjct: 559 LSDLNE 564
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 786 (281.7 bits), Expect = 2.8e-80, Sum P(2) = 2.8e-80
Identities = 155/301 (51%), Positives = 210/301 (69%)
Query: 376 VFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQ 435
V G+ FTY EL T FS+ N L EGGFG V++G L DG++VAVKQ K+ S QGD+
Sbjct: 333 VMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDR 392
Query: 436 EFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR 495
EF +EVE++S HR++V L+G+C+ D RLL+YEY+ N +L+ HL+G+ R LEW+ R
Sbjct: 393 EFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRV 452
Query: 496 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET 555
+IA+G+A+GL YLHE+C I+HRD++ NIL+ +FE V DFGLA+ V T
Sbjct: 453 RIAIGSAKGLAYLHEDCHPK-IIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVST 511
Query: 556 RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615
RV+GTFGYLAPEYAQSG++T+++DV+S GVVL+ELITGRK +D +P G++ L EWARPL
Sbjct: 512 RVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPL 571
Query: 616 LKRHA----IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML--EGD 669
L + EL+D RL Y E EV+ M++ A+ C+R RPRM QV+R L EGD
Sbjct: 572 LHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGD 631
Query: 670 I 670
+
Sbjct: 632 M 632
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 759 (272.2 bits), Expect = 4.5e-80, Sum P(3) = 4.5e-80
Identities = 145/296 (48%), Positives = 207/296 (69%)
Query: 376 VFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQ 435
V G FTY EL T F ++ + EGGFG V++G+L +G+ VA+KQ K S++G +
Sbjct: 350 VIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYR 409
Query: 436 EFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR 495
EF +EVE++S HR++V L+G+C+ + R L+YE++ N +LD HL+G++ LEWS R
Sbjct: 410 EFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRRV 469
Query: 496 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET 555
+IA+GAA+GL YLHE+C I+HRD++ +NIL+ +FE V DFGLAR + T
Sbjct: 470 RIAIGAAKGLAYLHEDCHPK-IIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHIST 528
Query: 556 RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615
RV+GTFGYLAPEYA SG++T+++DV+S GVVL+ELITGRK +D ++P G++ L EWARP
Sbjct: 529 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPR 588
Query: 616 L----KRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
L ++ I E++DPRL N Y E EVY M++ A+ C+R RPRM QV+R L+
Sbjct: 589 LIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALD 644
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 784 (281.0 bits), Expect = 7.4e-80, Sum P(2) = 7.4e-80
Identities = 156/318 (49%), Positives = 212/318 (66%)
Query: 355 LSRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGV 414
+ + P G Q ++ GN F+Y EL ATN FS+ N L EGGFG V++G+
Sbjct: 336 MQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGI 395
Query: 415 LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474
LPDG+VVAVKQ K+ QGD+EF +EVE LS HR++V ++G C+ RRLL+Y+Y+ N
Sbjct: 396 LPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSN 455
Query: 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE 534
L HL+G ++ L+W+ R KIA GAARGL YLHE+C I+HRD++ +NIL+ +F+
Sbjct: 456 NDLYFHLHG-EKSVLDWATRVKIAAGAARGLAYLHEDCHPR-IIHRDIKSSNILLEDNFD 513
Query: 535 PLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
V DFGLAR D + + TRV+GTFGY+APEYA SG++TEK+DV+S GVVL+ELITGR
Sbjct: 514 ARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 573
Query: 595 KAMDLNRPRGQQCLTEWARPLLKRHAI-----GELIDPRLRNCYSEREVYGMLQCASLCI 649
K +D ++P G + L EWARPL+ HAI L DP+L Y E E++ M++ A C+
Sbjct: 574 KPVDTSQPLGDESLVEWARPLIS-HAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACV 632
Query: 650 RKDPHSRPRMSQVLRMLE 667
R RPRM Q++R E
Sbjct: 633 RHLATKRPRMGQIVRAFE 650
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 775 (277.9 bits), Expect = 2.0e-79, Sum P(2) = 2.0e-79
Identities = 152/306 (49%), Positives = 210/306 (68%)
Query: 379 NPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFC 438
N WF+Y EL T+ FSE N L EGGFG V++GVL DG+ VAVKQ K+ SQG++EF
Sbjct: 322 NQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFK 381
Query: 439 SEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIA 498
+EVE++S HR++V L+G+C+ + RLLVY+Y+ N +L HL+ R + W R ++A
Sbjct: 382 AEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVA 441
Query: 499 VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG--VETR 556
GAARG+ YLHE+C I+HRD++ +NIL+ + FE LV DFGLA+ + D+ V TR
Sbjct: 442 AGAARGIAYLHEDCHPR-IIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTR 500
Query: 557 VLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLL 616
V+GTFGY+APEYA SG+++EKADVYS GV+L+ELITGRK +D ++P G + L EWARPLL
Sbjct: 501 VMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLL 560
Query: 617 ----KRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672
+ EL+DPRL + E++ M++ A+ C+R RP+MSQV+R L D L
Sbjct: 561 GQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRAL--DTLE 618
Query: 673 NSKDDT 678
+ D T
Sbjct: 619 EATDIT 624
|
|
| TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 750 (269.1 bits), Expect = 3.9e-79, Sum P(3) = 3.9e-79
Identities = 145/318 (45%), Positives = 209/318 (65%)
Query: 360 PPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQ 419
P PPP H + G FTY EL AT FS++ L +GGFG VH+G+LP+G+
Sbjct: 307 PSVPPP------HPSVALGFNKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGK 360
Query: 420 VVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDS 479
+AVK K S QG++EF +EV+++S HR +V L+G+C+ G+R+LVYE++ N +L+
Sbjct: 361 EIAVKSLKAGSGQGEREFQAEVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEF 420
Query: 480 HLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGD 539
HL+G+ L+W R KIA+G+A+GL YLHE+C I+HRD++ +NIL+ FE V D
Sbjct: 421 HLHGKSGKVLDWPTRLKIALGSAKGLAYLHEDCHPR-IIHRDIKASNILLDESFEAKVAD 479
Query: 540 FGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDL 599
FGLA+ D V TR++GTFGYLAPEYA SG++T+++DV+S GV+L+EL+TGR+ +DL
Sbjct: 480 FGLAKLSQDNVTHVSTRIMGTFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDL 539
Query: 600 NRPRGQQCLTEWARPLLKRHA----IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHS 655
+ L +WARP+ A EL+DPRL N Y E+ M+ CA+ +R
Sbjct: 540 TGEM-EDSLVDWARPICLNAAQDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARR 598
Query: 656 RPRMSQVLRMLEGDILMN 673
RP+MSQ++R LEGD ++
Sbjct: 599 RPKMSQIVRALEGDATLD 616
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 678 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-04 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 6e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 7e-44
Identities = 84/289 (29%), Positives = 124/289 (42%), Gaps = 52/289 (17%)
Query: 402 LAEGGFGSVHRGVLPDGQ----VVAVKQYKLASSQGDQ-EFCSEVEVLSCAQHRNVVMLI 456
L EG FG V++G L VAVK K +S+ ++ +F E V+ H NVV L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHL-------YGRDRDPLEWSARRKIAVGAARGLRYLH 509
G C E+ LV EY+ G L +L ++ L A+ A+G+ YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET-------RVLGTFG 562
+ VHRD+ N LV D + DFGL+R D D + R
Sbjct: 123 SK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR------ 172
Query: 563 YLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQ----CLTEWARPLLKR 618
++APE + G T K+DV+S GV+L E+ T G E L++
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFT----------LGATPYPGLSNEEVLEYLRK 222
Query: 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
G + P+ C E+Y ++ C + DP RP S+++ LE
Sbjct: 223 ---GYRL-PKPEYCPD--ELYELMLS---CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 92/277 (33%), Positives = 128/277 (46%), Gaps = 38/277 (13%)
Query: 402 LAEGGFGSVHRGVL-----PDGQVVAVKQYKL-ASSQGDQEFCSEVEVLSCAQHRNVVML 455
L EG FG V++G L VAVK K AS Q +EF E ++ H NVV L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRD-RDPLEWSARRKIAVGAARGLRYLHEECRV 514
+G C E+ +V EY+ G L S+L R R L S A+ ARG+ YL +
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLESK--- 121
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQI 574
+HRD+ N LV + + DFGL+R D D + ++APE + G+
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180
Query: 575 TEKADVYSLGVVLVELITGRKAMDLNRPRGQQ----CLTEWARPLLKRHAIGELIDPRLR 630
T K+DV+S GV+L E+ T G+Q E LK G + P+
Sbjct: 181 TSKSDVWSFGVLLWEIFT----------LGEQPYPGMSNEEVLEYLKN---GYRL-PQPP 226
Query: 631 NCYSEREVY-GMLQCASLCIRKDPHSRPRMSQVLRML 666
NC E+Y MLQ C +DP RP S+++ +L
Sbjct: 227 NC--PPELYDLMLQ----CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 86/276 (31%), Positives = 125/276 (45%), Gaps = 35/276 (12%)
Query: 402 LAEGGFGSVHRGVL-----PDGQVVAVKQYKL-ASSQGDQEFCSEVEVLSCAQHRNVVML 455
L EG FG V++G L VAVK K AS Q +EF E ++ H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
+G C E+ ++V EY+ G L +L L S A+ ARG+ YL +
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---- 122
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQIT 575
+HRD+ N LV + + DFGL+R D D ++APE + G+ T
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 576 EKADVYSLGVVLVELITGRKAMDLNRPRGQQ----CLTEWARPLLKRHAIGELIDPRLRN 631
K+DV+S GV+L E+ T G++ LK+ G + P+ N
Sbjct: 183 SKSDVWSFGVLLWEIFT----------LGEEPYPGMSNAEVLEYLKK---GYRL-PKPPN 228
Query: 632 CYSEREVY-GMLQCASLCIRKDPHSRPRMSQVLRML 666
C E+Y MLQ C +DP RP S+++ +L
Sbjct: 229 C--PPELYKLMLQ----CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 8e-43
Identities = 76/269 (28%), Positives = 114/269 (42%), Gaps = 58/269 (21%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVMLIGFC 459
L EGGFG+V+ G+ VA+K K S +E E+E+L H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVH 519
++ LV EY GSL L + L +I + GL YLH I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSN----GIIH 115
Query: 520 RDMRPNNILVTHD-FEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE-YAQSGQITEK 577
RD++P NIL+ D + + DFGL++ D + ++GT Y+APE G +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSK-LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 578 ADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSERE 637
+D++SLGV+L EL + L+++
Sbjct: 175 SDIWSLGVILYEL-------------------PELKDLIRK------------------- 196
Query: 638 VYGMLQCASLCIRKDPHSRPRMSQVLRML 666
++KDP RP ++L L
Sbjct: 197 ----------MLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 87/270 (32%), Positives = 124/270 (45%), Gaps = 29/270 (10%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQ--YKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGF 458
L G FG+V++ G++VAVK + S+ DQ E+ +L H N+V LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 459 CVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIV 518
+ LV EY G L +L PL +KIA+ RGL YLH G I+
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSN---G-II 120
Query: 519 HRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ-ITEK 577
HRD++P NIL+ + + DFGLA+ + T V GT Y+APE G K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK 179
Query: 578 ADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSERE 637
DV+SLGV+L EL+TG+ G+ L + I ++ P L + E +
Sbjct: 180 VDVWSLGVILYELLTGK-----PPFSGENILDQ-------LQLIRRILGPPLE--FDEPK 225
Query: 638 VYGMLQ-CASL---CIRKDPHSRPRMSQVL 663
+ L C+ KDP RP ++L
Sbjct: 226 WSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 6e-42
Identities = 80/270 (29%), Positives = 119/270 (44%), Gaps = 27/270 (10%)
Query: 400 NFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE-FCSEVEVLSCAQHRNVVMLIG 457
L EG FG V+ G++VA+K K + D+E E+++L +H N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 458 FCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCI 517
++ + LV EY G L L R R + + R L YLH + I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYLHSKG----I 118
Query: 518 VHRDMRPNNILVTHDFEPLVGDFGLAR-WQPDGDMGVETRVLGTFGYLAPEYAQSGQITE 576
VHRD++P NIL+ D + DFGLAR P + T +GT Y+APE +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYMAPEVLLGKGYGK 175
Query: 577 KADVYSLGVVLVELITGRKAMDLNRP-RGQQCLTEWARPLLKRHAIGELIDPRLRNCYSE 635
D++SLGV+L EL+TG+ P G L E + + K + P S
Sbjct: 176 AVDIWSLGVILYELLTGK------PPFPGDDQLLELFKKIGK----PKPPFPPPEWDISP 225
Query: 636 REVYGMLQCASLCIRKDPHSRPRMSQVLRM 665
E +++ + KDP R + L+
Sbjct: 226 -EAKDLIRK---LLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 1e-41
Identities = 83/276 (30%), Positives = 121/276 (43%), Gaps = 35/276 (12%)
Query: 402 LAEGGFGSVHRGVL-----PDGQVVAVKQYKL-ASSQGDQEFCSEVEVLSCAQHRNVVML 455
L EG FG V++G L VAVK K AS + +EF E ++ H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
+G C + +V EY+ G L L + + L ++A+ A+G+ YL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLESK---- 121
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL-----APEYAQ 570
VHRD+ N LVT + + DFGL+R D R G G L APE +
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSR---DIYEDDYYRKRGG-GKLPIKWMAPESLK 177
Query: 571 SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630
G+ T K+DV+S GV+L E+ T G+Q + + PR
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFT----------LGEQPYPGMSNEEVLELLEDGYRLPRPE 227
Query: 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666
NC E+Y ++ C DP RP S+++ L
Sbjct: 228 NC--PDELYELML---QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 86/281 (30%), Positives = 130/281 (46%), Gaps = 46/281 (16%)
Query: 400 NFLAEGGFGSVHRGVLPD-GQVVAVKQYKLA--SSQGDQEFCSEVEVLSCAQHRNVVMLI 456
L G FGSV+ + D G+++AVK +L+ S + + E+ +LS QH N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 457 GFCV-EDGRRLLVY-EYICNGSLDSHL--YGRDRDPLEWSAR---RKIAVGAARGLRYLH 509
G E+ L ++ EY+ GSL S L +G+ +P+ R R+I GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL----EGLAYLH 118
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR-VLGTFGYLAPEY 568
IVHRD++ NILV D + DFG A+ D + G T V GT ++APE
Sbjct: 119 SNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 569 AQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR-----PLLKRHAIGE 623
+ + AD++SLG ++E+ TG+ P W+ L +
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGK------PP--------WSELGNPMAALYKIGSSG 220
Query: 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
P + SE E L C+R+DP RP ++L+
Sbjct: 221 EP-PEIPEHLSE-EAKDFL---RKCLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 32/272 (11%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLA-SSQGDQEFC-SEVEVLSCAQHRNVVMLIGF 458
+ +G FG V+ DG++ +K+ L+ S+ ++E +EV++L H N++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 459 CVEDGRRLLVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
E G+ +V EY G L + ++ P V L+YLH +
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-K--- 123
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITE 576
I+HRD++P NI +T + +GDFG+++ + + V+GT YL+PE Q+
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTVVGTPYYLSPELCQNKPYNY 182
Query: 577 KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSE- 635
K+D++SLG VL EL T L P + L E A +LK P + + YS
Sbjct: 183 KSDIWSLGCVLYELCT------LKHPFEGENLLELALKILKGQY------PPIPSQYSSE 230
Query: 636 -RE-VYGMLQCASLCIRKDPHSRPRMSQVLRM 665
R V +LQ KDP RP ++Q+L+
Sbjct: 231 LRNLVSSLLQ-------KDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 76/277 (27%), Positives = 125/277 (45%), Gaps = 36/277 (12%)
Query: 396 FSEANFLAEGGFGSVHRG-VLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVM 454
F + +GGFG V++ G+ VA+K KL S + ++ +E+++L +H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHLYGRDR-DPLEWSARRKIAVGAARGLRYLHEECR 513
G ++ +V E+ GSL L ++ A + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIA--YVCKELLKGLEYLHSNG- 118
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM---GVETRVLGTFGYLAPEYAQ 570
I+HRD++ NIL+T D E + DFGL+ + ++GT ++APE
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLS-----AQLSDTKARNTMVGTPYWMAPEVIN 170
Query: 571 SGQITEKADVYSLGVVLVELITGR-KAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629
KAD++SLG+ +EL G+ +L + L + A P L
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-----------ALFKIATNGP--PGL 217
Query: 630 RN--CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
RN +S+ E L C++K+P RP Q+L+
Sbjct: 218 RNPEKWSD-EFKDFL---KKCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 40/280 (14%)
Query: 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQ--EFCSEVEVLSCAQHRN 451
+ + + G FG V++G+ L G VA+KQ L + + E+++L +H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 452 VVMLIGFCVEDGRRL-LVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAA---RGL 505
+V IG +E L ++ EY NGSL + +G + L +AV +GL
Sbjct: 61 IVKYIGS-IETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGL 112
Query: 506 RYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLA 565
YLHE+ ++HRD++ NIL T D + DFG+A + + + V+GT ++A
Sbjct: 113 AYLHEQG----VIHRDIKAANILTTKDGVVKLADFGVAT-KLNDVSKDDASVVGTPYWMA 167
Query: 566 PEYAQSGQITEKADVYSLGVVLVELITGRKAM-DLNRPRGQQCLTEWARPLLKRHAIGEL 624
PE + + +D++SLG ++EL+TG DLN P+ I +
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-------------PMAALFRIVQD 214
Query: 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
P L S E+ L C +KDP+ RP Q+L+
Sbjct: 215 DHPPLPEGISP-ELKDFLMQ---CFQKDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 2e-27
Identities = 76/280 (27%), Positives = 113/280 (40%), Gaps = 30/280 (10%)
Query: 401 FLAEGGFGSVHRGVLPDGQVVAVKQYKLA---SSQGDQEFCSEVEVL-SCAQHRNVVMLI 456
L EG FG V+ D ++VA+K S+ + F E+++L S N+V L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHL-YGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
F ++G LV EY+ GSL+ L + PL S I L YLH +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 516 CIVHRDMRPNNILVTHD-FEPLVGDFGLARWQPDGDMGVETR-----VLGTFGYLAPEYA 569
I+HRD++P NIL+ D + DFGLA+ PD +GT GY+APE
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 570 QS---GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626
+ +D++SLG+ L EL+TG + + A + +
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS-------ATSQTLKIILELPTP 233
Query: 627 PRLRNCYSEREVYGMLQCASL---CIRKDPHSRPRMSQVL 663
+ L + KDP +R S L
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 30/275 (10%)
Query: 396 FSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLAS-SQGDQEFC-SEVEVLSCAQHRNV 452
F N + +G FG V + V D +V A+KQ L+ ++ ++E E VL+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 453 VMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC 512
+ ++ G+ +V EY NG L L + PL + + GL +LH +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSG 572
I+HRD++ N+ + +GD G+A+ D T ++GT YL+PE +
Sbjct: 122 ----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDK 176
Query: 573 QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632
EK+DV++LGVVL E TG+ D N G LI +R
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQ-------------------GALILKIIRGV 217
Query: 633 Y---SEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
+ S+ + Q C+ KD RP Q+LR
Sbjct: 218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 9e-27
Identities = 83/273 (30%), Positives = 132/273 (48%), Gaps = 20/273 (7%)
Query: 398 EANFLAEGGFGSVHRGVLPDGQV-VAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLI 456
E N ++ G G+ ++G + VK+ +S E +++ L QH N+V LI
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEI-ADMGKL---QHPNIVKLI 749
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
G C + L++EYI +L L L W RRKIA+G A+ LR+LH C
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITE 576
+V ++ P I++ EP + R G + +T+ + Y+APE ++ ITE
Sbjct: 805 VVG-NLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITE 857
Query: 577 KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS-- 634
K+D+Y G++L+EL+TG+ D + EWAR + IDP +R S
Sbjct: 858 KSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916
Query: 635 EREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
+ E+ ++ A C DP +RP + VL+ LE
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 79/270 (29%), Positives = 123/270 (45%), Gaps = 27/270 (10%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYKLASSQGDQ-EFCSEVEVLSCAQHRNVVMLI 456
L G G V HR P G+++AVK +L ++ Q + E+++L +V
Sbjct: 9 LGAGNSGVVSKVLHR---PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
G +G + EY+ GSLD + + + KIAV +GL YLHE+ +
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--- 121
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITE 576
I+HRD++P+NILV + + DFG++ + + +T V GT Y+APE Q +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN-SLA-KTFV-GTSSYMAPERIQGNDYSV 178
Query: 577 KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN-CYSE 635
K+D++SLG+ L+EL TGR I PRL + +S
Sbjct: 179 KSDIWSLGLSLIELATGRFPYP-------PENDPPDGIFELLQYIVNEPPPRLPSGKFSP 231
Query: 636 REVYGMLQCASLCIRKDPHSRPRMSQVLRM 665
+LC+ KDP RP ++L
Sbjct: 232 D----FQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 24/228 (10%)
Query: 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD--QEFCSEVEVLSCAQHRN 451
R+ N + G FG V+ V L G+++AVK+ ++ + +E E++VL +H N
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHL-YGRDRDPLEWSARRKIAVGAARGLRYLHE 510
+V G V + + EY G+L+ L +GR D R + GL YLH
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEH---VIRVYTLQLLEGLAYLHS 117
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA-RWQPDGDMGVET--RVLGTFGYLAPE 567
IVHRD++P NI + H+ +GDFG A + + + E + GT Y+APE
Sbjct: 118 HG----IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 568 YAQSGQITEK---ADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWA 612
G+ AD++SLG V++E+ TG+ RP + E+
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGK------RP-WSELDNEFQ 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 87/288 (30%), Positives = 132/288 (45%), Gaps = 43/288 (14%)
Query: 402 LAEGGFGSVHRG----VLPDGQ--VVAVKQYK-LASSQGDQEFCSEVEVLSCAQHRNVVM 454
L EG FG V G + P+ +VAVK K AS+ ++F E E+L+ QH N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRD------------PLEWSARRKIAVGAA 502
G C E ++V+EY+ +G L+ L D L S +IAV A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD-MGVETRVLGTF 561
G+ YL + VHRD+ N LV +D +GDFG++R D V +
Sbjct: 133 SGMVYLASQ----HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 562 GYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKA-MDLNRPRGQQCLTEWARPLLKRH 619
++ PE + T ++DV+S GVVL E+ T G++ L+ +C+T+ LL+R
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ--GRLLQR- 245
Query: 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
P R C EVY ++ C ++DP R + + L+
Sbjct: 246 -------P--RTC--PSEVYDIMLG---CWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 63/194 (32%), Positives = 99/194 (51%), Gaps = 15/194 (7%)
Query: 404 EGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG 463
+G FG V G GQ VAVK K S+ F +E V++ +H N+V L+G ++
Sbjct: 16 KGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQGN 73
Query: 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMR 523
+V EY+ GSL +L R R + + + A+ G+ YL E+ VHRD+
Sbjct: 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK----NFVHRDLA 129
Query: 524 PNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF--GYLAPEYAQSGQITEKADVY 581
N+LV+ D V DFGLA+ + G ++ G + APE + + + K+DV+
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAK---EASQGQDS---GKLPVKWTAPEALREKKFSTKSDVW 183
Query: 582 SLGVVLVELIT-GR 594
S G++L E+ + GR
Sbjct: 184 SFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 88/288 (30%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 402 LAEGGFGSV---HRGVLPDGQ--VVAVKQYKLASSQGDQ---EFCSEVEVLSCAQHRNVV 453
L EG FG V L D VAVK L S +Q +F E+E+L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKS--LNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 454 MLIGFCVEDGRR--LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEE 511
G C + G R L+ EY+ +GSL +L R RD + + +G+ YL +
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD---MGVETRVLGTFGYLAPEY 568
I HRD+ NILV + + DFGLA+ P+ E F Y APE
Sbjct: 129 ---RYI-HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 569 AQSGQITEKADVYSLGVVLVELIT-GRK--------AMDLNRPRGQQCLTEWARPLLKRH 619
++ + + +DV+S GV L EL T G + +GQ +T LLK
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE-LLKE- 241
Query: 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
GE + PR +C EVY +++ LC +P RP + ++ +++
Sbjct: 242 --GERL-PRPPSCPD--EVYDLMK---LCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 22/267 (8%)
Query: 401 FLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGF 458
L +G G V++ P G++ A+K+ + + ++ E++ L + VV G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 459 CVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIV 518
++G +V EY+ GSL L + + IA +GL YLH + I+
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYLHTKRH---II 122
Query: 519 HRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKA 578
HRD++P+N+L+ E + DFG+++ + T V GT Y++PE Q + A
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAA 181
Query: 579 DVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR-NCYSERE 637
D++SLG+ L+E G+ P GQ E L++ AI + P L +S E
Sbjct: 182 DIWSLGLTLLECALGKFPFL---PPGQPSFFE----LMQ--AICDGPPPSLPAEEFSP-E 231
Query: 638 VYGMLQCASLCIRKDPHSRPRMSQVLR 664
+ C++KDP RP +++L+
Sbjct: 232 FRDFISA---CLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 77/277 (27%), Positives = 124/277 (44%), Gaps = 36/277 (12%)
Query: 402 LAEGGFGSVHRGVL--PDGQV--VAVKQYKLASSQGDQ-EFCSEVEVLSCAQHRNVVMLI 456
+ G FG V RG L P + VA+K K SS + +F +E ++ H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
G + +++ EY+ NGSLD L D + G A G++YL E
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---- 126
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR-----VLGTFGYLAPEYAQS 571
VHRD+ NILV + V DFGL+R D + T+ + T APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182
Query: 572 GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWA-RPLLKRHAIGELIDPRLR 630
+ T +DV+S G+V+ E+++ G++ + + + ++K G + P
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS----------YGERPYWDMSNQDVIKAVEDGYRL-PPPM 231
Query: 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
+C S + Q C +KD + RP SQ++ L+
Sbjct: 232 DCPS-----ALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-23
Identities = 79/288 (27%), Positives = 136/288 (47%), Gaps = 47/288 (16%)
Query: 396 FSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGD------QEFCSEVEVLSCAQH 449
+++ L +G +G+V+ G+ GQ++AVKQ +L +S ++ EV++L +H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 450 RNVVMLIGFCVEDGRRLLVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRY 507
N+V +G C++D + E++ GS+ S L +G +P+ ++I G A Y
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----Y 117
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR---WQPDGDMGVETRVL----GT 560
LH C+VHRD++ NN+++ + + DFG AR W G G + +L GT
Sbjct: 118 LHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV--GLHGTHSNMLKSMHGT 171
Query: 561 FGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR--PLLKR 618
++APE K+D++S+G + E+ TG+ A L
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP--------------LASMDRLAAM 217
Query: 619 HAIG--ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
IG + PRL + +S + + C+ +D H RP Q+LR
Sbjct: 218 FYIGAHRGLMPRLPDSFSAAAI----DFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 46/285 (16%)
Query: 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS-----EVEVLSCAQ 448
R+ + L G FGSV+ G+ L DG AVK+ LA + E+ +LS Q
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 449 HRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLR 506
H N+V +G E+ + E + GSL L YG +P+ R+I +G L
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LE 116
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAP 566
YLH+ VHRD++ NILV + + DFG+A+ + G+ ++AP
Sbjct: 117 YLHDRN----TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA--KSFKGSPYWMAP 170
Query: 567 EY-AQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL- 624
E AQ G AD++SLG ++E+ TG+ P Q E + K EL
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKP------PWSQL---EGVAAVFKIGRSKELP 221
Query: 625 -----IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
+ ++ C+++DP RP +++L
Sbjct: 222 PIPDHLSDEAKD------------FILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVMLIGFCV 460
+ +G FG V++GVL VAVK + ++F E E+L H N+V LIG CV
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
+ +V E + GSL + L + ++ L ++++ AA G+ YL + CI HR
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLR-KKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI-HR 117
Query: 521 DMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT----FGYLAPEYAQSGQITE 576
D+ N LV + + DFG++R + G V G + APE G+ T
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD---GLKQIPIKWTAPEALNYGRYTS 174
Query: 577 KADVYSLGVVLVELITG 593
++DV+S G++L E +
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 84/280 (30%), Positives = 122/280 (43%), Gaps = 49/280 (17%)
Query: 402 LAEGGFGSVH----RGVLPDGQ--VVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVML 455
L EG FG V +LP+ +VAVK K AS Q+F E E+L+ QH+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 456 IGFCVEDGRRLLVYEYICNGSL---------DSHLYGRDRD----PLEWSARRKIAVGAA 502
G C E L+V+EY+ +G L D+ + D L IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 503 RGLRY---LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD-MGVETRVL 558
G+ Y LH VHRD+ N LV +GDFG++R D V R +
Sbjct: 133 SGMVYLASLH-------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 559 GTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKA--MDLNRPRGQQCLTEWARPLL 616
++ PE + T ++D++S GVVL E+ T K L+ +C+T+ R L
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ-GREL- 243
Query: 617 KRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSR 656
R R C EVY ++Q C +++P R
Sbjct: 244 ----------ERPRTCPP--EVYAIMQG---CWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 70/280 (25%), Positives = 124/280 (44%), Gaps = 40/280 (14%)
Query: 395 RFSEANFLAEGGFGSVHR-GVLPDGQVVAVKQYKLAS-SQGD-QEFCSEVEVLSCAQHRN 451
F L +G +GSV++ L D Q A+K+ L S SQ + ++ +E+ +L+ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 452 VVMLIGF--CVEDGRRL-LVYEYICNGSLDSHLYGRD--RDPLEWSARRKIAVGAARGLR 506
+ I + DG +L +V EY G L + R R + +I + RGL+
Sbjct: 61 I---ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAP 566
LHE+ I+HRD++ NIL+ + +GD G+++ + +GT Y+AP
Sbjct: 118 ALHEQK----ILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAP 170
Query: 567 EYAQSGQITEKADVYSLGVVLVELITGR---KAMDLNRPRGQQCLTEWARPLLKRHAIGE 623
E + + K+D++SLG +L E+ T +A + R + ++
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY------------ 218
Query: 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663
P + YS+ + ++ P RP ++L
Sbjct: 219 ---PPIPPIYSQD----LQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 9e-21
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 5/203 (2%)
Query: 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQH 449
E F+ L G FG V G+ + VA+K K Q+F EV+ L +H
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 450 RNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLH 509
++++ L C ++ E + GSL + L + L ++ +A A G+ YL
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYA 569
E+ +HRD+ NILV D V DFGLAR + D+ + + + + APE A
Sbjct: 122 EQ----NSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAA 176
Query: 570 QSGQITEKADVYSLGVVLVELIT 592
G + K+DV+S G++L E+ T
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 9e-21
Identities = 70/225 (31%), Positives = 106/225 (47%), Gaps = 28/225 (12%)
Query: 388 ELELATNRFSEANFLAEGGFGSVHRG--VLPDG----QVVAVKQYK-LASSQGDQEFCSE 440
E+ L+ RF E L EG FG V++G P+ VA+K K A + QEF E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 441 VEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRD--------------R 486
E++S QH N+V L+G C ++ +++EY+ +G L L +
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 487 DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546
L+ S IA+ A G+ YL VHRD+ N LV + DFGL+R
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
Query: 547 PDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVEL 590
D V+++ L ++ PE G+ T ++D++S GVVL E+
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
+ G +G V++ + G++VA+K KL + E+ +L +H N+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
+ +V EY GSL +Y R PL + +GL YLHE + +HR
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHETGK----IHR 125
Query: 521 DMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQ---SGQITEK 577
D++ NIL+T D + + DFG++ Q + +GT ++APE A G K
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSA-QLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGK 184
Query: 578 ADVYSLGVVLVEL 590
D+++LG+ +EL
Sbjct: 185 CDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 73/201 (36%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 402 LAEGGFGSVHR---GVLPD--GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLI 456
L +G FGSV L D G+VVAVK+ + ++++ ++F E+E+L QH N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 457 GFCVEDGRR--LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514
G C GRR LV EY+ GSL +L + R+ L+ A +G+ YL + R
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSK-RY 129
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLG---TFGYLAPEYAQS 571
VHRD+ NILV + +GDFGL + P + R G F Y APE
Sbjct: 130 ---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTE 185
Query: 572 GQITEKADVYSLGVVLVELIT 592
+ + +DV+S GVVL EL T
Sbjct: 186 SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 6e-20
Identities = 67/194 (34%), Positives = 101/194 (52%), Gaps = 13/194 (6%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
+ EG FG+V +G GQ VAVK K + Q F E V++ H+N+V L+G +
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
+G + V E + G+L + L R R + + ++ A G+ YL + +VHRD
Sbjct: 71 NGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK----LVHRD 125
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVY 581
+ NILV+ D V DFGLAR MGV+ L + APE + + + K+DV+
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGS---MGVDNSKL-PVKWTAPEALKHKKFSSKSDVW 181
Query: 582 SLGVVLVELIT-GR 594
S GV+L E+ + GR
Sbjct: 182 SYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGD--QEFCSEVEVLSCAQHRN 451
+ E + L EG GSV + L + ++ + D ++ E+E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 452 VVMLIGFCVE--DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR------KIAVGAAR 503
+V G ++ + EY GSLDS +Y + + + R KIA +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVK---KRGGRIGEKVLGKIAESVLK 116
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG- 562
GL YLH I+HRD++P+NIL+T + + DFG++ G++ + GTF
Sbjct: 117 GLSYLHSRK----IIHRDIKPSNILLTRKGQVKLCDFGVS-----GELV--NSLAGTFTG 165
Query: 563 ---YLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
Y+APE Q + +DV+SLG+ L+E+ R
Sbjct: 166 TSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 1e-19
Identities = 66/201 (32%), Positives = 93/201 (46%), Gaps = 25/201 (12%)
Query: 405 GGFGSV----HRGVLPDGQVVAVKQYK----LASSQGDQEFCSEVEVLSCAQHRNVVMLI 456
G FG V + G++ A+K K + + + +E +LS H +V L
Sbjct: 4 GSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIVKLH 59
Query: 457 GFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIA--VGAARGLRYLHEECR 513
+ + +L LV EY G L SHL R E AR A V A L YLH
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER-ARFYAAEIVLA---LEYLH---S 111
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
+G I++RD++P NIL+ D + DFGLA+ T GT YLAPE
Sbjct: 112 LG-IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKG 169
Query: 574 ITEKADVYSLGVVLVELITGR 594
+ D +SLGV+L E++TG+
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 1e-19
Identities = 84/286 (29%), Positives = 132/286 (46%), Gaps = 41/286 (14%)
Query: 402 LAEGGFGSVHRG----VLP--DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVML 455
L EG FG V + P D +VAVK K AS ++F E E+L+ QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRD---------PLEWSARR--KIAVGAARG 504
G CVE ++V+EY+ +G L+ L D P E + + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD-MGVETRVLGTFGY 563
+ YL + VHRD+ N LV + +GDFG++R D V + +
Sbjct: 133 MVYLASQ----HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 564 LAPEYAQSGQITEKADVYSLGVVLVELITGRKA--MDLNRPRGQQCLTEWARPLLKRHAI 621
+ PE + T ++DV+SLGVVL E+ T K L+ +C+T+
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ----------- 237
Query: 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
G ++ R R C +EVY ++ C +++PH R + ++ +L+
Sbjct: 238 GRVLQ-RPRTC--PKEVYDLMLG---CWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 75/288 (26%), Positives = 116/288 (40%), Gaps = 39/288 (13%)
Query: 404 EGGFGSVHRG-VLPDGQVVAVKQYKLASSQGDQEFCS--EVEVLSCAQHRNVVMLIGFCV 460
EG +G V + G++VA+K++K + D + + EV+VL +H N+V L
Sbjct: 11 EGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR 70
Query: 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
GR LV+EY+ L+ L L A R + + Y H I+HR
Sbjct: 71 RKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN----IIHR 124
Query: 521 DMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE----YAQSGQITE 576
D++P NILV+ + DFG AR T + T Y APE G+
Sbjct: 125 DIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK--- 181
Query: 577 KADVYSLGVVLVELITGRKAM----DLNR-PRGQQCLTEWARPLLKRHAIGELIDPRLRN 631
DV+++G ++ EL+ G D+++ Q+CL PL H +PR
Sbjct: 182 PVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG----PLPPSHQELFSSNPRFAG 237
Query: 632 C--------------YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665
Y + L C+R DP R ++L+
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 32/211 (15%)
Query: 402 LAEGGFGSVHRGV-LPDGQ----VVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVML 455
L G FG+V++GV +P+G+ VA+K + +S + ++E E V++ H +VV L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYG-----RDRDPLEWSARRKIAVGAARGLRYLHE 510
+G C+ + L+ + + G L ++ + L W V A+G+ YL E
Sbjct: 75 LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC------VQIAKGMSYL-E 126
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG-----YLA 565
E R +VHRD+ N+LV + DFGLA+ E G ++A
Sbjct: 127 EKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD----EKEYHAEGGKVPIKWMA 179
Query: 566 PEYAQSGQITEKADVYSLGVVLVELIT-GRK 595
E T K+DV+S GV + EL+T G K
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 75/270 (27%), Positives = 115/270 (42%), Gaps = 26/270 (9%)
Query: 404 EGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS-EVEVLSCAQHRNVVMLIGFCVE 461
G V+ + LP+ + VA+K+ L Q + EV+ +S H NVV V
Sbjct: 11 VGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV 70
Query: 462 DGRRLLVYEYICNGS-LDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
LV Y+ GS LD R L+ + + +GL YLH ++ HR
Sbjct: 71 GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI----HR 126
Query: 521 DMRPNNILVTHDFEPLVGDFGLARWQPD-GDMGVETR--VLGTFGYLAPEYAQSGQ-ITE 576
D++ NIL+ D + DFG++ D GD + R +GT ++APE +
Sbjct: 127 DIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDF 186
Query: 577 KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSER 636
KAD++S G+ +EL TG P LT P P L ++
Sbjct: 187 KADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP------------PSLETG-ADY 233
Query: 637 EVYGML--QCASLCIRKDPHSRPRMSQVLR 664
+ Y + SLC++KDP RP ++L+
Sbjct: 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 77/283 (27%), Positives = 117/283 (41%), Gaps = 43/283 (15%)
Query: 402 LAEGGFGSVHRGV--LPDGQV--VAVKQYKL-ASSQGDQEFCSEVEVLSCAQHRNVVMLI 456
L G FGSV +GV + G+ VAVK K + G +EF E V++ H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGR----DRDPLEWSARRKIAVGAARGLRYLHEEC 512
G C + +LV E G L +L R D E A A G+ YL E
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYL-ESK 114
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF--GYLAPEYAQ 570
VHRD+ N+L+ + + + DFG++R G G + + APE
Sbjct: 115 H---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 571 SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630
G+ + K+DV+S GV L E + G + E +K + +++ R
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFS----------YGAKPYGE-----MKGAEVIAMLESGER 216
Query: 631 -NCYSE--REVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670
E +E+Y ++ C + P RP S++ D
Sbjct: 217 LPRPEECPQEIYSIML---SCWKYRPEDRPTFSELESTFRRDP 256
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 66/274 (24%), Positives = 115/274 (41%), Gaps = 36/274 (13%)
Query: 402 LAEGGFGSVHRGVL----PDGQVVAVKQYKLA--SSQGDQEFCSEVEVLSCAQHRNVVML 455
L +G FG L D +V K+ L S + ++ +E+ +LS QH N++
Sbjct: 8 LGKGAFGE---ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
++D L+ EY G+L + + E + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--- 121
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQIT 575
I+HRD++ NI +T +GDFG+++ ET V+GT Y++PE Q +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYN 179
Query: 576 EKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS- 634
K+D+++LG VL EL+T ++ D P L+ ++ Y+
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPL-------------------NLVVKIVQGNYTP 220
Query: 635 EREVY--GMLQCASLCIRKDPHSRPRMSQVLRML 666
VY ++ +++DP RP +VL
Sbjct: 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 81/292 (27%), Positives = 136/292 (46%), Gaps = 41/292 (14%)
Query: 390 ELATNRFSEANFLAEGGFGSVHRGVLP----DGQVVAVKQYKLASSQGD-QEFCSEVEVL 444
E+ + ++ + G FG V RG+L VA+K K ++ Q+F SE ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 445 SCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV--GAA 502
H N++ L G + +++ EY+ NG+LD +L RD D E+S+ + + + G A
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL--RDHDG-EFSSYQLVGMLRGIA 117
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG 562
G++YL + VHRD+ NILV + E V DFGL+R D G T G
Sbjct: 118 AGMKYLSDMN----YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173
Query: 563 --YLAPEYAQSGQITEKADVYSLGVVLVELIT--GRKAMDLNRPRGQQCLTEWAR---PL 615
+ APE + T +DV+S G+V+ E+++ R D++ + + + R P+
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPM 233
Query: 616 LKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
A+ +L MLQC ++D RPR ++ +L+
Sbjct: 234 DCPSAVYQL----------------MLQCW----QQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 10/196 (5%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
L G FG V G+ + VAVK K + ++F +E +++ +H ++ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
+ +V E + GSL +L G L+ +A A G+ YL + +HRD
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN----YIHRD 128
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF--GYLAPEYAQSGQITEKAD 579
+ N+LV + V DFGLAR + E R F + APE A + + K+D
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIY--EAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 580 VYSLGVVLVELIT-GR 594
V+S G++L E++T GR
Sbjct: 187 VWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 85/263 (32%), Positives = 115/263 (43%), Gaps = 34/263 (12%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
L G FG V G VAVK K + + F E +++ +H +V L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
+ +V EY+ GSL L + L +A A G+ YL E +HRD
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL-ESRNY---IHRD 128
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF--GYLAPEYAQSGQITEKAD 579
+ NILV + + DFGLAR D + R F + APE A G+ T K+D
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEY--TAREGAKFPIKWTAPEAANYGRFTIKSD 186
Query: 580 VYSLGVVLVELIT-GR---KAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSE 635
V+S G++L E++T GR M NR + L + R G + PR NC
Sbjct: 187 VWSFGILLTEIVTYGRVPYPGMT-NR----EVLEQVER--------GYRM-PRPPNC--P 230
Query: 636 REVYG-MLQCASLCIRKDPHSRP 657
E+Y MLQC KDP RP
Sbjct: 231 EELYDLMLQCW----DKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 69/271 (25%), Positives = 112/271 (41%), Gaps = 29/271 (10%)
Query: 405 GGFGSVHRGV-LPDGQVVAVKQ--YKLASSQGDQEFCSEVEVLSCAQHRNVVMLIG-FCV 460
G FG+V + DG+++ K+ Y + + Q+ SEV +L +H N+V
Sbjct: 11 GSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID 70
Query: 461 EDGRRL-LVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRYLH-EECRVGC 516
+ L +V EY G L + ++R +E +I L H
Sbjct: 71 RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT 130
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITE 576
++HRD++P NI + + +GDFGLA+ +T V GT Y++PE E
Sbjct: 131 VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHMSYDE 189
Query: 577 KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSE- 635
K+D++SLG ++ EL R Q L +K G+ R+ YS
Sbjct: 190 KSDIWSLGCLIYELCALSPPF---TARNQLQLAS----KIKE---GKF--RRIPYRYSSE 237
Query: 636 -REVYGMLQCASLCIRKDPHSRPRMSQVLRM 665
EV + DP RP ++L++
Sbjct: 238 LNEV------IKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 402 LAEGGFGSVHR-GVLPDGQVVAVKQYKLASSQGDQEFCS--EVEVLSCAQHRNVVMLIGF 458
+ EG G V + G+ VA+K+ L +G + E++ L QH VV L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 459 CVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIV 518
+LV EY L L +R PL + + +G+ Y+H I+
Sbjct: 68 FPHGSGFVLVMEY-MPSDLSEVLRDEER-PLPEAQVKSYMRMLLKGVAYMHANG----IM 121
Query: 519 HRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE--YAQSGQITE 576
HRD++P N+L++ D + DFGLAR + + + + + T Y APE Y +
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR-KYDP 180
Query: 577 KADVYSLGVVLVELITGR 594
D++++G + EL+ G
Sbjct: 181 GVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 74/241 (30%), Positives = 107/241 (44%), Gaps = 45/241 (18%)
Query: 381 PRWFTYAELELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASSQGD 434
P W EL +R + L EG FG V + + VAVK K +++ D
Sbjct: 5 PEW------ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58
Query: 435 -QEFCSEVEVL-SCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWS 492
+ SE+E++ +H+N++ L+G C ++G +V EY +G+L L R R P
Sbjct: 59 LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL--RARRPPGEY 116
Query: 493 ARRKI----------------AVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL 536
A A ARG+ +L + CI HRD+ N+LVT D
Sbjct: 117 ASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCI-HRDLAARNVLVTEDHVMK 172
Query: 537 VGDFGLARWQPDGDMGVETRVLGTFGYL-----APEYAQSGQITEKADVYSLGVVLVELI 591
+ DFGLAR D +T T G L APE T ++DV+S GV+L E+
Sbjct: 173 IADFGLARDIHHIDYYRKT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
Query: 592 T 592
T
Sbjct: 229 T 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 52/217 (23%)
Query: 404 EGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEF----CSEVEVLSCAQHRNVVMLIGF 458
EG +G V++ G++VA+K+ ++ + F E+++L +H N+V L
Sbjct: 9 EGTYGQVYKARNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 459 CVEDGRR--LLVYEYI---CNGSLDSHLYGRDRDPLEWSARRKIAVGAAR--------GL 505
G+ +V+EY+ G LDS K + GL
Sbjct: 67 VTSKGKGSIYMVFEYMDHDLTGLLDSPEV-------------KFTESQIKCYMKQLLEGL 113
Query: 506 RYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-WQPDGDMGVETRVLGTFGYL 564
+YLH I+HRD++ +NIL+ +D + DFGLAR + RV+ T Y
Sbjct: 114 QYLHSNG----ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYR 168
Query: 565 APE-------YAQSGQITEKADVYSLGVVLVELITGR 594
PE Y + D++S+G +L EL G+
Sbjct: 169 PPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 86/296 (29%), Positives = 133/296 (44%), Gaps = 54/296 (18%)
Query: 400 NFLAEGGFGSVHRG-VLPDG--QVVAVKQYKLASSQGD-QEFCSEVEVL-SCAQHRNVVM 454
+ + EG FG V + + DG A+K+ K +S+ D ++F E+EVL H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHLYGR---DRDPLEWSARRK-----------IAVG 500
L+G C G L EY +G+L L + DP A A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 501 AARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT 560
ARG+ YL ++ +HRD+ NILV ++ + DFGL+R G E V T
Sbjct: 133 VARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 181
Query: 561 FG-----YLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615
G ++A E T +DV+S GV+L E+++ + G C L
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS----LGGTPYCGMTCAE-----L 232
Query: 616 LKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL----RMLE 667
++ G ++ L NC + EVY +++ C R+ P+ RP +Q+L RMLE
Sbjct: 233 YEKLPQGYRLEKPL-NC--DDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 20/199 (10%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
+ EG G V++ G+ VA+K+ +L Q + +E+ ++ +H N+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYD-SY 84
Query: 461 EDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAA---RGLRYLHEECRVGC 516
G L +V EY+ GSL + E +IA +GL YLH
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIITQNFVRMNE----PQIAYVCREVLQGLEYLH---SQNV 137
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR--VLGTFGYLAPEYAQSGQI 574
I HRD++ +NIL++ D + DFG A R V+GT ++APE +
Sbjct: 138 I-HRDIKSDNILLSKDGSVKLADFGFA---AQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 575 TEKADVYSLGVVLVELITG 593
K D++SLG++ +E+ G
Sbjct: 194 GPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 401 FLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSCAQHRNVVML 455
+ EG +G V++ G++VA+K+ KL + E+++L H N++ L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKL--RFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLY---GRDRDPLEWSARRKIAVGAARGLRYLHEEC 512
+ G LV+E+ +D+ LY + L S + +GL + H
Sbjct: 64 LDVFRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH--- 115
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE-YAQS 571
G + HRD++P N+L+ + + DFGLAR + T + T Y APE
Sbjct: 116 SHGIL-HRDLKPENLLINTEGVLKLADFGLAR-SFGSPVRPYTHYVVTRWYRAPELLLGD 173
Query: 572 GQITEKADVYSLGVVLVELITGR 594
+ D++S+G + EL++ R
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 76/277 (27%), Positives = 115/277 (41%), Gaps = 32/277 (11%)
Query: 397 SEANFLAE---GGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVV 453
SE FL E G FG VH G VA+K + + + +F E +V+ H N+V
Sbjct: 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLV 62
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSAR-RKIAVGAARGLRYLHEEC 512
L G C + +V EY+ NG L ++L R+R + + + YL
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESN- 119
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT---FGYLAPEYA 569
+HRD+ N LV D V DFGLAR+ D T GT + PE
Sbjct: 120 ---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAPPEVF 173
Query: 570 QSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629
+ + K+DV+S GV++ E+ + K M R + + + L P+L
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGK-MPYERFSNSEVVESVSAGY-------RLYRPKL 225
Query: 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666
+ EVY ++ C + P RP ++L L
Sbjct: 226 ----APTEVYTIM---YSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 76/270 (28%), Positives = 119/270 (44%), Gaps = 27/270 (10%)
Query: 401 FLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQ-EFCSEVEVLSCAQHRNVVMLIGFC 459
L +G FG V +G L D VAVK K Q + +F SE +L H N+V LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVH 519
+ +V E + G S L + +D L+ K A+ AA G+ YL + CI H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESK---NCI-H 116
Query: 520 RDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKAD 579
RD+ N LV + + DFG++R + DG + APE G+ + ++D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 580 VYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSER--- 636
V+S G++L E + L P + E ++ R ++
Sbjct: 177 VWSYGILLWETFS---------------LGVCPYPGMTNQQAREQVEKGYRMSCPQKCPD 221
Query: 637 EVYGMLQCASLCIRKDPHSRPRMSQVLRML 666
+VY ++Q C P +RP+ S++ + L
Sbjct: 222 DVYKVMQ---RCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
L EG +GSV++ + GQVVA+K + + QE E+ +L +V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKV--VPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV---GAARGLRYLHEECRVGCI 517
++ +V EY GS+ + ++ E +IA +GL YLH
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTE----EEIAAILYQTLKGLEYLHSNK----K 120
Query: 518 VHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEK 577
+HRD++ NIL+ + + + DFG++ Q M V+GT ++APE Q K
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSG-QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK 179
Query: 578 ADVYSLGVVLVELITGR 594
AD++SLG+ +E+ G+
Sbjct: 180 ADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 65/293 (22%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS-EVEVLSCAQHRN 451
F+ + +G FG V++ + QVVA+K L ++ + E E++ LS +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGS-LDSHLYGRDRDPLEWSARRKIAV---GAARGLRY 507
+ G ++ + ++ EY GS LD G+ + IA GL Y
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDE-------TYIAFILREVLLGLEY 113
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF-G---Y 563
LHEE ++ HRD++ NIL++ + + + DFG++ G + TF G +
Sbjct: 114 LHEEGKI----HRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFW 164
Query: 564 LAPEYAQSGQITEKADVYSLGVVLVELITGR---------KAMDL---NRPRGQQCLTEW 611
+APE + EKAD++SLG+ +EL G + + L N P
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP--------- 215
Query: 612 ARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
P L+ + + ++ SLC+ KDP RP ++L+
Sbjct: 216 --PSLEGNKFSKPF----------KDF------VSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 24/221 (10%)
Query: 449 HRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR--KIAVGAARGLR 506
H N+V +E+ R +V + I L H ++ R I V LR
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW-QPDGDMGVETRVLGTFGYLA 565
YLH+E R IVHRD+ PNNI++ D + + DFGLA+ QP+ + T V+GT Y
Sbjct: 128 YLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILYSC 181
Query: 566 PEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625
PE ++ EKADV++ G +L ++ T L P + A +++ +
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATKIVE-----AVY 230
Query: 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666
+P YSE V ++ C+ D +RP + QV M+
Sbjct: 231 EPLPEGMYSED-VTDVITS---CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 21/265 (7%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
+ G FG V G + + VA+K + + +++F E +V+ H +V L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
LV+E++ +G L +L + R + + G+ YL ++HRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLES----SNVIHRD 125
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVY 581
+ N LV + V DFG+ R+ D T + +PE + + K+DV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 582 SLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGM 641
S GV++ E+ + K NR + T +A L PRL + + VY +
Sbjct: 186 SFGVLMWEVFSEGKTPYENRSNSEVVET--------INAGFRLYKPRL----ASQSVYEL 233
Query: 642 LQCASLCIRKDPHSRPRMSQVLRML 666
+Q C ++ P RP S +L L
Sbjct: 234 MQ---HCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 61/199 (30%), Positives = 87/199 (43%), Gaps = 20/199 (10%)
Query: 402 LAEGGFGSVHRGVL-PDGQVVAVKQYK----LASSQGDQEFCSEVEVLSCAQHRNVVMLI 456
L G FG V G+ A+K + Q + +E +L +H +V L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-VLNEKRILQSIRHPFLVNLY 67
Query: 457 GFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
G +D L LV EY+ G L SHL R P + R A L YLH
Sbjct: 68 G-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA--RFYAAQVVLALEYLHSL---- 120
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPEYAQSGQI 574
IV+RD++P N+L+ D + DFG A+ T L GT YLAPE S
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGY 175
Query: 575 TEKADVYSLGVVLVELITG 593
+ D ++LG+++ E++ G
Sbjct: 176 GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 388 ELELATNRFSEANFLAEGGFGSVHRGVLPDGQV-VAVKQYKLASSQGDQEFCSEVEVLSC 446
E E + E L +G +G V+ QV +A+K+ S+ Q E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 447 AQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAA--RG 504
+HRN+V +G E+G + E + GSL + L + PL+ + + I G
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEG 120
Query: 505 LRYLHEECRVGCIVHRDMRPNNILV-THDFEPLVGDFG----LARWQPDGDMGVETRVLG 559
L+YLH+ IVHRD++ +N+LV T+ + DFG LA P G
Sbjct: 121 LKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-----CTETFTG 171
Query: 560 TFGYLAPEYAQSGQ--ITEKADVYSLGVVLVELITGR 594
T Y+APE G AD++SLG +VE+ TG+
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 74/268 (27%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQ-YKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFC 459
L G GSV + +P G V+A K + A S ++ E++++ + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVH 519
+ + + E++ GSLD + P+ KIAV GL YL+ R I+H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMH 127
Query: 520 RDMRPNNILVTHDFEPLVGDFGLARWQPDGDM--GVETRVLGTFGYLAPEYAQSGQITEK 577
RD++P+NILV + + DFG++ G++ + +GT Y++PE Q G+ T K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQGGKYTVK 182
Query: 578 ADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSERE 637
+DV+SLG+ ++EL G+ + L + + E PRL S
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRLP---SSDF 238
Query: 638 VYGMLQCASLCIRKDPHSRPRMSQVLRM 665
+ C+ KDP RP Q+ M
Sbjct: 239 PEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (206), Expect = 2e-17
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 39/211 (18%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEF----CSEVEVLSCAQHRNVVMLI 456
L EG +G V++ G++VA+K+ +L ++ E+ +L +H N+V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSAR--RKIAVGAARGLRYLHEECRV 514
+ + LV+EY C+ L +L D+ P S + I RGL Y H
Sbjct: 65 DVIHTERKLYLVFEY-CDMDLKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYCHS---- 116
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE----TRVLGTFGYLAPE--- 567
I+HRD++P NIL+ D + DFGLAR G+ T + T Y APE
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPEILL 171
Query: 568 ----YAQSGQITEKADVYSLGVVLVELITGR 594
Y + D++S+G + E+ITG+
Sbjct: 172 GSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 26/243 (10%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE---------FCSEVEVLSCAQHRN 451
+ G FGSV+ G+ G+++AVKQ +L S + E+ +L QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRYLH 509
+V +G ++ + EY+ GS+ + L YG + L + R+I +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYLH 123
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR-----VLGTFGYL 564
I+HRD++ NILV + + DFG+++ + +T + G+ ++
Sbjct: 124 NRG----IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 565 APEYAQSGQITEKADVYSLGVVLVELITGRKAM-DLNRPRGQQCLTEWARPLLKRHAIGE 623
APE + T KAD++SLG ++VE++TG+ D + + + E A P + + E
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239
Query: 624 LID 626
ID
Sbjct: 240 AID 242
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 396 FSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS--EVEVLSCAQHRNV 452
F + N + EG +G V+R G++VA+K+ ++ + + S E+ +L +H N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 453 VMLIGFCVEDGRRL----LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYL 508
V L V G+ L LV EY C L S L P S + + + RGL+YL
Sbjct: 69 VELKEVVV--GKHLDSIFLVMEY-CEQDLASLLDNMPT-PFSESQVKCLMLQLLRGLQYL 124
Query: 509 HEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW--QPDGDMGVETRVLGTFGYLAP 566
HE I+HRD++ +N+L+T + DFGLAR P M T + T Y AP
Sbjct: 125 HENF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM---TPKVVTLWYRAP 177
Query: 567 EYA-QSGQITEKADVYSLGVVLVELITGR 594
E T D++++G +L EL+ +
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE----------FCSEVEVLSCAQHR 450
+ +G +G V+ + + G+++AVKQ +L ++ + SE+E L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 451 NVVMLIGFCVEDGRRLLVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRYL 508
N+V +GF + + EY+ GS+ S L YGR + L ++ GL YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGLAYL 124
Query: 509 HEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPE 567
H + I+HRD++ +N+LV D + DFG+++ D + + G+ ++APE
Sbjct: 125 HSKG----ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 568 YAQSGQ--ITEKADVYSLGVVLVELITGRK 595
S + K D++SLG V++E+ GR+
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 32/213 (15%)
Query: 402 LAEGGFGSVHRGV---LPDGQV---VAVKQYKLASSQGDQ-EFCSEVEVLSCAQHRNVVM 454
L +G FG V+ G+ + G+ VA+K +S ++ EF +E V+ +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHLYGR--------DRDPLEWSARRKIAVGAARGLR 506
L+G L+V E + G L S+L R P ++A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-------WQPDGDMGVETRVLG 559
YL + VHRD+ N +V D +GDFG+ R ++ G + R
Sbjct: 134 YLAAKK----FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 560 TFGYLAPEYAQSGQITEKADVYSLGVVLVELIT 592
++APE + G T K+DV+S GVVL E+ T
Sbjct: 187 ---WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 8e-17
Identities = 78/288 (27%), Positives = 118/288 (40%), Gaps = 55/288 (19%)
Query: 395 RFSEANFLAEGGFGSVH--RGVLPDGQVVAVKQYKLASSQGD---QEFCSEVEVLSCAQH 449
F++ + G FG+V+ R V +VVA+K+ + Q + Q+ EV L +H
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 450 RNVVMLIGFCVEDGRRLLVYEYICNGS----LDSHLYGRDRDPLEWSARRKIAVGAARGL 505
N + G + + LV EY C GS L+ H + PL+ I GA +GL
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEY-CLGSASDILEVH-----KKPLQEVEIAAICHGALQGL 128
Query: 506 RYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLA 565
YLH R+ HRD++ NIL+T + DFG A + +GT ++A
Sbjct: 129 AYLHSHERI----HRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFVGTPYWMA 179
Query: 566 PEY---AQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622
PE GQ K DV+SLG+ +E L E PL +A+
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIE------------------LAERKPPLFNMNAMS 221
Query: 623 ELI------DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
L P L + + C++K P RP ++L+
Sbjct: 222 ALYHIAQNDSPTLSSNDWSDYFRNFVD---SCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 54/297 (18%)
Query: 400 NFLAEGGFGSVHRGVLP-DGQVV--AVKQYKLASSQGD-QEFCSEVEVL-SCAQHRNVVM 454
+ + EG FG V R ++ DG + A+K K +S+ D ++F E+EVL H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHL-----------YGRDRDPLEWSARRKI---AVG 500
L+G C G + EY G+L L + ++ +++ A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 501 AARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT 560
A G++YL E+ +HRD+ N+LV + + DFGL+R G E V T
Sbjct: 128 VATGMQYLSEKQ----FIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKKT 176
Query: 561 FG-----YLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615
G ++A E T K+DV+S GV+L E+++ + G C L
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS----LGGTPYCGMTCAE-----L 227
Query: 616 LKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL----RMLEG 668
++ G ++ + RNC + EVY +++ C R P+ RP +Q+ RMLE
Sbjct: 228 YEKLPQGYRME-KPRNC--DDEVYELMR---QCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 83/285 (29%), Positives = 132/285 (46%), Gaps = 54/285 (18%)
Query: 400 NFLAEGGFGSVHRG----VLPDG---QVVAVKQYKLASSQGDQ-EFCSEVEVLSCAQHRN 451
NFL G FG V+ G +L G VAVK + ++ ++ EF E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYG----RDRDP-LEWSARRKIAVGAARGLR 506
+V L+G C+ + + ++ E + G L S+L R P L I + A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 507 YLHEECRVGCIVHRDMRPNNILVT---HDFEPLV--GDFGLAR-------WQPDGDMGVE 554
YL E+ +HRD+ N LV+ +D + +V GDFGLAR ++ +G+ +
Sbjct: 121 YL-EQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP 614
R ++APE G+ T ++DV+S GV++ E++T GQQ
Sbjct: 177 VR------WMAPESLLDGKFTTQSDVWSFGVLMWEILT----------LGQQPYPALNNQ 220
Query: 615 LLKRH--AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRP 657
+ +H A G L P NC ++Y ++ C +DP RP
Sbjct: 221 EVLQHVTAGGRLQKP--ENC--PDKIYQLMT---NCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 43/226 (19%)
Query: 395 RFSEANFLAEGGFGSVHRGVL---PDGQVVAVKQYKLASSQGD---QEFCSEVEVLSCAQ 448
++ + G +G V++ DG+ A+K++K Q Q C E+ +L +
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 449 HRNVVMLIGFCVEDGRRL--LVYEY-------ICNGSLDSHLYGRDRDPLEWSARRKIAV 499
H NVV L+ +E + L+++Y I R + S + +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIK-----FHRQAKRVSIPPSMVKSLLW 115
Query: 500 GAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL----VGDFGLAR--WQPDGDMGV 553
G+ YLH ++HRD++P NILV + +GD GLAR P +
Sbjct: 116 QILNGVHYLHSNW----VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 554 ETRVLGTFGYLAPE-------YAQSGQITEKADVYSLGVVLVELIT 592
V+ T Y APE Y T+ D++++G + EL+T
Sbjct: 172 LDPVVVTIWYRAPELLLGARHY------TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 82/296 (27%), Positives = 134/296 (45%), Gaps = 54/296 (18%)
Query: 400 NFLAEGGFGSVHRGVLP-DG--QVVAVKQYKLASSQGD-QEFCSEVEVL-SCAQHRNVVM 454
+ + EG FG V + + DG A+K+ K +S+ D ++F E+EVL H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHL-----------YGRDRDPLEWSARRKI---AVG 500
L+G C G L EY +G+L L + + +++ A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 501 AARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT 560
ARG+ YL ++ +HRD+ NILV ++ + DFGL+R G E V T
Sbjct: 121 VARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 169
Query: 561 FG-----YLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615
G ++A E T +DV+S GV+L E+++ + G C L
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS----LGGTPYCGMTCAE-----L 220
Query: 616 LKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL----RMLE 667
++ G ++ + NC + EVY +++ C R+ P+ RP +Q+L RMLE
Sbjct: 221 YEKLPQGYRLE-KPLNC--DDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 63/191 (32%), Positives = 87/191 (45%), Gaps = 6/191 (3%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
L +G FG V G VA+K K + + F E +V+ +H +V L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
+ +V EY+ GSL L G L +A A G+ Y+ R+ VHRD
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN-YVHRD 127
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVY 581
+R NILV + V DFGLAR D + + APE A G+ T K+DV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 582 SLGVVLVELIT 592
S G++L EL T
Sbjct: 188 SFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 72/277 (25%), Positives = 125/277 (45%), Gaps = 46/277 (16%)
Query: 404 EGGFGSVHRGV-LPDGQVVAVKQ---YKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFC 459
+G F V++ + L DG+VVA+K+ +++ ++ Q+ E+++L H NV+ +
Sbjct: 12 KGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF 71
Query: 460 VEDGRRLLVYEYICNGSLDSHL---YGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
+E+ +V E G L S + + + + + K V L ++H + R
Sbjct: 72 IENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-R--- 126
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITE 576
I+HRD++P N+ +T +GD GL R+ + V GT Y++PE
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 185
Query: 577 KADVYSLGVVLVEL------ITGRKA--MDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628
K+D++SLG +L E+ G K L + + ++C ++ PL H
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-KIEKC--DYP-PLPADH--------- 232
Query: 629 LRNCYSE--REVYGMLQCASLCIRKDPHSRPRMSQVL 663
YSE R++ CI DP RP +S VL
Sbjct: 233 ----YSEELRDLVSR------CINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 67/222 (30%), Positives = 100/222 (45%), Gaps = 14/222 (6%)
Query: 381 PRWFTYAE-LELATNRFSEANFLAEGGFGSVHR----GVLPDGQV--VAVKQYK-LASSQ 432
P Y E N S L G FG V G+ V VAVK K A S
Sbjct: 21 PTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS 80
Query: 433 GDQEFCSEVEVLS-CAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEW 491
+ SE++++S H N+V L+G C G L++ EY C G L + L + L
Sbjct: 81 EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 492 SARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-WQPDGD 550
+ A+G+ +L + CI HRD+ N+L+TH + DFGLAR D +
Sbjct: 141 EDLLSFSYQVAKGMAFLASK---NCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSN 196
Query: 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT 592
V+ ++APE + T ++DV+S G++L E+ +
Sbjct: 197 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 74/293 (25%), Positives = 120/293 (40%), Gaps = 28/293 (9%)
Query: 386 YAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKL-ASSQGDQEFCSEVEVL 444
+ E+ L + + +VAVK + AS ++F EV++L
Sbjct: 18 FGEVHLCEADGLQDFSEKAFAENDNADAPV----LVAVKVLRPDASDNAREDFLKEVKIL 73
Query: 445 SCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGR---------DRDPLEWSARR 495
S N+ L+G C D ++ EY+ NG L+ L + L +S
Sbjct: 74 SRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLL 133
Query: 496 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD-MGVE 554
+A A G+RYL VHRD+ N LV ++ + DFG++R D V+
Sbjct: 134 YMATQIASGMRYLESL----NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP 614
R ++A E G+ T K+DV++ GV L E++T + QQ +
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGH- 248
Query: 615 LLKRHAIGELIDPRLRNCYSEREVY-GMLQCASLCIRKDPHSRPRMSQVLRML 666
R ++ PR NC +++Y ML+C R+D RP ++ L
Sbjct: 249 -FFRDDGRQIYLPRPPNC--PKDIYELMLECW----RRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 59/194 (30%), Positives = 87/194 (44%), Gaps = 7/194 (3%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
L G FG V G VA+K K S + F +E ++ QH +V L V
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYA-VVT 71
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
++ EY+ NGSL L + L + +A A G+ ++ + +HRD
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN----YIHRD 127
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVY 581
+R NILV+ + DFGLAR D + + APE G T K+DV+
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 582 SLGVVLVELIT-GR 594
S G++L E++T GR
Sbjct: 188 SFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 78/285 (27%), Positives = 127/285 (44%), Gaps = 36/285 (12%)
Query: 402 LAEGGFGSV--------HRGVLPDGQVVAVKQYKLASSQGDQE-FCSEVEVLSCAQHRNV 452
L EG FG V + G G++VAVK K Q + + E+ +L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 453 VMLIGFCVEDGRR--LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE 510
V G C E G + L+ EY+ GSL +L + L + A G+ YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLG---TFGYLAPE 567
+ +HRD+ N+L+ +D +GDFGLA+ P+G R G F Y A E
Sbjct: 126 QH----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVE 180
Query: 568 YAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID- 626
+ + + +DV+S GV L EL+T + P+ + + + + + EL++
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239
Query: 627 ----PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
P +NC +EVY +++ C + RP ++ +L+
Sbjct: 240 GMRLPCPKNC--PQEVYILMKN---CWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 78/279 (27%), Positives = 119/279 (42%), Gaps = 51/279 (18%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
+ +G FG V G G VAVK K ++ Q F +E V++ +H N+V L+G VE
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 462 D-GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
+ G +V EY+ GSL +L R R L K ++ + YL VHR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN----FVHR 126
Query: 521 DMRPNNILVTHDFEPLVGDFGLAR----WQPDGDMGVETRVLGTFGYLAPEYAQSGQITE 576
D+ N+LV+ D V DFGL + Q G + V+ + APE + + +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--------WTAPEALREKKFST 178
Query: 577 KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSER 636
K+DV+S G++L E+ + + R R + +++ PR+ Y
Sbjct: 179 KSDVWSFGILLWEIYS------------------FGRVPYPRIPLKDVV-PRVEKGYKMD 219
Query: 637 EVYG--------MLQCASLCIRKDPHSRPRMSQVLRMLE 667
G M QC L D +RP Q+ LE
Sbjct: 220 APDGCPPVVYDVMKQCWHL----DAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 70/239 (29%), Positives = 106/239 (44%), Gaps = 39/239 (16%)
Query: 381 PRWFTYAELELATNRFSEANFLAEGGFGSVHR----GVLPDGQ----VVAVKQYKLASSQ 432
P+W E +R L EG FG V R G+ VAVK K ++
Sbjct: 5 PKW------EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD 58
Query: 433 GD-QEFCSEVEVLSC-AQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGR------ 484
D + SE+E++ +H+N++ L+G C ++G ++ EY G+L L R
Sbjct: 59 KDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPD 118
Query: 485 --------DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL 536
+ L + A ARG+ YL CI HRD+ N+LVT D
Sbjct: 119 YTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCI-HRDLAARNVLVTEDNVMK 174
Query: 537 VGDFGLARWQPDGDMGVET---RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT 592
+ DFGLAR D D +T R+ ++APE T ++DV+S G+++ E+ T
Sbjct: 175 IADFGLARGVHDIDYYKKTSNGRL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 79/279 (28%), Positives = 114/279 (40%), Gaps = 40/279 (14%)
Query: 402 LAEGGFGSVHRG--VLPDGQV--VAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVMLI 456
L +G FG V RG G+V VAVK K +F E ++ H N++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
G V ++V E GSL L S AV A G+RYL +
Sbjct: 63 GV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---- 117
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD----MGVETRVLGTFGYLAPEYAQSG 572
+HRD+ NIL+ D + +GDFGL R P + M +V F + APE ++
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRTR 175
Query: 573 QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL--- 629
+ +DV+ GV L E+ T G++ WA L I + ID
Sbjct: 176 TFSHASDVWMFGVTLWEMFT----------YGEE---PWAG--LSGSQILKKIDKEGERL 220
Query: 630 -RNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRML 666
R +++Y MLQC + +P RP + + L
Sbjct: 221 ERPEACPQDIYNVMLQCWA----HNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 73/244 (29%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 390 ELATNRFSEANFLAEGGFGSVHR-GVLPDGQVVAVKQYKLASSQG-DQEFCSEVEVLSCA 447
EL + F + L G G V + P G ++A K L + E++VL
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 448 QHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRY 507
+V G DG + E++ GSLD L R P E + IAV RGL Y
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAY 118
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE 567
L E+ + I+HRD++P+NILV E + DFG++ D + +GT Y++PE
Sbjct: 119 LREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPE 172
Query: 568 YAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK-RHAIGELID 626
Q + ++D++S+G+ LVEL GR + P ++ + RP++ I
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGR--YPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230
Query: 627 PRLR 630
PR R
Sbjct: 231 PRPR 234
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 93/329 (28%), Positives = 143/329 (43%), Gaps = 64/329 (19%)
Query: 381 PRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDG-----------QVVAVKQYKLA 429
PRW E+ +R L EG FG V V+ + VAVK K
Sbjct: 11 PRW------EVPRDRLVLGKPLGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSD 61
Query: 430 SSQGD-QEFCSEVEVLS-CAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHL------ 481
+++ D + SE+E++ +H+N++ L+G C +DG ++ EY G+L +L
Sbjct: 62 ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 121
Query: 482 -----YGRDRDPLEWSARRKI---AVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF 533
Y + P E + + + A ARG+ YL + CI HRD+ N+LVT D
Sbjct: 122 GMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCI-HRDLAARNVLVTEDN 177
Query: 534 EPLVGDFGLARWQPDGDMGVETRVLGTFG-----YLAPEYAQSGQITEKADVYSLGVVLV 588
+ DFGLAR D +T T G ++APE T ++DV+S GV+L
Sbjct: 178 VMKIADFGLARDIHHIDYYKKT----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 233
Query: 589 ELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLC 648
E+ T + P E LLK G +D + NC E+Y M++ C
Sbjct: 234 EIFTLGGSPYPGVP------VEELFKLLKE---GHRMD-KPSNC--TNELYMMMRD---C 278
Query: 649 IRKDPHSRPRMSQVLRMLEGDILMNSKDD 677
P RP Q++ L+ + + S +
Sbjct: 279 WHAVPSQRPTFKQLVEDLDRILALTSNQE 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 402 LAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGD-----QEFCSEVEVLSCAQHRNVVML 455
L +G FG V+ D G+ +AVKQ + E+++L QH +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 456 IGFCVEDGRRLLVY-EYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRYLHEEC 512
G C+ D L ++ EY+ GS+ L YG L + RK G+ YLH
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSNM 124
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLA-RWQPDGDMGVETR-VLGTFGYLAPEYAQ 570
IVHRD++ NIL +GDFG + R Q G + V GT +++PE
Sbjct: 125 ----IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 571 SGQITEKADVYSLGVVLVELIT 592
KADV+S+G +VE++T
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 34/221 (15%)
Query: 402 LAEGGFGSVHRGV------LPDGQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVM 454
L EG FG V + VAVK K +S + ++ SE +L H +V+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHL--------------YGRDRDPLEWSARRKIAVG 500
L G C +DG LL+ EY GSL S L R+ L+ R + +G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 501 --------AARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552
+RG++YL E +VHRD+ N+LV + + DFGL+R + D
Sbjct: 128 DLISFAWQISRGMQYLAEM----KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 553 VE-TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT 592
V+ ++ ++A E T ++DV+S GV+L E++T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 402 LAEGGFGSV------HRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVML 455
L EG FG V + D +VAVK K + ++F E E+L+ QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGR--------DRDPLE------WSARRKIAVGA 501
G C + ++V+EY+ +G L+ L D P + S IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 502 ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD-MGVETRVLGT 560
A G+ YL + VHRD+ N LV + +GDFG++R D V +
Sbjct: 133 ASGMVYLASQ----HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 561 FGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKA--MDLNRPRGQQCLTEWARPLLKR 618
++ PE + T ++DV+S GV+L E+ T K L+ +C+T+
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ-------- 240
Query: 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666
G +++ R R C +EVY ++ C +++P R + ++ ++L
Sbjct: 241 ---GRVLE-RPRVC--PKEVYDIMLG---CWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 41/273 (15%)
Query: 402 LAEGGFGSVHRG-VLPDGQVVAVKQYKL-ASSQGDQEFCSEVEVL-SCAQHRNVVMLIGF 458
L G G+V++ L +++AVK L + + ++ SE+E+L C + F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 459 CVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIV 518
VE+ R + E++ GSLD +Y + + + +IAV +GL YL I+
Sbjct: 69 FVEN-RISICTEFMDGGSLD--VYRKIPEHV----LGRIAVAVVKGLTYLWSLK----IL 117
Query: 519 HRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKA 578
HRD++P+N+LV + + DFG++ + + +GT Y+APE Q +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 579 DVYSLGVVLVELITGR-KAMDLNRPRGQ-------QCLTEWARPLLKRHAIGELIDPRLR 630
DV+SLG+ +EL GR + + +G QC+ + P+L
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ---------- 224
Query: 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663
+SE+ V+ + Q C+RK P RP ++
Sbjct: 225 --FSEKFVHFITQ----CMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 28/282 (9%)
Query: 396 FSEANFLAEGGFGSVHRGVLPDGQ-VVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVV 453
F++ + +G FG V +G+ Q VVA+K L ++ + ++ E+ VLS V
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
G ++D + ++ EY+ GS L + PL+ + I +GL YLH E +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 122
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
+ HRD++ N+L++ E + DFG+A D + +GT ++APE +
Sbjct: 123 I----HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQSA 177
Query: 574 ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCY 633
KAD++SLG+ +EL G P L P P L Y
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------------PTLEGNY 225
Query: 634 SEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSK 675
S+ + + C+ K+P RP ++L+ I+ +K
Sbjct: 226 SKP----LKEFVEACLNKEPSFRPTAKELLK--HKFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 6e-16
Identities = 70/272 (25%), Positives = 117/272 (43%), Gaps = 44/272 (16%)
Query: 405 GGFGSVH--RGVLPDGQVVAVKQYKLASSQGDQEFC--SEVEVLSCAQHRNVVMLIGFCV 460
G FG VH R D ++V +KQ + D+ +E +VL H N++ +
Sbjct: 11 GAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL 69
Query: 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
ED ++V EY G+L ++ R L+ V L ++H + I+HR
Sbjct: 70 EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL----ILHR 125
Query: 521 DMRPNNILVT-HDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKAD 579
D++ NIL+ H +GDFG+++ V+GT Y++PE + +K+D
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEGKPYNQKSD 183
Query: 580 VYSLGVVLVELITGRKAMD-LNRP-------RGQQCLTEWARPLLKRHAIGELIDPRLRN 631
+++LG VL EL + ++A + N P G I + P LR
Sbjct: 184 IWALGCVLYELASLKRAFEAANLPALVLKIMSGTF------------APISDRYSPDLR- 230
Query: 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663
+ + ML DP RP++SQ++
Sbjct: 231 ----QLILSMLNL-------DPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 7e-16
Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 20/266 (7%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
L G FG V G + VAVK K + Q F E ++ QH +V L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
+ ++ EY+ GSL L + + + A G+ Y+ + +HRD
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRD 128
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVY 581
+R N+LV+ + DFGLAR D + + APE G T K+DV+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 582 SLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGM 641
S G++L E++T K P ++ L + + + PR+ NC E+Y +
Sbjct: 189 SFGILLYEIVTYGKI-----PYPGMSNSDVMSALQRGYRM-----PRMENC--PDELYDI 236
Query: 642 LQCASLCIRKDPHSRPRMSQVLRMLE 667
++ C ++ RP + +L+
Sbjct: 237 MK---TCWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 63/194 (32%), Positives = 89/194 (45%), Gaps = 7/194 (3%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
L G FG V G VAVK K + + F E +++ +H +V L E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
+ +V EY+ GSL L + L+ +A A G+ Y+ R+ I HRD
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYI-HRD 127
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVY 581
+R NILV + DFGLAR D + + APE A G+ T K+DV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 582 SLGVVLVELIT-GR 594
S G++L EL+T GR
Sbjct: 188 SFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 48/224 (21%)
Query: 394 NRFSEANFLAEGGFGSVHRGVLPDGQV-VAVKQYKLASSQGDQEFCS----EVEVLSCAQ 448
+R+ + + G +G V VA+K KL+ E+ +L
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMD 72
Query: 449 HRNVVMLIG-FC----VEDGRRLLVYEYICNGSLDSHLYGRD------RDPLEWSARRKI 497
H NV+ L+ F +ED + VY L +HL G D L + +
Sbjct: 73 HENVIGLLDVFTPASSLEDFQD--VY-------LVTHLMGADLNNIVKCQKLSDDHIQFL 123
Query: 498 AVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV 557
RGL+Y+H G I+HRD++P+NI V D E + DFGLAR D +M T
Sbjct: 124 VYQILRGLKYIHS---AG-IIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDEM---TGY 175
Query: 558 LGTFGYLAPE-------YAQSGQITEKADVYSLGVVLVELITGR 594
+ T Y APE Y Q+ D++S+G ++ EL+TG+
Sbjct: 176 VATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 80/293 (27%), Positives = 125/293 (42%), Gaps = 47/293 (16%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQG-DQEFCSEVEVLSCAQHRNVVMLIGFC 459
L G G V + + P G ++A K L + E++VL +V G
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVH 519
DG + E++ GSLD L R P + IAV RGL YL E+ + I+H
Sbjct: 69 YSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV--LRGLTYLREKHK---IMH 123
Query: 520 RDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKAD 579
RD++P+NILV E + DFG++ D + +GT Y++PE Q T ++D
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYTVQSD 180
Query: 580 VYSLGVVLVELITGR----------------------KAMDLNRPRGQQCLTEWARPLLK 617
++SLG+ LVE+ GR +A + +RP RP+
Sbjct: 181 IWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS-PRPM-- 237
Query: 618 RHAIGELID-------PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663
AI EL+D P+L + E + C++K+P R + ++
Sbjct: 238 --AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDK---CLKKNPKERADLKELT 285
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 18/199 (9%)
Query: 405 GGFGSVHRGVL-PDG---QVVAVKQYKLA-SSQGDQEFCSEVEVLSCAQHRNVVMLIGFC 459
G FG V RG L G VA+K K + + ++F SE ++ H N++ L G
Sbjct: 15 GEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV--GAARGLRYLHEECRVGCI 517
+ +++ E++ NG+LDS L D +++ + + + G A G++YL E
Sbjct: 75 TKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEM----NY 127
Query: 518 VHRDMRPNNILVTHDFEPLVGDFGLARW-QPDGDMGVETRVLG---TFGYLAPEYAQSGQ 573
VHRD+ NILV + V DFGL+R+ + D T LG + APE +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 574 ITEKADVYSLGVVLVELIT 592
T +DV+S G+V+ E+++
Sbjct: 188 FTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 77/302 (25%), Positives = 125/302 (41%), Gaps = 63/302 (20%)
Query: 402 LAEGGFGSVHR----GVLPDGQ--VVAVKQYKL-ASSQGDQEFCSEVEVLSCAQHRNVVM 454
+ +G FG V + G+LP +VAVK K AS+ +F E +++ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHL--------------------YGRDRDPLEWSAR 494
L+G C L++EY+ G L+ L G + PL + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 495 RKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-------WQP 547
IA A G+ YL E VHRD+ N LV + + DFGL+R ++
Sbjct: 133 LCIAKQVAAGMAYLSER----KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC 607
+ + R ++ PE + T ++DV++ GVVL E+ + G Q
Sbjct: 189 SENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS----------YGMQP 232
Query: 608 LTEWARPLLKRHAIGELIDPRLRNC--YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665
A I + D + +C E+Y +++ LC K P RP + + R+
Sbjct: 233 YYGMAH----EEVIYYVRDGNVLSCPDNCPLELYNLMR---LCWSKLPSDRPSFASINRI 285
Query: 666 LE 667
L+
Sbjct: 286 LQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 54/227 (23%)
Query: 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE---FCS--EVEVLSCAQ 448
R+ + L EG + V++ G++VA+K+ KL + ++ F + E+++L +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 449 HRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAA------ 502
H N++ L+ LV+E+ +++ L +D + I + A
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEF-----METDLEKVIKD-------KSIVLTPADIKSYM 108
Query: 503 ----RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW--QPDGDMG--VE 554
RGL YLH I+HRD++PNN+L+ D + DFGLAR P+ M V
Sbjct: 109 LMTLRGLEYLHSNW----ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164
Query: 555 TRVLGTFGYLAPE-------YAQSGQITEKADVYSLGVVLVELITGR 594
TR Y APE Y D++S+G + EL+
Sbjct: 165 TRW-----YRAPELLFGARHYGVG------VDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 388 ELELATNRFSEANFLAEGGFGSVHRG--VLP---DGQVVAVKQYK-LASSQGDQEFCSEV 441
EL L+ RF E L E FG +++G LP Q+VA+K K + + Q EF E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 442 EVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRD---------------R 486
+++ H N+V L+G ++ +++EY+ G L L R +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 487 DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546
L+ IA+ A G+ YL VH+D+ NIL+ + D GL+R
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSH----FFVHKDLAARNILIGEQLHVKISDLGLSREI 174
Query: 547 PDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT 592
D V+ + L ++ PE G+ + +D++S GVVL E+ +
Sbjct: 175 YSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 6/204 (2%)
Query: 390 ELATNRFSEANFLAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ 448
E+ + + L G +G V+ GV VAVK K + + + EF E V+ +
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 60
Query: 449 HRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYL 508
H N+V L+G C + ++ E++ G+L +L +R + +A + + YL
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 509 HEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEY 568
++ +HRD+ N LV + V DFGL+R + APE
Sbjct: 121 EKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 569 AQSGQITEKADVYSLGVVLVELIT 592
+ + K+DV++ GV+L E+ T
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 15/210 (7%)
Query: 391 LATNRFSEANFLAEGGFGSVHRGV-LPDGQV----VAVKQYKLASS-QGDQEFCSEVEVL 444
L + L G FG+VH+G+ +P+G VA+K + S Q QE + +
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63
Query: 445 SCAQHRNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAAR 503
H +V L+G C G L LV + GSL H+ RD L+ V A+
Sbjct: 64 GSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAK 120
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-WQPDGDMGVETRVLGTFG 562
G+ YL E +VHR++ NIL+ D + DFG+A PD +
Sbjct: 121 GMYYLEEHR----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 563 YLAPEYAQSGQITEKADVYSLGVVLVELIT 592
++A E G+ T ++DV+S GV + E+++
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 85/290 (29%), Positives = 125/290 (43%), Gaps = 50/290 (17%)
Query: 402 LAEGGFGSVHRGVL--PDG--QVVAVKQYKLA--SSQGDQEFCSEVEVLSCAQHRNVVML 455
L EG FGSV G L DG VAVK KL + +EF SE + H NV+ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 456 IGFCVEDGRR------LLVYEYICNGSLDSHL-YGRDRD-----PLEWSARRKIAVGAAR 503
IG C E +++ ++ +G L S L Y R PL+ K V A
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQ--TLLKFMVDIAL 124
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT-FG 562
G+ YL +HRD+ N ++ D V DFGL++ GD + R+
Sbjct: 125 GMEYLSNRN----FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 563 YLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622
++A E T K+DV++ GV + E+ T RGQ P ++ H I
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT----------RGQT-----PYPGVENHEIY 225
Query: 623 ELI--DPRLR---NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
+ + RL+ +C E+Y ++ C R DP RP +++ +LE
Sbjct: 226 DYLRHGNRLKQPEDCLD--ELYDLM---YSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 26/271 (9%)
Query: 396 FSEANFLAEGGFGSVHRGVLPDGQ-VVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVV 453
F++ + +G FG V +G+ Q VVA+K L ++ + ++ E+ VLS V
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
G ++ + ++ EY+ GS L D + + K + +GL YLH E +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSEKK 122
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
+ HRD++ N+L++ + + DFG+A D + T V GT ++APE Q
Sbjct: 123 I----HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSA 177
Query: 574 ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCY 633
KAD++SLG+ +EL G P P+ I + P L +
Sbjct: 178 YDSKADIWSLGITAIELAKGEP------PNSDM------HPMRVLFLIPKNNPPTLTGEF 225
Query: 634 SEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
S+ + C+ KDP RP ++L+
Sbjct: 226 SK----PFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 72/266 (27%), Positives = 111/266 (41%), Gaps = 21/266 (7%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
L +G FG V G VA+K K + + F E +++ +H +V L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
+ +V E++ GSL L D L+ +A A G+ Y+ R+ I HRD
Sbjct: 73 E-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYI-HRD 127
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVY 581
+R NILV + + DFGLAR D + + APE A G+ T K+DV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 582 SLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGM 641
S G++L EL+T + P + + E ++ R + +
Sbjct: 188 SFGILLTELVTKGRV---------------PYPGMVNREVLEQVERGYRMPCPQGCPESL 232
Query: 642 LQCASLCIRKDPHSRPRMSQVLRMLE 667
+ LC +KDP RP + LE
Sbjct: 233 HELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 400 NFLAEGGFGSVHRGVL--PDGQVV--AVKQY-KLASSQGDQEFCSEVEVLSCAQHRNVVM 454
+ +G FG V+ G L DGQ + AVK ++ + ++F E ++ H NV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 455 LIGFCV-EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVG--AARGLRYLHEE 511
L+G C+ +G L+V Y+ +G L + + +P + + I G A+G+ YL +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP---TVKDLIGFGLQVAKGMEYLASK 117
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-------WQPDGDMGVETRVLGTFGYL 564
VHRD+ N ++ F V DFGLAR + G + V ++
Sbjct: 118 K----FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV----KWM 169
Query: 565 APEYAQSGQITEKADVYSLGVVLVELIT 592
A E Q+ + T K+DV+S GV+L EL+T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 7e-15
Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 32/218 (14%)
Query: 402 LAEGGFGSVHRGVL-PDGQVVAVKQY--KLASSQGDQEF-CSEVEVLSC-AQHRNVVMLI 456
+ EG F +V + A+K + + ++ E EVL+ H ++ L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 457 GFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
+ +D L V EY NG L ++ R L+ R A L YLH G
Sbjct: 69 -YTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLALEYLH---SKG 122
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL----------------- 558
I+HRD++P NIL+ D + DFG A+ +
Sbjct: 123 -IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 559 --GTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
GT Y++PE + +D+++LG ++ +++TG+
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 78/276 (28%), Positives = 118/276 (42%), Gaps = 45/276 (16%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD---QEFCSEVEVLSCAQHRNVVMLIG 457
+ G FG+V+ +VVAVK+ + Q + Q+ EV+ L +H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 458 FCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCI 517
+++ LV EY C GS S L + PL+ I GA +GL YLH +
Sbjct: 89 CYLKEHTAWLVMEY-CLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN----M 142
Query: 518 VHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEY---AQSGQI 574
+HRD++ NIL+T + + DFG A + V GT ++APE GQ
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQY 197
Query: 575 TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI------DPR 628
K DV+SLG+ +EL E PL +A+ L P
Sbjct: 198 DGKVDVWSLGITCIEL------------------AERKPPLFNMNAMSALYHIAQNDSPT 239
Query: 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
L++ G + C++K P RP +++LR
Sbjct: 240 LQSNEWTDSFRGFV---DYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 74/273 (27%), Positives = 125/273 (45%), Gaps = 30/273 (10%)
Query: 396 FSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVV 453
F++ + +G FG V++G+ +VVA+K L ++ + ++ E+ VLS +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 454 MLIGFCVEDGRRLLVYEYICNGS-LDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC 512
G ++ + ++ EY+ GS LD G PLE + I +GL YLH E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER 121
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSG 572
++ HRD++ N+L++ + + DFG+A D + T V GT ++APE +
Sbjct: 122 KI----HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176
Query: 573 QITEKADVYSLGVVLVELITGRKA-MDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631
KAD++SLG+ +EL G DL+ P+ I + P L
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLH-------------PMRVLFLIPKNSPPTLEG 223
Query: 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
YS+ + C+ KDP RP ++L+
Sbjct: 224 QYSKP----FKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 77/272 (28%), Positives = 133/272 (48%), Gaps = 39/272 (14%)
Query: 405 GGFGSVHRGV-LPDGQVVAVKQYKLASSQGD-QEFCSEVEVLS---CAQHRNVVMLIGFC 459
G +G+V+RG +P G+VVA+K L + D + EV +LS +Q N+ G
Sbjct: 12 GAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYG-S 70
Query: 460 VEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV---GAARGLRYLHEECRVG 515
G RL ++ EY GS+ + + P+ A + I+V L+Y+H +VG
Sbjct: 71 YLKGPRLWIIMEYAEGGSVRTLM---KAGPI---AEKYISVIIREVLVALKYIH---KVG 121
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQIT 575
++HRD++ NILVT+ + DFG+A + + + +GT ++APE G+
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAA-LLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 576 E-KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR-NCY 633
+ KAD++SLG+ + E+ TG N P + R ++ I + PRL N Y
Sbjct: 180 DTKADIWSLGITIYEMATG------NPPYSDV---DAFRAMM---LIPKSKPPRLEDNGY 227
Query: 634 SEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665
S+ + + + C+ ++P R ++L+
Sbjct: 228 SKL----LREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 74/281 (26%), Positives = 127/281 (45%), Gaps = 32/281 (11%)
Query: 402 LAEGGFGSVHRGVLPDGQVVA---VKQYKLASSQGDQ-EFCSEVEVLSCAQHRNVVMLIG 457
+ G FG V G G A VK+ + +++ +Q F EV+ H NV+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 458 FCVEDGRRLLVYEYICNGSLDSHL---YGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514
C+E LLV E+ G L ++L G + +++A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---- 118
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLA--RWQPDGDMGVETRVLGTFGYLAPEYAQSG 572
+H D+ N +T D +GD+GLA ++ D + + + +LAPE +
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEIR 177
Query: 573 Q-------ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625
T+K++++SLGV + EL T ++P + + +++ I +L
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAA-----DQPYPDLSDEQVLKQVVREQDI-KLP 231
Query: 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666
P+L YS+R Y ++Q L DP +RP +V +L
Sbjct: 232 KPQLDLKYSDR-WYEVMQFCWL----DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 64/211 (30%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 402 LAEGGFGSVHRGVL------PDGQVVAVKQYKLASSQGDQE-FCSEVEVLSCAQHRNVVM 454
L G FG V+ G+ VAVK + S+ D+ F E ++S H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHL-YGRDR----DPLEWSARRKIAVGAARGLRYLH 509
LIG E R ++ E + G L S L R R L A A+G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL- 132
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLV---GDFGLAR-------WQPDGDMGVETRVLG 559
EE +HRD+ N L+T V DFG+AR ++ G R +
Sbjct: 133 EENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG------RAML 183
Query: 560 TFGYLAPEYAQSGQITEKADVYSLGVVLVEL 590
++ PE G T K DV+S GV+L E+
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 396 FSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD---QEFCSEVEVLSCAQHRN 451
FS+ + G FG+V+ + + +VVA+K+ + Q + Q+ EV L +H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEE 511
+ G + + LV EY C GS S L + PL+ + GA +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEY-CLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEY--- 568
++HRD++ NIL++ +GDFG A M +GT ++APE
Sbjct: 135 N----MIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANXFVGTPYWMAPEVILA 185
Query: 569 AQSGQITEKADVYSLGVVLVEL 590
GQ K DV+SLG+ +EL
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 54/189 (28%), Positives = 91/189 (48%), Gaps = 20/189 (10%)
Query: 418 GQVVAVKQYKL----ASSQGD--QEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471
G ++AVKQ +S Q + + E+ +++ H +++ ++G ED L E+
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84
Query: 472 ICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV 529
+ GS+ L YG + + RGL YLHE I+HRD++ N+L+
Sbjct: 85 MAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHENQ----IIHRDVKGANLLI 136
Query: 530 THDFEPL-VGDFGLA-RWQPDGDMGVETR--VLGTFGYLAPEYAQSGQITEKADVYSLGV 585
+ L + DFG A R G E + +LGT ++APE + Q DV+S+G
Sbjct: 137 DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGC 196
Query: 586 VLVELITGR 594
V++E+ T +
Sbjct: 197 VIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 402 LAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
L +G FG V++ + G A K ++ S + ++F E+++LS +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
+ + ++ E+ G+LDS + +R L R + L +LH ++HR
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSH----KVIHR 127
Query: 521 DMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYA-----QSGQIT 575
D++ NIL+T D + + DFG++ +T + GT ++APE +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYD 186
Query: 576 EKADVYSLGVVLVELITGR 594
KAD++SLG+ L+EL
Sbjct: 187 YKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 73/244 (29%), Positives = 111/244 (45%), Gaps = 49/244 (20%)
Query: 381 PRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDG-----------QVVAVKQYKLA 429
P+W EL+ R + L EG FG V V+ + VAVK K
Sbjct: 5 PKW------ELSRTRLTLGKPLGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDD 55
Query: 430 SSQGD-QEFCSEVEVLS-CAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRD 487
++ D + SE+E++ +H+N++ L+G C +DG ++ EY G+L +L R
Sbjct: 56 ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPP 115
Query: 488 PLEWSARR--------------KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF 533
+++S A ARG+ YL + CI HRD+ N+LVT D
Sbjct: 116 GMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCI-HRDLAARNVLVTEDN 171
Query: 534 EPLVGDFGLARWQPDGDMGVETRVLGTFG-----YLAPEYAQSGQITEKADVYSLGVVLV 588
+ DFGLAR + D +T T G ++APE T ++DV+S GV+L
Sbjct: 172 VMKIADFGLARDVHNIDYYKKT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 227
Query: 589 ELIT 592
E+ T
Sbjct: 228 EIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 31/230 (13%)
Query: 390 ELATNRFSEANFLAEGGFGSVH----RGVLP---------DGQ--VVAVKQYKL-ASSQG 433
E + L EG FG VH G+ DGQ +VAVK + +
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 434 DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDP----- 488
+F E++++S ++ N++ L+G CV D ++ EY+ NG L+ L R+ +
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 489 -----LEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543
+ + +AV A G++YL VHRD+ N LV + + + DFG++
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASL----NFVHRDLATRNCLVGNHYTIKIADFGMS 176
Query: 544 RWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT 592
R GD ++ R + ++A E G+ T +DV++ GV L E+ T
Sbjct: 177 RNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 71/243 (29%), Positives = 110/243 (45%), Gaps = 47/243 (19%)
Query: 381 PRWFTYAELELATNRFSEANFLAEGGFGSV--------HRGVLPDGQVVAVKQYKLASSQ 432
PRW E + ++ + L EG FG V + + VAVK K +++
Sbjct: 8 PRW------EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE 61
Query: 433 GD-QEFCSEVEVLS-CAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLE 490
D + SE+E++ +H+N++ L+G C +DG ++ EY G+L +L R R P
Sbjct: 62 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPG 119
Query: 491 WSARRKIA----------------VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE 534
IA ARG+ YL + CI HRD+ N+LVT +
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCI-HRDLAARNVLVTENNV 175
Query: 535 PLVGDFGLARWQPDGDMGVETRVLGTFG-----YLAPEYAQSGQITEKADVYSLGVVLVE 589
+ DFGLAR + D +T T G ++APE T ++DV+S GV++ E
Sbjct: 176 MKIADFGLARDVNNIDYYKKT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 231
Query: 590 LIT 592
+ T
Sbjct: 232 IFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 77/306 (25%), Positives = 119/306 (38%), Gaps = 74/306 (24%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYK--LASSQGDQEFCSEVEVLSCAQ---HRNVVML 455
L +G FGSV+ G++VA+K+ K S + E + EV S + H N+V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE---ECMNLREVKSLRKLNEHPNIVKL 63
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYG----RDRDPLEWSARRKIAVGAARGLRYLHEE 511
E+ V+EY ++ +LY R P S R I +GL ++H
Sbjct: 64 KEVFRENDELYFVFEY-----MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH-- 116
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE-----TRVLGTFGYLAP 566
+ G HRD++P N+LV+ + DFGLAR + T + T Y AP
Sbjct: 117 -KHG-FFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYRAP 167
Query: 567 E-YAQSGQITEKADVYSLGVVLVELIT------GRKAMD-LNR-------------PRGQ 605
E +S + D+++LG ++ EL T G +D L + P G
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227
Query: 606 QCLTEWARPLLKR------HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRM 659
+ L + + + N E + +R DP RP
Sbjct: 228 K--------LASKLGFRFPQFAPTSLHQLIPNASPE-----AIDLIKDMLRWDPKKRPTA 274
Query: 660 SQVLRM 665
SQ L+
Sbjct: 275 SQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 79/285 (27%), Positives = 130/285 (45%), Gaps = 35/285 (12%)
Query: 402 LAEGGFGSVHRGVLPD---GQV---VAVKQYKLASSQGDQ-EFCSEVEVLSCAQHRNVVM 454
L +G FG V+ G D G+ VAVK ++S ++ EF +E V+ +VV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHLYG--------RDRDPLEWSARRKIAVGAARGLR 506
L+G + L+V E + +G L S+L R P ++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE-TRVLGTFGYLA 565
YL+ + VHRD+ N +V HDF +GDFG+ R + D + + L ++A
Sbjct: 134 YLNAKK----FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 566 PEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625
PE + G T +D++S GVVL E+ + L Q E +LK G +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNE---QVLKFVMDGGYL 240
Query: 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670
D + NC V +++ +C + +P RP +++ +L+ D+
Sbjct: 241 D-QPDNC--PERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDDL 279
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 402 LAEGGFGSVHRGVLPD-GQVVAVKQY---KLASSQGDQEFCSEVEVLSCAQHRNVVMLIG 457
L +GGFG V + G++ A K+ +L +G+Q +E ++L R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 458 FCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
+ E L LV + G L H+Y + A GL +LH+
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---- 115
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITE 576
IV+RD++P N+L+ + D GLA G ++ R GT GY+APE Q
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK-IKGRA-GTPGYMAPEVLQGEVYDF 173
Query: 577 KADVYSLGVVLVELITGR 594
D ++LG L E+I GR
Sbjct: 174 SVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 76/298 (25%), Positives = 119/298 (39%), Gaps = 55/298 (18%)
Query: 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVL-SCAQH 449
T F + EG +G V++ GQ+VA+K + + ++E E +L + H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNH 62
Query: 450 RNVVMLIGF------CVEDGRRLLVYEYICNGSL-----DSHLYGRDRDPLEWSARRKIA 498
N+ G D + LV E GS+ G+ R EW A I
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAY--IL 119
Query: 499 VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL 558
RGL YLHE ++HRD++ NIL+T + E + DFG++ Q D +G +
Sbjct: 120 RETLRGLAYLHENK----VIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFI 174
Query: 559 GTFGYLAPEYAQSGQ-----ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613
GT ++APE + ++DV+SLG+ +EL G
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG------------------KP 216
Query: 614 PLLKRHAIGELID------PRL-RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
PL H + L P L ++ + S C+ K+ RP M ++L
Sbjct: 217 PLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFI---SECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 396 FSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD---QEFCSEVEVLSCAQHRN 451
F++ + G FG+V+ + +VVA+K+ + Q + Q+ EV+ L +H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEE 511
+ G + + LV EY C GS S L + PL+ I GA +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEY-CLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEY--- 568
++HRD++ NIL+T + + DFG A + V GT ++APE
Sbjct: 145 N----MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILA 195
Query: 569 AQSGQITEKADVYSLGVVLVEL 590
GQ K DV+SLG+ +EL
Sbjct: 196 MDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 68/285 (23%), Positives = 124/285 (43%), Gaps = 48/285 (16%)
Query: 395 RFSEANFLAEGGFGSVHRGVL----PDGQVVAVKQYKLA--SSQGDQEFCSEVEVLSCAQ 448
++ + + EG FG + +L DG+ +K+ ++ S + +E EV VLS +
Sbjct: 1 KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK 57
Query: 449 HRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGR------DRDPLEWSARRKIAVGAA 502
H N+V E+G +V +Y G L + + + L+W V
Sbjct: 58 HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQIC 111
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG 562
L+++H+ I+HRD++ NI +T D +GDFG+AR + + + +GT
Sbjct: 112 LALKHVHDRK----ILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPY 166
Query: 563 YLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622
YL+PE ++ K+D+++LG VL E+ T + A + +
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------------------- 207
Query: 623 ELIDPRLRNCY---SEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
L+ +R Y S Y + S +++P RP ++ +L
Sbjct: 208 NLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 76/275 (27%), Positives = 131/275 (47%), Gaps = 36/275 (13%)
Query: 402 LAEGGFGSVHRGVL--PDGQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVMLIGF 458
L +G +GSV++ VL P G +A+K+ +L + + E+++L A +V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 459 CVEDGRRLLVYEYICNGSLDSHLY--GRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
+G + EY+ GSLD LY G + + R+I +GL++L EE
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--- 123
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM--GVETRVLGTFGYLAPEYAQSGQI 574
I+HRD++P N+LV + + + DFG++ G++ + +G Y+APE +SG
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTNIGCQSYMAPERIKSGGP 178
Query: 575 TE------KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628
+ ++DV+SLG+ ++E+ GR P + L AI + P
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGR------YPYPPETYANIFAQL---SAIVDGDPPT 229
Query: 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663
L + YS+ + C+ K P+ RP +Q+L
Sbjct: 230 LPSGYSDDA----QDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 63/207 (30%), Positives = 91/207 (43%), Gaps = 31/207 (14%)
Query: 405 GGFGSVH---RGVLPDGQVVAVKQYKLASSQG----DQEFCSEVEVLSCAQHRNVVMLIG 457
G +G V + G + A+K K A DQ +E ++LS AQ VV L
Sbjct: 4 GAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVL-TERDILSQAQSPYVVKL-- 58
Query: 458 FCVEDGRR--LLVYEYICNGSLDS--HLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
+ G++ LV EY+ G L S G L+ R L YLH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLH---S 111
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLA------RWQPDGDMGVET-RVLGTFGYLAP 566
G I+HRD++P+NIL+ + + DFGL+ R D E R++GT Y+AP
Sbjct: 112 NG-IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 567 EYAQSGQITEKADVYSLGVVLVELITG 593
E ++ D +SLG +L E + G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 390 ELATNRFSEANFLAEGGFGSVHRGV--LPDGQV--VAVKQYKLASSQGDQE-FCSEVEVL 444
E+ + + EG FG V++GV P+ + VAVK K +S +E F E ++
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 445 SCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARG 504
H ++V LIG E+ +V E G L S+L ++ L+ ++ + +
Sbjct: 62 RQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTA 119
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL 564
L YL + VHRD+ N+LV+ +GDFGL+R+ D ++ ++
Sbjct: 120 LAYLESK----RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM 175
Query: 565 APEYAQSGQITEKADVYSLGVVLVELI 591
APE + T +DV+ GV + E++
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 72/286 (25%), Positives = 125/286 (43%), Gaps = 45/286 (15%)
Query: 399 ANFLAE-----GGFGSVHRGV-LPDGQVVAVKQ---YKLASSQGDQEFCSEVEVLSCAQH 449
ANF E G F V+R L D + VA+K+ +++ ++ Q+ E+++L H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 450 RNVVMLIGFCVEDGRRLLVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRY 507
NV+ + +ED +V E G L + + + + + K V + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE 567
+H ++HRD++P N+ +T +GD GL R+ + V GT Y++PE
Sbjct: 122 MHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 568 YAQSGQITEKADVYSLGVVLVELIT------GRKAMDLNR--PRGQQCLTEWARPLLKRH 619
K+D++SLG +L E+ G K M+L + +QC ++ PL H
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLFSLCQKIEQC--DYP-PLPTEH 232
Query: 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665
YSE+ + + S+CI DP RP + V ++
Sbjct: 233 -------------YSEK----LRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 400 NFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSCAQHRNVV- 453
+ G +G V V G+ VA+K K+++ D E+++L +H N++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 454 ---MLIGFCVEDGRRL-LVYEYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRY 507
+L ED + +V E +++ L+ + PL + RGL+Y
Sbjct: 64 LLDILRPPSPEDFNDVYIVTEL-----METDLHKVIKSPQPLTDDHIQYFLYQILRGLKY 118
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-WQPDGDM------GVETRVLGT 560
LH ++HRD++P+NILV + + + DFGLAR PD D V TR
Sbjct: 119 LHS----ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW--- 171
Query: 561 FGYLAPE-YAQSGQITEKADVYSLGVVLVELITGR 594
Y APE S + T+ D++S+G + EL+T +
Sbjct: 172 --YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 402 LAEGGFGSVH------RGVLPDGQVVAVKQYKLASSQGDQ--EFCSEVEVLSCAQHRNVV 453
L EG FG V G G+ VAVK K S G+ + E+E+L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHENIV 69
Query: 454 MLIGFCVEDGRR--LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEE 511
G C EDG L+ E++ +GSL +L R+++ + + K AV +G+ YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD--GDMGVETRVLGTFGYLAPEYA 569
VHRD+ N+LV + + +GDFGL + V+ + + APE
Sbjct: 129 Q----YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 570 QSGQITEKADVYSLGVVLVELIT 592
+ +DV+S GV L EL+T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 390 ELATNRFSEANFLAEGGFGSV----HRGVLPDGQVVAVKQYKLASSQG-DQEFCSEVEVL 444
EL + F + + L G G V H+ P G ++A K L + E++VL
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHK---PSGLIMARKLIHLEIKPAIRNQIIRELQVL 57
Query: 445 SCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARG 504
+V G DG + E++ GSLD L R P + + IAV +G
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKG 115
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL 564
L YL E+ + I+HRD++P+NILV E + DFG++ D + +GT Y+
Sbjct: 116 LTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYM 169
Query: 565 APEYAQSGQITEKADVYSLGVVLVELITGR 594
+PE Q + ++D++S+G+ LVE+ GR
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 12/204 (5%)
Query: 396 FSEANFLAEGGFGSVHR-GVLPDGQVVAVKQY---KLASSQGDQEFCSEVEVLSCAQHRN 451
F + L +GGFG V V G++ A K+ ++ +G+ +E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 452 VVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE 510
VV L + E L LV + G L H+Y E A GL LH
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQ 570
E V+RD++P NIL+ + D GLA P+G+ + RV GT GY+APE
Sbjct: 121 EN----TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLN 174
Query: 571 SGQITEKADVYSLGVVLVELITGR 594
+ + T D + LG ++ E+I G+
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 74/266 (27%), Positives = 117/266 (43%), Gaps = 25/266 (9%)
Query: 396 FSEANFLAEGGFGSVHR-GVLPDGQVVAVKQY---KLASSQGDQEFCSEVEVLSCAQHRN 451
F + L +GGFG V V G++ A K+ ++ +G+ +E ++L R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 452 VVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE 510
VV L + E L LV + G L H+Y E A GL LH+
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQ 570
E IV+RD++P NIL+ + D GLA P+G ++ RV GT GY+APE +
Sbjct: 121 ER----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVK 174
Query: 571 SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630
+ + T D ++LG +L E+I G+ + + +KR + L+ ++
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK------------IKREEVERLVK-EVQ 221
Query: 631 NCYSEREVYGMLQCASLCIRKDPHSR 656
YSE+ + + KDP R
Sbjct: 222 EEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 12/195 (6%)
Query: 402 LAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
L +G FG V++ + G + A K + S + +++ E+E+L+ H +V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
DG+ ++ E+ G++D+ + DR L + I L+YLH I+HR
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHSM----KIIHR 134
Query: 521 DMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITE---- 576
D++ N+L+T D + + DFG++ + + +GT ++APE + +
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 577 -KADVYSLGVVLVEL 590
KAD++SLG+ L+E+
Sbjct: 194 YKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 82/315 (26%), Positives = 129/315 (40%), Gaps = 63/315 (20%)
Query: 395 RFSEANFLAEGGFGSVHRGVLPDGQ-----------------VVAVKQYKL-ASSQGDQE 436
F E L EG FG VH + + Q +VAVK + A+ +
Sbjct: 8 LFKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND 65
Query: 437 FCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLY----------GRDR 486
F EV++LS + N++ L+G CV++ ++ EY+ NG L+ L G D
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125
Query: 487 DP-------LEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGD 539
P + +S+ +A+ A G++YL VHRD+ N LV + + D
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSL----NFVHRDLATRNCLVGENLTIKIAD 181
Query: 540 FGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMD 598
FG++R GD ++ R + ++A E G+ T +DV++ GV L E++ K
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241
Query: 599 LNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSERE------VYG-MLQCASLCIRK 651
+Q + GE + R Y R +Y MLQC S +
Sbjct: 242 YGELTDEQVIEN----------AGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWS----R 287
Query: 652 DPHSRPRMSQVLRML 666
D RP S + L
Sbjct: 288 DCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 20/219 (9%)
Query: 390 ELATNRFSEANFLAEGGFGSVHRGVL-------PDGQVVAVKQYKLASSQGDQEFCSEVE 442
E+A + + + L +G FG V+ G+ P+ +V + AS + EF +E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 443 VLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRD--------PLEWSAR 494
V+ +VV L+G + L++ E + G L S+L + P
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 495 RKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554
++A A G+ YL+ VHRD+ N +V DF +GDFG+ R + D +
Sbjct: 122 IQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 555 -TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT 592
+ L +++PE + G T +DV+S GVVL E+ T
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 76/281 (27%), Positives = 111/281 (39%), Gaps = 49/281 (17%)
Query: 402 LAEGGFGSVHRGVL-PDGQVVAVKQYK-LASSQGDQEFCSEVEVLSCAQHRNVVMLIGFC 459
+ G FG V G L D VAVK + +F E +L H N+V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDP-LEWSARRKIAVGAARGLRYLHEECRVGCIV 518
+ +V E + G + L R P L+ ++ AA G+ YL + CI
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI- 116
Query: 519 HRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG--------YLAPEYAQ 570
HRD+ N LVT + DFG++R + DG V + G + APE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDG-------VYASTGGMKQIPVKWTAPEALN 169
Query: 571 SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630
G+ + ++DV+S G++L E + L L E I+ +R
Sbjct: 170 YGRYSSESDVWSFGILLWEAFS---------------LGAVPYANLSNQQTREAIEQGVR 214
Query: 631 -----NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666
C VY +++ C DP RP S V + L
Sbjct: 215 LPCPELC--PDAVYRLME---RCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 10/157 (6%)
Query: 440 EVEVLSCAQHRNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIA 498
E +L H +V L + +D + LV + + G L HL + + +
Sbjct: 50 ERRILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL-SQ-KVKFSEEQVKFWI 106
Query: 499 VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL 558
L YLH + I+HRD++P+NIL+ + DF +A + T
Sbjct: 107 CEIVLALEYLHSKG----IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS-- 160
Query: 559 GTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRK 595
GT GY+APE + D +SLGV E + G++
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 78/283 (27%), Positives = 122/283 (43%), Gaps = 37/283 (13%)
Query: 402 LAEGGFGSVHRGVL---PDGQVVAVKQYKL-ASSQGDQEFCSEVEVLSCAQHRNVVMLIG 457
+ G FG V + V VK+ K ASS+ EF + + QH N++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 458 FCVEDGRRLLVYEYICNGSLDSHL-----YGRDRDPLEWSARRKIAVGAARGLRYLHEEC 512
CVE LLV+EY G L S+L + R+ L +++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL---QRMACEIAAGVTHMHKH- 118
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGL--ARWQPDGDMGVETRVLGTFGYLAPEYAQ 570
+H D+ N +T D VGD+G+ +R++ D + E +LAPE
Sbjct: 119 ---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-IETEDDKCVPLRWLAPELVG 174
Query: 571 SGQ-------ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623
T+ ++V++LGV L EL +P E ++K + +
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAA-----QPYSHLSDREVLNHVIKDQQV-K 228
Query: 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666
L P+L YSER Y +LQ L P R +V R+L
Sbjct: 229 LFKPQLELPYSER-WYEVLQFCWL----SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 73/295 (24%), Positives = 119/295 (40%), Gaps = 73/295 (24%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHR-----NV 452
L G +G V H P G ++AVK ++ ++ QE Q R ++
Sbjct: 9 LGRGAYGVVDKMRHV---PTGTIMAVK--RIRATVNSQE-----------QKRLLMDLDI 52
Query: 453 VMLIGFCVEDGRRLLVYEY----------IC----NGSLDS---HLYGRDRDPLEWSARR 495
M C V Y IC + SLD +Y + E
Sbjct: 53 SMRSVDCPY-----TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPE-DILG 106
Query: 496 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET 555
KIAV + L YLH + V +HRD++P+N+L+ + + + DFG++ + D + +T
Sbjct: 107 KIAVSIVKALEYLHSKLSV---IHRDVKPSNVLINRNGQVKLCDFGISGYLVD-SV-AKT 161
Query: 556 RVLGTFGYLAPEY----AQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEW 611
G Y+APE K+DV+SLG+ ++EL TGR D W
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----------SW 210
Query: 612 ARPLLKRHAIGELIDPRL-RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665
P + + E P+L +S + + C++K+ RP ++L+
Sbjct: 211 KTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNK----CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 405 GGFGSVHRGVL--PDGQ--VVAVKQYKLASSQGDQ-EFCSEVEVLSCAQHRNVVMLIGFC 459
G FG V G L P + VA+K K ++ + +F SE ++ H N++ L G
Sbjct: 15 GEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV--GAARGLRYLHEECRVGCI 517
+ ++V EY+ NGSLD+ L D +++ + + + G A G++YL +
Sbjct: 75 TKSKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDM----GY 127
Query: 518 VHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG--YLAPEYAQSGQIT 575
VHRD+ NILV + V DFGL+R D T G + APE + T
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187
Query: 576 EKADVYSLGVVLVELIT 592
+DV+S G+V+ E+++
Sbjct: 188 SASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 395 RFSEANFLAEGGFGSVH--RGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA--QHR 450
R+ + EG FG ++ + V +K+ L ++ S+ EV+ A +H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 451 NVVMLIGFCVEDGRRLLVYEYICNGSLDSH-------LYGRDRDPLEWSARRKIAVGAAR 503
N+V E+GR +V EY G L L+ D+ L W V +
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ-ILSW------FVQISL 112
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHD-FEPLVGDFGLARWQPDGDMGVETRVLGTFG 562
GL+++H+ I+HRD++ NI ++ + +GDFG+AR Q + M + +GT
Sbjct: 113 GLKHIHDRK----ILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPY 167
Query: 563 YLAPEYAQSGQITEKADVYSLGVVLVELIT 592
YL+PE Q+ K D++SLG VL EL T
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 55/205 (26%), Positives = 83/205 (40%), Gaps = 18/205 (8%)
Query: 402 LAEGGFGSVHRGVLP------DGQVVAVKQYKLASSQGDQ-EFCSEVEVLSCAQHRNVVM 454
L G FG V +V VK + + Q EF E+++ H+NVV
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHLY---GRDRD----PLEWSARRKIAVGAARGLRY 507
L+G C E ++ EY G L L +D PL + + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE 567
L VHRD+ N LV+ E V L++ + + L +LAPE
Sbjct: 133 LSN----ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 568 YAQSGQITEKADVYSLGVVLVELIT 592
Q + K+DV+S GV++ E+ T
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFC-SEVEVLSCAQHRNVVMLIGFC 459
L EG + +V++G G++VA+K+ L + +G E+ ++ +H N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 460 VEDGRRLLVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCI 517
+ + +LV+EY + L ++ +G R L+ + + +G+ + HE +
Sbjct: 68 HTENKLMLVFEY-MDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR----V 121
Query: 518 VHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLG----TFGYLAPE-YAQSG 572
+HRD++P N+L+ E + DFGLAR G+ T Y AP+ S
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLAR-----AFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 573 QITEKADVYSLGVVLVELITGR 594
+ D++S+G ++ E+ITGR
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 70/290 (24%), Positives = 128/290 (44%), Gaps = 50/290 (17%)
Query: 396 FSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLS-CAQHRNVV 453
F + G +G V++G + GQ+ A+K + + ++E E+ +L + HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66
Query: 454 MLIGFCVE------DGRRLLVYEYICNGSLDSHLYGRDRDPL--EWSARRKIAVGAARGL 505
G ++ D + LV E+ GS+ + + L EW A I RGL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 506 RYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLA 565
+LH+ ++HRD++ N+L+T + E + DFG++ Q D +G +GT ++A
Sbjct: 125 SHLHQHK----VIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMA 179
Query: 566 PEYAQSGQITE-----KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620
PE + + K+D++SLG+ +E+ G A PL H
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEG------------------APPLCDMHP 221
Query: 621 IGELI------DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
+ L PRL++ ++ ++ C+ K+ RP Q+++
Sbjct: 222 MRALFLIPRNPAPRLKSKKWSKKFQSFIES---CLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 18/198 (9%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVMLI-GFC 459
L +G FG V++ + V+A + S+ + +++ E+++L+ H N+V L+ F
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVH 519
E+ +L+ E+ G++D+ + +R PL R + L YLHE I+H
Sbjct: 73 YENNLWILI-EFCAGGAVDAVMLELER-PLTEPQIRVVCKQTLEALNYLHENK----IIH 126
Query: 520 RDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR--VLGTFGYLAPEYAQSGQITE- 576
RD++ NIL T D + + DFG++ ++ R +GT ++APE +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 577 ----KADVYSLGVVLVEL 590
KADV+SLG+ L+E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 402 LAEGGFGSVHRGVLPDGQV---VAVKQYKLA--SSQGDQEFCSEVEVLSCAQHRNVVMLI 456
L EG FGSV G L VAVK K+A + ++F SE + H NV+ LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 457 GFCVEDGRR------LLVYEYICNGSLDSHL-YGRDRD-PLEWSARR--KIAVGAARGLR 506
G C++ +++ ++ +G L S L Y R D P + K A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT-FGYLA 565
YL + +HRD+ N ++ + V DFGL++ +GD + R+ ++A
Sbjct: 127 YLSSKS----FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 566 PEYAQSGQITEKADVYSLGVVLVELIT 592
E T K+DV+S GV + E+ T
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 401 FLAEGGFGSVHRGVLPD-GQVVAVKQYKL--ASSQGDQEFCS---EVEVLSCAQHRNVVM 454
L +G FG V+ D G+ +A KQ + S + +E + E+++L QH +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 455 LIGFCVEDGRRLLV--YEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRYLHE 510
G + + L EY+ GS+ L YG L S RK G+ YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHS 124
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA-RWQPDGDMGVETR-VLGTFGYLAPEY 568
IVHRD++ NIL +GDFG + R Q G R V GT +++PE
Sbjct: 125 NM----IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 569 AQSGQITEKADVYSLGVVLVELITGR 594
KADV+SLG +VE++T +
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 72/296 (24%), Positives = 128/296 (43%), Gaps = 43/296 (14%)
Query: 384 FTYAELELATNRFSEANFLAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQ-EFCSEV 441
FT +L+ + + G FG+V++ + G ++AVK+ + + +Q ++
Sbjct: 1 FTAEDLK-------DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 442 EVLSCAQH-RNVVMLIGFCVEDGRRLLVYEYICNGSLDS---HLYGRDRDPLEWSARRKI 497
+V+ + +V G +G + E + + SLD ++Y + + KI
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYEVLKSVIPEEILGKI 112
Query: 498 AVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG---DMGVE 554
AV + L YL EE + I+HRD++P+NIL+ + + DFG++ G D +
Sbjct: 113 AVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAK 164
Query: 555 TRVLGTFGYLAPEYAQSGQITE---KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEW 611
TR G Y+APE ++DV+SLG+ L E+ TG+ +W
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-----------KW 213
Query: 612 ARPL--LKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665
L + G+ P L N + +LC+ KD RP+ ++L
Sbjct: 214 NSVFDQLTQVVKGD--PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 74/286 (25%), Positives = 119/286 (41%), Gaps = 45/286 (15%)
Query: 399 ANFLAE-----GGFGSVHRGV-LPDGQVVAVKQ---YKLASSQGDQEFCSEVEVLSCAQH 449
ANF E G F V+R L DG VA+K+ + L ++ + E+++L H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 450 RNVVMLIGFCVEDGRRLLVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRY 507
NV+ +ED +V E G L + + + + + K V L +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE 567
+H ++HRD++P N+ +T +GD GL R+ + V GT Y++PE
Sbjct: 122 MHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 568 YAQSGQITEKADVYSLGVVLVELIT------GRKAMDLNR--PRGQQCLTEWARPLLKRH 619
K+D++SLG +L E+ G K M+L + +QC PL H
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCKKIEQCDYP---PLPSDH 232
Query: 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665
YSE + Q ++CI DP RP ++ V +
Sbjct: 233 -------------YSEE----LRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 80/290 (27%), Positives = 129/290 (44%), Gaps = 47/290 (16%)
Query: 404 EGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEF----CSEVEVLSCAQHRNVVMLIGF 458
EG +G V + + GQ+VA+K K S+ D+ E+ +L +H N+V LI
Sbjct: 11 EGSYGMVMKCKHKETGQIVAIK--KFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 459 CVEDGRRLLVYEYICNGSLDSHLYGRDRDP--LEWSARRKIAVGAARGLRYLHEECRVGC 516
R LV+E++ + LD ++ P L+ S RK RG+ + H
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDD----LEKYPNGLDESRVRKYLFQILRGIEFCHSHN---- 120
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARW-QPDGDMGVETRVLGTFGYLAPEYAQSGQIT 575
I+HRD++P NILV+ + DFG AR G+ V T + T Y APE
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKY 178
Query: 576 EKA-DVYSLGVVLVELITGRKAM----DLNR-PRGQQCLTEWARPLLKRHAIGELID--- 626
+A D++++G ++ E++TG D+++ +CL L+ RH E+
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN----LIPRHQ--EIFQKNP 232
Query: 627 -------PRLRNCYSEREVYG-----MLQCASLCIRKDPHSRPRMSQVLR 664
P ++ + + +L A C+R DP RP SQ+L
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 400 NFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEF----CSEVEVLSCAQHRNVV- 453
N + EG +G V+R G++VA+K+ K+ + F E+ +L QH N+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE--KEGFPITSLREINILLKLQHPNIVT 68
Query: 454 ---MLIGFCVEDGRRLLVYEYICNGSLDSH----LYGRDRDPLEWSARRKIAVGAARGLR 506
+++G ++ +V EY+ H L + P S + + + G+
Sbjct: 69 VKEVVVGSNLDK--IYMVMEYV------EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-WQ-PDGDMGVETRVLGTFGYL 564
+LH+ I+HRD++ +N+L+ + + DFGLAR + P T+++ T Y
Sbjct: 121 HLHDNW----ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY---TQLVVTLWYR 173
Query: 565 APEYAQSGQI-TEKADVYSLGVVLVELITGR 594
APE + + D++S+G + EL+T +
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS--EVEVLSCAQHRNVVMLIGF 458
L EG FG V++ + G+VVA+K+ + + + + E+++L +H NVV LI
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 459 CVE---DGRRLLVYEYICNGSLDSHLYGRDRDP---LEWSARRKIAVGAARGLRYLHEEC 512
VE +R Y+ +D L G +P L S + + G+ YLHE
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH 135
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR--------WQPDGDMGVE--TRVLGTFG 562
I+HRD++ NIL+ + + DFGLAR + G G T ++ T
Sbjct: 136 ----ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRW 191
Query: 563 YLAPEY-AQSGQITEKADVYSLGVVLVELITGR 594
Y PE + T D++ +G V E+ T R
Sbjct: 192 YRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 391 LATNRFSEANFLAEGGFGSVHRGV-LPDGQ----VVAVKQYKLASS-QGDQEFCSEVEVL 444
L F + L G FG+V++G+ +P+G+ VA+K+ + A+S + ++E E V+
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 445 SCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARG 504
+ + +V L+G C+ +L+ LD +D ++ V A+G
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKG 121
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG-- 562
+ YL E +VHRD+ N+LV + DFGLA+ +G + + G
Sbjct: 122 MNYLEERR----LVHRDLAARNVLVKTPQHVKITDFGLAKL-----LGADEKEYHAEGGK 172
Query: 563 ----YLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMD 598
++A E T ++DV+S GV + EL+T G K D
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 396 FSEANFLAEGGFGSV----HRGVLPDGQVVAVKQYK---LASSQGDQEFCSEVEVLSCAQ 448
F L G FG V H+G G+ A+K K + + Q E +L
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 449 HRNVV-MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLE----WSARRKIAVGAAR 503
H +V M+ F ++ R + E++ G L +HL R P + + A +A
Sbjct: 77 HPFIVNMMCSF-QDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----- 130
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFG 562
YLH + I++RD++P N+L+ + V DFG A+ PD T L GT
Sbjct: 131 -FEYLHSKD----IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPE 180
Query: 563 YLAPEYAQSGQITEKADVYSLGVVLVELITG 593
YLAPE QS + D +++GV+L E I G
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYKLASSQGDQEF----CSEVEVLSCAQHRNVV 453
+ EG +G V +R GQ+VA+K K S+ D E+ +L +H N+V
Sbjct: 9 IGEGSYGVVFKCRNR---ETGQIVAIK--KFVESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 454 MLIGFCVEDGRRL-LVYEYICNGS----LDSHLYGRDRDPLEWSARRKIAVGAARGLRYL 508
LI R+L LV+EY C+ + L+ + G + +KI + + +
Sbjct: 64 NLIE-VFRRKRKLHLVFEY-CDHTVLNELEKNPRGVPEHLI-----KKIIWQTLQAVNFC 116
Query: 509 HEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW--QPDGDMGVETRVLGTFGYLAP 566
H+ CI HRD++P NIL+T + + DFG AR P D T + T Y AP
Sbjct: 117 HKH---NCI-HRDVKPENILITKQGQIKLCDFGFARILTGPGDDY---TDYVATRWYRAP 169
Query: 567 EY-AQSGQITEKADVYSLGVVLVELITG 593
E Q DV+++G V EL+TG
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 71/268 (26%), Positives = 110/268 (41%), Gaps = 25/268 (9%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
L G FG V VAVK K S + F +E V+ QH +V L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
+ ++ E++ GSL L + + A G+ ++ + +HRD
Sbjct: 73 E-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRD 127
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVY 581
+R NILV+ + DFGLAR D + + APE G T K+DV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 582 SLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYG 640
S G++L+E++T GR P E R L + + + PR NC E+Y
Sbjct: 188 SFGILLMEIVTYGRI------PYPGMSNPEVIRALERGYRM-----PRPENC--PEELYN 234
Query: 641 -MLQCASLCIRKDPHSRPRMSQVLRMLE 667
M++C + P RP + +L+
Sbjct: 235 IMMRCW----KNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 26/204 (12%)
Query: 402 LAEGGFGSVHR-GVLPDGQVVAVKQY-KLASSQGDQE---FCSEVEVLSCAQHRNVVMLI 456
L GGFG V V + A+K K + Q+ F E E+L H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59
Query: 457 -GFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPL-EWSARRKIAVGAARGLRYLHEECR 513
F +D + + ++ EY G L + L RDR E++AR IA YLH
Sbjct: 60 RTF--KDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIA-CVVLAFEYLHNRG- 113
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR---VLGTFGYLAPEYAQ 570
I++RD++P N+L+ + + DFG A+ + + GT Y+APE
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGFAK-----KLKSGQKTWTFCGTPEYVAPEIIL 165
Query: 571 SGQITEKADVYSLGVVLVELITGR 594
+ D +SLG++L EL+TGR
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 9/99 (9%)
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW---QPDGDMGVETRVLG 559
RGL+Y+H ++HRD++P+N+LV D E +GDFG+AR P T +
Sbjct: 118 RGLKYIHS----ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 560 TFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAM 597
T Y APE S + T D++S+G + E++ GR+ +
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 405 GGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEFCSEVEV-----LSCAQHRNVVMLIGF 458
G +G+V++ P G VA+K ++ +++ + EV L H N+V L+
Sbjct: 11 GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDV 70
Query: 459 CV-----EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
C + + LV+E++ + L ++L L + + RGL +LH
Sbjct: 71 CATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---- 125
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
CIVHRD++P NILVT + + DFGLAR M + T V+ T Y APE
Sbjct: 126 ANCIVHRDLKPENILVTSGGQVKLADFGLARIY-SCQMAL-TPVVVTLWYRAPEVLLQST 183
Query: 574 ITEKADVYSLGVVLVEL 590
D++S+G + E+
Sbjct: 184 YATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSCAQHRNVVMLI 456
+ EG +G V++G GQ+VA+K+ +L S ++ S E+ +L QH N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 457 GFCVEDGRRLLVYEYIC---NGSLDSHLYGRDRDP-LEWSARRKIAVGAARGLRYLHEEC 512
+++ R L++E++ LDS G+ D L S +I +G+ + H
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQI----LQGILFCHSR- 120
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV----LGTFGYLAPEY 568
RV +HRD++P N+L+ + + DFGLAR G+ RV + T Y APE
Sbjct: 121 RV---LHRDLKPQNLLIDNKGVIKLADFGLAR-----AFGIPVRVYTHEVVTLWYRAPEV 172
Query: 569 AQSGQ-ITEKADVYSLGVVLVELITGR 594
+ D++S+G + E+ T +
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 36/215 (16%)
Query: 396 FSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKL-ASSQG-DQEFCSEVEVL---SCAQH 449
+ E + EG +G+V++ L G+ VA+K+ ++ S +G E+ +L +H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 450 RNVVMLIGFC--VEDGRRL---LVYEYICNGSLDSHLYGRDRDP---LEWSARRKIAVGA 501
N+V L+ C R L LV+E+ + L ++L + P L + +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYL---SKCPKPGLPPETIKDLMRQL 116
Query: 502 ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF 561
RG+ +LH IVHRD++P NILVT D + + DFGLAR +M + T V+ T
Sbjct: 117 LRGVDFLHSHR----IVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMAL-TSVVVTL 170
Query: 562 GYLAPE------YAQSGQITEKADVYSLGVVLVEL 590
Y APE YA D++S+G + EL
Sbjct: 171 WYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 40/137 (29%), Positives = 63/137 (45%), Gaps = 13/137 (9%)
Query: 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 526
LV EY+ G S + P +W+ ++ G+ LH+ I+HRD++P N
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLPEDWA--KQYIAEVVLGVEDLHQRG----IIHRDIKPEN 127
Query: 527 ILVTHDFEPLVGDFGLARWQPDGDMGVET-RVLGTFGYLAPEYAQSGQITEKADVYSLGV 585
+L+ + DFGL+R G+E + +GT YLAPE + +D +SLG
Sbjct: 128 LLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181
Query: 586 VLVELITGRKAMDLNRP 602
V+ E + G P
Sbjct: 182 VIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 47/211 (22%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLAS------SQGDQEFCSEVEVLSCAQHRNVVM 454
+ EG +G+V + ++VA+K+ +L S +E C +L +H+N+V
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKELKHKNIVR 63
Query: 455 LIGFCVEDGRRLLVYEYI----------CNGSLDSHLYGRDRDPLEWSARRKIAVGAARG 504
L D + LV+EY CNG +D + + +G
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIV------------KSFMFQLLKG 111
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLG----T 560
L + H ++HRD++P N+L+ + E + DFGLAR G+ R T
Sbjct: 112 LAFCHSHN----VLHRDLKPQNLLINKNGELKLADFGLAR-----AFGIPVRCYSAEVVT 162
Query: 561 FGYLAPEYAQSGQI-TEKADVYSLGVVLVEL 590
Y P+ ++ + D++S G + EL
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 77/274 (28%), Positives = 122/274 (44%), Gaps = 39/274 (14%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYKL--ASSQGDQEFCSEVEVLSCAQHRNVVML 455
+ +G +G V HR DG+ +K+ L AS + + E ++LS +H N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 456 I-GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514
+ EDG +V + G L L + L + + V A L+YLHE+
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-- 122
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLAR-WQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
I+HRD++ N+ +T VGD G+AR + DM + ++GT Y++PE +
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA--STLIGTPYYMSPELFSNKP 178
Query: 574 ITEKADVYSLGVVLVELITGRKAM---DLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630
K+DV++LG + E+ T + A D+N L+ R G+L P +
Sbjct: 179 YNYKSDVWALGCCVYEMATLKHAFNAKDMNS-------------LVYRIIEGKL--PPMP 223
Query: 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
YS G L L K P RP + +LR
Sbjct: 224 KDYSPE--LGELIATMLS--KRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 32/231 (13%)
Query: 390 ELATNRFSEANFLAEGGFGSVH----------------RGVLPDGQV-VAVKQYKL-ASS 431
E R + L EG FG VH V + V VAVK + A+
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 432 QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHL---------Y 482
+F E++++S + N++ L+ C+ ++ EY+ NG L+ L
Sbjct: 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120
Query: 483 GRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542
D + +S +A A G++YL VHRD+ N LV ++ + DFG+
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYLSSL----NFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 543 ARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT 592
+R GD ++ R + +++ E G+ T +DV++ GV L E++T
Sbjct: 177 SRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 57/194 (29%), Positives = 88/194 (45%), Gaps = 21/194 (10%)
Query: 418 GQVVAVKQYKLASSQGDQEFCS-EVEVLSCAQ--HRNVVMLI--GFCVEDGRRLLVYEYI 472
G VA+K + + + + + E CA+ H N+V L+ G G V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT-H 531
+L L P + R + V L H G IVHRD++P NI+V+
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQV--LDALACAH---NQG-IVHRDLKPQNIMVSQT 115
Query: 532 DFEP--LVGDFGLARWQPD-GDMGV-----ETRVLGTFGYLAPEYAQSGQITEKADVYSL 583
P V DFG+ P D V T VLGT Y APE + +T +D+Y+
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 584 GVVLVELITGRKAM 597
G++ +E +TG++ +
Sbjct: 176 GLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 74/274 (27%), Positives = 116/274 (42%), Gaps = 33/274 (12%)
Query: 402 LAEGGFGSVHRGVL--PDGQ--VVAVKQYKLASSQGDQE-FCSEVEVLSCAQHRNVVMLI 456
L G FG + RG L P + VA+ + S + F +E L H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
G ++V EY+ NG+LDS L + L + G A G++YL E +G
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQLMGMLPGLASGMKYLSE---MG- 127
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL--APEYAQSGQI 574
VH+ + + +LV D + F R Q D + T + G L APE Q
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 575 TEKADVYSLGVVLVELIT--GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632
+ +DV+S G+V+ E+++ R D++ + + + R P RNC
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------------PAPRNC 233
Query: 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666
+ + Q C +K+ RPR SQ+ +L
Sbjct: 234 PNL-----LHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/248 (24%), Positives = 116/248 (46%), Gaps = 24/248 (9%)
Query: 418 GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSL 477
G++VAVK+ L Q + +EV ++ QH NVV + + +V E++ G+L
Sbjct: 45 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 478 DSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLV 537
+ + + +A + + + L LH + ++HRD++ ++IL+THD +
Sbjct: 105 TDIVTHTRMNEEQIAA---VCLAVLKALSVLHAQG----VIHRDIKSDSILLTHDGRVKL 157
Query: 538 GDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAM 597
DFG Q ++ ++GT ++APE + D++SLG++++E++ G
Sbjct: 158 SDFGFCA-QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
Query: 598 DLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS-EREVYGMLQCASLCIRKDPHSR 656
N P PL I + + P+L+N + + G L L +R DP R
Sbjct: 217 -FNEP-----------PLKAMKMIRDNLPPKLKNLHKVSPSLKGFLD--RLLVR-DPAQR 261
Query: 657 PRMSQVLR 664
+++L+
Sbjct: 262 ATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 74/269 (27%), Positives = 112/269 (41%), Gaps = 31/269 (11%)
Query: 396 FSEANFLAEGGFGSVHR-GVLPDGQVVAVKQY---KLASSQGDQEFCSEVEVLSCAQHRN 451
F L +GGFG V V G++ A K+ ++ +G+ +E +L R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 452 VVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE 510
VV L + E L LV + G L H+Y + A GL L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQ 570
E IV+RD++P NIL+ + D GLA P+G+ V RV GT GY+APE
Sbjct: 121 ER----IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVIN 174
Query: 571 SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630
+ + T D + LG ++ E+I G+ + R +KR E +D R++
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER------------VKR----EEVDRRVK 218
Query: 631 N---CYSEREVYGMLQCASLCIRKDPHSR 656
YSE+ + + K+P R
Sbjct: 219 EDQEEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 402 LAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQGDQ-EFCSEVEVLSCAQHRNVVMLIGFC 459
L EG + +V++G +G++VA+K +L +G E +L +H N+V+L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 460 VEDGRRLLVYEYI----CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
LV+EY+ C +D H G + ++ + + RGL Y+H+
Sbjct: 73 HTKETLTLVFEYVHTDLCQ-YMDKHPGGLHPENVKLFLFQLL-----RGLSYIHQRY--- 123
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE-YAQSGQI 574
I+HRD++P N+L++ E + DFGLAR + V+ T Y P+ S +
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 575 TEKADVYSLGVVLVELITGRKAM 597
+ D++ +G + VE+I G A
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 55/194 (28%), Positives = 87/194 (44%), Gaps = 12/194 (6%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
L G FG V G VA+K K S D EF E +V+ H +V L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
+V EY+ NG L ++L + + S ++ G+ YL + +HRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRF-QPSQLLEMCKDVCEGMAYLESK----QFIHRD 125
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT---FGYLAPEYAQSGQITEKA 578
+ N LV V DFGL+R+ D + T +G+ + PE + + K+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 579 DVYSLGVVLVELIT 592
DV++ GV++ E+ +
Sbjct: 183 DVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 71/266 (26%), Positives = 115/266 (43%), Gaps = 34/266 (12%)
Query: 402 LAEGGFGSVHRGVL-PDGQVVAVKQY---KLASSQGDQEFCSEVEVLSCAQHRNVVMLIG 457
L +GGFG V + G++ A K+ +L +G + E +L+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 458 FCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAA--RGLRYLHEECRV 514
+ + L LV + G L H+Y D + + R A GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR-VLGTFGYLAPEYAQSGQ 573
I++RD++P N+L+ +D + D GLA DG +T+ GT G++APE Q +
Sbjct: 118 --IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEE 173
Query: 574 ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCY 633
D ++LGV L E+I R R RG++ LK+ + + + Y
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPF---RARGEKV----ENKELKQRILNDSVT------Y 220
Query: 634 SEREVYGMLQCASLC---IRKDPHSR 656
++ S C + KDP R
Sbjct: 221 PDK---FSPASKSFCEALLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 84/332 (25%), Positives = 136/332 (40%), Gaps = 65/332 (19%)
Query: 352 AVSLSRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSV- 410
AV L P S + P + +ELE N + G G+V
Sbjct: 42 AVPLPLPPPSSSSSSSS---SSSASGSAPSAAKSLSELE-------RVNRIGSGAGGTVY 91
Query: 411 ---HRGVLPDGQVVAVKQ-YKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466
HR P G++ A+K Y ++ C E+E+L H NVV +G
Sbjct: 92 KVIHR---PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148
Query: 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 526
++ E++ GSL+ ++ L AR+ ++ G+ YLH IVHRD++P+N
Sbjct: 149 VLLEFMDGGSLEGTHIADEQF-LADVARQILS-----GIAYLHRR----HIVHRDIKPSN 198
Query: 527 ILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS----GQITEKA-DVY 581
+L+ + DFG++R M +GT Y++PE + G A D++
Sbjct: 199 LLINSAKNVKIADFGVSRILAQ-TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIW 257
Query: 582 SLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSE------ 635
SLGV ++E GR + R +G +WA + AI C S+
Sbjct: 258 SLGVSILEFYLGRFPFGVGR-QG-----DWASLMC---AI----------CMSQPPEAPA 298
Query: 636 ---REVYGMLQCASLCIRKDPHSRPRMSQVLR 664
RE + C C++++P R Q+L+
Sbjct: 299 TASREFRHFISC---CLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQY--KLASSQGDQEFCSEVEVLSCAQH 449
TNR+ + + G FG V GQ VA+K+ ++ + E+++L +H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 450 RNVVMLIGFCV---EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLR 506
N++ L + ED V E + D H R PLE + RGL+
Sbjct: 69 ENIISLSDIFISPLED--IYFVTELL---GTDLHRLLTSR-PLEKQFIQYFLYQILRGLK 122
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAP 566
Y+H +VHRD++P+NIL+ + + + DFGLAR Q D M T + T Y AP
Sbjct: 123 YVHS----AGVVHRDLKPSNILINENCDLKICDFGLARIQ-DPQM---TGYVSTRYYRAP 174
Query: 567 EYAQSGQ-ITEKADVYSLGVVLVELITGR 594
E + Q + D++S G + E++ G+
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 83/280 (29%), Positives = 127/280 (45%), Gaps = 50/280 (17%)
Query: 402 LAEGGFGSVHRGV-LPDGQ----VVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVML 455
L G FG+V++G+ +PDG+ VA+K + +S + ++E E V++ V L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLY-GRDR----DPLEWSARRKIAVGAARGLRYLHE 510
+G C+ +L V + + G L ++ +DR D L W V A+G+ YL E
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYL-E 126
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG-----YLA 565
E R +VHRD+ N+LV + DFGLAR D D ET G ++A
Sbjct: 127 EVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL-DID---ETEYHADGGKVPIKWMA 179
Query: 566 PEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624
E + T ++DV+S GV + EL+T G K D R L E L
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL--------- 230
Query: 625 IDPRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVL 663
P+ C +VY M++C + D RPR +++
Sbjct: 231 --PQPPIC--TIDVYMIMVKCWMI----DSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-11
Identities = 63/231 (27%), Positives = 103/231 (44%), Gaps = 29/231 (12%)
Query: 379 NPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFC 438
N PR Y L + A F+A RG P +VVA ++ + + + +
Sbjct: 62 NNPREHMYVLTTLVGRNPTTAAFVAT-------RGSDPKEKVVA--KFVMLNDERQAAYA 112
Query: 439 -SEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKI 497
SE+ L+ H +V D + LL+ EY G L+ + R ++ L +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV- 171
Query: 498 AVGAARGLRYLH-----EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG-DM 551
GL + +E ++HRD++ NI + +GDFG ++ D +
Sbjct: 172 ------GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225
Query: 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRP 602
V + GT YLAPE + + ++KAD++SLGV+L EL+T L+RP
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT------LHRP 270
|
Length = 478 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 35/93 (37%), Positives = 55/93 (59%), Gaps = 9/93 (9%)
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG 562
+GL+Y+H I+HRD++P N+ V D E + DFGLAR Q D +M T + T
Sbjct: 129 KGLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEM---TGYVVTRW 180
Query: 563 YLAPEYAQSG-QITEKADVYSLGVVLVELITGR 594
Y APE + T+ D++S+G ++ E++TG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 16/217 (7%)
Query: 391 LATNRFSEANFLAEGGFGSVHRGV-LPDGQVV----AVKQY-KLASSQGDQEFCSEVEVL 444
L L G FG+V++G+ +P+G+ V A+K + + + EF E ++
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63
Query: 445 SCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARG 504
+ H ++V L+G C+ +L V + + +G L +++ +D + V A+G
Sbjct: 64 ASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKG 121
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF--G 562
+ YL EE R +VHRD+ N+LV + DFGLAR +GD G
Sbjct: 122 MMYL-EERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNADGGKMPIK 176
Query: 563 YLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMD 598
++A E + T ++DV+S GV + EL+T G K D
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 58/249 (23%), Positives = 113/249 (45%), Gaps = 26/249 (10%)
Query: 418 GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSL 477
G+ VAVK+ L Q + +EV ++ QH N+V + + +V E++ G+L
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 478 -DSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL 536
D + R + + + + L +LH + ++HRD++ ++IL+T D
Sbjct: 104 TDIVTHTRMNEE----QIATVCLAVLKALSFLHAQG----VIHRDIKSDSILLTSDGRVK 155
Query: 537 VGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKA 596
+ DFG Q ++ ++GT ++APE + D++SLG++++E++ G
Sbjct: 156 LSDFGFCA-QVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
Query: 597 MDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQC-ASLCIRKDPHS 655
N P PL I + + P+L+N + +V L+ + +DP
Sbjct: 215 Y-FNEP-----------PLQAMKRIRDNLPPKLKNLH---KVSPRLRSFLDRMLVRDPAQ 259
Query: 656 RPRMSQVLR 664
R +++L
Sbjct: 260 RATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 52/231 (22%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYK----LASSQGDQEFCSEVEVLSCAQHRNVV 453
+ G FG V + GQV A+K + + +Q +E ++L+ A +V
Sbjct: 9 IGRGAFGEVWLVRDK---DTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIV 64
Query: 454 MLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIA--VGAARGLRYLHE 510
L + +D L LV EY+ G L + L +D P E AR IA V A L +H
Sbjct: 65 KLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVLA---LDSVH- 118
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA---RWQPDG--------------DMGV 553
++G I HRD++P+NIL+ D + DFGL D ++ V
Sbjct: 119 --KLGFI-HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 554 ETR-----------VLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITG 593
R +GT Y+APE + + D +SLGV+L E++ G
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 12/204 (5%)
Query: 396 FSEANFLAEGGFGSVHR-GVLPDGQVVAVKQY---KLASSQGDQEFCSEVEVLSCAQHRN 451
F L +GGFG V V G++ A K+ ++ +G+ +E ++L R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 452 VVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE 510
VV L + E L LV + G L H+Y + A GL LH
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQ 570
E IV+RD++P NIL+ + D GLA P+G+ + RV GT GY+APE +
Sbjct: 121 ER----IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVK 174
Query: 571 SGQITEKADVYSLGVVLVELITGR 594
+ + T D + LG ++ E+I G+
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 394 NRFSEANFLAEGGFGSV----HRGVLPDGQVVAVKQYKLASSQGDQEF----CSEVEVLS 445
N+F + EG +G V H+ ++VA+K++K S+ ++E E+++L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKET---KEIVAIKKFK--DSEENEEVKETTLRELKMLR 55
Query: 446 CAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGL 505
+ N+V L G+ LV+EY+ +++ LE V +
Sbjct: 56 TLKQENIVELKEAFRRRGKLYLVFEYV------------EKNMLELLEEMPNGVPPEKVR 103
Query: 506 RYLHE------ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLG 559
Y+++ C IVHRD++P N+L++H+ + DFG AR +G T +
Sbjct: 104 SYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA 163
Query: 560 TFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
T Y +PE + D++S+G +L EL G+
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 67/288 (23%), Positives = 126/288 (43%), Gaps = 46/288 (15%)
Query: 396 FSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLS-CAQHRNVV 453
F + G +G V++G + GQ+ A+K + + ++E E+ +L + HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 454 MLIGFCVE------DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRY 507
G ++ D + LV E+ GS+ + + L+ I RGL +
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE 567
LH ++HRD++ N+L+T + E + DFG++ Q D +G +GT ++APE
Sbjct: 137 LH----AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPE 191
Query: 568 YAQSGQITE-----KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622
+ + ++D++SLG+ +E+ G A PL H +
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEG------------------APPLCDMHPMR 233
Query: 623 ELI------DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
L P+L++ ++ ++ C+ K+ SRP Q+L+
Sbjct: 234 ALFLIPRNPPPKLKSKKWSKKFIDFIEG---CLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 396 FSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKL-ASSQG-DQEFCSEVEVLSCAQHRNV 452
F + + EG +G V++ G+VVA+K+ +L ++G E+ +L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 453 VMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC 512
V L+ + + LV+E++ + L + + + +GL + H
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH- 119
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV----LGTFGYLAPEY 568
RV +HRD++P N+L+ + + DFGLAR GV R + T Y APE
Sbjct: 120 RV---LHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEVVTLWYRAPEI 171
Query: 569 AQSGQITEKA-DVYSLGVVLVELITGRKAM 597
+ A D++SLG + E++T R+A+
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 402 LAEGGFGSVH--RGVLPDGQVVAVKQYKLASSQGDQEFCSEVEV-----LSCAQHRNVVM 454
+ EG +G V R + G+ VA+K+ ++ + + + EV L +H NVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 455 LIGFCV-----EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLH 509
L C + + LV+E++ + L ++L + + + RGL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYA 569
RV VHRD++P NILVT + + DFGLAR T V+ T Y APE
Sbjct: 128 SH-RV---VHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVL 181
Query: 570 QSGQITEKADVYSLGVVLVELITGR 594
D++S+G + E+ +
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 55/177 (31%), Positives = 81/177 (45%), Gaps = 32/177 (18%)
Query: 496 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG---DMG 552
K+ V + L YL E+ V +HRD++P+NIL+ + DFG++ G D
Sbjct: 118 KMTVAIVKALHYLKEKHGV---IHRDVKPSNILLDASGNVKLCDFGIS-----GRLVDSK 169
Query: 553 VETRVLGTFGYLAPEYAQSGQITEK----ADVYSLGVVLVELITGRKAMDLNRPRGQQCL 608
+TR G Y+APE K ADV+SLG+ LVEL TG+ C
Sbjct: 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN-------CK 222
Query: 609 TEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCA--SLCIRKDPHSRPRMSQVL 663
TE+ +L + I + P L E + C+ LC+ KD RP+ ++L
Sbjct: 223 TEFE--VLTK--ILQEEPPSL----PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 404 EGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSCAQHRNVVMLIGF 458
EG +G V++ G++VA+K+ +L D+ S E+ +L H N+V L+
Sbjct: 9 EGTYGVVYKARDKLTGEIVALKKIRL--ETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 459 CVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIV 518
+ + LV+E++ + L ++ L+ + +G+ Y H R ++
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH-R---VL 121
Query: 519 HRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV----LGTFGYLAPE-YAQSGQ 573
HRD++P N+L+ + + DFGLAR GV R + T Y APE S Q
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLAR-----AFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 574 ITEKADVYSLGVVLVELITGR 594
+ D++S+G + E++ R
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 12/194 (6%)
Query: 402 LAEGGFGSVHRGV--LPDGQV-VAVKQYKLASSQGDQ-EFCSEVEVLSCAQHRNVVMLIG 457
L G FG V +GV + Q+ VA+K K + + + E E E++ + +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 458 FCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCI 517
C E +LV E G L+ L G+ +D + S ++ + G++YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN----F 116
Query: 518 VHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF--GYLAPEYAQSGQIT 575
VHRD+ N+L+ + + DFGL++ D + R G + + APE + +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 576 EKADVYSLGVVLVE 589
++DV+S G+ + E
Sbjct: 177 SRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 385 TYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVL 444
T+ + L +R SE + + V+ +V+ +KQ +Q +E VL
Sbjct: 13 TFGRVHLVRDRISEHYYALK---------VMAIPEVIRLKQ--------EQHVHNEKRVL 55
Query: 445 SCAQHRNVVMLIGFCVEDGRRLL--VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAA 502
H ++ L F E +R L + EY+ G L S+L R+ S A
Sbjct: 56 KEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIV 111
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTF 561
L YLH + IV+RD++P NIL+ + + DFG A+ D T L GT
Sbjct: 112 CALEYLHSKE----IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTP 162
Query: 562 GYLAPEYAQSGQITEKADVYSLGVVLVELITG 593
YLAPE QS + D ++LG+++ E++ G
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 378 GNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE 436
G+P + +T RF + + +G G+V+ + + GQ VA+KQ L +
Sbjct: 15 GDPKKKYT---------RFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL 62
Query: 437 FCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRK 496
+E+ V+ +H N+V + + +V EY+ GSL + D + +A
Sbjct: 63 IINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA--- 119
Query: 497 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL-ARWQPDGDMGVET 555
+ + L +LH ++HRD++ +NIL+ D + DFG A+ P+ +
Sbjct: 120 VCRECLQALEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RS 173
Query: 556 RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITG 593
++GT ++APE K D++SLG++ +E++ G
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 34/230 (14%)
Query: 388 ELELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYK-LASSQGDQEFCSE 440
E+ L+T RF E L E FG V++G L Q VA+K K A +EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 441 VEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRD--------------R 486
+ S QH N+V L+G ++ +++ Y + L L R +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 487 DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546
LE + I A G+ +L +VH+D+ N+LV + D GL R
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 547 PDGD----MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT 592
D MG L +++PE G+ + +D++S GVVL E+ +
Sbjct: 175 YAADYYKLMG---NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 4e-10
Identities = 48/200 (24%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVV 453
+++ + +G G+V+ + + GQ VA++Q L + +E+ V+ ++ N+V
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
+ + +V EY+ GSL + D + +A + + L +LH
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---VCRECLQALEFLHSNQ- 136
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
++HRD++ +NIL+ D + DFG Q + + ++GT ++APE
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 574 ITEKADVYSLGVVLVELITG 593
K D++SLG++ +E+I G
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 57/198 (28%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 402 LAEGGFGSV-HRGVLPDGQVVAVKQY---KLASSQGDQEFCSEVEVLSCAQHRNVVMLIG 457
L +GGFG V V G++ A K+ +L G++ E E+L +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 458 FCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
+ E L LV + G L H+Y LE + G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---- 115
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITE 576
IV+RDM+P N+L+ + D GLA DG T+ GT GY+APE + +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSY 173
Query: 577 KADVYSLGVVLVELITGR 594
D +++G + E++ GR
Sbjct: 174 PVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 65/248 (26%), Positives = 114/248 (45%), Gaps = 26/248 (10%)
Query: 418 GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVV-MLIGFCVEDGRRLLVYEYICNGS 476
G+ VAVK+ L Q + +EV ++ H NVV M + V D +V E++ G+
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD-ELWVVMEFLEGGA 105
Query: 477 LDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL 536
L + + R E A + + R L YLH + ++HRD++ ++IL+T D
Sbjct: 106 L-TDIVTHTRMNEEQIA--TVCLSVLRALSYLHNQG----VIHRDIKSDSILLTSDGRIK 158
Query: 537 VGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKA 596
+ DFG Q ++ ++GT ++APE + D++SLG++++E+I G
Sbjct: 159 LSDFGFCA-QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
Query: 597 MDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVY-GMLQCASLCIRKDPHS 655
N P PL I + + PR+++ + V G L L + ++P
Sbjct: 218 Y-FNEP-----------PLQAMRRIRDNLPPRVKDSHKVSSVLRGFL---DLMLVREPSQ 262
Query: 656 RPRMSQVL 663
R ++L
Sbjct: 263 RATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 5e-10
Identities = 48/200 (24%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVV 453
+++ + +G G+V+ + + GQ VA+KQ L + +E+ V+ ++ N+V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
+ + +V EY+ GSL + D + +A + + L +LH
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---VCRECLQALDFLHSNQ- 135
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
++HRD++ +NIL+ D + DFG Q + + ++GT ++APE
Sbjct: 136 ---VIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 574 ITEKADVYSLGVVLVELITG 593
K D++SLG++ +E++ G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 67/279 (24%), Positives = 114/279 (40%), Gaps = 36/279 (12%)
Query: 397 SEANFLAE---GGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVV 453
SE F+ E G FG VH G VA+K + +++F E +V+ H +V
Sbjct: 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLV 62
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
L G C + +V E++ NG L ++L R + L + G+ YL
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERN-- 119
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
+HRD+ N LV+ V DFG+ R+ D + + + PE +
Sbjct: 120 --SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 574 ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWA------RPLLKRHAIGELIDP 627
+ K+DV+S GV++ E+ T K M + + + + RP L + E+
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGK-MPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEV--- 233
Query: 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666
+ +C+ E+ P RP +++LR +
Sbjct: 234 -MYSCWHEK----------------PEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 402 LAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQGDQEFCS---EVEVLSCAQHRNVVMLIG 457
L EG + +V +G +VA+K+ +L +G C+ EV +L +H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP--CTAIREVSLLKNLKHANIVTLHD 70
Query: 458 FCVEDGRRLLVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAV-GAARGLRYLHEECRV 514
+ LV+EY LDS L Y + L KI + RGL Y H+
Sbjct: 71 IIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK-- 123
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE-YAQSGQ 573
I+HRD++P N+L+ E + DFGLAR + V+ T Y P+ S +
Sbjct: 124 --ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTE 180
Query: 574 ITEKADVYSLGVVLVELITGR 594
+ D++ +G +L E+ TGR
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 71/277 (25%), Positives = 114/277 (41%), Gaps = 49/277 (17%)
Query: 402 LAEGGFGSVHRGVL----PDGQVVAVKQYKLASSQGDQEFC-SEVEVLSCAQHRNVVMLI 456
+ EG FG R +L Q A+K+ +L S E E +L+ +H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 457 GFCVEDGRRLLVYEYICNGSL-------DSHLYGRDRDPLEWSARRKIAVGAARGLRYLH 509
DG +V EY G L L+ D L+W + + V +++H
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDT-ILQWFVQMCLGV------QHIH 117
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYA 569
E+ RV +HRD++ NI +T + + +GDFG AR +GT Y+ PE
Sbjct: 118 EK-RV---LHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-PGAYACTYVGTPYYVPPEIW 172
Query: 570 QSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629
++ K+D++SLG +L EL T + N W +LK
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPFQAN---------SWKNLILK----------VC 213
Query: 630 RNCYSEREVYGMLQCASLC---IRKDPHSRPRMSQVL 663
+ Y + + SL +++P SRP + +L
Sbjct: 214 QGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 36/93 (38%), Positives = 54/93 (58%), Gaps = 9/93 (9%)
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG 562
RGL+Y+H I+HRD++P+N+ V D E + DFGLAR D +M T + T
Sbjct: 131 RGLKYIHS----ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEM---TGYVATRW 182
Query: 563 YLAPEYAQSG-QITEKADVYSLGVVLVELITGR 594
Y APE + + D++S+G ++ EL+TGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 35/94 (37%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-WQPDGDMGVETRVLGTF 561
RGL+YLH I+HRD++P N+LV + + DFGLAR +PD + V+ +
Sbjct: 114 RGLKYLHS----AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169
Query: 562 GYLAPE-YAQSGQITEKADVYSLGVVLVELITGR 594
Y APE S T D++S+G + EL+ R
Sbjct: 170 -YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 68/240 (28%), Positives = 110/240 (45%), Gaps = 33/240 (13%)
Query: 402 LAEGGFGSVHRGVLPDG----QVVAVKQYKLAS---SQGDQEFC-SEVEVLSCAQHRNVV 453
L +GG+G V + G ++ A+K K A+ +Q D +E +L +H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
LI G+ L+ EY+ G L HL R+ +E +A ++ + L +LH++
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLE-REGIFMEDTACFYLS-EISLALEHLHQQG- 120
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
I++RD++P NIL+ + DFGL + T GT Y+APE
Sbjct: 121 ---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEILMRSG 176
Query: 574 ITEKADVYSLGVVLVELITG---------RKAMD------LNRPRGQQCLTEWARPLLKR 618
+ D +SLG ++ +++TG +K +D LN P LT AR LLK+
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP---PYLTPEARDLLKK 233
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 79/283 (27%), Positives = 119/283 (42%), Gaps = 48/283 (16%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVL-SCAQHRNVVMLIG-F 458
+ +G +G V++ DG + AVK S D+E +E +L S H NVV G F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 459 CVED----GRRLLVYEYICNGSLDSHLYG---RDRDPLEWSARRKIAVGAARGLRYLHEE 511
D G+ LV E +CNG + L L+ + I GA GL++LH
Sbjct: 89 YKADKLVGGQLWLVLE-LCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN 147
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS 571
I+HRD++ NNIL+T + + DFG++ + T V GT ++APE
Sbjct: 148 R----IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIAC 202
Query: 572 GQITE-----KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626
Q + + DV+SLG+ +EL G PL H + L
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDGDP------------------PLFDMHPVKTLFK 244
Query: 627 ------PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663
P L + E+ S C+ KD +RP ++ +L
Sbjct: 245 IPRNPPPTLLH--PEKWCRSFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 41/102 (40%), Positives = 56/102 (54%), Gaps = 15/102 (14%)
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR------WQPDGDMGVETR 556
GL+Y+H ++HRD++P N+LV D E + DFGLAR + G M T
Sbjct: 116 CGLKYIHS----ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM---TE 168
Query: 557 VLGTFGYLAPEYAQSGQITEKA-DVYSLGVVLVELITGRKAM 597
+ T Y APE S Q KA DV+S+G +L EL+ GRK +
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 64/207 (30%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 401 FLAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEFCSEVEVLSCA-------QHRNV 452
L G FG V+ D G+ +AVKQ QE EV L C +H +
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPF--DPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 453 VMLIGFCVED--GRRLLVY-EYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRY 507
V G C+ D ++L ++ EY+ GS+ L YG L + R+ +G+ Y
Sbjct: 67 VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSY 121
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA-RWQPDGDMGVETR-VLGTFGYLA 565
LH IVHRD++ NIL +GDFG + R Q G + V GT +++
Sbjct: 122 LHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 566 PEYAQSGQITEKADVYSLGVVLVELIT 592
PE KADV+S+ +VE++T
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 71/290 (24%), Positives = 117/290 (40%), Gaps = 59/290 (20%)
Query: 402 LAEGGFGSVHRGVL---PD------GQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRN 451
L +G F ++++GVL D GQ V+V L S F ++S H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEE 511
+V L G CV D ++V EY+ G LD L+ R+++ + + +A A L YL ++
Sbjct: 63 LVKLYGVCVRDE-NIMVEEYVKFGPLDVFLH-REKNNVSLHWKLDVAKQLASALHYLEDK 120
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD---GDMGVETRVLGT------FG 562
+VH ++ NILV G + P D G+ VL
Sbjct: 121 ----KLVHGNVCGKNILVARY-GLNEG------YVPFIKLSDPGIPITVLSREERVERIP 169
Query: 563 YLAPEYAQSGQ--ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR----PLL 616
++APE ++GQ +T AD +S G L+E+ + + L+ + + P+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE-PLSTLSSSEKERFYQDQHRLPMP 228
Query: 617 KRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666
+ LI C++ DP RP +LR L
Sbjct: 229 DCAELANLI----NQCWTY----------------DPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 49/195 (25%), Positives = 93/195 (47%), Gaps = 15/195 (7%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
+ G +G V++ + G++ A+K KL + E+ ++ +H N+V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 461 EDGRRLLVYEYICNGSLDS--HLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIV 518
+ + E+ GSL H+ G PL S ++ +GL YLH + ++
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKGKM---- 128
Query: 519 HRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYA---QSGQIT 575
HRD++ NIL+T + + DFG++ Q + +GT ++APE A + G
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSA-QITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 576 EKADVYSLGVVLVEL 590
+ D++++G+ +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 395 RFSEANFLAEGGFGSVHRGVLP-----DGQVVAVKQYK----LASSQGDQEFCSEVEVLS 445
++ + NF+ G GS R +L D VA+K+++ + Q D F SE ++L+
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILN 86
Query: 446 CAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGL 505
H V L G ++ LV E++ G + L R P + A +
Sbjct: 87 YINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP------NDVGCFYAAQI 140
Query: 506 RYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR---VLGTFG 562
+ E + IV+RD++P N+L+ D + DFG A+ V+TR + GT
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-------VDTRTYTLCGTPE 193
Query: 563 YLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRP 602
Y+APE + + AD ++LG+ + E++ G N P
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 47/176 (26%), Positives = 88/176 (50%), Gaps = 8/176 (4%)
Query: 418 GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSL 477
G+ VAVK L Q + +EV ++ QH+NVV + + ++ E++ G+L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 478 DSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLV 537
+ + + R E A + + L YLH + ++HRD++ ++IL+T D +
Sbjct: 106 -TDIVSQTRLNEEQIA--TVCESVLQALCYLHSQG----VIHRDIKSDSILLTLDGRVKL 158
Query: 538 GDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITG 593
DFG Q D+ ++GT ++APE + D++SLG++++E++ G
Sbjct: 159 SDFGFCA-QISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 35/93 (37%), Positives = 54/93 (58%), Gaps = 9/93 (9%)
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG 562
RGL+Y+H I+HRD++P+N+ V D E + DFGLAR Q D +M T + T
Sbjct: 129 RGLKYIHS----AGIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDEM---TGYVATRW 180
Query: 563 YLAPEYAQSG-QITEKADVYSLGVVLVELITGR 594
Y APE + + D++S+G ++ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 56/191 (29%), Positives = 88/191 (46%), Gaps = 20/191 (10%)
Query: 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 526
L+ +Y+ G + +HLY RD R + L +LH ++G IV+RD++ N
Sbjct: 82 LILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLH---KLG-IVYRDIKLEN 135
Query: 527 ILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKA-DVYSLGV 585
IL+ + ++ DFGL++ + GT Y+APE + KA D +SLG+
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGI 195
Query: 586 VLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCA 645
++ EL+TG L R Q +E +R +LK DP + E +L
Sbjct: 196 LIFELLTGASPFTLEGERNTQ--SEVSRRILK-------CDPPFPSFIGP-EAQDLLH-- 243
Query: 646 SLCIRKDPHSR 656
+RKDP R
Sbjct: 244 -KLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 42/126 (33%), Positives = 59/126 (46%), Gaps = 7/126 (5%)
Query: 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNI 527
V +Y+ G L HL R+R E AR A A L YLH I++RD++P NI
Sbjct: 74 VLDYVNGGELFFHLQ-RERSFPEPRARF-YAAEIASALGYLHSLN----IIYRDLKPENI 127
Query: 528 LVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVL 587
L+ ++ DFGL + + + GT YLAPE + D + LG VL
Sbjct: 128 LLDSQGHVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVL 186
Query: 588 VELITG 593
E++ G
Sbjct: 187 YEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 401 FLAEGGFGSVHRGVLPD-GQVVAVKQYKL--ASSQGDQEFCS---EVEVLSCAQHRNVVM 454
L +G FG V+ D G+ +AVKQ + S + +E + E+++L H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 455 LIGFCVEDGRRLL--VYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRYLHE 510
G + R L E++ GS+ L YG L + RK G+ YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHS 124
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA-RWQPDGDMGVETR-VLGTFGYLAPEY 568
IVHRD++ NIL +GDFG + R Q G + V GT +++PE
Sbjct: 125 NM----IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 569 AQSGQITEKADVYSLGVVLVELITGR 594
KAD++S+G +VE++T +
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 2e-09
Identities = 47/200 (23%), Positives = 94/200 (47%), Gaps = 9/200 (4%)
Query: 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVV 453
+++ + +G G+V + + GQ VA+KQ L + +E+ V+ ++ N+V
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
+ + +V EY+ GSL + D + +A + + L +LH
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA---VCRECLQALEFLH---- 132
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
++HRD++ +N+L+ D + DFG Q + + ++GT ++APE
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 574 ITEKADVYSLGVVLVELITG 593
K D++SLG++ +E++ G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 14/198 (7%)
Query: 402 LAEGGFGSVHRGVLP-DGQVVAVKQYKL-ASSQGDQEFCSEVE--VLSCAQHRNVVMLIG 457
L +G FG V L G++ AVK K Q D C+ E +LS A++ + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 458 FCVEDGRRLL-VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
C + RL V E++ G L H+ R + + R A L +LH++
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDKG---- 116
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPEYAQSGQIT 575
I++RD++ +N+L+ H+ + DFG+ + G T GT Y+APE Q
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 576 EKADVYSLGVVLVELITG 593
D +++GV+L E++ G
Sbjct: 175 PSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG 562
GL+Y+H I+HRD++P N+ V D E + DFGLAR D +M T + T
Sbjct: 128 CGLKYIHS----AGIIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEM---TGYVVTRW 179
Query: 563 YLAPEYAQSG-QITEKADVYSLGVVLVELITGR 594
Y APE + + D++S+G ++ E++TG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 58/186 (31%), Positives = 80/186 (43%), Gaps = 38/186 (20%)
Query: 451 NVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLE----WSARRKIAVGAARGLR 506
N+V L + V + LV ++ G L SH+ P E W+A +A+ A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW-----QPDGDMGVETRVLGTF 561
LH E IV RD+ PNNIL+ + F RW DG+ VE
Sbjct: 101 -LHREG----IVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGE-AVENM----- 147
Query: 562 GYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQ---------CLTEWA 612
Y APE + TE D +SLG +L EL+TG K + P G ++E A
Sbjct: 148 -YCAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEWVSEEA 205
Query: 613 RPLLKR 618
R LL++
Sbjct: 206 RSLLQQ 211
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
+ G +G V++ L G++ AVK KL E+ ++ +H N+V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 461 EDGRRLLVYEYICNGSLDS--HLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIV 518
+ + EY GSL H+ G PL + +GL YLH + ++
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSKGKM---- 128
Query: 519 HRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYA---QSGQIT 575
HRD++ NIL+T + + + DFG+A + + +GT ++APE A ++G
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAA-KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 576 EKADVYSLGVVLVEL 590
+ D++++G+ +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 402 LAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQGDQEFCS--EVEVLSCAQHRNVVMLIGF 458
L EG + +V++G+ +GQ+VA+K + + +G F + E +L +H N+V+L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71
Query: 459 CVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIV 518
V+EY+ + L ++ + L R RGL Y+H + I+
Sbjct: 72 IHTKETLTFVFEYM-HTDLAQYM-IQHPGGLHPYNVRLFMFQLLRGLAYIHGQH----IL 125
Query: 519 HRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE-YAQSGQITEK 577
HRD++P N+L+++ E + DFGLAR + + V+ T Y P+ + +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSA 184
Query: 578 ADVYSLGVVLVELITGRKA 596
D++ G + +E++ G+ A
Sbjct: 185 LDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 402 LAEGGFGSVHRG--VLPDGQVVAVKQYKLASSQGDQEFCS---EVEVLSCAQHRNVVMLI 456
L EG + +V +G L + +VA+K+ +L +G C+ EV +L +H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVTLH 70
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV-GAARGLRYLHEECRVG 515
D LV+EY+ D Y D + KI + RGL Y H
Sbjct: 71 DIVHTDKSLTLVFEYL---DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--- 124
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE-YAQSGQI 574
++HRD++P N+L+ E + DFGLAR + V+ T Y P+ S +
Sbjct: 125 -VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEY 182
Query: 575 TEKADVYSLGVVLVELITGR 594
+ + D++ +G + E+ +GR
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSCAQHRNVVMLI 456
+ EG +G V++ + +A+K+ +L Q D+ S E+ +L QH N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRL--EQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV---GAARGLRYLHEECR 513
+ R LV+EY+ + L H+ D P R I RG+ Y H R
Sbjct: 68 DVVHSEKRLYLVFEYL-DLDLKKHM---DSSPDFAKNPRLIKTYLYQILRGIAYCHSH-R 122
Query: 514 VGCIVHRDMRPNNILVTHDFEPL-VGDFGLARWQPDGDMGVETRVLG----TFGYLAPE- 567
V +HRD++P N+L+ L + DFGLAR G+ R T Y APE
Sbjct: 123 V---LHRDLKPQNLLIDRRTNALKLADFGLAR-----AFGIPVRTFTHEVVTLWYRAPEI 174
Query: 568 YAQSGQITEKADVYSLGVVLVELITGR 594
S + D++S+G + E++ +
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 34/95 (35%), Positives = 57/95 (60%), Gaps = 7/95 (7%)
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-WQPDGD-MGVETRVLGT 560
RGL+Y+H ++HRD++P+N+L+ + + + DFGLAR P+ D G T + T
Sbjct: 117 RGLKYIHS----ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 561 FGYLAPEYAQSGQITEKA-DVYSLGVVLVELITGR 594
Y APE + + KA D++S+G +L E+++ R
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 402 LAEGGFGSVHRG--VLPDGQVVAVKQYKLASSQGDQEFCS---EVEVLSCAQHRNVVMLI 456
L EG + +V++G L D +VA+K+ +L +G C+ EV +L +H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVTLH 70
Query: 457 GFCVEDGRRLLVYEYI----------CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLR 506
+ LV+EY+ C S++ H + RGL
Sbjct: 71 DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMH------------NVKLFLFQLLRGLN 118
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAP 566
Y H ++HRD++P N+L+ E + DFGLAR + V+ T Y P
Sbjct: 119 YCHRRK----VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPP 173
Query: 567 E-YAQSGQITEKADVYSLGVVLVELITGR 594
+ S + + D++ +G + E+ TGR
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 61/235 (25%), Positives = 108/235 (45%), Gaps = 30/235 (12%)
Query: 390 ELATNRFSEANFLAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEF----CSEVEVL 444
+ ++F + EG +G V++ D G++VA+K+ +L + + + F E+++L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60
Query: 445 SCAQHRNVVML----------IGFCVEDGRRLLVYEYICN---GSLDSHLYGRDRDPLEW 491
HRN+V L + F + G LV+EY+ + G L+S L D ++
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 492 SARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551
++ + GL Y H++ +HRD++ +NIL+ + + + DFGLAR +
Sbjct: 121 FMKQLL-----EGLNYCHKKN----FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 552 GVETRVLGTFGYLAPEYAQSGQ-ITEKADVYSLGVVLVELITGRKAMDLNRPRGQ 605
T + T Y PE + DV+S G +L EL T + N+ Q
Sbjct: 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 10/155 (6%)
Query: 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 526
L+ +Y+ G L +HLY R+ S R L +LH+ +G I++RD++ N
Sbjct: 82 LILDYVNGGELFTHLYQREH--FTESEVRVYIAEIVLALDHLHQ---LG-IIYRDIKLEN 135
Query: 527 ILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQI--TEKADVYSLG 584
IL+ + ++ DFGL++ + GT Y+APE + G + D +SLG
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195
Query: 585 VVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH 619
V+ EL+TG ++ + Q +E +R +LK
Sbjct: 196 VLTFELLTGASPFTVDGEQNSQ--SEISRRILKSK 228
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 53/186 (28%), Positives = 86/186 (46%), Gaps = 25/186 (13%)
Query: 424 KQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL--VYEYICNGSLDSHL 481
KQ + +Q Q F E ++L+ A++ VV + FC + +R L V EY+ G + L
Sbjct: 36 KQNLILRNQIQQVF-VERDILTFAENPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLL 92
Query: 482 YGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541
++ L R L YLH IVHRD++P+N+L+T + DFG
Sbjct: 93 --KNIGALPVDMARMYFAETVLALEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFG 146
Query: 542 LARWQ--------PDGDMGVETR------VLGTFGYLAPEYAQSGQITEKADVYSLGVVL 587
L++ +G + +TR V GT Y+APE + D +++G++L
Sbjct: 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIIL 206
Query: 588 VELITG 593
E + G
Sbjct: 207 YEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 8e-09
Identities = 34/97 (35%), Positives = 55/97 (56%), Gaps = 9/97 (9%)
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL---- 558
+ L+Y+H G ++HRD++P+NIL+ D + DFGLAR + + E VL
Sbjct: 118 KALKYIHS----GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 559 GTFGYLAPE-YAQSGQITEKADVYSLGVVLVELITGR 594
T Y APE S + T+ D++S+G +L E++ G+
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 75/293 (25%), Positives = 134/293 (45%), Gaps = 47/293 (16%)
Query: 395 RFSEANFLAEGGFGSVHRGVLPDG-----QVVAVKQYKLASSQGDQE-FCSEVEVLSCAQ 448
R + ++ L EG FG + G+L D + V VK K +S+ E +L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 449 HRNVVMLIGFCVEDGRRLLV-YEYICNGSLDSHL----YGRDRDPLEWSARR--KIAVGA 501
H+N++ ++ C+EDG V Y Y+ G+L L G +P S ++ +A+
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 502 ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR------WQPDGDMGVET 555
A G+ YLH + G ++H+D+ N ++ + + + D L+R + GD E
Sbjct: 127 ACGMSYLH---KRG-VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN--EN 180
Query: 556 RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT--GRKAMDLNRPRGQQCLTEWAR 613
R + ++A E + + + +DV+S GV+L EL+T ++++ E A
Sbjct: 181 RPVK---WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-------PFEMAA 230
Query: 614 PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666
L + + + I NC E++ ++ C C DP RP SQ+++ L
Sbjct: 231 YLKDGYRLAQPI-----NC--PDELFAVMAC---CWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 58/197 (29%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIG 457
+ +G FG V H+ V +++ + + ++ SE VL ++ +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 458 FCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
F + +L V +YI G L HL R+R LE AR A A L YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARF-YAAEIASALGYLHSLN---- 116
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITE 576
IV+RD++P NIL+ ++ DFGL + + + G + GT YLAPE
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 577 KADVYSLGVVLVELITG 593
D + LG VL E++ G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 12/94 (12%)
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG---VETRVLGT 560
G+++LH I+HRD++P+NI+V D + DFGLAR M V TR
Sbjct: 130 GIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 182
Query: 561 FGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
Y APE E D++S+G ++ E+I G
Sbjct: 183 --YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 402 LAEGGFGSVHRGVLPDG----QVVAVKQYKLASSQGDQ-EFCSEVEVLSCAQHRNVVMLI 456
+ G FG V G + G QVV VK+ ++++S +Q +F E + QH N++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYG-RDRDPL--EWSARRKIAVGAARGLRYLHEECR 513
G C E LLV E+ G L +L R + + + + +++A A GL +LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-- 119
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET-RVLGTFGYLAPEYAQS- 571
+H D+ N L+T D +GD+GL+ + D V ++ ++APE
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 572 -GQI-----TEKADVYSLGVVLVEL 590
G + T++++V+SLGV + EL
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 58/199 (29%), Positives = 86/199 (43%), Gaps = 14/199 (7%)
Query: 402 LAEGGFGSVHRGVLPD-GQVVAVKQYKL-ASSQGDQEFCSEVEVLSCAQHRNVVMLIGF- 458
L +G FG V L ++ AVK K Q D C+ E A L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 459 -CVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
C + RL V EY+ G L H+ R + R A GL++LHE
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA--RFYAAEIVLGLQFLHERG---- 116
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPEYAQSGQIT 575
I++RD++ +N+L+ + + DFG+ + G GV T GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 576 EKADVYSLGVVLVELITGR 594
D ++LGV+L E++ G+
Sbjct: 175 PAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 15/199 (7%)
Query: 402 LAEGGFGSVH--RGVL-PD-GQVVAVKQYKLASSQGDQEFCSEVE--VLSCAQHRNVVML 455
L +G FG V R + PD GQ+ A+K K A+ + +++E +L+ H +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 456 -IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514
F E G+ L+ +++ G L + L ++ E + +A A L +LH +
Sbjct: 64 HYAFQTE-GKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELALALDHLH---SL 117
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQI 574
G I++RD++P NIL+ + + DFGL++ D + + GT Y+APE
Sbjct: 118 G-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGH 175
Query: 575 TEKADVYSLGVVLVELITG 593
T+ AD +S GV++ E++TG
Sbjct: 176 TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 43/128 (33%), Positives = 61/128 (47%), Gaps = 8/128 (6%)
Query: 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 526
LV +Y+ G L HL R E A+ IA L +LH+ IV+RD++P N
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFS-EDRAKFYIA-ELVLALEHLHKYD----IVYRDLKPEN 126
Query: 527 ILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE-YAQSGQITEKADVYSLGV 585
IL+ + DFGL++ + T GT YLAPE T+ D +SLGV
Sbjct: 127 ILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDEKGYTKHVDFWSLGV 185
Query: 586 VLVELITG 593
++ E+ G
Sbjct: 186 LVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 43/148 (29%), Positives = 74/148 (50%), Gaps = 10/148 (6%)
Query: 455 LIGF--CVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEE 511
L+G C + RL LV EY+ G L H+ + + P E + R A L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHA--RFYAAEICIALNFLHER 115
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS 571
I++RD++ +N+L+ D + D+G+ + + G + GT Y+APE +
Sbjct: 116 G----IIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRG 170
Query: 572 GQITEKADVYSLGVVLVELITGRKAMDL 599
+ D ++LGV++ E++ GR D+
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 19/215 (8%)
Query: 395 RFSEANFLAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVV 453
R+ + L G G V V D + VAVK+ L Q + E++++ H N+V
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65
Query: 454 MLIGFCVEDGRRL---------LVYEYICNGSLDSHLYG-RDRDPLEWSARRKIAVGAAR 503
+ G L L YI +++ L ++ PL R R
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILV-THDFEPLVGDFGLAR-WQPD-GDMGVETRVLGT 560
GL+Y+H ++HRD++P N+ + T D +GDFGLAR P G + L T
Sbjct: 126 GLKYIHS----ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 561 FGYLAPEYA-QSGQITEKADVYSLGVVLVELITGR 594
Y +P T+ D+++ G + E++TG+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG 562
RGL+Y+H ++HRD++P+N+L+ + + + DFGLAR T + T
Sbjct: 119 RGLKYIHS----ANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRW 173
Query: 563 YLAPE-YAQSGQITEKADVYSLGVVLVELITGRK 595
Y APE + T DV+S+G + EL+ GRK
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 396 FSEANFLAEGGFGSVHRGVLP----DGQVVAVKQYK--LASSQGDQEFCSEVEVLSCAQH 449
F+ L +G FGSV L Q VAVK K + SS +EF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 450 RNVVMLIGFCVED---GR---RLLVYEYICNGSLDSHLY----GRDRDPLEWSARRKIAV 499
NV+ LIG + GR +++ ++ +G L + L G + L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 500 GAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD---MGVETR 556
A G+ YL + +HRD+ N ++ + V DFGL++ GD G ++
Sbjct: 121 DIASGMEYLSSKN----FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 557 VLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT 592
+ +LA E T +DV++ GV + E++T
Sbjct: 177 L--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 12/114 (10%)
Query: 492 SARRKIAV--------GAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543
+A+R IA+ R ++YLHE I+HRD++ NI + H + +GDFG A
Sbjct: 174 AAKRNIAICDILAIERSVLRAIQYLHENR----IIHRDIKAENIFINHPGDVCLGDFGAA 229
Query: 544 RWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAM 597
+ D + GT APE D++S G+VL E+ T ++
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 61/200 (30%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 402 LAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQGDQEF-CSEVE--VLSCA-QHRNVVMLI 456
L +G FG V L Q A+K K D + C+ VE VLS A +H + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61
Query: 457 GFCVEDGRRLL--VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514
+C + L V EY+ G L H+ + L + A GL++LH +
Sbjct: 62 -YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLHSKG-- 116
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQI 574
IV+RD++ +NIL+ D + DFG+ + GD T GT Y+APE +
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKY 173
Query: 575 TEKADVYSLGVVLVELITGR 594
D +S GV+L E++ G+
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 26/111 (23%)
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARW-------QPDGD----------MGVETRVLG 559
++HRD++P+NIL+ E ++ D+G A + D D M + +++G
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193
Query: 560 TFGYLAPEYAQSGQITEKADVYSLGVVLVELIT---------GRKAMDLNR 601
T Y+APE +E D+Y+LGV+L +++T GRK +
Sbjct: 194 TPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDV 244
|
Length = 932 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 52/159 (32%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 439 SEVEVLSCAQHRNVVML-IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKI 497
+E VL +H + L F +D R V EY+ G L HL R+R +S R
Sbjct: 44 TESRVLKNTRHPFLTSLKYSFQTKD-RLCFVMEYVNGGELFFHL-SRER---VFSEDRTR 98
Query: 498 AVGA--ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET 555
GA L YLH G IV+RD++ N+++ D + DFGL + + D
Sbjct: 99 FYGAEIVSALDYLHS----GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMK 153
Query: 556 RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
GT YLAPE + D + LGVV+ E++ GR
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 54/218 (24%)
Query: 402 LAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQGDQEFCS---EVEVLSCAQHRNVVMLIG 457
L EG + +V++G GQ+VA+K+ +L +G + E +L +H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP--FTAIREASLLKDLKHANIVTLHD 70
Query: 458 FCVEDGRRLLVYEYI----------CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRY 507
LV+EY+ C G L H R RGL Y
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH------------NVRLFLFQLLRGLAY 118
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLG----TFGY 563
H+ ++HRD++P N+L++ E + DFGLAR + V ++ T Y
Sbjct: 119 CHQRR----VLHRDLKPQNLLISERGELKLADFGLARAK-----SVPSKTYSNEVVTLWY 169
Query: 564 LAP-------EYAQSGQITEKADVYSLGVVLVELITGR 594
P EY S + D++ +G + E+ TGR
Sbjct: 170 RPPDVLLGSTEY--STSL----DMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 47/160 (29%), Positives = 83/160 (51%), Gaps = 12/160 (7%)
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGA-ARGLRYLHEECRVGCIVHR 520
D + L+ +YI G L +HL R+R +I G L +LH ++G I++R
Sbjct: 77 DTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEHLH---KLG-IIYR 129
Query: 521 DMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQIT-EKA- 578
D++ NIL+ + ++ DFGL++ + ++ GT Y+AP+ + G +KA
Sbjct: 130 DIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAV 189
Query: 579 DVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR 618
D +S+GV++ EL+TG ++ + Q E +R +LK
Sbjct: 190 DWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS 227
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 402 LAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEF-CSEVE--VLSCA-QHRNVVMLI 456
L +G FG V L + A+K K D + C+ VE VL+ A +H + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61
Query: 457 GFCVEDGRRLL--VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAA--RGLRYLHEEC 512
FC + L V EY+ G L H+ + + R A GL++LH++
Sbjct: 62 -FCTFQTKEHLFFVMEYLNGGDLMFHI----QSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSG 572
I++RD++ +N+L+ D + DFG+ + +G+ T GT Y+APE +
Sbjct: 117 ----IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQ 171
Query: 573 QITEKADVYSLGVVLVELITGR 594
+ E D +S GV+L E++ G+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 7/155 (4%)
Query: 440 EVEVLSCAQHRNVVMLIG-FCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIA 498
E+ +L C H+N++ L+ F + Y+ +D++L L+ +
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLL 129
Query: 499 VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL 558
G+++LH I+HRD++P+NI+V D + DFGLAR M T +
Sbjct: 130 YQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYV 183
Query: 559 GTFGYLAPEYAQSGQITEKADVYSLGVVLVELITG 593
T Y APE E D++S+G ++ EL+ G
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 14/157 (8%)
Query: 448 QHRNVVMLIGF--CVEDGRRLL-VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARG 504
Q N L+G C + RL V EY+ G L H+ + + P E + R + +
Sbjct: 51 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA--RFYSAEISLA 108
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR--WQPDGDMGVETRVLGTFG 562
L YLHE I++RD++ +N+L+ + + D+G+ + +P GD + GT
Sbjct: 109 LNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GD--TTSTFCGTPN 161
Query: 563 YLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDL 599
Y+APE + D ++LGV++ E++ GR D+
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 18/238 (7%)
Query: 440 EVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV 499
E +L H +V+ + V +V + + L ++L R R PL I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSR-PLPIDQALIIEK 164
Query: 500 GAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW---QPDGDMGVETR 556
GLRYLH + I+HRD++ NI + + +GD G A++ P +G+
Sbjct: 165 QILEGLRYLHAQR----IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA-FLGLA-- 217
Query: 557 VLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLL 616
GT APE + KAD++S G+VL E++ + + P + + L
Sbjct: 218 --GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275
Query: 617 KRHAIGELIDP-RLRNCYSEREVYGMLQCASLCIRKDPHSR-PRMSQVLRMLEGDILM 672
+ + P R V G ++ AS R+ P++R P +V ++G+ L+
Sbjct: 276 LKIISTLKVHPEEFPRDPGSRLVRGFIEYAS-LERQ-PYTRYPCFQRVNLPIDGEFLV 331
|
Length = 357 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 402 LAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQGDQEF-CSEVE--VLSCAQHRNVVMLIG 457
L +G FG V L G+ AVK K D + C+ VE VL+ A N +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWE-NPFLTHL 61
Query: 458 FCVEDGRRLL--VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
+C + L V E++ G L H+ +D+ + A GL++LH +
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHI--QDKGRFDLYRATFYAAEIVCGLQFLHSKG--- 116
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQIT 575
I++RD++ +N+++ D + DFG+ + GD T GT Y+APE Q + T
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYT 174
Query: 576 EKADVYSLGVVLVELITGR 594
D +S GV+L E++ G+
Sbjct: 175 FSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 31/207 (14%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYK----LASSQGDQEFCSE--VEVLSCAQHRN 451
L G FG V ++ G++ A+K K +A + + C + E + +H
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKI--AVGAARGLRYLH 509
+V L + V EY G L H++ D +S R + A GL+YLH
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDV----FSEPRAVFYAACVVLGLQYLH 118
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV---LGTFGYLAP 566
E IV+RD++ +N+L+ + + DFGL + MG R GT +LAP
Sbjct: 119 ENK----IVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTPEFLAP 170
Query: 567 EYAQSGQITEKADVYSLGVVLVELITG 593
E T D + LGV++ E++ G
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 400 NFLAEGGFGSVHRGVLPD----GQVVAVKQYKL-ASSQGDQEFCSEVE--VLSCAQHRNV 452
NFL G GS + +L + ++ A+K K Q D C+ VE VL+
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF 62
Query: 453 VMLIGFCVEDGRRL-LVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRYLH 509
+ + C + RL V EY+ G L H+ G+ ++P +I+VG L +LH
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFFLH 118
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPEY 568
I++RD++ +N+++ + + DFG+ + GV TR GT Y+APE
Sbjct: 119 RRG----IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEI 172
Query: 569 AQSGQITEKADVYSLGVVLVELITGRKAMD 598
+ D ++ GV+L E++ G+ D
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 52/159 (32%), Positives = 72/159 (45%), Gaps = 12/159 (7%)
Query: 439 SEVEVLSCAQHRNVVML-IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKI 497
+E VL ++H + L F D R V EY G L HL R+R +S R
Sbjct: 44 TENRVLQNSRHPFLTALKYSFQTHD-RLCFVMEYANGGELFFHL-SRER---VFSEDRAR 98
Query: 498 AVGA--ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET 555
GA L YLH E V V+RD++ N+++ D + DFGL + + D
Sbjct: 99 FYGAEIVSALDYLHSEKNV---VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMK 154
Query: 556 RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
GT YLAPE + D + LGVV+ E++ GR
Sbjct: 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ-PDGDMGV-ETRVLGT 560
R L+Y+H + HRD++P NIL D + + DFGLAR D + T + T
Sbjct: 114 RALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 169
Query: 561 FGYLAPEYAQS--GQITEKADVYSLGVVLVELITGR 594
Y APE S + T D++S+G + E++TG+
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 402 LAEGGFGSVHRGVLPD-GQVVAVKQYK---LASSQGDQEFCSEVEVLSCAQHRNVVMLIG 457
+ +GG+G V D G++VA+K+ K L + +E ++L+ + +V L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 458 FCVEDGRRL-LVYEYICNGSLDSHLYG----RDRDPLEWSARRKIAVGAARGLRYLHEEC 512
+ +D L L EY+ G + L + + A AV A LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA------LH--- 118
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSG 572
+G +HRD++P N L+ + DFGL++ G + V+G+ Y+APE +
Sbjct: 119 ELG-YIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGK 173
Query: 573 QITEKADVYSLGVVLVELITG 593
D +SLG +L E + G
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 448 QHRNVVMLIGF--CVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARG 504
N L+G C + RL V E++ G L H+ + + P E + R + +
Sbjct: 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHA--RFYSAEISLA 108
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ-PDGDMGVETRVLGTFGY 563
L +LHE I++RD++ +N+L+ + + D+G+ + GD + GT Y
Sbjct: 109 LNFLHE----RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNY 162
Query: 564 LAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDL 599
+APE + D ++LGV++ E++ GR D+
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 21/152 (13%)
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPD---GDMGVETRVLGTFGYLAPEYAQSGQ 573
++HRD++ NIL+ + +GDFG ++ D+G GT Y+APE +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG--RTFCGTPYYVAPEIWRRKP 221
Query: 574 ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCY 633
++KAD++SLGV+L EL+T ++ D E ++ + G DP +
Sbjct: 222 YSKKADMFSLGVLLYELLTLKRPFD----------GENMEEVMHKTLAGRY-DPLPPSIS 270
Query: 634 SEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665
E M + + + DP RP S++L M
Sbjct: 271 PE-----MQEIVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 25/216 (11%)
Query: 394 NRFSEANFLAEGGFGSVHRGVLPD---GQVVAVKQYKLASSQGDQE----FCSEVEVLSC 446
F + + G FG V V+ + G + A+K K S QE F E ++LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILSI 57
Query: 447 AQHRNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGL 505
+ + L + +D L LV EY G L S L R D + + +
Sbjct: 58 SNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAI 115
Query: 506 RYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG-LARWQPDGDMGVETRVLGTFGYL 564
+H+ +G VHRD++P N+L+ + DFG AR + M +GT Y+
Sbjct: 116 HSVHQ---MG-YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYI 170
Query: 565 APEYAQSGQITEKA------DVYSLGVVLVELITGR 594
APE + K D +SLGV+ E+I GR
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 43/129 (33%), Positives = 62/129 (48%), Gaps = 11/129 (8%)
Query: 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 526
V +Y+ G L HL R+R LE AR A A + YLH I++RD++P N
Sbjct: 73 FVLDYVNGGELFFHLQ-RERCFLEPRARF-YAAEVASAIGYLHSLN----IIYRDLKPEN 126
Query: 527 ILVTHDFEPLVGDFGLAR--WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLG 584
IL+ ++ DFGL + +P+ + GT YLAPE + D + LG
Sbjct: 127 ILLDSQGHVVLTDFGLCKEGVEPE---ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLG 183
Query: 585 VVLVELITG 593
VL E++ G
Sbjct: 184 AVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 7/156 (4%)
Query: 440 EVEVLSCAQHRNVVMLIG-FCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIA 498
E+ ++ C H+N++ L+ F + YI +D++L + L+ +
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL 132
Query: 499 VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL 558
G+++LH I+HRD++P+NI+V D + DFGLAR M + V+
Sbjct: 133 YQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVV 187
Query: 559 GTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
+ Y APE E D++S+G ++ E+I G
Sbjct: 188 TRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 45/210 (21%)
Query: 404 EGGFGSVHRG-VLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ---------HRNVV 453
EG F V + G+ A+K K + F S +V + + H N++
Sbjct: 9 EGTFSEVLKAQSRKTGKYYAIKCMK-------KHFKSLEQVNNLREIQALRRLSPHPNIL 61
Query: 454 MLIGFCVE--DGRRLLVYEYICNGSLDSHLY----GRDRDPLEWSARRKIAVGAARGLRY 507
LI + GR LV+E +D +LY GR + PL + + L +
Sbjct: 62 RLIEVLFDRKTGRLALVFEL-----MDMNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDH 115
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW----QPDGDMGVETRVLGTFGY 563
+H R G I HRD++P NIL+ D L DFG R P T + T Y
Sbjct: 116 MH---RNG-IFHRDIKPENILIKDDILKL-ADFGSCRGIYSKPP------YTEYISTRWY 164
Query: 564 LAPE-YAQSGQITEKADVYSLGVVLVELIT 592
APE G K D++++G V E+++
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 402 LAEGGFGSVHRGVLPD-GQVVAVK---QYKLASSQGDQEFCSEVEVLSCAQHRN----VV 453
+ GGFG V+ D G++ A+K + ++ QG+ +E +LS + V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
M F D + + + + G L HL R A GL ++H
Sbjct: 62 MTYAFHTPD-KLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEHMHNRF- 117
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLA----RWQPDGDMGVETRVLGTFGYLAPEYA 569
+V+RD++P NIL+ + D GLA + +P +GT GY+APE
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-------VGTHGYMAPEVL 167
Query: 570 QSGQITE-KADVYSLGVVLVELITG 593
Q G + AD +SLG +L +L+ G
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 22/161 (13%)
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGY 563
G+ Y+H+ I+HRD++ NI + ++ +GDFG++R G + T GT Y
Sbjct: 118 GVHYMHQRR----ILHRDLKAKNIFLKNNLLK-IGDFGVSRLLM-GSCDLATTFTGTPYY 171
Query: 564 LAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623
++PE + K+D++SLG +L E+ A + GQ L+ R I E
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE-----GQNFLSVVLR-------IVE 219
Query: 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
P L YS R++ ++Q + KDP RP +++LR
Sbjct: 220 GPTPSLPETYS-RQLNSIMQSM---LNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 43/134 (32%), Positives = 60/134 (44%), Gaps = 13/134 (9%)
Query: 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGA--ARGLRYLHEECRVGCIVHRD 521
R V EY G L HL R+R +S R GA L YLH +V+RD
Sbjct: 69 RLCFVMEYANGGELFFHL-SRER---VFSEDRARFYGAEIVSALGYLHS----CDVVYRD 120
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPEYAQSGQITEKADV 580
++ N+++ D + DFGL + G + GT YLAPE + D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 581 YSLGVVLVELITGR 594
+ LGVV+ E++ GR
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 388 ELELATNRFSEANFLAEGGFGSV----HRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEV 443
+L + + + G FG V H+ + + ++++ F E ++
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 444 LSCAQHRNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAA 502
++ A VV L + +D R L +V EY+ G L + + D P +W+ R
Sbjct: 97 MAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWA--RFYTAEVV 152
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA-RWQPDGDMGVETRVLGTF 561
L +H +G +HRD++P+N+L+ + DFG + +G + +T V GT
Sbjct: 153 LALDAIHS---MG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTP 207
Query: 562 GYLAPEYAQS----GQITEKADVYSLGVVLVELITG 593
Y++PE +S G + D +S+GV L E++ G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 7/153 (4%)
Query: 440 EVEVLSCAQHRNVVMLIG-FCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIA 498
E+ ++ C H+N++ L+ F + Y+ +D++L + L+ +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 125
Query: 499 VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL 558
G+++LH I+HRD++P+NI+V D + DFGLAR G + T +
Sbjct: 126 YQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 179
Query: 559 GTFGYLAPEYAQSGQITEKADVYSLGVVLVELI 591
T Y APE E D++S+G ++ E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 42/227 (18%)
Query: 400 NFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS--------------EVEVL 444
L EG +G V + G++VA+K+ K+ D E++++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 445 SCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARG 504
+ +H N++ L+ VE LV + + L + + R L S + I + G
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR--LTESQVKCILLQILNG 131
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR----------------WQPD 548
L LH+ +HRD+ P NI + + DFGLAR Q
Sbjct: 132 LNVLHKWY----FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 549 GDMGVETRVLGTFGYLAPEYAQ-SGQITEKADVYSLGVVLVELITGR 594
+M T + T Y APE + + D++S+G + EL+TG+
Sbjct: 188 EEM---TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 400 NFLAEGGFGSVHRGVLPD----GQVVAVKQYKL-ASSQGDQEFCSEVE--VLSCAQHRNV 452
NFL G GS + +L + ++ A+K K Q D C+ VE VL+ +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 453 VMLIGFCVEDGRRL-LVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRYLH 509
+ + C + RL V EY+ G L + GR ++P +IA+G L +LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFFLH 118
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR---WQPDGDMGVETRVL-GTFGYLA 565
+ I++RD++ +N+++ + + DFG+ + W GV T+ GT Y+A
Sbjct: 119 SKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-----GVTTKTFCGTPDYIA 169
Query: 566 PEYAQSGQITEKADVYSLGVVLVELITGRKAMD 598
PE + D ++ GV+L E++ G+ +
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 51/159 (32%), Positives = 70/159 (44%), Gaps = 13/159 (8%)
Query: 439 SEVEVLSCAQHRNVVML-IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKI 497
+E VL +H + L F D R V EY G L HL R+R E AR
Sbjct: 44 TESRVLQNTRHPFLTALKYAFQTHD-RLCFVMEYANGGELFFHL-SRERVFTEERAR--- 98
Query: 498 AVGA--ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET 555
GA L YLH +V+RD++ N+++ D + DFGL + + D
Sbjct: 99 FYGAEIVSALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMK 153
Query: 556 RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
GT YLAPE + D + LGVV+ E++ GR
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 42/217 (19%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE-----FCSEVEVL-SCAQHRNVVM 454
+ EG +G V++ G++VA+K+ +L D+E E+ +L ++ +V
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEM---DEEGIPPTALREISLLQMLSESIYIVR 65
Query: 455 LIGFCVE-----DGRRLL--VYEYICNGSLDSHL-------YGRDRDPLEWSARRKIAVG 500
L+ VE +G+ L V+EY LDS L PL +
Sbjct: 66 LL--DVEHVEEKNGKPSLYLVFEY-----LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 501 AARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL-VGDFGLAR--WQPDGDMGVETRV 557
+G+ + H+ ++HRD++P N+LV L + D GL R P + T
Sbjct: 119 LLKGVAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP---VKSYTHE 171
Query: 558 LGTFGYLAPE-YAQSGQITEKADVYSLGVVLVELITG 593
+ T Y APE S + D++S+G + E+
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 70/295 (23%), Positives = 114/295 (38%), Gaps = 50/295 (16%)
Query: 405 GGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEV--EVLSCA--QHRNVVMLIGFCV 460
+ + P +VAVK+ L S +E + E+++ QH N++ + +
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 461 EDGRRLLVYEYICNGS----LDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
D +V + GS L +H + L A I L Y+H + G
Sbjct: 70 VDSELYVVSPLMAYGSCEDLLKTHF----PEGLPELAIAFILKDVLNALDYIHSK---GF 122
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG--------YLAPEY 568
I HR ++ ++IL++ D V GL G RV+ F +L+PE
Sbjct: 123 I-HRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 569 AQ---SGQITEKADVYSLGVVLVELITG--------RKAMDLNRPRGQ-QCLTEWARPLL 616
Q G EK+D+YS+G+ EL G M L + RG CL + + L
Sbjct: 180 LQQNLQG-YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238
Query: 617 KRHAIGELIDPRLRNCYSE-REVYG-------MLQCASLCIRKDPHSRPRMSQVL 663
++ + + + Q LC+++DP SRP SQ+L
Sbjct: 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG---DQEFCSEVEVLSCAQHRNVVML--I 456
+ G +G V++ DG+ K+Y L +G C E+ +L +H NV+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGR----DRDPLEW--SARRKIAVGAARGLRYLHE 510
D + L+++Y + + R ++ P++ S + + G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH- 125
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPL----VGDFGLAR-----WQPDGDMGVETRVLGTF 561
++HRD++P NILV + + D G AR +P D+ V+ TF
Sbjct: 126 ---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL---DPVVVTF 179
Query: 562 GYLAPEYAQSGQITEKA-DVYSLGVVLVELIT 592
Y APE + KA D++++G + EL+T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 400 NFLAEGGFGSVHRGVLPD----GQVVAVKQYKL-ASSQGDQEFCSEVE--VLSCAQHRNV 452
NFL G GS + +L + ++ A+K K Q D C+ VE VL+
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62
Query: 453 VMLIGFCVEDGRRL-LVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRYLH 509
+ + C + RL V EY+ G L H+ G+ ++P +IA+G L +LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG----LFFLH 118
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPEY 568
+ I++RD++ +N+++ + + DFG+ + G G TR GT Y+APE
Sbjct: 119 SKG----IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTTRTFCGTPDYIAPEI 172
Query: 569 AQSGQITEKADVYSLGVVLVELITGRKAMD 598
+ D ++ GV+L E++ G+ D
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 402 LAEGGFGSVHRGVL---PDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCAQHRNVVMLI 456
L G FG+V +G+ + VAVK K ++ E E V+ + +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
G C E +LV E G L+ L +++ E + ++ + G++YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL-QKNKHVTEKNIT-ELVHQVSMGMKYLEETN---- 115
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF--GYLAPEYAQSGQI 574
VHRD+ N+L+ + DFGL++ + + + G + + APE +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 575 TEKADVYSLGVVLVE 589
+ K+DV+S GV++ E
Sbjct: 176 SSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 28/77 (36%), Positives = 43/77 (55%), Gaps = 1/77 (1%)
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITE 576
+++RD++P NIL+ + + DFGL + D T GT YLAPE T+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYTK 172
Query: 577 KADVYSLGVVLVELITG 593
D ++LGV+L E++TG
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 43/127 (33%), Positives = 59/127 (46%), Gaps = 7/127 (5%)
Query: 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 526
V +++ G L HL R+R E AR A A L YLH IV+RD++P N
Sbjct: 73 FVLDFVNGGELFFHLQ-RERSFPEPRARFYAA-EIASALGYLHSIN----IVYRDLKPEN 126
Query: 527 ILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVV 586
IL+ ++ DFGL + + T GT YLAPE + D + LG V
Sbjct: 127 ILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAV 185
Query: 587 LVELITG 593
L E++ G
Sbjct: 186 LYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 402 LAEGGFGSVHRGVL--PDGQVVAVKQYKLASSQGDQEFCSEVEVL-SCAQHRNVVMLIGF 458
+ +G +G V + VL +G AVK D+E +E +L + + H NVV G
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDI-DEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 459 C----VEDGRRLLVYEYICNGSLDSHL---YGRDRDPLEWSARRKIAVGAARGLRYLHEE 511
V++G +L + +CNG + L + + + +E I A GL++LH
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS 571
+HRD++ NNIL+T + + DFG++ + T V GT ++APE
Sbjct: 144 K----TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIAC 198
Query: 572 GQ-----ITEKADVYSLGVVLVELITG 593
Q + DV+SLG+ +EL G
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 387 AELELATNRFSEANFLAEGGFGSV----HRGVLPDGQVVAVKQ---YKLASSQGDQEFCS 439
+L + F + G FG V H+ QV A+K +++ F
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 440 EVEVLSCAQHRNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIA 498
E ++++ A +V L + +D + L +V EY+ G L + + D P +W+
Sbjct: 93 ERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-PEKWARFYTAE 150
Query: 499 VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA-RWQPDGDMGVETRV 557
V A L +H +G +HRD++P+N+L+ + DFG + +G + +T V
Sbjct: 151 VVLA--LDAIH---SMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV 204
Query: 558 LGTFGYLAPEYAQS----GQITEKADVYSLGVVLVELITG 593
GT Y++PE +S G + D +S+GV L E++ G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 389 LELATNRFSEANFLAEGGFGSV----HRGVLPDGQVVAVK---QYKLASSQGDQEFCSEV 441
L++ + + G FG V H+ +V A+K ++++ F E
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 442 EVLSCAQHRNVVMLIGFCV-EDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV 499
++++ A VV L FC +D + L +V EY+ G L + + D P +W+ V
Sbjct: 95 DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFYTAEV 151
Query: 500 GAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLG 559
A L +H +G ++HRD++P+N+L+ + DFG + M +G
Sbjct: 152 VLA--LDAIHS---MG-LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 560 TFGYLAPEYAQS----GQITEKADVYSLGVVLVELITG 593
T Y++PE +S G + D +S+GV L E++ G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 396 FSEANFLAEGGFGSVHRGVLPDG-QVVAVK---QYKLASSQGDQEFCSEVEVLSCAQHRN 451
F + G FG V L + +V A+K ++++ F E +VL ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYG-RDRDPLE----WSARRKIAVGAARGLR 506
+ L ++ LV +Y G L + L DR P + + A IA+ + L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG-LARWQPDGDMGVETRVLGTFGYLA 565
Y VHRD++P+NIL+ + + DFG + DG + V GT Y++
Sbjct: 123 Y----------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYIS 171
Query: 566 PEYAQS-----GQITEKADVYSLGVVLVELITG 593
PE Q+ G+ + D +SLGV + E++ G
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 84/355 (23%), Positives = 132/355 (37%), Gaps = 95/355 (26%)
Query: 390 ELATNRFSEANFLAEGGFGSV--------HRGVLPDGQVVAVKQYKLASSQGDQE-FCSE 440
E +R L G FG V + VAVK K ++ + + SE
Sbjct: 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKK--SSCNTVAVKMLKEGATASEHKALMSE 60
Query: 441 VEVL-SCAQHRNVVMLIGFCVE-DGRRLLVYEYICNGSLDSHLYG--------RDRDPLE 490
+++L H NVV L+G C + +G +++ E+ G+L + L R++ P +
Sbjct: 61 LKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQ 120
Query: 491 WS----------ARRKIAVGAARGLRYLHEECRVG------------------------- 515
R+I G A L + G
Sbjct: 121 RGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS 180
Query: 516 --------------CIVHRDMRPNNILVTHDFEPLVGDFGLAR---WQPDGDMGVETRVL 558
CI HRD+ NIL++ + + DFGLAR PD R+
Sbjct: 181 FQVARGMEFLASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238
Query: 559 GTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR 618
++APE T ++DV+S GV+L E+ + + + G Q E+ +R
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS----LGASPYPGVQINEEFC----QR 289
Query: 619 HAIGELIDPRLRNC-YSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671
G R+R + E+Y ML C DP RP S ++ +L GD+L
Sbjct: 290 LKDGT----RMRAPENATPEIYRIMLACWQ----GDPKERPTFSALVEIL-GDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 402 LAEGGFGSVHRGVLP-DGQVVAVKQYKLASS-QGDQEFCSEVE--VLSCAQHRNVVMLIG 457
L +G FG V L +V A+K K Q D C+ E +L+ A + +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 458 FCVEDGRRLL-VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
C + RL V EY+ G L + R R + R A L +LH R G
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQ-RSRK-FDEPRSRFYAAEVTLALMFLH---RHG- 116
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITE 576
+++RD++ +NIL+ + + DFG+ + + T GT Y+APE Q +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEILQELEYGP 175
Query: 577 KADVYSLGVVLVELITGR 594
D ++LGV++ E++ G+
Sbjct: 176 SVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 16/95 (16%)
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA----RWQPDGDMGVETRVLG 559
GL ++H +V+RD++P NIL+ + D GLA + +P +G
Sbjct: 109 GLEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-------VG 157
Query: 560 TFGYLAPEYAQSGQITE-KADVYSLGVVLVELITG 593
T GY+APE Q G + AD +SLG +L +L+ G
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 29/222 (13%)
Query: 388 ELELATNR-FSEANFLAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEFCSEVEVLS 445
++ + N+ + N + G FG V+ + D + VA+K+ Q Q E+ ++
Sbjct: 59 DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL----QDPQYKNRELLIMK 114
Query: 446 CAQHRNVVMLIGF----CVEDGRRLL----VYEYICNGSLDSHL--YGRDRDPLEWSARR 495
H N++ L + C + + + V E+I ++ ++ Y R+ L +
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVK 173
Query: 496 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV---THDFEPLVGDFGLARWQPDGDMG 552
+ R L Y+H + I HRD++P N+L+ TH + + DFG A+ G
Sbjct: 174 LYSYQLCRALAYIHSKF----ICHRDLKPQNLLIDPNTHTLK--LCDFGSAKNLLAGQRS 227
Query: 553 VETRVLGTFGYLAPEYA-QSGQITEKADVYSLGVVLVELITG 593
V + + F Y APE + T D++SLG ++ E+I G
Sbjct: 228 V-SYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 53/211 (25%), Positives = 82/211 (38%), Gaps = 50/211 (23%)
Query: 495 RKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554
I GA RGL YLH+ G I HR+++ ++IL++ D LV GL+ G +
Sbjct: 104 GNILFGALRGLNYLHQN---GYI-HRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQK 157
Query: 555 TRVLGTFG--------YLAPEYAQSG--QITEKADVYSLGVVLVELITGRKA-MDLNRPR 603
+V+ F +L+PE + K+D+YS+G+ EL TGR D+ R
Sbjct: 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM--LR 215
Query: 604 GQQCLTEWARP-------------------------------LLKRHAIGELIDPRLRNC 632
Q L + P ++ + RLR
Sbjct: 216 TQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTP 275
Query: 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663
S+ LC+++DP RP S +L
Sbjct: 276 SSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG---DQEFCSEVEVLSCAQHRNVVML--I 456
+ G +G V++ DG+ + Y L +G C E+ +L +H NV+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGK--DDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGR----DRDPLEW--SARRKIAVGAARGLRYLHE 510
D + L+++Y + + R ++ P++ + + G+ YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH- 125
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPL----VGDFGLAR-----WQPDGDMGVETRVLGTF 561
++HRD++P NILV + + D G AR +P D+ V+ TF
Sbjct: 126 ---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL---DPVVVTF 179
Query: 562 GYLAPEYAQSGQITEKA-DVYSLGVVLVELIT 592
Y APE + KA D++++G + EL+T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 55/211 (26%), Positives = 83/211 (39%), Gaps = 50/211 (23%)
Query: 439 SEVEVLSCAQHRNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKI 497
+E ++L+ A + VV L + +D L V +YI G + S L E AR I
Sbjct: 50 AERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFE-EDLARFYI 107
Query: 498 AVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA---RW-------QP 547
A + +H ++G I HRD++P+NIL+ D + DFGL RW Q
Sbjct: 108 A-ELTCAIESVH---KMGFI-HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQK 162
Query: 548 DGDMGVE---------------------------TRVL-----GTFGYLAPEYAQSGQIT 575
+ R L GT Y+APE T
Sbjct: 163 GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222
Query: 576 EKADVYSLGVVLVELITGRKAMDLNRPRGQQ 606
+ D +S+GV+L E++ G+ + P Q
Sbjct: 223 QLCDWWSVGVILYEMLVGQPPFLADTPAETQ 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 46/207 (22%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 402 LAEGGFGSVHRG----VLPDGQV----VAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVV 453
L +G F + +G V G++ V +K + + F ++S H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
+ G CV ++V EY+ GSLD++L ++++ + S + ++A A L +L ++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISWKLEVAKQLAWALHFLEDK-- 119
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT------FGYLAPE 567
+ H ++ N+L+ + + G+ + D G+ VL ++ PE
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLS---DPGISITVLPKEILLERIPWVPPE 174
Query: 568 YAQSGQ-ITEKADVYSLGVVLVELITG 593
++ Q ++ AD +S G L E+ +G
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 24/139 (17%)
Query: 467 LVYEYICNGSLDSHLYG-RDRDPLE----WSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
LV +Y G L + L DR P + + A +A+ + L Y VHRD
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY----------VHRD 127
Query: 522 MRPNNILVTHDFEPLVGDFG-LARWQPDGDMGVETRV-LGTFGYLAPEYAQS-----GQI 574
++P+N+L+ + + DFG R DG V++ V +GT Y++PE Q+ G+
Sbjct: 128 IKPDNVLLDKNGHIRLADFGSCLRLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRY 185
Query: 575 TEKADVYSLGVVLVELITG 593
+ D +SLGV + E++ G
Sbjct: 186 GPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 48/219 (21%), Positives = 85/219 (38%), Gaps = 39/219 (17%)
Query: 402 LAEGGFGSV--------------HRGVLPDGQVVA-----VKQYKLASSQGDQEFCSEVE 442
L G FG + RGV Q + + A S+ + +E+
Sbjct: 156 LPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEIL 215
Query: 443 VLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYG---------RDRDPLEWSA 493
L H N++ +E+ R Y+ D LY +DR PL
Sbjct: 216 ALGRLNHENILK-----IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDR-PLLKQT 269
Query: 494 RRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553
R I + Y+H++ ++HRD++ NI + D + ++GDFG A
Sbjct: 270 RA-IMKQLLCAVEYIHDKK----LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324
Query: 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT 592
+ +GT +PE E D++S G++L+++++
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 29/80 (36%), Positives = 48/80 (60%), Gaps = 10/80 (12%)
Query: 467 LVYEYICNGSLDS--HLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRP 524
LV EY+ G + S H+YG + + A + I+ A L YLH R G I+HRD++P
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEM---AVKYIS-EVALALDYLH---RHG-IIHRDLKP 132
Query: 525 NNILVTHDFEPLVGDFGLAR 544
+N+L++++ + DFGL++
Sbjct: 133 DNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 42/194 (21%), Positives = 88/194 (45%), Gaps = 17/194 (8%)
Query: 409 SVHRGVLPDGQVV--AVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE--DG- 463
S+++G+ + +V+ K++ +E++ L N++ + GF ++ D
Sbjct: 35 SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 464 -RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDM 522
R L+ EY G L L +++D L + + +A+ +GL L++ ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLD-KEKD-LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNL 149
Query: 523 RPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS--GQITEKADV 580
+ LVT +++ + GL + + + Y + + + T K D+
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPF----KNVNFMVYFSYKMLNDIFSEYTIKDDI 205
Query: 581 YSLGVVLVELITGR 594
YSLGVVL E+ TG+
Sbjct: 206 YSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 16/149 (10%)
Query: 449 HRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYL 508
H+++V+L G CV D ++V E++ G LD ++ R D L + K+A A L YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPWKFKVAKQLASALSYL 121
Query: 509 HEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLG------TFG 562
++ +VH ++ NIL+ E + G+ G + D G+ VL
Sbjct: 122 EDK----DLVHGNVCTKNILLAR--EGIDGECG--PFIKLSDPGIPITVLSRQECVERIP 173
Query: 563 YLAPEYAQ-SGQITEKADVYSLGVVLVEL 590
++APE + S ++ AD +S G L E+
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 40/138 (28%), Positives = 69/138 (50%), Gaps = 22/138 (15%)
Query: 467 LVYEYICNGSLDSHLYG-RDRDPLEWS----ARRKIAVGAARGLRYLHEECRVGCIVHRD 521
LV +Y G L + L DR P + + A +A+ + L Y VHRD
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY----------VHRD 127
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV-LGTFGYLAPEYAQS-----GQIT 575
++P+N+L+ + + DFG + + + D V++ V +GT Y++PE Q+ G+
Sbjct: 128 IKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYG 186
Query: 576 EKADVYSLGVVLVELITG 593
+ D +SLGV + E++ G
Sbjct: 187 PECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 38/106 (35%), Positives = 50/106 (47%), Gaps = 9/106 (8%)
Query: 390 ELATNRFSEANFLAEGGFGSVHR----GVLPDGQV--VAVKQYKLASSQGDQE-FCSEVE 442
E NR S L G FG V G+ VAVK K ++ ++E SE++
Sbjct: 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELK 90
Query: 443 VLS-CAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRD 487
VLS H N+V L+G C G L++ EY C G L + L R RD
Sbjct: 91 VLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLR-RKRD 135
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 25/173 (14%)
Query: 502 ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-WQPDGDMGVETRVLGT 560
A+G+ +L + CI HRD+ NIL+TH + DFGLAR + D + V+
Sbjct: 224 AKGMSFLASK---NCI-HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 561 FGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRP---RGQQCLTEWARPLLK 617
++APE + T ++DV+S G++L E+ + + P + + + E R L
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP 339
Query: 618 RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670
A E+ D +++C+ DP RP Q+++++E +
Sbjct: 340 ECAPSEMYDI-MKSCWD----------------ADPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 53/175 (30%), Positives = 83/175 (47%), Gaps = 28/175 (16%)
Query: 502 ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR---WQPDGDMGVETRVL 558
ARG+ +L CI HRD+ NIL++ + + DFGLAR PD + R+
Sbjct: 183 ARGMEFLASR---KCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237
Query: 559 GTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR 618
++APE T ++DV+S GV+L E+ + + + G Q E+ R L +
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS----LGASPYPGVQIDEEFCRRL--K 290
Query: 619 HAIGELIDPRLRNC-YSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671
R+R Y+ E+Y ML C +P RP S+++ +L GD+L
Sbjct: 291 EGT------RMRAPEYATPEIYSIMLDCW----HNNPEDRPTFSELVEIL-GDLL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 47/196 (23%), Positives = 86/196 (43%), Gaps = 39/196 (19%)
Query: 483 GRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542
D PL+ + + A+G+ +L + CI HRD+ N+L+T + DFGL
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCI-HRDVAARNVLLTDGRVAKICDFGL 258
Query: 543 AR-WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKA----M 597
AR D + V+ ++APE T ++DV+S G++L E+ + K+ +
Sbjct: 259 ARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
Query: 598 DLNR------PRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRK 651
+N RG Q +RP ++ E+Y +++ +C
Sbjct: 319 LVNSKFYKMVKRGYQM----SRPD-----------------FAPPEIYSIMK---MCWNL 354
Query: 652 DPHSRPRMSQVLRMLE 667
+P RP SQ+ ++++
Sbjct: 355 EPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 37/113 (32%), Positives = 54/113 (47%), Gaps = 14/113 (12%)
Query: 440 EVEVLSCAQHRNVVMLIGFC-----VEDGRR---LLVYEYICNGSLDSHLYGRDRDPLEW 491
E+++L +H NVV LI C + + LV+E+ C L L ++
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF-CEHDLAGLLSNKNVK-FTL 118
Query: 492 SARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544
S +K+ GL Y+H I+HRDM+ NIL+T D + DFGLAR
Sbjct: 119 SEIKKVMKMLLNGLYYIHRNK----ILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 24/59 (40%), Positives = 36/59 (61%), Gaps = 2/59 (3%)
Query: 421 VAVKQYKLASSQGDQE-FCSEVEVLS-CAQHRNVVMLIGFCVEDGRRLLVYEYICNGSL 477
VAVK K ++ ++E SE+++LS QH+N+V L+G C G L++ EY C G L
Sbjct: 71 VAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 24/90 (26%), Positives = 40/90 (44%), Gaps = 5/90 (5%)
Query: 15 VVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGH 74
V VAV K+ ++AL WAL ++ G I L+ V PP++S G + A+ +
Sbjct: 1 SVAVAVDKDKK-SKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSG----KLEVASAY 55
Query: 75 KSSLSGTSSDQKDDIVDSCSQMMRQLQEVY 104
K + + CS+ Q ++V
Sbjct: 56 KQEEDKEAKELLLPYRCFCSRKGVQCEDVV 85
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 60/244 (24%), Positives = 98/244 (40%), Gaps = 47/244 (19%)
Query: 437 FCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLY-GRDRDPLEWSARR 495
F ++S H ++ + G CV ++V E++ +G LD L + R P+ W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 496 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV--------THDF----EPLVGDFGLA 543
+A A L YL ++ +VH ++ NIL+ T F +P V L+
Sbjct: 121 TVAQQLASALSYLEDK----NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 544 RWQPDGDMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRP 602
R E RV ++APE G ++ AD +S G L+E+ D P
Sbjct: 177 R---------EERV-ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI-----CFDGEVP 221
Query: 603 RGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQV 662
++ +E R K+H + E L S+ C+ +P RP +
Sbjct: 222 LKERTPSEKERFYEKKHRLPEPSCKELATLISQ------------CLTYEPTQRPSFRTI 269
Query: 663 LRML 666
LR L
Sbjct: 270 LRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 26/177 (14%)
Query: 502 ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR---WQPDGDMGVETRVL 558
A+G+ +L CI HRD+ NIL++ + + DFGLAR PD + R+
Sbjct: 189 AKGMEFLASR---KCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243
Query: 559 GTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR 618
++APE T ++DV+S GV+L E+ + + + G + E+ R L +
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLKE- 297
Query: 619 HAIGELIDPRLRNC-YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNS 674
R+R Y+ E+Y Q C +P RP S+++ L G++L +
Sbjct: 298 -------GTRMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHL-GNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 28/66 (42%), Positives = 36/66 (54%), Gaps = 9/66 (13%)
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGY 563
GLR LH R+G IVHRD++P N+LVT D + + DFG A DM +G
Sbjct: 321 GLRKLH---RIG-IVHRDIKPENLLVTVDGQVKIIDFGAAV-----DMCTGINFNPLYGM 371
Query: 564 LAPEYA 569
L P Y+
Sbjct: 372 LDPRYS 377
|
Length = 507 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 27/98 (27%), Positives = 39/98 (39%), Gaps = 18/98 (18%)
Query: 497 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR 556
+ + LR LH R + NIL+T D L+ G ++ +
Sbjct: 22 VCLQCLGALRELH----------RQAKSGNILLTWDG--LLKLDGSVAFKTPEQSRPDPY 69
Query: 557 VLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
+ APE Q TEKAD+YSLG+ L E +
Sbjct: 70 FM------APEVIQGQSYTEKADIYSLGITLYEALDYE 101
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 678 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.6 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.15 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.1 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.07 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.04 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.98 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.97 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.95 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 98.92 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.79 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.74 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 98.64 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.64 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 98.58 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.52 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 98.44 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.41 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 98.25 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.18 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.15 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 98.14 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.1 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.09 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 98.05 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.02 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 97.93 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.92 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.87 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 97.81 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.81 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.81 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 97.79 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.7 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.69 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.65 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 97.64 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.59 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.49 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.35 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.3 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.21 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.19 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.16 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 97.12 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.09 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.05 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 96.83 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.76 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 96.71 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.69 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.57 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.55 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.5 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.5 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.31 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.72 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.17 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.15 | |
| PLN02236 | 344 | choline kinase | 94.11 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.07 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 93.8 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.5 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=428.65 Aligned_cols=289 Identities=55% Similarity=0.976 Sum_probs=256.4
Q ss_pred CCceeehhhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEE
Q 038949 380 PPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFC 459 (678)
Q Consensus 380 p~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 459 (678)
+.+.|++.++..++++|...+.||+|+||.||+|...+++.||||.+.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 57889999999999999999999999999999999888899999987654433145699999999999999999999999
Q ss_pred eeCC-eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccc
Q 038949 460 VEDG-RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVG 538 (678)
Q Consensus 460 ~~~~-~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~ 538 (678)
.+.+ +.+|||||+.+|+|.++|+.....+++|..+.+|+.++|+||+|||..|++ .|||||||++|||||.++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~-~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPP-PIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCC-CEecCCCCHHHeeECCCCCEEcc
Confidence 9988 599999999999999999776543799999999999999999999998754 59999999999999999999999
Q ss_pred cccccccccCCCccceeEE-EeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHH
Q 038949 539 DFGLARWQPDGDMGVETRV-LGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK 617 (678)
Q Consensus 539 DFGla~~~~~~~~~~~~~~-~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 617 (678)
|||+++..+.. ....... .||.+|+|||++..+..+.++|||||||+|+||+||+.+.+...+.....+.+|+.+.+.
T Consensus 220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999755431 1111222 799999999999999999999999999999999999999987776677779999999999
Q ss_pred HhhhhcccCcchh-cccch-hhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 618 RHAIGELIDPRLR-NCYSE-REVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 618 ~~~~~elld~~l~-~~~~~-~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
...+.+++|+.+. ..++. .....+..++.+|++.+|..||+|.+|++.|+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9999999999987 66664 67888999999999999999999999999996544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=405.92 Aligned_cols=374 Identities=25% Similarity=0.301 Sum_probs=277.4
Q ss_pred CCCCCCccCCcchhcccC-CchhHhhhhccCCCCCCC--CC---chhH----HH----HHHHHhhcCCCCCCccc-cc-c
Q 038949 276 CLPSTSSNHDPWMAESLS-PREEFLKLLEGSSERTND--PS---LTSA----YE----FLLEKLSTLNREPDIGV-LN-Y 339 (678)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~---~~~~----~~----~~~~~~~~~~~~~~~~~-~~-~ 339 (678)
++...+.+.+||.+..++ .+.+.+.+.+++....+. .+ +-.+ .+ .+..++.+++...-.+. .- +
T Consensus 72 ~~~~~~l~~~~Wf~~~isR~~ae~~ll~p~~~~G~flvR~se~~~g~yslsv~~~~~~~~~~~v~hyri~~~~~~~~~~~ 151 (468)
T KOG0197|consen 72 SPAFIKLSDEPWFFGKISREEAERQLLAPENKEGAFLVRESESDKGDYSLSVREGDSGGLGAKVKHYRIRQLDGGGLYPY 151 (468)
T ss_pred CCCccccccCCchhccccHHHHHHhhcCCCCCccceeeecccCCcCCeeEEEEeccccCCccceeeeeeeEcCCCCeecC
Confidence 345567788899988887 444445554544222221 11 1111 00 11224444443322111 11 1
Q ss_pred ccccccchhHHHHhhcccCCCC-CCCCcccccccCCCCCCCCCceeehhhhhhhhcCCcccceecccCccceeeccCCCC
Q 038949 340 KLDLKISKSVREAVSLSRNKPP-GPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDG 418 (678)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~pp-~~~p~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g 418 (678)
........++.+-+...+...+ ....++.+|....+..+. ..++....+++....+.+++.||+|.||.||+|.+...
T Consensus 152 ~~~~~~F~~l~~lv~~~~~~~~gl~~~l~~p~~~~~~~~p~-~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~ 230 (468)
T KOG0197|consen 152 IDERELFSSLQQLVNYYSKNADGLCTRLRDPCSKQGHTKPQ-TPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGS 230 (468)
T ss_pred CCHHHhhhhHHHHHhhhhccCcchhhcccCchhccCCCCCC-CCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCC
Confidence 2223344566666665444333 333444444432221111 12233566788888899999999999999999999777
Q ss_pred cEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhh
Q 038949 419 QVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIA 498 (678)
Q Consensus 419 ~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~ 498 (678)
..||+|.++.. ....+.|.+|+++|+.|+|+|||+++++|..++.+|||||||+.|+|.++|.......+.....+.++
T Consensus 231 ~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a 309 (468)
T KOG0197|consen 231 TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFA 309 (468)
T ss_pred CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHH
Confidence 79999999855 34456789999999999999999999999998899999999999999999977667779999999999
Q ss_pred hhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccceeEEEeeecccccccccccccceec
Q 038949 499 VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKA 578 (678)
Q Consensus 499 ~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ks 578 (678)
.||++|++||+++ ++|||||..+||||+++..+||+|||+++...+..+........+..|.|||.+..+.|+.||
T Consensus 310 ~qIaeGM~YLes~----~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kS 385 (468)
T KOG0197|consen 310 AQIAEGMAYLESK----NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKS 385 (468)
T ss_pred HHHHHHHHHHHhC----CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCccccc
Confidence 9999999999999 999999999999999999999999999996666665555555567889999999999999999
Q ss_pred ceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCc
Q 038949 579 DVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRP 657 (678)
Q Consensus 579 DVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RP 657 (678)
|||||||+||||+| |+.|+.... ...+.+.++...+-..|..|+..+.+++..||+.+|++||
T Consensus 386 DVWSFGVlL~E~fT~G~~py~~ms----------------n~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RP 449 (468)
T KOG0197|consen 386 DVWSFGVLLWELFTYGRVPYPGMS----------------NEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRP 449 (468)
T ss_pred ceeehhhhHHHHhccCCCCCCCCC----------------HHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCC
Confidence 99999999999999 777764322 2233445566677777888999999999999999999999
Q ss_pred hHHHHHHHhhcccc
Q 038949 658 RMSQVLRMLEGDIL 671 (678)
Q Consensus 658 T~~eVL~~Le~~~~ 671 (678)
||+.+...|+....
T Consensus 450 tF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 450 TFETLREVLEDFFT 463 (468)
T ss_pred CHHHHHHHHHHhhh
Confidence 99999999987654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=381.81 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=207.2
Q ss_pred hhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccC-------CccccccceeeecccccceEEEEeEEee
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQG-------DQEFCSEVEVLSCAQHRNVVMLIGFCVE 461 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~-------~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 461 (678)
+...+.|.+.+.||+|+||.|-+|. .++|+.||||+++...... .....+|+++|++|+|||||+++++|..
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 3466789999999999999999998 5789999999996433222 1235699999999999999999999999
Q ss_pred CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec---Cccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD---FEPLVG 538 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~---~~vkL~ 538 (678)
.+..||||||+.||+|.+.+.. ++.+.+...+.++.||+.|+.|||+. ||+||||||+|||+..+ ..+||+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~----GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQ----GIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred CCceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHc----CcccccCCcceEEeccCCcceEEEec
Confidence 9999999999999999999954 45588888899999999999999999 99999999999999866 889999
Q ss_pred cccccccccCCCccceeEEEeeeccccccccccccc---ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH
Q 038949 539 DFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQI---TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615 (678)
Q Consensus 539 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~---s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 615 (678)
|||+|+... ......+.||||.|.|||++.++.+ ..++|+||||||||-+|+|.+||..... +..+.+..
T Consensus 322 DFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~--~~sl~eQI--- 394 (475)
T KOG0615|consen 322 DFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT--DPSLKEQI--- 394 (475)
T ss_pred ccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC--CccHHHHH---
Confidence 999999775 3455678899999999999987654 3478999999999999999999965432 11111100
Q ss_pred HHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 LKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 ~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....+. +......+.+++..+||.+||..||++||++.|+|+
T Consensus 395 -~~G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 -LKGRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -hcCccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 011110 111223446678899999999999999999999874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=396.78 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=211.6
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehh---cccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA---SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
.+|...++||+|||+.||.++. .+|+.||+|++... .....+.+.+|+++.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6899999999999999999995 78999999999643 3334467899999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
|+|..++|..++ +.+.++++..++.++.||+.||.|||++ +|+|||||..|+||+++.+|||+|||+|......
T Consensus 98 ELC~~~sL~el~--Krrk~ltEpEary~l~QIv~GlkYLH~~----~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELL--KRRKPLTEPEARYFLRQIVEGLKYLHSL----GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHH--HhcCCCCcHHHHHHHHHHHHHHHHHHhc----CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999999 4667899999999999999999999999 9999999999999999999999999999877543
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
.....+.||||.|.|||++....++..+||||+||+||.||+|++||+...- .+ ....-...+..
T Consensus 172 -~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v------ke----ty~~Ik~~~Y~---- 236 (592)
T KOG0575|consen 172 -GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV------KE----TYNKIKLNEYS---- 236 (592)
T ss_pred -ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH------HH----HHHHHHhcCcc----
Confidence 2355678999999999999999999999999999999999999999974321 01 01111111111
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.|...+....+||..+|+.||.+|||+++||.
T Consensus 237 ---~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 ---MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22344557889999999999999999999984
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=377.13 Aligned_cols=253 Identities=30% Similarity=0.443 Sum_probs=208.5
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeCC-eEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG-RRLLVY 469 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~-~~~LV~ 469 (678)
..+++.++.||+|..|+||++.+ ++++.+|+|.+.... .....++.+|+++++..+|||||.+||.|..++ ..+|+|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 34566778899999999999995 579999999995433 233468899999999999999999999999988 599999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhh-cceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||.+|+|++++. ..+++++....+++.++++||.|||+ . +||||||||+|||++..|+|||||||.+....+
T Consensus 158 EYMDgGSLd~~~k--~~g~i~E~~L~~ia~~VL~GL~YLh~~~----~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 158 EYMDGGSLDDILK--RVGRIPEPVLGKIARAVLRGLSYLHEER----KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hhcCCCCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhcc----CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999994 34679999999999999999999996 5 899999999999999999999999999987654
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
. ...+++||..|||||.+.+..|+.++||||||+.++|+++|+.||....+. ...|...+ ..+..-..|.
T Consensus 232 S---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~----~~~~~~Ll---~~Iv~~ppP~ 301 (364)
T KOG0581|consen 232 S---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP----YLDIFELL---CAIVDEPPPR 301 (364)
T ss_pred h---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC----CCCHHHHH---HHHhcCCCCC
Confidence 4 557789999999999999999999999999999999999999999654111 11111111 1111111233
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+... .++.+|.++|..||++||.+||++.|+++
T Consensus 302 lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 302 LPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 3222 35668999999999999999999999974
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=391.07 Aligned_cols=262 Identities=32% Similarity=0.467 Sum_probs=214.5
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccC--CccccccceeeecccccceEEEEeEEeeCC-eEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCAQHRNVVMLIGFCVEDG-RRL 466 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~--~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~-~~~ 466 (678)
.+....+.+.+.||.|+||.||+|.+.+...||+|++....... ...|.+|+.+|++++|||||+|+|+|.+.. .++
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 34445556666799999999999999654459999997544333 348999999999999999999999999887 799
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeee-EEeccCCCCceEeeecC-ccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC-IVHRDMRPNNILVTHDF-EPLVGDFGLAR 544 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g-IvHrDLKp~NILl~~~~-~vkL~DFGla~ 544 (678)
+||||+++|+|..++.......+++..+..|+.+|++||.|||+. + ||||||||+|||++.++ ++||+|||+++
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~----~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE----GPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC----CCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 999999999999999765567799999999999999999999999 8 99999999999999997 99999999998
Q ss_pred cccCCCccceeEEEeeeccccccccc--ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQ--SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~--~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
...... ...+...||+.|||||++. ...|+.|+||||||++||||+||..||....+ .+ .+ .
T Consensus 193 ~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~-----~~---------~ 256 (362)
T KOG0192|consen 193 EKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ-----VA---------S 256 (362)
T ss_pred eecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH-----HH---------H
Confidence 654321 2233367999999999999 66999999999999999999999999976543 11 01 1
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.+.....+...+..++..+..|+.+||+.||++||++.+++..|+....
T Consensus 257 ~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 257 AVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 1111222233344466689999999999999999999999999986543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=373.61 Aligned_cols=202 Identities=30% Similarity=0.478 Sum_probs=181.4
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehh--cccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA--SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
.++|.+.+.||+|+||+||+|++ .++..||||.+... .....+.+..|+.+|+.++|||||.+++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 46899999999999999999995 56899999998755 3334466889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec------Ccccccccccc
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD------FEPLVGDFGLA 543 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~------~~vkL~DFGla 543 (678)
|||.||+|.+|+. ..+.+++..++.++.||+.||++||++ +||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~~----~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHEN----NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999994 455799999999999999999999999 99999999999999865 56899999999
Q ss_pred ccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCC
Q 038949 544 RWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRP 602 (678)
Q Consensus 544 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~ 602 (678)
+....+ ....+.+|+|-|||||++..++|+.|+|+||+|+|||++++|+.||+...+
T Consensus 163 R~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 163 RFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 987644 344668999999999999999999999999999999999999999986554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=362.31 Aligned_cols=259 Identities=24% Similarity=0.361 Sum_probs=211.5
Q ss_pred hcCCcccceecccCccceeecc-CCCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEe-EEeeCCe-EEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIG-FCVEDGR-RLL 467 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~-~~~~~~~-~~L 467 (678)
...|+++++||+|.||.||++. ..+|..+|.|.++....+ ..+.+..|+.+|++|+|||||++++ .|.++.. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 4568899999999999999998 578999999988744333 2357889999999999999999998 5555555 899
Q ss_pred EEEEeecCCcccccc--cCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 468 VYEYICNGSLDSHLY--GRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 468 V~E~~~ggsL~~~l~--~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|||||.+|+|..++. ......+++..+|+++.|++.||.++|...+.+-|+||||||.||+|+.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999983 345667999999999999999999999977766799999999999999999999999999997
Q ss_pred ccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
+.... ....+.+|||.||+||.+...+|+.++||||+||++|||+.-++||... ++....... .+-
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI------~qg- 243 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKI------EQG- 243 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHH------HcC-
Confidence 75443 4455688999999999999999999999999999999999999999643 222222111 110
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
.+........+.++..||..|+..||+.||+...+++.+.
T Consensus 244 --d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 244 --DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1111222556778999999999999999998555555444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=365.21 Aligned_cols=244 Identities=24% Similarity=0.311 Sum_probs=204.2
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
..+.|+++++||+|+||+||.++ ..+++.||+|+++.... .......+|..+|..++||+||+++..|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35789999999999999999998 45799999999974432 334578899999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
|+||+.||.|..+| .+.+.+++..++.++.+|+.||.|||++ |||||||||+|||||.+|+++|+|||+++...
T Consensus 103 Vld~~~GGeLf~hL--~~eg~F~E~~arfYlaEi~lAL~~LH~~----gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL--QREGRFSEDRARFYLAEIVLALGYLHSK----GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHH--HhcCCcchhHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999999 4556799999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
.. .....+++||+.|||||++.+..|+..+|.||||+++|+|++|.+||..... ..+........
T Consensus 177 ~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~~k-------- 241 (357)
T KOG0598|consen 177 KD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILKGK-------- 241 (357)
T ss_pred cC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhcCc--------
Confidence 32 2344568999999999999999999999999999999999999999965432 12222111111
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCch
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPR 658 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT 658 (678)
....+...+....+++.++|..||++|..
T Consensus 242 --~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 242 --LPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred --CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 11122224457889999999999999964
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=352.22 Aligned_cols=256 Identities=28% Similarity=0.400 Sum_probs=205.2
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCC--eEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG--RRLLVY 469 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~--~~~LV~ 469 (678)
..++...+.||+|.||.||++.. ++|...|||.+........+.+.+|+.+|++++|||||+++|...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 45678889999999999999995 458999999987654333456889999999999999999999744444 689999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-cCccccccccccccccC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-DFEPLVGDFGLARWQPD 548 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-~~~vkL~DFGla~~~~~ 548 (678)
||+++|+|.+++..... .+++..++.+++||++||.|||++ |||||||||+|||++. ++.+||+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~----g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK----GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999966554 799999999999999999999999 9999999999999999 79999999999986652
Q ss_pred --CCccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 549 --GDMGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 549 --~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
..........||+.|||||++..+.. ..++|||||||++.||+||.+||.... ......+...
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--------~~~~~~~~ig------ 236 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--------EEAEALLLIG------ 236 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--------chHHHHHHHh------
Confidence 22223445789999999999996433 359999999999999999999996520 0001111111
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
.......++...+....+++.+|+..||++|||++++|+..-
T Consensus 237 ~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 237 REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 011112455556668899999999999999999999997543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=362.90 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=208.3
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeeh---hcccCCccccccceeeecc-cccceEEEEeEEeeCCeEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKL---ASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~---~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~ 466 (678)
...+|.+++.||+|+|++|++|+ ..+++.||||++.. .......-...|-.+|.+| .||.|++|+..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34689999999999999999999 56899999999853 2233334567788899999 7999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+|+||+++|+|.++| ++.+.|++..++.++.+|+.||+|||+. |||||||||+|||||.|++++|+|||.|..+
T Consensus 151 FvLe~A~nGdll~~i--~K~Gsfde~caR~YAAeIldAleylH~~----GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLI--KKYGSFDETCARFYAAEILDALEYLHSN----GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHH--HHhCcchHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999 4557799999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCc----------c--ceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHH
Q 038949 547 PDGDM----------G--VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP 614 (678)
Q Consensus 547 ~~~~~----------~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 614 (678)
..... . ....++||..|.+||++..+..+..+|+|+||||||+|+.|.+||....+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------------ 292 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------------ 292 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------------
Confidence 43211 1 12568999999999999999999999999999999999999999965432
Q ss_pred HHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 LLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 ~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+..+.+.++ .-.+++..+..+.+||.++|..||.+|+|.++|-+
T Consensus 293 yliFqkI~~l-----~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 293 YLIFQKIQAL-----DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHHHHHHh-----cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1111112111 11234445568899999999999999999988865
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=361.89 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=208.1
Q ss_pred hhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehh----cc-cCCccccccceeeeccc-ccceEEEEeEEeeC
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLA----SS-QGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVED 462 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~----~~-~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~ 462 (678)
....++|.+.+.||+|.||.|++|. ..++..||+|++... .. ...+.+.+|+.++++++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 3556899999999999999999998 457899999977643 11 23356668999999998 99999999999999
Q ss_pred CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec-Ccccccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD-FEPLVGDFG 541 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~-~~vkL~DFG 541 (678)
..+|+||||+.||+|.+++.. .+++.+..++.+++||++|++|||+. ||+||||||+|||++.+ +++||+|||
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~----gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR----GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 999999999999999999954 66799999999999999999999999 99999999999999999 999999999
Q ss_pred ccccccCCCccceeEEEeeecccccccccccc-cc-eecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHh
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ-IT-EKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH 619 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s-~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 619 (678)
++.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... .... ...
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~----~ki 235 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLY----RKI 235 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHH----HHH
Confidence 998663 3344567789999999999999877 85 789999999999999999999986321 1111 110
Q ss_pred hhhcccCcchhcccchhh-hhhhhhccceeeccCCCCCchHHHHH
Q 038949 620 AIGELIDPRLRNCYSERE-VYGMLQCASLCIRKDPHSRPRMSQVL 663 (678)
Q Consensus 620 ~~~elld~~l~~~~~~~~-~~~l~~LI~~cL~~dP~~RPT~~eVL 663 (678)
...+. .++... +..+.+|+++||..||.+|+++.+++
T Consensus 236 ~~~~~-------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 236 RKGEF-------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred hcCCc-------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 00110 122222 55789999999999999999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=350.15 Aligned_cols=266 Identities=26% Similarity=0.361 Sum_probs=215.3
Q ss_pred hhhhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCC-ccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~-~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
.+....+.|.+...||.|..+.||+|+ .+.+..||||++.....+.. ..+.+|+..|+.++||||++++..|..+..+
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 345567889999999999999999999 57889999999987766555 7899999999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||.||.+|++.+++...-...+++..+..+++++++||.|||.+ |.||||||+.||||+.+|.|||+|||.+..
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~----G~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN----GHIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc----CceecccccccEEEcCCCcEEEcCceeeee
Confidence 9999999999999999776677799999999999999999999999 999999999999999999999999998865
Q ss_pred ccCCCcc--ce-eEEEeeecccccccccc--cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 546 QPDGDMG--VE-TRVLGTFGYLAPEYAQS--GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 546 ~~~~~~~--~~-~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
....... .. ..++||+.|||||++.. ..|+.|+||||||++..||.+|+.||....|.....+. . +. .
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-L-----qn-~ 248 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-L-----QN-D 248 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-h-----cC-C
Confidence 5443221 11 55789999999999643 57999999999999999999999999866542211110 0 00 0
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
........+...-.......|..++..||+.||.+|||++++|+
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00000001111111223347899999999999999999999984
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=361.21 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=214.5
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
....|.....||+|+.|.||.|. ..+++.||||++........+.+.+|+.+|+..+|+|||++++.|..++.+|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 34578889999999999999998 56788999999998877777889999999999999999999999998899999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|++||+|.|.+. ...+++.++..++++++.||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+....
T Consensus 351 ym~ggsLTDvVt---~~~~~E~qIA~Icre~l~aL~fLH~~----gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 351 YMEGGSLTDVVT---KTRMTEGQIAAICREILQGLKFLHAR----GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred ecCCCchhhhhh---cccccHHHHHHHHHHHHHHHHHHHhc----ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999999993 33489999999999999999999999 99999999999999999999999999998765443
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
....+.+|||.|||||+.....|++++||||||++++||+-|.+||-...|.... ..+...-.|.
T Consensus 424 -~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl------------yLIa~ng~P~-- 488 (550)
T KOG0578|consen 424 -SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------------YLIATNGTPK-- 488 (550)
T ss_pred -CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH------------HHHhhcCCCC--
Confidence 3566788999999999999999999999999999999999999999654332111 1111111122
Q ss_pred cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+...+..|.+++.+||+.|+.+|+++.|+|+
T Consensus 489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 2234445668999999999999999999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=342.62 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=202.6
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
++|+.+.++|+|+||.||++++ .+|+.||||.+..... ...+-.++|+++|++++|+|+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 5788899999999999999995 4799999999863322 122468899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
||+. ++.+-+... ...++.....+++.|++.|+.|+|++ ++|||||||+||||+.+|.+||||||+|+....+
T Consensus 82 ~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~----n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKN----NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhc----CeecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 9966 444444333 34588999999999999999999999 9999999999999999999999999999977632
Q ss_pred ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhh---------HHHHHHhh
Q 038949 551 MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWA---------RPLLKRHA 620 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~---------~~~~~~~~ 620 (678)
....+.++.|.+|.|||.+.+ -+|+..+||||+||++.||++|.+.|-...+..+..+..-. .-+-..+.
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 233456788999999999987 78999999999999999999999988665543332221110 00000111
Q ss_pred hhcccCcc------hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 IGELIDPR------LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ~~elld~~------l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+..+.-|. +...++ ....-+.+|+..||+.||.+|++-++++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111011 111111 23345789999999999999999999873
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=360.00 Aligned_cols=267 Identities=24% Similarity=0.317 Sum_probs=211.2
Q ss_pred hhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhccc-CCccccccceeeeccc-ccceEEEEeEEeeCC-eE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDG-RR 465 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~-~~ 465 (678)
....+||.+.+.||.|.||.||+|+ ..+|..||||.++..-.. ....=++|++.|+++. ||||++|.+++.+.+ .+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3456899999999999999999999 567999999998744322 1223457999999998 999999999999887 99
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||| ..+|++++..+ +..|++..++.|+.||+.||+|+|++ |+.||||||+|||+.....+||+|||+||.
T Consensus 86 ~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~----GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH----GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc----CcccccCChhheEecccceeEecccccccc
Confidence 9999999 55999999776 77899999999999999999999999 999999999999999999999999999997
Q ss_pred ccCCCccceeEEEeeecccccccc-cccccceecceeeeeeEEEEeeeCCccccccCCcccchh----------hhhhHH
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYA-QSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCL----------TEWARP 614 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l----------~~~~~~ 614 (678)
..... ..+.++.|.+|.|||++ +.+.|+.+.|+||+|||++|+++-++.|-+..+..+.+. ..|...
T Consensus 160 v~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 160 VRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 65433 34667889999999977 467899999999999999999999999865544322111 111111
Q ss_pred HHHHhh----hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 615 LLKRHA----IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 615 ~~~~~~----~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
..-... +.....-.+....+. ++.++.+||.+|+..||.+|||+.++|+.
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111 111111112222233 66788999999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=356.94 Aligned_cols=264 Identities=26% Similarity=0.382 Sum_probs=203.9
Q ss_pred hhhhhcCCcccceecccCccceeeccC------CCCcEEEEEeeehhcc-cCCccccccceeeecc-cccceEEEEeEEe
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCA-QHRNVVMLIGFCV 460 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~ 460 (678)
+.+..++|++.+.||+|+||.||+|.+ .+++.||+|+++.... .....+.+|+.++..+ +||||++++++|.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 345678999999999999999999962 2356899999864322 2234688999999999 8999999999887
Q ss_pred eC-CeEEEEEEEeecCCcccccccCC------------------------------------------------------
Q 038949 461 ED-GRRLLVYEYICNGSLDSHLYGRD------------------------------------------------------ 485 (678)
Q Consensus 461 ~~-~~~~LV~E~~~ggsL~~~l~~~~------------------------------------------------------ 485 (678)
.. +.+++||||+++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 64 46899999999999998885321
Q ss_pred ------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc-cceeEEE
Q 038949 486 ------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM-GVETRVL 558 (678)
Q Consensus 486 ------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~ 558 (678)
..++++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++....... .......
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence 12466777788999999999999998 999999999999999999999999999975432221 1122234
Q ss_pred eeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhh
Q 038949 559 GTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSERE 637 (678)
Q Consensus 559 Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~ 637 (678)
+++.|+|||++.+..++.++|||||||+||||++ |..||....... .+.. ..... .. ...+...
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~~~~-~~~~~-----~~----~~~~~~~ 302 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQ-RLKDG-----TR----MRAPENA 302 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHH-HHhcC-----CC----CCCCCCC
Confidence 5678999999999999999999999999999997 999986433211 0000 00000 00 1112334
Q ss_pred hhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 638 VYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 638 ~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
+..+.+|+.+||+.||++||++.++++.|+..+.
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5578999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=359.23 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=209.7
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
.+-|++++.||.|+.|.|-+|++ .+|+..|||++.... ......+.+|+-+|+.+.|||++++|+++++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 35688999999999999999995 689999999996442 22235688999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
.||+.||.|.+++ ...+++++..+.+++.||+.|+.|+|.. +|+||||||+|+||+..+++||+|||+|.....
T Consensus 91 lEyv~gGELFdyl--v~kG~l~e~eaa~ff~QIi~gv~yCH~~----~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 91 LEYVPGGELFDYL--VRKGPLPEREAAHFFRQILDGVSYCHAF----NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEecCCchhHHHH--HhhCCCCCHHHHHHHHHHHHHHHHHhhh----cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999999 5567899999999999999999999999 999999999999999999999999999986654
Q ss_pred CCccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
+ ....+.||.|+|.+||++.+.+| +.++||||+|||||.||||+.||+...- +.++..-.-+.
T Consensus 165 g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi----------r~LLlKV~~G~---- 228 (786)
T KOG0588|consen 165 G--KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI----------RVLLLKVQRGV---- 228 (786)
T ss_pred C--ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH----------HHHHHHHHcCc----
Confidence 4 34567799999999999999988 5799999999999999999999983221 11111111111
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
-..|...+.+..+||.+||..||.+|.|++||++.
T Consensus 229 ---f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 229 ---FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 12334556689999999999999999999999863
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=334.18 Aligned_cols=237 Identities=25% Similarity=0.326 Sum_probs=202.5
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
-++|+.++.||.|+||.|.+++. .+|..||+|+++... ....+...+|..+|+.+.||+++++++.|.+.+.+|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 35788899999999999999994 578899999996433 22335678899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.||.|.+++ +..+++++..++.++.||+.||+|||+. +|++|||||+|||||.+|.+||+|||+|.....
T Consensus 123 meyv~GGElFS~L--rk~~rF~e~~arFYAAeivlAleylH~~----~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYL--RKSGRFSEPHARFYAAEIVLALEYLHSL----DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHH--HhcCCCCchhHHHHHHHHHHHHHHHHhc----CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999999 5667799999999999999999999999 999999999999999999999999999987653
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
. ..+.||||.|+|||++.+.+|..++|.|||||++|||+.|.+||....+. .. +.+++...
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-----~i----------Y~KI~~~~ 257 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-----QI----------YEKILEGK 257 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-----HH----------HHHHHhCc
Confidence 3 56789999999999999999999999999999999999999999765541 11 11111111
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCC
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSR 656 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~R 656 (678)
-.+|......+.+|+..+|+.|-.+|
T Consensus 258 --v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 --VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 12444455578999999999999988
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=349.82 Aligned_cols=267 Identities=24% Similarity=0.338 Sum_probs=207.9
Q ss_pred hhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeC--CeE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVED--GRR 465 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~~ 465 (678)
...+.|..++.||+|.||.||+|+ ..+|+.||+|.+...... ...-..+|+.||++|.||||++|.+...+. +.+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 344678889999999999999999 578999999999866532 234577899999999999999999998876 689
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|||+|||++ +|.-++.. ..-.|++.++..++.||+.||+|||.. ||+|||||..|||||.+|.+||+|||+|++
T Consensus 194 YlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~----gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR----GVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc----CeeeccccccceEEcCCCCEEeccccceee
Confidence 999999955 88877733 334699999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhh----------hhhHH
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT----------EWARP 614 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~----------~~~~~ 614 (678)
+........+..+-|.+|.|||++.+ ..|+.++|+||.||||.||++|++.|....+..+.... .|...
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 76655555677788999999999887 47999999999999999999999999766543321111 12100
Q ss_pred HHHHhhh---hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 LLKRHAI---GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 ~~~~~~~---~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+..... ..-....+... -...+...++|+..+|..||.+|.|+.++|+
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0000000 00001111111 1123346788999999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=371.36 Aligned_cols=264 Identities=30% Similarity=0.409 Sum_probs=221.3
Q ss_pred hhhhhhhcCCcccceecccCccceeeccC------CCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEE
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFC 459 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 459 (678)
...++.+.+....+.||+|+||+||+|+. .+.+.||||.++..... ...+|.+|++++..++|||||+|+|+|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 34566778888899999999999999983 23568999999866555 567999999999999999999999999
Q ss_pred eeCCeEEEEEEEeecCCcccccccCC------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCce
Q 038949 460 VEDGRRLLVYEYICNGSLDSHLYGRD------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNI 527 (678)
Q Consensus 460 ~~~~~~~LV~E~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NI 527 (678)
.+++.+|||+|||..|||.++|.... ..+|+..+.+.|+.||+.|+.||-++ .+|||||..+|+
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~----~FVHRDLATRNC 634 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH----HFVHRDLATRNC 634 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----cccccchhhhhc
Confidence 99999999999999999999994321 23478888999999999999999999 899999999999
Q ss_pred EeeecCccccccccccccccCCCcccee-EEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCccc
Q 038949 528 LVTHDFEPLVGDFGLARWQPDGDMGVET-RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQ 605 (678)
Q Consensus 528 Ll~~~~~vkL~DFGla~~~~~~~~~~~~-~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~ 605 (678)
||.++..|||+|||+++.....++.... ...-..+||+||.+..++|+.+||||||||+|||+++ |..||.....
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--- 711 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--- 711 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---
Confidence 9999999999999999977666555433 4456789999999999999999999999999999998 8888764432
Q ss_pred chhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 606 QCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 606 ~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
..+.+.+..+-.-..|..++..++.|+..||+.+|++||+|+||-.+|+...
T Consensus 712 -------------~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 712 -------------QEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred -------------HHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 1111212111114467788899999999999999999999999999998654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=360.16 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=203.8
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecc-cccceEEEEeEEeeCCe
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~ 464 (678)
...-++|.++++||+|.||+|+++.. .+++.||||+++... .++.+..+.|.+|+... +||.+++++..|++..+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 44557899999999999999999994 578899999997543 33345677888888877 59999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+|+||||+.||++..+. ..+.+++..++.++..|+.||.|||++ ||||||||.+|||||.+|++||+|||+++
T Consensus 444 l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~----~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHEN----GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhc----CceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999955444 445699999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
.... ......+++|||.|||||++.+..|+.++|.|||||+|||||.|..||...++.. +.......
T Consensus 517 e~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee----------~FdsI~~d-- 583 (694)
T KOG0694|consen 517 EGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE----------VFDSIVND-- 583 (694)
T ss_pred ccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH----------HHHHHhcC--
Confidence 5432 2236678999999999999999999999999999999999999999997654311 11111011
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRM 659 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~ 659 (678)
++ .||...+.+...++.++|..||++|..+
T Consensus 584 -~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 -EV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 22 2444455688899999999999999876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=352.71 Aligned_cols=246 Identities=21% Similarity=0.300 Sum_probs=200.4
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
..++|.++..||+|+||.||+|+ ..+|..||+|+++.... ...+....|-.+|....+|+||++|..|++...+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999999 45899999999975443 334567889999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||++||++..+| ...+.|++..++.++.+++.|+..||+. |+|||||||+|+|||..|++||+|||++.-..
T Consensus 219 iMEylPGGD~mTLL--~~~~~L~e~~arfYiaE~vlAI~~iH~~----gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL--MRKDTLTEDWARFYIAETVLAIESIHQL----GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH--HhcCcCchHHHHHHHHHHHHHHHHHHHc----CcccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999 4566799999999999999999999999 99999999999999999999999999984110
Q ss_pred C----------------------CCcc-----c-------------------eeEEEeeecccccccccccccceeccee
Q 038949 548 D----------------------GDMG-----V-------------------ETRVLGTFGYLAPEYAQSGQITEKADVY 581 (678)
Q Consensus 548 ~----------------------~~~~-----~-------------------~~~~~Gt~~Y~APE~l~~~~~s~ksDVw 581 (678)
. .+.. . ....+|||.|+|||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 0 0000 0 0135799999999999999999999999
Q ss_pred eeeeEEEEeeeCCccccccCCcccc-hhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCch
Q 038949 582 SLGVVLVELITGRKAMDLNRPRGQQ-CLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR 658 (678)
Q Consensus 582 SLGviL~eLltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT 658 (678)
|||||+||||.|.+||....+..-. .+..|... +...-...+..+..+||.+||. ||++|..
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------LKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999999876652211 11111111 1111112233578999999999 9999976
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=346.47 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=212.6
Q ss_pred hcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccC-CccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQG-DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~-~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
...|....+||+|.||.||+|. ..+++.||+|++....... .+++.+|+.+|.+++++||.++|+.+..+..+|++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 3467777899999999999999 5689999999998655443 4788999999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
||.||++.+.+ +....+.+..+.-++++++.||.|||.+ +.+|||||+.|||+..+|.+||+|||.+.......
T Consensus 92 y~~gGsv~~lL--~~~~~~~E~~i~~ilre~l~~l~ylH~~----~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLL--KSGNILDEFEIAVILREVLKGLDYLHSE----KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhh--ccCCCCccceeeeehHHHHHHhhhhhhc----ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999999 4445568899999999999999999999 99999999999999999999999999998765443
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
....+++|||.|||||++....|+.++||||||++.+||++|.+|+....|..-.++ +.+--.|.+.
T Consensus 166 -~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~ 232 (467)
T KOG0201|consen 166 -KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLD 232 (467)
T ss_pred -hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCccc
Confidence 334788999999999999988999999999999999999999999987665222111 1222234444
Q ss_pred cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+ .++..|.+++..||..||+.||++.++|+
T Consensus 233 ~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 G----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred c----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 4 34457999999999999999999999984
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=324.18 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=207.5
Q ss_pred cCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccC--CccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~--~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
.+|...++||+|.||.||+|+ ..+|+.||||.++..+..+ .....+|++.|+.++|+||+.++++|.+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 578889999999999999999 5789999999998654332 3468899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+ ..+|...+..+ ...++...+..|+.++++||+|||++ .|+||||||.|+|++.+|.+||+|||+++.+....
T Consensus 82 fm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~----~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSK----WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhh----hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99 55888888543 45689999999999999999999999 99999999999999999999999999999886554
Q ss_pred ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhh--------hHHHHH-H--
Q 038949 551 MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEW--------ARPLLK-R-- 618 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~--------~~~~~~-~-- 618 (678)
..... .+-|.+|.|||.+.+ ..|+..+||||.|||+.||+-|.+-|....+..+.....- .++.+. -
T Consensus 156 ~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 RIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred ccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 33333 367999999998876 5799999999999999999999877765544333221110 001000 0
Q ss_pred -hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 619 -HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 619 -~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
..+.....+.+.. .-..++.+..+|+.+||..||.+|++++|+|+.
T Consensus 235 Y~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0111111222222 222345567999999999999999999998853
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=340.15 Aligned_cols=250 Identities=21% Similarity=0.341 Sum_probs=211.6
Q ss_pred hhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccC---CccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQG---DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~---~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
....+|.+.+.||+|.||.|-+|. +..|+.||||.++...... .-.+.+|++||+.|+||||+.+|++|+..+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 345789999999999999999998 5789999999997554333 346789999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
|||||..+|.|+||+ ..++.|++..++.+++||++|+.|+|++ +++|||||.+|||+|.++++||+|||++.++
T Consensus 130 ivMEYaS~GeLYDYi--Ser~~LsErEaRhfFRQIvSAVhYCHkn----rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 130 IVMEYASGGELYDYI--SERGSLSEREARHFFRQIVSAVHYCHKN----RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEEecCCccHHHHH--HHhccccHHHHHHHHHHHHHHHHHHhhc----cceecccchhheeecCCCCeeeeccchhhhh
Confidence 999999999999999 4456799999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCCccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
... ...+++||.|-|.+||++++.+| ++.+|.|||||+||.|+.|..||+..+. ..+++........
T Consensus 204 ~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----------k~lvrQIs~GaYr 271 (668)
T KOG0611|consen 204 ADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----------KRLVRQISRGAYR 271 (668)
T ss_pred ccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----------HHHHHHhhccccc
Confidence 544 45577899999999999999988 5789999999999999999999986542 1122222112221
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHh
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~L 666 (678)
. +..+....-||++||..||++|.|+++|....
T Consensus 272 E--------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 E--------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred C--------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1 22333567789999999999999999997643
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=337.85 Aligned_cols=251 Identities=26% Similarity=0.370 Sum_probs=202.3
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
.|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.++|+||+.+++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999984 579999999986432 2223457789999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+|+|.+++.......+++..+..++.|++.||+|||+. ||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE----RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999999888655555689999999999999999999999 99999999999999999999999999997653322
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ...... .+. . ..
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~------~~~---~--~~ 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDR------RVK---E--DQ 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHH------Hhh---c--cc
Confidence 12334689999999999999999999999999999999999999975432110 000000 000 0 01
Q ss_pred cccchhhhhhhhhccceeeccCCCCCch-----HHHHHH
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPR-----MSQVLR 664 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT-----~~eVL~ 664 (678)
..++...+..+.+|+.+||+.||.+||+ ++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1233344557899999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=337.59 Aligned_cols=245 Identities=20% Similarity=0.276 Sum_probs=198.0
Q ss_pred ceecccCccceeeccCCCCcEEEEEeeehhcccC---CccccccceeeecccccceEEEEeEEee----CCeEEEEEEEe
Q 038949 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG---DQEFCSEVEVLSCAQHRNVVMLIGFCVE----DGRRLLVYEYI 472 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~---~~~~~~Ev~iL~~L~HpnIv~l~~~~~~----~~~~~LV~E~~ 472 (678)
..||+|++|.||+|.+ +|+.||+|.++...... .+.+.+|+.+|++++||||+++++++.+ ...+++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68899999987543332 2567799999999999999999999876 34689999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 552 (678)
.+|+|.+++.. ...+++.....++.+++.||.|||+.. +++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999954 456889999999999999999999732 78899999999999999999999999997553322
Q ss_pred ceeEEEeeecccccccccc--cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 553 VETRVLGTFGYLAPEYAQS--GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
....|+..|+|||++.+ ..++.++|||||||++|||++|..||...... ++...... ....
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~i~~---------~~~~ 240 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDLIIN---------KNNS 240 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh---------cCCC
Confidence 23457889999999976 68999999999999999999999999754321 11111100 0111
Q ss_pred cccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
...+..++..+.+++.+||+.||++|||+.++++.|+..
T Consensus 241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 122334556899999999999999999999999999753
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.61 Aligned_cols=250 Identities=27% Similarity=0.432 Sum_probs=211.1
Q ss_pred hhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
+.|++..+...-++-||.|+.|.||+|++ .++.||||.++... ..+++-|+.|+||||+.|.|+|.....+|
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 34566677777788899999999999998 47789999876322 23677889999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
||||||..|-|...| +...++.......|..+|+.|+.|||.+ .|||||||.-||||+.+..|||+|||.++..
T Consensus 189 IiMEfCa~GqL~~VL--ka~~~itp~llv~Wsk~IA~GM~YLH~h----KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVL--KAGRPITPSLLVDWSKGIAGGMNYLHLH----KIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred EeeeccccccHHHHH--hccCccCHHHHHHHHHHhhhhhHHHHHh----hHhhhccCCCceEeeccceEEeccccchHhh
Confidence 999999999999999 5566788899999999999999999999 9999999999999999999999999999866
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.+. .....++||..|||||+++..+.+.|+|||||||||||||||..||..-+... .-|. +-.
T Consensus 263 ~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwG-----------VGs 325 (904)
T KOG4721|consen 263 SDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWG-----------VGS 325 (904)
T ss_pred hhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEe-----------ccC
Confidence 433 44556889999999999999999999999999999999999999996432211 0110 011
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
-.+.-..+..+++.|.-|++.||+-.|..||+|.++|..|+
T Consensus 326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 22334456778889999999999999999999999999886
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=342.65 Aligned_cols=252 Identities=21% Similarity=0.264 Sum_probs=202.9
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|.+.+.||+|+||.||+|.+ .+++.||+|+++.... .....+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4789999999999999999995 4689999999975432 22346788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+++|+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHEL----GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999994 345688999999999999999999999 999999999999999999999999999975433
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc-Ccc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI-DPR 628 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell-d~~ 628 (678)
......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...... ....+ .+.
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~---~~~~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKY---WKETLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH------HHHHHh---ccccccCCC
Confidence 22345689999999999999999999999999999999999999965432110 000000 00001 111
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.. ......+..+.+++.+||..+|.+||++.++++.
T Consensus 222 ~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 0001335578899999999999999999999854
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=331.51 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=209.1
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++..++|++.+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 34567899999999999999999997778889999876432 23457889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++.......+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK----NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999999665556688888999999999999999998 9999999999999999999999999999865433
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.........++..|+|||++..+.++.++||||||+++|+|++ |..||....... .... +.....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~------~~~~------~~~~~~-- 222 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD------VMSA------LQRGYR-- 222 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH------HHHH------HHcCCC--
Confidence 2222223345678999999998889999999999999999998 999985432110 0000 011111
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
.......+..+.+++.+||..+|++||+++++++.|+.
T Consensus 223 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 --MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112344578999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=352.55 Aligned_cols=246 Identities=28% Similarity=0.394 Sum_probs=208.7
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC--CccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~--~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
++|.+.+.||+|.||.||+|+. .+.+.||+|.+....... ...+.+|+++++.++||||+.+++.|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5789999999999999999994 478999999986443332 3568899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.| +|..++ ...+.++++.+..++.+++.||.|||++ +|+|||+||.|||+..+|.+|++|||+++....+
T Consensus 82 ~a~g-~L~~il--~~d~~lpEe~v~~~a~~LVsaL~yLhs~----rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTIL--EQDGKLPEEQVRAIAYDLVSALYYLHSN----RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhc----CcccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9966 999999 4556799999999999999999999999 9999999999999999999999999999976543
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
....+...|||-|||||+..+++|+..+|+||||||+||+++|++||-... +........ . |+
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~-----~---d~--- 216 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSIL-----K---DP--- 216 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHh-----c---CC---
Confidence 356677889999999999999999999999999999999999999995321 111111111 1 11
Q ss_pred cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..++...+..+.+++...|.+||.+|.+..+++.
T Consensus 217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1234456678999999999999999999999874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.56 Aligned_cols=241 Identities=24% Similarity=0.282 Sum_probs=195.7
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecC
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNG 475 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~gg 475 (678)
+.||+|+||.||++.. .+|+.||+|+++.... .....+.+|+.+++.++||||+++++++...+..|+||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 5789999999875422 22346778999999999999999999999999999999999999
Q ss_pred CcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcccee
Q 038949 476 SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET 555 (678)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 555 (678)
+|.+++. ....+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~ 153 (323)
T cd05571 81 ELFFHLS--RERVFSEDRARFYGAEIVSALGYLHSC----DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccc
Confidence 9998884 345689999999999999999999999 99999999999999999999999999987432211 2234
Q ss_pred EEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccch
Q 038949 556 RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSE 635 (678)
Q Consensus 556 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~ 635 (678)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...... . ..... ... +. .++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~----~~~~~-~~~--~~----~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------K----LFELI-LME--EI----RFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------H----HHHHH-HcC--CC----CCCC
Confidence 467999999999999999999999999999999999999999643210 0 00000 000 11 1233
Q ss_pred hhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 636 REVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 636 ~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
..+..+.+||.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 4455789999999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.20 Aligned_cols=264 Identities=30% Similarity=0.424 Sum_probs=213.7
Q ss_pred hhhhhhhcCCcccceecccCccceeeccCC--CC---cEEEEEeeehh---cccCCccccccceeeecccccceEEEEeE
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVLP--DG---QVVAVKQYKLA---SSQGDQEFCSEVEVLSCAQHRNVVMLIGF 458 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~--~g---~~vAvK~i~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~ 458 (678)
..|++.+++..+.+.||+|+||.||+|.++ ++ ..||+|..+.. ......+|++|+++|+.++|||||+|||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 447888888899999999999999999843 22 23899998752 23445789999999999999999999999
Q ss_pred EeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccc
Q 038949 459 CVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVG 538 (678)
Q Consensus 459 ~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~ 538 (678)
+.....+++|||+|.||+|.++|..... .++..+...++.+.+.||+|||++ ++|||||..+|+|++.++.+||+
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k----~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK----NCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC----CCcchhHhHHHheecCCCeEEeC
Confidence 9999999999999999999999954433 589999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCcccee-EEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHH
Q 038949 539 DFGLARWQPDGDMGVET-RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLL 616 (678)
Q Consensus 539 DFGla~~~~~~~~~~~~-~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~ 616 (678)
|||+++.... ..... ...-+..|+|||.+..+.|+.++|||||||++||+++ |..||..... .+ .
T Consensus 305 DFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~------~~-----v 371 (474)
T KOG0194|consen 305 DFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN------YE-----V 371 (474)
T ss_pred ccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH------HH-----H
Confidence 9999975431 11111 1124578999999999999999999999999999999 7888864332 11 1
Q ss_pred HHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 617 KRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 617 ~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
. ..+.....+...+...+..+..++.+||..||++||+|.++.+.|+.....
T Consensus 372 ~----~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 372 K----AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred H----HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 1 111122333344455666888899999999999999999999999876543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=336.98 Aligned_cols=265 Identities=22% Similarity=0.301 Sum_probs=201.8
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
++|.+.+.||+|+||.||++.. .+++.||+|+++.... .....+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4799999999999999999995 4688999999874422 223567889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.++.+..+. .....+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLE--EMPNGVPPEKVRSYIYQLIKAIHWCHKN----DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99887766544 2334688899999999999999999998 99999999999999999999999999998654433
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhh-hh--------hHHHHHHhhh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT-EW--------ARPLLKRHAI 621 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~-~~--------~~~~~~~~~~ 621 (678)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||............ .. ..........
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 33334457899999999999888999999999999999999999999654321110000 00 0000000000
Q ss_pred hcccCcch------hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 622 GELIDPRL------RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 622 ~elld~~l------~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.....+.. ...+....+..+.+|+.+||+.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 01111124457899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=331.18 Aligned_cols=258 Identities=26% Similarity=0.380 Sum_probs=212.6
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
+....+|.+.+.||.|+||.||+|...+++.+|+|.+..........+.+|+.+++.++||||+++++++.+....++||
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 34566799999999999999999997778999999987665545567889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++.......+++..++.++.|++.||.|||+. ||+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ----NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999999999766666789999999999999999999998 9999999999999999999999999999765432
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
... .....++..|+|||.+....++.++||||||+++|+|++ |..||...... +...... ..
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------~~~~~~~----------~~ 220 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------EVYDQIT----------AG 220 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHH----------hC
Confidence 221 123345678999999988899999999999999999998 88998643210 0001000 11
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
.....+..++..+.++|.+||+.||.+|||+.++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1112233455678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=329.95 Aligned_cols=258 Identities=26% Similarity=0.369 Sum_probs=209.4
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++..++|++.+.||+|++|.||+|...+++.||+|.++... .....+.+|+.++++++||||+++++++...+..++||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 45667899999999999999999997677889999987433 23456889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++.......+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ----NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999999655545689999999999999999999999 9999999999999999999999999999866432
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.........++..|+|||++.+..++.++|+||||+++|+|++ |+.||....... ... .+.. .
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------~~~--~~~~----~ 220 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE----------VLQ--QVDQ----G 220 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH----------HHH--HHHc----C
Confidence 2211122223457999999998899999999999999999999 998986432100 000 0000 1
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
.....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 221 YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1111233445689999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=333.65 Aligned_cols=257 Identities=24% Similarity=0.324 Sum_probs=204.1
Q ss_pred hhcCCcccceecccCccceeeccC----CCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL----PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
..++|++.+.||+|+||.||+|.+ ..+..||+|.++..... ....+.+|+.+++.++||||+++++++..++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 456799999999999999999973 24678999998754322 2246889999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.+|+|.+++... ...+++..++.++.||+.||+|||+. |++||||||+|||++.++.++++|||.+...
T Consensus 83 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~----~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM----GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999998543 34689999999999999999999998 9999999999999999999999999987643
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
............++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ... .. +.+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------~~~----~~--~~~~- 224 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------DVI----KA--VEDG- 224 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHH----HH--HHCC-
Confidence 2221111112234578999999999999999999999999999764 99999644321 000 00 0110
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
.....+..++..+.+++.+||+.+|.+||++++|++.|++.
T Consensus 225 ---~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 ---FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11112344556789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=337.66 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=201.0
Q ss_pred hhcCCcccceecccCccceeeccCC-----------------CCcEEEEEeeehhcc-cCCccccccceeeecccccceE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLP-----------------DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVV 453 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----------------~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv 453 (678)
..++|.+.+.||+|+||.||++.+. ++..||+|.+..... .....+.+|+.++..++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 3578999999999999999999742 234799998874322 2235688999999999999999
Q ss_pred EEEeEEeeCCeEEEEEEEeecCCcccccccCC-----------------CCccCccccchhhhhhccchhhhhhcceeee
Q 038949 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRD-----------------RDPLEWSARRKIAVGAARGLRYLHEECRVGC 516 (678)
Q Consensus 454 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-----------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g 516 (678)
++++++.+.+..++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+. |
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~ 158 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL----N 158 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC----C
Confidence 99999999999999999999999998874321 12356777889999999999999998 9
Q ss_pred EEeccCCCCceEeeecCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee--C
Q 038949 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT--G 593 (678)
Q Consensus 517 IvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt--G 593 (678)
|+||||||+|||++.++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|+|++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 99999999999999999999999999975533221 11222345778999999998899999999999999999986 5
Q ss_pred CccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 594 RKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 594 ~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
..||..... ............... .......+..++..+.+|+.+||+.||++|||+.+|.+.|+.
T Consensus 239 ~~p~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 239 EQPYGELTD---EQVIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCcCCH---HHHHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 567654321 111111111111000 000111223455689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=342.96 Aligned_cols=244 Identities=24% Similarity=0.309 Sum_probs=200.4
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
.++|.+.+.||+|+||.||+|.+ .+++.||+|+++.... .....+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 46799999999999999999995 4689999999874422 2335688999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.+|+|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSK----DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999843 45688899999999999999999999 999999999999999999999999999976543
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.. ....||+.|+|||++.+..++.++|||||||++|+|++|..||....+. ...... ....
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i---------~~~~ 231 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKI---------LAGR 231 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHH---------hcCC
Confidence 22 3457999999999999999999999999999999999999999643220 000000 0000
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCch-----HHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPR-----MSQVL 663 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT-----~~eVL 663 (678)
..++......+.+||.+||+.||.+||+ +++++
T Consensus 232 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 232 --LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred --cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 1122223457889999999999999997 57766
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=350.63 Aligned_cols=262 Identities=28% Similarity=0.405 Sum_probs=203.5
Q ss_pred hhhhhcCCcccceecccCccceeeccC------CCCcEEEEEeeehhcc-cCCccccccceeeecc-cccceEEEEeEEe
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCA-QHRNVVMLIGFCV 460 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~ 460 (678)
+....++|++.+.||+|+||.||+|.+ .++..||+|+++.... ...+.+.+|+.++..+ +||||++++++|.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 455667899999999999999999862 2466899999864322 2235688899999999 8999999999999
Q ss_pred eCCeEEEEEEEeecCCcccccccCC-------------------------------------------------------
Q 038949 461 EDGRRLLVYEYICNGSLDSHLYGRD------------------------------------------------------- 485 (678)
Q Consensus 461 ~~~~~~LV~E~~~ggsL~~~l~~~~------------------------------------------------------- 485 (678)
+.+..++||||+++|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999998884321
Q ss_pred ------------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 486 ------------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 486 ------------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 12467778889999999999999998 99999999999999999999999999997554
Q ss_pred CCCcc-ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 548 DGDMG-VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 548 ~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
..... ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... .... ....
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~----~~~~------- 332 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYK----MIKE------- 332 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHH----HHHh-------
Confidence 32211 1112234567999999999999999999999999999998 888885432111 0000 1110
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
......+...+..+.+|+.+||+.||++||++.+|++.|+..
T Consensus 333 --~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 333 --GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --CccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 001111222345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=335.17 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=200.0
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--------------CCccccccceeeecccccceEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--------------GDQEFCSEVEVLSCAQHRNVVM 454 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--------------~~~~~~~Ev~iL~~L~HpnIv~ 454 (678)
...-+.|.+.+.||+|.||.|-+|+. .+++.||||++...... ..+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34557899999999999999999994 57999999998532211 1146788999999999999999
Q ss_pred EEeEEee--CCeEEEEEEEeecCCcccccccCCCCc-cCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee
Q 038949 455 LIGFCVE--DGRRLLVYEYICNGSLDSHLYGRDRDP-LEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH 531 (678)
Q Consensus 455 l~~~~~~--~~~~~LV~E~~~ggsL~~~l~~~~~~~-l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~ 531 (678)
|+++..+ .+.+|||+|||..|.+...- ...+ +++.+++++++.++.||+|||.+ |||||||||.|+||+.
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q----giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ----GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEEcC
Confidence 9999876 45799999999988876543 3444 99999999999999999999999 9999999999999999
Q ss_pred cCccccccccccccccCC----CccceeEEEeeecccccccccccc----cceecceeeeeeEEEEeeeCCccccccCCc
Q 038949 532 DFEPLVGDFGLARWQPDG----DMGVETRVLGTFGYLAPEYAQSGQ----ITEKADVYSLGVVLVELITGRKAMDLNRPR 603 (678)
Q Consensus 532 ~~~vkL~DFGla~~~~~~----~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSLGviL~eLltG~~Pf~~~~~~ 603 (678)
+|++||+|||.+.....+ ........+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||.....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~- 324 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE- 324 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-
Confidence 999999999999765322 122233478999999999887632 35688999999999999999999964321
Q ss_pred ccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 604 GQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 604 ~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.+. +.+++...+.-...++....+.+||.+||.+||++|.+..+|...
T Consensus 325 -----~~l---------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 325 -----LEL---------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred -----HHH---------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 111 112222222222222455688999999999999999999998644
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=341.87 Aligned_cols=252 Identities=23% Similarity=0.284 Sum_probs=202.9
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|.+.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4799999999999999999995 4789999999975432 23356888999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++... ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~----giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL----GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999543 5689999999999999999999998 9999999999999999999999999999755432
Q ss_pred C----------------------------ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccC
Q 038949 550 D----------------------------MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNR 601 (678)
Q Consensus 550 ~----------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~ 601 (678)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112334568999999999999999999999999999999999999996543
Q ss_pred CcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCch-HHHHHHH
Q 038949 602 PRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR-MSQVLRM 665 (678)
Q Consensus 602 ~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT-~~eVL~~ 665 (678)
.. ....... .. ...+........+..+.+||.+||. ||.+||+ ++++++.
T Consensus 235 ~~------~~~~~i~------~~-~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQ------ETYNKII------NW-KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH------HHHHHHh------cc-CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 21 0001000 00 0001100111135578899999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=330.86 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=208.2
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
+....|.+.+.||+|+||.||+|.+ .+++.||+|.+.... .....+.+|+++++.++||||+++++++..+...++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 4456788999999999999999985 468899999886332 22356889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+++++|.+++.......+++..++.++.|++.||.|||+. |++||||||+|||++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999999998655556688999999999999999999998 9999999999999999999999999999765443
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .+..... . ..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~~------~----~~ 221 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELL------E----KG 221 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHH------H----CC
Confidence 2222222234567999999998899999999999999999998 8888854321 1111110 0 11
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
.....+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11122334456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=336.71 Aligned_cols=252 Identities=21% Similarity=0.251 Sum_probs=201.1
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|.+.+.||+|+||.||++.. .+++.||+|+++.... .....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4789999999999999999984 5789999999975432 23346788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+|+|.+++... ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~----~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM----GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 24689999999999999999999999 9999999999999999999999999999866443
Q ss_pred CccceeEEEeeeccccccccc------ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQ------SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~------~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
.........||+.|+|||++. ...++.++|||||||++|+|++|..||...... ......... ..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~---~~ 226 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNF---QR 226 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcC---CC
Confidence 333333457899999999986 456789999999999999999999999643321 101111100 00
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+ ........+..+.+|+.+||+ +|.+||++.+++.
T Consensus 227 ~~----~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FL----KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cc----CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 001112244578899999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=345.24 Aligned_cols=252 Identities=26% Similarity=0.326 Sum_probs=215.8
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCC--ccccccceeeecccccceEEEEeEEeeCCe-EEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGD--QEFCSEVEVLSCAQHRNVVMLIGFCVEDGR-RLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~--~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~-~~LV 468 (678)
.++|..++.+|+|+||.+++.++ .+++.|++|.+........ +...+|+.++++++|||||.+++.|.+++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 36789999999999999999985 4678999999976554333 367889999999999999999999999888 9999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|+||+||+|.+.|.+.+..-++++.+..|+.|++.|+.|||++ .|+|||||+.|||++.++.|+|+|||+++....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~----~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN----RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh----hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999999887777899999999999999999999998 999999999999999999999999999997754
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.. ....+.+||+.||.||++.+.+|..|+|||||||++|||++-+++|....... . ..... +.
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---------L--i~ki~-----~~ 221 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---------L--ILKIN-----RG 221 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---------H--HHHHh-----hc
Confidence 43 34567889999999999999999999999999999999999999997654211 0 01111 11
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.....+..++.++..||..||+.+|..||++.++|..
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1233455666789999999999999999999999876
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=347.74 Aligned_cols=267 Identities=28% Similarity=0.439 Sum_probs=213.0
Q ss_pred ehhhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeC
Q 038949 385 TYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVED 462 (678)
Q Consensus 385 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 462 (678)
+..+|++..+.+.+...||+|.||+||+|.|.+ .||||+++..... ..+.|.+|+.+|+.-+|.||+-|+|+|...
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 448899999999999999999999999999853 5999999755443 346899999999999999999999999887
Q ss_pred CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
.. .||.-+|+|.+|+.++.-.. ..|.....+.|++||+.|+.|||.+ +|||||||..||||.+++.|||+|||+
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK----~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK----NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh----hhhhhhccccceEEccCCcEEEecccc
Confidence 76 99999999999999996554 4588889999999999999999999 999999999999999999999999999
Q ss_pred cccccCC-CccceeEEEeeecccccccccc---cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHH
Q 038949 543 ARWQPDG-DMGVETRVLGTFGYLAPEYAQS---GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR 618 (678)
Q Consensus 543 a~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 618 (678)
+...... .........|...|||||+++. .+|+..+||||||+++|||+||..||..... . +.+-...+
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-d-qIifmVGr----- 607 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-D-QIIFMVGR----- 607 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-h-heEEEecc-----
Confidence 9643221 0011122346678999999864 5799999999999999999999999973221 1 11100000
Q ss_pred hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 619 ~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
+ .+.+.+ ......++.++.+|+..||..++++||.+.+||..|+....
T Consensus 608 ---G-~l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 608 ---G-YLMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ---c-ccCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 0 001111 11223466689999999999999999999999998887665
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=313.14 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=213.6
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeehh---cccCCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLA---SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
.-++|.+++.||+|.||.||+|+ .+++-.||+|++... ..+...++.+|+++-+.|+||||+++|++|.+..+.||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 34789999999999999999999 467889999998533 33445789999999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
++||..+|+|...|.......+++...+.+..|++.||.|+|.. ++|||||||+|+|++..+.+||+|||.+...+
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k----~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC----CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999877888899999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
.....+.+||..|++||...+..++..+|+|++|++.||++.|.+||..... ...+.++..
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---------------~etYkrI~k- 236 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---------------SETYKRIRK- 236 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---------------HHHHHHHHH-
Confidence 4566788999999999999999999999999999999999999999974331 001111110
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..-.++...+....+||.+|+..+|.+|.+..|+++
T Consensus 237 -~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 237 -VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -ccccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 111233455668999999999999999999999875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=338.09 Aligned_cols=245 Identities=24% Similarity=0.266 Sum_probs=200.7
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4789999999999999999995 4789999999864322 22356788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+|+|.+++.. ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSK----EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999843 45688999999999999999999999 9999999999999999999999999999765332
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...... ........ ..
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~~----~~------ 214 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKILA----GK------ 214 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh----CC------
Confidence 22356899999999999888999999999999999999999999643221 11111100 00
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCch-----HHHHHHH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPR-----MSQVLRM 665 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT-----~~eVL~~ 665 (678)
..++......+.+||.+||+.||.+||+ ++++++.
T Consensus 215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1122233457889999999999999995 8887743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=326.53 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=201.7
Q ss_pred cCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEee
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYIC 473 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ 473 (678)
++|.+.+.||+|+||.||++.++++..+|+|.+.... .....+.+|+.+++.++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 5688899999999999999998777889999876332 223578889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccc
Q 038949 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553 (678)
Q Consensus 474 ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 553 (678)
+|+|.+++.... ..+++..++.++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||+++.........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN----SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999885432 3588999999999999999999999 99999999999999999999999999997654332222
Q ss_pred eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
.....++..|+|||++.+..++.++|+||||+++|+|++ |+.||..... .+........ .. ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~~---~~-------~~ 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISRG---FR-------LY 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCC---CC-------CC
Confidence 222234568999999998889999999999999999999 8889864321 0111100000 00 01
Q ss_pred cchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
.+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11223447899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=348.73 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=203.7
Q ss_pred hhhhhcCCcccceecccCccceeeccC------CCCcEEEEEeeehhccc-CCccccccceeeecc-cccceEEEEeEEe
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCA-QHRNVVMLIGFCV 460 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~ 460 (678)
+....++|++.+.||+|+||.||+|.+ .++..||+|.++..... ....+.+|+.+++.+ +|+||++++++|.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 455667899999999999999999873 23457999998643222 234678899999999 8999999999999
Q ss_pred eCCeEEEEEEEeecCCcccccccCC-------------------------------------------------------
Q 038949 461 EDGRRLLVYEYICNGSLDSHLYGRD------------------------------------------------------- 485 (678)
Q Consensus 461 ~~~~~~LV~E~~~ggsL~~~l~~~~------------------------------------------------------- 485 (678)
..+..++||||+.+|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999998874321
Q ss_pred -------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc
Q 038949 486 -------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552 (678)
Q Consensus 486 -------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 552 (678)
..++++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK----NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 12467777889999999999999998 9999999999999999999999999999755332211
Q ss_pred -ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 553 -VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 553 -~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
......++..|+|||++.+..++.++|||||||++|+|++ |..||........ +. ... .....
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-----~~-~~~---------~~~~~ 333 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-----FY-KMV---------KRGYQ 333 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-----HH-HHH---------HcccC
Confidence 1112234567999999998899999999999999999997 9999864322110 00 000 00111
Q ss_pred cccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
...+...+..+.+++.+||+.||++||++.+|++.|++.+
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1112223457899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=335.49 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=198.6
Q ss_pred CCcccceecccCccceeeccC----CCCcEEEEEeeehhcc----cCCccccccceeeecc-cccceEEEEeEEeeCCeE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL----PDGQVVAVKQYKLASS----QGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~i~~~~~----~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~ 465 (678)
+|++.+.||+|+||.||++.. .+++.||+|++..... ...+.+..|+.++..+ +||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488999999999999999873 3688999999864321 1224577899999999 599999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKL----GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999843 44589999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
.............||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ........ ..
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~------~~- 225 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRI------LK- 225 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHH------hc-
Confidence 544333333456799999999999765 478899999999999999999999965432111 11111110 00
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
.++. ++...+..+.+++.+||+.||++|| +++++++
T Consensus 226 ~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111 2233445788999999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=340.62 Aligned_cols=252 Identities=21% Similarity=0.238 Sum_probs=196.1
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.+|+.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3689999999999999999984 578999999986432 122356778999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+|+|.+++.. ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999943 45688889999999999999999999 9999999999999999999999999997422100
Q ss_pred ------------------------------------------CccceeEEEeeecccccccccccccceecceeeeeeEE
Q 038949 550 ------------------------------------------DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVL 587 (678)
Q Consensus 550 ------------------------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL 587 (678)
........+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00011234799999999999999999999999999999
Q ss_pred EEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCc---hHHHHHH
Q 038949 588 VELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRP---RMSQVLR 664 (678)
Q Consensus 588 ~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RP---T~~eVL~ 664 (678)
|+|++|+.||....+... ..... .. ...+........+..+.++|.+|+ .+|.+|+ ++.++++
T Consensus 235 yell~G~~Pf~~~~~~~~------~~~i~---~~----~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAET------QLKVI---NW----ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHH------HHHHh---cc----CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999999975432111 00000 00 000111111123446777888866 5999999 7888874
Q ss_pred H
Q 038949 665 M 665 (678)
Q Consensus 665 ~ 665 (678)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=325.25 Aligned_cols=257 Identities=27% Similarity=0.386 Sum_probs=208.4
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++..++|++.+.||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 45678899999999999999999998888999999886433 22357889999999999999999999874 46789999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++.......+++..+..++.|++.||+|||+. |++||||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK----NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999998665556788999999999999999999998 9999999999999999999999999999765433
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.........++..|+|||++....++.++||||||+++|+|++ |+.||...... ...... .. .
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~------~~----~ 219 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP------EVIQNL------ER----G 219 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH------HHHHHH------Hc----C
Confidence 2222223345678999999998889999999999999999999 99999643311 101100 00 1
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
.....+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1111223344579999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=325.69 Aligned_cols=257 Identities=28% Similarity=0.404 Sum_probs=206.7
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++..++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 445678999999999999999999977788899999875332 3356889999999999999999999875 45689999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++.......+++..++.++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM----NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999998655555688999999999999999999999 9999999999999999999999999999765433
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.........++..|+|||++.+..++.++|+||||+++|+|++ |..||..... .+..... ...
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~----------~~~ 219 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLEQV----------ERG 219 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHH----------HcC
Confidence 2222222334567999999988889999999999999999999 8888854321 0111110 001
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
.....+...+..+.+++.+||..+|.+|||+.++++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112233445579999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=341.89 Aligned_cols=251 Identities=20% Similarity=0.275 Sum_probs=198.0
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++..++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4789999999999999999994 578999999997542 222345778999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.++|+|||++......
T Consensus 81 E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKL----GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999843 45689999999999999999999999 9999999999999999999999999998643211
Q ss_pred Ccc-------------------------------------ceeEEEeeecccccccccccccceecceeeeeeEEEEeee
Q 038949 550 DMG-------------------------------------VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT 592 (678)
Q Consensus 550 ~~~-------------------------------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt 592 (678)
... .....+||+.|+|||++....++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112469999999999999999999999999999999999
Q ss_pred CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCch---HHHHHH
Q 038949 593 GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR---MSQVLR 664 (678)
Q Consensus 593 G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT---~~eVL~ 664 (678)
|..||....+.. ....... .. ..+........+..+.+||.+|+. +|.+|++ +.++++
T Consensus 235 G~~Pf~~~~~~~------~~~~i~~---~~----~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQE------TYRKIIN---WK----ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHH------HHHHHHc---CC----CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999996543211 0000000 00 000000111234578889999996 9999998 777765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.68 Aligned_cols=241 Identities=23% Similarity=0.283 Sum_probs=193.5
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecC
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNG 475 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~gg 475 (678)
+.||+|+||.||++.. .+++.||+|+++.... .....+.+|++++..++||||+++++++...+..|+||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 5789999999975322 22345678999999999999999999999999999999999999
Q ss_pred CcccccccCCCCccCccccchhhhhhccchhhhhh-cceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 476 SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
+|..++. ....+++..++.++.||+.||.|||+ . ||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~----~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (325)
T cd05594 81 ELFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATM 153 (325)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcC----CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccc
Confidence 9998884 34468999999999999999999997 6 99999999999999999999999999987432221 122
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .. ....... .. .++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~----~~~i~~~---~~----~~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KL----FELILME---EI----RFP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HH----HHHHhcC---CC----CCC
Confidence 3456999999999999999999999999999999999999999643210 00 0000000 01 122
Q ss_pred hhhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 635 EREVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
...+..+.+|+.+||+.||++|+ ++.++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 33445788999999999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=329.84 Aligned_cols=262 Identities=23% Similarity=0.306 Sum_probs=195.3
Q ss_pred cCCcccceecccCccceeeccC--CCCcEEEEEeeehhcccC--Cccccccceeeecc---cccceEEEEeEEe-----e
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL--PDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCA---QHRNVVMLIGFCV-----E 461 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~--~~g~~vAvK~i~~~~~~~--~~~~~~Ev~iL~~L---~HpnIv~l~~~~~-----~ 461 (678)
.+|++.+.||+|+||.||+|.. .+++.||+|.++...... ...+.+|+.+++.+ .||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4799999999999999999984 357889999887443222 23456677766655 6999999999885 2
Q ss_pred CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
...+++||||+. ++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~----~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999995 6899888665556689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHH--HHh
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLL--KRH 619 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~--~~~ 619 (678)
++...... .......|++.|+|||++....++.++|||||||++|+|++|.+||........ +........ ...
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~--~~~i~~~~~~~~~~ 231 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPGEE 231 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHHhCCCChh
Confidence 99765432 223345689999999999888999999999999999999999999975432111 100000000 000
Q ss_pred hhh-------cccCcch---hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 AIG-------ELIDPRL---RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 ~~~-------elld~~l---~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... ..+.+.. ........+..+.+|+.+||+.||++|||+.++|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 0000000 00111223456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=339.20 Aligned_cols=248 Identities=22% Similarity=0.250 Sum_probs=201.5
Q ss_pred hhhcCCcccceecccCccceeeccCC--CCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLP--DGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
...++|.+.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+.+
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 34568999999999999999999843 34689999986432 22234678899999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++..
T Consensus 107 ~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSL----NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 999999999999999843 45688999999999999999999999 999999999999999999999999999976
Q ss_pred ccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+. ...... .
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i------~--- 241 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKI------L--- 241 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHH------h---
Confidence 5322 23467999999999999888999999999999999999999999653321 000000 0
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCc-----hHHHHHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLRM 665 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~~ 665 (678)
... ..++......+.++|.+||+.||.+|+ +++++++.
T Consensus 242 ~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 242 EGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 000 112233445688999999999999995 88888753
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=337.56 Aligned_cols=200 Identities=30% Similarity=0.424 Sum_probs=174.5
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
..++|++.+.||+|+||.||++.. .++..+|+|.+..... .....+.+|+++++.++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 457899999999999999999995 4788999999875422 22356889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+|+|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.++|+|||++......
T Consensus 83 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 83 EHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKH---QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999999843 345889999999999999999999851 6999999999999999999999999999755332
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDL 599 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~ 599 (678)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12335689999999999988999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=334.93 Aligned_cols=244 Identities=24% Similarity=0.271 Sum_probs=195.1
Q ss_pred ecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCc
Q 038949 402 LAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSL 477 (678)
Q Consensus 402 LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 477 (678)
||+|+||.||+|.. .+++.||+|+++... ......+.+|+.++..++||||+++++++.+.+..|+||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999985 468899999987432 22234677899999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccceeEE
Q 038949 478 DSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV 557 (678)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 557 (678)
.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++...... ......
T Consensus 81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 153 (312)
T cd05585 81 FHHLQR--EGRFDLSRARFYTAELLCALENLHKF----NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF 153 (312)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence 999843 45689999999999999999999999 99999999999999999999999999997543222 223446
Q ss_pred EeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhh
Q 038949 558 LGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSERE 637 (678)
Q Consensus 558 ~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~ 637 (678)
.||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......... . ...++...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~-----~------~~~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQ-----E------PLRFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHc-----C------CCCCCCcC
Confidence 799999999999999999999999999999999999999964321 111111110 0 01122334
Q ss_pred hhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 638 VYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 638 ~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
+..+.+++.+||+.||.+||++..+.+.|...
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence 45788999999999999998765554444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.27 Aligned_cols=258 Identities=29% Similarity=0.389 Sum_probs=206.6
Q ss_pred hhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
+..++|.+.+.||+|+||.||+|.+.+...||+|.++... .....+.+|+.+++.++||||+++++++.+ ...++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 4567899999999999999999987666789999987422 223568899999999999999999998754 56899999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+|+|.+++.......+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||.++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999654445678899999999999999999999 99999999999999999999999999997654433
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
........++..|+|||++.+..++.++|+||||+++|+|++ |..||....... ..... .. ..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~----------~~~~~--~~----~~ 220 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------VLDQV--ER----GY 220 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH----------HHHHH--hc----CC
Confidence 222223346678999999988899999999999999999999 888885432110 00000 00 00
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
....+...+..+.+++.+||+.||++||++.++++.|+..+
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 11122345567899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=329.22 Aligned_cols=256 Identities=29% Similarity=0.438 Sum_probs=203.9
Q ss_pred hcCCcccceecccCccceeeccCCC------CcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLPD------GQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
.++|++.+.||+|+||.||+|.... ...||+|.++.... .....+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 3578999999999999999997422 25799998864322 2234688999999999999999999999998999
Q ss_pred EEEEEEeecCCcccccccCCC--------------CccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee
Q 038949 466 LLVYEYICNGSLDSHLYGRDR--------------DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH 531 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~ 531 (678)
|++|||+.+++|.+++..... ..+++..++.++.|++.||.|||+. |++||||||+||+++.
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGE 159 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccccceEEEcC
Confidence 999999999999998854321 4577788889999999999999999 9999999999999999
Q ss_pred cCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhh
Q 038949 532 DFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLT 609 (678)
Q Consensus 532 ~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~ 609 (678)
++.++|+|||++........ .......+++.|+|||++.++.++.++|||||||++|||++ |..||....+.
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------ 233 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------ 233 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence 99999999999975433221 12233456788999999988899999999999999999998 99998643321
Q ss_pred hhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 610 EWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 610 ~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
+... .+........+..++..+.+|+.+||+.||.+||++.+|++.|+.
T Consensus 234 ~~~~----------~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 EVIE----------MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH----------HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1100 011111112334556789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.47 Aligned_cols=238 Identities=23% Similarity=0.292 Sum_probs=192.3
Q ss_pred ceecccCccceeeccC----CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEee
Q 038949 400 NFLAEGGFGSVHRGVL----PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYIC 473 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~----~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ 473 (678)
+.||+|+||.||++.. .+++.||+|+++..... ....+..|+++++.++||||+++++++.+++..|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999863 36889999999754322 22456789999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccc
Q 038949 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553 (678)
Q Consensus 474 ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 553 (678)
+|+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++....... ..
T Consensus 82 ~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 154 (318)
T cd05582 82 GGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK 154 (318)
T ss_pred CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence 999999884 345689999999999999999999999 99999999999999999999999999997543321 22
Q ss_pred eeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhccc
Q 038949 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCY 633 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~ 633 (678)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ...... .... ...
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i---------~~~~--~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMI---------LKAK--LGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHH---------HcCC--CCC
Confidence 33467899999999999888999999999999999999999999643210 000000 0000 112
Q ss_pred chhhhhhhhhccceeeccCCCCCchHHH
Q 038949 634 SEREVYGMLQCASLCIRKDPHSRPRMSQ 661 (678)
Q Consensus 634 ~~~~~~~l~~LI~~cL~~dP~~RPT~~e 661 (678)
+...+..+.+|+.+||+.||.+||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2334457889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=343.33 Aligned_cols=256 Identities=19% Similarity=0.218 Sum_probs=201.9
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
....++|.+.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.++..+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45567899999999999999999984 578899999986432 22234577899999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||+.||+|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999998843 3478888899999999999999999 999999999999999999999999999976
Q ss_pred ccCCCccceeEEEeeeccccccccccc----ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSG----QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
.............||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ..........
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~-- 263 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHK-- 263 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCC--
Confidence 543322223345799999999998653 4789999999999999999999999653321 0000000000
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCC--CchHHHHHHH
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHS--RPRMSQVLRM 665 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~--RPT~~eVL~~ 665 (678)
..+........+..+.+||.+||+.+|.+ ||++.++++.
T Consensus 264 -----~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 -----NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00000011124557889999999999998 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=329.14 Aligned_cols=263 Identities=23% Similarity=0.342 Sum_probs=198.4
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
++|.+.+.||.|+||.||+|.. .+++.||+|.++..... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5799999999999999999984 47899999998744322 234677899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+. |+|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKR----KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 96 5888887433 33478888999999999999999999 99999999999999999999999999997543222
Q ss_pred cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhh----------hhhHHHHHHhh
Q 038949 552 GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT----------EWARPLLKRHA 620 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~----------~~~~~~~~~~~ 620 (678)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||............ .|.. ......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 236 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG-ITSNEE 236 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc-cccchh
Confidence 12233468999999998865 56899999999999999999999999654321110000 0000 000000
Q ss_pred hhcccCcchhc----ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 IGELIDPRLRN----CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ~~elld~~l~~----~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
......+.... .........+.+|+.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11111111000 001123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.55 Aligned_cols=252 Identities=20% Similarity=0.237 Sum_probs=195.5
Q ss_pred cCCcccceecccCccceeecc-CCCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|.+.+.||+|+||.||++. ..+++.||||.+.... ......+.+|+++++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 478999999999999999998 4578999999986432 222346788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+|+|.+++.. ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.++|+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~----givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKL----GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999843 45688899999999999999999999 9999999999999999999999999998632110
Q ss_pred Cc------------c----------------------------------ceeEEEeeecccccccccccccceecceeee
Q 038949 550 DM------------G----------------------------------VETRVLGTFGYLAPEYAQSGQITEKADVYSL 583 (678)
Q Consensus 550 ~~------------~----------------------------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSL 583 (678)
.. . .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 0012469999999999999999999999999
Q ss_pred eeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCC---chHH
Q 038949 584 GVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSR---PRMS 660 (678)
Q Consensus 584 GviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~R---PT~~ 660 (678)
||++|||++|..||....+.. ........ .. .+.-......+..+.+||.+||. +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~------~~~~i~~~---~~----~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE------TYRKIINW---RE----TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH------HHHHHHcc---CC----ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999996443211 00000000 00 00000011234568899999997 67665 5888
Q ss_pred HHHHH
Q 038949 661 QVLRM 665 (678)
Q Consensus 661 eVL~~ 665 (678)
++++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 87753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=334.94 Aligned_cols=242 Identities=24% Similarity=0.281 Sum_probs=195.2
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecC
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNG 475 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~gg 475 (678)
+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..|+||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 578999999987432 222346778999999999999999999999999999999999999
Q ss_pred CcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcccee
Q 038949 476 SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET 555 (678)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 555 (678)
+|.+++. ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 153 (328)
T cd05593 81 ELFFHLS--RERVFSEDRTRFYGAEIVSALDYLHSG----KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMK 153 (328)
T ss_pred CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccc
Confidence 9988884 345689999999999999999999999 9999999999999999999999999998743221 12223
Q ss_pred EEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccch
Q 038949 556 RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSE 635 (678)
Q Consensus 556 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~ 635 (678)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...... .. .+. .++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~-----~~--~~~----~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELI-----LM--EDI----KFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHh-----cc--CCc----cCCC
Confidence 457899999999999889999999999999999999999999643211 000000 00 011 1233
Q ss_pred hhhhhhhhccceeeccCCCCCc-----hHHHHHHH
Q 038949 636 REVYGMLQCASLCIRKDPHSRP-----RMSQVLRM 665 (678)
Q Consensus 636 ~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~~ 665 (678)
..+..+.++|.+||+.||++|| ++.++++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3455789999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.45 Aligned_cols=251 Identities=21% Similarity=0.260 Sum_probs=195.2
Q ss_pred CCcccceecccCccceeecc-CCCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
.|..++.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58899999999999999998 45788999999974332 223468889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+++|+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~----givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKM----GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999843 44688899999999999999999998 99999999999999999999999999975321000
Q ss_pred ----------------------------------------------ccceeEEEeeecccccccccccccceecceeeee
Q 038949 551 ----------------------------------------------MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLG 584 (678)
Q Consensus 551 ----------------------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLG 584 (678)
.......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0011235799999999999988999999999999
Q ss_pred eEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccce--eeccCCCCCchHHHH
Q 038949 585 VVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASL--CIRKDPHSRPRMSQV 662 (678)
Q Consensus 585 viL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~--cL~~dP~~RPT~~eV 662 (678)
|++|||++|..||....+... ....... ...+........+..+.+||.+ |+..+|..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~------~~~i~~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTET------QLKVINW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHH------HHHHHcc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999975432110 0000000 0000000111233467778877 556666679999999
Q ss_pred HH
Q 038949 663 LR 664 (678)
Q Consensus 663 L~ 664 (678)
+.
T Consensus 303 l~ 304 (381)
T cd05626 303 KA 304 (381)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=323.19 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=201.6
Q ss_pred cCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEee
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYIC 473 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ 473 (678)
++|.+.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+....++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 5688899999999999999987667779999886432 223568899999999999999999999999889999999999
Q ss_pred cCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccc
Q 038949 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553 (678)
Q Consensus 474 ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 553 (678)
+|+|.+++.... ..+++..++.++.|++.||.|||+. |++|+||+|+|||++.++.+||+|||.++.........
T Consensus 83 ~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESK----QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999885433 3589999999999999999999999 99999999999999999999999999987654332211
Q ss_pred eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
.....++..|++||.+.+..++.++||||||+++|+|++ |..||...... ...... ..... ..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~------~~~~~----~~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------ETVEKV------SQGLR----LY 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHH------hcCCC----CC
Confidence 112234567999999998889999999999999999998 99998643321 000000 00000 01
Q ss_pred cchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
.+...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11223457899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.78 Aligned_cols=249 Identities=24% Similarity=0.409 Sum_probs=194.2
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
.++|...+.||+|+||.||+|.+ .+++.||||++...... ....+.+|+++++.++|+||+++++++.+.+.+++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 45677889999999999999984 57899999998643222 23568899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+|+|.+.. ...+..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 153 ~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~- 221 (353)
T PLN00034 153 FMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT- 221 (353)
T ss_pred cCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEcccccceecccc-
Confidence 99999987643 245667788999999999999999 9999999999999999999999999999765322
Q ss_pred ccceeEEEeeecccccccccc-----cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 551 MGVETRVLGTFGYLAPEYAQS-----GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
........||..|+|||++.. ...+.++|||||||++|+|++|+.||..... ..|...... ....
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~------~~~~~~~~~-~~~~--- 291 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ------GDWASLMCA-ICMS--- 291 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------ccHHHHHHH-Hhcc---
Confidence 122234578999999998743 2345689999999999999999999973321 111111100 0000
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.....+......+.+||.+||+.||++||++.|+++.
T Consensus 292 ---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 ---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011222344578999999999999999999999864
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=330.49 Aligned_cols=255 Identities=25% Similarity=0.274 Sum_probs=209.3
Q ss_pred hhhhcCCcccceecccCccceeeccCC-CCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
.+..+.|++++.||.|.-|.||++... ++..+|+|++..... ....+...|.+||+.++||.++.||..|+.+...
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 344567889999999999999999954 568999999975443 3335677899999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+|||||.||+|..+++.+....+++..++.++.+++-||+|||-. |||+|||||+||||.++|++.|+||.++..
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml----GivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML----GIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh----ceeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999999999998899999999999999999999999999 999999999999999999999999999842
Q ss_pred ccC---------------------------------C-C---------------------ccceeEEEeeeccccccccc
Q 038949 546 QPD---------------------------------G-D---------------------MGVETRVLGTFGYLAPEYAQ 570 (678)
Q Consensus 546 ~~~---------------------------------~-~---------------------~~~~~~~~Gt~~Y~APE~l~ 570 (678)
... . . ......++||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 110 0 0 01122468999999999999
Q ss_pred ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeec
Q 038949 571 SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIR 650 (678)
Q Consensus 571 ~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~ 650 (678)
+...+.++|.|+|||+||||+.|..||...... ..+..++...+.-...+..+..+.+||+++|.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~---------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch---------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence 999999999999999999999999999754321 11122222222222222455689999999999
Q ss_pred cCCCCCch----HHHHH
Q 038949 651 KDPHSRPR----MSQVL 663 (678)
Q Consensus 651 ~dP~~RPT----~~eVL 663 (678)
+||.+|.. +.||-
T Consensus 374 KdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIK 390 (459)
T ss_pred cChhhhhccccchHHhh
Confidence 99999988 66664
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=336.06 Aligned_cols=241 Identities=24% Similarity=0.287 Sum_probs=194.2
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecC
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNG 475 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~gg 475 (678)
+.||+|+||.||++.. .+|+.||+|+++.... .....+.+|+.+++.++||||++++++|...+..|+||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999984 5789999999875422 22345678999999999999999999999999999999999999
Q ss_pred CcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcccee
Q 038949 476 SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET 555 (678)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 555 (678)
+|..++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 153 (323)
T cd05595 81 ELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccc
Confidence 9988884 344689999999999999999999999 99999999999999999999999999987432221 1223
Q ss_pred EEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccch
Q 038949 556 RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSE 635 (678)
Q Consensus 556 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~ 635 (678)
...||+.|+|||++.++.++.++|||||||++|+|++|..||....... ..... ... .. .++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----------~~~~~-~~~--~~----~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----------LFELI-LME--EI----RFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH----------HHHHH-hcC--CC----CCCC
Confidence 4568999999999999999999999999999999999999996432210 00000 000 01 1223
Q ss_pred hhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 636 REVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 636 ~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
..+..+.++|.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 3455788999999999999998 7887764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=337.56 Aligned_cols=263 Identities=22% Similarity=0.314 Sum_probs=194.5
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeC-----CeEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED-----GRRL 466 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-----~~~~ 466 (678)
+|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999984 578999999886322 12234688899999999999999999987643 2589
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+ +++|.+++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~-~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELM-ESDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTA----NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecC-CCCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999999 578888884 344689999999999999999999999 9999999999999999999999999999754
Q ss_pred cCCC--ccceeEEEeeecccccccccc--cccceecceeeeeeEEEEeeeCCccccccCCcccchh-hhh-------hHH
Q 038949 547 PDGD--MGVETRVLGTFGYLAPEYAQS--GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCL-TEW-------ARP 614 (678)
Q Consensus 547 ~~~~--~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l-~~~-------~~~ 614 (678)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... ... ...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3221 112234568999999999875 6789999999999999999999999964332110000 000 000
Q ss_pred HHHHhh---hhcccCcchhccc---chhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 LLKRHA---IGELIDPRLRNCY---SEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 ~~~~~~---~~elld~~l~~~~---~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...... ....+.......+ .+.....+.+++.+||+.||++||+++++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 0000000000000 0123346789999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=322.80 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=201.6
Q ss_pred cCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEee
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYIC 473 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ 473 (678)
.+|++.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|+++++.++||||+++++++...+..|+||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4688899999999999999997777789999876332 223468889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccc
Q 038949 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553 (678)
Q Consensus 474 ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 553 (678)
+++|.+++.... ..+++..++.++.|++.||.|||+. |++||||||+||+++.++.++|+|||+++...+.....
T Consensus 83 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN----GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999985433 3588999999999999999999999 99999999999999999999999999997654322211
Q ss_pred eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||....+.. .... +.... ...
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~------~~~~~----~~~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE------VVES------VSAGY----RLY 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH------HHHH------HHcCC----cCC
Confidence 111223457999999998899999999999999999999 788886433210 0000 11111 111
Q ss_pred cchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
.+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 22334558999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=321.87 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=209.6
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++..++|.+.+.||+|+||.||+|...+++.+|+|.+.... .....+.+|+.+++.++|+||+++++++......++||
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 45678999999999999999999997777889999887433 23457889999999999999999999999889999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+++++|.+++.......+++..+..++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR----NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999999665555689999999999999999999999 9999999999999999999999999998765432
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.........++..|+|||.+.+..++.++|+||||+++|+|++ |+.||....... .... +.. .
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----------~~~~--~~~----~ 220 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE----------VLEQ--VER----G 220 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----------HHHH--HHc----C
Confidence 2222222334568999999998889999999999999999998 999985432100 0000 000 0
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
.....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1111222335578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=321.97 Aligned_cols=256 Identities=28% Similarity=0.386 Sum_probs=204.4
Q ss_pred hhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
...++|.+...||+|++|.||+|.+..+..+|+|.+.... ...+.+.+|+.+++.++|||++++++++. .+..++|||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 4457799999999999999999997666789999876432 22356888999999999999999999875 456899999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+++|.+++.......+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM----NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999655555688899999999999999999998 99999999999999999999999999997654333
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
........++..|+|||.+.+..++.++|+||||+++|+|++ |..||....+. +..... ... .
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~------~~~----~ 220 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR------EVLEQV------ERG----Y 220 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH------HcC----C
Confidence 222222345678999999998889999999999999999999 88898643211 000000 000 0
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
....+...+..+.+++.+||..||++||++++++++|+.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111223345578999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=342.88 Aligned_cols=261 Identities=21% Similarity=0.266 Sum_probs=198.2
Q ss_pred hhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
....+|.+.+.||+|+||.||++. ..+++.||+|... ...+.+|+++++.++||||++++++|......++||
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 345689999999999999999998 4578999999643 234678999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
|++ +++|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.++|+|||+++.....
T Consensus 163 e~~-~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~----~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 163 PRY-KTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred ecC-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 998 5788888743 34588899999999999999999999 9999999999999999999999999999754332
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccch-----hhhhhHH----------
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC-----LTEWARP---------- 614 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~-----l~~~~~~---------- 614 (678)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.........+ +......
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 2223344679999999999999999999999999999999999998864322111100 0000000
Q ss_pred ----HHHHh--hh--hcccCcchhccc--chhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 ----LLKRH--AI--GELIDPRLRNCY--SEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 ----~~~~~--~~--~elld~~l~~~~--~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..... .. .....+..+..+ ....+..+.+||.+||+.||++|||++|+|+
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00 000000000000 0123457889999999999999999999984
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.22 Aligned_cols=257 Identities=18% Similarity=0.231 Sum_probs=200.2
Q ss_pred hhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
+....++|++.+.||+|+||.||++.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 455568899999999999999999995 4688999999864321 223457789999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+|+||||+.+|+|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~----~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM----GLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEEecccce
Confidence 9999999999999998843 3478889999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCccceeEEEeeeccccccccccc----ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSG----QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
..............||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ..........
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~- 263 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHK- 263 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-
Confidence 6543332233456799999999998754 3788999999999999999999999643321 1011111000
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCC--CchHHHHHHH
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHS--RPRMSQVLRM 665 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~--RPT~~eVL~~ 665 (678)
..+........+..+.+++.+||..++.+ |+++.++++.
T Consensus 264 ------~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 ------NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ------cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00100111123456788899999865554 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=326.43 Aligned_cols=256 Identities=29% Similarity=0.402 Sum_probs=203.9
Q ss_pred hcCCcccceecccCccceeeccCC------CCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
.++|.+.+.||+|+||.||+|... +++.||+|.++..... ....+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 467899999999999999999743 3478999998754333 335788999999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccCC------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC
Q 038949 466 LLVYEYICNGSLDSHLYGRD------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF 533 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~ 533 (678)
++||||+++++|.+++.... ...+++..+..++.|++.||.|||++ |++||||||+||+++.++
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ----HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeeccccccceEEEcCCC
Confidence 99999999999999985332 24478888899999999999999999 999999999999999999
Q ss_pred ccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhh
Q 038949 534 EPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEW 611 (678)
Q Consensus 534 ~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~ 611 (678)
.++|+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||....... .
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------~ 233 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------V 233 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------H
Confidence 999999999975432211 11223345778999999999999999999999999999998 999985432210 0
Q ss_pred hHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 612 ARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 612 ~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
. .... . ......+...+..+.+++.+||+.||++||++.||++.|+.
T Consensus 234 ~----~~~~--~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 I----ECIT--Q----GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred H----HHHH--c----CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 0 0000 0 00011122345578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.05 Aligned_cols=241 Identities=23% Similarity=0.324 Sum_probs=194.0
Q ss_pred ceecccCccceeeccC----CCCcEEEEEeeehhcc----cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 400 NFLAEGGFGSVHRGVL----PDGQVVAVKQYKLASS----QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~----~~g~~vAvK~i~~~~~----~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+.||+|+||.||++.. .+++.||+|+++.... .....+.+|+.+++.++||||++++++|..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999873 3578999999874321 2224567899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+|+|.+++. ....+.+..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQQ----GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999999884 345578888899999999999999999 99999999999999999999999999987433222
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .... .+.... .
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~---------~~~~~~--~ 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTID---------KILKGK--L 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHH---------HHHcCC--C
Confidence 2223456899999999999888999999999999999999999999643321 0000 011110 1
Q ss_pred ccchhhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
..+...+..+.++|.+||+.||++|| +++++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 12333455789999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=330.51 Aligned_cols=263 Identities=24% Similarity=0.356 Sum_probs=196.9
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC-CccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG-DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~-~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
.++|.+.+.||+|+||.||+|.. .+++.||+|++....... ...+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999995 478999999987443222 2457789999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+ +++|.+++... ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR----YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 99 56787777433 34588889999999999999999999 99999999999999999999999999987543221
Q ss_pred ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHH---------hh
Q 038949 551 MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR---------HA 620 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---------~~ 620 (678)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|..||......... +..... .... ..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ-LERIFL-VLGTPNEDTWPGVHS 234 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-HHHHHH-HhCCCChhhccchhh
Confidence 12233567899999998865 45788999999999999999999999753321110 000000 0000 00
Q ss_pred hhcc--------cCcchhcccc-hhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 IGEL--------IDPRLRNCYS-EREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ~~el--------ld~~l~~~~~-~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.... ....+...++ ...+..+.+|+.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 0000000000 012346789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=315.15 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=203.0
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEe
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYI 472 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~ 472 (678)
+|++.+.||+|+||.||++.. .+++.+|+|.++... ....+.+.+|+.+++.++|+||+++++.+.+++.+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 588899999999999999984 478899999986432 223356788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 552 (678)
++++|.+++.......+++..++.++.|++.||.|||++ ||+|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-A 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEECCCCcEEEcccCcceeecccc-c
Confidence 999999988655556688999999999999999999999 99999999999999999999999999997554322 1
Q ss_pred ceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 553 VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ...... .... . ..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~-~~~~----~-----~~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILKV-CQGS----Y-----KP 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHHH-hcCC----C-----CC
Confidence 223456888999999999888999999999999999999999999643210 000000 0000 0 11
Q ss_pred cchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.+...+..+.+++.+||+.||++||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 222344578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=342.54 Aligned_cols=262 Identities=27% Similarity=0.392 Sum_probs=223.9
Q ss_pred hhhhcCCcccceecccCccceeeccCC-C---CcEEEEEeeehhcccC-CccccccceeeecccccceEEEEeEEeeCCe
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLP-D---GQVVAVKQYKLASSQG-DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~---g~~vAvK~i~~~~~~~-~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
++......+.++||.|.||.||+|+++ . -..||||.++....+. ..+|+.|+.||-+.+||||++|.|+......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 455567888999999999999999953 2 3479999998655443 3689999999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+.||.|||++|+|+.+|..+. +.|++.+..-+++.|+.|+.||.+. |+|||||..+|||++.+..+|++|||+++
T Consensus 705 vMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm----~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDM----NYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhc----CchhhhhhhhheeeccceEEEecccccee
Confidence 999999999999999997655 4599999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCccceeEEEe--eecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 545 WQPDGDMGVETRVLG--TFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 545 ~~~~~~~~~~~~~~G--t~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
...+......++.-| ..+|.|||.+...+++.++||||||++|||.++ |.+||.... ++.+
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS----------------NQdV 843 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----------------NQDV 843 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc----------------hHHH
Confidence 776544222222222 568999999999999999999999999999987 999986543 2333
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
.+.+...++-.-|.+|+..|.+|+..||++|-.+||+|.+|+..|.+++..
T Consensus 844 IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 844 IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 444556666667888999999999999999999999999999999988754
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.31 Aligned_cols=250 Identities=21% Similarity=0.241 Sum_probs=193.8
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
+|...+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 688999999999999999984 5788999999874322 223468889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+|+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~----~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999843 34688899999999999999999999 99999999999999999999999999975221000
Q ss_pred ----------------------------------------------ccceeEEEeeecccccccccccccceecceeeee
Q 038949 551 ----------------------------------------------MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLG 584 (678)
Q Consensus 551 ----------------------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLG 584 (678)
.......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001234689999999999999999999999999
Q ss_pred eEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCch---HHH
Q 038949 585 VVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR---MSQ 661 (678)
Q Consensus 585 viL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT---~~e 661 (678)
|+||||++|+.||....+... ..... .. ...+........+..+.++|.+|+ .+|.+|++ +.+
T Consensus 236 vil~elltG~~Pf~~~~~~~~------~~~i~------~~-~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLET------QMKVI------NW-QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHH------HHHHH------cc-CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 999999999999965432110 00000 00 001111111123446777777765 59999997 777
Q ss_pred HHH
Q 038949 662 VLR 664 (678)
Q Consensus 662 VL~ 664 (678)
+++
T Consensus 302 i~~ 304 (382)
T cd05625 302 IKA 304 (382)
T ss_pred Hhc
Confidence 664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=352.51 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=202.3
Q ss_pred cCCcccceecccCccceeeccC-CC-CcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PD-GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~-g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
..|.+.+.||+|+||.||+|.. .+ ++.||+|.+..........+.+|+.+|+.++||||++++++|..++.+||||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3489999999999999999983 34 678999977544434345677899999999999999999999999999999999
Q ss_pred eecCCcccccccC--CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 472 ICNGSLDSHLYGR--DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 472 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
+.+|+|.+++... ...++++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR----KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999887432 345688889999999999999999998 9999999999999999999999999999865432
Q ss_pred C-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 D-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........ .....
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~-----~~~~~-- 289 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVL-----YGKYD-- 289 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-----hCCCC--
Confidence 2 1223456799999999999999999999999999999999999999964321 01111000 00011
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+...+..+.++|.+||+.||++||++.+++.
T Consensus 290 ---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 ---PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 122334457899999999999999999999874
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.56 Aligned_cols=202 Identities=29% Similarity=0.422 Sum_probs=174.4
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
+..++|++.+.||+|+||.||++.+ .++..+|+|.+..... .....+.+|+++++.++||||++++++|.+++.+++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 3468999999999999999999995 4788999998865322 2235688999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.+|+|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999999999843 445888899999999999999999741 799999999999999999999999999975432
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCcccccc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLN 600 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~ 600 (678)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2 123346889999999999888999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.25 Aligned_cols=262 Identities=29% Similarity=0.413 Sum_probs=206.3
Q ss_pred hhhhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhcc-cCCccccccceeeecc-cccceEEEEeEEe
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCA-QHRNVVMLIGFCV 460 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~ 460 (678)
++...++|++.+.||+|+||.||++.+. ....+|+|.+..... .....+.+|+.+++++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4667788999999999999999999742 336899998864322 2224688899999999 7999999999999
Q ss_pred eCCeEEEEEEEeecCCcccccccC--------------CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCc
Q 038949 461 EDGRRLLVYEYICNGSLDSHLYGR--------------DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 526 (678)
Q Consensus 461 ~~~~~~LV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~N 526 (678)
.++..++||||+++|+|.+++..+ ....+++..++.++.|++.||+|||+. ||+||||||+|
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~N 162 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK----KCIHRDLAARN 162 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC----Cccccccceee
Confidence 999999999999999999988432 234588888999999999999999998 99999999999
Q ss_pred eEeeecCccccccccccccccCCCcc-ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcc
Q 038949 527 ILVTHDFEPLVGDFGLARWQPDGDMG-VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRG 604 (678)
Q Consensus 527 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~ 604 (678)
||++.++.++|+|||+++........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~- 241 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE- 241 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-
Confidence 99999999999999999765432211 1111234567999999998899999999999999999997 88888532210
Q ss_pred cchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 605 QQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 605 ~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
+... .. ........+..++..+.+|+.+||+.||++|||+.++++.|+..+
T Consensus 242 -----~~~~-~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 -----ELFK-LL---------KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----HHHH-HH---------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0000 00 011111223344567899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=344.21 Aligned_cols=264 Identities=23% Similarity=0.337 Sum_probs=206.1
Q ss_pred hhhhhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhccc-CCccccccceeeeccc-ccceEEEEeEE
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQ-HRNVVMLIGFC 459 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~-HpnIv~l~~~~ 459 (678)
.++...++|.+.++||+|+||.||+|.+. .+..||||+++..... ..+.+.+|+++++.+. ||||++++++|
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 45667889999999999999999998732 2347999998643322 2356889999999996 99999999999
Q ss_pred eeCCeEEEEEEEeecCCcccccccCC------------------------------------------------------
Q 038949 460 VEDGRRLLVYEYICNGSLDSHLYGRD------------------------------------------------------ 485 (678)
Q Consensus 460 ~~~~~~~LV~E~~~ggsL~~~l~~~~------------------------------------------------------ 485 (678)
.+.+..||||||+.+|+|.+++....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999999999988874321
Q ss_pred ----------------------------------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCC
Q 038949 486 ----------------------------------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPN 525 (678)
Q Consensus 486 ----------------------------------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~ 525 (678)
...+++..+..++.||+.||.|||+. +|+||||||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dikp~ 266 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK----NCVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChH
Confidence 12366777788999999999999998 9999999999
Q ss_pred ceEeeecCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCc
Q 038949 526 NILVTHDFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPR 603 (678)
Q Consensus 526 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~ 603 (678)
|||++.++.++|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 99999999999999999975533221 12223446788999999998899999999999999999997 88898543211
Q ss_pred ccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 604 GQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 604 ~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
.. ... .+.. ......+...+..+.+++.+||+.||++||++.+|.+.|+..+
T Consensus 347 ~~---------~~~--~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 ST---------FYN--KIKS----GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HH---------HHH--HHhc----CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 00 000 0000 0111122344567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.07 Aligned_cols=244 Identities=23% Similarity=0.326 Sum_probs=193.3
Q ss_pred CcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCcccccccee---eecccccceEEEEeEEeeCCeEEEE
Q 038949 396 FSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEV---LSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~i---L~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
|++.+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+++ ++.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67889999999999999984 578999999997442 1222345556544 4667899999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.+|+|..++. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHEN----KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988873 24589999999999999999999999 999999999999999999999999999864322
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.. .......|++.|+|||++.+..++.++|||||||++|+|++|..||...... ........ . ..
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~----~---~~- 218 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVN----D---EV- 218 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh----C---CC-
Confidence 11 2233467899999999999999999999999999999999999999643321 11110000 0 01
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
.++...+..+.++|.+||+.||.+|| ++.++++
T Consensus 219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 12233455788999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=319.32 Aligned_cols=264 Identities=24% Similarity=0.311 Sum_probs=202.6
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC--CccccccceeeecccccceEEEEeEEee--CCeEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCAQHRNVVMLIGFCVE--DGRRLLV 468 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~--~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~~~LV 468 (678)
+.|+.++.|++|.||.||+|+. ++++.||+|.++...... .-..++|+.+|.+++|||||.+-.+... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4677888999999999999994 689999999998554221 1356789999999999999999988764 3469999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
||||+. +|.+++.... .++...+++.++.|+++|+.|||.+ .|+|||||++|+|+++.|.+||+|||+|+.+..
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~----wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN----WILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc----eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999955 8888885544 5799999999999999999999999 999999999999999999999999999998765
Q ss_pred CCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhh--------hhhHHHHHH-
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT--------EWARPLLKR- 618 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~--------~~~~~~~~~- 618 (678)
. ....+..+-|.+|.|||.+.+ ..|+.+.|+||+|||+.||+++.+.|.......+.... +-.++....
T Consensus 230 p-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 230 P-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred C-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 4 345566788999999999876 46899999999999999999999998765442221110 000110000
Q ss_pred -----hhhhcccCcchhcccchh-hhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 619 -----HAIGELIDPRLRNCYSER-EVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 619 -----~~~~elld~~l~~~~~~~-~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+.+.....++..+... ..+.-++|+..+|..||.+|.|+++.|+
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 001111111222222222 3345678999999999999999999764
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=332.23 Aligned_cols=247 Identities=20% Similarity=0.276 Sum_probs=192.4
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++.+.||+|+||.||++.. .+++.||+|+++... ......+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688999999999999999984 578999999987432 222346778999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.||+|.+++. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~~L~~lH~~----givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQL----GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999984 345689999999999999999999999 9999999999999999999999999998643211
Q ss_pred Cc----------------------------------cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCc
Q 038949 550 DM----------------------------------GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRK 595 (678)
Q Consensus 550 ~~----------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~ 595 (678)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 00123469999999999999999999999999999999999999
Q ss_pred cccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHH
Q 038949 596 AMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMS 660 (678)
Q Consensus 596 Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~ 660 (678)
||....+.. ....... ....+ .+.. ....+..+.+||.+|+ .||.+|++..
T Consensus 235 Pf~~~~~~~------~~~~i~~---~~~~~--~~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~ 285 (360)
T cd05627 235 PFCSETPQE------TYRKVMN---WKETL--VFPP--EVPISEKAKDLILRFC-TDSENRIGSN 285 (360)
T ss_pred CCCCCCHHH------HHHHHHc---CCCce--ecCC--CCCCCHHHHHHHHHhc-cChhhcCCCC
Confidence 996543211 0000000 00000 0000 0113446778888876 4999999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.78 Aligned_cols=256 Identities=27% Similarity=0.387 Sum_probs=203.2
Q ss_pred hcCCcccceecccCccceeeccCC----CCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLP----DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
.++|++.+.||+|+||.||+|.++ +...||+|.++..... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 467999999999999999999853 2458999988643322 23468889999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+.+++|.+++.... ..+++..++.++.|++.||.|||+. ||+||||+|+|||++.++.++|+|||++....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999985432 3689999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCcc-ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 548 DGDMG-VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 548 ~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... +...
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------~~~~~------~~~~- 224 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------DVIKA------VEDG- 224 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------HHHHH------HHcC-
Confidence 21111 1111234568999999998899999999999999999998 99998543210 00000 0000
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
.....+..++..+.+++.+||+.+|++||++++|++.|++.
T Consensus 225 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 ---YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111233456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.84 Aligned_cols=249 Identities=34% Similarity=0.531 Sum_probs=193.5
Q ss_pred ccceecccCccceeeccCC-----CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 398 EANFLAEGGFGSVHRGVLP-----DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 398 ~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+.+.||.|.||.||+|.+. .+..|+||.++.... .....+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 5678999999999999854 367899999964322 2356899999999999999999999999988889999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+++|+|.+++.......+++..+..|+.|++.||.|||+. +++|+||+++|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~----~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN----NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT----TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccc
Confidence 9999999999776566799999999999999999999999 999999999999999999999999999976522211
Q ss_pred -cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 552 -GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 552 -~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
.......+...|+|||.+....++.++||||||+++|||++ |..||..... ..+...+ .. ..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~-~~---------~~ 222 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKL-KQ---------GQ 222 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHH-HT---------TE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc-cc---------cc
Confidence 11122346778999999999999999999999999999999 6788754321 1111111 11 11
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHHHh
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~L 666 (678)
....+..++..+.++|.+||..||++||++.++++.|
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1122334556899999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=363.38 Aligned_cols=260 Identities=28% Similarity=0.395 Sum_probs=213.9
Q ss_pred hhhcCCcccceecccCccceeeccCC--CCc----EEEEEeeehh-cccCCccccccceeeecccccceEEEEeEEeeCC
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLP--DGQ----VVAVKQYKLA-SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG 463 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~----~vAvK~i~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 463 (678)
.......+...||+|+||.||.|... .+. .||+|.++.. +.+...+|++|+.+|+.++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 45667888899999999999999832 343 4899988644 3344578999999999999999999999999999
Q ss_pred eEEEEEEEeecCCcccccccCC-----CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRD-----RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVG 538 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~ 538 (678)
..+|++|||+||+|..+|...+ ...++....+.++.+|+.|+.||+++ ++|||||..+|+||+....+||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~----~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK----HFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC----CCcCcchhhhheeecccCcEEEc
Confidence 9999999999999999996541 34578888899999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCccceeEE-EeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHH
Q 038949 539 DFGLARWQPDGDMGVETRV-LGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLL 616 (678)
Q Consensus 539 DFGla~~~~~~~~~~~~~~-~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~ 616 (678)
|||+|+...+.++...... .-...|||||.+..+.|+.|+|||||||+|||++| |..||...... +......
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~------~v~~~~~ 918 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------EVLLDVL 918 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH------HHHHHHH
Confidence 9999996655554433333 44578999999999999999999999999999999 77888543321 1111111
Q ss_pred HHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 617 KRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 617 ~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
. .. +-..|..|+..++++|..||+.+|++||+|..|++.+...+
T Consensus 919 ~---------gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 919 E---------GG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred h---------CC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 1 11 33457788889999999999999999999999999887654
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.79 Aligned_cols=251 Identities=27% Similarity=0.362 Sum_probs=201.5
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
+|++.+.||+|+||.||++.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478899999999999999984 5789999999864322 223457789999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+|+|.+++.......+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE----RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888655556689999999999999999999999 99999999999999999999999999997653322
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
. .....|++.|+|||++.+..++.++||||||+++|+|++|..||....... ... .... .+.. ..
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~---~~~~--~~~~-----~~ 221 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KRE---EVER--RVKE-----DQ 221 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHH---HHHH--Hhhh-----cc
Confidence 1 123468999999999998899999999999999999999999996432211 000 0000 0000 01
Q ss_pred cccchhhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
..++...+..+.+|+.+||+.||++|| ++.++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 112333455789999999999999999 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=318.92 Aligned_cols=257 Identities=25% Similarity=0.371 Sum_probs=207.1
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++..++|++.+.||+|+||.||++...++..+|+|.+.... .....+.+|+.+++.++|+||+++++++.+ ...+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 56678999999999999999999987677789999876432 223568889999999999999999999887 7789999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++.......+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999999665555678888999999999999999998 9999999999999999999999999999765433
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.........++..|+|||++..+.++.++|+||||+++|+|++ |..||....... .... +.. .
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----------~~~~--~~~----~ 219 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----------VIRA--LER----G 219 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH----------HHHH--HhC----C
Confidence 3222223345677999999998889999999999999999998 898986432100 0000 000 0
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
.........+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111122344578999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=336.25 Aligned_cols=201 Identities=22% Similarity=0.322 Sum_probs=173.7
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++.+.||+|+||.||++.. .+++.||+|+++.... .....+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999999984 5689999999974322 22246778999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.||+|.+++.. ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.++|+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~----givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQL----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999943 45689999999999999999999999 9999999999999999999999999998743211
Q ss_pred Cc----------------------------------cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCc
Q 038949 550 DM----------------------------------GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRK 595 (678)
Q Consensus 550 ~~----------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~ 595 (678)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 00 00123579999999999999999999999999999999999999
Q ss_pred ccccc
Q 038949 596 AMDLN 600 (678)
Q Consensus 596 Pf~~~ 600 (678)
||...
T Consensus 235 Pf~~~ 239 (363)
T cd05628 235 PFCSE 239 (363)
T ss_pred CCCCC
Confidence 99654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=336.02 Aligned_cols=264 Identities=25% Similarity=0.363 Sum_probs=204.2
Q ss_pred hhhhhcCCcccceecccCccceeeccC------CCCcEEEEEeeehhccc-CCccccccceeeecc-cccceEEEEeEEe
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCA-QHRNVVMLIGFCV 460 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~ 460 (678)
|+...++|++.+.||+|+||.||+|.. .+++.||+|+++..... ....+..|+.++.++ +|+||++++++|.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 456678999999999999999999963 23578999988643221 224577899999999 7999999999876
Q ss_pred e-CCeEEEEEEEeecCCcccccccCC------------------------------------------------------
Q 038949 461 E-DGRRLLVYEYICNGSLDSHLYGRD------------------------------------------------------ 485 (678)
Q Consensus 461 ~-~~~~~LV~E~~~ggsL~~~l~~~~------------------------------------------------------ 485 (678)
. +..++++|||+++++|.+++....
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 457889999999999998874321
Q ss_pred -----CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc-ceeEEEe
Q 038949 486 -----RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG-VETRVLG 559 (678)
Q Consensus 486 -----~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~G 559 (678)
..++++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++......... ......+
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence 12578888999999999999999998 9999999999999999999999999999865332211 1222345
Q ss_pred eecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhh
Q 038949 560 TFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREV 638 (678)
Q Consensus 560 t~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~ 638 (678)
+..|+|||++.+..++.++|||||||++|+|++ |..||........ ........ .....+....
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~---------~~~~~~~~~~ 302 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEG---------TRMRAPEYAT 302 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhcc---------CCCCCCccCC
Confidence 678999999999999999999999999999997 9999864322110 00011110 0111122344
Q ss_pred hhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 639 YGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 639 ~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
..+.+++.+||+.+|++||++.++++.|++.+.
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 578999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=330.35 Aligned_cols=247 Identities=20% Similarity=0.279 Sum_probs=193.9
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhccc---CCccccccceeeecc-cccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||++.. .+++.||+|+++..... ....+..|..++..+ +||||++++++|.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999984 57889999999754322 224577888888888 699999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++....... ...
T Consensus 81 g~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (329)
T cd05588 81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT 153 (329)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence 99988884 345699999999999999999999999 99999999999999999999999999987432211 223
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcc--cchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRG--QQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~--~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
....||+.|+|||++.+..++.++|+|||||++|+|++|+.||+...... ......+....... .. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------~~--~~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--------KQ--IR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc--------CC--CC
Confidence 44679999999999999999999999999999999999999997432211 11111111111111 00 01
Q ss_pred cchhhhhhhhhccceeeccCCCCCch------HHHHH
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRPR------MSQVL 663 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RPT------~~eVL 663 (678)
.+...+..+.+++.+||+.||.+||+ +++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 22334457889999999999999998 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.08 Aligned_cols=259 Identities=26% Similarity=0.379 Sum_probs=201.1
Q ss_pred hhhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeC
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVED 462 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 462 (678)
+...++|++.+.||+|+||.||+|.+. ++..||+|.+..... .....+.+|+.+++.++||||+++++++.++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456788999999999999999998632 356799998753221 1224588899999999999999999999999
Q ss_pred CeEEEEEEEeecCCcccccccCC--------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRD--------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE 534 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~ 534 (678)
...++||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+. |++||||||+|||++.++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCcchheEEEcCCCC
Confidence 99999999999999999885322 12356677888999999999999998 9999999999999999999
Q ss_pred cccccccccccccCCCcc-ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhh
Q 038949 535 PLVGDFGLARWQPDGDMG-VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWA 612 (678)
Q Consensus 535 vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 612 (678)
++|+|||+++........ ......+++.|+|||++.++.++.++||||||+++|+|++ |..||...... ...
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~~~ 231 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QVL 231 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHH
Confidence 999999998754332211 1111234678999999998899999999999999999999 67888543210 100
Q ss_pred HHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 613 RPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 613 ~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
.. .... .. ...+...+..+.+++.+||+.||++||++.++++.|++
T Consensus 232 ~~-~~~~---~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 RF-VMEG---GL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HH-HHcC---Cc------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 00 0000 00 01223345578999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=325.60 Aligned_cols=269 Identities=22% Similarity=0.316 Sum_probs=207.1
Q ss_pred hhhhhhcCCcccceecccCccceeecc-CCCCcEEEEEeee--hhcccCCccccccceeeecccccceEEEEeEEee---
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYK--LASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE--- 461 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~--~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--- 461 (678)
.......+|...+.||+|+||.|+.+. ..+|+.||||.+. .......++..+|+++|+.++|+||+.+++++..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 344556778889999999999999998 4689999999886 3444445788999999999999999999999865
Q ss_pred --CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccc
Q 038949 462 --DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGD 539 (678)
Q Consensus 462 --~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~D 539 (678)
-..+|+|+|+| +.+|...+ +.+..++...+..++.||++||.|+|+. +|+||||||.|+|++.+..+||+|
T Consensus 96 ~~f~DvYiV~elM-etDL~~ii--k~~~~L~d~H~q~f~YQiLrgLKyiHSA----nViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQII--KSQQDLTDDHAQYFLYQILRGLKYIHSA----NVIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred cccceeEEehhHH-hhHHHHHH--HcCccccHHHHHHHHHHHHHhcchhhcc----cccccccchhheeeccCCCEEecc
Confidence 34689999999 77999998 4455599999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCC-CccceeEEEeeeccccccccc-ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhh-----
Q 038949 540 FGLARWQPDG-DMGVETRVLGTFGYLAPEYAQ-SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWA----- 612 (678)
Q Consensus 540 FGla~~~~~~-~~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~----- 612 (678)
||+|+..... .....+..+-|.+|.|||++. ...|+.+.||||.||||.||++|++.|...+...+..+....
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 9999976432 223346678899999999875 468999999999999999999999999655432221111100
Q ss_pred ---HHHHHH---hhhhcccCcc----hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 613 ---RPLLKR---HAIGELIDPR----LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 613 ---~~~~~~---~~~~elld~~----l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+.. ..+..-+... +..-++ .......+|+.+||..||.+|+|++|.|+
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000 0011101111 111111 33446789999999999999999999985
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=328.89 Aligned_cols=241 Identities=22% Similarity=0.311 Sum_probs=192.2
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecc-cccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|.. .+++.||+|+++.... .....+..|.+++..+ +||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999985 4688999999875422 2224566788888765 799999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|..++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++....... ...
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05591 81 GDLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHRH----GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTT 153 (321)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccc
Confidence 99998884 344688899999999999999999999 99999999999999999999999999987543222 223
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.. ....... ... .++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~~----~~~-------~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESILH----DDV-------LYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHHc----CCC-------CCC
Confidence 34578999999999998899999999999999999999999997543210 0010000 000 112
Q ss_pred hhhhhhhhhccceeeccCCCCCc-------hHHHHHH
Q 038949 635 EREVYGMLQCASLCIRKDPHSRP-------RMSQVLR 664 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RP-------T~~eVL~ 664 (678)
...+..+.+++.+||+.||++|| +++++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 22345788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=322.97 Aligned_cols=268 Identities=25% Similarity=0.349 Sum_probs=202.4
Q ss_pred cCC-cccceecccCccceeecc-----CCCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeC--Ce
Q 038949 394 NRF-SEANFLAEGGFGSVHRGV-----LPDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVED--GR 464 (678)
Q Consensus 394 ~~y-~~~~~LG~G~fG~Vy~a~-----~~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~ 464 (678)
++| ++.+.||+|+||.||++. ..+++.||+|.++.... .....+.+|+++++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 889999999999998754 24678999999875432 2235678899999999999999999987653 45
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.++||||+.+++|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccChheEEEcCCCcEEEeeccccc
Confidence 8999999999999999843 3489999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCcc--ceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 545 WQPDGDMG--VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 545 ~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
........ ......++..|+|||.+....++.++||||||+++|+|++|..||......-. ................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLI 234 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhh
Confidence 65432211 11122345679999999888899999999999999999999999864322100 0000000000001111
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
+.++.......+...+..+.+++.+||+.||++||+++++++.|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11222222223344566899999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=329.33 Aligned_cols=241 Identities=22% Similarity=0.281 Sum_probs=193.3
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccc-cceEEEEeEEeeCCeEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQH-RNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~H-pnIv~l~~~~~~~~~~~LV~ 469 (678)
+|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+..|+.++..+.| ++|+.+++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 488899999999999999984 467899999987532 2233467788888888865 56889999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+|+|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++......
T Consensus 81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999998843 44588999999999999999999998 9999999999999999999999999998643221
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
. .......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... .... +.. .
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----------~~~~--i~~---~-- 216 (324)
T cd05587 155 G-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------LFQS--IME---H-- 216 (324)
T ss_pred C-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----------HHHH--HHc---C--
Confidence 1 22345679999999999999999999999999999999999999996433110 0000 000 0
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRM 659 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~ 659 (678)
...++...+..+.+++.+||..||.+|++.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111233345578899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=322.47 Aligned_cols=256 Identities=27% Similarity=0.421 Sum_probs=200.7
Q ss_pred hcCCcccceecccCccceeeccC-----CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-----PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
...|++.+.||+|+||.||+|.+ .++..+|+|.+..... .....+.+|+.+++.++||||+++++++..+...|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 35788899999999999999973 2467899998863322 22256888999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCC---------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee
Q 038949 467 LVYEYICNGSLDSHLYGRD---------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH 531 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~---------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~ 531 (678)
+||||+.+++|.+++.... ...+++..+..++.|++.||.|||++ ||+||||||+|||++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~nili~~ 159 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH----FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc----CeehhccccceEEEcC
Confidence 9999999999999884321 22467788889999999999999999 9999999999999999
Q ss_pred cCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhh
Q 038949 532 DFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLT 609 (678)
Q Consensus 532 ~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~ 609 (678)
++.++|+|||+++....... .......++..|+|||++.+..++.++||||||+++|+|++ |..||....+ ....
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~ 236 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVI 236 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHH
Confidence 99999999999975533221 11222335677999999998889999999999999999998 8888854321 0000
Q ss_pred hhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 610 EWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 610 ~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
+ .... .. ....+..++..+.+++.+||+.||.+||++.+|++.|.+
T Consensus 237 ~----~~~~---~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 E----MVRK---RQ------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----HHHc---CC------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0 1110 00 011223345578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.46 Aligned_cols=259 Identities=28% Similarity=0.413 Sum_probs=204.8
Q ss_pred hcCCcccceecccCccceeeccC------CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
..+|.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|+.+++.++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 46789999999999999999973 234568999886544444457889999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCC-----------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcc
Q 038949 467 LVYEYICNGSLDSHLYGRD-----------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEP 535 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~-----------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~v 535 (678)
+||||+.+++|.+++.... ...+++..++.++.|++.||+|||+. |++||||||+|||++.++.+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~----~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcE
Confidence 9999999999999885321 23489999999999999999999998 99999999999999999999
Q ss_pred ccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhH
Q 038949 536 LVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 536 kL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 613 (678)
+|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--------- 230 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------- 230 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---------
Confidence 9999999975432221 11122335678999999998899999999999999999998 888885433210
Q ss_pred HHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 614 PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 614 ~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
......... . . ..+...+..+.+|+.+||+.||.+||++.++++.|+....
T Consensus 231 -~~~~i~~~~-~-~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 231 -VIECITQGR-V-L----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred -HHHHHHcCC-c-C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 000000000 0 0 1122344579999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=316.25 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=201.5
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-----CCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-----GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-----~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
++|.+.+.||+|++|.||.+.. .+++.||+|.+...... ....+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999984 57899999988643221 12467889999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 34588889999999999999999998 99999999999999999999999999987543
Q ss_pred CCCccce--eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 548 DGDMGVE--TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 548 ~~~~~~~--~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
....... ....|+..|+|||++.+..++.++||||||+++|+|++|+.||....... .. .. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~----~~------~~ 220 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----AI----FK------IA 220 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----HH----HH------Hh
Confidence 3211111 23457789999999998889999999999999999999999986432210 00 00 00
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
........+......+.+++.+||..+|.+||++.++++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 221 TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111122333455578999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=328.40 Aligned_cols=240 Identities=24% Similarity=0.355 Sum_probs=189.7
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeec-ccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSC-AQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~-L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|.. .+++.||+|.++.... .....+..|..++.. .+||||+++++++..++.+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999984 5688999999875421 222345556666654 4799999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKK----GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999988843 44689999999999999999999998 99999999999999999999999999997543322 233
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...... .. .. ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~i------~~-~~----~~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDSI------LN-DR----PHFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHHH------Hc-CC----CCCC
Confidence 4467899999999999889999999999999999999999999643320 000000 00 01 1123
Q ss_pred hhhhhhhhhccceeeccCCCCCchHH-HHH
Q 038949 635 EREVYGMLQCASLCIRKDPHSRPRMS-QVL 663 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RPT~~-eVL 663 (678)
...+..+.+|+.+||+.||.+||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 33445788999999999999999875 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=316.41 Aligned_cols=258 Identities=23% Similarity=0.344 Sum_probs=204.6
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|.+.+.||+|+||.||+|.. .+++.||+|.++.... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999984 4789999998764322 12245788999999999999999999999999999999
Q ss_pred EEeecCCccccccc--CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 470 EYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 470 E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||+.+|+|.+++.. .....+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999988742 2234578888999999999999999998 99999999999999999999999999987654
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...+... +.....+
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~------~~~~~~~ 226 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQK------IEQCDYP 226 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHH------HhcCCCC
Confidence 3221 122345788999999998888999999999999999999999998543211 0111111 0010011
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
.......+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 227 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 ---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111123445789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=329.11 Aligned_cols=243 Identities=21% Similarity=0.292 Sum_probs=190.0
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhccc---CCccccccceeeecc-cccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||++.. .+++.||+|+++..... ....+..|+.++..+ +||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999984 57889999999754222 223567788887766 799999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|..++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++...... ...
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (329)
T cd05618 81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT 153 (329)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccc
Confidence 99988874 345689999999999999999999999 99999999999999999999999999987532221 123
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCccc--chhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQ--QCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~--~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
....||+.|+|||++.+..++.++|||||||++|+|++|..||........ .....+...... .. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~--------~~--~~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--------EK--QIR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh--------cC--CCC
Confidence 346789999999999999999999999999999999999999964321111 001111111100 00 011
Q ss_pred cchhhhhhhhhccceeeccCCCCCchH
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRPRM 659 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RPT~ 659 (678)
++......+.++|.+||+.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 233345578899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=320.26 Aligned_cols=259 Identities=27% Similarity=0.386 Sum_probs=204.2
Q ss_pred hhhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeC
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVED 462 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 462 (678)
++..++|.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.++..++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 456678999999999999999998743 346899998763321 2234678899999999999999999999999
Q ss_pred CeEEEEEEEeecCCcccccccCC--------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRD--------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE 534 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~ 534 (678)
...++||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~di~p~nill~~~~~ 157 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK----KFVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccChheEEEcCCCC
Confidence 99999999999999999985432 22467788899999999999999998 9999999999999999999
Q ss_pred cccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhh
Q 038949 535 PLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWA 612 (678)
Q Consensus 535 vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 612 (678)
++|+|||+++....... .......++..|+|||.+.++.++.++||||||+++|+|++ |..||....... ..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~ 231 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------VL 231 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------HH
Confidence 99999999975543221 11223346778999999988889999999999999999998 888885432210 00
Q ss_pred HHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 613 RPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 613 ~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
. ... . ......+..++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 232 ~-~~~-----~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 232 K-FVI-----D----GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred H-HHh-----c----CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 0 000 0 00111223345688999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=333.37 Aligned_cols=254 Identities=24% Similarity=0.263 Sum_probs=213.8
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCC---ccccccceeeeccc-ccceEEEEeEEeeCCe
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGD---QEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGR 464 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~---~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~ 464 (678)
......|.+.+.||+|.||.||+++. .+|+.+|+|.+........ +.+.+|+.+|+.+. ||||+.++++|++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 44567899999999999999999995 4699999999975554433 58899999999998 9999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec----Cccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD----FEPLVGDF 540 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~----~~vkL~DF 540 (678)
+++|||++.||.|.+.+... .+++..+..++.|++.++.|||+. ||+||||||+|+|+... +.++++||
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~----gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL----GVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC----CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 99999999999999999665 399999999999999999999998 99999999999999643 57999999
Q ss_pred cccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
|++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.......... .
T Consensus 184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------------~ 249 (382)
T KOG0032|consen 184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------------A 249 (382)
T ss_pred CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------------H
Confidence 99987755 446677899999999999999999999999999999999999999997654322110 0
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
+.. .+..+....-...+..+.++|..||..||.+|+|+.++|+.
T Consensus 250 i~~-~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 250 ILR-GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHc-CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 000 01122223333456789999999999999999999999983
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=335.45 Aligned_cols=260 Identities=19% Similarity=0.230 Sum_probs=201.7
Q ss_pred hhhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEee
Q 038949 386 YAELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461 (678)
Q Consensus 386 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 461 (678)
...+....++|.+.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 334566678999999999999999999995 478899999986432 1222457789999999999999999999999
Q ss_pred CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
+..+|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999998843 3478888899999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCccceeEEEeeeccccccccccc----ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHH
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQSG----QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK 617 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 617 (678)
++...............||+.|+|||++... .++.++|||||||++|+|++|..||...... ........
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~ 261 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMN 261 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHc
Confidence 9986543332233456799999999998753 3789999999999999999999999643321 00111110
Q ss_pred HhhhhcccCcchhcccchhhhhhhhhccceeeccCCCC--CchHHHHHHH
Q 038949 618 RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHS--RPRMSQVLRM 665 (678)
Q Consensus 618 ~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~--RPT~~eVL~~ 665 (678)
.. ..+........+..+.++|.+||..++.+ |++++++++.
T Consensus 262 ~~-------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 262 HK-------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CC-------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00 00111111234557889999999844443 7788888864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=314.14 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=206.7
Q ss_pred cCCcccceecccCccceeeccCC-CCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+++++.++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999964 889999998864322 22357889999999999999999999999999999999
Q ss_pred EEeecCCccccccc--CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 470 EYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 470 E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||+++|+|.+++.. .....+++..++.++.+++.||.|||+. ||+||||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK----RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999988843 2345588899999999999999999998 99999999999999999999999999987654
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ......... .....+
T Consensus 158 ~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-----~~~~~~ 227 (267)
T cd08224 158 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE-----KCDYPP 227 (267)
T ss_pred CCC-cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhhh-----cCCCCC
Confidence 322 1223456888999999999888999999999999999999999998543211 111111000 000111
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
.. ....+..+.++|.+||..+|.+||++.+|++.|+..
T Consensus 228 ~~----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 LP----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CC----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 10 113445788999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=323.77 Aligned_cols=258 Identities=25% Similarity=0.371 Sum_probs=204.8
Q ss_pred hcCCcccceecccCccceeeccC------CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
.++|.+.+.||+|+||.||+|.. .++..+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45688899999999999999973 235578999886544433457889999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCC--------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec
Q 038949 467 LVYEYICNGSLDSHLYGRD--------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD 532 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~ 532 (678)
+||||+.+++|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ----HFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccC
Confidence 9999999999999985422 23478889999999999999999999 99999999999999999
Q ss_pred CccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhh
Q 038949 533 FEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTE 610 (678)
Q Consensus 533 ~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~ 610 (678)
+.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|+| |..||.......
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------ 233 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------ 233 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------
Confidence 9999999999975433221 11223446788999999998899999999999999999998 999986433210
Q ss_pred hhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 611 WARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 611 ~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
...... ... ....+..++..+.+++.+||+.||++||++.+|++.|+...
T Consensus 234 ----~~~~~~-~~~-----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 234 ----VIECIT-QGR-----VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred ----HHHHHh-CCC-----CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 001000 000 00112234457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=313.58 Aligned_cols=250 Identities=29% Similarity=0.394 Sum_probs=203.5
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+|.+.+.||+|++|.||+|.. .+++.|++|.+..... .....+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477889999999999999985 4789999999864322 2335688899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|.+++.......+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~----~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEeCCCCEEEcccccceeccCcc-
Confidence 9999999999665456788999999999999999999998 99999999999999999999999999987654332
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ..... ..... ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-----~~~~~-----~~ 219 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------ALILK-----IIRGV-----FP 219 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-----HHcCC-----CC
Confidence 2223456888999999999999999999999999999999999999643310 00000 00010 11
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1222344578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=329.06 Aligned_cols=236 Identities=24% Similarity=0.341 Sum_probs=189.4
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecc-cccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|.. .+++.||+|++.... ......+..|..++..+ +||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999985 468899999987432 22234566788888766 699999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++....... ...
T Consensus 81 g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~----~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (320)
T cd05590 81 GDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT 153 (320)
T ss_pred chHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence 999988843 34689999999999999999999999 99999999999999999999999999987532221 223
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........ .. ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~----~~-------~~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILN----DE-------VVYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhc----CC-------CCCC
Confidence 3457899999999999889999999999999999999999999654321 11111100 00 0122
Q ss_pred hhhhhhhhhccceeeccCCCCCchH
Q 038949 635 EREVYGMLQCASLCIRKDPHSRPRM 659 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RPT~ 659 (678)
...+..+.+++.+||+.||.+||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 2344578899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=327.73 Aligned_cols=241 Identities=20% Similarity=0.260 Sum_probs=192.5
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecc-cccceEEEEeEEeeCCeEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
+|.+.+.||+|+||.||+|.. .+++.||+|+++.... .....+..|..++..+ +|++|+.+++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 478899999999999999984 4678999999875422 1223456677777766 5899999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+|+|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988843 34588999999999999999999998 9999999999999999999999999999743221
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ..
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~------~~~~~i~---------~~-- 216 (323)
T cd05616 155 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIM---------EH-- 216 (323)
T ss_pred C-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH------HHHHHHH---------hC--
Confidence 1 1223456899999999999999999999999999999999999999654321 0001000 00
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRM 659 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~ 659 (678)
...++...+..+.+++.+||+.||.+|++.
T Consensus 217 ~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 011233445578999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=340.50 Aligned_cols=268 Identities=24% Similarity=0.340 Sum_probs=235.3
Q ss_pred hhhhhhhhcCCcccceecccCccceeeccCCC-CcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 386 YAELELATNRFSEANFLAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 386 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
+.+|+..+.+.....+||-|.||.||.|.|+. .-.||||.++... ...++|+.|+.+|+.+.|||+|+|+|+|..+..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 36788888899999999999999999999864 4579999987443 345789999999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+|||.|||++|+|.+||....+.-++....+.++.||.+|++||..+ ++|||||..+|+|+.++..+|++|||+++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk----nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999999877777788888899999999999999999 99999999999999999999999999999
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
+.....+..+........|.|||-+....++.|+|||+|||+|||+.| |..||-.- ....+..
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi----------------dlSqVY~ 477 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYG 477 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc----------------cHHHHHH
Confidence 887777666666667889999999999999999999999999999998 66676321 2223455
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccccCC
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNS 674 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~~s 674 (678)
++...++...++.|+..+++|++.||+.+|.+||+|.|+-+.++.++...+
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 666677777888899999999999999999999999999999998886544
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=319.87 Aligned_cols=245 Identities=24% Similarity=0.319 Sum_probs=193.5
Q ss_pred ecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCc
Q 038949 402 LAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSL 477 (678)
Q Consensus 402 LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 477 (678)
||+|+||.||++.. .+|+.||+|.+..... .....+..|+++++.++||||+++++++..+...|+||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999984 5689999999864322 1223456699999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccceeEE
Q 038949 478 DSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV 557 (678)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 557 (678)
.+++.......+++..+..++.|++.||+|||+. ||+||||||+|||++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM----DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC----CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 9888655555688888999999999999999998 99999999999999999999999999997654322 22345
Q ss_pred EeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhh
Q 038949 558 LGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSERE 637 (678)
Q Consensus 558 ~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~ 637 (678)
.|++.|+|||++.+..++.++|||||||++|+|++|..||........ .... ........+.. .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~-----~~~~~~~~~~~-----~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEEL-----KRRTLEDEVKF-----EHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHH-----HHHhhcccccc-----ccccC
Confidence 689999999999988899999999999999999999999864322110 0011 11111110000 01123
Q ss_pred hhhhhhccceeeccCCCCCchHHHHHH
Q 038949 638 VYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 638 ~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+..+.+|+.+||+.||++||++.|+++
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchh
Confidence 457899999999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=317.44 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=202.0
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
..++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++||||+++++++..++..++|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 346799999999999999999994 5788999999875443444567789999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+++|.+++. ...++++..+..++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++.......
T Consensus 87 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 87 YCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSK----GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999884 345688999999999999999999998 99999999999999999999999999997553221
Q ss_pred ccceeEEEeeeccccccccc---ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 551 MGVETRVLGTFGYLAPEYAQ---SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
.......|++.|+|||.+. ...++.++|+||||+++|+|++|..||....+...... +. . .....+
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--~~-----~---~~~~~~ 229 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--MS-----K---SNFQPP 229 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--ee-----c---CCCCCC
Confidence 1223456888999999884 34578899999999999999999999854332111000 00 0 000011
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHh
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~L 666 (678)
.... ....+..+.+++.+||+.+|++||+++++++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 112345788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=325.78 Aligned_cols=262 Identities=26% Similarity=0.391 Sum_probs=206.3
Q ss_pred hhhhhcCCcccceecccCccceeeccC------CCCcEEEEEeeehhcc-cCCccccccceeeecc-cccceEEEEeEEe
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCA-QHRNVVMLIGFCV 460 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~ 460 (678)
+....++|.+.+.||+|+||.||++.. .++..||+|.++.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 345567899999999999999999862 2345799998864322 2235688999999999 7999999999999
Q ss_pred eCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 461 ~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
..+..++||||+.+|+|.+++.......+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.++|+||
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeehhhhccceEEEcCCCeEEECCC
Confidence 999999999999999999998654444589999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHH
Q 038949 541 GLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKR 618 (678)
Q Consensus 541 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 618 (678)
|++........ .......++..|+|||++....++.++||||||+++|+|++ |..||....... ....
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-----~~~~----- 255 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-----KFYK----- 255 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-----HHHH-----
Confidence 99975543221 11122335678999999998899999999999999999998 999986432210 0000
Q ss_pred hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 619 ~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
.+........+...+..+.+++.+||..+|++||++.++++.|+..
T Consensus 256 -----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 -----LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0001111111222345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=320.88 Aligned_cols=271 Identities=27% Similarity=0.339 Sum_probs=200.7
Q ss_pred cCCcccceecccCccceeeccC-----CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEee--CCeEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-----PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE--DGRRL 466 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~~~ 466 (678)
.+|++.+.||+|+||.||++.. .++..||+|.+..........+.+|+++++.++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788999999999999999863 3578999999875544445678899999999999999999998754 34689
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.+++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSK----RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998533 34588999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCccce--eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 547 PDGDMGVE--TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 547 ~~~~~~~~--~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
........ ....++..|+|||++.+..++.++||||||+++|||++|..++......-................+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 43321111 1112344699999999888999999999999999999987765322110000000000000000000011
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
+........+...+..+.+|+.+||..+|++|||+.+|++.|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111111112233456799999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=325.92 Aligned_cols=238 Identities=24% Similarity=0.293 Sum_probs=188.0
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccce-eeecccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVE-VLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~-iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|.. .+|+.||+|++..... .....+..|.. +++.++||||+++++++...+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999984 5789999999864321 22234455554 46778999999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|..++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++..... ....
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~----givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 153 (325)
T cd05604 81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSI----NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTT 153 (325)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCc
Confidence 99988884 445689999999999999999999999 9999999999999999999999999998743221 1223
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...... +....... . .. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~-----~--~~----~~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILH-----K--PL----VLR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHc-----C--Cc----cCC
Confidence 4567999999999999999999999999999999999999999643211 11111110 0 00 111
Q ss_pred hhhhhhhhhccceeeccCCCCCchHHH
Q 038949 635 EREVYGMLQCASLCIRKDPHSRPRMSQ 661 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RPT~~e 661 (678)
+..+..+.+++.+||+.||.+||++.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 223457889999999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=320.75 Aligned_cols=256 Identities=28% Similarity=0.386 Sum_probs=202.7
Q ss_pred hcCCcccceecccCccceeeccC------CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
..+|...+.||+|+||.||++.. .++..+|+|.+..........+.+|+++++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 46788899999999999999862 245689999887554444567899999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCC-------------CccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC
Q 038949 467 LVYEYICNGSLDSHLYGRDR-------------DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF 533 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~-------------~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~ 533 (678)
+||||+.+++|.+++..... ..+++..+..++.|++.||+|||+. |++||||||+|||++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL----HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC----CeecccccHhhEEEcCCC
Confidence 99999999999998854321 3478889999999999999999998 999999999999999999
Q ss_pred ccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhh
Q 038949 534 EPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEW 611 (678)
Q Consensus 534 ~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~ 611 (678)
.++|+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |.+||....... .
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~ 233 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------A 233 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------H
Confidence 999999999975432221 11222345678999999998899999999999999999998 888985432210 0
Q ss_pred hHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 612 ARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 612 ~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
... ...... ...+..++..+.+++.+||+.||.+||++.+|++.|++
T Consensus 234 ----~~~--~~~~~~----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 ----IEC--ITQGRE----LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----HHH--HHcCcc----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 000 000000 11122344578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=314.86 Aligned_cols=251 Identities=29% Similarity=0.429 Sum_probs=205.5
Q ss_pred hhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
..++|++.+.||.|+||.||+|... ++.||+|.++.... ....+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 3567899999999999999999874 78899999875443 346788999999999999999999999988999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|.+++.......+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK----NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999999665555789999999999999999999999 999999999999999999999999999986532221
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
...++..|+|||++..+.++.++|+||||+++|+|++ |..||...... .. ..... . ...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~-~~~~~-----~----~~~ 217 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DV-VPHVE-----K----GYR 217 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH------HH-HHHHh-----c----CCC
Confidence 2234567999999998889999999999999999997 99998543211 00 00000 0 011
Q ss_pred cccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
...+...+..+.+++.+||..+|.+||++.++++.|+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11223345678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.10 Aligned_cols=237 Identities=24% Similarity=0.301 Sum_probs=187.6
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccce-eeecccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVE-VLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~-iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|.. .+++.||+|++..... .....+..|.. +++.++||||+++++.+.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999995 5789999999874322 11233444544 45778999999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|..++. ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 99998884 345688999999999999999999999 99999999999999999999999999987432221 223
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
....||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+...... .. .. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~-----~~--~~----~~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNIL-----NK--PL----RLK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHH-----cC--CC----CCC
Confidence 345789999999999999999999999999999999999999964321 11111110 00 00 112
Q ss_pred hhhhhhhhhccceeeccCCCCCchHH
Q 038949 635 EREVYGMLQCASLCIRKDPHSRPRMS 660 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RPT~~ 660 (678)
...+..+.++|.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 23355789999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=322.27 Aligned_cols=256 Identities=24% Similarity=0.311 Sum_probs=200.7
Q ss_pred hcCCcccceecccCccceeeccCC------CCcEEEEEeeehhcccC-CccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASSQG-DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~~~-~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
..+|.+.+.||+|+||.||+|... +++.||+|.++...... ...+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 356888999999999999999742 35789999987433221 24578899999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccC--------------CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee
Q 038949 466 LLVYEYICNGSLDSHLYGR--------------DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH 531 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~ 531 (678)
++++||+.+++|.+++... ....+++..+..++.|++.||.|||+. ||+||||||+|||++.
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~----gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFD 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc----CccccccchhheEecC
Confidence 9999999999999887422 123477778889999999999999998 9999999999999999
Q ss_pred cCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhh
Q 038949 532 DFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLT 609 (678)
Q Consensus 532 ~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~ 609 (678)
++.+||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|||++ |..||..... .
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~ 233 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------Q 233 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------H
Confidence 99999999999875433221 11223345678999999988889999999999999999998 7778754321 1
Q ss_pred hhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 610 EWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 610 ~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
++..... +. .....+..++..+.+|+.+||+.+|.+||++.+|++.|+.
T Consensus 234 ~~~~~i~---------~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 DVIEMIR---------NR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHH---------cC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111100 10 0112234455678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=314.29 Aligned_cols=247 Identities=27% Similarity=0.384 Sum_probs=195.1
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCc
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSL 477 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 477 (678)
+.||+|+||.||+|.. .+++.||+|.+.... .+....+.+|+++++.++||||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999985 478999999875332 22235688999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce-eE
Q 038949 478 DSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE-TR 556 (678)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~ 556 (678)
.+++... ...+++..++.++.|++.||.|||+. ||+||||+|+|||++.++.++|+|||++........... ..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESK----HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998432 34588999999999999999999999 999999999999999999999999999875432211110 11
Q ss_pred EEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccch
Q 038949 557 VLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSE 635 (678)
Q Consensus 557 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~ 635 (678)
..++..|+|||.+.++.++.++||||||+++|+|++ |..||....+.. .... +. .......+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~-----~~----~~~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREA-----IE----QGVRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHH-----HH----cCCCCCCcc
Confidence 122457999999998899999999999999999997 888886432110 0000 00 111112233
Q ss_pred hhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 636 REVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 636 ~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
..+..+.+++.+||+.+|++||++.++++.|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 44567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=320.31 Aligned_cols=245 Identities=25% Similarity=0.354 Sum_probs=194.4
Q ss_pred ecccCccceeeccC-CCCcEEEEEeeehhccc---CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCc
Q 038949 402 LAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSL 477 (678)
Q Consensus 402 LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 477 (678)
||+|+||.||++.. .+++.||+|.+...... ..+.+..|+++++.++|+||+++++++..+...|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999984 57889999998643322 224567899999999999999999999999999999999999999
Q ss_pred cccccc--CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcccee
Q 038949 478 DSHLYG--RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET 555 (678)
Q Consensus 478 ~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 555 (678)
.+++.. .....+++..++.++.||+.||.|||+. ||+||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR----RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 887743 2345689999999999999999999999 999999999999999999999999999976543322 223
Q ss_pred EEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccch
Q 038949 556 RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSE 635 (678)
Q Consensus 556 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~ 635 (678)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ... .. ...+.. ...++.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~-----~~----~~~~~~--~~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKE-----LK----QRILND--SVTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHH-----HH----Hhhccc--CCCCcc
Confidence 45689999999999999999999999999999999999999964322110 000 00 001111 012233
Q ss_pred hhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 636 REVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 636 ~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
..+..+.+++.+||+.||++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 4556789999999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.18 Aligned_cols=254 Identities=19% Similarity=0.229 Sum_probs=195.4
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|.+.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999984 468899999986422 122245778899999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.||+|.+++... ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~----~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL----HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999542 34588899999999999999999999 9999999999999999999999999999765433
Q ss_pred CccceeEEEeeecccccccccc-----cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQS-----GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
.........||+.|+|||++.+ +.++.++||||||++||+|++|+.||...... +......... .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~---~- 225 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHE---E- 225 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCC---C-
Confidence 3222334569999999999875 56789999999999999999999999643211 0000000000 0
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCC--CchHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHS--RPRMSQVLR 664 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~--RPT~~eVL~ 664 (678)
...+. ......+..+.+++.+||..++.+ |++++++++
T Consensus 226 -~~~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 226 -RFQFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -cccCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 00000 011123457888999999866544 457777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=319.48 Aligned_cols=261 Identities=25% Similarity=0.323 Sum_probs=194.1
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecc---cccceEEEEeEEee-----CC
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCA---QHRNVVMLIGFCVE-----DG 463 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L---~HpnIv~l~~~~~~-----~~ 463 (678)
+|++.+.||+|+||.||+|.. .+++.||+|.++..... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588999999999999999984 47899999988743222 123456677777665 69999999998764 34
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
..++||||+. ++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 5899999996 5888888655555689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHH--HHhhh
Q 038949 544 RWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLL--KRHAI 621 (678)
Q Consensus 544 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~--~~~~~ 621 (678)
....... ......|+..|+|||++.+..++.++|||||||++|+|++|.+||........ +........ .....
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHHHhCCCChhhC
Confidence 7654321 22335678999999999988999999999999999999999999864332110 100000000 00000
Q ss_pred h-------cccCcc---hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 622 G-------ELIDPR---LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 622 ~-------elld~~---l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. ....+. ......+.....+.+|+.+||+.||++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000000 000111234456789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=352.86 Aligned_cols=262 Identities=22% Similarity=0.254 Sum_probs=214.6
Q ss_pred hhhhhhcCCcccceecccCccceeeccCCC-CcEEEEEeeehhcccCCccccccceeeeccc-ccceEEEEeE-Eee---
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-HRNVVMLIGF-CVE--- 461 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~-~~~--- 461 (678)
.+.+...++++.+.|.+|||+.||+|.... |..||+|++-..+....+.+.+|+.+|+.|. |+|||.+++. ...
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 356677889999999999999999999544 4999999987777777788999999999996 9999999993 221
Q ss_pred ---CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccc
Q 038949 462 ---DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVG 538 (678)
Q Consensus 462 ---~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~ 538 (678)
.-.++|.||||.||.|.|++..+....|++.++++|+.++++|+.+||..-+ -|||||||-+||||..+|+.|||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~p--PiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKP--PIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCC--ccchhhhhhhheEEcCCCCEEeC
Confidence 1357899999999999999987777779999999999999999999998722 59999999999999999999999
Q ss_pred cccccccccCCCcc--------ceeEEEeeecccccccc---cccccceecceeeeeeEEEEeeeCCccccccCCcccch
Q 038949 539 DFGLARWQPDGDMG--------VETRVLGTFGYLAPEYA---QSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC 607 (678)
Q Consensus 539 DFGla~~~~~~~~~--------~~~~~~Gt~~Y~APE~l---~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~ 607 (678)
|||.+.-....... ......-|+-|.|||++ .+..+++|+|||+|||+||-|+....||+....
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----- 263 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----- 263 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----
Confidence 99999743221100 11122358899999987 467889999999999999999999999976432
Q ss_pred hhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 608 LTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 608 l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
..+++..+.-.-.+.++..|.+||..||+.||.+||++-+|+..+-++.
T Consensus 264 --------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 264 --------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred --------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 2233444443334567789999999999999999999999998886554
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.69 Aligned_cols=243 Identities=22% Similarity=0.272 Sum_probs=191.5
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecc-cccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||++.. .+++.||+|+++.... .....+.+|+.++..+ +||||+.+++++.+.+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999984 5688999999975422 2224577888888877 699999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|..++. ....+++..++.++.||+.||+|||+. ||+||||||+|||++.++.++|+|||++....... ...
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (327)
T cd05617 81 GDLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHER----GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT 153 (327)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence 99988884 334689999999999999999999999 99999999999999999999999999987432211 223
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||.............+........ ...++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK----------PIRIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC----------CCCCC
Confidence 44679999999999999999999999999999999999999996533222111111111111100 01122
Q ss_pred hhhhhhhhhccceeeccCCCCCchH
Q 038949 635 EREVYGMLQCASLCIRKDPHSRPRM 659 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RPT~ 659 (678)
...+..+.+++.+||+.||.+|+++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 3344578899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=326.58 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=200.0
Q ss_pred hcCCcccceecccCccceeeccCC-CCc----EEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLP-DGQ----VVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
..+|++.+.||+|+||.||+|.+. +++ .||+|.++.... ....++.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 457999999999999999999842 333 489998864322 2235788899999999999999999998764 578
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+|+||+.+|+|.+++... ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~----~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999998543 23478888899999999999999999 9999999999999999999999999999865
Q ss_pred cCCCcc-ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 547 PDGDMG-VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 547 ~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
...... ......++..|+|||++.+..++.++||||||+++|+|++ |..||+.... .++.. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~------~~~~~-~~~~------ 226 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEISS-ILEK------ 226 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHH-HHhC------
Confidence 432211 1111234668999999999999999999999999999987 9999864321 01100 0000
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
......+..+...+.+++.+||+.||.+||++.+++..|....
T Consensus 227 ---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 227 ---GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111112334457889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=312.80 Aligned_cols=247 Identities=28% Similarity=0.414 Sum_probs=197.1
Q ss_pred ceecccCccceeeccCCCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCcc
Q 038949 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLD 478 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~ 478 (678)
+.||+|+||.||+|...+++.+|+|.++..... ....+.+|+++++.++||||+++++++...+..++||||+.+++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 369999999999999778889999988643322 1236888999999999999999999999999999999999999999
Q ss_pred cccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccceeEEE
Q 038949 479 SHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL 558 (678)
Q Consensus 479 ~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 558 (678)
+++... ...+++..+..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||++...............
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK-KDELKTKQLVKFALDAAAGMAYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 988543 34578899999999999999999998 9999999999999999999999999999754332221112223
Q ss_pred eeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhh
Q 038949 559 GTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSERE 637 (678)
Q Consensus 559 Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~ 637 (678)
++..|+|||++.++.++.++||||||+++|+|++ |..||...... .... .+.. ......+...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~------~~~~------~~~~----~~~~~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ------QARE------QVEK----GYRMSCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH------HHHH------HHHc----CCCCCCCCCC
Confidence 4567999999998899999999999999999998 99898543210 0000 0001 1111223345
Q ss_pred hhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 638 VYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 638 ~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
+..+.+++.+||..+|++||++.++++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.93 Aligned_cols=255 Identities=21% Similarity=0.233 Sum_probs=195.6
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++..++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999994 568999999986422 122345788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+|+|.+++... ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.++|+|||++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL----GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998532 34588999999999999999999999 9999999999999999999999999998765443
Q ss_pred CccceeEEEeeecccccccccc-----cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQS-----GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
.........||+.|+|||++.. +.++.++|||||||++|+|++|+.||..... .+.............
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~- 228 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQ- 228 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCccc-
Confidence 3333334569999999999863 4578899999999999999999999964321 111111111000000
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCC--CCchHHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPH--SRPRMSQVLRM 665 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~--~RPT~~eVL~~ 665 (678)
+. ......+..+.+++.+||..+++ .||++.++++.
T Consensus 229 ----~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 ----FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ----CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 01112345678888887765443 37888888754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=311.69 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=206.7
Q ss_pred hhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehh--cccCCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLA--SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~--~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
...+.|++.+.||+|.|+.||++. .++|+.+|+|++... ...+.+++.+|+.|-+.|+||||+++.+.+.+.+..||
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 456789999999999999999998 468999999998633 23355789999999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee---cCccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH---DFEPLVGDFGLAR 544 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~---~~~vkL~DFGla~ 544 (678)
|+|+++|++|..-|..+ ..+++..+-.+++||++||.|+|.+ ||||||+||+|+|+.. ..-+||+|||++.
T Consensus 88 vFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n----~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN----GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999998877443 4578888899999999999999999 9999999999999964 4569999999998
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
.... ......++|||+|||||++...+|+..+|||+.|||||-||.|.+||...+. ..+.+ +.....
T Consensus 162 ~l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rlye--------~I~~g~ 228 (355)
T KOG0033|consen 162 EVND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYE--------QIKAGA 228 (355)
T ss_pred EeCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHHHH--------HHhccc
Confidence 7763 3345667899999999999999999999999999999999999999975321 11111 111111
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+| +....-.....+..+|+++||..||.+|.|+.|.|.
T Consensus 229 yd--~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 229 YD--YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cC--CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11 111122335568899999999999999999999763
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=326.27 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=193.3
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecc-cccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|.. .+++.||+|+++... ......+..|..++..+ +||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999985 468899999997542 22234566788888777 699999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|..++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++...... ...
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (318)
T cd05570 81 GDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHER----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTT 153 (318)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccc
Confidence 99998884 344689999999999999999999999 99999999999999999999999999987432221 223
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
....|++.|+|||++.+..++.++|||||||++|+|++|..||...... ........ . . ..++
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~i~~----~---~----~~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQSILE----D---E----VRYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHHHHc----C---C----CCCC
Confidence 3457899999999999999999999999999999999999999643210 00000000 0 0 1122
Q ss_pred hhhhhhhhhccceeeccCCCCCchH-----HHHHH
Q 038949 635 EREVYGMLQCASLCIRKDPHSRPRM-----SQVLR 664 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RPT~-----~eVL~ 664 (678)
...+..+.+||.+||+.||.+||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 3345578999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=348.04 Aligned_cols=258 Identities=22% Similarity=0.295 Sum_probs=204.8
Q ss_pred hhhhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCC-
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG- 463 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~- 463 (678)
......++|.+.+.||+|+||.||+|. ..+++.||||++..... .....+.+|+.++..++|+||+++++.+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 345566899999999999999999998 45789999999865432 22346778999999999999999988765432
Q ss_pred -------eEEEEEEEeecCCcccccccC--CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc
Q 038949 464 -------RRLLVYEYICNGSLDSHLYGR--DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE 534 (678)
Q Consensus 464 -------~~~LV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~ 534 (678)
.+++||||+.+|+|.+++..+ ....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~----~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK----HMIHRDIKSANILLCSNGL 181 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEeCCCC
Confidence 368999999999999988543 235688999999999999999999999 9999999999999999999
Q ss_pred cccccccccccccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH
Q 038949 535 PLVGDFGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 535 vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~ 613 (678)
+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .....
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~ 255 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMH 255 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHH
Confidence 9999999997654321 1223346799999999999999999999999999999999999999964321 11111
Q ss_pred HHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 614 PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 614 ~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.. ..... ...+...+..+.+++.+||+.||.+||++.++++.
T Consensus 256 ~~-----~~~~~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KT-----LAGRY-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HH-----hcCCC-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 10 00111 11233455679999999999999999999999863
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.53 Aligned_cols=244 Identities=23% Similarity=0.288 Sum_probs=190.0
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccce-eeecccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVE-VLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~-iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|.. .+++.||+|++..... .....+..|.. +++.++||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 4688999999864321 12234445544 57788999999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|..++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQ--RERCFLEPRARFYAAEVASAIGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 99988874 345588888999999999999999998 99999999999999999999999999987532221 223
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ........ .. ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~-----~~------~~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNIL-----HK------PLQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHh-----cC------CCCCC
Confidence 446789999999999988999999999999999999999999964321 11111110 00 01123
Q ss_pred hhhhhhhhhccceeeccCCCCCchHH-HHHHHhh
Q 038949 635 EREVYGMLQCASLCIRKDPHSRPRMS-QVLRMLE 667 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RPT~~-eVL~~Le 667 (678)
......+.+++.+||+.||.+||++. ++++.++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~ 250 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKN 250 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhC
Confidence 33455788999999999999999864 3444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=319.25 Aligned_cols=257 Identities=25% Similarity=0.345 Sum_probs=201.1
Q ss_pred hhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCC
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG 463 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 463 (678)
...++|.+.+.||+|+||.||+|.+. .+..||+|.+...... ....+.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 34578999999999999999999853 4568999987633222 2346888999999999999999999999989
Q ss_pred eEEEEEEEeecCCcccccccCCC-----CccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC---cc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDR-----DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF---EP 535 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~---~v 535 (678)
..++||||+.+++|.+++..... ..+++..+..++.||+.||+|||+. +++||||||+|||++.++ .+
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN----HFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchheEEEeccCCCcce
Confidence 99999999999999998854321 2478888999999999999999999 999999999999998755 58
Q ss_pred ccccccccccccCCCcc-ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhH
Q 038949 536 LVGDFGLARWQPDGDMG-VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 536 kL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 613 (678)
+|+|||+++........ .......+..|+|||++.+..++.++|||||||++|+|++ |..||....... ...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~ 232 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VME 232 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH
Confidence 99999999765322211 1112223567999999998899999999999999999997 999986433211 000
Q ss_pred HHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 614 PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 614 ~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
. +........+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 233 ~----------~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 F----------VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred H----------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 0001111223344567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.55 Aligned_cols=240 Identities=24% Similarity=0.342 Sum_probs=190.5
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecc-cccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|.. .+++.||+|.++... ......+..|..++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999995 478899999997542 12234566677777654 899999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.++|+|||+++...... ...
T Consensus 81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSK----GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 999988843 45688899999999999999999999 99999999999999999999999999987432211 223
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...... . ...... ...+. ++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~----~~~~~~---~~~~~----~~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------E----LFESIR---VDTPH----YP 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------H----HHHHHH---hCCCC----CC
Confidence 4567899999999999999999999999999999999999999643221 0 011000 00111 22
Q ss_pred hhhhhhhhhccceeeccCCCCCchHH-HHH
Q 038949 635 EREVYGMLQCASLCIRKDPHSRPRMS-QVL 663 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RPT~~-eVL 663 (678)
......+.+++.+||+.||.+||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 22345788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=324.28 Aligned_cols=267 Identities=26% Similarity=0.377 Sum_probs=208.0
Q ss_pred hhhhhcCCcccceecccCccceeeccC--------CCCcEEEEEeeehhc-ccCCccccccceeeecc-cccceEEEEeE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL--------PDGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCA-QHRNVVMLIGF 458 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~--------~~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~ 458 (678)
++...++|.+.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.+ +||||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 356678899999999999999999862 134579999886332 22235688999999999 89999999999
Q ss_pred EeeCCeEEEEEEEeecCCcccccccCC--------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCC
Q 038949 459 CVEDGRRLLVYEYICNGSLDSHLYGRD--------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRP 524 (678)
Q Consensus 459 ~~~~~~~~LV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp 524 (678)
+......|+||||+.+|+|.+++.... ...+++..+..++.||+.||.|||++ ||+||||||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----givH~dlkp 165 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ----KCIHRDLAA 165 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC----Ceeeccccc
Confidence 999999999999999999999985432 13467777888999999999999999 999999999
Q ss_pred CceEeeecCccccccccccccccCCCcc-ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCC
Q 038949 525 NNILVTHDFEPLVGDFGLARWQPDGDMG-VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRP 602 (678)
Q Consensus 525 ~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~ 602 (678)
+|||++.++.++|+|||+++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999999999765432211 1122235678999999998889999999999999999998 7778753321
Q ss_pred cccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccccCCC
Q 038949 603 RGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSK 675 (678)
Q Consensus 603 ~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~~s~ 675 (678)
.++.... .. ......+..++..+.+++.+||+.+|.+||++.++++.|++.+...++
T Consensus 246 ------~~~~~~~-~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 246 ------EELFKLL-KE---------GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred ------HHHHHHH-Hc---------CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 1111110 00 001112234556789999999999999999999999999987766554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=325.67 Aligned_cols=241 Identities=24% Similarity=0.290 Sum_probs=188.8
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccce-eeecccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVE-VLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~-iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|.. .+++.||+|++..... .....+..|.. +++.++||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999985 4678999999874321 11223444443 46778999999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++...... ...
T Consensus 81 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~----giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~ 153 (325)
T cd05602 81 GELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTT 153 (325)
T ss_pred CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCc
Confidence 999998843 44578888889999999999999999 99999999999999999999999999997532221 223
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...... +....... . . ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~-----~--~----~~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILN-----K--P----LQLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHh-----C--C----cCCC
Confidence 4567999999999999999999999999999999999999999643221 11111100 0 0 0122
Q ss_pred hhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 635 EREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+..+.+++.+||+.||.+||++.+.+.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 234557899999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.91 Aligned_cols=250 Identities=20% Similarity=0.320 Sum_probs=203.1
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
..+|.+.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.+.|+||+++++.+..+...|+||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 46899999999999999999984 57889999998765555556788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~----gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~- 170 (296)
T cd06654 99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (296)
T ss_pred cCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence 999999998832 3478889999999999999999999 99999999999999999999999999987543222
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+... +. .... ......
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-----~~-~~~~--------~~~~~~ 236 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LY-LIAT--------NGTPEL 236 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-----HH-HHhc--------CCCCCC
Confidence 112234688899999999988899999999999999999999999965432110 00 0000 000001
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+......+.+++.+||..||++||++.++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 112234456889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=320.06 Aligned_cols=256 Identities=30% Similarity=0.392 Sum_probs=201.0
Q ss_pred CCcccceecccCccceeeccCC------CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
+|++.+.||+|+||.||+|... ....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788899999999999999732 235788988764322 223568889999999999999999999999999999
Q ss_pred EEEEeecCCcccccccC----------------------CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCC
Q 038949 468 VYEYICNGSLDSHLYGR----------------------DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPN 525 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~----------------------~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~ 525 (678)
||||+.+|+|.+++... ...++++..++.++.|++.||.|||+. ||+||||||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~ivH~dikp~ 156 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM----KLVHRDLAAR 156 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC----Ceehhhhhhh
Confidence 99999999999887432 123477888899999999999999998 9999999999
Q ss_pred ceEeeecCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCc
Q 038949 526 NILVTHDFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPR 603 (678)
Q Consensus 526 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~ 603 (678)
|||++.++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999975433221 11222345678999999988889999999999999999998 99898543221
Q ss_pred ccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 604 GQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 604 ~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
. +.. .+........+...+..+.+++.+||+.+|++||++.++++.|+..+
T Consensus 237 ~---~~~-------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 R---LFN-------------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred H---HHH-------------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 0 000 01111111123334557899999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=308.81 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=202.9
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccC----C----ccccccceeeecc-cccceEEEEeEEee
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQG----D----QEFCSEVEVLSCA-QHRNVVMLIGFCVE 461 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~----~----~~~~~Ev~iL~~L-~HpnIv~l~~~~~~ 461 (678)
.-..|...+.||+|..+.|-++. .++|+.+|+|++....... . +.-.+|+.+|+++ .||||+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 34678888999999999999988 4678899999986433221 1 2355789999998 69999999999999
Q ss_pred CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
+..+++|+|.|+.|.|.|+|. ..-.+++...+.+++|+++|++|||.. +||||||||+|||++++-+++|+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~----~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHAR----NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHh----hhhhcccChhheeeccccceEEeccc
Confidence 999999999999999999994 445699999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCccceeEEEeeecccccccccc------cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQS------GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 615 (678)
+++....+. .....||||+|+|||.+.. ..|+..+|+|++|||||.|+.|.+||.... +... ..+
T Consensus 169 Fa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlM----LR~ 239 (411)
T KOG0599|consen 169 FACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLM----LRM 239 (411)
T ss_pred eeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHH----HHH
Confidence 999887664 3456799999999998853 468889999999999999999999996321 1000 000
Q ss_pred HHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 LKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 ~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+....+ .+...--.+.+....+||.+||+.||.+|.|++|+|+
T Consensus 240 ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 IMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 111100 1111122345567899999999999999999999875
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=315.26 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=200.0
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEeeC------
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVED------ 462 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~------ 462 (678)
.+.++|.+.+.||+|+||.||+|.. .+++.||+|.+.... .....+..|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3567899999999999999999984 568899999986443 3345678899999888 699999999998753
Q ss_pred CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
..+|+||||+.+++|.+++.......+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~----~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 4689999999999999998655556689999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeeccccccccc-----ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHH
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQ-----SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK 617 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 617 (678)
+...... ........|++.|+|||++. ...++.++|||||||++|+|++|..||....+.... . ..
T Consensus 158 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~--~~- 228 (272)
T cd06637 158 SAQLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----F--LI- 228 (272)
T ss_pred ceecccc-cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----H--HH-
Confidence 8754322 12234456899999999986 345788999999999999999999999643321100 0 00
Q ss_pred HhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 618 RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 618 ~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.....+. ......+..+.+|+.+||..||.+||++.++++
T Consensus 229 ----~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 ----PRNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----hcCCCCC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000111 111223457889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=333.23 Aligned_cols=263 Identities=24% Similarity=0.305 Sum_probs=196.9
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeCC-----eEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG-----RRL 466 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~-----~~~ 466 (678)
+|++.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999984 578999999885321 122356888999999999999999999998776 789
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+. ++|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSA----GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999985 67877773 345689999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchh----------hhhhHH-
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCL----------TEWARP- 614 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l----------~~~~~~- 614 (678)
............+++.|+|||++.+. .++.++|||||||++|+|++|+.||....+...... ..+...
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 43332223334678899999998764 578999999999999999999999975443211000 000000
Q ss_pred -HHHHhhhhcccC-cchhc--ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 -LLKRHAIGELID-PRLRN--CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 -~~~~~~~~elld-~~l~~--~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
............ +.... ......+..+.+||.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000000000000 00000 112223557889999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.43 Aligned_cols=240 Identities=25% Similarity=0.342 Sum_probs=190.9
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeec-ccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSC-AQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~-L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|.. .+++.||+|+++... ......+..|..++.. ++||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 468899999987542 1223445667777765 4899999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++....... ...
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05619 81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSK----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKT 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cce
Confidence 999998843 34588889999999999999999999 99999999999999999999999999987432222 223
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...... + ........ .+. ++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~----~~~~i~~~---~~~----~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE------E----LFQSIRMD---NPC----YP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH------H----HHHHHHhC---CCC----CC
Confidence 4567899999999999989999999999999999999999999643211 0 11110000 111 12
Q ss_pred hhhhhhhhhccceeeccCCCCCchHH-HHH
Q 038949 635 EREVYGMLQCASLCIRKDPHSRPRMS-QVL 663 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RPT~~-eVL 663 (678)
......+.+++.+||+.||.+||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 22345788999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=325.23 Aligned_cols=263 Identities=29% Similarity=0.376 Sum_probs=205.1
Q ss_pred hhhhcCCcccceecccCccceeeccCC--------CCcEEEEEeeehhc-ccCCccccccceeeecc-cccceEEEEeEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLP--------DGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCA-QHRNVVMLIGFC 459 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~ 459 (678)
+...++|.+.+.||+|+||.||++... +...+|+|.++... ......+.+|+.+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 455678999999999999999998732 23579999987432 12234678899999999 799999999999
Q ss_pred eeCCeEEEEEEEeecCCcccccccCC--------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCC
Q 038949 460 VEDGRRLLVYEYICNGSLDSHLYGRD--------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPN 525 (678)
Q Consensus 460 ~~~~~~~LV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~ 525 (678)
...+..|+||||+.+|+|.+++..+. ...+++..++.++.|++.||+|||+. |++||||||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~ 169 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK----KCIHRDLAAR 169 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHH
Confidence 99999999999999999999995432 13478888899999999999999998 9999999999
Q ss_pred ceEeeecCccccccccccccccCCCccc-eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCc
Q 038949 526 NILVTHDFEPLVGDFGLARWQPDGDMGV-ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPR 603 (678)
Q Consensus 526 NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~ 603 (678)
|||++.++.++|+|||++.......... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~- 248 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 248 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-
Confidence 9999999999999999987553322111 111223468999999998889999999999999999998 8888753221
Q ss_pred ccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 604 GQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 604 ~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
.+.... ... ......+...+..+.+|+.+||..+|++||++.++++.|+..+..
T Consensus 249 -----~~~~~~-~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 -----EELFKL-LKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -----HHHHHH-HHc---------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111110 010 111122334456888999999999999999999999999986654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.37 Aligned_cols=252 Identities=24% Similarity=0.404 Sum_probs=201.2
Q ss_pred cCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEee
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYIC 473 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ 473 (678)
.+|++.+.||+|+||.||++.+.+++.+|+|.+.... .....+.+|+++++.++||||+++++++......++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4788889999999999999987667889999876332 223568899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccc
Q 038949 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553 (678)
Q Consensus 474 ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 553 (678)
+++|.+++... ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESS----NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC----CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999988543 24578899999999999999999998 99999999999999999999999999987554332222
Q ss_pred eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
.....++..|+|||++.++.++.++||||||+++|+|++ |..||...... ...... ........
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~---~~~~~~~~------ 222 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVETI---NAGFRLYK------ 222 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHH---hCCCCCCC------
Confidence 222334678999999998899999999999999999998 89998643211 111100 00001111
Q ss_pred cchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
+...+..+.+|+.+||+.+|++||++.++++.|.
T Consensus 223 -~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 -PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1123457899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.61 Aligned_cols=254 Identities=28% Similarity=0.377 Sum_probs=198.0
Q ss_pred CcccceecccCccceeeccCC----CCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCe-----
Q 038949 396 FSEANFLAEGGFGSVHRGVLP----DGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR----- 464 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~----- 464 (678)
|.+.+.||+|+||.||+|... .+..||+|.++.... .....+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 577889999999999999842 246899999874322 223468899999999999999999998866554
Q ss_pred -EEEEEEEeecCCcccccccC----CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccc
Q 038949 465 -RLLVYEYICNGSLDSHLYGR----DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGD 539 (678)
Q Consensus 465 -~~LV~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~D 539 (678)
.++||||+.+|+|..++... ....+++..+..++.|++.||.|||+. |++||||||+||++++++.++|+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR----NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchheEEECCCCeEEECC
Confidence 79999999999999887432 224588888999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCcc-ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHH
Q 038949 540 FGLARWQPDGDMG-VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLK 617 (678)
Q Consensus 540 FGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 617 (678)
||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||...... +.....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~~~~~-- 228 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EIYDYL-- 228 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH--
Confidence 9999865433211 1112234678999999988889999999999999999999 88888543210 110000
Q ss_pred HhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 618 RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 618 ~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
..... ...+..++..+.+++.+||+.||++||++.++++.|+..
T Consensus 229 ----~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 ----RHGNR----LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----HcCCC----CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00001 112334456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=341.18 Aligned_cols=259 Identities=20% Similarity=0.300 Sum_probs=192.9
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeC--------
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED-------- 462 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-------- 462 (678)
...+|.+.+.||+|+||.||+|.. .+++.||||.+... .....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 356899999999999999999985 57889999987532 23345799999999999999999876432
Q ss_pred CeEEEEEEEeecCCccccccc--CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC-cccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF-EPLVGD 539 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~-~vkL~D 539 (678)
..+++||||+. ++|.+++.. .....+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~----~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK----FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCcCHHHEEEcCCCCceeeec
Confidence 24679999996 467666532 2345688999999999999999999999 999999999999999664 799999
Q ss_pred ccccccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHH----
Q 038949 540 FGLARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP---- 614 (678)
Q Consensus 540 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~---- 614 (678)
||+++...... ......||+.|+|||++.+ ..++.++|||||||+||+|++|.+||........ +......
T Consensus 215 FGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~~~~p 290 (440)
T PTZ00036 215 FGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQVLGTP 290 (440)
T ss_pred cccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCC
Confidence 99998654332 2234568999999998865 4689999999999999999999999965432111 1110000
Q ss_pred HHH----------HhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHH
Q 038949 615 LLK----------RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663 (678)
Q Consensus 615 ~~~----------~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL 663 (678)
... ...+.......+...++...+..+.+||.+||+.||.+|||+.+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 000 0000011111122223334556889999999999999999999987
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.21 Aligned_cols=246 Identities=25% Similarity=0.352 Sum_probs=194.2
Q ss_pred eecccCccceeeccC---CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecC
Q 038949 401 FLAEGGFGSVHRGVL---PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNG 475 (678)
Q Consensus 401 ~LG~G~fG~Vy~a~~---~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~gg 475 (678)
.||+|+||.||+|.+ .++..+|+|+++..... ..+.+.+|+.+++.+.||||+++++++. ....++||||+.+|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999963 46789999988643222 2356888999999999999999999885 45679999999999
Q ss_pred CcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccc--
Q 038949 476 SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV-- 553 (678)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~-- 553 (678)
+|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||.||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEET----NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999843 34688999999999999999999998 99999999999999999999999999997654322111
Q ss_pred eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
.....++..|+|||.+....++.++|+||||+++|||++ |..||...... .+.. ... ......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~-~i~---------~~~~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------EVTQ-MIE---------SGERME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHH-HHH---------CCCCCC
Confidence 111223578999999988889999999999999999998 99998643221 1111 011 111112
Q ss_pred cchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
.+..++..+.++|.+||+.||++||++.+|.+.|++-
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 3334556899999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.61 Aligned_cols=250 Identities=27% Similarity=0.378 Sum_probs=200.5
Q ss_pred hhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEe-eCCeEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV-EDGRRLLVYE 470 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~-~~~~~~LV~E 470 (678)
...+|.+.+.||+|+||.||++.. .+..+|+|.++... ....+.+|+.+++.++|+|++++++++. .++..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 346899999999999999999986 47789999886332 2356889999999999999999999754 4567899999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+++|.+++.......+++..++.++.|++.||+|||++ |++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999998665555688899999999999999999998 99999999999999999999999999987543221
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
....++..|+|||++....++.++||||||+++|+|++ |..||..... ....... .. ..
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~------~~----~~ 216 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRV------EK----GY 216 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH------hc----CC
Confidence 12234567999999998889999999999999999997 8888853221 1111110 00 01
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
....+..++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 111223345578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.00 Aligned_cols=258 Identities=24% Similarity=0.358 Sum_probs=205.7
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++.+.||+|+||.||++.. .+++.+|+|.+..... .....+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4788899999999999999994 5789999998764322 12246888999999999999999999999999999999
Q ss_pred EEeecCCccccccc--CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 470 EYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 470 E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||+.+++|.+++.. .....+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999998842 2345688999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
.... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...... ...+... +.....+
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~------~~~~~~~ 226 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK------IEQCDYP 226 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhh------hhcCCCC
Confidence 3321 123346888999999999888999999999999999999999998543211 0111110 0111111
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
.. .....+..+.+++.+||+.||.+|||+.+|++.++++
T Consensus 227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11 1122445789999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=325.03 Aligned_cols=249 Identities=21% Similarity=0.287 Sum_probs=210.7
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCC--ccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGD--QEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~--~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
+.+-|.+.+.||+|.|+.|-+|++ -+|..||||++.....+.. ..+++|++.|+.++|||||+||++......+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 356689999999999999999984 5899999999976554443 4688999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee-ecCcccccccccccccc
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT-HDFEPLVGDFGLARWQP 547 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~-~~~~vkL~DFGla~~~~ 547 (678)
+|+-.+|+|++||..... .+.+..+.+++.||+.|+.|+|+. .+|||||||+|+.+- .-|-+||.|||++..+.
T Consensus 96 LELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqL----HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQL----HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhh----hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999976654 499999999999999999999999 899999999998765 56999999999998765
Q ss_pred CCCccceeEEEeeecccccccccccccc-eecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQIT-EKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.+. ..++.+|...|.|||++.+..|+ +++||||||||||.|++|++||+...... .+..++|
T Consensus 171 PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImD 233 (864)
T KOG4717|consen 171 PGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMD 233 (864)
T ss_pred Ccc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhc
Confidence 553 45678999999999999998886 68899999999999999999997544311 1112222
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
=.+ ..|...+.++.+||..||..||++|.+.++|..
T Consensus 234 CKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 234 CKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 111 235566778999999999999999999999863
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.26 Aligned_cols=270 Identities=24% Similarity=0.317 Sum_probs=200.4
Q ss_pred cCCcccceecccCccceeeccC-----CCCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeC--CeE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-----PDGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED--GRR 465 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~~ 465 (678)
.-|++.+.||+|+||.||++.. .++..||+|.++... ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478899999999999999862 357889999986432 22235688999999999999999999998775 568
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++||||++|++|.+++... ...+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999998443 23588999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCcc--ceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 546 QPDGDMG--VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 546 ~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
....... ......++..|+|||++.+..++.++||||||+++|+|++++.|+...................... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 237 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR-LVR 237 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH-HHH
Confidence 5432211 1122446677999999988889999999999999999999877643211100000000000000000 000
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
.+........+..++..+.+|+.+||+.||++||++.++++.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000001112233456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.51 Aligned_cols=257 Identities=27% Similarity=0.412 Sum_probs=202.4
Q ss_pred hhcCCcccceecccCccceeeccCC-CC---cEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLP-DG---QVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g---~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
..++|...+.||+|+||.||+|... ++ ..+|+|.++.... .....+..|+++++.++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 3457888999999999999999853 33 3799998864321 22356888999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.+++|.+++... ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 83 IITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDM----NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999988543 34688999999999999999999998 9999999999999999999999999999755
Q ss_pred cCCCccceeE--EEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 547 PDGDMGVETR--VLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 547 ~~~~~~~~~~--~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
.......... ...+..|+|||++....++.++||||||+++|+|++ |..||...... .+..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~------~ 225 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAIN------D 225 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHh------c
Confidence 4322111111 112457999999998889999999999999999987 99998643210 1111100 0
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
......+...+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 226 ----~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 ----GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011112233456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.60 Aligned_cols=263 Identities=27% Similarity=0.376 Sum_probs=201.8
Q ss_pred hhcCCcccceecccCccceeeccCC-----------------CCcEEEEEeeehhcc-cCCccccccceeeecccccceE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLP-----------------DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVV 453 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----------------~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv 453 (678)
...+|++.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+++++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3568999999999999999998742 124689998864432 2335788899999999999999
Q ss_pred EEEeEEeeCCeEEEEEEEeecCCcccccccCC---------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCC
Q 038949 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRD---------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRP 524 (678)
Q Consensus 454 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp 524 (678)
++++++..++..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+. ||+||||||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~----~i~H~dlkp 158 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL----NFVHRDLAT 158 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc----Cccccccch
Confidence 99999999999999999999999999885432 12588999999999999999999998 999999999
Q ss_pred CceEeeecCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee--CCccccccC
Q 038949 525 NNILVTHDFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT--GRKAMDLNR 601 (678)
Q Consensus 525 ~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt--G~~Pf~~~~ 601 (678)
+||+++.++.++|+|||+++....... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999999875433221 11223345678999999988889999999999999999988 667775322
Q ss_pred CcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 602 PRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 602 ~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
. .. ...... ..............+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 239 ~--~~-~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 D--QQ-VIENAG------HFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred h--HH-HHHHHH------hccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 00 000000 000000111111122334467999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.77 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=199.2
Q ss_pred hhcCCcccceecccCccceeeccCCC---------------CcEEEEEeeehhcc-cCCccccccceeeecccccceEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLPD---------------GQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVML 455 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~~---------------g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l 455 (678)
..++|++.+.||+|+||.||++.... ...||+|.++.... .....+.+|+++++.++|+||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 35689999999999999999987432 23589998864322 223468899999999999999999
Q ss_pred EeEEeeCCeEEEEEEEeecCCcccccccCC----------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCC
Q 038949 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRD----------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPN 525 (678)
Q Consensus 456 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~ 525 (678)
++++......++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+. |++||||||+
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~ 158 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL----NFVHRDLATR 158 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc----CeeccccChh
Confidence 999999999999999999999999884321 12367778889999999999999999 9999999999
Q ss_pred ceEeeecCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee--CCccccccCC
Q 038949 526 NILVTHDFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT--GRKAMDLNRP 602 (678)
Q Consensus 526 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt--G~~Pf~~~~~ 602 (678)
||+++.++.+||+|||++........ .......++..|+|||++..+.++.++|+||||+++|+|++ |..||.....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 99999999999999999975433221 11122334678999999998899999999999999999987 5667754321
Q ss_pred cccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 603 RGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 603 ~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
.. ............ ........+...+..+.+|+.+||+.||++||++.+|++.|+
T Consensus 239 ~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQ---VIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HH---HHHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 10 000000000000 000111122234458999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.98 Aligned_cols=254 Identities=27% Similarity=0.370 Sum_probs=195.3
Q ss_pred CcccceecccCccceeeccCC-CCc--EEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeC------Ce
Q 038949 396 FSEANFLAEGGFGSVHRGVLP-DGQ--VVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED------GR 464 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~~-~g~--~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~------~~ 464 (678)
|.+.+.||+|+||.||+|.+. ++. .+|+|.++... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 456788999999999999853 333 68999886432 22335688899999999999999999987432 24
Q ss_pred EEEEEEEeecCCccccccc----CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYG----RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~----~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
.++||||+.+|+|.+++.. .....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK----SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhheEEcCCCCEEECCC
Confidence 6899999999999887732 1234578899999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCccc-eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHH
Q 038949 541 GLARWQPDGDMGV-ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKR 618 (678)
Q Consensus 541 Gla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 618 (678)
|+++......... .....+++.|++||++.+..++.++||||||+++|+|++ |..||...... .... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~-~~~~ 229 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------EIYD-YLRQ 229 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHH-HHHc
Confidence 9998654332211 122235678999999999899999999999999999999 78888543211 1101 0111
Q ss_pred hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 619 ~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
. .. ...+...+..+.++|.+||+.||++||++.++++.|+..
T Consensus 230 ~---~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 G---NR------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C---CC------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00 011223455789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.95 Aligned_cols=251 Identities=27% Similarity=0.384 Sum_probs=200.5
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC---CccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG---DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~---~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
.|+..+.||+|+||.||++.. .+++.||+|.+....... ...+.+|+.+++.++|+||+.+++.+.+.+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377888999999999999984 578999999886443221 2356789999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+++++|.+++.......+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999988655555689999999999999999999998 99999999999999999999999999987543322
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
. .....|+..|+|||++.+..++.++||||||+++|+|++|..||........ .+....... ...
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~---~~~~~~~~~----------~~~ 221 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLVK----------EVQ 221 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch---HHHHHhhhh----------hhh
Confidence 1 1234689999999999999999999999999999999999999965322110 000000000 001
Q ss_pred cccchhhhhhhhhccceeeccCCCCCch-----HHHHHH
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPR-----MSQVLR 664 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT-----~~eVL~ 664 (678)
..++......+.+|+.+||+.||++||| ++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1122334457889999999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=321.77 Aligned_cols=240 Identities=23% Similarity=0.268 Sum_probs=184.3
Q ss_pred ecccCccceeeccC-CCCcEEEEEeeehhcccC---Cccccccceeeecc---cccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 402 LAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG---DQEFCSEVEVLSCA---QHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 402 LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~---~~~~~~Ev~iL~~L---~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
||+|+||.||+|.. .+++.||+|++....... ...+..|..++.++ .||||+.+++++.+....|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999984 568999999986432211 12344566666544 699999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++....... ...
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~ 153 (330)
T cd05586 81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKY----DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTT 153 (330)
T ss_pred ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCc
Confidence 99998884 345689999999999999999999999 99999999999999999999999999987533222 223
Q ss_pred eEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhccc
Q 038949 555 TRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCY 633 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~ 633 (678)
....||+.|+|||++.+. .++.++|||||||++|+|++|..||...... + ......... ..+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~----~~~~i~~~~---~~~~~-- 218 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------Q----MYRNIAFGK---VRFPK-- 218 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------H----HHHHHHcCC---CCCCC--
Confidence 346799999999998754 5799999999999999999999999643210 0 111100011 01100
Q ss_pred chhhhhhhhhccceeeccCCCCCc----hHHHHHH
Q 038949 634 SEREVYGMLQCASLCIRKDPHSRP----RMSQVLR 664 (678)
Q Consensus 634 ~~~~~~~l~~LI~~cL~~dP~~RP----T~~eVL~ 664 (678)
...+..+.+++.+||+.||.+|| ++.++++
T Consensus 219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11344678999999999999998 4555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=334.70 Aligned_cols=266 Identities=26% Similarity=0.387 Sum_probs=225.5
Q ss_pred hhhhhhhhcCCcccceecccCccceeeccCC---CCc--EEEEEeeeh-hcccCCccccccceeeecccccceEEEEeEE
Q 038949 386 YAELELATNRFSEANFLAEGGFGSVHRGVLP---DGQ--VVAVKQYKL-ASSQGDQEFCSEVEVLSCAQHRNVVMLIGFC 459 (678)
Q Consensus 386 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~---~g~--~vAvK~i~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 459 (678)
...+++.+....+.++||+|.||.||.|.+. .|. .||||..+. ...+..+.|+.|+.+|+.++||||++++|+|
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 3456777788888999999999999999832 333 588999875 3445567899999999999999999999999
Q ss_pred eeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccc
Q 038949 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGD 539 (678)
Q Consensus 460 ~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~D 539 (678)
.+ ...|||||+++.|.|..|+..+ ...++......++.||+.||.|||+. .+|||||..+|||+....-+||+|
T Consensus 461 ~e-~P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSk----rfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 461 VE-QPMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESK----RFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred ec-cceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhh----chhhhhhhhhheeecCcceeeecc
Confidence 76 5789999999999999999654 34588889999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHH
Q 038949 540 FGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKR 618 (678)
Q Consensus 540 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 618 (678)
||++++..+..+...+...-+..|||||-++-..++.++|||-|||.+||++. |..||..-..
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN---------------- 598 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN---------------- 598 (974)
T ss_pred cchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------------
Confidence 99999998877776666666788999999999999999999999999999986 8899964322
Q ss_pred hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccccC
Q 038949 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMN 673 (678)
Q Consensus 619 ~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~~ 673 (678)
..+...+...-+...|+.|+..++.|+.+||..+|.+||++.++...|.+...++
T Consensus 599 sDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 599 SDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred cceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 2222233444455677888899999999999999999999999999998766543
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.06 Aligned_cols=254 Identities=22% Similarity=0.366 Sum_probs=201.3
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
..++|.+.+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 346889999999999999999984 5788999999875544444567889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+++|.+++. ..+.+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd06645 87 FCGGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSK----GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT- 159 (267)
T ss_pred ccCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECcceeeeEccCc-
Confidence 999999999884 345689999999999999999999999 9999999999999999999999999998754322
Q ss_pred ccceeEEEeeeccccccccc---ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 551 MGVETRVLGTFGYLAPEYAQ---SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
........|++.|+|||++. .+.++.++|+|||||++|+|++|..||....+..... . ... .....+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~------~-~~~---~~~~~~ 229 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------L-MTK---SNFQPP 229 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH------h-hhc---cCCCCC
Confidence 22233456899999999874 4568899999999999999999999985433211100 0 000 000011
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.... ....+..+.+++.+||..+|++||+++++++
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 230 KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1110 0123346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.61 Aligned_cols=256 Identities=27% Similarity=0.389 Sum_probs=197.5
Q ss_pred hcCCcccceecccCccceeeccC-CCCc----EEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQ----VVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~----~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
.++|++.+.||+|+||.||+|.+ .+++ .+++|.+..... ....++..|+.++..+.||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 35788899999999999999985 3444 477787653221 122456777888899999999999998764 5678
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+++||+++|+|.+++... ...+++..+..++.||+.||.|||+. |++||||||+|||++.++.+||+|||+++..
T Consensus 85 ~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEH----RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999999543 34588999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 547 PDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 547 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
..... .......++..|+|||++.++.++.++||||||+++|||++ |..||....+.. ... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~----~~~~~~---- 228 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPD----LLEKGE---- 228 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHCCC----
Confidence 43221 11223446778999999998899999999999999999998 999986443211 111 111100
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
....+..+...+.+++.+||..||.+||++.++++.|....
T Consensus 229 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 229 -----RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 00111223446788999999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=336.35 Aligned_cols=264 Identities=23% Similarity=0.318 Sum_probs=205.6
Q ss_pred hhhhhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhcccC-Cccccccceeeeccc-ccceEEEEeEE
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASSQG-DQEFCSEVEVLSCAQ-HRNVVMLIGFC 459 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~~~-~~~~~~Ev~iL~~L~-HpnIv~l~~~~ 459 (678)
+++...++|.+.+.||+|+||.||+|.+. +++.||+|+++...... ...+.+|+.+|.++. ||||++++++|
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 46777788999999999999999999742 34689999997432222 246888999999997 99999999999
Q ss_pred eeCCeEEEEEEEeecCCcccccccCCC-----------------------------------------------------
Q 038949 460 VEDGRRLLVYEYICNGSLDSHLYGRDR----------------------------------------------------- 486 (678)
Q Consensus 460 ~~~~~~~LV~E~~~ggsL~~~l~~~~~----------------------------------------------------- 486 (678)
...+..++||||+.+|+|.+++.....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999998853211
Q ss_pred -------------------------------------------CccCccccchhhhhhccchhhhhhcceeeeEEeccCC
Q 038949 487 -------------------------------------------DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMR 523 (678)
Q Consensus 487 -------------------------------------------~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLK 523 (678)
..+++..++.++.||+.||.|||+. +|+|||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrdlk 266 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK----NCVHRDLA 266 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CcCcccCC
Confidence 1245556677889999999999998 99999999
Q ss_pred CCceEeeecCccccccccccccccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccC
Q 038949 524 PNNILVTHDFEPLVGDFGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNR 601 (678)
Q Consensus 524 p~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~ 601 (678)
|+|||++.++.++|+|||+++...... ........++..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999997543221 111223456788999999998889999999999999999998 888885432
Q ss_pred CcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 602 PRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 602 ~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
... .....+ ........+...+..+.+|+.+||..+|.+||++.+|++.|+..+
T Consensus 347 ~~~------~~~~~~---------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 MNE------QFYNAI---------KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred chH------HHHHHH---------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 110 000000 011111123334568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=320.52 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=201.8
Q ss_pred hhhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeC
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVED 462 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 462 (678)
+...++|++.+.||+|+||.||+|..+ .+..||+|.++.... .....+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 566789999999999999999998632 245799998753321 1223577899999999999999999999999
Q ss_pred CeEEEEEEEeecCCcccccccCC--------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRD--------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE 534 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~ 534 (678)
...++||||+.+|+|.+++.... ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK----KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCCChheEEEcCCCc
Confidence 99999999999999999995422 12345566788999999999999999 9999999999999999999
Q ss_pred cccccccccccccCCCcc-ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhh
Q 038949 535 PLVGDFGLARWQPDGDMG-VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWA 612 (678)
Q Consensus 535 vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 612 (678)
++|+|||+++........ ......++..|+|||.+.++.++.++|+|||||++|+|++ |..||...... +..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~ 231 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVL 231 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHH
Confidence 999999998754332211 1112234678999999998899999999999999999998 77888543210 111
Q ss_pred HHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 613 RPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 613 ~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
... .+.. ....+...+..+.+++.+||+.||++||++.++++.|+..+
T Consensus 232 ~~~---------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 KFV---------MDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHH---------HcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 100 0000 00112233457999999999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=312.35 Aligned_cols=270 Identities=24% Similarity=0.341 Sum_probs=203.9
Q ss_pred cCCcccceecccCccceeeccCC-----CCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEee--CCeE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLP-----DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVE--DGRR 465 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~~ 465 (678)
+.|++.+.||+|+||.||+|.+. +++.||+|.+...... ....+.+|+++++.+.||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 56788899999999999999842 4789999998754432 34678999999999999999999999877 5578
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ----RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999995433 2588999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCcc--ceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 546 QPDGDMG--VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 546 ~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
....... ......++..|++||.+.+..++.++||||||+++|+|++|..|+................. .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ-MIVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc-ccHHHHHH
Confidence 6422111 11112345569999999888999999999999999999999998854321110000000000 00000011
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
.+........+..++..+.+++.+||+.+|.+||++.+|+++|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111112233456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=321.85 Aligned_cols=255 Identities=20% Similarity=0.234 Sum_probs=195.4
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|.+.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4789999999999999999984 467899999986322 122235778899999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+|+|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++......
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~----~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999542 34588889999999999999999998 9999999999999999999999999998754333
Q ss_pred CccceeEEEeeeccccccccc-----ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQ-----SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
.........||+.|+|||++. ...++.++|||||||++|+|++|+.||...... ..........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~----- 224 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHK----- 224 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCC-----
Confidence 222233457999999999986 346889999999999999999999999643210 1011110000
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCC--CchHHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHS--RPRMSQVLRM 665 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~--RPT~~eVL~~ 665 (678)
....+ .......+..+.+|+.+||..++++ |+++.++++.
T Consensus 225 ~~~~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 225 ERFQF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccccC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00000 0111234557888888988665544 6888888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.80 Aligned_cols=255 Identities=27% Similarity=0.367 Sum_probs=198.4
Q ss_pred cCCcccceecccCccceeeccCC-CCc--EEEEEeeehh-cccCCccccccceeeecc-cccceEEEEeEEeeCCeEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLP-DGQ--VVAVKQYKLA-SSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~--~vAvK~i~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV 468 (678)
++|++.+.||+|+||.||+|... ++. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57899999999999999999853 333 4788877632 222335688899999999 799999999999999999999
Q ss_pred EEEeecCCcccccccCC--------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc
Q 038949 469 YEYICNGSLDSHLYGRD--------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE 534 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~ 534 (678)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK----QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCcCCcceEEECCCCe
Confidence 99999999999885422 13478888999999999999999998 9999999999999999999
Q ss_pred cccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhH
Q 038949 535 PLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 535 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 613 (678)
+||+|||++...... ........+..|+|||++.+..++.++|||||||++|+|++ |..||...... ....
T Consensus 158 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~~~~ 229 (297)
T cd05089 158 SKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------ELYE 229 (297)
T ss_pred EEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHH
Confidence 999999998632211 01111122457999999998889999999999999999997 99998643221 0000
Q ss_pred HHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 614 PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 614 ~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
. . ........+..++..+.+|+.+||+.+|.+||++.++++.|+..+
T Consensus 230 ~------~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 230 K------L----PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred H------H----hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 0 111111122334557899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.77 Aligned_cols=256 Identities=27% Similarity=0.373 Sum_probs=201.8
Q ss_pred hcCCcccceecccCccceeeccCC-C---CcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLP-D---GQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~-~---g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
..+|++.+.||+|+||.||+|.+. + +..+|+|.++.... .....+.+|+.+++.++||||+++++++.+++..|+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 467889999999999999999842 2 34799998864322 123568889999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+. |++||||||+|||++.++.++|+|||++....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC----CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999985432 4578889999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccceeE--EEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 548 DGDMGVETR--VLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 548 ~~~~~~~~~--~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
......... ..++..|+|||++.++.++.++|+||||+++|++++ |..||....... .... +.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~------~~~~------~~~~ 225 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD------VIKA------IEEG 225 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH------HHHH------HhCC
Confidence 332211111 123467999999998899999999999999999886 999986433211 0000 0010
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
. ....+...+..+.+++.+||+.+|.+||++.++++.|++.
T Consensus 226 ~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 Y----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 1111223455789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=311.45 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=194.4
Q ss_pred eecccCccceeeccCC---CCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCC
Q 038949 401 FLAEGGFGSVHRGVLP---DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGS 476 (678)
Q Consensus 401 ~LG~G~fG~Vy~a~~~---~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggs 476 (678)
.||+|+||.||+|.+. ++..||+|++...... ..+.+.+|+.+++.++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999742 4557999988644322 22568899999999999999999998864 57899999999999
Q ss_pred cccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccceeE
Q 038949 477 LDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR 556 (678)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 556 (678)
|.+++... ...+++..++.++.|++.||.|||+. |++||||||+|||++.++.++|+|||++.............
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK----NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc----CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99988543 34689999999999999999999998 99999999999999999999999999997543322111111
Q ss_pred --EEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhccc
Q 038949 557 --VLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCY 633 (678)
Q Consensus 557 --~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~ 633 (678)
..+++.|+|||++....++.++||||||+++|+|++ |..||...... .+... +........
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~----------~~~~~~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP------EVMSF----------IEQGKRLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHH----------HHCCCCCCC
Confidence 123568999999988889999999999999999996 99998643221 11100 011111223
Q ss_pred chhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 634 SEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 634 ~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
+..++..+.+++.+||..||++||++.+|++.|+..+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 3445668999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=340.10 Aligned_cols=266 Identities=19% Similarity=0.241 Sum_probs=192.1
Q ss_pred hhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeeccc------ccceEEEEeEE
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ------HRNVVMLIGFC 459 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~------HpnIv~l~~~~ 459 (678)
.+++...++|++.+.||+|+||.||+|.. .+++.||||+++... .....+..|+.++..++ |.+++.++++|
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 44556678999999999999999999984 568899999986322 11233455666665554 45689999988
Q ss_pred eeC-CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhh-cceeeeEEeccCCCCceEeeecC----
Q 038949 460 VED-GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILVTHDF---- 533 (678)
Q Consensus 460 ~~~-~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~~~~~gIvHrDLKp~NILl~~~~---- 533 (678)
..+ .++|+|||++ +++|.+++.. ...+++..+..++.||+.||.|||+ . |||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~----gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTEL----HLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHEEEecCCcccc
Confidence 764 5789999987 8889888843 3568999999999999999999997 5 899999999999998765
Q ss_pred ------------ccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccC
Q 038949 534 ------------EPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNR 601 (678)
Q Consensus 534 ------------~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~ 601 (678)
.+||+|||.+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998864321 2245679999999999999999999999999999999999999997543
Q ss_pred Ccccchh---------hhhhHHHH-H-Hhhhh---cccCcchhc-----------ccchhhhhhhhhccceeeccCCCCC
Q 038949 602 PRGQQCL---------TEWARPLL-K-RHAIG---ELIDPRLRN-----------CYSEREVYGMLQCASLCIRKDPHSR 656 (678)
Q Consensus 602 ~~~~~~l---------~~~~~~~~-~-~~~~~---elld~~l~~-----------~~~~~~~~~l~~LI~~cL~~dP~~R 656 (678)
....... ..|..... . ...+. ..+.+.... .........+.+||.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 2111000 00100000 0 00000 000000000 0000112357799999999999999
Q ss_pred chHHHHHH
Q 038949 657 PRMSQVLR 664 (678)
Q Consensus 657 PT~~eVL~ 664 (678)
||++|+|+
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99999986
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=316.54 Aligned_cols=263 Identities=23% Similarity=0.381 Sum_probs=199.9
Q ss_pred hhcCCcccceecccCccceeeccCC-----------------CCcEEEEEeeehhcc-cCCccccccceeeecccccceE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLP-----------------DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVV 453 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----------------~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv 453 (678)
..++|++.+.||+|+||.||++.+. ++..+|+|.+..... .....+.+|+.+++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 4568999999999999999998532 244689998874322 2235788999999999999999
Q ss_pred EEEeEEeeCCeEEEEEEEeecCCcccccccCCC---------CccCccccchhhhhhccchhhhhhcceeeeEEeccCCC
Q 038949 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDR---------DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRP 524 (678)
Q Consensus 454 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~---------~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp 524 (678)
++++++..++..++||||+.+++|.+++..... ..+++..+..++.|++.||+|||+. |++||||||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dlkp 158 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL----NFVHRDLAT 158 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CeecccCCh
Confidence 999999999999999999999999998854321 2356678899999999999999999 999999999
Q ss_pred CceEeeecCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee--CCccccccC
Q 038949 525 NNILVTHDFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT--GRKAMDLNR 601 (678)
Q Consensus 525 ~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt--G~~Pf~~~~ 601 (678)
+|||++.++.++|+|||++........ .......+++.|++||....+.++.++|+|||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 999999999999999999975433221 11122334678999999888899999999999999999998 677875432
Q ss_pred CcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 602 PRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 602 ~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
+.. ............. ... ....+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 239 ~~~---~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 239 DEQ---VIENTGEFFRDQG-RQV-----YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred hHH---HHHHHHHHHhhcc-ccc-----cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 211 0000000000000 000 01112234467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=312.91 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=203.2
Q ss_pred hcCCcccceecccCccceeeccCC------CCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
.++|++...||+|+||.||+|..+ +.+.|++|.+...... ....+.+|++++++++|+||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 367899999999999999999843 3467999987643322 235688999999999999999999999998999
Q ss_pred EEEEEEeecCCcccccccCCC-------CccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDR-------DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVG 538 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~-------~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~ 538 (678)
|+||||+++|+|.+++..... ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA----RFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc----CcccCcCccceEEEeCCCcEEEc
Confidence 999999999999999854331 2589999999999999999999998 99999999999999999999999
Q ss_pred cccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHH
Q 038949 539 DFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLK 617 (678)
Q Consensus 539 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 617 (678)
|||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~----------~~~ 229 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE----------VLN 229 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH----------HHH
Confidence 999987544333333334456788999999988888999999999999999998 778885322100 011
Q ss_pred HhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 618 RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 618 ~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
....... ....+...+..+.+++.+||+.+|.+||++.+++..|.
T Consensus 230 ~~~~~~~-----~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 RLQAGKL-----ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHcCCc-----CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1000110 01112234457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=331.84 Aligned_cols=212 Identities=25% Similarity=0.322 Sum_probs=182.5
Q ss_pred CceeehhhhhhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeeccc-c-----cceE
Q 038949 381 PRWFTYAELELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-H-----RNVV 453 (678)
Q Consensus 381 ~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-H-----pnIv 453 (678)
...+.+..-+...-+|.++++||+|.||.|.+|. ..+++.||||+++... .-..+...|+.+|..|+ | -|+|
T Consensus 173 ~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~V 251 (586)
T KOG0667|consen 173 DGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIV 251 (586)
T ss_pred CCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEE
Confidence 3445555556666699999999999999999998 5689999999998432 33345677999999886 4 4899
Q ss_pred EEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee--
Q 038949 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-- 531 (678)
Q Consensus 454 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-- 531 (678)
+++++|...+++|||+|.+ ..+|++++...+-.+++...++.++.||+.||.+||+. ||||+||||+||||.+
T Consensus 252 rm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l----~IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 252 RMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL----GIIHCDLKPENILLKDPK 326 (586)
T ss_pred Eeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCChhheeeccCC
Confidence 9999999999999999998 77999999877777899999999999999999999999 9999999999999975
Q ss_pred cCccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCC
Q 038949 532 DFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRP 602 (678)
Q Consensus 532 ~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~ 602 (678)
...+||+|||.++.....- .+++.+..|.|||++.+.+|+.+.||||||||+.||++|.+.|....+
T Consensus 327 r~~vKVIDFGSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cCceeEEecccccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 4589999999998664332 267788899999999999999999999999999999999888865544
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=315.17 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=201.9
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
...+.|++.+.||.|+||.||+|.. .+++.+++|.+..........+.+|+.+++.++||||+++++.+..++..|+||
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 3457799999999999999999985 468899999987555444567888999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|..++... ...+++..+..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||++......
T Consensus 89 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 89 EFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSM----KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred ecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcC----CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 999999998877433 34589999999999999999999998 9999999999999999999999999998754322
Q ss_pred CccceeEEEeeeccccccccc-----ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQ-----SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
........+++.|+|||++. ...++.++|+|||||++|+|++|..||....+.. ... . ....
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~---~---~~~~ 230 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLL---K---IAKS 230 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHH---H---HhcC
Confidence 22234456888999999984 3456889999999999999999999986433210 000 0 0000
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+. ...+...+..+.+++.+||..||++||+++++++
T Consensus 231 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 231 EPPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCcc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0111 0112233457889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.05 Aligned_cols=248 Identities=33% Similarity=0.438 Sum_probs=201.1
Q ss_pred ceecccCccceeeccCCC----CcEEEEEeeehhcccC-CccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVLPD----GQVVAVKQYKLASSQG-DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~----g~~vAvK~i~~~~~~~-~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|.... +..|++|.++...... ...+.+|+++++.++|+||+++++++......++||||+.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998543 7889999987544333 46788999999999999999999999999999999999999
Q ss_pred CCcccccccCC-------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 475 GSLDSHLYGRD-------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 475 gsL~~~l~~~~-------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
++|.+++.... ...+++..++.++.|++.||.|||++ |++||||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC----CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999995542 36689999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 548 DGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 548 ~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
.... .......+++.|+|||.+....++.++||||||+++|+|++ |..||....+ ........ .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~------~-- 222 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYLR------K-- 222 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHH------c--
Confidence 4321 12233456889999999988889999999999999999999 6889865422 11111100 0
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
......+...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 223 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 --GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111223334568999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.44 Aligned_cols=251 Identities=27% Similarity=0.365 Sum_probs=199.7
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhccc---CCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
.|+..+.||+|+||.||+|.+ .+++.||+|.+...... ....+.+|+++++.++|+||+.+++.+..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 377888999999999999984 57899999998643322 22457789999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+++|.+++.......+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~----~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE----NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999888655555799999999999999999999998 99999999999999999999999999997543322
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||........ ...+.. .+... .
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~------~~~~~-----~ 221 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDR------RVLET-----E 221 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH------hhhcc-----c
Confidence 11234689999999999988999999999999999999999999964322100 000000 00000 0
Q ss_pred cccchhhhhhhhhccceeeccCCCCCch-----HHHHHH
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPR-----MSQVLR 664 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT-----~~eVL~ 664 (678)
..++......+.+|+.+||+.||++||+ +.+++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1122334457889999999999999999 666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.72 Aligned_cols=263 Identities=21% Similarity=0.331 Sum_probs=197.1
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC-CccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG-DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~-~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
++|.+.+.||+|+||.||+|.. .+++.||+|.++...... ...+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 6799999999999999999984 468899999987543322 34577899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+. ++|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 86 LD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 96 4887777443 33478888999999999999999998 99999999999999999999999999997543322
Q ss_pred cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhh----------hhhHHHHHHhh
Q 038949 552 GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT----------EWARPLLKRHA 620 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~----------~~~~~~~~~~~ 620 (678)
.......+++.|+|||++.+ ..++.++||||||+++|+|+||+.||............ .|.. ......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 237 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG-ISSNDE 237 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh-hcchhh
Confidence 12223457899999998865 46889999999999999999999999654321110000 0000 000000
Q ss_pred hhcccCcchh----cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 IGELIDPRLR----NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ~~elld~~l~----~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....-.+... .......+..+.+||.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000 0011123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=313.58 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=197.7
Q ss_pred CcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 396 FSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
|++.+.||+|+||.||+|.. .++..+++|.+..........+.+|+++++.++||||+++++++..++..++||||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 67888999999999999995 46788999988654444456788899999999999999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
++|..++.. ...++++..+..++.|++.||.|||+. |++||||+|+|||++.++.++|+|||++....... ...
T Consensus 87 ~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 87 GAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHEN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 999887743 234689999999999999999999998 99999999999999999999999999987543221 222
Q ss_pred eEEEeeeccccccccc-----ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 555 TRVLGTFGYLAPEYAQ-----SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
....+++.|+|||++. +..++.++|+|||||++|+|++|..||....+... ...... ...+.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~------~~~~~- 227 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAK------SEPPT- 227 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhh------cCCCC-
Confidence 3356889999999984 34578899999999999999999999864332110 000000 00010
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+...+..+.++|.+||+.||.+||++.++++
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 228 -LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112234457899999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=314.03 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=196.6
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3688889999999999999984 578899999886432 22234688899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+++++|..+. .+++..+..++.|++.||.|||+. ||+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL----KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999986542 367788889999999999999999 9999999999999999999999999999754332
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccch-hhhhhHHHHHHhhhhcccCcchh
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC-LTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~-l~~~~~~~~~~~~~~elld~~l~ 630 (678)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||.......... ...+.. .......+.+
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~------~~~~~~~~~~- 220 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ------CIVDEDPPVL- 220 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH------HHhccCCCCC-
Confidence 1233568999999999998899999999999999999999999996533211110 000000 0000001111
Q ss_pred cccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
........+.+++.+||+.||++||+++++++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011233468899999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=308.52 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=203.9
Q ss_pred hcCCcccceecccCccceeeccCC-CCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
.++|.+.+.||.|+||.||+|.+. +++.+++|.+..... ...+.+|+++++.++||||+++++++.+....|+++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 367999999999999999999964 488999999875433 56789999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|.+++... ...+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN----KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999999998533 35689999999999999999999998 999999999999999999999999999986543321
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
......++..|+|||++.+..++.++||||||+++|+|++|..||....+.... . .......+. .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~---------~---~~~~~~~~~--~ 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI---------F---MIPNKPPPT--L 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh---------h---hhccCCCCC--C
Confidence 223345788999999999889999999999999999999999999754321110 0 000000011 1
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+......+.+++.+||+.||++||++.++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 112234457899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.86 Aligned_cols=263 Identities=28% Similarity=0.402 Sum_probs=203.6
Q ss_pred hhhhhcCCcccceecccCccceeeccCC--------CCcEEEEEeeehhcc-cCCccccccceeeecc-cccceEEEEeE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLP--------DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCA-QHRNVVMLIGF 458 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L-~HpnIv~l~~~ 458 (678)
+....++|.+.+.||+|+||.||++... ....+|+|.++.... .....+.+|+.+++.+ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 3555678999999999999999998631 245799998764322 2234678899999988 69999999999
Q ss_pred EeeCCeEEEEEEEeecCCcccccccCC--------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCC
Q 038949 459 CVEDGRRLLVYEYICNGSLDSHLYGRD--------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRP 524 (678)
Q Consensus 459 ~~~~~~~~LV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp 524 (678)
+...+.+|+||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+. ||+||||||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp 162 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR----RCIHRDLAA 162 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC----Ceeeccccc
Confidence 999999999999999999999985432 23477888889999999999999998 999999999
Q ss_pred CceEeeecCccccccccccccccCCCccc-eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCC
Q 038949 525 NNILVTHDFEPLVGDFGLARWQPDGDMGV-ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRP 602 (678)
Q Consensus 525 ~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~ 602 (678)
+|||++.++.++|+|||+++......... .....++..|+|||++.++.++.++||||||+++|+|++ |..||.....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999997553322111 111223467999999998899999999999999999999 8888854321
Q ss_pred cccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 603 RGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 603 ~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
. .... ..... .....+..++..+.+++.+||+.||++||++.++++.|.+...
T Consensus 243 ~------~~~~-~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 243 E------ELFK-LLREG---------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred H------HHHH-HHHcC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1 0000 01100 0111233445578899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.35 Aligned_cols=260 Identities=24% Similarity=0.345 Sum_probs=204.1
Q ss_pred hhhcCCcccceecccCccceeeccCCC-----CcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEee-CC
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLPD-----GQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE-DG 463 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-~~ 463 (678)
...++|.+.+.||+|+||.||+|.+.. +..|++|.+.... ......+.+|+.+++.++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 456789999999999999999998644 6889999876332 1223567889999999999999999998766 46
Q ss_pred eEEEEEEEeecCCcccccccCCC------CccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDR------DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLV 537 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~------~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL 537 (678)
..++++||+.+++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR----GVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCHhhEEEcCCCcEEE
Confidence 78999999999999999854322 4588999999999999999999998 9999999999999999999999
Q ss_pred ccccccccccCCCcc-ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHH
Q 038949 538 GDFGLARWQPDGDMG-VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPL 615 (678)
Q Consensus 538 ~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 615 (678)
+|||+++........ ......++..|+|||++.+..++.++||||||+++|++++ |+.||....+. ++....
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~ 232 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF------EMAAYL 232 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH------HHHHHH
Confidence 999999755332211 1112235667999999988889999999999999999999 99998643321 111100
Q ss_pred HHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 616 LKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 616 ~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
. . ......+..++..+.+++.+||+.||++||++.++++.|+...
T Consensus 233 ~------~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 233 K------D----GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred H------c----CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 0 0011112234457899999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.47 Aligned_cols=255 Identities=27% Similarity=0.392 Sum_probs=200.2
Q ss_pred cCCcccceecccCccceeeccCC-CC---cEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLP-DG---QVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~-~g---~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
..|++.+.||+|+||.||+|... ++ ..||+|.++... ......|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45888999999999999999853 23 369999886432 22235788999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.+++|.+++... ...+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~----g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988543 34588899999999999999999998 999999999999999999999999999875543
Q ss_pred CCccc-eeEEE---eeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 549 GDMGV-ETRVL---GTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 549 ~~~~~-~~~~~---Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
..... ..... .+..|+|||++.+..++.++||||||+++|||++ |..||...... ..... +..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~------~~~~~------i~~ 226 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------DVINA------IEQ 226 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH------HHHHH------HHc
Confidence 22111 11111 1457999999998999999999999999999886 99998643221 10000 001
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
. .....+..++..+.+++.+||+.+|.+||++.+++..|+..
T Consensus 227 ~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 D----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01112233455788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.97 Aligned_cols=257 Identities=27% Similarity=0.364 Sum_probs=198.6
Q ss_pred hcCCcccceecccCccceeeccCC-CCc--EEEEEeeehhc-ccCCccccccceeeecc-cccceEEEEeEEeeCCeEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLP-DGQ--VVAVKQYKLAS-SQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~--~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~L 467 (678)
.++|++.+.||+|+||.||+|.+. ++. .+|+|.++... ......+.+|+.++.++ +||||+++++++.+++..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457899999999999999999853 454 45777665322 22234678899999999 89999999999999999999
Q ss_pred EEEEeecCCcccccccCC--------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC
Q 038949 468 VYEYICNGSLDSHLYGRD--------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF 533 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~ 533 (678)
||||+.+++|.+++.... ...+++..++.++.||+.||+|||+. |++||||||+|||++.++
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEecCCC
Confidence 999999999999885332 23578888999999999999999998 999999999999999999
Q ss_pred ccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhh
Q 038949 534 EPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWA 612 (678)
Q Consensus 534 ~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 612 (678)
.++|+|||++...... .......++..|+|||++.+..++.++||||||+++|+|+| |..||...... +..
T Consensus 162 ~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~ 233 (303)
T cd05088 162 VAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELY 233 (303)
T ss_pred cEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHH
Confidence 9999999998632211 11111223567999999988889999999999999999998 99998543211 111
Q ss_pred HHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 613 RPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 613 ~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.. +.. ......+...+..+.+|+.+||+.+|++||++.++++.|+..+.
T Consensus 234 ~~------~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 234 EK------LPQ----GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HH------Hhc----CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 10 000 01111122234578899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.55 Aligned_cols=241 Identities=21% Similarity=0.272 Sum_probs=192.4
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeeccc-ccceEEEEeEEeeCCeEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~LV~ 469 (678)
+|...+.||+|+||.||+|.. .+++.||+|++.... ......+..|..++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999984 578999999987432 222245677888887775 578889999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+|+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRR----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999884 345689999999999999999999998 9999999999999999999999999998753322
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||....+. ....... ..
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~---------~~-- 216 (323)
T cd05615 155 G-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIM---------EH-- 216 (323)
T ss_pred C-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHH---------hC--
Confidence 1 1223456899999999999989999999999999999999999999654321 0000000 00
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRM 659 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~ 659 (678)
...++...+..+.+++.+||+.||.+|++.
T Consensus 217 ~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 217 NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 011223344578899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=308.69 Aligned_cols=248 Identities=27% Similarity=0.466 Sum_probs=199.4
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCC---------ccccccceeeecccccceEEEEeEEeeCCe
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGD---------QEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~---------~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
+|.+...||.|+||.||+|.. .+++.+|+|.+........ +.+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 578889999999999999984 4688999998864433221 457789999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~----~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNR----GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhc----CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999943 35688889999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCc-----cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHh
Q 038949 545 WQPDGDM-----GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH 619 (678)
Q Consensus 545 ~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 619 (678)
....... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~----~~~--- 222 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----Q----AIF--- 222 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----H----HHH---
Confidence 6542111 1112345788999999999888999999999999999999999999643210 0 000
Q ss_pred hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 ~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.......+ ..+...+..+.++|.+||+.||.+||++.++++
T Consensus 223 ~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 KIGENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHhccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 01111111 122334557899999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.69 Aligned_cols=266 Identities=27% Similarity=0.428 Sum_probs=218.2
Q ss_pred hhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCC-ccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~-~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
.+.++.+..+.+.||+|-||.|.+++...+.+||+|.++....... .+|..|+++|.+|+||||++++|+|..++.+++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 3677888999999999999999999987789999999986554444 789999999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
|+||+++|+|.+++....-..+.......++.||+.|++||.+. ++|||||.++|+|++.++++||+|||+++-..
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~----nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL----NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh----chhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999999665434345566678999999999999998 99999999999999999999999999999665
Q ss_pred CCCcc-ceeEEEeeecccccccccccccceecceeeeeeEEEEeee--CCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 548 DGDMG-VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT--GRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 548 ~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt--G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
.+++. ...+.+-+.+|||||.+..++++.++|+|+||++|||+++ ...||....... ..+ ...++
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vve---------n~~~~ 756 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVE---------NAGEF 756 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHH---------hhhhh
Confidence 55543 3445667889999999999999999999999999999875 667775432210 001 11222
Q ss_pred cCcc---hhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 625 IDPR---LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 625 ld~~---l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
++.. .....|.-++..+++++.+||+.|-.+||+++++...|..+.
T Consensus 757 ~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 757 FRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred cCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 2211 112234557788999999999999999999999999887653
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=308.09 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=204.5
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
.++|.+.+.||.|+||.||+|.. .+++.+++|.+..........+.+|+.+++.++||||+++++++.....+|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 46899999999999999999985 46789999999865555557788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|.+++... ...+++..+..++.|++.||.|||+. ||+|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET----GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC----CceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 9999999988443 25688999999999999999999998 99999999999999999999999999997553321
Q ss_pred cceeEEEeeeccccccccccc---ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 552 GVETRVLGTFGYLAPEYAQSG---QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.......++..|+|||.+... .++.++|+||||+++|+|++|..||....+.... . .... .....+.
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~--~-----~~~~---~~~~~~~ 225 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL--F-----LISK---SNFPPPK 225 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--H-----HHHh---ccCCCcc
Confidence 122335678899999999776 7899999999999999999999998654321110 0 0000 0000111
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.......+..+.+++.+||..+|.+||++.+++.
T Consensus 226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 --LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1122334557899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.62 Aligned_cols=260 Identities=24% Similarity=0.319 Sum_probs=203.6
Q ss_pred hhhcCCcccceecccCccceeeccCCC----CcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLPD----GQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
+...+|.+.+.||+|+||.||+|.+.+ ...||+|...... ....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 345678999999999999999998432 3468999876443 2334578899999999999999999999875 567
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||+++|+|.+++... ...+++..++.++.|++.||.|||+. |++||||||+|||++.++.++|+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 82 WIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK----RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccChheEEEecCCCeEEccCceeee
Confidence 8999999999999999543 23589999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
.............++..|+|||.+....++.++||||||+++|+|++ |..||....... ..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~------~~~ 224 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND------VIGRI------ENG 224 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHH------HcC
Confidence 54332222222234567999999988889999999999999999886 999986443210 00000 000
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
. ....+..++..+.+++.+||..+|.+||++.++++.|++....
T Consensus 225 ~----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 225 E----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred C----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 0112234456799999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.49 Aligned_cols=247 Identities=29% Similarity=0.424 Sum_probs=199.3
Q ss_pred cCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEee
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYIC 473 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ 473 (678)
++|.+.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.+++.++||||+++++++..+ ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5789999999999999999975 67789999886432 235688899999999999999999998764 4799999999
Q ss_pred cCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccc
Q 038949 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553 (678)
Q Consensus 474 ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 553 (678)
+++|.+++.......+++..++.++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK----KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999999665555688889999999999999999998 99999999999999999999999999987543221
Q ss_pred eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
.....+..|+|||++.++.++.++|+||||+++|+|++ |+.||...... +.... .. ......
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~-~~---------~~~~~~ 217 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKEC-VE---------KGYRME 217 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHH-Hh---------CCCCCC
Confidence 11223567999999998899999999999999999997 99998643321 11110 00 011111
Q ss_pred cchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
.+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 123345578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=325.02 Aligned_cols=263 Identities=24% Similarity=0.292 Sum_probs=194.8
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeCC----
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG---- 463 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~---- 463 (678)
...++|++.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3458999999999999999999984 568999999986432 223356778999999999999999999986543
Q ss_pred --eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 464 --RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 464 --~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.++|+|||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEecCC
Confidence 57999999954 5665552 2377888899999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccch---------hhhhh
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC---------LTEWA 612 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~---------l~~~~ 612 (678)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ...+.
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 99754322 12233568999999999999999999999999999999999999997543211000 00000
Q ss_pred HHH---HHH----h-h-----hhcccCcch---hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 613 RPL---LKR----H-A-----IGELIDPRL---RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 613 ~~~---~~~----~-~-----~~elld~~l---~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... ... . . ..+...... ...........+.+||.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000 0 0 000000000 00011112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=311.99 Aligned_cols=264 Identities=24% Similarity=0.296 Sum_probs=202.3
Q ss_pred hcCCcccceecccCccceeecc-CCCCcEEEEEeeehhccc--CCccccccceeeecccccc-eEEEEeEEeeCC-----
Q 038949 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRN-VVMLIGFCVEDG----- 463 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~~~~~----- 463 (678)
...|...+.||+|.||.||+|+ ..+|+.||+|.++....+ ......+|+.+|+.++|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4567778889999999999999 568899999999866542 3456789999999999999 999999998877
Q ss_pred -eEEEEEEEeecCCcccccccCCC--CccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 464 -RRLLVYEYICNGSLDSHLYGRDR--DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 464 -~~~LV~E~~~ggsL~~~l~~~~~--~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
.+++||||+ .-+|..++..... ..++...++.++.||+.||+|||++ +|+||||||.||||+.+|.+||+||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~----~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH----GILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCcceEEECCCCcEeeecc
Confidence 799999998 6699998855442 3577788999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHh
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH 619 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 619 (678)
|+|+...-+. ...+..++|.+|.|||++.+. .|+...||||+|||++||+++++-|....+..+..... + .+...
T Consensus 165 GlAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If--~-~lGtP 240 (323)
T KOG0594|consen 165 GLARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIF--R-LLGTP 240 (323)
T ss_pred chHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHH--H-HcCCC
Confidence 9998654222 224556789999999999876 79999999999999999999998887654422211100 0 00000
Q ss_pred ------hhhccc--Ccchhc-----ccchh---hhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 620 ------AIGELI--DPRLRN-----CYSER---EVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 620 ------~~~ell--d~~l~~-----~~~~~---~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.+..+. +..+.. .+... ......+++.+||+.+|.+|.++..+|+.
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000000 000000 01111 11367789999999999999999999874
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=308.95 Aligned_cols=248 Identities=28% Similarity=0.394 Sum_probs=197.2
Q ss_pred ceecccCccceeeccCC--CC--cEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVLP--DG--QVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~--~g--~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|++|.||+|.+. ++ ..||+|.+..... .....+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 36899999999999853 23 3699999875544 344678899999999999999999999988 889999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc--c
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM--G 552 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~--~ 552 (678)
++|.+++.......+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK----RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC----CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 9999998654435689999999999999999999999 999999999999999999999999999986543221 1
Q ss_pred ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 553 VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
......++..|+|||++.+..++.++||||||+++|+|++ |..||...... +....... ... ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~---~~~------~~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDK---EGE------RL 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHh---cCC------cC
Confidence 1112346778999999998899999999999999999998 99998643221 11111000 000 01
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 112234457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=307.97 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=200.3
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEee-CCeEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE-DGRRLLVYE 470 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-~~~~~LV~E 470 (678)
+|++.+.||.|++|.||++.. .+++.||+|.+..... .....+.+|+++++.++|+|++++++.+.. +..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 588999999999999999984 4678999999864332 223467889999999999999999998764 446899999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+++++|.+++.......+++..++.++.+++.||.+||+. |++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~----~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK----HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999665556689999999999999999999999 99999999999999999999999999997653322
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
.......+++.|+|||++.+..++.++|+||||+++|+|++|+.||..... ........ ...+
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~-----~~~~----- 219 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRII-----EGKL----- 219 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHH-----hcCC-----
Confidence 223345688999999999999999999999999999999999999864321 11111100 0111
Q ss_pred cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+...+..+.+++.+||+.||++||++.++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1122334457899999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=309.98 Aligned_cols=250 Identities=27% Similarity=0.446 Sum_probs=199.7
Q ss_pred CCcccceecccCccceeeccCCCCcEEEEEeeehhccc------CCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ------GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~------~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
+|...+.||.|+||.||+|...+++.+|+|.+...... ....+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47888999999999999998778899999988643221 124578899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.+++|.+++.. ..++++..+..++.|++.||+|||+. ||+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999843 34688999999999999999999998 999999999999999999999999999875422
Q ss_pred CC-----ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 549 GD-----MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 549 ~~-----~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
.. ........|+..|+|||++.+..++.++|+||||+++|+|++|..||....... .. .... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~----~~~~-~~~ 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AM----FYIG-AHR 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HH----HHhh-hcc
Confidence 11 111223457889999999998889999999999999999999999996432111 00 0000 000
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+. .+......+.++|.+||+.+|++||++.++++
T Consensus 225 ~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GLMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01111 22234457899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=317.39 Aligned_cols=250 Identities=21% Similarity=0.330 Sum_probs=203.5
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
..+|.+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 47899999999999999999984 57899999998765555556788899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+++++|.+++.. ..+++..+..++.|++.||.|||+. |++||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~----~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~- 169 (297)
T cd06656 98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (297)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEECcCccceEccCCc-
Confidence 999999998842 3478889999999999999999998 99999999999999999999999999987543322
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....+...... . . .......
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~--~----------~--~~~~~~~ 235 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--I----------A--TNGTPEL 235 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--e----------c--cCCCCCC
Confidence 122334688899999999988899999999999999999999999965433111000 0 0 0000001
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+...+..+.+++.+||+.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112233456789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=311.17 Aligned_cols=262 Identities=25% Similarity=0.333 Sum_probs=202.6
Q ss_pred eehhhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEe-
Q 038949 384 FTYAELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCV- 460 (678)
Q Consensus 384 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~- 460 (678)
..+..+....++|++.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 34556677889999999999999999999984 568899999876322 2235677899999998 6999999999874
Q ss_pred ----eCCeEEEEEEEeecCCccccccc--CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc
Q 038949 461 ----EDGRRLLVYEYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE 534 (678)
Q Consensus 461 ----~~~~~~LV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~ 534 (678)
.+...++||||+++++|.+++.. .....+++..++.++.|++.||.|||+. +++||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN----KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC----CccccCCCHHhEEECCCCC
Confidence 34578999999999999987742 2334688888999999999999999998 9999999999999999999
Q ss_pred cccccccccccccCCCccceeEEEeeecccccccccc-----cccceecceeeeeeEEEEeeeCCccccccCCcccchhh
Q 038949 535 PLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS-----GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT 609 (678)
Q Consensus 535 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~ 609 (678)
++|+|||++....... .......|++.|+|||++.. ..++.++|||||||++|+|++|..||....+... +
T Consensus 163 ~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~- 238 (286)
T cd06638 163 VKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--L- 238 (286)
T ss_pred EEEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--H-
Confidence 9999999987653322 12233468999999998853 4578899999999999999999999864432110 0
Q ss_pred hhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 610 EWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 610 ~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.. ......+. ...+......+.+++.+||+.||++||++.|+++.
T Consensus 239 ------~~---~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 239 ------FK---IPRNPPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ------hh---ccccCCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00 00000000 01112234468899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=307.64 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=204.2
Q ss_pred CCcccceecccCccceeecc-CCCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+|+..+.||.|+||.||.+. ..+++.+++|.+.... ......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58899999999999999988 4578899999886443 23335688999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|.+++.......+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA----GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999999655456689999999999999999999998 999999999999999999999999999976543321
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... +...... .....+
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-----~~~~~~---- 220 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIV-----QGNYTP---- 220 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-----cCCCCC----
Confidence 223456889999999998888899999999999999999999998643221 1111100 000111
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHHHh
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~L 666 (678)
.+...+..+.+++.+||+.+|.+||++.++++.+
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 -VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1133445788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.23 Aligned_cols=264 Identities=25% Similarity=0.351 Sum_probs=200.5
Q ss_pred hhhhhcCCcccceecccCccceeeccC------CCCcEEEEEeeehhcc-cCCccccccceeeecc-cccceEEEEeEEe
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCA-QHRNVVMLIGFCV 460 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~ 460 (678)
|+...++|++.+.||+|+||.||+|.+ .+++.||||+++.... .....+.+|+.++..+ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 345678999999999999999999962 3578999999874322 2234678899999999 6899999999876
Q ss_pred e-CCeEEEEEEEeecCCcccccccCC------------------------------------------------------
Q 038949 461 E-DGRRLLVYEYICNGSLDSHLYGRD------------------------------------------------------ 485 (678)
Q Consensus 461 ~-~~~~~LV~E~~~ggsL~~~l~~~~------------------------------------------------------ 485 (678)
. +...++||||+.+|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 5 456789999999999998874321
Q ss_pred -----------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc-cc
Q 038949 486 -----------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM-GV 553 (678)
Q Consensus 486 -----------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~ 553 (678)
...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.++|+|||++........ ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence 12356677788999999999999998 999999999999999999999999999975432211 11
Q ss_pred eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... .... ..... ... .
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~-~~~~~-----~~~----~ 302 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCR-RLKEG-----TRM----R 302 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-----HHHH-HHhcc-----CCC----C
Confidence 122335677999999988899999999999999999996 888885432110 0000 00000 000 1
Q ss_pred cchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.+......+.+++.+||+.||++||++.+|++.|+..+.
T Consensus 303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111223468899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=308.40 Aligned_cols=247 Identities=30% Similarity=0.393 Sum_probs=194.4
Q ss_pred ceecccCccceeeccCC--C--CcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVLP--D--GQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~--~--g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|.+. + +..+|+|.+...... ....+.+|+.+++.+.||||+++++++. ....++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999732 2 368999998744432 3356888999999999999999999876 4568999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|.+++... ..+++..+..++.|++.||.|||.. +++|+||||+|||++.++.++|+|||+++..........
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESK----HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhc----CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999999543 3689999999999999999999998 999999999999999999999999999986543322111
Q ss_pred --eEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 555 --TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 555 --~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +..... .. ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~------~~~~~~-~~---------~~~~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA------EVIAML-ES---------GERL 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH------HHHHHH-Hc---------CCcC
Confidence 11123467999999998899999999999999999998 99998654321 110000 00 0011
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
..+..++..+.++|.+||..+|.+||++.++++.|++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 12233455789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=316.66 Aligned_cols=250 Identities=20% Similarity=0.348 Sum_probs=202.9
Q ss_pred hcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
..+|++.+.||.|+||.||+|. ..+++.||+|.+..........+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 3579999999999999999998 457899999998765544556788899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|..++.. ..+++..+..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~----~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN----QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999998832 3589999999999999999999999 999999999999999999999999999875433221
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
......+++.|+|||.+.+..++.++|+|||||++|+|++|..||....+.... .. ..... .+. .
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~-~~~~~-----~~~--~ 235 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YL-IATNG-----TPE--L 235 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHhcC-----Ccc--c
Confidence 122345788999999999888999999999999999999999999654331110 00 00000 000 0
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+...+..+.++|.+||..||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 112233457889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=307.23 Aligned_cols=251 Identities=30% Similarity=0.434 Sum_probs=200.1
Q ss_pred CcccceecccCccceeeccCCC-----CcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 396 FSEANFLAEGGFGSVHRGVLPD-----GQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
|.+.+.||.|+||.||++.+.. +..||+|.++..... ....+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4577889999999999998532 488999998754433 3457889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++.......+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~----~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC----CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999998554433389999999999999999999999 9999999999999999999999999999766543
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.........+++.|+|||.+.+..++.++|+||||+++|+|++ |..||..... .... .......
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~----~~~~~~~----- 221 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVL----EYLKKGY----- 221 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHH----HHHhcCC-----
Confidence 2222212236789999999988889999999999999999998 7888754211 0111 1000000
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHh
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~L 666 (678)
....+...+..+.+++.+||..||++|||+.++++.|
T Consensus 222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111222455789999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=313.12 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=202.4
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
.++|.+.+.||.|+||.||++.+ .+++.+|+|.+..........+.+|+++++.++||||+++++++..+...|+||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 46799999999999999999985 46889999998765544456788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|.+++... ...+++..++.++.|++.||.|||+. ||+|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSH----KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 9999999988443 34589999999999999999999999 99999999999999999999999999987543222
Q ss_pred cceeEEEeeeccccccccc-----ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 552 GVETRVLGTFGYLAPEYAQ-----SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.......+++.|+|||.+. ...++.++|+||||+++|+|++|..||....... ..... .....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~------~~~~~ 225 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKI------LKSEP 225 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHH------hcCCC
Confidence 2233456899999999875 3457789999999999999999999996543211 00000 00000
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+.+ ..+...+..+.+++.+||+.+|.+||++.++++
T Consensus 226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 111 112234457889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=317.34 Aligned_cols=196 Identities=24% Similarity=0.367 Sum_probs=159.1
Q ss_pred cceecccCccceeeccCC---CCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEee--CCeEEEEEEEee
Q 038949 399 ANFLAEGGFGSVHRGVLP---DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE--DGRRLLVYEYIC 473 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~---~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~~~LV~E~~~ 473 (678)
.+.||+|+||.||+|... +++.||+|.+... .....+.+|+.+++.++||||+++++++.. +...|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~- 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA- 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence 357999999999999843 5678999988633 223457889999999999999999998854 45689999998
Q ss_pred cCCcccccccC-------CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe----eecCccccccccc
Q 038949 474 NGSLDSHLYGR-------DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV----THDFEPLVGDFGL 542 (678)
Q Consensus 474 ggsL~~~l~~~-------~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl----~~~~~vkL~DFGl 542 (678)
+++|.+++... ....+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 55777766321 123588888999999999999999999 99999999999999 4568999999999
Q ss_pred cccccCCC--ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccC
Q 038949 543 ARWQPDGD--MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNR 601 (678)
Q Consensus 543 a~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~ 601 (678)
++...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 98654321 112234578999999999876 458999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=310.92 Aligned_cols=263 Identities=22% Similarity=0.313 Sum_probs=196.0
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+|++.+.||+|++|.||+|.. .+++.||+|.++..... ....+.+|+.+++.++||||+++++++.++...|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 478889999999999999985 47899999998643322 234678899999999999999999999999999999999
Q ss_pred eecCCcccccccCC-CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 472 ICNGSLDSHLYGRD-RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 472 ~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
+. ++|.+++.... ...+++..++.++.||+.||.|||+. ||+||||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR----RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 96 68888774432 35689999999999999999999999 99999999999999999999999999997543221
Q ss_pred ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccch----------hhhhhHHH-HH-
Q 038949 551 MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC----------LTEWARPL-LK- 617 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~----------l~~~~~~~-~~- 617 (678)
.......+++.|+|||++.+ ..++.++||||||+++|+|+||+.||.......... ...|.... ..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 12223356889999998865 457889999999999999999999996543211000 00000000 00
Q ss_pred -HhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 618 -RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 618 -~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
............ .......+..+.++|.+||+.||.+|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 0011123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=306.50 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=197.2
Q ss_pred ceecccCccceeeccCCCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCcc
Q 038949 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLD 478 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~ 478 (678)
++||+|+||.||++...+++.||+|.+...... ....+.+|+++++.+.|+||+++++++.+....++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999766999999988654333 3357889999999999999999999999999999999999999999
Q ss_pred cccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce-eEE
Q 038949 479 SHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE-TRV 557 (678)
Q Consensus 479 ~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~~ 557 (678)
+++... ...+++..+..++.+++.||.|||++ +++||||+|+|||++.++.++|+|||++........... ...
T Consensus 81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998543 33578888899999999999999999 999999999999999999999999999975432221111 112
Q ss_pred EeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchh
Q 038949 558 LGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSER 636 (678)
Q Consensus 558 ~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~ 636 (678)
.++..|+|||.+.++.++.++|+||||+++|+|++ |..||....... .... + ........+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~------~~~~------~----~~~~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRER------I----ESGYRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH------HHHH------H----hcCCCCCCCcc
Confidence 23567999999998899999999999999999999 788885433210 0000 0 00111112233
Q ss_pred hhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 637 EVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 637 ~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
.+..+.+++.+||+.+|.+||++.++++.|++
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 45579999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=312.59 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=202.2
Q ss_pred ehhhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEee-
Q 038949 385 TYAELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVE- 461 (678)
Q Consensus 385 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~- 461 (678)
+..++....+.|++.+.||.|+||.||+|.. .+++.+|+|++.... .....+..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3344555678999999999999999999994 578899999886433 2234677888888888 69999999999853
Q ss_pred -----CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccc
Q 038949 462 -----DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL 536 (678)
Q Consensus 462 -----~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vk 536 (678)
...+|++|||+.+|+|.+++.......+++..+..++.||+.||.|||+. ||+|+||+|+||+++.++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH----KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEE
Confidence 45789999999999999998655555688888899999999999999998 999999999999999999999
Q ss_pred cccccccccccCCCccceeEEEeeeccccccccc-----ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhh
Q 038949 537 VGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQ-----SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEW 611 (678)
Q Consensus 537 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~ 611 (678)
|+|||++....... .......|++.|+|||.+. ...++.++|+||||+++|+|++|..||....+....
T Consensus 162 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----- 235 (282)
T cd06636 162 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----- 235 (282)
T ss_pred EeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence 99999987543211 1223456889999999875 346788999999999999999999999643321110
Q ss_pred hHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 612 ARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 612 ~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. .+.....+. ......+..+.++|.+||+.||.+||++.++++
T Consensus 236 ----~---~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 ----F---LIPRNPPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----h---hHhhCCCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000100111 111234457999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=328.84 Aligned_cols=261 Identities=20% Similarity=0.213 Sum_probs=198.4
Q ss_pred hhcCCcccceecccCccceeeccC---CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL---PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~---~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
...+|.+.+.||+|+||.||++.. ..+..||+|.+... ..+.+|+++|+.++||||+++++++......|+|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 456899999999999999999863 34678999987532 3456899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
||++ +++|.+++ .....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++....
T Consensus 165 ~e~~-~~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH~~----givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKY-KCDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLHGR----GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhc-CCCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9998 56888888 3445689999999999999999999999 999999999999999999999999999975543
Q ss_pred CCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCccc-chhhhhhHHHHHH--------
Q 038949 549 GDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQ-QCLTEWARPLLKR-------- 618 (678)
Q Consensus 549 ~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~-~~l~~~~~~~~~~-------- 618 (678)
... .......||+.|+|||++....++.++|||||||++|+|++|+.||........ ..+......+...
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 322 122345799999999999999999999999999999999999999965433211 1111110000000
Q ss_pred -----hhhhcccCcchhcccc-------hhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 619 -----HAIGELIDPRLRNCYS-------EREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 619 -----~~~~elld~~l~~~~~-------~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
..+.. +....+..+. ......+.++|.+||..||++||++.++|..
T Consensus 318 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQ-YAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHh-hcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 0000000000 1123467889999999999999999999853
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=311.23 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=201.6
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
++|++.+.||.|++|.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 4788999999999999999984 478999999987543 22234678899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|.+++... ++++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE----GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999998432 689999999999999999999998 99999999999999999999999999997664332
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
.......+++.|+|||++.+..++.++||||||+++|+|+||..||....+.. ... .+.....+.+..
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~------~~~~~~~~~~~~ 220 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLF------LIPKNNPPSLEG 220 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHH------HhhhcCCCCCcc
Confidence 22234567889999999998889999999999999999999999996543211 000 001111111111
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. ..+..+.+++.+||..+|++||+++++++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1 03447889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.00 Aligned_cols=264 Identities=27% Similarity=0.359 Sum_probs=199.2
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
++|++.+.||+|+||.||++.+ .++..+|+|.++.... .....+.+|++++++++||||++++++|.+++.+++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4689999999999999999984 4688899998864322 2224588899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 999999999843 356889999999999999999999732 89999999999999999999999999987543221
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHH--------------
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK-------------- 617 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~-------------- 617 (678)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|..||....................
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence 2335688999999999888899999999999999999999999854321110000000000000
Q ss_pred ---HhhhhcccCcch---hcccc-hhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 618 ---RHAIGELIDPRL---RNCYS-EREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 618 ---~~~~~elld~~l---~~~~~-~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.....+..+... ....+ ......+.+++.+||..||++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 00001 1134468899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=315.47 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=200.8
Q ss_pred hhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
..++|++.+.||+|+||.||++... ++..||+|++..... .....+.+|+.+++.++||||+++++++.++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4578999999999999999999742 467899998864322 223568889999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccCC--------------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCC
Q 038949 465 RLLVYEYICNGSLDSHLYGRD--------------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRP 524 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~--------------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp 524 (678)
.++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+. |++||||||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~----~i~H~dl~p 158 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER----KFVHRDLAT 158 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CeecccccH
Confidence 999999999999999985321 12467778899999999999999998 999999999
Q ss_pred CceEeeecCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCC
Q 038949 525 NNILVTHDFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRP 602 (678)
Q Consensus 525 ~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~ 602 (678)
+|||++.++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999875432211 11112234567999999998899999999999999999997 8778753221
Q ss_pred cccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 603 RGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 603 ~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
.+.... ... ... ...+...+..+.+++.+||+.||.+||++.|+++.|+.
T Consensus 239 ------~~~~~~-~~~---~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ------EEVIYY-VRD---GNV------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHH-Hhc---CCC------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111110 000 000 01122345579999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=305.34 Aligned_cols=267 Identities=25% Similarity=0.321 Sum_probs=213.1
Q ss_pred hhhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCC----
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG---- 463 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~---- 463 (678)
+-+..+||++.+.||+|||+.||+++ ..++..||+|++.....++.+..++|++..++++|||+++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 45677899999999999999999999 5688999999998777677788999999999999999999998865433
Q ss_pred -eEEEEEEEeecCCcccccccCC--CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 464 -RRLLVYEYICNGSLDSHLYGRD--RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 464 -~~~LV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
..||+++|...|+|.+.+.... ...+++.+++.|+.+|++||.+||+.-+ .+.||||||.|||+.+++.++|.||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~--~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP--PYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC--cccccCCCcceeEecCCCceEEEec
Confidence 4899999999999999995543 3468999999999999999999999822 3999999999999999999999999
Q ss_pred cccccccCCC--------ccceeEEEeeecccccccccc---cccceecceeeeeeEEEEeeeCCccccccCCcccchhh
Q 038949 541 GLARWQPDGD--------MGVETRVLGTFGYLAPEYAQS---GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT 609 (678)
Q Consensus 541 Gla~~~~~~~--------~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~ 609 (678)
|.++...-.- ......-..|..|.|||.+.- ...+.++|||||||+||.|+.|..||+..-..+...-
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla- 252 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA- 252 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-
Confidence 9997432110 011112235788999999863 4578999999999999999999999975433222110
Q ss_pred hhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 610 EWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 610 ~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
-.+..+.+...-....++.+.++|.+||+.||.+||++.+++..++.++
T Consensus 253 ------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 ------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111222322233346678999999999999999999999999988654
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=313.18 Aligned_cols=258 Identities=25% Similarity=0.359 Sum_probs=200.0
Q ss_pred hhcCCcccceecccCccceeeccC-CCCc----EEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQ----VVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~----~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
...+|++.+.||+|+||.||+|.+ .+++ .||+|.++.... .....+.+|+.++..+.||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 346789999999999999999984 3444 489998864322 223567889999999999999999999875 457
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
+++|||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++.
T Consensus 84 ~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~----~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEV----RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceEEEcCCCcEEECCCCceee
Confidence 8999999999999998543 34588999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCccc-eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 546 QPDGDMGV-ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 546 ~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
........ .....+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ..+..+ ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~----~~~----- 226 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDL----LEK----- 226 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHC-----
Confidence 54322111 111234678999999998899999999999999999998 8889864321 001110 110
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
......+...+..+.+++.+||+.||++||++.++++.|+....
T Consensus 227 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 227 ----GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ----CCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 00111122345578899999999999999999999999886643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=308.91 Aligned_cols=256 Identities=25% Similarity=0.330 Sum_probs=200.5
Q ss_pred hhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
++..++.+.....||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 345566666777899999999999984 4678899998875554555678899999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCcc--CccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-cCccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPL--EWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-DFEPLVGDFGLAR 544 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l--~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-~~~vkL~DFGla~ 544 (678)
||||+.+++|.+++.... ..+ ++..+..++.||+.||.|||+. ||+||||||+||+++. ++.++|+|||++.
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999999985432 234 7778888999999999999998 9999999999999986 6799999999987
Q ss_pred cccCCCccceeEEEeeecccccccccccc--cceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQ--ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
....... ......|++.|+|||++.... ++.++|+||||+++|+|++|+.||........ ..+... ..
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~------~~ 227 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVG------MF 227 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhh------hh
Confidence 5533221 122345788999999986643 78899999999999999999999864322110 001000 00
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.....++......+.+++.+||+.+|.+||++.++++
T Consensus 228 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 -----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0111223334557889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.60 Aligned_cols=192 Identities=25% Similarity=0.314 Sum_probs=164.3
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
...+|.+.+.||+|+||.||+|.. .+++.||+|+... .....|+.+++.++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 345799999999999999999995 4678899997432 234568999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
++ .++|.+++... ..++++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++.....
T Consensus 138 ~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ----RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred cc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 98 56888887443 34689999999999999999999999 9999999999999999999999999999743222
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccc
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAM 597 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf 597 (678)
.......||+.|+|||++.+..++.++|||||||++|+|+++..++
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999999999999999999999999866554
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=320.99 Aligned_cols=264 Identities=29% Similarity=0.383 Sum_probs=205.0
Q ss_pred hhhhhhcCCcccceecccCccceeeccCC--------CCcEEEEEeeehhcc-cCCccccccceeeecc-cccceEEEEe
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVLP--------DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCA-QHRNVVMLIG 457 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L-~HpnIv~l~~ 457 (678)
++++...+|.+.+.||+|+||.||++... +...||+|.++.... .....+.+|+++++++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 35677788999999999999999999631 123689998764322 2235788899999999 7999999999
Q ss_pred EEeeCCeEEEEEEEeecCCcccccccCC--------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCC
Q 038949 458 FCVEDGRRLLVYEYICNGSLDSHLYGRD--------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMR 523 (678)
Q Consensus 458 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLK 523 (678)
+|...+..+++|||+.+|+|.+++.... ...+++..+..++.|++.||.|||++ ||+|||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----givH~dlk 161 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ----KCIHRDLA 161 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----Ceeccccc
Confidence 9999999999999999999999985432 22466777888999999999999998 99999999
Q ss_pred CCceEeeecCccccccccccccccCCCcc-ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccC
Q 038949 524 PNNILVTHDFEPLVGDFGLARWQPDGDMG-VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNR 601 (678)
Q Consensus 524 p~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~ 601 (678)
|+|||++.++.++|+|||+++........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999755432211 1112233567999999999999999999999999999998 888885432
Q ss_pred CcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 602 PRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 602 ~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
. .++.... .. ......+...+..+.+++.+||+.+|.+||++.++++.|+..+.
T Consensus 242 ~------~~~~~~~-~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 242 V------EELFKLL-KE---------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred H------HHHHHHH-Hc---------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1 1111111 00 01111223345578899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=306.36 Aligned_cols=247 Identities=27% Similarity=0.366 Sum_probs=199.6
Q ss_pred CCcccceecccCccceeeccCC-CCcEEEEEeeehhcc-----cCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASS-----QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~-----~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
+|+..+.||+|+||.||+|... +++.|++|.+..... +....+.+|+.+++.++|+||+++++++..+..+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5788899999999999999954 789999998864332 1235688899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 34588899999999999999999998 999999999999999999999999999876543
Q ss_pred CCccceeEEEeeecccccccccccc-cceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQ-ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
.. ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||....+.. . ........
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~---~~~~~~~~----- 218 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------A---VFKIGRSK----- 218 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------H---HHHHHhcc-----
Confidence 32 223456888999999987766 8999999999999999999999996543100 0 00000000
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.....+......+.+++.+||+.+|++||++.++++
T Consensus 219 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 219 -ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 011122334457889999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.46 Aligned_cols=244 Identities=27% Similarity=0.385 Sum_probs=203.0
Q ss_pred eecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCccc
Q 038949 401 FLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDS 479 (678)
Q Consensus 401 ~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~ 479 (678)
+||+|.||+||.|+. .+...+|||.+........+-+.+|+.+.+.|+|.|||+++|.|.+++.+-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 599999999999995 4567899999876666666788999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcc--CccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-cCccccccccccccccCCCccceeE
Q 038949 480 HLYGRDRDPL--EWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-DFEPLVGDFGLARWQPDGDMGVETR 556 (678)
Q Consensus 480 ~l~~~~~~~l--~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~ 556 (678)
++..+ =+++ ++...-.+..||++||.|||++ .|||||||-+|+||+. .|.+||+|||.++....-+ ....+
T Consensus 662 LLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen----~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TET 735 (1226)
T KOG4279|consen 662 LLRSK-WGPLKDNESTMNFYTKQILEGLKYLHEN----KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTET 735 (1226)
T ss_pred HHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhc----ceeeccccCCcEEEeeccceEEecccccchhhccCC-ccccc
Confidence 99543 3456 7888889999999999999999 9999999999999974 7999999999998765433 34456
Q ss_pred EEeeeccccccccccc--ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 557 VLGTFGYLAPEYAQSG--QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 557 ~~Gt~~Y~APE~l~~~--~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
+.||..|||||++..+ .|+.++|||||||++.||.||++||........ .+++-.. -.....+|
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGm------yKvHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGM------YKVHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcc------eecCCCCc
Confidence 7899999999999765 589999999999999999999999965432110 1111111 11223456
Q ss_pred hhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 635 EREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+.+.....+|.+|+.+||.+||++.++|+
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 677778999999999999999999999874
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=311.47 Aligned_cols=257 Identities=25% Similarity=0.340 Sum_probs=197.6
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCC-----eEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG-----RRLL 467 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~-----~~~L 467 (678)
-.|.-.+++|.|.||.||.|.. .+++.||||..... .+.-.+|+++|+.+.|||||+++-+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 3577788999999999999994 56799999987533 234457999999999999999998876522 3468
Q ss_pred EEEEeecCCccccccc--CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec-Cccccccccccc
Q 038949 468 VYEYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD-FEPLVGDFGLAR 544 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~-~~vkL~DFGla~ 544 (678)
||||++. +|..++.. +.+..++...++-+..||++||+|||+. ||+||||||.|+|+|.+ |.+||||||.|+
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~----~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH----GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc----CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 9999955 88888842 2356688899999999999999999998 99999999999999976 999999999999
Q ss_pred cccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHH---hh
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR---HA 620 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~~ 620 (678)
....+... ..+..+..|.|||.+.+ ..|+.+.||||.|||+.||+-|++.|...+...+ +.++.. ++.. ..
T Consensus 175 ~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik-~lG~Pt~e~ 249 (364)
T KOG0658|consen 175 VLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIK-VLGTPTRED 249 (364)
T ss_pred eeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHH-HhCCCCHHH
Confidence 87665533 66778999999998876 5799999999999999999999999976443222 222111 1110 00
Q ss_pred -------hhcccCcchhc-----ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 -------IGELIDPRLRN-----CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 -------~~elld~~l~~-----~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+.-.|.+.. .+....+.++.+|+.++|+.+|.+|.++.|++.
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 00111122211 133445567899999999999999999999873
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.44 Aligned_cols=257 Identities=27% Similarity=0.411 Sum_probs=202.9
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
..++|++.+.||+|+||.||++.. .+++.||+|++..... .....+.+|+++++.++||||+++++++.....+++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 346789999999999999999984 5688999998764332 23357889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++.. .+++++..+..++.+++.||.|||+.. +++||||+|+||+++.++.++|+|||++......
T Consensus 83 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 83 EFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred ecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999988843 456899999999999999999999731 8999999999999999999999999998644222
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccch-----hhhhhHHHHHHhhhhcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC-----LTEWARPLLKRHAIGEL 624 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~-----l~~~~~~~~~~~~~~el 624 (678)
......|+..|+|||++.++.++.++|+|||||++|+|++|..||.......... ..++..... ...
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 229 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-----QEP 229 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-----hcc
Confidence 1223568999999999988899999999999999999999999997544321100 001111100 000
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.+.+ .....+..+.+|+.+||+.||++||++.|+++.
T Consensus 230 -~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 230 -PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred -CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0111 011244578899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=311.50 Aligned_cols=252 Identities=31% Similarity=0.446 Sum_probs=197.4
Q ss_pred CcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCc--cccccceeeecccccceEEEEeEEeeCCeEEEEEEEe
Q 038949 396 FSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQ--EFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYI 472 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~--~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~ 472 (678)
|++.+.||+|+||.||++.. .+++.||+|.+......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 67889999999999999995 46779999999754433222 3345999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 552 (678)
.+++|.+++. ....+++..++.++.||+.||.+||+. ||+|+||||+||+++.++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~----~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK----GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNE 153 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT----TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTS
T ss_pred cccccccccc--ccccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccc-cccc
Confidence 9999999995 445689999999999999999999999 99999999999999999999999999997531 1122
Q ss_pred ceeEEEeeeccccccccc-ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 553 VETRVLGTFGYLAPEYAQ-SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
......++..|+|||++. +..++.++|+||||+++|+|++|..||........ ......... ...... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~----~~~~~~---~ 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ---LEIIEKILK----RPLPSS---S 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH---HHHHHHHHH----THHHHH---T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhh---hhhhhhccc----cccccc---c
Confidence 333456789999999998 88899999999999999999999999975411010 000000000 000000 0
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.........+.+++.+||+.||++||++.++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001111257999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.53 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=188.4
Q ss_pred ceecccCccceeeccCC---CCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecC
Q 038949 400 NFLAEGGFGSVHRGVLP---DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNG 475 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~---~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~gg 475 (678)
+.||+|+||.||+|.+. ++..+|+|.++..... ....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35999999999999743 3567999987644322 2246888999999999999999999999988999999999999
Q ss_pred CcccccccCC---CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc-
Q 038949 476 SLDSHLYGRD---RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM- 551 (678)
Q Consensus 476 sL~~~l~~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~- 551 (678)
+|.+++.... ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN----NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999985432 22356667788999999999999998 999999999999999999999999999975432221
Q ss_pred cceeEEEeeeccccccccccc-------ccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSG-------QITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~-------~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
.......++..|+|||++... .++.++|+||||+++|+|++ |..||....+... .. .........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~~~~~ 229 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LT----YTVREQQLK 229 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HH----HHhhcccCC
Confidence 112234567889999988642 35789999999999999996 9999964332110 00 000011111
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
..++.+. ......+.+++.+|| .+|++|||+++|++.|+
T Consensus 230 ~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1122221 123346788999998 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=309.45 Aligned_cols=249 Identities=28% Similarity=0.384 Sum_probs=192.2
Q ss_pred ceecccCccceeeccCC-CCc--EEEEEeeehhc-ccCCccccccceeeecc-cccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVLP-DGQ--VVAVKQYKLAS-SQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~-~g~--~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|... ++. .+++|.++... ......+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36999999999999853 443 56888776322 22335688899999999 799999999999999999999999999
Q ss_pred CCcccccccCC--------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 475 GSLDSHLYGRD--------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 475 gsL~~~l~~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
|+|.+++.... ...+++..+..++.|++.||+|||+. |++||||||+|||++.++.++|+||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccccceEEEcCCCeEEECCC
Confidence 99999885432 12478888899999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHh
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRH 619 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 619 (678)
|++...... ........+..|+|||++....++.++||||||+++|+|++ |..||...... ......
T Consensus 157 gl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~---- 224 (270)
T cd05047 157 GLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKL---- 224 (270)
T ss_pred CCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHH----
Confidence 998532211 11111223567999999988889999999999999999997 99998543210 000000
Q ss_pred hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 620 ~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
........+......+.+++.+||+.||.+||++.+++..|+..+
T Consensus 225 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 ------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ------hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000111112234457889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=315.00 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=197.5
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
++|.+.+.||+|+||.||+|.. .+++.||+|.++..... ....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5799999999999999999985 46889999998744322 234677899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+. ++|.+++... ...+++..+..++.|++.||.|||+. ||+|+||||+|||++.++.++|+|||++........
T Consensus 86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 95 6888887543 34588889999999999999999999 999999999999999999999999999975432221
Q ss_pred cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchh----------hhhhHHHHHHhh
Q 038949 552 GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCL----------TEWARPLLKRHA 620 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l----------~~~~~~~~~~~~ 620 (678)
......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||........... ..|.. ......
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 237 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG-ILSNEE 237 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh-hhcccc
Confidence 1223457889999998865 4578899999999999999999999965432111000 00000 000000
Q ss_pred hhcccCcchhc----ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 IGELIDPRLRN----CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ~~elld~~l~~----~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....-.+.... ......+..+.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000011000 011223456889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.52 Aligned_cols=240 Identities=22% Similarity=0.336 Sum_probs=187.4
Q ss_pred ceecccCccceeeccCCC-------------CcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 400 NFLAEGGFGSVHRGVLPD-------------GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~-------------g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
+.||+|+||.||+|.+.+ ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999997421 2358899877554444457888999999999999999999999989999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc-------ccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE-------PLVGD 539 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~-------vkL~D 539 (678)
+||||+.+|+|..++... ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDK----DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC----CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999998887433 34589999999999999999999999 9999999999999987664 89999
Q ss_pred ccccccccCCCccceeEEEeeeccccccccc-ccccceecceeeeeeEEEEee-eCCccccccCCcccchhhhhhHHHHH
Q 038949 540 FGLARWQPDGDMGVETRVLGTFGYLAPEYAQ-SGQITEKADVYSLGVVLVELI-TGRKAMDLNRPRGQQCLTEWARPLLK 617 (678)
Q Consensus 540 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSLGviL~eLl-tG~~Pf~~~~~~~~~~l~~~~~~~~~ 617 (678)
||++...... ....++..|+|||.+. +..++.++||||||+++|+|+ +|..||...... +... ..
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~-~~- 222 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------EKER-FY- 222 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh------HHHH-HH-
Confidence 9998644221 2345788899999886 467899999999999999997 588787532210 0000 00
Q ss_pred HhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 618 RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 618 ~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
... .. ........+.+||.+||+.||.+||++.+|++.|+
T Consensus 223 ~~~-~~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQ-CM---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcC-cc---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 00 01112346889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=323.71 Aligned_cols=256 Identities=22% Similarity=0.363 Sum_probs=206.1
Q ss_pred hhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeeh--hcccCCccccccceeeeccc-ccceEEEEeEEeeCCeE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKL--ASSQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~--~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~ 465 (678)
+.+....|++++.||+||.+.||++...+.+.||+|.+.. ...+....|++|+..|.+|+ |.+|++||+|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 4556678999999999999999999987788899987643 33344467999999999994 99999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
||||||= ..+|..+|..+......| .++.+..||+.|+.++|.+ ||||.||||.|+|+-. |.+||+|||+|..
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~----gIVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH----GIVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh----ceeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 9999984 668988886655443334 7789999999999999999 9999999999999865 6999999999987
Q ss_pred ccCC-CccceeEEEeeeccccccccccc-----------ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH
Q 038949 546 QPDG-DMGVETRVLGTFGYLAPEYAQSG-----------QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 546 ~~~~-~~~~~~~~~Gt~~Y~APE~l~~~-----------~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~ 613 (678)
.... ........+||+.||+||.+... +.+.++||||||||||+|+.|+.||+.... .|
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~-- 579 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QI-- 579 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HH--
Confidence 6543 33455667899999999988432 256899999999999999999999964221 11
Q ss_pred HHHHHhhhhcccCcchhcccchhhhhh-hhhccceeeccCCCCCchHHHHHHH
Q 038949 614 PLLKRHAIGELIDPRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 614 ~~~~~~~~~elld~~l~~~~~~~~~~~-l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
..+..+.+|.-...|+..-... +.+++..||..||++||+..++|+.
T Consensus 580 -----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 -----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2234556665555555433333 8999999999999999999999863
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=305.09 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=202.3
Q ss_pred CCcccceecccCccceeecc-CCCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+|++.+.||+|+||.||++. ..+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 58899999999999999998 45788999999874422 2234788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|.+++.......+++..+..++.|++.||.|||+. |++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 9999999988655455688899999999999999999998 99999999999999999999999999997553322
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||..... .+...... .... .
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-----~~~~-----~ 219 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKII-----RGSY-----P 219 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHh-----cCCC-----C
Confidence 112234578899999999988899999999999999999999999864321 11111100 0000 1
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+......+.++|.+||+.+|.+||++.+|++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 122334557899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=324.94 Aligned_cols=264 Identities=22% Similarity=0.263 Sum_probs=195.5
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeC-----
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVED----- 462 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~----- 462 (678)
...++|++.+.||+|+||.||++.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3568999999999999999999984 4688999998864322 2235677899999999999999999988643
Q ss_pred -CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 463 -GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 463 -~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
...|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999954 6666552 2378888899999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchh---------hhhh
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCL---------TEWA 612 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l---------~~~~ 612 (678)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... .++.
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99754322 222345689999999999988999999999999999999999999964332110000 0000
Q ss_pred -------HHHHHH-hhhhcccCcch--------hcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 613 -------RPLLKR-HAIGELIDPRL--------RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 613 -------~~~~~~-~~~~elld~~l--------~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
...... .....+..+.. ...........+.+||.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000 00000000000 000111223467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.59 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=203.2
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
++|++.+.||.|+||.||+|.. .++..+|+|++..... .....+.+|+++++.++|+||+++++.+..+...++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4789999999999999999984 4688999999864332 2345788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCC-CccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 472 ICNGSLDSHLYGRDR-DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
+.+++|.+++..... ..+++..+..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~----~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN----GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999854332 5688999999999999999999998 99999999999999999999999999997654432
Q ss_pred cc---ceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 551 MG---VETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 551 ~~---~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.. ......|+..|+|||++... .++.++|+||||+++|+|++|..||....+... ... ... . ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~----~~~-----~-~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LML----TLQ-----N-DP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHH----Hhc-----C-CC
Confidence 21 22345688999999998876 789999999999999999999999965432110 000 000 0 01
Q ss_pred cchhccc-chhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 627 PRLRNCY-SEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 627 ~~l~~~~-~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+.+.... ....+..+.+++.+||+.||++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111100 1233457889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=315.89 Aligned_cols=252 Identities=22% Similarity=0.260 Sum_probs=201.3
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc---CCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+++++.++||||+++++.+.++...|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4788999999999999999985 45899999998754322 2346888999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++.......+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL----GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999998655556789999999999999999999998 9999999999999999999999999998644221
Q ss_pred Cc----------------------------cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccC
Q 038949 550 DM----------------------------GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNR 601 (678)
Q Consensus 550 ~~----------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~ 601 (678)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 10 01112467889999999998889999999999999999999999996443
Q ss_pred CcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCch----HHHHHH
Q 038949 602 PRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR----MSQVLR 664 (678)
Q Consensus 602 ~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT----~~eVL~ 664 (678)
... .+ ..+.............+..+.+++.+||..||++||+ +++++.
T Consensus 237 ~~~-----~~----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDE-----TF----------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHH-----HH----------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 210 00 0011111100011114567999999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.86 Aligned_cols=262 Identities=19% Similarity=0.268 Sum_probs=192.7
Q ss_pred ccceeccc--CccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEe
Q 038949 398 EANFLAEG--GFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYI 472 (678)
Q Consensus 398 ~~~~LG~G--~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~ 472 (678)
++++||+| +|+.||++.. .+|+.||+|.++.... .....+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 6789999984 6799999999875432 22245778999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc-
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM- 551 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~- 551 (678)
++|+|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999998654455689999999999999999999998 999999999999999999999999986543221110
Q ss_pred -----cceeEEEeeecccccccccc--cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH--------H
Q 038949 552 -----GVETRVLGTFGYLAPEYAQS--GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL--------L 616 (678)
Q Consensus 552 -----~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~--------~ 616 (678)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ......... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhcCCccccccccch
Confidence 01112346778999999976 4689999999999999999999999964321100 000000000 0
Q ss_pred HHhhhh-----cccC-----------------cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 617 KRHAIG-----ELID-----------------PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 617 ~~~~~~-----elld-----------------~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...... ...+ ......+.......+.+|+.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000000 0000 00000111223457889999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.10 Aligned_cols=254 Identities=28% Similarity=0.387 Sum_probs=199.8
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEeeCC-----
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDG----- 463 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~----- 463 (678)
...++|++.+.||+|++|.||+|.. .+++.+++|.+..... ....+.+|+.+++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 3468999999999999999999995 4678999999875432 235688999999998 6999999999997644
Q ss_pred -eEEEEEEEeecCCcccccccCC--CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 464 -RRLLVYEYICNGSLDSHLYGRD--RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 464 -~~~LV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
.+++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN----KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEEccCCeEEECCC
Confidence 4899999999999999885433 45789999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCccceeEEEeeecccccccccc-----cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQS-----GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 615 (678)
|++....... .......|+..|+|||++.. ..++.++||||||+++|+|++|..||....+... +.
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~------ 228 (275)
T cd06608 158 GVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LF------ 228 (275)
T ss_pred ccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HH------
Confidence 9987543321 22234568899999998753 3467899999999999999999999964322100 00
Q ss_pred HHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 LKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 ~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. +.....+.+ ..+......+.+++.+||..||++|||+.++++
T Consensus 229 -~---~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 -K---IPRNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -H---hhccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 001001111 112224557889999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=322.67 Aligned_cols=259 Identities=24% Similarity=0.316 Sum_probs=194.0
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeC-----
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVED----- 462 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~----- 462 (678)
...++|.+.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4568899999999999999999984 5788999998864321 2234577899999999999999999987543
Q ss_pred -CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 463 -GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 463 -~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
...|+++|++ +++|.+++. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSA----GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecccCChhhEEECCCCCEEEcCCc
Confidence 3578999987 889988773 34589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHH------
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP------ 614 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~------ 614 (678)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ +..+...
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 237 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVGTPSP 237 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCCH
Confidence 99755332 234568999999999876 5689999999999999999999999964321100 0000000
Q ss_pred -HHH---Hh---hhhc----ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 -LLK---RH---AIGE----LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 -~~~---~~---~~~e----lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... .. .... .....+...+ ......+.+|+.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00 0000 0000000000 012235779999999999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.48 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=201.7
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
..|+..+.||.|+||.||+|.+ .+++.||+|.+.... ......+.+|+.+++.+.||||+++++++.++...|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 4678889999999999999985 468899999987433 22335688899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|.+++.. .++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~----~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE----KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC----CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998842 4588888999999999999999998 999999999999999999999999999976543221
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
......++..|+|||++.+..++.++|+||||+++|+|++|..||....+.... ..+......
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~~~~~~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----------------FLIPKNNPP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----------------hhhhcCCCC
Confidence 222345788999999998888999999999999999999999998654321100 000011112
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
......+..+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2233455678899999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.95 Aligned_cols=264 Identities=23% Similarity=0.299 Sum_probs=198.1
Q ss_pred cCCcccceecccCccceeeccCC-CCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
++|++.+.||+|+||.||+|..+ +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47899999999999999999854 689999998864322 222457789999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|++++.|..++. ....+++..++.++.|++.||.|||+. |++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKH----NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988877763 334589999999999999999999998 99999999999999999999999999998654332
Q ss_pred ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhh-----hhhHHHHH---Hhhh
Q 038949 551 MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT-----EWARPLLK---RHAI 621 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~-----~~~~~~~~---~~~~ 621 (678)
. ......++..|+|||++.+ ..++.++|+||||+++|+|++|..||....+....... .+...... ....
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1 1223457888999999875 56789999999999999999999999654321110000 00000000 0000
Q ss_pred -hcccCcchhcc-----cchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 622 -GELIDPRLRNC-----YSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 622 -~elld~~l~~~-----~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.....+..... .....+..+.+|+.+||+.||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000000 01123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=311.19 Aligned_cols=194 Identities=25% Similarity=0.358 Sum_probs=157.7
Q ss_pred ceecccCccceeeccCC---CCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEee--CCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVLP---DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE--DGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~---~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~~~LV~E~~~g 474 (678)
..||+|+||.||+|... ++..||+|.+... .....+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 57999999999999843 4578999988633 223467889999999999999999998854 567899999985
Q ss_pred CCcccccccC-------CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe----eecCcccccccccc
Q 038949 475 GSLDSHLYGR-------DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV----THDFEPLVGDFGLA 543 (678)
Q Consensus 475 gsL~~~l~~~-------~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl----~~~~~vkL~DFGla 543 (678)
++|.+++... ....+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5776665311 223578888999999999999999999 99999999999999 45679999999999
Q ss_pred ccccCCCc--cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCcccccc
Q 038949 544 RWQPDGDM--GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLN 600 (678)
Q Consensus 544 ~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~ 600 (678)
+....... .......||+.|+|||++.+ ..++.++|||||||++|+|+||.+||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 86543221 12334578999999999876 45799999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.85 Aligned_cols=265 Identities=26% Similarity=0.366 Sum_probs=201.4
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
++|++.+.||+|+||.||+|.+ .+++.||+|.++.... .....+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4789999999999999999985 4688999998864332 233578899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.++.+..+.. ....+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSH----NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 998877765552 334588999999999999999999999 99999999999999999999999999998665433
Q ss_pred ccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhh-hhh----HHHHH----Hh-
Q 038949 551 MGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT-EWA----RPLLK----RH- 619 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~-~~~----~~~~~----~~- 619 (678)
........++..|+|||++.+. .++.++|+||||+++|+|++|..||............ ... ..... ..
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 2233445678899999999887 8899999999999999999999998643221100000 000 00000 00
Q ss_pred ----hhhcccCc-chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 ----AIGELIDP-RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 ----~~~elld~-~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+..++ .....++...+..+.++|.+||..+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 0011122233567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=328.92 Aligned_cols=261 Identities=23% Similarity=0.282 Sum_probs=195.3
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
...+|.+.+.||+|+||.||++.+ .+++.||||... ...+.+|+++|++++|+||+++++++..++..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 356899999999999999999995 468899999532 2346789999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
++ .++|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+||||+.++.++|+|||+++......
T Consensus 241 ~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGE----GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 98 57888887433 33689999999999999999999999 99999999999999999999999999997653321
Q ss_pred c-cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCcccc-ccCCcc-cchhhhhhHHHHHHhhh--hcc-
Q 038949 551 M-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMD-LNRPRG-QQCLTEWARPLLKRHAI--GEL- 624 (678)
Q Consensus 551 ~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~-~~~~~~-~~~l~~~~~~~~~~~~~--~el- 624 (678)
. .......||+.|+|||++.+..++.++|||||||+||||++|..++- ...... ..+.....+ .+..... .+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~-~i~~~~~~~~~~~ 393 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILR-IIRQAQVHVDEFP 393 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHH-HHHhhccccccCC
Confidence 1 12234569999999999999999999999999999999999876542 221111 111111111 1110000 000
Q ss_pred ------------------cCcc-hhcccc--hhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 625 ------------------IDPR-LRNCYS--EREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 625 ------------------ld~~-l~~~~~--~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
..+. ....+. ......+.+||.+||+.||.+|||+.|+|+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 000000 0122367889999999999999999999864
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.63 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=200.7
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+|+..+.||+|+||.||++.. .+++.+|+|.+..... .....+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999984 4788999999864322 2235688899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec-CccccccccccccccCCC
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD-FEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~-~~vkL~DFGla~~~~~~~ 550 (678)
+++++|.+++.......+++..+..++.+++.||.|||++ |++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK----LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999665556689999999999999999999998 99999999999999865 468999999998654332
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||...... ....... ... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~-----~~~-----~ 218 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIM-----SGT-----F 218 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHH-----hcC-----C
Confidence 122356788999999999888999999999999999999999998643321 1111000 000 0
Q ss_pred cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+...+..+.+++.+||+.||.+|||+.++++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1112234457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=311.33 Aligned_cols=264 Identities=26% Similarity=0.393 Sum_probs=198.4
Q ss_pred cCCcccceecccCccceeeccCC-CCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
++|++.+.||+|+||.||+|.+. +++.||+|.+...... ..+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47889999999999999999964 6899999987643222 23467889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+++|..+.. ....+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999988887763 234589999999999999999999998 99999999999999999999999999997654332
Q ss_pred ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccch-hhhhhH-------HHHHHhh-
Q 038949 551 MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC-LTEWAR-------PLLKRHA- 620 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~-l~~~~~-------~~~~~~~- 620 (678)
.......++..|+|||++.+ ..++.++||||||+++|+|++|.+||.......... +..+.. .......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 22233567889999998875 457889999999999999999999986433211000 000000 0000000
Q ss_pred hhcccCcchh-----cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 IGELIDPRLR-----NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ~~elld~~l~-----~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
......+... ....+..+..+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000 0011234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.96 Aligned_cols=263 Identities=21% Similarity=0.259 Sum_probs=194.8
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeC------
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED------ 462 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~------ 462 (678)
..++|.+.+.||+|+||.||++.. .+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999984 468899999986432 22235677899999999999999999987543
Q ss_pred CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
..+|+||||+. ++|.+++. ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 35799999995 46766662 2377888899999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchh---------hhhhH
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCL---------TEWAR 613 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l---------~~~~~ 613 (678)
++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... .++..
T Consensus 173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9754322 122345689999999999999999999999999999999999999965432110000 00000
Q ss_pred HH-------HHHh-hh-----hcccCcch---hcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 614 PL-------LKRH-AI-----GELIDPRL---RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 614 ~~-------~~~~-~~-----~elld~~l---~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.. .... .. ........ ...........+.+||.+||+.||++|||+.++|+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0000 00 00000000 000111123467899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.94 Aligned_cols=239 Identities=21% Similarity=0.351 Sum_probs=186.5
Q ss_pred eecccCccceeeccCCC-------------------------CcEEEEEeeehhcccCCccccccceeeecccccceEEE
Q 038949 401 FLAEGGFGSVHRGVLPD-------------------------GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVML 455 (678)
Q Consensus 401 ~LG~G~fG~Vy~a~~~~-------------------------g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l 455 (678)
.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999986311 13589998875544444578889999999999999999
Q ss_pred EeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC--
Q 038949 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF-- 533 (678)
Q Consensus 456 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~-- 533 (678)
++++.+....++||||+.+|+|..++.. ....+++..+..++.||+.||+|||+. ||+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDK----NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcC----CccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999988843 234688899999999999999999998 999999999999998654
Q ss_pred -----ccccccccccccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEe-eeCCccccccCCcccc
Q 038949 534 -----EPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVEL-ITGRKAMDLNRPRGQQ 606 (678)
Q Consensus 534 -----~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eL-ltG~~Pf~~~~~~~~~ 606 (678)
.++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|+| ++|..||....+...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 3799999988643221 12346788999998865 5689999999999999998 578999865432110
Q ss_pred hhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 607 CLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 607 ~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
.. .... ... .+......+.++|.+||+.+|++||++.++++.|.
T Consensus 231 --~~----~~~~-------~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 --ER----FYEK-------KHR----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HH----HHHh-------ccC----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00 0000 000 11112236889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=307.39 Aligned_cols=249 Identities=30% Similarity=0.441 Sum_probs=194.5
Q ss_pred ceecccCccceeeccCCC-------CcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 400 NFLAEGGFGSVHRGVLPD-------GQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~-------g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+.||+|+||.||+|...+ ++.+|+|.+..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998532 25799998754321 2345788999999999999999999999999999999999
Q ss_pred eecCCcccccccC-----CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC-----cccccccc
Q 038949 472 ICNGSLDSHLYGR-----DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF-----EPLVGDFG 541 (678)
Q Consensus 472 ~~ggsL~~~l~~~-----~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~-----~vkL~DFG 541 (678)
+.+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM----HFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC----CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999998543 223477888899999999999999998 999999999999999887 89999999
Q ss_pred ccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHh
Q 038949 542 LARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRH 619 (678)
Q Consensus 542 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 619 (678)
++........ .......++..|+|||++.++.++.++||||||+++|+|++ |..||...... ..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~------~~~~~-~--- 226 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------EVLQH-V--- 226 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH------HHHHH-H---
Confidence 9975533221 11122345678999999999999999999999999999998 99998533210 00000 0
Q ss_pred hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 620 ~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
........+...+..+.+++.+||..+|.+||++.++++.|++
T Consensus 227 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 ------TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0000111223345678999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.10 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=200.0
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+|++.+.||+|+||.||+|.+ .+++.||+|.+..... .....+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999985 4789999999875432 2235788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+ +++|.+++.... .++++..++.++.||+.||.|||+. |++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999885433 5689999999999999999999999 999999999999999999999999999986644332
Q ss_pred cceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccch--hhhh------hHHHHH-Hhhh
Q 038949 552 GVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC--LTEW------ARPLLK-RHAI 621 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~--l~~~------~~~~~~-~~~~ 621 (678)
.......|+..|+|||++.+. .++.++||||||+++|+|++|.++|....+..... .... .++... ....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 223345688999999998654 46899999999999999999988875433211000 0000 000000 0000
Q ss_pred hcccCcch----hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 622 GELIDPRL----RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 622 ~elld~~l----~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+..+.. ...........+.+++.+||+.||++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000 00011223467899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=303.94 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=198.4
Q ss_pred CCcccceecccCccceeeccCC--CCcEEEEEeeehhccc----------CCccccccceeeec-ccccceEEEEeEEee
Q 038949 395 RFSEANFLAEGGFGSVHRGVLP--DGQVVAVKQYKLASSQ----------GDQEFCSEVEVLSC-AQHRNVVMLIGFCVE 461 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~i~~~~~~----------~~~~~~~Ev~iL~~-L~HpnIv~l~~~~~~ 461 (678)
.|++.+.||+|+||.||+|... +++.+|+|.+...... ...++.+|+.++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4788899999999999999954 4788999987533211 11346678887764 689999999999999
Q ss_pred CCeEEEEEEEeecCCccccccc--CCCCccCccccchhhhhhccchhhhhh-cceeeeEEeccCCCCceEeeecCccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILVTHDFEPLVG 538 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH~-~~~~~gIvHrDLKp~NILl~~~~~vkL~ 538 (678)
++..++||||+.+++|.+++.. .....+++..++.++.|++.||.|||+ . |++|+||+|+|||++.++.++|+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~----~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK----RIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC----ceeecCCCHHHEEECCCCcEEEe
Confidence 9999999999999999988743 234468888999999999999999996 4 89999999999999999999999
Q ss_pred cccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHH
Q 038949 539 DFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR 618 (678)
Q Consensus 539 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 618 (678)
|||++....... ......|+..|++||.+.++.++.++|+||||+++|+|++|..||...... .......
T Consensus 157 dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~~~-- 226 (269)
T cd08528 157 DFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATKIV-- 226 (269)
T ss_pred cccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHHHh--
Confidence 999997654332 334456888999999999888999999999999999999999998643210 0011000
Q ss_pred hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 619 ~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
.....+.. ....+..+.++|.+||+.||++||++.|+..+++
T Consensus 227 ---~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 ---EAVYEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---hccCCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 01111111 1123457889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=346.30 Aligned_cols=259 Identities=23% Similarity=0.298 Sum_probs=200.5
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc---CCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|.+.+.||+|+||.||+|.. .+++.||+|++...... ...++.+|+++++.++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5899999999999999999984 46899999998643222 1246889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCC---------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 470 EYICNGSLDSHLYGRD---------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
||++||+|.+++.... ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++.++|+||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~----GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK----GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC----CccccCCchheEEEcCCCCEEEEec
Confidence 9999999999884311 12345566788999999999999999 9999999999999999999999999
Q ss_pred cccccccCCC-----------------ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCc
Q 038949 541 GLARWQPDGD-----------------MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPR 603 (678)
Q Consensus 541 Gla~~~~~~~-----------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~ 603 (678)
|++....... ........||+.|+|||++.+..++.++|||||||++|+|+||..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9997552110 01112346899999999999999999999999999999999999999643211
Q ss_pred ccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCc-hHHHHHHHhhccc
Q 038949 604 GQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRP-RMSQVLRMLEGDI 670 (678)
Q Consensus 604 ~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RP-T~~eVL~~Le~~~ 670 (678)
.. .... ....+.... .....+..+.+++.+||+.||++|| +++++++.|+..+
T Consensus 238 ki----------~~~~---~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 238 KI----------SYRD---VILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred hh----------hhhh---hccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 10 0000 001111000 0112345688999999999999995 6777777776544
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=308.34 Aligned_cols=240 Identities=20% Similarity=0.356 Sum_probs=187.9
Q ss_pred ceecccCccceeeccCC-C-------CcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 400 NFLAEGGFGSVHRGVLP-D-------GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~-~-------g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+.||.|+||.||+|... . ...+|+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36999999999999843 2 234888887644444445788899999999999999999999998999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc--------ccccccccc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE--------PLVGDFGLA 543 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~--------vkL~DFGla 543 (678)
+.+|+|.+++.... ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK----GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999985433 3588889999999999999999999 9999999999999988765 589999988
Q ss_pred ccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCC-ccccccCCcccchhhhhhHHHHHHhhh
Q 038949 544 RWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGR-KAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 544 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~-~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
...... ....++..|+|||++.+ ..++.++||||||+++|+|++|. .||....+... .....
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-------~~~~~---- 219 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-------LQFYE---- 219 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-------HHHHH----
Confidence 644322 23457889999999976 45789999999999999999995 55543221100 00000
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
. ....+......+.+++.+||+.||++|||++++++.|+
T Consensus 220 -~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 -D------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -c------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 01122223346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=310.94 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=199.8
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+.|+..+.||+|+||.||+|.+ .+++.||+|.+..... .....+.+|+.+++.++||||+++++++..+...|+||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 4577888899999999999984 4688999998864332 2234688999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|.+++. ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~----~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 84 LGGGSALDLLK---PGPLEETYIATILREILKGLDYLHSE----RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred cCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC----CeeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 99999999883 24588899999999999999999998 99999999999999999999999999997654322
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
.......|+..|+|||++.+..++.++|+||||+++|+|++|..||....+... .. .+.....+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~------~~~~~~~~---- 219 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LF------LIPKNSPP---- 219 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hh------hhhcCCCC----
Confidence 122234578899999999988899999999999999999999999864322110 00 00111111
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
......+..+.+++.+||+.+|.+||++.++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 122234457889999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=325.94 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=205.3
Q ss_pred cCCcccceecccCccceeeccCC-CCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEe
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYI 472 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~ 472 (678)
+-|.++..||.|+||.||+|..+ ++-.-|-|++.....+..++|+-|++||..+.||+||+|++.|..++.+||+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 44667778999999999999965 45556788888777777889999999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 552 (678)
.||-++..+..- ..+|++.++..++.|++.||.|||++ +|||||||..|||++-+|.++|+|||.+.... ....
T Consensus 112 ~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~----~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQ----NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQ 185 (1187)
T ss_pred CCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhc----chhhhhccccceEEEecCcEeeecccccccch-hHHh
Confidence 999988877544 34599999999999999999999999 99999999999999999999999999985332 2233
Q ss_pred ceeEEEeeeccccccccc-----ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 553 VETRVLGTFGYLAPEYAQ-----SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
....++|||.|||||+.. ..+|+.++||||||++|.||..+.+|-....+.. .+. .+..--.|
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--Vll----------KiaKSePP 253 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLL----------KIAKSEPP 253 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHH----------HHhhcCCC
Confidence 456789999999999874 5689999999999999999999999975443311 010 11111011
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+ .-|..++..|.+++.+||..||..||++.++++
T Consensus 254 TL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 254 TL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11 124556778999999999999999999999875
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.06 Aligned_cols=252 Identities=23% Similarity=0.390 Sum_probs=199.6
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhccc------CCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ------GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~------~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
+|+..+.||+|++|.||++.. .+++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999984 67899999998643311 12568899999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC-ccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF-EPLVGDFGLARWQ 546 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~-~vkL~DFGla~~~ 546 (678)
||||+.+++|.+++.. ..++++..++.++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~----~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHEN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999843 44688999999999999999999999 999999999999998776 5999999999765
Q ss_pred cCCCc---cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 547 PDGDM---GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 547 ~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
..... .......|+..|+|||++.+..++.++|+||||+++|+|++|..||........ .... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~---~~------ 222 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALI---FK------ 222 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHH---HH------
Confidence 43211 112234678899999999888899999999999999999999999864322111 0000 00
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..........+......+.+++.+||+.+|.+||++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00001111223334457889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=303.15 Aligned_cols=251 Identities=29% Similarity=0.454 Sum_probs=199.9
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+|++.+.||+|+||.||+|.. .+++.|++|.++..... ....+.+|+.+++.++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 688999999999999999984 47889999998755433 346788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|.+++.. ...+++..+..++.+++.||.|||+. ||+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH----GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999843 34578889999999999999999999 999999999999999999999999999976543322
Q ss_pred cce---eEEEeeecccccccccccc---cceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 552 GVE---TRVLGTFGYLAPEYAQSGQ---ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 552 ~~~---~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
... ....+++.|+|||++.... ++.++||||||+++|+|++|+.||...... +..... +....
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~~----~~~~~ 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFH----VGAGH 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHHH----HhcCC
Confidence 111 1345788999999998766 889999999999999999999999643211 100000 00000
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+.+.. .......+.+++.+||+.+|.+||++.+++.
T Consensus 224 ~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111 1112456789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=304.71 Aligned_cols=238 Identities=24% Similarity=0.363 Sum_probs=188.0
Q ss_pred ceecccCccceeeccCCC-C----------cEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 400 NFLAEGGFGSVHRGVLPD-G----------QVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~-g----------~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
+.||+|+||.||+|.+.. + ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 369999999999998643 3 25788877644333 5678899999999999999999999888 778999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC-------cccccccc
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF-------EPLVGDFG 541 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~-------~vkL~DFG 541 (678)
|||+.+|+|.+++..... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++ .++|+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK----KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC----CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999854332 588889999999999999999998 999999999999999887 79999999
Q ss_pred ccccccCCCccceeEEEeeeccccccccccc--ccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHH
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQSG--QITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKR 618 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 618 (678)
++..... .....++..|+|||++... .++.++||||||+++|+|++ |..||....+.. +..... .
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~------~~~~~~-~ 221 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------KERFYQ-D 221 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh------HHHHHh-c
Confidence 9975432 2234467789999999876 78999999999999999999 567775432211 000000 0
Q ss_pred hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 619 ~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
. .. .+......+.+++.+||..+|.+||++.++++.|+
T Consensus 222 ~--~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 Q--HR---------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C--CC---------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 01111157889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=303.98 Aligned_cols=249 Identities=25% Similarity=0.339 Sum_probs=193.5
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-----CCccccccceeeecccccceEEEEeEEee--CCeE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-----GDQEFCSEVEVLSCAQHRNVVMLIGFCVE--DGRR 465 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-----~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~~ 465 (678)
.+|...+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688999999999999999985 46889999988643211 12457889999999999999999998875 3578
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
+++|||+.+++|.+++.. ...+++...+.++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~----~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999843 34588888999999999999999998 999999999999999999999999999875
Q ss_pred ccCCC--ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 546 QPDGD--MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 546 ~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
..... ........++..|+|||++.+..++.++|+||||+++|+|++|+.||....... . . .. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~-~---~~--~~~~ 224 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----A-I---FK--IATQ 224 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----H-H---HH--HhcC
Confidence 43211 111123457889999999998889999999999999999999999996432110 0 0 00 0001
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+ .++......+.+++ +||..+|++||++++|++
T Consensus 225 ~~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 PTNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111 22233344567777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=304.42 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=197.3
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC----------CccccccceeeecccccceEEEEeEEeeCC
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG----------DQEFCSEVEVLSCAQHRNVVMLIGFCVEDG 463 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~----------~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 463 (678)
+|.+.+.||.|+||.||+|.. .+++.||+|.++...... .+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 578889999999999999984 468899999886422111 134678999999999999999999999999
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK----GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC----CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998443 5688899999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCC-ccceeEEEeeecccccccccccc--cceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 544 RWQPDGD-MGVETRVLGTFGYLAPEYAQSGQ--ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 544 ~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
....... ........|+..|+|||.+.... ++.++|+||||+++|+|++|..||...... .. .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~----~~~~~- 225 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AA----MFKLG- 225 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HH----HHHhh-
Confidence 7543211 11122345788999999987654 789999999999999999999998532210 00 00000
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.....+.+........+..+.+++.+||..+|++||++.++++
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 226 -NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0001111111122234567899999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=306.89 Aligned_cols=257 Identities=25% Similarity=0.350 Sum_probs=201.4
Q ss_pred hhcCCcccceecccCccceeeccCC-CCc----EEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLP-DGQ----VVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
...+|++.+.||+|+||.||+|.+. ++. .+|+|.+..... .....+.+|+.++..++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 3467899999999999999999843 332 689998764432 223568889999999999999999999887 789
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++||||+.+|+|.+++... ...+++..+..++.|++.||+|||+. |++||||+|+|||++.++.++|+|||+++.
T Consensus 84 ~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEK----RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999998543 33489999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCccc-eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 546 QPDGDMGV-ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 546 ~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
........ .....++..|+|||.+....++.++|+||||+++|+|++ |..||..... .++..... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~------~ 226 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEIPDLLE------K 226 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHh------C
Confidence 54322111 111223567999999988899999999999999999998 9999865432 11111100 0
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
......+..+...+.+++.+||..||..||++.++++.|+...
T Consensus 227 ----~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 227 ----GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0011112223456889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.19 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=185.6
Q ss_pred eecccCccceeeccCC---CCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCC
Q 038949 401 FLAEGGFGSVHRGVLP---DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGS 476 (678)
Q Consensus 401 ~LG~G~fG~Vy~a~~~---~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggs 476 (678)
.||+|+||.||+|... ....+|+|.+...... ....+.+|+.+++.++||||+++++.+.+....++||||+.+|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5999999999999732 3457888877533222 22467889999999999999999999999999999999999999
Q ss_pred cccccccCCC---CccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc-c
Q 038949 477 LDSHLYGRDR---DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM-G 552 (678)
Q Consensus 477 L~~~l~~~~~---~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 552 (678)
|.+++..... ...++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA----DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc----CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999854322 2345677789999999999999999 999999999999999999999999999865432211 1
Q ss_pred ceeEEEeeecccccccccc-------cccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 553 VETRVLGTFGYLAPEYAQS-------GQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
......++..|+|||++.. ..++.++|||||||++|+|++ |..||....+.. ........ ....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~-~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVRE-QDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhc-cCccC
Confidence 1122345678999998743 356789999999999999999 777875432210 00000000 01111
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
..+. .+...+..+.+++..|| .||++||++++|++.|.
T Consensus 231 ~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1222 22334456777888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.78 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=188.9
Q ss_pred ceecccCccceeeccCC----CCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEe-eCCeEEEEEEEee
Q 038949 400 NFLAEGGFGSVHRGVLP----DGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCV-EDGRRLLVYEYIC 473 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~----~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~-~~~~~~LV~E~~~ 473 (678)
+.||+|+||.||+|.+. ++..+|+|.+.... ......+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999742 34579999875322 222357788999999999999999999775 4556899999999
Q ss_pred cCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc--
Q 038949 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM-- 551 (678)
Q Consensus 474 ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 551 (678)
+|+|.+++.... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||+++.......
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK----KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999985432 3356677788999999999999998 999999999999999999999999999975432211
Q ss_pred -cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeC-CccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 552 -GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITG-RKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 552 -~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
.......++..|+|||++.+..++.++||||||+++|+|++| .+||..... ........ ....+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~------~~~~~-- 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLL------QGRRL-- 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHh------cCCCC--
Confidence 111123356789999999888999999999999999999995 455542211 01111000 00000
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
..+...+..+.+++.+||+.+|++||++.++++.|+..+
T Consensus 222 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 --LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 111223457889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=310.90 Aligned_cols=258 Identities=22% Similarity=0.274 Sum_probs=202.7
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|.+.+.||+|+||.||++.. .+++.||+|.+..... .....+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4688999999999999999985 4678999998875432 22346778999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.|++|.+++.. ...+++..+..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999943 35689999999999999999999998 9999999999999999999999999998632110
Q ss_pred C--------------ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH
Q 038949 550 D--------------MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615 (678)
Q Consensus 550 ~--------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 615 (678)
. ........++..|+|||.+....++.++|+||||+++|+|++|..||....+. ++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~--- 225 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELF--- 225 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH---
Confidence 0 00111235788899999998888999999999999999999999998643211 111
Q ss_pred HHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 616 LKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 616 ~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
..........+... ...+..+.++|.+||+.||++||++.++++.|+..+.
T Consensus 226 -~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 226 -GQVISDDIEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred -HHHHhcccCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 11111111111111 1234478999999999999999998888888877654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=322.68 Aligned_cols=246 Identities=28% Similarity=0.399 Sum_probs=203.0
Q ss_pred cCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccC---CccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQG---DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~---~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
..|.-++.||.|.||.||.|+ ..+.+.||||.+.....+. ..++..|+..|+.+.|||++.+.|+|..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 457788899999999999999 4688999999987544443 367899999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||| -|+-.|++. ....++.+..+..|+.+.+.||+|||++ +.||||||..|||+++.|.|||+|||.+....+
T Consensus 106 EYC-lGSAsDlle-VhkKplqEvEIAAi~~gaL~gLaYLHS~----~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 106 EYC-LGSASDLLE-VHKKPLQEVEIAAITHGALQGLAYLHSH----NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHH-hccHHHHHH-HHhccchHHHHHHHHHHHHHHHHHHHHh----hHHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 998 667777773 3456799999999999999999999999 999999999999999999999999999975533
Q ss_pred CccceeEEEeeeccccccccc---ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 550 DMGVETRVLGTFGYLAPEYAQ---SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
-..++|||.|||||++. .+.|+-++||||||++-.||.-.++|+-.... +.....+...-.
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------------MSALYHIAQNes 242 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------------MSALYHIAQNES 242 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------------HHHHHHHHhcCC
Confidence 35689999999999874 58899999999999999999999998632110 111112222222
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
|.+. ..+++..|.+++..||+.-|.+|||.+++|..
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 3222 35567789999999999999999999998753
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.46 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=205.0
Q ss_pred cCCcccceecccCccceeeccCC-CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
++|++.+.||.|++|.||+|... +++.|++|++..... .....+.+|+..+..++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999954 689999999875443 2346788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhh-cceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
+.+++|.+++... ..+++..++.++.|++.||.|||+ . |++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~----~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR----HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC----CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999543 568999999999999999999999 8 99999999999999999999999999998654332
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... +.... . .+.....
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~------~~~~~-~--~~~~~~~---- 220 (264)
T cd06623 155 D-QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS------FFELM-Q--AICDGPP---- 220 (264)
T ss_pred C-cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC------HHHHH-H--HHhcCCC----
Confidence 2 2234568899999999998899999999999999999999999996543200 01100 0 0001001
Q ss_pred cccchh-hhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 631 NCYSER-EVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 631 ~~~~~~-~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
...+.. .+..+.++|.+||..+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 112222 45689999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=303.23 Aligned_cols=249 Identities=22% Similarity=0.282 Sum_probs=194.5
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-----CCccccccceeeecccccceEEEEeEEeeC--CeE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-----GDQEFCSEVEVLSCAQHRNVVMLIGFCVED--GRR 465 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-----~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~~ 465 (678)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788999999999999999985 56899999988633211 124677899999999999999999988763 468
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN----MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999988433 4578888899999999999999998 999999999999999999999999999875
Q ss_pred ccCCCc--cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 546 QPDGDM--GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 546 ~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
...... .......|+..|+|||++.+..++.++|+||||+++|+|++|+.||....... .. .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~----------~~ 220 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----AI----------FK 220 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----HH----------HH
Confidence 432111 11223457889999999988889999999999999999999999986432110 00 00
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..........+......+.+++.+||. +|.+||+++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 221 IATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 000011112233445567888999985 9999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=306.29 Aligned_cols=261 Identities=28% Similarity=0.376 Sum_probs=201.6
Q ss_pred eehhhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEee
Q 038949 384 FTYAELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVE 461 (678)
Q Consensus 384 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~ 461 (678)
+.+..+..+.++|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 34456667789999999999999999999984 578899999886432 2234567888898888 79999999999875
Q ss_pred C-----CeEEEEEEEeecCCccccccc--CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc
Q 038949 462 D-----GRRLLVYEYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE 534 (678)
Q Consensus 462 ~-----~~~~LV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~ 534 (678)
. +..++||||+.+++|.+++.. .....+++..++.++.|++.||.|||+. |++||||||+||+++.++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN----RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCC
Confidence 3 368999999999999988743 2345688999999999999999999998 9999999999999999999
Q ss_pred cccccccccccccCCCccceeEEEeeeccccccccccc-----ccceecceeeeeeEEEEeeeCCccccccCCcccchhh
Q 038949 535 PLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSG-----QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT 609 (678)
Q Consensus 535 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~ 609 (678)
++|+|||++........ ......|+..|+|||.+... .++.++|||||||++|+|++|+.||....+.. .+
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~- 242 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TL- 242 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HH-
Confidence 99999999876543221 12234578899999988643 36889999999999999999999986432210 00
Q ss_pred hhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 610 EWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 610 ~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.. +.....+.+ ..+......+.++|.+||+.+|++||++.++++
T Consensus 243 ------~~---~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 243 ------FK---IPRNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ------HH---HhcCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 000000111 112223446899999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.73 Aligned_cols=255 Identities=26% Similarity=0.351 Sum_probs=211.8
Q ss_pred hhhhhhhcCCcccceecccCccceeecc-CCCCcEEEEEeee---hhcccCCccccccceeeecccccceEEEEeEEeeC
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYK---LASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED 462 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~---~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 462 (678)
+.+....+.|+..++||+||||.||-++ ..+|+.||.|.+. .....+....++|..+|.+++.+.||.+-..|++.
T Consensus 178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK 257 (591)
T ss_pred HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence 3344556789999999999999999988 4589999999874 33445566788999999999999999999999999
Q ss_pred CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
+.+|+||..|.||+|.-+|+...+..+++..++.++.+|+.||++||+. +||+|||||+|||+|+.|+++|+|+|+
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~----~iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR----RIVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc----ceeeccCChhheeeccCCCeEeeccce
Confidence 9999999999999999999988888999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
|..++.+.. ....+||.+|||||+++++.|+...|.|||||+||||+.|+.||....... .+..+.....
T Consensus 334 Avei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-------k~eEvdrr~~- 403 (591)
T KOG0986|consen 334 AVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-------KREEVDRRTL- 403 (591)
T ss_pred EEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-------hHHHHHHHHh-
Confidence 998766543 334489999999999999999999999999999999999999996432211 0101111111
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHH
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMS 660 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~ 660 (678)
.....++...+.+..+|.+..|..||.+|....
T Consensus 404 -----~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 -----EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -----cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 011234555666888999999999999997543
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=343.23 Aligned_cols=258 Identities=31% Similarity=0.408 Sum_probs=209.3
Q ss_pred hhhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
+...+-+++...+||.|.||.||-|. ..+|...|+|-++.... .......+|..+|..+.|||+|++||+-.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34455678888999999999999999 46899999998865433 3346788999999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
+|.||||.+|+|.+.+ ....-.++.....+..|++.|+.|||++ |||||||||.||||+.+|.+|++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll--~~gri~dE~vt~vyt~qll~gla~LH~~----gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLL--EHGRIEDEMVTRVYTKQLLEGLAYLHEH----GIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHH--HhcchhhhhHHHHHHHHHHHHHHHHHhc----CceecCCCccceeeecCCcEEeecccceeE
Confidence 9999999999999999 3334467777788999999999999999 999999999999999999999999999987
Q ss_pred ccCCC---ccceeEEEeeecccccccccc---cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHh
Q 038949 546 QPDGD---MGVETRVLGTFGYLAPEYAQS---GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH 619 (678)
Q Consensus 546 ~~~~~---~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 619 (678)
..+.. ........||+.|||||++.+ .....+.||||||||+.||+||+.||...+. +|+.- .
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIM----y 1452 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIM----Y 1452 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHH----h
Confidence 65432 223445789999999999965 3456789999999999999999999975432 23221 1
Q ss_pred hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 620 ~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
.+.. .-...+|...+..-.++|++||..||++|+++.|+++.--
T Consensus 1453 ~V~~----gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1453 HVAA----GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred HHhc----cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 1111 1223445556667889999999999999999998887543
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=345.59 Aligned_cols=263 Identities=20% Similarity=0.286 Sum_probs=200.7
Q ss_pred hhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEee--
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE-- 461 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-- 461 (678)
...+...++|.+.+.||+|+||.||++.. .++..||+|.+..... .....+..|+.+++.++||||++++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 34456678999999999999999999984 4678999998864322 223568889999999999999999998854
Q ss_pred CCeEEEEEEEeecCCcccccccC--CCCccCccccchhhhhhccchhhhhhcce---eeeEEeccCCCCceEeeec----
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGR--DRDPLEWSARRKIAVGAARGLRYLHEECR---VGCIVHRDMRPNNILVTHD---- 532 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qI~~aL~yLH~~~~---~~gIvHrDLKp~NILl~~~---- 532 (678)
...+||||||+.+|+|.++|... ....+++..++.|+.||+.||.|||+... ..+||||||||+||||+.+
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 45689999999999999988542 23569999999999999999999998510 0159999999999999642
Q ss_pred -------------CccccccccccccccCCCccceeEEEeeecccccccccc--cccceecceeeeeeEEEEeeeCCccc
Q 038949 533 -------------FEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS--GQITEKADVYSLGVVLVELITGRKAM 597 (678)
Q Consensus 533 -------------~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~eLltG~~Pf 597 (678)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||+|+||..||
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 348999999997553322 2234578999999999854 45889999999999999999999999
Q ss_pred cccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHH--HHhh
Q 038949 598 DLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL--RMLE 667 (678)
Q Consensus 598 ~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL--~~Le 667 (678)
...... ..+...+ ... +.+. ....+..+.+||..||+.+|.+||++.++| .++.
T Consensus 244 ~~~~~~-----~qli~~l------k~~--p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 244 HKANNF-----SQLISEL------KRG--PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred CcCCcH-----HHHHHHH------hcC--CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 643211 1111110 000 1100 012245789999999999999999999998 4444
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=305.01 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=194.8
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
++|++.+.||+|++|.||+|.. .+++.||+|.+...... ....+.+|+++++.++|+||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 6799999999999999999985 46889999998754322 224567899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+. ++|.+++.... ..+++..++.++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR----RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 96 58988875433 3688899999999999999999999 999999999999999999999999999875432211
Q ss_pred cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhh----------HHHHHHhh
Q 038949 552 GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWA----------RPLLKRHA 620 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~----------~~~~~~~~ 620 (678)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||.............+. ........
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1122346788999998865 45789999999999999999999999643311110000000 00000000
Q ss_pred hhcc----c-Ccchhcccc-hhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 IGEL----I-DPRLRNCYS-EREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ~~el----l-d~~l~~~~~-~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.... . ...+....+ ......+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 0 000000000 001146778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=308.04 Aligned_cols=243 Identities=25% Similarity=0.317 Sum_probs=198.9
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++.+.||+|+||.||++.+ .+++.||+|.+..... .....+.+|++++++++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4789999999999999999984 4689999999864322 22356888999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++.. ...+++..+..++.|++.||.|||+. |++|+||+|.|||++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSL----DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999844 35689999999999999999999998 9999999999999999999999999999765433
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ..... +...
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~~~~~-----~~~~-- 213 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----------QIYEK-----ILEG-- 213 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----------HHHHH-----HhcC--
Confidence 23346889999999998888899999999999999999999998643310 00000 0000
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCc-----hHHHHH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRP-----RMSQVL 663 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL 663 (678)
...++......+.+++.+||..||.+|+ ++++++
T Consensus 214 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 214 KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 0112223345788999999999999999 777776
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=301.13 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=199.8
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEee--CCeEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE--DGRRLLVY 469 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~~~LV~ 469 (678)
+|++.+.||.|+||.||++.. .+++.+|+|.+..... .....+.+|+.+++.++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588899999999999999984 5788999998864322 223467889999999999999999998754 45689999
Q ss_pred EEeecCCcccccccC--CCCccCccccchhhhhhccchhhhh-----hcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 470 EYICNGSLDSHLYGR--DRDPLEWSARRKIAVGAARGLRYLH-----EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 470 E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qI~~aL~yLH-----~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
||+.+++|.+++... ...++++..++.++.||+.||.||| +. +++|+||+|+||+++.++.++|+|||+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~----~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN----TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC----cceecCCCHHHEEEecCCCEEEecccc
Confidence 999999999998542 2456899999999999999999999 77 899999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ...... +.
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~------~~ 223 (265)
T cd08217 157 AKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQLASK------IK 223 (265)
T ss_pred cccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HHHHHH------Hh
Confidence 986643321 12335689999999999988899999999999999999999999964321 111110 00
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. ......+...+..+.+++.+||+.+|++||++.+|++
T Consensus 224 ~----~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 224 E----GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred c----CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 1111233345568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=308.17 Aligned_cols=251 Identities=21% Similarity=0.317 Sum_probs=202.2
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
.++|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..|+|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 47899999999999999999984 46889999998654444446788899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|.+++.. ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~----gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC----CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998843 3478888999999999999999999 999999999999999999999999999875543322
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
......|++.|++||.+..+.++.++|+||||+++|+|++|..||....+..... .. . ..+....
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--~~----~--------~~~~~~~ 235 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--LI----A--------TNGTPEL 235 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--eh----h--------cCCCCCC
Confidence 2233468889999999988889999999999999999999999996543311100 00 0 0000001
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
..+......+.+++.+||..+|++||++.+++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122234468899999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=305.15 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=197.6
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-----CCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-----GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-----~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
+|.+.+.||+|+||.||+|.. .+++.||+|.++..... ....+.+|+++++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588889999999999999985 46899999998754332 223567899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+ +++|.+++.... ..+++..++.++.||++||.|||++ ||+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN----WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999985433 3689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH----H----HHh
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL----L----KRH 619 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~----~----~~~ 619 (678)
... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.++|....+... +....... . ...
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 155 PNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhhhhhcc
Confidence 321 1222346788999998854 4678999999999999999999877754332110 00000000 0 000
Q ss_pred hhhcccCcchh-----cccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 620 AIGELIDPRLR-----NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 620 ~~~elld~~l~-----~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
........... .......+..+.++|.+||+.||++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 00112334578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=310.46 Aligned_cols=247 Identities=22% Similarity=0.338 Sum_probs=197.9
Q ss_pred CcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 396 FSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
|.....||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..|+||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 33445799999999999984 47899999998755444456788899999999999999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
++|.+++.. ..+++..++.++.|++.||.|||+. |++||||+|+||+++.++.++|+|||++....... ...
T Consensus 103 ~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 103 GALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred CCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 999987732 4588999999999999999999999 99999999999999999999999999987543322 222
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
....|+..|+|||++.+..++.++||||||+++|+|++|..||....+... + .. +. ....+.. ...
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~----~~-~~-----~~~~~~~--~~~ 240 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--M----KR-LR-----DSPPPKL--KNA 240 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H----HH-Hh-----ccCCCCc--ccc
Confidence 345689999999999988899999999999999999999999864332110 0 00 00 0000000 011
Q ss_pred hhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 635 EREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
......+.+++.+||+.+|.+||+++++++
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 223446889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.15 Aligned_cols=253 Identities=29% Similarity=0.443 Sum_probs=200.7
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
++|+..+.||.|+||.||++.. .+++.+|+|.+..... .....+.+|++++++++||||+++++++..+...++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 4688889999999999999985 4689999998875432 2335688999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhh-cceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
+.+++|.+++.... ..+++..+..++.|++.||.|||+ . |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~----~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH----KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC----CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999985432 568889999999999999999999 7 99999999999999999999999999987543221
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
. ....++..|+|||++.+..++.++||||||+++|+|++|..||........ .......... ....+.+.
T Consensus 156 ~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~------~~~~~~~~ 225 (265)
T cd06605 156 A---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIV------NEPPPRLP 225 (265)
T ss_pred h---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHh------cCCCCCCC
Confidence 1 126688899999999988999999999999999999999999864421111 1111111110 00011111
Q ss_pred cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. ...+..+.++|.+||..||++||++.+++.
T Consensus 226 ~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 S---GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred h---hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1 114457899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.69 Aligned_cols=262 Identities=20% Similarity=0.269 Sum_probs=195.0
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+|.+.+.||+|+||.||+|.. .+|+.||+|.++.... .....+.+|+.+++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 588899999999999999995 4789999999864322 2234677899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+. ++|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH----NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 95 5787776432 34589999999999999999999998 99999999999999999999999999997543221
Q ss_pred cceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH-----HHHhhhhccc
Q 038949 552 GVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL-----LKRHAIGELI 625 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~-----~~~~~~~ell 625 (678)
.......+++.|+|||++.+. .++.++|||||||++|+|+||..||........ .+....... .....+....
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHHHHHHhCCCChHHhHHhhhcc
Confidence 112234568899999988764 478999999999999999999988643222110 000000000 0000000000
Q ss_pred C----cchh-----cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 626 D----PRLR-----NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 626 d----~~l~-----~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+ +... .......+..+.++|.+||+.||.+|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 0000 0111234457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=303.51 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=190.9
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCcccccccee-eecccccceEEEEeEEeeCCeEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEV-LSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~i-L~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
++|++.+.||+|+||.||++.. .+|+.||+|.++.... .....+..|+.+ ++.++||||+++++++..++..|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4688999999999999999985 4799999998864322 122345556554 566689999999999999999999999
Q ss_pred EeecCCcccccccC--CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 471 YICNGSLDSHLYGR--DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 471 ~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|++ |+|.+++... ....+++..++.++.|++.||.|||+++ +++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL---SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 6777766432 3356899999999999999999999853 799999999999999999999999999976532
Q ss_pred CCccceeEEEeeecccccccccc----cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQS----GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
. .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... +..... ...
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~------~~~ 223 (283)
T cd06617 157 S--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-----QQLKQV------VEE 223 (283)
T ss_pred c--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-----HHHHHH------Hhc
Confidence 2 12233457889999998864 456889999999999999999999986322100 000000 000
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+.+. ....+..+.++|.+||..+|.+||++.++++
T Consensus 224 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 1123457899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=306.96 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=197.6
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
++|++.+.||+|+||.||++.+ .+++.||+|.++... ......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 4688999999999999999995 478999999886432 12235688899999999999999999999999999999999
Q ss_pred eecCCcccccccCC-CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 472 ICNGSLDSHLYGRD-RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 472 ~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
+.+++|..++.... ...+++..+..++.|++.||.|||+.+ ||+||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999988884321 236899999999999999999999632 8999999999999999999999999998754322
Q ss_pred ccceeEEEeeeccccccccccc------ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 551 MGVETRVLGTFGYLAPEYAQSG------QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||....... .... +..+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------~~~~------~~~~ 222 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN------IFAQ------LSAI 222 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh------HHHH------HHHH
Confidence 12234578899999998554 35789999999999999999999996432110 0000 0001
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.. ......+......+.++|.+||+.+|++||++.+++.
T Consensus 223 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 223 VD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11 0011123335567889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.53 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=200.1
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
.+.|.....||+|+||.||++.. .++..||||.+........+.+.+|+.+++.++|+||+++++.+..++..++||||
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 34455567799999999999984 46889999998754444456788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|.+++.. ..+++..+..++.||+.||.|||+. ||+||||+|+||+++.++.++|+|||++.......
T Consensus 101 ~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~- 172 (292)
T cd06658 101 LEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ----GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV- 172 (292)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-
Confidence 999999998732 3588899999999999999999999 99999999999999999999999999987543222
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....+... . . .+...+.+.+..
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---------~-~--~~~~~~~~~~~~ 240 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---------M-R--RIRDNLPPRVKD 240 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---------H-H--HHHhcCCCcccc
Confidence 222345689999999999888899999999999999999999999864322100 0 0 011111111111
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.......+.+++.+||..||.+|||++++++.
T Consensus 241 --~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 --SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234468889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=301.87 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=197.3
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeeccc---ccceEEEEeEEeeCCeEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQ---HRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~---HpnIv~l~~~~~~~~~~~LV~ 469 (678)
.|+..+.||+|+||.||+|.+ .+++.||+|.++.... .....+.+|+.+++.++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 478888999999999999994 5789999998864322 22346778999988886 999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++.. ..+++..++.++.|++.||.|||+. ||+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998843 3688999999999999999999998 9999999999999999999999999999866443
Q ss_pred CccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
. .......|+..|+|||.+.++ .++.++|+||||+++|+|++|..||......... . .......+.
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~---------~~~~~~~~~ 221 (277)
T cd06917 155 S-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---M---------LIPKSKPPR 221 (277)
T ss_pred c-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh---h---------ccccCCCCC
Confidence 3 223345688899999988654 5689999999999999999999999644321100 0 000000111
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+.. ......+.+++.+||+.||++||++.+++.
T Consensus 222 ~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LED---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 113457889999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=293.68 Aligned_cols=249 Identities=30% Similarity=0.456 Sum_probs=202.7
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEee
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYIC 473 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ 473 (678)
.|...+.||+|++|.||++.. .+++.+++|++..........+.+|+++++.++|+|++++++++..+...++++||+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 477889999999999999995 4788999999875544445678899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccc
Q 038949 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553 (678)
Q Consensus 474 ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 553 (678)
+++|.+++.... ..+++..+..++.|++.||.|||.. |++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN----GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC----CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999885432 4689999999999999999999998 999999999999999999999999999976644332
Q ss_pred eeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhccc
Q 038949 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCY 633 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~ 633 (678)
.....++..|++||++....++.++|+||||+++|+|++|+.||........ ..... ....+... .
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---------~~~~~---~~~~~~~~--~ 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---------LFKIA---TNGPPGLR--N 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---------HHHHH---hcCCCCcC--c
Confidence 3456788999999999888899999999999999999999999864321100 00000 00001110 1
Q ss_pred chhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 634 SEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 634 ~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+...+..+.++|.+||+.||++|||+.++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112457899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=299.48 Aligned_cols=252 Identities=24% Similarity=0.281 Sum_probs=203.3
Q ss_pred hhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
...++|..+++||+|.||+|.+++ ..+++.||+|+++..-. +....-+.|-++|+..+||.+..+...|+..+++|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 455789999999999999999998 56899999999974322 22234566888999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||..||.|.-+| .....+++...+.+-..|+.||.|||+. +||+||||.+|+|+|.||++||+|||+++.-
T Consensus 245 FVMeyanGGeLf~HL--srer~FsE~RtRFYGaEIvsAL~YLHs~----~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 245 FVMEYANGGELFFHL--SRERVFSEDRTRFYGAEIVSALGYLHSR----NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEccCceEeeeh--hhhhcccchhhhhhhHHHHHHhhhhhhC----CeeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999999999 3455699999999999999999999998 9999999999999999999999999999743
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.. ......+++|||.|+|||++....|+.++|.|.+||++|||++|+.||..-+... ++...-+.++
T Consensus 319 I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----------LFeLIl~ed~-- 385 (516)
T KOG0690|consen 319 IK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----------LFELILMEDL-- 385 (516)
T ss_pred cc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----------HHHHHHhhhc--
Confidence 21 2234567899999999999999999999999999999999999999995432111 1111111111
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCc--hHHHHHHHh
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRP--RMSQVLRML 666 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RP--T~~eVL~~L 666 (678)
.+|...+.+...|+..+|..||.+|. ..+++.+..
T Consensus 386 -----kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~ 422 (516)
T KOG0690|consen 386 -----KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIM 422 (516)
T ss_pred -----cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHH
Confidence 13334445788899999999999995 334444443
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=303.61 Aligned_cols=261 Identities=22% Similarity=0.312 Sum_probs=196.7
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+|+..+.||.|++|.||+|.. .+++.||||.++..... ....+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488899999999999999985 47899999988643322 224688899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+. ++|.+++.......+++..++.++.|++.||+|||+. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~----~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 95 6888888665566789999999999999999999998 99999999999999999999999999987543221
Q ss_pred cceeEEEeeecccccccccccc-cceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH----------HHHH---
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQ-ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR----------PLLK--- 617 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~----------~~~~--- 617 (678)
.......+++.|+|||++.+.. ++.++||||||+++|+|+||..||........ +..... +...
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHHH
Confidence 1122334678899999887644 58899999999999999999999964332110 000000 0000
Q ss_pred --HhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 618 --RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 618 --~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+.......+.. ........+.++|.+||+.||.+|||+++++.
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000000 11123346788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=301.95 Aligned_cols=251 Identities=26% Similarity=0.371 Sum_probs=185.8
Q ss_pred eecccCccceeeccCCCC---cEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCC
Q 038949 401 FLAEGGFGSVHRGVLPDG---QVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGS 476 (678)
Q Consensus 401 ~LG~G~fG~Vy~a~~~~g---~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggs 476 (678)
.||+|+||.||+|...++ ..+++|.+..... .....+.+|+.+++.++||||+++++.|......|+||||+.+|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999974332 3566776653322 233578899999999999999999999999999999999999999
Q ss_pred cccccccCC--CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC-ccc
Q 038949 477 LDSHLYGRD--RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD-MGV 553 (678)
Q Consensus 477 L~~~l~~~~--~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~ 553 (678)
|.+++.... ...+++..++.++.||+.||.|||+. +++||||||+|||++.++.++|+|||++....... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH----NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999985432 23356667788999999999999998 99999999999999999999999999986432211 112
Q ss_pred eeEEEeeecccccccccc-------cccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 554 ETRVLGTFGYLAPEYAQS-------GQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
.....++..|+|||++.. ..++.++||||||+++|+|++ |..||....+ .+........ ....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~-~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKD-QQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhh-cccccC
Confidence 233467889999998753 245789999999999999997 4667754322 1111111111 112223
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
++.+... ....+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3333322 3346778888999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=301.66 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=194.6
Q ss_pred CcccceecccCccceeeccCC----CCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeCC------
Q 038949 396 FSEANFLAEGGFGSVHRGVLP----DGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG------ 463 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~------ 463 (678)
|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 667889999999999999742 46899999886432 222356888999999999999999999886532
Q ss_pred eEEEEEEEeecCCcccccccC----CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGR----DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGD 539 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~D 539 (678)
..++++||+.+|+|.+++... ....+++..++.++.|++.||+|||+. ||+||||||+||+++.++.++|+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK----NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccchhhEEEcCCCCEEECc
Confidence 247889999999998876322 122478888899999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHH
Q 038949 540 FGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLK 617 (678)
Q Consensus 540 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 617 (678)
||+++....... .......+++.|++||.+....++.++||||||+++|+|++ |..||..... ..+ ....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~---~~~~-- 228 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEI---YNYL-- 228 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHH---HHHH--
Confidence 999975533221 11122345678999999998889999999999999999999 8888853321 000 0000
Q ss_pred HhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 618 RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 618 ~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
...... ..+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 229 ----~~~~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 ----IKGNRL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----HcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000000 11123445789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.09 Aligned_cols=257 Identities=26% Similarity=0.350 Sum_probs=198.4
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEee--CCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE--DGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~~~LV~ 469 (678)
++|...+.||.|++|.||++.. .+++.+|+|.+..... .....+.+|++++++++||||++++++|.+ .+.+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4688899999999999999995 4688999998874332 233568899999999999999999998865 34789999
Q ss_pred EEeecCCccccccc--CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 470 EYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 470 E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||+.+++|.+++.. .....+++..+..++.||+.||.|||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999887642 2345578888999999999999999998 99999999999999999999999999986543
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
... .....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ...+....... ...+
T Consensus 157 ~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~------~~~~ 226 (287)
T cd06621 157 NSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELLSYIVN------MPNP 226 (287)
T ss_pred ccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHHHHHhc------CCch
Confidence 221 1234578889999999989999999999999999999999999975432100 01111111000 0001
Q ss_pred chhcccc--hhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 628 RLRNCYS--EREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 628 ~l~~~~~--~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+..... ...+..+.+++.+||+.+|.+|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1111101 123457889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=300.92 Aligned_cols=250 Identities=27% Similarity=0.407 Sum_probs=211.3
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEe
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYI 472 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~ 472 (678)
+-|.++.+||+|.||.||+|.+ .+|+.+|||.+... .+.+++..|+.++.++..|++|++||.+-....+|+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 3478889999999999999995 47999999987533 34578889999999999999999999988888999999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 552 (678)
..|++.+.+..+ +.+|++..+..+++..+.||+|||.. .-||||||..|||++.+|..||+|||.+..+. ....
T Consensus 111 GAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~----~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT-DTMA 184 (502)
T KOG0574|consen 111 GAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL----KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT-DTMA 184 (502)
T ss_pred CCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH----HHHHhhcccccEEEcccchhhhhhccccchhh-hhHH
Confidence 999999998654 56799999999999999999999998 77999999999999999999999999997654 3445
Q ss_pred ceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 553 VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
...+..|||.|||||++..-.|..++||||||+...||.-|++||..-.|....+. +.....|.+ .
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM------------IPT~PPPTF--~ 250 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM------------IPTKPPPTF--K 250 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe------------ccCCCCCCC--C
Confidence 66788999999999999999999999999999999999999999976554222111 011111222 2
Q ss_pred cchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.++..+..+.++++.||-.+|++|-|+.++++.
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 356677889999999999999999999988763
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=299.32 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=201.0
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+|.+.+.||+|+||.||+|.. .++..+|+|.+..... .....+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 588899999999999999995 4688999999875432 2234678899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC-ccccccccccccccCCC
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF-EPLVGDFGLARWQPDGD 550 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~-~vkL~DFGla~~~~~~~ 550 (678)
+.+++|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999998665555688999999999999999999998 999999999999999885 46999999997654322
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||..... ..+..... .....
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-----~~~~~---- 220 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKIC-----QGYFA---- 220 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHh-----cccCC----
Confidence 122234588899999999888899999999999999999999999864321 11111100 11111
Q ss_pred cccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
......+..+.+++.+||..+|++|||+.++++.
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1122334578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.00 Aligned_cols=254 Identities=23% Similarity=0.353 Sum_probs=204.8
Q ss_pred hhhhcCCcccceecccCccceeeccCC-CCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
....+.|...+.||.|++|.||+|.+. +++.+++|.+..... ....+.+|+++++.++|+||+++++++......|+|
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 345677999999999999999999964 688999999875543 345788999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
+||+.+++|.+++.... ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~----gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ----NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 99999999999995533 3689999999999999999999998 999999999999999999999999999865433
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.. .......++..|++||++.+..++.++|+||||+++|+|++|..||....+... ... ... ....+
T Consensus 169 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~-~~~----~~~~~- 235 (286)
T cd06614 169 EK-SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFL-ITT----KGIPP- 235 (286)
T ss_pred ch-hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHh----cCCCC-
Confidence 22 122334578899999999888899999999999999999999999864332110 000 000 00000
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.......+..+.++|.+||+.+|.+||++.++++
T Consensus 236 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 --LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1111224457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.58 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=198.5
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEe
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYI 472 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~ 472 (678)
-|+..+.||.|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++..+...|+||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 477888999999999999984 5788999998764322 22246888999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 552 (678)
.+++|.+++. ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHccC----CeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999884 24588999999999999999999998 999999999999999999999999999875543221
Q ss_pred ceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 553 VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
......++..|+|||++.+..++.++|+||||+++|+|++|..||....+.. .... +..... ..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~------~~~~~~----~~ 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFL------IPKNNP----PT 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHH------HhcCCC----CC
Confidence 2233457889999999988888999999999999999999999986432210 0000 000001 11
Q ss_pred cchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+...+..+.+++.+||+.+|.+||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 22234457889999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=308.88 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=197.3
Q ss_pred hcCCcccceecccCccceeeccC-CCCc----EEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQ----VVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~----~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
.++|+..+.||+|+||.||+|.+ .++. .+|+|.+...... ....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 45788899999999999999984 3444 5788887633221 123678899999999999999999998754 578
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+++||+++|+|.+++... ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER----RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhc----CeeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998543 33578889999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCcc-ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 547 PDGDMG-VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 547 ~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
...... ......++..|+|||++.+..++.++||||||+++|+|++ |..||..... ... ...... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~------~~~-~~~~~~---~~- 228 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT------REI-PDLLEK---GE- 228 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHH-HHHHHC---CC-
Confidence 432211 1122335678999999998899999999999999999997 8888854321 000 111110 00
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
....+..+...+.+++.+||..+|++||++.++++.|+...
T Consensus 229 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 229 -----RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00112223457889999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=301.63 Aligned_cols=247 Identities=21% Similarity=0.279 Sum_probs=201.2
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
+|++.+.||.|+||.||+|.. .+++.||+|.+..... .....+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 588999999999999999995 4689999999874432 233578899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+++|.+++... .++++..+..++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998443 5688999999999999999999999 99999999999999999999999999997654332
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||....... ..+.. .... . ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~---~~~~--~-----~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIR---AKQE--T-----AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHH---HHhc--c-----cc
Confidence 2234557889999999998889999999999999999999999997543210 11111 0000 0 11
Q ss_pred cccchhhhhhhhhccceeeccCCCCCchH--HHHH
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPRM--SQVL 663 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT~--~eVL 663 (678)
...+...+..+.++|.+||+.||.+||++ .+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 22333345688999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.74 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=204.4
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+|.+.+.||.|+||.||++.. .+++.||+|.+..... .....+.+|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 588899999999999999995 4689999999875433 3345688899999999999999999999999999999999
Q ss_pred eecCCcccccccCC--CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 472 ICNGSLDSHLYGRD--RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 472 ~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
+++++|.+++.... ...+++..+..++.+++.||.|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~----~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999885543 46789999999999999999999999 9999999999999999999999999999765443
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
. .......|++.|+|||.+....++.++|+||||+++|+|++|..||..... ....... ....
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~-----~~~~----- 219 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKI-----LKGQ----- 219 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHH-----hcCC-----
Confidence 2 233345789999999999888899999999999999999999999864321 1111110 0111
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....+......+.+++.+||..+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11123344567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.29 Aligned_cols=248 Identities=21% Similarity=0.340 Sum_probs=199.4
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEee
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYIC 473 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ 473 (678)
.|...+.||+|++|.||++.. .+++.+++|.++.........+.+|+.+++.++||||+++++++...+..++|+||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 455667999999999999984 5788999998865444444568889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccc
Q 038949 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553 (678)
Q Consensus 474 ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 553 (678)
+++|.+++.. .++++..+..++.|++.||+|||++ ||+||||+|+||+++.++.++|+|||++....... ..
T Consensus 100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~ 171 (285)
T cd06648 100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ----GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PR 171 (285)
T ss_pred CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cc
Confidence 9999998844 4588889999999999999999999 99999999999999999999999999887543322 12
Q ss_pred eeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhccc
Q 038949 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCY 633 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~ 633 (678)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|..||....+. ..... +.....+... .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~------~~~~~~~~~~--~ 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKR------IRDNLPPKLK--N 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHH------HHhcCCCCCc--c
Confidence 23356889999999998888999999999999999999999998643321 11110 0111111111 1
Q ss_pred chhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 634 SEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 634 ~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+...+..+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1123457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=293.70 Aligned_cols=253 Identities=23% Similarity=0.262 Sum_probs=199.6
Q ss_pred hhcCCccc-ceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEee----CCe
Q 038949 392 ATNRFSEA-NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVE----DGR 464 (678)
Q Consensus 392 ~~~~y~~~-~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~----~~~ 464 (678)
.+++|++. ++||-|-.|.|..+.+ .+++++|+|++.. .....+|++..-.. .|||||.++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 46677774 5799999999999884 5899999998852 24566788874444 69999999998764 456
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee---cCcccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH---DFEPLVGDFG 541 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~---~~~vkL~DFG 541 (678)
+.+|||.++||.|.+.+..+....+++..+..|+.||..|+.|||+. +|.||||||+|+|.+. |..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~----nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM----NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc----chhhccCChhheeeecCCCCcceEecccc
Confidence 78999999999999999888888999999999999999999999999 9999999999999974 6789999999
Q ss_pred ccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
+|+.... .....+.+.||.|.|||++...+|+..+|+||+||++|-||+|.+||..... ........+. +... .
T Consensus 210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~r-I~~g-q 283 (400)
T KOG0604|consen 210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRR-IRTG-Q 283 (400)
T ss_pred cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhH-hhcc-C
Confidence 9985432 2345667889999999999999999999999999999999999999965432 1111111110 0000 0
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.++.+ . --...++...++|+.+|+.+|.+|.|+++++.
T Consensus 284 y~FP~----p-EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 YEFPE----P-EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ccCCC----h-hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 01111 1 11234567889999999999999999999874
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.34 Aligned_cols=265 Identities=23% Similarity=0.317 Sum_probs=194.5
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC-CccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG-DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~-~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+....... ...+.+|+.+++.++|+||+++++++..+...|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46899999999999999999984 568899999986543332 2357789999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+. ++|.+++... ...+++..+..++.|++.||.|||+. ||+|+||||+|||++.++.++|+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQ----HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 994 6777766433 34577888889999999999999998 99999999999999999999999999987543221
Q ss_pred ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH----------HHHHHh
Q 038949 551 MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR----------PLLKRH 619 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~----------~~~~~~ 619 (678)
. ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+........|.. ......
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 158 Q-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred C-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 1 1123346889999999875 357889999999999999999999997543211100000000 000000
Q ss_pred hh-hccc----Ccchhcccc-hhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 AI-GELI----DPRLRNCYS-EREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 ~~-~ell----d~~l~~~~~-~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.. .+.. ...+...+. ......+.+++.+|+..||.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 0000 000000000 012346788999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.23 Aligned_cols=265 Identities=23% Similarity=0.305 Sum_probs=195.2
Q ss_pred CCcccceecccCccceeeccCC---CCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeC--CeEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVLP---DGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED--GRRL 466 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~~---~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~~~ 466 (678)
+|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 5888999999999999999953 57899999987533 23335678899999999999999999999987 7899
Q ss_pred EEEEEeecCCcccccccC---CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee----cCcccccc
Q 038949 467 LVYEYICNGSLDSHLYGR---DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH----DFEPLVGD 539 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~----~~~vkL~D 539 (678)
+||||+. ++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.+||+|
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN----WVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 9999985 4666655321 223688899999999999999999999 9999999999999999 99999999
Q ss_pred ccccccccCCCc--cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH-
Q 038949 540 FGLARWQPDGDM--GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL- 615 (678)
Q Consensus 540 FGla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~- 615 (678)
||++........ .......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.................+
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999976533211 12234567889999998865 45789999999999999999999999754432200000000000
Q ss_pred --HH---------------Hhhhhcc---------cCcchhcccch--hhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 --LK---------------RHAIGEL---------IDPRLRNCYSE--REVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 --~~---------------~~~~~el---------ld~~l~~~~~~--~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+. ....... ....+...... .....+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 0000000 00000011111 23456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=303.92 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=194.4
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeeccc-ccceEEEEeEEeeCCeEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~LV~E 470 (678)
++|...+.||+|+||.||++.. .+++.||+|.+..... .....+.+|+.++.++. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 3566778899999999999984 5689999998864332 22346788999998886 9999999999999899999999
Q ss_pred EeecCCcccc---cccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 471 YICNGSLDSH---LYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 471 ~~~ggsL~~~---l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
|+. ++|.++ +.......+++..+..++.|++.||+|||+.+ +++||||||+||+++.++.++|+|||++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 984 455443 23333466899999999999999999999742 89999999999999999999999999997554
Q ss_pred CCCccceeEEEeeeccccccccccc---ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSG---QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
... ......|++.|+|||++.+. .++.++||||||+++|+|++|..||..... ... ........
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~------~~~~~~~~ 226 (288)
T cd06616 160 DSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFD------QLTQVVKG 226 (288)
T ss_pred cCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHH------HHhhhcCC
Confidence 322 12334578899999998766 689999999999999999999999864321 000 00011111
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+.+........+..+.+|+.+||+.||++||++++|++
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122222222335567899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=321.17 Aligned_cols=254 Identities=26% Similarity=0.331 Sum_probs=210.2
Q ss_pred hhhcCCcccceecccCccceeeccCC--CCc--EEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLP--DGQ--VVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~--~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
+..+...+.++||+|.||.|++|.|. +|+ .||||.++..... ...+|++|+.+|.+|+|||+++|||+..+ ...
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 44566778899999999999999974 344 6899999865544 45789999999999999999999999887 678
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
.||||+++.|+|.+.|.......|.......++.||+.|+.||..+ ++|||||..+|+||.....|||+|||+.+.
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk----rlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK----RLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh----hhhhhhhhhhhheecccceeeeecccceec
Confidence 8999999999999999776677788888899999999999999999 999999999999999999999999999997
Q ss_pred ccCCCccc-ee-EEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 546 QPDGDMGV-ET-RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 546 ~~~~~~~~-~~-~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
+..++... .. ...-...|.|||.++...|+.++|||+|||++|||+| |..||-.... ..+-
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------------~qIL 325 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------------IQIL 325 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----------------HHHH
Confidence 76543221 11 1123557999999999999999999999999999998 6678754332 1123
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
+.+|..-+-.-+..|++++++++..||..+|.+||||..|.+.
T Consensus 326 ~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 326 KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 3344444445567788999999999999999999999999743
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=293.13 Aligned_cols=250 Identities=29% Similarity=0.400 Sum_probs=203.7
Q ss_pred CCcccceecccCccceeeccCC-CCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeC--CeEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVED--GRRLLVY 469 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~~~LV~ 469 (678)
+|+..+.||+|++|.||+|... +++.|++|.+..... .....+.+|+.++++++||||+++++.+... ..+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999954 789999999875442 3346788999999999999999999999988 8899999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++.... .+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~----~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN----GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999985433 789999999999999999999998 9999999999999999999999999999866543
Q ss_pred Ccc-ceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 DMG-VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
... ......++..|++||.+....++.++||||||+++|+|++|..||....... . .. ..+....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~---~~------~~~~~~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----A---AL------YKIGSSG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----H---HH------HhccccC
Confidence 221 1233567889999999988889999999999999999999999997543100 0 00 0111111
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.....+...+..+.++|.+||..||++||++.++++
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 112233344568999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=329.70 Aligned_cols=266 Identities=20% Similarity=0.271 Sum_probs=187.2
Q ss_pred hhhhcCCcccceecccCccceeeccCC--CCcEEEEE------------------eeehhcccCCccccccceeeecccc
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLP--DGQVVAVK------------------QYKLASSQGDQEFCSEVEVLSCAQH 449 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK------------------~i~~~~~~~~~~~~~Ev~iL~~L~H 449 (678)
....++|++.+.||+|+||.||++..+ ++...+.| .+. ........+.+|+.+|+.++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence 345679999999999999999997632 22222222 111 111122457889999999999
Q ss_pred cceEEEEeEEeeCCeEEEEEEEeecCCcccccccCC---CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCc
Q 038949 450 RNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRD---RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 526 (678)
Q Consensus 450 pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~N 526 (678)
|||+++++++...+..|+|+|++ +++|.+++.... ........++.++.||+.||.|||++ |||||||||+|
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~----gIiHrDLKP~N 297 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK----KLIHRDIKLEN 297 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHH
Confidence 99999999999999999999998 567777664321 11223455678999999999999999 99999999999
Q ss_pred eEeeecCccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCcc-ccccCCccc
Q 038949 527 ILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKA-MDLNRPRGQ 605 (678)
Q Consensus 527 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~P-f~~~~~~~~ 605 (678)
||++.++.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|..+ +........
T Consensus 298 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 9999999999999999986654433333456799999999999999999999999999999999998754 432221111
Q ss_pred chhhhhhHH-----------------HHHHhhhhc---ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 606 QCLTEWARP-----------------LLKRHAIGE---LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 606 ~~l~~~~~~-----------------~~~~~~~~e---lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+...... .+....+.. .+.+.+.. ......+.++|.+||+.||++|||+.|+|+
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN---LGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh---cCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111111000 000000000 00000000 012335677899999999999999999986
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=297.10 Aligned_cols=242 Identities=24% Similarity=0.313 Sum_probs=195.6
Q ss_pred ecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCc
Q 038949 402 LAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSL 477 (678)
Q Consensus 402 LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 477 (678)
||.|++|.||++.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++.++...++||||+.+++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999995 4689999999864332 2235688999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccceeEE
Q 038949 478 DSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV 557 (678)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 557 (678)
.+++.. ...+++..+..++.||+.||.|||+. |++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~----~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHNR----GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 999943 34588899999999999999999998 99999999999999999999999999998664432 22334
Q ss_pred EeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhh
Q 038949 558 LGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSERE 637 (678)
Q Consensus 558 ~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~ 637 (678)
.+++.|++||.+....++.++|+||||+++|+|++|..||....... ..... ..........++...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~---------~~~~~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYN---------DILKGNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHH---------HHhccCCCCCCCccc
Confidence 67889999999988889999999999999999999999997543210 01111 111111112233334
Q ss_pred hhhhhhccceeeccCCCCCch-----HHHHHH
Q 038949 638 VYGMLQCASLCIRKDPHSRPR-----MSQVLR 664 (678)
Q Consensus 638 ~~~l~~LI~~cL~~dP~~RPT-----~~eVL~ 664 (678)
+..+.++|.+||+.||++||+ +.|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 568999999999999999999 777775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.48 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=197.4
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC--CccccccceeeecccccceEEEEeEEeeC--CeEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCAQHRNVVMLIGFCVED--GRRLLV 468 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~--~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~~~LV 468 (678)
++|++.+.||.|+||.||+|.. .+++.+|+|.++...... ...+.+|+.+++.++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5789999999999999999995 468899999987443221 23467899999999999999999998877 889999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+. ++|.+++.... ..+++..++.++.|++.||.|||+. |++|+||+|+|||++.++.++|+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN----WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99996 58888875433 3589999999999999999999998 999999999999999999999999999986543
Q ss_pred CCccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccch-hh---------hhhHH---
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC-LT---------EWARP--- 614 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~-l~---------~~~~~--- 614 (678)
.. .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.......... +. .|...
T Consensus 159 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred Cc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 32 122334578899999988754 46899999999999999999999996443211000 00 00000
Q ss_pred -HHHHhhhhcccCcchhcccchh-hhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 -LLKRHAIGELIDPRLRNCYSER-EVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 -~~~~~~~~elld~~l~~~~~~~-~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..............+...++.. ....+.++|.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000000111111222222 3556889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=346.51 Aligned_cols=262 Identities=31% Similarity=0.525 Sum_probs=207.1
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
...|...+.||+|+||.||+|.. .++..||+|.++... .....|++++++++||||++++++|.+.+..|+||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN----SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc----cccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 35677788999999999999985 578999999886322 1223468889999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+++|+|.+++. .++|..+..++.|++.||+|||..+. .+|+||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999993 37899999999999999999995432 289999999999999998887765 555432211
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
.....|++.|+|||++.+..++.++|||||||++|||+||+.||+.... ....+..|.+...........+++.+..
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence 1223578999999999999999999999999999999999999964332 2233555655444333344455655533
Q ss_pred c--cchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 632 C--YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 632 ~--~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
. .+..+...+.+++.+||+.||++||+|.++++.|+....
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2 334556678899999999999999999999999997654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=288.19 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=195.7
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehh-cccCCccccccceeeecc-cccceEEEEeEEeeCCeEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA-SSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
.+..+.+..||.|..|.||++.. .+|...|||.+... +.+...+++..+.++... .+|+||+++|+|..+..+++.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 34566777899999999999995 57899999998643 333445677777776555 4899999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
|.| ...++.++ .+-.+++++..+-++...++.||.||.+++ ||+|||+||+|||+|..|++||||||++.+.-+.
T Consensus 171 elM-s~C~ekLl-krik~piPE~ilGk~tva~v~AL~YLKeKH---~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 171 ELM-STCAEKLL-KRIKGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHH-HHHHHHHH-HHhcCCchHHhhhhhHHHHHHHHHHHHHhc---ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 987 33444444 344567999999999999999999999874 9999999999999999999999999999766433
Q ss_pred CccceeEEEeeecccccccccc---cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 550 DMGVETRVLGTFGYLAPEYAQS---GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
..++...|.+.|||||.+.. ..|+.++||||||+.|+||.||+.||...... -..++. .+ .-..
T Consensus 246 --kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~ltk----vl------n~eP 312 (391)
T KOG0983|consen 246 --KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVLTK----VL------NEEP 312 (391)
T ss_pred --cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHHHH----HH------hcCC
Confidence 45566789999999999864 46899999999999999999999999765421 000111 11 1111
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
|.+.... ..+..|.+++..||+.|+.+||...++|+
T Consensus 313 P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 313 PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 3332221 13457899999999999999999999875
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.06 Aligned_cols=263 Identities=24% Similarity=0.332 Sum_probs=196.7
Q ss_pred CcccceecccCccceeeccCC-CCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeC--CeEEEEEE
Q 038949 396 FSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED--GRRLLVYE 470 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~~~LV~E 470 (678)
|.+.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+++++.++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677889999999999999854 68899999997553 22234678899999999999999999999887 88999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+. ++|.+++.... ..+++..++.++.||+.||+|||+. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~----~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN----GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 996 58888874432 4689999999999999999999998 99999999999999999999999999998664433
Q ss_pred ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccch-hh---------hhhHH----H
Q 038949 551 MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC-LT---------EWARP----L 615 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~-l~---------~~~~~----~ 615 (678)
........++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......... +. .|... .
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 222233456788999997764 457899999999999999999999996543211000 00 00000 0
Q ss_pred HHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 LKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 ~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.............+...+...++..+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000111111111113557899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.74 Aligned_cols=260 Identities=22% Similarity=0.302 Sum_probs=196.8
Q ss_pred CcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEe
Q 038949 396 FSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYI 472 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~ 472 (678)
|++.+.||.|++|.||+|.. .+|+.||+|++..... .....+.+|+.+++.++|||++++++++.+++..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67788999999999999984 5799999999874432 22246788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 552 (678)
+++|.+++.......+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++....... .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~----~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~ 154 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH----RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-R 154 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-c
Confidence 56899888555445689999999999999999999998 99999999999999999999999999997543221 1
Q ss_pred ceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH-----------HHHhh
Q 038949 553 VETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL-----------LKRHA 620 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~-----------~~~~~ 620 (678)
......+++.|+|||++.+. .++.++|+||||+++|+|++|..||....+... +....... .....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchh
Confidence 11223468899999988654 578899999999999999999999965432111 00000000 00000
Q ss_pred ----hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 ----IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ----~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
......+.. .......+..+.++|.+||+.||.+|||++++++
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 1112233457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=298.97 Aligned_cols=244 Identities=26% Similarity=0.354 Sum_probs=193.4
Q ss_pred ecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCc
Q 038949 402 LAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSL 477 (678)
Q Consensus 402 LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 477 (678)
||+|+||.||++.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999984 578899999986432 22234567899999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccceeEE
Q 038949 478 DSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV 557 (678)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 557 (678)
.+++.......+++..+..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR----RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 9999665555789999999999999999999998 99999999999999999999999999987554321 12234
Q ss_pred EeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhh
Q 038949 558 LGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSERE 637 (678)
Q Consensus 558 ~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~ 637 (678)
.++..|+|||++.++.++.++|+||||+++|+|++|+.||......... ..+...... .....+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~------~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-------EELKRRTLE------MAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-------HHHHhcccc------ccccCCccC
Confidence 5778999999998888999999999999999999999999654321110 000000000 011122334
Q ss_pred hhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 638 VYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 638 ~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
+..+.++|.+||+.||.+|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 55789999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-34 Score=302.07 Aligned_cols=248 Identities=28% Similarity=0.382 Sum_probs=195.3
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc---CCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
...+|...+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+++++.++||||++++++|.+++..|+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 446799999999999999999985 46899999988643322 22467889999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+. |+|.+++... ...+++..+..++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++....
T Consensus 93 v~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~----~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 93 VMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH----ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999995 5776666432 34589999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCccceeEEEeeeccccccccc---ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQ---SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
.. ....+++.|+|||++. .+.++.++||||||+++|+|++|..||........ .. .+...
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~------~~~~~ 229 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY------HIAQN 229 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HH------HHhcC
Confidence 22 2345788999999874 45688999999999999999999999854321110 00 00000
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
..+.+ ....++..+.+++.+||+.||++||++.+++..
T Consensus 230 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 DSPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00111 112244578999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-33 Score=309.94 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=206.6
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCC--ccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGD--QEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~--~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
...+.|.+.+.||+|.|+.|.+|++ .++..||||+++....+.. ..+.+|+++|..+.|||||+++.+.+....+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3456899999999999999999994 5799999999975443332 458899999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+.+|.+.+++. ..+...+..+..++.|+++|++|||++ +|||||||++||||+.+-++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k----~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSK----NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhc----ceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999994 455577789999999999999999999 99999999999999999999999999998775
Q ss_pred CCCccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.+ ....+++|++.|.|||++.+..| ++.+|+||+|++||.|+.|..||+...-.. . ++..+ .
T Consensus 207 ~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~------L-----r~rvl----~ 269 (596)
T KOG0586|consen 207 YG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE------L-----RPRVL----R 269 (596)
T ss_pred cc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc------c-----cchhe----e
Confidence 43 34567899999999999998877 579999999999999999999997543211 1 11111 1
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..++ .+.....++.+||+++|-.+|.+|++.+++.+
T Consensus 270 gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 270 GKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeec--ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 1111 12223346788999999999999999999864
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-34 Score=297.74 Aligned_cols=265 Identities=21% Similarity=0.267 Sum_probs=194.7
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
++|++.+.||+|++|.||+|.. .+++.||+|.+..... .....+.+|+++++.++||||+++++++..+...|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5789999999999999999985 4788999998864332 223467889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-cCccccccccccccccCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-DFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-~~~vkL~DFGla~~~~~~ 549 (678)
|+. ++|.+++.......+++..++.++.||+.||+|||+. |++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 994 5888777544444467788889999999999999998 9999999999999985 567999999999754322
Q ss_pred CccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhh-h-hhHHHHHH-------h
Q 038949 550 DMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT-E-WARPLLKR-------H 619 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~-~-~~~~~~~~-------~ 619 (678)
. .......+++.|+|||++.+ ..++.++||||||+++|+|+||..||............ . +..+.... .
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 157 V-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred c-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 1 11223457889999998865 45789999999999999999999999654321110000 0 00000000 0
Q ss_pred hhhc---ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 AIGE---LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 ~~~e---lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.... ...+..........+..+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00000000011223456889999999999999999999885
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-34 Score=300.69 Aligned_cols=262 Identities=21% Similarity=0.262 Sum_probs=193.2
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeeccc-ccceEEEEeEEeeCCe-----
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGR----- 464 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~----- 464 (678)
++|++.+.||+|+||.||+|.. .+++.||+|.++..... ....+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4789999999999999999994 57899999988654322 2356788999999995 6999999999887665
Q ss_pred EEEEEEEeecCCcccccccCC---CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-cCccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRD---RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-DFEPLVGDF 540 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-~~~vkL~DF 540 (678)
.|+||||+.+ +|.+++.... ...+++..++.++.||+.||.|||+. ||+||||+|+||+++. ++.++|+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH----GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999975 7888774432 34689999999999999999999999 9999999999999998 899999999
Q ss_pred cccccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH----
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL---- 615 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~---- 615 (678)
|++....... .......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||....+... +.......
T Consensus 156 g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~ 232 (295)
T cd07837 156 GLGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFKLLGTPT 232 (295)
T ss_pred ccceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence 9987543221 11122346888999998865 4578999999999999999999999864322110 00000000
Q ss_pred -------HHHhh---hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 -------LKRHA---IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 -------~~~~~---~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..... .... .+.......+..+..+.++|.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQW-KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcc-cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 0000 000000111224457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-34 Score=308.55 Aligned_cols=263 Identities=22% Similarity=0.269 Sum_probs=195.6
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeC-----
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED----- 462 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~----- 462 (678)
...++|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||++++++|...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3568899999999999999999984 578999999885321 22234677899999999999999999988643
Q ss_pred -CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 463 -GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 463 -~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
...|+||||+ .++|.+.+.. .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~~lv~e~~-~~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 93 FQDVYLVMELM-DANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cCcEEEEEecc-CCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 3579999999 4588777732 278888999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccch---------hhhhh
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC---------LTEWA 612 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~---------l~~~~ 612 (678)
+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.......... ..++.
T Consensus 164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 997653322 1233457889999999999999999999999999999999999996433211000 00000
Q ss_pred HH-------HHHHh------hhhcccCc----chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 613 RP-------LLKRH------AIGELIDP----RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 613 ~~-------~~~~~------~~~elld~----~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.. ..... .+.++... ..........+..+.++|.+||+.||++|||+.|+|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 00000 00000000 0000001123456789999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-34 Score=311.47 Aligned_cols=262 Identities=23% Similarity=0.321 Sum_probs=193.9
Q ss_pred hcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeC-----CeE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVED-----GRR 465 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-----~~~ 465 (678)
.++|.+.+.||+|+||.||+|. ..+++.||+|.+..... .....+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 5789999999999999999998 45789999999864322 2234677899999999999999999887643 357
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+|+||+. ++|.+++. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999995 57777763 34589999999999999999999999 999999999999999999999999999975
Q ss_pred ccCCCc--cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHH---Hh
Q 038949 546 QPDGDM--GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK---RH 619 (678)
Q Consensus 546 ~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~---~~ 619 (678)
...... .......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ...+ ...+. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~--~~~~-~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ--LNLI-LGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-HHHcCCCCHH
Confidence 433211 11233567899999998754 5689999999999999999999999964321110 0000 00000 00
Q ss_pred hhhcccCc-----------chhc---ccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 620 AIGELIDP-----------RLRN---CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 620 ~~~elld~-----------~l~~---~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
....+.+. .... ...+..+..+.+++.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000 0011234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-34 Score=301.14 Aligned_cols=265 Identities=25% Similarity=0.309 Sum_probs=197.2
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCC---
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG--- 463 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~--- 463 (678)
+...++|++.+.||+|+||.||+|.. .+++.||+|.++.... .....+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 45668899999999999999999995 4688999999875432 22245678999999999999999999987654
Q ss_pred -------eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccc
Q 038949 464 -------RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL 536 (678)
Q Consensus 464 -------~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vk 536 (678)
.+++|+||+.+ +|..++... ...+++..++.++.|++.||+|||+. ||+|+||+|+||+++.++.++
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK----NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCcEE
Confidence 78999999965 666666433 34689999999999999999999999 999999999999999999999
Q ss_pred cccccccccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH
Q 038949 537 VGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615 (678)
Q Consensus 537 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 615 (678)
|+|||++...............++..|+|||.+.+ ..++.++|||||||++|+|++|++||........ +..... .
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--~~~~~~-~ 233 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--LELISR-L 233 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHH-H
Confidence 99999997654433222223346788999998864 4578899999999999999999999964332110 000000 0
Q ss_pred HHH---h---hhhcc-----cC------cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 LKR---H---AIGEL-----ID------PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 ~~~---~---~~~el-----ld------~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... . .+.+. .+ ...... ....+..+.+++.+||+.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 0 00000 00 000000 1123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-34 Score=303.39 Aligned_cols=265 Identities=26% Similarity=0.335 Sum_probs=194.5
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC--CccccccceeeecccccceEEEEeEEeeC--CeEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCAQHRNVVMLIGFCVED--GRRLL 467 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~--~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~~~L 467 (678)
.++|++.+.||+|+||.||+|.. .+|+.||+|.++...... ...+.+|+.+++.++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46799999999999999999995 578999999987443222 23466799999999999999999998754 56899
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+. ++|.+++... ...+++..++.++.||+.||.|||+. |++||||+|+||+++.++.++|+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHEN----FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999995 5788777433 35689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhh-hh-------hHHHHHH
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT-EW-------ARPLLKR 618 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~-~~-------~~~~~~~ 618 (678)
... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....+....... .. ..+....
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 160 LPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred Ccc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 322 12223345788999998865 56789999999999999999999999654331110000 00 0000000
Q ss_pred hhh-hcc-cCcchhccc---chhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 619 HAI-GEL-IDPRLRNCY---SEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 619 ~~~-~el-ld~~l~~~~---~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... ... +........ .......+.++|.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 000 000000000 0112446788999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-34 Score=294.73 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=196.1
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc-----ccCCccccccceeeecccccceEEEEeEEeeC--CeE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS-----SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED--GRR 465 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~-----~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~~ 465 (678)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4789999999999999999984 568999999875321 11224678899999999999999999998763 468
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998843 34578888999999999999999998 999999999999999999999999999975
Q ss_pred ccCCC--ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 546 QPDGD--MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 546 ~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
..... ........|+..|+|||++.+..++.++|+||||+++|+|++|+.||....... . +..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------~------~~~ 220 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---------A------IFK 220 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---------H------HHH
Confidence 43211 111123458899999999998889999999999999999999999996432110 0 001
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..........+......+.+++.+||+ +|.+||++.+++.
T Consensus 221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111111122344455678999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-34 Score=299.61 Aligned_cols=242 Identities=22% Similarity=0.303 Sum_probs=186.0
Q ss_pred eecccCccceeeccC-CCCcEEEEEeeehhccc---CCccccccceeee---cccccceEEEEeEEeeCCeEEEEEEEee
Q 038949 401 FLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---GDQEFCSEVEVLS---CAQHRNVVMLIGFCVEDGRRLLVYEYIC 473 (678)
Q Consensus 401 ~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~---~L~HpnIv~l~~~~~~~~~~~LV~E~~~ 473 (678)
+||+|+||.||++.. .+++.+|+|.+...... ....+.+|..+++ ...||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999985 56899999988643221 1123344443333 3469999999999999999999999999
Q ss_pred cCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccc
Q 038949 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553 (678)
Q Consensus 474 ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 553 (678)
+|+|.+++. ....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999998884 345689999999999999999999999 99999999999999999999999999987543221
Q ss_pred eeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 554 ETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
.....|+..|+|||.+.. ..++.++|+|||||++|+|++|..||......... . .... ..... ..
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~-----~~~~--~~~~~----~~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E-----IDRM--TLTVN----VE 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---H-----HHHH--hhcCC----cC
Confidence 123468999999998864 56899999999999999999999999654321110 0 0000 00011 12
Q ss_pred cchhhhhhhhhccceeeccCCCCCc-----hHHHHHHH
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLRM 665 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~~ 665 (678)
.+...+..+.++|.+||+.||.+|| +++++++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2333455789999999999999999 59888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-34 Score=296.92 Aligned_cols=262 Identities=22% Similarity=0.326 Sum_probs=197.0
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEe
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYI 472 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~ 472 (678)
+|+..+.||.|++|.||+|.. .+++.||+|.++..... ....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 588899999999999999995 46889999998754433 2356778999999999999999999999999999999999
Q ss_pred ecCCcccccccCC-CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 473 CNGSLDSHLYGRD-RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 473 ~ggsL~~~l~~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
. ++|.+++.... ...+++..+..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN----RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 6 48888774432 34689999999999999999999998 99999999999999999999999999997543221
Q ss_pred cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHH-----------HHHHh
Q 038949 552 GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP-----------LLKRH 619 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~-----------~~~~~ 619 (678)
.......++..|++||.+.+ ..++.++|+||||+++|+|++|..||........ ....... .....
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhHHHHhcCc
Confidence 11223456889999998865 4578899999999999999999999965432111 0000000 00000
Q ss_pred hhhcccC---cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 AIGELID---PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 ~~~elld---~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....... ........+..+..+.+++.+||+.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 00001111233457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-34 Score=296.16 Aligned_cols=248 Identities=27% Similarity=0.376 Sum_probs=198.6
Q ss_pred ecccCccceeeccCC-CCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCc
Q 038949 402 LAEGGFGSVHRGVLP-DGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSL 477 (678)
Q Consensus 402 LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 477 (678)
||.|+||.||++... +++.+++|.+..... .....+.+|++++++++||||+++++.+..+...|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999964 589999999864432 3345788899999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc------
Q 038949 478 DSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM------ 551 (678)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~------ 551 (678)
.+++... ..+++..+..++.||+.||.|||+. |++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSN----GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc----CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9998543 3689999999999999999999998 999999999999999999999999999875433211
Q ss_pred -cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 552 -GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 552 -~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
.......++..|++||.+....++.++|+||||+++|+|++|..||....+. ........ .. ..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~----~~-~~---- 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILN----GK-IE---- 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc----CC-cC----
Confidence 1223345788999999998888899999999999999999999999644321 11100000 00 00
Q ss_pred cccchh--hhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 631 NCYSER--EVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 631 ~~~~~~--~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
.+.. .+..+.+++.+||+.+|.+|||+..+.+.|+..+..
T Consensus 220 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~ 261 (265)
T cd05579 220 --WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261 (265)
T ss_pred --CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence 1111 245789999999999999999998888888776653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-34 Score=295.87 Aligned_cols=259 Identities=23% Similarity=0.266 Sum_probs=191.2
Q ss_pred CcccceecccCccceeeccC-CCCcEEEEEeeehhccc-CCccccccceeeeccc-ccceEEEEeEEeeC--CeEEEEEE
Q 038949 396 FSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQ-HRNVVMLIGFCVED--GRRLLVYE 470 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~--~~~~LV~E 470 (678)
|++.+.||+|+||.||+|.. .+++.||+|.++..... ......+|+.++.++. |+||+++++++.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67788999999999999984 57889999988643222 2234457888888885 99999999999987 88999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+. |+|.+++... ...+++..++.++.|++.||.|||+. |++||||+|+||+++. +.++|+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRN----GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 995 5787777443 24689999999999999999999998 9999999999999999 999999999997654322
Q ss_pred ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccc-hh--------hhhhHHHHHHhh
Q 038949 551 MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQ-CL--------TEWARPLLKRHA 620 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~-~l--------~~~~~~~~~~~~ 620 (678)
. .....++..|+|||++.. +.++.++|||||||++|+|++|..||....+.... .. ..+.. ......
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 230 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK-KFRKSR 230 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHH-hhcccc
Confidence 1 123457889999997654 56788999999999999999999999654321100 00 00000 000000
Q ss_pred hhcccCcc-hh---cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 IGELIDPR-LR---NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ~~elld~~-l~---~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
......+. .. .......+..+.++|.+||+.||++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000 00 0011234568999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-34 Score=292.34 Aligned_cols=247 Identities=28% Similarity=0.430 Sum_probs=201.6
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+|++.+.||+|++|.||++.. .+++.|++|.+..... .....+.+|++++++++|||++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 588899999999999999985 4678999999875443 2335788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+++|.+++... ..+++..++.++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998433 5689999999999999999999999 999999999999999999999999999986654332
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
. .....++..|+|||.+.+..++.++|+|+||+++|+|++|..||....+.. ..+. ... ....
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~~--------~~~----~~~~ 217 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFR--------IVQ----DDHP 217 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHHH--------Hhc----cCCC
Confidence 1 233567889999999988888999999999999999999999986432100 0000 000 0111
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+...+..+.+++.+||..+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 123334557889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-34 Score=309.27 Aligned_cols=264 Identities=20% Similarity=0.291 Sum_probs=196.5
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehh--cccCCccccccceeeecccccceEEEEeEEeeC-----Ce
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA--SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED-----GR 464 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-----~~ 464 (678)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46899999999999999999984 57899999988643 222234677899999999999999999987654 34
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.|+||||+ +++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 84 ~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELM-DTDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSA----NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCC-CCCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 79999999 578888874 345689999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccch-hh---------hh--
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC-LT---------EW-- 611 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~-l~---------~~-- 611 (678)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.......... .. .+
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 654322 22233467889999998865 468899999999999999999999996432100000 00 00
Q ss_pred -hHHHHHH--hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 612 -ARPLLKR--HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 612 -~~~~~~~--~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
....... .......++.... .....+..+.++|.+||+.||++||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000 0000000111111 112345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-34 Score=293.34 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=200.9
Q ss_pred CCcccceecccCccceeecc-CCCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+|++.+.||+|+||.||++. ..+++.+|+|.+..... .....+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58889999999999999998 45788999999875432 2234677899999999999999999999999999999999
Q ss_pred eecCCcccccccC--CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 472 ICNGSLDSHLYGR--DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 472 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
+.+++|.+++... ....+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~----~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ----KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999988442 234588889999999999999999999 9999999999999999999999999999766443
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
......+++.|++||.+.+..++.++|+||||+++|+|++|+.||....... ... ... ...
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~~-~~~---------~~~ 217 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------LRY-KVQ---------RGK 217 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH-HHh---------cCC
Confidence 2223457889999999998889999999999999999999999996543210 000 000 011
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....+......+.+++.+||+.+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11122345567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-33 Score=300.88 Aligned_cols=243 Identities=23% Similarity=0.350 Sum_probs=199.9
Q ss_pred cceecccCccceeeccC-CCCcEEEEEeeehh--cccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecC
Q 038949 399 ANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA--SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNG 475 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~gg 475 (678)
.+.||.|.||+||-|++ ++|+.||||++..- .......+.+|+.||..++||.||.+...|++.+++++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 57899999999999994 68999999998633 2333467899999999999999999999999999999999999 67
Q ss_pred CcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec---CccccccccccccccCCCcc
Q 038949 476 SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD---FEPLVGDFGLARWQPDGDMG 552 (678)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~---~~vkL~DFGla~~~~~~~~~ 552 (678)
++.++|.....++|++.....+..||+.||+|||-+ +|+|+||||+|||+... .++||||||+|+.+... .
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k----nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--s 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK----NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--S 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc----ceeeccCCchheeeccCCCCCceeeccccceeecchh--h
Confidence 888888777788899999999999999999999999 99999999999999753 57999999999987543 3
Q ss_pred ceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 553 VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
.....+|||.|+|||+++.+.|...-|+||.|||+|--|.|..||+...+..++ +++..+ +..+.
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ---------IQNAaF--MyPp~---- 786 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ---------IQNAAF--MYPPN---- 786 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH---------hhcccc--ccCCC----
Confidence 456689999999999999999999999999999999999999999765432111 111111 11111
Q ss_pred cchhhhhhhhhccceeeccCCCCCchHHHHH
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL 663 (678)
--.+......+||..+|+..-.+|.+.+.-|
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 1123444678899999999999999887754
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-34 Score=307.95 Aligned_cols=265 Identities=24% Similarity=0.336 Sum_probs=196.2
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEee----CCeE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE----DGRR 465 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~----~~~~ 465 (678)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 47899999999999999999984 5789999999864322 233567789999999999999999988753 3568
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSA----NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehh-hhhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999999 5688888843 34589999999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCc---cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhh--hHH---HH
Q 038949 546 QPDGDM---GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEW--ARP---LL 616 (678)
Q Consensus 546 ~~~~~~---~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~--~~~---~~ 616 (678)
...... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.............. ..+ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 533221 11223468889999998865 4688999999999999999999999964332111000000 000 00
Q ss_pred ---HHhhhhccc---Ccchh---cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 617 ---KRHAIGELI---DPRLR---NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 617 ---~~~~~~ell---d~~l~---~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....+.+.. ..... .......+..+.++|.+||+.+|.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000000 00000 0011223567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-34 Score=317.26 Aligned_cols=240 Identities=24% Similarity=0.359 Sum_probs=192.4
Q ss_pred cceecccCccceeeccC-CCCcEEEEEeeehh----cccCCccccccceeeecccccceEEEEeEEeeCCe--EEEEEEE
Q 038949 399 ANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA----SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR--RLLVYEY 471 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~--~~LV~E~ 471 (678)
...||+|+|-+||+|.+ .+|-.||--.++.. .....++|..|+.+|+.|+||||+++|+++.+... .-+|+|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 44699999999999995 46777774444322 22334789999999999999999999999987655 7789999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-cCccccccccccccccCCC
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-DFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-~~~vkL~DFGla~~~~~~~ 550 (678)
++.|+|..|+. +.+..+...++.|++||+.||.|||++.| .|||||||-+||+|+. .|.|||+|+|+|.......
T Consensus 125 ~TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~~P--PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQDP--PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcCCC--CccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999994 44557888999999999999999999866 7999999999999986 5999999999998765433
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHH---HhhhhcccCc
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK---RHAIGELIDP 627 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~---~~~~~elld~ 627 (678)
. ...+|||.|||||++. ..|...+||||||+.|+||+|+.+||...... .++.+.... +..+..+-|
T Consensus 201 a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-----AQIYKKV~SGiKP~sl~kV~d- 270 (632)
T KOG0584|consen 201 A---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-----AQIYKKVTSGIKPAALSKVKD- 270 (632)
T ss_pred c---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-----HHHHHHHHcCCCHHHhhccCC-
Confidence 2 3378999999999998 88999999999999999999999999765432 222222111 112222222
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+.++|.+||.. ...|||+.|+|.
T Consensus 271 -----------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 -----------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 2588999999999 999999999984
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-34 Score=299.57 Aligned_cols=262 Identities=15% Similarity=0.172 Sum_probs=184.1
Q ss_pred hhhhcCCcccceecccCccceeeccCCC----CcEEEEEeeehhcccCC-----------ccccccceeeecccccceEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPD----GQVVAVKQYKLASSQGD-----------QEFCSEVEVLSCAQHRNVVM 454 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~i~~~~~~~~-----------~~~~~Ev~iL~~L~HpnIv~ 454 (678)
+...++|.+.+.||+|+||.||+|.+.+ +..+|+|.......... .....+...+..+.|+|+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 4556899999999999999999998543 45667775432221110 01112233455678999999
Q ss_pred EEeEEeeCC----eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee
Q 038949 455 LIGFCVEDG----RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT 530 (678)
Q Consensus 455 l~~~~~~~~----~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~ 530 (678)
+++++.... ..++++|++ ..++.+.+.. ....++..+..++.|++.||.|||+. +|+||||||+|||++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiHrDiKp~Nill~ 160 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH----GISHGDIKPENIMVD 160 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEc
Confidence 998765543 346777776 3355555422 22356777889999999999999998 999999999999999
Q ss_pred ecCccccccccccccccCCCc------cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcc
Q 038949 531 HDFEPLVGDFGLARWQPDGDM------GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRG 604 (678)
Q Consensus 531 ~~~~vkL~DFGla~~~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~ 604 (678)
.++.++|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 999999999999976532111 11223468999999999999999999999999999999999999997542211
Q ss_pred cchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 605 QQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 605 ~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
.. ........ +..+....+ ....++..+.+++..|+..+|++||++.++++.|+
T Consensus 241 ~~-~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 NL-IHAAKCDF-----IKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HH-HHHhHHHH-----HHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 10 00000000 011111111 01223457889999999999999999999998774
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-34 Score=299.75 Aligned_cols=266 Identities=24% Similarity=0.298 Sum_probs=192.0
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCC------
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG------ 463 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~------ 463 (678)
-++|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45799999999999999999985 47899999988643322 1234567999999999999999999987643
Q ss_pred --eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 464 --RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 464 --~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
..++||||+. ++|.+++... ...+++..++.++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN----KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEECCCCcEEECcCC
Confidence 4599999984 5787777432 33589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCc---cceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH----
Q 038949 542 LARWQPDGDM---GVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR---- 613 (678)
Q Consensus 542 la~~~~~~~~---~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~---- 613 (678)
++........ .......++..|+|||++.+. .++.++||||||+++|+|++|+.||....+...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9975533221 111234578889999988654 47889999999999999999999986543211100000000
Q ss_pred -HH---------HHHhhhhcccCcchhcc-cchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 614 -PL---------LKRHAIGELIDPRLRNC-YSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 614 -~~---------~~~~~~~elld~~l~~~-~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.. ................. .+......+.++|.+||+.||.+||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 00000000000000000 00112345678999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-34 Score=292.03 Aligned_cols=250 Identities=22% Similarity=0.264 Sum_probs=192.2
Q ss_pred ceecccCccceeeccC-CCCcEEEEEeeehhccc---CCcccccccee-eecccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---GDQEFCSEVEV-LSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---~~~~~~~Ev~i-L~~L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|.. .+++.||+|.+...... ....+..|..+ ....+|+|++++++++..++..|+||||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999985 46889999998643221 11233444443 3445899999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
++|.+++. ....+++..+..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||++..... .
T Consensus 82 ~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIK--TLGGLPEDWAKQYIAEVVLGVEDLHQR----GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 99999984 335688999999999999999999998 999999999999999999999999999875432 2
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
....|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ....... .. . . .......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~---~-~--~~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNIL-SR---R-I--NWPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-hc---c-c--CCCCccc
Confidence 2345788999999998888899999999999999999999999643221 1111100 00 0 0 0011111
Q ss_pred hhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccccC
Q 038949 635 EREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMN 673 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~~ 673 (678)
..++..+.+++.+||+.||++||++..+.+.|...+..+
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 234557899999999999999998887777776655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-33 Score=291.85 Aligned_cols=245 Identities=19% Similarity=0.229 Sum_probs=189.3
Q ss_pred hhhcCCccccee--cccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEeeCCeEE
Q 038949 391 LATNRFSEANFL--AEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~L--G~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~ 466 (678)
...++|.+.+.+ |.|+||.||++.. .++..+|+|.+........ |+.....+ +||||+++++.+...+..|
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 344677777776 9999999999984 5788999999864332211 22222222 6999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC-cccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF-EPLVGDFGLARW 545 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~-~vkL~DFGla~~ 545 (678)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+. |++||||+|+||+++.++ .++|+|||++..
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 999999999999998433 3799999999999999999999999 999999999999999988 999999999875
Q ss_pred ccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
.... ....++..|+|||++.+..++.++|+||||+++|+|++|..||....... .....+.... ..
T Consensus 160 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~------~~-- 225 (267)
T PHA03390 160 IGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ------QK-- 225 (267)
T ss_pred cCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh------cc--
Confidence 5322 22357889999999998899999999999999999999999997432211 0011111100 00
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCch-HHHHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR-MSQVLR 664 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT-~~eVL~ 664 (678)
........+..+.++|.+||+.||.+||+ ++++++
T Consensus 226 ----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 ----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00111234457899999999999999995 688873
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-34 Score=296.50 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=196.4
Q ss_pred CCcccceecccCccceeeccC----CCCcEEEEEeeehhcc----cCCccccccceeeecc-cccceEEEEeEEeeCCeE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL----PDGQVVAVKQYKLASS----QGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~i~~~~~----~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~ 465 (678)
.|++.+.||.|+||.||++.. .+|+.||+|+++.... ...+.+.+|+.+++.+ +|+||+.+++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999874 3688999999874322 2235677899999999 599999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||+++++|.+++.. ..++++..+..++.|++.||.|||+. |++||||+|+|||++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999843 35688889999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCccceeEEEeeeccccccccccc--ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSG--QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
.............|+..|+|||.+... .++.++||||||+++|+|++|..||....... ....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~------ 226 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILK------ 226 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhc------
Confidence 544332333345688999999998753 46789999999999999999999986432211 11111111100
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
.. ..++......+.+++.+||+.||++|| ++++++.
T Consensus 227 -~~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 -SE----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -cC----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01 112233445788999999999999997 6677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-34 Score=304.84 Aligned_cols=265 Identities=25% Similarity=0.329 Sum_probs=196.5
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehh--cccCCccccccceeeecc-cccceEEEEeEEeeC--CeE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA--SSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVED--GRR 465 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~--~~~ 465 (678)
..++|.+.+.||+|+||.||+|.. .+++.+|+|.+... .......+.+|+.+++.+ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 467899999999999999999985 46889999987532 222334677899999999 999999999988653 368
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||+. ++|.+++... .+++..++.++.||+.||.|||+. ||+||||+|+||+++.++.++|+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~----~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG----NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999995 5888887432 678888899999999999999998 999999999999999999999999999976
Q ss_pred ccCCCc----cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccch-hhhhh-------
Q 038949 546 QPDGDM----GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC-LTEWA------- 612 (678)
Q Consensus 546 ~~~~~~----~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~-l~~~~------- 612 (678)
...... .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||....+..... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 543221 12334568999999998754 567889999999999999999999996433211100 00000
Q ss_pred HHHHHHhhhhcccC-------cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 613 RPLLKRHAIGELID-------PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 613 ~~~~~~~~~~elld-------~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
...+.......+++ ..+. ......+..+.++|.+||+.||++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000 0000 1111245678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-33 Score=302.82 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=190.5
Q ss_pred ceeccc--CccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEG--GFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G--~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
..||+| +||.||++.+ .+++.||+|++...... ..+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 8999999985 57999999998643322 225678899999999999999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc--
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG-- 552 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 552 (678)
++|.+++.......+++..+..++.|++.||+|||+. ||+||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN----GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999988655445688899999999999999999998 9999999999999999999999999865432211100
Q ss_pred ----ceeEEEeeeccccccccccc--ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH------------H
Q 038949 553 ----VETRVLGTFGYLAPEYAQSG--QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR------------P 614 (678)
Q Consensus 553 ----~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~------------~ 614 (678)
......++..|+|||++.+. .++.++|||||||++|+|++|..||........ ...... +
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence 01112345679999999763 478999999999999999999999964321100 000000 0
Q ss_pred -----H------HH----Hhh-----hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 -----L------LK----RHA-----IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 -----~------~~----~~~-----~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. .. ... ........+.......+...+.+|+.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 00 000 00011111122223345567899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-33 Score=300.19 Aligned_cols=247 Identities=27% Similarity=0.384 Sum_probs=194.3
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC---CccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG---DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~---~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
..|...+.||+|+||.||++.. .++..+|+|.+....... ...+.+|+++++.++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4488889999999999999984 578899999886432222 246788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+. |+|.+++.. ...++++..+..++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~----~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9995 577776643 244588999999999999999999998 9999999999999999999999999998654322
Q ss_pred CccceeEEEeeeccccccccc---ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 550 DMGVETRVLGTFGYLAPEYAQ---SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
....|++.|+|||++. .+.++.++||||||+++|+|++|..||....... . ......
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~-~~~~~~--------- 238 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----A-LYHIAQ--------- 238 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-----H-HHHHHh---------
Confidence 2345788999999874 4568899999999999999999999985432100 0 000000
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHh
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~L 666 (678)
..............+.+++.+||+.+|.+||++.++++.+
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 239 NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0000011122344688999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-34 Score=297.12 Aligned_cols=248 Identities=22% Similarity=0.318 Sum_probs=200.7
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeeccc-ccceEEEEeEEeeCCeEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~LV 468 (678)
++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4789999999999999999985 478999999986432 222356788999999998 99999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.+++|.+++.. ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~----~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSK----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999943 34699999999999999999999998 999999999999999999999999999875543
Q ss_pred CCc-------------------cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhh
Q 038949 549 GDM-------------------GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT 609 (678)
Q Consensus 549 ~~~-------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~ 609 (678)
... .......++..|+|||.+....++.++|+||||+++++|++|+.||.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------- 227 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------- 227 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-------
Confidence 221 222334678899999999888899999999999999999999999974431
Q ss_pred hhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchH----HHHHH
Q 038949 610 EWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRM----SQVLR 664 (678)
Q Consensus 610 ~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~----~eVL~ 664 (678)
+.. .. .+.. ....++...+..+.+++.+||+.+|.+||++ +++++
T Consensus 228 -~~~--~~--~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 -YLT--FQ--KILK-----LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -HHH--HH--HHHh-----cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 000 00 0000 1112223335578999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-33 Score=295.72 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=202.2
Q ss_pred CCcccceecccCccceeeccC----CCCcEEEEEeeehhcc----cCCccccccceeeecc-cccceEEEEeEEeeCCeE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL----PDGQVVAVKQYKLASS----QGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~i~~~~~----~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~ 465 (678)
+|++.+.||+|++|.||++.. .+++.||+|.++.... .....+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999873 3578899999864321 2234678899999999 599999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++||||+.+|+|.+++.. ...+++..+..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~----~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQL----GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998843 34588889999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCccceeEEEeeecccccccccccc--cceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQ--ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
.............|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||....... ....+..... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~-----~~ 227 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRIL-----KS 227 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHH-----cc
Confidence 5443322233356889999999987654 7889999999999999999999986432111 1111111110 00
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.+ ..+......+.+++.+||+.||++|||+.++.+.|+..+.
T Consensus 228 --~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 228 --KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred --CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 11 1222234578899999999999999999999888877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-34 Score=296.80 Aligned_cols=261 Identities=24% Similarity=0.302 Sum_probs=197.5
Q ss_pred CcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEe
Q 038949 396 FSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYI 472 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~ 472 (678)
|.+.+.||.|++|.||+|.. .+++.+++|.++..... ....+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 66788999999999999985 47899999988644322 2356788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 552 (678)
. ++|.+++.... ..+++..+..++.|++.||.|||+. ||+|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 D-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH----GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred C-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC----CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 5 48888775433 5689999999999999999999999 99999999999999999999999999997664432 1
Q ss_pred ceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhh--hhhH-------HHHH--Hh-
Q 038949 553 VETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT--EWAR-------PLLK--RH- 619 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~--~~~~-------~~~~--~~- 619 (678)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||............ .... .... ..
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 22234578889999998776 7899999999999999999999998644321110000 0000 0000 00
Q ss_pred --hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 --AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 --~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.......... .......+..+.++|.+||+.||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 234 KFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000000 1112234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-34 Score=298.32 Aligned_cols=247 Identities=22% Similarity=0.370 Sum_probs=196.3
Q ss_pred CcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 396 FSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
|.....||+|+||.||++.. .+++.||+|.+..........+.+|+.+++.++|+||+++++++..++..++||||+.+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 33446799999999999985 57899999988654444445688899999999999999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
++|.+++. ...+++..+..++.|++.||+|||+. |++||||+|+||+++.++.++|+|||++....... ...
T Consensus 102 ~~L~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~----givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~ 173 (292)
T cd06657 102 GALTDIVT---HTRMNEEQIAAVCLAVLKALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 173 (292)
T ss_pred CcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccc
Confidence 99998773 23578889999999999999999999 99999999999999999999999999987553322 122
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
....|++.|+|||++.+..++.++|+||||+++|+|++|..||....... ... .. ...+.+.+.. .
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~------~~~-~~-----~~~~~~~~~~--~ 239 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMK-MI-----RDNLPPKLKN--L 239 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH-HH-----HhhCCcccCC--c
Confidence 33568899999999988888999999999999999999999986432110 000 00 0111111110 1
Q ss_pred hhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 635 EREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+..+.+++.+||+.||.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 123446788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-33 Score=294.13 Aligned_cols=241 Identities=22% Similarity=0.295 Sum_probs=186.0
Q ss_pred eecccCccceeeccC-CCCcEEEEEeeehhcccC---Ccccccccee---eecccccceEEEEeEEeeCCeEEEEEEEee
Q 038949 401 FLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG---DQEFCSEVEV---LSCAQHRNVVMLIGFCVEDGRRLLVYEYIC 473 (678)
Q Consensus 401 ~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~---~~~~~~Ev~i---L~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ 473 (678)
.||+|+||.||++.. .+++.||+|.+....... ...+..|..+ ++...||||+.+++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999984 468899999886432221 1223344333 334579999999999999999999999999
Q ss_pred cCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccc
Q 038949 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553 (678)
Q Consensus 474 ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 553 (678)
||+|.+++. ....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999998884 345689999999999999999999998 99999999999999999999999999987543221
Q ss_pred eeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 554 ETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
.....|+..|+|||++.++ .++.++||||||+++|+|++|..||......... .. .. ...... ..
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~---~~-----~~--~~~~~~----~~ 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EI-----DR--MTLTMA----VE 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH---HH-----HH--HhhccC----CC
Confidence 1234689999999998754 6899999999999999999999999754321110 00 00 000011 11
Q ss_pred cchhhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
++...+..+.+++.+||..+|.+|| ++.++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 2223455789999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-33 Score=292.08 Aligned_cols=259 Identities=25% Similarity=0.325 Sum_probs=192.9
Q ss_pred CcccceecccCccceeeccCC-CCcEEEEEeeehhccc--CCccccccceeeecc---cccceEEEEeEEeeCCe-----
Q 038949 396 FSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCA---QHRNVVMLIGFCVEDGR----- 464 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L---~HpnIv~l~~~~~~~~~----- 464 (678)
|++.+.||+|+||.||+|.++ +++.||+|.++..... ....+.+|+.+++.+ .||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677889999999999999964 5899999998743322 123466677776655 59999999999988776
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.+++|||+. ++|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~----~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 999999995 5888887554444689999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHH-------
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK------- 617 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~------- 617 (678)
...... ......++..|+|||++.+..++.++|+||||+++|+|++|.+||....... .+..+......
T Consensus 156 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcC
Confidence 653322 1223357889999999998899999999999999999999999986543211 01000000000
Q ss_pred ------HhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 618 ------RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 618 ------~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
............ ..........+.+++.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000000 0111123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-34 Score=304.61 Aligned_cols=263 Identities=24% Similarity=0.306 Sum_probs=198.5
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeCC-----eEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG-----RRL 466 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~-----~~~ 466 (678)
+|.+.+.||.|++|.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 688999999999999999995 458999999887433 233457889999999999999999999988765 789
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+. ++|.+++.. ..++++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~----gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSA----NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999996 588888843 34799999999999999999999999 9999999999999999999999999999866
Q ss_pred cCCCc--cceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchh-hhh-hH---HHH--
Q 038949 547 PDGDM--GVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCL-TEW-AR---PLL-- 616 (678)
Q Consensus 547 ~~~~~--~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l-~~~-~~---~~~-- 616 (678)
..... .......+++.|+|||++.+. .++.++|+||||+++|+|++|..||........... ... .. ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 44321 122344678899999999887 789999999999999999999999965432110000 000 00 000
Q ss_pred -HHhhhhcc---cCcch---hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 617 -KRHAIGEL---IDPRL---RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 617 -~~~~~~el---ld~~l---~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
........ ..... ........+..+.++|.+||+.+|.+||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00000000 00000 00011223457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-33 Score=298.18 Aligned_cols=260 Identities=22% Similarity=0.282 Sum_probs=190.5
Q ss_pred ccceecccCccceeeccCCCCcEEEEEeeehh--cccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecC
Q 038949 398 EANFLAEGGFGSVHRGVLPDGQVVAVKQYKLA--SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNG 475 (678)
Q Consensus 398 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~--~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~gg 475 (678)
+.+.+|.|+++.||++.. +++.||+|++... .......+.+|+.+++.++|+||+++++++.+.+..+++|||+.+|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455555655555555 7899999998754 2233357889999999999999999999999999999999999999
Q ss_pred CcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc----
Q 038949 476 SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM---- 551 (678)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~---- 551 (678)
+|.+++.......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||.+........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~----~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK----GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999999665555688999999999999999999999 999999999999999999999999998864432111
Q ss_pred --cceeEEEeeecccccccccc--cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH----HHHH------
Q 038949 552 --GVETRVLGTFGYLAPEYAQS--GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR----PLLK------ 617 (678)
Q Consensus 552 --~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~----~~~~------ 617 (678)
.......++..|+|||++.. ..++.++|+|||||++|+|++|..||........ +.+... ....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhh
Confidence 11223456778999999875 3588999999999999999999999975432110 000000 0000
Q ss_pred -Hhhhhc----ccCcc----hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 618 -RHAIGE----LIDPR----LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 618 -~~~~~e----lld~~----l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...... ..++. ............+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000 00000 011112223456889999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-33 Score=327.03 Aligned_cols=251 Identities=27% Similarity=0.390 Sum_probs=188.3
Q ss_pred hhcCCcccceecccCccceeeccCC-CCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeC-------
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED------- 462 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~------- 462 (678)
-..+|..+++||+||||.||+++++ +|+.||||.+.... ......+.+|+.+|.+|+|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4567888999999999999999954 89999999987554 22335788999999999999999988654310
Q ss_pred --------------------------------------------------------------------------------
Q 038949 463 -------------------------------------------------------------------------------- 462 (678)
Q Consensus 463 -------------------------------------------------------------------------------- 462 (678)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhh
Q 038949 463 --------------------------------GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE 510 (678)
Q Consensus 463 --------------------------------~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~ 510 (678)
..+||=||||+..+|.+++....... .....|+++++|++||.|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHh
Confidence 12577888888877777773322211 356789999999999999999
Q ss_pred cceeeeEEeccCCCCceEeeecCcccccccccccccc-----------------CCCccceeEEEeeeccccccccccc-
Q 038949 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP-----------------DGDMGVETRVLGTFGYLAPEYAQSG- 572 (678)
Q Consensus 511 ~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~-----------------~~~~~~~~~~~Gt~~Y~APE~l~~~- 572 (678)
. |||||||||.||+++.++.|||+|||++.... .......+..+||.-|+|||++.+.
T Consensus 716 ~----giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 716 Q----GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred C----ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9 99999999999999999999999999997511 0112245667899999999999764
Q ss_pred --ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc--cchhhhhhhhhcccee
Q 038949 573 --QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC--YSEREVYGMLQCASLC 648 (678)
Q Consensus 573 --~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~--~~~~~~~~l~~LI~~c 648 (678)
.|+.|+|+||||+|||||+. ||....+ +...+..+-++.+... +.......-..+|.+|
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--------------Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSME--------------RASILTNLRKGSIPEPADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHH--------------HHHHHHhcccCCCCCCcccccccchHHHHHHHHH
Confidence 59999999999999999986 5653321 2222222222222222 1111122345789999
Q ss_pred eccCCCCCchHHHHHH
Q 038949 649 IRKDPHSRPRMSQVLR 664 (678)
Q Consensus 649 L~~dP~~RPT~~eVL~ 664 (678)
++.||.+|||+.|+|.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999974
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-34 Score=330.51 Aligned_cols=257 Identities=21% Similarity=0.267 Sum_probs=206.4
Q ss_pred ehhhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehh---cccCCccccccceeeecccccceEEEEeEEe
Q 038949 385 TYAELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA---SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460 (678)
Q Consensus 385 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 460 (678)
...++....++|.++++||+|+||.|.+++. .+++.||+|++... ......-|..|-.+|.....+=|++++-.|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 3456677789999999999999999999995 57899999998752 2333456888999988888899999999999
Q ss_pred eCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 461 ~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
++.++||||||++||+|..++.... ++++..++.++..|+.||..||+. |+|||||||+|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m----gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM----GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc----cceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999995443 799999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCccceeEEEeeecccccccccc-----cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQS-----GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 615 (678)
|.+-.............+|||.|.+||++.. +.|+..+|.||+||++|||+.|..||.... ....+.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----lveTY~--- 291 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----LVETYG--- 291 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----HHHHHH---
Confidence 9998776555556667789999999999952 678999999999999999999999995321 111111
Q ss_pred HHHhhhhcccCcchhcccc--hhhhhhhhhccceeeccCCCCCch---HHHHH
Q 038949 616 LKRHAIGELIDPRLRNCYS--EREVYGMLQCASLCIRKDPHSRPR---MSQVL 663 (678)
Q Consensus 616 ~~~~~~~elld~~l~~~~~--~~~~~~l~~LI~~cL~~dP~~RPT---~~eVL 663 (678)
.+++-.-.-.+| ...+....+||++.+. +|+.|.. ++++-
T Consensus 292 -------KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 292 -------KIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred -------HHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 111111111122 3355567777776654 6777777 66664
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=286.52 Aligned_cols=271 Identities=23% Similarity=0.311 Sum_probs=207.4
Q ss_pred eehhhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeeccc-c-c----ceEEEE
Q 038949 384 FTYAELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-H-R----NVVMLI 456 (678)
Q Consensus 384 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-H-p----nIv~l~ 456 (678)
+-+...+...++|.+...+|+|.||.|..+.. .++..||||+++.... -.+..+-|+++|.++. + | -++++.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 45666677899999999999999999999883 4578999999974432 2244566888998883 2 3 378888
Q ss_pred eEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-----
Q 038949 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH----- 531 (678)
Q Consensus 457 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~----- 531 (678)
++|...++.|||+|.+ |-++.+++......+++...++.++.|++++++|||+. +++|-||||+|||+..
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~----kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL----KLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc----ceeecCCChheEEEeccceEE
Confidence 9999999999999998 77999999887888899999999999999999999999 9999999999999942
Q ss_pred ---------------cCccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCcc
Q 038949 532 ---------------DFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKA 596 (678)
Q Consensus 532 ---------------~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~P 596 (678)
+..++|+|||.|++..... ...+.|..|.|||++.+-+++.++||||+||||+||+||...
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 3457899999998654332 667889999999999999999999999999999999999999
Q ss_pred ccccCCcccchhhh-----hhHHHHHHhhhhc-----ccC------------------cch-hcccchhhhhhhhhccce
Q 038949 597 MDLNRPRGQQCLTE-----WARPLLKRHAIGE-----LID------------------PRL-RNCYSEREVYGMLQCASL 647 (678)
Q Consensus 597 f~~~~~~~~~~l~~-----~~~~~~~~~~~~e-----lld------------------~~l-~~~~~~~~~~~l~~LI~~ 647 (678)
|......+...+.+ .-..++......+ -+| |.. .......+...|.+|+++
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 97655322211111 0011111110000 001 000 001112344568999999
Q ss_pred eeccCCCCCchHHHHHH
Q 038949 648 CIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 648 cL~~dP~~RPT~~eVL~ 664 (678)
||..||.+|+|+.|+|.
T Consensus 389 mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 389 MLEFDPARRITLREALS 405 (415)
T ss_pred HHccCccccccHHHHhc
Confidence 99999999999999885
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-34 Score=306.40 Aligned_cols=263 Identities=24% Similarity=0.290 Sum_probs=193.1
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeC---------
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED--------- 462 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--------- 462 (678)
..+|.+.+.||.|+||.||+|.. .+++.||+|.+..........+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 47899999999999999999984 57899999998766555556788899999999999999999776543
Q ss_pred -----CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-cCccc
Q 038949 463 -----GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-DFEPL 536 (678)
Q Consensus 463 -----~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-~~~vk 536 (678)
...|+||||+. ++|.+++. ...+++..++.++.||+.||.|||+. ||+||||||+||+++. ++.++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~----givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCceEE
Confidence 35799999995 58887773 23588999999999999999999998 9999999999999984 56789
Q ss_pred cccccccccccCCCc--cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhh--
Q 038949 537 VGDFGLARWQPDGDM--GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEW-- 611 (678)
Q Consensus 537 L~DFGla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~-- 611 (678)
|+|||++........ .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||....+.........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999975432111 11122357889999998754 5678899999999999999999999965432111000000
Q ss_pred -------hHHHHHH--hhhh---cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 612 -------ARPLLKR--HAIG---ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 612 -------~~~~~~~--~~~~---elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....... .... ....... ..........+.+|+.+||+.||.+|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPL-RDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCH-HHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000 0000 0000000 0011123456889999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-33 Score=296.25 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=192.6
Q ss_pred hhhhcCCcccceecccCccceeeccCC-CCcEEEEEeeehhcc-cCCccccccceeeecc-cccceEEEEeEEeeCCeEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~ 466 (678)
....++|.+.+.||+|+||.||+|.+. +++.||||.++.... .....+..|+.++..+ .||||+++++++.++...|
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 445578999999999999999999964 589999999874322 2224456677666556 4999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+ +++|.+++... ...+++..+..++.|++.||.|||+.+ ||+||||+|+||+++.++.++|+|||++...
T Consensus 91 ~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 91 ICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999998 55676666432 346889999999999999999999731 8999999999999999999999999998755
Q ss_pred cCCCccceeEEEeeecccccccccccc----cceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQ----ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
..... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... .+...... .
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~-----~ 233 (296)
T cd06618 166 VDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKIL-----Q 233 (296)
T ss_pred cCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHh-----c
Confidence 33221 12234778899999987543 788999999999999999999998642110 00000000 0
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.. .+.. .........+.+|+.+||+.||++||++.++++.
T Consensus 234 ~~-~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 234 EE-PPSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC-CCCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0000 0111234578999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-33 Score=292.35 Aligned_cols=261 Identities=27% Similarity=0.343 Sum_probs=195.5
Q ss_pred CcccceecccCccceeeccCC-CCcEEEEEeeehhccc-CCccccccceeeeccc-ccceEEEEeEEeeCCeEEEEEEEe
Q 038949 396 FSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGRRLLVYEYI 472 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~LV~E~~ 472 (678)
|.+.+.||+|++|.||+|... +++.|++|.+...... ......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677889999999999999954 5889999988643221 1223456888899998 999999999999999999999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 552 (678)
+|+|.+++.......+++..+..++.|++.+|.|||++ |++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH----GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 88999888655445689999999999999999999998 99999999999999999999999999997554322
Q ss_pred ceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccch----------hhhhhHHHHHHhhh
Q 038949 553 VETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC----------LTEWARPLLKRHAI 621 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~----------l~~~~~~~~~~~~~ 621 (678)
......++..|+|||++.. ..++.++|+||||+++|+|++|..||.......... ...|..........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 1233457889999998754 457899999999999999999999986543211100 00011100000000
Q ss_pred hcccC----cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 622 GELID----PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 622 ~elld----~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+. ..+. .........+.+++.+||+.||++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000 0011 111122457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-33 Score=295.99 Aligned_cols=248 Identities=28% Similarity=0.396 Sum_probs=193.8
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
....|...+.||+|+||.||+|.. .+++.+|+|.+..... .....+.+|+++++.++|+|++++++++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 445688889999999999999994 4688999998864222 122457789999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+. |+|.+++... ..++++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++....
T Consensus 93 v~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 93 VMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 999995 6777766432 34588899999999999999999998 99999999999999999999999999987543
Q ss_pred CCCccceeEEEeeeccccccccc---ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQ---SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
.. ....+++.|+|||.+. .+.++.++|||||||++|+|++|..||........ .. .....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~----------~~~~~ 229 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LY----------HIAQN 229 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HH----------HHhhc
Confidence 22 2345788999999874 35678899999999999999999999854321000 00 00000
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
..+.. ........+.++|.+||+.+|++||+++++++.
T Consensus 230 ~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 230 ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred CCCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 00111 112334568899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-33 Score=299.03 Aligned_cols=261 Identities=23% Similarity=0.297 Sum_probs=193.9
Q ss_pred hcCCcc-cceecccCccceeeccC-CCCcEEEEEeeehhcccC--------------CccccccceeeecccccceEEEE
Q 038949 393 TNRFSE-ANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG--------------DQEFCSEVEVLSCAQHRNVVMLI 456 (678)
Q Consensus 393 ~~~y~~-~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~--------------~~~~~~Ev~iL~~L~HpnIv~l~ 456 (678)
.++|.. .+.||.|+||.||+|.. .+++.||+|.++...... ...+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456764 57799999999999984 478999999886433221 11467899999999999999999
Q ss_pred eEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccc
Q 038949 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL 536 (678)
Q Consensus 457 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vk 536 (678)
+++..++..++||||+. |+|.+++. ....+++.....++.|++.||.|||+. ||+|+||+|+||+++.++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~----~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKW----YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHeEECCCCCEE
Confidence 99999999999999995 68988884 344588899999999999999999998 999999999999999999999
Q ss_pred cccccccccccCCC-------------ccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCC
Q 038949 537 VGDFGLARWQPDGD-------------MGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRP 602 (678)
Q Consensus 537 L~DFGla~~~~~~~-------------~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~ 602 (678)
|+|||++....... ........+++.|+|||.+.+. .++.++|+||||+++|+|++|..||....+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999997554110 0111123467889999998764 468999999999999999999999975432
Q ss_pred cccchhhhhhHHHHHHhh---h------------hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 603 RGQQCLTEWARPLLKRHA---I------------GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 603 ~~~~~l~~~~~~~~~~~~---~------------~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... +.. ......... . .....+... ......+..+.++|.+||+.+|++||++++++.
T Consensus 240 ~~~--~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQ--LGR-IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHH--HHH-HHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 111 000 000000000 0 000000000 011223456889999999999999999999985
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-33 Score=295.30 Aligned_cols=265 Identities=26% Similarity=0.295 Sum_probs=192.5
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeC-------
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVED------- 462 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~------- 462 (678)
.++|.+.+.||+|+||.||+|.. .+++.+|+|.+...... ....+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999994 46889999988643322 224567899999999999999999987543
Q ss_pred -CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 463 -GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 463 -~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
..+++||||+. ++|...+.. ....+++..+..++.|+++||.|||+. ||+|+||||+||+++.++.++|+|||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHEN----HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECcCc
Confidence 34699999985 466666643 234689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCc----------cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhh-
Q 038949 542 LARWQPDGDM----------GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT- 609 (678)
Q Consensus 542 la~~~~~~~~----------~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~- 609 (678)
+++....... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9975432211 11123467889999998765 45789999999999999999999998643321110000
Q ss_pred h-hhH----HHHHHhhhhc--------ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 610 E-WAR----PLLKRHAIGE--------LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 610 ~-~~~----~~~~~~~~~e--------lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. +.. .+.....+.. ...+.+...+ ......+.++|.+||+.||.+|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 000 0000000000 0011111100 112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-33 Score=301.66 Aligned_cols=264 Identities=25% Similarity=0.307 Sum_probs=196.5
Q ss_pred hhhhhhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeC
Q 038949 386 YAELELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVED 462 (678)
Q Consensus 386 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 462 (678)
..++....++|.+.+.||+|+||.||+|. ..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 34556678999999999999999999998 45789999998864321 2234677899999999999999999988643
Q ss_pred ------CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccc
Q 038949 463 ------GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL 536 (678)
Q Consensus 463 ------~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vk 536 (678)
...|++++++ +++|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEcCCCCEE
Confidence 3468888886 8899887732 3588999999999999999999999 999999999999999999999
Q ss_pred cccccccccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHH-
Q 038949 537 VGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP- 614 (678)
Q Consensus 537 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~- 614 (678)
|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ +......
T Consensus 161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~ 234 (345)
T cd07877 161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLV 234 (345)
T ss_pred Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHh
Confidence 9999998754321 233467889999998865 5688999999999999999999999854322110 0000000
Q ss_pred ------HHH------Hhhhh----cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 ------LLK------RHAIG----ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 ------~~~------~~~~~----elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... ..... ......+.. ........+.++|.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 000 00000 000000000 00113446889999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-34 Score=282.41 Aligned_cols=258 Identities=24% Similarity=0.371 Sum_probs=197.9
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeee-cccccceEEEEeEEeeCCeEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLS-CAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~-~L~HpnIv~l~~~~~~~~~~~L 467 (678)
...++.+-+..||.|+||.|++-.+ +.|+..|||+++.... ....+++.|.++.. .-.+||||++||.+-.++..|+
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi 140 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI 140 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence 3445566677899999999999984 6899999999986554 23356777777654 4479999999999988899999
Q ss_pred EEEEeecCCccc---ccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 468 VYEYICNGSLDS---HLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 468 V~E~~~ggsL~~---~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.||+| ..+|+. +++......+++...-.+....+.||.||-+.. .|||||+||+|||++..|.+||||||++.
T Consensus 141 CMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l---kiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 141 CMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL---KIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh---hhhhccCChhheEEecCCCEeeecccchH
Confidence 99998 556543 334455667999999999999999999998875 79999999999999999999999999997
Q ss_pred cccCCCccceeEEEeeecccccccccc--cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQS--GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
...+. ...+.-.|...|||||.+.. ..|+.++||||||++|||+.||..|+... ..-+.+-..+.
T Consensus 217 qLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-----------~svfeql~~Vv 283 (361)
T KOG1006|consen 217 QLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-----------DSVFEQLCQVV 283 (361)
T ss_pred hHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-----------HHHHHHHHHHH
Confidence 65432 23344568899999999864 45899999999999999999999998643 22222211111
Q ss_pred cccCcchhcc-cchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 623 ELIDPRLRNC-YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 623 elld~~l~~~-~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
..-.|.+... -.-+.+..|..+|.-||.+|-..||.+.+++.+
T Consensus 284 ~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 284 IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1111222111 113355689999999999999999999998753
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-33 Score=289.16 Aligned_cols=245 Identities=21% Similarity=0.282 Sum_probs=197.3
Q ss_pred hhhhcCCcccceecccCccceeeccCC-CCcEEEEEeeehhcc---cCCccccccceeeecc-cccceEEEEeEEeeCCe
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASS---QGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~ 464 (678)
.+-..+|.++.+||+|+||.|.+|..+ +.+.||||+++..-. ++.+--+.|-++|... +-|.++++..+|++-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 344568999999999999999999853 577999999974322 2223345677787766 46889999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+|+||||+.||+|--++ +.-+.+.+..+..++.+|+-||-+||++ |||+||||.+||||+.+|++||+|||++.
T Consensus 425 LyFVMEyvnGGDLMyhi--QQ~GkFKEp~AvFYAaEiaigLFFLh~k----gIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHI--QQVGKFKEPVAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeeEEEEecCchhhhHH--HHhcccCCchhhhhhHHHHHHhhhhhcC----CeeeeeccccceEeccCCceEeeeccccc
Confidence 99999999999999888 4556799999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
.---+ .....+++|||.|+|||++...+|+..+|.|||||+||||+.|++||+..+... +++. +
T Consensus 499 Eni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e----------lF~a-----I 562 (683)
T KOG0696|consen 499 ENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------LFQA-----I 562 (683)
T ss_pred ccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH----------HHHH-----H
Confidence 43222 234567899999999999999999999999999999999999999998765421 1111 1
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCch
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR 658 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT 658 (678)
.+. ...||...+.+...+....|...|.+|..
T Consensus 563 ~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 MEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHc--cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 111 11244455556777788888899998853
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-33 Score=306.48 Aligned_cols=240 Identities=25% Similarity=0.276 Sum_probs=195.7
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEeeCCeEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
.+..|.+...+|.|+|+.|-.+. ..+++.+++|++... ..+..+|+.++... +||||+++.+.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 46778898899999999999988 467899999998744 23455678776666 6999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe-eecCccccccccccccccC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV-THDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl-~~~~~vkL~DFGla~~~~~ 548 (678)
|++.|+.|.+.+..... +. ..+..|+.+|+.|+.|||++ |+|||||||+|||+ +..++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~----gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQ----GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhc----CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999999888843322 33 67778999999999999999 99999999999999 5899999999999986644
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
. ....+-|..|.|||++....|+.++|+||||++||+||+|+.||..... + .++....
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~-~-----------------~ei~~~i 526 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA-G-----------------IEIHTRI 526 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc-h-----------------HHHHHhh
Confidence 3 2344568899999999999999999999999999999999999975432 1 0111111
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+.++...+...++|+.+||+.||.+||++.+++.
T Consensus 527 ~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 527 QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 112233455668999999999999999999999864
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=293.25 Aligned_cols=246 Identities=29% Similarity=0.413 Sum_probs=192.4
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc---CCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
+.|...+.||+|+||.||+|.. .+++.|++|.+...... ....+.+|+.+++.++|||++++++++.+....|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 3477788899999999999984 47889999988643222 2245778999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+. |+|.+++.. ...++++..+..++.||+.||.|||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 101 e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 101 EYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred ecCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 9994 677776643 234688999999999999999999998 999999999999999999999999999864322
Q ss_pred CccceeEEEeeeccccccccc---ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 550 DMGVETRVLGTFGYLAPEYAQ---SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.....|+..|+|||++. .+.++.++||||||+++|+|++|..||........ ...... .. .
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~----~~--~ 237 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ----ND--S 237 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHh----cC--C
Confidence 22346888999999984 45688899999999999999999999864332110 000000 00 0
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
+.. .....+..+.+++.+||+.+|.+||++.+++..
T Consensus 238 ~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 PTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 112233468899999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-33 Score=288.06 Aligned_cols=248 Identities=24% Similarity=0.289 Sum_probs=192.6
Q ss_pred CCcccceecccCccceeeccCC-CCcEEEEEeeehhcc-----cCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASS-----QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~-----~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
+|.+.+.||+|+||.||++... .+..+++|.++.... .....+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6889999999999999999843 345566666543211 1223466788999999999999999999998999999
Q ss_pred EEEeecCCccccccc--CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 469 YEYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
|||+.+++|.+++.. .....+++..++.++.|++.||.|||+. |++|+||+|+||+++. +.++|+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR----RILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc----CccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999988743 2345689999999999999999999998 9999999999999975 56999999998765
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ...... ......
T Consensus 156 ~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~------~~~~~~ 222 (260)
T cd08222 156 MGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLR------IVEGPT 222 (260)
T ss_pred CCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH------HHcCCC
Confidence 3322 222334578899999999888889999999999999999999999853221 111110 001111
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+. .+...+..+.++|.+||+.||++||++.++++
T Consensus 223 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11 22344557899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-33 Score=309.72 Aligned_cols=201 Identities=33% Similarity=0.428 Sum_probs=172.4
Q ss_pred CcccceecccCccceeecc-CCCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCC------eEEE
Q 038949 396 FSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG------RRLL 467 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~------~~~L 467 (678)
+...+.||+||||.||+|+ ..+|+.||||.++.... ...+...+|+++|+++.|+|||+++++-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4455679999999999999 46899999999875432 23367889999999999999999999865543 4689
Q ss_pred EEEEeecCCcccccccC-CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec--C--ccccccccc
Q 038949 468 VYEYICNGSLDSHLYGR-DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD--F--EPLVGDFGL 542 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~--~--~vkL~DFGl 542 (678)
|||||.||+|...+..- +...|++...+.++..++.||.|||++ ||+||||||.||++-.. | ..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn----~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN----GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc----CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999543 335699999999999999999999998 99999999999998532 3 478999999
Q ss_pred cccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCC
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRP 602 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~ 602 (678)
|+...++. .....+||..|++||++.. +.|+..+|.|||||++|+..||..||.....
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 99776554 6788999999999999984 8899999999999999999999999976543
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-33 Score=295.87 Aligned_cols=264 Identities=23% Similarity=0.313 Sum_probs=195.8
Q ss_pred hhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEee-CCeE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE-DGRR 465 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-~~~~ 465 (678)
....++|++.+.||.|+||.||++. ..+++.||+|.+.... ......+.+|+.+++.++||||++++++|.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 4567899999999999999999998 4578999999875322 2223567789999999999999999999865 5578
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++||||+ +++|..++. ..++++..+..++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~----~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSA----GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 678887773 23578888889999999999999999 999999999999999999999999999874
Q ss_pred ccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccch-h--------hhhhHHH
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC-L--------TEWARPL 615 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~-l--------~~~~~~~ 615 (678)
.... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... + .++....
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4221 123456888999998866 568999999999999999999999996433211000 0 0000000
Q ss_pred HHHhh---hhccc--CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 616 LKRHA---IGELI--DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 616 ~~~~~---~~ell--d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
..... +..+. .+.............+.++|.+||+.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000 0000000111234578999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=287.66 Aligned_cols=258 Identities=26% Similarity=0.375 Sum_probs=200.9
Q ss_pred hhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCC-------ccccccceeeecccccceEEEEeEEee-
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD-------QEFCSEVEVLSCAQHRNVVMLIGFCVE- 461 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~-------~~~~~Ev~iL~~L~HpnIv~l~~~~~~- 461 (678)
...++|-++.+||+|||+.||+|. ....+.||+|+...+..... ...++|..|.+.|.||.||++|++|.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 456689999999999999999998 45688999998765443222 357889999999999999999999864
Q ss_pred CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee---ecCccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT---HDFEPLVG 538 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~---~~~~vkL~ 538 (678)
.+.+|-|+|||+|.+|+.|| +....+++..++.|+.||+.||.||.+..+ .|||-||||.||||- ..|.+||.
T Consensus 540 tdsFCTVLEYceGNDLDFYL--KQhklmSEKEARSIiMQiVnAL~YLNEikp--PIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYL--KQHKLMSEKEARSIIMQIVNALKYLNEIKP--PIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHH--HhhhhhhHHHHHHHHHHHHHHHHHHhccCC--CeeeeccCCccEEEecCcccceeEee
Confidence 55789999999999999999 555669999999999999999999999855 699999999999995 46899999
Q ss_pred cccccccccCCCc------cceeEEEeeecccccccccc----cccceecceeeeeeEEEEeeeCCccccccCCcccchh
Q 038949 539 DFGLARWQPDGDM------GVETRVLGTFGYLAPEYAQS----GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCL 608 (678)
Q Consensus 539 DFGla~~~~~~~~------~~~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l 608 (678)
|||++....+..+ .......||.+|++||.+-- .+.+.++||||.|||+|+.+.|+.||+.+.. ++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQ-- 691 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQ-- 691 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HH--
Confidence 9999987654322 23344679999999998753 3568899999999999999999999986542 11
Q ss_pred hhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHH
Q 038949 609 TEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663 (678)
Q Consensus 609 ~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL 663 (678)
..++.+.+.....-.+ .--+..+.....+|++||+.--++|....++.
T Consensus 692 -----dILqeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 -----DILQENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -----HHHhhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1222222222111111 11123445688899999999999998777764
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-33 Score=299.45 Aligned_cols=261 Identities=24% Similarity=0.338 Sum_probs=192.6
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCC------
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG------ 463 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~------ 463 (678)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 57899999999999999999984 4789999998864321 12245778999999999999999999987542
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
.+++|+||+. .+|..++ ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.++|+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA----GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 4699999985 4665554 23588899999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH------H--
Q 038949 544 RWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR------P-- 614 (678)
Q Consensus 544 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~------~-- 614 (678)
+..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ +..... +
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~ 238 (342)
T cd07879 165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGPEF 238 (342)
T ss_pred cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHH
Confidence 754322 223467889999999876 4688999999999999999999999964332110 000000 0
Q ss_pred --HHHH----hhh---hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH--Hhhcc
Q 038949 615 --LLKR----HAI---GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR--MLEGD 669 (678)
Q Consensus 615 --~~~~----~~~---~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~--~Le~~ 669 (678)
.... ... .......+.. ..+.....+.++|.+||+.||.+||++.+++. .+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000 000 0000000000 01123446889999999999999999999984 35543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=303.92 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=215.7
Q ss_pred hhhhhhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEee--
Q 038949 386 YAELELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVE-- 461 (678)
Q Consensus 386 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~-- 461 (678)
+..+...++.|.+...||.|.+|.||++. .++++..|+|++.... +..+++..|.++|+.+ .|||++.++|+|..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 44445567789999999999999999999 4689999999987554 4456788899999887 59999999999864
Q ss_pred ---CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccc
Q 038949 462 ---DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVG 538 (678)
Q Consensus 462 ---~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~ 538 (678)
++.+|||||||.||+..|++.......+.|..+..|++.++.||.|||.+ .++|||+|-.|||++.++.|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n----kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN----KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc----ceeeecccCceEEEeccCcEEEe
Confidence 56899999999999999999776678899999999999999999999999 89999999999999999999999
Q ss_pred cccccccccCCCccceeEEEeeecccccccccc-----cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH
Q 038949 539 DFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS-----GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 539 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~ 613 (678)
|||++.... .+.....+.+|||.|||||++.. ..|+.++|+||||++..||.-|.+|+....|....+
T Consensus 166 DFGvSaQld-sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF------ 238 (953)
T KOG0587|consen 166 DFGVSAQLD-STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF------ 238 (953)
T ss_pred eeeeeeeee-cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc------
Confidence 999997653 34455667889999999999964 357889999999999999999999987655422111
Q ss_pred HHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 614 PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 614 ~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+.. +|...-.-+...+..|.++|+.||..|-++||++.++|+
T Consensus 239 ------~IpR--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 ------LIPR--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ------cCCC--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0111 233333345677789999999999999999999999875
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-33 Score=297.89 Aligned_cols=261 Identities=22% Similarity=0.316 Sum_probs=195.2
Q ss_pred hhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCC---
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG--- 463 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~--- 463 (678)
....++|++.+.||+|+||.||++. ..+++.||+|.+...... ....+.+|+.+++.++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 3457889999999999999999998 457899999988532211 2245778999999999999999999987643
Q ss_pred ---eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 464 ---RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 464 ---~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
.+++||||+ +++|.+++. ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~----gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAA----GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999998 788888773 24589999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccch-h--------hh
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC-L--------TE 610 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~-l--------~~ 610 (678)
|++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... . ..
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 163 GLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 999754322 123457889999998876 457899999999999999999999996433210000 0 00
Q ss_pred hhHHHHHH--hhh----hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHH
Q 038949 611 WARPLLKR--HAI----GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663 (678)
Q Consensus 611 ~~~~~~~~--~~~----~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL 663 (678)
+....... ... .......+ ..........+.++|.+||+.||++|||+.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00000000 000 00000000 011123445688999999999999999999988
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-33 Score=296.84 Aligned_cols=261 Identities=24% Similarity=0.306 Sum_probs=189.8
Q ss_pred CCcccceecccCccceeeccCC-C--CcEEEEEeeehhcc--cCCccccccceeeecc-cccceEEEEeEEeeC----Ce
Q 038949 395 RFSEANFLAEGGFGSVHRGVLP-D--GQVVAVKQYKLASS--QGDQEFCSEVEVLSCA-QHRNVVMLIGFCVED----GR 464 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~~-~--g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~----~~ 464 (678)
+|.+.+.||+|+||.||++... + +..||+|.+..... .....+.+|+.+++++ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5888999999999999999943 4 78999998863221 1234677899999988 599999999875432 45
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+|+++||+ +++|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++.
T Consensus 81 ~~~~~e~~-~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELM-EADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSA----NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEecc-cCCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 78899988 568888883 345689999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCc---cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCccc-------------ch
Q 038949 545 WQPDGDM---GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQ-------------QC 607 (678)
Q Consensus 545 ~~~~~~~---~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~-------------~~ 607 (678)
....... .......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||........ ..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 5543211 11233568999999998765 4689999999999999999999999865432110 00
Q ss_pred hhhhhHHHHHHh--hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHH
Q 038949 608 LTEWARPLLKRH--AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663 (678)
Q Consensus 608 l~~~~~~~~~~~--~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL 663 (678)
+..+..+..... .........+.. ........+.+++.+||+.||.+|||+.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000000000000 000000000111 1112345788999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-33 Score=287.04 Aligned_cols=261 Identities=26% Similarity=0.343 Sum_probs=195.5
Q ss_pred CcccceecccCccceeeccC-CCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEe
Q 038949 396 FSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYI 472 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~ 472 (678)
|+..+.||+|++|.||+|.. .+++.||+|.+.... ......+..|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56778899999999999995 468999999987553 222356778999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 552 (678)
. ++|.+++.... ..+++..+..++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH----RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 6 58999885432 4589999999999999999999999 999999999999999999999999999975543221
Q ss_pred ceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccch-hhh-------hhHHHHHH-----
Q 038949 553 VETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC-LTE-------WARPLLKR----- 618 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~-l~~-------~~~~~~~~----- 618 (678)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.......... ... ...+....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 12223457789999998766 78999999999999999999999986533211000 000 00000000
Q ss_pred hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 619 ~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..............+ +.....+.++|.+||+.||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000111 112457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-33 Score=300.60 Aligned_cols=262 Identities=22% Similarity=0.312 Sum_probs=194.8
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeCCe---
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR--- 464 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~--- 464 (678)
...++|.+.+.||+|++|.||+|.. .+++.||+|.+.... ......+.+|+.+++.+.||||+++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3467899999999999999999995 468899999876432 2223457789999999999999999988766554
Q ss_pred ---EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 465 ---RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 465 ---~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
.++|+||+ +++|.+++.. .++++..++.++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA----GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 7799888843 4589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccc-hhhh--------h
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQ-CLTE--------W 611 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~-~l~~--------~ 611 (678)
++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... .+.. +
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 99755332 223457888999998865 36789999999999999999999999643321100 0000 0
Q ss_pred hHHHHHH--hhhhcccCcchhccc---chhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 612 ARPLLKR--HAIGELIDPRLRNCY---SEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 612 ~~~~~~~--~~~~elld~~l~~~~---~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....... ..+...+.......+ ....+..+.++|.+||+.||.+|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000 000000000000000 0123557899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=314.75 Aligned_cols=263 Identities=29% Similarity=0.413 Sum_probs=214.0
Q ss_pred hhhhhhcCCcccceecccCccceeeccCC----C----CcEEEEEeeehhccc-CCccccccceeeecc-cccceEEEEe
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVLP----D----GQVVAVKQYKLASSQ-GDQEFCSEVEVLSCA-QHRNVVMLIG 457 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~----~----g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L-~HpnIv~l~~ 457 (678)
.++...++..+.+.||+|+||.|++|... . ...||||.++..... ....+..|+++|+.+ .|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 46777788888889999999999999721 1 457999998744333 346799999999998 5999999999
Q ss_pred EEeeCCeEEEEEEEeecCCcccccccCC------------C--CccCccccchhhhhhccchhhhhhcceeeeEEeccCC
Q 038949 458 FCVEDGRRLLVYEYICNGSLDSHLYGRD------------R--DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMR 523 (678)
Q Consensus 458 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~------------~--~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLK 523 (678)
+|...+.+++|+||+..|+|.+++.... . ..++....+.++.||+.|++||++. .+|||||.
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~----~~vHRDLA 445 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV----PCVHRDLA 445 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC----Cccchhhh
Confidence 9999999999999999999999995544 0 1377788899999999999999999 89999999
Q ss_pred CCceEeeecCccccccccccccccCCCccceeEEE--eeecccccccccccccceecceeeeeeEEEEeee-CCcccccc
Q 038949 524 PNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL--GTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLN 600 (678)
Q Consensus 524 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~--Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~ 600 (678)
.+|||++.+..+||+|||+++.............. -...|||||.+....|+.++||||||++||||+| |..||...
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999966554443322222 2456999999999999999999999999999998 67777431
Q ss_pred CCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 601 RPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 601 ~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
.. ...+.+.+.+..+...|..+..++++++..||+.+|++||++.++.+.|+..
T Consensus 526 ~~---------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 PP---------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred Cc---------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 10 0011223344555566777788999999999999999999999999999884
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=279.80 Aligned_cols=236 Identities=28% Similarity=0.300 Sum_probs=190.7
Q ss_pred ecccCccceeeccC-CCCcEEEEEeeehhccc---CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCc
Q 038949 402 LAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSL 477 (678)
Q Consensus 402 LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 477 (678)
||+|+||.||++.. .+++.+|+|.+...... ....+..|+.+++.++||||+++++.+..+...++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999985 36889999998754322 234688899999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccceeEE
Q 038949 478 DSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV 557 (678)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 557 (678)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~----~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 81 FSHLSK--EGRFSEERARFYAAEIVLALEYLHSL----GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 999843 34589999999999999999999998 99999999999999999999999999997654322 123345
Q ss_pred EeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhh
Q 038949 558 LGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSERE 637 (678)
Q Consensus 558 ~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~ 637 (678)
.++..|++||.+.+..++.++|+||||+++|+|++|..||..... ...... +.. ....++...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~---------~~~--~~~~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEK---------ILK--DPLRFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHH---------Hhc--CCCCCCCCC
Confidence 678899999999888889999999999999999999999964322 000000 000 011123333
Q ss_pred hhhhhhccceeeccCCCCCchHHH
Q 038949 638 VYGMLQCASLCIRKDPHSRPRMSQ 661 (678)
Q Consensus 638 ~~~l~~LI~~cL~~dP~~RPT~~e 661 (678)
+..+.+++.+||..||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 557899999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=315.73 Aligned_cols=146 Identities=27% Similarity=0.350 Sum_probs=129.6
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc---CCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++..... ....+..|+.++..++||||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 36899999999999999999995 47899999998743322 125678899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||.. ||+||||||+||||+.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~----gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRH----GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999843 34588889999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-33 Score=285.70 Aligned_cols=256 Identities=26% Similarity=0.348 Sum_probs=196.6
Q ss_pred cceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeeccc-ccceEEEEeEEeeCCeEEEEEEEeecCC
Q 038949 399 ANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGRRLLVYEYICNGS 476 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~LV~E~~~ggs 476 (678)
.+.||+|+|+.|--+. ..+|..||||++.........+..+|++++...+ |+||++|+++|+++..+|||||.|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3579999999999988 6789999999998776666678999999998885 9999999999999999999999999999
Q ss_pred cccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC---ccccccccccccccCCC---
Q 038949 477 LDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF---EPLVGDFGLARWQPDGD--- 550 (678)
Q Consensus 477 L~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~---~vkL~DFGla~~~~~~~--- 550 (678)
|..+|. .+..+++..+.++...|+.||.|||.+ ||.||||||+|||..+.. -+||+||.+..-+....
T Consensus 163 lLshI~--~~~~F~E~EAs~vvkdia~aLdFlH~k----gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQ--KRKHFNEREASRVVKDIASALDFLHTK----GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHH--HhhhccHHHHHHHHHHHHHHHHHHhhc----CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999994 445699999999999999999999999 999999999999997643 48999999885322111
Q ss_pred ---ccceeEEEeeeccccccccc-----ccccceecceeeeeeEEEEeeeCCccccccCCc------ccchhhhhhHHHH
Q 038949 551 ---MGVETRVLGTFGYLAPEYAQ-----SGQITEKADVYSLGVVLVELITGRKAMDLNRPR------GQQCLTEWARPLL 616 (678)
Q Consensus 551 ---~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~------~~~~l~~~~~~~~ 616 (678)
.....+.+|+..|||||+.. ...|+.++|.||||||||-||.|.+||...-.. +..|- .-...++
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr-~CQ~~LF 315 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR-VCQNKLF 315 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH-HHHHHHH
Confidence 11223467888999999763 346899999999999999999999999653221 11111 1111111
Q ss_pred HHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 617 KRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 617 ~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+ .+.+--... ...--...+....+|++.+|-.|+.+|.++.+++.
T Consensus 316 e--sIQEGkYeF-PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 316 E--SIQEGKYEF-PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred H--HHhccCCcC-ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1 111110000 01111235567789999999999999999998876
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-33 Score=281.24 Aligned_cols=203 Identities=26% Similarity=0.384 Sum_probs=169.5
Q ss_pred hhcCCcccceecccCccceeeccC-C--C--CcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEee-CC
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-P--D--GQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVE-DG 463 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~--~--g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-~~ 463 (678)
.-..|+..+.||+|.||.||+|.. + + .+.+|||.++..... .....++|+.+++.++||||+.+..+|.+ +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 345799999999999999999962 1 2 237999998744322 22568899999999999999999999887 88
Q ss_pred eEEEEEEEeecCCccccccc---CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec----Cccc
Q 038949 464 RRLLVYEYICNGSLDSHLYG---RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD----FEPL 536 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~---~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~----~~vk 536 (678)
.++|++||.+. +|...|.- .....++...+..++.||+.|+.|||++ =|+||||||.|||+..+ |.||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N----WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN----WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh----heeeccCCcceEEEeccCCccCeeE
Confidence 89999999855 77777632 1234688889999999999999999999 79999999999999988 9999
Q ss_pred cccccccccccCC--CccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccc
Q 038949 537 VGDFGLARWQPDG--DMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDL 599 (678)
Q Consensus 537 L~DFGla~~~~~~--~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~ 599 (678)
|+|||+++.+.+. ........+-|.+|.|||.+.+ ..|+.+.|||+.|||+.||+|-.+.|..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999999977653 2334566788999999999887 4689999999999999999999888754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=290.52 Aligned_cols=270 Identities=27% Similarity=0.411 Sum_probs=200.2
Q ss_pred cCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeec--ccccceEEEEeEEeeCC----eEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSC--AQHRNVVMLIGFCVEDG----RRLL 467 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~--L~HpnIv~l~~~~~~~~----~~~L 467 (678)
...++.++||+|.||.||+|.+ +++.||||++.... .+.|.+|-+|.+. ++|+||++|+++-.... .++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3455677899999999999998 46899999997543 3467777776654 58999999999865544 7999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhccee-----eeEEeccCCCCceEeeecCccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRV-----GCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~-----~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
|+||.+.|+|.+||. ...++|....+++..|++||+|||+..+. .+|+|||||.+||||..|+...|+|||+
T Consensus 286 Vt~fh~kGsL~dyL~---~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLK---ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EeeeccCCcHHHHHH---hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999993 34589999999999999999999987554 2599999999999999999999999999
Q ss_pred cccccCC-CccceeEEEeeeccccccccccc-ccc-----eecceeeeeeEEEEeeeCCccccccCCcccchhh---hh-
Q 038949 543 ARWQPDG-DMGVETRVLGTFGYLAPEYAQSG-QIT-----EKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT---EW- 611 (678)
Q Consensus 543 a~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~-~~s-----~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~---~~- 611 (678)
|..+..+ .......-+||.+|||||++.+. .+. .+.||||+|.|||||++....++...+ ....+. +.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v-p~Yqlpfe~evG 441 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV-PEYQLPFEAEVG 441 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC-CcccCchhHHhc
Confidence 9876543 22333447899999999999753 122 368999999999999987655532111 000000 00
Q ss_pred hH---HHHHHhhhhcccCcchhcccchh-hhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 612 AR---PLLKRHAIGELIDPRLRNCYSER-EVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 612 ~~---~~~~~~~~~elld~~l~~~~~~~-~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.. ..++...+.+...|.+...+-.. ....+.+.++.||+.||+.|.|+.-+-+++..+..
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 00 01122233333344444433322 33457889999999999999999999988876654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-32 Score=276.71 Aligned_cols=219 Identities=23% Similarity=0.184 Sum_probs=174.2
Q ss_pred cCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCccccccc
Q 038949 405 GGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYG 483 (678)
Q Consensus 405 G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~ 483 (678)
|.+|.||++.. .+++.||+|.+.... .+..|...+....||||+++++++.+....++||||+.+|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999994 578999999986442 223344444445699999999999999999999999999999998843
Q ss_pred CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccceeEEEeeecc
Q 038949 484 RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGY 563 (678)
Q Consensus 484 ~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y 563 (678)
...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 --~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 79 --FLNIPEECVKRWAAEMVVALDALHRE----GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred --hcCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 34589999999999999999999998 99999999999999999999999999876543221 223456779
Q ss_pred cccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhh
Q 038949 564 LAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQ 643 (678)
Q Consensus 564 ~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~ 643 (678)
+|||.+....++.++|+||||+++|+|++|..|+....... ... .....+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~----~~~~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTH----TTLNIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccc----cccCCcccCCHHHHH
Confidence 99999988889999999999999999999998875321100 000 000122233457889
Q ss_pred ccceeeccCCCCCchH
Q 038949 644 CASLCIRKDPHSRPRM 659 (678)
Q Consensus 644 LI~~cL~~dP~~RPT~ 659 (678)
++.+||+.||++||++
T Consensus 208 li~~~l~~dp~~R~~~ 223 (237)
T cd05576 208 LLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHccCCHHHhcCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-33 Score=299.95 Aligned_cols=245 Identities=22% Similarity=0.279 Sum_probs=204.1
Q ss_pred hhhcCCcccceecccCccceeeccCCC-CcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLPD-GQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
....+++.+..||-||||.|-++.... ...+|+|+++... ....+....|-++|..++.|.||++|..|.++..+|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 334567778889999999999988533 3348899886433 333456888999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
|+||-|-||.|...+ +.++.+....++.++..+++|++|||++ |||+|||||+|++++.+|-+||.|||+|+..
T Consensus 497 mLmEaClGGElWTiL--rdRg~Fdd~tarF~~acv~EAfeYLH~k----~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 497 MLMEACLGGELWTIL--RDRGSFDDYTARFYVACVLEAFEYLHRK----GIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhHHhhcCchhhhhh--hhcCCcccchhhhhHHHHHHHHHHHHhc----CceeccCChhheeeccCCceEEeehhhHHHh
Confidence 999999999999999 5667799999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
..+ ....+++|||.|.|||++..+..+.++|.||||+++|||++|.+||...++.. .-+.+ +.
T Consensus 571 ~~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk------------tYn~I---Lk 633 (732)
T KOG0614|consen 571 GSG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK------------TYNLI---LK 633 (732)
T ss_pred ccC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH------------HHHHH---Hh
Confidence 654 35677999999999999999999999999999999999999999997665421 11111 11
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCch
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPR 658 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT 658 (678)
..-...+|........+||.++.+.+|.+|..
T Consensus 634 Gid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 634 GIDKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 11122355556667889999999999999976
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-31 Score=271.32 Aligned_cols=203 Identities=23% Similarity=0.322 Sum_probs=176.0
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC---Cccccccceeeecc-cccceEEEEeEEeeCCeEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG---DQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~---~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~ 466 (678)
.-.+|.++.+||+|.|++|.++++ ++.+.||+|+++..--.. ..-...|..+.... +||.+|-+..+|+++.+++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 356899999999999999999994 678999999997433222 23345566666555 6999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+|.||++||+|--++. ....++++.++.+..+|+.||.|||+. |||+||||.+|+|++..|++||.|||+++.-
T Consensus 328 fvieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~r----giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhc----CeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999999884 445699999999999999999999999 9999999999999999999999999999743
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccC
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNR 601 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~ 601 (678)
.. ......+++|||.|.|||++.+..|+..+|.|+|||+++||+.|+.||+.-.
T Consensus 402 l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg 455 (593)
T KOG0695|consen 402 LG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG 455 (593)
T ss_pred CC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence 32 2345567899999999999999999999999999999999999999998654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-31 Score=298.33 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=205.8
Q ss_pred CcccceecccCccceeeccC-CCCc----EEEEEeeehh-cccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 396 FSEANFLAEGGFGSVHRGVL-PDGQ----VVAVKQYKLA-SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~-~~g~----~vAvK~i~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
.+..++||+|+||+||+|.| +.|+ +||+|++... ......++++|+.+|.+++|||+++|+++|.... +-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 45678999999999999984 4454 6899987533 3334578999999999999999999999998755 88999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
+|+++|+|.+++.. .+..+.....+.|..||++||.|||++ .+|||||..+|||+..-..+||.|||+++.....
T Consensus 777 q~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~q----rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQ----RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhc----chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999965 445688889999999999999999999 9999999999999999999999999999866543
Q ss_pred Cccc-eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 550 DMGV-ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 550 ~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
.... .....-.+.|||-|.+....|+.++|||||||++|||+| |..|++.... ..+..++..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~----------------~eI~dlle~ 915 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA----------------EEIPDLLEK 915 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH----------------HHhhHHHhc
Confidence 2211 111223567999999999999999999999999999998 8888764321 112233333
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
.-+-..|+.++.++..++.+||..|+..||+|+++...+.+..
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 3334457778889999999999999999999999998876543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=284.13 Aligned_cols=205 Identities=26% Similarity=0.386 Sum_probs=174.3
Q ss_pred CcccceecccCccceeecc-CCCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 396 FSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
|..++.||-|+||.|.++. ..+...||+|.++... .+.......|-.||.....+-||+||..|++.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 6778889999999999998 4567889999886432 23334567788888889999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc---c---
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR---W--- 545 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~---~--- 545 (678)
++||++-.+|.. .+-|++..++.++.++..|+++.|+. |+|||||||+|||||.+|++||.|||++. |
T Consensus 711 IPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkm----GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 711 IPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred cCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhc----cceecccCccceEEccCCceeeeeccccccceeccc
Confidence 999999999954 45599999999999999999999999 99999999999999999999999999994 1
Q ss_pred ---ccCCCc--------------------------------cceeEEEeeecccccccccccccceecceeeeeeEEEEe
Q 038949 546 ---QPDGDM--------------------------------GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVEL 590 (678)
Q Consensus 546 ---~~~~~~--------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eL 590 (678)
+..++. ......+||+.|+|||++....|+..+|.||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 111110 001135799999999999999999999999999999999
Q ss_pred eeCCccccccCCcccc
Q 038949 591 ITGRKAMDLNRPRGQQ 606 (678)
Q Consensus 591 ltG~~Pf~~~~~~~~~ 606 (678)
+.|++||....+.+-+
T Consensus 865 ~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQ 880 (1034)
T ss_pred hhCCCCccCCCCCcce
Confidence 9999999887775543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=276.04 Aligned_cols=269 Identities=24% Similarity=0.339 Sum_probs=202.6
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeec--ccccceEEEEeEEeeC----C
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSC--AQHRNVVMLIGFCVED----G 463 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~--L~HpnIv~l~~~~~~~----~ 463 (678)
.....+..+.+.||+|.||.||+|.|+ |+.||||+|.. .+...+.+|.++++. |+|+||+.|++.-..+ .
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 455678889999999999999999995 88999999863 334568888888765 5999999999874432 3
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcc----eeeeEEeccCCCCceEeeecCcccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC----RVGCIVHRDMRPNNILVTHDFEPLVGD 539 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~----~~~gIvHrDLKp~NILl~~~~~vkL~D 539 (678)
++|||.+|.+.|+|.|||.. ..++....++++..++.||+|||-.- ....|.|||||..|||+..+|.+-|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 68999999999999999943 55888999999999999999999531 123699999999999999999999999
Q ss_pred ccccccccCCC---ccceeEEEeeeccccccccccc----ccc--eecceeeeeeEEEEeeeC----------Ccccccc
Q 038949 540 FGLARWQPDGD---MGVETRVLGTFGYLAPEYAQSG----QIT--EKADVYSLGVVLVELITG----------RKAMDLN 600 (678)
Q Consensus 540 FGla~~~~~~~---~~~~~~~~Gt~~Y~APE~l~~~----~~s--~ksDVwSLGviL~eLltG----------~~Pf~~~ 600 (678)
+|+|-...... ....+..+||.+|||||++... .|. ..+||||||.|+||++.. +.||...
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 99997654332 2234567899999999999642 222 358999999999999853 3566544
Q ss_pred CCcccchhhhhhHHHHHHhhhhcccCcchhcccc-hhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 601 RPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS-EREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 601 ~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~-~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.+....+ ..++.-.-.+.+.|.+...+. ......+.+|++.||..||.-|.|+=-+-+.|.+...
T Consensus 440 Vp~DPs~------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPSF------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCH------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 4322210 011111112223444443333 3456678899999999999999999988888876653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-31 Score=262.63 Aligned_cols=238 Identities=29% Similarity=0.356 Sum_probs=190.2
Q ss_pred CccceeeccCC-CCcEEEEEeeehhcccC-CccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCccccccc
Q 038949 406 GFGSVHRGVLP-DGQVVAVKQYKLASSQG-DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYG 483 (678)
Q Consensus 406 ~fG~Vy~a~~~-~g~~vAvK~i~~~~~~~-~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~ 483 (678)
+||.||+|... +++.+|+|++....... ...+.+|++.+++++|+||+++++++......+++|||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999964 58999999987554444 56889999999999999999999999999999999999999999998844
Q ss_pred CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccceeEEEeeecc
Q 038949 484 RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGY 563 (678)
Q Consensus 484 ~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y 563 (678)
.. .+++..++.++.+++.++.|||+. +++|+||+|.||+++.++.++|+|||.+....... ......++..|
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLHSN----GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHHc----CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 32 378889999999999999999999 99999999999999999999999999998664432 23345578899
Q ss_pred cccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhh
Q 038949 564 LAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQ 643 (678)
Q Consensus 564 ~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~ 643 (678)
++||.+....++.++|+|+||+++|+|++|..||....... .... ..... .... .......+..+.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-----~~~~-~~~~~----~~~~---~~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-----ELFK-KIGKP----KPPF---PPPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----HHHH-HHhcc----CCCC---ccccccCCHHHHH
Confidence 99999988888999999999999999999999986531100 0000 00000 0000 0000003457889
Q ss_pred ccceeeccCCCCCchHHHHHH
Q 038949 644 CASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 644 LI~~cL~~dP~~RPT~~eVL~ 664 (678)
++.+||..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=247.33 Aligned_cols=264 Identities=21% Similarity=0.275 Sum_probs=194.2
Q ss_pred CCcccceecccCccceeecc-CCCCcEEEEEeeehhcccC--CccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~--~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+|.-.++||+|.||+||+|+ +.+++.||+|.++....+. .....+|+-+|+.+.|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 56677889999999999999 5678999999987654332 35688999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
| ..+|..+... -++.+....++.++.|+++||.|+|++ ++.||||||.|+||+.+|.+||+|||+++.+.-+-.
T Consensus 83 c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchsh----nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 C-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSH----NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred h-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhh----hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 8 5577777643 345588889999999999999999999 999999999999999999999999999997654332
Q ss_pred cceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHH---hhhhcccC
Q 038949 552 GVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKR---HAIGELID 626 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~elld 626 (678)
. ...-+-|.+|.+|.++.+. -|+...|+||-|||+.||.. |++.|...+-..+.....|......+ ..+..+.|
T Consensus 157 c-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred e-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 2 2233568999999999875 57899999999999999987 55555443322221111111111111 11122222
Q ss_pred cchhcccch---------hhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 627 PRLRNCYSE---------REVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 627 ~~l~~~~~~---------~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
-.....++. .....=.+|+.+.|.-+|.+|.++++.++.
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111111111 111123567778888999999999988763
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-30 Score=296.27 Aligned_cols=258 Identities=21% Similarity=0.227 Sum_probs=167.2
Q ss_pred hhcCCcccceecccCccceeeccC-CC----CcEEEEEeeehhcccCCccccccceeeecccccceEEEEeE------Ee
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PD----GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGF------CV 460 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~----g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~------~~ 460 (678)
..++|.+.+.||+|+||.||+|.+ .+ +..||+|.+..... .+.+..+ .++...+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999995 45 78999998753211 1111111 1111112222222111 24
Q ss_pred eCCeEEEEEEEeecCCcccccccCCCC------------------ccCccccchhhhhhccchhhhhhcceeeeEEeccC
Q 038949 461 EDGRRLLVYEYICNGSLDSHLYGRDRD------------------PLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDM 522 (678)
Q Consensus 461 ~~~~~~LV~E~~~ggsL~~~l~~~~~~------------------~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDL 522 (678)
.+...++||||+.+++|.+++...... ...+..+..++.||+.||.|||+. ||+||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~----gIiHRDL 281 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST----GIVHRDV 281 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC----CEEeCcC
Confidence 566799999999999999888533210 011233557999999999999998 9999999
Q ss_pred CCCceEeee-cCccccccccccccccCCCccceeEEEeeeccccccccccc----------------------ccceecc
Q 038949 523 RPNNILVTH-DFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSG----------------------QITEKAD 579 (678)
Q Consensus 523 Kp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----------------------~~s~ksD 579 (678)
||+|||++. ++.+||+|||+++..............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999996 68999999999986544333344567789999999965322 2345679
Q ss_pred eeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHH----hhhhcccCcchhcc----cc--hhhhhhhhhccceee
Q 038949 580 VYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR----HAIGELIDPRLRNC----YS--EREVYGMLQCASLCI 649 (678)
Q Consensus 580 VwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~----~~~~elld~~l~~~----~~--~~~~~~l~~LI~~cL 649 (678)
||||||+||||+++..+++.. +..+...+... ......+.+..... +. ........+||.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999977664321 11111110000 00001111110000 00 001123458999999
Q ss_pred ccCCCCCchHHHHHH
Q 038949 650 RKDPHSRPRMSQVLR 664 (678)
Q Consensus 650 ~~dP~~RPT~~eVL~ 664 (678)
+.||++|||+.++|+
T Consensus 435 ~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 435 RFKGRQRISAKAALA 449 (566)
T ss_pred cCCcccCCCHHHHhC
Confidence 999999999999986
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-31 Score=264.37 Aligned_cols=266 Identities=25% Similarity=0.352 Sum_probs=195.4
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc-ccC-CccccccceeeecccccceEEEEeEEee--------
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS-SQG-DQEFCSEVEVLSCAQHRNVVMLIGFCVE-------- 461 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~-~~~-~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-------- 461 (678)
.+.|....+||+|.||.||+|+. ++++.||+|++-..+ ..+ .....+|+.+|..|.|+|++.++++|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 45677888999999999999994 578889998764322 222 3567899999999999999999988764
Q ss_pred CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
...+|+||.+|+. +|.-++... ...++...+.+++.+++.||.|+|+. .|+|||+|+.|+||+.+|.+||+|||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~----kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN----KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh----hHHhhcccHhhEEEcCCceEEeeccc
Confidence 2348999999854 888877433 34588999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCcc---ceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhh--------
Q 038949 542 LARWQPDGDMG---VETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT-------- 609 (678)
Q Consensus 542 la~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~-------- 609 (678)
+++.+...... ..+..+-|.+|.+||.+.+ ..|+++.|||.-|||+.+|.||.+-|..+....+..+.
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 99865433221 2234556999999998875 67999999999999999999999998766542221111
Q ss_pred hhhHHHHHHhhhhccc--Ccchhcccc--------hhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 610 EWARPLLKRHAIGELI--DPRLRNCYS--------EREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 610 ~~~~~~~~~~~~~ell--d~~l~~~~~--------~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.-.+|....-.+.+.+ .|...+.+. ..-.....+|+..+|..||.+|+.+.+++.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 0011111111111111 111111110 011225678999999999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-29 Score=284.01 Aligned_cols=243 Identities=28% Similarity=0.356 Sum_probs=184.6
Q ss_pred CcccceecccCcc-ceeeccCCCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEeeCCeEEEEEEEee
Q 038949 396 FSEANFLAEGGFG-SVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLVYEYIC 473 (678)
Q Consensus 396 y~~~~~LG~G~fG-~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV~E~~~ 473 (678)
|.-.+.+|.|..| .||+|.. .|+.||||.+-.. ......+|+..|+.- .||||+++|+.-.+....||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 4455679999987 5799998 6889999987532 223567899998877 5999999999988999999999998
Q ss_pred cCCcccccccC--CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee---c--Cccccccccccccc
Q 038949 474 NGSLDSHLYGR--DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH---D--FEPLVGDFGLARWQ 546 (678)
Q Consensus 474 ggsL~~~l~~~--~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~---~--~~vkL~DFGla~~~ 546 (678)
.-+|.+++... ..........+.++.|++.||+|||+. +||||||||.||||+. + ..++|+|||+++..
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl----~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL----KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc----ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 66999999653 111122245578999999999999997 9999999999999976 2 57889999999877
Q ss_pred cCCCcc--ceeEEEeeecccccccccccccceecceeeeeeEEEEeeeC-CccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 547 PDGDMG--VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITG-RKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 547 ~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
..+... ......||.+|+|||++....-+.++||||||||+|+.++| .+||+..-.+....+. .......
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~-------~~~~L~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT-------GNYTLVH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc-------Cccceee
Confidence 654322 23446789999999999988888899999999999999996 8999754321111000 0000000
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHH
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL 663 (678)
+ .+ ..++ ...+||.+|+.++|..||++.+||
T Consensus 735 L-~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 735 L-EP------LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred e-cc------CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0 00 0111 678999999999999999999996
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=285.48 Aligned_cols=265 Identities=22% Similarity=0.268 Sum_probs=176.4
Q ss_pred hhcCCcccceecccCccceeeccC-----------------CCCcEEEEEeeehhcccCCccc--------------ccc
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-----------------PDGQVVAVKQYKLASSQGDQEF--------------CSE 440 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-----------------~~g~~vAvK~i~~~~~~~~~~~--------------~~E 440 (678)
..++|.+.++||+|+||.||+|.. ..++.||||.++.......++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999852 2356799999864432222223 335
Q ss_pred ceeeecccccce-----EEEEeEEee--------CCeEEEEEEEeecCCcccccccCCC---------------------
Q 038949 441 VEVLSCAQHRNV-----VMLIGFCVE--------DGRRLLVYEYICNGSLDSHLYGRDR--------------------- 486 (678)
Q Consensus 441 v~iL~~L~HpnI-----v~l~~~~~~--------~~~~~LV~E~~~ggsL~~~l~~~~~--------------------- 486 (678)
+.++.+++|.++ ++++++|.. .+..||||||+.+++|.+++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 555566655543 667777653 3568999999999999998853211
Q ss_pred -CccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccceeEEEeeecccc
Q 038949 487 -DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLA 565 (678)
Q Consensus 487 -~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~A 565 (678)
..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++...............+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~----~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI----GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 1235566788999999999999998 99999999999999999999999999997543322211122234789999
Q ss_pred cccccccc--------------------c--ceecceeeeeeEEEEeeeCCc-cccccCCcccchhhhhhHHHHHHhhhh
Q 038949 566 PEYAQSGQ--------------------I--TEKADVYSLGVVLVELITGRK-AMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 566 PE~l~~~~--------------------~--s~ksDVwSLGviL~eLltG~~-Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
||.+.... | ..+.||||+||++|+|++|.. ||......... +..+.. ... ...
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~~~~-~~~--~~r 454 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQYDN-DLN--RWR 454 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-Hhhccc-hHH--HHH
Confidence 99875322 1 124799999999999999875 66422110000 000000 000 000
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCC---CCCchHHHHHH
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDP---HSRPRMSQVLR 664 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP---~~RPT~~eVL~ 664 (678)
........-...........+|+.+||..+| .+|+|++|+|+
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0000000011112234578899999999766 68999999885
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=244.78 Aligned_cols=210 Identities=24% Similarity=0.398 Sum_probs=171.6
Q ss_pred ehhhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehh-cccCCccccccceeee-cccccceEEEEeEEee
Q 038949 385 TYAELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA-SSQGDQEFCSEVEVLS-CAQHRNVVMLIGFCVE 461 (678)
Q Consensus 385 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~-~~~~~~~~~~Ev~iL~-~L~HpnIv~l~~~~~~ 461 (678)
....++...+.+..+..||+|++|.|-+.++ .+|+..|+|.+... +.+...+.++|+.+.. ...+|++|.|||....
T Consensus 37 ~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 37 GDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred ecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 3444677777888888999999999988874 68999999998643 2333456788888754 4579999999999888
Q ss_pred CCeEEEEEEEeecCCccccccc--CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGD 539 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~D 539 (678)
....|+.||.| ..+|+.+-.. ...+.+++..+-+++..++.||.|||++. .+||||+||+||||+.+|++|+||
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL---~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL---SVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh---hhhhccCCcceEEEccCCcEEEcc
Confidence 89999999998 4566554311 34567899999999999999999999986 799999999999999999999999
Q ss_pred ccccccccCCCccceeEEEeeecccccccccc----cccceecceeeeeeEEEEeeeCCcccccc
Q 038949 540 FGLARWQPDGDMGVETRVLGTFGYLAPEYAQS----GQITEKADVYSLGVVLVELITGRKAMDLN 600 (678)
Q Consensus 540 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSLGviL~eLltG~~Pf~~~ 600 (678)
||++.++.+.- ..+--.|...|||||.+.. ..|+.++||||||+.+.||.++++||+..
T Consensus 193 FGIsG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 193 FGISGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cccceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 99998764432 2232457889999998853 47999999999999999999999999654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-28 Score=269.24 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=209.4
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
..++|.++..+|.|.+|.||+++ ..+++..|+|+++....+...-+..|+-+++..+||||+.+++.+.....+|+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 45789999999999999999999 46899999999998888888889999999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
||.||+|.+.- .-.+++++.++..+++..++||.|||+. |-+|||||-.|||+++.|.+|++|||.+..+. ..
T Consensus 93 ycgggslQdiy--~~TgplselqiayvcRetl~gl~ylhs~----gk~hRdiKGanilltd~gDvklaDfgvsaqit-at 165 (829)
T KOG0576|consen 93 YCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLKYLHSQ----GKIHRDIKGANILLTDEGDVKLADFGVSAQIT-AT 165 (829)
T ss_pred ecCCCccccee--eecccchhHHHHHHHhhhhccchhhhcC----CcccccccccceeecccCceeecccCchhhhh-hh
Confidence 99999999877 4567899999999999999999999999 88999999999999999999999999997553 23
Q ss_pred ccceeEEEeeecccccccc---cccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC-
Q 038949 551 MGVETRVLGTFGYLAPEYA---QSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID- 626 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l---~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld- 626 (678)
......+.||+.|||||+. +.+.|...+|||++|+...||---++|.....+.... .++.. ...+
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-------~LmTk----S~~qp 234 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-------FLMTK----SGFQP 234 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH-------HHhhc----cCCCC
Confidence 4456678999999999976 4678999999999999999998777775433321111 11111 1111
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
|.+++ .......|.++++.||..+|++||+++.+|+
T Consensus 235 p~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11111 1234447889999999999999999998765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-29 Score=264.57 Aligned_cols=141 Identities=24% Similarity=0.343 Sum_probs=119.9
Q ss_pred ehhhhhhhh-cCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeeccc-----c---cceEE
Q 038949 385 TYAELELAT-NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-----H---RNVVM 454 (678)
Q Consensus 385 ~~~~~~~~~-~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-----H---pnIv~ 454 (678)
+....+... +||.+.++||.|.|++||++. ..+.+.||+|+.+... .-.+....|+++|++++ | .+||+
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 333445555 899999999999999999998 4678899999998443 22356778999999884 2 36999
Q ss_pred EEeEEee----CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee
Q 038949 455 LIGFCVE----DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT 530 (678)
Q Consensus 455 l~~~~~~----~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~ 530 (678)
|++.|.. +.++|||+|++ |.+|..+|.......++...++.|++||+.||.|||+.| ||||-||||+|||+.
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLLC 222 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeeee
Confidence 9999975 55899999998 889999997777788999999999999999999999998 999999999999994
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-28 Score=264.08 Aligned_cols=213 Identities=24% Similarity=0.272 Sum_probs=178.6
Q ss_pred CCceeehhhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeeccc------ccce
Q 038949 380 PPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ------HRNV 452 (678)
Q Consensus 380 p~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~------HpnI 452 (678)
...+|.+...+.+-.+|.+....|+|-|+.|..|.. ..|+.||||+|..+.. ....-+.|+++|+.|. --|+
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHH
Confidence 346788888999999999999999999999999984 4578999999985432 2344567999999986 2478
Q ss_pred EEEEeEEeeCCeEEEEEEEeecCCcccccccC-CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee
Q 038949 453 VMLIGFCVEDGRRLLVYEYICNGSLDSHLYGR-DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH 531 (678)
Q Consensus 453 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~ 531 (678)
++|+..|...+++|||||-+ ..+|.++|... .+-.|....+..++.|+.-||.+|-.. ||+|.||||+|||+++
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c----~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC----GVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc----CeeecccCccceEecc
Confidence 99999999999999999987 66888888443 244588899999999999999999986 9999999999999996
Q ss_pred -cCccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccC
Q 038949 532 -DFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNR 601 (678)
Q Consensus 532 -~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~ 601 (678)
...+||||||.|........ +.+.-+..|.|||++.+-+|+...|+||.||.||||+||+..|....
T Consensus 572 ~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred CcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 46799999999987655432 22334556999999999999999999999999999999999886443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-28 Score=260.33 Aligned_cols=196 Identities=22% Similarity=0.331 Sum_probs=168.6
Q ss_pred cCCcccceecccCccceeeccCC-CCcEEEEEeeehhcc--------cCCccccccceeeeccc---ccceEEEEeEEee
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASS--------QGDQEFCSEVEVLSCAQ---HRNVVMLIGFCVE 461 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~--------~~~~~~~~Ev~iL~~L~---HpnIv~l~~~~~~ 461 (678)
..|..++.+|+|+||.|++|.++ +...|+||.+....- ...-....|+.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45889999999999999999954 567899998753221 11124667999999997 9999999999999
Q ss_pred CCeEEEEEEEe-ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 462 DGRRLLVYEYI-CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 462 ~~~~~LV~E~~-~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
++.+||+||-. +|.+|.++|. ....+.+..+..|+.|++.|+++||++ ||||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~----~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQ----GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhcccccccc----CceecccccccEEEecCCeEEEeec
Confidence 99999999964 4568888884 445699999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCcccc
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMD 598 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~ 598 (678)
|.+.+...+ ....++||..|.|||++.+.+| +..-|||+||++||.++....||.
T Consensus 715 gsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999876554 3467889999999999999887 567899999999999999988873
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-28 Score=235.63 Aligned_cols=211 Identities=34% Similarity=0.520 Sum_probs=181.5
Q ss_pred ecccCccceeeccCC-CCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCccc
Q 038949 402 LAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDS 479 (678)
Q Consensus 402 LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~ 479 (678)
||+|.+|.||++... +++.+++|.+...... ....+.+|+.+++.+.|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999964 4899999998754332 23578899999999999999999999999899999999999899999
Q ss_pred ccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-cCccccccccccccccCCCccceeEEE
Q 038949 480 HLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-DFEPLVGDFGLARWQPDGDMGVETRVL 558 (678)
Q Consensus 480 ~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~ 558 (678)
++.... ..+++..++.++.+++.+|.+||+. |++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~----~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN----GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 985432 3588899999999999999999999 9999999999999999 89999999999976543321 223345
Q ss_pred eeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhh
Q 038949 559 GTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSERE 637 (678)
Q Consensus 559 Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~ 637 (678)
+...|++||.+... .++.+.|+|+||+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78889999999877 788999999999999998
Q ss_pred hhhhhhccceeeccCCCCCchHHHHHHHh
Q 038949 638 VYGMLQCASLCIRKDPHSRPRMSQVLRML 666 (678)
Q Consensus 638 ~~~l~~LI~~cL~~dP~~RPT~~eVL~~L 666 (678)
..+.+++.+|++.||.+||++.++++.+
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2577889999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-30 Score=255.20 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=193.5
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeeh--hcccCCccccccceeeecccccceEEEEeEEeeCC-----eEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKL--ASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG-----RRL 466 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~--~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~-----~~~ 466 (678)
+.+..+.||.|+||.||.... ++|+.||+|.+.. .+......+.+|+++|...+|.|++..+++..-.. .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345567899999999999985 5899999998752 22233467899999999999999998887755332 368
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+|.|++ ..+|...| .....++.+.+.-++.||++||.|||+. +|.||||||.|+|++.+..+||+|||+++..
T Consensus 134 V~TELm-QSDLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHsA----~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELM-QSDLHKII--VSPQALTPDHVKVFVYQILRGLKYLHTA----NILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHH-Hhhhhhee--ccCCCCCcchhhhhHHHHHhhhHHHhhc----chhhccCCCccEEeccCceEEeccccccccc
Confidence 889988 56898888 4566799999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchh-hhhh--------HHHH
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCL-TEWA--------RPLL 616 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l-~~~~--------~~~~ 616 (678)
...+..-.+.-+-|..|.|||++.+ ..|+.+.||||.|||+.||+..+..|....|..+.-+ ++.. +...
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 4433222233345788999999987 5789999999999999999998888876665433221 1110 0000
Q ss_pred HHhhhhcccC-----cchhcc----cchhhhhhhhhccceeeccCCCCCchHHHHHHHh
Q 038949 617 KRHAIGELID-----PRLRNC----YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666 (678)
Q Consensus 617 ~~~~~~elld-----~~l~~~----~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~L 666 (678)
+ .....++. |.+... -+.........++..++..||++|.+.++.+..+
T Consensus 287 E-GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 287 E-GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred h-hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0 11111111 111100 0111222456778889999999999999987654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-29 Score=257.79 Aligned_cols=263 Identities=24% Similarity=0.303 Sum_probs=211.6
Q ss_pred hhhhhhhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhcccC-CccccccceeeecccccceEEEEeE
Q 038949 386 YAELELATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASSQG-DQEFCSEVEVLSCAQHRNVVMLIGF 458 (678)
Q Consensus 386 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~~~-~~~~~~Ev~iL~~L~HpnIv~l~~~ 458 (678)
..++..-..|++...++-+|.||.||.|.|. +.+.|.+|.++....+. ...++.|.-.+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4667778889999999999999999999754 23456777776444332 2468888888899999999999999
Q ss_pred EeeC-CeEEEEEEEeecCCccccccc------CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee
Q 038949 459 CVED-GRRLLVYEYICNGSLDSHLYG------RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH 531 (678)
Q Consensus 459 ~~~~-~~~~LV~E~~~ggsL~~~l~~------~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~ 531 (678)
+.++ ...+.+|.++.-|+|..++.. ...+.++..+...++.|++.|++|||++ |+||.||..+|.+|++
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~----~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH----GVIHKDIAARNCVIDD 431 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc----Ccccchhhhhcceehh
Confidence 8764 457888999988999999851 1223466777789999999999999999 9999999999999999
Q ss_pred cCccccccccccccccCCCccce-eEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhh
Q 038949 532 DFEPLVGDFGLARWQPDGDMGVE-TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLT 609 (678)
Q Consensus 532 ~~~vkL~DFGla~~~~~~~~~~~-~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~ 609 (678)
..++||+|=.+++.....++... ..-..+..||+||.+....|+.++|+|||||+||||+| |+.|+..-+|.+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE----- 506 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE----- 506 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-----
Confidence 99999999999987665553321 11223568999999999999999999999999999998 888886554422
Q ss_pred hhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 610 EWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 610 ~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
+...+...++-.-|.+|+++++.++.-||..+|++||++++++.-|.+
T Consensus 507 -----------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 507 -----------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -----------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 222334455556677899999999999999999999999999988764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-26 Score=232.54 Aligned_cols=258 Identities=17% Similarity=0.239 Sum_probs=189.4
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeE-EeeCCeEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGF-CVEDGRRLLV 468 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~-~~~~~~~~LV 468 (678)
..+.|.+.+.||+|.||.+-++++ .+.+.+++|.+.. ......+|.+|...--.| .|.||+.-|++ |+..+.+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 457899999999999999999996 4678999998763 234457899998876666 58999988864 7778888999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee--ecCccccccccccccc
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT--HDFEPLVGDFGLARWQ 546 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~--~~~~vkL~DFGla~~~ 546 (678)
+||++.|+|.+.+.. ..+.+....+++.|+++||.|+|++ ++||||||.+||||- +..++||||||+.+..
T Consensus 101 qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk----nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK----NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc----chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999998833 4588888999999999999999999 999999999999995 3458999999999744
Q ss_pred cCCCccceeEEEeeecccccccccc---c--ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQS---G--QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~---~--~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
...- ....-+..|.+||.... + ...+.+|+|.||+|+|.++||..||+... ..+....+|... ..+..
T Consensus 174 g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w--~~rk~ 246 (378)
T KOG1345|consen 174 GTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQW--LKRKN 246 (378)
T ss_pred Ccee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHH--hcccC
Confidence 2211 11223556999997643 2 23678899999999999999999997432 222222233222 22211
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
.. -|..-..++ ..++.+..+-|.++|++|--..++-++.+.++
T Consensus 247 ~~--~P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 247 PA--LPKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred cc--CchhhcccC----HHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 11 122222233 35777888899999999955555555444433
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-27 Score=233.92 Aligned_cols=256 Identities=19% Similarity=0.304 Sum_probs=194.1
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeeccc-ccceEEEEeEEeeC--CeEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVED--GRRLL 467 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~--~~~~L 467 (678)
..++|++.+.+|+|.++.||.|. ..++++++||++++.. ...+.+|+.+|..|. ||||+.++++..+. ....|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 34689999999999999999999 4678999999998543 357889999999996 99999999998764 45789
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-cCccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-DFEPLVGDFGLARWQ 546 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-~~~vkL~DFGla~~~ 546 (678)
|+||+.+.+...+. ..++...++.++.+++.||.|+|+. ||.|||+||.|++||+ ...++|+|+|+|.++
T Consensus 113 iFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~----GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc----CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999887765544 3477788999999999999999999 9999999999999996 467999999999877
Q ss_pred cCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHH--------HHH
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP--------LLK 617 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~--------~~~ 617 (678)
..+.. -.-.+.+..|--||.+-. ..|+..-|+|||||+|..|+..+.||-......++ +...+.- .+.
T Consensus 184 Hp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhChHHHHHHHH
Confidence 55432 122345667889998854 67899999999999999999999998654432222 1111111 011
Q ss_pred HhhhhcccCcchhc--------ccch-------h-hhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 618 RHAIGELIDPRLRN--------CYSE-------R-EVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 618 ~~~~~elld~~l~~--------~~~~-------~-~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. ..--+||.+.+ .+.. . ...+..+|+.+.|+.|..+|+|+.|.+.
T Consensus 261 K--Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 K--YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred H--HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1 11113333322 1110 1 2246789999999999999999999864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-27 Score=240.22 Aligned_cols=256 Identities=24% Similarity=0.342 Sum_probs=192.6
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeeh--hcccCCccccccceeeecccccceEEEEeEEeeCC-----
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKL--ASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG----- 463 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~--~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~----- 463 (678)
...||..+..+|.|+- .|..+. .-.++.||+|.+.. ......++..+|..++..+.|+||+.++.+|.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3468888899999998 555555 33688999997642 23344467889999999999999999999986433
Q ss_pred -eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 464 -RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 464 -~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
..|+|||+| .++|...+. ..+.-..+..++.|++.|++|||+. ||+||||||+||++..++.+||.|||+
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~----~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSA----GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc----ceeecccCcccceecchhheeeccchh
Confidence 579999999 668888774 2356677889999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHH--------
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP-------- 614 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~-------- 614 (678)
++..... -..+.++.|..|.|||++.+-.|...+||||+||++.||++|...|.... .+..|..-
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPD 237 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCC
Confidence 9844222 35567788999999999998889999999999999999999998886322 22222211
Q ss_pred -------------HHHHh------hhhccc-Ccchhcc--cchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 -------------LLKRH------AIGELI-DPRLRNC--YSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 -------------~~~~~------~~~ell-d~~l~~~--~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+.. .+.+++ |..+... .+......+.+++.+||-.||++|.+++++|+
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 11100 011111 1111111 11122344678999999999999999999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-27 Score=232.23 Aligned_cols=199 Identities=34% Similarity=0.438 Sum_probs=171.1
Q ss_pred CcccceecccCccceeeccCC-CCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEee
Q 038949 396 FSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYIC 473 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ 473 (678)
|.+.+.||.|++|.||++... +++.+|+|.+...... ....+.+|++.++.++|+|++++++++......++++|++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 567789999999999999964 4889999998755444 45678889999999999999999999999899999999999
Q ss_pred cCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccc
Q 038949 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553 (678)
Q Consensus 474 ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 553 (678)
+++|.+++...... +++.....++.+++.+|.+||+. +++|+||+|.||+++.++.++|+|||.+..........
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~----~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL----GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 99999998543221 78888999999999999999998 99999999999999999999999999998665432112
Q ss_pred eeEEEeeecccccccc-cccccceecceeeeeeEEEEeeeCCccccc
Q 038949 554 ETRVLGTFGYLAPEYA-QSGQITEKADVYSLGVVLVELITGRKAMDL 599 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSLGviL~eLltG~~Pf~~ 599 (678)
.....++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 3345678889999998 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-26 Score=242.60 Aligned_cols=200 Identities=25% Similarity=0.338 Sum_probs=165.6
Q ss_pred hhhhcCCcccceecccCccceeeccCC----CCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEeeCCe
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLP----DGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~ 464 (678)
....+.|...++||+|.|+.||++... .++.||+|.+... ....++.+|+++|..+ .+.||+++.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 445678999999999999999999842 5779999987644 3446789999999998 49999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-cCcccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-DFEPLVGDFGLA 543 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-~~~vkL~DFGla 543 (678)
..+||||++.....++... ++...+..+++.++.||.++|.+ |||||||||.|+|.+. .+.-.|.|||++
T Consensus 110 v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~----GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN----GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc----CccccCCCccccccccccCCceEEechhH
Confidence 9999999999888887732 56778889999999999999999 9999999999999984 678889999999
Q ss_pred ccccC--------C-----------C------------------------ccceeEEEeeecccccccccc-cccceecc
Q 038949 544 RWQPD--------G-----------D------------------------MGVETRVLGTFGYLAPEYAQS-GQITEKAD 579 (678)
Q Consensus 544 ~~~~~--------~-----------~------------------------~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksD 579 (678)
..... . . ........||++|.|||++.. ..-+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 72110 0 0 000112469999999999875 45688999
Q ss_pred eeeeeeEEEEeeeCCcccccc
Q 038949 580 VYSLGVVLVELITGRKAMDLN 600 (678)
Q Consensus 580 VwSLGviL~eLltG~~Pf~~~ 600 (678)
|||.|+|++.+++++.||-..
T Consensus 261 iws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eeeccceeehhhccccccccC
Confidence 999999999999999999543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-26 Score=269.97 Aligned_cols=197 Identities=18% Similarity=0.215 Sum_probs=142.2
Q ss_pred eecccc-cceEEEEeEE-------eeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceee
Q 038949 444 LSCAQH-RNVVMLIGFC-------VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515 (678)
Q Consensus 444 L~~L~H-pnIv~l~~~~-------~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~ 515 (678)
.+.++| +||++++++| .+...++++|||+ +++|.+++... ...+++..++.++.||+.||.|||++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---- 99 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---- 99 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC----
Confidence 345667 6888888887 2334677889987 77999999533 34589999999999999999999998
Q ss_pred eEEeccCCCCceEeee-------------------cCccccccccccccccCCC---------------ccceeEEEeee
Q 038949 516 CIVHRDMRPNNILVTH-------------------DFEPLVGDFGLARWQPDGD---------------MGVETRVLGTF 561 (678)
Q Consensus 516 gIvHrDLKp~NILl~~-------------------~~~vkL~DFGla~~~~~~~---------------~~~~~~~~Gt~ 561 (678)
||+||||||+||||+. ++.+|++|||+++...... ........||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999954 4567777888776421100 00111245788
Q ss_pred cccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhh
Q 038949 562 GYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGM 641 (678)
Q Consensus 562 ~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l 641 (678)
.|||||++.+..|+.++|||||||+||||++|..|+..... ....+ . ...+.+.... .....
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~-----~----~~~~~~~~~~-----~~~~~ 241 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSL-----R----HRVLPPQILL-----NWPKE 241 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHH-----H----HhhcChhhhh-----cCHHH
Confidence 99999999999999999999999999999999887642110 00000 0 0111111111 12235
Q ss_pred hhccceeeccCCCCCchHHHHHH
Q 038949 642 LQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 642 ~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+++.+||++||.+||++.|+++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 67788999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-24 Score=208.50 Aligned_cols=167 Identities=26% Similarity=0.263 Sum_probs=125.0
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
|+|.+++..+ ..++++..++.++.|++.||.|||+. + ||+|||++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~----~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ----A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc----C------CcccEeEcCccceee--ccceEeecccc----
Confidence 6888888533 44699999999999999999999998 5 999999999999999 99997654322
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
..||+.|+|||++.+..++.++|||||||++|||+||+.||....... .......... ... .+.. ....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~--~~~-~~~~-~~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-----AILEILLNGM--PAD-DPRD-RSNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-----HHHHHHHHHh--ccC-Cccc-cccH
Confidence 258899999999999999999999999999999999999986432211 1111111100 000 0000 0111
Q ss_pred hhhhh--hhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 635 EREVY--GMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 635 ~~~~~--~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
..... .+.+++.+||..||.+||++.++++.+...
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 22222 589999999999999999999999987644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.7e-23 Score=220.55 Aligned_cols=183 Identities=23% Similarity=0.243 Sum_probs=136.9
Q ss_pred hhhhcCCcccceecccCccceeeccCC--CCcEEEEEeeehhc-----ccCCccccccceeeecccccceEE-EEeEEee
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLP--DGQVVAVKQYKLAS-----SQGDQEFCSEVEVLSCAQHRNVVM-LIGFCVE 461 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~i~~~~-----~~~~~~~~~Ev~iL~~L~HpnIv~-l~~~~~~ 461 (678)
....++|.+.+.||+|+||.||+|.+. +++.+|||++.... ......+.+|+++|+.++|+|++. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 456788999999999999999999853 57788999865221 112346889999999999999985 5442
Q ss_pred CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccC-CCCceEeeecCccccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDM-RPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDL-Kp~NILl~~~~~vkL~DF 540 (678)
+..|+||||+.|++|.... ... ...++.+++.||.|||+. ||+|||| ||+|||++.++.++|+||
T Consensus 91 -~~~~LVmE~~~G~~L~~~~---~~~------~~~~~~~i~~aL~~lH~~----gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLAR---PHG------DPAWFRSAHRALRDLHRA----GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred -CCcEEEEEccCCCCHHHhC---ccc------hHHHHHHHHHHHHHHHHC----CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 4589999999999996321 111 146789999999999999 9999999 999999999999999999
Q ss_pred cccccccCCCcc-------ceeEEEeeecccccccccccc------cceeccee-eeeeEEEE
Q 038949 541 GLARWQPDGDMG-------VETRVLGTFGYLAPEYAQSGQ------ITEKADVY-SLGVVLVE 589 (678)
Q Consensus 541 Gla~~~~~~~~~-------~~~~~~Gt~~Y~APE~l~~~~------~s~ksDVw-SLGviL~e 589 (678)
|+++........ .-....+++.|+|||++.... .+...|-| .-|=+.+.
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW~~TGDlg~~ 219 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIWLATGKKVYN 219 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcEEeCCCEEEE
Confidence 999865432211 113456888999999986432 23346666 44554443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-22 Score=231.84 Aligned_cols=253 Identities=21% Similarity=0.232 Sum_probs=185.7
Q ss_pred cccceecccCccceeecc-CCCCcEEEEEeeehh--cccCC----ccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 397 SEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLA--SSQGD----QEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 397 ~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~--~~~~~----~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
.....+|.|++|.|+... ......++.|.+... ..... ..+..|+-+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999777765 233444455543311 11111 22667888888999999988887777766666669
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
|||++ +|..++.. ...++...+..++.|++.|+.|+|+. ||.|||||++|++++.+|.+||+|||.+..+..+
T Consensus 401 E~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~----GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSM----GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhc----CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99999843 34688888999999999999999999 9999999999999999999999999999765432
Q ss_pred C---ccceeEEEeeecccccccccccccce-ecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 550 D---MGVETRVLGTFGYLAPEYAQSGQITE-KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 550 ~---~~~~~~~~Gt~~Y~APE~l~~~~~s~-ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
. .......+|...|+|||++....|++ ..||||.|+++..|++|+.||........++. ........-
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~--------~~~~~~~~~ 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK--------TNNYSDQRN 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh--------hhccccccc
Confidence 2 24556688999999999999999976 57999999999999999999976654433320 000000000
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...-........+.....+|.+||+.||.+|.|+++|++
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000011112223445678999999999999999999874
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-22 Score=213.93 Aligned_cols=261 Identities=19% Similarity=0.205 Sum_probs=195.7
Q ss_pred CCcccceecccCccceeeccCCC--CcEEEEEeeehhcccCCccccccceeeecccc----cceEEEEeEE-eeCCeEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVLPD--GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQH----RNVVMLIGFC-VEDGRRLL 467 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~~~--g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~H----pnIv~l~~~~-~~~~~~~L 467 (678)
+|.+.+.||+|+||.||++.... ...+|+|............+..|..++..+.. +++..+++.. ..+...|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999543 35789998765443433478889999988873 6899999988 47778999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec-----Cccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD-----FEPLVGDFGL 542 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~-----~~vkL~DFGl 542 (678)
||+.+ |.+|.++......+.++......++.|++.+|++||+. |++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~----G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK----GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc----CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 99999988555567799999999999999999999999 99999999999999865 4689999999
Q ss_pred cc--cccCCCc-----c-c-eeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH
Q 038949 543 AR--WQPDGDM-----G-V-ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 543 a~--~~~~~~~-----~-~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~ 613 (678)
++ ....... . . ...+.||..|.++..+.+...+.+.|+||++.++.+|+.|..||........ ..
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~---- 247 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KS---- 247 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HH----
Confidence 98 3222111 0 1 2235599999999999999999999999999999999999999954432111 00
Q ss_pred HHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 614 PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 614 ~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
............. .....+..+.++...+-..+...+|....+...|+..+..
T Consensus 248 -~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 248 -KFEKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred -HHHHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0011111111111 1111223455555555558999999999999888766543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.8e-23 Score=205.62 Aligned_cols=251 Identities=20% Similarity=0.287 Sum_probs=198.5
Q ss_pred cCCcccceecccCccceeeccCCCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
..+.+..+|.+...|..|+|+|++ ..++.|+++... ....++|..|.-.|+...||||+.+++.|....++.++..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 345556679999999999999964 456778776433 23346899999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccc--ccccccccccCC
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLV--GDFGLARWQPDG 549 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL--~DFGla~~~~~~ 549 (678)
|+.|+|+..+.....-.....++.+++..+++|++|||+.-+ -|.---|....++||++...+| +|--++...
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~kfsfqe--- 343 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTKFSFQE--- 343 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheecccceeeeec---
Confidence 999999999988877778888999999999999999999732 2444468899999999887776 343333211
Q ss_pred CccceeEEEeeecccccccccccccc---eecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQIT---EKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s---~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
....-.|.||+||.++..+-+ .++|+|||+++||||.|...||....+.... .++.-
T Consensus 344 -----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkial 403 (448)
T KOG0195|consen 344 -----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIAL 403 (448)
T ss_pred -----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhh
Confidence 112236789999999876654 4789999999999999999999866553221 11222
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
..++..+++..+..+..|+.-|+..||.+||.+..++-.||++.
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 45566677777888999999999999999999999999998754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.9e-22 Score=202.15 Aligned_cols=260 Identities=29% Similarity=0.400 Sum_probs=193.9
Q ss_pred CcccceecccCccceeeccCCCCcEEEEEeeehhcccC---Cccccccceeeeccccc-ceEEEEeEEeeCCeEEEEEEE
Q 038949 396 FSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG---DQEFCSEVEVLSCAQHR-NVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~---~~~~~~Ev~iL~~L~Hp-nIv~l~~~~~~~~~~~LV~E~ 471 (678)
|.+...||.|+||.||++... ..+++|.+....... ...+.+|+.++..+.|+ +|+.+++++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999975 789999887544332 46788999999999888 799999999777778999999
Q ss_pred eecCCcccccccCCC-CccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC-ccccccccccccccCC
Q 038949 472 ICNGSLDSHLYGRDR-DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF-EPLVGDFGLARWQPDG 549 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~-~vkL~DFGla~~~~~~ 549 (678)
+.++++.+++..... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~----~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK----GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999966632221 2688889999999999999999999 999999999999999988 7999999999755433
Q ss_pred Ccc-----ceeEEEeeecccccccccc---cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 550 DMG-----VETRVLGTFGYLAPEYAQS---GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 550 ~~~-----~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
... ......|+..|++||.+.+ ..+....|+|++|++++++++|..||...... ...............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~ 232 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPT 232 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCC
Confidence 221 3456789999999999987 57889999999999999999999997544321 000000000000000
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
. .................+.+++..|+..+|..|.+..+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000000001112457788899999999999988877653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.3e-21 Score=187.77 Aligned_cols=205 Identities=20% Similarity=0.271 Sum_probs=170.5
Q ss_pred hhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeecccc-cceEEEEeEEeeCCeEEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQH-RNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~H-pnIv~l~~~~~~~~~~~L 467 (678)
.+..++|.+++.||.|+||.+|+|. ..+|..||||+-... .....+..|.++.+.|++ ..|..+..+..+...-.+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 3556899999999999999999999 578999999986533 233568889999999975 778888888888888899
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee---ecCccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT---HDFEPLVGDFGLAR 544 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~---~~~~vkL~DFGla~ 544 (678)
||+++ |-+|.+++.- ....++..+.+-++-|++.-++|+|.. ++|||||||+|+|.. +...+.|+|||+++
T Consensus 89 VMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r----~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLR----NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhh----ccccccCCccceeeccccccceEEEEeccchh
Confidence 99998 8899888743 334588889999999999999999999 999999999999996 45678899999998
Q ss_pred cccCCC------ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCC
Q 038949 545 WQPDGD------MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRP 602 (678)
Q Consensus 545 ~~~~~~------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~ 602 (678)
.+.+.. ........||.+|.+--.+.+..-+.+.|+=|+|.+|..+..|..||+....
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 664432 2233346799999998877777778899999999999999999999986543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.4e-21 Score=192.48 Aligned_cols=172 Identities=12% Similarity=0.100 Sum_probs=134.7
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCcc---------ccccceeeecccccceEEEEeEEe
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQE---------FCSEVEVLSCAQHRNVVMLIGFCV 460 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~---------~~~Ev~iL~~L~HpnIv~l~~~~~ 460 (678)
....++|+..++||.|+||.||+... ++..+|+|+++......... +.+|+..+.++.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 56789999999999999999999766 57789999997544333222 578999999999999999988865
Q ss_pred eC--------CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec
Q 038949 461 ED--------GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD 532 (678)
Q Consensus 461 ~~--------~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~ 532 (678)
.. +..+|||||++|.+|.++.. +++ ....+++.+|..||.. |++|||++|+||+++.+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~----gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH----GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc----CCccCCCChHHEEEeCC
Confidence 33 35899999999999987641 222 3466999999999999 99999999999999998
Q ss_pred CccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEe
Q 038949 533 FEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVEL 590 (678)
Q Consensus 533 ~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eL 590 (678)
| ++|+|||.......... ...+.....|..++|+|+||+.+..+
T Consensus 172 g-i~liDfg~~~~~~e~~a-------------~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKA-------------KDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred C-EEEEECCCcccccchhh-------------HHHHHHHhHhcccccccceeEeehHH
Confidence 8 99999998864422110 01134445677899999999997654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.3e-21 Score=194.78 Aligned_cols=202 Identities=19% Similarity=0.255 Sum_probs=171.9
Q ss_pred hhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEeeCCeEEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV 468 (678)
...-.|+++++||+|.||.++.|. .-+++.||||.-... ....++..|.+..+.| ..++|...|-+-.++.+-.||
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 345679999999999999999999 458999999965322 3345788888888888 479999999998888889999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-----cCcccccccccc
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-----DFEPLVGDFGLA 543 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-----~~~vkL~DFGla 543 (678)
+|++ |-+|.|+..- ....|+...+..++.|++.-++|+|++ .+|+|||||+|+||.. ...+.|+|||+|
T Consensus 103 idLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k----~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEK----DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhc----ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 9998 8899888743 345699999999999999999999999 9999999999999964 345789999999
Q ss_pred ccccCCCc------cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCcccccc
Q 038949 544 RWQPDGDM------GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLN 600 (678)
Q Consensus 544 ~~~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~ 600 (678)
+.+.+... .......||.+||+--...+..-+.+.|+=|||-++++.|.|..||...
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 97765432 3344567999999999999999999999999999999999999999764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.3e-20 Score=184.14 Aligned_cols=139 Identities=19% Similarity=0.210 Sum_probs=107.5
Q ss_pred cceecccCccceeeccCCCCcEEEEEeeehhcccC---------Ccccc-----------------ccceeeecccccce
Q 038949 399 ANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG---------DQEFC-----------------SEVEVLSCAQHRNV 452 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~---------~~~~~-----------------~Ev~iL~~L~HpnI 452 (678)
.+.||+|+||.||+|...+|+.||+|+++...... ...|. .|++++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999997789999999997542211 12233 38889998887766
Q ss_pred EEEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhh-hhcceeeeEEeccCCCCceEeee
Q 038949 453 VMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYL-HEECRVGCIVHRDMRPNNILVTH 531 (678)
Q Consensus 453 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yL-H~~~~~~gIvHrDLKp~NILl~~ 531 (678)
.....+.. ...+|||||+.|+++...+. ...++++..+..++.|++.+|.+| |+. ||+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~----giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDC----RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEE-
Confidence 33222222 22389999998877765432 234688889999999999999999 688 999999999999998
Q ss_pred cCccccccccccccc
Q 038949 532 DFEPLVGDFGLARWQ 546 (678)
Q Consensus 532 ~~~vkL~DFGla~~~ 546 (678)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999999744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-21 Score=223.46 Aligned_cols=252 Identities=23% Similarity=0.270 Sum_probs=185.7
Q ss_pred CCcccceecccCccceeeccCCCCcEEEEEeeehhcc-cCCcccc---ccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASS-QGDQEFC---SEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~-~~~~~~~---~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
.|...+.||.+.|=+|.+|+++.|. |+||++-.... -....|. .|++ ...++|||.+.+.-+...+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6778889999999999999988886 89998854332 2223333 3444 455689999999988888888899999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc--cccC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR--WQPD 548 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~--~~~~ 548 (678)
|. ..+|+|.+ ..+..+...+.+.|+.||+.||..+|+. ||+|||||.+||||+.-+-+.|+||...+ +.+.
T Consensus 102 yv-khnLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH~~----gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YV-KHNLYDRL--STRPFLVLIEKKWIAFQLLKALSQCHKL----GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HH-hhhhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHHHc----CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 98 55999999 4556678888889999999999999999 99999999999999999999999997664 3333
Q ss_pred CCccceeEEEee----eccccccccccc----------c-cceecceeeeeeEEEEeee-CCccccccCCcccchhhhhh
Q 038949 549 GDMGVETRVLGT----FGYLAPEYAQSG----------Q-ITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWA 612 (678)
Q Consensus 549 ~~~~~~~~~~Gt----~~Y~APE~l~~~----------~-~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 612 (678)
.+......+..| ..|.|||.+... . .+++.||||+||+++||++ |+++|...+- +.+.-.
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL----~aYr~~ 250 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL----LAYRSG 250 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH----HhHhcc
Confidence 333333333333 359999987431 2 5778999999999999998 6888875321 000000
Q ss_pred HHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 613 RPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 613 ~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.....+..+.++-|. .+.+||..|++.||.+|.++++.|+.-.|.+.
T Consensus 251 ~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred CccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 000111111222121 57789999999999999999999998776654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-20 Score=207.77 Aligned_cols=236 Identities=22% Similarity=0.246 Sum_probs=182.0
Q ss_pred eecccCccceeecc----CCCCcEEEEEeeehhcccC--Cccccccceeeeccc-ccceEEEEeEEeeCCeEEEEEEEee
Q 038949 401 FLAEGGFGSVHRGV----LPDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGRRLLVYEYIC 473 (678)
Q Consensus 401 ~LG~G~fG~Vy~a~----~~~g~~vAvK~i~~~~~~~--~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~LV~E~~~ 473 (678)
.+|+|.||.|+++. ...+..||+|..+...... ......|..++...+ ||.++++...++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999976 2347789999876432211 124556777777776 9999999999999999999999999
Q ss_pred cCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccc
Q 038949 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553 (678)
Q Consensus 474 ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 553 (678)
||+|...+. ....+.+.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l----~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKL----GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchh----HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999998884 445577888888999999999999999 9999999999999999999999999999865443322
Q ss_pred eeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhccc
Q 038949 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCY 633 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~ 633 (678)
+||..|||||+++ .....+|.||||+++|+|+||..||.. +....++. .....
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~-----------~~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILK-----------AELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhh-----------hccCC
Confidence 8999999999998 667889999999999999999999964 11111111 01122
Q ss_pred chhhhhhhhhccceeeccCCCCCchH--HHHHHHhhccc
Q 038949 634 SEREVYGMLQCASLCIRKDPHSRPRM--SQVLRMLEGDI 670 (678)
Q Consensus 634 ~~~~~~~l~~LI~~cL~~dP~~RPT~--~eVL~~Le~~~ 670 (678)
+......+.+++..++..+|.+|.-. ..+.+..+..+
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f 245 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEF 245 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccch
Confidence 33344456677778888888888655 45555554433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4e-19 Score=176.17 Aligned_cols=140 Identities=22% Similarity=0.193 Sum_probs=108.1
Q ss_pred cceecccCccceeeccCCCCcEEEEEeeehhcccC--------------------------Cccccccceeeecccccce
Q 038949 399 ANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG--------------------------DQEFCSEVEVLSCAQHRNV 452 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~--------------------------~~~~~~Ev~iL~~L~HpnI 452 (678)
.+.||+|+||.||+|...+|+.||||+++...... ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 56899999999999997689999999987542110 0112467788888888887
Q ss_pred EEEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhh-cceeeeEEeccCCCCceEeee
Q 038949 453 VMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILVTH 531 (678)
Q Consensus 453 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~~~~~gIvHrDLKp~NILl~~ 531 (678)
.....+... ..+|||||+.|+++..... ...+++......++.|++.+|.++|. . ||+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~----givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEA----GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhC----CEecCCCChhhEEEE-
Confidence 433333222 2489999998876544321 22457778889999999999999999 8 999999999999999
Q ss_pred cCcccccccccccccc
Q 038949 532 DFEPLVGDFGLARWQP 547 (678)
Q Consensus 532 ~~~vkL~DFGla~~~~ 547 (678)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.8e-19 Score=208.71 Aligned_cols=260 Identities=18% Similarity=0.196 Sum_probs=188.8
Q ss_pred CceeehhhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeeccc---ccceEEEEe
Q 038949 381 PRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ---HRNVVMLIG 457 (678)
Q Consensus 381 ~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~---HpnIv~l~~ 457 (678)
+..-...+++.....|.+.+.||+|+||.||+|...+|+.||+|+-++...... .--.+++.+|+ -+.|..+..
T Consensus 685 ~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~ 761 (974)
T KOG1166|consen 685 PKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISS 761 (974)
T ss_pred cccCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHH
Confidence 344455667888899999999999999999999977799999998776554422 11222333444 234445555
Q ss_pred EEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee------
Q 038949 458 FCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH------ 531 (678)
Q Consensus 458 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~------ 531 (678)
.+.-.+..+||+||.+.|+|.+++. ..+.++|.....+..||+..+++||.. +||||||||+|+||..
T Consensus 762 a~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~----~IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 762 AHVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM----GIIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred HHccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc----ceecccCCcceeEeecccCCCC
Confidence 5555667889999999999999995 666799999999999999999999998 9999999999999953
Q ss_pred -cCccccccccccccccC-CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhh
Q 038949 532 -DFEPLVGDFGLARWQPD-GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT 609 (678)
Q Consensus 532 -~~~vkL~DFGla~~~~~-~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~ 609 (678)
...++|+|||.+..... .+.......++|-.+-.+|+..+++++..+|.|.|+.+++.||.|++.= ...
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~------- 906 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VKN------- 906 (974)
T ss_pred cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hcC-------
Confidence 45689999999953321 2224566778899999999999999999999999999999999997542 000
Q ss_pred hhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 610 EWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 610 ~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.....++..++.-+..+....+++ .+|..|=..=|...++...|++.+.
T Consensus 907 ----------g~~~~~~~~~~Ry~~~~~W~~~F~---~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 907 ----------GSSWMVKTNFPRYWKRDMWNKFFD---LLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred ----------CcceeccccchhhhhHHHHHHHHH---HHhCcCcccchhHHHHHHHHHHHHH
Confidence 011112222222233333333333 4444444444778888877776654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-19 Score=187.98 Aligned_cols=232 Identities=22% Similarity=0.321 Sum_probs=145.1
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhccc---CCccccccceeeeccc----------ccceEEEEeEEe
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCAQ----------HRNVVMLIGFCV 460 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L~----------HpnIv~l~~~~~ 460 (678)
.+...+.||.|+++.||.+.+ .+++.+|+|++...... ..+.+.+|.-....+. |-.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 456778899999999999995 57999999998543322 1234444443332221 212222122111
Q ss_pred ---------eC---C-----eEEEEEEEeecCCcccccc---cC--CCCccCccccchhhhhhccchhhhhhcceeeeEE
Q 038949 461 ---------ED---G-----RRLLVYEYICNGSLDSHLY---GR--DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIV 518 (678)
Q Consensus 461 ---------~~---~-----~~~LV~E~~~ggsL~~~l~---~~--~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIv 518 (678)
.. . ..+++|+-+ .++|.+++. .. ....+....+..+..|+++.+++||.. |+|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~----GlV 167 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY----GLV 167 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----TEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc----ceE
Confidence 11 1 236778776 567777652 11 122344555567779999999999999 999
Q ss_pred eccCCCCceEeeecCccccccccccccccCCCccceeEEEeeecccccccccc--------cccceecceeeeeeEEEEe
Q 038949 519 HRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS--------GQITEKADVYSLGVVLVEL 590 (678)
Q Consensus 519 HrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--------~~~s~ksDVwSLGviL~eL 590 (678)
|+||+|+|+|++.+|.+.|+||+........ ... ...+..|.+||.... -.++.+.|.|+||+++|.|
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~--~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTR--YRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEE--EEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCce--eec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999999887644221 110 123467999997644 2478899999999999999
Q ss_pred eeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCC
Q 038949 591 ITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSR 656 (678)
Q Consensus 591 ltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~R 656 (678)
.+|+.||+...+.... . ..+..|- +.++.+..||..+|+.||.+|
T Consensus 244 WC~~lPf~~~~~~~~~---~----------------~~f~~C~--~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADP---E----------------WDFSRCR--DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTS---G----------------GGGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccc---c----------------ccchhcC--CcCHHHHHHHHHHccCCcccC
Confidence 9999999865432211 0 1233333 667789999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.8e-18 Score=169.57 Aligned_cols=137 Identities=20% Similarity=0.181 Sum_probs=106.2
Q ss_pred CcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecc-----cccceEEEEeEEeeCC---e-EE
Q 038949 396 FSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-----QHRNVVMLIGFCVEDG---R-RL 466 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-----~HpnIv~l~~~~~~~~---~-~~ 466 (678)
+.-..+||+|+||.||. ...++.. +||++..........+.+|+.+++.+ .||||+++++++.++. . +.
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34457899999999996 3224444 79988765444556799999999999 5799999999998863 4 33
Q ss_pred EEEEE--eecCCcccccccCCCCccCccccchhhhhhccch-hhhhhcceeeeEEeccCCCCceEeee----cCcccccc
Q 038949 467 LVYEY--ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGL-RYLHEECRVGCIVHRDMRPNNILVTH----DFEPLVGD 539 (678)
Q Consensus 467 LV~E~--~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL-~yLH~~~~~~gIvHrDLKp~NILl~~----~~~vkL~D 539 (678)
+|+|| +.+|+|.+++.. ..+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~----~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDN----RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 557999999943 235555 35678888888 999999 9999999999999974 34899999
Q ss_pred cccc
Q 038949 540 FGLA 543 (678)
Q Consensus 540 FGla 543 (678)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.1e-18 Score=170.85 Aligned_cols=186 Identities=17% Similarity=0.079 Sum_probs=138.0
Q ss_pred cccceecccCccceeeccCCCCcEEEEEeeehhcccCC----ccccccceeeeccc-ccceEEEEeEEeeCCeEEEEEEE
Q 038949 397 SEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGD----QEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 397 ~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~----~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
.....|++|+||+||++.. .+.+++.+.+.....-.. ..+.+|+++|++|. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3456799999999998766 677888887764332111 25788999999995 5889999886 346999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccC-CCCceEeeecCccccccccccccccCCC
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDM-RPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDL-Kp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
+.|.+|...+.. ....++.|++.+|.++|++ ||+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~----GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC----GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC----cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999888654311 1135778999999999999 9999999 7999999999999999999997543322
Q ss_pred cc----c--------eeEEEeeeccccccccccc-ccc-eecceeeeeeEEEEeeeCCcccccc
Q 038949 551 MG----V--------ETRVLGTFGYLAPEYAQSG-QIT-EKADVYSLGVVLVELITGRKAMDLN 600 (678)
Q Consensus 551 ~~----~--------~~~~~Gt~~Y~APE~l~~~-~~s-~ksDVwSLGviL~eLltG~~Pf~~~ 600 (678)
.. . ......++.|++|+...-. ..+ ...+.++.|.-+|.++|++.++...
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 10 0 0112257778888754321 223 5678999999999999999887543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.3e-18 Score=177.32 Aligned_cols=197 Identities=22% Similarity=0.272 Sum_probs=137.5
Q ss_pred cccceEEEEeEEee---------------------------CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhh
Q 038949 448 QHRNVVMLIGFCVE---------------------------DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVG 500 (678)
Q Consensus 448 ~HpnIv~l~~~~~~---------------------------~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~q 500 (678)
.|||||+++++|.+ ...+|+||... .-+|..++-.+ ..+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence 59999999988753 23579999887 45888888433 2455667789999
Q ss_pred hccchhhhhhcceeeeEEeccCCCCceEee--ec--CccccccccccccccCCC-----ccceeEEEeeecccccccccc
Q 038949 501 AARGLRYLHEECRVGCIVHRDMRPNNILVT--HD--FEPLVGDFGLARWQPDGD-----MGVETRVLGTFGYLAPEYAQS 571 (678)
Q Consensus 501 I~~aL~yLH~~~~~~gIvHrDLKp~NILl~--~~--~~vkL~DFGla~~~~~~~-----~~~~~~~~Gt~~Y~APE~l~~ 571 (678)
+++|+.|||++ ||.|||||.+||||. +| ..+.|+|||.+-...... .......-|.-..||||+...
T Consensus 350 lLEav~hL~~h----gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 350 LLEAVTHLHKH----GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHc----cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999 999999999999994 33 357789999885322110 111122347778999998864
Q ss_pred c--cc----ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhcc
Q 038949 572 G--QI----TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCA 645 (678)
Q Consensus 572 ~--~~----s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI 645 (678)
. +. -.++|.|+.|.+.||+++...||.... ...+. ...+.+---| ..+..++..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG---em~L~--------~r~Yqe~qLP----alp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG---EMLLD--------TRTYQESQLP----ALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccc---hheec--------hhhhhhhhCC----CCcccCChHHHHHH
Confidence 3 22 248999999999999999999996421 11111 0111111011 23344555788999
Q ss_pred ceeeccCCCCCchHHHHHHHhh
Q 038949 646 SLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 646 ~~cL~~dP~~RPT~~eVL~~Le 667 (678)
...|+.||.+|++..-....|.
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999998776655543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.3e-17 Score=184.35 Aligned_cols=219 Identities=22% Similarity=0.311 Sum_probs=161.3
Q ss_pred eecccccceEEEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCC
Q 038949 444 LSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMR 523 (678)
Q Consensus 444 L~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLK 523 (678)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+.. ....+++.....+.+.|+.||.|||.. + ...|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~-i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS--P-IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC--c-ceeeeeec
Confidence 4568999999999999999999999999999999999965 344588888899999999999999986 1 22999999
Q ss_pred CCceEeeecCccccccccccccccC-CCccceeEEEeeeccccccccccc-------ccceecceeeeeeEEEEeeeCCc
Q 038949 524 PNNILVTHDFEPLVGDFGLARWQPD-GDMGVETRVLGTFGYLAPEYAQSG-------QITEKADVYSLGVVLVELITGRK 595 (678)
Q Consensus 524 p~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~~~Gt~~Y~APE~l~~~-------~~s~ksDVwSLGviL~eLltG~~ 595 (678)
..|.+++....+||+|||+...... ..........-..-|.|||.+... ..+.+.||||||++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 9999999999999999999976542 111111111223459999998753 14677999999999999999999
Q ss_pred cccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 596 AMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 596 Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
||+........ .+....... .-...+.|.+.... +....+..++..||..+|..||+++.+-..++.....
T Consensus 157 ~~~~~~~~~~~--~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 157 PFDLRNLVEDP--DEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccccCCh--HHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99764322111 122221111 01111222222111 2333688899999999999999999999888866543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.6e-17 Score=166.57 Aligned_cols=141 Identities=21% Similarity=0.144 Sum_probs=110.3
Q ss_pred CCcccceecccCccceeecc--CCCCcEEEEEeeehhcccC------------------------Cccccccceeeeccc
Q 038949 395 RFSEANFLAEGGFGSVHRGV--LPDGQVVAVKQYKLASSQG------------------------DQEFCSEVEVLSCAQ 448 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~--~~~g~~vAvK~i~~~~~~~------------------------~~~~~~Ev~iL~~L~ 448 (678)
-|.+.+.||+|+||.||+|. ..+|+.||+|+++...... ...+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 5689999999987442110 012457889998887
Q ss_pred cc--ceEEEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeee-EEeccCCCC
Q 038949 449 HR--NVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC-IVHRDMRPN 525 (678)
Q Consensus 449 Hp--nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g-IvHrDLKp~ 525 (678)
+. .+..++++ ...++||||+.|++|...... ...+.......++.|++.+|.+||+. | |+||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----g~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKE----GELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhc----CCEEeCCCChh
Confidence 53 34455543 235899999999888766522 23355556678999999999999999 9 999999999
Q ss_pred ceEeeecCccccccccccccc
Q 038949 526 NILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 526 NILl~~~~~vkL~DFGla~~~ 546 (678)
||+++ ++.++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4e-17 Score=188.49 Aligned_cols=216 Identities=24% Similarity=0.317 Sum_probs=147.6
Q ss_pred hcCCcccceecccCccceeeccCC-CCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
..+|..+++|..|+||.||+.+++ +.+.+|+|+=+ .+ .+.+. ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee------------------
Confidence 467889999999999999999864 57889985422 11 11111 33344445444
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC-
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD- 550 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~- 550 (678)
|+=...+ +..++++. +++.+++|||+. ||+|||+||+|.+|+.-|++|+.|||+........
T Consensus 136 ---gDc~tll--k~~g~lPv--------dmvla~Eylh~y----givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLL--KNIGPLPV--------DMVLAVEYLHSY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhc--ccCCCCcc--------hhhHHhHhhccC----CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 3333333 22233432 237899999999 99999999999999999999999999986432110
Q ss_pred -------------ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHH
Q 038949 551 -------------MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK 617 (678)
Q Consensus 551 -------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 617 (678)
.......+|||.|.|||++....|+..+|+|++|+|+|+.+-|..||....+... ...++.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~vis 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQVIS 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhhhhh
Confidence 0112246899999999999999999999999999999999999999987765321 011111
Q ss_pred HhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 618 RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 618 ~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.++..+.-. .....+..++|.++|+.+|..|--....++.
T Consensus 273 ----d~i~wpE~d----ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ev 312 (1205)
T KOG0606|consen 273 ----DDIEWPEED----EALPPEAQDLIEQLLRQNPLCRLGTGGALEV 312 (1205)
T ss_pred ----hhccccccC----cCCCHHHHHHHHHHHHhChHhhcccchhhhh
Confidence 111111111 1223368889999999999999644444443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.6e-18 Score=182.96 Aligned_cols=168 Identities=26% Similarity=0.432 Sum_probs=129.5
Q ss_pred eEEEEEEEeecCCccccccc-CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYG-RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
++|+.|++|...+|.+||.. +.....++.....++.|++.|+.| + |.+|+|+||.||+...+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k----~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K----GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c----cchhhhccccccccccchhhhhhhhhh
Confidence 57899999999999999963 334456778889999999999999 5 899999999999999999999999999
Q ss_pred cccccCCC-----ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHH
Q 038949 543 ARWQPDGD-----MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLL 616 (678)
Q Consensus 543 a~~~~~~~-----~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~ 616 (678)
........ ....+...||..||+||.+.+..|+.++||||||+||+||++ =..+|+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------------------ 464 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------------------ 464 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------------------
Confidence 98665443 345667789999999999999999999999999999999987 111221
Q ss_pred HHhhhh----cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHH
Q 038949 617 KRHAIG----ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQ 661 (678)
Q Consensus 617 ~~~~~~----elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~e 661 (678)
+..... ..++|.....++. -..|+.+++.+.|.+||++.+
T Consensus 465 r~~t~~d~r~g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 465 RIATLTDIRDGIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred HHHhhhhhhcCCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence 111111 1222222222322 346778999999999995444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.2e-16 Score=159.96 Aligned_cols=134 Identities=19% Similarity=0.266 Sum_probs=111.1
Q ss_pred ceecccCccceeeccCCCCcEEEEEeeehhcccC--------CccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG--------DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~--------~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
+.||+|++|.||+|.+ .|..+++|......... ...+.+|+.++..+.|++|.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 67789999765322111 13577899999999999887776666677788999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
+.|++|.+++... .. .+..++.+++.+|.++|.. |++|||++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~----~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSA----GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhC----CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988432 11 6788999999999999999 999999999999999 88999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.6e-16 Score=180.97 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=191.8
Q ss_pred hcCCcccceecccCccceeeccCC--CCcEEEEEeeehhc--ccCCccccccceeeeccc-ccceEEEEeEEeeCCeEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLP--DGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~L 467 (678)
...|.+.+.||+|+|+.|-..... ....+|.|.+.... .........|..+-..+. |.|++.+++...+....++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345667777999999999888742 34467777665443 222245556777777776 9999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhh-hcceeeeEEeccCCCCceEeeecC-cccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLH-EECRVGCIVHRDMRPNNILVTHDF-EPLVGDFGLARW 545 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH-~~~~~~gIvHrDLKp~NILl~~~~-~vkL~DFGla~~ 545 (678)
+++|..|+++.+.+........+...+..++.|+..++.|+| .. ++.|+|+||+|.+++..+ .++++|||++..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~----~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN----GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc----ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999999884333335677788899999999999999 76 999999999999999999 999999999987
Q ss_pred ccC--CCccceeEEEe-eeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 546 QPD--GDMGVETRVLG-TFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 546 ~~~--~~~~~~~~~~G-t~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
+.. +........+| ++.|+|||...+. ......|+||+|+++..+++|..|++....... ....|...-
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~------ 247 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK------ 247 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc------
Confidence 665 44455566778 9999999999874 456789999999999999999999875543221 111111110
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHH
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQV 662 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eV 662 (678)
................+++.+++..+|..|.+.+++
T Consensus 248 -----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 248 -----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred -----cccccCccccCChhhhhcccccccCCchhccccccc
Confidence 000111112233467788899999999999998886
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.4e-16 Score=156.41 Aligned_cols=130 Identities=25% Similarity=0.315 Sum_probs=104.3
Q ss_pred eecccCccceeeccCCCCcEEEEEeeehhcccC--------CccccccceeeecccccceEEEEeEEeeCCeEEEEEEEe
Q 038949 401 FLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG--------DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYI 472 (678)
Q Consensus 401 ~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~--------~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~ 472 (678)
.||+|+||.||+|.+ ++..+++|......... ..++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 57789999865322111 145678999999998887554444445566779999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
+|++|.+++... . . .++.+++.+|.+||+. |++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~--~-~------~~~~~i~~~l~~lH~~----gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG--N-D------ELLREIGRLVGKLHKA----GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc--H-H------HHHHHHHHHHHHHHHC----CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887321 1 1 7899999999999999 999999999999999 89999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.3e-16 Score=154.52 Aligned_cols=137 Identities=22% Similarity=0.142 Sum_probs=107.9
Q ss_pred cCCcccceecccCccceeeccCCCCcEEEEEeeehhcccC----------------------Cccccccceeeecccccc
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG----------------------DQEFCSEVEVLSCAQHRN 451 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~----------------------~~~~~~Ev~iL~~L~Hpn 451 (678)
..|.+.+.||+|+||.||++...+|+.||||++....... ...+..|+.++..+.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3488899999999999999998789999999876432100 012456777788787763
Q ss_pred --eEEEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe
Q 038949 452 --VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV 529 (678)
Q Consensus 452 --Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl 529 (678)
++..++. ...++||||+.|++|..+... .....++.+++.++.++|.. ||+||||+|+||++
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~----gi~H~Dl~p~Nill 158 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH----GIIHGDLSEFNILV 158 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC----CCCcCCCCcccEEE
Confidence 4444442 345899999999998765421 34567889999999999998 99999999999999
Q ss_pred eecCccccccccccccc
Q 038949 530 THDFEPLVGDFGLARWQ 546 (678)
Q Consensus 530 ~~~~~vkL~DFGla~~~ 546 (678)
+.++.++|+|||++...
T Consensus 159 ~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 159 DDDEKIYIIDWPQMVST 175 (198)
T ss_pred cCCCcEEEEECCccccC
Confidence 99999999999999644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.9e-16 Score=176.68 Aligned_cols=140 Identities=21% Similarity=0.288 Sum_probs=112.3
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehh--cc------cCCccccccceeeecccccceEEEEeEEee
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLA--SS------QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~--~~------~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 461 (678)
......|...+.||+|+||.||+|.+.+. .+++|..... .. .....+.+|+++++.++|++++..+.++..
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 34445667789999999999999987443 3444432111 10 112457889999999999999888777777
Q ss_pred CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
....++||||++|++|.+++. ....++.+++.+|.+||+. |++||||||+|||+ .++.++|+|||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~----giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA----GIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC----CCccCCCChHHEEE-ECCcEEEEeCc
Confidence 777899999999999998883 3467899999999999999 99999999999999 67899999999
Q ss_pred cccc
Q 038949 542 LARW 545 (678)
Q Consensus 542 la~~ 545 (678)
+++.
T Consensus 473 la~~ 476 (535)
T PRK09605 473 LGKY 476 (535)
T ss_pred cccc
Confidence 9974
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.8e-15 Score=144.43 Aligned_cols=136 Identities=24% Similarity=0.209 Sum_probs=95.7
Q ss_pred cceecccCccceeeccCCCCcEEEEEeeehhcccCC--ccc----------------------cccceeeeccccc--ce
Q 038949 399 ANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGD--QEF----------------------CSEVEVLSCAQHR--NV 452 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~--~~~----------------------~~Ev~iL~~L~Hp--nI 452 (678)
.+.||+|+||.||+|...+++.||||++........ ..+ ..|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 567999999999999977899999999864322111 111 1233334444322 23
Q ss_pred EEEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhh-cceeeeEEeccCCCCceEeee
Q 038949 453 VMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILVTH 531 (678)
Q Consensus 453 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~~~~~gIvHrDLKp~NILl~~ 531 (678)
.+.+++ ...++||||+.++.+......... .. ..+..++.+++.++.++|. . ||+||||+|+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~----~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREA----GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhcc----CcCcCCCChhhEEEE-
Confidence 344433 246899999998654322111100 11 5678899999999999999 7 999999999999999
Q ss_pred cCccccccccccccc
Q 038949 532 DFEPLVGDFGLARWQ 546 (678)
Q Consensus 532 ~~~vkL~DFGla~~~ 546 (678)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 999999999999644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-14 Score=134.47 Aligned_cols=136 Identities=23% Similarity=0.183 Sum_probs=112.4
Q ss_pred ccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccc--cceEEEEeEEeeCCeEEEEEEEeecC
Q 038949 398 EANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQH--RNVVMLIGFCVEDGRRLLVYEYICNG 475 (678)
Q Consensus 398 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~H--pnIv~l~~~~~~~~~~~LV~E~~~gg 475 (678)
+.+.||.|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++.++...+..+++|||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45679999999999999744 7899998764332 4578899999999976 58999999888888899999999888
Q ss_pred CcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 476 SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
.+..+ +......++.+++.+|.+||... ..+++|+||+|+||+++.++.+++.|||.+...
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~-~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLP-LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCC-ceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 77654 33455678899999999999852 127999999999999999999999999998743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.8e-14 Score=144.47 Aligned_cols=136 Identities=20% Similarity=0.209 Sum_probs=102.7
Q ss_pred cceec-ccCccceeeccCCCCcEEEEEeeehhc-------------ccCCccccccceeeecccccce--EEEEeEEeeC
Q 038949 399 ANFLA-EGGFGSVHRGVLPDGQVVAVKQYKLAS-------------SQGDQEFCSEVEVLSCAQHRNV--VMLIGFCVED 462 (678)
Q Consensus 399 ~~~LG-~G~fG~Vy~a~~~~g~~vAvK~i~~~~-------------~~~~~~~~~Ev~iL~~L~HpnI--v~l~~~~~~~ 462 (678)
...|| .||.|.||.+... +..++||.+.... ......+.+|++++..+.|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 34677 7888999988763 6789999874211 0112457789999999998875 6677664432
Q ss_pred -C---eEEEEEEEeec-CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccc
Q 038949 463 -G---RRLLVYEYICN-GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLV 537 (678)
Q Consensus 463 -~---~~~LV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL 537 (678)
. ..++|||+++| .+|.+++.. .++++ ..+.+|+.+|.+||+. ||+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~----~~~~~i~~~l~~lH~~----GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE---APLSE----EQWQAIGQLIARFHDA----GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc---CCCCH----HHHHHHHHHHHHHHHC----CCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 688887732 23433 2467899999999999 9999999999999999999999
Q ss_pred ccccccccc
Q 038949 538 GDFGLARWQ 546 (678)
Q Consensus 538 ~DFGla~~~ 546 (678)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999998753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.8e-12 Score=144.76 Aligned_cols=140 Identities=26% Similarity=0.286 Sum_probs=97.9
Q ss_pred ceecccCccceeeccCCCCcEEEEEeeehhcccC----------------------------------------Cccccc
Q 038949 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG----------------------------------------DQEFCS 439 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~----------------------------------------~~~~~~ 439 (678)
+.||.|++|.||+|++++|+.||||+.++.-... .-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6799999999999998899999999985431100 013445
Q ss_pred cceeeeccc----ccceEEEEeEEe-eCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhcc-chhhhhhcce
Q 038949 440 EVEVLSCAQ----HRNVVMLIGFCV-EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAAR-GLRYLHEECR 513 (678)
Q Consensus 440 Ev~iL~~L~----HpnIv~l~~~~~-~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~-aL~yLH~~~~ 513 (678)
|+..+.++. |.+-+.+-.++. .....+|||||++|++|.++......+ . ....++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~---~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-L---DRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-C---CHHHHHHHHHHHHHHHHHhC--
Confidence 555555542 222233322222 234579999999999999876322111 1 23456666655 46788888
Q ss_pred eeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 514 ~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
|++|+|++|.||+++.++.++++|||++....
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.1e-12 Score=143.52 Aligned_cols=251 Identities=24% Similarity=0.246 Sum_probs=181.8
Q ss_pred hhhhcCCcccceecc--cCccceeeccC---CCCcEEEEEeeeh--hcccCCccccccceeeecc-cccceEEEEeEEee
Q 038949 390 ELATNRFSEANFLAE--GGFGSVHRGVL---PDGQVVAVKQYKL--ASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVE 461 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~--G~fG~Vy~a~~---~~g~~vAvK~i~~--~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~ 461 (678)
......|.+...+|. |.+|.||.+.. .++..+|+|.-+. ........=.+|+....++ .|+|.++.+..+..
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 344567788888999 99999999985 3678899997432 2223333445666666666 49999999999999
Q ss_pred CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhcc----chhhhhhcceeeeEEeccCCCCceEeeec-Cccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAAR----GLRYLHEECRVGCIVHRDMRPNNILVTHD-FEPL 536 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~----aL~yLH~~~~~~gIvHrDLKp~NILl~~~-~~vk 536 (678)
.+..++-+|++ +.+|..+..... ..++...++..+.+... ||.++|.. +++|-|+||.||++..+ ...+
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~----~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN----NIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred CCcceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC----cccccccchhheecccccceee
Confidence 99999999997 678888774332 23677777888888877 99999998 99999999999999999 8999
Q ss_pred cccccccccccCCCccc----eeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhh
Q 038949 537 VGDFGLARWQPDGDMGV----ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWA 612 (678)
Q Consensus 537 L~DFGla~~~~~~~~~~----~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~ 612 (678)
++|||+...+..+.... ..+..|...|++||.++ +-++...|+|+||.+..+..+|.......- ...|.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~~~W~ 336 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGK------NSSWS 336 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCC------CCCcc
Confidence 99999998776654322 22235677899999887 566889999999999999988876653221 01111
Q ss_pred HHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHH
Q 038949 613 RPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663 (678)
Q Consensus 613 ~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL 663 (678)
.. .... +...+.......+...+..|++.+|-.|++.+.++
T Consensus 337 ~~-------r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 337 QL-------RQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cc-------cccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 10 0000 11111122223455578889999999999988775
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.5e-11 Score=116.87 Aligned_cols=132 Identities=19% Similarity=0.062 Sum_probs=97.1
Q ss_pred cceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccce-EEEEeEEeeCCeEEEEEEEeecCCc
Q 038949 399 ANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNV-VMLIGFCVEDGRRLLVYEYICNGSL 477 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnI-v~l~~~~~~~~~~~LV~E~~~ggsL 477 (678)
.+.|+.|.++.||++... +..|++|+...... ....+..|+.+++.+.+.++ .+++.+.. ...++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 356889999999999864 77899998753321 23356789999998865544 45555433 345899999999887
Q ss_pred ccccccCCCCccCccccchhhhhhccchhhhhhcce-eeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 478 DSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR-VGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 478 ~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~-~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
.... .....++.+++.+|+.||.... ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6531 1123467789999999998721 12369999999999999 67899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.1e-12 Score=142.63 Aligned_cols=146 Identities=21% Similarity=0.202 Sum_probs=96.8
Q ss_pred hhhhcCCcccceecccCccceeeccCCC-CcEEEEEeeehhccc----------------------C------------C
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQ----------------------G------------D 434 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~i~~~~~~----------------------~------------~ 434 (678)
+.....|.. +.||+|++|.||+|++++ |+.||||+.++.-.. . .
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 344556777 789999999999999766 999999998643100 0 0
Q ss_pred ------ccccccceeeeccc----ccceEEEEeEEee-CCeEEEEEEEeecCCcccccccCCCC----ccCccccchhhh
Q 038949 435 ------QEFCSEVEVLSCAQ----HRNVVMLIGFCVE-DGRRLLVYEYICNGSLDSHLYGRDRD----PLEWSARRKIAV 499 (678)
Q Consensus 435 ------~~~~~Ev~iL~~L~----HpnIv~l~~~~~~-~~~~~LV~E~~~ggsL~~~l~~~~~~----~l~~~~~~~i~~ 499 (678)
-++.+|+..+.++. +.+.+.+-.++.+ ....+|||||+.|+.+.++-.-...+ .+.+..+..++.
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 12444554444442 3333443333332 45578999999999997743111111 244444444455
Q ss_pred hhccchhhhhhcceeeeEEeccCCCCceEeeecC----cccccccccccccc
Q 038949 500 GAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF----EPLVGDFGLARWQP 547 (678)
Q Consensus 500 qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~----~vkL~DFGla~~~~ 547 (678)
|++ .. |++|+|++|.||+++.++ .++++|||+.....
T Consensus 275 Qif-------~~----GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 QVF-------RD----GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHH-------hC----CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 543 35 999999999999999988 99999999997553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.4e-11 Score=139.25 Aligned_cols=249 Identities=22% Similarity=0.248 Sum_probs=180.0
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehh---cccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA---SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
...+.+.+.+-+-+|.++.++.+.- ..|...++|..... .....+....+-.++-..++|-++...--+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 3456677778899999999999873 34545555554322 2233445566666655566788887766666667799
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
|+++|+.+++|...+. ..+..+...++.....+..+++|||.. .++|+|++|.|+|+..+++.++.|||.....
T Consensus 881 L~~~~~~~~~~~Skl~--~~~~~saepaRs~i~~~vqs~e~L~s~----~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLH--NSGCLSAEPARSPILERVQSLESLHSS----LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhh--cCCCcccccccchhHHHHhhhhccccc----hhhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999884 344577777888888899999999997 6899999999999999999999999844211
Q ss_pred cC------------------------------CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCcc
Q 038949 547 PD------------------------------GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKA 596 (678)
Q Consensus 547 ~~------------------------------~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~P 596 (678)
.. .+........||+.|.+||.+.+......+|.|++|+++++.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 00 000113345789999999999999999999999999999999999999
Q ss_pred ccccCCcccchhhhhhHHHHHHhhhhcccCcchh-cccchhhhhhhhhccceeeccCCCCCchHH
Q 038949 597 MDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR-NCYSEREVYGMLQCASLCIRKDPHSRPRMS 660 (678)
Q Consensus 597 f~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~-~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~ 660 (678)
|+...+... +..++..... ...+....+...+++.+.+..+|.+|-.+.
T Consensus 1035 ~na~tpq~~---------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQI---------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhh---------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 986654211 1111111110 112233445778888899999999997766
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.04 E-value=2e-10 Score=114.34 Aligned_cols=137 Identities=16% Similarity=0.129 Sum_probs=95.7
Q ss_pred cceecccCccceeeccCCC-------CcEEEEEeeehhccc---------CCcc-------------cc----ccceeee
Q 038949 399 ANFLAEGGFGSVHRGVLPD-------GQVVAVKQYKLASSQ---------GDQE-------------FC----SEVEVLS 445 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~-------g~~vAvK~i~~~~~~---------~~~~-------------~~----~Ev~iL~ 445 (678)
...||.|.-+.||.|...+ +..+|||+++..... +..+ +. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998542 479999998532110 0111 12 6888888
Q ss_pred cccc--cceEEEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhh-hhcceeeeEEeccC
Q 038949 446 CAQH--RNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYL-HEECRVGCIVHRDM 522 (678)
Q Consensus 446 ~L~H--pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yL-H~~~~~~gIvHrDL 522 (678)
++.. -++...+++ ..-+|||||+.+..+..-.. ....++......+..+++.+|..| |+. |||||||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L--kd~~~~~~~~~~i~~~i~~~l~~l~H~~----glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL--KDAKLNDEEMKNAYYQVLSMMKQLYKEC----NLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh--hccccCHHHHHHHHHHHHHHHHHHHHhC----CeecCCC
Confidence 7753 355666654 44689999996543322111 112244445567789999999999 887 9999999
Q ss_pred CCCceEeeecCccccccccccccc
Q 038949 523 RPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 523 Kp~NILl~~~~~vkL~DFGla~~~ 546 (678)
++.|||++ ++.+.|+|||.+...
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeC
Confidence 99999997 578999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.9e-11 Score=133.96 Aligned_cols=166 Identities=21% Similarity=0.264 Sum_probs=126.2
Q ss_pred CCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCcccc
Q 038949 415 LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSAR 494 (678)
Q Consensus 415 ~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~ 494 (678)
..++.+|.|..++..+........+-++.|+.++||||+++++.++.++..|||+|.+ ..|..++.. +.....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHHHH
Confidence 4467888888887555433345667788899999999999999999999999999987 456666633 334556
Q ss_pred chhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccceeEEEeeeccccccccccccc
Q 038949 495 RKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQI 574 (678)
Q Consensus 495 ~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~ 574 (678)
..-+.||+.||.|||..| +++|++|....|+++..|+.||++|.++........ ..........|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~---~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC---NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC---CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 677899999999999775 899999999999999999999999998864432221 111122233466676554322
Q ss_pred ceecceeeeeeEEEEeeeC
Q 038949 575 TEKADVYSLGVVLVELITG 593 (678)
Q Consensus 575 s~ksDVwSLGviL~eLltG 593 (678)
-..|.|-||+++++++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 356999999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.9e-10 Score=112.16 Aligned_cols=143 Identities=22% Similarity=0.207 Sum_probs=106.8
Q ss_pred ceecccCccceeeccCCCCcEEEEEeeehhcc-cCCccccccceeeecccc--cceEEEEeEEeeC---CeEEEEEEEee
Q 038949 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQH--RNVVMLIGFCVED---GRRLLVYEYIC 473 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~H--pnIv~l~~~~~~~---~~~~LV~E~~~ 473 (678)
+.|+.|.++.||++...+|+.+++|....... .....+..|++++..+.+ .++.+++.+.... +..++||||+.
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999876668899998754322 134578889999998865 3456777776653 36789999999
Q ss_pred cCCcccccccCCCCccCccccchhhhhhccchhhhhhcc-----------------------------------------
Q 038949 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC----------------------------------------- 512 (678)
Q Consensus 474 ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~----------------------------------------- 512 (678)
|.++.+.+.. ..++......++.+++.+|.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876631 23555566667777777777777421
Q ss_pred -----------eeeeEEeccCCCCceEeee--cCcccccccccccc
Q 038949 513 -----------RVGCIVHRDMRPNNILVTH--DFEPLVGDFGLARW 545 (678)
Q Consensus 513 -----------~~~gIvHrDLKp~NILl~~--~~~vkL~DFGla~~ 545 (678)
...+++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0247899999999999998 66788999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.4e-11 Score=125.88 Aligned_cols=200 Identities=21% Similarity=0.264 Sum_probs=135.4
Q ss_pred eecccccceEEEEeEEeeC-----CeEEEEEEEeecCCcccccccC--CCCccCccccchhhhhhccchhhhhhcceeee
Q 038949 444 LSCAQHRNVVMLIGFCVED-----GRRLLVYEYICNGSLDSHLYGR--DRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516 (678)
Q Consensus 444 L~~L~HpnIv~l~~~~~~~-----~~~~LV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g 516 (678)
|-.+.|.|||++..|+.+. .+..++.||+.-|+|..+|.+. ....+....-.+|+-||+.||.|||+..+ -
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P--p 198 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP--P 198 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC--c
Confidence 3446799999999887653 3578999999999999999542 33457777778999999999999999644 6
Q ss_pred EEeccCCCCceEeeecCcccccccccccccc---CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeC
Q 038949 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQP---DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITG 593 (678)
Q Consensus 517 IvHrDLKp~NILl~~~~~vkL~DFGla~~~~---~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG 593 (678)
|+|+++..+-|++.++|-+|++----..... ...........+.++|.+||.-..-..+.++|||+||+..++|..|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999988875321111000 0111112233467899999987777778899999999888888776
Q ss_pred CccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 594 RKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 594 ~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..--..... . ...+. -....+..+-++ .-..++.+|++..|..||+|.+++.
T Consensus 279 Eiq~tnseS-~--~~~ee----~ia~~i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 279 EIQSTNSES-K--VEVEE----NIANVIIGLENG------------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eeccCCCcc-e--eehhh----hhhhheeeccCc------------cccCcCcccccCCCCCCcchhhhhc
Confidence 532111100 0 00000 000011111111 1245788999999999999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.8e-10 Score=128.17 Aligned_cols=248 Identities=20% Similarity=0.175 Sum_probs=173.9
Q ss_pred hhhhcCCcccceecccCccceeeccC--CCCcEEEEEeeehhcccCC--ccccccceeeecc-cccceEEEEeEEeeCCe
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL--PDGQVVAVKQYKLASSQGD--QEFCSEVEVLSCA-QHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~--~~g~~vAvK~i~~~~~~~~--~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~ 464 (678)
.....+|..+..||.|.|+.|+.... .++..|++|.......... ..-..|+.+...+ .|.+++..+..+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34556899999999999999998762 4678899997653322222 2333455555555 48899988887777788
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec-Ccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD-FEPLVGDFGLA 543 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~-~~vkL~DFGla 543 (678)
.|+=.|||.++++...+ .....+.+...+.+..|++.++.++|+. .++|+|++|+||++..+ +..+++|||..
T Consensus 341 ~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~----~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSK----LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccch----hhhcccccccceeeccchhhhhccccccc
Confidence 88999999999887766 3444577888899999999999999998 99999999999999886 88899999988
Q ss_pred ccccCCCccceeEEEeeeccc--ccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 544 RWQPDGDMGVETRVLGTFGYL--APEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 544 ~~~~~~~~~~~~~~~Gt~~Y~--APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
....-.. ......-++. +++......+-.+.|+|+||.-+.+.++|...-... . .|. .+
T Consensus 415 t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----~----~~~-------~i 475 (524)
T KOG0601|consen 415 TRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----V----QSL-------TI 475 (524)
T ss_pred cccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccc----c----cce-------ee
Confidence 6321111 1111233344 555555667788999999999999999986532211 1 011 01
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
..-.-++... ....+..+...++..++..||.+.++....+
T Consensus 476 ~~~~~p~~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 476 RSGDTPNLPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ecccccCCCc-----hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1111111111 1135677788899999999999988765544
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.2e-09 Score=101.24 Aligned_cols=132 Identities=17% Similarity=0.284 Sum_probs=94.7
Q ss_pred EEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhHHH
Q 038949 15 VVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSCS 94 (678)
Q Consensus 15 ~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 94 (678)
+|+|++|.| +.|..||.||+...-..|+.|+||||.++..... +. .+... ...+...+..+...
T Consensus 1 ~ILVavD~S-~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~--~~---------~~~~~----~~~~~~~~~~~~~~ 64 (146)
T cd01989 1 SVAVAVDKD-KKSKNALKWALDNLATKGQTIVLVHVHPPITSIP--SS---------SGKLE----VASAYKQEEDKEAK 64 (146)
T ss_pred CEEEEecCc-cccHHHHHHHHHhccCCCCcEEEEEeccCcccCC--CC---------ccchH----HHHHHHHHHHHHHH
Confidence 489999998 6699999999998888899999999998643211 00 00000 00000122223334
Q ss_pred HHHHHhhhcCCCCcceEEEEEEec-CCcchhhhhhhcccccEEEEccccchhh----------hhhccccc--ccEEEEe
Q 038949 95 QMMRQLQEVYDPEKIKVRVKIVSG-SPYGVVAVEAKKAQSNWVILDKQLKHEK----------KCCMEELQ--CNVVVMK 161 (678)
Q Consensus 95 ~~~~~l~~~~~~~~v~~~i~v~~g-~~~~~v~~e~k~~~a~~vVld~~~k~~~----------~~~~~~l~--c~i~~~~ 161 (678)
+.+.+..+.|+..+++++..++.| +|...|+++|++.+|+.|||++|=+... .+++++.+ |-|.+++
T Consensus 65 ~~l~~~~~~~~~~~~~~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~gssva~~Vi~~a~~~c~Vlvv~ 144 (146)
T cd01989 65 ELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVS 144 (146)
T ss_pred HHHHHHHHHHhhcCCeEEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccCCchhHHHHhcCCCCceEEEEe
Confidence 556666667777799999999987 7888999999999999999999944332 26888999 9999987
Q ss_pred c
Q 038949 162 R 162 (678)
Q Consensus 162 ~ 162 (678)
+
T Consensus 145 ~ 145 (146)
T cd01989 145 K 145 (146)
T ss_pred C
Confidence 5
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.6e-09 Score=103.92 Aligned_cols=131 Identities=24% Similarity=0.288 Sum_probs=97.0
Q ss_pred ceecccCccceeeccCCCCcEEEEEeeehhcccC--------CccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG--------DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~--------~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
..+++|+-+.+|.+.+. |..+++|.=....... ..+..+|+.++..+.--.|..-+-+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35889999999999874 4446666432111111 13566799998888755554434444556667899999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++|-.|.+.+... ...++..+-.-+.-||.. ||+|+||.++||++..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~----givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA----GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc----CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888432 256778888888999999 999999999999998775 89999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=6.3e-09 Score=100.87 Aligned_cols=143 Identities=19% Similarity=0.259 Sum_probs=103.4
Q ss_pred ccceecccCccceeeccCCCCcEEEEEeeehhc--------ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 398 EANFLAEGGFGSVHRGVLPDGQVVAVKQYKLAS--------SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 398 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~--------~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
.+.+|-+|+-+.|+++.+ .|+.++||.-.... .-...+..+|++.|.++.--.|.--.-+|.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999998 57777777421111 111246778999988886545543334455556667999
Q ss_pred EEeec-CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc---ccccccccccc
Q 038949 470 EYICN-GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE---PLVGDFGLARW 545 (678)
Q Consensus 470 E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~---vkL~DFGla~~ 545 (678)
||+.| .++.+++...-...........++..|-+.+.-||.+ +|+||||..+||+|..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n----diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN----DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC----CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99966 3777777544443333344468899999999999999 9999999999999976543 36999999863
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=7.8e-08 Score=90.30 Aligned_cols=132 Identities=16% Similarity=0.326 Sum_probs=92.9
Q ss_pred eEEEEEEeeccc-ccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhH
Q 038949 14 KVVIVAVKASKE-IPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDS 92 (678)
Q Consensus 14 ~~VvV~~das~~-~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (678)
++|+|++|.|.. .+..|+.||+.-.-+.|..|+||+|+++...... .++. . .. .. ...++..+.
T Consensus 3 ~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~~-~~~~-------~-~~-----~~-~~~~~~~~~ 67 (144)
T PRK15005 3 RTILVPIDISDSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYAS-LGLA-------Y-SA-----EL-PAMDDLKAE 67 (144)
T ss_pred ccEEEecCCCchhHHHHHHHHHHHHHhccCCeEEEEEEEccCccccc-cccc-------c-cc-----cc-hHHHHHHHH
Confidence 579999998853 2578999999987778899999999985432210 1110 0 00 00 001222232
Q ss_pred HHHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhhh---------hhcccccccEEEEe
Q 038949 93 CSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEKK---------CCMEELQCNVVVMK 161 (678)
Q Consensus 93 ~~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~~---------~~~~~l~c~i~~~~ 161 (678)
-.+.+.++.+.+...++.+++.+..|+|...|+..|++.+|+.||++.| +.... +++++.+|-|.+++
T Consensus 68 ~~~~l~~~~~~~~~~~~~~~~~v~~G~p~~~I~~~a~~~~~DLIV~Gs~-~~~~~~~llGS~a~~vl~~a~cpVlvVr 144 (144)
T PRK15005 68 AKSQLEEIIKKFKLPTDRVHVHVEEGSPKDRILELAKKIPADMIIIASH-RPDITTYLLGSNAAAVVRHAECSVLVVR 144 (144)
T ss_pred HHHHHHHHHHHhCCCCCceEEEEeCCCHHHHHHHHHHHcCCCEEEEeCC-CCCchheeecchHHHHHHhCCCCEEEeC
Confidence 3345556665566678889999999999989998999999999999999 54432 68999999998874
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.2e-08 Score=113.37 Aligned_cols=149 Identities=21% Similarity=0.283 Sum_probs=103.2
Q ss_pred hhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc--------ceeEEEeeecccccccccc
Q 038949 500 GAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG--------VETRVLGTFGYLAPEYAQS 571 (678)
Q Consensus 500 qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~--------~~~~~~Gt~~Y~APE~l~~ 571 (678)
+++.||.|+|.. +++||++|.|++|.++.++..||+.|+++.....+... ..-...-...|.|||++..
T Consensus 107 ~v~dgl~flh~s---Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRS---AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccC---cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 455999999987 58999999999999999999999999988643321111 0111123457999999998
Q ss_pred cccceecceeeeeeEEEEeeeC-CccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeec
Q 038949 572 GQITEKADVYSLGVVLVELITG-RKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIR 650 (678)
Q Consensus 572 ~~~s~ksDVwSLGviL~eLltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~ 650 (678)
...+.++|+||||+++|.+..| ..-+....... . .......+..-...++...+.++.+-+.+++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~---~----------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL---S----------YSFSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcc---h----------hhhhhcccccccccccccCcHHHHHHHHHHhc
Confidence 8888999999999999999954 44443321100 0 00111112222233445566688888889999
Q ss_pred cCCCCCchHHHHHH
Q 038949 651 KDPHSRPRMSQVLR 664 (678)
Q Consensus 651 ~dP~~RPT~~eVL~ 664 (678)
.++..||++..++.
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999997777643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.3e-08 Score=100.87 Aligned_cols=125 Identities=26% Similarity=0.259 Sum_probs=80.7
Q ss_pred ceeeccCCCCcEEEEEeeehhccc---------------------CC-----ccccccceeeeccccc--ceEEEEeEEe
Q 038949 409 SVHRGVLPDGQVVAVKQYKLASSQ---------------------GD-----QEFCSEVEVLSCAQHR--NVVMLIGFCV 460 (678)
Q Consensus 409 ~Vy~a~~~~g~~vAvK~i~~~~~~---------------------~~-----~~~~~Ev~iL~~L~Hp--nIv~l~~~~~ 460 (678)
.||.|...+|..+|+|+.+..... .. ....+|++.|.++..- ++.+.+++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389998878999999988532111 00 1245688888888654 466776553
Q ss_pred eCCeEEEEEEEee--cCCcccccccCCCCccCccccchhhhhhccchhh-hhhcceeeeEEeccCCCCceEeeecCcccc
Q 038949 461 EDGRRLLVYEYIC--NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRY-LHEECRVGCIVHRDMRPNNILVTHDFEPLV 537 (678)
Q Consensus 461 ~~~~~~LV~E~~~--ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~y-LH~~~~~~gIvHrDLKp~NILl~~~~~vkL 537 (678)
.-+|||||+. |..+..+... .++......++.+++..+.. +|+. ||+||||.+.|||++.+ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~----givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKA----GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCT----TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhc----CceecCCChhhEEeecc-eEEE
Confidence 2469999998 5445443311 12245566788888885555 5687 99999999999999987 9999
Q ss_pred ccccccccc
Q 038949 538 GDFGLARWQ 546 (678)
Q Consensus 538 ~DFGla~~~ 546 (678)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999998644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.9e-08 Score=103.19 Aligned_cols=134 Identities=27% Similarity=0.220 Sum_probs=98.4
Q ss_pred CcccceecccCccceeeccCCCCcEEEEEeeehhccc----------------------CCccccccceeeeccccc--c
Q 038949 396 FSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ----------------------GDQEFCSEVEVLSCAQHR--N 451 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~----------------------~~~~~~~Ev~iL~~L~Hp--n 451 (678)
+.+...||-|.-+.||.|..+.|.++|||..+..... ......+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 5667889999999999999989999999976432111 002355688888877643 5
Q ss_pred eEEEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee
Q 038949 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH 531 (678)
Q Consensus 452 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~ 531 (678)
+...+++ ++-.+||||+.|-.|...- +.......++..|+.-+..+-.. ||||+|+++-||+++.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~----GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR----GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc----CccccCCchheEEEec
Confidence 5555554 4567999999887665433 22334445666666666666665 9999999999999999
Q ss_pred cCccccccccccc
Q 038949 532 DFEPLVGDFGLAR 544 (678)
Q Consensus 532 ~~~vkL~DFGla~ 544 (678)
||.+.++||-.+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999997664
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.2e-07 Score=89.28 Aligned_cols=130 Identities=16% Similarity=0.231 Sum_probs=90.6
Q ss_pred eEEEEEEeecc-cccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhH
Q 038949 14 KVVIVAVKASK-EIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDS 92 (678)
Q Consensus 14 ~~VvV~~das~-~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (678)
++|+|++|-|. +.+..|+.||+.- .+.+..|.||+|+++..... ...+ .. ...+..+...+.
T Consensus 3 ~~ILv~vD~S~~~~s~~al~~A~~l-a~~~~~l~llhv~~~~~~~~-~~~~--------~~-------~~~~~~~~~~~~ 65 (142)
T PRK15456 3 KTIIMPVDVFEMELSDKAVRHAEFL-AQDDGVIHLLHVLPGSASLS-LHRF--------AA-------DVRRFEEHLQHE 65 (142)
T ss_pred ccEEEeccCCchhHHHHHHHHHHHH-HhcCCeEEEEEEecCccccc-cccc--------cc-------chhhHHHHHHHH
Confidence 67999999884 5799999999975 44466899999998653211 0000 00 000011222222
Q ss_pred HHHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhhh---------hhcccccccEEEEe
Q 038949 93 CSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEKK---------CCMEELQCNVVVMK 161 (678)
Q Consensus 93 ~~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~~---------~~~~~l~c~i~~~~ 161 (678)
-.+.+.++.+.++..+++++..+..|+|...|++.|++.+|+.||+|.|- +... +++++.+|-|.++|
T Consensus 66 ~~~~l~~~~~~~~~~~~~v~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~g-~~~~~~llGS~a~~v~~~a~~pVLvV~ 142 (142)
T PRK15456 66 AEERLQTMVSHFTIDPSRIKQHVRFGSVRDEVNELAEELGADVVVIGSRN-PSISTHLLGSNASSVIRHANLPVLVVR 142 (142)
T ss_pred HHHHHHHHHHHhCCCCcceEEEEcCCChHHHHHHHHhhcCCCEEEEcCCC-CCccceecCccHHHHHHcCCCCEEEeC
Confidence 23445555555555688899999999999999988999999999999995 3332 58899999998875
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.5e-08 Score=102.46 Aligned_cols=138 Identities=18% Similarity=0.096 Sum_probs=94.8
Q ss_pred ecccCccceeeccCCCCcEEEEEeeehhcc-----------cCCccccccceeeecccccce--EEEEeEEee-----CC
Q 038949 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASS-----------QGDQEFCSEVEVLSCAQHRNV--VMLIGFCVE-----DG 463 (678)
Q Consensus 402 LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~-----------~~~~~~~~Ev~iL~~L~HpnI--v~l~~~~~~-----~~ 463 (678)
+-+.....|++..+ +|+.|.||....... .....+.+|...+.++..-+| +..+++... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344666655 577899997632211 011136788888887754333 333444432 23
Q ss_pred eEEEEEEEeecC-CcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-------cCcc
Q 038949 464 RRLLVYEYICNG-SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-------DFEP 535 (678)
Q Consensus 464 ~~~LV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-------~~~v 535 (678)
..+||+|++.+. +|.+++......+.+......++.+++..+.-||.. ||+|+||++.|||++. ++.+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~----Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA----GINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC----cCccCCCChhhEEEeccccCCCCCceE
Confidence 578999999775 788887422223345566678999999999999999 9999999999999985 4688
Q ss_pred ccccccccc
Q 038949 536 LVGDFGLAR 544 (678)
Q Consensus 536 kL~DFGla~ 544 (678)
.|+||+.+.
T Consensus 185 ~LIDl~r~~ 193 (268)
T PRK15123 185 SVIDLHRAQ 193 (268)
T ss_pred EEEECCccc
Confidence 999999885
|
|
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=6.1e-07 Score=84.70 Aligned_cols=128 Identities=13% Similarity=0.125 Sum_probs=87.4
Q ss_pred eEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhHH
Q 038949 14 KVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSC 93 (678)
Q Consensus 14 ~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (678)
++++|++|.| +.|..|+.||+...-+.|-.|+||||.++....- -++ .. ....+..+...+..
T Consensus 4 k~ILvavD~S-~~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~--~~~-------------~~-~~~~~~~~~~~~~~ 66 (142)
T PRK09982 4 KHIGVAISGN-EEDALLVNKALELARHNDAHLTLIHIDDGLSELY--PGI-------------YF-PATEDILQLLKNKS 66 (142)
T ss_pred eEEEEEecCC-cchHHHHHHHHHHHHHhCCeEEEEEEccCcchhc--hhh-------------hc-cchHHHHHHHHHHH
Confidence 6899999998 5589999999998778899999999998543110 000 00 00001112222222
Q ss_pred HHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhhh-------hhcccccccEEEEe
Q 038949 94 SQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEKK-------CCMEELQCNVVVMK 161 (678)
Q Consensus 94 ~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~~-------~~~~~l~c~i~~~~ 161 (678)
...+.++....+ ...++..|+.|+|...|+..|++.+|+.||+|.| ++... .++.+.+|-|.+++
T Consensus 67 ~~~l~~~~~~~~--~~~~~~~v~~G~p~~~I~~~A~~~~aDLIVmG~~-~~~~~~~~~va~~V~~~s~~pVLvv~ 138 (142)
T PRK09982 67 DNKLYKLTKNIQ--WPKTKLRIERGEMPETLLEIMQKEQCDLLVCGHH-HSFINRLMPAYRGMINKMSADLLIVP 138 (142)
T ss_pred HHHHHHHHHhcC--CCcceEEEEecCHHHHHHHHHHHcCCCEEEEeCC-hhHHHHHHHHHHHHHhcCCCCEEEec
Confidence 233444444333 2357788899999999999999999999999998 66655 36778888887775
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.3e-08 Score=107.58 Aligned_cols=167 Identities=20% Similarity=0.211 Sum_probs=126.5
Q ss_pred ccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEee----CCeEEEEEEEeec-CCcccc
Q 038949 407 FGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE----DGRRLLVYEYICN-GSLDSH 480 (678)
Q Consensus 407 fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~----~~~~~LV~E~~~g-gsL~~~ 480 (678)
-.+.|++. ..+|..|++|+++....+.......-++.++++.|+|+|+|.++|.. +..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35778887 56899999999965544444455567888999999999999998873 4568999999865 356554
Q ss_pred cccC-------------CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 481 LYGR-------------DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 481 l~~~-------------~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
-+.. .+...++..+|.++.|+..||.++|+. |+.-+-|.|.+||++.+-+++|...|+.....
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss----GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS----GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc----CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 4221 234478889999999999999999999 99999999999999999999998888775443
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRK 595 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~ 595 (678)
... . |.+.. -.+-|.=.||.+++.|.||..
T Consensus 445 ~d~-------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDP-------------T--EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC-------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 221 0 11111 234577789999999999953
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.5e-06 Score=81.88 Aligned_cols=128 Identities=15% Similarity=0.126 Sum_probs=84.7
Q ss_pred eEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhHH
Q 038949 14 KVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSC 93 (678)
Q Consensus 14 ~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (678)
++|+|++|.| +.+..||.||+.-.-..|..|+||+|.++..... -++ ......+..++..+.
T Consensus 4 ~~ILvavD~S-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~--~~~--------------~~~~~~~~~~~~~~~- 65 (144)
T PRK15118 4 KHILIAVDLS-PESKVLVEKAVSMARPYNAKVSLIHVDVNYSDLY--TGL--------------IDVNLGDMQKRISEE- 65 (144)
T ss_pred eEEEEEccCC-hhHHHHHHHHHHHHHhhCCEEEEEEEccChhhhh--hhh--------------hhcchHHHHHHHHHH-
Confidence 6799999998 4589999999997656788999999954321110 000 000000111222221
Q ss_pred HHHHHHhhhcCCCCcceE-EEEEEecCCcchhhhhhhcccccEEEEccccchhhh-------hhcccccccEEEEec
Q 038949 94 SQMMRQLQEVYDPEKIKV-RVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEKK-------CCMEELQCNVVVMKR 162 (678)
Q Consensus 94 ~~~~~~l~~~~~~~~v~~-~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~~-------~~~~~l~c~i~~~~~ 162 (678)
....|..+.+..++.+ .+.+..|+|...|+..|++.+|+.||++.| .+-.. +++++.+|-|.+++.
T Consensus 66 --~~~~l~~~~~~~~~~~~~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~-~~~~~~lgSva~~v~~~a~~pVLvv~~ 139 (144)
T PRK15118 66 --THHALTELSTNAGYPITETLSGSGDLGQVLVDAIKKYDMDLVVCGHH-QDFWSKLMSSARQLINTVHVDMLIVPL 139 (144)
T ss_pred --HHHHHHHHHHhCCCCceEEEEEecCHHHHHHHHHHHhCCCEEEEeCc-ccHHHHHHHHHHHHHhhCCCCEEEecC
Confidence 2233334444557775 445568999999999999999999999999 44322 588999999999874
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.5e-07 Score=99.42 Aligned_cols=192 Identities=17% Similarity=0.180 Sum_probs=126.4
Q ss_pred cccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEE--------EEeEEeeCCeEEEE
Q 038949 397 SEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVM--------LIGFCVEDGRRLLV 468 (678)
Q Consensus 397 ~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~--------l~~~~~~~~~~~LV 468 (678)
.....||+|+-+.+|-.-- -...+-|++.........+...|+. .--.||-+-. ++|- ..+....++
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk~a~la--~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQKVAELA--ATPDAPLLNYRVAWPQATLHGG-RRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHHHHHHHhc--cCCCCcchhhhhcccHHHhhCC-CccceeEEe
Confidence 3456799999999996432 1123557765333222222222211 1113443221 1221 122336788
Q ss_pred EEEeecCCcccccc-----cCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 469 YEYICNGSLDSHLY-----GRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 469 ~E~~~ggsL~~~l~-----~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
|..+.|..--..++ ++......|...++.++.++.+.+.||.. |.+-+|++++|+|+.+++.+.|.|=...
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~----Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH----GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc----CCcccccCccceeeecCceEEEEcccce
Confidence 88876653222222 12334578999999999999999999999 9999999999999999999999885444
Q ss_pred ccccCCCccceeEEEeeecccccccccc-----cccceecceeeeeeEEEEeeeC-Cccccc
Q 038949 544 RWQPDGDMGVETRVLGTFGYLAPEYAQS-----GQITEKADVYSLGVVLVELITG-RKAMDL 599 (678)
Q Consensus 544 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~eLltG-~~Pf~~ 599 (678)
....++ ...-..+|...|.+||...- -.-+...|.|.||+++|+||.| ++||..
T Consensus 165 qi~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 165 QINANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred eeccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 322222 33445678899999997652 2346788999999999999987 899964
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.15 E-value=9.2e-07 Score=89.01 Aligned_cols=107 Identities=24% Similarity=0.259 Sum_probs=81.1
Q ss_pred Cccccccceeeecccccc--eEEEEeEEeeC----CeEEEEEEEeecC-CcccccccCCCCccCccccchhhhhhccchh
Q 038949 434 DQEFCSEVEVLSCAQHRN--VVMLIGFCVED----GRRLLVYEYICNG-SLDSHLYGRDRDPLEWSARRKIAVGAARGLR 506 (678)
Q Consensus 434 ~~~~~~Ev~iL~~L~Hpn--Iv~l~~~~~~~----~~~~LV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~ 506 (678)
...+.+|...+..|..-+ .+..+++.... ...+||+|++++. +|.+++..... .+......++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 346778888877775433 34445554432 2458999999874 78888843222 555667889999999999
Q ss_pred hhhhcceeeeEEeccCCCCceEeeecC---ccccccccccccc
Q 038949 507 YLHEECRVGCIVHRDMRPNNILVTHDF---EPLVGDFGLARWQ 546 (678)
Q Consensus 507 yLH~~~~~~gIvHrDLKp~NILl~~~~---~vkL~DFGla~~~ 546 (678)
-||.. ||+|+|+++.|||++.++ .+.++||+.++..
T Consensus 133 ~lH~~----gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDA----GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHC----cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 999999999999999887 8999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.6e-06 Score=79.11 Aligned_cols=129 Identities=21% Similarity=0.293 Sum_probs=87.6
Q ss_pred eEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhHH
Q 038949 14 KVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSC 93 (678)
Q Consensus 14 ~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (678)
++|+|++|.+ +.+..|+.||+...-+.|..|++|+|++....... +. .. ............
T Consensus 3 ~~Ilv~~d~~-~~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~--~~----------~~------~~~~~~~~~~~~ 63 (140)
T PF00582_consen 3 KRILVAIDGS-EESRRALRFALELAKRSGAEITLLHVIPPPPQYSF--SA----------AE------DEESEEEAEEEE 63 (140)
T ss_dssp SEEEEEESSS-HHHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHH--HH----------HH------HHHHHHHHHHHH
T ss_pred CEEEEEECCC-HHHHHHHHHHHHHHHhhCCeEEEEEeecccccccc--cc----------cc------ccccccccchhh
Confidence 6899999987 55889999999988889999999999996554320 00 00 000000000000
Q ss_pred HHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEEe
Q 038949 94 SQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVMK 161 (678)
Q Consensus 94 ~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~~ 161 (678)
..............+....+.+..|++...++..+++.+++.||+++|-+... .+++.+.+|-|.+++
T Consensus 64 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~gs~~~~l~~~~~~pVlvv~ 140 (140)
T PF00582_consen 64 QARQAEAEEAEAEGGIVIEVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLFGSVAEKLLRHAPCPVLVVP 140 (140)
T ss_dssp HHHHHHHHHHHHHTTSEEEEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSSHHHHHHHHHHTSSEEEEEE
T ss_pred hhhhHHHHHHhhhccceeEEEEEeeccchhhhhccccccceeEEEeccCCCCccCCCcCCHHHHHHHcCCCCEEEeC
Confidence 00111101123335778899999999999999999999999999999942222 369999999998875
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.1e-06 Score=99.56 Aligned_cols=139 Identities=26% Similarity=0.330 Sum_probs=90.4
Q ss_pred ceecccCccceeeccCCCCcEEEEEeeehhccc---------------------C-------------------Cccccc
Q 038949 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ---------------------G-------------------DQEFCS 439 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~---------------------~-------------------~~~~~~ 439 (678)
..|+.++-|.||+|++++|+.||||+.+++-.. . .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 579999999999999989999999987432111 0 012445
Q ss_pred cceeeeccc-----ccceEEEEeEEe-eCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccc-hhhhhhcc
Q 038949 440 EVEVLSCAQ-----HRNVVMLIGFCV-EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARG-LRYLHEEC 512 (678)
Q Consensus 440 Ev~iL~~L~-----HpnIv~l~~~~~-~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~a-L~yLH~~~ 512 (678)
|+..+.+++ .++ +.+-.++. -.+...|+|||+.|..+.+...-.. ..++ ...++..++.+ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhc-
Confidence 555555443 233 22223332 2456789999999999988853232 2233 12222222222 2222223
Q ss_pred eeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 513 ~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
|++|.|..|.||+++.+|.+.+.|||+.....
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 89999999999999999999999999997543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.4e-06 Score=87.41 Aligned_cols=138 Identities=19% Similarity=0.167 Sum_probs=101.0
Q ss_pred ecccCccceeeccCCCCcEEEEEeeeh------hcccCCccccccceeeecccccc--eEEEEeEEe---e--CCeEEEE
Q 038949 402 LAEGGFGSVHRGVLPDGQVVAVKQYKL------ASSQGDQEFCSEVEVLSCAQHRN--VVMLIGFCV---E--DGRRLLV 468 (678)
Q Consensus 402 LG~G~fG~Vy~a~~~~g~~vAvK~i~~------~~~~~~~~~~~Ev~iL~~L~Hpn--Iv~l~~~~~---~--~~~~~LV 468 (678)
-|+||.+-|+.... +|+.+-+|.-.. ..+.+...|.+|+..|..|..-+ +.+.. ++. . ..+-+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 57789999998776 345788886531 11335567999999999886433 44444 222 1 1246799
Q ss_pred EEEeec-CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc--ccccccccccc
Q 038949 469 YEYICN-GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE--PLVGDFGLARW 545 (678)
Q Consensus 469 ~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~--vkL~DFGla~~ 545 (678)
+|-+.| -+|.+++......+.+......++.+++.+++-||+. |+.|+|+.+.|||++.++. +.++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~----Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV----NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998743 4777777544444566777789999999999999999 9999999999999986666 99999987763
|
|
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.2e-05 Score=72.50 Aligned_cols=103 Identities=22% Similarity=0.358 Sum_probs=80.2
Q ss_pred EEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhHHH
Q 038949 15 VVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSCS 94 (678)
Q Consensus 15 ~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 94 (678)
+|+|++|.+ +.+..+|.||++-.-+.+..|++|+|.+....... +..........
T Consensus 1 ~ilv~i~~~-~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~------------------------~~~~~~~~~~~ 55 (130)
T cd00293 1 RILVAVDGS-EESERALRWAARLARRLGAELVLLHVVDPPPSSAA------------------------ELAELLEEEAR 55 (130)
T ss_pred CEEEEeCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcch------------------------hHHHHHHHHHH
Confidence 489999976 55899999999998888999999999985443210 00122233334
Q ss_pred HHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEcccc
Q 038949 95 QMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQL 142 (678)
Q Consensus 95 ~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~ 142 (678)
+.+.++...|+..++.+...+..|++...++.++++.++++||+|.+-
T Consensus 56 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dlvvig~~~ 103 (130)
T cd00293 56 ALLEALREALAEAGVKVETVVLEGDPAEAILEAAEELGADLIVMGSRG 103 (130)
T ss_pred HHHHHHHHHHhcCCCceEEEEecCCCHHHHHHHHHHcCCCEEEEcCCC
Confidence 667777777777899999999999998888989999999999999983
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.1e-06 Score=85.51 Aligned_cols=149 Identities=29% Similarity=0.294 Sum_probs=93.9
Q ss_pred hhhhhhhcCCcccc---eecccCccceeeccCCCCcEEEEEeeehhccc---------CCcc---------------ccc
Q 038949 387 AELELATNRFSEAN---FLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ---------GDQE---------------FCS 439 (678)
Q Consensus 387 ~~~~~~~~~y~~~~---~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~---------~~~~---------------~~~ 439 (678)
..+.....+..+.. .|..|.-+.||+|...++..+|+|+++..... +..+ ...
T Consensus 38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~k 117 (268)
T COG1718 38 ETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARK 117 (268)
T ss_pred HHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHH
Confidence 33344444444443 46667778899999878999999998643221 1111 223
Q ss_pred cceeeeccc--ccceEEEEeEEeeCCeEEEEEEEeecC-CcccccccCCCCccCccccchhhhhhccchhhhhhcceeee
Q 038949 440 EVEVLSCAQ--HRNVVMLIGFCVEDGRRLLVYEYICNG-SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516 (678)
Q Consensus 440 Ev~iL~~L~--HpnIv~l~~~~~~~~~~~LV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g 516 (678)
|+..|+++. +=.+.+-+.+. .-.|||||+... .-.-.| ..-++....+..+..++++.+.-|-.. ++
T Consensus 118 Ef~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~---a~ 187 (268)
T COG1718 118 EFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKE---AG 187 (268)
T ss_pred HHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHh---cC
Confidence 555555553 22333444443 246999999443 111122 112233335667778888888777763 39
Q ss_pred EEeccCCCCceEeeecCccccccccccccc
Q 038949 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 517 IvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||+||+.-|||+. ++.+.|+|||.+...
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECcccccc
Confidence 99999999999999 899999999998644
|
|
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=97.93 E-value=1.9e-05 Score=72.16 Aligned_cols=113 Identities=8% Similarity=0.057 Sum_probs=76.2
Q ss_pred EEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhHHH
Q 038949 15 VVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSCS 94 (678)
Q Consensus 15 ~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 94 (678)
+|+|++|.+ +.++.||.||....-+.|..|+||+|.++.... .. ++. .
T Consensus 1 ~Ilv~vd~s-~~s~~al~~a~~la~~~~~~l~ll~v~~~~~~~------------------------~~---~~~----~ 48 (124)
T cd01987 1 RILVCISGG-PNAERLIRRAARLADRLKAPWYVVYVETPRLNR------------------------LS---EAE----R 48 (124)
T ss_pred CEEEEECCC-cchHHHHHHHHHHHHHhCCCEEEEEEecCcccc------------------------CC---HHH----H
Confidence 589999988 559999999999887888899999999843210 00 111 1
Q ss_pred HHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhhh---------hhcccc-cccEEEE
Q 038949 95 QMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEKK---------CCMEEL-QCNVVVM 160 (678)
Q Consensus 95 ~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~~---------~~~~~l-~c~i~~~ 160 (678)
+.+..+.+.++..++.+. .+..|++...+++++++.+++.||++.|-+.-.+ +...+. +|-|.++
T Consensus 49 ~~l~~~~~~~~~~~~~~~-~~~~~~~~~~I~~~~~~~~~dllviG~~~~~~~~~~~~Gs~~~~v~~~a~~~~v~v~ 123 (124)
T cd01987 49 RRLAEALRLAEELGAEVV-TLPGDDVAEAIVEFAREHNVTQIVVGKSRRSRWRELFRGSLVDRLLRRAGNIDVHIV 123 (124)
T ss_pred HHHHHHHHHHHHcCCEEE-EEeCCcHHHHHHHHHHHcCCCEEEeCCCCCchHHHHhcccHHHHHHHhCCCCeEEEe
Confidence 223333333333355443 3445688888999999999999999999443222 466666 7766553
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.92 E-value=9.4e-06 Score=81.97 Aligned_cols=139 Identities=15% Similarity=0.154 Sum_probs=91.8
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCcc---------ccccceeeecccc---cceEEEEe
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQE---------FCSEVEVLSCAQH---RNVVMLIG 457 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~---------~~~Ev~iL~~L~H---pnIv~l~~ 457 (678)
....++|...+++-......|.+-.. +|+.+++|..+.......+. ..+++..+.+++. ..+..++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 45667889988888888888877665 57899999876433221111 2223333333321 22222222
Q ss_pred EE-----eeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec
Q 038949 458 FC-----VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD 532 (678)
Q Consensus 458 ~~-----~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~ 532 (678)
+. ......+|+|||++|..|.++.. +++ .++..+..++.-||+. |++|+|..|.|++++.+
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~----G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH----GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc----CCccCCCCcCcEEEECC
Confidence 22 22234679999999998877652 222 2445677889999999 99999999999999855
Q ss_pred Cccccccccccc
Q 038949 533 FEPLVGDFGLAR 544 (678)
Q Consensus 533 ~~vkL~DFGla~ 544 (678)
.++++||+.-+
T Consensus 172 -~i~iID~~~k~ 182 (229)
T PF06176_consen 172 -GIRIIDTQGKR 182 (229)
T ss_pred -cEEEEECcccc
Confidence 49999997765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.87 E-value=1.1e-05 Score=82.37 Aligned_cols=139 Identities=16% Similarity=0.160 Sum_probs=83.5
Q ss_pred ceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccc--eEEEEeEEeeCCeEEEEEEEeecCC-
Q 038949 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN--VVMLIGFCVEDGRRLLVYEYICNGS- 476 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn--Iv~l~~~~~~~~~~~LV~E~~~ggs- 476 (678)
..||.|..+.||+. .+..+++|...... ......+|.++++.+..-+ +.+.+++....+..++|||++.|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 24467888876322 2345688999998886433 4677787777778899999998864
Q ss_pred cccccc---------------------cCCCCccCccccc-hhhh----------hhcc-chhhhhhcceeeeEEeccCC
Q 038949 477 LDSHLY---------------------GRDRDPLEWSARR-KIAV----------GAAR-GLRYLHEECRVGCIVHRDMR 523 (678)
Q Consensus 477 L~~~l~---------------------~~~~~~l~~~~~~-~i~~----------qI~~-aL~yLH~~~~~~gIvHrDLK 523 (678)
+...+. .-........... .+.. .+.. ...+|...-....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 0000000000000 0000 0000 11122111112257899999
Q ss_pred CCceEeeecCccccccccccc
Q 038949 524 PNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 524 p~NILl~~~~~vkL~DFGla~ 544 (678)
|.||+++.++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999885
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=97.81 E-value=6.1e-05 Score=69.02 Aligned_cols=122 Identities=19% Similarity=0.176 Sum_probs=88.5
Q ss_pred EEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhHHH
Q 038949 15 VVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSCS 94 (678)
Q Consensus 15 ~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 94 (678)
+|+|.+|.+ +-+..||.||..-.-+.+-.|+||+|+++.... .+ . . .....+...
T Consensus 1 ~ILv~vd~s-~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~----~~---------~-------~----~~~~~~~~~ 55 (132)
T cd01988 1 RILVPVANP-NTARDLLELAAALARAQNGEIIPLNVIEVPNHS----SP---------S-------Q----LEVNVQRAR 55 (132)
T ss_pred CEEEecCCc-hhHHHHHHHHHHHhhcCCCeEEEEEEEecCCCC----Cc---------c-------h----hHHHHHHHH
Confidence 489999988 568999999998776677789999999854322 11 0 0 011223334
Q ss_pred HHHHHhhhcCCCCcceEEEEEEe-cCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEEe
Q 038949 95 QMMRQLQEVYDPEKIKVRVKIVS-GSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVMK 161 (678)
Q Consensus 95 ~~~~~l~~~~~~~~v~~~i~v~~-g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~~ 161 (678)
+.+..+.+.....++.++..+.. |++.+.|+..|++.+++.||++.|-+... .+++.+.+|-|.++|
T Consensus 56 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~lGs~~~~v~~~~~~pvlvv~ 132 (132)
T cd01988 56 KLLRQAERIAASLGVPVHTIIRIDHDIASGILRTAKERQADLIIMGWHGSTSLRDRLFGGVIDQVLESAPCDVAVVK 132 (132)
T ss_pred HHHHHHHHHhhhcCCceEEEEEecCCHHHHHHHHHHhcCCCEEEEecCCCCCccceecCchHHHHHhcCCCCEEEeC
Confidence 56666666676778999888765 78888999889999999999999944322 247788888887764
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.81 E-value=1e-05 Score=81.18 Aligned_cols=143 Identities=24% Similarity=0.184 Sum_probs=82.5
Q ss_pred cceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeeccccc--ceEEEEeEEe---eCCeEEEEEEEee
Q 038949 399 ANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHR--NVVMLIGFCV---EDGRRLLVYEYIC 473 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hp--nIv~l~~~~~---~~~~~~LV~E~~~ 473 (678)
++.|+.|..+.||+....+ ..+++|..... .....+.+|+.+++.+... .+.+++.+.. .....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999765 58999987544 3345677888888877533 3456666432 2345789999998
Q ss_pred cCCccc----------------ccc---cC--CCCccCccc---------cch------------hhhhhcc-chhhhhh
Q 038949 474 NGSLDS----------------HLY---GR--DRDPLEWSA---------RRK------------IAVGAAR-GLRYLHE 510 (678)
Q Consensus 474 ggsL~~----------------~l~---~~--~~~~l~~~~---------~~~------------i~~qI~~-aL~yLH~ 510 (678)
|..+.. .+. .. ...++.... ... ....+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 887776 110 00 001110000 000 0111222 3333433
Q ss_pred cc---eeeeEEeccCCCCceEee-ecCccccccccccc
Q 038949 511 EC---RVGCIVHRDMRPNNILVT-HDFEPLVGDFGLAR 544 (678)
Q Consensus 511 ~~---~~~gIvHrDLKp~NILl~-~~~~vkL~DFGla~ 544 (678)
.. ...+++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 21 123799999999999999 66666899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.81 E-value=2.2e-06 Score=96.51 Aligned_cols=185 Identities=20% Similarity=0.115 Sum_probs=132.8
Q ss_pred CcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccc-eEEEEeEEeeCCeEEEEEEEeec
Q 038949 396 FSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN-VVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~~~~~~~~LV~E~~~g 474 (678)
|....-+++|+++++|+.+....+....+.+... ....-++++|.+++||| .+..++-+..+...+++++++.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3444558999999999988422223335544322 34445788899999999 67777777778889999999977
Q ss_pred C-CcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccc
Q 038949 475 G-SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553 (678)
Q Consensus 475 g-sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 553 (678)
+ +...... ...-.+.+.+...+.+.-.++|+++|+. --+|+| ||+..+ +..+.+||+....+.... .
T Consensus 319 ~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~----~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~ 386 (829)
T KOG0576|consen 319 GRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSS----YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--K 386 (829)
T ss_pred CccccccCC-hhhHhhhhhhhhhhhhhhcccccccccc----cccCcc----cccccc-cccccccccCCcccCccc--c
Confidence 7 2222221 1222345555667777888999999987 348888 777655 788999999987554332 4
Q ss_pred eeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccc
Q 038949 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAM 597 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf 597 (678)
.....+++.++|||+...+.+....|+|++|+-..++--|.+|-
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 45567899999999999999999999999998766776666654
|
|
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=97.79 E-value=5.6e-05 Score=70.72 Aligned_cols=128 Identities=13% Similarity=0.112 Sum_probs=85.4
Q ss_pred eEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhHH
Q 038949 14 KVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSC 93 (678)
Q Consensus 14 ~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (678)
++++|++|.+. .+..||.+|+.---+.|..|+||++++..... .++. .. ...+..+...+
T Consensus 4 ~~ILv~~D~s~-~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~---~~~~-------~~-------~~~~~~~~~~~-- 63 (142)
T PRK10116 4 SNILVAVAVTP-ESQQLLAKAVSIARPVNGKISLITLASDPEMY---NQFA-------AP-------MLEDLRSVMQE-- 63 (142)
T ss_pred ceEEEEccCCc-chHHHHHHHHHHHHHhCCEEEEEEEccCcccc---hhhh-------HH-------HHHHHHHHHHH--
Confidence 67999999884 58889999998765667899999998753221 1110 00 00011111111
Q ss_pred HHHHHHhhhcCCCCcceE-EEEEEecCCcchhhhhhhcccccEEEEccccchhhh-------hhcccccccEEEEec
Q 038949 94 SQMMRQLQEVYDPEKIKV-RVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEKK-------CCMEELQCNVVVMKR 162 (678)
Q Consensus 94 ~~~~~~l~~~~~~~~v~~-~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~~-------~~~~~l~c~i~~~~~ 162 (678)
+....|..+++..++.+ .+.+..|+|...|+..|++.+++.||++.|-+.... +++.+..|-|.+++-
T Consensus 64 -~~~~~l~~~~~~~~~~~~~~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~~s~a~~v~~~~~~pVLvv~~ 139 (142)
T PRK10116 64 -ETQSFLDKLIQDADYPIEKTFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSRASCSAKRVIASSEVDVLLVPL 139 (142)
T ss_pred -HHHHHHHHHHHhcCCCeEEEEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHHHHHHHHHHHhcCCCCEEEEeC
Confidence 22233444445557765 467778999989998899999999999999443333 588889999888863
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.70 E-value=5.2e-05 Score=77.85 Aligned_cols=139 Identities=19% Similarity=0.076 Sum_probs=84.1
Q ss_pred ecccCc-cceeeccCCCCcEEEEEeeehhcccCCccccccceeeeccc-ccceEEEEeEEeeCCeEEEEEEEeecCCccc
Q 038949 402 LAEGGF-GSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGRRLLVYEYICNGSLDS 479 (678)
Q Consensus 402 LG~G~f-G~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~ 479 (678)
|..|.. ..||+.... +..+++|+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 555555 788998764 4678888765332 345778999888874 4445677777776667899999999887764
Q ss_pred ccc-------------------cCCCC--ccCcc--ccchhh--------------------hhhccchhhhhhc---ce
Q 038949 480 HLY-------------------GRDRD--PLEWS--ARRKIA--------------------VGAARGLRYLHEE---CR 513 (678)
Q Consensus 480 ~l~-------------------~~~~~--~l~~~--~~~~i~--------------------~qI~~aL~yLH~~---~~ 513 (678)
... ..... ++... ...... ..+...+..|-.. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 421 00000 00000 000000 0011111111111 01
Q ss_pred eeeEEeccCCCCceEeeecCccccccccccc
Q 038949 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 514 ~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2379999999999999998778899998875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=1.6e-05 Score=89.99 Aligned_cols=138 Identities=22% Similarity=0.213 Sum_probs=89.1
Q ss_pred ceecccCccceeeccCCCCcEEEEEeeehhccc-------------------------------------CCccccccce
Q 038949 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ-------------------------------------GDQEFCSEVE 442 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~-------------------------------------~~~~~~~Ev~ 442 (678)
+.||.-..|.||+|+.++|+.||||+-++.-.. ..-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 569999999999999989999999986432111 0113455555
Q ss_pred eeecc----cccc------eEEEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchh-hhhhc
Q 038949 443 VLSCA----QHRN------VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLR-YLHEE 511 (678)
Q Consensus 443 iL~~L----~Hpn------Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~-yLH~~ 511 (678)
...+. .|-+ |.++|-.+ .....|+||||.|..+.|.-.-...+ ++... ++..+.++.. -|-..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~---i~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG-ISPHD---ILNKLVEAYLEQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC-CCHHH---HHHHHHHHHHHHHHhc
Confidence 44433 2444 33333322 34578999999999888865333222 33332 3333333321 12222
Q ss_pred ceeeeEEeccCCCCceEeee----cCcccccccccccccc
Q 038949 512 CRVGCIVHRDMRPNNILVTH----DFEPLVGDFGLARWQP 547 (678)
Q Consensus 512 ~~~~gIvHrDLKp~NILl~~----~~~vkL~DFGla~~~~ 547 (678)
|++|+|=.|.||++.. ++.+.+.|||+.....
T Consensus 321 ----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 ----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ----CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 8999999999999983 6789999999997554
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00013 Score=72.89 Aligned_cols=125 Identities=22% Similarity=0.354 Sum_probs=87.8
Q ss_pred cCCcccceecccCc-cceeeccCCCCcEEEEEeeeh---hccc------------------CCccccccceeeeccc---
Q 038949 394 NRFSEANFLAEGGF-GSVHRGVLPDGQVVAVKQYKL---ASSQ------------------GDQEFCSEVEVLSCAQ--- 448 (678)
Q Consensus 394 ~~y~~~~~LG~G~f-G~Vy~a~~~~g~~vAvK~i~~---~~~~------------------~~~~~~~Ev~iL~~L~--- 448 (678)
..++.++.||.|.- |.||++.. +|+.||+|+++. .... -..-|..|.++..+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78999999999999 99999998 577999999431 1110 0123566777777764
Q ss_pred ccce--EEEEeEEeeC------------------CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhh
Q 038949 449 HRNV--VMLIGFCVED------------------GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYL 508 (678)
Q Consensus 449 HpnI--v~l~~~~~~~------------------~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yL 508 (678)
+.++ |+++|+..-. ..+.||.||+.... .....-+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQIRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccchhHHHHHHHHHHHH
Confidence 4455 8999986321 12456777664432 11233456777788889
Q ss_pred hhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 509 HEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 509 H~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
|.. ||+-+|+++.|.. .=+|+|||.+
T Consensus 181 ~k~----gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL----GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC----CeeeccCcccccc-----CCEEEecccC
Confidence 998 9999999999986 3468899864
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00011 Score=77.86 Aligned_cols=134 Identities=13% Similarity=0.247 Sum_probs=89.0
Q ss_pred eEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhHH
Q 038949 14 KVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSC 93 (678)
Q Consensus 14 ~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (678)
++++|++|.| +.+..||.||+.---+.|..|+||+|++...... .++ + ..... .+..+...+..
T Consensus 4 ~~ILv~~D~s-~~~~~al~~a~~lA~~~~a~l~ll~v~~~~~~~~--~~~--~----~~~~~-------~~~~~~~~~~~ 67 (305)
T PRK11175 4 QNILVVIDPN-QDDQPALRRAVYLAQRNGGKITAFLPIYDFSYEM--TTL--L----SPDER-------EAMRQGVISQR 67 (305)
T ss_pred ceEEEEcCCC-ccccHHHHHHHHHHHhcCCCEEEEEeccCchhhh--hcc--c----chhHH-------HHHHHHHHHHH
Confidence 5799999999 4589999999996555677899999987543221 010 0 00000 00001111111
Q ss_pred HHHHHHhhhcCCCCcceEEEEEE-ecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEEecC
Q 038949 94 SQMMRQLQEVYDPEKIKVRVKIV-SGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVMKRS 163 (678)
Q Consensus 94 ~~~~~~l~~~~~~~~v~~~i~v~-~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~~~~ 163 (678)
.+.+..+...+...+++++..|+ .|+|...|+..|++.+++.||+|.|-+.-. .+.+.+.+|-|.+++..
T Consensus 68 ~~~l~~~~~~~~~~~~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~gs~~~~l~~~~~~pvlvv~~~ 147 (305)
T PRK11175 68 TAWIREQAKPYLDAGIPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIFTPTDWHLLRKCPCPVLMVKDQ 147 (305)
T ss_pred HHHHHHHHHHHhhcCCceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhccChhHHHHHhcCCCCEEEeccc
Confidence 23344444445556899999887 588888888889999999999999843211 25889999999999874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.59 E-value=8.3e-05 Score=74.49 Aligned_cols=128 Identities=22% Similarity=0.269 Sum_probs=88.9
Q ss_pred cceecccCccceeeccCCCCcEEEEEeeehhc----------------ccCCccccccceeeeccc------ccceEEEE
Q 038949 399 ANFLAEGGFGSVHRGVLPDGQVVAVKQYKLAS----------------SQGDQEFCSEVEVLSCAQ------HRNVVMLI 456 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~----------------~~~~~~~~~Ev~iL~~L~------HpnIv~l~ 456 (678)
...||+|+.-.||. +++.....||+..... .....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999987 5566678899887555 112344556666555444 78999999
Q ss_pred eEEeeCCeEEEEEEEeecC------CcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee
Q 038949 457 GFCVEDGRRLLVYEYICNG------SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT 530 (678)
Q Consensus 457 ~~~~~~~~~~LV~E~~~gg------sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~ 530 (678)
|+.+++.-..+|+|.+.+. +|.+++. ...++. .+...+-+-..||-++ +|+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~----~~~~~L~~f~~~l~~~----~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE----ELRQALDEFKRYLLDH----HIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH----HHHHHHHHHHHHHHHc----CCeecCCCcccEEEE
Confidence 9999999999999998653 4555552 222433 2333334445677777 899999999999997
Q ss_pred ecC----cccccc
Q 038949 531 HDF----EPLVGD 539 (678)
Q Consensus 531 ~~~----~vkL~D 539 (678)
... .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 532 456666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00012 Score=88.60 Aligned_cols=80 Identities=15% Similarity=0.234 Sum_probs=56.5
Q ss_pred cceecccCccceeeccCCCC---cEEEEEeeehhcc-cCCccccccceeeeccc-ccce--EEEEeEEeeC---CeEEEE
Q 038949 399 ANFLAEGGFGSVHRGVLPDG---QVVAVKQYKLASS-QGDQEFCSEVEVLSCAQ-HRNV--VMLIGFCVED---GRRLLV 468 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~g---~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~-HpnI--v~l~~~~~~~---~~~~LV 468 (678)
...|+.|.+..+|+....++ ..+++|+...... .....+.+|+++|+.+. |.++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45688899999998775443 4677776543221 12246789999999985 6665 7888887664 467899
Q ss_pred EEEeecCCcc
Q 038949 469 YEYICNGSLD 478 (678)
Q Consensus 469 ~E~~~ggsL~ 478 (678)
|||+.|..+.
T Consensus 123 ME~v~G~~~~ 132 (822)
T PLN02876 123 MEYLEGRIFV 132 (822)
T ss_pred EEecCCcccC
Confidence 9999876543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.35 E-value=6.2e-05 Score=73.25 Aligned_cols=133 Identities=21% Similarity=0.202 Sum_probs=93.7
Q ss_pred hcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccce-EEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNV-VMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnI-v~l~~~~~~~~~~~LV~E~ 471 (678)
.......+.||+|.+|.||+|.+. |..+|+|+-+..+ ....+..|+++|..+.--++ .++|.|-. -++.|||
T Consensus 21 ~~~~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~ 93 (201)
T COG2112 21 KYELRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY 93 (201)
T ss_pred chhhhhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence 334556778999999999999995 5588888765332 33578899999998876555 35555532 3466999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCC-CCceEeeecCcccccccccccc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMR-PNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLK-p~NILl~~~~~vkL~DFGla~~ 545 (678)
+.|-.|.++.... -.+-...+++.-.-|-.. ||-|+.|. |..++|..++.+.|+||..|+.
T Consensus 94 i~G~~L~~~~~~~---------~rk~l~~vlE~a~~LD~~----GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG---------DRKHLLRVLEKAYKLDRL----GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc---------cHHHHHHHHHHHHHHHHh----ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9888888766321 123344455554445555 99999987 6666666677999999999873
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00021 Score=73.06 Aligned_cols=75 Identities=15% Similarity=0.055 Sum_probs=46.3
Q ss_pred ceecccCcc-ceeeccCCCCcEEEEEeeehhcccCCccccccceeeeccccc---ceEEEEeEEeeC---CeEEEEEEEe
Q 038949 400 NFLAEGGFG-SVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHR---NVVMLIGFCVED---GRRLLVYEYI 472 (678)
Q Consensus 400 ~~LG~G~fG-~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hp---nIv~l~~~~~~~---~~~~LV~E~~ 472 (678)
+.|+.||.. .||+.. ..+++|..+.. .....+.+|++++..+... .+..+++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~----~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG----DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC----CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777776 488752 34777865432 1234688898888777421 234444443322 2458999999
Q ss_pred ecCCcccc
Q 038949 473 CNGSLDSH 480 (678)
Q Consensus 473 ~ggsL~~~ 480 (678)
+|.++.+.
T Consensus 77 ~G~~l~~~ 84 (235)
T cd05155 77 EGETATAA 84 (235)
T ss_pred cCCCCCcc
Confidence 99887544
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.00046 Score=70.24 Aligned_cols=74 Identities=15% Similarity=0.124 Sum_probs=48.0
Q ss_pred ceecccCccceeeccCCC--CcEEEEEeeehhcccCCccccccceeeecccccc-eEEEEeEEeeCCeEEEEEEEeecCC
Q 038949 400 NFLAEGGFGSVHRGVLPD--GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN-VVMLIGFCVEDGRRLLVYEYICNGS 476 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~--g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~~~~~~~~LV~E~~~ggs 476 (678)
+.|..|-...+|+....+ ++.|++|+..... .......+|+.+++.+...+ .+++++.+. -.+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778888999987654 6789999765321 11123346888888875333 345554433 248999999877
Q ss_pred cc
Q 038949 477 LD 478 (678)
Q Consensus 477 L~ 478 (678)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 64
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.00032 Score=74.04 Aligned_cols=142 Identities=15% Similarity=0.052 Sum_probs=82.6
Q ss_pred cceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccc--eEEEEeE------EeeCCeEEEEEE
Q 038949 399 ANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN--VVMLIGF------CVEDGRRLLVYE 470 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn--Iv~l~~~------~~~~~~~~LV~E 470 (678)
.+.|..|....+|+.... +..+++|+... .....+..|+.++..+.+.+ +.+++.. ...++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456777888899998754 34688898753 22345667888777775332 3444332 123456789999
Q ss_pred EeecCCcccc----c----------cc--CC-CCc------cCccccc----------hhhhhhccchhhhhhc---cee
Q 038949 471 YICNGSLDSH----L----------YG--RD-RDP------LEWSARR----------KIAVGAARGLRYLHEE---CRV 514 (678)
Q Consensus 471 ~~~ggsL~~~----l----------~~--~~-~~~------l~~~~~~----------~i~~qI~~aL~yLH~~---~~~ 514 (678)
|++|..+... . +. .. ... ..|.... .....+..++.++... .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9988776431 0 00 00 000 0100000 0001112233333321 112
Q ss_pred eeEEeccCCCCceEeeecCccccccccccc
Q 038949 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 515 ~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999998777899999885
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.00049 Score=71.30 Aligned_cols=137 Identities=14% Similarity=0.032 Sum_probs=76.3
Q ss_pred ecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccce-EEEEeEEeeCCeEEEEEEEeecCCcccc
Q 038949 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNV-VMLIGFCVEDGRRLLVYEYICNGSLDSH 480 (678)
Q Consensus 402 LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnI-v~l~~~~~~~~~~~LV~E~~~ggsL~~~ 480 (678)
+..|-.+.+|+... ++..+++|..............+|..+++.+...++ .+++..+. -++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998874 566888887543322211245678888888853323 34444432 3699999998776532
Q ss_pred c-----------------ccCC--CCccCcc-ccchhhhhh---------ccchhhhhhc----ceeeeEEeccCCCCce
Q 038949 481 L-----------------YGRD--RDPLEWS-ARRKIAVGA---------ARGLRYLHEE----CRVGCIVHRDMRPNNI 527 (678)
Q Consensus 481 l-----------------~~~~--~~~l~~~-~~~~i~~qI---------~~aL~yLH~~----~~~~gIvHrDLKp~NI 527 (678)
. +... ..++... ....+..++ ...+..+-.. ..+..++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 0 0000 0011100 001111111 0111111111 0112689999999999
Q ss_pred EeeecCccccccccccc
Q 038949 528 LVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 528 Ll~~~~~vkL~DFGla~ 544 (678)
+++.++ +.|+||..+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999877 7899999885
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0008 Score=73.20 Aligned_cols=103 Identities=14% Similarity=0.226 Sum_probs=71.4
Q ss_pred cceEEEEEEeecccccchhheehhhccccC--CCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchh
Q 038949 12 VGKVVIVAVKASKEIPRSALVWALTHVVQP--GDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDI 89 (678)
Q Consensus 12 ~~~~VvV~~das~~~s~~al~WaL~~v~~~--gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (678)
.-++++|++|.| +.|..|+.-|++---.. |..|+||||.+..... .+ . ...
T Consensus 4 ~ykkILVavDGS-e~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~---~~------------~-----------~~~ 56 (357)
T PRK12652 4 AANRLLVPVADS-VTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVD---PE------------G-----------QDE 56 (357)
T ss_pred ccCeEEEEeCCC-HHHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccc---cc------------h-----------hHH
Confidence 457899999999 66999999999865544 4799999999853211 00 0 000
Q ss_pred hhHHHHHHHHhhhcC------CCCcceEEEEEEe--------cCCcchhhhhhhcccccEEEEccc
Q 038949 90 VDSCSQMMRQLQEVY------DPEKIKVRVKIVS--------GSPYGVVAVEAKKAQSNWVILDKQ 141 (678)
Q Consensus 90 ~~~~~~~~~~l~~~~------~~~~v~~~i~v~~--------g~~~~~v~~e~k~~~a~~vVld~~ 141 (678)
...-.+.+.++.+.. +..+|+++..|+. |+|...|++.|++.+|+.||+|..
T Consensus 57 ~~~~eelle~~~~~~~~~l~~~~~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~ 122 (357)
T PRK12652 57 LAAAEELLERVEVWATEDLGDDASSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPE 122 (357)
T ss_pred HHHHHHHHHHHHHHHHHhhhcccCCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCC
Confidence 000111222222222 2369999999987 899999998999999999999998
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.00065 Score=72.35 Aligned_cols=79 Identities=14% Similarity=0.066 Sum_probs=57.0
Q ss_pred CcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccc---cceEEEEeEEee---CCeEEEEE
Q 038949 396 FSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQH---RNVVMLIGFCVE---DGRRLLVY 469 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~H---pnIv~l~~~~~~---~~~~~LV~ 469 (678)
..-.+.||.|..+.||.....++ .+++|..+. ......+..|+..|+.+.- -.+.++++++.. .+..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 33455799999999999876455 467777542 1123578889999888852 357788887754 36689999
Q ss_pred EEeecCCc
Q 038949 470 EYICNGSL 477 (678)
Q Consensus 470 E~~~ggsL 477 (678)
|++.|+++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998766
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.00029 Score=69.98 Aligned_cols=102 Identities=26% Similarity=0.247 Sum_probs=78.7
Q ss_pred ccceeeecccc-cceEEEEeEEeeCCeEEEEEEEeecCCccccccc-CCCCccCccccchhhhhhccchhhhhhcceeee
Q 038949 439 SEVEVLSCAQH-RNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYG-RDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516 (678)
Q Consensus 439 ~Ev~iL~~L~H-pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g 516 (678)
.|.-+++.+++ +++++++|+|- .++|.||...+++...-.. ..-...+|..+.+++.++++.+.+|+... .+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~-~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGP-LGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC-CCc
Confidence 46667777765 69999999994 3678999987766432100 01123689999999999999999998853 335
Q ss_pred EEeccCCCCceEeeecCcccccccccccc
Q 038949 517 IVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 517 IvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
+...|++++|+-++.+|++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987753
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.002 Score=68.26 Aligned_cols=133 Identities=20% Similarity=0.244 Sum_probs=81.7
Q ss_pred ceEEEEEEeeccccc------chhheehhhccccC-CCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcc
Q 038949 13 GKVVIVAVKASKEIP------RSALVWALTHVVQP-GDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQ 85 (678)
Q Consensus 13 ~~~VvV~~das~~~s------~~al~WaL~~v~~~-gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (678)
.++|+|++|-+.+.+ ..||.+|+.=.-.. |-.|+||+|.+....... .++ ... ...+.
T Consensus 152 ~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~-~~~--------~~~------~~~~~ 216 (305)
T PRK11175 152 GGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIA-IEL--------PEF------DPSVY 216 (305)
T ss_pred CCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhcc-ccc--------ccc------chhhH
Confidence 578999999775432 56888888643333 667999999874322100 000 000 00001
Q ss_pred cchhhhHHHHHHHHhhhcCCCCcceE-EEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccc
Q 038949 86 KDDIVDSCSQMMRQLQEVYDPEKIKV-RVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQC 155 (678)
Q Consensus 86 ~~~~~~~~~~~~~~l~~~~~~~~v~~-~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c 155 (678)
.+.+.+...+.+.++.+ ..++.. .+.|..|+|...++..|++.+|+.||++.|-+.-. .+++.+.+|
T Consensus 217 ~~~~~~~~~~~l~~~~~---~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~llGS~a~~v~~~~~~ 293 (305)
T PRK11175 217 NDAIRGQHLLAMKALRQ---KFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAAFLGNTAEHVIDHLNC 293 (305)
T ss_pred HHHHHHHHHHHHHHHHH---HhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcceeecchHHHHHhcCCC
Confidence 11122211222333332 335543 46678899988888889999999999999944322 368999999
Q ss_pred cEEEEecC
Q 038949 156 NVVVMKRS 163 (678)
Q Consensus 156 ~i~~~~~~ 163 (678)
.|.++|..
T Consensus 294 pVLvv~~~ 301 (305)
T PRK11175 294 DLLAIKPD 301 (305)
T ss_pred CEEEEcCC
Confidence 99999743
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.00015 Score=76.57 Aligned_cols=134 Identities=17% Similarity=0.086 Sum_probs=94.0
Q ss_pred CCcccceecccCccceeeccCCCCcEEEEEeeehhccc-----------------CC-----ccccccceeeeccc-cc-
Q 038949 395 RFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ-----------------GD-----QEFCSEVEVLSCAQ-HR- 450 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~-----------------~~-----~~~~~Ev~iL~~L~-Hp- 450 (678)
-+.+++.||-|.-+.||.+-...|+..++|..+..... .+ -...+|+..|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 47888999999999999999888999999976432111 00 12345666666664 22
Q ss_pred ceEEEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee
Q 038949 451 NVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT 530 (678)
Q Consensus 451 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~ 530 (678)
-+.+.+++ ++-++|||++.|..|...-.- .....+...+..-+--|..+ |+||+|+.-=||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~Iv~la~~----GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGLIVRLANH----GLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec--------CChHHHHHHHHHHHHHHHHc----CceecccchheeEEe
Confidence 23444444 456899999988888654411 12233444455555666677 999999999999999
Q ss_pred ecCccccccccccc
Q 038949 531 HDFEPLVGDFGLAR 544 (678)
Q Consensus 531 ~~~~vkL~DFGla~ 544 (678)
+++.++++||-...
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999997654
|
|
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0054 Score=57.14 Aligned_cols=137 Identities=19% Similarity=0.292 Sum_probs=90.5
Q ss_pred ceEEEEEEe-ecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhh
Q 038949 13 GKVVIVAVK-ASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVD 91 (678)
Q Consensus 13 ~~~VvV~~d-as~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (678)
.+++++++| .+ +.+..|+.||+......|..+.+++|.+..........+. .... ......+...
T Consensus 5 ~~~il~~~d~~s-~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~----~~~~---------~~~~~~~~~~ 70 (154)
T COG0589 5 YKKILVAVDVGS-EAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVAL----ADAP---------IPLSEEELEE 70 (154)
T ss_pred cceEEEEeCCCC-HHHHHHHHHHHHHHHhcCCeEEEEEEeccccccccccccc----ccch---------hhhhHHHHHH
Confidence 478999999 66 6689999999998887888888999987544321100000 0000 0000011122
Q ss_pred HHHHHHHHhhhcCCCCcce-EEEEEEecCCc-chhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEE
Q 038949 92 SCSQMMRQLQEVYDPEKIK-VRVKIVSGSPY-GVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVM 160 (678)
Q Consensus 92 ~~~~~~~~l~~~~~~~~v~-~~i~v~~g~~~-~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~ 160 (678)
...+....+.+.....+++ +...+..|.|. ..++..|.+.+|+.+|++.+-+... .+.+.+.+|.|.++
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~~llGsvs~~v~~~~~~pVlvv 150 (154)
T COG0589 71 EAEELLAEAKALAEAAGVPVVETEVVEGSPSAEEILELAEEEDADLIVVGSRGRSGLSRLLLGSVAEKVLRHAPCPVLVV 150 (154)
T ss_pred HHHHHHHHHHHHHHHcCCCeeEEEEecCCCcHHHHHHHHHHhCCCEEEECCCCCccccceeeehhHHHHHhcCCCCEEEE
Confidence 2234555555555556777 59999999995 6777778888999999999722222 26899999999988
Q ss_pred ecC
Q 038949 161 KRS 163 (678)
Q Consensus 161 ~~~ 163 (678)
+..
T Consensus 151 ~~~ 153 (154)
T COG0589 151 RSE 153 (154)
T ss_pred ccC
Confidence 753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0016 Score=69.42 Aligned_cols=143 Identities=18% Similarity=0.121 Sum_probs=79.0
Q ss_pred cceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccc--eEEEEeE------EeeCCeEEEEEE
Q 038949 399 ANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN--VVMLIGF------CVEDGRRLLVYE 470 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn--Iv~l~~~------~~~~~~~~LV~E 470 (678)
.+.++.|....+|+....++ .+++|+.+... .......|++++..|...+ +.+++.. ....+..+++||
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999875444 68889765321 1234445666666663222 3333332 112456789999
Q ss_pred EeecCCccccc--------------ccCCCC---c-------cCccccc------------hhhhhhccchhhhhhc---
Q 038949 471 YICNGSLDSHL--------------YGRDRD---P-------LEWSARR------------KIAVGAARGLRYLHEE--- 511 (678)
Q Consensus 471 ~~~ggsL~~~l--------------~~~~~~---~-------l~~~~~~------------~i~~qI~~aL~yLH~~--- 511 (678)
|++|..+.... +....+ + -.|.... .....+...++++...
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99886653210 000000 0 0000000 0011122234444321
Q ss_pred ceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 512 ~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
..+.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 012389999999999999998877899999885
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.0019 Score=68.50 Aligned_cols=74 Identities=22% Similarity=0.192 Sum_probs=47.9
Q ss_pred eecccCccceeeccCCC-------CcEEEEEeeehhcccCCccccccceeeecccccc-eEEEEeEEeeCCeEEEEEEEe
Q 038949 401 FLAEGGFGSVHRGVLPD-------GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN-VVMLIGFCVEDGRRLLVYEYI 472 (678)
Q Consensus 401 ~LG~G~fG~Vy~a~~~~-------g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~~~~~~~~LV~E~~ 472 (678)
.|..|-...+|+....+ ++.+++|+..... .......+|++++..+...+ ..++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 45556667888887544 5789999875432 23345677888888775333 3455555542 3689999
Q ss_pred ecCCccc
Q 038949 473 CNGSLDS 479 (678)
Q Consensus 473 ~ggsL~~ 479 (678)
+|..+..
T Consensus 80 ~G~~l~~ 86 (302)
T cd05156 80 PSRTLTT 86 (302)
T ss_pred CCCcCCH
Confidence 8887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.0029 Score=67.66 Aligned_cols=29 Identities=28% Similarity=0.288 Sum_probs=25.8
Q ss_pred eEEeccCCCCceEeeecCccccccccccc
Q 038949 516 CIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 516 gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+++|+|+.|.|||++.+...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 79999999999999976556799999885
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.0023 Score=70.84 Aligned_cols=75 Identities=19% Similarity=0.113 Sum_probs=51.9
Q ss_pred ceecccCccceeeccCCCC-cEEEEEeeehhc-------ccCCccccccceeeeccc---ccceEEEEeEEeeCCeEEEE
Q 038949 400 NFLAEGGFGSVHRGVLPDG-QVVAVKQYKLAS-------SQGDQEFCSEVEVLSCAQ---HRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~g-~~vAvK~i~~~~-------~~~~~~~~~Ev~iL~~L~---HpnIv~l~~~~~~~~~~~LV 468 (678)
+.||.|.+..||++...+| +.++||.-.... .-..+++..|.+.|..+. -.++++++.+. ....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 4589999999999997666 589999743111 112345677888877763 24577777763 3557899
Q ss_pred EEEeecCC
Q 038949 469 YEYICNGS 476 (678)
Q Consensus 469 ~E~~~ggs 476 (678)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.0021 Score=69.17 Aligned_cols=139 Identities=21% Similarity=0.237 Sum_probs=90.6
Q ss_pred cccceecccCccceeeccCCCCcEEEEEeeehhc-----c----cCCcc-----------------ccccceeeeccccc
Q 038949 397 SEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLAS-----S----QGDQE-----------------FCSEVEVLSCAQHR 450 (678)
Q Consensus 397 ~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~-----~----~~~~~-----------------~~~Ev~iL~~L~Hp 450 (678)
.+-.+|..|.-+.||.+...+|..+|||+++..- . .+.-+ ...|++-|.++...
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3456788899999999998899999999985211 0 01111 12344555555433
Q ss_pred ceEEEEeEEeeCCeEEEEEEEeecCCccccccc-CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe
Q 038949 451 NVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYG-RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV 529 (678)
Q Consensus 451 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl 529 (678)
.|.----+.. ..-.|||+|+. ++ .+... -....++...+..+-.+++.-+.-|...| ++||.||+--|+|+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlG-rd--gw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c---~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLG-RD--GWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC---RLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCCceee--ecceEeeeecc-CC--CCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh---ceeccchhhhhheE
Confidence 3211100111 12369999983 32 12111 12334677778888899999999998887 79999999999987
Q ss_pred eecCccccccccccc
Q 038949 530 THDFEPLVGDFGLAR 544 (678)
Q Consensus 530 ~~~~~vkL~DFGla~ 544 (678)
++|.+.|+|.+.+.
T Consensus 299 -hdG~lyiIDVSQSV 312 (520)
T KOG2270|consen 299 -HDGKLYIIDVSQSV 312 (520)
T ss_pred -ECCEEEEEEccccc
Confidence 56789999987774
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.00034 Score=84.03 Aligned_cols=194 Identities=21% Similarity=0.207 Sum_probs=132.1
Q ss_pred ccceeeecccccceEEEEeEEeeCCeEE----EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhccee
Q 038949 439 SEVEVLSCAQHRNVVMLIGFCVEDGRRL----LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514 (678)
Q Consensus 439 ~Ev~iL~~L~HpnIv~l~~~~~~~~~~~----LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~ 514 (678)
-|...+....|+|++.++.|-.+..... +..|++...++...+ .....++....+.+..+++.||.|+|+.
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~--q~v~~i~~~~~r~~~~~~~~GL~~~h~~--- 305 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL--QSVGSIPLETLRILHQKLLEGLAYLHSL--- 305 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH--hhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence 4566677788999999998876543332 444777777887777 4455678888899999999999999998
Q ss_pred eeEEeccCCCC---ceEeeecCccccc--cccccccccCCCccceeEEEeeecccccccccccccce--ecceeeeeeEE
Q 038949 515 GCIVHRDMRPN---NILVTHDFEPLVG--DFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITE--KADVYSLGVVL 587 (678)
Q Consensus 515 ~gIvHrDLKp~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~--ksDVwSLGviL 587 (678)
...|.-|... +-..+.++.+.++ ||+......+... ......+..|.++|......++. ..|+|.+|..+
T Consensus 306 -~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 -SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -ccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 5555555444 4555566777766 8888876544332 22233455688888877655544 47999999999
Q ss_pred EEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHh
Q 038949 588 VELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRML 666 (678)
Q Consensus 588 ~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~L 666 (678)
..+..|..+-..... ...+++.. . ...+.++..+|+..++++|+.+.+++...
T Consensus 383 ~~~~~~~~i~~~~~~------------------~~~~l~~~----~----~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAV------------------PVSLLDVL----S----TSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcCcccccccc------------------hhhhhccc----c----chhhhhhhhhhcchhhhhccchhhhhhch
Confidence 999888655322110 01111110 0 01356777899999999999999998654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.013 Score=62.84 Aligned_cols=128 Identities=23% Similarity=0.207 Sum_probs=75.2
Q ss_pred ceeeccCCCCcEEEEEeeeh--hcccCCccccccceeeecccc--cceEEEEeEEeeCC--eEEEEEEEeecCCcccccc
Q 038949 409 SVHRGVLPDGQVVAVKQYKL--ASSQGDQEFCSEVEVLSCAQH--RNVVMLIGFCVEDG--RRLLVYEYICNGSLDSHLY 482 (678)
Q Consensus 409 ~Vy~a~~~~g~~vAvK~i~~--~~~~~~~~~~~Ev~iL~~L~H--pnIv~l~~~~~~~~--~~~LV~E~~~ggsL~~~l~ 482 (678)
.+|.... +++.+++. ... ..........+|+.+++.+.- --+...+++|.++. ..|.||+|++|..+.+.+.
T Consensus 40 ~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 40 DTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred ceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 3444433 27778877 221 111222455667777766632 23445567777665 6799999998865544431
Q ss_pred cCCCCccCccccchhhh-hhccchhhhhhc--------------------------------------------------
Q 038949 483 GRDRDPLEWSARRKIAV-GAARGLRYLHEE-------------------------------------------------- 511 (678)
Q Consensus 483 ~~~~~~l~~~~~~~i~~-qI~~aL~yLH~~-------------------------------------------------- 511 (678)
..... ..++. .+++.|.-||+.
T Consensus 118 ~~~~~-------~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~ 190 (321)
T COG3173 118 PESLG-------RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN 190 (321)
T ss_pred cccch-------HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence 11100 11111 333333333322
Q ss_pred c----eeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 512 C----RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 512 ~----~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
- ....++|+|+.+.||+++.++-+=+.||+++..
T Consensus 191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 1 123699999999999999988899999999864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.024 Score=60.22 Aligned_cols=74 Identities=23% Similarity=0.245 Sum_probs=47.3
Q ss_pred ccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeeccc---ccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 398 EANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ---HRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 398 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~---HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
-...|+-|....+|+.. .+++.+.||+-. ......|..|++-|+.|. --.+++.+++....+..+|||||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34568888889999877 467789999765 334467888888888773 34577888887777777999999977
Q ss_pred C
Q 038949 475 G 475 (678)
Q Consensus 475 g 475 (678)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.017 Score=60.85 Aligned_cols=30 Identities=30% Similarity=0.475 Sum_probs=25.3
Q ss_pred eEEeccCCCCceEeeecCc-ccccccccccc
Q 038949 516 CIVHRDMRPNNILVTHDFE-PLVGDFGLARW 545 (678)
Q Consensus 516 gIvHrDLKp~NILl~~~~~-vkL~DFGla~~ 545 (678)
.++|+|+.+.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 6899999999999997555 45999998863
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.064 Score=58.38 Aligned_cols=140 Identities=19% Similarity=0.209 Sum_probs=79.0
Q ss_pred eecccCccceeeccCC-----CCcEEEEEeeehhcccCCccccccceeeecccccce-EEEEeEEeeCCeEEEEEEEeec
Q 038949 401 FLAEGGFGSVHRGVLP-----DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNV-VMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 401 ~LG~G~fG~Vy~a~~~-----~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnI-v~l~~~~~~~~~~~LV~E~~~g 474 (678)
.|-.|-...+|+..+. .++.|++|+..... ...-+-.+|..+++.+..-++ .++++.+..+ .|+||+.+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 4545777888887642 23689999876432 222233568888888854333 3556666432 68999977
Q ss_pred CCccccc-----------------ccCC----CCccCccccchhhhhh-----------------ccchhhh----hhcc
Q 038949 475 GSLDSHL-----------------YGRD----RDPLEWSARRKIAVGA-----------------ARGLRYL----HEEC 512 (678)
Q Consensus 475 gsL~~~l-----------------~~~~----~~~l~~~~~~~i~~qI-----------------~~aL~yL----H~~~ 512 (678)
.+|...- +... ..+..+..+..+..++ ...+..| ....
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 7664210 0000 0011112222222111 1111111 1111
Q ss_pred eeeeEEeccCCCCceEeee-cCcccccccccccc
Q 038949 513 RVGCIVHRDMRPNNILVTH-DFEPLVGDFGLARW 545 (678)
Q Consensus 513 ~~~gIvHrDLKp~NILl~~-~~~vkL~DFGla~~ 545 (678)
....++|+|+++.|||++. ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2237999999999999986 47899999998863
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.07 E-value=0.051 Score=58.81 Aligned_cols=139 Identities=24% Similarity=0.271 Sum_probs=77.6
Q ss_pred ecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccc------eEEEEe----EEeeCCeEEEEEEE
Q 038949 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN------VVMLIG----FCVEDGRRLLVYEY 471 (678)
Q Consensus 402 LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn------Iv~l~~----~~~~~~~~~LV~E~ 471 (678)
|.+ .-..+|+....+|+. ++|+.... ....++..|...|..|.-.+ +..+-| ......+.+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456788888766655 89988754 33345556666665553211 222222 11112377889999
Q ss_pred eecCCccc-ccc------------------cCC------CCccCccc-------------cchhhhhhccchhhhh----
Q 038949 472 ICNGSLDS-HLY------------------GRD------RDPLEWSA-------------RRKIAVGAARGLRYLH---- 509 (678)
Q Consensus 472 ~~ggsL~~-~l~------------------~~~------~~~l~~~~-------------~~~i~~qI~~aL~yLH---- 509 (678)
++|..+.. ... ... .....|.. ......++...+..+.
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 98888873 110 000 00122220 0012222233333333
Q ss_pred hcceeee--EEeccCCCCceEeeecCc-cccccccccc
Q 038949 510 EECRVGC--IVHRDMRPNNILVTHDFE-PLVGDFGLAR 544 (678)
Q Consensus 510 ~~~~~~g--IvHrDLKp~NILl~~~~~-vkL~DFGla~ 544 (678)
...+..+ +||+|+.|.||+++.+.. +-+.||+-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2223334 999999999999999875 8899999885
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=93.80 E-value=0.00079 Score=82.57 Aligned_cols=160 Identities=13% Similarity=0.045 Sum_probs=111.9
Q ss_pred ccccceeeecccccceEEEEeEEee--CCeEEEEEEEeecCCcccccccCCC--CccCccccchhhhhhccchhhhhhcc
Q 038949 437 FCSEVEVLSCAQHRNVVMLIGFCVE--DGRRLLVYEYICNGSLDSHLYGRDR--DPLEWSARRKIAVGAARGLRYLHEEC 512 (678)
Q Consensus 437 ~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~~~LV~E~~~ggsL~~~l~~~~~--~~l~~~~~~~i~~qI~~aL~yLH~~~ 512 (678)
...|..-++...|+++...+.-... ....|.+++|+.+|.+.+.|..... .++...-+.....+.+.+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445555555678888776655432 3456899999999999998854432 22322222223333245555544431
Q ss_pred ee-eeEEeccCCCCceEeeecCccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEee
Q 038949 513 RV-GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELI 591 (678)
Q Consensus 513 ~~-~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLl 591 (678)
.- .-.+|++||+-|.+|..+..++++++|+.+.. ...........+++.|+.|++.+.-.++.++|+|..|+.+|.+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk-np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK-NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCccccccccccccc-CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 11 12689999999999999999999999999833 23333444566788999999999888999999999999999998
Q ss_pred eCCccc
Q 038949 592 TGRKAM 597 (678)
Q Consensus 592 tG~~Pf 597 (678)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 888776
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.50 E-value=0.063 Score=58.10 Aligned_cols=77 Identities=17% Similarity=0.125 Sum_probs=57.7
Q ss_pred CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
....|++|++- |++| ..+ ....+.+...++.+-+..+.-+..+. ..-||||...||||+ +|++.|+||-
T Consensus 298 ~~y~yl~~kdh-gt~i-s~i-----k~~~~~e~lsff~s~~sil~~lekkf---~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 298 TLYLYLHFKDH-GTPI-SII-----KADRSEEELSFFWSCISILDILEKKF---PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred ceEEEEEEecC-Ccee-eee-----ecccHHHHHHHHHHHHHHHhhhhhcC---Ccccccccccceeee-cCceEEEEee
Confidence 34567788873 4444 333 12346677888888888888888775 578999999999999 9999999999
Q ss_pred ccccccCC
Q 038949 542 LARWQPDG 549 (678)
Q Consensus 542 la~~~~~~ 549 (678)
+++....+
T Consensus 367 lsRl~~~q 374 (488)
T COG5072 367 LSRLSYSQ 374 (488)
T ss_pred eeecccCC
Confidence 99854433
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 678 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-67 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-66 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-47 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-37 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-16 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 9e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 492 bits (1268), Expect = e-171
Identities = 137/301 (45%), Positives = 193/301 (64%), Gaps = 7/301 (2%)
Query: 377 FGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG-DQ 435
G + F+ EL++A++ FS N L GGFG V++G L DG +VAVK+ K +QG +
Sbjct: 14 LGQL-KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGEL 72
Query: 436 EFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRD--PLEWSA 493
+F +EVE++S A HRN++ L GFC+ RLLVY Y+ NGS+ S L R PL+W
Sbjct: 73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 494 RRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553
R++IA+G+ARGL YLH+ C I+HRD++ NIL+ +FE +VGDFGLA+ D V
Sbjct: 133 RQRIALGSARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 191
Query: 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQ--CLTEW 611
T V GT G++APEY +G+ +EK DV+ GV+L+ELITG++A DL R L +W
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 612 ARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671
+ LLK + L+D L+ Y + EV ++Q A LC + P RP+MS+V+RMLEGD L
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311
Query: 672 M 672
Sbjct: 312 A 312
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 442 bits (1140), Expect = e-152
Identities = 114/292 (39%), Positives = 161/292 (55%), Gaps = 7/292 (2%)
Query: 382 RWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEV 441
+LE ATN F + G FG V++GVL DG VA+K+ SSQG +EF +E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 442 EVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRD--PLEWSARRKIAV 499
E LS +H ++V LIGFC E +L+Y+Y+ NG+L HLYG D + W R +I +
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 500 GAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG-VETRVL 558
GAARGL YLH I+HRD++ NIL+ +F P + DFG+++ + D + T V
Sbjct: 147 GAARGLHYLHT----RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 559 GTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR 618
GT GY+ PEY G++TEK+DVYS GVVL E++ R A+ + PR L EWA
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670
+ +++DP L + + A C+ RP M VL LE +
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 418 bits (1078), Expect = e-143
Identities = 107/307 (34%), Positives = 161/307 (52%), Gaps = 22/307 (7%)
Query: 376 VFGNPPRWFTYAELELATNRFSE------ANFLAEGGFGSVHRGVLPDGQVVAVKQ---- 425
V F++ EL+ TN F E N + EGGFG V++G + + VAVK+
Sbjct: 7 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAM 65
Query: 426 YKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRD 485
+ + + Q+F E++V++ QH N+V L+GF + LVY Y+ NGSL L D
Sbjct: 66 VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125
Query: 486 -RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544
PL W R KIA GAA G+ +LHE +HRD++ NIL+ F + DFGLAR
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 545 WQPDGDMG-VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPR 603
+ +R++GT Y+APE G+IT K+D+YS GVVL+E+ITG A+D +R
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE- 239
Query: 604 GQQCLTEWARPLLK-RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQV 662
Q L + + I + ID ++ + V M AS C+ + + RP + +V
Sbjct: 240 -PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 663 LRMLEGD 669
++L+
Sbjct: 298 QQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 2e-77
Identities = 71/306 (23%), Positives = 114/306 (37%), Gaps = 27/306 (8%)
Query: 384 FTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEV 443
L + A G FG V + + VAVK + + Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 444 LSCAQHRNVVMLIGFCVED----GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV 499
L +H N++ IG L+ + GSL L + + W+ IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHIAE 128
Query: 500 GAARGLRYLHEECRVG------CIVHRDMRPNNILVTHDFEPLVGDFGLAR-WQPDGDMG 552
ARGL YLHE+ I HRD++ N+L+ ++ + DFGLA ++ G
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 553 VETRVLGTFGYLAPEYAQSG-----QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC 607
+GT Y+APE + + D+Y++G+VL EL + A D
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 608 LTEWARPL-----LKRHAIGELIDPRLRNCYSEREVYGML-QCASLCIRKDPHSRPRMSQ 661
E ++ + + P LR+ + + ML + C D +R
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 662 VLRMLE 667
V +
Sbjct: 309 VGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 6e-60
Identities = 69/328 (21%), Positives = 124/328 (37%), Gaps = 42/328 (12%)
Query: 384 FTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEV 443
+E L + + G +G+V++G L D + VAVK + S Q F +E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNI 58
Query: 444 --LSCAQHRNVVMLIGFCVEDGRR-----LLVYEYICNGSLDSHLYGRDRDPLEWSARRK 496
+ +H N+ I LLV EY NGSL +L +W + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 497 IAVGAARGLRYLHEECRVG-----CIVHRDMRPNNILVTHDFEPLVGDFGLAR------- 544
+A RGL YLH E G I HRD+ N+LV +D ++ DFGL+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 545 WQPDGDMGVETRVLGTFGYLAPEYAQS-------GQITEKADVYSLGVVLVELITGRKAM 597
+P + +GT Y+APE + ++ D+Y+LG++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 598 -------DLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVY--GMLQCASLC 648
+ + ++ E P+ + E + + + C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 649 IRKDPHSRPRMSQVLRMLEGDILMNSKD 676
+D +R + +++ ++
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 3e-56
Identities = 75/275 (27%), Positives = 121/275 (44%), Gaps = 34/275 (12%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGD--QEFCSEVEVLSCAQHRNVVMLIGFC 459
+ G FG+VHR G VAVK + EF EV ++ +H N+V+ +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRD-RDPLEWSARRKIAVGAARGLRYLHEECRVGCIV 518
+ +V EY+ GSL L+ R+ L+ R +A A+G+ YLH IV
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP--IV 161
Query: 519 HRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKA 578
HR+++ N+LV + V DFGL+R + + ++ GT ++APE + EK+
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEPSNEKS 220
Query: 579 DVYSLGVVLVELITGR------KAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632
DVYS GV+L EL T + + G +C R I ++P++
Sbjct: 221 DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK----RL-----EIPRNLNPQVAAI 271
Query: 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
+ C +P RP + ++ +L
Sbjct: 272 --------IEG----CWTNEPWKRPSFATIMDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 5e-56
Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 32/271 (11%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
+ G FG V + + VA+K ++ S + F E+ LS H N+V L G C+
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDP-LEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
LV EY GSL + L+G + P + + ++G+ YLH ++HR
Sbjct: 73 P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA-LIHR 129
Query: 521 DMRPNNILVTHDFEPL-VGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKAD 579
D++P N+L+ L + DFG A M T G+ ++APE + +EK D
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDI-QTHM---TNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 580 VYSLGVVLVELITGR---KAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSER 636
V+S G++L E+IT R + R + RP + + + + +
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-----PLIKNLPKPIESL---- 236
Query: 637 EVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
M +C S KDP RP M ++++++
Sbjct: 237 ----MTRCWS----KDPSQRPSMEEIVKIMT 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-55
Identities = 87/289 (30%), Positives = 129/289 (44%), Gaps = 53/289 (18%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD-------QEFCSEVEVLSCAQHRNVV 453
+ +GGFG VH+G + D VVA+K L S+G+ QEF EV ++S H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
L G +V E++ G L L + P++WS + ++ + A G+ Y+ +
Sbjct: 87 KLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQ--NQ 141
Query: 514 VGCIVHRDMRPNNILVTHDFEPL-----VGDFGLARWQPDGDMGVETRVLGTFGYLAPE- 567
IVHRD+R NI + E V DFGL++ G +LG F ++APE
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG----LLGNFQWMAPET 197
Query: 568 -YAQSGQITEKADVYSLGVVLVELITGRK--------AMDLNRPRGQQCLTEWARPLLKR 618
A+ TEKAD YS ++L ++TG + ++ L RP
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL----RP---- 249
Query: 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
I E PRLRN + C S DP RP S +++ L
Sbjct: 250 -TIPEDCPPRLRNV--------IELCWS----GDPKKRPHFSYIVKELS 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-54
Identities = 80/295 (27%), Positives = 113/295 (38%), Gaps = 44/295 (14%)
Query: 402 LAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
L +G FG + G+V+ +K+ + + F EV+V+ C +H NV+ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
+D R + EYI G+L + D WS R A A G+ YLH I+HR
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSM----NIIHR 132
Query: 521 DMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR-------------VLGTFGYLAPE 567
D+ +N LV + +V DFGLAR D E V+G ++APE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 568 YAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627
EK DV+S G+VL E+I A PR G +
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM--------------DFGLNVRG 238
Query: 628 RLR-----NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSKDD 677
L NC C DP RP ++ LE + M+
Sbjct: 239 FLDRYCPPNCPPS-----FFPITVRCCDLDPEKRPSFVKLEHWLE-TLRMHLAGH 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-54
Identities = 74/281 (26%), Positives = 116/281 (41%), Gaps = 41/281 (14%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGD----QEFCSEVEVLSCAQHRNVVMLIG 457
+ GGFG V+R G VAVK + + + E ++ + +H N++ L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 458 FCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCI 517
C+++ LV E+ G L+ L G+ + AV ARG+ YLH+E V I
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVP-I 129
Query: 518 VHRDMRPNNILVTHDFEPL--------VGDFGLARWQPDGDMGVETRVLGTFGYLAPEYA 569
+HRD++ +NIL+ E + DFGLAR G + ++APE
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPEVI 186
Query: 570 QSGQITEKADVYSLGVVLVELITGR---KAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626
++ ++ +DV+S GV+L EL+TG + +D I
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV-AMNKLAL-----PIPSTCP 240
Query: 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
M C + DPHSRP + +L L
Sbjct: 241 EPFAKL--------MEDCWN----PDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-52
Identities = 62/295 (21%), Positives = 110/295 (37%), Gaps = 51/295 (17%)
Query: 394 NRFSEANF--------LAEGGFGSVHRGVLPDGQVVAVKQYKL--ASSQGDQEFCSEVEV 443
N+ S +F L E G + +G G + VK K+ S++ ++F E
Sbjct: 2 NKHSGIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 444 LSCAQHRNVVMLIGFCVE--DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGA 501
L H NV+ ++G C L+ ++ GSL + L+ ++ S K A+
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 502 ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF 561
ARG+ +LH + I + ++++ D + + +
Sbjct: 121 ARGMAFLHTLEPL--IPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAP 172
Query: 562 GYLAPE---YAQSGQITEKADVYSLGVVLVELITGR------KAMDLNRPRGQQCLTEWA 612
++APE AD++S V+L EL+T M++ G + E
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI----GMKVALEGL 228
Query: 613 RPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
RP I I P + M C + +DP RP+ ++ +LE
Sbjct: 229 RP-----TIPPGISPHVSKL--------MKICMN----EDPAKRPKFDMIVPILE 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-50
Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 43/281 (15%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGD--QEFCSEVEVLSCAQHRNVVMLIGFC 459
+ G FG+V++G G V AVK + + Q F +EV VL +H N+++ +G+
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVH 519
+ +V ++ SL HL+ + E IA ARG+ YLH + I+H
Sbjct: 90 TAP-QLAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLHAKS----IIH 143
Query: 520 RDMRPNNILVTHDFEPLVGDFGLAR----WQPDGDMGVETRVLGTFGYLAPE---YAQSG 572
RD++ NNI + D +GDFGLA W + G+ ++APE S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPEVIRMQDSN 200
Query: 573 QITEKADVYSLGVVLVELITGR---KAMDLNRPRGQ---QCLTEWARPLLKRHAIGELID 626
+ ++DVY+ G+VL EL+TG+ ++ R Q P L + +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNIN---NRDQIIEMVGRGSLSPDLSK--VRSNCP 255
Query: 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
R++ M + C++K RP ++L +E
Sbjct: 256 KRMKRL--------MAE----CLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 7e-50
Identities = 61/282 (21%), Positives = 112/282 (39%), Gaps = 40/282 (14%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGD--QEFCSEVEVLSCAQHRNVVMLIGFC 459
+ +G FG V+ G G+V A++ + D + F EV +H NVV+ +G C
Sbjct: 41 IGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVH 519
+ ++ +L S + + L+ + R+IA +G+ YLH + I+H
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK----GILH 153
Query: 520 RDMRPNNILVTHDFEPLVGDFGLAR----WQPDGDMGVETRVLGTFGYLAPEYAQSGQI- 574
+D++ N+ + + ++ DFGL Q G +LAPE +
Sbjct: 154 KDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 575 --------TEKADVYSLGVVLVELITGRKAMDLNRP-RGQQCLTEWARPLLKRHAIGELI 625
++ +DV++LG + EL P + Q +G +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREW------PFKTQP-------AEAIIWQMGTGM 259
Query: 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
P L +E+ +L C + RP ++++ MLE
Sbjct: 260 KPNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLE 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-48
Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 43/296 (14%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEV--LSCAQHRNVVMLIGFC 459
+ +G +G V G G+ VAVK + + + + E E+ +H N++ I
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 460 VEDGRR----LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
++ L+ +Y NGSL +L L+ + K+A + GL +LH E
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 516 ----CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE---TRVLGTFGYLAPE- 567
I HRD++ NILV + + D GLA V+ +GT Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 568 -----YAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622
Q AD+YS G++L E+ R Q + +
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPS---DPSYE 273
Query: 623 ELID--------PRLRNCYSEREVYGMLQCASL---CIRKDPHSRPRMSQVLRMLE 667
++ + P N +S E + L C +P SR +V + L
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQM--GKLMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-47
Identities = 67/294 (22%), Positives = 123/294 (41%), Gaps = 39/294 (13%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEV--LSCAQHRNVVMLIGFC 459
+ +G FG V RG G+ VAVK + S+ ++ + E E+ +H N++ I
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 460 VEDGRR----LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
+D LV +Y +GSL +L +R + K+A+ A GL +LH E
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 516 ----CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE---TRVLGTFGYLAPE- 567
I HRD++ NILV + + D GLA ++ +GT Y+APE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 568 -----YAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622
+ + ++AD+Y++G+V E+ R ++ Q + +
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 623 EL---------IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
++ I R ++C + R + +++ C + +R ++ + L
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-46
Identities = 64/296 (21%), Positives = 115/296 (38%), Gaps = 43/296 (14%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEV--LSCAQHRNVVMLIGFC 459
+ +G +G V RG G+ VAVK + SS+ ++ + E E+ +H N++ I
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 460 VEDGRR----LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
+ L+ Y GSL +L L+ + +I + A GL +LH E
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 516 ----CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE---TRVLGTFGYLAPE- 567
I HRD++ NILV + + + D GLA ++ +GT Y+APE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 568 -----YAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622
++ D+++ G+VL E+ R + + + +
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPN---DPSFE 244
Query: 623 ELID--------PRLRNCYSEREVYGMLQCASL---CIRKDPHSRPRMSQVLRMLE 667
++ P + N + L A L C ++P +R ++ + L
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSL--AKLMKECWYQNPSARLTALRIKKTLT 298
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 63/278 (22%), Positives = 113/278 (40%), Gaps = 24/278 (8%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQ---YKLASSQGDQEFCSEVEVLSCAQH 449
F + G F V+R L DG VA+K+ + L ++ + E+++L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 450 RNVVMLIGFCVEDGRRLLVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRY 507
NV+ +ED +V E G L + + + + + K V L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE 567
+H ++HRD++P N+ +T +GD GL R ++GT Y++PE
Sbjct: 152 MHSRR----VMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSPE 206
Query: 568 YAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627
K+D++SLG +L E+ + ++ L + P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---------LCKKIEQCDYPP 257
Query: 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665
+ YSE E+ ++ ++CI DP RP ++ V +
Sbjct: 258 LPSDHYSE-ELRQLV---NMCINPDPEKRPDVTYVYDV 291
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 74/328 (22%), Positives = 112/328 (34%), Gaps = 59/328 (17%)
Query: 356 SRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVL 415
+ P + P +W L + G FG V G L
Sbjct: 86 LSTQQPLTKKSGVVLHRAVP----KDKW------VLNHEDLVLGEQIGRGNFGEVFSGRL 135
Query: 416 PDGQV-VAVKQYK-LASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYIC 473
VAVK + +F E +L H N+V LIG C + +V E +
Sbjct: 136 RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 195
Query: 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF 533
G + L L ++ AA G+ YL + C +HRD+ N LVT
Sbjct: 196 GGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESK----CCIHRDLAARNCLVTEKN 250
Query: 534 EPLVGDFGLARWQPDGDMGVETRVLGTFGY----LAPEYAQSGQITEKADVYSLGVVLVE 589
+ DFG++R + DG G APE G+ + ++DV+S G++L E
Sbjct: 251 VLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307
Query: 590 LIT-GRK---AMDLNRPRGQQCLTEWARPLLKRHAIGELID-----PRLRNCYSEREVYG 640
+ G + QQ E ++ P C V+
Sbjct: 308 TFSLGASPYPNLSN-----QQTR--------------EFVEKGGRLPCPELC--PDAVFR 346
Query: 641 -MLQCASLCIRKDPHSRPRMSQVLRMLE 667
M Q C +P RP S + + L+
Sbjct: 347 LMEQ----CWAYEPGQRPSFSTIYQELQ 370
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-37
Identities = 82/326 (25%), Positives = 124/326 (38%), Gaps = 38/326 (11%)
Query: 356 SRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVL 415
S++ L ++C P + E+ L +G FG V G
Sbjct: 150 SKHADGLCHRLTTVCPTSKP----QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 205
Query: 416 PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNG 475
VA+K K + + F E +V+ +H +V L E+ +V EY+ G
Sbjct: 206 NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKG 263
Query: 476 SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEP 535
SL L G L +A A G+ Y+ VHRD+R NILV +
Sbjct: 264 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGENLVC 319
Query: 536 LVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRK 595
V DFGLAR D + + APE A G+ T K+DV+S G++L EL T +
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379
Query: 596 AMDLNRPRGQQCLTEWARPLLKRHAIGELID-----PRLRNCYSEREVYG-MLQCASLCI 649
P P + + + ++ P C ++ M Q C
Sbjct: 380 -----VP----------YPGMVNREVLDQVERGYRMPCPPEC--PESLHDLMCQ----CW 418
Query: 650 RKDPHSRPRMSQVLRMLEGDILMNSK 675
RK+P RP + LE D +++
Sbjct: 419 RKEPEERPTFEYLQAFLE-DYFTSTE 443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-37
Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 26/281 (9%)
Query: 402 LAEGGFGSVHRGVLP-----DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLI 456
L +G FGSV G+VVAVK+ + ++ + ++F E+E+L QH N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 457 GFCVEDGRR--LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514
G C GRR L+ EY+ GSL +L + ++ ++ + +G+ YL R
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYL-GTKR- 134
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF--GYLAPEYAQSG 572
+HRD+ NILV ++ +GDFGL + P + + G + APE
Sbjct: 135 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 573 QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID-----P 627
+ + +DV+S GVVL EL T + + + + + + EL+ P
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 252
Query: 628 RLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
R C E+Y M +C + + + RP + ++
Sbjct: 253 RPDGC--PDEIYMIMTECWN----NNVNQRPSFRDLALRVD 287
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-37
Identities = 70/326 (21%), Positives = 124/326 (38%), Gaps = 35/326 (10%)
Query: 356 SRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVL 415
S L + Y + E+ + + L G +G V+ GV
Sbjct: 183 STVADGLITTLHYPAPKRNKPTIYGVSP-NYDKWEMERTDITMKHKLGGGQYGEVYEGVW 241
Query: 416 PDGQV-VAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474
+ VAVK K + + +EF E V+ +H N+V L+G C + ++ E++
Sbjct: 242 KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 300
Query: 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE 534
G+L +L +R + +A + + YL ++ +HR++ N LV +
Sbjct: 301 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRNLAARNCLVGENHL 356
Query: 535 PLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
V DFGL+R + APE + + K+DV++ GV+L E+ T
Sbjct: 357 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 416
Query: 595 KAMDLNRPRGQQCLTEWARPLLKRHAIGELID-----PRLRNCYSEREVYG-MLQCASLC 648
P P + + EL++ R C +VY M C
Sbjct: 417 M-----SP----------YPGIDLSQVYELLEKDYRMERPEGC--PEKVYELMRA----C 455
Query: 649 IRKDPHSRPRMSQVLRMLEGDILMNS 674
+ +P RP +++ + E + S
Sbjct: 456 WQWNPSDRPSFAEIHQAFE-TMFQES 480
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 26/281 (9%)
Query: 402 LAEGGFGSVHRGVLP-----DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLI 456
L +G FGSV G+VVAVK+ + ++ + ++F E+E+L QH N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 457 GFCVEDGRR--LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514
G C GRR L+ EY+ GSL +L + ++ ++ + +G+ YL +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 164
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF--GYLAPEYAQSG 572
+HRD+ NILV ++ +GDFGL + P + + G + APE
Sbjct: 165 -RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223
Query: 573 QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID-----P 627
+ + +DV+S GVVL EL T + + + + + + EL+ P
Sbjct: 224 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 283
Query: 628 RLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
R C E+Y M +C + + + RP + ++
Sbjct: 284 RPDGC--PDEIYMIMTECWN----NNVNQRPSFRDLALRVD 318
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 68/308 (22%), Positives = 115/308 (37%), Gaps = 36/308 (11%)
Query: 378 GNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE 436
G +F + + + L EGGF V L DG A+K+ Q +E
Sbjct: 13 GRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREE 72
Query: 437 FCSEVEVLSCAQHRNVVMLIGFCVEDGRR----LLVYEYICNGSLDSHLYGRDRDPLEWS 492
E ++ H N++ L+ +C+ + L+ + G+L + + +
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132
Query: 493 AR--RKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550
+ +G RGL +H + HRD++P NIL+ + +P++ D G
Sbjct: 133 EDQILWLLLGICRGLEAIHAKG----YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188
Query: 551 MGVETRVL--------GTFGYLAPEYAQS---GQITEKADVYSLGVVLVELITGRKAMDL 599
G + T Y APE I E+ DV+SLG VL ++ G D+
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 600 NRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRM 659
+G + +L P +S + Q + + DPH RP +
Sbjct: 249 VFQKGD---------SVALAVQNQLSIP-QSPRHSSA----LWQLLNSMMTVDPHQRPHI 294
Query: 660 SQVLRMLE 667
+L LE
Sbjct: 295 PLLLSQLE 302
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 65/265 (24%), Positives = 118/265 (44%), Gaps = 24/265 (9%)
Query: 404 EGGFGSVHRGV-LPDGQVVAVKQYKLAS-SQGDQEFC-SEVEVLSCAQHRNVVMLIGFCV 460
EG FG DG+ +K+ ++ S ++E EV VL+ +H N+V
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE 93
Query: 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
E+G +V +Y G L + + + V L+++H+ I+HR
Sbjct: 94 ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK----ILHR 149
Query: 521 DMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADV 580
D++ NI +T D +GDFG+AR + + + +GT YL+PE ++ K+D+
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACIGTPYYLSPEICENKPYNNKSDI 208
Query: 581 YSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYG 640
++LG VL EL T + A + + L+ + I P + YS ++
Sbjct: 209 WALGCVLYELCTLKHAFEAGSMKN----------LVLK--IISGSFPPVSLHYSY-DLRS 255
Query: 641 MLQCASLCIRKDPHSRPRMSQVLRM 665
++ S +++P RP ++ +L
Sbjct: 256 LV---SQLFKRNPRDRPSVNSILEK 277
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 71/283 (25%), Positives = 110/283 (38%), Gaps = 30/283 (10%)
Query: 402 LAEGGFGSVHRGVLP-----DGQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVML 455
L EG FG V G+ VAVK K S + E+E+L H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 456 IGFCVEDGRR--LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
G C EDG L+ E++ +GSL +L ++++ + + K AV +G+ YL +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYL-GSRQ 146
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF--GYLAPEYAQS 571
VHRD+ N+LV + + +GDFGL + + + APE
Sbjct: 147 ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 572 GQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID---- 626
+ +DV+S GV L EL+T + + + +
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT--HGQMTVTRLVNTLKEGKR 261
Query: 627 -PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
P NC EVY M +C P +R ++ E
Sbjct: 262 LPCPPNC--PDEVYQLMRKCWE----FQPSNRTSFQNLIEGFE 298
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-36
Identities = 82/326 (25%), Positives = 125/326 (38%), Gaps = 38/326 (11%)
Query: 356 SRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVL 415
S++ L ++C P + E+ L +G FG V G
Sbjct: 233 SKHADGLCHRLTTVCPTSKP----QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 288
Query: 416 PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNG 475
VA+K K + + F E +V+ +H +V L E+ +V EY+ G
Sbjct: 289 NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKG 346
Query: 476 SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEP 535
SL L G L +A A G+ Y+ VHRD+R NILV +
Sbjct: 347 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGENLVC 402
Query: 536 LVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRK 595
V DFGLAR D + + APE A G+ T K+DV+S G++L EL T
Sbjct: 403 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--- 459
Query: 596 AMDLNRPRGQQCLTEWARPLLKRHAIGELID-----PRLRNCYSEREVYG-MLQCASLCI 649
+G+ P + + + ++ P C ++ M Q C
Sbjct: 460 -------KGRV-----PYPGMVNREVLDQVERGYRMPCPPEC--PESLHDLMCQ----CW 501
Query: 650 RKDPHSRPRMSQVLRMLEGDILMNSK 675
RK+P RP + LE D +++
Sbjct: 502 RKEPEERPTFEYLQAFLE-DYFTSTE 526
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 79/290 (27%), Positives = 118/290 (40%), Gaps = 30/290 (10%)
Query: 402 LAEGGFGSVHRGVLP-----DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLI 456
L +G FGSV G +VAVKQ + + ++F E+++L +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 457 GFCVEDGRR--LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514
G GR+ LV EY+ +G L L R R L+ S + +G+ YL R
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYL-GSRR- 147
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF--GYLAPEYAQSG 572
VHRD+ NILV + + DFGLA+ P R G + APE
Sbjct: 148 --CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 573 QITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID----- 626
+ ++DV+S GVVL EL T K+ + + R + + EL++
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSC--SPSAEFLRMMGCERDVPALSRLLELLEEGQRL 263
Query: 627 PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSK 675
P C EV+ M C + P RP S + L+ + S+
Sbjct: 264 PAPPAC--PAEVHELMKLCWA----PSPQDRPSFSALGPQLD-MLWSGSR 306
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 66/295 (22%), Positives = 122/295 (41%), Gaps = 58/295 (19%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNV 452
F E + GGFG V + DG+ +K+ K + ++ EV+ L+ H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 453 VMLIGFCVEDGRRL----------------LVYEYICNGSLDSHLYGRDRDPLEWSARRK 496
V G + E+ G+L+ + R + L+ +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 497 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW-QPDGDMGVET 555
+ +G+ Y+H + +++RD++P+NI + + +GDFGL + DG T
Sbjct: 127 LFEQITKGVDYIHSKK----LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---T 179
Query: 556 RVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARP 614
R GT Y++PE S ++ D+Y+LG++L EL+ A + ++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK------------- 226
Query: 615 LLKRHAIGELIDPRLRNCYSERE---VYGMLQCASLCIRKDPHSRPRMSQVLRML 666
+L D + + + ++E + +L K P RP S++LR L
Sbjct: 227 -----FFTDLRDGIISDIFDKKEKTLLQKLLS-------KKPEDRPNTSEILRTL 269
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 31/273 (11%)
Query: 404 EGGFGSVHRGV-LPDGQVVAVKQYKLAS-SQGDQEFC-SEVEVLSCAQHRNVVMLIG-FC 459
G +G + DG+++ K+ S ++ +++ SEV +L +H N+V
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75
Query: 460 VEDGRRL-LVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
L +V EY G L S + ++R L+ ++ L+ H G
Sbjct: 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135
Query: 517 -IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQIT 575
++HRD++P N+ + +GDFGLAR +T V GT Y++PE
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMSYN 194
Query: 576 EKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSE 635
EK+D++SLG +L EL + L + G+ R+ YS+
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFSQKE----------LAGKIREGKF--RRIPYRYSD 242
Query: 636 REVYGMLQCASL---CIRKDPHSRPRMSQVLRM 665
+ + + + RP + ++L
Sbjct: 243 -------ELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 72/293 (24%), Positives = 113/293 (38%), Gaps = 44/293 (15%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKL--ASSQGDQEFCSEVEVLSC-AQ 448
T F E + G FGSV + V DG + A+K+ K A S +Q EV + Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 449 HRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLR 506
H +VV ED L+ EY GSL + R + + + + + RGLR
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD--------GDMGVETRVL 558
Y+H +VH D++P+NI ++ P GD+G TR+
Sbjct: 130 YIHSMS----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 559 ------GTFGYLAPE-YAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEW 611
G +LA E ++ KAD+++L + +V +W
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR--------NGDQW 237
Query: 612 ARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
H I + PR+ S+ E +L + I DP RP +++
Sbjct: 238 -------HEIRQGRLPRIPQVLSQ-EFTELL---KVMIHPDPERRPSAMALVK 279
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-34
Identities = 75/334 (22%), Positives = 120/334 (35%), Gaps = 51/334 (15%)
Query: 356 SRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVL 415
+ L C P + + E+ L G FG V
Sbjct: 155 KKGNDGLCQKLSVPCMSSKP-----QKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATY 209
Query: 416 PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNG 475
VAVK K S + F +E V+ QH +V L ++ ++ E++ G
Sbjct: 210 NKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKG 267
Query: 476 SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEP 535
SL L + + A G+ ++ + +HRD+R NILV+
Sbjct: 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRDLRAANILVSASLVC 323
Query: 536 LVGDFGLARWQPDGDMGVETRVLGTFGY--LAPEYAQSGQITEKADVYSLGVVLVELIT- 592
+ DFGLAR D + R F APE G T K+DV+S G++L+E++T
Sbjct: 324 KIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 381
Query: 593 GRK---AMDLNRPRGQQCLTEWARPLLKRHAIGELID-----PRLRNCYSEREVYG-MLQ 643
GR M + + ++ PR NC E+Y M++
Sbjct: 382 GRIPYPGMS-----NPEVI--------------RALERGYRMPRPENC--PEELYNIMMR 420
Query: 644 CASLCIRKDPHSRPRMSQVLRMLEGDILMNSKDD 677
C + P RP + +L+ D ++
Sbjct: 421 ----CWKNRPEERPTFEYIQSVLD-DFYTATESQ 449
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 62/276 (22%), Positives = 95/276 (34%), Gaps = 33/276 (11%)
Query: 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLA--SSQGDQEFCSEVEVL-SCAQHR 450
F + L G +G V + DG++ AVK+ + +EV QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 451 NVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE 510
V L E G L E C SL H L + L +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTEL-CGPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQ 570
+ +VH D++P NI + +GDFGL + E + G Y+APE Q
Sbjct: 176 QG----LVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQE-GDPRYMAPELLQ 229
Query: 571 SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID-PRL 629
G ADV+SLG+ ++E+ + + + P
Sbjct: 230 -GSYGTAADVFSLGLTILEVACNMELPHGGEG---------------WQQLRQGYLPPEF 273
Query: 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665
S E+ +L + + DP R +L +
Sbjct: 274 TAGLSS-ELRSVL---VMMLEPDPKLRATAEALLAL 305
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 68/298 (22%), Positives = 111/298 (37%), Gaps = 50/298 (16%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRN 451
F L GGFG V D A+K+ +L + + ++ EV+ L+ +H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 452 VVMLIGFCVEDG---------RRLLVY---EYICNGSLDSHLYGRDR-DPLEWSARRKIA 498
+V +E ++ +Y + +L + GR + E S I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 499 VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-----------WQP 547
+ A + +LH + ++HRD++P+NI T D VGDFGL P
Sbjct: 125 LQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITG-RKAMDLNRPRGQQ 606
T +GT Y++PE + K D++SLG++L EL+ M+ R
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVR----- 235
Query: 607 CLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
L + L P L Y M+Q + P RP ++
Sbjct: 236 --------TLTD--VRNLKFPPLFTQKYP-CEYVMVQ---DMLSPSPMERPEAINIIE 279
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 57/200 (28%), Positives = 84/200 (42%), Gaps = 16/200 (8%)
Query: 402 LAEGGFGSVHRG---VLPDGQVVAVKQYKLASSQGDQEFCS--EVEVLSCA--QHRNVVM 454
+ GG G V+ V ++VA+K + D F + + E + Q +VV
Sbjct: 42 VGRGGMGDVYEAEDTVR--ERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514
+ F DG+ + I L + L R + PL I L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH---AA 153
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQI 574
G HRD++P NILV+ D + DFG+A D + +GT Y+APE
Sbjct: 154 G-ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 575 TEKADVYSLGVVLVELITGR 594
T +AD+Y+L VL E +TG
Sbjct: 213 TYRADIYALTCVLYECLTGS 232
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-34
Identities = 79/322 (24%), Positives = 119/322 (36%), Gaps = 47/322 (14%)
Query: 356 SRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVL 415
+ + L + V F + L + +G FG V G
Sbjct: 157 TTDADGLCTRLIKPKVMEGTVAAQDE--FYRSGWALNMKELKLLQTIGKGEFGDVMLGDY 214
Query: 416 PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL-LVYEYICN 474
G VAVK K ++ Q F +E V++ +H N+V L+G VE+ L +V EY+
Sbjct: 215 -RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271
Query: 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE 534
GSL +L R R L K ++ + YL VHRD+ N+LV+ D
Sbjct: 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----FVHRDLAARNVLVSEDNV 327
Query: 535 PLVGDFGLARWQPDGDMGVETRVLGTFGY--LAPEYAQSGQITEKADVYSLGVVLVELIT 592
V DFGL + G APE + + + K+DV+S G++L E+ +
Sbjct: 328 AKVSDFGLTKEASSTQDT------GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
Query: 593 -GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID-----PRLRNCYSEREVYG-MLQCA 645
GR P P + + ++ C VY M
Sbjct: 382 FGR------VP----------YPRIPLKDVVPRVEKGYKMDAPDGC--PPAVYDVMKN-- 421
Query: 646 SLCIRKDPHSRPRMSQVLRMLE 667
C D +RP Q+ LE
Sbjct: 422 --CWHLDAATRPTFLQLREQLE 441
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 32/283 (11%)
Query: 402 LAEGGFGSVHRGVL-----PDGQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVML 455
L EG FG V G++VAVK K + + E+++L H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 456 IGFCVEDGRR--LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
G C + G LV EY+ GSL +L R + + A G+ YL
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYL-HAQH 154
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF--GYLAPEYAQS 571
+HRD+ N+L+ +D +GDFGLA+ P+G R G + APE +
Sbjct: 155 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 572 GQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID---- 626
+ +DV+S GV L EL+T + + P L A+ + + EL++
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQ--SPPTKFLELIGIAQGQMTVLRLTELLERGER 269
Query: 627 -PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
PR C EVY M C + RP ++ +L+
Sbjct: 270 LPRPDKC--PAEVYHLMKNCW----ETEASFRPTFENLIPILK 306
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 77/285 (27%), Positives = 115/285 (40%), Gaps = 40/285 (14%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
L G FG V G VAVK K S F +E ++ QH+ +V L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
+ ++ EY+ NGSL L L + +A A G+ ++ E +HRD
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 134
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGY--LAPEYAQSGQITEKAD 579
+R NILV+ + DFGLAR D + R F APE G T K+D
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 580 VYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID-----PRLRNCY 633
V+S G++L E++T GR P P + + + ++ R NC
Sbjct: 193 VWSFGILLTEIVTHGR------IP----------YPGMTNPEVIQNLERGYRMVRPDNC- 235
Query: 634 SEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSKDD 677
E+Y M C ++ P RP + +LE D ++
Sbjct: 236 -PEELYQLMRLCW----KERPEDRPTFDYLRSVLE-DFFTATEGQ 274
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 69/282 (24%), Positives = 114/282 (40%), Gaps = 47/282 (16%)
Query: 402 LAEGGFGSVHRGVL--PDGQV-VAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVMLIG 457
L G FGSV +GV Q+ VA+K K + + D +E E +++ + +V LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 458 FCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCI 517
C + +LV E G L L G+ + + S ++ + G++YL EE
Sbjct: 78 VCQAE-ALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL-EEKN---F 131
Query: 518 VHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF--GYLAPEYAQSGQIT 575
VHRD+ N+L+ + + DFGL++ D R G + + APE + +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 576 EKADVYSLGVVLVELIT-GRK---AMDLNRPRGQQCLTEWARPLLKRHAIGELID----- 626
++DV+S GV + E ++ G+K M G + + I+
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMK-----GPEVM--------------AFIEQGKRM 232
Query: 627 PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
C E+Y M C RP V + +
Sbjct: 233 ECPPEC--PPELYALMSDCW----IYKWEDRPDFLTVEQRMR 268
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 402 LAEGGFGSVHRGVLPD---GQVVAVKQYKLASSQGDQEFCS--EVEVLSCAQ--HRNVVM 454
L GG +V+ D VA+K + +E E EV + +Q H+N+V
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514
+I ED LV EYI +L ++ PL G+++ H +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQI 574
IVHRD++P NIL+ + + DFG+A+ + + VLGT Y +PE A+
Sbjct: 131 R-IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 575 TEKADVYSLGVVLVELITGR 594
E D+YS+G+VL E++ G
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 50/285 (17%)
Query: 402 LAEGGFGSVHRGVL--PDGQV---VAVKQYKL-ASSQGDQEFCSEVEVLSCAQHRNVVML 455
+ G FG V++G+L G+ VA+K K + + +F E ++ H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDP-LEWSARRKIAVGAARGLRYLHEECRV 514
G + +++ EY+ NG+LD L R++D + G A G++YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL-ANMN- 167
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGY--LAPEYAQSG 572
VHRD+ NILV + V DFGL+R D T G APE
Sbjct: 168 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 573 QITEKADVYSLGVVLVELIT-GRK---AMDLNRPRGQQCLTEWARPLLKRHAIGELID-- 626
+ T +DV+S G+V+ E++T G + + + + + I+
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERPYWELS-----NHEVM--------------KAINDG 266
Query: 627 ---PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
P +C +Y M+QC +++ RP+ + ++ +L+
Sbjct: 267 FRLPTPMDC--PSAIYQLMMQCW----QQERARRPKFADIVSILD 305
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 78/311 (25%), Positives = 115/311 (36%), Gaps = 64/311 (20%)
Query: 384 FTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEV 443
F + L + +G FG V G G VAVK K ++ Q F +E V
Sbjct: 11 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASV 67
Query: 444 LSCAQHRNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAA 502
++ +H N+V L+G VE+ L +V EY+ GSL +L R R L K ++
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 127
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG 562
+ YL VHRD+ N+LV+ D V DFGL + G
Sbjct: 128 EAMEYLEGNN----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---------G 174
Query: 563 YL-----APEYAQSGQITEKADVYSLGVVLVELIT-GRK---AMDLNRPRGQQCLTEWAR 613
L APE + + + K+DV+S G++L E+ + GR + L
Sbjct: 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------------- 221
Query: 614 PLLKRHAIGELID--------PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLR 664
+++ C VY M C D RP Q+
Sbjct: 222 ---------DVVPRVEKGYKMDAPDGC--PPAVYEVMKNCW----HLDAAMRPSFLQLRE 266
Query: 665 MLEGDILMNSK 675
LE I +
Sbjct: 267 QLE-HIKTHEL 276
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 69/291 (23%), Positives = 125/291 (42%), Gaps = 47/291 (16%)
Query: 402 LAEGGFGSVHRGVL-PDGQ----VVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVML 455
L G FG+V++G+ P+G+ VA+K+ + A+S +E E V++ + +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
+G C+ L+ + + G L ++ +D + V A+G+ YL E+ R
Sbjct: 83 LGICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYL-EDRR-- 137
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT---FGYLAPEYAQSG 572
+VHRD+ N+LV + DFGLA+ + E G ++A E
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 194
Query: 573 QITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID----- 626
T ++DV+S GV + EL+T G +P + + I +++
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGS------KP--------Y--DGIPASEISSILEKGERL 238
Query: 627 PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSKD 676
P+ C +VY M +C D SRP+ +++ + + +
Sbjct: 239 PQPPIC--TIDVYMIMRKCWM----IDADSRPKFRELIIEFS-KMARDPQR 282
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 69/305 (22%), Positives = 120/305 (39%), Gaps = 57/305 (18%)
Query: 379 NPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQV-VAVKQYKLASSQGDQEF 437
N +W E+ + + L G +G V+ GV + VAVK K + + +EF
Sbjct: 4 NYDKW------EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEF 56
Query: 438 CSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKI 497
E V+ +H N+V L+G C + ++ E++ G+L +L +R + +
Sbjct: 57 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 498 AVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV 557
A + + YL ++ +HRD+ N LV + V DFGL+R
Sbjct: 117 ATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHA 170
Query: 558 LGTFGY--LAPEYAQSGQITEKADVYSLGVVLVELIT-GRK---AMDLNRPRGQQCLTEW 611
F APE + + K+DV++ GV+L E+ T G +DL+
Sbjct: 171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------- 219
Query: 612 ARPLLKRHAIGELID--------PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQV 662
++ + R C +VY M C + +P RP +++
Sbjct: 220 -----------QVYELLEKDYRMERPEGC--PEKVYELMRACW----QWNPSDRPSFAEI 262
Query: 663 LRMLE 667
+ E
Sbjct: 263 HQAFE 267
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 6e-33
Identities = 67/279 (24%), Positives = 106/279 (37%), Gaps = 47/279 (16%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
L G FG V G VAVK K S + EF E + + H +V G C +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
+ +V EYI NG L ++L + LE S ++ G+ +L E + +HRD
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL-ESHQF---IHRD 129
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT---FGYLAPEYAQSGQITEKA 578
+ N LV D V DFG+ R+ D +GT + APE + + K+
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 579 DVYSLGVVLVELIT-GRK---AMDLNRPRGQQCLTEWARPLLKRHAIGELID-----PRL 629
DV++ G+++ E+ + G+ + + + R
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTN-----SEVV--------------LKVSQGHRLYRP 227
Query: 630 RNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
+Y M C + P RP Q+L +E
Sbjct: 228 HLA--SDTIYQIMYSCW----HELPEKRPTFQQLLSSIE 260
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 75/284 (26%), Positives = 119/284 (41%), Gaps = 49/284 (17%)
Query: 402 LAEGGFGSVHRGVLP----DGQVVAVKQYKL-ASSQGDQEFCSEVEVLSCAQHRNVVMLI 456
+ G FG V G L VA+K K+ + + ++F E ++ H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDP-LEWSARRKIAVGAARGLRYLHEECRVG 515
G + ++V EY+ NGSLDS L R D + G A G++YL +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL-SDMGY- 168
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL--APEYAQSGQ 573
VHRD+ NIL+ + V DFGL R D T G +PE +
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 574 ITEKADVYSLGVVLVELIT-GRK---AMDLNRPRGQQCLTEWARPLLKRHAIGELID--- 626
T +DV+S G+VL E+++ G + M Q + + +D
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMS-----NQDVI--------------KAVDEGY 267
Query: 627 --PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
P +C +Y ML C +KD ++RP+ Q++ +L+
Sbjct: 268 RLPPPMDC--PAALYQLMLDCW----QKDRNNRPKFEQIVSILD 305
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 66/304 (21%), Positives = 108/304 (35%), Gaps = 47/304 (15%)
Query: 384 FTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEV 443
Y E+ + L G FG V G VA+K K S + EF E +V
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKV 72
Query: 444 LSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDP-LEWSARRKIAVGAA 502
+ H +V L G C + ++ EY+ NG L ++L R+ + ++
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVC 130
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG 562
+ YL E + +HRD+ N LV V DFGL+R+ D + + V F
Sbjct: 131 EAMEYL-ESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFP 184
Query: 563 Y--LAPEYAQSGQITEKADVYSLGVVLVELIT-GRK---AMDLNRPRGQQCLTEWARPLL 616
PE + + K+D+++ GV++ E+ + G+ +
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----SETA-------- 231
Query: 617 KRHAIGELID-----PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670
E I R +VY M C + RP +L + +
Sbjct: 232 ------EHIAQGLRLYRPHLA--SEKVYTIMYSCW----HEKADERPTFKILLSNILDVM 279
Query: 671 LMNS 674
S
Sbjct: 280 DEES 283
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 65/283 (22%), Positives = 113/283 (39%), Gaps = 49/283 (17%)
Query: 402 LAEGGFGSVHRGVL--PDGQV-VAVKQYKLASSQGD--QEFCSEVEVLSCAQHRNVVMLI 456
L G FG+V +G VAVK K ++ E +E V+ + +V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
G C + +LV E G L+ +L + ++ ++ + G++YL EE
Sbjct: 85 GICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL-EESN--- 137
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF--GYLAPEYAQSGQI 574
VHRD+ N+L+ + DFGL++ + + + G + + APE +
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 575 TEKADVYSLGVVLVELIT-GRK---AMDLNRPRGQQCLTEWARPLLKRHAIGELID---- 626
+ K+DV+S GV++ E + G+K M G + +++
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GSEVT--------------AMLEKGER 238
Query: 627 -PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
C RE+Y M C + D +RP + V L
Sbjct: 239 MGCPAGC--PREMYDLMNLCWT----YDVENRPGFAAVELRLR 275
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 86/336 (25%), Positives = 126/336 (37%), Gaps = 51/336 (15%)
Query: 358 NKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPD 417
+ P + + NP + + L EG FG V +
Sbjct: 5 SGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHN 64
Query: 418 G------QVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471
+VAVK K AS Q+F E E+L+ QH+++V G C E L+V+EY
Sbjct: 65 LLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124
Query: 472 ICNGSLDSHLYGRDRDPLEWSARR-------------KIAVGAARGLRYLHEECRVGCIV 518
+ +G L+ L D + +A A G+ YL V
Sbjct: 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL----HFV 180
Query: 519 HRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL-----APEYAQSGQ 573
HRD+ N LV +GDFG++R D RV G L PE +
Sbjct: 181 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRV-GGRTMLPIRWMPPESILYRK 236
Query: 574 ITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632
T ++DV+S GVVL E+ T G+ +P Q TE + + + R R C
Sbjct: 237 FTTESDVWSFGVVLWEIFTYGK------QPWYQLSNTEAIDCITQGREL-----ERPRAC 285
Query: 633 YSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
EVY M C +++P R + V L+
Sbjct: 286 --PPEVYAIMRGCW----QREPQQRHSIKDVHARLQ 315
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 72/283 (25%), Positives = 110/283 (38%), Gaps = 47/283 (16%)
Query: 402 LAEGGFGSVHRGVLPDG----QVVAVKQYKLASSQGDQ-EFCSEVEVLSCAQHRNVVMLI 456
+ G G V G L VA+K K ++ + +F SE ++ H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
G ++V EY+ NGSLD+ L D + G G+RYL +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYL-SDLGY-- 172
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL--APEYAQSGQI 574
VHRD+ N+LV + V DFGL+R D T G APE
Sbjct: 173 -VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231
Query: 575 TEKADVYSLGVVLVELIT-GRK---AMDLNRPRGQQCLTEWARPLLKRHAIGELID---- 626
+ +DV+S GVV+ E++ G + M + + ++
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERPYWNMT-----NRDVI--------------SSVEEGYR 272
Query: 627 -PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
P C ++ ML C KD RPR SQ++ +L+
Sbjct: 273 LPAPMGC--PHALHQLMLDCW----HKDRAQRPRFSQIVSVLD 309
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 72/295 (24%), Positives = 115/295 (38%), Gaps = 49/295 (16%)
Query: 402 LAEGGFGSVHRGVLPDG----QVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVMLI 456
+ G FG V+ G L D AVK + G+ +F +E ++ H NV+ L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 457 GFCVE-DGRRLLVYEYICNGSLDSHLYGRDRDP-LEWSARRKIAVGAARGLRYLHEECRV 514
G C+ +G L+V Y+ +G L + + R+ + A+G++YL +
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLASK--- 147
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL------APEY 568
VHRD+ N ++ F V DFGLAR D + V G A E
Sbjct: 148 KF-VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY---YSVHNKTGAKLPVKWMALES 203
Query: 569 AQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID-- 626
Q+ + T K+DV+S GV+L EL+T RG P + I +
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT----------RGAP-----PYPDVNTFDITVYLLQG 248
Query: 627 ---PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSKDD 677
+ C +Y ML+C RP S+++ + +
Sbjct: 249 RRLLQPEYC--PDPLYEVMLKCWH----PKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 8e-32
Identities = 71/275 (25%), Positives = 111/275 (40%), Gaps = 39/275 (14%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
+ G FG VH G + VA+K + + +++F E EV+ H +V L G C+E
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
LV E++ +G L +L + R + + G+ YL EE V +HRD
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYL-EEACV---IHRD 129
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGY--LAPEYAQSGQITEKAD 579
+ N LV + V DFG+ R+ D + F +PE + + K+D
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 580 VYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID-----PRLRNCY 633
V+S GV++ E+ + G+ P + E I + R
Sbjct: 188 VWSFGVLMWEVFSEGK------IP----------YENRSNSEVVEDISTGFRLYKPRLA- 230
Query: 634 SEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
VY M C R+ P RP S++LR L
Sbjct: 231 -STHVYQIMNHCW----RERPEDRPAFSRLLRQLA 260
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 80/404 (19%), Positives = 139/404 (34%), Gaps = 58/404 (14%)
Query: 291 SLSPREEF--LKLLEGSSERTNDPSLTSAYEFLLEKLSTLNREPDIGVLNYKLDLKISKS 348
+ +F L L + D + E ++ L
Sbjct: 222 CIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQ 281
Query: 349 VREAVSLSRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEAN-------- 400
R S P P + S + + +++ E ++
Sbjct: 282 RRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIAD 341
Query: 401 -FLAEGGFGSVHRGVL--PDGQV-VAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVML 455
L G FGSV +GV Q+ VA+K K + + D +E E +++ + +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
IG C + +LV E G L L G+ + + S ++ + G++YL EE
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL-EEKN-- 456
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGY--LAPEYAQSGQ 573
VHR++ N+L+ + + DFGL++ D R G + APE +
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 574 ITEKADVYSLGVVLVELIT-GRK---AMDLNRPRGQQCLTEWARPLLKRHAIGELID--- 626
+ ++DV+S GV + E ++ G+K M G + + I+
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GPEVM--------------AFIEQGK 556
Query: 627 --PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
C E+Y M C RP V + +
Sbjct: 557 RMECPPEC--PPELYALMSDCW----IYKWEDRPDFLTVEQRMR 594
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 58/293 (19%), Positives = 112/293 (38%), Gaps = 64/293 (21%)
Query: 402 LAEGGFGSVHRGVL--------PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVV 453
L +G F + +GV V +K A + F ++S H+++V
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
+ G CV +LV E++ GSLD++L ++++ + + ++A A + +L EE
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL-EENT 133
Query: 514 VGCIVHRDMRPNNILVTHDFEPL--------VGDFGLARWQPDGDMGVETRVLGTFGYLA 565
+ +H ++ NIL+ + + + D G++ D+ E R+
Sbjct: 134 L---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE-RIPWV----P 185
Query: 566 PEYAQSGQI-TEKADVYSLGVVLVELIT-GRK---AMDLNRPRGQQCLTEWARPLLKRHA 620
PE ++ + D +S G L E+ + G K A+D Q+ L
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQRKL------------ 228
Query: 621 IGELID-----PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
+ + P + E+ + C +P RP ++R L
Sbjct: 229 --QFYEDRHQLPAPKAA----ELANLINNCMD----YEPDHRPSFRAIIRDLN 271
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 78/293 (26%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 402 LAEGGFGSVHRGVLPDG------QVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVML 455
L EG FG V + +VAVK K + ++F E E+L+ QH ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR--------------KIAVGA 501
G C + ++V+EY+ +G L+ L D + + IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 502 ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF 561
A G+ YL + VHRD+ N LV + +GDFG++R D RV G
Sbjct: 143 ASGMVYLASQ----HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD---YYRV-GGH 194
Query: 562 GYL-----APEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPL 615
L PE + T ++DV+S GV+L E+ T G+ +P Q TE +
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------QPWFQLSNTEVIECI 248
Query: 616 LKRHAIGELIDPRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
+ + R R C +EVY ML C +++P R + ++ ++L
Sbjct: 249 TQGRVL-----ERPRVC--PKEVYDVMLGCW----QREPQQRLNIKEIYKILH 290
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 67/305 (21%), Positives = 113/305 (37%), Gaps = 59/305 (19%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN 451
+ F E L +G FG V + D + A+K+ + + SEV +L+ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 452 VVMLIGFCVEDGRRL-------------LVYEYICNGSLDSHLYGRDRDPLEWSARRKIA 498
VV +E + + EY NG+L ++ + + R +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR-LF 122
Query: 499 VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-------------W 545
L Y+H + I+HRD++P NI + +GDFGLA+
Sbjct: 123 RQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 546 QPDGDMGVETRVLGTFGYLAPE-YAQSGQITEKADVYSLGVVLVELITG-RKAMDLNRPR 603
G T +GT Y+A E +G EK D+YSLG++ E+I M+
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN-- 236
Query: 604 GQQCLTEWARPLLKRHAIGEL-IDPRLRNCYSERE---VYGMLQCASLCIRKDPHSRPRM 659
+LK+ + P + + E + ++ DP+ RP
Sbjct: 237 -----------ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLID-------HDPNKRPGA 278
Query: 660 SQVLR 664
+L
Sbjct: 279 RTLLN 283
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 61/301 (20%), Positives = 120/301 (39%), Gaps = 56/301 (18%)
Query: 379 NPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD--Q 435
N R+ + + G F +V++G+ VA + + Q
Sbjct: 23 NDGRFLKFDIE------------IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ 70
Query: 436 EFCSEVEVLSCAQHRNVVMLIGFCV---EDGRRLLVY-EYICNGSLDSHLYGRDRDPLEW 491
F E E+L QH N+V + + +++ E + +G+L ++L + ++
Sbjct: 71 RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKI 128
Query: 492 SARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-DFEPLVGDFGLARWQPDGD 550
R +GL++LH R I+HRD++ +NI +T +GD GLA +
Sbjct: 129 KVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186
Query: 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTE 610
V+GT ++APE + E DVY+ G+ ++E+ T +C +
Sbjct: 187 A---KAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATS-------EYPYSEC--Q 233
Query: 611 WARPLLKR-------HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663
A + +R + ++ P ++ +++ CIR++ R + +L
Sbjct: 234 NAAQIYRRVTSGVKPASFDKVAIPEVKE---------IIE---GCIRQNKDERYSIKDLL 281
Query: 664 R 664
Sbjct: 282 N 282
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 77/283 (27%), Positives = 111/283 (39%), Gaps = 45/283 (15%)
Query: 402 LAEGGFGSVHRGVL--PDGQV--VAVKQYK---LASSQGDQEFCSEVEVLSCAQHRNVVM 454
L +G FG V RG P G+ VAVK K L+ + +F EV + HRN++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514
L G + +V E GSL L + + AV A G+ YL E R
Sbjct: 86 LYGVVLTP-PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYL-ESKR- 141
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGY--LAPEYAQSG 572
+HRD+ N+L+ +GDFGL R P D + + APE ++
Sbjct: 142 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 573 QITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID----- 626
+ +D + GV L E+ T G++ P W L I ID
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQE------P--------W--IGLNGSQILHKIDKEGER 243
Query: 627 -PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
PR +C +++Y M+QC P RP + L
Sbjct: 244 LPRPEDC--PQDIYNVMVQCW----AHKPEDRPTFVALRDFLL 280
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 73/284 (25%), Positives = 115/284 (40%), Gaps = 52/284 (18%)
Query: 402 LAEGGFGSVHRGVL--PDGQV--VAVKQYKL-ASSQGDQEFCSEVEVLSCAQHRNVVMLI 456
+ EG FG VH+G+ P+ VA+K K S ++F E + H ++V LI
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
G E+ ++ E G L S L R + L+ ++ A + L YL E R
Sbjct: 83 GVITEN-PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYL-ESKR--- 136
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF--GYLAPEYAQSGQI 574
VHRD+ N+LV+ + +GDFGL+R+ D G ++APE +
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPESINFRRF 194
Query: 575 TEKADVYSLGVVLVELIT-GRKAMDLNRP----RGQQCLTEWARPLLKRHAIGELID--- 626
T +DV+ GV + E++ G +P + + I+
Sbjct: 195 TSASDVWMFGVCMWEILMHGV------KPFQGVKNNDVI--------------GRIENGE 234
Query: 627 --PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
P NC +Y M +C DP RPR +++ L
Sbjct: 235 RLPMPPNC--PPTLYSLMTKCW----AYDPSRRPRFTELKAQLS 272
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 71/284 (25%), Positives = 121/284 (42%), Gaps = 28/284 (9%)
Query: 388 ELELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSC 446
E + + + L +G +G V+ G L + +A+K+ S+ Q E+ +
Sbjct: 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKH 75
Query: 447 AQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSAR--RKIAVGAARG 504
+H+N+V +G E+G + E + GSL S L PL+ + + G
Sbjct: 76 LKHKNIVQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQILEG 134
Query: 505 LRYLHEECRVGCIVHRDMRPNNILV-THDFEPLVGDFGLARWQPDGDMGVETRVLGTFGY 563
L+YLH+ IVHRD++ +N+L+ T+ + DFG ++ + G GT Y
Sbjct: 135 LKYLHDN----QIVHRDIKGDNVLINTYSGVLKISDFGTSK-RLAGINPCTETFTGTLQY 189
Query: 564 LAPEYAQSGQI--TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621
+APE G + AD++SLG ++E+ TG+ P + L E + K +
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK------PPFYE--LGEPQAAMFK---V 238
Query: 622 GELID-PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
G P + S E + C DP R + +L
Sbjct: 239 GMFKVHPEIPESMSA-EAKAFI---LKCFEPDPDKRACANDLLV 278
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 71/295 (24%), Positives = 117/295 (39%), Gaps = 49/295 (16%)
Query: 402 LAEGGFGSVHRGVLPDG----QVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVMLI 456
+ G FG V+ G L D AVK + G+ +F +E ++ H NV+ L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 457 GFCVE-DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR--KIAVGAARGLRYLHEECR 513
G C+ +G L+V Y+ +G L + + R+ + + + A+G+++L +
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI--RNETH-NPTVKDLIGFGLQVAKGMKFL-ASKK 212
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL-----APEY 568
VHRD+ N ++ F V DFGLAR D + T L A E
Sbjct: 213 ---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMALES 267
Query: 569 AQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID-- 626
Q+ + T K+DV+S GV+L EL+T RG P + I +
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT----------RGAP-----PYPDVNTFDITVYLLQG 312
Query: 627 ---PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSKDD 677
+ C +Y ML+C RP S+++ + +
Sbjct: 313 RRLLQPEYC--PDPLYEVMLKCWH----PKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 70/296 (23%), Positives = 121/296 (40%), Gaps = 55/296 (18%)
Query: 402 LAEGGFGSVHRGVL--PDGQV--VAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVMLI 456
L EG FG V+ GV G+ VAVK K + + ++F SE ++ H ++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDP-LEWSARRKIAVGAARGLRYLHEECRVG 515
G E+ ++ E G L +L L+ ++ + + YL E
Sbjct: 80 GIIEEE-PTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYL-ESINC- 134
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT---FGYLAPEYAQSG 572
VHRD+ NILV +GDFGL+R+ D D + T +++PE
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWMSPESINFR 189
Query: 573 QITEKADVYSLGVVLVELIT-GRK---AMDLNRPRGQQCLTEWARPLLKRHAIGELID-- 626
+ T +DV+ V + E+++ G++ ++ + + +++
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLE-----NKDVI--------------GVLEKG 230
Query: 627 ---PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSKDDT 678
P+ C +Y M +C DP RPR ++++ L D+ KD
Sbjct: 231 DRLPKPDLC--PPVLYTLMTRCWD----YDPSDRPRFTELVCSLS-DVYQMEKDIA 279
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 83/309 (26%), Positives = 122/309 (39%), Gaps = 71/309 (22%)
Query: 402 LAEGGFGSVHRGVLPDG---QVVAVKQYKLASSQGD-QEFCSEVEVLS-CAQHRNVVMLI 456
+ EG FG V + + A+K+ K +S+ D ++F E+EVL H N++ L+
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR----------------KIAVG 500
G C G L EY +G+L L R LE A
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 501 AARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT 560
ARG+ YL ++ I HRD+ NILV ++ + DFGL+R + V T
Sbjct: 151 VARGMDYLSQK---QFI-HRDLAARNILVGENYVAKIADFGLSR---GQE----VYVKKT 199
Query: 561 FGYL-----APEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP- 614
G L A E T +DV+S GV+L E+++ G P
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS----------LGGT-------PY 242
Query: 615 --LLKRHAIGELID----PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
+ +L + NC + EVY M QC R+ P+ RP +Q+L L
Sbjct: 243 CGMTCAELYEKLPQGYRLEKPLNC--DDEVYDLMRQCW----REKPYERPSFAQILVSLN 296
Query: 668 GDILMNSKD 676
+L K
Sbjct: 297 -RMLEERKT 304
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 74/297 (24%), Positives = 114/297 (38%), Gaps = 53/297 (17%)
Query: 402 LAEGGFGSVHRGVLPDG----QVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVMLI 456
+ +G FG V+ G D A+K + + F E ++ H NV+ LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 457 GFCV-EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR--KIAVGAARGLRYLHEECR 513
G + +G ++ Y+C+G L + R+P + + + ARG+ YL E +
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP---TVKDLISFGLQVARGMEYL-AEQK 144
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL-----APEY 568
VHRD+ N ++ F V DFGLAR D + + L A E
Sbjct: 145 ---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQHRHARLPVKWTALES 199
Query: 569 AQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP---LLKRHAIGELI 625
Q+ + T K+DV+S GV+L EL+T RG P + L
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT----------RGAP-------PYRHIDPFDLTHFLA 242
Query: 626 D----PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSKDD 677
P+ C +Y M QC DP RP ++ +E + D
Sbjct: 243 QGRRLPQPEYC--PDSLYQVMQQCW----EADPAVRPTFRVLVGEVEQIVSALLGDH 293
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 77/294 (26%), Positives = 109/294 (37%), Gaps = 59/294 (20%)
Query: 402 LAEGGFGSVHRGVL------PDGQVVAVKQYK-LASSQGDQEFCSEVEVLSCAQHRNVVM 454
L G FG V+ G + P VAVK + S Q + +F E ++S H+N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR-------KIAVGAARGLRY 507
IG ++ R ++ E + G L S L R+ P +A A G +Y
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLV---GDFGLARWQPDGDMGVETRVLGTFGYL 564
L E +HRD+ N L+T V GDFG+AR R G L
Sbjct: 156 LEEN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YRK-GGCAML 207
Query: 565 -----APEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH 619
PE G T K D +S GV+L E+ + G P
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----------LGYM-----PYPSKSNQ 252
Query: 620 AIGELID-----PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
+ E + +NC VY M QC + P RP + +L +E
Sbjct: 253 EVLEFVTSGGRMDPPKNC--PGPVYRIMTQCW----QHQPEDRPNFAIILERIE 300
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 72/302 (23%), Positives = 108/302 (35%), Gaps = 69/302 (22%)
Query: 402 LAEGGFGSVHRGVLPDG------QVVAVKQYK-LASSQGDQEFCSEVEVLSCAQHRNVVM 454
L E FG V++G L Q VA+K K A +EF E + + QH NVV
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR--------------KIAVG 500
L+G +D +++ Y +G L L R S +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 501 AARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT 560
A G+ YL +VH+D+ N+LV + D GL R D ++
Sbjct: 137 IAAGMEYL-SSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD---YYKL-LG 188
Query: 561 FGYL-----APEYAQSGQITEKADVYSLGVVLVELIT-GRK---AMDLNRPRGQQCLTEW 611
L APE G+ + +D++S GVVL E+ + G + Q +
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQDVV--- 240
Query: 612 ARPLLKRHAIGELID-----PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRM 665
E+I P +C VY M++C + P RPR +
Sbjct: 241 -----------EMIRNRQVLPCPDDC--PAWVYALMIECW----NEFPSRRPRFKDIHSR 283
Query: 666 LE 667
L
Sbjct: 284 LR 285
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 402 LAEGGFGSVHRGVLPD---GQVVAVKQYKLASSQGDQEFCS--EVEVLSCAQ--HRNVVM 454
L GG VH D + VAVK + A D F E + A H +V
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 455 L--IGFCVEDGRRL--LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE 510
+ G L +V EY+ +L + P+ ++ A + L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH- 133
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR---VLGTFGYLAPE 567
+ G I+HRD++P NI+++ V DFG+AR D V T+ V+GT YL+PE
Sbjct: 134 --QNG-IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGTAQYLSPE 189
Query: 568 YAQSGQITEKADVYSLGVVLVELITGR 594
A+ + ++DVYSLG VL E++TG
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-30
Identities = 77/304 (25%), Positives = 122/304 (40%), Gaps = 47/304 (15%)
Query: 387 AELELATNRFSEANFLAEGGFGSVHRGVL--PDGQV--VAVKQYKL-ASSQGDQEFCSEV 441
+ E+ R + EG FG VH+G+ P+ VA+K K S ++F E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 442 EVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGA 501
+ H ++V LIG E+ ++ E G L S L R + L+ ++ A
Sbjct: 443 LTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQL 500
Query: 502 ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF 561
+ L YL E R VHRD+ N+LV+ + +GDFGL+R+ D ++
Sbjct: 501 STALAYL-ESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 562 GYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRK---AMDLNRPRGQQCLTEWARPLLK 617
++APE + T +DV+ GV + E++ G K + +
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVI--------- 602
Query: 618 RHAIGELID-----PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671
I+ P NC +Y M +C DP RPR +++ L IL
Sbjct: 603 -----GRIENGERLPMPPNC--PPTLYSLMTKCW----AYDPSRRPRFTELKAQLS-TIL 650
Query: 672 MNSK 675
K
Sbjct: 651 EEEK 654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 24/211 (11%)
Query: 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKL--ASSQGDQEFCSEVEVLSCAQH--RNVVML 455
+ GG V + + Q+ A+K L A +Q + +E+ L+ Q ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
+ + D +V E N L+S L + + ++ R+ + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 128
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARW-QPDGDMGVETRVLGTFGYLAPE------- 567
IVH D++P N L+ + DFG+A QPD V+ +GT Y+ PE
Sbjct: 129 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 568 ----YAQSGQITEKADVYSLGVVLVELITGR 594
+I+ K+DV+SLG +L + G+
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 47/202 (23%), Positives = 82/202 (40%), Gaps = 25/202 (12%)
Query: 402 LAEGGFGSVHRGV--LPDGQVVAVKQYKLASSQGDQE-FCSEVEVLSCAQHRNVVMLIGF 458
+A GG G ++ + +G+ V +K + Q +E + L+ H ++V + F
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 459 CVEDGRRL------LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC 512
VE R +V EY+ SL L + + L YLH
Sbjct: 148 -VEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH--- 199
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSG 572
+G +V+ D++P NI++T + + + D G + + GT G+ APE +
Sbjct: 200 SIG-LVYNDLKPENIMLTEE-QLKLIDLGAVS-----RINSFGYLYGTPGFQAPEIVR-T 251
Query: 573 QITEKADVYSLGVVLVELITGR 594
T D+Y++G L L
Sbjct: 252 GPTVATDIYTVGRTLAALTLDL 273
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 74/306 (24%), Positives = 119/306 (38%), Gaps = 55/306 (17%)
Query: 388 ELELATNRFSEANFLAEGGFGSVHRGVLPDG------QVVAVKQYKLASSQGD-QEFCSE 440
E E+A + + + L +G FG V+ GV VA+K A+S + EF +E
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 441 VEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR----- 495
V+ +VV L+G + L++ E + G L S+L
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 496 ---KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552
++A A G+ YL+ VHRD+ N +V DF +GDFG+ R + D
Sbjct: 139 KMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-- 192
Query: 553 VETRVLGTFGYL-----APEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC 607
R G G L +PE + G T +DV+S GVVL E+ T +Q
Sbjct: 193 -YYRK-GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ- 239
Query: 608 LTEWARPLLKRHAIGELID-----PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQ 661
L + + + NC ++ M C + +P RP +
Sbjct: 240 ----PYQGLSNEQVLRFVMEGGLLDKPDNC--PDMLFELMRMCW----QYNPKMRPSFLE 289
Query: 662 VLRMLE 667
++ ++
Sbjct: 290 IISSIK 295
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGD--QEFCSEVEVLSCAQHRN--VVML 455
+ GG V + + Q+ A+K L + + +E+ L+ Q + ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
+ + D +V E N L+S L + + ++ R+ + +H+
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 147
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARW-QPDGDMGVETRVLGTFGYLAPE------- 567
IVH D++P N L+ + DFG+A QPD V+ +GT Y+ PE
Sbjct: 148 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 568 ----YAQSGQITEKADVYSLGVVLVELITGR 594
+I+ K+DV+SLG +L + G+
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 81/318 (25%), Positives = 122/318 (38%), Gaps = 62/318 (19%)
Query: 388 ELELATNRFSEANFLAEGGFGSVHRGVLPDG----QVVAVKQYKL--ASSQGDQEFCSEV 441
++ + N L EG FGSV G L VAVK KL +S + +EF SE
Sbjct: 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEA 87
Query: 442 EVLSCAQHRNVVMLIGFCVEDG-----RRLLVYEYICNGSLDSHLYGR--DRDPLEWSAR 494
+ H NV+ L+G C+E + +++ ++ G L ++L + P +
Sbjct: 88 ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 495 R--KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552
K V A G+ YL +HRD+ N ++ D V DFGL++ GD
Sbjct: 148 TLLKFMVDIALGMEYLSNR----NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD-- 201
Query: 553 VETRVLGTFGYL-----APEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC 607
R G + A E T K+DV++ GV + E+ T RG
Sbjct: 202 -YYRQ-GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT----------RGMT- 248
Query: 608 LTEWARP--------LLKRHAIGELIDPRLRNCYSEREVYG-MLQCASLCIRKDPHSRPR 658
P + G + + +C E+Y M C R DP RP
Sbjct: 249 ------PYPGVQNHEMYDYLLHGHRL-KQPEDC--LDELYEIMYSCW----RTDPLDRPT 295
Query: 659 MSQVLRMLEGDILMNSKD 676
S + LE +L + D
Sbjct: 296 FSVLRLQLE-KLLESLPD 312
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 68/308 (22%), Positives = 111/308 (36%), Gaps = 55/308 (17%)
Query: 389 LELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVL-SC 446
+EL R LAEGGF V+ + G+ A+K+ + ++ EV +
Sbjct: 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKL 82
Query: 447 AQHRNVVMLIGFCVEDGRR-------LLVYEYICNGSLDSHLYGR-DRDPLEWSARRKIA 498
+ H N+V L+ +C G L L R PL KI
Sbjct: 83 SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF 142
Query: 499 VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR---------WQPDG 549
R ++++H + I+HRD++ N+L+++ + DFG A W
Sbjct: 143 YQTCRAVQHMH--RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 550 DMGVE---TRVLGTFGYLAPE---YAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPR 603
VE TR T Y PE + I EK D+++LG +L L + +
Sbjct: 201 RALVEEEITRN-TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259
Query: 604 GQQCLTEWARPLLKRHAI--GELIDPRLRNCYSERE--VYGMLQCASLCIRKDPHSRPRM 659
I G+ P Y+ + MLQ +P R +
Sbjct: 260 ----------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQ-------VNPEERLSI 296
Query: 660 SQVLRMLE 667
++V+ L+
Sbjct: 297 AEVVHQLQ 304
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 74/296 (25%), Positives = 107/296 (36%), Gaps = 63/296 (21%)
Query: 402 LAEGGFGSVHRGVLPDG------QVVAVKQYK-LASSQGDQEFCSEVEVLSCAQHRNVVM 454
L G FG V+ G + VAVK + S Q + +F E ++S H+N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR-------KIAVGAARGLRY 507
IG ++ R ++ E + G L S L R+ P +A A G +Y
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLV---GDFGLARWQPDGDMGVETRVLGTFGYL 564
L E +HRD+ N L+T V GDFG+AR G L
Sbjct: 197 LEEN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCAML 248
Query: 565 -----APEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP---LL 616
PE G T K D +S GV+L E+ + G P
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----------LGYM-------PYPSKS 291
Query: 617 KRHAIGELID----PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
+ + + +NC VY M QC + P RP + +L +E
Sbjct: 292 NQEVLEFVTSGGRMDPPKNC--PGPVYRIMTQCW----QHQPEDRPNFAIILERIE 341
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 69/282 (24%), Positives = 122/282 (43%), Gaps = 46/282 (16%)
Query: 402 LAEGGFGSVHRGVL-PDGQ----VVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVML 455
L G FG+V++G+ P+G+ VA+K+ + A+S +E E V++ + +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
+G C+ L+ + + G L ++ +D + V A+G+ YL E+ R
Sbjct: 83 LGICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYL-EDRR-- 137
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT---FGYLAPEYAQSG 572
+VHRD+ N+LV + DFGLA+ + E G ++A E
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 194
Query: 573 QITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID----- 626
T ++DV+S GV + EL+T G +P + I +++
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGS------KP----------YDGIPASEISSILEKGERL 238
Query: 627 PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
P+ C +VY M++C D SRP+ +++
Sbjct: 239 PQPPIC--TIDVYMIMVKCWM----IDADSRPKFRELIIEFS 274
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 71/282 (25%), Positives = 117/282 (41%), Gaps = 46/282 (16%)
Query: 402 LAEGGFGSVHRGVL-PDGQ----VVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVML 455
L G FG+VH+GV P+G+ V +K + S + Q + + H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
+G C LV +Y+ GSL H+ R L V A+G+ YL EE
Sbjct: 81 LGLCPGS-SLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYL-EEHG-- 135
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT---FGYLAPEYAQSG 572
+VHR++ N+L+ + V DFG+A P D + ++A E G
Sbjct: 136 -MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD--KQLLYSEAKTPIKWMALESIHFG 192
Query: 573 QITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID----- 626
+ T ++DV+S GV + EL+T G P L+ + +L++
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGA------EP----------YAGLRLAEVPDLLEKGERL 236
Query: 627 PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLE 667
+ + C +VY M++C D + RP ++
Sbjct: 237 AQPQIC--TIDVYMVMVKCWM----IDENIRPTFKELANEFT 272
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 56/278 (20%), Positives = 96/278 (34%), Gaps = 31/278 (11%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN 451
+ + + G FG VHR G AVK+ +L + + E+ +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPR 111
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEE 511
+V L G E + E + GSL + + L A GL YLH
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPL-VGDFG----LARWQPDGDMGVETRVLGTFGYLAP 566
I+H D++ +N+L++ D + DFG L + + GT ++AP
Sbjct: 170 R----ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 567 EYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626
E K D++S +++ ++ G P Q L + A
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGC------HPWTQ--YFRGP--LCLKIASEPPPI 275
Query: 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
+ + Q +RK+P R ++ R
Sbjct: 276 REIPPSCAPL----TAQAIQEGLRKEPVHRASAMELRR 309
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 64/297 (21%), Positives = 104/297 (35%), Gaps = 65/297 (21%)
Query: 395 RFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLS-CAQHRNVV 453
F + L G G++ + D + VAVK+ EV++L +H NV+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVI 81
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
+ + + E C +L ++ +D L + GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIEL-CAATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHSLN- 138
Query: 514 VGCIVHRDMRPNNILVTHDFE-----PLVGDFGLARWQPDGDMGVETR--VLGTFGYLAP 566
IVHRD++P+NIL++ ++ DFGL + G R V GT G++AP
Sbjct: 139 ---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 567 EY---AQSGQITEKADVYSLGVVLVELITG----------------RKAMDLNRPRGQQC 607
E T D++S G V +I+ A L+ ++
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 608 LTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
AR L+++ I DP RP VL+
Sbjct: 256 EDVIARELIEK-----------------------------MIAMDPQKRPSAKHVLK 283
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 83/361 (22%), Positives = 135/361 (37%), Gaps = 81/361 (22%)
Query: 356 SRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVL 415
+ P L + +++ P P+W E ++ + L EG FG V
Sbjct: 52 RLSSTADTPMLAGVSEYELP---EDPKW------EFPRDKLTLGKPLGEGCFGQVVMAEA 102
Query: 416 --------PDGQVVAVKQYK-LASSQGDQEFCSEVEVLSC-AQHRNVVMLIGFCVEDGRR 465
+ VAVK K A+ + + SE+E++ +H+N++ L+G C +DG
Sbjct: 103 VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162
Query: 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARR----------------KIAVGAARGLRYLH 509
++ EY G+L +L R R P ARG+ YL
Sbjct: 163 YVIVEYASKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL- 219
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL----- 564
+ +HRD+ N+LVT + + DFGLAR + D T G L
Sbjct: 220 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNID----YYKKTTNGRLPVKWM 272
Query: 565 APEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP---LLKRHAI 621
APE T ++DV+S GV++ E+ T G P +
Sbjct: 273 APEALFDRVYTHQSDVWSFGVLMWEIFT----------LGGS-------PYPGIPVEELF 315
Query: 622 GELID----PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSKD 676
L + + NC E+Y M C P RP Q++ L+ + + + +
Sbjct: 316 KLLKEGHRMDKPANC--TNELYMMMRDCW----HAVPSQRPTFKQLVEDLDRILTLTTNE 369
Query: 677 D 677
+
Sbjct: 370 E 370
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 64/281 (22%), Positives = 117/281 (41%), Gaps = 38/281 (13%)
Query: 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKL--ASSQGDQEFCSEVEVLSCAQH--RNVVML 455
+ GG V + + Q+ A+K L A +Q + +E+ L+ Q ++ L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
+ + D +V E N L+S L + + ++ R+ + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 175
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARW-QPDGDMGVETRVLGTFGYLAPE------- 567
IVH D++P N L+ D + DFG+A QPD V+ +G Y+ PE
Sbjct: 176 -IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 568 ----YAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623
+I+ K+DV+SLG +L + G+ P + + K HAI +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKT------P-----FQQIINQISKLHAIID 282
Query: 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
E+++ +L+C C+++DP R + ++L
Sbjct: 283 PNHEIEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELLA 320
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 79/370 (21%), Positives = 125/370 (33%), Gaps = 74/370 (20%)
Query: 341 LDLKISKSVREAVSLSRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEAN 400
+D K + + V + I + P +W E N
Sbjct: 2 VDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPY---NEKW------EFPRNNLQFGK 52
Query: 401 FLAEGGFGSVHRGVLPD------GQVVAVKQYK-LASSQGDQEFCSEVEVLSC-AQHRNV 452
L G FG V VAVK K A + + SE++++S QH N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 453 VMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR------------KIAVG 500
V L+G C G L++ EY C G L + L + R A +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 501 AARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT 560
A+G+ +L + CI HRD+ N+L+T+ +GDFGLAR + V
Sbjct: 173 VAQGMAFLASK---NCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---NYIV-KG 224
Query: 561 FGYL-----APEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615
L APE T ++DV+S G++L E+ + G P
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----------LGLN-------PY 267
Query: 616 LKRHAIGELID--------PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRML 666
+ + + +Y M C +P RP Q+ L
Sbjct: 268 PGILVNSKFYKLVKDGYQMAQPAFA--PKNIYSIMQACW----ALEPTHRPTFQQICSFL 321
Query: 667 EGDILMNSKD 676
+ + ++
Sbjct: 322 QEQAQEDRRE 331
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 401 FLAEGGFGSVHRGV-LPDGQVVAVK---QYKLASSQGDQEFCSEVEVLSCAQHRNVVMLI 456
L +G F V+R + G VA+K + + + Q +EV++ +H +++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 457 GFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
ED + LV E NG ++ +L R + E AR + G+ YLH
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLHSHG--- 132
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLA-RWQPDGDMGVETRVLGTFGYLAPEYAQSGQI 574
I+HRD+ +N+L+T + + DFGLA + + + T + GT Y++PE A
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-HYT-LCGTPNYISPEIATRSAH 189
Query: 575 TEKADVYSLGVVLVELITGR 594
++DV+SLG + L+ GR
Sbjct: 190 GLESDVWSLGCMFYTLLIGR 209
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 76/321 (23%), Positives = 119/321 (37%), Gaps = 63/321 (19%)
Query: 388 ELELATNRFSEANFLAEGGFGSVHRGVLPDG----QVVAVKQYKL-ASSQGD-QEFCSEV 441
++ + +F+ L +G FGSV L VAVK K + D +EF E
Sbjct: 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 442 EVLSCAQHRNVVMLIGFCVEDGRR------LLVYEYICNGSLDSHLYGR--DRDPLEWSA 493
+ H +V L+G + + +++ ++ +G L + L +P
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 494 RR--KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551
+ + V A G+ YL +HRD+ N ++ D V DFGL+R GD
Sbjct: 137 QTLVRFMVDIACGMEYL-SSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD- 191
Query: 552 GVETRVLGTFGYL-----APEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQ 606
R G L A E T +DV++ GV + E++T RGQ
Sbjct: 192 --YYRQ-GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT----------RGQT 238
Query: 607 CLTEWARP--------LLKRHAIGELIDPRLRNCYSEREVYG-MLQCASLCIRKDPHSRP 657
P + G + + C EVY M QC S DP RP
Sbjct: 239 -------PYAGIENAEIYNYLIGGNRL-KQPPEC--MEEVYDLMYQCWS----ADPKQRP 284
Query: 658 RMSQVLRMLEGDILMNSKDDT 678
+ + LE +IL + +
Sbjct: 285 SFTCLRMELE-NILGHLSVLS 304
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 75/315 (23%), Positives = 115/315 (36%), Gaps = 74/315 (23%)
Query: 402 LAEGGFGSVHRGVLPD------GQVVAVKQYKLASSQGD-QEFCSEVEVLSC-AQHRNVV 453
L G FG V VAVK K ++ + + SE++VLS H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRK----------------- 496
L+G C G L++ EY C G L + L R + ++
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 497 -IAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET 555
+ A+G+ +L + CI HRD+ NIL+TH + DFGLAR +
Sbjct: 149 SFSYQVAKGMAFLASK---NCI-HRDLAARNILLTHGRITKICDFGLARDIKNDS----N 200
Query: 556 RVLGTFGYL-----APEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTE 610
V+ L APE + T ++DV+S G+ L EL + G
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS----------LGSS---- 246
Query: 611 WARPLLKRHAIGELID--------PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQ 661
P + + E+Y M C DP RP Q
Sbjct: 247 ---PYPGMPVDSKFYKMIKEGFRMLSPEHA--PAEMYDIMKTCW----DADPLKRPTFKQ 297
Query: 662 VLRMLEGDILMNSKD 676
+++++E + S +
Sbjct: 298 IVQLIE-KQISESTN 311
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 80/329 (24%), Positives = 124/329 (37%), Gaps = 73/329 (22%)
Query: 388 ELELATNRFSEANFLAEGGFGSVHRGVLPD--------GQVVAVKQYK-LASSQGDQEFC 438
+ E ++ + L EG FG V VAVK K A+ + +
Sbjct: 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 88
Query: 439 SEVEVLSC-AQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR-- 495
SE+E++ +H+N++ L+G C +DG ++ EY G+L +L R R P
Sbjct: 89 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDI 146
Query: 496 --------------KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541
ARG+ YL + +HRD+ N+LVT + + DFG
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYL-ASQK---CIHRDLAARNVLVTENNVMKIADFG 202
Query: 542 LARWQPDGDMGVETRVLGTFGYL-----APEYAQSGQITEKADVYSLGVVLVELITGRKA 596
LAR + D T G L APE T ++DV+S GV++ E+ T
Sbjct: 203 LARDINNID----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT---- 254
Query: 597 MDLNRPRGQQCLTEWARP---LLKRHAIGELID----PRLRNCYSEREVYG-MLQCASLC 648
G P + L + + NC E+Y M C
Sbjct: 255 ------LGGS-------PYPGIPVEELFKLLKEGHRMDKPANC--TNELYMMMRDCW--- 296
Query: 649 IRKDPHSRPRMSQVLRMLEGDILMNSKDD 677
P RP Q++ L+ IL + ++
Sbjct: 297 -HAVPSQRPTFKQLVEDLD-RILTLTTNE 323
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 71/333 (21%), Positives = 117/333 (35%), Gaps = 80/333 (24%)
Query: 388 ELELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYK-LASSQGDQEFCSE 440
+ E +R L G FG V + VAVK K A+ + SE
Sbjct: 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 80
Query: 441 VEVLS-CAQHRNVVMLIGFCVEDGR-RLLVYEYICNGSLDSHLYGRDRDPLEWSARR--- 495
+++L H NVV L+G C + G +++ E+ G+L ++L R + +
Sbjct: 81 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPE 138
Query: 496 -------------KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542
+ A+G+ +L + +HRD+ NIL++ + DFGL
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFL-ASRK---CIHRDLAARNILLSEKNVVKICDFGL 194
Query: 543 ARWQPDGDMGVETRVLGTFGYL-----APEYAQSGQITEKADVYSLGVVLVELIT-GRK- 595
AR V L APE T ++DV+S GV+L E+ + G
Sbjct: 195 ARDIYKDP----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 596 --AMDLNRPRGQQCLTEWARPLLKRHAIGELID--------PRLRNCYSEREVYG-MLQC 644
+ ++ E E+Y ML C
Sbjct: 251 YPGVKIDE---------------------EFCRRLKEGTRMRAPDYT--TPEMYQTMLDC 287
Query: 645 ASLCIRKDPHSRPRMSQVLRMLEGDILMNSKDD 677
+P RP S+++ L + N++ D
Sbjct: 288 W----HGEPSQRPTFSELVEHLGNLLQANAQQD 316
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 49/376 (13%), Positives = 90/376 (23%), Gaps = 77/376 (20%)
Query: 328 LNREPDIGVLNYKLDLKISKSVREAVSLSRNKPPGPPPLCSICQHKAPVFGNPPRWFTYA 387
L RE ++ + LK ++ EAV+ + + S+ R
Sbjct: 15 LKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSL-------LSQGERKLKLV 67
Query: 388 ELELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVK---QYKLASSQGDQEFCSEVEV 443
E L G V + + A+K S +
Sbjct: 68 EP------------LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 444 LSCAQHRNVVMLIG-------------------FCVEDGRR-------LLVYEYICNGSL 477
+ + + G+ LL+ + L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDL 174
Query: 478 DS-----HLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD 532
+ R A + R L + +VH P+N+ + D
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK----GLVHGHFTPDNLFIMPD 230
Query: 533 FEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSG--QITEKADVYSLGVVLVEL 590
++GD G G Y E+ + T + + LG+ + +
Sbjct: 231 GRLMLGDVSALW--KVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286
Query: 591 ITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSERE--VYGMLQCASLC 648
L P + W RP L+ L + + L
Sbjct: 287 WCLFLPFGLVTPGIKG---SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN----- 338
Query: 649 IRKDPHSRPRMSQVLR 664
D R + +
Sbjct: 339 --FDRRRRLLPLEAME 352
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 85/351 (24%), Positives = 128/351 (36%), Gaps = 70/351 (19%)
Query: 366 LCSICQHKAPVFGNPPRWFTYA--ELELATNRFSEANFLAEGGFGSVHRGVLPD------ 417
+ + + + EL +R L EG FG V
Sbjct: 39 PTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKP 98
Query: 418 --GQVVAVKQYK-LASSQGDQEFCSEVEVLSC-AQHRNVVMLIGFCVEDGRRLLVYEYIC 473
VAVK K A+ + + SE+E++ +H+N++ L+G C +DG ++ EY
Sbjct: 99 NRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 158
Query: 474 NGSLDSHLYGRDRDPLEWSARR--------------KIAVGAARGLRYLHEECRVGCIVH 519
G+L +L R LE+S A ARG+ YL + +H
Sbjct: 159 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL-ASKK---CIH 214
Query: 520 RDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL-----APEYAQSGQI 574
RD+ N+LVT D + DFGLAR D T G L APE
Sbjct: 215 RDLAARNVLVTEDNVMKIADFGLARDIHHID----YYKKTTNGRLPVKWMAPEALFDRIY 270
Query: 575 TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP---LLKRHAIGELID----P 627
T ++DV+S GV+L E+ T G P + L +
Sbjct: 271 THQSDVWSFGVLLWEIFT----------LGGS-------PYPGVPVEELFKLLKEGHRMD 313
Query: 628 RLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSKDD 677
+ NC E+Y M C P RP Q++ L+ + + S +
Sbjct: 314 KPSNC--TNELYMMMRDCW----HAVPSQRPTFKQLVEDLDRIVALTSNQE 358
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 19/200 (9%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVK---QYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIG 457
L +G FG+V+ ++A+K + +L + + + EVE+ S +H N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 458 FCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
+ D R+ L+ EY G++ L + E I A L Y H +
Sbjct: 77 Y-FHDATRVYLILEYAPLGTVYRELQKLSKFD-EQRTATYIT-ELANALSYCHSKR---- 129
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR--VLGTFGYLAPEYAQSGQI 574
++HRD++P N+L+ E + DFG + P R + GT YL PE +
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTDLCGTLDYLPPEMIEGRMH 184
Query: 575 TEKADVYSLGVVLVELITGR 594
EK D++SLGV+ E + G+
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK 204
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 87/356 (24%), Positives = 129/356 (36%), Gaps = 87/356 (24%)
Query: 364 PPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDG----- 418
P S+ K P+W E L EG FG V +
Sbjct: 2 PLSLSVDAFKILE---DPKW------EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG 52
Query: 419 -QVVAVKQYK-LASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGS 476
VAVK K AS ++ SE VL H +V+ L G C +DG LL+ EY GS
Sbjct: 53 YTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGS 112
Query: 477 LDSHLYGRDRDPLEWSARR------------------------KIAVGAARGLRYLHEEC 512
L L R+ + A ++G++YL
Sbjct: 113 LRGFL--RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AE 168
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL-----APE 567
+VHRD+ NILV + + DFGL+R + D + V + G + A E
Sbjct: 169 M--KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED----SYVKRSQGRIPVKWMAIE 222
Query: 568 YAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP---LLKRHAIGEL 624
T ++DV+S GV+L E++T G P + L
Sbjct: 223 SLFDHIYTTQSDVWSFGVLLWEIVT----------LGGN-------PYPGIPPERLFNLL 265
Query: 625 ID----PRLRNCYSEREVYG-MLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSK 675
R NC E+Y MLQC +++P RP + + + LE +++ +
Sbjct: 266 KTGHRMERPDNC--SEEMYRLMLQCW----KQEPDKRPVFADISKDLE-KMMVKRR 314
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 54/214 (25%), Positives = 81/214 (37%), Gaps = 31/214 (14%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE-FCSEVEVLSCAQHRNVVMLIGFC 459
L +G +V RG G + A+K + S + E EVL H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 460 VEDGRRL--LVYEYICNGSLDSHLYGRDRDPL--EWSAR---RKIAVGAARGLRYLHEEC 512
E R L+ E+ GSL + L E R + G+ +L E
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV----GGMNHLRENG 132
Query: 513 RVGCIVHRDMRPNNILVTHDFEPL----VGDFGLARWQPDGDMGVETRVLGTFGYLAPE- 567
IVHR+++P NI+ + + DFG AR D + + GT YL P+
Sbjct: 133 ----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLY-GTEEYLHPDM 186
Query: 568 -------YAQSGQITEKADVYSLGVVLVELITGR 594
+ D++S+GV TG
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE-FCSEVEVLSCAQHRNVVMLI--- 456
L GGFG V R + G+ VA+KQ + S ++E +C E++++ H NVV
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 457 ---GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPL--EWSARRKIAVGAARGLRYLHEE 511
+ LL EY G L +L + E R ++ + LRYLHE
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD-ISSALRYLHEN 140
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPL---VGDFGLARWQPDGDMGVETRVLGTFGYLAPEY 568
I+HRD++P NI++ + L + D G A+ G++ V GT YLAPE
Sbjct: 141 R----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEFV-GTLQYLAPEL 194
Query: 569 AQSGQITEKADVYSLGVVLVELITGR 594
+ + T D +S G + E ITG
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 60/245 (24%), Positives = 96/245 (39%), Gaps = 18/245 (7%)
Query: 356 SRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGV- 414
K P AP P + R+ FL +GGF
Sbjct: 6 DPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPR---SRRRYVRGRFLGKGGFAKCFEISD 62
Query: 415 LPDGQVVAVK---QYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL-LVYE 470
+V A K + L ++ E+ + H++VV G ED + +V E
Sbjct: 63 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLE 121
Query: 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT 530
SL R E AR + G +YLH ++HRD++ N+ +
Sbjct: 122 LCRRRSLLELHKRRKALT-EPEARYYL-RQIVLGCQYLHRNR----VIHRDLKLGNLFLN 175
Query: 531 HDFEPLVGDFGLA-RWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVE 589
D E +GDFGLA + + DG+ + + GT Y+APE + + DV+S+G ++
Sbjct: 176 EDLEVKIGDFGLATKVEYDGER-KKV-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 233
Query: 590 LITGR 594
L+ G+
Sbjct: 234 LLVGK 238
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 72/274 (26%), Positives = 119/274 (43%), Gaps = 44/274 (16%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVMLIGFC 459
+ +G FG V +G+ +VVA+K L ++ + ++ E+ VLS V G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV---GAARGLRYLHEECRVGC 516
++D + ++ EY+ GS L + PL+ +IA +GL YLH E
Sbjct: 90 LKDTKLWIIMEYLGGGSA-LDLL--EPGPLD---ETQIATILREILKGLDYLHSE---KK 140
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITE 576
I HRD++ N+L++ E + DFG+A Q +GT ++APE +
Sbjct: 141 I-HRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198
Query: 577 KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID------PRLR 630
KAD++SLG+ +EL G P P + H + L P L
Sbjct: 199 KADIWSLGITAIELARG-------EP-----------PHSELHPMKVLFLIPKNNPPTLE 240
Query: 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
YS+ + + C+ K+P RP ++L+
Sbjct: 241 GNYSK----PLKEFVEACLNKEPSFRPTAKELLK 270
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 74/304 (24%), Positives = 127/304 (41%), Gaps = 37/304 (12%)
Query: 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEF-CSEVEVLSCA 447
EL + F + + L G G V + P G V+A K L + E++VL
Sbjct: 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 448 QHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRY 507
+V G DG + E++ GSLD L + + K+++ +GL Y
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTY 146
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE 567
L E+ + I+HRD++P+NILV E + DFG++ Q M + V GT Y++PE
Sbjct: 147 LREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSM-ANSFV-GTRSYMSPE 200
Query: 568 YAQSGQITEKADVYSLGVVLVELITGR------KAMDLNRPRGQQCLTEWARPLLKRHAI 621
Q + ++D++S+G+ LVE+ GR A +L G Q + A +
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260
Query: 622 GELIDPRLRNCYSEREVYGMLQCA---------------------SLCIRKDPHSRPRMS 660
G ++ + ++ +L + C+ K+P R +
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320
Query: 661 QVLR 664
Q++
Sbjct: 321 QLMV 324
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 59/273 (21%), Positives = 115/273 (42%), Gaps = 31/273 (11%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE-FCSEVEV-LSCAQHRNVVMLIGF 458
L G +G V + +P GQ++AVK+ + + +Q+ ++++ + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 459 CVEDGRRLLVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
+G + E + SLD + KIAV + L +LH +
Sbjct: 75 LFREGDVWICMEL-MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--- 130
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE----YAQSG 572
++HRD++P+N+L+ + + DFG++ D+ + G Y+APE
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDIDA-GCKPYMAPERINPELNQK 188
Query: 573 QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL-RN 631
+ K+D++SLG+ ++EL R W P + + E P+L +
Sbjct: 189 GYSVKSDIWSLGITMIELAILR-------F----PYDSWGTPFQQLKQVVEEPSPQLPAD 237
Query: 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
+S + S C++K+ RP ++++
Sbjct: 238 KFSAE----FVDFTSQCLKKNSKERPTYPELMQ 266
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 76/333 (22%), Positives = 115/333 (34%), Gaps = 74/333 (22%)
Query: 386 YAELELATNRFSEANFLAEGGFGSVHRGVLPDG------QVVAVKQYK-LASSQGDQEFC 438
LE N + EG FG V + P +VAVK K AS+ +F
Sbjct: 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 98
Query: 439 SEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR--- 495
E +++ + N+V L+G C L++EY+ G L+ L + +
Sbjct: 99 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 496 -------------------KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL 536
IA A G+ YL E VHRD+ N LV +
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLVGENMVVK 214
Query: 537 VGDFGLARWQPDGDMGVETRVLGTFGYL-----APEYAQSGQITEKADVYSLGVVLVELI 591
+ DFGL+R D + PE + T ++DV++ GVVL E+
Sbjct: 215 IADFGLSRNIYSAD----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
Query: 592 TGRKAMDLNRPRGQQCLTEWARP---LLKRHAIGELID----PRLRNCYSEREVYG-MLQ 643
+ G Q P + I + D NC E+Y M
Sbjct: 271 S----------YGLQ-------PYYGMAHEEVIYYVRDGNILACPENC--PLELYNLMRL 311
Query: 644 CASLCIRKDPHSRPRMSQVLRMLEGDILMNSKD 676
C K P RP + R+L+ + ++
Sbjct: 312 CW----SKLPADRPSFCSIHRILQ-RMCERAEG 339
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 65/344 (18%), Positives = 109/344 (31%), Gaps = 95/344 (27%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE-FCSEVEVLSCAQHRN 451
F + GGFG V D A+K+ +L + + +E EV+ L+ +H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 452 VVMLIGFCVEDGRRLLVYE----------------------------------------- 470
+V +E E
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 471 YICNGSLDSHLY-----------------GRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
+ S +LY + E I + A + +LH +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-----------WQPDGDMGVETRVLGTFG 562
++HRD++P+NI T D VGDFGL P T +GT
Sbjct: 184 --GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 563 YLAPEYAQSGQITEKADVYSLGVVLVELITGRK-AMDLNRPRGQQCLTEWARPLLKRHAI 621
Y++PE + K D++SLG++L EL+ M+ R ++
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-------------IITDVRN 288
Query: 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665
+ P L +E + M+Q + P RP + ++
Sbjct: 289 LKF--PLLFTQKYPQE-HMMVQ---DMLSPSPTERPEATDIIEN 326
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 72/325 (22%), Positives = 106/325 (32%), Gaps = 86/325 (26%)
Query: 402 LAEGGFGSVHRGVLPDG------QVVAVKQYK-LASSQGDQEFCSEVEVLSC-AQHRNVV 453
L G FG V VAVK K A S + SE+++++ H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR------------------ 495
L+G C G L++EY C G L ++L R +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYL--RSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 496 -----KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550
A A+G+ +L E VHRD+ N+LVTH + DFGLAR
Sbjct: 171 FEDLLCFAYQVAKGMEFL-EFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 551 MGVETRVLGTFGYL-----APEYAQSGQITEKADVYSLGVVLVELIT-GRK---AMDLNR 601
V+ L APE G T K+DV+S G++L E+ + G + ++
Sbjct: 227 ----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 602 PRGQQCLTEWARPLLKRHAIGELID--------PRLRNCYSEREVYG-MLQCASLCIRKD 652
+ E+Y M C D
Sbjct: 283 ---------------------NFYKLIQNGFKMDQPFYA--TEEIYIIMQSCW----AFD 315
Query: 653 PHSRPRMSQVLRMLEGDILMNSKDD 677
RP + L + +
Sbjct: 316 SRKRPSFPNLTSFLGCQLADAEEAM 340
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 53/212 (25%), Positives = 81/212 (38%), Gaps = 27/212 (12%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE-FCSEVEVLSCAQHRNVVMLIGFC 459
L +G +V RG G + A+K + S + E EVL H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 460 VEDGRRL--LVYEYICNGSLDSHLYGRDRDPL--EWSARRKIA-VGAARGLRYLHEECRV 514
E R L+ E+ GSL + L E + V + +L E
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHLRENG-- 132
Query: 515 GCIVHRDMRPNNILVTHDFEPL----VGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQ 570
IVHR+++P NI+ + + DFG AR D + + GT YL P+ +
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLY-GTEEYLHPDMYE 188
Query: 571 SGQI--------TEKADVYSLGVVLVELITGR 594
+ D++S+GV TG
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 8e-27
Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 401 FLAEGGFGSVHRGV-LPDGQVVAVK---QYKLASSQGDQEFCSEVEVLSCAQHRNVVMLI 456
FL +GGF +V A K + L ++ E+ + H++VV
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 457 GFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
G ED + +V E SL R E AR + G +YLH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALT-EPEARYYL-RQIVLGCQYLHRNR--- 135
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLA-RWQPDGDMGVETRVLGTFGYLAPEYAQSGQI 574
++HRD++ N+ + D E +GDFGLA + + DG+ + + GT Y+APE
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKV-LCGTPNYIAPEVLSKKGH 192
Query: 575 TEKADVYSLGVVLVELITGR 594
+ + DV+S+G ++ L+ G+
Sbjct: 193 SFEVDVWSIGCIMYTLLVGK 212
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 68/280 (24%), Positives = 123/280 (43%), Gaps = 41/280 (14%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE-FCSEVEV-LSCAQHRNVVMLIGF 458
+ G +GSV++ V P GQ++AVK+ + + +Q+ +++V + + +V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 459 CVEDGRRLLVYEYICNGSLDS---HLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
+G + E + S D ++Y D + KI + + L +L E +
Sbjct: 90 LFREGDCWICMEL-MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-- 146
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQI- 574
I+HRD++P+NIL+ + DFG++ Q + +TR G Y+APE
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISG-QLVDSIA-KTRDAGCRPYMAPERIDPSASR 203
Query: 575 ---TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID----- 626
++DV+SLG+ L EL TG R P K +++ + +
Sbjct: 204 QGYDVRSDVWSLGITLYELATG-------RF-----------PYPKWNSVFDQLTQVVKG 245
Query: 627 --PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
P+L N + +LC+ KD RP+ ++L+
Sbjct: 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-27
Identities = 34/311 (10%), Positives = 74/311 (23%), Gaps = 81/311 (26%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD-------------------------Q 435
L + + G+ V +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 436 EFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYI----CNGSLDSHL-----YGRDR 486
+ + +I +++ ++ + +L + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 487 DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546
L AR ++ + R L LH +VH +RP +I++ + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 547 PDGDMGVETRVLGTFGYLAPEYAQSGQ-----ITEKADVYSLGVVLVELITGR------K 595
+ R A GQ +T D ++LG+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 596 AMDLNRPRGQQC--LTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDP 653
A+ + + C + + R LL+ +R
Sbjct: 322 ALGGSEWIFRSCKNIPQPVRALLEG-----------------------------FLRYPK 352
Query: 654 HSRPRMSQVLR 664
R Q +
Sbjct: 353 EDRLLPLQAME 363
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVK---QYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIG 457
L +G FG+V+ + ++A+K + +L + + E+E+ S +H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 458 FCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
+ D +R+ L+ E+ G L L R E + + A L Y HE
Sbjct: 82 Y-FHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSATFME-ELADALHYCHERK---- 134
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPEYAQSGQIT 575
++HRD++P N+L+ + E + DFG + P R + GT YL PE +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHD 190
Query: 576 EKADVYSLGVVLVELITGR 594
EK D++ GV+ E + G
Sbjct: 191 EKVDLWCAGVLCYEFLVGM 209
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 63/294 (21%), Positives = 113/294 (38%), Gaps = 46/294 (15%)
Query: 388 ELELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE-FCSEVEVL- 444
+ N + G G V + G V+AVKQ + + ++ + + +++V+
Sbjct: 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVL 78
Query: 445 SCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARG 504
+V G + + + E + L R + P+ K+ V +
Sbjct: 79 KSHDCPYIVQCFGTFITNTDVFIAMEL-MGTCAEK-LKKRMQGPIPERILGKMTVAIVKA 136
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL 564
L YL E+ ++HRD++P+NIL+ + + DFG++ + D + G Y+
Sbjct: 137 LYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISG-RLVDDKAKDRSA-GCAAYM 191
Query: 565 APEYAQSGQITE-----KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH 619
APE T+ +ADV+SLG+ LVEL TG+ P
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQF------------------PYKNCK 233
Query: 620 AIGELID-------PRLRN--CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
E++ P L +S C+ KD RP+ +++L
Sbjct: 234 TDFEVLTKVLQEEPPLLPGHMGFSGD----FQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 39/258 (15%), Positives = 81/258 (31%), Gaps = 36/258 (13%)
Query: 363 PPPLCS---ICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGV----- 414
P+ S + + + P E +L + + L EG F V+
Sbjct: 35 SKPVSSYPNTFEWQCKL----PAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLN 90
Query: 415 -LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYIC 473
+ Q +K K A+ +E L + + + +LV E
Sbjct: 91 DAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150
Query: 474 NGSLDSHL---YGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT 530
G+L + + + A+ + +H+ I+H D++P+N ++
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD----CEIIHGDIKPDNFILG 206
Query: 531 HDFEPLVG-----------DFGLA---RWQPDGDMGVETRVLGTFGYLAPEYAQSGQITE 576
+ F D G + + P G + T T G+ E +
Sbjct: 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI--FTAKCETSGFQCVEMLSNKPWNY 264
Query: 577 KADVYSLGVVLVELITGR 594
+ D + + + ++ G
Sbjct: 265 QIDYFGVAATVYCMLFGT 282
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 51/303 (16%), Positives = 99/303 (32%), Gaps = 50/303 (16%)
Query: 405 GGFGSVHRGV-LPDGQVVAVKQYKLASSQGD--QEFCSEVEVLSCAQHRNVVMLIGFCVE 461
+V+ P G+ V V++ L + + E+ V H N+V +
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV---GAARGLRYLHEECRVGCIV 518
D +V ++ GS + D + IA G + L Y+H G +
Sbjct: 98 DNELWVVTSFMAYGSAKDLICTHFMDGMN---ELAIAYILQGVLKALDYIHHM---GYV- 150
Query: 519 HRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL------GTFGYLAPEYAQSG 572
HR ++ ++IL++ D + + +L+PE Q
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN 210
Query: 573 QI--TEKADVYSLGVVLVELITGR---------KAM------------DLNRPRGQQCLT 609
K+D+YS+G+ EL G + + D + ++
Sbjct: 211 LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTM 270
Query: 610 EWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCAS--------LCIRKDPHSRPRMSQ 661
+R + L R + + + S C++++P +RP S
Sbjct: 271 SPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330
Query: 662 VLR 664
+L
Sbjct: 331 LLN 333
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 36/318 (11%), Positives = 74/318 (23%), Gaps = 92/318 (28%)
Query: 401 FLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE----------------------- 436
L + + G+ V
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 437 -----FCSEVEVLSCAQHRNVVMLIG-FCVEDGRRLLVYEYICNGSLDSHL-----YGRD 485
F +++ Q + ++ + +L + +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 486 RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545
L AR ++ + R L LH +VH +RP +I++ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 546 QPDGDMGVETRVLGTFGYLAPEYAQS-----------GQITEKADVYSLGVVLVELITGR 594
G + G+ PE +T D ++LG+V+ +
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 595 ------KAMDLNRPRGQQC--LTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCAS 646
A+ + + C + + R LL+ L+
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLEG----------------------FLR--- 345
Query: 647 LCIRKDPHSRPRMSQVLR 664
R Q +
Sbjct: 346 ----YPKEDRLLPLQAME 359
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 66/301 (21%), Positives = 106/301 (35%), Gaps = 66/301 (21%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLS-CAQHRNVVMLIGFCV 460
L G G+V G+ VAVK+ + E+++L+ H NV+
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSET 79
Query: 461 EDGRRLLVYEYICNGSLD-----SHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
D + E CN +L ++ + + + A G+ +LH
Sbjct: 80 TDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--- 135
Query: 516 CIVHRDMRPNNILVTH-------------DFEPLVGDFGLARWQPDGDMGVETR---VLG 559
I+HRD++P NILV+ + L+ DFGL + G T G
Sbjct: 136 -IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 560 TFGYLAPE-------YAQSGQITEKADVYSLGVVLVELITG-------RKAMDLNRPRGQ 605
T G+ APE ++T D++S+G V +++ + + + N RG
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI 254
Query: 606 QCLTEWARPLLKRHAIG--ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663
L E + +LI S I DP RP +VL
Sbjct: 255 FSLDEMKCLHDRSLIAEATDLI--------------------SQMIDHDPLKRPTAMKVL 294
Query: 664 R 664
R
Sbjct: 295 R 295
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 69/295 (23%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLS-CAQHR 450
F + G +G V++G + GQ+ A+K + + ++E E+ +L + HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 451 NVVMLIG------FCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV---GA 501
N+ G D + LV E+ GS+ + + L+ IA
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK---EEWIAYICREI 138
Query: 502 ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF 561
RGL +LH+ ++HRD++ N+L+T + E + DFG++ Q D +G +GT
Sbjct: 139 LRGLSHLHQHK----VIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTP 193
Query: 562 GYLAPEYAQSGQITE-----KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLL 616
++APE + + K+D++SLG+ +E+ G P PL
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG-------AP-----------PLC 235
Query: 617 KRHAIGELID------PRLRNC-YSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
H + L PRL++ +S++ C+ K+ RP Q+++
Sbjct: 236 DMHPMRALFLIPRNPAPRLKSKKWSKK----FQSFIESCLVKNHSQRPATEQLMK 286
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 46/284 (16%), Positives = 81/284 (28%), Gaps = 57/284 (20%)
Query: 391 LATNRFSEANFLAEGGFGSVHRGVLPD---GQVVAVKQYKLASSQGD---QEFCSEVEVL 444
+A R+ F + + D + VA+ D QE S L
Sbjct: 28 IANGRYRLLIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85
Query: 445 SCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARG 504
S V ++ L+V E+I GSL + A
Sbjct: 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAA 141
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL 564
H R G + P+ + V+ D G VL +
Sbjct: 142 ADAAH---RAG-VALSIDHPSRVRVSID--------GDV-------------VLAYPATM 176
Query: 565 APEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624
+ D+ +G L L+ R + R +R G+
Sbjct: 177 PDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRS-------GLAPAERDTAGQP 222
Query: 625 IDPRLRNCYSEREVYGML-QCASLCIRKDPHSRPRMSQVLRMLE 667
I+P + R++ + A+ ++ D R S +L +++
Sbjct: 223 IEPADID----RDIPFQISAVAARSVQGDGGIRSA-STLLNLMQ 261
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 73/286 (25%), Positives = 111/286 (38%), Gaps = 48/286 (16%)
Query: 404 EGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVMLIGFCVE 461
G V P + VA+K+ L Q E E++ +S H N+V V
Sbjct: 25 SGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSAR----RKIAV---GAARGLRYLHEECRV 514
LV + + GS+ + E + IA GL YLH+
Sbjct: 85 KDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN--- 140
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF-G---YLAPE-YA 569
G I HRD++ NIL+ D + DFG++ + G +V TF G ++APE
Sbjct: 141 GQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 570 QSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID--- 626
Q KAD++S G+ +EL TG P K + L+
Sbjct: 200 QVRGYDFKADIWSFGITAIELATG-------AA-----------PYHKYPPMKVLMLTLQ 241
Query: 627 ---PRLRNCYSEREVYGML-----QCASLCIRKDPHSRPRMSQVLR 664
P L ++E+ + SLC++KDP RP +++LR
Sbjct: 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 40/219 (18%), Positives = 86/219 (39%), Gaps = 34/219 (15%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVK--------QYKLASSQGDQEFCS---------EVEVL 444
L +G F + D + A+K + + + + + E++++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 445 SCAQHRNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSAR------RKI 497
+ ++ + G + + + ++YEY+ N S+ ++ + I
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 498 AVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV 557
Y+H E I HRD++P+NIL+ + + DFG + + D + +
Sbjct: 157 IKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--KGSR 211
Query: 558 LGTFGYLAPE--YAQSGQITEKADVYSLGVVLVELITGR 594
GT+ ++ PE +S K D++SLG+ L +
Sbjct: 212 -GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 56/274 (20%), Positives = 113/274 (41%), Gaps = 25/274 (9%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN 451
+++ + +G G+V+ + + GQ VA++Q L + +E+ V+ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEE 511
+V + + +V EY+ GSL + ++ + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS 571
++HRD++ +NIL+ D + DFG Q + + ++GT ++APE
Sbjct: 136 ----QVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 572 GQITEKADVYSLGVVLVELITGRKAM-DLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630
K D++SLG++ +E+I G + N R + P L+ E + R
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP---EKLSAIFR 247
Query: 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
+ + C+ D R ++L+
Sbjct: 248 D------------FLNRCLEMDVEKRGSAKELLQ 269
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 62/204 (30%), Positives = 88/204 (43%), Gaps = 24/204 (11%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQ---YKLASSQGDQEFCSEVEVLSCAQHRNVVMLIG 457
L +G FG V GQ AVK ++ + EV++L H N++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 458 FCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSAR---RKIAVGAARGLRYLHEECR 513
F ED LV E G L + R R E A R++ G+ Y+H+
Sbjct: 94 FF-EDKGYFYLVGEVYTGGELFDEIISRKRFS-EVDAARIIRQV----LSGITYMHKN-- 145
Query: 514 VGCIVHRDMRPNNILVTH---DFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQ 570
IVHRD++P N+L+ D + DFGL+ +GT Y+APE
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPE-VL 200
Query: 571 SGQITEKADVYSLGVVLVELITGR 594
G EK DV+S GV+L L++G
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGC 224
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 70/284 (24%), Positives = 112/284 (39%), Gaps = 45/284 (15%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN 451
F L EG +GSV++ + GQ+VA+KQ + QE E+ ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPH 85
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV---GAARGLRYL 508
VV G ++ +V EY GS+ + L +IA +GL YL
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLT---EDEIATILQSTLKGLEYL 141
Query: 509 HEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEY 568
H +HRD++ NIL+ + + DFG+A Q M V+GT ++APE
Sbjct: 142 HFMR----KIHRDIKAGNILLNTEGHAKLADFGVAG-QLTDTMAKRNTVIGTPFWMAPEV 196
Query: 569 AQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID-- 626
Q AD++SLG+ +E+ G +P P H + +
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEG-------KP-----------PYADIHPMRAIFMIP 238
Query: 627 ----PRLRNC--YSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
P R +S+ C+ K P R +Q+L+
Sbjct: 239 TNPPPTFRKPELWSDN----FTDFVKQCLVKSPEQRATATQLLQ 278
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 60/286 (20%), Positives = 118/286 (41%), Gaps = 42/286 (14%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN 451
+ L +G FG V++ G + A K + S + +++ E+E+L+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEE 511
+V L+G DG+ ++ E+ G++D+ + L + + L +LH +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE---- 567
I HRD++ N+L+T + + + DFG++ + + +GT ++APE
Sbjct: 137 ---RII-HRDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 568 -YAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626
+ KAD++SLG+ L+E+ P P + + + L+
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQI-------EP-----------PHHELNPMRVLLK 233
Query: 627 ------PRLRNC--YSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
P L +S + + K+P +RP +Q+L
Sbjct: 234 IAKSDPPTLLTPSKWSVE----FRDFLKIALDKNPETRPSAAQLLE 275
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 67/285 (23%), Positives = 114/285 (40%), Gaps = 26/285 (9%)
Query: 323 EKLSTLNREPDIGVLNYKLDLKISKSVREAVSLSRNKPPGPPPLCSICQHKAPVFGNPPR 382
L T N + D + + + V + + P A PP
Sbjct: 12 VDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPA 71
Query: 383 WFTYAELELATNRFSE------ANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQ 435
F + + + L G FG VH+ G +A K K + +
Sbjct: 72 PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE 131
Query: 436 EFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSAR 494
E +E+ V++ H N++ L E + LV EY+ G L + + E
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAF-ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI 190
Query: 495 ---RKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL-VTHDFEPL-VGDFGLAR-WQPD 548
++I G+R++H+ I+H D++P NIL V D + + + DFGLAR ++P
Sbjct: 191 LFMKQI----CEGIRHMHQM----YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242
Query: 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITG 593
+ V GT +LAPE ++ D++S+GV+ L++G
Sbjct: 243 EKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-23
Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLA--SSQGDQEFCSEVEVLSCAQHRNVVMLIGF 458
L G +G V A+K + S+ + + EV VL H N++ L F
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 459 CVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSAR---RKIAVGAARGLRYLHEECRV 514
ED R LV E G L + R + E A +++ G+ YLH+
Sbjct: 105 F-EDKRNYYLVMECYKGGELFDEIIHRMKFN-EVDAAVIIKQVL----SGVTYLHKHN-- 156
Query: 515 GCIVHRDMRPNNILVT---HDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS 571
IVHRD++P N+L+ D + DFGL+ + LGT Y+APE
Sbjct: 157 --IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPE-VLR 211
Query: 572 GQITEKADVYSLGVVLVELITGR 594
+ EK DV+S+GV+L L+ G
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGY 234
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 49/193 (25%), Positives = 89/193 (46%), Gaps = 9/193 (4%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
+ EG G V G+ VAVK L Q + +EV ++ QH NVV + +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
++ E++ G+L + + L + + L YLH + ++HR
Sbjct: 113 VGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQ----GVIHR 165
Query: 521 DMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADV 580
D++ ++IL+T D + DFG Q D+ ++GT ++APE + D+
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCA-QISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDI 224
Query: 581 YSLGVVLVELITG 593
+SLG++++E++ G
Sbjct: 225 WSLGIMVIEMVDG 237
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 80/289 (27%), Positives = 123/289 (42%), Gaps = 53/289 (18%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD---QEFCSEVEVLSCAQ 448
FS+ + G FG+V+ + + +VVA+K+ + Q + Q+ EV L +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 449 HRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV---GAARGL 505
H N + G + + LV EY C GS S L + PL+ +IA GA +GL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEY-CLGSA-SDLLEVHKKPLQ---EVEIAAVTHGALQGL 167
Query: 506 RYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLA 565
YLH ++HRD++ NIL++ +GDFG A M +GT ++A
Sbjct: 168 AYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMA 218
Query: 566 PE---YAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622
PE GQ K DV+SLG+ +EL +P PL +A+
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAER-------KP-----------PLFNMNAMS 260
Query: 623 ELID------PRLRNC-YSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
L P L++ +SE C++K P RP +L+
Sbjct: 261 ALYHIAQNESPALQSGHWSEY----FRNFVDSCLQKIPQDRPTSEVLLK 305
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 54/200 (27%), Positives = 87/200 (43%), Gaps = 33/200 (16%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
L G F V G++ A+K K + + D +E+ VL +H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY- 75
Query: 461 EDGRRL-LVYEYICNGSL-D-----SHLYGRDRDPLEWSAR---RKIAVGAARGLRYLHE 510
E LV + + G L D +D A +++ ++YLHE
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKD-------ASLVIQQVL----SAVKYLHE 124
Query: 511 ECRVGCIVHRDMRPNNILVTHDFE--PL-VGDFGLARWQPDGDMGVETRVLGTFGYLAPE 567
IVHRD++P N+L E + + DFGL++ + +G M + GT GY+APE
Sbjct: 125 NG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPE 177
Query: 568 YAQSGQITEKADVYSLGVVL 587
++ D +S+GV+
Sbjct: 178 VLAQKPYSKAVDCWSIGVIT 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 50/206 (24%), Positives = 81/206 (39%), Gaps = 32/206 (15%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
L G FG VHR V G+V K +E+ +++ H ++ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF- 117
Query: 461 EDGRRL-LVYEYICNGSL------DSHLYGRDRDPLEWSAR---RKIAVGAARGLRYLHE 510
ED + L+ E++ G L + + E R+ GL+++HE
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMS------EAEVINYMRQA----CEGLKHMHE 167
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLV--GDFGLAR-WQPDGDMGVETRVLGTFGYLAPE 567
IVH D++P NI+ V DFGLA PD + T + APE
Sbjct: 168 H----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPE 220
Query: 568 YAQSGQITEKADVYSLGVVLVELITG 593
+ D++++GV+ L++G
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 34/214 (15%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQ-------------YKLASSQGDQEFCSEVEVLSCA 447
L G +G V A+K + +E +E+ +L
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 448 QHRNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSAR---RKIAVGAAR 503
H N++ L ED + LV E+ G L + R + E A ++I
Sbjct: 104 DHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHKFD-ECDAANIMKQIL----S 157
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTH---DFEPLVGDFGLARWQPDGDMGVETRVLGT 560
G+ YLH+ IVHRD++P NIL+ + + DFGL+ + LGT
Sbjct: 158 GICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGT 211
Query: 561 FGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
Y+APE + EK DV+S GV++ L+ G
Sbjct: 212 AYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-21
Identities = 61/203 (30%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLA--SSQGDQEFCSEVEVLSCAQHRNVVMLIGF 458
L +G FG V + Q AVK A ++ EVE+L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 459 CVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSAR---RKIAVGAARGLRYLHEECRV 514
ED +V E G L + R R E A +++ G+ Y+H+
Sbjct: 90 L-EDSSSFYIVGELYTGGELFDEIIKRKRFS-EHDAARIIKQVF----SGITYMHKHN-- 141
Query: 515 GCIVHRDMRPNNILVTH---DFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS 571
IVHRD++P NIL+ D + + DFGL+ +GT Y+APE
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPE-VLR 196
Query: 572 GQITEKADVYSLGVVLVELITGR 594
G EK DV+S GV+L L++G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGT 219
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 50/244 (20%), Positives = 84/244 (34%), Gaps = 55/244 (22%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVK-----QYKLASSQGDQEFCSEVEVLSCAQHRNVVML 455
+ +G +G V + + A+K + + + + + +EV ++ H N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVG--------------- 500
++ LV E G L L D A +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 501 ----------------AAR-------GLRYLHEECRVGCIVHRDMRPNNILVTHD--FEP 535
+ L YLH + G I HRD++P N L + + FE
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---G-ICHRDIKPENFLFSTNKSFEI 209
Query: 536 LVGDFGLARWQPDGDMGVETR---VLGTFGYLAPE--YAQSGQITEKADVYSLGVVLVEL 590
+ DFGL++ + G GT ++APE + K D +S GV+L L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 591 ITGR 594
+ G
Sbjct: 270 LMGA 273
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-20
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 36/208 (17%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
L G FG VHR G A K + E++ +S +H +V L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 461 EDGRRL-LVYEYICNGSL-------DSHLYGRDRDPLEWSARRKIAVGAAR----GLRYL 508
ED + ++YE++ G L + + + AV R GL ++
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE------------AVEYMRQVCKGLCHM 271
Query: 509 HEECRVGCIVHRDMRPNNILVTHDFEPLV--GDFGLAR-WQPDGDMGVETRVLGTFGYLA 565
HE VH D++P NI+ T + DFGL P + V GT + A
Sbjct: 272 HEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAA 324
Query: 566 PEYAQSGQITEKADVYSLGVVLVELITG 593
PE A+ + D++S+GV+ L++G
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 51/214 (23%), Positives = 82/214 (38%), Gaps = 41/214 (19%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD------QEFCSEVEVLSCAQHRNVVM 454
L G F V + G A K K S+ +E EV +L H NV+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 455 LIGFCVEDGRRLLVYEYICNGSL------DSHLYGRDRDPLEWSARRKIAVGAAR----G 504
L +L+ E + G L L + A + G
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE------------ATSFIKQILDG 127
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPL----VGDFGLAR-WQPDGDMGVETRVLG 559
+ YLH + I H D++P NI++ P+ + DFGLA + + + G
Sbjct: 128 VNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFG 180
Query: 560 TFGYLAPEYAQSGQITEKADVYSLGVVLVELITG 593
T ++APE + +AD++S+GV+ L++G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 49/215 (22%), Positives = 83/215 (38%), Gaps = 43/215 (20%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD------QEFCSEVEVLSCAQHRNVVM 454
L G F V + G+ A K K +E EV +L +H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 455 LIGFCVEDGRRL-LVYEYICNGSL------DSHLYGRDRDPLEWSARRKIAVGAAR---- 503
L E+ + L+ E + G L L + A +
Sbjct: 73 LHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDE------------ATQFLKQILD 119
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL----VGDFGLAR-WQPDGDMGVETRVL 558
G+ YLH + I H D++P NI++ P + DFG+A + + +
Sbjct: 120 GVHYLHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIF 172
Query: 559 GTFGYLAPEYAQSGQITEKADVYSLGVVLVELITG 593
GT ++APE + +AD++S+GV+ L++G
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 37/222 (16%)
Query: 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSC 446
++++F + L G + +V++G+ G VA+K+ KL S +G S E+ ++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKE 59
Query: 447 AQHRNVVMLIGFCVEDGRRLLVYEYICN---GSLDSHLYGRDRDPLEWSARRKIAVGAAR 503
+H N+V L + + LV+E++ N +DS G LE + + +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLG---- 559
GL + HE I+HRD++P N+L+ + +GDFGLAR G+
Sbjct: 120 GLAFCHE----NKILHRDLKPQNLLINKRGQLKLGDFGLARA-----FGIPVNTFSSEVV 170
Query: 560 TFGYLAPE-------YAQSGQITEKADVYSLGVVLVELITGR 594
T Y AP+ Y + D++S G +L E+ITG+
Sbjct: 171 TLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 51/215 (23%), Positives = 82/215 (38%), Gaps = 43/215 (20%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD------QEFCSEVEVLSCAQHRNVVM 454
L G F V + G A K K ++ ++ EV +L QH NV+
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 455 LIGFCVEDGRRL-LVYEYICNGSL------DSHLYGRDRDPLEWSARRKIAVGAAR---- 503
L E+ + L+ E + G L L + A +
Sbjct: 79 LHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEE------------ATEFLKQILN 125
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL----VGDFGLAR-WQPDGDMGVETRVL 558
G+ YLH I H D++P NI++ P + DFGLA + +
Sbjct: 126 GVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIF 178
Query: 559 GTFGYLAPEYAQSGQITEKADVYSLGVVLVELITG 593
GT ++APE + +AD++S+GV+ L++G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 50/214 (23%), Positives = 82/214 (38%), Gaps = 41/214 (19%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD------QEFCSEVEVLSCAQHRNVVM 454
L G F V + G A K K S+ +E EV +L H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 455 LIGFCVEDGRRLLVYEYICNGSL------DSHLYGRDRDPLEWSARRKIAVGAAR----G 504
L +L+ E + G L L + A + G
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE------------ATSFIKQILDG 127
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPL----VGDFGLAR-WQPDGDMGVETRVLG 559
+ YLH + I H D++P NI++ P+ + DFGLA + + + G
Sbjct: 128 VNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFG 180
Query: 560 TFGYLAPEYAQSGQITEKADVYSLGVVLVELITG 593
T ++APE + +AD++S+GV+ L++G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 57/202 (28%), Positives = 86/202 (42%), Gaps = 35/202 (17%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQ-YKLASSQGDQE-FCSEVEVLSCAQHRNVVMLIGF 458
L +G FG V + Q AVK K ++ D EVE+L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 459 CVEDGRRLLVYEYICNGSL------DSHLYGRDRDPLEWSAR---RKIAVGAARGLRYLH 509
+ +V E G L D A +++ G+ Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD-------AARIIKQVF----SGITYMH 138
Query: 510 EECRVGCIVHRDMRPNNILVTHDFE--PL-VGDFGLAR-WQPDGDMGVETRVLGTFGYLA 565
+ IVHRD++P NIL+ + + + DFGL+ +Q + M +GT Y+A
Sbjct: 139 KHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIA 191
Query: 566 PEYAQSGQITEKADVYSLGVVL 587
PE + G EK DV+S GV+L
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVIL 212
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVL-SCAQHRNVVMLIGFC 459
L EG V + L Q AVK + EVE+L C HRNV+ LI F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSAR---RKIAVGAARGLRYLHEECRVGC 516
E+ R LV+E + GS+ SH++ R E A + + A L +LH +
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFN-ELEASVVVQDV----ASALDFLHNK----G 131
Query: 517 IVHRDMRPNNILVTHDFE--PL-VGDFGLARWQPDGDMGVETR------VLGTFGYLAPE 567
I HRD++P NIL H + P+ + DF L G+ Y+APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 568 --YAQSGQIT---EKADVYSLGVVL 587
A S + + ++ D++SLGV+L
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 53/194 (27%), Positives = 77/194 (39%), Gaps = 16/194 (8%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE-FCSEVEVLSCAQHRNVVMLIGFC 459
L G FG VH G +K SQ E +E+EVL H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 460 VEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSAR--RKIAVGAARGLRYLHEECRVGC 516
ED + +V E G L + S ++ L Y H +
Sbjct: 90 -EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---H- 144
Query: 517 IVHRDMRPNNILVT---HDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
+VH+D++P NIL + DFGLA + T GT Y+APE +
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK-RD 201
Query: 574 ITEKADVYSLGVVL 587
+T K D++S GVV+
Sbjct: 202 VTFKCDIWSAGVVM 215
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 24/201 (11%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQ---YKLASSQGD--QEFCSEVEVLSCAQHRNVVML 455
+ +G F V R + GQ AVK K SS G ++ E + +H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSAR------RKIAVGAARGLRYLH 509
+ DG +V+E++ L + R +S R+I LRY H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI----LEALRYCH 147
Query: 510 EECRVGCIVHRDMRPNNILVTHDFE--PL-VGDFGLARWQPDGDMGVETRVLGTFGYLAP 566
+ I+HRD++P+ +L+ P+ +G FG+A + + RV GT ++AP
Sbjct: 148 DN----NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAP 202
Query: 567 EYAQSGQITEKADVYSLGVVL 587
E + + DV+ GV+L
Sbjct: 203 EVVKREPYGKPVDVWGCGVIL 223
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 45/200 (22%), Positives = 73/200 (36%), Gaps = 33/200 (16%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
+ G +G V V A K+ + F E+E++ H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF- 75
Query: 461 EDGRRL-LVYEYICNGSL------DSHLYGRDRDPLEWSAR---RKIAVGAARGLRYLHE 510
ED + LV E G L D A + + + Y H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESD-------AARIMKDV----LSAVAYCHK 124
Query: 511 ECRVGCIVHRDMRPNNILVTH---DFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE 567
+ HRD++P N L D + DFGLA G + +GT Y++P+
Sbjct: 125 L----NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQ 178
Query: 568 YAQSGQITEKADVYSLGVVL 587
+ G + D +S GV++
Sbjct: 179 VLE-GLYGPECDEWSAGVMM 197
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 56/246 (22%), Positives = 90/246 (36%), Gaps = 34/246 (13%)
Query: 356 SRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGV- 414
+ N + P W + + ++ F + L G V+R
Sbjct: 15 TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQ 74
Query: 415 LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474
+ A+K L + + +E+ VL H N++ L LV E +
Sbjct: 75 KGTQKPYALKV--LKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132
Query: 475 GSL-D-----SHLYGRDRDPLEWSARRKIAVGAAR----GLRYLHEECRVGCIVHRDMRP 524
G L D + RD A A + + YLHE IVHRD++P
Sbjct: 133 GELFDRIVEKGYYSERD------------AADAVKQILEAVAYLHENG----IVHRDLKP 176
Query: 525 NNILVTHDFE--PL-VGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVY 581
N+L PL + DFGL++ + V GT GY APE + + D++
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMW 234
Query: 582 SLGVVL 587
S+G++
Sbjct: 235 SVGIIT 240
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 48/200 (24%), Positives = 81/200 (40%), Gaps = 21/200 (10%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
L G FG VHR V + K K E+ +L+ A+HRN++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF- 70
Query: 461 EDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSAR---RKIAVGAARGLRYLHEECRVGC 516
E L +++E+I + + + E ++ L++LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC----EALQFLHSHN---- 122
Query: 517 IVHRDMRPNNILVTHDFEPLV--GDFGLAR-WQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
I H D+RP NI+ + +FG AR +P + + Y APE Q
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDV 179
Query: 574 ITEKADVYSLGVVLVELITG 593
++ D++SLG ++ L++G
Sbjct: 180 VSTATDMWSLGTLVYVLLSG 199
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 30/210 (14%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQ---YKLASSQGDQE-----FCSEVEVLSCAQHRNV 452
L G G V + VA++ K A + +E+E+L H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 453 VMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSAR---RKIAVGAARGLRYLH 509
+ + F + +V E + G L + G R E + + ++ ++YLH
Sbjct: 203 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLK-EATCKLYFYQM----LLAVQYLH 256
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPL---VGDFGLARWQPDGDMGVETRVLGTFGYLAP 566
E I+HRD++P N+L++ E + DFG ++ + + + T GT YLAP
Sbjct: 257 EN----GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTPTYLAP 310
Query: 567 E---YAQSGQITEKADVYSLGVVLVELITG 593
E + D +SLGV+L ++G
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 47/201 (23%), Positives = 81/201 (40%), Gaps = 31/201 (15%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQ-YKLASSQGDQE-FCSEVEVLSCAQHRNVVMLIGF 458
L +G F V R V + GQ A S D + E + +H N+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 459 CVEDGRRLLVYEYICNGSL-D-----SHLYGRDRDPLEWSAR---RKIAVGAARGLRYLH 509
E+G L+++ + G L + + D A ++I + + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD-------ASHCIQQIL----EAVLHCH 127
Query: 510 EECRVGCIVHRDMRPNNILVTHDFE--PL-VGDFGLARWQPDGDMGVETRVLGTFGYLAP 566
+ +VHR+++P N+L+ + + + DFGLA GT GYL+P
Sbjct: 128 QMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSP 182
Query: 567 EYAQSGQITEKADVYSLGVVL 587
E + + D+++ GV+L
Sbjct: 183 EVLRKDPYGKPVDLWACGVIL 203
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 42/220 (19%)
Query: 394 NRFSEANFLAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEFCS----EVEVLSCAQ 448
+ + + L EG + +V++G +VA+K+ +L +G EV +L +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLK 58
Query: 449 HRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYG---RDRDPLEWSARRKIAVGAARGL 505
H N+V L + LV+EY LD L + + + RGL
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 506 RYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLG----TF 561
Y H + ++HRD++P N+L+ E + DFGLAR + T+ T
Sbjct: 114 AYCHRQK----VLHRDLKPQNLLINERGELKLADFGLARA-----KSIPTKTYDNEVVTL 164
Query: 562 GYLAPE-------YAQSGQITEKADVYSLGVVLVELITGR 594
Y P+ Y S QI D++ +G + E+ TGR
Sbjct: 165 WYRPPDILLGSTDY--STQI----DMWGVGCIFYEMATGR 198
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 42/210 (20%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQ---YKLASSQGDQE-----FCSEVEVLSCAQHRNV 452
L G G V + VA+K K A + +E+E+L H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 453 VMLIGFCVEDGRRLLVYEYICNGSL------DSHLYGRDRDPLEWSAR---RKIAVGAAR 503
+ + F + +V E + G L + L + ++
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEAT-------CKLYFYQM----LL 125
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL---VGDFGLARWQPDGDMGVETRVLGT 560
++YLHE I+HRD++P N+L++ E + DFG ++ + + + T GT
Sbjct: 126 AVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GT 179
Query: 561 FGYLAPE---YAQSGQITEKADVYSLGVVL 587
YLAPE + D +SLGV+L
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 46/222 (20%)
Query: 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQE---FCS----EVEVLSC 446
++ + + EG +G V++ G++VA+K+ +L D E S E+ +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL-----DAEDEGIPSTAIREISLLKE 75
Query: 447 AQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYG---RDRDPLEWSARRKIAVGAAR 503
H N+V LI + LV+E+ ++ L ++ L+ S + R
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLG---- 559
G+ + H+ I+HRD++P N+L+ D + DFGLAR G+ R
Sbjct: 131 GVAHCHQHR----ILHRDLKPQNLLINSDGALKLADFGLARA-----FGIPVRSYTHEVV 181
Query: 560 TFGYLAPE-------YAQSGQITEKADVYSLGVVLVELITGR 594
T Y AP+ Y + D++S+G + E+ITG+
Sbjct: 182 TLWYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 31/200 (15%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVL-SCAQHRNVVMLIGFC 459
L G G V GQ A+K L S ++ EV+ + ++V ++
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKL--LYDSPKARQ---EVDHHWQASGGPHIVCILDVY 91
Query: 460 VEDGRR-----LLVYEYICNGSLDSHLYGRDRDPL-EWSAR---RKIAVGAARGLRYLHE 510
E+ L++ E + G L S + R E A R I +++LH
Sbjct: 92 -ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG----TAIQFLHS 146
Query: 511 ECRVGCIVHRDMRPNNILVTHDFE--PL-VGDFGLARWQPDGDMGVETRVLGTFGYLAPE 567
I HRD++P N+L T + L + DFG A+ + +T T Y+APE
Sbjct: 147 HN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QTPC-YTPYYVAPE 199
Query: 568 YAQSGQITEKADVYSLGVVL 587
+ + D++SLGV++
Sbjct: 200 VLGPEKYDKSCDMWSLGVIM 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 29/204 (14%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQ---YKLASSQGDQEFCSEVEVL-SCAQHRNVVMLI 456
L EG F + V Q AVK A++Q E+ L C H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ------KEITALKLCEGHPNIVKLH 72
Query: 457 GFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSAR---RKIAVGAARGLRYLHEEC 512
D LV E + G L + + E A RK+ + ++H+
Sbjct: 73 EVF-HDQLHTFLVMELLNGGELFERIKKKKHFS-ETEASYIMRKLV----SAVSHMHDVG 126
Query: 513 RVGCIVHRDMRPNNILVTHDFE--PL-VGDFGLARWQPDGDMGVETRVLGTFGYLAPEYA 569
+VHRD++P N+L T + + + + DFG AR +P + ++T T Y APE
Sbjct: 127 ----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELL 181
Query: 570 QSGQITEKADVYSLGVVLVELITG 593
E D++SLGV+L +++G
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSG 205
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 32/201 (15%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQY--KLASSQGDQEFCSEVEVLSCAQHRNVVMLIGF 458
L +G F V R V G A K K S++ Q+ E + QH N+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 459 CVEDGRRLLVYEYICNGSL-D-----SHLYGRDRDPLEWSAR---RKIAVGAARGLRYLH 509
E+ LV++ + G L + D A ++I + Y H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEAD-------ASHCIQQIL----ESIAYCH 145
Query: 510 EECRVGCIVHRDMRPNNILVTHDFE--PL-VGDFGLARWQPDGDMGVETRVLGTFGYLAP 566
IVHR+++P N+L+ + + + DFGLA D + GT GYL+P
Sbjct: 146 SNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSP 199
Query: 567 EYAQSGQITEKADVYSLGVVL 587
E + ++ D+++ GV+L
Sbjct: 200 EVLKKDPYSKPVDIWACGVIL 220
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQY-KLASSQGDQE-FCSEVEVLSCAQHR-NVVMLIG 457
L G F V + + GQ A K K Q + E+ VL A+ V+ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 458 FCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPL-EWSAR---RKIAVGAARGLRYLHEEC 512
E+ + L+ EY G + S + + E ++I G+ YLH+
Sbjct: 97 VY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL----EGVYYLHQNN 151
Query: 513 RVGCIVHRDMRPNNILVTHDFE--PL-VGDFGLAR-WQPDGDMGVETRVLGTFGYLAPEY 568
IVH D++P NIL++ + + + DFG++R ++ ++GT YLAPE
Sbjct: 152 ----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPEI 204
Query: 569 AQSGQITEKADVYSLGVVLVELITG 593
IT D++++G++ L+T
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 3e-18
Identities = 52/201 (25%), Positives = 82/201 (40%), Gaps = 32/201 (15%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQY--KLASSQGDQEFCSEVEVLSCAQHRNVVMLIGF 458
L +G F V R V G A K K S++ Q+ E + QH N+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 459 CVEDGRRLLVYEYICNGSL-D-----SHLYGRDRDPLEWSAR---RKIAVGAARGLRYLH 509
E+ LV++ + G L + D A ++I + Y H
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSEAD-------ASHCIQQI----LESIAYCH 122
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPL---VGDFGLARWQPDGDMGVETRVLGTFGYLAP 566
IVHR+++P N+L+ + + DFGLA D + GT GYL+P
Sbjct: 123 SN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSP 176
Query: 567 EYAQSGQITEKADVYSLGVVL 587
E + ++ D+++ GV+L
Sbjct: 177 EVLKKDPYSKPVDIWACGVIL 197
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 19/203 (9%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYKLAS-SQGDQEFCSEVE--VLSCAQHRNVVM 454
L GGFG V + G++ A K+ + + VE +L+ R +V
Sbjct: 193 LGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 455 LIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGA--ARGLRYLHEE 511
L + E L LV + G + H+Y D D + R I A GL +LH+
Sbjct: 250 LA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS 571
I++RD++P N+L+ D + D GLA G + GT G++APE
Sbjct: 309 N----IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLG 363
Query: 572 GQITEKADVYSLGVVLVELITGR 594
+ D ++LGV L E+I R
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 40/221 (18%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE-FCS----EVEVLSCA 447
R+ + +FL EG F +V++ Q+VA+K+ KL ++ E+++L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 448 QHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYG---RDRDPLEWSARRKIAVGAARG 504
H N++ L+ LV+++ +++ L + L S + + +G
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLG----T 560
L YLH+ I+HRD++PNN+L+ + + DFGLA+ G R T
Sbjct: 125 LEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKS-----FGSPNRAYTHQVVT 175
Query: 561 FGYLAPE-------YAQSGQITEKADVYSLGVVLVELITGR 594
Y APE Y + D++++G +L EL+
Sbjct: 176 RWYRAPELLFGARMY--GVGV----DMWAVGCILAELLLRV 210
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 4e-18
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 20/211 (9%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSCA 447
R+ + G G V + VA+K KL+ +Q E+ ++ C
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 448 QHRNVVMLIG-FCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLR 506
H+N++ L+ F + Y+ +D++L + L+ + G++
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 178
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG---VETRVLGTFGY 563
+LH I+HRD++P+NI+V D + DFGLAR M V TR Y
Sbjct: 179 HLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----Y 229
Query: 564 LAPEYAQSGQITEKADVYSLGVVLVELITGR 594
APE E D++S+G ++ E++ +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 15/200 (7%)
Query: 402 LAEGGFGSVHRGVL-PDGQVVAVKQYKLAS-SQGDQEFC--SEVEVLSCAQHRNVVMLIG 457
L EG F +V + A+K + + ++ E +V+S H V L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 458 FCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIA-VGAARGLRYLHEECRVG 515
F +D +L Y NG L ++ + E R A + +A L YLH +
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSA--LEYLHGKG--- 150
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPEYAQSGQI 574
I+HRD++P NIL+ D + DFG A+ GT Y++PE
Sbjct: 151 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 209
Query: 575 TEKADVYSLGVVLVELITGR 594
+ +D+++LG ++ +L+ G
Sbjct: 210 CKSSDLWALGCIIYQLVAGL 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 6e-18
Identities = 49/223 (21%), Positives = 93/223 (41%), Gaps = 41/223 (18%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE---FCS----EVEVLS 445
++ + + EG +G+V + ++VA+K+ +L D + S E+ +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-----DDDDEGVPSSALREICLLK 56
Query: 446 CAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGL 505
+H+N+V L D + LV+E+ C+ L + L+ + +GL
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEF-CDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGL 114
Query: 506 RYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLG----TF 561
+ H ++HRD++P N+L+ + E + +FGLAR G+ R T
Sbjct: 115 GFCHSRN----VLHRDLKPQNLLINRNGELKLANFGLARA-----FGIPVRCYSAEVVTL 165
Query: 562 GYLAPE-------YAQSGQITEKADVYSLGVVLVELITGRKAM 597
Y P+ Y + D++S G + EL + +
Sbjct: 166 WYRPPDVLFGAKLY------STSIDMWSAGCIFAELANAGRPL 202
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 49/202 (24%), Positives = 83/202 (41%), Gaps = 37/202 (18%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVL-SCAQHRNVVMLIGFC 459
+ G + R + AVK + +E +E+L QH N++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKDVY 85
Query: 460 VEDGRRL-LVYEYICNGSL-D-----SHLYGRDRDPLEWSAR---RKIAVGAARGLRYLH 509
+DG+ + +V E + G L D R+ A I + + YLH
Sbjct: 86 -DDGKYVYVVTELMKGGELLDKILRQKFFSERE-------ASAVLFTIT----KTVEYLH 133
Query: 510 EECRVGCIVHRDMRPNNILVTH---DFEPL-VGDFGLARWQPDGDMGVETRVLGTFGYLA 565
+ +VHRD++P+NIL + E + + DFG A+ + + T T ++A
Sbjct: 134 AQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVA 188
Query: 566 PEYAQSGQITEKADVYSLGVVL 587
PE + D++SLGV+L
Sbjct: 189 PEVLERQGYDAACDIWSLGVLL 210
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 8e-18
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 46/222 (20%)
Query: 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQE---FCS----EVEVLSC 446
++ + EG +G V++ G+ A+K+ +L ++E S E+ +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL-----EKEDEGIPSTTIREISILKE 56
Query: 447 AQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYG---RDRDPLEWSARRKIAVGAAR 503
+H N+V L R +LV+E+ LD L LE + +
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLG---- 559
G+ Y H+ ++HRD++P N+L+ + E + DFGLAR G+ R
Sbjct: 112 GIAYCHDRR----VLHRDLKPQNLLINREGELKIADFGLARA-----FGIPVRKYTHEIV 162
Query: 560 TFGYLAPE-------YAQSGQITEKADVYSLGVVLVELITGR 594
T Y AP+ Y + D++S+G + E++ G
Sbjct: 163 TLWYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 54/213 (25%), Positives = 83/213 (38%), Gaps = 45/213 (21%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVK-----QYKLASSQGDQE----FCSEVEVL-SCAQHR 450
L G V R + P + AVK S++ QE EV++L + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 451 NVVMLIGFCVEDGRRL-LVYEYICNGSL-D-----SHLYGRDRDPLEWSAR---RKIAVG 500
N++ L E LV++ + G L D L ++ R R +
Sbjct: 85 NIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE-------TRKIMRALL-- 134
Query: 501 AARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT 560
+ LH+ IVHRD++P NIL+ D + DFG + G+ V GT
Sbjct: 135 --EVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGT 186
Query: 561 FGYLAPE------YAQSGQITEKADVYSLGVVL 587
YLAPE ++ D++S GV++
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 49/218 (22%), Positives = 89/218 (40%), Gaps = 37/218 (16%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS--EVEVLSCAQHR 450
++ + + EG +G V + GQ+VA+K++ + + + E+ +L +H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 451 NVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYG---RDRDPLEWSARRKIAVGAARGLRY 507
N+V L+ R LV+EY D + R + + + I + + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL----GTFGY 563
H+ +HRD++P NIL+T + DFG AR + + T Y
Sbjct: 118 CHKHN----CIHRDVKPENILITKHSVIKLCDFGFAR-----LLTGPSDYYDDEVATRWY 168
Query: 564 LAPE-------YAQSGQITEKADVYSLGVVLVELITGR 594
+PE Y DV+++G V EL++G
Sbjct: 169 RSPELLVGDTQYGPP------VDVWAIGCVFAELLSGV 200
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 20/211 (9%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSCA 447
R+ + G G V + VA+K KL+ +Q E+ ++ C
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 448 QHRNVVMLIG-FCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLR 506
H+N++ L+ F + YI +D++L + L+ + G++
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 141
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG---VETRVLGTFGY 563
+LH I+HRD++P+NI+V D + DFGLAR M V TR Y
Sbjct: 142 HLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----Y 192
Query: 564 LAPEYAQSGQITEKADVYSLGVVLVELITGR 594
APE E D++S+G ++ E+I G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 51/208 (24%), Positives = 78/208 (37%), Gaps = 25/208 (12%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQ------YKLASSQGDQEFCSEVEVL----SCAQHR 450
L +GGFG+V G L D VA+K + EV +L + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 451 NVVMLIGFCVEDGRRLLVYEYICNGS--LDSHLYGRDRDPLEWSARRKIAVGAARGLRYL 508
V+ L+ + +LV E D Y ++ PL R +++
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFD---YITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 509 HEECRVGCIVHRDMRPNNILVTHDFEPL-VGDFGLARWQPDGDMGVETRVLGTFGYLAPE 567
H +VHRD++ NIL+ + DFG D GT Y PE
Sbjct: 156 HSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFD-GTRVYSPPE 208
Query: 568 YAQSGQIT-EKADVYSLGVVLVELITGR 594
+ Q A V+SLG++L +++ G
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 32/207 (15%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVK---QYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIG 457
+ +G F V + G+ VA+K + +L + + F EV ++ H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 458 FCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRK---IAVGAARGLRYLHEECR 513
+E + L L+ EY G + +L R E AR K I ++Y H++
Sbjct: 82 -VIETEKTLYLIMEYASGGEVFDYLVAHGRMK-EKEARSKFRQIV----SAVQYCHQKR- 134
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE------ 567
IVHRD++ N+L+ D + DFG + G ++ G Y APE
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDAFC-GAPPYAAPELFQGKK 189
Query: 568 YAQSGQITEKADVYSLGVVLVELITGR 594
Y + DV+SLGV+L L++G
Sbjct: 190 YDGP-----EVDVWSLGVILYTLVSGS 211
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 58/268 (21%), Positives = 94/268 (35%), Gaps = 47/268 (17%)
Query: 346 SKSVREAVSLSRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEG 405
S+S + P ++ P W E ++ + + G
Sbjct: 49 SQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY---QKYDPKDVIGRG 105
Query: 406 GFGSVHRGV-LPDGQVVAVK---QYKLASSQGDQE-----FCSEVEVL-SCAQHRNVVML 455
V R V G AVK S E E +L A H +++ L
Sbjct: 106 VSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165
Query: 456 IGFCVEDGRRL-LVYEYICNGSL-D-----SHLYGRDRDPLEWSAR---RKIAVGAARGL 505
I E + LV++ + G L D L ++ R R + +
Sbjct: 166 IDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEKE-------TRSIMRSLL----EAV 213
Query: 506 RYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLA 565
+LH IVHRD++P NIL+ + + + DFG + G+ + GT GYLA
Sbjct: 214 SFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLA 267
Query: 566 PE------YAQSGQITEKADVYSLGVVL 587
PE ++ D+++ GV+L
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 39/226 (17%)
Query: 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQ-GDQEFCS----EVEVL- 444
AT+R+ + G +G+V++ G VA+K ++ + G EV +L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 445 --SCAQHRNVVMLIGFCVEDGRRL-----LVYEYICNGSLDSHLYGRDRDPLEWSARRKI 497
+H NVV L+ C LV+E+ + L ++L L + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 498 AVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE--- 554
RGL +LH C IVHRD++P NILVT + DFGLAR +
Sbjct: 126 MRQFLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARI-----YSYQMAL 176
Query: 555 TRVLGTFGYLAPE------YAQSGQITEKADVYSLGVVLVELITGR 594
T V+ T Y APE YA D++S+G + E+ +
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATP------VDMWSVGCIFAEMFRRK 216
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 52/212 (24%), Positives = 80/212 (37%), Gaps = 35/212 (16%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVK--------QYKLASSQGDQEFCSEVEVLSCAQHRNV 452
L G FG V V + V VK + + E+ +LS +H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 453 VMLIGFCVEDGRRLLVYEYICNGS-LDSHLYGRDRDPLEWSARRK---IAVGAARGLRYL 508
+ ++ G LV E +G L + + R E A + + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLD-EPLASYIFRQLV----SAVGYL 146
Query: 509 HEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE- 567
I+HRD++ NI++ DF + DFG A + G + T GT Y APE
Sbjct: 147 RL----KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL-FYTFC-GTIEYCAPEV 200
Query: 568 -----YAQSGQITEKADVYSLGVVLVELITGR 594
Y + +++SLGV L L+
Sbjct: 201 LMGNPYRGP-----ELEMWSLGVTLYTLVFEE 227
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 60/269 (22%), Positives = 103/269 (38%), Gaps = 43/269 (15%)
Query: 345 ISKSVREAVSLSRNKPPGPPPLCSICQHKAPVFGNP------PRWFTYAELELATNRFSE 398
+S S ++ + P PP + P P P++ + L++ N +
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID 61
Query: 399 -----ANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS-EVEVL-SCAQHR 450
+ L G G V + + A+K + D EVE+ +Q
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWRASQCP 115
Query: 451 NVVMLIGFCVEDGRR-----LLVYEYICNGSLDSHLYGRDRDPL-EWSAR---RKIAVGA 501
++V ++ E+ L+V E + G L S + R E A + I
Sbjct: 116 HIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG--- 171
Query: 502 ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE--PL-VGDFGLARWQPDGDMGVETRVL 558
++YLH I HRD++P N+L T L + DFG A+ + + T
Sbjct: 172 -EAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPC- 224
Query: 559 GTFGYLAPEYAQSGQITEKADVYSLGVVL 587
T Y+APE + + D++SLGV++
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 41/220 (18%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSCAQ 448
++ + EG +G V + G++VA+K++ S D+ E+++L +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE--SDDDKMVKKIAMREIKLLKQLR 82
Query: 449 HRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYG---RDRDPLEWSARRKIAVGAARGL 505
H N+V L+ C + R LV+E+ +D + + L++ +K G+
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 506 RYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL----GTF 561
+ H I+HRD++P NILV+ + DFG AR + V T
Sbjct: 138 GFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVYDDEVATR 188
Query: 562 GYLAPE-------YAQSGQITEKADVYSLGVVLVELITGR 594
Y APE Y ++ DV+++G ++ E+ G
Sbjct: 189 WYRAPELLVGDVKYGKA------VDVWAIGCLVTEMFMGE 222
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 3e-17
Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYKLAS-SQGDQEFCSEVE--VLSCAQHRNVVM 454
L +GGFG V R G++ A K+ + + E + E +L R VV
Sbjct: 192 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 455 LIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
L + E L LV + G L H+Y + + A GL LH E
Sbjct: 249 LA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER- 306
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
IV+RD++P NIL+ + D GLA P+G ++ RV GT GY+APE ++ +
Sbjct: 307 ---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNER 361
Query: 574 ITEKADVYSLGVVLVELITGR 594
T D ++LG +L E+I G+
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQ 382
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 58/213 (27%), Positives = 88/213 (41%), Gaps = 43/213 (20%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVK---QYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIG 457
L G FG V G G VAVK + K+ S + E++ L +H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 458 FCV-EDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRK----IAVGAARGLRYLHEE 511
+ V +V EY+ G L ++ R E ARR ++ + Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVE-EMEARRLFQQILS-----AVDYCHRH 130
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF----GYLAPE 567
+VHRD++P N+L+ + DFGL+ DG+ L T Y APE
Sbjct: 131 M----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF------LRTSCGSPNYAAPE 180
Query: 568 ------YAQSGQITEKADVYSLGVVLVELITGR 594
YA + D++S GV+L L+ G
Sbjct: 181 VISGRLYAGP-----EVDIWSCGVILYALLCGT 208
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 49/225 (21%), Positives = 84/225 (37%), Gaps = 47/225 (20%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE---FCS----EVEVLS 445
+R+ L EG +G V++ + + VA+K+ +L + E EV +L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL-----EHEEEGVPGTAIREVSLLK 88
Query: 446 CAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGL 505
QHRN++ L + R L++EY D Y + + G+
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYA---ENDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 506 RYLHEECRVGCIVHRDMRPNNILVTHDFEPLVG-----DFGLARWQPDGDMGVETRVLG- 559
+ H +HRD++P N+L++ DFGLAR G+ R
Sbjct: 146 NFCHSRR----CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA-----FGIPIRQFTH 196
Query: 560 ---TFGYLAPE-------YAQSGQITEKADVYSLGVVLVELITGR 594
T Y PE Y + D++S+ + E++
Sbjct: 197 EIITLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 54/213 (25%), Positives = 82/213 (38%), Gaps = 35/213 (16%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVK---QYKLASSQGDQEFCS-EVEVLSCAQHRNVVMLI 456
L EG +G V + AVK + KL + E+++L +H+NV+ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 457 G-FCVEDGRRL-LVYEYICNGS---LDSHLYGRDRDPLEWSARRK----IAVGAARGLRY 507
E+ +++ +V EY G LDS R A I GL Y
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFP---VCQAHGYFCQLID-----GLEY 124
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF----GY 563
LH + IVH+D++P N+L+T + G+A T +
Sbjct: 125 LHSQG----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD---DTCRTSQGSPAF 177
Query: 564 LAPEYAQSGQITE--KADVYSLGVVLVELITGR 594
PE A K D++S GV L + TG
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 1e-16
Identities = 59/208 (28%), Positives = 84/208 (40%), Gaps = 32/208 (15%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS-EVEVLSCAQHRNVVMLIGFC 459
L EG +G V V + VAVK + + E E+ + H NVV G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 460 VEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRK----IAVGAARGLRYLHEECRV 514
+G L EY G L + P E A+R +A G+ YLH +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMP-EPDAQRFFHQLMA-----GVVYLH---GI 124
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG--VETRVLGTFGYLAPE----- 567
G I HRD++P N+L+ + DFGLA + + GT Y+APE
Sbjct: 125 G-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRR 182
Query: 568 -YAQSGQITEKADVYSLGVVLVELITGR 594
+ E DV+S G+VL ++ G
Sbjct: 183 EFH--A---EPVDVWSCGIVLTAMLAGE 205
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSCA 447
+ + G +GSV + G+ VA+K KL+ + F E+ +L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 448 QHRNVVMLI-----GFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGA 501
QH NV+ L+ + + LV + + + L + +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEEKIQYLVYQM 135
Query: 502 ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG--VETRVLG 559
+GL+Y+H +VHRD++P N+ V D E + DFGLAR D +M V TR
Sbjct: 136 LKGLKYIHS----AGVVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVVTRW-- 188
Query: 560 TFGYLAPEYA-QSGQITEKADVYSLGVVLVELITGR 594
Y APE + D++S+G ++ E++TG+
Sbjct: 189 ---YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 36/217 (16%)
Query: 402 LAEGGFGSVHRGV---LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGF 458
+ G +G V++ D + A+KQ + C E+ +L +H NV+ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 459 CVEDGRRL--LVYEYICN---GSLDSHLYGRDRD---PLEWSARRKIAVGAARGLRYLHE 510
+ R L+++Y + + H + L + + G+ YLH
Sbjct: 87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPL----VGDFGLAR--WQPDGDMGVETRVLGTFGYL 564
++HRD++P NILV + + D G AR P + V+ TF Y
Sbjct: 147 NW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 565 APE-------YAQSGQITEKADVYSLGVVLVELITGR 594
APE Y T+ D++++G + EL+T
Sbjct: 203 APELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 53/232 (22%), Positives = 88/232 (37%), Gaps = 54/232 (23%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVK-------------------QYKLASSQGDQEFCS-- 439
+ +G +G V D A+K + + G +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 440 -----EVEVLSCAQHRNVVMLIGFCV----EDGRRLLVYEYICNGSLDSHLYGRDRDPL- 489
E+ +L H NVV L V + +V+E + G + + PL
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLS 135
Query: 490 EWSARRK----IAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545
E AR I G+ YLH + I+HRD++P+N+LV D + DFG++
Sbjct: 136 EDQARFYFQDLIK-----GIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQIT---EKADVYSLGVVLVELITGR 594
D + V GT ++APE + + DV+++GV L + G+
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 48/204 (23%), Positives = 79/204 (38%), Gaps = 19/204 (9%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQ------YKLASSQGDQEFCSEVEVLSCAQHR--NV 452
L GGFGSV+ G+ + D VA+K EV +L V
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 453 VMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC 512
+ L+ + +L+ E D + +R L+ R +R+ H
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 169
Query: 513 RVGCIVHRDMRPNNILVTHDFEPL-VGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS 571
++HRD++ NIL+ + L + DFG D GT Y PE+ +
Sbjct: 170 ----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFD-GTRVYSPPEWIRY 222
Query: 572 GQIT-EKADVYSLGVVLVELITGR 594
+ A V+SLG++L +++ G
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 58/208 (27%), Positives = 83/208 (39%), Gaps = 32/208 (15%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS-EVEVLSCAQHRNVVMLIGFC 459
L EG +G V V + VAVK + + E E+ + H NVV G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 460 VEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRK----IAVGAARGLRYLHEECRV 514
+G L EY G L + P E A+R +A G+ YLH +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMP-EPDAQRFFHQLMA-----GVVYLH---GI 124
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV--ETRVLGTFGYLAPE----- 567
G I HRD++P N+L+ + DFGLA + GT Y+APE
Sbjct: 125 G-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRR 182
Query: 568 -YAQSGQITEKADVYSLGVVLVELITGR 594
+ + DV+S G+VL ++ G
Sbjct: 183 EFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 40/222 (18%)
Query: 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCS-EVEVLSCAQHR 450
+++ + G FG V++ L G++VA+K+ D+ F + E++++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHC 107
Query: 451 NVVMLIGFCVEDGRRL------LVYEYI-CNGSLDSHLYGRDRDPLEWSARRKIAVGAAR 503
N+V L F G + LV +Y+ + Y R + L + R
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL-VGDFGLARWQPDGDMGVE---TRVLG 559
L Y+H I HRD++P N+L+ D L + DFG A+ G+ V +R
Sbjct: 168 SLAYIHS----FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221
Query: 560 TFGYLAPE-------YAQSGQITEKADVYSLGVVLVELITGR 594
Y APE Y T DV+S G VL EL+ G+
Sbjct: 222 ---YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 8e-16
Identities = 70/289 (24%), Positives = 103/289 (35%), Gaps = 56/289 (19%)
Query: 382 RWFTYAELELATNRFSEANF-----LAEGGFGSV----HRGVLPDGQVVAVKQYKLAS-- 430
+W + L R +F + G F V + GQV A+K
Sbjct: 44 QWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDML 100
Query: 431 SQGDQE-FCSEVEVLSCAQHRNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDP 488
+G+ F E +VL R + L F +D L LV EY G L + L
Sbjct: 101 KRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERI 159
Query: 489 LEWSARRKIA--VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA-RW 545
AR +A V A + +H VHRD++P+NIL+ + DFG +
Sbjct: 160 PAEMARFYLAEIVMA---IDSVHRLG----YVHRDIKPDNILLDRCGHIRLADFGSCLKL 212
Query: 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVY-------SLGVVLVELITGR---- 594
+ DG + V GT YL+PE Q+ Y +LGV E+ G+
Sbjct: 213 RADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY 271
Query: 595 -------------KAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630
L+ P + + E AR ++ L P R
Sbjct: 272 ADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQ----RLLCPPETR 316
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 59/213 (27%), Positives = 86/213 (40%), Gaps = 44/213 (20%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVK---QYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIG 457
L EG FG V Q VA+K + L S E+ L +H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 458 FCV-EDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRK----IAVGAARGLRYLHEE 511
+ V + +V EY G L ++ + R E RR I + Y H
Sbjct: 75 YDVITTPTDIVMVIEY-AGGELFDYIVEKKRMT-EDEGRRFFQQIIC-----AIEYCHRH 127
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF----GYLAPE 567
IVHRD++P N+L+ + + DFGL+ DG+ L T Y APE
Sbjct: 128 K----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF------LKTSCGSPNYAAPE 177
Query: 568 ------YAQSGQITEKADVYSLGVVLVELITGR 594
YA + DV+S G+VL ++ GR
Sbjct: 178 VINGKLYAGP-----EVDVWSCGIVLYVMLVGR 205
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 41/227 (18%)
Query: 393 TNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCS------------- 439
+ ++ F++ G +G+V GV +G VA+K ++ ++ D +
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIK--RVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 440 EVEVLSCAQHRNVVMLIG-FCVEDGRRL----LVYEYICNGSLDSHLY---GRDRDPLEW 491
E+ +L+ H N++ L F + + LV E + + L R +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVISP 133
Query: 492 SARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-WQPDGD 550
+ GL LHE +VHRD+ P NIL+ + + + DF LAR D +
Sbjct: 134 QHIQYFMYHILLGLHVLHE----AGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 551 MG--VETRVLGTFGYLAPEY-AQSGQITEKADVYSLGVVLVELITGR 594
V R Y APE Q T+ D++S G V+ E+ +
Sbjct: 190 KTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 43/213 (20%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVK---QYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIG 457
L G FG V G G VAVK + K+ S + E++ L +H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 458 FCV-EDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRK----IAVGAARGLRYLHEE 511
+ V + +V EY+ G L ++ R E +RR ++ G+ Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLD-EKESRRLFQQILS-----GVDYCHRH 135
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTF----GYLAPE 567
+VHRD++P N+L+ + DFGL+ DG+ L T Y APE
Sbjct: 136 M----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF------LRTSCGSPNYAAPE 185
Query: 568 ------YAQSGQITEKADVYSLGVVLVELITGR 594
YA + D++S GV+L L+ G
Sbjct: 186 VISGRLYAGP-----EVDIWSSGVILYALLCGT 213
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 2e-15
Identities = 54/202 (26%), Positives = 82/202 (40%), Gaps = 19/202 (9%)
Query: 402 LAEGGFGSVHRGVLPD-GQVVAVKQYKLAS-SQGDQEFCSEVE--VL---SCAQHRNVVM 454
+ GGFG V+ D G++ A+K E + E +L S +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 455 LIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
+ + +L + + + G L HL + E R A GL ++H
Sbjct: 257 MS-YAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAA-EIILGLEHMHNRF- 312
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
+V+RD++P NIL+ + D GLA V GT GY+APE Q G
Sbjct: 313 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASV-GTHGYMAPEVLQKGV 366
Query: 574 I-TEKADVYSLGVVLVELITGR 594
AD +SLG +L +L+ G
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGH 388
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 60/247 (24%), Positives = 100/247 (40%), Gaps = 39/247 (15%)
Query: 402 LAEGGFGSVHRGVLPD-GQVVAVKQYKLAS--SQGDQE-FCSEVEVLSCAQHRNVVMLIG 457
+ G FG V L + +V A+K + + F E +VL + + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140
Query: 458 FCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIA--VGAARGLRYLHEECRV 514
+ +D L LV +Y G L + L + E AR +A V A + +H+
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA---IDSVHQLH-- 195
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLA-RWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
VHRD++P+NIL+ + + DFG + DG + V GT Y++PE Q+ +
Sbjct: 196 --YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAME 252
Query: 574 ITEK-----ADVYSLGVVLVELITGR-----------------KAMDLNRPRGQQCLTEW 611
+ D +SLGV + E++ G P ++E
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSEN 312
Query: 612 ARPLLKR 618
A+ L++R
Sbjct: 313 AKDLIRR 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 53/231 (22%), Positives = 84/231 (36%), Gaps = 52/231 (22%)
Query: 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFC----SEVEVLSCA 447
+RF +G FG+V G G VA+K+ D F ++ L+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVL 76
Query: 448 QHRNVVMLIGFCVEDGRR-------LLVYEYICNGSLDSH----LYGRDRDPLEWSARRK 496
H N+V L + G R +V EY+ H Y R + +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV---PDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 497 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILV---THDFEPLVGDFGLARWQPDGDMGV 553
R + LH + HRD++P+N+LV + + DFG A+ + V
Sbjct: 134 FLFQLIRSIGCLHLPSV--NVCHRDIKPHNVLVNEADGTLK--LCDFGSAKKLSPSEPNV 189
Query: 554 E---TRVLGTFGYLAPE-------YAQSGQITEKADVYSLGVVLVELITGR 594
+R Y APE Y T D++S+G + E++ G
Sbjct: 190 AYICSRY-----YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSCA 447
+ + + G +G+V V G VA+K KL + F E+ +L
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHM 81
Query: 448 QHRNVVMLIG-FCVEDGRRLLVYEYICNGSLDSHLYGRDR-DPLEWSARRKIAVGAARGL 505
+H NV+ L+ F ++ Y+ + + L + + L + + +GL
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 506 RYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG--VETRVLGTFGY 563
RY+H I+HRD++P N+ V D E + DFGLAR Q D +M V TR Y
Sbjct: 142 RYIHA----AGIIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGYVVTRW-----Y 191
Query: 564 LAPEYA-QSGQITEKADVYSLGVVLVELITGR 594
APE + T+ D++S+G ++ E+ITG+
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 35/221 (15%)
Query: 394 NRFSEANFLAEGGFGSVHRG--VLPDGQVVAVKQYKLASSQGDQE---FCS----EVEVL 444
++ + EG +G V + + G+ VA+K+ ++ EV VL
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVL 65
Query: 445 ---SCAQHRNVVMLIGFCVEDGRRL-----LVYEYICNGSLDSHLYGRDRDPLEWSARRK 496
+H NVV L C LV+E+ + L ++L + +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKD 124
Query: 497 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE-- 554
+ RGL +LH +VHRD++P NILVT + + DFGLAR +
Sbjct: 125 MMFQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARI-----YSFQMA 175
Query: 555 -TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
T V+ T Y APE D++S+G + E+ +
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 55/231 (23%), Positives = 90/231 (38%), Gaps = 51/231 (22%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE---FCS----EVEVLS 445
+++ + + +G FG V + GQ VA+K+ + + E F E+++L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-----ENEKEGFPITALREIKILQ 71
Query: 446 CAQHRNVVMLIGFCVEDGRRL--------LVYEYICN---GSLDSHLYGRDRDPLEWSAR 494
+H NVV LI C LV+++ + G L + S
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEI 126
Query: 495 RKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW--QPDGDMG 552
+++ GL Y+H I+HRDM+ N+L+T D + DFGLAR
Sbjct: 127 KRVMQMLLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 553 VE--TRVLGTFGYLAPE-------YAQSGQITEKADVYSLGVVLVELITGR 594
RV+ T Y PE Y D++ G ++ E+ T
Sbjct: 183 NRYTNRVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 45/224 (20%)
Query: 393 TNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCS-EVEVLSCAQHRN 451
++ + G FG V + L + VA+K+ D+ F + E++++ +H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPN 93
Query: 452 VVMLIGFCVEDGRRL------LVYEYICNGSLDSH----LYGRDRDPLEWSARRKIAVGA 501
VV L F +G + LV EY+ + Y + + + +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYV---PETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 502 ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL-VGDFGLARWQPDGDMGVE---TRV 557
R L Y+H I HRD++P N+L+ L + DFG A+ G+ V +R
Sbjct: 151 LRSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY 206
Query: 558 LGTFGYLAPE-------YAQSGQITEKADVYSLGVVLVELITGR 594
Y APE Y T D++S G V+ EL+ G+
Sbjct: 207 -----YRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 9e-15
Identities = 50/207 (24%), Positives = 77/207 (37%), Gaps = 33/207 (15%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS-EVEVLSCAQHRNVVMLIGFC 459
+ G FG ++VAVK + E E+ +H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKY--IERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRK----IAVGAARGLRYLHEECRVG 515
+ ++ EY G L + R E AR ++ G+ Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFS-EDEARFFFQQLLS-----GVSYCHSMQ--- 136
Query: 516 CIVHRDMRPNNILVTHDFEPL--VGDFGLARWQPDGDMGVETRVLGTFGYLAPE------ 567
I HRD++ N L+ P + DFG ++ ++ V GT Y+APE
Sbjct: 137 -ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV-GTPAYIAPEVLLRQE 193
Query: 568 YAQSGQITEKADVYSLGVVLVELITGR 594
Y G+ ADV+S GV L ++ G
Sbjct: 194 YD--GK---IADVWSCGVTLYVMLVGA 215
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 405 GGFGSV----HRGVLPDGQVVAVKQYKLAS--SQGDQE-FCSEVEVLSCAQHRNVVMLIG 457
G FG V H+ +V A+K + D F E ++++ A VV L
Sbjct: 80 GAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 458 FCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIA-VGAARGLRYLHEECRVG 515
+ +D R L +V EY+ G L + + + D E AR A V A L +H
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLA--LDAIHSMG--- 188
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPEYAQS--- 571
+HRD++P+N+L+ + DFG + + + V GT Y++PE +S
Sbjct: 189 -FIHRDVKPDNMLLDKSGHLKLADFGTCM-KMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 572 -GQITEKADVYSLGVVLVELITGR 594
G + D +S+GV L E++ G
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 54/199 (27%), Positives = 78/199 (39%), Gaps = 18/199 (9%)
Query: 402 LAEGGFGSVHRGVL-PDGQVVAVKQYKLAS-SQGDQEFC--SEVEVLSCAQHRNVVMLIG 457
L G FG V G A+K + Q +E +L +V L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 458 FCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC 516
F +D L +V EY+ G + SHL R + R A YLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHSLD---- 161
Query: 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPEYAQSGQIT 575
+++RD++P N+L+ V DFG A+ T L GT LAPE S
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYN 216
Query: 576 EKADVYSLGVVLVELITGR 594
+ D ++LGV++ E+ G
Sbjct: 217 KAVDWWALGVLIYEMAAGY 235
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 32/217 (14%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSCA 447
R+ + + G +GSV G VAVK KL+ E+ +L
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 448 QHRNVVMLI-----GFCVEDGRRL-LVYEYICNGSLDSHLYGRDR-DPLEWSARRKIAVG 500
+H NV+ L+ +E+ + LV + + L + L + +
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 501 AARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG--VETRVL 558
RGL+Y+H I+HRD++P+N+ V D E + DFGLAR +M V TR
Sbjct: 141 ILRGLKYIHS----ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGYVATRW- 194
Query: 559 GTFGYLAPEYA-QSGQITEKADVYSLGVVLVELITGR 594
Y APE + D++S+G ++ EL+TGR
Sbjct: 195 ----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 67/259 (25%), Positives = 103/259 (39%), Gaps = 25/259 (9%)
Query: 351 EAVSLSRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELAT--NRFSEANF-----LA 403
E + + G + + E+ LA +R + F L
Sbjct: 98 EWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLG 157
Query: 404 EGGFGSV----HRGVLPDGQVVAVKQYKLAS-SQGDQEFCSEVE--VLSCAQHRNVVMLI 456
+G FG V + G+ A+K K D+ + E VL ++H + L
Sbjct: 158 KGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 457 GFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
+ + RL V EY G L HL R+R E AR A + L YLH E
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVS-ALDYLHSEKN-- 269
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQIT 575
+V+RD++ N+++ D + DFGL + ++T GT YLAPE +
Sbjct: 270 -VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYG 327
Query: 576 EKADVYSLGVVLVELITGR 594
D + LGVV+ E++ GR
Sbjct: 328 RAVDWWGLGVVMYEMMCGR 346
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 439 SEVEVLSCAQHRNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKI 497
E++++ +H +V L + +D + +V + + G L HL ++ E + + I
Sbjct: 64 KELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKEETVKLFI 121
Query: 498 A-VGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR 556
+ A L YL + I+HRDM+P+NIL+ + DF +A P T
Sbjct: 122 CELVMA--LDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TT 173
Query: 557 VLGTFGYLAPEYAQSGQI---TEKADVYSLGVVLVELITGR 594
+ GT Y+APE S + + D +SLGV EL+ GR
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSCA 447
R++ +++ EG +G V + VA+K K++ + Q +C E+++L
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--KISPFE-HQTYCQRTLREIKILLRF 82
Query: 448 QHRNVVMLIGFCVEDGRRL-----LVYEYICNGSLDSHLYGRDR-DPLEWSARRKIAVGA 501
+H N++ + +V + +++ LY + L
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICYFLYQI 137
Query: 502 ARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-WQPDGDMG------VE 554
RGL+Y+H ++HRD++P+N+L+ + + DFGLAR PD D V
Sbjct: 138 LRGLKYIHS----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 555 TRVLGTFGYLAPEYA-QSGQITEKADVYSLGVVLVELITGR 594
TR Y APE S T+ D++S+G +L E+++ R
Sbjct: 194 TR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 6e-13
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYKLAS--SQGDQEFCSEVE--VLSCAQHRNVV 453
L +GG+G V G++ A+K K A ++ E +L +H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 454 MLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIA-VGAARGLRYLHEE 511
LI + + G +L L+ EY+ G L L R+ +E +A +A + A L +LH++
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLAEISMA--LGHLHQK 140
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS 571
I++RD++P NI++ H + DFGL + T GT Y+APE
Sbjct: 141 G----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMAPEILMR 195
Query: 572 GQITEKADVYSLGVVLVELITGR 594
D +SLG ++ +++TG
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGA 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 6e-13
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYKLAS-SQGDQEFC-SEVEVLSCAQHRNVVML 455
L +G FG V Q+ A+K K A+ D+ E ++L H +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 456 IGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIA-VGAARGLRYLHEECR 513
+ + +L L+ +++ G L + L ++ E + +A + A L +LH
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLAELALA--LDHLHSLG- 146
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
I++RD++P NIL+ + + DFGL++ D + + GT Y+APE
Sbjct: 147 ---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRG 202
Query: 574 ITEKADVYSLGVVLVELITGR 594
T+ AD +S GV++ E++TG
Sbjct: 203 HTQSADWWSFGVLMFEMLTGT 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 9e-13
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 36/208 (17%)
Query: 402 LAEGGFGSVHRGVL----PDGQVVAVKQYKLAS-SQGDQEFC--SEVEVLSCAQHRNVVM 454
L G FG VH L +G+ A+K K + Q E +LS H ++
Sbjct: 14 LGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 455 LIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIA-VGAARGLRYLHEEC 512
+ +D +++ ++ +YI G L S L + + A+ A V A L YLH +
Sbjct: 71 MW-GTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLA--LEYLHSKD 126
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVG-----DFGLARWQPDGDMGVETRVL-GTFGYLAP 566
I++RD++P NIL+ + G DFG A++ PD T L GT Y+AP
Sbjct: 127 ----IIYRDLKPENILLDKN-----GHIKITDFGFAKYVPD-----VTYTLCGTPDYIAP 172
Query: 567 EYAQSGQITEKADVYSLGVVLVELITGR 594
E + + D +S G+++ E++ G
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 37/226 (16%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSCA 447
+R+ + L GG G V V + VA+K K+ + D + E++++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK--KIVLT--DPQSVKHALREIKIIRRL 65
Query: 448 QHRNVVMLIGFCVEDGRRLLVYEYICNGSLD----SHLYGRD------RDPLEWSARRKI 497
H N+V + G +L D + PL R
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF 125
Query: 498 AVGAARGLRYLHEECRVGCIVHRDMRPNNILV-THDFEPLVGDFGLAR-----WQPDGDM 551
RGL+Y+H ++HRD++P N+ + T D +GDFGLAR + G +
Sbjct: 126 MYQLLRGLKYIHS----ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 552 --GVETRVLGTFGYLAPE-YAQSGQITEKADVYSLGVVLVELITGR 594
G+ T+ Y +P T+ D+++ G + E++TG+
Sbjct: 182 SEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 52/253 (20%), Positives = 90/253 (35%), Gaps = 43/253 (16%)
Query: 436 EFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARR 495
+ V + R + + + + + + + +D L
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI 196
Query: 496 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVET 555
+ A+G+ +L R CI HRD+ NIL++ + DFGLAR
Sbjct: 197 CYSFQVAKGMEFL--ASR-KCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDP----D 248
Query: 556 RVLGTFGYL-----APEYAQSGQITEKADVYSLGVVLVELIT-GRK---AMDLNRPRGQQ 606
V L APE T ++DV+S GV+L E+ + G + ++
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 303
Query: 607 CLTEWARPLLKRHAIGELIDPRLR---NCYSEREVYG-MLQCASLCIRKDPHSRPRMSQV 662
E+ R L + R+R E+Y ML C +P RP S++
Sbjct: 304 ---EFCRRLKEGT--------RMRAPDYT--TPEMYQTMLDCWH----GEPSQRPTFSEL 346
Query: 663 LRMLEGDILMNSK 675
+ L + N++
Sbjct: 347 VEHLGNLLQANAQ 359
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 26/89 (29%), Positives = 40/89 (44%), Gaps = 9/89 (10%)
Query: 402 LAEGGFGSVHRGVL------PDGQVVAVKQYK-LASSQGDQEFCSEVEVLSCA-QHRNVV 453
L G FG V + VAVK K A+ + SE+++L H NVV
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 454 MLIGFC-VEDGRRLLVYEYICNGSLDSHL 481
L+G C G +++ E+ G+L ++L
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 47/238 (19%), Positives = 90/238 (37%), Gaps = 45/238 (18%)
Query: 380 PPRWFTYAELELA---TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQ 435
P ++ Y + + + L G + V + + + + V VK K +
Sbjct: 19 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KK 75
Query: 436 EFCSEVEVL-SCAQHRNVVMLIGFCV----EDGRRLLVYEYICNGSLDSHLYGRDRDPLE 490
+ E+++L + N++ L + LV+E++ N L
Sbjct: 76 KIKREIKILENLRGGPNIITLA--DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLT 128
Query: 491 WSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL-VGDFGLAR-WQPD 548
R + L Y H I+HRD++P+N+++ H+ L + D+GLA + P
Sbjct: 129 DYDIRFYMYEILKALDYCHS----MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184
Query: 549 GDMGVE--TRVLGTFGYLAPE-------YAQSGQITEKADVYSLGVVLVELITGRKAM 597
+ V +R + PE Y S D++SLG +L +I ++
Sbjct: 185 QEYNVRVASRY-----FKGPELLVDYQMYDYS------LDMWSLGCMLASMIFRKEPF 231
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 47/238 (19%), Positives = 84/238 (35%), Gaps = 45/238 (18%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSCA 447
+ + + + G +G V+ + VA+K K+ D C E+ +L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRL 82
Query: 448 QHRNVVMLIG-FCVEDGRRL----LVYEYICNGSLDSHLYG--RDRDPLEWSARRKIAVG 500
+ ++ L +D + +V E DS L + L + I
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEI-----ADSDLKKLFKTPIFLTEEHIKTILYN 137
Query: 501 AARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-WQPDGDMGVETRVLG 559
G ++HE I+HRD++P N L+ D V DFGLAR + D + +
Sbjct: 138 LLLGENFIHE----SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 560 TFGYLAPEYAQSGQITE--------------------KA-DVYSLGVVLVELITGRKA 596
Q+T K+ D++S G + EL+ ++
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 44/215 (20%), Positives = 84/215 (39%), Gaps = 31/215 (14%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSC-----------AQH 449
L G F +V + + VA+K + + E+++L
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE-DEIKLLQRVNDADNTKEDSMGA 85
Query: 450 RNVVMLIG---FCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGL 505
+++ L+ +G + +V+E + +L + + + + ++I+ GL
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144
Query: 506 RYLHEECRVGCIVHRDMRPNNILVTHDFEPL------VGDFGLARWQPDGDMGVETRVLG 559
Y+H C I+H D++P N+L+ P + D G A W + T +
Sbjct: 145 DYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HYTNSIQ 197
Query: 560 TFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
T Y +PE AD++S ++ ELITG
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 29/102 (28%), Positives = 45/102 (44%), Gaps = 14/102 (13%)
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG 562
R ++ LH ++HRD++P+N+L+ + + V DFGLAR + G
Sbjct: 123 RAVKVLHG----SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 563 ---------YLAPEYAQSGQI-TEKADVYSLGVVLVELITGR 594
Y APE + + DV+S G +L EL R
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYKLAS--SQGDQEFCSEVE--VLSCAQHRN-V 452
L G +G V G++ A+K K A+ + + E VL + +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 453 VMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIA-VGAARGLRYLHE 510
V L + + +L L+ +YI G L +HL R+R + + + A L +LH+
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-VQIYVGEIVLA--LEHLHK 177
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPE-- 567
G I++RD++ NIL+ + ++ DFGL++ + D GT Y+AP+
Sbjct: 178 L---G-IIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEYMAPDIV 232
Query: 568 -YAQSGQITEKADVYSLGVVLVELITGR 594
SG + D +SLGV++ EL+TG
Sbjct: 233 RGGDSGH-DKAVDWWSLGVLMYELLTGA 259
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 28/113 (24%), Positives = 47/113 (41%), Gaps = 25/113 (22%)
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG 562
+ ++YLH G ++HRDM+P+NIL+ + V DFGL+R + L
Sbjct: 120 KVIKYLHS----GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 563 YLAPEYAQSGQITE--------------------KA-DVYSLGVVLVELITGR 594
+T+ K D++SLG +L E++ G+
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 54/250 (21%), Positives = 84/250 (33%), Gaps = 46/250 (18%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS----EVEVLSCA 447
+R+ + + G +G V + +VVA+K K+ D C E+ +L+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRL 109
Query: 448 QHRNVV----MLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAA 502
H +VV ++I VE L +V E D R L + +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA---DSDFKKLFRTPVYLTELHIKTLLYNLL 166
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR------WQPDGDMGVETR 556
G++Y+H I+HRD++P N LV D V DFGLAR
Sbjct: 167 VGVKYVHS----AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 557 VLGTFGYLAPEYAQSGQITE--------------------KA-DVYSLGVVLVELITGRK 595
Q+T +A DV+S+G + EL+ K
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282
Query: 596 AMDLNRPRGQ 605
Sbjct: 283 ENVAYHADRG 292
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 51/258 (19%), Positives = 89/258 (34%), Gaps = 72/258 (27%)
Query: 389 LELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS-EVEVLSC 446
LE ++ ++S L G FG V + G+ A+K+ D + + E++++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKV 56
Query: 447 AQHRNVVMLIGFCVEDGRRL--------------------------------------LV 468
H N++ L+ + G ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 469 YEYI-CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNI 527
EY+ + R + + R + ++H I HRD++P N+
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS----LGICHRDIKPQNL 172
Query: 528 LVTHDFEPL-VGDFGLARWQPDGDMGVE---TRVLGTFGYLAPE-------YAQSGQITE 576
LV L + DFG A+ + V +R Y APE Y T
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY------TP 221
Query: 577 KADVYSLGVVLVELITGR 594
D++S+G V ELI G+
Sbjct: 222 SIDLWSIGCVFGELILGK 239
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 46/201 (22%), Positives = 73/201 (36%), Gaps = 53/201 (26%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCS-EVEVL-SCAQHRNVVMLIGF 458
L G G V + + A+K + D EVE+ +Q ++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWRASQCPHIVRIVDV 79
Query: 459 CVEDGRR-----LLVYEYICNGSLDSHLYGRDRDPL-EWSAR---RKIAVGAARGLRYLH 509
E+ L+V E + G L S + R E A + I ++YLH
Sbjct: 80 Y-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG----EAIQYLH 134
Query: 510 EECRVGCIVHRDMRPNNILVTHDFE--PL-VGDFGLARWQPDGDMGVETRVLGTFGYLAP 566
I HRD++P N+L T L + DFG A+ G Y
Sbjct: 135 SIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTGE-KY--- 175
Query: 567 EYAQSGQITEKADVYSLGVVL 587
+ D++SLGV++
Sbjct: 176 --------DKSCDMWSLGVIM 188
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 9e-10
Identities = 58/202 (28%), Positives = 85/202 (42%), Gaps = 21/202 (10%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYKLAS-SQGDQEFCSEVE--VLSCAQHRNVVM 454
L +G FG V + G+ A+K + D+ + E VL +H +
Sbjct: 13 LGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 455 LIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
L + + RL V EY G L HL R+R E AR A L YLH
Sbjct: 70 LK-YAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGA-EIVSALEYLHSRD- 125
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPEYAQSG 572
+V+RD++ N+++ D + DFGL + G + GT YLAPE +
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 573 QITEKADVYSLGVVLVELITGR 594
D + LGVV+ E++ GR
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR 202
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 52/264 (19%), Positives = 84/264 (31%), Gaps = 71/264 (26%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSC----- 446
R+ L G F +V + + VA+K K A + E+ +L
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSD 94
Query: 447 ---AQHRNVVMLIG-FCVE--DGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV 499
VV L+ F + +G + +V+E + L + + L +KI
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 500 GAARGLRYLHEECRVGCIVHRDMRPNNILVT----------------------------- 530
+GL YLH +CR I+H D++P NIL++
Sbjct: 154 QVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 531 --------------------HDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQ 570
+ + D G A W T + T Y + E
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQYRSLEVLI 266
Query: 571 SGQITEKADVYSLGVVLVELITGR 594
AD++S + EL TG
Sbjct: 267 GSGYNTPADIWSTACMAFELATGD 290
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.6 bits (146), Expect = 1e-09
Identities = 76/526 (14%), Positives = 139/526 (26%), Gaps = 170/526 (32%)
Query: 1 MKQKGGFSELVVGKVVIVA-VKASKEIPRS---ALVWA-LTHVVQPGDYIKLLVVMPPLS 55
+ G GK + V S ++ + W L + P +++L +
Sbjct: 158 V---LGS-----GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL---- 205
Query: 56 SSKKIWGFSRFT-NDCATGHKSSLSGTSSDQKDDIVDSCSQMMRQ---------LQEVYD 105
+ N + SS + I ++++ L V +
Sbjct: 206 -------LYQIDPNWTSRSDHSS---NIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN 255
Query: 106 PEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEKKCCMEELQCNVVVMKRSQP 165
+ + L C +++ R +
Sbjct: 256 AKAWNA--------------------------FN-------------LSCKILLTTRFKQ 276
Query: 166 KVLRLNLVASPTMKSQVARSETF----SLEVSPKYLKSKHDD-PYMMKGPFVTPASSPEQ 220
L+ A+ T S S T + KYL + D P + ++P +
Sbjct: 277 VTDFLS-AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT------TNPRR 329
Query: 221 ESLLTATDVGTSSISSSDPGTFSEI----CENLKK--ECS---LVSEERQDR------FG 265
S++ + T+ C+ L E S L E + F
Sbjct: 330 LSIIAESI-------RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP 382
Query: 266 PDSDSDCEVLCLPSTSSNHDPWMAESLSPREEFLKLLEGSS--ERTNDPSLTSAYEFLLE 323
P + +L L W S + L S E+ S S LE
Sbjct: 383 PSAHIPTILLSL--------IWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLE 434
Query: 324 KLSTLNREPDIGVLNYKLDLKISKSVREAVSLSRNKPP---GPPPLCS-ICQH------- 372
L E L+ +S+ + ++ + PP L H
Sbjct: 435 LKVKLENEYA---LH--------RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN 483
Query: 373 -----KAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYK 427
+ +F F L+ RF E + + +L Q +K YK
Sbjct: 484 IEHPERMTLF---RMVF----LDF---RFLEQKIRHDSTAWNASGSILNTLQQ--LKFYK 531
Query: 428 LASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYIC 473
D ++ R V ++ F + L+ +Y
Sbjct: 532 PYICDNDPKY-----------ERLVNAILDFLPKIEENLICSKYTD 566
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 3e-08
Identities = 63/436 (14%), Positives = 116/436 (26%), Gaps = 104/436 (23%)
Query: 227 TDVGTSSISSSDPGTFSEICENLKK--ECSLVSEERQDRFGPDSDSDC-EVLCLPSTSSN 283
+ G D S + +C V + + S + ++ S
Sbjct: 9 FETGEHQYQYKD--ILSVFEDAFVDNFDCKDVQDMPKSIL---SKEEIDHIIMSKDAVSG 63
Query: 284 HDPWMAESLSPREEFLKLLEGSSERTNDPSLTSAYEFLLEKLSTLNREPDIGVLNYKLDL 343
LS +EE ++ R N Y+FL+ + T R+P + Y
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEEVLRIN-------YKFLMSPIKTEQRQPSMMTRMY---- 112
Query: 344 KISKSVREAVSLSRNKPPGPPPLCSICQHKAPVFGNPPRWFTYAELELATNRFSEANFLA 403
I + R L + N R Y +L A A +
Sbjct: 113 -IEQRDR----LYNDNQVFAK-------------YNVSRLQPYLKLRQALLELRPAKNVL 154
Query: 404 -EG--GFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVV-MLIGFC 459
+G G G K + +A + C +V C + + + C
Sbjct: 155 IDGVLGSG---------------KTW-VAL-----DVCLSYKVQ-CKMDFKIFWLNLKNC 192
Query: 460 VEDGRRL-----LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514
L L+Y+ N + S + + R L +
Sbjct: 193 NSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL--------RRLLKSKPYE 244
Query: 515 GC-IVHRDMRPNNILVTHDFE--PLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS 571
C +V +++ + L+ R V + S
Sbjct: 245 NCLLVLLNVQNAKAWNAFNLSCKILL----TTR-----FKQVTDFLSAATTTHISLDHHS 295
Query: 572 GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631
+T L+ + DL PR + T P + +I +R+
Sbjct: 296 MTLTPD---EVKS--LLLKYLDCRPQDL--PR-EVLTTN---PR----RLS-IIAESIRD 339
Query: 632 CYSEREVYGMLQCASL 647
+ + + + C L
Sbjct: 340 GLATWDNWKHVNCDKL 355
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 66/303 (21%), Positives = 114/303 (37%), Gaps = 29/303 (9%)
Query: 311 DPSLTSAYEFLLEKLSTLNREPDIGVLNYKLDLKISKSVREAVSLSRNKPPGPPPLCSIC 370
D LTS +F+ ++ GV + L + V + G L
Sbjct: 247 DWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKF 306
Query: 371 QHKAPVFGN------PPRWFTYAELELATNRFSEANF-----LAEGGFGSV----HRGVL 415
+ G + + +R +F L +G FG V +G
Sbjct: 307 ERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG-- 364
Query: 416 PDGQVVAVKQYKLAS-SQGDQEFCSEVE--VLSCAQHRNVVMLIGFCVEDGRRL-LVYEY 471
++ AVK K Q D C+ VE VL+ + + C + RL V EY
Sbjct: 365 -TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 423
Query: 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH 531
+ G L H+ R + A A GL +L + I++RD++ +N+++
Sbjct: 424 VNGGDLMYHIQQVGRFKEPHA--VFYAAEIAIGLFFLQSKG----IIYRDLKLDNVMLDS 477
Query: 532 DFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELI 591
+ + DFG+ + + +T GT Y+APE + D ++ GV+L E++
Sbjct: 478 EGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536
Query: 592 TGR 594
G+
Sbjct: 537 AGQ 539
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYKLAS-SQGDQEFCSEVE--VLS-CAQHRNVV 453
+ +G FG V H+ + AVK + + + +E E VL +H +V
Sbjct: 46 IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 454 MLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC 512
L F + +L V +YI G L HL R+R LE AR A A L YLH
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAA-EIASALGYLHSLN 159
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPEYAQS 571
IV+RD++P NIL+ ++ DFGL + + + T GT YLAPE
Sbjct: 160 ----IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHK 213
Query: 572 GQITEKADVYSLGVVLVELITGR 594
D + LG VL E++ G
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYKLAS-SQGDQEFCSEVE--VLSCA-QHRNVV 453
L +G FG V +G ++ AVK K Q D C+ VE VL+ + +
Sbjct: 28 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 454 MLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC 512
L C + RL V EY+ G L H+ R + A A GL +L +
Sbjct: 85 QLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA--VFYAAEIAIGLFFLQSKG 141
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPEYAQS 571
I++RD++ +N+++ + + DFG+ + + GV T+ GT Y+APE
Sbjct: 142 ----IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAY 195
Query: 572 GQITEKADVYSLGVVLVELITGR 594
+ D ++ GV+L E++ G+
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 26/205 (12%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYKLAS-SQGDQEFCSEVE--VLSCA-QHRNVV 453
L +G FG V + Q A+K K D C+ VE VLS A +H +
Sbjct: 25 LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 454 MLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC 512
+ + L V EY+ G L H+ + L + A GL++LH +
Sbjct: 82 HMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA--TFYAAEIILGLQFLHSKG 138
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL---GTFGYLAPEYA 569
IV+RD++ +NIL+ D + DFG+ + +M + + GT Y+APE
Sbjct: 139 ----IVYRDLKLDNILLDKDGHIKIADFGMCK----ENMLGDAKTNTFCGTPDYIAPEIL 190
Query: 570 QSGQITEKADVYSLGVVLVELITGR 594
+ D +S GV+L E++ G+
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 5e-09
Identities = 36/234 (15%), Positives = 61/234 (26%), Gaps = 57/234 (24%)
Query: 368 SICQHKAPVFGNPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYK 427
C K PV F++ L T + + EG FG V + + D VA+K
Sbjct: 3 GECSQKGPV------PFSHC---LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIA 52
Query: 428 LASSQGDQ--------EFCSEVEVL---------SCAQHRNVVMLIGFCVEDGR--RLLV 468
+ E E+ + C + + L G LL+
Sbjct: 53 IEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLL 112
Query: 469 YEYIC----NGSLDSHLYGRDRDPL---------------------EWSARRKIAVGAAR 503
+ GS + D L + + I
Sbjct: 113 KAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTA 172
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV 557
L R HRD+ N+L+ + + G++ +
Sbjct: 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 400 NFLA---EGGFGSV----HRGVLPDGQVVAVKQYKLAS-SQGDQEFCSEVE--VLSCA-Q 448
F+ +G FG V + G + AVK K Q D C+ E +LS A
Sbjct: 26 EFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 449 HRNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRY 507
H + L C + RL V E++ G L H+ R + R A L +
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA--RFYAAEIISALMF 139
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAP 566
LH++ I++RD++ +N+L+ H+ + DFG+ + GV T GT Y+AP
Sbjct: 140 LHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAP 193
Query: 567 EYAQSGQITEKADVYSLGVVLVELITGR 594
E Q D +++GV+L E++ G
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 33/221 (14%)
Query: 392 ATNRFSEANF-----LAEGGFGSV----HRGVLPDGQVVAVKQYKLAS-SQGDQEFCSEV 441
A + +F + G + V + ++ A+K K + + +
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQT 58
Query: 442 E--VLSCA-QHRNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSAR--- 494
E V A H +V L C + RL V EY+ G L H+ R R E AR
Sbjct: 59 EKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYS 116
Query: 495 RKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554
+I++ L YLHE I++RD++ +N+L+ + + D+G+ + G
Sbjct: 117 AEISLA----LNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDT 166
Query: 555 TRVL-GTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
T GT Y+APE + D ++LGV++ E++ GR
Sbjct: 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 28/206 (13%)
Query: 402 LAEGGFGSV----HRGVLPDGQVVAVKQYKLAS-SQGDQEFCSEVE--VLSCA-QHRNVV 453
+ G + V + ++ A++ K + + + E V A H +V
Sbjct: 60 IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 454 MLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSAR---RKIAVGAARGLRYLH 509
L C + RL V EY+ G L H+ R R E AR +I++ L YLH
Sbjct: 117 GLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLA----LNYLH 170
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVL-GTFGYLAPEY 568
E I++RD++ +N+L+ + + D+G+ + G T GT Y+APE
Sbjct: 171 ERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEI 224
Query: 569 AQSGQITEKADVYSLGVVLVELITGR 594
+ D ++LGV++ E++ GR
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 48/225 (21%), Positives = 83/225 (36%), Gaps = 39/225 (17%)
Query: 390 ELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVK------QYKLASSQGDQEFCSEVE 442
E +R+ + + +G FG V + + + VA+K + + EV
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-------QIEVR 102
Query: 443 VLSCAQHR------NVVMLIGFCVEDGRRLLVYEYICNGSLDSHLY----GRDRDPLEWS 492
+L +V L + LV+E L +LY + + +
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLN 157
Query: 493 ARRKIAVGAARGLRYLH-EECRVGCIVHRDMRPNNILVTHDFEPL--VGDFGLARWQPDG 549
RK A L +L E I+H D++P NIL+ + + DFG +
Sbjct: 158 LTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ- 213
Query: 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
+ + + Y +PE D++SLG +LVE+ TG
Sbjct: 214 ---RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 51/229 (22%), Positives = 82/229 (35%), Gaps = 55/229 (24%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVK------QYKLASSQGDQEFCSEVEVLS 445
R+ + +G FG V + Q VA+K ++ + E+ +L
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-------AEEIRILE 148
Query: 446 C------AQHRNVVMLIGF-------CV--EDGRRLL---VYEYICNGSLDSHLYGRDRD 487
NV+ ++ C+ E LL +YE I
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICMTFE----LLSMNLYELIKKNKFQ--------- 195
Query: 488 PLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL--VGDFGLARW 545
RK A + L LH+ R I+H D++P NIL+ V DFG + +
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHK-NR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251
Query: 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
+ + + Y APE + D++SLG +L EL+TG
Sbjct: 252 EHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 43/223 (19%), Positives = 76/223 (34%), Gaps = 39/223 (17%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQH-RN 451
F + G FG + G L + VA+K S+ Q E
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP-MKSRAPQ-LHLEYRFYKQLGSGDG 66
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRD-RDPLEWSARR-------KIAVGAAR 503
+ + F +V E L G D + R IA+
Sbjct: 67 IPQVYYFGPCGKYNAMVLE----------LLGPSLEDLFDLCDRTFSLKTVLMIAIQLIS 116
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILV----THDFEPL-VGDFGLARWQPDGDMGV----- 553
+ Y+H + +++RD++P N L+ + + + DF LA+ D +
Sbjct: 117 RMEYVHSKN----LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 554 ETRVL-GTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGR 594
E + L GT Y G + + + D+ +LG + + + G
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 44/213 (20%), Positives = 80/213 (37%), Gaps = 37/213 (17%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQH-RNVVMLIGFC 459
+ G FG ++ G + G+ VA+K + + + E ++ Q + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRD-RDPLEWSARR-------KIAVGAARGLRYLHEE 511
E ++V E L G D + +R+ +A + Y+H +
Sbjct: 75 AEGDYNVMVME----------LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 512 CRVGCIVHRDMRPNNILV---THDFEPLVGDFGLAR--WQPDGDMGVETR----VLGTFG 562
+HRD++P+N L+ + DFGLA+ + R + GT
Sbjct: 125 N----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 563 YLAPEYAQSG-QITEKADVYSLGVVLVELITGR 594
Y A G + + + D+ SLG VL+ G
Sbjct: 181 Y-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 48/257 (18%), Positives = 81/257 (31%), Gaps = 85/257 (33%)
Query: 390 ELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVK------QYKLASSQGDQEFCSEVE 442
L N F + +G FG V + + + AVK +Y ++ E +
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK-------IEAD 83
Query: 443 VLSC-----AQHRNVVMLIGF-------CVEDGRRLLVYEYICNGSLDSHLY----GRDR 486
+L + N+V G C L++E L LY +
Sbjct: 84 ILKKIQNDDINNNNIVKYHGKFMYYDHMC-------LIFE-----PLGPSLYEIITRNNY 131
Query: 487 DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546
+ + + + L YL + + H D++P NIL+ P + +
Sbjct: 132 NGFHIEDIKLYCIEILKALNYLRK-MS---LTHTDLKPENILLDD---PYFEKSLITVRR 184
Query: 547 PDGDMGVETRVLGT-------FG-----------------YLAPE------YAQSGQITE 576
++ + FG Y APE + S
Sbjct: 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVS----- 239
Query: 577 KADVYSLGVVLVELITG 593
+D++S G VL EL TG
Sbjct: 240 -SDMWSFGCVLAELYTG 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 46/215 (21%), Positives = 78/215 (36%), Gaps = 39/215 (18%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQH-RNVVMLIGFC 459
+ EG FG + G L + Q VA+K S + E + + F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRD-RDPLEWSARR-------KIAVGAARGLRYLHEE 511
E +LV + L G D L+ R+ A ++ +HE+
Sbjct: 76 QEGLHNVLVID----------LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 512 CRVGCIVHRDMRPNNILVTHDFEP-----LVGDFGLARWQPDGDMGV-----ETRVL-GT 560
+V+RD++P+N L+ V DFG+ ++ D E + L GT
Sbjct: 126 S----LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 561 FGYLAPEYAQSG-QITEKADVYSLGVVLVELITGR 594
Y G + + + D+ +LG V + + G
Sbjct: 182 ARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 50/245 (20%), Positives = 80/245 (32%), Gaps = 71/245 (28%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV--LPDGQVVAVK------QYKLASSQGDQEFCSEVEVL 444
R+ L EG FG V + VA+K +Y+ A+ E+ VL
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-------RLEINVL 70
Query: 445 SC------AQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLY----GRDRDPLEWSAR 494
V++ + G + +E L + + + P
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHV 125
Query: 495 RKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG----- 549
R +A LR+LHE + + H D++P NIL + + + + +
Sbjct: 126 RHMAYQLCHALRFLHE-NQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 550 ---DMG------------VETRVLGTFGYLAPE------YAQSGQITEKADVYSLGVVLV 588
D G V TR Y PE +AQ DV+S+G +L
Sbjct: 182 RVADFGSATFDHEHHTTIVATRH-----YRPPEVILELGWAQP------CDVWSIGCILF 230
Query: 589 ELITG 593
E G
Sbjct: 231 EYYRG 235
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 46/213 (21%), Positives = 83/213 (38%), Gaps = 37/213 (17%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-HRNVVMLIGFC 459
+ G FG ++ G + + VA+K + + + E ++ Q + + F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRD-RDPLEWSARR-------KIAVGAARGLRYLHEE 511
VE +LV + L G D + +R+ +A + ++H +
Sbjct: 73 VEGDYNVLVMD----------LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 512 CRVGCIVHRDMRPNNILVTHDFEP---LVGDFGLARWQPDGDMGV-----ETRVL-GTFG 562
+HRD++P+N L+ + DFGLA+ D E + L GT
Sbjct: 123 S----FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 563 YLAPEYAQSG-QITEKADVYSLGVVLVELITGR 594
Y A G + + + D+ SLG VL+ + G
Sbjct: 179 Y-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 55/258 (21%), Positives = 88/258 (34%), Gaps = 91/258 (35%)
Query: 390 ELATNRFSEANFLAEGGFGSV-----HRGVLPDGQVVAVK------QYKLASSQGDQEFC 438
++ + R+ + L EG FG V H+ G+ VAVK +Y A+
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKA---GGRHVAVKIVKNVDRYCEAA-------R 59
Query: 439 SEVEVLSCAQHR------NVVMLIGF-------CVEDGRRLLVYEYICNGSLDSHLY--- 482
SE++VL V ++ + C +V+E L Y
Sbjct: 60 SEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC-------IVFE-----LLGLSTYDFI 107
Query: 483 -GRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541
P RK+A + + +LH + + H D++P NIL +
Sbjct: 108 KENGFLPFRLDHIRKMAYQICKSVNFLHS-NK---LTHTDLKPENILFVQSDYTEAYNPK 163
Query: 542 LARWQPDG--------DMG------------VETRVLGTFGYLAPE------YAQSGQIT 575
+ R + D G V TR Y APE ++Q
Sbjct: 164 IKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQP---- 214
Query: 576 EKADVYSLGVVLVELITG 593
DV+S+G +L+E G
Sbjct: 215 --CDVWSIGCILIEYYLG 230
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 41/247 (16%), Positives = 75/247 (30%), Gaps = 69/247 (27%)
Query: 394 NRFSEANFLAEGGFGSVHRGV---------LPDGQVVAVK----------QYKLASSQGD 434
++ +F G ++ P Q ++K +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 435 QEFCSEVEVLSCAQHRNVVMLIGFCVEDGR-RLLVYEYICNGSLDSHLYGRD-RDPLEWS 492
++ + L + +GF V + R LV GR + L+ S
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP----------SLGRSLQSALDVS 151
Query: 493 ARRK--------IAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLV--GDFGL 542
+ +A L +LHE VH ++ NI V + + V +G
Sbjct: 152 PKHVLSERSVLQVACRLLDALEFLHENE----YVHGNVTAENIFVDPEDQSQVTLAGYGF 207
Query: 543 A-RWQPDGD-----MGVETRVLGTFGYLAPEYA---------QSGQITEKADVYSLGVVL 587
A R+ P G G + G E+ S ++D+ SLG +
Sbjct: 208 AFRYCPSGKHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPS----RRSDLQSLGYCM 258
Query: 588 VELITGR 594
++ + G
Sbjct: 259 LKWLYGF 265
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 38/231 (16%), Positives = 74/231 (32%), Gaps = 56/231 (24%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
+ GGFG ++ + A K+ + F E++ ++ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIKKW-IER 102
Query: 461 EDGRRLLVYEYICNGSLDSH----------LYGRDRDPLE--WSARRK--------IAVG 500
+ L + + +G + G D L+ + +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID---LQKISGQNGTFKKSTVLQLGIR 159
Query: 501 AARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLV--GDFGLA-RWQPDG-----DMG 552
L Y+HE VH D++ N+L+ + V D+GL+ R+ P+G
Sbjct: 160 MLDVLEYIHENE----YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 553 VETRVLGTFGYLAPEYA---------QSGQITEKADVYSLGVVLVELITGR 594
GT E+ S ++DV LG ++ + G+
Sbjct: 216 PRKGHNGT-----IEFTSLDAHKGVALS----RRSDVEILGYCMLRWLCGK 257
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 678 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.83 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 98.66 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 98.61 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 98.51 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 98.5 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.49 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 98.47 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 98.46 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 98.45 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 98.44 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 98.42 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 98.41 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 98.38 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 98.29 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 98.2 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 98.19 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.13 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.1 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.02 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.02 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.99 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 97.94 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.86 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 97.78 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 97.74 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 97.73 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 97.72 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 97.66 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 97.64 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.6 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 97.55 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 97.49 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.46 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.37 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.17 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.92 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.89 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 96.67 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.57 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.57 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.47 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.33 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.08 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.03 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.03 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.93 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.13 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.92 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 88.56 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=447.68 Aligned_cols=261 Identities=28% Similarity=0.384 Sum_probs=209.1
Q ss_pred hhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
+..++|.+.+.||+|+||.||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++++|.+.+.
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 44578889999999999999999743 578999999976555555789999999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccCC-------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee
Q 038949 465 RLLVYEYICNGSLDSHLYGRD-------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH 531 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~-------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~ 531 (678)
+|||||||++|+|.+++.... ..++++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL----HFVHRDLATRNCLVGQ 193 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEET
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHhhEEECC
Confidence 999999999999999985432 34689999999999999999999998 9999999999999999
Q ss_pred cCccccccccccccccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhh
Q 038949 532 DFEPLVGDFGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLT 609 (678)
Q Consensus 532 ~~~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~ 609 (678)
++.+||+|||+++...... ........||+.|||||++.+..|+.++|||||||+||||+| |+.||..... .
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------~ 267 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------T 267 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------H
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH------H
Confidence 9999999999998654432 223345679999999999999999999999999999999999 8999964332 1
Q ss_pred hhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 610 EWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 610 ~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
+...... . ..+...+..++..+.+||.+||+.||++|||+.||++.|+....
T Consensus 268 ~~~~~i~-~---------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 268 EAIDCIT-Q---------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHH-H---------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHH-c---------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1111111 1 01122345566789999999999999999999999999987543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=443.65 Aligned_cols=260 Identities=28% Similarity=0.394 Sum_probs=214.0
Q ss_pred hhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
+..++|.+.+.||+|+||.||+|.+. +++.||||+++.......++|.+|+++|++++|||||+++++|.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 44578999999999999999999742 478899999976555555789999999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccC-----------CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC
Q 038949 465 RLLVYEYICNGSLDSHLYGR-----------DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF 533 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~-----------~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~ 533 (678)
+|||||||++|+|.++|... ....+++..+..++.||+.||.|||++ +||||||||+||||+.++
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENL 165 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGG
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccCHhhEEECCCC
Confidence 99999999999999999543 234699999999999999999999999 999999999999999999
Q ss_pred ccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhh
Q 038949 534 EPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEW 611 (678)
Q Consensus 534 ~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~ 611 (678)
.+||+|||+++....... .......||+.|||||++.++.|+.++|||||||+||||+| |+.||..... .+.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------~~~ 239 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEV 239 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHH
Confidence 999999999986543322 22234679999999999999999999999999999999998 8999965432 111
Q ss_pred hHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 612 ARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 612 ~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
..... .. .....+..++..+.+||.+||+.||++|||+++|++.|+...
T Consensus 240 ~~~i~-~~---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 240 IECIT-QG---------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHHH-HT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHH-cC---------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111 10 112234556678999999999999999999999999998654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=439.71 Aligned_cols=258 Identities=25% Similarity=0.348 Sum_probs=211.2
Q ss_pred hhhcCCcccceecccCccceeeccC------CCCcEEEEEeeehhcccC-CccccccceeeecccccceEEEEeEEeeCC
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASSQG-DQEFCSEVEVLSCAQHRNVVMLIGFCVEDG 463 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~~~~-~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 463 (678)
+....+++.+.||+|+||.||+|.+ .+++.||||+++...... .++|.+|+.++++++|||||+++|+|.+++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 3456678889999999999999985 246789999997543332 357999999999999999999999999999
Q ss_pred eEEEEEEEeecCCcccccccCC--------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe
Q 038949 464 RRLLVYEYICNGSLDSHLYGRD--------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV 529 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl 529 (678)
.++||||||++|+|.++|..+. ...+++..+..++.||+.||+|||++ +||||||||+||||
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLK~~NILl 178 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH----HVVHKDLATRNVLV 178 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEE
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCccccceEE
Confidence 9999999999999999995432 24588999999999999999999999 99999999999999
Q ss_pred eecCccccccccccccccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccch
Q 038949 530 THDFEPLVGDFGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQC 607 (678)
Q Consensus 530 ~~~~~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~ 607 (678)
+.++.+||+|||+++.....+ ........||+.|||||++.++.|+.++|||||||+||||+| |..||.....
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~----- 253 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----- 253 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-----
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-----
Confidence 999999999999998654322 223344679999999999999999999999999999999998 8999965332
Q ss_pred hhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 608 LTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 608 l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
.+.... +. .......+..++..+.+|+.+||+.||++||||.+|++.|+.
T Consensus 254 -~~~~~~-i~---------~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 254 -QDVVEM-IR---------NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp -HHHHHH-HH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -HHHHHH-HH---------cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111111 11 111122455667789999999999999999999999999985
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=433.59 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=207.0
Q ss_pred hhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
.|++..++|.+.+.||+|+||.||+|++.+ .||||+++.... +..+.|.+|+.+|++++|||||++++++.+ +.+
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 357778899999999999999999999743 599999874332 223579999999999999999999998865 568
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|||||||+||+|.+++... ..++++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.
T Consensus 107 ~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~----~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAK----NIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp EEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred EEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 9999999999999999643 34699999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCC-ccceeEEEeeecccccccccc---cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 546 QPDGD-MGVETRVLGTFGYLAPEYAQS---GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 546 ~~~~~-~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
..... .......+||+.|||||++.+ +.|+.++|||||||+||||+||+.||....+.. .......
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~---- 251 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVG---- 251 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHH----
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHh----
Confidence 54322 223345689999999999964 468999999999999999999999996543211 0111111
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
.....|.+ ...+..++..+.+||.+||+.||++|||+.+|++.|+.
T Consensus 252 ~~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 252 RGYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp TTCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred cCCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11112221 12344566789999999999999999999999988874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=439.41 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=211.2
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
...|++.+.||+|+||.||+|.+ .+|+.||||+++.......+.+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 35699999999999999999995 57999999999877666667899999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
|+||+|.+++.. ..+++..++.++.||+.||.|||++ |||||||||+||||+.+|.+||+|||+++......
T Consensus 153 ~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 224 (346)
T 4fih_A 153 LEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 224 (346)
T ss_dssp CTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred CCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence 999999998843 4599999999999999999999999 99999999999999999999999999998664332
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||....+. +... .+.....+.+
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~------~i~~~~~~~~-- 290 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMK------MIRDNLPPRL-- 290 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH------HHHHSSCCCC--
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHH------HHHcCCCCCC--
Confidence 2345578999999999999999999999999999999999999999643321 1001 0111111111
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
......+..+.+||.+||+.||++|||+.|+|+
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122345568999999999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=444.83 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=203.6
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
++|++++.||+|+||.||+|++ .+|+.||||+++.... ...+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999984 5799999999974432 223578899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
||.||+|.++|..+....+++..++.|+.||+.||.|||++ |||||||||+||||+.+|.+||+|||+++.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 99999999999766666789999999999999999999999 9999999999999999999999999999865322
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
.......+||+.|||||++.+..|+.++|||||||+||||+||+.||..... .+....... ... +
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~-----~~~-~--- 243 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIIS-----GSF-P--- 243 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH-----TCC-C---
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHc-----CCC-C---
Confidence 1223346799999999999999999999999999999999999999965332 111111111 001 1
Q ss_pred cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+...+..+.+||.+||+.||++|||++|+|+
T Consensus 244 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 -PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 123345568999999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=433.85 Aligned_cols=253 Identities=21% Similarity=0.229 Sum_probs=206.6
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
.+.|.+.+.||+|+||.||+|++ .+|+.||||+++.. ....+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~-----~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-----TCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHH-----HhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45688899999999999999994 57999999999743 2345799999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC-ccccccccccccccCCC
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF-EPLVGDFGLARWQPDGD 550 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~-~vkL~DFGla~~~~~~~ 550 (678)
|+||+|.+++.. .+++++..++.++.||+.||.|||++ |||||||||+||||+.+| ++||+|||+++......
T Consensus 132 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTR----RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999943 45699999999999999999999999 999999999999999988 69999999998664332
Q ss_pred cc----ceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 551 MG----VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 551 ~~----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.. .....+||+.|||||++.+..|+.++|||||||+||||+||++||........ .......
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~~-------- 271 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL------CLKIASE-------- 271 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC------HHHHHHS--------
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHHcC--------
Confidence 11 12335799999999999999999999999999999999999999975433211 1111110
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
+.....++..++..+.+||.+||+.||.+|||+.|+++.|...+
T Consensus 272 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 272 PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 00011234455668999999999999999999999998876543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=432.52 Aligned_cols=247 Identities=21% Similarity=0.290 Sum_probs=208.3
Q ss_pred cCCcccceecccCccceeecc-CCCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++.+.||+|+||.||+|+ ..+++.||||++.... ....+.+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999999 4679999999997432 333467899999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
|||+||+|.+++. ..+.+++..++.++.||+.||.|||++ ||+||||||+||||+.+|.+||+|||+++.....
T Consensus 112 Ey~~gG~L~~~i~--~~~~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999994 345699999999999999999999999 9999999999999999999999999999876432
Q ss_pred -CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 -DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 -~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
......+.+||+.|||||++.+..|+.++|||||||+||+|+||+.||..... .+....... . .
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~----~---~-- 250 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIK----L---E-- 250 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH----T---C--
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHc----C---C--
Confidence 23344567899999999999999999999999999999999999999964321 111111111 0 1
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL 663 (678)
..++...+..+.+||.+||+.||++|||++|++
T Consensus 251 --~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 113344556789999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=440.14 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=211.0
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
.+.|++.+.||+|+||.||+|.+ .+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 46799999999999999999994 57999999999876666667899999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
|.||+|.+++.. ..+++..++.++.||+.||.|||++ |||||||||+||||+.+|.+||+|||+++......
T Consensus 230 ~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~----~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 999999999843 4599999999999999999999999 99999999999999999999999999998664332
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||....+.. ... .+.....+.+.
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~------~i~~~~~~~~~- 368 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMK------MIRDNLPPRLK- 368 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH------HHHHSCCCCCS-
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHH------HHHcCCCCCCc-
Confidence 23456789999999999999999999999999999999999999996433211 000 11111111111
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.....+..+.+||.+||+.||++|||+.|+|+
T Consensus 369 -~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12334568999999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=422.47 Aligned_cols=244 Identities=23% Similarity=0.343 Sum_probs=196.7
Q ss_pred cccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEee----CCeEEEEE
Q 038949 397 SEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE----DGRRLLVY 469 (678)
Q Consensus 397 ~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~----~~~~~LV~ 469 (678)
++.+.||+|+||.||+|.+ .+++.||+|.+..... ...+.|.+|+++|+.++|||||+++++|.+ +..+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 6677899999999999984 5789999999864432 223568999999999999999999999875 35689999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeee--EEeccCCCCceEeee-cCccccccccccccc
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILVTH-DFEPLVGDFGLARWQ 546 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g--IvHrDLKp~NILl~~-~~~vkL~DFGla~~~ 546 (678)
|||.||+|.+++.. ...+++..++.|+.||+.||+|||++ | ||||||||+||||+. +|.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~----~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999943 45699999999999999999999998 7 999999999999985 799999999999854
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.. ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||....... .... .+.....
T Consensus 183 ~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~~~~------~i~~~~~ 247 (290)
T 3fpq_A 183 RA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYR------RVTSGVK 247 (290)
T ss_dssp CT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHH------HHTTTCC
T ss_pred CC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----HHHH------HHHcCCC
Confidence 32 23456789999999999874 69999999999999999999999996432211 1110 0111111
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...++...+..+.+||.+||+.||++|||++|+|+
T Consensus 248 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 ---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11222334457899999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=437.47 Aligned_cols=273 Identities=25% Similarity=0.333 Sum_probs=219.7
Q ss_pred ehhhhhhhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhccc-CCccccccceeeecccc-cceEEEE
Q 038949 385 TYAELELATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQH-RNVVMLI 456 (678)
Q Consensus 385 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~H-pnIv~l~ 456 (678)
...+|++..++|++.+.||+|+||.||+|.+. +++.||||.++..... ..+.|.+|+++|+.+.| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34567889999999999999999999999742 2468999998754332 23568999999999965 9999999
Q ss_pred eEEeeC-CeEEEEEEEeecCCcccccccCC--------------CCccCccccchhhhhhccchhhhhhcceeeeEEecc
Q 038949 457 GFCVED-GRRLLVYEYICNGSLDSHLYGRD--------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521 (678)
Q Consensus 457 ~~~~~~-~~~~LV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrD 521 (678)
++|.+. +.+|||||||++|+|.++|.... ...+++..+..++.||+.||.|||++ +|||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~----~iiHRD 210 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRD 210 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC----CeecCc
Confidence 999764 56899999999999999995432 34588999999999999999999999 999999
Q ss_pred CCCCceEeeecCccccccccccccccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccc
Q 038949 522 MRPNNILVTHDFEPLVGDFGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDL 599 (678)
Q Consensus 522 LKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~ 599 (678)
|||+|||++.++.+||+|||+|+...... ........||+.|||||++.++.|+.++|||||||+||||+| |..||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998664432 333445789999999999999999999999999999999998 8999965
Q ss_pred cCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccccCCCC
Q 038949 600 NRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSKD 676 (678)
Q Consensus 600 ~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~~s~~ 676 (678)
..... . ....+.. ..+...+..++..+.+||.+||+.||++|||+.+|++.|+..+.....+
T Consensus 291 ~~~~~-----~-~~~~i~~---------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~q 352 (353)
T 4ase_A 291 VKIDE-----E-FCRRLKE---------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 352 (353)
T ss_dssp CCCSH-----H-HHHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC--
T ss_pred CCHHH-----H-HHHHHHc---------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhCC
Confidence 43211 1 1111111 1112234455668999999999999999999999999999877654443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=415.59 Aligned_cols=249 Identities=22% Similarity=0.317 Sum_probs=192.9
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++.+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999984 579999999986432 222356889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+ +|+|.+++.. .+++++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 998 7899999843 45699999999999999999999999 9999999999999999999999999999865433
Q ss_pred CccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
......+||+.|||||++.+..| +.++|||||||++|+|+||+.||..... ........ .. .
T Consensus 166 --~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i~-~~------~-- 228 (275)
T 3hyh_A 166 --NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNIS-NG------V-- 228 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HT------C--
T ss_pred --CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-cC------C--
Confidence 23345789999999999998876 5799999999999999999999964321 11111111 00 0
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH--Hhhc
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR--MLEG 668 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~--~Le~ 668 (678)
..++...+..+.+||.+||+.||++|||++|+++ +++.
T Consensus 229 --~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 229 --YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 1123344567899999999999999999999986 4443
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=421.89 Aligned_cols=247 Identities=23% Similarity=0.289 Sum_probs=197.4
Q ss_pred cCCcccceecccCccceeeccC----CCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL----PDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
++|++.+.||+|+||.||+|+. .+++.||||+++... ......+.+|+++|+.++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 6799999999999999999973 357899999986432 2233568899999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999943 45699999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
... ......+||+.|||||++.+..|+.++|||||||+||||+||+.||..... .+....... . .
T Consensus 178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~-----~--~- 242 (304)
T 3ubd_A 178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILK-----A--K- 242 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-----C--C-
T ss_pred CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHc-----C--C-
Confidence 322 223456899999999999999999999999999999999999999965332 111111110 0 0
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchH-----HHHHH
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRM-----SQVLR 664 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~-----~eVL~ 664 (678)
..++...+..+.+||.+||+.||++|||+ +|+++
T Consensus 243 ---~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 ---LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11234455689999999999999999985 56653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=417.44 Aligned_cols=275 Identities=23% Similarity=0.277 Sum_probs=206.2
Q ss_pred hcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCC----eEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG----RRLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~----~~~LV 468 (678)
.++|.+.+.||+|+||.||+|++ +|+.||||+++..... ...+..|+..+..++|||||+++++|.+++ .+|||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 35688899999999999999998 5899999998743321 122345677778899999999999998754 58999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcc----eeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC----RVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~----~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
||||++|+|.+++.. .++++..+.+++.|++.||+|||+++ ...+||||||||+||||+.++.+||+|||+++
T Consensus 80 ~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999953 35899999999999999999999762 12279999999999999999999999999998
Q ss_pred cccCCCcc---ceeEEEeeeccccccccccc------ccceecceeeeeeEEEEeeeCCccccccCCcccch----hhhh
Q 038949 545 WQPDGDMG---VETRVLGTFGYLAPEYAQSG------QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC----LTEW 611 (678)
Q Consensus 545 ~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~----l~~~ 611 (678)
........ .....+||+.|||||++.+. .|+.++|||||||+||||+||.+||.......... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 66543321 23346899999999998754 57889999999999999999998886443211110 0111
Q ss_pred hHHHHHHhhhhcccCcchhccc-chhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 612 ARPLLKRHAIGELIDPRLRNCY-SEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 612 ~~~~~~~~~~~elld~~l~~~~-~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
....+........++|.+...+ +..++..+.+|+.+||+.||++||||.||++.|+.....
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1111122222233334333222 234556789999999999999999999999999876543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=406.63 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=187.4
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCC--------
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG-------- 463 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~-------- 463 (678)
++|++++.||+|+||.||+|++ .+|+.||||+++....+ ..+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4589999999999999999984 57999999998754332 2356889999999999999999999987644
Q ss_pred ----eEEEEEEEeecCCcccccccCCC-CccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccc
Q 038949 464 ----RRLLVYEYICNGSLDSHLYGRDR-DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVG 538 (678)
Q Consensus 464 ----~~~LV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~ 538 (678)
.+|+|||||.||+|.+++..+.. ...++..++.++.||+.||+|||++ |||||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~----~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC----cCccccCcHHHeEECCCCcEEEc
Confidence 37999999999999999954432 2234455788999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCc-----------cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccch
Q 038949 539 DFGLARWQPDGDM-----------GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC 607 (678)
Q Consensus 539 DFGla~~~~~~~~-----------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~ 607 (678)
|||+|+....... ......+||+.|||||++.+..|+.++|||||||+||||++ ||....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------ 231 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ 231 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------
Confidence 9999986543221 12334689999999999999999999999999999999996 664211
Q ss_pred hhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH--Hhhc
Q 038949 608 LTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR--MLEG 668 (678)
Q Consensus 608 l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~--~Le~ 668 (678)
+....+. .+...-.|. ........+.+||.+||+.||++|||+.|+++ ++++
T Consensus 232 --~~~~~~~---~~~~~~~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 232 --ERVRTLT---DVRNLKFPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp --HHHHHHH---HHHTTCCCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred --HHHHHHH---HHhcCCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 0000000 011110111 11223345678999999999999999999987 4443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=416.01 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=199.7
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEee------CC
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE------DG 463 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~------~~ 463 (678)
.++|++++.||+|+||.||+|.+ .+|+.||||+++.... .....+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46899999999999999999994 5899999999864322 122467899999999999999999998764 36
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
.+||||||| +|+|.+++. ..+++++..++.++.||+.||.|||++ |||||||||+|||++.+|.+||+|||++
T Consensus 133 ~~~ivmE~~-~g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLM-ESDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSA----QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECC-SEEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCC-CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----cCcCCCcCccccccCCCCCEEEeeccee
Confidence 789999999 568999984 456799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCC---CccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH----
Q 038949 544 RWQPDG---DMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL---- 615 (678)
Q Consensus 544 ~~~~~~---~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~---- 615 (678)
+..... ........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.......... ......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~--~I~~~~g~p~ 283 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQ--LIMMVLGTPS 283 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH--HHHHHHCCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHH--HHHHhcCCCC
Confidence 865332 12233456899999999998764 56999999999999999999999996543211100 000000
Q ss_pred ------HH---HhhhhcccCcchhc---ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 ------LK---RHAIGELIDPRLRN---CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 ------~~---~~~~~elld~~l~~---~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.. .......+.+.... ...+..+..+.+||.+||..||++|||+.|+|+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00000000000000 011123457889999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=390.48 Aligned_cols=286 Identities=40% Similarity=0.670 Sum_probs=243.8
Q ss_pred eeehhhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeC
Q 038949 383 WFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED 462 (678)
Q Consensus 383 ~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 462 (678)
.+++.+++...++|.+.+.||+|+||.||+|.+.+++.||+|.+........+.+.+|+.+++.++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34556677788999999999999999999999888999999988765555556789999999999999999999999999
Q ss_pred CeEEEEEEEeecCCcccccccCCC--CccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDR--DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~--~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
+..++||||+.+|+|.+++..... ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCSTTEEECTTCCEEECCC
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC----CeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999965432 3588999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCC-CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHh
Q 038949 541 GLARWQPDG-DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH 619 (678)
Q Consensus 541 Gla~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 619 (678)
|++...... .........||+.|+|||++.++.++.++||||||+++|+|++|+.||....+........|........
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 999764332 2222344568999999999999999999999999999999999999998766655555556655554455
Q ss_pred hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 620 ~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
.+...+++.+........+..+.+++.+||+.||++|||+.++++.|+.....
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 55666777777777788888999999999999999999999999999977654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=387.89 Aligned_cols=293 Identities=46% Similarity=0.814 Sum_probs=245.3
Q ss_pred CceeehhhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEE
Q 038949 381 PRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFC 459 (678)
Q Consensus 381 ~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 459 (678)
...+++.+++...++|.+.+.||+|+||.||+|...+++.||+|++...... ....+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 4678899999999999999999999999999999888999999998754332 334688999999999999999999999
Q ss_pred eeCCeEEEEEEEeecCCcccccccCC--CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccc
Q 038949 460 VEDGRRLLVYEYICNGSLDSHLYGRD--RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLV 537 (678)
Q Consensus 460 ~~~~~~~LV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL 537 (678)
.+....++||||+.+|+|.+++.... ..++++..++.++.|++.||.|||+.+. .||+||||||+|||++.++.++|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD-PKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSS-SCEECCCCSGGGEEECTTCCEEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999996543 3458999999999999999999999743 37999999999999999999999
Q ss_pred ccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccC--CcccchhhhhhHHH
Q 038949 538 GDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNR--PRGQQCLTEWARPL 615 (678)
Q Consensus 538 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~--~~~~~~l~~~~~~~ 615 (678)
+|||++...............||+.|+|||++.+..++.++||||||+++|+|++|..||.... .........|....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999998765444444455569999999999999999999999999999999999999996322 12223344444444
Q ss_pred HHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccccCC
Q 038949 616 LKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNS 674 (678)
Q Consensus 616 ~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~~s 674 (678)
........+.+..+...++...+..+.+++.+||+.||.+|||+.+|++.|++....+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~ 314 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAER 314 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhh
Confidence 44455566667777777788888999999999999999999999999999998665443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=398.67 Aligned_cols=201 Identities=25% Similarity=0.340 Sum_probs=171.2
Q ss_pred hhhhhcCCcccceecccCccceeeccC----CCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEeeCC
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL----PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDG 463 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~ 463 (678)
+....++|++.+.||+|+||.||+|+. .+++.||+|.+.... ....+.+|+++|+.+ +||||++++++|.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 345678999999999999999999973 357899999886432 235678899999988 6999999999999999
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec-Cccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD-FEPLVGDFGL 542 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~-~~vkL~DFGl 542 (678)
++||||||++||+|.+++. .+++..++.++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~----gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF----GIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 9999999999999999982 489999999999999999999999 99999999999999977 8999999999
Q ss_pred cccccCCCc---------------------------cceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCC
Q 038949 543 ARWQPDGDM---------------------------GVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGR 594 (678)
Q Consensus 543 a~~~~~~~~---------------------------~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~ 594 (678)
|+....... ......+||+.|+|||++.+. .|+.++||||+||++|+|++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 975432211 112335799999999999775 5899999999999999999999
Q ss_pred cccccc
Q 038949 595 KAMDLN 600 (678)
Q Consensus 595 ~Pf~~~ 600 (678)
.||...
T Consensus 245 ~Pf~~~ 250 (361)
T 4f9c_A 245 YPFYKA 250 (361)
T ss_dssp SSSSCC
T ss_pred CCCCCC
Confidence 999643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=416.56 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=209.6
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.+|+.++||||++++++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999984 57999999998755444456788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec--CccccccccccccccCC
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD--FEPLVGDFGLARWQPDG 549 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~--~~vkL~DFGla~~~~~~ 549 (678)
|.||+|.+++..+ ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 236 ~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999988543 35699999999999999999999999 99999999999999854 89999999999876443
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
......+||+.|||||++.+..|+.++|||||||+||+|++|..||...... +. +.. +.. .+..+
T Consensus 311 --~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~----~~~--i~~-~~~~~ 375 (573)
T 3uto_A 311 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ET----LRN--VKS-CDWNM 375 (573)
T ss_dssp --SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HH----HHH--HHT-TCCCC
T ss_pred --CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HH----HHH--HHh-CCCCC
Confidence 2345678999999999999999999999999999999999999999654321 00 000 000 01111
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
........+..+.+||.+||+.||.+|||+.|+|+
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11222334567899999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=413.67 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=200.4
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCcccccc---ceeeecccccceEEEEeEEeeCCe
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSE---VEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~E---v~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
.-++|.+++.||+|+||.||+|+. .+|+.||||+++... ......+.+| +.+++.++|||||+++++|.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 347899999999999999999994 579999999996432 2222233333 566777899999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+|||||||.||+|.++|.. .+.+++..++.++.||+.||.|||++ |||||||||+||||+.+|++||+|||+|+
T Consensus 267 lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~----gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHeEEeCCCCEEecccceee
Confidence 9999999999999999943 45699999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
...... ..+.+||+.|||||++.. ..|+.++|+|||||+||||++|.+||........ ........ ..
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~-----~~ 409 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTL-----TM 409 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHH-----HC
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhc-----CC
Confidence 664432 244689999999999975 5799999999999999999999999965432111 11111000 00
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCch-----HHHHH
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR-----MSQVL 663 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT-----~~eVL 663 (678)
. ..++...+..+.+||.+||+.||.+|++ ++||+
T Consensus 410 --~----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 410 --A----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp --C----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred --C----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 1 1233445568999999999999999998 57765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=367.42 Aligned_cols=251 Identities=21% Similarity=0.337 Sum_probs=209.2
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
..++|++.+.||+|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 45789999999999999999998 46799999999986665556778899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+|+|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999854 2588999999999999999999999 99999999999999999999999999997654332
Q ss_pred ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchh
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~ 630 (678)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||....+.. ........ . .+ .
T Consensus 171 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~-~-----~~--~ 235 (297)
T 3fxz_A 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATN-G-----TP--E 235 (297)
T ss_dssp -CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHH-C-----SC--C
T ss_pred -cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhC-C-----CC--C
Confidence 23344579999999999999999999999999999999999999996443211 00000000 0 00 1
Q ss_pred cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 631 ~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+...+..+.+||.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1123345567899999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=370.76 Aligned_cols=260 Identities=29% Similarity=0.426 Sum_probs=212.2
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
..++|.+.+.||+|+||.||+|.+ .+++.||+|.+..........+.+|+++++.++||||+++++++.+++..++|||
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 357899999999999999999995 5789999998865444455678999999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 88 YIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM----NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999543 34589999999999999999999999 99999999999999999999999999998654322
Q ss_pred ccc-------------eeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHH
Q 038949 551 MGV-------------ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK 617 (678)
Q Consensus 551 ~~~-------------~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 617 (678)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||....+........ ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~--- 238 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRG--- 238 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHH---
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhc---
Confidence 111 113568999999999999999999999999999999999999986543322111100 000
Q ss_pred HhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 618 RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 618 ~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
......+..++..+.+++.+||+.||++|||+.++++.|+...
T Consensus 239 ----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 239 ----------FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp ----------HHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------cccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111123344557899999999999999999999999998654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=364.25 Aligned_cols=266 Identities=25% Similarity=0.331 Sum_probs=210.7
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC---CccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG---DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~---~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
+...++|++.+.||+|+||.||+|.. .+++.||+|.+....... ...+.+|+.+++.++||||+++++++.+++..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 34568999999999999999999984 578999999986433222 24688999999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||+.+++|.+++.. ..++++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++..
T Consensus 87 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDM----RIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 999999999999999943 34689999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
.............||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .. ...+...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~-----~~~~~~~- 228 (294)
T 4eqm_A 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IA-----IKHIQDS- 228 (294)
T ss_dssp C-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HH-----HHHHSSC-
T ss_pred cccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HH-----HHHhhcc-
Confidence 65444334455679999999999999999999999999999999999999996543210 00 0011111
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCc-hHHHHHHHhhcccccC
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRP-RMSQVLRMLEGDILMN 673 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RP-T~~eVL~~Le~~~~~~ 673 (678)
.+..........+..+.++|.+||+.||.+|| +++++++.|+..+...
T Consensus 229 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 229 VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 11222223344556899999999999999998 9999999998876533
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=368.50 Aligned_cols=265 Identities=28% Similarity=0.395 Sum_probs=205.8
Q ss_pred hhhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCC
Q 038949 386 YAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG 463 (678)
Q Consensus 386 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 463 (678)
...++...++|++.+.||+|+||.||+|.+ +++.||+|++...... ....+.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 344567788999999999999999999987 5889999998643322 2246889999999999999999999999999
Q ss_pred eEEEEEEEeecCCcccccccCC-CCccCccccchhhhhhccchhhhhhcceeee--EEeccCCCCceEeeecCccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRD-RDPLEWSARRKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g--IvHrDLKp~NILl~~~~~vkL~DF 540 (678)
..++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+. | |+||||||+|||++.++.+||+||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR----NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS----SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC----CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 9999999999999999995432 12488999999999999999999999 8 999999999999999999999999
Q ss_pred cccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
|+++..... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.. .. ....
T Consensus 184 g~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~----~~~~ 252 (309)
T 3p86_A 184 GLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VV----AAVG 252 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HH----HHHH
T ss_pred CCCcccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH----HHHH
Confidence 999754332 223345679999999999999999999999999999999999999996543210 00 0000
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.. ......+...+..+.+||.+||+.||.+|||+.++++.|+..+.
T Consensus 253 -~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 253 -FK----CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp -HS----CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -hc----CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00 01112334455679999999999999999999999999987664
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=357.63 Aligned_cols=261 Identities=26% Similarity=0.351 Sum_probs=214.1
Q ss_pred hhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
++...++|++.+.||+|+||.||+|.+.++..||+|+++.... ....+.+|+.+++.++||||+++++++.+....++|
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 3556789999999999999999999988888999999874432 335688999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.+++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH----QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 9999999999998543 33589999999999999999999999 999999999999999999999999999986654
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
..........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ..... +....
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~------~~~~~-- 222 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLK------VSQGH-- 222 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHH------HHTTC--
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHH------HHcCC--
Confidence 44333333456778999999999899999999999999999999 99999644321 00000 00000
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
....+...+..+.+++.+||+.||.+|||+.++++.|+....
T Consensus 223 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 223 --RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp --CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred --CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 011122234578999999999999999999999999997643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=387.69 Aligned_cols=263 Identities=29% Similarity=0.374 Sum_probs=211.3
Q ss_pred hhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
..+++..++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|+.++||||+++++++.+ +..+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 44677888999999999999999999998777889999987543 234678999999999999999999999876 6789
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.+|+|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 999999999999999644445688999999999999999999999 9999999999999999999999999999866
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
............+++.|+|||++..+.++.++||||||+++|+|++ |+.||..... .+..... .
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i------~--- 395 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQV------E--- 395 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHH------H---
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHH------H---
Confidence 5443333344557889999999999999999999999999999999 9999864321 1111110 0
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
...+...+..++..+.+||.+||+.||++|||+++|++.|+..+.
T Consensus 396 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 396 -RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp -TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 111122344566689999999999999999999999999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=378.68 Aligned_cols=266 Identities=26% Similarity=0.387 Sum_probs=213.0
Q ss_pred hhhhcCCcccceecccCccceeeccC--------CCCcEEEEEeeehhcc-cCCccccccceeeecc-cccceEEEEeEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL--------PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCA-QHRNVVMLIGFC 459 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~--------~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~ 459 (678)
+...++|.+.+.||+|+||.||+|.+ .++..||+|+++.... .....+.+|+.+++.+ +||||++++++|
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 44568899999999999999999973 2456899999874422 2235688999999999 899999999999
Q ss_pred eeCCeEEEEEEEeecCCcccccccCC--------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCC
Q 038949 460 VEDGRRLLVYEYICNGSLDSHLYGRD--------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPN 525 (678)
Q Consensus 460 ~~~~~~~LV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~ 525 (678)
.+.+.+|+||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~ 232 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAAR 232 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----Ceeccccchh
Confidence 99999999999999999999985432 23478888999999999999999999 9999999999
Q ss_pred ceEeeecCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCc
Q 038949 526 NILVTHDFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPR 603 (678)
Q Consensus 526 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~ 603 (678)
|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999986543221 11222346789999999999999999999999999999999 99998653321
Q ss_pred ccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccccCCC
Q 038949 604 GQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNSK 675 (678)
Q Consensus 604 ~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~~s~ 675 (678)
. ... .+.. ......+..++..+.++|.+||+.||.+||++.++++.|+..+...+.
T Consensus 313 ~------~~~-~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 313 E------LFK-LLKE---------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp G------HHH-HHHT---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred H------HHH-HHhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 1 110 0000 111123344566899999999999999999999999999987765443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=388.55 Aligned_cols=266 Identities=24% Similarity=0.339 Sum_probs=220.5
Q ss_pred hhhhhhhhcCCcccceecccCccceeeccCC-CCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 386 YAELELATNRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 386 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
+..++....+|.+.+.||+|+||.||+|.+. ++..||||.++... ...+.|.+|+.+|+.++||||++++++|.+...
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 3456777889999999999999999999964 58899999987433 234678999999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+|+||||+.+|+|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhEEECCCCcEEEeecccce
Confidence 99999999999999999765566789999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
..............+++.|+|||++..+.++.++|||||||+||||++ |..||...... .... .+
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~------~~~~-~~------- 432 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYE-LL------- 432 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------GHHH-HH-------
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH------HHHH-HH-------
Confidence 664433222333446788999999999999999999999999999999 99998654321 1111 01
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
....+...+..++..+.+||.+||+.||++|||+.+|++.|+..+..
T Consensus 433 --~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 433 --EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp --HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred --HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 11112223445566899999999999999999999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=359.69 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=212.6
Q ss_pred hhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
+.+..++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 345567899999999999999999998788899999987443 2335788999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.+++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhC----CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999999999543 34589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
..........+++.|+|||++.+..++.++||||||+++|+|++ |..||...... ..... +...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~------~~~~--- 223 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVED------ISTG--- 223 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHH------HHTT---
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHH------HhcC---
Confidence 22222223346788999999999999999999999999999999 99998643321 11110 0110
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
.....+...+..+.+++.+||+.||.+||++.++++.|+...
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 224 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 111122334557899999999999999999999999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=363.36 Aligned_cols=265 Identities=22% Similarity=0.327 Sum_probs=213.7
Q ss_pred hhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
..++...++|++.+.||+|+||.||+|.+.++..||+|+++.... ....+.+|+++++.++||||+++++++.+.+..+
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 345677889999999999999999999988888999999974432 3357889999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.+++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 96 IITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp EEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred EEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCccceEEEcCCCCEEEccccccccc
Confidence 999999999999999543 34589999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... .... .+....
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~------~~~~~~ 238 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAE------HIAQGL 238 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHH------HHHTTC
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHH------HHhccc
Confidence 4322222222346788999999999999999999999999999998 99999654321 0000 011111
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccccC
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMN 673 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~~ 673 (678)
....+...+..+.+++.+||+.||.+|||+.++++.|+..+..+
T Consensus 239 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 239 ----RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 11122333457899999999999999999999999999877554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=360.54 Aligned_cols=265 Identities=24% Similarity=0.333 Sum_probs=221.1
Q ss_pred hhhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 386 YAELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 386 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
+..++...++|++.+.||+|+||.||+|.+ .+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 345677889999999999999999999995 458899999987432 234578899999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.++||||+.+++|.+++.......+++..++.++.||+.||.|||+. ||+||||||+||+++.++.++|+|||++.
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH----TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC----CccCCCCCcceEEEcCCCCEEEccCccce
Confidence 99999999999999999766667799999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
..............+++.|+|||++.+..++.++||||||+++|+|++ |..||....... .... . ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~------~~~~-~-----~~ 227 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYEL-L-----EK 227 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------HHHH-H-----HT
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH-H-----hc
Confidence 765544444445667889999999999999999999999999999999 999986543211 0000 0 01
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
......+...+..+.+|+.+||+.||.+||++.++++.|+..+.
T Consensus 228 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 228 ----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 11112233455689999999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=368.68 Aligned_cols=262 Identities=27% Similarity=0.365 Sum_probs=210.5
Q ss_pred hhhhcCCcccceecccCccceeeccCC----CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLP----DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
+...++|.+.+.||+|+||.||+|.+. .+..||||.++.... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 456789999999999999999999853 345699999874322 223568899999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDL----GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred cEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999998543 34699999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCc--cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 545 WQPDGDM--GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 545 ~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ..... +
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~~~~------~ 267 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------DVISS------V 267 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHH------H
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH------HHHHH------H
Confidence 6643321 12223446778999999999999999999999999999999 99999643321 00000 0
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
.. ......+..++..+.+||.+||+.||.+||++.+|++.|+..+..
T Consensus 268 ~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 268 EE----GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred Hc----CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 11 111123344556899999999999999999999999999987643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=388.50 Aligned_cols=263 Identities=25% Similarity=0.355 Sum_probs=216.3
Q ss_pred hhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
..+++..++|.+.+.||+|+||.||+|.+.++..||||.++... ...+.|.+|+.+|+.++||||+++++++. .+..|
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 45677889999999999999999999998788899999997543 34567999999999999999999999986 56789
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.+|+|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999999999654444588889999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
............+++.|+|||++..+.++.++||||||++||||+| |+.||..... .+.......
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i~~-------- 400 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------PEVIRALER-------- 400 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHH--------
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHc--------
Confidence 4322222223346788999999999999999999999999999999 9999964321 111111110
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
......+..++..+.+||.+||+.||++|||+++|++.|+....
T Consensus 401 --~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 401 --GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp --TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred --CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11112234456689999999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=371.83 Aligned_cols=269 Identities=26% Similarity=0.347 Sum_probs=214.9
Q ss_pred eehhhhhhhhcCCcccceecccCccceeecc------CCCCcEEEEEeeehhccc-CCccccccceeeecc-cccceEEE
Q 038949 384 FTYAELELATNRFSEANFLAEGGFGSVHRGV------LPDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCA-QHRNVVML 455 (678)
Q Consensus 384 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~------~~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L-~HpnIv~l 455 (678)
+....++...++|.+.+.||+|+||.||+|. ..+++.||||+++..... ..+.+.+|++++..+ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4456778889999999999999999999996 345689999999743322 235688999999999 79999999
Q ss_pred EeEEeeCC-eEEEEEEEeecCCcccccccCCC------------------------------------------------
Q 038949 456 IGFCVEDG-RRLLVYEYICNGSLDSHLYGRDR------------------------------------------------ 486 (678)
Q Consensus 456 ~~~~~~~~-~~~LV~E~~~ggsL~~~l~~~~~------------------------------------------------ 486 (678)
++++.+.+ ..++||||+.+|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99988755 48999999999999999965432
Q ss_pred ----------------CccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC-
Q 038949 487 ----------------DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG- 549 (678)
Q Consensus 487 ----------------~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~- 549 (678)
..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1288888999999999999999999 9999999999999999999999999999865432
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.........||+.|+|||++.+..++.++||||||+++|+|++ |..||....... . ........
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~-~~~~~~~~--------- 312 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----E-FCRRLKEG--------- 312 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-----H-HHHHHHHT---------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-----H-HHHHHHcC---------
Confidence 2223445678999999999999999999999999999999998 999996543211 0 01111111
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.....+...+..+.+++.+||+.||.+|||+.++++.|+..+.
T Consensus 313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 0111223344578999999999999999999999999987653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=363.66 Aligned_cols=277 Identities=26% Similarity=0.338 Sum_probs=211.2
Q ss_pred hhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCC----e
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG----R 464 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~----~ 464 (678)
+....++|++.+.||+|+||.||+|.+. ++.||||++...... ...+..|+.+++.++||||+++++++.... .
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 4556789999999999999999999874 789999998744322 234566899999999999999999998754 4
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcc------eeeeEEeccCCCCceEeeecCccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC------RVGCIVHRDMRPNNILVTHDFEPLVG 538 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~------~~~gIvHrDLKp~NILl~~~~~vkL~ 538 (678)
+++||||+.+|+|.+++.. ..+++..++.++.|++.||.|||+.+ +..||+||||||+|||++.++.+||+
T Consensus 97 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 7999999999999999943 34899999999999999999999862 22389999999999999999999999
Q ss_pred cccccccccCCCc-cceeEEEeeecccccccccc-----cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhh-
Q 038949 539 DFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQS-----GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEW- 611 (678)
Q Consensus 539 DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~- 611 (678)
|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||..............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999976543321 12233568999999999986 4677899999999999999999999975443221111110
Q ss_pred ----hHHHHHHhhhhcccCcchhcccc-hhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 612 ----ARPLLKRHAIGELIDPRLRNCYS-EREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 612 ----~~~~~~~~~~~elld~~l~~~~~-~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
...............+.+...+. ...+..+.+||.+||+.||++|||+.+|++.|+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00011111112222222222222 234556999999999999999999999999998653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=365.78 Aligned_cols=276 Identities=24% Similarity=0.324 Sum_probs=207.7
Q ss_pred hhhhcCCcccceecccCccceeecc-----CCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEee--C
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGV-----LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE--D 462 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~-----~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~ 462 (678)
+...++|++.+.||+|+||.||+|. ..+++.||+|++........+.+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 3456899999999999999999997 24688999999875544444678899999999999999999999865 3
Q ss_pred CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
..+++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 5689999999999999999543 23589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCc--cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 543 ARWQPDGDM--GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 543 a~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
+........ .......++..|+|||++.+..++.++||||||+++|+|++|..||.......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 986543221 111222366779999999999999999999999999999999998853211000000000000000000
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
..+.+........+..++..+.+||.+||+.||++|||+.++++.|+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111111122234456678999999999999999999999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=375.61 Aligned_cols=262 Identities=25% Similarity=0.373 Sum_probs=212.6
Q ss_pred hhhhhhcCCcccceecccCccceeeccCC-CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
.+....++|.+.+.||+|+||.||+|.+. +++.||||.++.... .....+.+|+.+++.++||||+++++++...+..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 45677889999999999999999999964 789999999874322 2235788999999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||+.+|+|.+++... ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 188 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK----CCIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 9999999999999999532 34588999999999999999999999 999999999999999999999999999975
Q ss_pred ccCCCccc-eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 546 QPDGDMGV-ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 546 ~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
........ .....+++.|+|||++.++.++.++||||||+++|||++ |..||...... +. .....
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~------~~-~~~~~------ 329 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ------QT-REFVE------ 329 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH------HH-HHHHH------
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HH-HHHHH------
Confidence 43321111 112246788999999999999999999999999999998 99998643210 00 00110
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
.......+..++..+.+||.+||+.||++|||+.++++.|+...
T Consensus 330 ---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 330 ---KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11112233445668999999999999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=362.73 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=202.6
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 47899999999999999999984 4789999999864432 234678899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+|+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999994 445699999999999999999999999 99999999999999999999999999997553222
Q ss_pred -ccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 551 -MGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 551 -~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ...+. .......
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~-------~~~~~~~-- 229 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK-------EKKTYLN-- 229 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHH-------TTCTTST--
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHh-------cccccCC--
Confidence 122234579999999999987775 88999999999999999999999754332110 10000 0000011
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.....+..+.+||.+||+.||.+|||+.|+++
T Consensus 230 ----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11234457889999999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=366.28 Aligned_cols=253 Identities=22% Similarity=0.291 Sum_probs=206.2
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC------CccccccceeeecccccceEEEEeEEeeCC
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG------DQEFCSEVEVLSCAQHRNVVMLIGFCVEDG 463 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~------~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 463 (678)
...++|.+.+.||+|+||.||+|.. .+|+.||+|+++...... .+.+.+|+.+|+.++||||+++++++.+..
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 4567899999999999999999984 579999999987543321 246889999999999999999999999999
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC----cccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF----EPLVGD 539 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~----~vkL~D 539 (678)
.+|+||||+.||+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|
T Consensus 89 ~~~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999994 345699999999999999999999999 999999999999998877 799999
Q ss_pred ccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHh
Q 038949 540 FGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH 619 (678)
Q Consensus 540 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 619 (678)
||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... +.....
T Consensus 163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~~i---- 230 (361)
T 2yab_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANI---- 230 (361)
T ss_dssp CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHH----
T ss_pred cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH----
Confidence 99998664432 233457999999999999999999999999999999999999999643211 100000
Q ss_pred hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 ~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... ...+...+....+..+.+||.+||..||.+|||+.++++
T Consensus 231 --~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 231 --TAV-SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --HTT-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --Hhc-CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 000111112234557899999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=364.66 Aligned_cols=266 Identities=26% Similarity=0.354 Sum_probs=212.9
Q ss_pred hhhhhhcCCcccceecccCccceeeccC------CCCcEEEEEeeehhc-ccCCccccccceeeecc-cccceEEEEeEE
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCA-QHRNVVMLIGFC 459 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~ 459 (678)
+++...++|.+.+.||+|+||.||+|.+ .+++.||+|+++... ......+.+|+.+++.+ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4567789999999999999999999984 246689999987432 23446788999999999 899999999999
Q ss_pred eeCCeEEEEEEEeecCCcccccccCCC---------------------CccCccccchhhhhhccchhhhhhcceeeeEE
Q 038949 460 VEDGRRLLVYEYICNGSLDSHLYGRDR---------------------DPLEWSARRKIAVGAARGLRYLHEECRVGCIV 518 (678)
Q Consensus 460 ~~~~~~~LV~E~~~ggsL~~~l~~~~~---------------------~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIv 518 (678)
...+..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+. ||+
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~iv 194 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCV 194 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC----Ccc
Confidence 999999999999999999999965432 2478889999999999999999999 999
Q ss_pred eccCCCCceEeeecCccccccccccccccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCcc
Q 038949 519 HRDMRPNNILVTHDFEPLVGDFGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKA 596 (678)
Q Consensus 519 HrDLKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~P 596 (678)
||||||+|||++.++.++|+|||++....... ........||+.|+|||++.+..++.++||||||+++|+|+| |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999998654332 223334567889999999999999999999999999999998 9999
Q ss_pred ccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 597 MDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 597 f~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
|........ ....... ......+...+..+.+|+.+||+.||.+||++.++++.|+..+..
T Consensus 275 ~~~~~~~~~------~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 275 YPGIPVDAN------FYKLIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp STTCCCSHH------HHHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cccCCcHHH------HHHHHhc---------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 965432110 0011111 111122334456899999999999999999999999999976654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=367.94 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=205.7
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
...++|++.+.||+|+||.||+|.+ .+|+.||||++..... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3457899999999999999999995 6899999999875432 223568899999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQK----RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 9999999999999844 34589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccceeEEEeeecccccccccccccc-eecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQIT-EKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
... .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||..... ......... ..
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~----~~--- 230 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLR----GK--- 230 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH----CC---
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHh----CC---
Confidence 332 23345799999999999888765 799999999999999999999965321 111111110 00
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+...+..+.+|+.+||+.||.+|||++++++
T Consensus 231 ----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 231 ----YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ----CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1122334557899999999999999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=363.83 Aligned_cols=248 Identities=24% Similarity=0.286 Sum_probs=205.2
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehh---cccCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA---SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
.++|++.+.||+|+||.||+|.. .+++.||+|+++.. .......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 46899999999999999999984 57999999999754 223345688899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.||+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999998843 34689999999999999999999999 999999999999999999999999999975332
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......... ..
T Consensus 158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~----~~----- 221 (337)
T 1o6l_A 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILM----EE----- 221 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH----CC-----
T ss_pred CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHc----CC-----
Confidence 21 233456899999999999999999999999999999999999999964321 111111110 00
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
..++...+..+.+||.+||+.||++|| +++++++
T Consensus 222 --~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 112334456789999999999999999 8888875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=357.44 Aligned_cols=247 Identities=22% Similarity=0.331 Sum_probs=204.8
Q ss_pred CcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 396 FSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
|...+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 77788999999999999985 47999999999866655556788999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
++|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++....... ...
T Consensus 127 ~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 198 (321)
T 2c30_A 127 GALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 198 (321)
T ss_dssp CBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred CCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-ccc
Confidence 999998842 4589999999999999999999999 99999999999999999999999999997654322 223
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccc
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYS 634 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~ 634 (678)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .... .+.....+.+. ..
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------~~~~------~~~~~~~~~~~--~~ 264 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMK------RLRDSPPPKLK--NS 264 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH------HHHHSSCCCCT--TG
T ss_pred ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH------HHhcCCCCCcC--cc
Confidence 4457999999999999999999999999999999999999999643321 1000 01111111111 12
Q ss_pred hhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 635 EREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 635 ~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+..+.+++.+||+.||++|||+.++++
T Consensus 265 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 265 HKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 234457899999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=360.19 Aligned_cols=269 Identities=28% Similarity=0.401 Sum_probs=217.0
Q ss_pred hhhhhhhcCCcccceecccCccceeeccC------CCCcEEEEEeeehhcc-cCCccccccceeeecc-cccceEEEEeE
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCA-QHRNVVMLIGF 458 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L-~HpnIv~l~~~ 458 (678)
..++...++|.+.+.||+|+||.||+|.+ .+++.||+|+++.... ...+.+.+|+.+++.+ +||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 44677788999999999999999999963 3578999999874432 2235788999999999 89999999999
Q ss_pred EeeCCeEEEEEEEeecCCcccccccCCC----------------CccCccccchhhhhhccchhhhhhcceeeeEEeccC
Q 038949 459 CVEDGRRLLVYEYICNGSLDSHLYGRDR----------------DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDM 522 (678)
Q Consensus 459 ~~~~~~~~LV~E~~~ggsL~~~l~~~~~----------------~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDL 522 (678)
+.+++..++||||+.+|+|.+++..... ..+++..++.++.||+.||.|||++ ||+||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl 171 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDL 171 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCC
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCC
Confidence 9999999999999999999999965432 2489999999999999999999999 9999999
Q ss_pred CCCceEeeecCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCcccccc
Q 038949 523 RPNNILVTHDFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLN 600 (678)
Q Consensus 523 Kp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~ 600 (678)
||+|||++.++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 172 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999999999986544322 12233457889999999999999999999999999999999 99998654
Q ss_pred CCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccccCC
Q 038949 601 RPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNS 674 (678)
Q Consensus 601 ~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~~s 674 (678)
..... ....... . .....+...+..+.+++.+||+.||.+|||+.++++.|+..+....
T Consensus 252 ~~~~~------~~~~~~~-----~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 252 PVDSK------FYKMIKE-----G----FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp CSSHH------HHHHHHH-----T----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred cchhH------HHHHhcc-----C----CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 32110 0111111 1 1111223345579999999999999999999999999998776443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=356.76 Aligned_cols=263 Identities=28% Similarity=0.383 Sum_probs=214.8
Q ss_pred hhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
.+++...++|++.+.||+|+||.||+|...+++.||+|.+.... .....+.+|+++++.++||||+++++++.. +..+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence 45677889999999999999999999998788899999987443 234678899999999999999999999864 5689
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.+++|.+++.......+++..++.++.|++.||.|||++ ||+||||||+|||++.++.++|+|||++...
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 999999999999999544333689999999999999999999999 9999999999999999999999999999866
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
............+++.|+|||++.++.++.++||||||+++|+|++ |..||...... +..... ...
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~------~~~- 226 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNL------ERG- 226 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHH------HTT-
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHHH------hcc-
Confidence 5433222233456788999999998899999999999999999999 89998643211 111110 000
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.....+...+..+.+++.+||+.||++|||+.++++.|+..+.
T Consensus 227 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 227 ---YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 1111233445689999999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.10 Aligned_cols=261 Identities=22% Similarity=0.365 Sum_probs=201.9
Q ss_pred hhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeec--ccccceEEEEeEEee----CCe
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSC--AQHRNVVMLIGFCVE----DGR 464 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~--L~HpnIv~l~~~~~~----~~~ 464 (678)
...++|++.+.||+|+||.||+|.+ +++.||||++.... ...+..|.+++.. ++||||+++++++.. ...
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 4568999999999999999999987 68899999986432 2345566666655 789999999998654 346
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhh--------hcceeeeEEeccCCCCceEeeecCccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLH--------EECRVGCIVHRDMRPNNILVTHDFEPL 536 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH--------~~~~~~gIvHrDLKp~NILl~~~~~vk 536 (678)
.++||||+.+|+|.+++. ...+++..++.++.||+.||.||| +. ||+||||||+|||++.++.+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP----AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC----EEECSCCCGGGEEECTTSCEE
T ss_pred eEEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC----CeecCCCChHhEEEcCCCCEE
Confidence 899999999999999993 346899999999999999999999 77 999999999999999999999
Q ss_pred cccccccccccCCCccc---eeEEEeeeccccccccccc------ccceecceeeeeeEEEEeeeC----------Cccc
Q 038949 537 VGDFGLARWQPDGDMGV---ETRVLGTFGYLAPEYAQSG------QITEKADVYSLGVVLVELITG----------RKAM 597 (678)
Q Consensus 537 L~DFGla~~~~~~~~~~---~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSLGviL~eLltG----------~~Pf 597 (678)
|+|||+++......... .....||+.|+|||++.+. .++.++||||||+++|+|++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999997654432211 2234789999999999876 667899999999999999999 6666
Q ss_pred cccCCcccchhhhhhHHHHHHhhhhcccCcch-hcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 598 DLNRPRGQQCLTEWARPLLKRHAIGELIDPRL-RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 598 ~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l-~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
....+.... .. ............+.+ ....+...+..+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 234 ~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 234 YDVVPNDPS-FE-----DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTTSCSSCC-HH-----HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccCCCCcc-hh-----hhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 443221111 00 011111111111211 122334566789999999999999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=352.19 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=197.0
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--------------------------cCCccccccceee
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--------------------------QGDQEFCSEVEVL 444 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--------------------------~~~~~~~~Ev~iL 444 (678)
..++|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 357899999999999999999984 5789999999864321 1135688999999
Q ss_pred ecccccceEEEEeEEee--CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccC
Q 038949 445 SCAQHRNVVMLIGFCVE--DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDM 522 (678)
Q Consensus 445 ~~L~HpnIv~l~~~~~~--~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDL 522 (678)
+.++||||+++++++.+ ....|+||||+.+++|.+++. ..++++..++.++.||+.||.|||++ ||+||||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dl 163 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQ----KIIHRDI 163 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCC
Confidence 99999999999999986 568999999999999998763 34699999999999999999999999 9999999
Q ss_pred CCCceEeeecCccccccccccccccCCCccceeEEEeeecccccccccccc---cceecceeeeeeEEEEeeeCCccccc
Q 038949 523 RPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ---ITEKADVYSLGVVLVELITGRKAMDL 599 (678)
Q Consensus 523 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSLGviL~eLltG~~Pf~~ 599 (678)
||+|||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999998654332 2233457899999999997654 47889999999999999999999964
Q ss_pred cCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 600 NRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 600 ~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... ..+.... .. .... .......+..+.+||.+||+.||++||++.++++
T Consensus 243 ~~~------~~~~~~~-~~----~~~~----~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERI------MCLHSKI-KS----QALE----FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSH------HHHHHHH-HH----CCCC----CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccH------HHHHHHH-hc----ccCC----CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 321 1111110 00 0000 0111234457899999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=357.73 Aligned_cols=261 Identities=16% Similarity=0.188 Sum_probs=209.6
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEeeCCeEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
..++|.+.+.||+|+||.||+|. ..+++.||||++.... ....+.+|+.+++.+ +||||+++++++..++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 45789999999999999999999 4679999999987442 345788999999999 8999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc-----cccccccccc
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE-----PLVGDFGLAR 544 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~-----vkL~DFGla~ 544 (678)
||+ +++|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++. +||+|||+++
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK----NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 999 99999998543 45699999999999999999999999 9999999999999999887 9999999998
Q ss_pred cccCCCcc------ceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHH
Q 038949 545 WQPDGDMG------VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR 618 (678)
Q Consensus 545 ~~~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 618 (678)
........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ .+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~---~~~~~~i~~~ 235 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL---KERYQKIGDT 235 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH---HHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH---HHHHHHHHhh
Confidence 65433221 12456799999999999999999999999999999999999999976432211 1111111000
Q ss_pred hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 619 ~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
. .. ... .......+ .+.+++.+||+.||.+||++.+|++.|+..+
T Consensus 236 ~-~~--~~~---~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 236 K-RA--TPI---EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp H-HH--SCH---HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred h-cc--CCH---HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 0 00 000 00111123 7899999999999999999999999998654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=360.15 Aligned_cols=265 Identities=29% Similarity=0.379 Sum_probs=213.9
Q ss_pred hhhhhhhcCCcccceecccCccceeeccC------CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEE
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFC 459 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 459 (678)
..++...++|.+.+.||+|+||.||+|.. .+++.||+|+++.... ...+.+.+|+.+++.++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 34567788999999999999999999973 2458999999874322 2235688999999999999999999999
Q ss_pred eeCCeEEEEEEEeecCCcccccccCCC----------------------CccCccccchhhhhhccchhhhhhcceeeeE
Q 038949 460 VEDGRRLLVYEYICNGSLDSHLYGRDR----------------------DPLEWSARRKIAVGAARGLRYLHEECRVGCI 517 (678)
Q Consensus 460 ~~~~~~~LV~E~~~ggsL~~~l~~~~~----------------------~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gI 517 (678)
.+.+..++||||+.+|+|.+++..... ..+++..++.++.||+.||.|||++ ||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i 171 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM----KL 171 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT----TE
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC----CC
Confidence 999999999999999999999965332 3488889999999999999999999 99
Q ss_pred EeccCCCCceEeeecCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCc
Q 038949 518 VHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRK 595 (678)
Q Consensus 518 vHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~ 595 (678)
+||||||+|||++.++.++|+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999976543221 12223456788999999999999999999999999999999 999
Q ss_pred cccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 596 AMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 596 Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
||....... ... .... ......+...+..+.+++.+||+.||.+||++.++++.|+..+.
T Consensus 252 p~~~~~~~~------~~~-~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 252 PYPGIPPER------LFN-LLKT---------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp SSTTCCGGG------HHH-HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHH------HHH-Hhhc---------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 996543211 000 0110 00112233455689999999999999999999999999987654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=375.86 Aligned_cols=263 Identities=21% Similarity=0.249 Sum_probs=210.9
Q ss_pred ehhhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehh---cccCCccccccceeeecccccceEEEEeEEe
Q 038949 385 TYAELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA---SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460 (678)
Q Consensus 385 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 460 (678)
.+.++....++|.+.+.||+|+||.||+|.+ .+++.||+|+++.. .......+.+|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3455667788999999999999999999995 46889999999742 2233456889999999999999999999999
Q ss_pred eCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 461 ~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
+.+.+|+||||+.||+|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999542 35699999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCccceeEEEeeeccccccccc-----ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQ-----SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 615 (678)
|+++.............+||+.|+|||++. .+.|+.++|||||||++|||++|+.||...... +.....
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------~~~~~i 293 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKI 293 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------HHHHhh
Confidence 999766544333334467999999999987 567899999999999999999999999653321 111111
Q ss_pred HHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCC--CchHHHHHH
Q 038949 616 LKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHS--RPRMSQVLR 664 (678)
Q Consensus 616 ~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~--RPT~~eVL~ 664 (678)
..... ...-|. .....+..+.+||.+||..+|++ ||+++|+++
T Consensus 294 ~~~~~--~~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 294 MNHKE--RFQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HTHHH--HCCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhccc--cccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11100 000011 11224557899999999888888 999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=347.24 Aligned_cols=254 Identities=20% Similarity=0.263 Sum_probs=206.9
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeC--CeE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVED--GRR 465 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~~~ 465 (678)
....++|.+.+.||+|+||.||+|.+. ++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 345678999999999999999999984 88999999875432 2235688999999999999999999999886 788
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeee--EEeccCCCCceEeeecCcccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g--IvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
++||||+.+|+|.+++.......+++..++.++.||+.||.|||+. | |+||||||+|||++.++.++|+|||++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL----EPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS----SSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC----CCceecCCCccceEEEcCCcceeEEeccce
Confidence 9999999999999999766555799999999999999999999998 8 999999999999999999999988887
Q ss_pred ccccCCCccceeEEEeeecccccccccccccce---ecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 544 RWQPDGDMGVETRVLGTFGYLAPEYAQSGQITE---KADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 544 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~---ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
...... ...||+.|+|||++.+..++. ++||||||+++|+|++|+.||...... .... ..
T Consensus 161 ~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~-----~~ 223 (271)
T 3kmu_A 161 FSFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGM-----KV 223 (271)
T ss_dssp CTTSCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHH-----HH
T ss_pred eeeccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHH-----HH
Confidence 543222 235799999999998765544 799999999999999999999643321 1000 01
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
...... ...+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 224 ~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 224 ALEGLR----PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp HHSCCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 111111 223344556899999999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=364.06 Aligned_cols=266 Identities=27% Similarity=0.371 Sum_probs=214.2
Q ss_pred hhhhhhhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeE
Q 038949 386 YAELELATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGF 458 (678)
Q Consensus 386 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~ 458 (678)
...++...++|.+.+.||+|+||.||+|.+. +++.||+|+++..... ....+.+|+.+++.++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3455677899999999999999999999853 3589999998744322 23568899999999999999999999
Q ss_pred EeeCCeEEEEEEEeecCCcccccccCC----------------------CCccCccccchhhhhhccchhhhhhcceeee
Q 038949 459 CVEDGRRLLVYEYICNGSLDSHLYGRD----------------------RDPLEWSARRKIAVGAARGLRYLHEECRVGC 516 (678)
Q Consensus 459 ~~~~~~~~LV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g 516 (678)
+.+.+..|+||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++ |
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----~ 194 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----K 194 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----T
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC----C
Confidence 999999999999999999999985432 15688999999999999999999999 9
Q ss_pred EEeccCCCCceEeeecCccccccccccccccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CC
Q 038949 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GR 594 (678)
Q Consensus 517 IvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~ 594 (678)
|+||||||+|||++.++.+||+|||++....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999997653322 122334567899999999999999999999999999999999 99
Q ss_pred ccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 595 KAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 595 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.||..... .+.... .... . ....+..++..+.+|+.+||+.||.+||++.++++.|+....
T Consensus 275 ~p~~~~~~------~~~~~~-~~~~---~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 275 QPYYGMAH------EEVIYY-VRDG---N------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp CTTTTSCH------HHHHHH-HHTT---C------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CcCCCCCh------HHHHHH-HhCC---C------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 99864321 011110 0000 0 011233455689999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=370.87 Aligned_cols=261 Identities=27% Similarity=0.388 Sum_probs=200.3
Q ss_pred hhhhcCCcccceecccCccceeeccCC----CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLP----DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
+...++|.+.+.||+|+||.||+|.+. ++..||||.++.... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 445678999999999999999999853 577899999875422 223578899999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 99999999999999999543 34689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCcc--ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 545 WQPDGDMG--VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 545 ~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
........ ......+++.|+|||++.+..++.++||||||+++|||++ |..||...... .....
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~~~~~------- 262 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------DVIKA------- 262 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------HHHHH-------
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-------
Confidence 65433211 1122345778999999999999999999999999999998 99999643210 11100
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
+........+..++..+.+||.+||+.||.+||++.+|++.|+..+.
T Consensus 263 ---i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 263 ---VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ---HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 01111122233456689999999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=355.19 Aligned_cols=262 Identities=25% Similarity=0.369 Sum_probs=199.9
Q ss_pred hhhhhhcCCcccceecccCccceeeccCC----CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeC
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVLP----DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVED 462 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 462 (678)
+++...++|++.+.||+|+||.||+|.+. .+..||+|.++.... ...+.+.+|+.+++.++||||+++++++. +
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 34667789999999999999999999843 355799998864322 22356889999999999999999999985 5
Q ss_pred CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
+..|+||||+.+++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHEEECCCCCEEECcccc
Confidence 6789999999999999999543 34589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
++..............+++.|+|||++.+..++.++||||||+++|+|++ |..||....... ..... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~------~~~~i-~~--- 232 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRI-EN--- 232 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHH-HT---
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH------HHHHH-Hc---
Confidence 98665443333344557889999999998999999999999999999996 999997543211 00000 00
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
. .....+...+..+.+++.+||+.||++||++.++++.|+..+.
T Consensus 233 ~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 233 G------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp T------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 0111234455689999999999999999999999999987654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=373.62 Aligned_cols=258 Identities=19% Similarity=0.247 Sum_probs=208.8
Q ss_pred hhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehh---cccCCccccccceeeecccccceEEEEeEEeeC
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA---SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED 462 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 462 (678)
..+....++|.+.+.||+|+||.||+|.. .+++.||+|+++.. .......+.+|+.+++.++||||++++++|.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 34556678999999999999999999995 46899999998642 233445688999999999999999999999999
Q ss_pred CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
..+|+||||+.||+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.+|.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999998843 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccccc----cceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHH
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ----ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR 618 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 618 (678)
++.............+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... .........
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~ 288 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNH 288 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTH
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHhc
Confidence 9866544333344567999999999998655 889999999999999999999999643321 111111111
Q ss_pred hhhhcccCcchhcccchhhhhhhhhccceeeccCCCC--CchHHHHHH
Q 038949 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHS--RPRMSQVLR 664 (678)
Q Consensus 619 ~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~--RPT~~eVL~ 664 (678)
.. .+.-+ .....+..+.+||.+||..+|.+ ||+++||++
T Consensus 289 ~~--~~~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 289 KN--SLTFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HH--HCCCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred cc--cccCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 00 00001 11134457899999999999999 999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=348.17 Aligned_cols=265 Identities=16% Similarity=0.182 Sum_probs=212.7
Q ss_pred hhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEeeCCeEEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~L 467 (678)
....++|.+.+.||+|+||.||+|. ..+++.||+|++... .....+.+|+.+++.+ +|+|++++++++.+....++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 3456889999999999999999999 467999999988633 3446788999999999 79999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc-----cccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE-----PLVGDFGL 542 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~-----vkL~DFGl 542 (678)
||||+ +++|.+++... ..++++..++.++.||+.||.|||+. ||+||||||+|||++.++. ++|+|||+
T Consensus 84 v~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 99999 99999999543 34589999999999999999999999 9999999999999988776 99999999
Q ss_pred cccccCCCc------cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHH
Q 038949 543 ARWQPDGDM------GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLL 616 (678)
Q Consensus 543 a~~~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 616 (678)
++....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||............. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~---~~~ 234 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE---RIG 234 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH---HHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH---HHH
Confidence 986544322 12345679999999999999999999999999999999999999997644322111111 000
Q ss_pred HHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 617 KRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 617 ~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.... . . .........+..+.+++.+||+.||++||++.+|++.|+..+.
T Consensus 235 ~~~~-~-~----~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 235 EKKQ-S-T----PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHHH-H-S----CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hhcc-C-c----cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 0000 0 0 0001112344579999999999999999999999999987664
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=349.80 Aligned_cols=253 Identities=28% Similarity=0.427 Sum_probs=197.2
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccC----CccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG----DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~----~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
+...++|++.+.||+|+||.||+|.+ .++.||+|+++...... .+.+.+|+.+++.++||||+++++++.+++..
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 34567899999999999999999997 48899999986443222 25688899999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeee---EEeccCCCCceEeee--------cCc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC---IVHRDMRPNNILVTH--------DFE 534 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g---IvHrDLKp~NILl~~--------~~~ 534 (678)
++||||+.+++|.+++. ...+++..++.++.|++.||.|||+. | |+||||||+|||++. ++.
T Consensus 82 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~----~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDE----AIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp EEEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHS----SSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred EEEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CCCceeecCCchHHEEEecccccccccCcc
Confidence 99999999999999883 34689999999999999999999998 7 999999999999986 788
Q ss_pred cccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHH
Q 038949 535 PLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP 614 (678)
Q Consensus 535 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 614 (678)
++|+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 155 ~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------- 221 (271)
T 3dtc_A 155 LKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---------- 221 (271)
T ss_dssp EEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH----------
T ss_pred eEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------
Confidence 9999999997554322 234578999999999999999999999999999999999999996433110
Q ss_pred HHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 615 LLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 615 ~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
. ..... ........+..++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 222 ~-~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 222 V-AYGVA----MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp H-HHHHH----TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred H-HHhhh----cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0 00000 1111122334455689999999999999999999999999985
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=355.20 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=206.0
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
..++|.+.+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 357899999999999999999984 578999999986432 223568899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee--cCccccccccccccccC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH--DFEPLVGDFGLARWQPD 548 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~--~~~vkL~DFGla~~~~~ 548 (678)
|+.||+|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99999999999543 34689999999999999999999999 9999999999999987 78999999999986644
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ........ ....
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~-----~~~~-- 221 (321)
T 1tki_A 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMN-----AEYT-- 221 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-----TCCC--
T ss_pred CC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHc-----CCCC--
Confidence 32 345577999999999999988999999999999999999999999653321 11111110 0000
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.........+..+.+||.+||..||.+|||+.|+++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000111234557899999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=356.33 Aligned_cols=266 Identities=22% Similarity=0.301 Sum_probs=202.9
Q ss_pred hhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccC--CccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~--~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
.+...++|++.+.||+|+||.||+|...+++.||+|++....... ...+.+|+.+++.++||||+++++++.++...+
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 356678999999999999999999998789999999987543322 246889999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.+ +|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 96 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH----RILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp EEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred EEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 99999964 777777543 34589999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHH-------
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR------- 618 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~------- 618 (678)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +..... ....
T Consensus 170 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~-~~~~~~~~~~~ 245 (311)
T 3niz_A 170 GIPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFS-ILGTPNPREWP 245 (311)
T ss_dssp TSCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHH-HHCCCCTTTSG
T ss_pred CCCc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHH-HHCCCChHHhh
Confidence 4322 22333568999999999876 5689999999999999999999999975443221 110000 0000
Q ss_pred ---------hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 619 ---------HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 619 ---------~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...................+..+.+||.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000100011112234457889999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=358.05 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=205.6
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc------CCccccccceeeecccccceEEEEeEEeeCC
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ------GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG 463 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~------~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 463 (678)
...++|.+.+.||+|+||.||+|.. .+++.||+|+++..... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 3457899999999999999999994 57899999998744322 1246889999999999999999999999999
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC----cccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF----EPLVGD 539 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~----~vkL~D 539 (678)
..++||||+.+|+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|
T Consensus 88 ~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHC----CeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 9999999999999999994 345699999999999999999999999 999999999999999887 899999
Q ss_pred ccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHh
Q 038949 540 FGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH 619 (678)
Q Consensus 540 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 619 (678)
||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... +......
T Consensus 162 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~--- 230 (326)
T 2y0a_A 162 FGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVS--- 230 (326)
T ss_dssp CTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHH---
T ss_pred CCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHH---
Confidence 99998654322 223456999999999999999999999999999999999999999643211 0000000
Q ss_pred hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 ~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.. ............+..+.+||.+||+.||++|||+.++++
T Consensus 231 ~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 231 AV----NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HT----CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hc----CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 011111112234457889999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=350.88 Aligned_cols=280 Identities=37% Similarity=0.594 Sum_probs=222.1
Q ss_pred CceeehhhhhhhhcCCccc------ceecccCccceeeccCCCCcEEEEEeeehhcc----cCCccccccceeeeccccc
Q 038949 381 PRWFTYAELELATNRFSEA------NFLAEGGFGSVHRGVLPDGQVVAVKQYKLASS----QGDQEFCSEVEVLSCAQHR 450 (678)
Q Consensus 381 ~~~~~~~~~~~~~~~y~~~------~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~----~~~~~~~~Ev~iL~~L~Hp 450 (678)
...|++.++...+++|... +.||+|+||.||+|.. +++.||+|.+..... .....+.+|+.+++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3557788888888888777 8999999999999987 688999999864321 1235688999999999999
Q ss_pred ceEEEEeEEeeCCeEEEEEEEeecCCcccccccC-CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe
Q 038949 451 NVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGR-DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV 529 (678)
Q Consensus 451 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl 529 (678)
||+++++++.+.+..++||||+.+++|.+++... ...++++..++.++.|++.||.|||+. ||+||||||+|||+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHEEE
Confidence 9999999999999999999999999999998543 245689999999999999999999999 99999999999999
Q ss_pred eecCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchh
Q 038949 530 THDFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCL 608 (678)
Q Consensus 530 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l 608 (678)
+.++.++|+|||++........ .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||....... .+
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LL 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HH
Confidence 9999999999999976543221 12233568999999998874 58899999999999999999999997543321 12
Q ss_pred hhhhHHHHH-HhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 609 TEWARPLLK-RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 609 ~~~~~~~~~-~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
..+...... ...+...+++.+ ...+...+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 222221111 111223333333 224455677899999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=370.52 Aligned_cols=266 Identities=29% Similarity=0.378 Sum_probs=214.6
Q ss_pred hhhhhcCCcccceecccCccceeeccC--------CCCcEEEEEeeehhccc-CCccccccceeeecc-cccceEEEEeE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL--------PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCA-QHRNVVMLIGF 458 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~--------~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L-~HpnIv~l~~~ 458 (678)
+++..++|.+.+.||+|+||.||+|.+ ..+..||+|+++..... ....+.+|+++++.+ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 466778999999999999999999973 23468999998744322 235688999999999 89999999999
Q ss_pred EeeCCeEEEEEEEeecCCcccccccCC--------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCC
Q 038949 459 CVEDGRRLLVYEYICNGSLDSHLYGRD--------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRP 524 (678)
Q Consensus 459 ~~~~~~~~LV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp 524 (678)
+.+.+..++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+. ||+||||||
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp 219 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAA 219 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCc
Confidence 999999999999999999999996543 24589999999999999999999999 999999999
Q ss_pred CceEeeecCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCC
Q 038949 525 NNILVTHDFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRP 602 (678)
Q Consensus 525 ~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~ 602 (678)
+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986543221 22233457889999999999999999999999999999999 9999864321
Q ss_pred cccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccccCC
Q 038949 603 RGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMNS 674 (678)
Q Consensus 603 ~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~~s 674 (678)
.+.... + .. ......+..++..+.+||.+||+.||++||++.+|++.|+..+...+
T Consensus 300 ------~~~~~~-~-----~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 300 ------EELFKL-L-----KE----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp ------HHHHHH-H-----HT----TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred ------HHHHHH-H-----Hc----CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 111110 0 01 11112233455689999999999999999999999999998775443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=391.76 Aligned_cols=265 Identities=28% Similarity=0.369 Sum_probs=216.8
Q ss_pred ehhhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 385 TYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 385 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
....+++..++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|+.++||||+++++++.+ +.
T Consensus 258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 3455778889999999999999999999998777889999997543 234678999999999999999999999876 67
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.||||||+.+|+|.+++.......+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 89999999999999999644445688999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
..............++..|+|||++..+.++.++|||||||+||||++ |..||..... .+..... .
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------~~~~~~i------~- 478 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQV------E- 478 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------HHHHHHH------H-
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH------H-
Confidence 654322112222346788999999999999999999999999999999 8999864321 1111110 0
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
...+...+..++..+.+||.+||+.||++|||+++|++.|+..+.
T Consensus 479 ---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 479 ---RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ---cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 011122334556689999999999999999999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=356.40 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=204.3
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcE----EEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQV----VAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~----vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
..++|++.+.||+|+||.||+|.+ .+++. ||+|.+.... ......+.+|+.+++.++||||+++++++. ++..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 356899999999999999999984 34543 7888775332 333467888999999999999999999986 4678
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH----GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT----TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC----CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999999999999543 35699999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 546 QPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 546 ~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
..... ........|++.|+|||++.++.++.++||||||+++|+|++ |..||....... ... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~-~~~------ 231 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE------VPD-LLE------ 231 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH------HHH-HHH------
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH------HHH-HHH------
Confidence 65432 223345567889999999999999999999999999999999 999997543211 000 000
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
.......+..++..+.+++.+||+.||.+||++.++++.|+...
T Consensus 232 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 232 ---KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ---TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ---cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00111222334557899999999999999999999999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=363.80 Aligned_cols=255 Identities=22% Similarity=0.351 Sum_probs=201.2
Q ss_pred hhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhccc--CCccccccceeeecccc--cceEEEEeEEeeCCe
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQH--RNVVMLIGFCVEDGR 464 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~H--pnIv~l~~~~~~~~~ 464 (678)
+....++|++.+.||+|+||.||++...+++.||||++...... ....+.+|+.+|..++| |||+++++++.++..
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 34567889999999999999999999888999999998744322 22568899999999976 999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.|+|||+ .+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++ ++.+||+|||+++
T Consensus 84 ~~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~----~iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp EEEEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred EEEEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEE-CCcEEEeeccccc
Confidence 9999995 68899999954 45689999999999999999999999 999999999999997 6889999999998
Q ss_pred cccCCCc-cceeEEEeeecccccccccc-----------cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhh
Q 038949 545 WQPDGDM-GVETRVLGTFGYLAPEYAQS-----------GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWA 612 (678)
Q Consensus 545 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~ 612 (678)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------- 226 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--------- 226 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---------
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---------
Confidence 6543322 22345679999999999865 67899999999999999999999999643210
Q ss_pred HHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 613 RPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 613 ~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
...+...+++.....++...+..+.+||.+||+.||.+|||+.++++.
T Consensus 227 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 227 -----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -----HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 001112223333333444445678999999999999999999999853
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=352.89 Aligned_cols=272 Identities=21% Similarity=0.233 Sum_probs=211.9
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCC--eEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG--RRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~--~~~ 466 (678)
...++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+++++.++||||+++++++.... ..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 3467899999999999999999995 4689999999975432 23356789999999999999999999988755 789
Q ss_pred EEEEEeecCCcccccccCC-CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe----eecCcccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRD-RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV----THDFEPLVGDFG 541 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl----~~~~~vkL~DFG 541 (678)
+||||+.+++|.+++.... ...+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.+||+|||
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 9999999999999996543 23389999999999999999999999 99999999999999 777889999999
Q ss_pred ccccccCCCccceeEEEeeeccccccccc--------ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQ--------SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~--------~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~ 613 (678)
+++...... ......||+.|+|||++. +..++.++|||||||++|+|++|..||........ ......
T Consensus 162 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~ 237 (319)
T 4euu_A 162 AARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMY 237 (319)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHH
T ss_pred CceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHH
Confidence 998664432 223456899999999986 57789999999999999999999999975432211 111111
Q ss_pred HHHHHhhh---h---ccc--------CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 614 PLLKRHAI---G---ELI--------DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 614 ~~~~~~~~---~---ell--------d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
........ . ... +.......+......+.+++.+||+.||++|||++|+++...+..
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11111100 0 000 001112344556678899999999999999999999999887543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=375.92 Aligned_cols=257 Identities=26% Similarity=0.362 Sum_probs=211.8
Q ss_pred hhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCC-eE
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG-RR 465 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~-~~ 465 (678)
..+++..++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+.+|+.++||||+++++++.+.. ..
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 345677889999999999999999999874 7899999987432 4567999999999999999999999987655 79
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||+.+|+|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 9999999999999999765555578899999999999999999999 999999999999999999999999999975
Q ss_pred ccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
.... .....+++.|+|||++.+..++.++||||||++||||++ |..||....... .... +. .
T Consensus 339 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~~~~-i~-----~- 401 (450)
T 1k9a_A 339 ASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPR-VE-----K- 401 (450)
T ss_dssp CC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT------HHHH-HH-----T-
T ss_pred cccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH-HH-----c-
Confidence 4321 122357889999999999999999999999999999998 999996543211 1111 10 0
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
..+...+..++..+.+||.+||+.||.+|||+.++++.|+...
T Consensus 402 ---~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 402 ---GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1112234455668999999999999999999999999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=359.85 Aligned_cols=255 Identities=23% Similarity=0.268 Sum_probs=192.6
Q ss_pred hhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
..+...++|.+.+.||+|+||.||+|.. .+++.||||+++... ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 3456678999999999999999999995 468899999987432 3456889999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee---cCcccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH---DFEPLVGDFGLA 543 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~---~~~vkL~DFGla 543 (678)
+||||+.+|+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+|||++
T Consensus 125 lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 125 LVLELVTGGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHEN----GIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp EEECCCCSCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred EEEEeCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 9999999999999984 345689999999999999999999999 9999999999999975 899999999999
Q ss_pred ccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 544 RWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 544 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
+..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....... . ..
T Consensus 199 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~i~-~---~~ 267 (349)
T 2w4o_A 199 KIVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFRRIL-N---CE 267 (349)
T ss_dssp ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHHHHH-T---TC
T ss_pred cccCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHHHHH-h---CC
Confidence 865432 22345679999999999999999999999999999999999999996433210 0000000 0 00
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
......+....+..+.+||.+||+.||++|||+.++++
T Consensus 268 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 268 ---YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ---CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111122334557899999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=350.79 Aligned_cols=259 Identities=25% Similarity=0.413 Sum_probs=211.2
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
.+..++|++.+.||+|+||.||+|.+.+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 445678999999999999999999987888999999875432 2357889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++......
T Consensus 83 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999999999543 34588999999999999999999999 9999999999999999999999999999765332
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.........+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ....... ....
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~i------~~~~--- 222 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDI------STGF--- 222 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHH------HTTC---
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHHH------hcCC---
Confidence 2112222346788999999998899999999999999999999 8999864321 1111100 0100
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
....+...+..+.+++.+||+.||.+||++.++++.|+...
T Consensus 223 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 223 -RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11122334557899999999999999999999999998654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=346.62 Aligned_cols=254 Identities=33% Similarity=0.548 Sum_probs=204.6
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCC-------ccccccceeeecccccceEEEEeEEeeC
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGD-------QEFCSEVEVLSCAQHRNVVMLIGFCVED 462 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~-------~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 462 (678)
...++|.+.+.||+|+||.||+|.+ .+++.||+|++........ ..+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 4467899999999999999999984 5789999999864433222 5688999999999999999999998765
Q ss_pred CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeee--EEeccCCCCceEeeecCc-----c
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILVTHDFE-----P 535 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g--IvHrDLKp~NILl~~~~~-----v 535 (678)
. ++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+. | |+||||||+|||++.++. +
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~----~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQ----NPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred C--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhC----CCCeecCCCCcceEEEeccCCCCceeE
Confidence 4 7999999999998888543 34689999999999999999999999 8 999999999999988776 9
Q ss_pred ccccccccccccCCCccceeEEEeeecccccccc--cccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH
Q 038949 536 LVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYA--QSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 536 kL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l--~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~ 613 (678)
||+|||+++.... ......||+.|+|||++ ....++.++||||||+++|+|++|+.||........ ....
T Consensus 169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~ 240 (287)
T 4f0f_A 169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFIN 240 (287)
T ss_dssp EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHH
T ss_pred EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHH
Confidence 9999999974332 23445689999999998 455678999999999999999999999975432111 0000
Q ss_pred HHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 614 PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 614 ~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
.. . .. ......+..++..+.++|.+||+.||.+|||+.++++.|+.
T Consensus 241 ~~-~----~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 241 MI-R----EE----GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HH-H----HS----CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HH-h----cc----CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 00 0 11 11122334455689999999999999999999999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=365.20 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=199.6
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehh---cccCCccccccceeeecc-cccceEEEEeEEeeCCeE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA---SSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~ 465 (678)
...++|++.+.||+|+||.||+|+. .+++.||+|+++.. .......+.+|..++..+ +||||+++++++.+.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4457899999999999999999984 57899999999743 223345677899999887 699999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++.
T Consensus 100 ~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999999843 35699999999999999999999999 999999999999999999999999999975
Q ss_pred ccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
.... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... +....... ..
T Consensus 174 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~----~~-- 240 (353)
T 3txo_A 174 GICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILN----DE-- 240 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH----CC--
T ss_pred cccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHHc----CC--
Confidence 3322 22345568999999999999999999999999999999999999999654321 11111111 01
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchH------HHHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRM------SQVLR 664 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~------~eVL~ 664 (678)
..++...+..+.+||.+||+.||.+||++ +++++
T Consensus 241 -----~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 -----VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11233345578999999999999999998 66664
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=362.07 Aligned_cols=254 Identities=20% Similarity=0.230 Sum_probs=194.2
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
...++|.+.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 3457899999999999999999995 479999999987432 33467889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc--ccccccccccccc
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE--PLVGDFGLARWQP 547 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~--vkL~DFGla~~~~ 547 (678)
||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++. +||+|||+++...
T Consensus 96 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~----~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 96 EYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSM----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999999843 34699999999999999999999999 9999999999999987765 9999999997432
Q ss_pred CCCccceeEEEeeeccccccccccccccee-cceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEK-ADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~k-sDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......... ...... +..
T Consensus 170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~---------~~~ 236 (361)
T 3uc3_A 170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQR---------ILS 236 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHH---------HHT
T ss_pred cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHH---------Hhc
Confidence 22 22344679999999999988777555 89999999999999999999754322110 110000 011
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...........+..+.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 11111111123457899999999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=353.33 Aligned_cols=273 Identities=24% Similarity=0.304 Sum_probs=207.3
Q ss_pred hhcCCcccceecccCccceeecc-----CCCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeC--C
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-----LPDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVED--G 463 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-----~~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~--~ 463 (678)
..++|++.+.||+|+||.||+|. ..+++.||+|+++..... ....+.+|+.+++.++||||+++++++.+. .
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 35679999999999999999997 347899999998754322 235788999999999999999999999876 6
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
.+++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcC----CcccCCCchheEEEcCCCCEEECccccc
Confidence 789999999999999998543 34589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCc--cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 544 RWQPDGDM--GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 544 ~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
........ .......||..|+|||++.+..++.++||||||+++|+|++|..|+.................. ....+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 252 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM-TVTRL 252 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGG-HHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccccc-CHHHH
Confidence 86544321 1222345788899999999999999999999999999999999987432100000000000000 00001
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
...+........+...+..+.+||.+||+.||.+|||+.++++.|+..+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111111122234455668999999999999999999999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=362.96 Aligned_cols=210 Identities=23% Similarity=0.298 Sum_probs=183.3
Q ss_pred CceeehhhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeeccc-----ccceEE
Q 038949 381 PRWFTYAELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-----HRNVVM 454 (678)
Q Consensus 381 ~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-----HpnIv~ 454 (678)
...+++.......++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+..|+.+++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 45577788888999999999999999999999995 578999999986321 22345667888888775 999999
Q ss_pred EEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee---
Q 038949 455 LIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH--- 531 (678)
Q Consensus 455 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~--- 531 (678)
+++++...+..++||||+ +++|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM----SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCcccEEEccccc
Confidence 999999999999999999 99999999766666799999999999999999999999 9999999999999975
Q ss_pred ----------------------cCccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEE
Q 038949 532 ----------------------DFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVE 589 (678)
Q Consensus 532 ----------------------~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~e 589 (678)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 7899999999998644322 34568999999999999999999999999999999
Q ss_pred eeeCCcccccc
Q 038949 590 LITGRKAMDLN 600 (678)
Q Consensus 590 LltG~~Pf~~~ 600 (678)
|++|+.||...
T Consensus 252 ll~g~~pf~~~ 262 (360)
T 3llt_A 252 LYTGSLLFRTH 262 (360)
T ss_dssp HHHSSCSCCCS
T ss_pred HHHCCCCCCCC
Confidence 99999999654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=356.30 Aligned_cols=245 Identities=23% Similarity=0.312 Sum_probs=203.9
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
.++|++.+.||+|+||.||++.. .+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 46899999999999999999984 579999999997542 23335677899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.||+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999953 45689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......... . .
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~-----~--~-- 219 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILN-----A--E-- 219 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-----C--C--
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-----C--C--
Confidence 2 2345799999999999999999999999999999999999999964321 111111110 0 0
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
..++...+..+.+||.+||+.||.+|| +++++++
T Consensus 220 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 112334455789999999999999999 8888873
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=371.64 Aligned_cols=250 Identities=24% Similarity=0.292 Sum_probs=196.4
Q ss_pred hhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehh---cccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLA---SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
...++|++.+.||+|+||.||+|. ..+++.||||+++.. .......+.+|+.+++.++||||++++++|.+.+.+|
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 345789999999999999999998 457999999999754 2333457889999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhh-cceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+ . ||+||||||+||||+.++.+||+|||+++.
T Consensus 225 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EEECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHT----CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEEeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcC----CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 99999999999998843 3468999999999999999999998 7 999999999999999999999999999975
Q ss_pred ccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ....... ..
T Consensus 299 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~-----~~-- 364 (446)
T 4ejn_A 299 GIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELIL-----ME-- 364 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-----HC--
T ss_pred ccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHH-----hC--
Confidence 43221 2233467999999999999999999999999999999999999999643210 1111100 00
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
. ..++...+..+.+||.+||+.||.+|| +++++++
T Consensus 365 ~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 365 E----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp C----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0 112333455789999999999999999 9999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=353.86 Aligned_cols=250 Identities=22% Similarity=0.344 Sum_probs=194.8
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCC-------
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG------- 463 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~------- 463 (678)
.++|++.+.||+|+||.||+|.+ .+++.||||+++..... ..+.+.+|+.+++.++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46899999999999999999995 48999999998754322 2357889999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEEEeecCCcccccccCCC-CccCcc
Q 038949 464 --------------------------------------------------RRLLVYEYICNGSLDSHLYGRDR-DPLEWS 492 (678)
Q Consensus 464 --------------------------------------------------~~~LV~E~~~ggsL~~~l~~~~~-~~l~~~ 492 (678)
..++||||+.+|+|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 38999999999999999955432 223444
Q ss_pred ccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc-----------cceeEEEeee
Q 038949 493 ARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM-----------GVETRVLGTF 561 (678)
Q Consensus 493 ~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~-----------~~~~~~~Gt~ 561 (678)
.++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....... .......||+
T Consensus 165 ~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHhC----CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 5789999999999999999 999999999999999999999999999986544321 1223346999
Q ss_pred cccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhh
Q 038949 562 GYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGM 641 (678)
Q Consensus 562 ~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l 641 (678)
.|+|||++.+..++.++||||||+++|+|++|..|+.... .... .......+. ........+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~------------~~~~--~~~~~~~~~----~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV------------RIIT--DVRNLKFPL----LFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH------------HHHH--HHHTTCCCH----HHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH------------HHHH--HhhccCCCc----ccccCChhH
Confidence 9999999999999999999999999999999877653110 0000 001111111 112334467
Q ss_pred hhccceeeccCCCCCchHHHHHH
Q 038949 642 LQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 642 ~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+||.+||+.||++|||+.++++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 89999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=366.12 Aligned_cols=253 Identities=21% Similarity=0.242 Sum_probs=192.6
Q ss_pred hhcCCccc-ceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeec-ccccceEEEEeEEee----CCe
Q 038949 392 ATNRFSEA-NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSC-AQHRNVVMLIGFCVE----DGR 464 (678)
Q Consensus 392 ~~~~y~~~-~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~-L~HpnIv~l~~~~~~----~~~ 464 (678)
..++|.+. +.||+|+||.||+|.+ .+++.||||+++. ...+.+|+.++.+ .+||||++++++|.. ...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 34567666 7899999999999984 5789999999862 2456778888744 489999999999875 567
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee---cCcccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH---DFEPLVGDFG 541 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~---~~~vkL~DFG 541 (678)
+||||||+.||+|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+|||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCcceEEEecCCCCccEEEEecc
Confidence 89999999999999999766556799999999999999999999998 9999999999999997 7899999999
Q ss_pred ccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
+++..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......... ... ...+..
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~-~~~i~~--- 281 (400)
T 1nxk_A 210 FAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGM-KTRIRM--- 281 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC--CSH-HHHHHH---
T ss_pred cccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc--HHH-HHHHHc---
Confidence 99865332 2234567899999999999999999999999999999999999999754332110 000 000111
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.....+ .......+..+.+||.+||+.||++|||+.++++
T Consensus 282 ~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 282 GQYEFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp TCCCCC---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccCC---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 110000 0011234557899999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.29 Aligned_cols=275 Identities=25% Similarity=0.287 Sum_probs=212.2
Q ss_pred hhcCCcccceecccCccceeecc-----CCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEe--eCCe
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-----LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV--EDGR 464 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-----~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~--~~~~ 464 (678)
..++|++.+.||+|+||.||+|. ..+++.||+|++........+.+.+|+++++.++||||+++++++. +...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 35789999999999999999997 3468899999987555444567899999999999999999999886 4567
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.++||||+.+++|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSR----RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChhhEEECCCCCEEEcccccce
Confidence 89999999999999999542 23589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCc--cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 545 WQPDGDM--GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 545 ~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.......... ..+.........+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERDVPALSRLL 254 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----CCHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-cccccccccHHHHH
Confidence 6643321 12223457888999999999999999999999999999999999986432100000 00000000000111
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
+.+........+..++..+.+||.+||+.||++|||+.++++.|+..+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 11112222233445666899999999999999999999999999987653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=365.21 Aligned_cols=251 Identities=20% Similarity=0.286 Sum_probs=200.2
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecc-cccceEEEEeEEeeCCeEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~ 466 (678)
..++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|..++..+ +||||++++++|.+.+.+|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 456899999999999999999984 578899999997543 22334577899998877 8999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.||+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+||||+.+|.+||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999999843 35699999999999999999999999 9999999999999999999999999999753
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccc--hhhhhhHHHHHHhhhhcc
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQ--CLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~--~l~~~~~~~~~~~~~~el 624 (678)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .......... ...
T Consensus 204 ~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i----~~~- 277 (396)
T 4dc2_A 204 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI----LEK- 277 (396)
T ss_dssp CCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH----HHC-
T ss_pred ccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH----hcc-
Confidence 222 12344568999999999999999999999999999999999999999643221110 0001011000 000
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRM 659 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~ 659 (678)
...++...+..+.+||.+||+.||.+||++
T Consensus 278 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 278 -----QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 012333455578999999999999999996
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=359.34 Aligned_cols=266 Identities=24% Similarity=0.336 Sum_probs=197.1
Q ss_pred hhhhhhhhcCCcccceecccCccceeeccCCC-Cc---EEEEEeeehh--cccCCccccccceeeecccccceEEEEeEE
Q 038949 386 YAELELATNRFSEANFLAEGGFGSVHRGVLPD-GQ---VVAVKQYKLA--SSQGDQEFCSEVEVLSCAQHRNVVMLIGFC 459 (678)
Q Consensus 386 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g~---~vAvK~i~~~--~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 459 (678)
...+....++|.+.+.||+|+||.||+|.+.. +. .||+|+++.. .....+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 34456677899999999999999999998543 32 7999998744 223346788999999999999999999999
Q ss_pred eeCCeE------EEEEEEeecCCcccccccCC----CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe
Q 038949 460 VEDGRR------LLVYEYICNGSLDSHLYGRD----RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV 529 (678)
Q Consensus 460 ~~~~~~------~LV~E~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl 529 (678)
...... ++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+. ||+||||||+|||+
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~Dikp~NIli 170 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR----NFIHRDLAARNCML 170 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEE
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC----CcccCCCCcceEEE
Confidence 876655 99999999999999984322 22588999999999999999999999 99999999999999
Q ss_pred eecCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccch
Q 038949 530 THDFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQC 607 (678)
Q Consensus 530 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~ 607 (678)
+.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--- 247 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--- 247 (323)
T ss_dssp CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---
T ss_pred cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---
Confidence 9999999999999986543321 22233456789999999999999999999999999999999 899997543211
Q ss_pred hhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 608 LTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 608 l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
........ .....+...+..+.+|+.+||+.||++|||+.++++.|+..+.
T Consensus 248 ---~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 248 ---IYNYLIGG----------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp ---HHHHHHTT----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHhcC----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11100000 0111233455679999999999999999999999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=359.74 Aligned_cols=246 Identities=23% Similarity=0.321 Sum_probs=203.5
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehh---cccCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA---SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999994 68999999998643 233345788999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+ +|+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRH----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH----TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 7899888844 34689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
.. .....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ ...+..
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~ 222 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNS 222 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCS
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHc
Confidence 32 2234569999999999988776 6899999999999999999999975432111 000000
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.....+...+..+.+||.+||+.||.+|||++|+++
T Consensus 223 -~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 223 -CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp -SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred -CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 011123334557899999999999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=361.06 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=204.1
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-----CCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-----GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-----~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
...++|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3457899999999999999999984 57899999998643211 23568899999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccC--CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc---ccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGR--DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE---PLVGD 539 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~---vkL~D 539 (678)
+|+||||+.+|+|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++. +||+|
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN----NIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChHHeEEecCCCCCcEEEec
Confidence 99999999999998887543 234588999999999999999999999 9999999999999987655 99999
Q ss_pred ccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHh
Q 038949 540 FGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH 619 (678)
Q Consensus 540 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 619 (678)
||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ........ .
T Consensus 177 fg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~i~~-~ 247 (351)
T 3c0i_A 177 FGVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RLFEGIIK-G 247 (351)
T ss_dssp CTTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HHHHHHHH-T
T ss_pred CcceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HHHHHHHc-C
Confidence 99998664432 223345799999999999999999999999999999999999999964210 00000000 0
Q ss_pred hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 ~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. ....+.. ....+..+.+||.+||+.||++|||+.++++
T Consensus 248 ~--~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 K--YKMNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCCCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCCCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0011111 1223457899999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=358.50 Aligned_cols=265 Identities=25% Similarity=0.353 Sum_probs=212.1
Q ss_pred hhhhhhcCCcccceecccCccceeeccCC-C-----CcEEEEEeeehhcc-cCCccccccceeeecc-cccceEEEEeEE
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVLP-D-----GQVVAVKQYKLASS-QGDQEFCSEVEVLSCA-QHRNVVMLIGFC 459 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~-----g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~ 459 (678)
.++...++|.+.+.||+|+||.||+|... + ...||+|.+..... .....+.+|+.+++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45677899999999999999999999842 2 24899999874432 2235688999999999 899999999999
Q ss_pred eeCCeEEEEEEEeecCCcccccccCC------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCce
Q 038949 460 VEDGRRLLVYEYICNGSLDSHLYGRD------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNI 527 (678)
Q Consensus 460 ~~~~~~~LV~E~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NI 527 (678)
.+.+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. ||+||||||+||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NI 195 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK----NCIHRDVAARNV 195 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGC
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC----CcccCCcccceE
Confidence 99999999999999999999985431 34578899999999999999999999 999999999999
Q ss_pred EeeecCccccccccccccccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCccc
Q 038949 528 LVTHDFEPLVGDFGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQ 605 (678)
Q Consensus 528 Ll~~~~~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~ 605 (678)
|++.++.++|+|||++....... ........||+.|+|||++.+..++.++||||||+++|+|+| |..||.......
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~- 274 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS- 274 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-
Confidence 99999999999999998654322 222334557889999999999999999999999999999998 889986543211
Q ss_pred chhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 606 QCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 606 ~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
......... .....+...+..+.+|+.+||+.||.+|||+.++++.|+....
T Consensus 275 -----~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 275 -----KFYKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp -----HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 001111110 1111223345578999999999999999999999999987654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=369.06 Aligned_cols=262 Identities=22% Similarity=0.232 Sum_probs=207.8
Q ss_pred ehhhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehh---cccCCccccccceeeecccccceEEEEeEEe
Q 038949 385 TYAELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA---SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460 (678)
Q Consensus 385 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 460 (678)
.+.+.....++|.+.+.||+|+||.||++.. .+++.||+|+++.. .......+.+|..++..++||||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3455667788999999999999999999995 57999999999643 2233456888999999999999999999999
Q ss_pred eCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 461 ~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
+.+.+|+||||+.||+|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL----GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999999543 23689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCccceeEEEeeeccccccccc-------ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQ-------SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~-------~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~ 613 (678)
|+++.............+||+.|+|||++. ...|+.++|||||||++|||++|+.||...... +...
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~ 280 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------ETYG 280 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------HHHH
Confidence 999866443322233467999999999997 357899999999999999999999999653321 1111
Q ss_pred HHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCC---chHHHHHH
Q 038949 614 PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSR---PRMSQVLR 664 (678)
Q Consensus 614 ~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~R---PT~~eVL~ 664 (678)
....... ....+. .+...+..+.+||.+||. +|.+| |+++|+++
T Consensus 281 ~i~~~~~--~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 281 KIVHYKE--HLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHhccc--CcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111000 000111 112345578999999999 99998 58888864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=358.08 Aligned_cols=257 Identities=25% Similarity=0.360 Sum_probs=201.0
Q ss_pred hhcCCcccceecccCccceeeccC-CCCc----EEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQ----VVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~----~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
..++|++.+.||+|+||.||+|.+ .+++ +||+|.++.... .....+.+|+.+++.++||||++++++|.++ ..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SE
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-Ce
Confidence 457899999999999999999984 3444 468887753332 3335788999999999999999999999875 47
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++|+||+.+|+|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 8999999999999999653 34589999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 546 QPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 546 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... .. ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~-~~~~------ 233 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------IS-SILE------ 233 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HH-HHHH------
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH------HH-HHHH------
Confidence 643322 22233456889999999999999999999999999999999 999997543211 00 0111
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
.......+..++..+.+++.+||+.||.+||++.++++.|+...
T Consensus 234 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 234 ---KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ---TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ---cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111223445567999999999999999999999999987643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=355.69 Aligned_cols=261 Identities=20% Similarity=0.192 Sum_probs=202.4
Q ss_pred hhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc-----ccCCccccccceeeecccccceEEEEeEEe
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS-----SQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~-----~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 460 (678)
..+....++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 34567789999999999999999999984 578899999987442 233357889999999999999999999999
Q ss_pred eCCeEEEEEEEeecCCcccccccC--------------------------------------CCCccCccccchhhhhhc
Q 038949 461 EDGRRLLVYEYICNGSLDSHLYGR--------------------------------------DRDPLEWSARRKIAVGAA 502 (678)
Q Consensus 461 ~~~~~~LV~E~~~ggsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~qI~ 502 (678)
+.+..++||||+.+|+|.+++... ....+++..++.++.||+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 999999999999999999988421 012245667788999999
Q ss_pred cchhhhhhcceeeeEEeccCCCCceEeeecC--ccccccccccccccCC---CccceeEEEeeecccccccccc--cccc
Q 038949 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDF--EPLVGDFGLARWQPDG---DMGVETRVLGTFGYLAPEYAQS--GQIT 575 (678)
Q Consensus 503 ~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~--~vkL~DFGla~~~~~~---~~~~~~~~~Gt~~Y~APE~l~~--~~~s 575 (678)
.||.|||+. ||+||||||+|||++.++ .+||+|||++...... .........||+.|+|||++.+ ..++
T Consensus 179 ~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 179 SALHYLHNQ----GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHHHT----TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHHHC----CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence 999999999 999999999999998776 8999999999865332 2222345679999999999975 6789
Q ss_pred eecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCC
Q 038949 576 EKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHS 655 (678)
Q Consensus 576 ~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~ 655 (678)
.++||||||+++|+|++|..||...... +....... .. ...........+..+.+||.+||+.||.+
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~-----~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLN-----KK--LCFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-----CC--CCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHh-----cc--cccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 9999999999999999999999644321 11111111 00 00111111224457899999999999999
Q ss_pred CchHHHHHH
Q 038949 656 RPRMSQVLR 664 (678)
Q Consensus 656 RPT~~eVL~ 664 (678)
||++.++++
T Consensus 322 Rps~~~~l~ 330 (345)
T 3hko_A 322 RFDAMRALQ 330 (345)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHhc
Confidence 999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=368.89 Aligned_cols=261 Identities=26% Similarity=0.343 Sum_probs=207.1
Q ss_pred hhhhcCCcccceecccCccceeeccC------CCCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeC
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED 462 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 462 (678)
+...++|.+.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|+.+++.++||||+++++++.+.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 44568899999999999999999983 246789999986332 22334688999999999999999999999999
Q ss_pred CeEEEEEEEeecCCcccccccCC-----CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC---c
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRD-----RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF---E 534 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~---~ 534 (678)
...++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEEecCCCCce
Confidence 99999999999999999995432 24588889999999999999999999 999999999999999655 4
Q ss_pred cccccccccccccC-CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhh
Q 038949 535 PLVGDFGLARWQPD-GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWA 612 (678)
Q Consensus 535 vkL~DFGla~~~~~-~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 612 (678)
+||+|||+++.... ..........||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ...
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~~~ 296 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVL 296 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHH
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHH
Confidence 99999999975422 11122233457889999999999999999999999999999998 99999653321 100
Q ss_pred HHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 613 RPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 613 ~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
... .. ......+..++..+.+|+.+||+.||.+||++.+|++.|+...
T Consensus 297 ~~i------~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 297 EFV------TS----GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHH------HT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH------Hc----CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 000 00 0111223345567899999999999999999999999997654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=361.63 Aligned_cols=252 Identities=20% Similarity=0.265 Sum_probs=205.9
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
.++|.+.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.+|+.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 57899999999999999999984 57899999998754433445788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee--cCccccccccccccccCC
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH--DFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~--~~~vkL~DFGla~~~~~~ 549 (678)
+.+|+|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999998543 34589999999999999999999999 9999999999999974 478999999999866433
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... . . ....
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~i~-~---~---~~~~ 269 (387)
T 1kob_A 205 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVK-R---C---DWEF 269 (387)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHH-H---C---CCCC
T ss_pred c--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHHHH-h---C---CCCC
Confidence 2 334567999999999999999999999999999999999999999653210 1001000 0 0 0001
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
........+..+.+||.+||+.||++|||+.++++
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 11112234557899999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.48 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=198.5
Q ss_pred cCCcccceecccCccceeeccCCCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
++|.+.+.||+|+||.||+|...+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999987899999999864332 2335688999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.+ +|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 965 888888543 35689999999999999999999999 99999999999999999999999999997653221
Q ss_pred cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHh------hhhc-
Q 038949 552 GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH------AIGE- 623 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------~~~e- 623 (678)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ +..... ..... ...+
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFR-ILGTPNSKNWPNVTEL 231 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHH-HHCCCCTTTSTTGGGS
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH-HHCCCChhhchhhhcc
Confidence 22334578999999999875 4589999999999999999999999965432110 000000 00000 0000
Q ss_pred -ccCcchh-------cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 624 -LIDPRLR-------NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 624 -lld~~l~-------~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..++.+. ..+....+..+.+||.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0011100 1111234557889999999999999999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=348.46 Aligned_cols=262 Identities=26% Similarity=0.336 Sum_probs=200.6
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-----CCccccccceeeeccc---ccceEEEEeEEe
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-----GDQEFCSEVEVLSCAQ---HRNVVMLIGFCV 460 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-----~~~~~~~Ev~iL~~L~---HpnIv~l~~~~~ 460 (678)
....++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.+++.+. ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 35578999999999999999999994 57899999998743321 1245678888887775 999999999998
Q ss_pred eCC-----eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcc
Q 038949 461 EDG-----RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEP 535 (678)
Q Consensus 461 ~~~-----~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~v 535 (678)
... ..++||||+. ++|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCTTTEEECTTSCE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCE
Confidence 755 5899999995 6999999766666699999999999999999999999 99999999999999999999
Q ss_pred ccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH
Q 038949 536 LVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615 (678)
Q Consensus 536 kL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 615 (678)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ....
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~------~~~i 231 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ------LGKI 231 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH------HHHH
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH
Confidence 999999998654322 22345689999999999999999999999999999999999999965432110 0111
Q ss_pred HHHhh------hhc-------cc---CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 LKRHA------IGE-------LI---DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 ~~~~~------~~e-------ll---d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..... ... .. .+..........+..+.+||.+||+.||++|||+.|+|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11000 000 00 000001112234567889999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=355.78 Aligned_cols=270 Identities=25% Similarity=0.353 Sum_probs=208.7
Q ss_pred hcCC-cccceecccCccceeeccC-----CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEee--CC
Q 038949 393 TNRF-SEANFLAEGGFGSVHRGVL-----PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE--DG 463 (678)
Q Consensus 393 ~~~y-~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~ 463 (678)
.++| ++.+.||+|+||.||++.+ .+++.||||+++.... .....+.+|+++++.++||||+++++++.+ ..
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 4455 9999999999999977642 3688999999975422 223568899999999999999999999987 46
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
.+++||||+.+|+|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ----HYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred eEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEEcCCCCEEECCcccc
Confidence 789999999999999999432 489999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCc--cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 544 RWQPDGDM--GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 544 ~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
........ .......+|+.|+|||++.+..++.++||||||+++|+|++|..||....... .....+.........+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRL 260 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHH
Confidence 87654322 12233457888999999999999999999999999999999999986432100 0000111111111112
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
.+.+........+..++..+.+||.+||+.||.+|||+.++++.|+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 2222222223344556678999999999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=355.23 Aligned_cols=270 Identities=26% Similarity=0.349 Sum_probs=214.9
Q ss_pred ehhhhhhhhcCCcccceecccCccceeeccC------CCCcEEEEEeeehhccc-CCccccccceeeecc-cccceEEEE
Q 038949 385 TYAELELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCA-QHRNVVMLI 456 (678)
Q Consensus 385 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L-~HpnIv~l~ 456 (678)
....++...++|.+.+.||+|+||.||+|.+ .+++.||+|+++..... ....+.+|+.++..+ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 4456777889999999999999999999962 35789999998744322 224688999999999 799999999
Q ss_pred eEEeeCC-eEEEEEEEeecCCcccccccCCC--------------CccCccccchhhhhhccchhhhhhcceeeeEEecc
Q 038949 457 GFCVEDG-RRLLVYEYICNGSLDSHLYGRDR--------------DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521 (678)
Q Consensus 457 ~~~~~~~-~~~LV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrD 521 (678)
+++...+ ..++||||+.+|+|.+++..... ..+++..++.++.||+.||.|||+. ||+|||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~d 173 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRD 173 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT----TCCCSC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC----Cccccc
Confidence 9987754 58999999999999999965432 2278889999999999999999999 999999
Q ss_pred CCCCceEeeecCccccccccccccccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccc
Q 038949 522 MRPNNILVTHDFEPLVGDFGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDL 599 (678)
Q Consensus 522 LKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~ 599 (678)
|||+|||++.++.+||+|||+++...... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999999999999998654322 223334668899999999999999999999999999999998 9999965
Q ss_pred cCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccccC
Q 038949 600 NRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMN 673 (678)
Q Consensus 600 ~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~~ 673 (678)
..... .... ..... .. ...+...+..+.+++.+||+.||.+|||+.++++.|+..+...
T Consensus 254 ~~~~~-----~~~~-~~~~~-----~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 254 VKIDE-----EFCR-RLKEG-----TR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCCSH-----HHHH-HHHHT-----CC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhH-----HHHH-HhccC-----cc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 43211 0111 11111 00 1122334457899999999999999999999999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=351.80 Aligned_cols=264 Identities=25% Similarity=0.281 Sum_probs=199.0
Q ss_pred hhcCCccc-ceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEeeCCeEEEE
Q 038949 392 ATNRFSEA-NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 392 ~~~~y~~~-~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV 468 (678)
..++|.+. +.||+|+||.||+|.. .+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..|+|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 35688885 7899999999999984 57899999999755444456788999999885 799999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc---ccccccccccc
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE---PLVGDFGLARW 545 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~---vkL~DFGla~~ 545 (678)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++. +||+|||++..
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNK----GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999954 34689999999999999999999999 9999999999999998776 99999999975
Q ss_pred ccCCC------ccceeEEEeeecccccccccc-----cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhh---
Q 038949 546 QPDGD------MGVETRVLGTFGYLAPEYAQS-----GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEW--- 611 (678)
Q Consensus 546 ~~~~~------~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~--- 611 (678)
..... ........||+.|+|||++.. ..++.++|||||||++|+|++|+.||..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 43211 111223568999999999875 5688999999999999999999999976543221110000
Q ss_pred --hHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 612 --ARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 612 --~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
........ ...... +........+..+.+||.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~i-~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESI-QEGKYE--FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHH-HHCCCC--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHH-hccCcc--cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00011100 000000 000001124457899999999999999999999987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=362.64 Aligned_cols=249 Identities=24% Similarity=0.275 Sum_probs=195.1
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCcccccccee-eecccccceEEEEeEEeeCCeE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEV-LSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~i-L~~L~HpnIv~l~~~~~~~~~~ 465 (678)
...++|.+.+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|..+ ++.++||||++++++|.+.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 3457899999999999999999995 5688999999975432 223456677776 5778999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|++||+|||+++.
T Consensus 115 ~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 999999999999999843 34588999999999999999999999 999999999999999999999999999985
Q ss_pred ccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
..... ......+||+.|+|||++.+..++.++|+|||||++|||++|..||..... .+....... .
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~-----~-- 254 (373)
T 2r5t_A 189 NIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILN-----K-- 254 (373)
T ss_dssp GBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHH-----S--
T ss_pred cccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHh-----c--
Confidence 43222 233456799999999999999999999999999999999999999964321 111111111 0
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL 663 (678)
. ..++...+..+.+||.+||+.||.+||++.+.+
T Consensus 255 ~----~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 255 P----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp C----CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred c----cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 0 112333455789999999999999999985433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.12 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=206.0
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
....++|.+.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34567899999999999999999984 578999999986432 23335788999999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||+.||+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.+|.+||+|||++..
T Consensus 91 ~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQ----RIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp EEEECCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEECCCCCEEEeccceeee
Confidence 99999999999999994 345699999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCccceeEEEeeecccccccccc---cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQS---GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
.... ......+||+.|+|||++.. ..|+.++|||||||++|+|++|..||........ ........ .
T Consensus 165 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~---~~~~~~~~-~---- 234 (384)
T 4fr4_A 165 LPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS---KEIVHTFE-T---- 234 (384)
T ss_dssp CCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH---HHHHHHHH-H----
T ss_pred ccCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH---HHHHHHHh-h----
Confidence 5433 23345679999999999964 4589999999999999999999999975432211 11111000 0
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCch-HHHHHH
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR-MSQVLR 664 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT-~~eVL~ 664 (678)
....++...+..+.+||.+||+.||.+||+ ++++++
T Consensus 235 ------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 ------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011233344568999999999999999998 777664
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.86 Aligned_cols=259 Identities=19% Similarity=0.273 Sum_probs=198.9
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCC--ccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGD--QEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~--~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
++|++.+.||+|+||.||+|.. .+++.||+|++........ ..+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999995 5789999999975443322 567899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+ +|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~----~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9965 55555533 345699999999999999999999999 99999999999999999999999999998654322
Q ss_pred ccceeEEEeeecccccccccccc-cceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh---------
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQ-ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA--------- 620 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~--------- 620 (678)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ...........
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-----~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-----DQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-----HHHHHHHHHHCCCCTTTCTT
T ss_pred -ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHHhCCCChhhhhh
Confidence 2233456899999999997765 7999999999999999999988864322111 11111111000
Q ss_pred hhcccC---------cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 IGELID---------PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ~~elld---------~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.....+ ...........+..+.+||.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000000 00000112234557889999999999999999999885
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=358.72 Aligned_cols=245 Identities=21% Similarity=0.265 Sum_probs=204.5
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 46899999999999999999995 579999999996443 23335688899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.||+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999954 34589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......... ..
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~----~~----- 254 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVS----GK----- 254 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH----CC-----
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHc----CC-----
Confidence 2 2345799999999999999999999999999999999999999964321 111111110 00
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCch-----HHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPR-----MSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT-----~~eVL~ 664 (678)
..++...+..+.+||.+||+.||.+||+ ++++++
T Consensus 255 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1123345568999999999999999998 888764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=361.18 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=205.0
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
....++|.+.+.||+|+||.||+|.. .+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 44567899999999999999999984 57899999999744322 2356889999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec---Ccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD---FEPLVGDFGLA 543 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~---~~vkL~DFGla 543 (678)
+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||++
T Consensus 105 lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 99999999999998843 45689999999999999999999999 99999999999999865 45999999999
Q ss_pred ccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 544 RWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 544 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....... ... .
T Consensus 179 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i-~~~---~ 246 (362)
T 2bdw_A 179 IEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQI-KAG---A 246 (362)
T ss_dssp BCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-HHT---C
T ss_pred eEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH-HhC---C
Confidence 8654332 22345799999999999998999999999999999999999999964321 0111100 000 0
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+ .........+..+.+||.+||+.||++||++.++|+
T Consensus 247 -~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 247 -YD--YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -CC--CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -CC--CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 001111234557899999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=356.81 Aligned_cols=268 Identities=26% Similarity=0.391 Sum_probs=214.7
Q ss_pred eehhhhhhhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEE
Q 038949 384 FTYAELELATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLI 456 (678)
Q Consensus 384 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~ 456 (678)
+...+++...++|.+.+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 445567888999999999999999999999743 467899999864322 2224688999999999999999999
Q ss_pred eEEeeCCeEEEEEEEeecCCcccccccCC--------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceE
Q 038949 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRD--------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL 528 (678)
Q Consensus 457 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NIL 528 (678)
+++.+.+..++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~NIl 170 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCM 170 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CCccCCCccceEE
Confidence 99999999999999999999999985421 24568889999999999999999999 9999999999999
Q ss_pred eeecCccccccccccccccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccc
Q 038949 529 VTHDFEPLVGDFGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQ 606 (678)
Q Consensus 529 l~~~~~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~ 606 (678)
++.++.+||+|||++....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 246 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---- 246 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH----
Confidence 9999999999999997553322 112223457889999999999999999999999999999999 8889864321
Q ss_pred hhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 607 CLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 607 ~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
........ . ... ...+...+..+.+++.+||+.||.+||++.++++.|+..+.
T Consensus 247 --~~~~~~~~-~---~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 --EQVLRFVM-E---GGL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --HHHHHHHH-T---TCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --HHHHHHHH-c---CCc------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 01111000 0 000 11233455679999999999999999999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=353.43 Aligned_cols=244 Identities=23% Similarity=0.283 Sum_probs=204.1
Q ss_pred hhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcc--------cCCccccccceeeecccccceEEEEeEEee
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS--------QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~--------~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 461 (678)
...++|.+.+.||+|+||.||+|. ..+++.||||+++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 345789999999999999999998 45789999999875432 133578889999999999999999999999
Q ss_pred CCeEEEEEEEeecC-CcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 462 DGRRLLVYEYICNG-SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 462 ~~~~~LV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
.+..++||||+.+| +|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLK----DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999998776 9999884 345699999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHh
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH 619 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 619 (678)
|++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 175 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------- 235 (335)
T 3dls_A 175 GSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------- 235 (335)
T ss_dssp TTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred ccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence 9998664432 3345679999999999988777 8899999999999999999999953211
Q ss_pred hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 620 ~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
...... ..+...+..+.+||.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 TVEAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp GTTTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHhhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 1112234578999999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=358.39 Aligned_cols=265 Identities=26% Similarity=0.383 Sum_probs=211.3
Q ss_pred hhhhhcCCcccceecccCccceeeccC--------CCCcEEEEEeeehhcc-cCCccccccceeeecc-cccceEEEEeE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL--------PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCA-QHRNVVMLIGF 458 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~--------~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L-~HpnIv~l~~~ 458 (678)
++...++|.+.+.||+|+||.||+|.+ .+++.||+|+++.... .....+.+|+.+++.+ +||||++++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 456678999999999999999999974 3567899999874422 2235688999999999 89999999999
Q ss_pred EeeCCeEEEEEEEeecCCcccccccCCC--------------CccCccccchhhhhhccchhhhhhcceeeeEEeccCCC
Q 038949 459 CVEDGRRLLVYEYICNGSLDSHLYGRDR--------------DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRP 524 (678)
Q Consensus 459 ~~~~~~~~LV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp 524 (678)
+.+.+..|+||||+.+|+|.+++..... ..+++..++.++.||+.||.|||+. ||+||||||
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp 185 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAA 185 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCcc
Confidence 9999999999999999999999965432 2478889999999999999999999 999999999
Q ss_pred CceEeeecCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCC
Q 038949 525 NNILVTHDFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRP 602 (678)
Q Consensus 525 ~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~ 602 (678)
+|||++.++.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 999999999999999999986543321 11223456788999999998899999999999999999999 9999864321
Q ss_pred cccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccccC
Q 038949 603 RGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMN 673 (678)
Q Consensus 603 ~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~~ 673 (678)
.+..... ... .....+..++..+.++|.+||+.||.+||++.++++.|+..+...
T Consensus 266 ------~~~~~~~-~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 266 ------EELFKLL-KEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp ------HHHHHHH-HHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------HHHHHHH-hcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 1111111 110 011123345567999999999999999999999999999876543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=350.44 Aligned_cols=262 Identities=22% Similarity=0.258 Sum_probs=200.5
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC---CccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG---DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~---~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
..++|.+.+.||+|+||.||+|.. .+++.||+|++....... ...+.+|+.+++.++||||+++++++..++..|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 357899999999999999999984 478999999987543322 2568899999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAA----GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999853 34689999999999999999999999 99999999999999999999999999997665
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
...........|++.|+|||++.+..++.++||||||+++|+|++|..||..... .. ... .+.....
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~-----~~~-~~~~~~~- 252 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------SV-----MGA-HINQAIP- 252 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------HH-----HHH-HHHSCCC-
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------HH-----HHH-HhccCCC-
Confidence 4433334456799999999999999999999999999999999999999964321 00 000 0111110
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCc-hHHHHHHHhhcccccC
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRP-RMSQVLRMLEGDILMN 673 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RP-T~~eVL~~Le~~~~~~ 673 (678)
.....+...+..+.++|.+||+.||++|| +++++++.|+..+...
T Consensus 253 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 253 -RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 01122334555789999999999999999 9999999999776543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=368.96 Aligned_cols=255 Identities=21% Similarity=0.281 Sum_probs=204.1
Q ss_pred hhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
....++|++.+.||+|+||.||+|. ..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+++..|
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 3456789999999999999999998 45799999999864332 22356889999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee---ecCcccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT---HDFEPLVGDFGLA 543 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~---~~~~vkL~DFGla 543 (678)
+||||+.||+|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||++
T Consensus 87 lv~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~----givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQM----GVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EEECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 99999999999999854 35699999999999999999999999 999999999999998 4678999999999
Q ss_pred ccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 544 RWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 544 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...... .. ..
T Consensus 161 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~~~~~i-~~---~~ 229 (444)
T 3soa_A 161 IEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------RLYQQI-KA---GA 229 (444)
T ss_dssp BCCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHH-HH---TC
T ss_pred EEecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------HHHHHH-Hh---CC
Confidence 7654332 2233457999999999999999999999999999999999999999643210 101100 00 00
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+ +........+..+.+||.+||+.||.+|||+.++|+
T Consensus 230 -~~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 230 -YD--FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -CC--CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CC--CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 001111234557899999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=356.13 Aligned_cols=267 Identities=14% Similarity=0.167 Sum_probs=201.1
Q ss_pred hhhcCCcccceecccCccceeeccCC----CCcEEEEEeeehhccc-----------CCccccccceeeecccccceEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLP----DGQVVAVKQYKLASSQ-----------GDQEFCSEVEVLSCAQHRNVVML 455 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~i~~~~~~-----------~~~~~~~Ev~iL~~L~HpnIv~l 455 (678)
...++|.+.+.||+|+||.||+|... ++..+|+|++...... ....+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 44678999999999999999999853 5788999988643211 12346677888888999999999
Q ss_pred EeEEee----CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee
Q 038949 456 IGFCVE----DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH 531 (678)
Q Consensus 456 ~~~~~~----~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~ 531 (678)
++++.. ....|+||||+ +++|.+++... ..+++..++.++.||+.||.|||+. ||+||||||+|||++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHEN----EYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEES
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCcCHHHEEEcc
Confidence 999988 67899999999 99999999543 3799999999999999999999999 9999999999999998
Q ss_pred cC--ccccccccccccccCCC------ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCc
Q 038949 532 DF--EPLVGDFGLARWQPDGD------MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPR 603 (678)
Q Consensus 532 ~~--~vkL~DFGla~~~~~~~------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~ 603 (678)
++ .+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 87 99999999997653211 11123456899999999999999999999999999999999999999643221
Q ss_pred ccchhhhhhHHHHHHhhhhcccCcchhccc-chhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 604 GQQCLTEWARPLLKRHAIGELIDPRLRNCY-SEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 604 ~~~~l~~~~~~~~~~~~~~elld~~l~~~~-~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
... ..... ......+...+.... ....+..+.++|.+||+.||++||++++|++.|+....
T Consensus 267 ~~~-~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 267 PVA-VQTAK------TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHH-HHHHH------HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cHH-HHHHH------HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 110 00000 011111111111111 11345589999999999999999999999999997654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=350.56 Aligned_cols=248 Identities=23% Similarity=0.254 Sum_probs=194.1
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecc-cccceEEEEeEEeeCCeE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~ 465 (678)
+...++|++.+.||+|+||.||+|.. .+++.||||++...... ....+..|+..+..+ +||||++++++|.+++..
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 45567899999999999999999995 47999999987533221 123444555555544 899999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||+ +++|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++..
T Consensus 133 ~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ----GLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 9999999 77998888543 34699999999999999999999999 999999999999999999999999999976
Q ss_pred ccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+..... +. .+.
T Consensus 207 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~~----------~~~ 265 (311)
T 3p1a_A 207 LGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------WQ----------QLR 265 (311)
T ss_dssp CC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------HH----------HHT
T ss_pred cccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HH----------HHh
Confidence 53322 2234468999999999875 789999999999999999999776532110 00 000
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.......++...+..+.+||.+||+.||++|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 266 QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111111223334567999999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=362.69 Aligned_cols=269 Identities=19% Similarity=0.270 Sum_probs=204.8
Q ss_pred hhhcCCcccceeccc--CccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 391 LATNRFSEANFLAEG--GFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G--~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
...++|++.+.||+| +||.||+|.. .+++.||||+++..... ....+.+|+.+++.++||||+++++++.+++.+
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 446789999999999 9999999995 47999999999754322 235677899999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||+.+|+|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||.+..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999999766556799999999999999999999999 999999999999999999999999999864
Q ss_pred ccCCCc------cceeEEEeeecccccccccc--cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH--
Q 038949 546 QPDGDM------GVETRVLGTFGYLAPEYAQS--GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL-- 615 (678)
Q Consensus 546 ~~~~~~------~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~-- 615 (678)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ...+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~ 256 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKLNGTVPC 256 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH-HHC-------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHhcCCCCc
Confidence 322110 11122368889999999987 67999999999999999999999999654322110 00000000
Q ss_pred -HHH------------------hhhhccc---------CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 -LKR------------------HAIGELI---------DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 -~~~------------------~~~~ell---------d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... ......+ .......++...+..+.+||.+||+.||.+|||+.|+|+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000 0000000 000001123334567899999999999999999999984
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=359.47 Aligned_cols=269 Identities=15% Similarity=0.176 Sum_probs=204.2
Q ss_pred hhhcCCcccceecccCccceeeccCCC------CcEEEEEeeehhccc-----------CCccccccceeeecccccceE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLPD------GQVVAVKQYKLASSQ-----------GDQEFCSEVEVLSCAQHRNVV 453 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~i~~~~~~-----------~~~~~~~Ev~iL~~L~HpnIv 453 (678)
...++|.+.+.||+|+||.||+|.+.. ++.||||++...... ....+..|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 456799999999999999999998543 478999998643211 111233455566777899999
Q ss_pred EEEeEEeeC----CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe
Q 038949 454 MLIGFCVED----GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV 529 (678)
Q Consensus 454 ~l~~~~~~~----~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl 529 (678)
++++++... ...||||||+ +++|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~----~iiHrDlkp~Nill 185 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH----EYVHGDIKASNLLL 185 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEEecCCHHHEEE
Confidence 999998764 4589999999 99999998543 35699999999999999999999999 99999999999999
Q ss_pred e--ecCccccccccccccccCCCc------cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccC
Q 038949 530 T--HDFEPLVGDFGLARWQPDGDM------GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNR 601 (678)
Q Consensus 530 ~--~~~~vkL~DFGla~~~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~ 601 (678)
+ .++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 889999999999976533211 11234559999999999999999999999999999999999999997533
Q ss_pred CcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 602 PRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 602 ~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.... ........ ....+..++++.+. ....+..+.+++..||+.||.+||++.+|++.|+..+.
T Consensus 266 ~~~~--~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 266 KDPK--YVRDSKIR-YRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp TCHH--HHHHHHHH-HHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCHH--HHHHHHHH-hhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 2111 11111100 01112222222221 12345579999999999999999999999999987664
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=346.43 Aligned_cols=263 Identities=28% Similarity=0.433 Sum_probs=198.8
Q ss_pred hhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
.++..++|++.+.||+|+||.||+|.+.. .||+|+++..... ..+.+.+|+.+++.++||||+++++++ .....+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 47788999999999999999999998643 5999998644322 235688999999999999999999965 456789
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.+++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK----SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCCCEEEccceecccc
Confidence 999999999999998543 35589999999999999999999999 9999999999999999999999999999754
Q ss_pred cCC-CccceeEEEeeeccccccccc---ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 547 PDG-DMGVETRVLGTFGYLAPEYAQ---SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 547 ~~~-~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
... .........||+.|+|||++. +..++.++||||||+++|+|++|+.||....... ..........
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~-- 242 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGS-- 242 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTS--
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccc--
Confidence 331 122234457899999999986 5678899999999999999999999996543211 1111111111
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
..+.+ ......++..+.+|+.+||+.||.+||++.++++.|+...
T Consensus 243 --~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 243 --LSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp --CCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --cCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11111 1122345568999999999999999999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=352.10 Aligned_cols=258 Identities=25% Similarity=0.368 Sum_probs=196.4
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC---CccccccceeeecccccceEEEEeEEeeCC---
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG---DQEFCSEVEVLSCAQHRNVVMLIGFCVEDG--- 463 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~---~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~--- 463 (678)
...++|++.+.||+|+||.||+|.. .+++.||+|+++...... ...+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 4568999999999999999999994 679999999997543222 246889999999999999999999987654
Q ss_pred -eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 464 -RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 464 -~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
..|+||||+.+++|.+++.. ..++++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cccEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 34999999999999999943 34689999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCC--ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 543 ARWQPDGD--MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 543 a~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
+....... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||....+. ........
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~--- 233 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVR--- 233 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH---
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhc---
Confidence 97654322 12233457899999999999999999999999999999999999999654321 11110000
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHH-HHhh
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL-RMLE 667 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL-~~Le 667 (678)
.....+ .......+..+.++|.+||+.||++||++.+++ ..|.
T Consensus 234 -~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 234 -EDPIPP---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp -CCCCCH---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -CCCCCc---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 011111 111223455789999999999999999766655 3443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=360.43 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=203.2
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecc-cccceEEEEeEEeeCCe
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~ 464 (678)
....++|.+.+.||+|+||.||+|.. .+++.||+|+++... ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 44568999999999999999999995 578999999997542 23335677888888876 89999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999943 34689999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
...... ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||...... ........ .
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~----~-- 233 (345)
T 1xjd_A 167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRM----D-- 233 (345)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH----C--
T ss_pred hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHh----C--
Confidence 543222 2234567999999999999999999999999999999999999999643211 11111000 0
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHH-HHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMS-QVL 663 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~-eVL 663 (678)
.+ .++...+..+.+||.+||+.||.+||++. +++
T Consensus 234 -~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 -NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -CC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11 12333455789999999999999999997 654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=363.81 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=198.7
Q ss_pred hhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcc--cCCccccccceeeeccc--ccceEEEEeEEeeCCeEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQ--HRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~--HpnIv~l~~~~~~~~~~~ 466 (678)
....+|.+.+.||+|+||.||+|...+++.||||++..... .....+.+|+.+|+.++ ||||+++++++..++.+|
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 34567999999999999999999977799999999864432 22357889999999996 599999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||| +.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++ ++.+||+|||+++..
T Consensus 133 lv~E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEEE-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEEe-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 9999 568899999954 34688889999999999999999999 999999999999995 689999999999865
Q ss_pred cCCCc-cceeEEEeeecccccccccc-----------cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHH
Q 038949 547 PDGDM-GVETRVLGTFGYLAPEYAQS-----------GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP 614 (678)
Q Consensus 547 ~~~~~-~~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 614 (678)
..... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.......
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---------- 274 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---------- 274 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----------
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH----------
Confidence 43221 12334579999999999865 468899999999999999999999996432100
Q ss_pred HHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 LLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 ~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+..++++.....++...+..+.+||.+||+.||.+||++.++++
T Consensus 275 ----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 275 ----SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp ----HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 0111222222222333334557899999999999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=338.88 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=204.1
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
..++|++.+.||+|+||.||+|.. .+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 357899999999999999999985 47899999998754322 2357889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++. ....+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++......
T Consensus 85 e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999994 345689999999999999999999999 9999999999999999999999999999755322
Q ss_pred C-ccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 550 D-MGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 550 ~-~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
. ........|++.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+. .. ....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-----~~--~~~~-- 228 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK-----EK--KTYL-- 228 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH-----TT--CTTS--
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh-----hc--cccc--
Confidence 2 112234568999999999987765 7899999999999999999999975432111 011110 00 0000
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
......+..+.+||.+||+.||.+|||+.++++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 011234457889999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.84 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=207.1
Q ss_pred hhhhhhcCCcccc-eecccCccceeecc---CCCCcEEEEEeeehhcccC--CccccccceeeecccccceEEEEeEEee
Q 038949 388 ELELATNRFSEAN-FLAEGGFGSVHRGV---LPDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCAQHRNVVMLIGFCVE 461 (678)
Q Consensus 388 ~~~~~~~~y~~~~-~LG~G~fG~Vy~a~---~~~g~~vAvK~i~~~~~~~--~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 461 (678)
++....++|.+.+ .||+|+||.||+|. ..+++.||+|+++...... .+.+.+|+.+++.++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3455678899988 99999999999995 2457899999987543222 35688999999999999999999999 5
Q ss_pred CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
.+..++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhC----CeEcCCCCcceEEEeCCCcEEEccCC
Confidence 6788999999999999999954 34589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCccc--eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHH
Q 038949 542 LARWQPDGDMGV--ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKR 618 (678)
Q Consensus 542 la~~~~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 618 (678)
++.......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...... .... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~-~~~- 234 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTA-MLE- 234 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHH-HHH-
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHHH-HHH-
Confidence 998664433211 222345688999999998899999999999999999999 99999653321 0000 000
Q ss_pred hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 619 ~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
. ......+...+..+.++|.+||+.||.+||++.++++.|+..+.
T Consensus 235 ----~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 235 ----K----GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ----T----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----c----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 01112334455689999999999999999999999999997664
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=340.06 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=206.7
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEee-------
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE------- 461 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~------- 461 (678)
....++|++.+.||+|+||.||+|.+ .+++.||+|.+... ...+.+|+++++.++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 44567899999999999999999995 47999999998743 2568899999999999999999998854
Q ss_pred ---------CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec
Q 038949 462 ---------DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD 532 (678)
Q Consensus 462 ---------~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~ 532 (678)
...+++||||+.+|+|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK----KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEET
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHEEEcCC
Confidence 44589999999999999999665556799999999999999999999999 99999999999999999
Q ss_pred CccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhh
Q 038949 533 FEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWA 612 (678)
Q Consensus 533 ~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~ 612 (678)
+.++|+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..|+.... .
T Consensus 159 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~-- 226 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------K-- 226 (284)
T ss_dssp TEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------H--
T ss_pred CCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------H--
Confidence 999999999997654332 2233468999999999999999999999999999999999998874210 0
Q ss_pred HHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 613 RPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 613 ~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
... .+.... .+...+..+.++|.+||+.||.+||++.++++.|+...
T Consensus 227 --~~~-----~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 227 --FFT-----DLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp --HHH-----HHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred --HHH-----Hhhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 000 000111 12223446889999999999999999999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=358.14 Aligned_cols=250 Identities=20% Similarity=0.258 Sum_probs=202.7
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecc-cccceEEEEeEEeeCCeE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~ 465 (678)
...++|.+.+.||+|+||.||+|.. .+++.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 3457899999999999999999995 468899999997542 23335677899999887 799999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++.
T Consensus 97 ~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 999999999999999943 34589999999999999999999999 999999999999999999999999999975
Q ss_pred ccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+....... .
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~-----~-- 236 (353)
T 2i0e_A 171 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIME-----H-- 236 (353)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-----C--
T ss_pred cccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHh-----C--
Confidence 32221 223456799999999999999999999999999999999999999964321 111111111 0
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCch-----HHHHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR-----MSQVLR 664 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT-----~~eVL~ 664 (678)
. ..++...+..+.+||.+||+.||.+||+ ++++++
T Consensus 237 ~----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 237 N----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp C----CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred C----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 1123345568899999999999999995 566653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=340.50 Aligned_cols=263 Identities=18% Similarity=0.235 Sum_probs=202.7
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeE-EeeCCeEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGF-CVEDGRRLLVY 469 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~-~~~~~~~~LV~ 469 (678)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+|+.+++.++|++++..+.. +......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999994 678999999875432 33568899999999988776655554 46677889999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe---eecCccccccccccccc
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV---THDFEPLVGDFGLARWQ 546 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl---~~~~~vkL~DFGla~~~ 546 (678)
||+ +++|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998532 34599999999999999999999999 99999999999999 78899999999999865
Q ss_pred cCCCc------cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 547 PDGDM------GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 547 ~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~-~ 234 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI---SEK-K 234 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH---HHH-H
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh---hcc-c
Confidence 44322 1223457899999999999999999999999999999999999999764432221111100 000 0
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
... + ........+..+.+|+.+||+.||++||++.++++.|+..+.
T Consensus 235 ~~~---~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 235 MST---P--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHS---C--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred ccc---h--hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 000 0 000112234579999999999999999999999999987664
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=349.61 Aligned_cols=263 Identities=24% Similarity=0.346 Sum_probs=188.2
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
.++|++.+.||+|+||.||+|.. .+++.||+|+++..... ....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46899999999999999999985 57899999998754332 33578899999999999999999999999999999999
Q ss_pred EeecCCcccccccC----CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 471 YICNGSLDSHLYGR----DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 471 ~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
|+. |+|.+++... ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN----KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 996 6998888432 224588899999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHh------
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH------ 619 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------ 619 (678)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +..... .....
T Consensus 159 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~-~~~~~~~~~~~ 234 (317)
T 2pmi_A 159 GIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ--LKLIFD-IMGTPNESLWP 234 (317)
T ss_dssp TSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHH-HHCSCCTTTCG
T ss_pred CCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHH-HhCCCChhHhh
Confidence 4321 12234568999999999876 4689999999999999999999999965432111 000000 00000
Q ss_pred hhhcc--cC------------cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 AIGEL--ID------------PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 ~~~el--ld------------~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..... .. ..+........+..+.+||.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 00 00011111234457899999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=355.19 Aligned_cols=250 Identities=21% Similarity=0.282 Sum_probs=199.8
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc---CCccccccceeeecc-cccceEEEEeEEeeCCeEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~L 467 (678)
.++|.+.+.||+|+||.||+|+. .+++.||+|+++..... ....+.+|+.++..+ +||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 46899999999999999999995 57899999999754322 224577899999887 89999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+.||+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999843 34689999999999999999999999 99999999999999999999999999997533
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccc--hhhhhhHHHHHHhhhhccc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQ--CLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~--~l~~~~~~~~~~~~~~ell 625 (678)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ........... ..
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~----~~-- 234 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL----EK-- 234 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH----HC--
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH----cC--
Confidence 221 2234567999999999999999999999999999999999999999643211100 00000000000 00
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRM 659 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~ 659 (678)
...++...+..+.+||.+||+.||.+||++
T Consensus 235 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 235 ----QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 011333455678999999999999999996
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=347.87 Aligned_cols=260 Identities=24% Similarity=0.334 Sum_probs=204.7
Q ss_pred hhhhcCCcccceecccCccceeeccCC----CCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLP----DGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
....++|.+.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+ +.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 456789999999999999999999742 23469999987542 2233578899999999999999999999865 45
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.++||||+.+++|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.++|+|||++.
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESI----NCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred CEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEECCCCcEEeCccCCCc
Confidence 78999999999999999543 34588999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
..............+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... ... ..... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~------~~~-~~~~~---~ 231 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD------VIG-VLEKG---D 231 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG------HHH-HHHHT---C
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH------HHH-HHhcC---C
Confidence 665433323333456889999999998999999999999999999998 999996433211 001 01110 0
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
....+...+..+.+++.+||+.||.+||++.++++.|+....
T Consensus 232 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 232 ------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 011223344578999999999999999999999999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=379.82 Aligned_cols=261 Identities=24% Similarity=0.341 Sum_probs=206.0
Q ss_pred hhhhhcCCcccc-eecccCccceeeccC---CCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCC
Q 038949 389 LELATNRFSEAN-FLAEGGFGSVHRGVL---PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG 463 (678)
Q Consensus 389 ~~~~~~~y~~~~-~LG~G~fG~Vy~a~~---~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 463 (678)
+....++|.+.. .||+|+||.||+|.+ .++..||||+++..... ..+.+.+|+++|+.++||||++++++|.. +
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 344555666666 799999999999974 35678999999754322 34678999999999999999999999976 5
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
.+++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~----~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK----NFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred CeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 699999999999999999543 45689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCc--cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhh
Q 038949 544 RWQPDGDM--GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 544 ~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
+....... .......+++.|+|||++.++.++.++|||||||+||||++ |+.||...... +.... +.
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~~~~-i~--- 553 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAF-IE--- 553 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH------HHHHH-HH---
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH------HHHHH-HH---
Confidence 86543221 11222345689999999999999999999999999999998 99999754321 11110 00
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.......+..++..+.+||.+||+.||++||++.+|++.|+..+.
T Consensus 554 ------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 554 ------QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp ------TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 111122344566789999999999999999999999999988654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=354.58 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=201.6
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEeeCCeEEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV 468 (678)
...++|.+.+.||+|+||.||+|.. .+++.||+|+++... ....+|++++.++ +||||+++++++.++...|+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 3467899999999999999999984 578999999987432 3456788888887 799999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec----Cccccccccccc
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD----FEPLVGDFGLAR 544 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~----~~vkL~DFGla~ 544 (678)
|||+.||+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||+..+ +.+||+|||++.
T Consensus 95 ~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~----givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 95 TELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQ----GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp ECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 999999999999844 45699999999999999999999999 99999999999998543 359999999998
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+..... ... .
T Consensus 169 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~~~~i-~~~---~- 239 (342)
T 2qr7_A 169 QLRAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---PEEILARI-GSG---K- 239 (342)
T ss_dssp ECBCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC---HHHHHHHH-HHC---C-
T ss_pred cCcCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC---HHHHHHHH-ccC---C-
Confidence 654332 22334578999999999998889999999999999999999999997432111 11111111 110 0
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+...+....+..+.+||.+||+.||++||++.++++
T Consensus 240 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 240 --FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111122345568899999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=347.31 Aligned_cols=261 Identities=25% Similarity=0.340 Sum_probs=209.3
Q ss_pred hhhhhcCCcccc-eecccCccceeeccC---CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCC
Q 038949 389 LELATNRFSEAN-FLAEGGFGSVHRGVL---PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG 463 (678)
Q Consensus 389 ~~~~~~~y~~~~-~LG~G~fG~Vy~a~~---~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 463 (678)
+....++|.+.. .||+|+||.||+|.+ .+++.||+|+++.... ...+.+.+|+.+++.++||||+++++++ ..+
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 345567888877 999999999999974 3678899999875322 2335688999999999999999999999 556
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCchheEEEcCCCCEEECcccce
Confidence 79999999999999999854 345589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCcc--ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhh
Q 038949 544 RWQPDGDMG--VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 544 ~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... +.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~-i---- 226 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAF-I---- 226 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------HHHHH-H----
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------HHHHH-H----
Confidence 865432211 1122346789999999998899999999999999999998 99999654321 11110 0
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.. ......+...+..+.++|.+||+.||.+||++.++++.|+..+.
T Consensus 227 -~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 227 -EQ----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp -HT----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hc----CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 01112334556689999999999999999999999999987664
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=347.27 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=196.9
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
.++|++.+.||+|+||.||+|.+ .+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 36899999999999999999995 46899999988543222 1245778999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++......
T Consensus 82 e~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKH----NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999988874 345589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhh--------hHHHHHHhh
Q 038949 550 DMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEW--------ARPLLKRHA 620 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~--------~~~~~~~~~ 620 (678)
. .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.............. .........
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 S-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 2 22344578999999999876 6789999999999999999999999965432111100000 000000000
Q ss_pred -hh--cccCcchhc---ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 -IG--ELIDPRLRN---CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 -~~--elld~~l~~---~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.. ...++.... ......+..+.+||.+||+.||.+|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 000000000 001234556889999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=346.40 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=205.6
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC------CccccccceeeecccccceEEEEeEEeeCC
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG------DQEFCSEVEVLSCAQHRNVVMLIGFCVEDG 463 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~------~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 463 (678)
...++|.+.+.||+|+||.||+|.. .+++.||+|.+....... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 3567899999999999999999984 478999999987543222 245889999999999999999999999999
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC----cccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF----EPLVGD 539 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~----~vkL~D 539 (678)
..++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++ .++|+|
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~----~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 99999999999999999943 45689999999999999999999999 999999999999999887 799999
Q ss_pred ccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHh
Q 038949 540 FGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH 619 (678)
Q Consensus 540 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 619 (678)
||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... +......
T Consensus 163 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~--- 231 (321)
T 2a2a_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANIT--- 231 (321)
T ss_dssp CTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHH---
T ss_pred CccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH---
Confidence 99998654432 223456899999999999999999999999999999999999999643211 1000000
Q ss_pred hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 ~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
......++. .....+..+.+||.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 232 SVSYDFDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TTCCCCCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hcccccChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000001111 12234457899999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.98 Aligned_cols=261 Identities=22% Similarity=0.261 Sum_probs=192.5
Q ss_pred hhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeeccc-ccceEEEEeEEe----
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCV---- 460 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~---- 460 (678)
..++....+|++.+.||+|+||.||+|.+ .+++.||+|++..........+.+|+.++..+. ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 34566778999999999999999999994 578999999986554444567889999999996 999999999984
Q ss_pred ----eCCeEEEEEEEeecCCccccccc-CCCCccCccccchhhhhhccchhhhhhcceeee--EEeccCCCCceEeeecC
Q 038949 461 ----EDGRRLLVYEYICNGSLDSHLYG-RDRDPLEWSARRKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILVTHDF 533 (678)
Q Consensus 461 ----~~~~~~LV~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g--IvHrDLKp~NILl~~~~ 533 (678)
....+++||||+ +|+|.+++.. ....++++..++.++.||+.||.|||+. | |+||||||+|||++.++
T Consensus 101 ~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ----KPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp TSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCCCCCGGGCEECTTS
T ss_pred ccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCEEEccCCcccEEECCCC
Confidence 344589999999 5789888843 2345699999999999999999999998 8 99999999999999999
Q ss_pred ccccccccccccccCCCcc-----------ceeEEEeeecccccccc---cccccceecceeeeeeEEEEeeeCCccccc
Q 038949 534 EPLVGDFGLARWQPDGDMG-----------VETRVLGTFGYLAPEYA---QSGQITEKADVYSLGVVLVELITGRKAMDL 599 (678)
Q Consensus 534 ~vkL~DFGla~~~~~~~~~-----------~~~~~~Gt~~Y~APE~l---~~~~~s~ksDVwSLGviL~eLltG~~Pf~~ 599 (678)
.+||+|||++......... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999865432211 11245689999999998 566789999999999999999999999964
Q ss_pred cCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 600 NRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 600 ~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
..... .+...............+.+||.+||+.||.+||++.++++.|+....
T Consensus 256 ~~~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 256 GAKLR-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHH-------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 32110 001111111112233468899999999999999999999999986553
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=354.20 Aligned_cols=250 Identities=22% Similarity=0.295 Sum_probs=194.5
Q ss_pred hhhcCCcccceecccCccceeeccC----CCCcEEEEEeeehhc----ccCCccccccceeeecccccceEEEEeEEeeC
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL----PDGQVVAVKQYKLAS----SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED 462 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~i~~~~----~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 462 (678)
...++|.+.+.||+|+||.||++.. .+++.||+|+++... ......+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 3457899999999999999999984 478999999987432 22335678899999999999999999999999
Q ss_pred CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
+.+|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQK----GIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred CEEEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC----CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 999999999999999999843 34588999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .........
T Consensus 168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~----- 235 (327)
T 3a62_A 168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILK----- 235 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH-----
T ss_pred ccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh-----
Confidence 97543221 122234689999999999999999999999999999999999999964321 111111111
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
. . ..++...+..+.+||.+||+.||.+|| ++.++++
T Consensus 236 ~--~----~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 236 C--K----LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp T--C----CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred C--C----CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 0 112333455789999999999999999 6777764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=346.71 Aligned_cols=255 Identities=19% Similarity=0.300 Sum_probs=204.5
Q ss_pred hhhcCCcccceecccCccceeeccCC-CC-------cEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeC
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLP-DG-------QVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED 462 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g-------~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 462 (678)
+..++|.+.+.||+|+||.||+|... ++ ..||+|++........+.+.+|+.+++.++||||+++++++.++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 45678999999999999999999843 33 57999999766555567899999999999999999999999999
Q ss_pred CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc--------
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE-------- 534 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~-------- 534 (678)
+..++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN----TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhC----CeECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999543 23488999999999999999999999 9999999999999999887
Q ss_pred cccccccccccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH
Q 038949 535 PLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 535 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~ 613 (678)
++|+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..|+....... ...
T Consensus 160 ~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----~~~- 228 (289)
T 4fvq_A 160 IKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-----RKL- 228 (289)
T ss_dssp EEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHH-
T ss_pred eeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-----HHH-
Confidence 999999999654321 22347889999999987 778999999999999999999655443221100 000
Q ss_pred HHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 614 PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 614 ~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
.... . . ...+...+..+.+|+.+||+.||.+|||+.++++.|+..+..
T Consensus 229 ~~~~-----~--~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 229 QFYE-----D--R----HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHHH-----T--T----CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred HHhh-----c--c----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 0000 0 0 111222344788999999999999999999999999987753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=349.09 Aligned_cols=258 Identities=28% Similarity=0.368 Sum_probs=205.3
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEE--EEEeeehh-cccCCccccccceeeecc-cccceEEEEeEEeeCCeEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVV--AVKQYKLA-SSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~v--AvK~i~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~ 466 (678)
..++|.+.+.||+|+||.||+|.. .++..+ |+|.++.. .......+.+|+.+++.+ +||||+++++++.+.+..|
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 347899999999999999999985 456644 99988642 233446788999999999 8999999999999999999
Q ss_pred EEEEEeecCCcccccccCC--------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec
Q 038949 467 LVYEYICNGSLDSHLYGRD--------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD 532 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~ 532 (678)
+||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGEN 178 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCccceEEEcCC
Confidence 9999999999999995432 24689999999999999999999999 99999999999999999
Q ss_pred CccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhh
Q 038949 533 FEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEW 611 (678)
Q Consensus 533 ~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~ 611 (678)
+.+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...... ..
T Consensus 179 ~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~ 250 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------EL 250 (327)
T ss_dssp GCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HH
T ss_pred CeEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------HH
Confidence 99999999999743211 12233456889999999998899999999999999999998 99999643210 00
Q ss_pred hHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 612 ARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 612 ~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
. . .+.. ......+...+..+.+||.+||+.||.+||++.++++.|+..+.
T Consensus 251 ~----~--~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 251 Y----E--KLPQ----GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp H----H--HGGG----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----H--Hhhc----CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 0 0111 11112233455689999999999999999999999999987654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=354.15 Aligned_cols=275 Identities=24% Similarity=0.329 Sum_probs=209.1
Q ss_pred hhhcCCcccceecccCccceeecc-----CCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCC--
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGV-----LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG-- 463 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~-----~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~-- 463 (678)
...++|++.+.||+|+||.||++. ..+++.||+|++..........+.+|+.+++.++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 345789999999999999999997 3468999999987654444467889999999999999999999987644
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
..++||||+.+++|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 789999999999999999543 34589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCcc--ceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 544 RWQPDGDMG--VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 544 ~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
......... ......++..|+|||.+.+..++.++||||||+++|+|+||..||......-................+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 866433211 112234677899999999989999999999999999999999988532100000000000000000001
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
.+.+........+..++..+.+||.+||+.||++||++.++++.|+...
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111111233445668999999999999999999999999998653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=342.44 Aligned_cols=265 Identities=25% Similarity=0.362 Sum_probs=188.0
Q ss_pred hhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
+....++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 356678999999999999999999985 478999999986443 233467889999999999999999999999999999
Q ss_pred EEEEEeecCCccccccc------CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 467 LVYEYICNGSLDSHLYG------RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~------~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
+||||+.+++|.+++.. .....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN----GQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCCChhhEEEcCCCCEEEEec
Confidence 99999999999998853 1345689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCC----ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH
Q 038949 541 GLARWQPDGD----MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615 (678)
Q Consensus 541 Gla~~~~~~~----~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 615 (678)
|++....... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||......... ...
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~ 239 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLT 239 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHH
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHH
Confidence 9997654321 112234578999999999876 56899999999999999999999999754331110 000
Q ss_pred HHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 LKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 ~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.. ...................+..+.+||.+||+.||.+||++.++++
T Consensus 240 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 240 LQ-NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HT-SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hc-cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 0000000000111122234457899999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=352.85 Aligned_cols=254 Identities=23% Similarity=0.299 Sum_probs=180.5
Q ss_pred cCCccc---ceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeeccc-ccceEEEEeEEeeCCeEEEE
Q 038949 394 NRFSEA---NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 394 ~~y~~~---~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~LV 468 (678)
++|.+. +.||+|+||.||+|.+ .+++.||||++... ....+.+|+.+++.+. ||||+++++++.+....|+|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 345553 7899999999999995 57899999998643 2346778999999997 99999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC---cccccccccccc
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF---EPLVGDFGLARW 545 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~---~vkL~DFGla~~ 545 (678)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 85 MELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDV----GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp ECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 999999999999954 45699999999999999999999999 999999999999998765 899999999986
Q ss_pred ccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||............ ..........
T Consensus 159 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~---~~~~~~i~~~--- 231 (325)
T 3kn6_A 159 KPPDN-QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA---VEIMKKIKKG--- 231 (325)
T ss_dssp CCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCH---HHHHHHHTTT---
T ss_pred cCCCC-CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccH---HHHHHHHHcC---
Confidence 54322 2334567899999999999999999999999999999999999999754321110000 0011100000
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL 663 (678)
............+..+.+||.+||+.||.+|||+.+++
T Consensus 232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 00111111123456789999999999999999999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=349.28 Aligned_cols=253 Identities=26% Similarity=0.378 Sum_probs=197.5
Q ss_pred hhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
..++|.+.+.||+|+||.||+|.+ .++.||+|.+... ...+.+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred CHhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 357899999999999999999987 4788999988632 233578899999999999999999999874 48999999
Q ss_pred eecCCcccccccCCC-CccCccccchhhhhhccchhhhhh---cceeeeEEeccCCCCceEeeecCc-cccccccccccc
Q 038949 472 ICNGSLDSHLYGRDR-DPLEWSARRKIAVGAARGLRYLHE---ECRVGCIVHRDMRPNNILVTHDFE-PLVGDFGLARWQ 546 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qI~~aL~yLH~---~~~~~gIvHrDLKp~NILl~~~~~-vkL~DFGla~~~ 546 (678)
+.+|+|.+++..... ..+++..++.++.|++.||.|||+ + ||+||||||+|||++.++. +||+|||++...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~----~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK----ALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSS----CCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCC----CeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999999999965432 236778889999999999999999 6 8999999999999998886 799999999754
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ..... ......
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~------~~~~~~ 222 (307)
T 2eva_A 157 QTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWA------VHNGTR 222 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHH------HHTTCC
T ss_pred ccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHH------HhcCCC
Confidence 322 2334689999999999999999999999999999999999999964332110 00000 000011
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.......+..+.+++.+||+.||.+|||+.++++.|+....
T Consensus 223 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 223 ----PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp ----CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred ----CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11223345578999999999999999999999999987653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=349.85 Aligned_cols=261 Identities=21% Similarity=0.296 Sum_probs=193.9
Q ss_pred hhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
....++|++.+.||+|+||.||+|. ..+++.||||+++..... ....+.+|+.+++.++||||+++++++.+++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 3445789999999999999999998 457899999998644322 2356889999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee-----ecCcccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT-----HDFEPLVGDFG 541 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~-----~~~~vkL~DFG 541 (678)
+||||+. |+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++ .++.+||+|||
T Consensus 110 lv~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSR----RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999996 599998843 34589999999999999999999999 999999999999995 44569999999
Q ss_pred ccccccCCCccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHh-
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH- 619 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~- 619 (678)
+++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||........ + .......
T Consensus 183 ~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~----~~~~~~~~ 255 (329)
T 3gbz_A 183 LARAFGIP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--L----FKIFEVLG 255 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H----HHHHHHHC
T ss_pred CccccCCc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--H----HHHHHHhC
Confidence 99865432 2223445689999999999874 589999999999999999999999965432110 0 0011000
Q ss_pred ------------------hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 ------------------AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 ------------------~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.........+....+......+.+||.+||+.||.+|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000111111122224457889999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=347.45 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=194.5
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
++|.+.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5799999999999999999995 47899999998744332 234677899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+. |+|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 96 5888888543 34588999999999999999999999 99999999999999999999999999997543322
Q ss_pred cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHH------------
Q 038949 552 GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR------------ 618 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~------------ 618 (678)
.......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ +.... .....
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i~-~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ--LHFIF-RILGTPTEETWPGILSN 231 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHH-HHHCCCCTTTSTTGGGC
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCChHhchhhhcc
Confidence 22334578999999999876 5689999999999999999999999975432111 00000 00000
Q ss_pred hhhhcccCcch----hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 619 HAIGELIDPRL----RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 619 ~~~~elld~~l----~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
........+.. ........+..+.+||.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000000 00111234457889999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=356.26 Aligned_cols=251 Identities=24% Similarity=0.291 Sum_probs=197.1
Q ss_pred cCCcc--cceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 394 NRFSE--ANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 394 ~~y~~--~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
..|.+ .+.||+|+||.||+|.. .+|+.||+|+++.......+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 33444 67899999999999984 5799999999986544445678999999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee--ecCccccccccccccccC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT--HDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~--~~~~vkL~DFGla~~~~~ 548 (678)
|+.+|+|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++ .++.+||+|||+++....
T Consensus 167 ~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 167 YVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQM----YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp CCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred CCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 99999999988543 34588999999999999999999999 999999999999994 567899999999986643
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... +........ ..+
T Consensus 242 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~-----~~~-- 306 (373)
T 2x4f_A 242 RE--KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILAC-----RWD-- 306 (373)
T ss_dssp TC--BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHT-----CCC--
T ss_pred cc--ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhc-----cCC--
Confidence 32 223346999999999999999999999999999999999999999644321 111111110 000
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+........+..+.+||.+||+.||.+||++.++++
T Consensus 307 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 307 LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011111234557899999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=339.47 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=184.2
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
.++|.+.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999984 5799999999964432 2235688999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.+++|.+++... ..++++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH----GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999998543 35689999999999999999999999 999999999999999999999999999976543
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.. .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ .. ......
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------~~-----~~~~~~ 228 (278)
T 3cok_A 165 PH-EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------LN-----KVVLAD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred CC-CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------HH-----HHhhcc
Confidence 22 122345789999999999988999999999999999999999999975432110 00 000000
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+...+..+.+||.+||+.||++||++.++++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1122334557899999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=340.37 Aligned_cols=251 Identities=21% Similarity=0.263 Sum_probs=204.1
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
..++|++.+.||+|+||.||+|.. .++..+|+|.+........+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 467899999999999999999984 4678999999986655556789999999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe---eecCcccccccccccccc
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV---THDFEPLVGDFGLARWQP 547 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl---~~~~~vkL~DFGla~~~~ 547 (678)
|+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.++|+|||++....
T Consensus 87 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKL----NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999998843 34589999999999999999999999 99999999999999 788999999999997654
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...... +..... .. .....+
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~-~~---~~~~~~ 227 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKI-RE---GTFTFP 227 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH-HH---CCCCCC
T ss_pred Ccc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHH-Hh---CCCCCC
Confidence 332 2234568999999999875 4899999999999999999999999653321 100000 00 000000
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.......+..+.+||.+||+.||.+||++.++++
T Consensus 228 ---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 ---EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001123457899999999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=347.49 Aligned_cols=261 Identities=22% Similarity=0.262 Sum_probs=207.3
Q ss_pred ehhhhhhhhcCCccc-ceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecc-cccceEEEEeEE
Q 038949 385 TYAELELATNRFSEA-NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCA-QHRNVVMLIGFC 459 (678)
Q Consensus 385 ~~~~~~~~~~~y~~~-~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L-~HpnIv~l~~~~ 459 (678)
.+...+...++|.+. +.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.++..+ .||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344567778899998 8999999999999984 47999999998744322 235688899999988 469999999999
Q ss_pred eeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee---cCccc
Q 038949 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH---DFEPL 536 (678)
Q Consensus 460 ~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~---~~~vk 536 (678)
.+.+..++||||+.+|+|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~----givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN----NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESCBTTBCCEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCChHHEEEecCCCCCcEE
Confidence 9999999999999999999999666567799999999999999999999999 9999999999999998 78999
Q ss_pred cccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHH
Q 038949 537 VGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLL 616 (678)
Q Consensus 537 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 616 (678)
|+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .....
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i- 245 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNI- 245 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHH-
Confidence 99999998654322 2344679999999999999999999999999999999999999996533210 00000
Q ss_pred HHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 617 KRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 617 ~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... ............+..+.+||.+||+.||.+|||++++++
T Consensus 246 -----~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 246 -----SQV-NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -----HHT-CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----Hhc-ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 000 111111122234557899999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.77 Aligned_cols=263 Identities=17% Similarity=0.213 Sum_probs=206.6
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeE-EeeCCeEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGF-CVEDGRRLLVY 469 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~-~~~~~~~~LV~ 469 (678)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+|+.+++.++|++++..+.+ +.+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 457899999999999999999994 689999999886432 34578899999999998776555554 46677889999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee---ecCccccccccccccc
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT---HDFEPLVGDFGLARWQ 546 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~---~~~~vkL~DFGla~~~ 546 (678)
||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 99999999532 34699999999999999999999999 999999999999994 7899999999999865
Q ss_pred cCCCc------cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccch-hhhhhHHHHHHh
Q 038949 547 PDGDM------GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC-LTEWARPLLKRH 619 (678)
Q Consensus 547 ~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~-l~~~~~~~~~~~ 619 (678)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 233 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----- 233 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH-----
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc-----
Confidence 44322 12244578999999999999999999999999999999999999997643322111 1111110
Q ss_pred hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 620 ~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
.... ..+. .....+..+.+++.+||+.||.+||++.++++.|+..+..
T Consensus 234 ~~~~-~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 234 KMST-PIEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHS-CHHH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCC-chHH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 0000 0001 1122345789999999999999999999999999876643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=348.02 Aligned_cols=260 Identities=20% Similarity=0.328 Sum_probs=206.8
Q ss_pred hhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCC-----------------ccccccceeeecccccce
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGD-----------------QEFCSEVEVLSCAQHRNV 452 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~-----------------~~~~~Ev~iL~~L~HpnI 452 (678)
....++|.+.+.||+|+||.||+|.. +++.||+|.+........ ..+.+|+.+++.++||||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 34467999999999999999999998 899999999975443322 678899999999999999
Q ss_pred EEEEeEEeeCCeEEEEEEEeecCCcccc------cccCCCCccCccccchhhhhhccchhhhhh-cceeeeEEeccCCCC
Q 038949 453 VMLIGFCVEDGRRLLVYEYICNGSLDSH------LYGRDRDPLEWSARRKIAVGAARGLRYLHE-ECRVGCIVHRDMRPN 525 (678)
Q Consensus 453 v~l~~~~~~~~~~~LV~E~~~ggsL~~~------l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~~~~~gIvHrDLKp~ 525 (678)
+++++++.+.+..++||||+.+|+|.++ +.......+++..++.++.||+.||.|||+ . ||+||||||+
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----~i~H~dl~p~ 181 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK----NICHRDVKPS 181 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS----CEECCCCCGG
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC----CEeecCCChH
Confidence 9999999999999999999999999999 654446779999999999999999999999 8 9999999999
Q ss_pred ceEeeecCccccccccccccccCCCccceeEEEeeeccccccccccc-ccce-ecceeeeeeEEEEeeeCCccccccCCc
Q 038949 526 NILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSG-QITE-KADVYSLGVVLVELITGRKAMDLNRPR 603 (678)
Q Consensus 526 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~-ksDVwSLGviL~eLltG~~Pf~~~~~~ 603 (678)
|||++.++.++|+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|+|++|..||......
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred hEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999999999999999999865433 23345689999999999877 6766 999999999999999999999754321
Q ss_pred ccchhhhhhHHHHHHhhhhccc----------CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 604 GQQCLTEWARPLLKRHAIGELI----------DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 604 ~~~~l~~~~~~~~~~~~~~ell----------d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. ...... ..... ... .+..........+..+.+||.+||+.||.+||++.++++
T Consensus 259 ~-----~~~~~i-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 V-----ELFNNI-RTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp H-----HHHHHH-TSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H-----HHHHHH-hccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 000000 00000 000 000001111334567899999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.81 Aligned_cols=271 Identities=24% Similarity=0.296 Sum_probs=201.3
Q ss_pred hhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeee--cccccceEEEEeEEeeC---
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLS--CAQHRNVVMLIGFCVED--- 462 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~--~L~HpnIv~l~~~~~~~--- 462 (678)
......++|++.+.||+|+||.||+|.+. ++.||||++.... ...+..|.+++. .++||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 34566789999999999999999999874 8999999986432 223344444444 45899999999999887
Q ss_pred -CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcc----eeeeEEeccCCCCceEeeecCcccc
Q 038949 463 -GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC----RVGCIVHRDMRPNNILVTHDFEPLV 537 (678)
Q Consensus 463 -~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~----~~~gIvHrDLKp~NILl~~~~~vkL 537 (678)
...++||||+.+|+|.+++.. ..+++..++.++.|++.||.|||+.+ ...||+||||||+|||++.++.+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 789999999999999999943 35899999999999999999999751 1127999999999999999999999
Q ss_pred ccccccccccCCCcc---ceeEEEeeeccccccccccccccee------cceeeeeeEEEEeeeCCcc----------cc
Q 038949 538 GDFGLARWQPDGDMG---VETRVLGTFGYLAPEYAQSGQITEK------ADVYSLGVVLVELITGRKA----------MD 598 (678)
Q Consensus 538 ~DFGla~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~k------sDVwSLGviL~eLltG~~P----------f~ 598 (678)
+|||++......... ......||+.|+|||++.+..++.. +|||||||++|+|+||..| |.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 999999755432211 1123468999999999987665554 9999999999999999544 43
Q ss_pred ccCCcccchhhhhhHHHHHHhhhhcccCcchhcc-cchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 599 LNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC-YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 599 ~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~-~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
...+.... ..............+.+... .+..++..+.+||.+||+.||.+|||+.+|++.|+....
T Consensus 264 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 264 DLVPSDPS------YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTSCSSCC------HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCCCCc------hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 22211110 01111111111222222222 123567789999999999999999999999999987654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=345.11 Aligned_cols=255 Identities=27% Similarity=0.370 Sum_probs=201.9
Q ss_pred hhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeC-CeEEE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED-GRRLL 467 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-~~~~L 467 (678)
+....++|++.+.||+|+||.||+|.+ +++.||+|+++.. ...+.+.+|+.+++.++||||+++++++.+. +..++
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred ccCChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 455678999999999999999999987 4889999998643 2446788999999999999999999987554 47899
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+.+++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC----CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999999654434478889999999999999999999 99999999999999999999999999997543
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.. .....+++.|+|||++.+..++.++||||||+++|+|++ |..||....... .... +..
T Consensus 169 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~------~~~--- 229 (278)
T 1byg_A 169 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPR------VEK--- 229 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------HHHH------HTT---
T ss_pred cc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH------Hhc---
Confidence 22 123457889999999999999999999999999999998 999986432210 0000 001
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
......+...+..+.++|.+||+.||.+||++.++++.|+...
T Consensus 230 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 230 -GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 1111233445568999999999999999999999999998654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=357.94 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=193.9
Q ss_pred hhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcc--------cCCccccccceeeecccccceEEEEeEEe
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS--------QGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~--------~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 460 (678)
....++|.+.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4567899999999999999999998 45789999999864321 12246789999999999999999999975
Q ss_pred eCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC---cccc
Q 038949 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF---EPLV 537 (678)
Q Consensus 461 ~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~---~vkL 537 (678)
. +..|+||||+.+|+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred c-CceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCCCcceEEE
Confidence 4 56899999999999999984 445699999999999999999999999 999999999999997544 5999
Q ss_pred ccccccccccCCCccceeEEEeeeccccccccc---ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHH
Q 038949 538 GDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQ---SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP 614 (678)
Q Consensus 538 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 614 (678)
+|||+++..... .......||+.|+|||++. ...++.++|||||||++|+|++|..||........ +..
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~---- 355 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD---- 355 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH----
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH----
Confidence 999999865432 2334567999999999985 36789999999999999999999999965432111 100
Q ss_pred HHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 LLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 ~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....... ...+. .....+..+.+||.+||+.||++||++.++++
T Consensus 356 ~i~~~~~--~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 QITSGKY--NFIPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHTTCC--CCCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCC--CCCch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000000 00011 11224457899999999999999999999886
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=365.01 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=206.2
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
...++|.+.+.||+|+||.||+|.+ .+|+.||||++..... .....+.+|+.+++.++||||+++++++.+.+..|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3457899999999999999999985 4799999999974432 23357889999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.+|+|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 93 lv~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 93 MVMEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEEECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 9999999999999994 445699999999999999999999999 9999999999999999999999999999866
Q ss_pred cCCCccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
.... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .......
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~i~--------- 229 (476)
T 2y94_A 167 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFKKIC--------- 229 (476)
T ss_dssp CTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHHHHH---------
T ss_pred cccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHHHHh---------
Confidence 4432 2334579999999999988766 68999999999999999999999753321 1111110
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+.. ...+...+..+.+||.+||+.||.+|||+.++++
T Consensus 230 ~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 230 DGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp TTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 000 0112234457899999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=344.87 Aligned_cols=263 Identities=22% Similarity=0.344 Sum_probs=199.0
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
...++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 3456899999999999999999984 5789999999874322 22356889999999999999999999999999999
Q ss_pred EEEEEeecCCccccccc--CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+||||+.+++|.+++.. .....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++.
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 99999999999998843 2345688999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
...... .......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ........ .. ..
T Consensus 185 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~~---~~- 254 (310)
T 2wqm_A 185 FFSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-EQ---CD- 254 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHH-HT---TC-
T ss_pred eecCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHh-hc---cc-
Confidence 654322 2233456899999999999999999999999999999999999998643211 11111110 00 00
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
..+ ......+..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus 255 ~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 255 YPP----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp SCC----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 011 1112344578999999999999999999999999987654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=347.12 Aligned_cols=268 Identities=24% Similarity=0.324 Sum_probs=209.3
Q ss_pred hhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeec--ccccceEEEEeEEeeCC--
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSC--AQHRNVVMLIGFCVEDG-- 463 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~--L~HpnIv~l~~~~~~~~-- 463 (678)
......++|.+.+.||+|+||.||+|.+ +++.||||++.... ...+.+|++++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3466778999999999999999999997 58999999986432 3457778888876 78999999999998876
Q ss_pred --eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhh--------hcceeeeEEeccCCCCceEeeecC
Q 038949 464 --RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLH--------EECRVGCIVHRDMRPNNILVTHDF 533 (678)
Q Consensus 464 --~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH--------~~~~~~gIvHrDLKp~NILl~~~~ 533 (678)
..++||||+.+|+|.+++.. ..+++..++.++.|++.||.||| +. ||+||||||+|||++.++
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP----AIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC----EEECSCCSGGGEEECTTS
T ss_pred cceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC----CeeeCCCCHHHEEECCCC
Confidence 79999999999999999943 35899999999999999999999 77 999999999999999999
Q ss_pred ccccccccccccccCCCcc---ceeEEEeeeccccccccccc------ccceecceeeeeeEEEEeeeC----------C
Q 038949 534 EPLVGDFGLARWQPDGDMG---VETRVLGTFGYLAPEYAQSG------QITEKADVYSLGVVLVELITG----------R 594 (678)
Q Consensus 534 ~vkL~DFGla~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSLGviL~eLltG----------~ 594 (678)
.+||+|||++......... ......||+.|+|||++.+. .++.++||||||+++|+|++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999765443321 12334689999999999765 455789999999999999999 5
Q ss_pred ccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc-cchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 595 KAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC-YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 595 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~-~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
.||....+.... ...+ ........+.+.+... ....++..+.+|+.+||+.||++|||+.+|++.|+.....
T Consensus 265 ~p~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 265 LPYYDLVPSDPS-VEEM-----RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CTTTTTSCSSCC-HHHH-----HHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCccccCcCccc-HHHH-----HHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 666543221110 1111 1111112222222222 2235566899999999999999999999999999976543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=373.15 Aligned_cols=255 Identities=28% Similarity=0.385 Sum_probs=210.2
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
...++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4567899999999999999999985 579999999996432 233356789999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.||+|.+++.......+++..++.++.||+.||.|||++ ||+||||||+||||+.+|.+||+|||++...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~----gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE----RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999999766556699999999999999999999999 9999999999999999999999999999866
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....... . ..
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~~~-i-----~~--- 403 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERL-V-----KE--- 403 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHHHH-H-----HH---
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHHHH-h-----hc---
Confidence 4432 22345799999999999999999999999999999999999999975432111 0111110 0 00
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
....++...+..+.+||.+||+.||.+|| +++|+++
T Consensus 404 --~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 404 --VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 01122334556899999999999999999 7888874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=338.80 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=203.1
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
..++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 467899999999999999999984 56899999998754322 225678899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc---ccccccccccc
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE---PLVGDFGLARW 545 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~---vkL~DFGla~~ 545 (678)
|||+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++. ++|+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999888844 34589999999999999999999999 9999999999999987655 99999999976
Q ss_pred ccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..... ... ...
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~-~~~---~~~- 224 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQ-IKA---GAY- 224 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHH---TCC-
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHHHH-HHh---ccc-
Confidence 54332 223456899999999999999999999999999999999999999643211 10100 000 000
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. .........+..+.+|+.+||+.||++|||+.++++
T Consensus 225 ~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 225 D--YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp C--CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c--CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 000111233457899999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=358.97 Aligned_cols=273 Identities=21% Similarity=0.233 Sum_probs=211.4
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCC--eEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG--RRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~--~~~ 466 (678)
...++|.+.+.||+|+||.||+|.+ .+++.||||++..... .....+.+|+++++.++||||+++++++.... ..+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 4467899999999999999999995 4689999999975432 22356789999999999999999999998755 789
Q ss_pred EEEEEeecCCcccccccCC-CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe----eecCcccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRD-RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV----THDFEPLVGDFG 541 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl----~~~~~vkL~DFG 541 (678)
+||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.+||+|||
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC----CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 9999999999999995433 23389999999999999999999999 99999999999999 677889999999
Q ss_pred ccccccCCCccceeEEEeeecccccccccc--------cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQS--------GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--------~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~ 613 (678)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+...
T Consensus 162 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~ 237 (396)
T 4eut_A 162 AARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMY 237 (396)
T ss_dssp GCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHH
T ss_pred CceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHH
Confidence 998654322 2234568999999999875 67889999999999999999999999754322111 11111
Q ss_pred HHHHHhhh---h---ccc--------CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 614 PLLKRHAI---G---ELI--------DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 614 ~~~~~~~~---~---ell--------d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
........ . ... +.......+......+.+++.+||+.||++||++.++++.++..+.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 11111100 0 000 0011122345566788999999999999999999999999876543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=338.61 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=201.5
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
...++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 3457899999999999999999984 568899999986432 223356889999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++...
T Consensus 86 lv~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT----TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 99999999999999843 34589999999999999999999999 9999999999999999999999999998644
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ..... +..
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~------~~~--- 221 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKR------ISR--- 221 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH------HHH---
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHHH------HHh---
Confidence 322 234457899999999999999999999999999999999999999643211 00000 000
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....++...+..+.+||.+||+.||.+||++.++++
T Consensus 222 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 222 --VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp --TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 011123334557899999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.93 Aligned_cols=268 Identities=25% Similarity=0.327 Sum_probs=207.8
Q ss_pred hhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEee----C
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE----D 462 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~----~ 462 (678)
.+.+..++|.+.+.||+|+||.||++.. .+++.||+|++..........+.+|+.+++.++||||+++++++.. .
T Consensus 23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp EEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred EEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 3456678999999999999999999994 6799999999875544455678899999999999999999999873 3
Q ss_pred CeEEEEEEEeecCCcccccccC--CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGR--DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
...++||||+.+|+|.+++... ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK----GYAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCC
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCCEEEEec
Confidence 4789999999999999988542 345689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCcc--------ceeEEEeeecccccccccccc---cceecceeeeeeEEEEeeeCCccccccCCcccchhh
Q 038949 541 GLARWQPDGDMG--------VETRVLGTFGYLAPEYAQSGQ---ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT 609 (678)
Q Consensus 541 Gla~~~~~~~~~--------~~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~ 609 (678)
|++......... ......||+.|+|||++.... ++.++||||||+++|+|++|..||...........
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~- 257 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA- 257 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH-
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh-
Confidence 998644211000 011234689999999987543 68899999999999999999999964211111000
Q ss_pred hhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccccC
Q 038949 610 EWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMN 673 (678)
Q Consensus 610 ~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~~ 673 (678)
... .. ..........+..+.++|.+||+.||.+||++.++++.|+......
T Consensus 258 ----~~~-----~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 258 ----LAV-----QN----QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp ----HHH-----HC----C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred ----HHh-----hc----cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 000 00 0111112334557999999999999999999999999999765443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=360.71 Aligned_cols=268 Identities=25% Similarity=0.346 Sum_probs=190.8
Q ss_pred hhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehh--cccCCccccccceeeeccc-ccceEEEEeEEeeCC--
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLA--SSQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDG-- 463 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~--~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~-- 463 (678)
....++|++.+.||+|+||.||+|. ..+++.||||++... .......+.+|+.+++.+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 3456899999999999999999998 457999999988532 1222356778999999997 999999999997544
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
.+|+||||+. ++|..++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG----GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 7899999996 688888843 3588899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCC--------------------CccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCC
Q 038949 544 RWQPDG--------------------DMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRP 602 (678)
Q Consensus 544 ~~~~~~--------------------~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~ 602 (678)
+..... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 764321 1112334579999999999876 6789999999999999999999999965432
Q ss_pred cccchhh-----------------hhhHHHHHHhh-hhcccCcchhcc------------cchhhhhhhhhccceeeccC
Q 038949 603 RGQQCLT-----------------EWARPLLKRHA-IGELIDPRLRNC------------YSEREVYGMLQCASLCIRKD 652 (678)
Q Consensus 603 ~~~~~l~-----------------~~~~~~~~~~~-~~elld~~l~~~------------~~~~~~~~l~~LI~~cL~~d 652 (678)
....... .+......... ............ .....+..+.+|+.+||+.|
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 1110000 00000000000 000000000000 01133457899999999999
Q ss_pred CCCCchHHHHHHH
Q 038949 653 PHSRPRMSQVLRM 665 (678)
Q Consensus 653 P~~RPT~~eVL~~ 665 (678)
|++|||++|+|+.
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=348.03 Aligned_cols=266 Identities=27% Similarity=0.364 Sum_probs=202.4
Q ss_pred hhhhhhhhcCCcccceecccCccceeeccCC----CCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEE
Q 038949 386 YAELELATNRFSEANFLAEGGFGSVHRGVLP----DGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFC 459 (678)
Q Consensus 386 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 459 (678)
+..+....++|.+.+.||+|+||.||+|... +++.||+|.++..... ....+.+|+.+++.++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 4456677889999999999999999999732 4568999998744322 235688999999999999999999998
Q ss_pred eeCC-----eEEEEEEEeecCCccccccc----CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee
Q 038949 460 VEDG-----RRLLVYEYICNGSLDSHLYG----RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT 530 (678)
Q Consensus 460 ~~~~-----~~~LV~E~~~ggsL~~~l~~----~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~ 530 (678)
.+.. ..++||||+.+|+|.+++.. .....+++..++.++.||+.||.|||+. ||+||||||+|||++
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~ 181 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR----NFLHRDLAARNCMLR 181 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCSGGGEEEC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEc
Confidence 8754 35999999999999998832 2345689999999999999999999999 999999999999999
Q ss_pred ecCccccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchh
Q 038949 531 HDFEPLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCL 608 (678)
Q Consensus 531 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l 608 (678)
.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 257 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---- 257 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH----
Confidence 999999999999976543321 22233457889999999999999999999999999999999 888986543211
Q ss_pred hhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 609 TEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 609 ~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
...... .. .....+...+..+.++|.+||+.||.+||++.++++.|+..+.
T Consensus 258 --~~~~~~------~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 258 --MYDYLL------HG----HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp --HHHHHH------TT----CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHH------cC----CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111100 00 0112234455689999999999999999999999999987653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=351.11 Aligned_cols=257 Identities=24% Similarity=0.357 Sum_probs=199.0
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcE----EEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQV----VAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~----vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
..++|++.+.||+|+||.||+|.+ .+++. ||+|.+.... ......+.+|+.+++.++||||+++++++..+ ..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~ 91 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 91 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SE
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cc
Confidence 457899999999999999999984 34543 5777765332 22335788999999999999999999999875 48
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++|+||+.+|+|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred eEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC----CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 8999999999999998543 34589999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 546 QPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 546 ~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
..... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... ... .+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~-~~~------ 233 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISS-ILE------ 233 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHH-HHH------
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHH-HHH------
Confidence 54322 122233456788999999999999999999999999999999 999997543211 000 010
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
.......+..++..+.++|.+||+.||.+||++.++++.|+...
T Consensus 234 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 234 ---KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ---TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01111223345557899999999999999999999999998654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=363.82 Aligned_cols=194 Identities=25% Similarity=0.342 Sum_probs=152.9
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEee-----CCe
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE-----DGR 464 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-----~~~ 464 (678)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+|+.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47899999999999999999984 578999999886322 1223568899999999999999999999854 357
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+|+||||+ +++|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~----~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSA----GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhC----CcCCCCCChhhEEECCCCCEeecccccch
Confidence 89999997 679998884 345699999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCc--------------------------cceeEEEeeecccccccc-cccccceecceeeeeeEEEEeeeC
Q 038949 545 WQPDGDM--------------------------GVETRVLGTFGYLAPEYA-QSGQITEKADVYSLGVVLVELITG 593 (678)
Q Consensus 545 ~~~~~~~--------------------------~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSLGviL~eLltG 593 (678)
....... ......+||+.|+|||++ ....|+.++||||||||||||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 6532211 123456789999999976 556799999999999999999994
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.01 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=199.6
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
.++|.....||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 34566667999999999999994 57889999998765555557788999999999999999999999999999999999
Q ss_pred eecCCcccccccCC-CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-cCccccccccccccccCC
Q 038949 472 ICNGSLDSHLYGRD-RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-DFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 472 ~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-~~~vkL~DFGla~~~~~~ 549 (678)
+.+++|.+++.... ...+++..++.++.|++.||.|||+. ||+||||||+|||++. ++.++|+|||++......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC----CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 99999999986542 23467888889999999999999999 9999999999999997 899999999999765432
Q ss_pred CccceeEEEeeecccccccccccc--cceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQ--ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
. .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||........ ...... .. ...+
T Consensus 177 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~-~~-~~~~ 245 (295)
T 2clq_A 177 N-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--------AMFKVG-MF-KVHP 245 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--------HHHHHH-HH-CCCC
T ss_pred C-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--------HHHhhc-cc-cccc
Confidence 2 1223456899999999997654 78999999999999999999999964322110 000000 00 1111
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+...+..+.++|.+||+.||++||++.++++
T Consensus 246 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 ----EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 223344557899999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=353.89 Aligned_cols=255 Identities=24% Similarity=0.316 Sum_probs=203.9
Q ss_pred hhcCCcccceecccCccceeeccC----CCCcEEEEEeeehhc----ccCCccccccceeeecc-cccceEEEEeEEeeC
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL----PDGQVVAVKQYKLAS----SQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVED 462 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~i~~~~----~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~ 462 (678)
..++|.+.+.||+|+||.||++.. .+++.||||+++... ......+.+|+.+++.+ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 347899999999999999999985 478999999986432 23346788999999999 699999999999999
Q ss_pred CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
..+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ceEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 999999999999999999954 34589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccc--cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQS--GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
++..............||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+......
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~--- 280 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILK--- 280 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHH---
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhc---
Confidence 98654333233334568999999999985 3578899999999999999999999975432211 1111111110
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCc-----hHHHHHHH
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLRM 665 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~~ 665 (678)
. . ..++...+..+.+||.+||+.||.+|| +++++++.
T Consensus 281 --~--~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 281 --S--E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp --C--C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --c--C----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 0 1 123334455788999999999999999 89998764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=347.48 Aligned_cols=260 Identities=25% Similarity=0.392 Sum_probs=201.7
Q ss_pred eehhhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEee
Q 038949 384 FTYAELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVE 461 (678)
Q Consensus 384 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~ 461 (678)
+.+.++....++|++.+.||+|+||.||+|.+ .+++.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 34455666789999999999999999999995 578999999987433 3456788999999998 79999999999987
Q ss_pred ------CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcc
Q 038949 462 ------DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEP 535 (678)
Q Consensus 462 ------~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~v 535 (678)
....++||||+.+|+|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCcHHHEEEcCCCCE
Confidence 46899999999999999999665556789999999999999999999999 99999999999999999999
Q ss_pred ccccccccccccCCCccceeEEEeeeccccccccc-----ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhh
Q 038949 536 LVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQ-----SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTE 610 (678)
Q Consensus 536 kL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~ 610 (678)
+|+|||++...... ........|++.|+|||++. +..++.++||||||+++|+|++|..||.......
T Consensus 169 kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------ 241 (326)
T 2x7f_A 169 KLVDFGVSAQLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ 241 (326)
T ss_dssp EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------
T ss_pred EEeeCcCceecCcC-ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------
Confidence 99999999755322 12234457899999999987 5678899999999999999999999996433210
Q ss_pred hhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 611 WARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 611 ~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... .... ...+.. .+...+..+.+||.+||..||.+||++.++++
T Consensus 242 ~~~-~~~~-----~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 242 ALF-LIPR-----NPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHH-HHHH-----SCCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH-Hhhc-----CccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 0000 001111 12233457899999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=337.62 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=201.3
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc------CCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ------GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~------~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
..++|.+.+.||+|+||.||+|.. .+++.||+|+++..... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 356899999999999999999995 47899999998744322 12468899999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC----ccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF----EPLVGDF 540 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~----~vkL~DF 540 (678)
.++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .++|+||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK----RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 9999999999999999943 34689999999999999999999999 999999999999999877 8999999
Q ss_pred cccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
|++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ... ..
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~----~~-- 222 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETL----TN-- 222 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH----HH--
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHH----HH--
Confidence 9998654322 223456899999999999999999999999999999999999999643211 000 00
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+.. .............+..+.+|+.+||+.||.+||++.++++
T Consensus 223 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 223 ISA-VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHT-TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hHh-cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000 0011111112234457899999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=353.84 Aligned_cols=264 Identities=17% Similarity=0.208 Sum_probs=205.9
Q ss_pred hhcCCcccceecccCccceeeccCC---------CCcEEEEEeeehhcccCCccccccceeeecccccceEE--------
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLP---------DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVM-------- 454 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~---------~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~-------- 454 (678)
..++|.+.+.||+|+||.||+|... +++.||+|++... ..+.+|+.+++.++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 3578999999999999999999854 3789999998633 56889999999999999887
Q ss_pred -------EEeEEee-CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCc
Q 038949 455 -------LIGFCVE-DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 526 (678)
Q Consensus 455 -------l~~~~~~-~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~N 526 (678)
+++++.. +...|+||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~N 189 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN----EYVHGNVTAEN 189 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCGGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHH
Confidence 6677766 67899999999 99999999765456799999999999999999999999 99999999999
Q ss_pred eEeeecC--ccccccccccccccCCCc------cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCcccc
Q 038949 527 ILVTHDF--EPLVGDFGLARWQPDGDM------GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMD 598 (678)
Q Consensus 527 ILl~~~~--~vkL~DFGla~~~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~ 598 (678)
||++.++ .++|+|||+++....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999988 999999999975532211 11123468999999999999999999999999999999999999997
Q ss_pred ccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 599 LNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 599 ~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
...+.... +....... ......+.+... .....+..+.+||.+||+.||.+||+++++++.|+..+.
T Consensus 270 ~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 270 NCLPNTED-IMKQKQKF--VDKPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp GGTTCHHH-HHHHHHHH--HHSCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCCcCHHH-HHHHHHhc--cCChhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 65422111 11111100 001111111110 011234579999999999999999999999999988764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.61 Aligned_cols=252 Identities=26% Similarity=0.329 Sum_probs=197.7
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
..++|.+.+.||+|+||.||++.. .+++.+|+|.+...... ..+.+.+|+++++.++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 457899999999999999999984 57899999998755433 2367889999999999999999999999999999999
Q ss_pred EEeecCCcccccccC--CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe---eecCccccccccccc
Q 038949 470 EYICNGSLDSHLYGR--DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV---THDFEPLVGDFGLAR 544 (678)
Q Consensus 470 E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl---~~~~~vkL~DFGla~ 544 (678)
||+.+|+|.+++... ....+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.++|+|||++.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ----HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999988432 235689999999999999999999999 99999999999999 456889999999997
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
..... .......||+.|+|||++. +.++.++||||||+++|+|++|..||...... ... .......
T Consensus 176 ~~~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~----~~~~~~~- 241 (285)
T 3is5_A 176 LFKSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQ----QKATYKE- 241 (285)
T ss_dssp C------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH----HHHHHCC-
T ss_pred ecCCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHH----hhhccCC-
Confidence 65432 2234567899999999886 56899999999999999999999999643211 100 1100011
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+.... .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 242 --~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 --PNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --ccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11100 01113447889999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=353.93 Aligned_cols=267 Identities=22% Similarity=0.280 Sum_probs=204.6
Q ss_pred hhhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeeccc--------ccceEEEEeEE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ--------HRNVVMLIGFC 459 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~--------HpnIv~l~~~~ 459 (678)
.+...++|.+.+.||+|+||.||+|. ..+++.||||+++... .....+.+|+.+++.++ |+||+++++++
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 34557899999999999999999998 4578999999986332 22356788999999886 78899999998
Q ss_pred e----eCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC--
Q 038949 460 V----EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF-- 533 (678)
Q Consensus 460 ~----~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~-- 533 (678)
. .....|+||||+ +++|.+++.......+++..++.++.||+.||.|||+++ ||+||||||+||||+.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC---RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECCCCSGGGEEECCCHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHeeEeccchh
Confidence 7 556899999999 777777776555567999999999999999999999863 899999999999998775
Q ss_pred -----------------------------------------------ccccccccccccccCCCccceeEEEeeeccccc
Q 038949 534 -----------------------------------------------EPLVGDFGLARWQPDGDMGVETRVLGTFGYLAP 566 (678)
Q Consensus 534 -----------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~AP 566 (678)
.+||+|||++...... .....||+.|+||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aP 262 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCC
Confidence 7999999999865432 2334689999999
Q ss_pred ccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHH-----------Hhhh-hcccCc-------
Q 038949 567 EYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK-----------RHAI-GELIDP------- 627 (678)
Q Consensus 567 E~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~-----------~~~~-~elld~------- 627 (678)
|++.+..++.++|||||||+||+|++|+.||.................... .... ......
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 999999999999999999999999999999975443221111111110000 0000 000000
Q ss_pred ----------c--hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 628 ----------R--LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 628 ----------~--l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. -...++...+..+.+||.+||+.||++|||+.|+|+
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 001234556678899999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.76 Aligned_cols=264 Identities=21% Similarity=0.309 Sum_probs=205.4
Q ss_pred ehhhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeC
Q 038949 385 TYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED 462 (678)
Q Consensus 385 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 462 (678)
...++++..++|.+.+.||+|+||.||+|.+.+ .+|+|+++... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 345667788999999999999999999998643 49999886443 23346789999999999999999999999999
Q ss_pred CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
...++||||+.+++|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++ ++.++|+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK----GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHT----TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChhhEEEe-CCCEEEeecCC
Confidence 9999999999999999999543 34689999999999999999999999 999999999999998 68999999999
Q ss_pred cccccCC----CccceeEEEeeecccccccccc---------cccceecceeeeeeEEEEeeeCCccccccCCcccchhh
Q 038949 543 ARWQPDG----DMGVETRVLGTFGYLAPEYAQS---------GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT 609 (678)
Q Consensus 543 a~~~~~~----~~~~~~~~~Gt~~Y~APE~l~~---------~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~ 609 (678)
+...... .........|++.|+|||++.. ..++.++||||||+++|+|++|..||......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------ 249 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------ 249 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 8654211 1112223458999999999864 45788999999999999999999999643321
Q ss_pred hhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 610 EWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 610 ~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
..... +.....+.. .....+..+.+++.+||..||.+|||+.++++.|+....
T Consensus 250 ~~~~~------~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 250 AIIWQ------MGTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HHHHH------HHTTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred HHHHH------hccCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 00000 011111111 111234578999999999999999999999999997654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=348.30 Aligned_cols=274 Identities=24% Similarity=0.383 Sum_probs=198.4
Q ss_pred hhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCcccc--ccceeeecccccceEEEEeEEee-----CC
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFC--SEVEVLSCAQHRNVVMLIGFCVE-----DG 463 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~--~Ev~iL~~L~HpnIv~l~~~~~~-----~~ 463 (678)
...++|++.+.||+|+||.||+|.. +++.||||++..... ..+. .|+..+..++||||+++++.+.. ..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 4467899999999999999999987 689999999874432 2233 34444556899999999986542 33
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceee-----eEEeccCCCCceEeeecCccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG-----CIVHRDMRPNNILVTHDFEPLVG 538 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~-----gIvHrDLKp~NILl~~~~~vkL~ 538 (678)
.+++||||+.+|+|.+++... .+++..++.++.||+.||.|||+.+..+ ||+||||||+|||++.++.+||+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred eEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 678999999999999999432 3578888999999999999999863222 89999999999999999999999
Q ss_pred cccccccccCCCc-------cceeEEEeeecccccccccc-------cccceecceeeeeeEEEEeeeCCccccccCCcc
Q 038949 539 DFGLARWQPDGDM-------GVETRVLGTFGYLAPEYAQS-------GQITEKADVYSLGVVLVELITGRKAMDLNRPRG 604 (678)
Q Consensus 539 DFGla~~~~~~~~-------~~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~ 604 (678)
|||++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999986543221 11223358999999999976 567889999999999999999988775433211
Q ss_pred cchhhhh----hHH---HHHHhhhhcccCcchhccc--chhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 605 QQCLTEW----ARP---LLKRHAIGELIDPRLRNCY--SEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 605 ~~~l~~~----~~~---~~~~~~~~elld~~l~~~~--~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
....... ..+ ............+.+...+ ....+..+.+||.+||+.||++|||+.++++.|+..+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 1100000 000 0000001111112211111 12355579999999999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=350.51 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=203.1
Q ss_pred hhhhcCCcccceecccCccceeeccCCC-----CcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCC
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVLPD-----GQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG 463 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 463 (678)
++...+|.+.+.||+|+||.||+|.+.. +..||+|.++..... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 4556789999999999999999998432 346999998743222 2346889999999999999999999999999
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
..++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChheEEECCCCcEEECCCCcc
Confidence 999999999999999998543 34689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCcc--ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhh
Q 038949 544 RWQPDGDMG--VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 544 ~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
+........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... +....
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~~------ 262 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKA------ 262 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHH------
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------HHHHH------
Confidence 865432211 1222345788999999999999999999999999999999 99999643210 11110
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
+... .....+..++..+.+++.+||+.||.+||++.++++.|+..+.
T Consensus 263 ~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 263 INDG----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp HHTT----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHCC----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0000 1111233455679999999999999999999999999987653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=337.98 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=205.8
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
..++|.+.+.||+|+||.||+|. ..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 34679999999999999999998 457899999999755432 2367889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++. ..++++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++......
T Consensus 100 e~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 100 EYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp ECCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EeCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999984 34689999999999999999999999 9999999999999999999999999999765433
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
. .......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ... . +.....+.
T Consensus 173 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~-~-----~~~~~~~~- 238 (303)
T 3a7i_A 173 Q-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK------VLF-L-----IPKNNPPT- 238 (303)
T ss_dssp B-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH-H-----HHHSCCCC-
T ss_pred c-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH------HHH-H-----hhcCCCCC-
Confidence 2 22334568999999999999999999999999999999999999996433210 000 0 01111111
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHHH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~ 665 (678)
.+...+..+.+||.+||+.||.+|||+.++++.
T Consensus 239 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 ---LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ---CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ---CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 222344578999999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.02 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=198.0
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEee----CCeE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE----DGRR 465 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~----~~~~ 465 (678)
...|.+.+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 45688899999999999999984 5788999999874432 223568899999999999999999999875 3568
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeee--EEeccCCCCceEee-ecCccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILVT-HDFEPLVGDFGL 542 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g--IvHrDLKp~NILl~-~~~~vkL~DFGl 542 (678)
++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+. | |+||||||+|||++ .++.++|+|||+
T Consensus 105 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcC----CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 999999999999999943 35588999999999999999999998 7 99999999999998 789999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
+...... ......||+.|+|||++. +.++.++||||||+++|+|++|+.||....... .... .+.
T Consensus 179 ~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~------~~~ 243 (290)
T 1t4h_A 179 ATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYR------RVT 243 (290)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHH------HHT
T ss_pred ccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----HHHH------HHh
Confidence 9754332 233456899999999887 468999999999999999999999996433211 1000 001
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.... ....+...+..+.+||.+||+.||.+|||+.++++
T Consensus 244 ~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 244 SGVK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTCC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCC---ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1011 11122233457899999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.11 Aligned_cols=257 Identities=14% Similarity=0.119 Sum_probs=205.7
Q ss_pred hhhhhhhcCCcccceecccCccceeecc------CCCCcEEEEEeeehhcccCCccccccceeeeccc---ccceEEEEe
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGV------LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ---HRNVVMLIG 457 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~------~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~---HpnIv~l~~ 457 (678)
.+++...++|.+.+.||+|+||.||+|. ..+++.||+|+++... ...+..|+.++..++ |+||+.+++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 4556778899999999999999999993 4568899999986432 345666777766665 999999999
Q ss_pred EEeeCCeEEEEEEEeecCCcccccccC---CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee---
Q 038949 458 FCVEDGRRLLVYEYICNGSLDSHLYGR---DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH--- 531 (678)
Q Consensus 458 ~~~~~~~~~LV~E~~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~--- 531 (678)
++...+..|+||||+.+|+|.+++... ....+++..++.++.||+.||+|||+. ||+||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~----~ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC----EIIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECGGGT
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEeccccc
Confidence 999999999999999999999999532 345699999999999999999999998 9999999999999998
Q ss_pred --------cCccccccccccccccC-CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCC
Q 038949 532 --------DFEPLVGDFGLARWQPD-GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRP 602 (678)
Q Consensus 532 --------~~~vkL~DFGla~~~~~-~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~ 602 (678)
++.+||+|||+++.... .........+||+.|+|||++.+..++.++|||||||++|+|+||+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999975432 222233445799999999999999999999999999999999999999864322
Q ss_pred cccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCC-chHHHHHHHhhcccc
Q 038949 603 RGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSR-PRMSQVLRMLEGDIL 671 (678)
Q Consensus 603 ~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~R-PT~~eVL~~Le~~~~ 671 (678)
... .+...+... .....+.+++..||+.+|.+| |+++++.+.|+..+.
T Consensus 291 ~~~------------------~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 291 GEC------------------KPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp TEE------------------EECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred Cce------------------eechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 110 011111111 123357788899999999999 678888888877654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=353.79 Aligned_cols=267 Identities=28% Similarity=0.385 Sum_probs=203.4
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
+...++|.+.+.||+|+||.||+|.+ .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 34567899999999999999999995 4789999999874422 223568899999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ ||+||||||+|||++.++.++|+|||++....
T Consensus 109 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEECCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999999943 345889999999999999999999842 89999999999999999999999999997543
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhh---------------
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWA--------------- 612 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~--------------- 612 (678)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...............
T Consensus 184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 184 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred cc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 22 223457899999999999999999999999999999999999999653321100000000
Q ss_pred -HHH-------HHHhhhhcccC----cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 613 -RPL-------LKRHAIGELID----PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 613 -~~~-------~~~~~~~elld----~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... .......+.++ ...........+..+.+||.+||+.||++|||+.++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 00000000000 00000111223457899999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=363.25 Aligned_cols=252 Identities=25% Similarity=0.314 Sum_probs=202.1
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
...++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 3567899999999999999999985 579999999986443 2233578899999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee---ecCccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT---HDFEPLVGDFGLAR 544 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~---~~~~vkL~DFGla~ 544 (678)
||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++ .++.+||+|||+++
T Consensus 99 v~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 99 VGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999998844 34689999999999999999999999 999999999999995 45679999999997
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
...... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||..... .+..... ... ..
T Consensus 173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i-~~~---~~ 239 (486)
T 3mwu_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRV-ETG---KY 239 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-HHT---CC
T ss_pred ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH-HhC---CC
Confidence 654332 2234568999999999875 589999999999999999999999964322 1111111 010 00
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. .........+..+.+||.+||+.||.+|||+.++|+
T Consensus 240 -~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 240 -A--FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp -C--SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -C--CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 001111234557899999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=339.10 Aligned_cols=245 Identities=25% Similarity=0.345 Sum_probs=197.3
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecc-cccceEEEEeEEeeCCeEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~L 467 (678)
..++|.+.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 467899999999999999999995 4799999999874322 2235678899998888 89999999999999999999
Q ss_pred EEEEeecCCcccccccCC--CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec-------------
Q 038949 468 VYEYICNGSLDSHLYGRD--RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD------------- 532 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~------------- 532 (678)
||||+.+++|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM----SLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999995432 25689999999999999999999999 99999999999999844
Q ss_pred ------CccccccccccccccCCCccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCccc
Q 038949 533 ------FEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQ 605 (678)
Q Consensus 533 ------~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~ 605 (678)
..++|+|||++....... ...||+.|+|||++.+. .++.++||||||+++|+|++|.+++....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 479999999998654332 23489999999999865 67789999999999999999987763211
Q ss_pred chhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 606 QCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 606 ~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+ ... .....+ ..+...+..+.+||.+||+.||++|||+.++++
T Consensus 236 ----~~--~~~-----~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 ----QW--HEI-----RQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----HH--HHH-----HTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HH--HHH-----HcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 00 000 110111 123334557999999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=364.36 Aligned_cols=254 Identities=25% Similarity=0.318 Sum_probs=200.2
Q ss_pred hhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
.....++|++.+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.+++.++||||++++++|.+...+
T Consensus 32 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp BCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 345667899999999999999999995 478999999987443 23346788999999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec---Cccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD---FEPLVGDFGL 542 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~---~~vkL~DFGl 542 (678)
|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.. +.+||+|||+
T Consensus 112 ~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKH----NIVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 999999999999998843 34589999999999999999999999 99999999999999764 5599999999
Q ss_pred cccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
+....... ......||+.|+|||++. +.|+.++|||||||++|+|++|..||...... +...... . .
T Consensus 186 a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~-~---~ 252 (494)
T 3lij_A 186 SAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKVE-K---G 252 (494)
T ss_dssp CEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-H---T
T ss_pred CeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-h---C
Confidence 98664332 233457999999999986 56899999999999999999999999654321 1111110 0 0
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.. . +........+..+.+||.+||+.||.+|||+.++|+
T Consensus 253 ~~-~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 253 KY-T--FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CC-C--CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC-C--CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00 0 001111234457899999999999999999999984
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=340.96 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=202.7
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
...++|.+.+.||+|+||.||++.. .+++.||+|.++.........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 3467899999999999999999985 478999999998554444567889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe---eecCccccccccccccc
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV---THDFEPLVGDFGLARWQ 546 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl---~~~~~vkL~DFGla~~~ 546 (678)
||+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.++|+|||++...
T Consensus 86 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 86 QLVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHEN----GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EcCCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99999999998843 34589999999999999999999999 99999999999999 77899999999999754
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ...... ... ..
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i-~~~----~~- 224 (304)
T 2jam_A 160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KLFEKI-KEG----YY- 224 (304)
T ss_dssp CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHH-HHC----CC-
T ss_pred CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH-HcC----CC-
Confidence 322 122345899999999999999999999999999999999999999643210 111110 000 00
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..........+..+.++|.+||+.||++||++.++++
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 225 -EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111122334557899999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=342.05 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=199.7
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
...++|++.+.||+|+||.||+|.+ .+++.||+|++..........+.+|+.+++.++||||+++++++..++..++||
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 4567899999999999999999995 468999999987665555578889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+++|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++......
T Consensus 96 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 96 EFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSK----RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999888542 34589999999999999999999999 9999999999999999999999999997533211
Q ss_pred CccceeEEEeeeccccccccc-----ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 550 DMGVETRVLGTFGYLAPEYAQ-----SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
........||+.|+|||++. ...++.++||||||+++|+|++|..||...... ........ ..
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~----~~- 238 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAK----SD- 238 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH----SC-
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhc----cC-
Confidence 11123456899999999983 567889999999999999999999999654321 00000000 00
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+ ....+...+..+.++|.+||+.||.+|||+.++++
T Consensus 239 -~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 239 -PP--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -CC--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -Cc--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 01122334557899999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=342.88 Aligned_cols=262 Identities=25% Similarity=0.329 Sum_probs=202.6
Q ss_pred hhhcCCcccceecccCccceeeccCCC----CcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEe-eCCe
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLPD----GQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCV-EDGR 464 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~-~~~~ 464 (678)
....+|.+.+.||+|+||.||+|.+.+ ...+|+|.+..... .....+.+|+.+++.++||||+++++++. .++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 345679999999999999999998432 33689998864322 22356889999999999999999999854 4567
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK----KFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred eEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEECCCCCEEECcccccc
Confidence 89999999999999999543 34588899999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCc---cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhh
Q 038949 545 WQPDGDM---GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 545 ~~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
....... .......||+.|+|||.+.+..++.++||||||+++|+|++ |.+||....... .......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~------~~~~~~~--- 247 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQ--- 247 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT------HHHHHHT---
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH------HHHHHhc---
Confidence 6543221 12333457889999999999999999999999999999999 555554332211 0000000
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccccC
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMN 673 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~~ 673 (678)
. .....+...+..+.+++.+||+.||.+||++.++++.|+..+..-
T Consensus 248 ---~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 248 ---G----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ---T----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ---C----CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 011112334457999999999999999999999999999876543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=343.75 Aligned_cols=262 Identities=22% Similarity=0.344 Sum_probs=202.2
Q ss_pred CceeehhhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcc--cCCccccccceeeeccc--ccceEEEE
Q 038949 381 PRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQ--HRNVVMLI 456 (678)
Q Consensus 381 ~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~--HpnIv~l~ 456 (678)
.+.+.+..+....++|.+.+.||+|+||.||++...+++.||+|++..... .....+.+|+.++..++ ||||++++
T Consensus 15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp -----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 445666777888899999999999999999999987899999999864332 22356889999999997 49999999
Q ss_pred eEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccc
Q 038949 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL 536 (678)
Q Consensus 457 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vk 536 (678)
+++.+++..++||| +.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++ ++.+|
T Consensus 95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~-~~~~k 166 (313)
T 3cek_A 95 DYEITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLK 166 (313)
T ss_dssp EEEECSSEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEE-TTEEE
T ss_pred EEeecCCEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEEE-CCeEE
Confidence 99999999999999 568899999954 34688999999999999999999999 999999999999996 58999
Q ss_pred cccccccccccCCCc-cceeEEEeeecccccccccc-----------cccceecceeeeeeEEEEeeeCCccccccCCcc
Q 038949 537 VGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQS-----------GQITEKADVYSLGVVLVELITGRKAMDLNRPRG 604 (678)
Q Consensus 537 L~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~ 604 (678)
|+|||++........ .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.......
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence 999999986543221 12334578999999999875 468889999999999999999999996432110
Q ss_pred cchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 605 QQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 605 ~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. .+...+++.....++...+..+.++|.+||+.||.+||++.++++
T Consensus 247 -----~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 247 -----S---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp -----H---------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----H---------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 0 011112222222333334557899999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=359.93 Aligned_cols=200 Identities=23% Similarity=0.285 Sum_probs=166.7
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeC-----C
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED-----G 463 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-----~ 463 (678)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+|+.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 467999999999999999999984 578999999986432 12235788999999999999999999999776 5
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
.+|+||||+ +|+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~----givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIA-DSDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHES----GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECC-SEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CcCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC----CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 799999998 469999984 345699999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCc---------------------cceeEEEeeecccccccc-cccccceecceeeeeeEEEEeeeCCcccc
Q 038949 544 RWQPDGDM---------------------GVETRVLGTFGYLAPEYA-QSGQITEKADVYSLGVVLVELITGRKAMD 598 (678)
Q Consensus 544 ~~~~~~~~---------------------~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSLGviL~eLltG~~Pf~ 598 (678)
+....... ......+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 86543221 123456789999999986 55679999999999999999998665553
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=359.82 Aligned_cols=244 Identities=14% Similarity=0.134 Sum_probs=190.5
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccc---eeeecccccceEEEE------
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEV---EVLSCAQHRNVVMLI------ 456 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev---~iL~~L~HpnIv~l~------ 456 (678)
....++|.+.+.||+|+||.||+|.+ .+|+.||||++.... ....+.+.+|+ ++++.++||||++++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 34467899999999999999999995 579999999987432 22235688999 666677899999988
Q ss_pred -eEEeeCC-----------------eEEEEEEEeecCCcccccccCC-----CCccCccccchhhhhhccchhhhhhcce
Q 038949 457 -GFCVEDG-----------------RRLLVYEYICNGSLDSHLYGRD-----RDPLEWSARRKIAVGAARGLRYLHEECR 513 (678)
Q Consensus 457 -~~~~~~~-----------------~~~LV~E~~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qI~~aL~yLH~~~~ 513 (678)
+++...+ ..|+||||+ +|+|.+++.... ...+++..++.++.||+.||.|||++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 225 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-- 225 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 6665543 288999999 789999995421 12344578888999999999999999
Q ss_pred eeeEEeccCCCCceEeeecCccccccccccccccCCCccceeEEEeeeccccccccccc-----------ccceecceee
Q 038949 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSG-----------QITEKADVYS 582 (678)
Q Consensus 514 ~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----------~~s~ksDVwS 582 (678)
||+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||
T Consensus 226 --~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 226 --GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp --TEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred --CeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 999999999999999999999999999985322 2334567 999999999887 8999999999
Q ss_pred eeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHH
Q 038949 583 LGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQV 662 (678)
Q Consensus 583 LGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eV 662 (678)
|||++|+|++|+.||......... ..+.. .....+..+.+||.+||+.||++||++.++
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~~---------------~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 357 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGGS---------------EWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQA 357 (377)
T ss_dssp HHHHHHHHHHSSCCC------CCS---------------GGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred HHHHHHHHHHCCCCCcccccccch---------------hhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 999999999999999643321110 00000 012334578999999999999999999999
Q ss_pred HH
Q 038949 663 LR 664 (678)
Q Consensus 663 L~ 664 (678)
++
T Consensus 358 l~ 359 (377)
T 3byv_A 358 ME 359 (377)
T ss_dssp HT
T ss_pred hh
Confidence 85
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=350.00 Aligned_cols=264 Identities=23% Similarity=0.395 Sum_probs=199.1
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC--CccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~--~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
..++|++.+.||+|+||.||+|.. .+++.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 357899999999999999999995 468999999886433221 24577899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.+++|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++.....
T Consensus 103 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHC----CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999988763 344589999999999999999999999 999999999999999999999999999975543
Q ss_pred CCccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhh----------HHHHH
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWA----------RPLLK 617 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~----------~~~~~ 617 (678)
.. .......||+.|+|||++.+. .++.++||||||+++|+|++|..||........ +.... .....
T Consensus 177 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 177 PG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHH
T ss_pred Cc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHhh
Confidence 22 222345689999999999875 789999999999999999999999965432111 00000 00000
Q ss_pred H-hhhhcccCcchh-----cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 618 R-HAIGELIDPRLR-----NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 618 ~-~~~~elld~~l~-----~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. ........+... .......+..+.+||.+||+.||++|||+.|+|+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 001111111111 1111234567999999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=353.12 Aligned_cols=247 Identities=28% Similarity=0.392 Sum_probs=199.0
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhccc---CCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
..++|...+.||+|+||.||+|. ..+++.||||++...... ....+.+|+.+++.++||||+++++++.+++..++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 34669999999999999999998 468999999998643222 22468899999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+. |+|.+++... ..++++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 132 v~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 999996 6777777432 35689999999999999999999999 99999999999999999999999999997653
Q ss_pred CCCccceeEEEeeeccccccccc---ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQ---SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
.. ....||+.|+|||++. .+.++.++|||||||++|+|++|..||...... ........ .
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~------~ 268 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQ------N 268 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH------S
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHh------c
Confidence 32 2356899999999984 567899999999999999999999998643211 10111110 0
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+.. .+...+..+.+||.+||+.||++|||+.++++
T Consensus 269 ~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 269 ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 01111 12234457889999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=339.32 Aligned_cols=261 Identities=25% Similarity=0.348 Sum_probs=197.9
Q ss_pred hhhcCCcccceecccCccceeeccC--CCCc--EEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCC
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL--PDGQ--VVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG 463 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~--~~g~--~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 463 (678)
...++|++.+.||+|+||.||+|.+ .+++ .||+|+++.... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 4467899999999999999999984 2333 689999875422 22357889999999999999999999998754
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
.++||||+.+++|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.++|+|||++
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred -ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEEcCCCCEEEcccccc
Confidence 89999999999999998543 34588999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCcc--ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhh
Q 038949 544 RWQPDGDMG--VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 544 ~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... .......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~---- 238 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKID---- 238 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHH----
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHH----
Confidence 866443221 2233457888999999998899999999999999999999 99999643321 1111000
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
........+...+..+.+++.+||+.||.+||++.++++.|+.....
T Consensus 239 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 239 -----KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -----TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -----ccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 00111112334556899999999999999999999999999876543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=355.44 Aligned_cols=257 Identities=25% Similarity=0.344 Sum_probs=193.9
Q ss_pred cCCcccceecccCccceeeccCC--C--CcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEee-CCeEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLP--D--GQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE-DGRRLL 467 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~--~--g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-~~~~~L 467 (678)
..|.+.+.||+|+||.||+|.+. + +..||+|.++... ......+.+|+.+++.++||||+++++++.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 45788899999999999999842 2 2468999886432 2223578899999999999999999998654 567899
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+.+|+|.+++... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999999543 34578889999999999999999999 99999999999999999999999999998654
Q ss_pred CCCc---cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhc
Q 038949 548 DGDM---GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623 (678)
Q Consensus 548 ~~~~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~e 623 (678)
.... .......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||........ ....... .
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~------~~~~~~~----~ 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------TVYLLQG----R 313 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH------HHHHHTT----C
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH------HHHHHcC----C
Confidence 3221 12233457789999999999999999999999999999999 6777754332110 0000000 0
Q ss_pred ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 624 lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
....+..++..+.+++.+||+.||++||++.++++.|+..+.
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011223445679999999999999999999999999987664
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=375.95 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=198.3
Q ss_pred ceecccCccceeeccC---CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVL---PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~---~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|.+ .+++.||||+++..... ..+.+.+|+.+|+.++||||+++++++.. +..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999953 35689999999754332 23578999999999999999999999864 568999999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC--cc
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD--MG 552 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~--~~ 552 (678)
|+|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++...... ..
T Consensus 454 g~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH~~----~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999994 345689999999999999999999999 99999999999999999999999999998664332 12
Q ss_pred ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 553 VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... +... . +......
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~~~-~---------i~~~~~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTA-M---------LEKGERM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHH-H---------HHTTCCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHH-H---------HHcCCCC
Confidence 2333456789999999999999999999999999999998 99999654321 1000 0 0111112
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
..+..++..+.+||.+||+.||++||++.+|++.|+..+
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 234456678999999999999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=365.15 Aligned_cols=253 Identities=24% Similarity=0.333 Sum_probs=204.9
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
....++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45678999999999999999999995 4799999999864432 2335688999999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe---eecCccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV---THDFEPLVGDFGL 542 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl---~~~~~vkL~DFGl 542 (678)
|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+
T Consensus 102 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 999999999999998843 45699999999999999999999999 99999999999999 4678999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
+....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...... +..... ...
T Consensus 176 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i-~~~--- 242 (484)
T 3nyv_A 176 STHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY------DILKKV-EKG--- 242 (484)
T ss_dssp HHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH-HHC---
T ss_pred eEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH-HcC---
Confidence 98664432 2233468999999999875 6899999999999999999999999654321 111110 010
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. .. .........+..+.+||.+||+.||.+|||+.++|+
T Consensus 243 ~-~~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 243 K-YT--FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp C-CC--CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-CC--CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 00 011111234567899999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=336.10 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=204.1
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 457899999999999999999985 468899999986432 2223568899999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 92 MLEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHER----KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999999854 34589999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
... .....|++.|+|||++.+..++.++||||||+++|+|++|..||...... ...... .. .+
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~------~~-~~- 228 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRI------VN-VD- 228 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH------HT-TC-
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHH------hc-cc-
Confidence 322 23456899999999999999999999999999999999999999643210 111100 00 01
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..++...+..+.++|.+||+.||.+||++.++++
T Consensus 229 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 ---LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1123344557899999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=340.44 Aligned_cols=256 Identities=22% Similarity=0.309 Sum_probs=203.5
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEee--CCeEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE--DGRRLL 467 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~~~L 467 (678)
.++|++.+.||+|+||.||++.. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999985 5789999999874432 223568899999999999999999998754 678999
Q ss_pred EEEEeecCCcccccccC--CCCccCccccchhhhhhccchhhhhhcceeee-----EEeccCCCCceEeeecCccccccc
Q 038949 468 VYEYICNGSLDSHLYGR--DRDPLEWSARRKIAVGAARGLRYLHEECRVGC-----IVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g-----IvHrDLKp~NILl~~~~~vkL~DF 540 (678)
||||+.+++|.+++... ....+++..++.++.|++.||.|||+. | |+||||||+|||++.++.++|+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR----SDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH----C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc----cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 99999999999998543 234589999999999999999999998 7 999999999999999999999999
Q ss_pred cccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
|++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ...... +....
T Consensus 161 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~-i~~~~ 232 (279)
T 2w5a_A 161 GLARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGK-IREGK 232 (279)
T ss_dssp CHHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH-HHHTC
T ss_pred chheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH------HHHHHH-Hhhcc
Confidence 9997654322 112234588999999999998999999999999999999999999965421 011111 11111
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
. ...+...+..+.++|.+||+.||.+||++.++++.+...
T Consensus 233 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 233 F---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred c---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 0 112334456899999999999999999999999877643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=345.43 Aligned_cols=261 Identities=23% Similarity=0.297 Sum_probs=195.6
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-----CCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-----GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-----~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
...++|.+.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 4467899999999999999999995 46899999998643322 12467889999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.++||||+.+ +|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999965 88887743 334689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh---
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA--- 620 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~--- 620 (678)
...... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||....... . .........
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-----~-~~~i~~~~~~~~ 233 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-----Q-LTRIFETLGTPT 233 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----H-HHHHHHHHCCCC
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-----H-HHHHHHHcCCCC
Confidence 654322 223345689999999998754 58999999999999999999999986543211 0 011111000
Q ss_pred ------hhcccCcch--------hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 ------IGELIDPRL--------RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ------~~elld~~l--------~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.....+... ........+..+.+||.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000000000 00011234467899999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=338.56 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=200.1
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
....++|.+.+.||+|+||.||+|.. .+|+.||+|.+... .....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 34567899999999999999999985 46899999998743 3456788999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.+++|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+||+++.++.++|+|||++.....
T Consensus 103 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 103 MEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFM----RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred eecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999999853 245689999999999999999999999 999999999999999999999999999976543
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.. .......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ... .. .....+.
T Consensus 178 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~-~~-----~~~~~~~ 244 (314)
T 3com_A 178 TM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIF-MI-----PTNPPPT 244 (314)
T ss_dssp TB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH-HH-----HHSCCCC
T ss_pred hc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHH-HH-----hcCCCcc
Confidence 21 22334568999999999999999999999999999999999999996433210 000 00 0000111
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+ ..+...+..+.+||.+||+.||.+|||+.++++
T Consensus 245 ~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 F--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp C--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1 122334557899999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=344.29 Aligned_cols=263 Identities=24% Similarity=0.305 Sum_probs=196.2
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEee--------
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVE-------- 461 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-------- 461 (678)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999995 67999999988644322 23467889999999999999999999887
Q ss_pred CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
.+.+|+||||+.+ +|.+.+... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 4568999999965 777666433 34589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCC---ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHH
Q 038949 542 LARWQPDGD---MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK 617 (678)
Q Consensus 542 la~~~~~~~---~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 617 (678)
+++...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... .. ......
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~-i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL--AL-ISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH--HH-HHHHhC
Confidence 997654221 122234568999999998876 56899999999999999999999999754321110 00 000000
Q ss_pred H-----------hhhhcccC------cchhcccc-hhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 618 R-----------HAIGELID------PRLRNCYS-EREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 618 ~-----------~~~~elld------~~l~~~~~-~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. ....+.+. ..+..... ......+.+||.+||+.||++|||+.|+|+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0 00000000 00000000 001345789999999999999999999885
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=338.61 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=187.5
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC--CccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~--~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
+...++|++.+.||+|+||.||+|.. .+++.||+|+++...... ...+.++...++.++||||+++++++.+++..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 45678999999999999999999994 689999999986432211 123444555577889999999999999999999
Q ss_pred EEEEEeecCCccccccc--CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+||||+. |+|.+++.. .....+++..++.++.|++.||.|||+++ ||+||||||+|||++.++.+||+|||++.
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL---SVIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS---CCCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 9999996 588777633 23456999999999999999999999853 89999999999999999999999999997
Q ss_pred cccCCCccceeEEEeeecccccccc----cccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYA----QSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l----~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
...... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||....... ... ...
T Consensus 159 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~-~~~----- 226 (290)
T 3fme_A 159 YLVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF----QQL-KQV----- 226 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH----HHH-HHH-----
T ss_pred cccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH----HHH-HHH-----
Confidence 654322 22334689999999996 56678999999999999999999999996432210 000 000
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.... .+. ......+..+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~~-~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 227 VEEP-SPQ---LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHSC-CCC---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hccC-CCC---cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0010 111 111234457899999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=362.33 Aligned_cols=255 Identities=23% Similarity=0.297 Sum_probs=201.7
Q ss_pred hhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-------------cCCccccccceeeecccccceE
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-------------QGDQEFCSEVEVLSCAQHRNVV 453 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-------------~~~~~~~~Ev~iL~~L~HpnIv 453 (678)
......++|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+
T Consensus 30 ~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 109 (504)
T 3q5i_A 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109 (504)
T ss_dssp ECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred cCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3345678999999999999999999994 5788999999864332 1224688899999999999999
Q ss_pred EEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC
Q 038949 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF 533 (678)
Q Consensus 454 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~ 533 (678)
++++++.+...+|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~ 183 (504)
T 3q5i_A 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKH----NIVHRDIKPENILLENKN 183 (504)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESSTT
T ss_pred eEEEEEEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCcHHHEEEecCC
Confidence 999999999999999999999999998844 35589999999999999999999999 999999999999999776
Q ss_pred ---ccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhh
Q 038949 534 ---EPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTE 610 (678)
Q Consensus 534 ---~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~ 610 (678)
.+||+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++|..||...... +
T Consensus 184 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~ 254 (504)
T 3q5i_A 184 SLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------D 254 (504)
T ss_dssp CCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H
T ss_pred CCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------H
Confidence 69999999998664332 233456999999999987 56899999999999999999999999653321 1
Q ss_pred hhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 611 WARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 611 ~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...... . ... . .........+..+.+||.+||+.||.+|||+.++|+
T Consensus 255 ~~~~i~-~---~~~-~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 255 IIKKVE-K---GKY-Y--FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHH-H---CCC-C--CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHH-c---CCC-C--CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111110 0 000 0 000011234457899999999999999999999984
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=349.65 Aligned_cols=263 Identities=21% Similarity=0.302 Sum_probs=197.7
Q ss_pred hhhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEee------
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE------ 461 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~------ 461 (678)
++...++|.+.+.||+|+||.||+|. ..+|+.||||++... .....+|+.+++.++||||++++++|..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 35567899999999999999999998 468999999988632 3445689999999999999999999844
Q ss_pred --------------------------------CCeEEEEEEEeecCCccccccc--CCCCccCccccchhhhhhccchhh
Q 038949 462 --------------------------------DGRRLLVYEYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRY 507 (678)
Q Consensus 462 --------------------------------~~~~~LV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~y 507 (678)
...+++||||+. |+|.+.+.. .....+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 334889999996 577776642 345669999999999999999999
Q ss_pred hhhcceeeeEEeccCCCCceEee-ecCccccccccccccccCCCccceeEEEeeeccccccccccc-ccceecceeeeee
Q 038949 508 LHEECRVGCIVHRDMRPNNILVT-HDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGV 585 (678)
Q Consensus 508 LH~~~~~~gIvHrDLKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGv 585 (678)
||+. ||+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||
T Consensus 157 LH~~----gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 157 IHSL----GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHTT----TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHC----cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 9999 999999999999998 68999999999998654332 22345689999999998764 5899999999999
Q ss_pred EEEEeeeCCccccccCCcccchhhhhhHH--------HHHH-h-----hhhcccCcchhcccchhhhhhhhhccceeecc
Q 038949 586 VLVELITGRKAMDLNRPRGQQCLTEWARP--------LLKR-H-----AIGELIDPRLRNCYSEREVYGMLQCASLCIRK 651 (678)
Q Consensus 586 iL~eLltG~~Pf~~~~~~~~~~l~~~~~~--------~~~~-~-----~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~ 651 (678)
++|+|++|+.||........ +...... +... . .+...........++...+..+.+||.+||+.
T Consensus 231 il~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 99999999999975432111 1111000 0000 0 00001111122223444566799999999999
Q ss_pred CCCCCchHHHHHH
Q 038949 652 DPHSRPRMSQVLR 664 (678)
Q Consensus 652 dP~~RPT~~eVL~ 664 (678)
||.+|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999984
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=348.26 Aligned_cols=261 Identities=25% Similarity=0.339 Sum_probs=203.0
Q ss_pred hhhhcCCcccceecccCccceeeccC------CCCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeC
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED 462 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~ 462 (678)
+...++|.+.+.||+|+||.||+|.+ .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 45678999999999999999999983 357789999986332 22235688999999999999999999999999
Q ss_pred CeEEEEEEEeecCCcccccccCCC-----CccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee---cCc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDR-----DPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH---DFE 534 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~---~~~ 534 (678)
...|+||||+.+++|.+++..... ..+++..++.++.||+.||.|||+. ||+||||||+|||++. +..
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeecCcCCHhHEEEecCCCcce
Confidence 999999999999999999965432 3488888999999999999999999 9999999999999994 446
Q ss_pred cccccccccccccCCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhh
Q 038949 535 PLVGDFGLARWQPDGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWA 612 (678)
Q Consensus 535 vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 612 (678)
++|+|||++........ .......|++.|+|||++.+..++.++||||||+++|+|++ |..||...... ...
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~ 255 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVL 255 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHH
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------HHH
Confidence 99999999975433221 11222346889999999999999999999999999999998 98998643210 111
Q ss_pred HHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 613 RPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 613 ~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
.. . ... .....+..++..+.++|.+||+.||.+||++.++++.|+...
T Consensus 256 ~~-~-----~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 256 EF-V-----TSG----GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HH-H-----HTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH-H-----hcC----CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 00 0 000 011122344557899999999999999999999999987543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=360.37 Aligned_cols=262 Identities=21% Similarity=0.262 Sum_probs=192.8
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeehh--cccCCccccccceeeecccccceEEEEeEEeeC------
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLA--SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED------ 462 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~--~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~------ 462 (678)
..++|++.+.||+|+||.||+|. ..+++.||||++... .......+.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 46899999999999999999998 457899999998643 222235688999999999999999999998654
Q ss_pred CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
..+|+||||+.+ +|.+.+. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 457999999965 4666652 2388899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhh-------------
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT------------- 609 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~------------- 609 (678)
++..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||............
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9865432 2345578999999999999999999999999999999999999999654321110000
Q ss_pred hh---hHHHHHHhh------hhcccCcchh---cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 610 EW---ARPLLKRHA------IGELIDPRLR---NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 610 ~~---~~~~~~~~~------~~elld~~l~---~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+ ......... ........+. ..........+.+||.+||+.||++|||++|+|+
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 000000000 0000000000 0001112456899999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=338.38 Aligned_cols=256 Identities=20% Similarity=0.286 Sum_probs=199.4
Q ss_pred hcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeeccc-ccceEEEEeEEee--CCeEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVE--DGRRLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~--~~~~~LV 468 (678)
.++|++.+.||+|+||.||+|. ..+++.||+|+++.. ....+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 4789999999999999999998 467899999998632 2357889999999997 9999999999987 6678999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC-cccccccccccccc
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF-EPLVGDFGLARWQP 547 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~-~vkL~DFGla~~~~ 547 (678)
|||+.+++|.+++. .+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .++|+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998883 388889999999999999999999 999999999999999776 89999999998654
Q ss_pred CCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh-----
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI----- 621 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~----- 621 (678)
... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||......... +....... .....
T Consensus 183 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~-~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVL-GTEDLYDYID 258 (330)
T ss_dssp TTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHH-CHHHHHHHHH
T ss_pred CCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhc-CCchhhhHHH
Confidence 332 2233468999999999877 67899999999999999999999999543321111 11100000 00000
Q ss_pred --hcccCc----------------chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 622 --GELIDP----------------RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 622 --~elld~----------------~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....++ ..........+..+.+||.+||+.||.+|||++|+|+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000010 0111112224567899999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=333.77 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=197.0
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
....++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 34567999999999999999999985 479999999987543 22335788999999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.++|+|||++..
T Consensus 87 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH----CSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred EEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChhhEEECCCCCEEEeecccccc
Confidence 999999999999999843 34588999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
..... ......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||..... ...... ... ..
T Consensus 161 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~-~~~----~~ 227 (276)
T 2h6d_A 161 MSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFKK-IRG----GV 227 (276)
T ss_dssp CCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH-HHH----CC
T ss_pred cCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHH-hhc----Cc
Confidence 54332 2234568999999999987765 7899999999999999999999964321 111110 000 00
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+...+..+.++|.+||+.||.+|||+.++++
T Consensus 228 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 228 ------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0122334457899999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=340.44 Aligned_cols=258 Identities=25% Similarity=0.303 Sum_probs=201.1
Q ss_pred cCCcccceecccCccceeeccCC----CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeE-EE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLP----DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR-LL 467 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~-~L 467 (678)
-.|...+.||+|+||.||+|.+. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 35667799999999999999732 233799998864322 2235788999999999999999999999876655 99
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+.+|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||+++...
T Consensus 101 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ----KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999999543 45588999999999999999999999 99999999999999999999999999997543
Q ss_pred CCC---ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 548 DGD---MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 548 ~~~---~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
... ........+++.|+|||.+.+..++.++||||||+++|+|++|..|+....... ..... . ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-----~~~~~-~-----~~~ 244 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-----DLTHF-L-----AQG 244 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-----GHHHH-H-----HTT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-----HHHHH-h-----hcC
Confidence 321 112223457889999999999999999999999999999999665543222110 00000 0 000
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.....+...+..+.+++.+||+.||.+|||+.++++.|+..+.
T Consensus 245 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 245 ----RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0111233345579999999999999999999999999998664
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.97 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=204.9
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
...++|.+.+.||+|+||.||++.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 3467899999999999999999995 4688999999864422 22356888999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.++|+|||++...
T Consensus 118 lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 118 VVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EEECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 99999999999998843 34689999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+..... ... .
T Consensus 192 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~-~~~------~ 257 (335)
T 2owb_A 192 EYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRI-KKN------E 257 (335)
T ss_dssp CSTT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHH-HHT------C
T ss_pred ccCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHH-hcC------C
Confidence 4322 222345689999999999999999999999999999999999999964321 1111100 000 0
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. ..+......+.+||.+||+.||++||++.++++
T Consensus 258 ~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 Y----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 122234457889999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=373.42 Aligned_cols=249 Identities=20% Similarity=0.259 Sum_probs=204.7
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehh---cccCCccccccceeeecc-cccceEEEEeEEeeCCeE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA---SSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~ 465 (678)
...++|.+.+.||+|+||.||+|.. .+++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4457899999999999999999994 57889999999743 334456678899998887 799999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
||||||+.||+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+||||+.++++||+|||+++.
T Consensus 418 ~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999954 34699999999999999999999999 999999999999999999999999999985
Q ss_pred ccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
..... ......+||+.|+|||++.+..|+.++|||||||+||||++|..||..... .+..... +
T Consensus 492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i---------~ 555 (674)
T 3pfq_A 492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSI---------M 555 (674)
T ss_dssp CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH---------H
T ss_pred cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHH---------H
Confidence 43222 234456799999999999999999999999999999999999999965332 1111111 1
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchH-----HHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRM-----SQVL 663 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~-----~eVL 663 (678)
.. ...++...+..+.+||.+||+.||.+||++ ++|+
T Consensus 556 ~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 556 EH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp SS--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred hC--CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 11 012334455689999999999999999998 6665
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=365.33 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=207.2
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
...++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+...+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 3457899999999999999999995 579999999996443 233356888999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCC--CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRD--RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+||||+.||+|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+||||+.+|.+||+|||+++
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~----gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR----NIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc----CCcccCCChHHEEEeCCCCEEEeecceee
Confidence 9999999999999986543 45699999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||........ ...+..... ..
T Consensus 338 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~-----~~- 408 (543)
T 3c4z_A 338 ELKAGQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVL-----EQ- 408 (543)
T ss_dssp ECCTTC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHH-----HC-
T ss_pred eccCCC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHh-----hc-
Confidence 654332 223345799999999999999999999999999999999999999975432111 111111111 00
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchH-----HHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRM-----SQVL 663 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~-----~eVL 663 (678)
...++...+..+.+||.+||+.||.+||++ ++++
T Consensus 409 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 409 -----AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred -----ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 012334455688999999999999999975 5565
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.74 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=204.5
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
...++|.+.+.||+|+||.||++.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 3457899999999999999999995 4688999999864432 22356888999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++...
T Consensus 92 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 92 VVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 99999999999998843 34689999999999999999999999 9999999999999999999999999999765
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...... +..... .. . .
T Consensus 166 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~-~~---~---~ 231 (294)
T 2rku_A 166 EYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRI-KK---N---E 231 (294)
T ss_dssp CSTT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH-HT---T---C
T ss_pred ccCc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH-hh---c---c
Confidence 4222 1223456899999999999889999999999999999999999999643211 100000 00 0 0
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+...+..+.+++.+||+.||++||++.++++
T Consensus 232 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 232 ----YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1122334457889999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=334.79 Aligned_cols=251 Identities=21% Similarity=0.268 Sum_probs=198.2
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc----ccCCccccccceeeecccccceEEEEeEE--eeCCe
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS----SQGDQEFCSEVEVLSCAQHRNVVMLIGFC--VEDGR 464 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~----~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~--~~~~~ 464 (678)
..++|.+.+.||+|+||.||++.. .+++.||+|+++... ......+.+|+.+++.++||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 357899999999999999999985 578999999997543 22335788999999999999999999998 44568
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.++||||+.++ |.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ----GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999776 77777655566799999999999999999999999 99999999999999999999999999998
Q ss_pred cccCC-CccceeEEEeeecccccccccccc--cceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 545 WQPDG-DMGVETRVLGTFGYLAPEYAQSGQ--ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 545 ~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
..... .........||+.|+|||++.+.. ++.++||||||+++|+|++|..||..... ....... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i-~~~-- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLFENI-GKG-- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHH-HHC--
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHHH-hcC--
Confidence 65432 122233456899999999987643 47799999999999999999999964321 1111110 000
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. ...+..++..+.++|.+||+.||.+||++.++++
T Consensus 229 ----~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 229 ----S----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ----C----CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----C----CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0122334557899999999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=340.68 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=197.6
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--------cCCccccccceeeecccccceEEEEeEEe
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--------QGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--------~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~ 460 (678)
....++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 34567899999999999999999984 5789999999864321 22346889999999999999999999987
Q ss_pred eCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc---ccc
Q 038949 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE---PLV 537 (678)
Q Consensus 461 ~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~---vkL 537 (678)
.+. .|+||||+.+++|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++. +||
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSSSCCEEE
T ss_pred CCc-eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEecCCCCCeEEE
Confidence 654 899999999999999884 345689999999999999999999999 9999999999999987654 999
Q ss_pred ccccccccccCCCccceeEEEeeeccccccccc---ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHH
Q 038949 538 GDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQ---SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP 614 (678)
Q Consensus 538 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 614 (678)
+|||++...... .......||+.|+|||++. ...++.++||||||+++|+|++|..||........ +..
T Consensus 159 ~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~---- 230 (322)
T 2ycf_A 159 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD---- 230 (322)
T ss_dssp CCCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH----
T ss_pred ccCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH----
Confidence 999999865432 1222346899999999974 46788999999999999999999999975432111 100
Q ss_pred HHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 LLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 ~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....... ...+. .....+..+.+||.+||+.||++||++.++++
T Consensus 231 ~~~~~~~--~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 QITSGKY--NFIPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHTCC--CCCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhCcc--ccCch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0111100 00111 11233457899999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=346.62 Aligned_cols=271 Identities=24% Similarity=0.314 Sum_probs=198.9
Q ss_pred ehhhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCC-----------ccccccceeeecccccceE
Q 038949 385 TYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGD-----------QEFCSEVEVLSCAQHRNVV 453 (678)
Q Consensus 385 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~-----------~~~~~Ev~iL~~L~HpnIv 453 (678)
...++....++|.+.+.||+|+||.||+|...+++.||||++........ +.+.+|+.+++.++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35677888999999999999999999999977799999999864332221 4678999999999999999
Q ss_pred EEEeEEee-----CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceE
Q 038949 454 MLIGFCVE-----DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL 528 (678)
Q Consensus 454 ~l~~~~~~-----~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NIL 528 (678)
++++++.. ...+|+||||+. |+|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEA----GVVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC----cCEecCCChHHEE
Confidence 99999854 346899999996 688887753 344689999999999999999999999 9999999999999
Q ss_pred eeecCccccccccccccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccch
Q 038949 529 VTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC 607 (678)
Q Consensus 529 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~ 607 (678)
++.++.++|+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999999754322 22345678999999999876 678999999999999999999999997543211000
Q ss_pred -hhh------------hhHHHHHHhhhhccc---CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 608 -LTE------------WARPLLKRHAIGELI---DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 608 -l~~------------~~~~~~~~~~~~ell---d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+.. +..+... ....... ............+..+.+||.+||+.||.+|||+.++++
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSAR-DYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHH-HHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCChHHhhhccchhhh-HHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 000 0000000 0000000 000011122234457889999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=341.20 Aligned_cols=266 Identities=22% Similarity=0.341 Sum_probs=204.5
Q ss_pred hhhhhcCCcccceecccCccceeeccC--CCCcEEEEEeeehhcccCCccccccceeeecccccc------eEEEEeEEe
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL--PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN------VVMLIGFCV 460 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~--~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn------Iv~l~~~~~ 460 (678)
.+...++|++.+.||+|+||.||+|.. .+++.||+|+++... .....+.+|+.+++.++|++ ++++++++.
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 345678999999999999999999974 468899999986332 22356788999999888765 999999999
Q ss_pred eCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee---------
Q 038949 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH--------- 531 (678)
Q Consensus 461 ~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~--------- 531 (678)
+.+..++||||+ +++|.+++......++++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN----KLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeccccccccCC
Confidence 999999999999 99999999766656789999999999999999999999 9999999999999987
Q ss_pred ----------cCccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccC
Q 038949 532 ----------DFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNR 601 (678)
Q Consensus 532 ----------~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~ 601 (678)
++.++|+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 6789999999998643322 23468999999999999999999999999999999999999997543
Q ss_pred Ccccchhhhh-----hHHHHHHhh---------------------hhcccCcch-hcccchhhhhhhhhccceeeccCCC
Q 038949 602 PRGQQCLTEW-----ARPLLKRHA---------------------IGELIDPRL-RNCYSEREVYGMLQCASLCIRKDPH 654 (678)
Q Consensus 602 ~~~~~~l~~~-----~~~~~~~~~---------------------~~elld~~l-~~~~~~~~~~~l~~LI~~cL~~dP~ 654 (678)
.......... ...+..... ......+.. ........+..+.+||.+||+.||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 2111000000 000000000 000000000 0111233456789999999999999
Q ss_pred CCchHHHHHH
Q 038949 655 SRPRMSQVLR 664 (678)
Q Consensus 655 ~RPT~~eVL~ 664 (678)
+|||+.|+++
T Consensus 319 ~Rpt~~ell~ 328 (339)
T 1z57_A 319 KRITLREALK 328 (339)
T ss_dssp TSCCHHHHTT
T ss_pred cccCHHHHhc
Confidence 9999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=355.11 Aligned_cols=263 Identities=19% Similarity=0.257 Sum_probs=208.9
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccc-cceEEEEeEEeeCCeEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQH-RNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~H-pnIv~l~~~~~~~~~~~LV~ 469 (678)
..++|.+.+.||+|+||.||+|.+ .+++.||||++.... ....+.+|+++++.++| ++|..+..++.+....+|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 457899999999999999999984 679999999876443 33568899999999976 66667777778888999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe---eecCccccccccccccc
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV---THDFEPLVGDFGLARWQ 546 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl---~~~~~vkL~DFGla~~~ 546 (678)
||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||| +.++.+||+|||+++..
T Consensus 83 e~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK----SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 999 99999999533 34699999999999999999999999 99999999999999 58899999999999866
Q ss_pred cCCCc------cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 547 PDGDM------GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 547 ~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
..... .......||+.|+|||++.+..++.++|||||||+||+|++|..||............. ... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~---~i~-~~~ 232 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE---KIS-EKK 232 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHH---HHH-HHH
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHH---HHh-hcc
Confidence 54322 12235679999999999999999999999999999999999999997644322111111 111 111
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
....+. .....++..+.+||.+||+.||++||++.+|++.|+..+.
T Consensus 233 ~~~~~~-----~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 233 VATSIE-----ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHSCHH-----HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccccHH-----HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111110 1112334579999999999999999999999999987764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=352.93 Aligned_cols=202 Identities=22% Similarity=0.296 Sum_probs=173.8
Q ss_pred hhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcccCCccccccceeeecc------cccceEEEEeEEeeC
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA------QHRNVVMLIGFCVED 462 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L------~HpnIv~l~~~~~~~ 462 (678)
+....+|++.+.||+|+||.||+|. ..+++.||||+++... .....+.+|+.+++.+ .|+||+++++++...
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 4456789999999999999999998 4578999999986432 2224566788877776 467999999999999
Q ss_pred CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc--cccccc
Q 038949 463 GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE--PLVGDF 540 (678)
Q Consensus 463 ~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~--vkL~DF 540 (678)
..+++||||+ +++|.+++.......+++..++.++.||+.||.|||+. ||+||||||+||||+.++. +||+||
T Consensus 172 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 172 NHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN----RIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH----TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred CeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEccCCCcceEEeec
Confidence 9999999999 57999998766666799999999999999999999999 9999999999999999887 999999
Q ss_pred cccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccC
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNR 601 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~ 601 (678)
|+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||....
T Consensus 247 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 247 GSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999754332 223468999999999999999999999999999999999999996543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=345.54 Aligned_cols=257 Identities=23% Similarity=0.321 Sum_probs=204.7
Q ss_pred hhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC--------Cccccccceeeecc-cccceEEEE
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG--------DQEFCSEVEVLSCA-QHRNVVMLI 456 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~--------~~~~~~Ev~iL~~L-~HpnIv~l~ 456 (678)
.......++|.+.+.||+|+||.||+|.+ .+|+.||||++....... .+.+.+|+.+++.+ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 34455668899999999999999999995 479999999987543211 24577899999999 799999999
Q ss_pred eEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccc
Q 038949 457 GFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL 536 (678)
Q Consensus 457 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vk 536 (678)
+++......|+||||+.|++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~----gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHAN----NIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999853 34689999999999999999999999 999999999999999999999
Q ss_pred cccccccccccCCCccceeEEEeeecccccccccc------cccceecceeeeeeEEEEeeeCCccccccCCcccchhhh
Q 038949 537 VGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS------GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTE 610 (678)
Q Consensus 537 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~ 610 (678)
|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .
T Consensus 241 l~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~ 312 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------L 312 (365)
T ss_dssp ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------H
T ss_pred EEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH------H
Confidence 99999998664332 2234679999999999863 35889999999999999999999999643210 0
Q ss_pred hhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 611 WARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 611 ~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..... ... ..... .......+..+.+||.+||+.||++||++.++++
T Consensus 313 ~~~~i-~~~----~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 MLRMI-MEG----QYQFS--SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHH-HHT----CCCCC--HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHH-HhC----CCCCC--CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000 000 00000 0001123456899999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=350.80 Aligned_cols=254 Identities=12% Similarity=0.068 Sum_probs=181.7
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc---cCCccccccceeeecc--cccceEEEE-------eEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS---QGDQEFCSEVEVLSCA--QHRNVVMLI-------GFC 459 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L--~HpnIv~l~-------~~~ 459 (678)
...|.+.+.||+|+||.||+|.+ .+++.||+|++..... .....+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 45699999999999999999994 5789999999975432 2234567785555555 599988865 444
Q ss_pred eeC-----------------CeEEEEEEEeecCCcccccccCCCCccCcccc------chhhhhhccchhhhhhcceeee
Q 038949 460 VED-----------------GRRLLVYEYICNGSLDSHLYGRDRDPLEWSAR------RKIAVGAARGLRYLHEECRVGC 516 (678)
Q Consensus 460 ~~~-----------------~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~------~~i~~qI~~aL~yLH~~~~~~g 516 (678)
... ..+|+||||+. |+|.+++.... ..+++..+ ..++.||+.||+|||++ |
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~----~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSK----G 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT----T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHC----C
Confidence 332 33899999997 89999995432 23555556 67889999999999999 9
Q ss_pred EEeccCCCCceEeeecCccccccccccccccCCCccceeEEEeeecccccccccc--cccceecceeeeeeEEEEeeeCC
Q 038949 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS--GQITEKADVYSLGVVLVELITGR 594 (678)
Q Consensus 517 IvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~eLltG~ 594 (678)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+||+|++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999855321 113346799999999987 78999999999999999999999
Q ss_pred ccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 595 KAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 595 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.||....+..... +... ..................+..+.+||.+||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~~---~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS---WKRP-----SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC---CCBC-----CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc---hhhh-----hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9997654321110 0000 000000111111112244568999999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=337.97 Aligned_cols=261 Identities=23% Similarity=0.297 Sum_probs=203.3
Q ss_pred hhhcCCcccceecccCccceeeccC--CCCcEEEEEeeehhccc--CCccccccceeeecc---cccceEEEEeEEe---
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL--PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCA---QHRNVVMLIGFCV--- 460 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~--~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L---~HpnIv~l~~~~~--- 460 (678)
...++|.+.+.||+|+||.||+|.. .+++.||+|+++..... ....+.+|+.+++.+ .||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4568999999999999999999985 46889999998744322 234677888888777 7999999999987
Q ss_pred --eCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccc
Q 038949 461 --EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVG 538 (678)
Q Consensus 461 --~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~ 538 (678)
.....++||||+. |+|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999996 6999999766566699999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHH
Q 038949 539 DFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR 618 (678)
Q Consensus 539 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 618 (678)
|||++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ........
T Consensus 163 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~ 234 (326)
T 1blx_A 163 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD------QLGKILDV 234 (326)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHH
T ss_pred cCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHHH
Confidence 99999755322 12334568999999999999999999999999999999999999997543211 00111110
Q ss_pred h------hhhc-------cc---CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 619 H------AIGE-------LI---DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 619 ~------~~~e-------ll---d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. .... .. .......+....+..+.+||.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0000 00 000011122334567889999999999999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=338.12 Aligned_cols=245 Identities=24% Similarity=0.322 Sum_probs=191.9
Q ss_pred hhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc------cCCccccccceeeecc----cccceEEEE
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS------QGDQEFCSEVEVLSCA----QHRNVVMLI 456 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~------~~~~~~~~Ev~iL~~L----~HpnIv~l~ 456 (678)
..+...++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++..+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3466788999999999999999999984 5789999999864432 2235677899999888 899999999
Q ss_pred eEEeeCCeEEEEEEE-eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee-ecCc
Q 038949 457 GFCVEDGRRLLVYEY-ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT-HDFE 534 (678)
Q Consensus 457 ~~~~~~~~~~LV~E~-~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~-~~~~ 534 (678)
+++...+..++|||+ +.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++ .++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSR----GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH----TEECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChhhEEEeCCCCe
Confidence 999999999999999 789999999954 34589999999999999999999999 999999999999999 8899
Q ss_pred cccccccccccccCCCccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH
Q 038949 535 PLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 535 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~ 613 (678)
++|+|||++....... .....|++.|+|||++.+..+ +.++||||||+++|+|++|+.||....
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------ 243 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------ 243 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------
Confidence 9999999998664432 234568999999999987666 558999999999999999999985321
Q ss_pred HHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 614 PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 614 ~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.... . ...++...+..+.++|.+||+.||++||++.++++
T Consensus 244 ~~~~-----~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 EILE-----A------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHH-----T------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHhh-----h------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0 01122334557899999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=349.32 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=194.1
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCC-----
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG----- 463 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~----- 463 (678)
..++|.+.+.||+|+||.||+|.. .+|+.||||.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 467899999999999999999984 5799999999853321 12246789999999999999999999987653
Q ss_pred -eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 464 -RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 464 -~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 8899998843 4589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH-------H
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR-------P 614 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~-------~ 614 (678)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +..... .
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPAE 248 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHH
Confidence 9865432 233568999999999877 6799999999999999999999999975432111 000000 0
Q ss_pred HHH-------H---hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 LLK-------R---HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 ~~~-------~---~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... . ..........+ .......+..+.+|+.+||+.||.+|||+.++|+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000 0 00000000111 1112234567899999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.25 Aligned_cols=253 Identities=23% Similarity=0.283 Sum_probs=202.4
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc---------CCccccccceeeeccc-ccceEEEEeEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---------GDQEFCSEVEVLSCAQ-HRNVVMLIGFC 459 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---------~~~~~~~Ev~iL~~L~-HpnIv~l~~~~ 459 (678)
...++|.+.+.||+|+||.||+|.. .+++.||+|+++..... ..+.+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 3467999999999999999999995 57899999998754311 1245778999999995 99999999999
Q ss_pred eeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccc
Q 038949 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGD 539 (678)
Q Consensus 460 ~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~D 539 (678)
...+..++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999953 34689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCccceeEEEeeeccccccccc------ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH
Q 038949 540 FGLARWQPDGDMGVETRVLGTFGYLAPEYAQ------SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 540 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~------~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~ 613 (678)
||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|..||..... .....
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~ 239 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLR 239 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHH
Confidence 99997654332 223456899999999985 45688999999999999999999999964321 01111
Q ss_pred HHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 614 PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 614 ~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... ... . ..........+..+.+|+.+||+.||.+||++.++++
T Consensus 240 ~~~-~~~----~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIM-SGN----Y--QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHH-HTC----C--CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHh-cCC----c--ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111 100 0 0011111234557999999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=346.58 Aligned_cols=264 Identities=23% Similarity=0.285 Sum_probs=199.4
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeC-----C
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVED-----G 463 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-----~ 463 (678)
...++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+++++.++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 3457999999999999999999984 57889999998643222 225688999999999999999999998754 4
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
..|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 6899999995 589888843 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCC--ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH-----
Q 038949 544 RWQPDGD--MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL----- 615 (678)
Q Consensus 544 ~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~----- 615 (678)
....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .......
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~i~~~~~~~~~ 253 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL--NHILGILGSPSQ 253 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH--HHHHHHHCSCCH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH--HHHHHHhCCCCH
Confidence 8654321 111234579999999998754 45899999999999999999999999754432111 0000000
Q ss_pred --H-------HHhhhhcccCcc--hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 --L-------KRHAIGELIDPR--LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 --~-------~~~~~~elld~~--l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. ..........+. .........+..+.+||.+||+.||.+|||+.++|+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000000000000 000111234457899999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=350.27 Aligned_cols=205 Identities=24% Similarity=0.354 Sum_probs=156.7
Q ss_pred hhhhcCCcc-cceecccCccceeeccCC---CCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEee--CC
Q 038949 390 ELATNRFSE-ANFLAEGGFGSVHRGVLP---DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE--DG 463 (678)
Q Consensus 390 ~~~~~~y~~-~~~LG~G~fG~Vy~a~~~---~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~ 463 (678)
+...+.|.+ .++||+|+||.||+|.+. +++.||+|++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 344566777 458999999999999843 5789999998633 234578899999999999999999999954 67
Q ss_pred eEEEEEEEeecCCcccccccC-------CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe----eec
Q 038949 464 RRLLVYEYICNGSLDSHLYGR-------DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV----THD 532 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~-------~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl----~~~ 532 (678)
.+|+||||+. |+|.+++... ....+++..++.++.||+.||.|||+. ||+||||||+|||| +.+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECCSSTTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeCCCcCHHHeEEecCCCCC
Confidence 8999999985 5787776321 223489999999999999999999999 99999999999999 677
Q ss_pred CccccccccccccccCCC--ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccC
Q 038949 533 FEPLVGDFGLARWQPDGD--MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNR 601 (678)
Q Consensus 533 ~~vkL~DFGla~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~ 601 (678)
+.+||+|||+++...... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999998654321 123345679999999999987 458999999999999999999999996543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.03 Aligned_cols=269 Identities=22% Similarity=0.319 Sum_probs=204.2
Q ss_pred eehhhhhhhhcCCcccceecccCccceeeccC-CCC-cEEEEEeeehhcccCCccccccceeeecccccc------eEEE
Q 038949 384 FTYAELELATNRFSEANFLAEGGFGSVHRGVL-PDG-QVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN------VVML 455 (678)
Q Consensus 384 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g-~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn------Iv~l 455 (678)
+.....+...++|.+.+.||+|+||.||+|.. .++ +.||+|+++... .....+.+|+.+++.++|++ ++.+
T Consensus 9 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 9 LVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred cccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 33344456678999999999999999999984 344 789999986322 22356788999999998776 9999
Q ss_pred EeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEe------
Q 038949 456 IGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILV------ 529 (678)
Q Consensus 456 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl------ 529 (678)
++++...+..++||||+ +++|.+++......++++..++.++.||+.||.|||++ ||+||||||+|||+
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN----QLTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEESCCCEE
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeccccc
Confidence 99999999999999999 77888877665556799999999999999999999999 99999999999999
Q ss_pred -------------eecCccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCcc
Q 038949 530 -------------THDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKA 596 (678)
Q Consensus 530 -------------~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~P 596 (678)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 238 (355)
T 2eu9_A 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 238 (355)
T ss_dssp EEECCC-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccccccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence 678899999999998643322 234689999999999999999999999999999999999999
Q ss_pred ccccCCcccchhhhhhH-------HHHHHhh---------------------hhcccCcch-hcccchhhhhhhhhccce
Q 038949 597 MDLNRPRGQQCLTEWAR-------PLLKRHA---------------------IGELIDPRL-RNCYSEREVYGMLQCASL 647 (678)
Q Consensus 597 f~~~~~~~~~~l~~~~~-------~~~~~~~---------------------~~elld~~l-~~~~~~~~~~~l~~LI~~ 647 (678)
|........ +..... .+..... ..+...+.. ...........+.+||.+
T Consensus 239 f~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 316 (355)
T 2eu9_A 239 FQTHENREH--LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR 316 (355)
T ss_dssp CCCSSHHHH--HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred CCCCCHHHH--HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH
Confidence 975432110 000000 0000000 000000000 001112334578899999
Q ss_pred eeccCCCCCchHHHHHH
Q 038949 648 CIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 648 cL~~dP~~RPT~~eVL~ 664 (678)
||+.||++|||+.++++
T Consensus 317 ~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 317 MLEFDPAQRITLAEALL 333 (355)
T ss_dssp HTCSSTTTSCCHHHHTT
T ss_pred HhcCChhhCcCHHHHhc
Confidence 99999999999999973
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=339.11 Aligned_cols=264 Identities=23% Similarity=0.312 Sum_probs=193.2
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEe---------
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV--------- 460 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~--------- 460 (678)
...++|.+.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 3467999999999999999999995 468999999987655445567889999999999999999999873
Q ss_pred -----eCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee-ecCc
Q 038949 461 -----EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT-HDFE 534 (678)
Q Consensus 461 -----~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~-~~~~ 534 (678)
+....|+||||+. |+|.+++. ..++++..++.++.||+.||.|||+. ||+||||||+|||++ .++.
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTTE
T ss_pred cccccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCe
Confidence 3467899999996 69999883 34688999999999999999999999 999999999999998 5679
Q ss_pred cccccccccccccCCC--ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhh
Q 038949 535 PLVGDFGLARWQPDGD--MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEW 611 (678)
Q Consensus 535 vkL~DFGla~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~ 611 (678)
+||+|||+++...... ........+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ +...
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~ 237 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLI 237 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHH
Confidence 9999999998653211 111122346889999998865 6789999999999999999999999975432110 0000
Q ss_pred hHHH-----HHHhhhhcccC---------cc-hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 612 ARPL-----LKRHAIGELID---------PR-LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 612 ~~~~-----~~~~~~~elld---------~~-l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.... .....+...+. +. .........+..+.+||.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000 00000000000 00 000112234567999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=370.97 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=207.5
Q ss_pred hhhhhhhcCCcccceecccCccceeeccCC----CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEee
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVLP----DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~ 461 (678)
..++...++|.+.+.||+|+||.||+|.+. .+..||+|.++.... ...+.+.+|+.+++.++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 345666789999999999999999999842 356799998864322 22357889999999999999999999985
Q ss_pred CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
++..|+||||+.+|+|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchHhEEEeCCCCEEEEecC
Confidence 46789999999999999999543 34588999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhh
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
+++..............+|+.|+|||++.+..++.++||||||+++|||++ |..||...... +..... ...
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------~~~~~i-~~~- 608 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRI-ENG- 608 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHH-HHT-
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHH-HcC-
Confidence 998765443333344567889999999999999999999999999999997 99998643321 111110 000
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.....+..++..+.+||.+||+.||.+||++.++++.|+..+.
T Consensus 609 --------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 609 --------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 0111334455689999999999999999999999999987653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=341.87 Aligned_cols=262 Identities=21% Similarity=0.258 Sum_probs=190.3
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCC-----
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG----- 463 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~----- 463 (678)
..++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 457899999999999999999984 5789999999864321 22346789999999999999999999997654
Q ss_pred -eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 464 -RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 464 -~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
..|+||||+. |+|.+++. ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999996 57877773 2488899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchh---------hhhh-
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCL---------TEWA- 612 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l---------~~~~- 612 (678)
++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... ..+.
T Consensus 174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9755322 223456799999999999999999999999999999999999999965432110000 0000
Q ss_pred ------HHHHHHh-h-----hhcccCcchh---cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 613 ------RPLLKRH-A-----IGELIDPRLR---NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 613 ------~~~~~~~-~-----~~elld~~l~---~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....... . .......... .......+..+.+||.+||+.||.+|||++++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000000 0 0000000000 0011223567899999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=348.40 Aligned_cols=259 Identities=25% Similarity=0.308 Sum_probs=182.9
Q ss_pred hhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeC-----
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVED----- 462 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~----- 462 (678)
...++|.+.+.||+|+||.||+|. ..+|+.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 345899999999999999999998 46799999999864321 2235678999999999999999999998654
Q ss_pred -CeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 463 -GRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 463 -~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
...|+|||++ +++|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999998 7899998843 4699999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH-----
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL----- 615 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~----- 615 (678)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +.......
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~ 251 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGA 251 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCH
T ss_pred cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCH
Confidence 99864322 345679999999999876 6789999999999999999999999965432111 00000000
Q ss_pred --HH------HhhhhcccC----cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 --LK------RHAIGELID----PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 --~~------~~~~~elld----~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.. ...+...+. ..+. ......+..+.+||.+||+.||.+|||+.++|+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHH-HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHH-HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00 000000000 0000 011123456889999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=330.72 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=192.4
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEee---------
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE--------- 461 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--------- 461 (678)
..++|++.+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356899999999999999999994 579999999986422 233578899999999999999999998865
Q ss_pred ----CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccc
Q 038949 462 ----DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLV 537 (678)
Q Consensus 462 ----~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL 537 (678)
....|+||||+.+|+|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.++|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQ----GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhC----CeecccCCHHhEEEcCCCCEEE
Confidence 45689999999999999999543 34577888999999999999999999 9999999999999999999999
Q ss_pred ccccccccccCCC-------------ccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCc
Q 038949 538 GDFGLARWQPDGD-------------MGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPR 603 (678)
Q Consensus 538 ~DFGla~~~~~~~-------------~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~ 603 (678)
+|||++....... ........|++.|+|||++.+. .++.++||||||+++|+|++ ||.....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~- 233 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME- 233 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-
Confidence 9999997553211 1223345789999999999764 78999999999999999998 4421100
Q ss_pred ccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 604 GQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 604 ~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.... ... +.. ....+...++...+..+.++|.+||+.||.+|||+.++++
T Consensus 234 ----~~~~----~~~--~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 ----RVNI----LKK--LRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ----HHHH----HHH--HHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHHH----HHh--ccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0000 000 000 1112222344445567899999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=347.63 Aligned_cols=262 Identities=21% Similarity=0.281 Sum_probs=195.1
Q ss_pred hhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCC------e
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG------R 464 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~------~ 464 (678)
....+|.+.+.||+|+||.||+|.+..+..+|+|.+... .....+|+.+++.++||||++++++|...+ .
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecC----cchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 345689999999999999999999766667999987532 234457999999999999999999986543 3
Q ss_pred EEEEEEEeecCCcccccc-cCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee-ecCccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLY-GRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT-HDFEPLVGDFGL 542 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~-~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~-~~~~vkL~DFGl 542 (678)
+++||||+.++.+..... ......+++..++.++.||+.||.|||+. ||+||||||+|||++ .++.+||+|||+
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI----GICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 889999997654333221 12345689999999999999999999999 999999999999999 799999999999
Q ss_pred cccccCCCccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHH-------
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP------- 614 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~------- 614 (678)
++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .+......
T Consensus 189 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 189 AKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPSRE 264 (394)
T ss_dssp CEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHH
T ss_pred cccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 986543322 2335689999999998764 58999999999999999999999997543211 11111100
Q ss_pred HHHH--hhhh-----cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 LLKR--HAIG-----ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 ~~~~--~~~~-----elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+.. .... ......+...++...+..+.+||.+||+.||.+|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000 0000 000111111223335568999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.81 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=201.3
Q ss_pred hhhhhhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhccc------CCccccccceeeeccc--ccceEEEE
Q 038949 386 YAELELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQ------GDQEFCSEVEVLSCAQ--HRNVVMLI 456 (678)
Q Consensus 386 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~------~~~~~~~Ev~iL~~L~--HpnIv~l~ 456 (678)
..+.+...++|++.+.||+|+||.||+|. ..+++.||||++...... ....+.+|+.+++.+. ||||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 34456678899999999999999999998 457899999999755432 2356888999999996 59999999
Q ss_pred eEEeeCCeEEEEEEEeec-CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee-ecCc
Q 038949 457 GFCVEDGRRLLVYEYICN-GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT-HDFE 534 (678)
Q Consensus 457 ~~~~~~~~~~LV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~-~~~~ 534 (678)
+++...+..++|||++.+ ++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++ .++.
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTE
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcEeCCCCHHHEEEeCCCCC
Confidence 999999999999999975 899998844 35689999999999999999999999 999999999999999 7899
Q ss_pred cccccccccccccCCCccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH
Q 038949 535 PLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 535 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~ 613 (678)
+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 189 ~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------- 254 (320)
T 3a99_A 189 LKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------- 254 (320)
T ss_dssp EEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred EEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----------
Confidence 9999999998654332 233568999999999987766 7889999999999999999999853210
Q ss_pred HHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 614 PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 614 ~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... .. ..++...+..+.+||.+||+.||.+||++.++++
T Consensus 255 -~~~----~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 -IIR----GQ-------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -HHH----CC-------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hhc----cc-------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00 0112234457899999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=347.81 Aligned_cols=259 Identities=23% Similarity=0.300 Sum_probs=193.7
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeC------CeE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED------GRR 465 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~------~~~ 465 (678)
..+|.+.+.||+|+||.||+|.+ .+++.||||++... ...+.+|+++|+.++||||++++++|... ..+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 34799999999999999999995 57999999988632 23456799999999999999999988542 236
Q ss_pred EEEEEEeecCCccccccc--CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec-Cccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD-FEPLVGDFGL 542 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~-~~vkL~DFGl 542 (678)
++||||+.+ +|.+.+.. .....+++..++.++.||+.||.|||++ ||+||||||+||||+.+ +.+||+|||+
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChhhEEEeCCCCeEEeccchh
Confidence 799999965 56555522 2345689999999999999999999999 99999999999999965 6789999999
Q ss_pred cccccCCCccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHH-------
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP------- 614 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~------- 614 (678)
++....... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||....... .+..+...
T Consensus 204 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 204 AKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTRE 279 (420)
T ss_dssp CEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHH
T ss_pred hhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 986543322 2345789999999998764 78999999999999999999999997543211 11111110
Q ss_pred HHHH--hhhhcccCcch-----hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 LLKR--HAIGELIDPRL-----RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 ~~~~--~~~~elld~~l-----~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+.. ....+...+.+ ...++...+..+.+||.+||+.||.+||++.|+++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000 00000000110 11122334567999999999999999999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=338.33 Aligned_cols=268 Identities=19% Similarity=0.283 Sum_probs=201.1
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeeccc-----------ccceEEEEeEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-----------HRNVVMLIGFC 459 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-----------HpnIv~l~~~~ 459 (678)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+|+.+++.+. ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 457899999999999999999984 578999999986322 22346778888888876 89999999998
Q ss_pred eeCC----eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec---
Q 038949 460 VEDG----RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD--- 532 (678)
Q Consensus 460 ~~~~----~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~--- 532 (678)
...+ .+++||||+ +++|.+++.......+++..++.++.||+.||.|||+++ ||+||||||+|||++.+
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChHHeEEeccCCC
Confidence 8654 789999999 999999997666667999999999999999999999953 89999999999999644
Q ss_pred ---CccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhh
Q 038949 533 ---FEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT 609 (678)
Q Consensus 533 ---~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~ 609 (678)
+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 47999999999765432 12346899999999999999999999999999999999999999754321110000
Q ss_pred hhhHHHHH-----------Hhhh-hcccC-----------------c--chhcccchhhhhhhhhccceeeccCCCCCch
Q 038949 610 EWARPLLK-----------RHAI-GELID-----------------P--RLRNCYSEREVYGMLQCASLCIRKDPHSRPR 658 (678)
Q Consensus 610 ~~~~~~~~-----------~~~~-~elld-----------------~--~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT 658 (678)
........ .... ..... . .....++...+..+.+||.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 00000000 0000 00000 0 0011234566778999999999999999999
Q ss_pred HHHHHH--Hhhc
Q 038949 659 MSQVLR--MLEG 668 (678)
Q Consensus 659 ~~eVL~--~Le~ 668 (678)
+.|+++ ++.+
T Consensus 328 ~~ell~hp~f~~ 339 (373)
T 1q8y_A 328 AGGLVNHPWLKD 339 (373)
T ss_dssp HHHHHTCGGGTT
T ss_pred HHHHhhChhhhc
Confidence 999986 4444
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=339.55 Aligned_cols=267 Identities=22% Similarity=0.288 Sum_probs=187.3
Q ss_pred hhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCe--
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR-- 464 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~-- 464 (678)
......++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.++++.+..++||||++++++|...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 3456678999999999999999999995 578999999886432 333456677777888899999999999876443
Q ss_pred -----EEEEEEEeecCCccccccc--CCCCccCccccchhhhhhccchhhhh--hcceeeeEEeccCCCCceEeee-cCc
Q 038949 465 -----RLLVYEYICNGSLDSHLYG--RDRDPLEWSARRKIAVGAARGLRYLH--EECRVGCIVHRDMRPNNILVTH-DFE 534 (678)
Q Consensus 465 -----~~LV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qI~~aL~yLH--~~~~~~gIvHrDLKp~NILl~~-~~~ 534 (678)
.++||||+.+ +|...+.. .....+++..++.++.|++.||.||| +. ||+||||||+|||++. ++.
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~----~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV----NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT----CCBCSCCCGGGEEEETTTTE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC----CeecCcCCHHHEEEeCCCCc
Confidence 8899999965 55444321 34556888899999999999999999 87 9999999999999997 899
Q ss_pred cccccccccccccCCCccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH
Q 038949 535 PLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 535 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~ 613 (678)
+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||........ +..+..
T Consensus 171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~ 246 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVR 246 (360)
T ss_dssp EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH
T ss_pred EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHH
Confidence 9999999998654332 22334689999999998654 489999999999999999999999975432111 111110
Q ss_pred H-------HHHHhh----hhcccC------cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 614 P-------LLKRHA----IGELID------PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 614 ~-------~~~~~~----~~elld------~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. .+.... .....+ ...........+..+.+||.+||+.||.+|||+.|+|+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000000 000000 00001112224567999999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=336.64 Aligned_cols=257 Identities=22% Similarity=0.277 Sum_probs=176.8
Q ss_pred hhhcCCcccc-eecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccce-eeecccccceEEEEeEEee----CC
Q 038949 391 LATNRFSEAN-FLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVE-VLSCAQHRNVVMLIGFCVE----DG 463 (678)
Q Consensus 391 ~~~~~y~~~~-~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~-iL~~L~HpnIv~l~~~~~~----~~ 463 (678)
...++|.+.+ .||+|+||.||+|.. .+++.||||++.... ...+|+. .++.+.||||+++++++.. ..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 3567899955 699999999999985 479999999986321 2222333 3456689999999999876 45
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee---cCccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH---DFEPLVGDF 540 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~---~~~vkL~DF 540 (678)
..++||||+.+|+|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~----~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH----NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 689999999999999999776666799999999999999999999999 9999999999999986 455999999
Q ss_pred cccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
|++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ..... ....
T Consensus 176 g~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~----~~~~ 246 (336)
T 3fhr_A 176 GFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI--SPGMK----RRIR 246 (336)
T ss_dssp TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred ccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh--hhhHH----Hhhh
Confidence 999755332 23345789999999999999999999999999999999999999965432110 00000 0000
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH--Hhhc
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR--MLEG 668 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~--~Le~ 668 (678)
... ..+........+..+.+||.+||+.||.+|||+.++++ ++..
T Consensus 247 ~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 247 LGQ---YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ccc---cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 000 00111111234557899999999999999999999997 4443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=340.06 Aligned_cols=207 Identities=23% Similarity=0.254 Sum_probs=174.1
Q ss_pred ehhhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeeccc-cc-----ceEEEEe
Q 038949 385 TYAELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-HR-----NVVMLIG 457 (678)
Q Consensus 385 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-Hp-----nIv~l~~ 457 (678)
.....+...++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+..|+.+++.+. |+ +|+++++
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 3444566678999999999999999999984 578899999986322 22345667888887774 44 5999999
Q ss_pred EEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhh--cceeeeEEeccCCCCceEee--ecC
Q 038949 458 FCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE--ECRVGCIVHRDMRPNNILVT--HDF 533 (678)
Q Consensus 458 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~--~~~~~gIvHrDLKp~NILl~--~~~ 533 (678)
++...+..|+||||+ +|+|.+++.......+++..++.++.|++.||.|||. . ||+||||||+|||++ .++
T Consensus 124 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~----~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 124 HFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL----SIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTT----CEECCCCSGGGEEESSTTSC
T ss_pred eeccCCceEEEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCC----CEEcCCCCcccEEEecCCCC
Confidence 999999999999999 4699999976655679999999999999999999994 5 899999999999995 478
Q ss_pred ccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccC
Q 038949 534 EPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNR 601 (678)
Q Consensus 534 ~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~ 601 (678)
.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 199 ~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8999999999865432 123568999999999999999999999999999999999999997543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=337.46 Aligned_cols=263 Identities=22% Similarity=0.293 Sum_probs=197.5
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeC-----C
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVED-----G 463 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~-----~ 463 (678)
...++|.+.+.||+|+||.||+|.+ .+|+.||||.+..... .....+.+|+.+++.++||||+++++++... .
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 3467999999999999999999995 4789999999863322 1224677899999999999999999987754 6
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
..|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS----NVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 7899999995 689888843 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCcc---------ceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH
Q 038949 544 RWQPDGDMG---------VETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613 (678)
Q Consensus 544 ~~~~~~~~~---------~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~ 613 (678)
......... ......||+.|+|||++.. ..++.++|||||||++|+|++|..||........ +.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~ 237 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ--LLLIFG 237 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHH
Confidence 865432111 1122468999999998764 6789999999999999999999999975432110 000000
Q ss_pred ----------------HHHHH--hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 614 ----------------PLLKR--HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 614 ----------------~~~~~--~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..... ..........+ .......+..+.+||.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcch-hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 00000000000 0111234557889999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=327.89 Aligned_cols=254 Identities=24% Similarity=0.292 Sum_probs=202.4
Q ss_pred hhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
.....++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 355678999999999999999999985 47899999998754332 235688999999999999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec---Cccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD---FEPLVGDFGL 542 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~---~~vkL~DFGl 542 (678)
++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.+ +.+||+|||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 999999999999988843 34589999999999999999999999 99999999999999764 4799999999
Q ss_pred cccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
+....... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||..... ....... ....
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~-~~~~-- 238 (287)
T 2wei_A 171 STCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRV-ETGK-- 238 (287)
T ss_dssp GGTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-HHCC--
T ss_pred ceeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH------HHHHHHH-HcCC--
Confidence 98654332 1223458899999999875 589999999999999999999999964321 1111111 1100
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... ........+..+.++|.+||+.||.+|||+.++++
T Consensus 239 --~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 239 --YAF--DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp --CCC--CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCC--CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 00011234457899999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=333.46 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=180.6
Q ss_pred hhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccce-eeecccccceEEEEeEEeeCCeE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVE-VLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~-iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
+....++|.+.+.||+|+||.||+|.. .+++.||||+++.... .....+..|+. +++.++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 355668999999999999999999995 5799999999874322 12234555555 67778999999999999999999
Q ss_pred EEEEEEeecCCccccccc---CCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYG---RDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~---~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
++||||+.+ +|.+++.. .....+++..++.++.|++.||.|||+.. ||+||||||+|||++.++.+||+|||+
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL---KIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH---SCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC---CEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 999999965 77776632 23556899999999999999999999853 899999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeecccccccc----cccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHH
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYA----QSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR 618 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l----~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 618 (678)
++...... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||........ ..
T Consensus 173 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----------~~ 239 (327)
T 3aln_A 173 SGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----------QL 239 (327)
T ss_dssp SCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------
T ss_pred ceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----------HH
Confidence 97654322 22334689999999998 456789999999999999999999999964321100 00
Q ss_pred hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 619 ~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+.....+.+........+..+.+||.+||+.||.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0001111111222222334567999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=341.69 Aligned_cols=258 Identities=23% Similarity=0.304 Sum_probs=194.4
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeE---
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR--- 465 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~--- 465 (678)
..++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 457999999999999999999984 57999999998643222 135688999999999999999999999876654
Q ss_pred ---EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 466 ---LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 466 ---~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
|+||||+. ++|.+++. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999995 68877772 3489999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH------
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL------ 615 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~------ 615 (678)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ +.......
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTE 264 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHH
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCcHH
Confidence 9754322 223457999999999887 6889999999999999999999999975432110 00000000
Q ss_pred -HH------HhhhhcccCcchh---cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 -LK------RHAIGELIDPRLR---NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 -~~------~~~~~elld~~l~---~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.. .......+..... .......+..+.+||.+||+.||.+|||+.++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00 0000000000000 0112234567899999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=341.82 Aligned_cols=253 Identities=24% Similarity=0.306 Sum_probs=187.3
Q ss_pred hhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEeeCCeEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
..+.|...+.||+|+||.||.+...+|+.||||++.... ...+.+|+.+++.+ +||||+++++++.+++..|+|||
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 345667788999999999987665579999999986432 24577899999876 89999999999999999999999
Q ss_pred EeecCCcccccccCCCCc-----cCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec-------------
Q 038949 471 YICNGSLDSHLYGRDRDP-----LEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD------------- 532 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~-----l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~------------- 532 (678)
|+ +|+|.+++....... .++..++.++.||+.||.|||+. ||+||||||+|||++.+
T Consensus 90 ~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 90 LC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL----KIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred cC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCcccccccccCCCc
Confidence 99 569999995443211 23445678999999999999999 99999999999999764
Q ss_pred CccccccccccccccCCCcc---ceeEEEeeecccccccccc-------cccceecceeeeeeEEEEeee-CCccccccC
Q 038949 533 FEPLVGDFGLARWQPDGDMG---VETRVLGTFGYLAPEYAQS-------GQITEKADVYSLGVVLVELIT-GRKAMDLNR 601 (678)
Q Consensus 533 ~~vkL~DFGla~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~ 601 (678)
+.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 48999999999866443211 2234579999999999975 678999999999999999999 999996432
Q ss_pred CcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 602 PRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 602 ~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... ...... ....+..........+..+.+||.+||+.||.+|||+.++++
T Consensus 245 ~~~--------~~i~~~----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SRE--------SNIIRG----IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp THH--------HHHHHT----CCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhH--------HHHhcC----CCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 211 001110 000111111223345668999999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.22 Aligned_cols=258 Identities=23% Similarity=0.306 Sum_probs=194.9
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCe----
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR---- 464 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~---- 464 (678)
..++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 357899999999999999999984 57999999998643221 12467889999999999999999999987654
Q ss_pred --EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 465 --RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 465 --~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999995 68888773 2489999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHH-------
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP------- 614 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~------- 614 (678)
++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||........ +......
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTE 246 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCHH
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence 9754322 234578999999999876 6789999999999999999999999975432110 0000000
Q ss_pred HHH------HhhhhcccCcchh---cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 LLK------RHAIGELIDPRLR---NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 ~~~------~~~~~elld~~l~---~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... .......+..... .......+..+.+||.+||+.||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0000000000000 1112344567999999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=340.31 Aligned_cols=253 Identities=25% Similarity=0.295 Sum_probs=188.2
Q ss_pred hhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEeeCCeEEE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~L 467 (678)
+.....+|.+.+.||+|+||.||.....+++.||||++... ....+.+|+.+|+.+ +||||+++++++.+....|+
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 34455679999999999999966544457899999998642 234577899999998 79999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee---c--Cccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH---D--FEPLVGDFGL 542 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~---~--~~vkL~DFGl 542 (678)
||||+. |+|.+++.... ..+.+..++.++.||+.||.|||+. ||+||||||+|||++. + ..++|+|||+
T Consensus 96 v~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSL----NIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHT----TCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHC----cCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 999995 69999986543 3356667789999999999999999 9999999999999953 3 3567999999
Q ss_pred cccccCCCc--cceeEEEeeeccccccccc---ccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHH
Q 038949 543 ARWQPDGDM--GVETRVLGTFGYLAPEYAQ---SGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLL 616 (678)
Q Consensus 543 a~~~~~~~~--~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~ 616 (678)
++....... .......||+.|+|||++. ...++.++|||||||++|+|++ |..||....... ...
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~-- 240 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANI-- 240 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHH--
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHH--
Confidence 986543321 2234457999999999997 4567889999999999999999 899985432110 000
Q ss_pred HHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 617 KRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 617 ~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.......... .........+.+||.+||+.||.+|||+.++++
T Consensus 241 ---~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 241 ---LLGACSLDCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ---HTTCCCCTTS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---HhccCCcccc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0000000000 011223445789999999999999999999983
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=358.95 Aligned_cols=243 Identities=21% Similarity=0.285 Sum_probs=193.5
Q ss_pred hhhhhcCCcccceecccCccceeeccCC--CCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeCCe-
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLP--DGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR- 464 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~- 464 (678)
.+...++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 3456789999999999999999999853 68999999886332 1223468899999999999999999999987665
Q ss_pred ----EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 465 ----RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 465 ----~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
.||||||+.|++|.+++.. .+++..++.++.||+.||.|||++ ||+||||||+|||++.+ .+||+||
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~----giiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI----GLVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSS-CEEECCC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC----CCeecccChHHeEEeCC-cEEEEec
Confidence 7999999999999988732 689999999999999999999999 99999999999999885 9999999
Q ss_pred cccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
|+++..... ....||+.|+|||++.++. +.++|||||||++|+|++|..||........
T Consensus 226 G~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------- 284 (681)
T 2pzi_A 226 GAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------- 284 (681)
T ss_dssp TTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------
T ss_pred ccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc---------------
Confidence 999865432 3456899999999987654 8899999999999999999988853211100
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCch-HHHHHHHhhcc
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR-MSQVLRMLEGD 669 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT-~~eVL~~Le~~ 669 (678)
.. ..........+.+||.+||+.||.+||+ ++++.+.|.+.
T Consensus 285 ----~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 ----PE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ----CT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----cc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00 0001122346889999999999999995 56666666543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=322.60 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=180.5
Q ss_pred hhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC--CccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~--~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
+....++|.+.+.||+|+||.||+|.+ .+++.||||++....... ...+.++..+++.++||||+++++++.+.+..
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 345567899999999999999999995 478999999987443221 12344445567778999999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhh-cceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
++||||+ ++.+..+. ......+++..++.++.|++.||.|||+ . ||+||||||+|||++.++.++|+|||++.
T Consensus 100 ~lv~e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLKEKH----GVIHRDVKPSNILLDERGQIKLCDFGISG 173 (318)
T ss_dssp EEEECCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHHHH----CCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred EEEEecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHhhC----CEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence 9999998 44444443 3334568999999999999999999998 5 89999999999999999999999999997
Q ss_pred cccCCCccceeEEEeeeccccccccc-----ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHh
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQ-----SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH 619 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 619 (678)
...... ......|++.|+|||++. ...++.++||||||+++|+|++|..||...... ..........
T Consensus 174 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~- 245 (318)
T 2dyl_A 174 RLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQE- 245 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHS-
T ss_pred hccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhcc-
Confidence 554322 233457899999999984 456888999999999999999999999643221 0111111110
Q ss_pred hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 ~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+.+. .....+..+.+||.+||+.||.+||++.++++
T Consensus 246 -----~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 246 -----EPPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -----CCCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----CCCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011111 01123457899999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.39 Aligned_cols=235 Identities=15% Similarity=0.100 Sum_probs=185.1
Q ss_pred hhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC---CccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG---DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~---~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
...++|++.+.||+|+||.||+|.+ .+++.||||++....... ...+.+|+.++..++||||+++++++.+++..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 5668999999999999999999995 468999999997543322 257889999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+.|++|.+++.. + .....+..++.||+.||.|||++ ||+||||||+|||++.+|.++|+++|
T Consensus 108 lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~----givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRA----GVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHC----CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 99999999999999832 2 34446788999999999999999 99999999999999999999998543
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
|++ .++.++|||||||++|+|+||+.||............. ..... .
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~--~ 221 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------RDTAG--Q 221 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC--------BCTTS--C
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH--------HHhcc--C
Confidence 333 36889999999999999999999997654322100000 00000 0
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
+..........+..+.+||.+||+.||++| |+.++++.|+.....
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 000011223345578999999999999999 999999999875543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=321.00 Aligned_cols=244 Identities=15% Similarity=0.144 Sum_probs=186.9
Q ss_pred hhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhccc--------CCccccccceeeeccc---------ccceE
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ--------GDQEFCSEVEVLSCAQ---------HRNVV 453 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~--------~~~~~~~Ev~iL~~L~---------HpnIv 453 (678)
...++|++.+.||+|+||.||+|++ +|+.||||++...... ..+.+.+|+.+++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 4467899999999999999999998 6899999999754321 1156788999988886 77777
Q ss_pred EEEeEEe-----------------e-------------CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhcc
Q 038949 454 MLIGFCV-----------------E-------------DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAAR 503 (678)
Q Consensus 454 ~l~~~~~-----------------~-------------~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~ 503 (678)
++.+++. + .+.+|+||||+.+|++.+.+.. ..+++..++.++.||+.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA 172 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence 7766542 2 6789999999999987777732 45899999999999999
Q ss_pred chhhhh-hcceeeeEEeccCCCCceEeeecC--------------------ccccccccccccccCCCccceeEEEeeec
Q 038949 504 GLRYLH-EECRVGCIVHRDMRPNNILVTHDF--------------------EPLVGDFGLARWQPDGDMGVETRVLGTFG 562 (678)
Q Consensus 504 aL~yLH-~~~~~~gIvHrDLKp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~Gt~~ 562 (678)
||.||| +. ||+||||||+||||+.++ .+||+|||+++..... ..+||+.
T Consensus 173 aL~~lH~~~----~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEASL----RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHH----CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHhC----CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 999999 88 999999999999999987 9999999999866432 4579999
Q ss_pred ccccccccccccceecceeeeeeE-EEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhh
Q 038949 563 YLAPEYAQSGQITEKADVYSLGVV-LVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGM 641 (678)
Q Consensus 563 Y~APE~l~~~~~s~ksDVwSLGvi-L~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l 641 (678)
|+|||++.+.. +.++||||||++ .+++++|..||... .|.........-................+..+
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHhhhhhhccCcccchhhhhhcCHHH
Confidence 99999998666 889999998776 78889999998421 11111111100000111111122334567789
Q ss_pred hhccceeeccCCCCCchHHHHH
Q 038949 642 LQCASLCIRKDPHSRPRMSQVL 663 (678)
Q Consensus 642 ~~LI~~cL~~dP~~RPT~~eVL 663 (678)
.+||.+||+.| |+.|+|
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999977 898888
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=350.65 Aligned_cols=259 Identities=25% Similarity=0.346 Sum_probs=196.8
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEee------CCe
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE------DGR 464 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~------~~~ 464 (678)
.++|.+.+.||+|+||.||+|.+ .+|+.||||+++... ......+.+|+.+++.++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999995 578999999986432 2223568899999999999999999998765 677
Q ss_pred EEEEEEEeecCCcccccccCC-CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCc---cccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRD-RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFE---PLVGDF 540 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~---vkL~DF 540 (678)
.|+||||+.||+|.+++.... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++. ++|+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~----gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN----RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT----TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999996533 33689999999999999999999999 9999999999999997765 899999
Q ss_pred cccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...|.........
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSN 241 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC----
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccc
Confidence 9998664432 22345789999999999999999999999999999999999999964321 1111111000000
Q ss_pred ----hhcccCc--------chhcccchhhhhhhhhccceeeccCCCCCchHHHH
Q 038949 621 ----IGELIDP--------RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQV 662 (678)
Q Consensus 621 ----~~elld~--------~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eV 662 (678)
....... ..........+..+.++|.+||..||++|||+.++
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000000 01122344566789999999999999999999774
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=309.45 Aligned_cols=230 Identities=20% Similarity=0.238 Sum_probs=180.8
Q ss_pred hhcCCccc-ceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceee-ecccccceEEEEeEEee----CCe
Q 038949 392 ATNRFSEA-NFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVL-SCAQHRNVVMLIGFCVE----DGR 464 (678)
Q Consensus 392 ~~~~y~~~-~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL-~~L~HpnIv~l~~~~~~----~~~ 464 (678)
..++|.+. +.||+|+||.||+|.. .+++.||+|+++. ...+.+|+.++ +.++||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 34667776 7899999999999984 5789999999863 34577888887 55589999999999887 678
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee---cCcccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH---DFEPLVGDFG 541 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~---~~~vkL~DFG 541 (678)
.++||||+.+|+|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.++|+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 99999999999999999776666799999999999999999999999 9999999999999998 7899999999
Q ss_pred ccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
++.... +..++.++|||||||++|+|++|..||......... ....
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~ 211 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMK 211 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHH
Confidence 986432 245788999999999999999999999643321100 0000
Q ss_pred hcccCc--chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 622 GELIDP--RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 622 ~elld~--~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+... ..........+..+.+||.+||+.||.+|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 0000011234557899999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=330.92 Aligned_cols=243 Identities=15% Similarity=0.146 Sum_probs=180.5
Q ss_pred hhhhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhccc---CCccccccceeeecccc-cc-------------
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCAQH-RN------------- 451 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L~H-pn------------- 451 (678)
......|...+.||+|+||.||+|. ..+|+.||||++...... ..+.+.+|+.+++.++| +|
T Consensus 74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 3344568888999999999999999 567999999998733222 24668889988888876 21
Q ss_pred --------eEEEEeEEee-----CCeEEEEEEEeecCCcccccc-----cCCCCccCccccchhhhhhccchhhhhhcce
Q 038949 452 --------VVMLIGFCVE-----DGRRLLVYEYICNGSLDSHLY-----GRDRDPLEWSARRKIAVGAARGLRYLHEECR 513 (678)
Q Consensus 452 --------Iv~l~~~~~~-----~~~~~LV~E~~~ggsL~~~l~-----~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~ 513 (678)
...++.++.. ...++++|+++ +++|.+++. ......+++..++.++.||+.||.|||++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 230 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-- 230 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 1112222222 22467777765 789998883 23355688889999999999999999999
Q ss_pred eeeEEeccCCCCceEeeecCccccccccccccccCCCccceeEEEeeecccccccc----------cccccceecceeee
Q 038949 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYA----------QSGQITEKADVYSL 583 (678)
Q Consensus 514 ~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l----------~~~~~s~ksDVwSL 583 (678)
||+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||
T Consensus 231 --~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 231 --GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp --TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred --CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999999999999999999999998754322 334567 999999999 55668899999999
Q ss_pred eeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHH
Q 038949 584 GVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663 (678)
Q Consensus 584 GviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL 663 (678)
||++|+|++|+.||........ ....+.. ....+..+.+||.+||+.||++||++.+++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~-------------------~~~~~~~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGG-------------------SEWIFRS--CKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSC-------------------SGGGGSS--CCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHHHHCCCCCCCcchhhh-------------------HHHHHhh--cccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999999964332110 0000110 012345799999999999999999977764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-29 Score=287.57 Aligned_cols=186 Identities=18% Similarity=0.117 Sum_probs=131.8
Q ss_pred eecccCccceeecc-CCCCcEEEEEeeehhcc----------cCCccccccceeeecc-cccceEEEEeEEeeCCeEEEE
Q 038949 401 FLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS----------QGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 401 ~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~----------~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~LV 468 (678)
.++.|++|.+..++ .-.|+.||+|.+..... ...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666655 33588899999864321 1124699999999999 699999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||++|++|.++|.. .++++. ..|+.||+.||.|||++ |||||||||+||||+.+|.+||+|||+++....
T Consensus 321 MEyv~G~~L~d~i~~--~~~l~~---~~I~~QIl~AL~ylH~~----GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA--GEEIDR---EKILGSLLRSLAALEKQ----GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT--TCCCCH---HHHHHHHHHHHHHHHHT----TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh--CCCCCH---HHHHHHHHHHHHHHHHC----CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999943 445654 35899999999999999 999999999999999999999999999986543
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAM 597 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf 597 (678)
.. ......+||+.|+|||++.+ .+..++|+|++|+++++|.++..++
T Consensus 392 ~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 22 22344679999999999875 5677899999999999999987765
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-25 Score=255.73 Aligned_cols=180 Identities=16% Similarity=0.162 Sum_probs=135.2
Q ss_pred CCcccceecccCccceeeccCCCCcEEEEEeeehhccc--------CCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ--------GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~--------~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
.+...+.||+|+||.||+|.. .++.+++|........ ..+.+.+|++++++++||||+++..++...+..|
T Consensus 337 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 337 RKIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp -----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred cCCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence 335567899999999999965 5778899976432111 1234789999999999999995555555677789
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
|||||++|++|.+++.. +..++.|++.||.|||++ ||+||||||+|||++. .+||+|||+++..
T Consensus 416 lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~----gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN----DVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT----TEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC----cCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 99999999999999943 678999999999999999 9999999999999998 9999999999876
Q ss_pred cCCCcc------ceeEEEeeecccccccccc--cccceecceeeeeeEEEEee
Q 038949 547 PDGDMG------VETRVLGTFGYLAPEYAQS--GQITEKADVYSLGVVLVELI 591 (678)
Q Consensus 547 ~~~~~~------~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~eLl 591 (678)
...... ......||+.|+|||++.. ..|+..+|+|+..+-..+-+
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v 532 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDV 532 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHH
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHH
Confidence 432211 1235679999999999987 67888899998655444333
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-22 Score=212.13 Aligned_cols=149 Identities=15% Similarity=0.026 Sum_probs=119.2
Q ss_pred hhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhccc------------------CCccccccceeeecccccce
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQ------------------GDQEFCSEVEVLSCAQHRNV 452 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~------------------~~~~~~~Ev~iL~~L~HpnI 452 (678)
.....|.+.+.||+|+||.||+|.+.+|+.||+|.++..... ....+.+|+.+++.++|
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~--- 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG--- 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---
T ss_pred hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---
Confidence 345567788999999999999999877999999998643221 12347899999999984
Q ss_pred EEEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec
Q 038949 453 VMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD 532 (678)
Q Consensus 453 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~ 532 (678)
+++.+++.. +..|+||||++||+|.+ +. ......++.|++.||.|||+. ||+||||||+|||++ +
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~~----giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEE-T
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHHC----CCEeCCCCHHHEEEE-C
Confidence 555554433 55699999999999998 41 123457999999999999999 999999999999999 9
Q ss_pred CccccccccccccccCCCccceeEEEeeecccccccccc
Q 038949 533 FEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS 571 (678)
Q Consensus 533 ~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~ 571 (678)
+.++|+|||+++ .+..|+|||++..
T Consensus 229 ~~vkl~DFG~a~--------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 229 EGIWIIDFPQSV--------------EVGEEGWREILER 253 (282)
T ss_dssp TEEEECCCTTCE--------------ETTSTTHHHHHHH
T ss_pred CcEEEEECCCCe--------------ECCCCCHHHHHHH
Confidence 999999999996 2445789998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=7.3e-19 Score=180.76 Aligned_cols=137 Identities=21% Similarity=0.152 Sum_probs=105.6
Q ss_pred CCcccceecccCccceeeccC-CCCcE--EEEEeeehhcccC------------------------Cccccccceeeecc
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQV--VAVKQYKLASSQG------------------------DQEFCSEVEVLSCA 447 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~--vAvK~i~~~~~~~------------------------~~~~~~Ev~iL~~L 447 (678)
-|.+.+.||+|+||.||+|.+ .+|+. ||||+++...... ...+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999997 68888 9999875432110 01467899999999
Q ss_pred cccce--EEEEeEEeeCCeEEEEEEEeec-C----CcccccccCCCCccCccccchhhhhhccchhhhh-hcceeeeEEe
Q 038949 448 QHRNV--VMLIGFCVEDGRRLLVYEYICN-G----SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLH-EECRVGCIVH 519 (678)
Q Consensus 448 ~HpnI--v~l~~~~~~~~~~~LV~E~~~g-g----sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH-~~~~~~gIvH 519 (678)
.|+++ +.++++ ...+|||||+.+ | +|.++.. ..++..+..++.|++.||.||| +. ||+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~----givH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR-----ELKELDVEGIFNDVVENVKRLYQEA----ELVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG-----GGGGSCHHHHHHHHHHHHHHHHHTS----CEEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh-----ccChHHHHHHHHHHHHHHHHHHHHC----CEEe
Confidence 88754 444432 356899999943 4 4444331 1345677899999999999999 87 9999
Q ss_pred ccCCCCceEeeecCccccccccccccc
Q 038949 520 RDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 520 rDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
|||||+|||++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.5e-16 Score=170.84 Aligned_cols=134 Identities=13% Similarity=0.127 Sum_probs=97.0
Q ss_pred CcccceecccCccceeeccCCCCcEEEEEeeehhcccC-----Ccccc-----------------ccceeeecccccce-
Q 038949 396 FSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQG-----DQEFC-----------------SEVEVLSCAQHRNV- 452 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~-----~~~~~-----------------~Ev~iL~~L~HpnI- 452 (678)
|.+.+.||.|+||.||+|...+|+.||||+++...... ..++. .|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 99999999999999999998889999999986432211 11111 23333444433322
Q ss_pred -EEEEeEEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee
Q 038949 453 -VMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH 531 (678)
Q Consensus 453 -v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~ 531 (678)
...+++ ...+|||||+.|++|..+.. ......++.||+.+|.+||+. |||||||||.|||++.
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~----gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKH----GLIHGDFNEFNILIRE 240 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEEE
T ss_pred CCeeeec----cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeC
Confidence 111221 12379999999888876541 224467889999999999998 9999999999999998
Q ss_pred cCc----------ccccccccccc
Q 038949 532 DFE----------PLVGDFGLARW 545 (678)
Q Consensus 532 ~~~----------vkL~DFGla~~ 545 (678)
++. +.|+||+.+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 873 78999998753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=5.8e-12 Score=128.40 Aligned_cols=145 Identities=14% Similarity=0.037 Sum_probs=114.4
Q ss_pred hhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeeccc-ccceEEEEeEEeeCCeEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~LV~E 470 (678)
....|.+...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. +..+.++++++...+..|+|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3457888888999999999999764 6789999987543344457889999999884 6778889999988889999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcc--------------------------------------
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC-------------------------------------- 512 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~-------------------------------------- 512 (678)
|++|.+|.+.+. +......++.+++.+|..||+.-
T Consensus 91 ~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 91 EADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred ecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999877641 12233467889999999999810
Q ss_pred -----------------eeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 513 -----------------RVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 513 -----------------~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.+.+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01379999999999999876566799998874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=5.9e-11 Score=119.75 Aligned_cols=138 Identities=20% Similarity=0.060 Sum_probs=98.4
Q ss_pred cCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccc--eEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN--VVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn--Iv~l~~~~~~~~~~~LV~E~ 471 (678)
..|.+..+.+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344544444456669999998767788999986532 3356788999999886544 56688888887889999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcc---------------------------------------
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC--------------------------------------- 512 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~--------------------------------------- 512 (678)
++|.+|. +.. .....++.+++..|..||+..
T Consensus 97 i~G~~l~--~~~--------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 97 VPGQDLL--SSH--------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CSSEETT--TSC--------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cCCcccC--cCc--------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 9998884 211 011245556666666666531
Q ss_pred ---------------eeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 513 ---------------RVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 513 ---------------~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.+.+++|+|++|.|||++.++.+.|+|||.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 11259999999999999877667799999985
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.83 E-value=1.5e-09 Score=116.09 Aligned_cols=143 Identities=18% Similarity=0.240 Sum_probs=104.9
Q ss_pred ccceecccCccceeeccCCCCcEEEEEeee--hhcc-cCCccccccceeeeccc--ccceEEEEeEEeeC---CeEEEEE
Q 038949 398 EANFLAEGGFGSVHRGVLPDGQVVAVKQYK--LASS-QGDQEFCSEVEVLSCAQ--HRNVVMLIGFCVED---GRRLLVY 469 (678)
Q Consensus 398 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~--~~~~-~~~~~~~~Ev~iL~~L~--HpnIv~l~~~~~~~---~~~~LV~ 469 (678)
..+.|+.|.++.||+.... +..+++|+.. .... .....+.+|+.+++.+. +..+++++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3566899999999998874 4678888765 3221 22357888999999886 45578888888776 4589999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcc-------------------------------------
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC------------------------------------- 512 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~------------------------------------- 512 (678)
||++|..+.+.. ...++......++.+++.+|..||...
T Consensus 121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999988885532 123566777788999999999999720
Q ss_pred -----------------eeeeEEeccCCCCceEeeecCc--ccccccccccc
Q 038949 513 -----------------RVGCIVHRDMRPNNILVTHDFE--PLVGDFGLARW 545 (678)
Q Consensus 513 -----------------~~~gIvHrDLKp~NILl~~~~~--vkL~DFGla~~ 545 (678)
...+++|||+++.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 0237999999999999997753 68999998863
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=3.7e-08 Score=90.45 Aligned_cols=132 Identities=13% Similarity=0.299 Sum_probs=89.3
Q ss_pred ceEEEEEEeecccc--cchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhh
Q 038949 13 GKVVIVAVKASKEI--PRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIV 90 (678)
Q Consensus 13 ~~~VvV~~das~~~--s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (678)
.++|+|++|.| +. +..|+.||+.-.-+.|..|+||||.++..... ++. .... .. .+..++..
T Consensus 1 ~k~ILv~vD~s-~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~---~~~-------~~~~----~~-~~~~~~~~ 64 (143)
T 3fdx_A 1 SNAILVPIDIS-DKEFTERIISHVESEARIDDAEVHFLTVIPSLPYYA---SLG-------MAYT----AE-LPGMDELR 64 (143)
T ss_dssp CCEEEEECCTT-CSSCCTTHHHHHHHHHHHHTCEEEEEEEECC-------------------------------CHHHHH
T ss_pred CCEEEEEecCC-hHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCcccc---ccc-------cccc----ch-hhhHHHHH
Confidence 36899999988 55 89999999987777889999999998643221 110 0000 00 01112333
Q ss_pred hHHHHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEEe
Q 038949 91 DSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVMK 161 (678)
Q Consensus 91 ~~~~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~~ 161 (678)
+...+.+.++.+-+...+++++..|..|+|...|+..|++.+|+.||++.| +... .+++.+.+|-|.+++
T Consensus 65 ~~~~~~l~~~~~~~~~~~~~v~~~~~~g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~~~~Gs~~~~v~~~~~~pVlvv~ 143 (143)
T 3fdx_A 65 EGSETQLKEIAKKFSIPEDRMHFHVAEGSPKDKILALAKSLPADLVIIASH-RPDITTYLLGSNAAAVVRHAECSVLVVR 143 (143)
T ss_dssp HHHHHHHHHHHTTSCCCGGGEEEEEEESCHHHHHHHHHHHTTCSEEEEESS-CTTCCSCSSCHHHHHHHHHCSSEEEEEC
T ss_pred HHHHHHHHHHHHHcCCCCCceEEEEEecChHHHHHHHHHHhCCCEEEEeCC-CCCCeeeeeccHHHHHHHhCCCCEEEeC
Confidence 333334444444443356788999999999999999999999999999999 5443 258889999998874
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=98.61 E-value=1.7e-08 Score=93.15 Aligned_cols=130 Identities=16% Similarity=0.239 Sum_probs=96.0
Q ss_pred eEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhHH
Q 038949 14 KVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSC 93 (678)
Q Consensus 14 ~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (678)
++|+|++|.| +.+..||.||+.-.-+.|..|+||||.++..... ++. + .. ..+..++..+.-
T Consensus 6 ~~ILv~~D~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~--~~~----~----~~-------~~~~~~~~~~~~ 67 (146)
T 3s3t_A 6 TNILVPVDSS-DAAQAAFTEAVNIAQRHQANLTALYVVDDSAYHT--PAL----D----PV-------LSELLDAEAAHA 67 (146)
T ss_dssp CEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCC--GGG----H----HH-------HHHHHHHHHHHH
T ss_pred ceEEEEcCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCccccc--ccc----c----cc-------cHHHHHHHHHHH
Confidence 6799999988 5589999999998777799999999998654331 110 0 00 001112233333
Q ss_pred HHHHHHhhhcCCCCcc-eEEEEEEecCCcchhhh-hhhcccccEEEEccccchhh---------hhhcccccccEEEEe
Q 038949 94 SQMMRQLQEVYDPEKI-KVRVKIVSGSPYGVVAV-EAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVMK 161 (678)
Q Consensus 94 ~~~~~~l~~~~~~~~v-~~~i~v~~g~~~~~v~~-e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~~ 161 (678)
.+.+.++.+.+...++ +++..|..|+|...|+. .|++.+|+.||++.|-+... .+++.+.+|-|.+++
T Consensus 68 ~~~l~~~~~~~~~~g~~~~~~~~~~g~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pVlvV~ 146 (146)
T 3s3t_A 68 KDAMRQRQQFVATTSAPNLKTEISYGIPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAVGSTTSYVVDHAPCNVIVIR 146 (146)
T ss_dssp HHHHHHHHHHHTTSSCCCCEEEEEEECHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSSCHHHHHHHHHCSSEEEEEC
T ss_pred HHHHHHHHHHHHhcCCcceEEEEecCChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEEcchHHHHhccCCCCEEEeC
Confidence 4566677777777799 99999999999999999 89999999999999833222 368889999998874
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=98.51 E-value=4.1e-08 Score=89.64 Aligned_cols=127 Identities=17% Similarity=0.207 Sum_probs=92.6
Q ss_pred eEEEEEEeecccccchhheehhhcc-ccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhh-h
Q 038949 14 KVVIVAVKASKEIPRSALVWALTHV-VQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIV-D 91 (678)
Q Consensus 14 ~~VvV~~das~~~s~~al~WaL~~v-~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 91 (678)
++|+|++|.| +.+..|+.||+.-. -+.|..|+||||.++...... .++. . .+..++.. +
T Consensus 2 ~~ILv~~D~s-~~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~-~~~~-------~----------~~~~~~~~~~ 62 (138)
T 3idf_A 2 KKLLFAIDDT-EACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGE-AVLA-------A----------YDEIEMKEEE 62 (138)
T ss_dssp EEEEEECCSS-HHHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCHH-HHHH-------H----------HHHHHHHHHH
T ss_pred ceEEEEeCCC-HHHHHHHHHHHHHhccCCCCEEEEEEEecCCCcccc-cccC-------c----------HHHHHHHHHH
Confidence 6899999998 55999999999988 888999999999996543210 0000 0 00112233 3
Q ss_pred HHHHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhh--------hhhcccccccEEEEe
Q 038949 92 SCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK--------KCCMEELQCNVVVMK 161 (678)
Q Consensus 92 ~~~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~--------~~~~~~l~c~i~~~~ 161 (678)
...+.+.++.+.++..+++++..|..|+|...|+..|+ +|+.||++.|-+... .+++.+.+|-|.+++
T Consensus 63 ~~~~~l~~~~~~~~~~g~~~~~~v~~g~~~~~I~~~a~--~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~~pVlvv~ 138 (138)
T 3idf_A 63 KAKLLTQKFSTFFTEKGINPFVVIKEGEPVEMVLEEAK--DYNLLIIGSSENSFLNKIFASHQDDFIQKAPIPVLIVK 138 (138)
T ss_dssp HHHHHHHHHHHHHHTTTCCCEEEEEESCHHHHHHHHHT--TCSEEEEECCTTSTTSSCCCCTTCHHHHHCSSCEEEEC
T ss_pred HHHHHHHHHHHHHHHCCCCeEEEEecCChHHHHHHHHh--cCCEEEEeCCCcchHHHHhCcHHHHHHhcCCCCEEEeC
Confidence 33455666666666679999999999999999998898 999999999933222 367788889888764
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.50 E-value=6.2e-08 Score=91.09 Aligned_cols=143 Identities=18% Similarity=0.213 Sum_probs=93.4
Q ss_pred ceEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCC-ccccccccccccccCCcccCCCC---CCcccch
Q 038949 13 GKVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSK-KIWGFSRFTNDCATGHKSSLSGT---SSDQKDD 88 (678)
Q Consensus 13 ~~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 88 (678)
-++|+|++|.| +.+..|+.||+.-.-+.|..|+||+|.++..... ...+|. .......... ..+..++
T Consensus 5 ~~~ILv~vD~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 76 (162)
T 1mjh_A 5 YKKILYPTDFS-ETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLL-------LGVAGLNKSVEEFENELKNK 76 (162)
T ss_dssp CCEEEEECCSC-HHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC------------------------CHHHHHHHHHH
T ss_pred cceEEEEeCCC-HHHHHHHHHHHHHHhhcCCeEEEEEEecCcccccccccccc-------ccccccccchhhhHHHHHHH
Confidence 46899999988 4589999999998777899999999998430000 000110 0000000000 0001122
Q ss_pred hhhHHHHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEE
Q 038949 89 IVDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVV 159 (678)
Q Consensus 89 ~~~~~~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~ 159 (678)
..+...+.+..+.+.++..+++++..|..|+|...|+..|++.+|+.||++.|=+... .+++.+.+|-|.+
T Consensus 77 ~~~~~~~~l~~~~~~~~~~g~~~~~~v~~G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~GSv~~~vl~~~~~pVlv 156 (162)
T 1mjh_A 77 LTEEAKNKMENIKKELEDVGFKVKDIIVVGIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSNKPVLV 156 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCEEEEEEEEECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCCSCEEE
T ss_pred HHHHHHHHHHHHHHHHHHcCCceEEEEcCCCHHHHHHHHHHHcCCCEEEEcCCCCCCccceEecchHHHHHHhCCCCEEE
Confidence 2222234455555555567999999999999999999999999999999999933222 3688999999999
Q ss_pred EecC
Q 038949 160 MKRS 163 (678)
Q Consensus 160 ~~~~ 163 (678)
++..
T Consensus 157 v~~~ 160 (162)
T 1mjh_A 157 VKRK 160 (162)
T ss_dssp ECCC
T ss_pred EeCC
Confidence 9754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.49 E-value=8.1e-10 Score=115.44 Aligned_cols=187 Identities=17% Similarity=0.135 Sum_probs=115.5
Q ss_pred cceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeeccc-ccc--eEEEEeEEeeCC---eEEEEEEEe
Q 038949 399 ANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-HRN--VVMLIGFCVEDG---RRLLVYEYI 472 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-Hpn--Iv~l~~~~~~~~---~~~LV~E~~ 472 (678)
.+.++.|....||+.. ..+++|+.... .....+.+|+.+|+.+. +.. +.+++....... ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3458999999999875 35888976432 22356888999988773 322 345555443332 358999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhc-----------------------------------------
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEE----------------------------------------- 511 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~----------------------------------------- 511 (678)
+|.+|.+... ..++...+..++.+++..|..||+.
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988875331 1244455556666666666666641
Q ss_pred -------------ceeeeEEeccCCCCceEeee--cCccccccccccccccCCCcc-cee------------EEEeeecc
Q 038949 512 -------------CRVGCIVHRDMRPNNILVTH--DFEPLVGDFGLARWQPDGDMG-VET------------RVLGTFGY 563 (678)
Q Consensus 512 -------------~~~~gIvHrDLKp~NILl~~--~~~vkL~DFGla~~~~~~~~~-~~~------------~~~Gt~~Y 563 (678)
.....++|+|++|.||+++. +..+.|+||+.+......... ... .+....++
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 01136899999999999998 556789999998643211000 000 00000011
Q ss_pred cc-cccccccccceecceeeeeeEEEEeeeCCccc
Q 038949 564 LA-PEYAQSGQITEKADVYSLGVVLVELITGRKAM 597 (678)
Q Consensus 564 ~A-PE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf 597 (678)
.. |+.... .....+.|++|.++|.+.+|..+|
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 222211 123368999999999999998876
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=98.47 E-value=3e-08 Score=91.34 Aligned_cols=133 Identities=17% Similarity=0.170 Sum_probs=92.1
Q ss_pred eEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhHH
Q 038949 14 KVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSC 93 (678)
Q Consensus 14 ~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (678)
++|+|++|.| +.+..|+.||+.-.-+.|..|+||||.++.... .++.. ........ +..++..+.-
T Consensus 3 ~~ILv~vD~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~---~~~~~------~~~~~~~~----~~~~~~~~~~ 68 (147)
T 3hgm_A 3 NRIMVPVDGS-KGAVKALEKGVGLQQLTGAELYILCVFKHHSLL---EASLS------MARPEQLD----IPDDALKDYA 68 (147)
T ss_dssp SEEEEECCSB-HHHHHHHHHHHHHHHHHCCEEEEEEEECCHHHH---HHTBS------SCCCGGGC----CCTTHHHHHH
T ss_pred ceEEEEeCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCcccc---ccccc------ccChhhhh----hHHHHHHHHH
Confidence 5799999988 559999999999877789999999999853311 11100 00000000 1112333333
Q ss_pred HHHHHHhhhcCCCCcceE---EEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEE
Q 038949 94 SQMMRQLQEVYDPEKIKV---RVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVM 160 (678)
Q Consensus 94 ~~~~~~l~~~~~~~~v~~---~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~ 160 (678)
.+.+.++.+.++..++++ +..|..|+|...|+..|++.+|+.||++.|-+... .+++.+.+|-|.++
T Consensus 69 ~~~l~~~~~~~~~~g~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pVlvV 147 (147)
T 3hgm_A 69 TEIAVQAKTRATELGVPADKVRAFVKGGRPSRTIVRFARKRECDLVVIGAQGTNGDKSLLLGSVAQRVAGSAHCPVLVV 147 (147)
T ss_dssp HHHHHHHHHHHHHTTCCGGGEEEEEEESCHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCCCHHHHHHHHHCSSCEEEC
T ss_pred HHHHHHHHHHHHhcCCCccceEEEEecCCHHHHHHHHHHHhCCCEEEEeCCCCccccceeeccHHHHHHhhCCCCEEEC
Confidence 455566666666668777 99999999999999999999999999999843322 25788889988764
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.46 E-value=8.8e-08 Score=90.94 Aligned_cols=134 Identities=10% Similarity=0.068 Sum_probs=89.6
Q ss_pred eecceEEEEEEeecccccchhheehhhccccCCCeEEEE--EEeCCCCCCCccccccccccccccCCcccCCCCCCcccc
Q 038949 10 LVVGKVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLL--VVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKD 87 (678)
Q Consensus 10 ~~~~~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll--~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (678)
....++|+|++|.| +.|..||.||+.-.- .|..|+|| +|.++.... .++.. ... ... +
T Consensus 14 ~~~~~~ILv~vD~s-~~s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~---~~~~~-------~~~-----~~~---~ 73 (163)
T 1tq8_A 14 LSAYKTVVVGTDGS-DSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDAR---AADIL-------KDE-----SYK---V 73 (163)
T ss_dssp CCCCCEEEEECCSS-HHHHHHHHHHHHHHT-TTSEEEEEEECCC------------------------------------
T ss_pred cccCCEEEEEcCCC-HHHHHHHHHHHHHhC-CCCEEEEEEeeeccCcccc---ccccc-------ccH-----HHH---H
Confidence 34458999999988 558999999999776 88999999 888743221 11110 000 000 1
Q ss_pred hhhhHHHHHHHHhhhcCCCCcce-EEEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccE
Q 038949 88 DIVDSCSQMMRQLQEVYDPEKIK-VRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNV 157 (678)
Q Consensus 88 ~~~~~~~~~~~~l~~~~~~~~v~-~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i 157 (678)
+..+...+.+..+.+.++..+++ ++..|..|+|...|+..|++.+|+.||++.|=+... .+++.+.+|-|
T Consensus 74 ~~~~~~~~~l~~~~~~~~~~gv~~v~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSva~~vl~~a~~PV 153 (163)
T 1tq8_A 74 TGTAPIYEILHDAKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAKVDV 153 (163)
T ss_dssp --CCTHHHHHHHHHHHHHTTTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHcCCCeEEEEEecCCHHHHHHHHHHhcCCCEEEECCCCCCcccceeeccHHHHHHHhCCCCE
Confidence 11111223445555555556888 999999999988999889999999999999943322 26889999999
Q ss_pred EEEecC
Q 038949 158 VVMKRS 163 (678)
Q Consensus 158 ~~~~~~ 163 (678)
.+++..
T Consensus 154 lvV~~~ 159 (163)
T 1tq8_A 154 LIVHTT 159 (163)
T ss_dssp EEECCC
T ss_pred EEEeCC
Confidence 999754
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.7e-07 Score=86.73 Aligned_cols=135 Identities=16% Similarity=0.222 Sum_probs=87.9
Q ss_pred cceEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhh
Q 038949 12 VGKVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVD 91 (678)
Q Consensus 12 ~~~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (678)
.-++|+|++|.| +.+..|+.||+.-.-+.|..|+||+|.++.......++. . ......+..++..+
T Consensus 5 ~~~~ILv~vD~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~----------~---~~~~~~~~~~~~~~ 70 (150)
T 3tnj_A 5 VYHHILLAVDFS-SEDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTPYGT----------A---IPLDTETTYDAMLD 70 (150)
T ss_dssp CCSEEEEECCCS-TTHHHHHHHHHHHHHHHTCEEEEEEEEC--------CTT----------C---CCSSSCCCHHHHHH
T ss_pred ccceEEEEeCCC-HHHHHHHHHHHHHHhhcCCEEEEEEEEcCcccccccccc----------c---cCcCHHHHHHHHHH
Confidence 357899999998 559999999999877789999999999864332100110 0 00011111233333
Q ss_pred HHHHHHHHhhhcCCCCcce-EEEEEEecCCcchhhhhhhcccccEEEEccccchhh--------hhhcccccccEEEEec
Q 038949 92 SCSQMMRQLQEVYDPEKIK-VRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK--------KCCMEELQCNVVVMKR 162 (678)
Q Consensus 92 ~~~~~~~~l~~~~~~~~v~-~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~--------~~~~~~l~c~i~~~~~ 162 (678)
...+.+..+.+ ..++. ++..|..|+|...|+..|++.+|+.||+++|=+... .+++.+.+|-|.+++.
T Consensus 71 ~~~~~l~~~~~---~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~~pVlvv~~ 147 (150)
T 3tnj_A 71 VEKQKLSQIGN---TLGIDPAHRWLVWGEPREEIIRIAEQENVDLIVVGSHGRHGLALLLGSTANSVLHYAKCDVLAVRL 147 (150)
T ss_dssp HHHHHHHHHHH---HHTCCGGGEEEEESCHHHHHHHHHHHTTCSEEEEEEC--------CCCHHHHHHHHCSSEEEEEEC
T ss_pred HHHHHHHHHHH---HcCCCcceEEEecCCHHHHHHHHHHHcCCCEEEEecCCCCCcCeEecchHHHHHHhCCCCEEEEeC
Confidence 33334444433 33555 577889999999999999999999999999833222 3678999999999886
Q ss_pred C
Q 038949 163 S 163 (678)
Q Consensus 163 ~ 163 (678)
.
T Consensus 148 ~ 148 (150)
T 3tnj_A 148 R 148 (150)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=98.44 E-value=1.3e-07 Score=89.78 Aligned_cols=142 Identities=17% Similarity=0.114 Sum_probs=92.3
Q ss_pred ceEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhH
Q 038949 13 GKVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDS 92 (678)
Q Consensus 13 ~~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (678)
-++|+|++|.+ +.+..||.||+.-.-+.|..|+||+|.++.......-+++.+ ... .. ....+..++..+.
T Consensus 5 ~~~ILv~vD~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~---~~~--~~---~~~~~~~~~~~~~ 75 (170)
T 2dum_A 5 FRKVLFPTDFS-EGAYRAVEVFEKRNKMEVGEVILLHVIDEGTLEELMDGYSFF---YDN--AE---IELKDIKEKLKEE 75 (170)
T ss_dssp CSEEEEECCSS-HHHHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCCC--------------------CCTTSHHHHHHH
T ss_pred cceEEEEecCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccc---ccc--cc---ccHHHHHHHHHHH
Confidence 47899999988 448999999999887889999999999743211000011000 000 00 0000111222232
Q ss_pred HHHHHHHhhhcCCCCcceEEE--EEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEEe
Q 038949 93 CSQMMRQLQEVYDPEKIKVRV--KIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVMK 161 (678)
Q Consensus 93 ~~~~~~~l~~~~~~~~v~~~i--~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~~ 161 (678)
..+.+..+.+.++..+++++. .|..|+|...|+..|++.+|+.||++.|-+... .+++.+.+|-|.+++
T Consensus 76 ~~~~l~~~~~~~~~~g~~~~~~~~~~~g~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~Gsv~~~vl~~~~~PVlvv~ 155 (170)
T 2dum_A 76 ASRKLQEKAEEVKRAFRAKNVRTIIRFGIPWDEIVKVAEEENVSLIILPSRGKLSLSHEFLGSTVMRVLRKTKKPVLIIK 155 (170)
T ss_dssp HHHHHHHHHHHHHHHTTCSEEEEEEEEECHHHHHHHHHHHTTCSEEEEESCCCCC--TTCCCHHHHHHHHHCSSCEEEEC
T ss_pred HHHHHHHHHHHHHHcCCceeeeeEEecCChHHHHHHHHHHcCCCEEEECCCCCCccccceechHHHHHHHhCCCCEEEEc
Confidence 334445555555455888877 899999999999999999999999999943322 268899999999997
Q ss_pred cC
Q 038949 162 RS 163 (678)
Q Consensus 162 ~~ 163 (678)
..
T Consensus 156 ~~ 157 (170)
T 2dum_A 156 EV 157 (170)
T ss_dssp CC
T ss_pred cC
Confidence 54
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=98.42 E-value=9e-08 Score=89.48 Aligned_cols=130 Identities=9% Similarity=0.128 Sum_probs=92.6
Q ss_pred cceEEEEEEe--ecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchh
Q 038949 12 VGKVVIVAVK--ASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDI 89 (678)
Q Consensus 12 ~~~~VvV~~d--as~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (678)
.-++|+|++| .| +.+..|+.||+.-.-+.|..|+||||.++.... ++. ... .+..++.
T Consensus 14 ~~~~ILv~vD~~~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~----~~~--------~~~-------~~~~~~~ 73 (156)
T 3fg9_A 14 VYRRILLTVDEDDN-TSSERAFRYATTLAHDYDVPLGICSVLESEDIN----IFD--------SLT-------PSKIQAK 73 (156)
T ss_dssp CCC-EEEECCSCCC-HHHHHHHHHHHHHHHHHTCCEEEEEEECCCCTT----CCC--------SSH-------HHHHHHH
T ss_pred cCceEEEEECCCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCcc----ccc--------cCC-------HHHHHHH
Confidence 3478999999 88 569999999999777778999999999865421 110 000 0111222
Q ss_pred hhHHHHHHHHhhhcCCCCcc-eEEEEEEe-cCCcchhhhh-hhcccccEEEEccccchhh--------hhhcccccccEE
Q 038949 90 VDSCSQMMRQLQEVYDPEKI-KVRVKIVS-GSPYGVVAVE-AKKAQSNWVILDKQLKHEK--------KCCMEELQCNVV 158 (678)
Q Consensus 90 ~~~~~~~~~~l~~~~~~~~v-~~~i~v~~-g~~~~~v~~e-~k~~~a~~vVld~~~k~~~--------~~~~~~l~c~i~ 158 (678)
.+...+.+.++.+.++..++ .++..|.. |+|...|+.. |++.+|+.||++.|-+... .+++.+.+|-|.
T Consensus 74 ~~~~~~~l~~~~~~~~~~g~~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~~~Gs~~~~vl~~a~~PVl 153 (156)
T 3fg9_A 74 RKHVEDVVAEYVQLAEQRGVNQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHSKIAGAIGPRLARKAPISVI 153 (156)
T ss_dssp HHHHHHHHHHHHHHHHHHTCSSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTSSSCSCHHHHHHHHCSSEEE
T ss_pred HHHHHHHHHHHHHHHHHcCCCceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccceeecchHHHHHHhCCCCEE
Confidence 23333455555555555688 59999999 9999999999 9999999999999943322 368888999988
Q ss_pred EEe
Q 038949 159 VMK 161 (678)
Q Consensus 159 ~~~ 161 (678)
+++
T Consensus 154 vV~ 156 (156)
T 3fg9_A 154 VVR 156 (156)
T ss_dssp EEC
T ss_pred EeC
Confidence 874
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.41 E-value=1.7e-07 Score=89.40 Aligned_cols=140 Identities=19% Similarity=0.262 Sum_probs=89.5
Q ss_pred ceEEEEEEeeccc--------ccchhheehhhccccC---CCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCC
Q 038949 13 GKVVIVAVKASKE--------IPRSALVWALTHVVQP---GDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGT 81 (678)
Q Consensus 13 ~~~VvV~~das~~--------~s~~al~WaL~~v~~~---gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (678)
.++|+|++|.|.. .+..||.||+....+. |..|+||+|.++.... +.++. +.... .. .
T Consensus 5 ~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~--~~~~~---~~~~~--~~----~ 73 (175)
T 2gm3_A 5 PTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDG--FDDVD---SIYAS--PE----D 73 (175)
T ss_dssp CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC---------------CCCCS--HH----H
T ss_pred ccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeeccccc--ccccc---cccCC--HH----H
Confidence 4789999998841 6899999999987664 6789999998643211 00000 00000 00 0
Q ss_pred CCcccchhhhHHHHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhccc
Q 038949 82 SSDQKDDIVDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEE 152 (678)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~ 152 (678)
..+..++..+.-.+.+..+.+.+...+++++..|..|+|...|+..|++.+|+.|||+.|=+... .+++.+
T Consensus 74 ~~~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~Gsva~~vl~~ 153 (175)
T 2gm3_A 74 FRDMRQSNKAKGLHLLEFFVNKCHEIGVGCEAWIKTGDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKH 153 (175)
T ss_dssp HHHHTTSHHHHHHHHHHHHHHHHHHHTCEEEEEEEESCHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHCCCceEEEEecCCHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhcCchHHHHHhC
Confidence 00000111111223444444445556899999999999988999899999999999999943322 368899
Q ss_pred ccccEEEEecC
Q 038949 153 LQCNVVVMKRS 163 (678)
Q Consensus 153 l~c~i~~~~~~ 163 (678)
..|-|.+++..
T Consensus 154 a~~pVlvv~~~ 164 (175)
T 2gm3_A 154 AECPVMTIKRN 164 (175)
T ss_dssp CSSCEEEEECC
T ss_pred CCCCEEEEcCC
Confidence 99999999864
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=2e-07 Score=87.66 Aligned_cols=119 Identities=12% Similarity=0.126 Sum_probs=85.9
Q ss_pred eEEEEEEee-cccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhH
Q 038949 14 KVVIVAVKA-SKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDS 92 (678)
Q Consensus 14 ~~VvV~~da-s~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (678)
++|+|++|. | +.+..||.||+.-.-+.|..|+||+|.++.... . ++..+.
T Consensus 25 ~~ILv~vD~~s-~~s~~al~~A~~la~~~~a~l~llhV~~~~~~~------------------------~----~~~~~~ 75 (155)
T 3dlo_A 25 MPIVVAVDKKS-DRAERVLRFAAEEARLRGVPVYVVHSLPGGGRT------------------------K----DEDIIE 75 (155)
T ss_dssp CCEEEECCSSS-HHHHHHHHHHHHHHHHHTCCEEEEEEECCSTTS------------------------C----HHHHHH
T ss_pred CeEEEEECCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCcc------------------------c----HHHHHH
Confidence 679999999 8 569999999999877778999999999843210 0 111222
Q ss_pred HHHHHHHhhhcCCCCcceEEEE--EEecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEEe
Q 038949 93 CSQMMRQLQEVYDPEKIKVRVK--IVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVMK 161 (678)
Q Consensus 93 ~~~~~~~l~~~~~~~~v~~~i~--v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~~ 161 (678)
..+.+..+.+.++..++.+++. |..|+|...|+..|++.+|+.||++.|=+... .+++.+.+|-|.++|
T Consensus 76 ~~~~l~~~~~~~~~~g~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSv~~~vl~~a~~PVLvVr 155 (155)
T 3dlo_A 76 AKETLSWAVSIIRKEGAEGEEHLLVRGKEPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIFGSVARDVILKANKPVICIK 155 (155)
T ss_dssp HHHHHHHHHHHHHHTTCCEEEEEEESSSCHHHHHHHHHHHTTCSEEEEECCEECTTSCEECCHHHHHHHHHCSSCEEEEC
T ss_pred HHHHHHHHHHHHHhcCCCceEEEEecCCCHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEeccHHHHHHHhCCCCEEEeC
Confidence 2234444444444456666654 55699999999999999999999999833222 268889999998875
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=98.29 E-value=3.6e-07 Score=83.43 Aligned_cols=125 Identities=13% Similarity=0.225 Sum_probs=84.6
Q ss_pred eEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhHH
Q 038949 14 KVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSC 93 (678)
Q Consensus 14 ~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (678)
++|+|++|.| +.+..|+.||+.-.-+.|..|+||+|.++... ++..+ . . + +..++..+..
T Consensus 3 ~~ILv~~D~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~-----~~~~~-----~--~---~----~~~~~~~~~~ 62 (137)
T 2z08_A 3 KTILLAYDGS-EHARRAAEVAKAEAEAHGARLIVVHAYEPVPD-----YLGEP-----F--F---E----EALRRRLERA 62 (137)
T ss_dssp SEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEEECC---------------------------------CHHHHHH
T ss_pred ceEEEEeCCC-HHHHHHHHHHHHHHhhcCCEEEEEEEecCCCc-----ccccc-----c--h---H----HHHHHHHHHH
Confidence 6799999988 45889999999987777899999999984321 11000 0 0 0 0112222222
Q ss_pred HHHHHHhhhcCCCCcc-eEEEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEEe
Q 038949 94 SQMMRQLQEVYDPEKI-KVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVMK 161 (678)
Q Consensus 94 ~~~~~~l~~~~~~~~v-~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~~ 161 (678)
.+.+..+.+. .++ +++..+..|+|...|+..|++.+|+.||++.|-+... .+++.+.+|-|.+++
T Consensus 63 ~~~l~~~~~~---~g~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pVlvv~ 137 (137)
T 2z08_A 63 EGVLEEARAL---TGVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAPCPVLLVR 137 (137)
T ss_dssp HHHHHHHHHH---HCCCGGGEEEEESSHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSSCHHHHHHHHHCSSCEEEEC
T ss_pred HHHHHHHHHH---cCCCccEEEEEecCHHHHHHHHHHHcCCCEEEECCCCCchhhhhhhccHHHHHHhcCCCCEEEeC
Confidence 3334444332 477 7777888999999999999999999999999943322 257888999998874
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.20 E-value=1.3e-06 Score=79.70 Aligned_cols=131 Identities=14% Similarity=0.072 Sum_probs=88.1
Q ss_pred ceEEEEEEeecccccchhheehhhccccCCCeEEEEEEe-CC-CCCCCccccccccccccccCCcccCCCCCCcccchhh
Q 038949 13 GKVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVM-PP-LSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIV 90 (678)
Q Consensus 13 ~~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (678)
-++|+|++|.| +.+..||.||+.-.-+.|..|+||+|. +. ... ..+++. +.. .. .+..++..
T Consensus 4 ~~~ILv~~D~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~--~~~~~~--------~~~--~~---~~~~~~~~ 67 (138)
T 1q77_A 4 MKVLLVLTDAY-SDCEKAITYAVNFSEKLGAELDILAVLEDVYNLE--RANVTF--------GLP--FP---PEIKEESK 67 (138)
T ss_dssp CEEEEEEESTT-CCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHH--HHHHHH--------CCC--CC---THHHHHHH
T ss_pred ccEEEEEccCC-HhHHHHHHHHHHHHHHcCCeEEEEEEeccccccc--cccccc--------CCC--CC---hHHHHHHH
Confidence 36899999988 558999999998877788999999998 52 100 001110 000 00 01112222
Q ss_pred hHHHHHHHHhhhc--CCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhhhhhcccccccEEEEe
Q 038949 91 DSCSQMMRQLQEV--YDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEKKCCMEELQCNVVVMK 161 (678)
Q Consensus 91 ~~~~~~~~~l~~~--~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~~~~~~~l~c~i~~~~ 161 (678)
+...+.+..+ +. ....+ +++..+..|+|...|+..|++.+|+.||++.|-+.--.+++.+.+|-|.+++
T Consensus 68 ~~~~~~l~~~-~~~~~~~~~-~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~g~sv~~~vl~~a~~PVlvv~ 138 (138)
T 1q77_A 68 KRIERRLREV-WEKLTGSTE-IPGVEYRIGPLSEEVKKFVEGKGYELVVWACYPSAYLCKVIDGLNLASLIVK 138 (138)
T ss_dssp HHHHHHHHHH-HHHHHSCCC-CCCEEEECSCHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHHHSSSEEEECC
T ss_pred HHHHHHHHHH-HHHhhccCC-cceEEEEcCCHHHHHHHHHHhcCCCEEEEeCCCCchHHHHHHhCCCceEeeC
Confidence 2223444444 43 24456 7777888999999999899999999999999944334578999999998864
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.19 E-value=7.3e-07 Score=81.55 Aligned_cols=129 Identities=16% Similarity=0.120 Sum_probs=85.5
Q ss_pred eEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhHH
Q 038949 14 KVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSC 93 (678)
Q Consensus 14 ~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (678)
++|+|++|.| +.+..|+.||+.-.-+.|..|+||+|.+..... ..++. ........+. ..++..
T Consensus 3 ~~ILv~~D~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~--~~~~~-------~~~~~~~~~~---~~~~~~--- 66 (141)
T 1jmv_A 3 KHILVAVDLS-EESPILLKKAVGIAKRHDAKLSIIHVDVNFSDL--YTGLI-------DVNMSSMQDR---ISTETQ--- 66 (141)
T ss_dssp SEEEEEECCS-TTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGG--CCCCE-------EHHHHHHTTC---CCCHHH---
T ss_pred ceEEEEecCc-hhhHHHHHHHHHHHHhcCCEEEEEEEecCchhh--hcccc-------ccchHHHHHH---HHHHHH---
Confidence 5799999988 458999999999877778999999999532110 00110 0000000000 011111
Q ss_pred HHHHHHhhhcCCCCcceE-EEEEEecCCcchhhhhhhcccccEEEEccccchhhh-------hhcccccccEEEEecC
Q 038949 94 SQMMRQLQEVYDPEKIKV-RVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEKK-------CCMEELQCNVVVMKRS 163 (678)
Q Consensus 94 ~~~~~~l~~~~~~~~v~~-~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~~-------~~~~~l~c~i~~~~~~ 163 (678)
+.+.++.+ ..++.+ +..+..|+|...|+..|++.+|+.||++.| +...+ +++.+.+|-|.+++..
T Consensus 67 -~~l~~~~~---~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~lgs~~~~vl~~~~~pVlvv~~~ 139 (141)
T 1jmv_A 67 -KALLDLAE---SVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHH-QDFWSKLMSSTRQVMNTIKIDMLVVPLR 139 (141)
T ss_dssp -HHHHHHHH---HSSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEEC-CCCHHHHHHHHHHHHTTCCSEEEEEECC
T ss_pred -HHHHHHHH---HcCCCceEEEEecCCHHHHHHHHHHhcCCCEEEEeCC-CchhhhhcchHHHHHhcCCCCEEEeeCC
Confidence 22333332 236665 677889999999998999999999999999 65443 6889999999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=2e-06 Score=87.49 Aligned_cols=134 Identities=17% Similarity=0.063 Sum_probs=86.1
Q ss_pred ecccCcc-ceeeccC-CCCcEEEEEeeehhcccCCccccccceeeeccc-ccceEEEEeEEeeCCeEEEEEEEeecCCcc
Q 038949 402 LAEGGFG-SVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGRRLLVYEYICNGSLD 478 (678)
Q Consensus 402 LG~G~fG-~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~ 478 (678)
+..|..+ .||+... .++..+++|+-... ....+.+|+.+|+.+. +--+.+++.++.+++..|+|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445555 5888764 35678999976533 2345778888888774 333677888888889999999999887765
Q ss_pred cccccCCCCccCccccchhhhhhccchhhhhhc-----------------------------------------------
Q 038949 479 SHLYGRDRDPLEWSARRKIAVGAARGLRYLHEE----------------------------------------------- 511 (678)
Q Consensus 479 ~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~----------------------------------------------- 511 (678)
+..... ......+..++...|..||..
T Consensus 109 ~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 109 QVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 433110 011112222222222222211
Q ss_pred -------ceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 512 -------CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 512 -------~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.....++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 112258999999999999987777799999885
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=2.5e-06 Score=90.68 Aligned_cols=82 Identities=10% Similarity=-0.041 Sum_probs=57.4
Q ss_pred ccee-cccCccceeeccCC-------CCcEEEEEeeehhc---ccCCccccccceeeeccc-c--cceEEEEeEEeeC--
Q 038949 399 ANFL-AEGGFGSVHRGVLP-------DGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQ-H--RNVVMLIGFCVED-- 462 (678)
Q Consensus 399 ~~~L-G~G~fG~Vy~a~~~-------~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~-H--pnIv~l~~~~~~~-- 462 (678)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3557 78888999987653 26688999765332 112356788999998885 3 2467788877654
Q ss_pred -CeEEEEEEEeecCCcccc
Q 038949 463 -GRRLLVYEYICNGSLDSH 480 (678)
Q Consensus 463 -~~~~LV~E~~~ggsL~~~ 480 (678)
+..|+||||++|..+.+.
T Consensus 105 ~g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp TSSCEEEEECCCCBCCCBT
T ss_pred cCCceEEEEecCCCChhhc
Confidence 357899999998887653
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=97.94 E-value=5.7e-06 Score=85.52 Aligned_cols=133 Identities=14% Similarity=0.170 Sum_probs=93.7
Q ss_pred cceEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhh
Q 038949 12 VGKVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVD 91 (678)
Q Consensus 12 ~~~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (678)
.-++|+|++|.| +.+..|+.||+.-.-+.|..|+||+|.++.... ++. .+. ...+..++..+
T Consensus 21 m~~~ILv~vD~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~----~~~-------~~~------~~~~~~~~~~~ 82 (294)
T 3loq_A 21 QSNAMLLPTDLS-ENSFKVLEYLGDFKKVGVEEIGVLFVINLTKLS----TVS-------GGI------DIDHYIDEMSE 82 (294)
T ss_dssp TTCEEEEECCSC-TGGGGGGGGHHHHHHTTCCEEEEECCEECTTC----------------CC------CTTHHHHHHHH
T ss_pred hhccEEEecCCC-HHHHHHHHHHHHHHhhcCCEEEEEEEecCcccc----ccc-------ccc------cHHHHHHHHHH
Confidence 347999999998 559999999999777778899999999854432 110 000 00011122223
Q ss_pred HHHHHHHHhhhcCCCCcceEEE-EEE-ecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEE
Q 038949 92 SCSQMMRQLQEVYDPEKIKVRV-KIV-SGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVM 160 (678)
Q Consensus 92 ~~~~~~~~l~~~~~~~~v~~~i-~v~-~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~ 160 (678)
...+.+..+.+.+...++.++. .|+ .|+|...| .+++.+|+.||+++|-+... .+++.+.+|-|.++
T Consensus 83 ~~~~~l~~~~~~~~~~g~~~~~~~v~~~g~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~~PVlvv 160 (294)
T 3loq_A 83 KAEEVLPEVAQKIEAAGIKAEVIKPFPAGDPVVEI--IKASENYSFIAMGSRGASKFKKILLGSVSEGVLHDSKVPVYIF 160 (294)
T ss_dssp HHHHHHHHHHHHHHHTTCEEEECSSCCEECHHHHH--HHHHTTSSEEEEECCCCCHHHHHHHCCHHHHHHHHCSSCEEEE
T ss_pred HHHHHHHHHHHHHHHcCCCcceeEeeccCChhHhe--eeccCCCCEEEEcCCCCccccceeeccHHHHHHhcCCCCEEEe
Confidence 3334556666666667999998 888 99987777 89999999999999843322 25888999999999
Q ss_pred ecCC
Q 038949 161 KRSQ 164 (678)
Q Consensus 161 ~~~~ 164 (678)
+...
T Consensus 161 ~~~~ 164 (294)
T 3loq_A 161 KHDM 164 (294)
T ss_dssp CCCT
T ss_pred cCcc
Confidence 8764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=2.6e-06 Score=89.15 Aligned_cols=136 Identities=20% Similarity=0.156 Sum_probs=86.4
Q ss_pred cceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeeccccc---ceEEEEeEEe-eCCeEEEEEEEeec
Q 038949 399 ANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHR---NVVMLIGFCV-EDGRRLLVYEYICN 474 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hp---nIv~l~~~~~-~~~~~~LV~E~~~g 474 (678)
...++.|....||+. +..+++|+... ......+.+|+.+|+.+.+. .+.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 345788888899987 45688887432 12235688999999988642 3556666653 45567899999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcc------------------------------------------
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC------------------------------------------ 512 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~------------------------------------------ 512 (678)
.+|.+.... .++......++.++...|..||+..
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888652210 1122222233333333333333210
Q ss_pred --------------eeeeEEeccCCCCceEeee---cCcc-ccccccccc
Q 038949 513 --------------RVGCIVHRDMRPNNILVTH---DFEP-LVGDFGLAR 544 (678)
Q Consensus 513 --------------~~~gIvHrDLKp~NILl~~---~~~v-kL~DFGla~ 544 (678)
.+..++|+|+.+.|||++. ++.+ .|+||+.+.
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1236899999999999987 4554 799999885
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=1.2e-05 Score=83.70 Aligned_cols=133 Identities=14% Similarity=0.139 Sum_probs=89.4
Q ss_pred ecceEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhh
Q 038949 11 VVGKVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIV 90 (678)
Q Consensus 11 ~~~~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (678)
...++|+|++|.| +.+..||.||+.-.-+.|..|+||+|.++.... |+.. .. .. +..++..
T Consensus 17 ~~~~~ILv~~D~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~---~~~~--------~~----~~---~~~~~~~ 77 (309)
T 3cis_A 17 NSSLGIIVGIDDS-PAAQVAVRWAARDAELRKIPLTLVHAVSPEVAT---WLEV--------PL----PP---GVLRWQQ 77 (309)
T ss_dssp -CTTEEEEECCSS-HHHHHHHHHHHHHHHHHTCCEEEEEECCCCCCC---TTCC--------CC----CH---HHHHHHH
T ss_pred CCCCeEEEEECCC-HHHHHHHHHHHHHHHhcCCcEEEEEEecCcccc---cccC--------CC----Cc---hhhHHHH
Confidence 4458899999988 558999999999877788999999999742211 1110 00 00 0001111
Q ss_pred hHHHHHHHHhhhcCCC-----CcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhccccccc
Q 038949 91 DSCSQMMRQLQEVYDP-----EKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCN 156 (678)
Q Consensus 91 ~~~~~~~~~l~~~~~~-----~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~ 156 (678)
+...+.+.++.+.++. .+++++..|..|++...|+..|+ +|+.||++.|-+... .+++.+..|-
T Consensus 78 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~~P 155 (309)
T 3cis_A 78 DHGRHLIDDALKVVEQASLRAGPPTVHSEIVPAAAVPTLVDMSK--DAVLMVVGCLGSGRWPGRLLGSVSSGLLRHAHCP 155 (309)
T ss_dssp HHHHHHHHHHHHHHHHHCSSSCCSCEEEEEESSCHHHHHHHHGG--GEEEEEEESSCTTCCTTCCSCHHHHHHHHHCSSC
T ss_pred HHHHHHHHHHHHHHHHhcccCCCceEEEEEecCCHHHHHHHHhc--CCCEEEECCCCCccccccccCcHHHHHHHhCCCC
Confidence 2122333333333322 38999999999999888888887 899999999943221 3688999999
Q ss_pred EEEEecCC
Q 038949 157 VVVMKRSQ 164 (678)
Q Consensus 157 i~~~~~~~ 164 (678)
|.+++...
T Consensus 156 Vlvv~~~~ 163 (309)
T 3cis_A 156 VVIIHDED 163 (309)
T ss_dssp EEEECTTC
T ss_pred EEEEcCCc
Confidence 99998664
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=97.74 E-value=1.6e-05 Score=82.93 Aligned_cols=138 Identities=14% Similarity=0.205 Sum_probs=94.6
Q ss_pred ecceEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhh
Q 038949 11 VVGKVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIV 90 (678)
Q Consensus 11 ~~~~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (678)
..-++|+|++|.| +.+..||.||+.---+.|-.|+||||+++..... .++ . ..... .+..+...
T Consensus 5 ~~~k~ILv~~D~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~--~~~---~---~~~~~-------~~~~~~~~ 68 (319)
T 3olq_A 5 EKYQNLLVVIDPN-QDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDM--TTL---L---SPDER-------NAMRKGVI 68 (319)
T ss_dssp CCSCEEEEECCTT-CSCCHHHHHHHHHHHHHCCEEEEEEEECCGGGGC--TTT---S---CHHHH-------HHHHHHHH
T ss_pred cccceEEEEECCC-cccHHHHHHHHHHHHHcCCeEEEEEEecccchhh--ccc---c---ChhhH-------HHHHHHHH
Confidence 3458899999988 5589999999997667788999999987432110 000 0 00000 00001122
Q ss_pred hHHHHHHHHhhhcCCCCcceEEEEEE-ecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEE
Q 038949 91 DSCSQMMRQLQEVYDPEKIKVRVKIV-SGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVM 160 (678)
Q Consensus 91 ~~~~~~~~~l~~~~~~~~v~~~i~v~-~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~ 160 (678)
+...+.+..+.+.+...++.++..+. .|+|...|+.+|++.+|+.||++.|-+... ...+.+.+|-|.++
T Consensus 69 ~~~~~~l~~~~~~~~~~~v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~Gs~~~~vl~~~~~PVlvv 148 (319)
T 3olq_A 69 NQKTAWIKQQARYYLEAGIQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIFTPLDWQLLRKCPAPVWMV 148 (319)
T ss_dssp HHHHHHHHHHHHHHHHTTCCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBCCHHHHHHHHHCSSCEEEE
T ss_pred HHHHHHHHHHHHHHhhcCCeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhcccccccHHHHHhcCCCCEEEe
Confidence 22234555555555567999999999 899999999899999999999999843322 25888999999999
Q ss_pred ecCC
Q 038949 161 KRSQ 164 (678)
Q Consensus 161 ~~~~ 164 (678)
+...
T Consensus 149 ~~~~ 152 (319)
T 3olq_A 149 KDKE 152 (319)
T ss_dssp ESSC
T ss_pred cCcc
Confidence 8653
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=8.6e-06 Score=82.82 Aligned_cols=137 Identities=11% Similarity=0.110 Sum_probs=91.1
Q ss_pred eEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcc----cchh
Q 038949 14 KVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQ----KDDI 89 (678)
Q Consensus 14 ~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~ 89 (678)
++|+|++|.| +.+..|+.||+.-.-+.|..|+||+|.++.... +.+. .+ .. . ......+. .++.
T Consensus 1 k~ILv~vD~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~--~~~~---~~---~~--~-~~~~~~~~~~~~~~~~ 68 (268)
T 3ab8_A 1 MRILLATDGS-PQARGAEALAEWLAYKLSAPLTVLFVVDTRLAR--IPEL---LD---FG--A-LTVPVPVLRTELERAL 68 (268)
T ss_dssp CCEEEECCSC-GGGHHHHHHHHHHHHHHTCCEEEEEEEEHHHHT--HHHH---C-------------CHHHHHHHHHHHH
T ss_pred CcEEEEcCCC-HHHHHHHHHHHHHHHHhCCcEEEEEEeccCCcc--cccc---cC---ch--H-HHHHHHHHHHHHHHHH
Confidence 4699999988 558999999999877778899999998742210 0010 00 00 0 00000000 1122
Q ss_pred hhHHHHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccch-hh---------hhhcccccccEEE
Q 038949 90 VDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKH-EK---------KCCMEELQCNVVV 159 (678)
Q Consensus 90 ~~~~~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~-~~---------~~~~~~l~c~i~~ 159 (678)
.+...+.+.++.+.+...++.++..+..|+|...|++. +.+|+.||+++|-+. .. .+++.+.+|-|.+
T Consensus 69 ~~~~~~~l~~~~~~~~~~g~~~~~~~~~g~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~Gs~~~~v~~~a~~PVlv 146 (268)
T 3ab8_A 69 ALRGEAVLERVRQSALAAGVAVEAVLEEGVPHEAILRR--ARAADLLVLGRSGEAHGDGFGGLGSTADRVLRASPVPVLL 146 (268)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCEEEEEEEECHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSCCHHHHHHHHHCSSCEEE
T ss_pred HHHHHHHHHHHHHHHHhCCCCeEEEEecCCHHHHHHhh--ccCCCEEEEeccCCCccccccccchhHHHHHHhCCCCEEE
Confidence 22233455556555656689999999999998888766 889999999999443 22 3688999999999
Q ss_pred EecCC
Q 038949 160 MKRSQ 164 (678)
Q Consensus 160 ~~~~~ 164 (678)
++...
T Consensus 147 v~~~~ 151 (268)
T 3ab8_A 147 APGEP 151 (268)
T ss_dssp ECSSC
T ss_pred ECCCC
Confidence 98654
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=97.72 E-value=1.6e-05 Score=82.13 Aligned_cols=129 Identities=14% Similarity=0.183 Sum_probs=87.3
Q ss_pred cceEEEEEEeeccc------ccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcc
Q 038949 12 VGKVVIVAVKASKE------IPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQ 85 (678)
Q Consensus 12 ~~~~VvV~~das~~------~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (678)
..++|+|++|.|.. ++..|+.||+.-.-+.|..|+||+|.++..... .. . .. +.
T Consensus 133 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~---~~-----------~-----~~-~~ 192 (290)
T 3mt0_A 133 TGGKILAAVDVGNNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSS---AD-----------P-----TF-QL 192 (290)
T ss_dssp TTCEEEEEECTTCCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC----------------------------CH-HH
T ss_pred CCCeEEEEECCCCcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCccccc---cC-----------c-----hh-HH
Confidence 46899999999864 279999999998777899999999998543210 00 0 00 11
Q ss_pred cchhhhHHHHHHHHhhhcCCCCcce-EEEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccc
Q 038949 86 KDDIVDSCSQMMRQLQEVYDPEKIK-VRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQC 155 (678)
Q Consensus 86 ~~~~~~~~~~~~~~l~~~~~~~~v~-~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c 155 (678)
.++..+...+.+..+. +..++. ++..|..|+|...|+..|++.+|+.||++.|=+... .+.+.+.+|
T Consensus 193 ~~~~~~~~~~~l~~~~---~~~g~~~~~~~v~~g~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~Gsv~~~vl~~~~~ 269 (290)
T 3mt0_A 193 SETIEARYREACRTFQ---AEYGFSDEQLHIEEGPADVLIPRTAQKLDAVVTVIGTVARTGLSGALIGNTAEVVLDTLES 269 (290)
T ss_dssp HHHHHHHHHHHHHHHH---HHHTCCTTTEEEEESCHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCSCHHHHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHHH---HHcCCCcceEEEeccCHHHHHHHHHHhcCCCEEEECCCCCcCCcceecchHHHHHHhcCCC
Confidence 1222222223333333 333663 567888999999999899999999999999843333 268899999
Q ss_pred cEEEEecC
Q 038949 156 NVVVMKRS 163 (678)
Q Consensus 156 ~i~~~~~~ 163 (678)
-|.+++..
T Consensus 270 pVLvv~~~ 277 (290)
T 3mt0_A 270 DVLVLKPD 277 (290)
T ss_dssp EEEEECCH
T ss_pred CEEEECCC
Confidence 99999754
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=97.66 E-value=2.4e-05 Score=80.85 Aligned_cols=117 Identities=22% Similarity=0.258 Sum_probs=88.7
Q ss_pred ecceEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhh
Q 038949 11 VVGKVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIV 90 (678)
Q Consensus 11 ~~~~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (678)
...++|+|++|.+ +.+..||.||+.-.-..|..|+||+|.++.. .+
T Consensus 168 ~~~~~Ilv~~d~s-~~s~~al~~a~~la~~~~~~l~ll~v~~~~~------------------------------~~--- 213 (294)
T 3loq_A 168 SLFDRVLVAYDFS-KWADRALEYAKFVVKKTGGELHIIHVSEDGD------------------------------KT--- 213 (294)
T ss_dssp CTTSEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEECSSSC------------------------------CH---
T ss_pred ccCCEEEEEECCC-HHHHHHHHHHHHHhhhcCCEEEEEEEccCch------------------------------HH---
Confidence 3458899999988 4589999999987767888999999998321 01
Q ss_pred hHHHHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEEe
Q 038949 91 DSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVMK 161 (678)
Q Consensus 91 ~~~~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~~ 161 (678)
+.+..+.+..+..+++++..|..|++...++..|++.+|+.||++.|-+.-. .+.+.+.+|-|.+++
T Consensus 214 ----~~l~~~~~~l~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pvLvv~ 289 (294)
T 3loq_A 214 ----ADLRVMEEVIGAEGIEVHVHIESGTPHKAILAKREEINATTIFMGSRGAGSVMTMILGSTSESVIRRSPVPVFVCK 289 (294)
T ss_dssp ----HHHHHHHHHHHHTTCCEEEEEECSCHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHHHCHHHHHHHHCSSCEEEEC
T ss_pred ----HHHHHHHHHHHHcCCcEEEEEecCCHHHHHHHHHHhcCcCEEEEeCCCCCCccceeeCcHHHHHHhcCCCCEEEEC
Confidence 1222222223334888999999999988999889999999999999833222 358899999999998
Q ss_pred cCCc
Q 038949 162 RSQP 165 (678)
Q Consensus 162 ~~~~ 165 (678)
...+
T Consensus 290 ~~~~ 293 (294)
T 3loq_A 290 RGDD 293 (294)
T ss_dssp SCTT
T ss_pred CCCC
Confidence 7653
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=97.64 E-value=2.8e-05 Score=80.21 Aligned_cols=115 Identities=15% Similarity=0.121 Sum_probs=86.8
Q ss_pred ecceEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhh
Q 038949 11 VVGKVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIV 90 (678)
Q Consensus 11 ~~~~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (678)
..-++|+|++|.| +.+..|+.||+.-.-+.|-.|+||+|.++ ++..
T Consensus 5 ~~~~~ILv~~D~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~---------------------------------~~~~ 50 (290)
T 3mt0_A 5 QAIRSILVVIEPD-QLEGLALKRAQLIAGVTQSHLHLLVCEKR---------------------------------RDHS 50 (290)
T ss_dssp TTCCEEEEECCSS-CSCCHHHHHHHHHHHHHCCEEEEEEECSS---------------------------------SCCH
T ss_pred hhhceEEEEeCCC-ccchHHHHHHHHHHHhcCCeEEEEEeeCc---------------------------------HHHH
Confidence 3457899999988 55899999999977777888999999973 0001
Q ss_pred hHHHHHHHHhhhcCCCCcceEEEEEE-ecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEE
Q 038949 91 DSCSQMMRQLQEVYDPEKIKVRVKIV-SGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVM 160 (678)
Q Consensus 91 ~~~~~~~~~l~~~~~~~~v~~~i~v~-~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~ 160 (678)
+.+.++.+.+...+++++..+. .|++...|+.+|++.+|+.||++.|-+... ...+.+..|-|.++
T Consensus 51 ----~~l~~~~~~~~~~~~~~~~~~~~~g~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~gs~~~~vl~~~~~PVlvv 126 (290)
T 3mt0_A 51 ----AALNDLAQELREEGYSVSTNQAWKDSLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAILTPDDWKLLRFAPCPVLMT 126 (290)
T ss_dssp ----HHHHHHHHHHHHTTCCEEEEEECSSSHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSCCHHHHHHHHHCSSCEEEE
T ss_pred ----HHHHHHHHHHhhCCCeEEEEEEeCCCHHHHHHHHHHhcCCCEEEEecccCCchhhcccCHHHHHHHhcCCCCEEEe
Confidence 1222233333345899999998 578888899899999999999999843211 35888999999999
Q ss_pred ecC
Q 038949 161 KRS 163 (678)
Q Consensus 161 ~~~ 163 (678)
+..
T Consensus 127 ~~~ 129 (290)
T 3mt0_A 127 KTA 129 (290)
T ss_dssp CCC
T ss_pred cCC
Confidence 854
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=1.4e-05 Score=86.23 Aligned_cols=75 Identities=12% Similarity=-0.014 Sum_probs=48.5
Q ss_pred cceecccCccceeeccCC-CCcEEEEEeeehhcc-------cCCccccccceeeecccc--c-ceEEEEeEEeeCCeEEE
Q 038949 399 ANFLAEGGFGSVHRGVLP-DGQVVAVKQYKLASS-------QGDQEFCSEVEVLSCAQH--R-NVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~~~-------~~~~~~~~Ev~iL~~L~H--p-nIv~l~~~~~~~~~~~L 467 (678)
.+.||.|.++.||++... +++.+++|....... .....+..|+++|+.+.. + .+.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 356899999999999743 467899997643211 122456778888887742 3 34566654 3445689
Q ss_pred EEEEeecC
Q 038949 468 VYEYICNG 475 (678)
Q Consensus 468 V~E~~~gg 475 (678)
|||++.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=6.1e-05 Score=78.38 Aligned_cols=126 Identities=12% Similarity=0.146 Sum_probs=85.5
Q ss_pred cceEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhh
Q 038949 12 VGKVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVD 91 (678)
Q Consensus 12 ~~~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (678)
..++|||++|.+. .+..||.||+.-.-+.|..|+||+|.++.... ++ .+.. .++..+
T Consensus 170 ~~~~Ilv~~D~s~-~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~----~~---------------~~~~---~~~~~~ 226 (309)
T 3cis_A 170 QQAPVLVGVDGSS-ASELATAIAFDEASRRNVDLVALHAWSDVDVS----EW---------------PGID---WPATQS 226 (309)
T ss_dssp CCCCEEEECCSSH-HHHHHHHHHHHHHHHTTCCEEEEEESCSSCCT----TC---------------SSCC---HHHHHH
T ss_pred CCCeEEEEeCCCh-HHHHHHHHHHHHHHhcCCEEEEEEEeeccccc----CC---------------Cccc---HHHHHH
Confidence 3478999999884 48899999998777778999999998743211 00 0000 011222
Q ss_pred HHHHHHHHhhhcC-CC-CcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEE
Q 038949 92 SCSQMMRQLQEVY-DP-EKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVM 160 (678)
Q Consensus 92 ~~~~~~~~l~~~~-~~-~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~ 160 (678)
...+.+..+...+ +. .+++++..|..|+|...|++.|+ +|+.|||+.|-+... .+.+.+.+|-|.++
T Consensus 227 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~g~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~Gsv~~~vl~~~~~pVlvv 304 (309)
T 3cis_A 227 MAEQVLAERLAGWQERYPNVAITRVVVRDQPARQLVQRSE--EAQLVVVGSRGRGGYAGMLVGSVGETVAQLARTPVIVA 304 (309)
T ss_dssp HHHHHHHHHHTTHHHHCTTSCEEEEEESSCHHHHHHHHHT--TCSEEEEESSCSSCCTTCSSCHHHHHHHHHCSSCEEEE
T ss_pred HHHHHHHHHHHHHHhhCCCCcEEEEEEcCCHHHHHHHhhC--CCCEEEECCCCCCCccccccCcHHHHHHhcCCCCEEEe
Confidence 2222232222211 11 48899999999999889888887 999999999933222 35889999999998
Q ss_pred ec
Q 038949 161 KR 162 (678)
Q Consensus 161 ~~ 162 (678)
+.
T Consensus 305 ~~ 306 (309)
T 3cis_A 305 RE 306 (309)
T ss_dssp CC
T ss_pred CC
Confidence 75
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=97.49 E-value=5.9e-05 Score=78.55 Aligned_cols=135 Identities=13% Similarity=0.132 Sum_probs=88.1
Q ss_pred cceEEEEEEeeccc------ccchhheehhhccccC--CCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCC
Q 038949 12 VGKVVIVAVKASKE------IPRSALVWALTHVVQP--GDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSS 83 (678)
Q Consensus 12 ~~~~VvV~~das~~------~s~~al~WaL~~v~~~--gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (678)
..++|+|++|.+.+ .+..||.||+.-.-.. |..|+||+|.++..... +. +.. .....
T Consensus 155 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~--~~----------~~~---~~~~~ 219 (319)
T 3olq_A 155 EYGTIVVAANLSNEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINI--AI----------ELP---DFDPN 219 (319)
T ss_dssp TTCEEEEECCCSCCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSC--CT----------TCT---TCCHH
T ss_pred cCCeEEEEECCCCcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhh--hc----------cCC---cccHH
Confidence 45899999999865 5689999998865544 88999999998644321 00 000 00000
Q ss_pred cccchhhhHHHHHHHHhhhcCCCCcc-eEEEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccc
Q 038949 84 DQKDDIVDSCSQMMRQLQEVYDPEKI-KVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEEL 153 (678)
Q Consensus 84 ~~~~~~~~~~~~~~~~l~~~~~~~~v-~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l 153 (678)
+..++..+...+.+..+.. ..++ .++..|..|+|...++..|++.+|+.||++.|=+.-. .+++.+.
T Consensus 220 ~~~~~~~~~~~~~l~~~~~---~~~~~~~~~~v~~g~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~Gsv~~~vl~~~ 296 (319)
T 3olq_A 220 LYNNALRGQHLIAMKELRQ---KFSIPEEKTHVKEGLPEQVIPQVCEELNAGIVVLGILGRTGLSAAFLGNTAEQLIDHI 296 (319)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTCCGGGEEEEESCHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHH---HhCCCcccEEEecCCcHHHHHHHHHHhCCCEEEEeccCccCCccccccHHHHHHHhhC
Confidence 0011222222233333332 3244 3456678999988999889999999999999833322 2688999
Q ss_pred cccEEEEecCC
Q 038949 154 QCNVVVMKRSQ 164 (678)
Q Consensus 154 ~c~i~~~~~~~ 164 (678)
+|-|.+++...
T Consensus 297 ~~pVLvv~~~~ 307 (319)
T 3olq_A 297 KCDLLAIKPDG 307 (319)
T ss_dssp CSEEEEECCTT
T ss_pred CCCEEEECCCC
Confidence 99999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.46 E-value=3.4e-05 Score=80.59 Aligned_cols=140 Identities=14% Similarity=0.176 Sum_probs=77.4
Q ss_pred ceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeeccccc--ceEEEEe------EEeeCCeEEEEEEE
Q 038949 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHR--NVVMLIG------FCVEDGRRLLVYEY 471 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hp--nIv~l~~------~~~~~~~~~LV~E~ 471 (678)
..|+.|..+.||+....++ .+++|+.... ...+..|+.+++.|... .+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466667889999876444 5899988641 12344455665555321 2233332 12346678999999
Q ss_pred eecCCccc-----------cc---cc--CCC-Cc---------cCccc-------------------------------c
Q 038949 472 ICNGSLDS-----------HL---YG--RDR-DP---------LEWSA-------------------------------R 494 (678)
Q Consensus 472 ~~ggsL~~-----------~l---~~--~~~-~~---------l~~~~-------------------------------~ 494 (678)
++|..+.. .+ +. ... .+ ..|.. .
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 98876531 00 00 000 00 01100 0
Q ss_pred chhhhhhccchhhhhh--------c-ceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 495 RKIAVGAARGLRYLHE--------E-CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 495 ~~i~~qI~~aL~yLH~--------~-~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
..+..++..++.+|+. . ..+.+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0011123334556653 0 012389999999999999988899999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00013 Score=76.72 Aligned_cols=76 Identities=20% Similarity=0.166 Sum_probs=59.2
Q ss_pred cceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeeccc---ccceEEEEeEEeeCCeEEEEEEEeecC
Q 038949 399 ANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ---HRNVVMLIGFCVEDGRRLLVYEYICNG 475 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~---HpnIv~l~~~~~~~~~~~LV~E~~~gg 475 (678)
.+.|+.|....+|+... ++..+++|+.... ....+..|+..|+.|. ...+++++.+....+..++||||++|.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45689999999999886 4678889986532 2356788999888884 256778888887778899999999988
Q ss_pred Ccc
Q 038949 476 SLD 478 (678)
Q Consensus 476 sL~ 478 (678)
.+.
T Consensus 117 ~~~ 119 (312)
T 3jr1_A 117 KNK 119 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.17 E-value=7.3e-05 Score=77.03 Aligned_cols=82 Identities=18% Similarity=0.103 Sum_probs=58.3
Q ss_pred hhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccc---cceEEEEeEEeeCCeEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQH---RNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~H---pnIv~l~~~~~~~~~~~LV 468 (678)
...+..-...+|.|..+.||+....+|+.|++|+...........|..|+..|+.|.- -.+++++++. ..++|
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 3445666778999999999999988999999998654443434567789998887742 1234455432 24789
Q ss_pred EEEeecCCc
Q 038949 469 YEYICNGSL 477 (678)
Q Consensus 469 ~E~~~ggsL 477 (678)
|||+.++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999977654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.00017 Score=78.51 Aligned_cols=31 Identities=23% Similarity=0.381 Sum_probs=27.3
Q ss_pred eeEEeccCCCCceEeeecCccccccccccccc
Q 038949 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 515 ~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
..++|+|+++.|||++.++ +.|+||+.+.+-
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 3899999999999998876 999999998643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0004 Score=72.24 Aligned_cols=142 Identities=13% Similarity=0.076 Sum_probs=77.2
Q ss_pred ceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccc--eEEEEeE------EeeCCeEEEEEEE
Q 038949 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN--VVMLIGF------CVEDGRRLLVYEY 471 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn--Iv~l~~~------~~~~~~~~LV~E~ 471 (678)
+.|+.|....+|+....++ .+++|+.... .....+..|+.++..+...+ +.+++.. ....+..+++|+|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4567788889999876545 6889987642 12345667777777664222 2233321 1224567899999
Q ss_pred eecCCcccc--------------ccc--CC-CCc-------cCcccc--------chh----hhhhccchhhhhhcc---
Q 038949 472 ICNGSLDSH--------------LYG--RD-RDP-------LEWSAR--------RKI----AVGAARGLRYLHEEC--- 512 (678)
Q Consensus 472 ~~ggsL~~~--------------l~~--~~-~~~-------l~~~~~--------~~i----~~qI~~aL~yLH~~~--- 512 (678)
++|..+... ++. .. ..+ ..|... ..+ ...+...+.++....
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 988765321 000 00 000 011110 000 001222334443221
Q ss_pred eeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 513 ~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.+.+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 12489999999999999987666899998875
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=96.67 E-value=0.00075 Score=68.26 Aligned_cols=111 Identities=9% Similarity=0.028 Sum_probs=79.1
Q ss_pred cceEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhh
Q 038949 12 VGKVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVD 91 (678)
Q Consensus 12 ~~~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (678)
..++|+|++|.+. .+..||.||..-.-..|..|+||+|.++. ++..
T Consensus 153 ~~~~ilv~~d~s~-~~~~al~~a~~la~~~~a~l~ll~v~~~~--------------------------------~~~~- 198 (268)
T 3ab8_A 153 ELEGALLGYDASE-SAVRALHALAPLARALGLGVRVVSVHEDP--------------------------------ARAE- 198 (268)
T ss_dssp CCCEEEEECCSCH-HHHHHHHHHHHHHHHHTCCEEEEEECSSH--------------------------------HHHH-
T ss_pred CCCEEEEEECCCH-HHHHHHHHHHHhhhcCCCEEEEEEEcCcH--------------------------------HHHH-
Confidence 3478999999884 47889999887655567789999998731 0111
Q ss_pred HHHHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhh-----hhhcccccccEEEEe
Q 038949 92 SCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK-----KCCMEELQCNVVVMK 161 (678)
Q Consensus 92 ~~~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~-----~~~~~~l~c~i~~~~ 161 (678)
+.+..+.+.....+++++..|..|+|...+++.|++. +.||++..+++-. .+.+.+.+|-|.+++
T Consensus 199 ---~~l~~~~~~l~~~~~~~~~~~~~g~~~~~i~~~a~~~--dliV~G~~~~~~~~Gs~~~~vl~~~~~pvlvv~ 268 (268)
T 3ab8_A 199 ---AWALEAEAYLRDHGVEASALVLGGDAADHLLRLQGPG--DLLALGAPVRRLVFGSTAERVIRNAQGPVLTAR 268 (268)
T ss_dssp ---HHHHHHHHHHHHTTCCEEEEEECSCHHHHHHHHCCTT--EEEEEECCCSCCSSCCHHHHHHHHCSSCEEEEC
T ss_pred ---HHHHHHHHHHHHcCCceEEEEeCCChHHHHHHHHHhC--CEEEECCcccccEeccHHHHHHhcCCCCEEEeC
Confidence 1222233333334889999999999988998888888 9999998332211 358888999988874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.57 E-value=0.00075 Score=70.35 Aligned_cols=77 Identities=14% Similarity=0.078 Sum_probs=49.0
Q ss_pred ceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccc--eEEEEeE-----EeeCCeEEEEEEEe
Q 038949 400 NFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN--VVMLIGF-----CVEDGRRLLVYEYI 472 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn--Iv~l~~~-----~~~~~~~~LV~E~~ 472 (678)
..|+ |....||+....+|+.+++|...... .....+..|..++..+.... +++++.. ...++..++||+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 88889999887677789999886321 12345666777777664222 3333332 22345678999999
Q ss_pred ecCCcc
Q 038949 473 CNGSLD 478 (678)
Q Consensus 473 ~ggsL~ 478 (678)
+|..+.
T Consensus 110 ~G~~~~ 115 (328)
T 1zyl_A 110 GGRQFE 115 (328)
T ss_dssp CCEECC
T ss_pred CCCCCC
Confidence 876553
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.57 E-value=0.00084 Score=73.56 Aligned_cols=73 Identities=16% Similarity=0.163 Sum_probs=49.6
Q ss_pred cceecccCccceeeccCCC--------CcEEEEEeeehhcccCC-ccccccceeeecccccce-EEEEeEEeeCCeEEEE
Q 038949 399 ANFLAEGGFGSVHRGVLPD--------GQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNV-VMLIGFCVEDGRRLLV 468 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~--------g~~vAvK~i~~~~~~~~-~~~~~Ev~iL~~L~HpnI-v~l~~~~~~~~~~~LV 468 (678)
.+.|+.|....+|+....+ ++.+++|+.... .. ..+..|+.+++.+...++ .++++.+.+ .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 3457778888999987542 578999987421 22 456678888888753333 566766543 389
Q ss_pred EEEeecCCcc
Q 038949 469 YEYICNGSLD 478 (678)
Q Consensus 469 ~E~~~ggsL~ 478 (678)
|||++|.+|.
T Consensus 151 ~e~l~G~~l~ 160 (429)
T 1nw1_A 151 EEYIPSRPLS 160 (429)
T ss_dssp ECCCCEEECC
T ss_pred EEEeCCcccC
Confidence 9999875654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.00074 Score=70.77 Aligned_cols=30 Identities=33% Similarity=0.370 Sum_probs=26.6
Q ss_pred eEEeccCCCCceEeeec----Ccccccccccccc
Q 038949 516 CIVHRDMRPNNILVTHD----FEPLVGDFGLARW 545 (678)
Q Consensus 516 gIvHrDLKp~NILl~~~----~~vkL~DFGla~~ 545 (678)
+++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 89999999999999874 6789999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0007 Score=70.04 Aligned_cols=72 Identities=13% Similarity=0.031 Sum_probs=45.6
Q ss_pred cceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccce-EEEEeEEeeCCeEEEEEEEe-ecCC
Q 038949 399 ANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNV-VMLIGFCVEDGRRLLVYEYI-CNGS 476 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnI-v~l~~~~~~~~~~~LV~E~~-~ggs 476 (678)
.+.|+.|....+|+. +.+++|+..... .......+|+.+++.+...++ .+++.++ ...-++|+||+ .|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 567888999999998 458888876432 222234568888877743222 4555543 33357899999 6655
Q ss_pred cc
Q 038949 477 LD 478 (678)
Q Consensus 477 L~ 478 (678)
|.
T Consensus 95 l~ 96 (301)
T 3dxq_A 95 MS 96 (301)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.08 E-value=0.0021 Score=68.40 Aligned_cols=73 Identities=15% Similarity=0.094 Sum_probs=43.5
Q ss_pred ceecccCccceeeccCCC---------CcEEEEEeeehhcccCCccccccceeeecccccc-eEEEEeEEeeCCeEEEEE
Q 038949 400 NFLAEGGFGSVHRGVLPD---------GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN-VVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~---------g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~~~~~~~~LV~ 469 (678)
..|+.|....+|+....+ +..+++|+..... ........|+.+++.+...+ ..++++.+ . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457778788899887533 2688999875332 11123457888888775333 34566544 2 26899
Q ss_pred EEeecCCc
Q 038949 470 EYICNGSL 477 (678)
Q Consensus 470 E~~~ggsL 477 (678)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987655
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.03 E-value=0.0034 Score=69.42 Aligned_cols=74 Identities=9% Similarity=0.022 Sum_probs=47.1
Q ss_pred ceecccCccceeeccCCC-CcEEEEEeeehhcccCCccccccceeeecccccce-EEEEeEEeeCCeEEEEEEEeecCCc
Q 038949 400 NFLAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNV-VMLIGFCVEDGRRLLVYEYICNGSL 477 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~-g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnI-v~l~~~~~~~~~~~LV~E~~~ggsL 477 (678)
+.|+.|-...+|+....+ +..+++|+..... ...-.-.+|+.++..|...++ .++++++.. .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 457778888999988644 4788999874321 111122478888888864443 567777632 359999988665
Q ss_pred c
Q 038949 478 D 478 (678)
Q Consensus 478 ~ 478 (678)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.03 E-value=0.0027 Score=68.46 Aligned_cols=140 Identities=17% Similarity=0.176 Sum_probs=80.2
Q ss_pred ceecccCccceeeccCC--------CCcEEEEEeeehhcccCCccccccceeeeccc-ccceEEEEeEEeeCCeEEEEEE
Q 038949 400 NFLAEGGFGSVHRGVLP--------DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~--------~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~LV~E 470 (678)
+.|..|-...+|+.... +++.+++|+.... ........+|..+++.|. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 34666777888887753 3478999986322 122345668999988875 3223566776654 39999
Q ss_pred EeecCCccccc-c----------------cCC---CCcc--Cccccchhhhhhcc-------------------chhhhh
Q 038949 471 YICNGSLDSHL-Y----------------GRD---RDPL--EWSARRKIAVGAAR-------------------GLRYLH 509 (678)
Q Consensus 471 ~~~ggsL~~~l-~----------------~~~---~~~l--~~~~~~~i~~qI~~-------------------aL~yLH 509 (678)
|++|.+|..-- . ... .... -+..+.+|..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99887664211 0 000 0011 12333344433311 122222
Q ss_pred h----cceeeeEEeccCCCCceEeeec----Cccccccccccc
Q 038949 510 E----ECRVGCIVHRDMRPNNILVTHD----FEPLVGDFGLAR 544 (678)
Q Consensus 510 ~----~~~~~gIvHrDLKp~NILl~~~----~~vkL~DFGla~ 544 (678)
+ ......++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 1 1123479999999999999876 789999998885
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.93 E-value=0.0046 Score=65.28 Aligned_cols=67 Identities=6% Similarity=-0.039 Sum_probs=43.0
Q ss_pred ccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccc---cceEEEEeE------EeeCCeEEEEEEEeec
Q 038949 404 EGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQH---RNVVMLIGF------CVEDGRRLLVYEYICN 474 (678)
Q Consensus 404 ~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~H---pnIv~l~~~------~~~~~~~~LV~E~~~g 474 (678)
.|....||+....+| .+++|+..... ...|+.+++.|.. |++++.+.. ....+..++||+|++|
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~------~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYH------DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSS------CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred CccccceEEEEeCCC-CEEEEEecCcc------chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 333678999987666 89999875432 2456666666532 224444432 2335678999999998
Q ss_pred CCc
Q 038949 475 GSL 477 (678)
Q Consensus 475 gsL 477 (678)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 776
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.13 E-value=0.029 Score=61.31 Aligned_cols=74 Identities=12% Similarity=0.031 Sum_probs=46.6
Q ss_pred ceecccCccceeeccCCC--------CcEEEEEeeehhcccCCccccccceeeecccccc-eEEEEeEEeeCCeEEEEEE
Q 038949 400 NFLAEGGFGSVHRGVLPD--------GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN-VVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~~--------g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~~~~~~~~LV~E 470 (678)
+.|..|-...+|+....+ ++.|++++.... ....-+..+|..+++.+...+ ..++++.+. -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 346667778888887542 578999986432 122223457888888875322 345555432 278999
Q ss_pred EeecCCcc
Q 038949 471 YICNGSLD 478 (678)
Q Consensus 471 ~~~ggsL~ 478 (678)
|++|.+|.
T Consensus 151 fI~G~~l~ 158 (424)
T 3mes_A 151 FIDGEPLT 158 (424)
T ss_dssp CCCSEECC
T ss_pred EeCCccCC
Confidence 99887653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=88.56 E-value=0.019 Score=56.87 Aligned_cols=98 Identities=18% Similarity=0.121 Sum_probs=61.2
Q ss_pred CcccccccCCCCccCccccchhhhhhccchhhhhh-cceeeeEEeccCCCCceEeeecCccccccccccccccCCCccce
Q 038949 476 SLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554 (678)
Q Consensus 476 sL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 554 (678)
+|.+.|.. .+.+++++++|.++.|.+.+|.-+-. . .-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~----~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRR----QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT----CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcc----cCCceecCCcceEEecCCceeccc-cccc----------
Confidence 67777744 35679999999999999998876621 1 101222347889999999888764 1110
Q ss_pred eEEEeeecccccccccccccceecceeeeeeEEEEeeeC
Q 038949 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITG 593 (678)
Q Consensus 555 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG 593 (678)
.....+.+||... ...+.+.=|||||+++|.-+--
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1123467888764 3345677899999999977653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 678 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 2e-66
Identities = 70/284 (24%), Positives = 126/284 (44%), Gaps = 21/284 (7%)
Query: 388 ELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA 447
+ E+ + + + G FG+V++G V + + Q Q F +EV VL
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 448 QHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRY 507
+H N+++ +G+ + +V ++ SL HL+ E IA A+G+ Y
Sbjct: 62 RHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDY 119
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE-TRVLGTFGYLAP 566
LH + I+HRD++ NNI + D +GDFGLA + + ++ G+ ++AP
Sbjct: 120 LHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 567 EYAQ---SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623
E + + ++DVY+ G+VL EL+TG+ P + ++ R +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLSP 229
Query: 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
+ NC M + + C++K RP Q+L +E
Sbjct: 230 DLSKVRSNCPKA-----MKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 6e-65
Identities = 73/282 (25%), Positives = 107/282 (37%), Gaps = 25/282 (8%)
Query: 388 ELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA 447
E E+ L G FG V G VAVK K S F +E ++
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQL 65
Query: 448 QHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRY 507
QH+ +V L ++ EY+ NGSL L L + +A A G+ +
Sbjct: 66 QHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 508 LHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPE 567
+ E +HRD+R NILV+ + DFGLAR D + + APE
Sbjct: 125 IEERN----YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 568 YAQSGQITEKADVYSLGVVLVELITGRKA--MDLNRPRGQQCLTEWARPLLKRHAIGELI 625
G T K+DV+S G++L E++T + + P Q L R + + EL
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240
Query: 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
LC ++ P RP + +LE
Sbjct: 241 Q-----------------LMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 5e-64
Identities = 71/305 (23%), Positives = 124/305 (40%), Gaps = 37/305 (12%)
Query: 389 LELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD-QEFCSEVEVLSC 446
+EL + F + + L G G V + P G V+A K L + E++VL
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 447 AQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLR 506
+V G DG + E++ GSLD L + + K+++ +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLT 118
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAP 566
YL E+ + I+HRD++P+NILV E + DFG++ D +GT Y++P
Sbjct: 119 YLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSP 172
Query: 567 EYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQ-------------------- 606
E Q + ++D++S+G+ LVE+ GR + + +
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 607 ---CLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCA----SLCIRKDPHSRPRM 659
L+ + AI EL+D + + + C+ K+P R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 660 SQVLR 664
Q++
Sbjct: 293 KQLMV 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-61
Identities = 66/274 (24%), Positives = 110/274 (40%), Gaps = 21/274 (7%)
Query: 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVV 453
+ + + G FG VH G + VA+K + + +++F E EV+ H +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
L G C+E LV+E++ +G L + R + + G+ YL E C
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
++HRD+ N LV + V DFG+ R+ D T + +PE +
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 574 ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCY 633
+ K+DV+S GV++ E+ + K NR + I
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-----------EDISTGFRLYKPRLA 227
Query: 634 SEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
S + Q + C ++ P RP S++LR L
Sbjct: 228 STH----VYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (520), Expect = 3e-61
Identities = 65/288 (22%), Positives = 117/288 (40%), Gaps = 21/288 (7%)
Query: 381 PRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEFCS 439
P Y + E+ + + L G +G V+ GV VAVK K + + +EF
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLK 62
Query: 440 EVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAV 499
E V+ +H N+V L+G C + ++ E++ G+L +L +R + +A
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 500 GAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLG 559
+ + YL ++ +HRD+ N LV + V DFGL+R
Sbjct: 123 QISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 560 TFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH 619
+ APE + + K+DV++ GV+L E+ T + P +
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---------------PGIDLS 223
Query: 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
+ EL++ R E + + C + +P RP +++ + E
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-60
Identities = 72/284 (25%), Positives = 105/284 (36%), Gaps = 21/284 (7%)
Query: 384 FTYAELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEV 443
E+ L +G FG V G VA+K K + + F E +V
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQV 65
Query: 444 LSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAAR 503
+ +H +V L + +V EY+ GSL L G L +A A
Sbjct: 66 MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGY 563
G+ Y+ VHRD+R NILV + V DFGLAR D + +
Sbjct: 125 GMAYVERMN----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
Query: 564 LAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623
APE A G+ T K+DV+S G++L EL T + P + + +
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY---------------PGMVNREVLD 225
Query: 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
++ R + C RK+P RP + LE
Sbjct: 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 3e-60
Identities = 78/308 (25%), Positives = 121/308 (39%), Gaps = 43/308 (13%)
Query: 388 ELELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASSQGD-QEFCSE 440
+ E NR S L G FG V VAVK K ++ + + SE
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 441 VEVLS-CAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGR--------------- 484
++VLS H N+V L+G C G L++ EY C G L + L +
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 485 -DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543
D L+ + A+G+ +L + +HRD+ NIL+TH + DFGLA
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 544 RW-QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRP 602
R + D + V+ ++APE + T ++DV+S G+ L EL + + P
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 603 RGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQV 662
+ ++I R E M C DP RP Q+
Sbjct: 253 VDSK--------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
Query: 663 LRMLEGDI 670
++++E I
Sbjct: 299 VQLIEKQI 306
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-60
Identities = 59/269 (21%), Positives = 96/269 (35%), Gaps = 22/269 (8%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE 461
L G FG V G VA+K K S + EF E +V+ H +V L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521
++ EY+ NG L ++L R + ++ + YL + +HRD
Sbjct: 71 QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ----FLHRD 125
Query: 522 MRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVY 581
+ N LV V DFGL+R+ D + + PE + + K+D++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 582 SLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGM 641
+ GV++ E+ + K E I LR +
Sbjct: 186 AFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLYRPHLASEKV 230
Query: 642 LQCASLCIRKDPHSRPRMSQVLRMLEGDI 670
C + RP +L + D+
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSNIL-DV 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-59
Identities = 67/290 (23%), Positives = 121/290 (41%), Gaps = 31/290 (10%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA--QHRNVVMLIGFC 459
+ +G FG V RG G+ VAVK + S+ ++ + E E+ +H N++ I
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 460 VEDG----RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
+D + LV +Y +GSL +L +R + K+A+ A GL +LH E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 516 C----IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE---TRVLGTFGYLAPEY 568
I HRD++ NILV + + D GLA ++ +GT Y+APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 569 AQS------GQITEKADVYSLGVVLVELITGRKAM----DLNRPRGQQCLTEWARPLLKR 618
+ ++AD+Y++G+V E+ D P ++ + +++
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 619 HAIGELIDPRLRNCYSEREV-YGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
+ + P + N + E M + C + +R ++ + L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-59
Identities = 68/279 (24%), Positives = 109/279 (39%), Gaps = 27/279 (9%)
Query: 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQH 449
L + +G FG V G G VAVK + + Q F +E V++ +H
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRH 59
Query: 450 RNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYL 508
N+V L+G VE+ L +V EY+ GSL +L R R L K ++ + YL
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 509 HEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEY 568
VHRD+ N+LV+ D V DFGL + + + APE
Sbjct: 120 EGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEA 171
Query: 569 AQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628
+ + + K+DV+S G++L E+ + + P + L + + +
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVP------RVEKGYKMD 220
Query: 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
+ + + C D RP Q+ LE
Sbjct: 221 APDGCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (502), Expect = 1e-58
Identities = 69/302 (22%), Positives = 118/302 (39%), Gaps = 38/302 (12%)
Query: 384 FTYAELELATNRFSEA---------NFLAEGGFGSVHRGVLP----DGQVVAVKQYKLAS 430
FT+ + A F++ + G FG V G L VA+K K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 431 SQGD-QEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPL 489
++ ++F SE ++ H NV+ L G + +++ E++ NGSLD ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQF 125
Query: 490 EWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549
+ G A G++YL + VHRD+ NILV + V DFGL+R+ D
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 550 DMGVETR----VLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQ 605
+ APE Q + T +DV+S G+V+ E+++ + +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 606 QCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRM 665
+ I+ R + Q C +KD + RP+ Q++
Sbjct: 242 ---------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 666 LE 667
L+
Sbjct: 287 LD 288
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 4e-58
Identities = 66/289 (22%), Positives = 112/289 (38%), Gaps = 32/289 (11%)
Query: 388 ELELATNRFSEANF-LAEGGFGSVHRGVL---PDGQVVAVKQYKLASSQGD-QEFCSEVE 442
+L L + A+ L G FGSV +GV VA+K K + + D +E E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 443 VLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAA 502
++ + +V LIG C + +LV E G L L G+ R+ + S ++ +
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVS 119
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR--VLGT 560
G++YL E+ VHRD+ N+L+ + + DFGL++ D R
Sbjct: 120 MGMKYLEEKN----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 561 FGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKA--MDLNRPRGQQCLTEWARPLLKR 618
+ APE + + ++DV+S GV + E ++ + + P + + R
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 235
Query: 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
EL S C RP V + +
Sbjct: 236 ECPPELYA-----------------LMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 6e-57
Identities = 66/289 (22%), Positives = 117/289 (40%), Gaps = 28/289 (9%)
Query: 390 ELATNRFSEANFLAEGGFGSVHRGVLPDGQ-----VVAVKQYKLASSQGDQ-EFCSEVEV 443
E+ + + + G FG V++G+L VA+K K ++ + +F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 444 LSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAAR 503
+ H N++ L G + +++ EY+ NG+LD L +D + G A
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAA 121
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRV--LGTF 561
G++YL VHRD+ NILV + V DFGL+R D T
Sbjct: 122 GMKYLANMN----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 562 GYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621
+ APE + T +DV+S G+V+ E++T + H +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------------NHEV 222
Query: 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670
+ I+ R + Q C +++ RP+ + ++ +L+ I
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 1e-56
Identities = 70/312 (22%), Positives = 110/312 (35%), Gaps = 49/312 (15%)
Query: 386 YAELELATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASSQGDQ-EFC 438
LE N + EG FG V + P +VAVK K +S Q +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 439 SEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRD----------- 487
E +++ + N+V L+G C L++EY+ G L+ L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 488 -----------PLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL 536
PL + + IA A G+ YL E VHRD+ N LV +
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLVGENMVVK 180
Query: 537 VGDFGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRK 595
+ DFGL+R D + ++ PE + T ++DV++ GVVL E+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 596 AMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHS 655
+ ++ G + + LC K P
Sbjct: 241 QPYYGMAHEE---------VIYYVRDGNI--LACPENCPLE----LYNLMRLCWSKLPAD 285
Query: 656 RPRMSQVLRMLE 667
RP + R+L+
Sbjct: 286 RPSFCSIHRILQ 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 1e-55
Identities = 67/279 (24%), Positives = 114/279 (40%), Gaps = 33/279 (11%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD---QEFCSEVEVLSCAQ 448
FS+ + G FG+V+ + + +VVA+K+ + Q + Q+ EV L +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 449 HRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYL 508
H N + G + + LV EY + D + PL+ + GA +GL YL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 509 HEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEY 568
H ++HRD++ NIL++ +GDFG A +GT ++APE
Sbjct: 132 HSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEV 182
Query: 569 AQS---GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625
+ GQ K DV+SLG+ +EL + + + I +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------------YHIAQNE 230
Query: 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
P L++ + + C++K P RP +L+
Sbjct: 231 SPALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-55
Identities = 73/318 (22%), Positives = 112/318 (35%), Gaps = 49/318 (15%)
Query: 381 PRWFTY-AELELATNRFSEANFLAEGGFGSVHRGVLPD------GQVVAVKQYKLASSQG 433
R + Y + E L G FG V VAVK K +
Sbjct: 23 FREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS 82
Query: 434 DQE-FCSEVEVLS-CAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGR------- 484
++E SE+++++ H N+V L+G C G L++EY C G L ++L +
Sbjct: 83 EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 142
Query: 485 --------------DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT 530
D + L + A A+G+ +L + VHRD+ N+LVT
Sbjct: 143 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARNVLVT 198
Query: 531 HDFEPLVGDFGLARW-QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVE 589
H + DFGLAR D + V ++APE G T K+DV+S G++L E
Sbjct: 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258
Query: 590 LITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCI 649
+ + P +LI + + C
Sbjct: 259 IFSLGVNPYPGIPVDAN--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCW 304
Query: 650 RKDPHSRPRMSQVLRMLE 667
D RP + L
Sbjct: 305 AFDSRKRPSFPNLTSFLG 322
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-55
Identities = 68/275 (24%), Positives = 114/275 (41%), Gaps = 29/275 (10%)
Query: 402 LAEGGFGSVHRGVLPD----GQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHRNVVMLI 456
+ G FG V+ G L D AVK + G+ +F +E ++ H NV+ L+
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 457 GFCVE-DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
G C+ +G L+V Y+ +G L + + +P + A+G+++L +
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASK---- 149
Query: 516 CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG---VETRVLGTFGYLAPEYAQSG 572
VHRD+ N ++ F V DFGLAR D + +T ++A E Q+
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209
Query: 573 QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632
+ T K+DV+S GV+L EL+T P + LL+ L+ P C
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGR---RLLQP--EYC 259
Query: 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
+ + C RP S+++ +
Sbjct: 260 PDP-----LYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-54
Identities = 61/279 (21%), Positives = 105/279 (37%), Gaps = 33/279 (11%)
Query: 398 EANFLAEGGFGSVHRGVLPD---GQVVAVKQYKLASSQGD--QEFCSEVEVLSCAQHRNV 452
E L G FG+V +G + VAVK K ++ E +E V+ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 453 VMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC 512
V +IG C E +LV E G L+ +L ++ ++ + G++YL E
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETR--VLGTFGYLAPEYAQ 570
VHRD+ N+L+ + DFGL++ + + + + APE
Sbjct: 128 ----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 571 SGQITEKADVYSLGVVLVELITGRKA--MDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628
+ + K+DV+S GV++ E + + + L + R E+ D
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD-- 241
Query: 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
+LC D +RP + V L
Sbjct: 242 ---------------LMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 4e-54
Identities = 63/269 (23%), Positives = 116/269 (43%), Gaps = 26/269 (9%)
Query: 402 LAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
L +G FG V++ + + A K S + +++ E+++L+ H N+V L+
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
+ ++ E+ G++D+ + +R PL S + + L YLH+ I+HR
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDN----KIIHR 134
Query: 521 DMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ-----IT 575
D++ NIL T D + + DFG++ ++ + GT ++APE
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYD 193
Query: 576 EKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSE 635
KADV+SLG+ L+E+ P +L + A E + +S
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMR----------VLLKIAKSEPPTLAQPSRWSS 243
Query: 636 REVYGMLQCASLCIRKDPHSRPRMSQVLR 664
L+ C+ K+ +R SQ+L+
Sbjct: 244 -NFKDFLKK---CLEKNVDARWTTSQLLQ 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 5e-54
Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 30/275 (10%)
Query: 394 NRFSEANFLAEGGFGSVHRGVLP-DGQVVAVKQYK---LASSQGDQEFCSEVEVLSCAQH 449
F L +G FG+V+ ++A+K L + + + EVE+ S +H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 450 RNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLH 509
N++ L G+ + R L+ EY G++ L + + A L Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 123
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYA 569
+ ++HRD++P N+L+ E + DFG + P T + GT YL PE
Sbjct: 124 SKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMI 176
Query: 570 QSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629
+ EK D++SLGV+ E + G+ + N + + R + +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----YKRISRVEFTFPDFVTEGA 231
Query: 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
R+ S ++ +P RP + +VL
Sbjct: 232 RD------------LISRLLKHNPSQRPMLREVLE 254
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 5e-54
Identities = 60/271 (22%), Positives = 107/271 (39%), Gaps = 25/271 (9%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD--QEFCSEVEVLSCAQHRNVVMLIGF 458
+ G +G + DG+++ K+ S Q SEV +L +H N+V
Sbjct: 12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71
Query: 459 CVE--DGRRLLVYEYICNGSLDSHL--YGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514
++ + +V EY G L S + ++R L+ ++ L+ H
Sbjct: 72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 131
Query: 515 G-CIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
G ++HRD++P N+ + +GDFGLAR + D +GT Y++PE
Sbjct: 132 GHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKAFVGTPYYMSPEQMNRMS 190
Query: 574 ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCY 633
EK+D++SLG +L EL + I E R+ Y
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------------AGKIREGKFRRIPYRY 238
Query: 634 SEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
S+ + + + + + RP + ++L
Sbjct: 239 SDE----LNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 6e-53
Identities = 57/273 (20%), Positives = 104/273 (38%), Gaps = 23/273 (8%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN 451
+++ + +G G+V+ + + GQ VA++Q L + +E+ V+ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEE 511
+V + + +V EY+ GSL + D + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLHSN 135
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS 571
++HRD++ +NIL+ D + DFG T V GT ++APE
Sbjct: 136 ----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 572 GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631
K D++SLG++ +E+I G P L A + +
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----------LYLIATNGTPELQNPE 240
Query: 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
S L C+ D R ++L+
Sbjct: 241 KLSA-IFRDFLNR---CLDMDVEKRGSAKELLQ 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 6e-53
Identities = 57/271 (21%), Positives = 106/271 (39%), Gaps = 30/271 (11%)
Query: 402 LAEGGFGSVHRGVLPD-GQVVAVKQYKL--ASSQGDQEFCSEVEVLSCAQHRNVVMLIGF 458
+ G F +V++G+ + VA + + + Q F E E+L QH N+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 459 CVEDGRR----LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514
+ +LV E + +G+L ++L + ++ R +GL++LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRTP- 133
Query: 515 GCIVHRDMRPNNILVTH-DFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
I+HRD++ +NI +T +GD GLA + V+GT ++APE + +
Sbjct: 134 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYE-EK 188
Query: 574 ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCY 633
E DVY+ G+ ++E+ T + R +
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYS----------ECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 634 SEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
+ + CIR++ R + +L
Sbjct: 239 IPE----VKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-52
Identities = 59/267 (22%), Positives = 97/267 (36%), Gaps = 24/267 (8%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE-FCSEVEVLSCAQHRNVVMLIGFC 459
L EG +G V V + VAVK + + E E+ + H NVV G
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 460 VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVH 519
E + L EY G L + + ++ G+ YLH I H
Sbjct: 73 REGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI----GITH 126
Query: 520 RDMRPNNILVTHDFEPLVGDFGLARW-QPDGDMGVETRVLGTFGYLAPEYAQSGQI-TEK 577
RD++P N+L+ + DFGLA + + + ++ GT Y+APE + + E
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 578 ADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSERE 637
DV+S G+VL ++ G D Q + + S
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQ---------EYSDWKEKKTYLNPWKKIDSA-- 235
Query: 638 VYGMLQCASLCIRKDPHSRPRMSQVLR 664
L + ++P +R + + +
Sbjct: 236 ---PLALLHKILVENPSARITIPDIKK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-51
Identities = 67/285 (23%), Positives = 112/285 (39%), Gaps = 26/285 (9%)
Query: 388 ELELATNRFSEANFLAEGGFGSVHRGVLPD----GQVVAVKQYKLASSQGDQE-FCSEVE 442
+ E+ R + EG FG VH+G+ VA+K K +S +E F E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 443 VLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAA 502
+ H ++V LIG + ++ E G L S L R L+ ++ A +
Sbjct: 61 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLS 118
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFG 562
L YL + VHRD+ N+LV+ + +GDFGL+R+ D ++
Sbjct: 119 TALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 563 YLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622
++APE + T +DV+ GV + E++ +P + + +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGERL- 228
Query: 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
P NC + + C DP RPR +++ L
Sbjct: 229 ----PMPPNCPPT-----LYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-51
Identities = 73/293 (24%), Positives = 115/293 (39%), Gaps = 40/293 (13%)
Query: 394 NRFSEANFLAEGGFGSVHRGVLPDG---QVVAVKQYKLASSQGD-QEFCSEVEVLS-CAQ 448
N + + EG FG V + + A+K+ K +S+ D ++F E+EVL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 449 HRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRD--------------RDPLEWSAR 494
H N++ L+G C G L EY +G+L L L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 495 RKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVE 554
A ARG+ YL ++ +HRD+ NILV ++ + DFGL+R Q
Sbjct: 130 LHFAADVARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-- 183
Query: 555 TRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARP 614
T ++A E T +DV+S GV+L E+++ P E
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEK 238
Query: 615 LLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
L + + + + NC E + C R+ P+ RP +Q+L L
Sbjct: 239 LPQGYRL-----EKPLNCDDE-----VYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-51
Identities = 65/275 (23%), Positives = 100/275 (36%), Gaps = 29/275 (10%)
Query: 402 LAEGGFGSVHRGVLP----DGQVVAVKQYK---LASSQGDQEFCSEVEVLSCAQHRNVVM 454
L +G FG V RG VAVK K L+ + +F EV + HRN++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 455 LIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRV 514
L G +V E GSL + + + AV A G+ YL +
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESK--- 130
Query: 515 GCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD--MGVETRVLGTFGYLAPEYAQSG 572
+HRD+ N+L+ +GDFGL R P D ++ F + APE ++
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 573 QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632
+ +D + GV L E+ T + + Q +L + PR +C
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---------ILHKIDKEGERLPRPEDC 240
Query: 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
+ + C P RP + L
Sbjct: 241 PQD-----IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-50
Identities = 76/312 (24%), Positives = 132/312 (42%), Gaps = 41/312 (13%)
Query: 381 PRWFTYAEL------ELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKL 428
P +F+ A++ E+A + + + L +G FG V+ GV VA+K
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 429 ASSQGD-QEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRD 487
A+S + EF +E V+ +VV L+G + L++ E + G L S+L
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 488 --------PLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGD 539
P S ++A A G+ YL+ VHRD+ N +V DF +GD
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGD 176
Query: 540 FGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMD 598
FG+ R + D + L +++PE + G T +DV+S GVVL E+ T +
Sbjct: 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 236
Query: 599 LNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR 658
Q +L+ G L+ + NC + + +C + +P RP
Sbjct: 237 QGLSNEQ---------VLRFVMEGGLL-DKPDNCPDM-----LFELMRMCWQYNPKMRPS 281
Query: 659 MSQVLRMLEGDI 670
+++ ++ ++
Sbjct: 282 FLEIISSIKEEM 293
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 3e-49
Identities = 73/320 (22%), Positives = 121/320 (37%), Gaps = 48/320 (15%)
Query: 379 NPPRWFTYAELELATNRFSEANFLAEGGFGSVHRGV------LPDGQVVAVKQYKLASSQ 432
+ +W E +R L G FG V + VAVK K ++
Sbjct: 4 DASKW------EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 57
Query: 433 GD-QEFCSEVEVLS-CAQHRNVVMLIGFCVEDGRRL-LVYEYICNGSLDSHLYGRD---- 485
+ + SE+++L H NVV L+G C + G L ++ E+ G+L ++L +
Sbjct: 58 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 117
Query: 486 ----------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEP 535
+D L + A+G+ +L +HRD+ NIL++
Sbjct: 118 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK----CIHRDLAARNILLSEKNVV 173
Query: 536 LVGDFGLARW-QPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
+ DFGLAR D D + ++APE T ++DV+S GV+L E+ +
Sbjct: 174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233
Query: 595 KAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPH 654
P + E LK R + + M Q C +P
Sbjct: 234 A-----SPYPGVKIDEEFCRRLKEG-----TRMRAPDYTTPE----MYQTMLDCWHGEPS 279
Query: 655 SRPRMSQVLRMLEGDILMNS 674
RP S+++ L + N+
Sbjct: 280 QRPTFSELVEHLGNLLQANA 299
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 9e-49
Identities = 60/279 (21%), Positives = 112/279 (40%), Gaps = 28/279 (10%)
Query: 396 FSEANFLAEGGFGSVHRGV-LPDGQV----VAVKQYKLASS-QGDQEFCSEVEVLSCAQH 449
F + L G FG+V++G+ +P+G+ VA+K+ + A+S + ++E E V++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 450 RNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLH 509
+V L+G C L+ + + G L ++ +D + V A+G+ YL
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-WQPDGDMGVETRVLGTFGYLAPEY 568
+ +VHRD+ N+LV + DFGLA+ + ++A E
Sbjct: 129 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 569 AQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628
T ++DV+S GV + EL+T + I +++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSILEKG 229
Query: 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
R + C D SRP+ +++
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-48
Identities = 79/320 (24%), Positives = 122/320 (38%), Gaps = 50/320 (15%)
Query: 380 PPRWFTYAELELATNRFSEANFLAEGGFGSVHRGVLP--------DGQVVAVKQYKLASS 431
PRW EL +R L EG FG V VAVK K ++
Sbjct: 5 DPRW------ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58
Query: 432 QGD-QEFCSEVEVLS-CAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGR----- 484
+ D + SE+E++ +H+N++ L+G C +DG ++ EY G+L +L R
Sbjct: 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 485 ---------DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEP 535
+ L A ARG+ YL + +HRD+ N+LVT D
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK----CIHRDLAARNVLVTEDNVM 174
Query: 536 LVGDFGLARWQPDGDMGVETRVL-GTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR 594
+ DFGLAR D +T ++APE T ++DV+S GV+L E+ T
Sbjct: 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234
Query: 595 KAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPH 654
+ P + +L+ R + C P
Sbjct: 235 GSPYPGVP---------------VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPS 279
Query: 655 SRPRMSQVLRMLEGDILMNS 674
RP Q++ L+ + + S
Sbjct: 280 QRPTFKQLVEDLDRIVALTS 299
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 170 bits (431), Expect = 6e-48
Identities = 54/274 (19%), Positives = 97/274 (35%), Gaps = 23/274 (8%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNV 452
+ + L G FG VHR G A K + E++ +S +H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 453 VMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC 512
V L +D +++YE++ G L + + + + +GL ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN- 143
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLV--GDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQ 570
VH D++P NI+ T + DFGL T GT + APE A+
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAE 198
Query: 571 SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLR 630
+ D++S+GV+ L++G L+ +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----------DETLRNVKSCDWNMDDSA 248
Query: 631 NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
+ ++ + DP++R + Q L
Sbjct: 249 FSGISEDGKDFIRK---LLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (420), Expect = 2e-46
Identities = 54/266 (20%), Positives = 95/266 (35%), Gaps = 23/266 (8%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
L G FG VHR V G+V K +E+ +++ H ++ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
+ +L+ E++ G L + D + + A GL+++HE IVH
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEH----SIVHL 151
Query: 521 DMRPNNILVTHDFEPLV--GDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKA 578
D++P NI+ V DFGLA ++ T T + APE +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYT 209
Query: 579 DVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREV 638
D++++GV+ L++G E L+ + E
Sbjct: 210 DMWAIGVLGYVLLSGLSPFA----------GEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259
Query: 639 YGMLQCASLCIRKDPHSRPRMSQVLR 664
++ ++K+P R + L
Sbjct: 260 KDFIKN---LLQKEPRKRLTVHDALE 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 3e-46
Identities = 56/278 (20%), Positives = 98/278 (35%), Gaps = 28/278 (10%)
Query: 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYK---LASSQGDQEFCSEVEVLSCAQHR 450
F L EG F +V L + A+K + + E +V+S H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 451 NVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE 510
V L +D + Y NG L ++ + + R L YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR-WQPDGDMGVETRVLGTFGYLAPEYA 569
+ I+HRD++P NIL+ D + DFG A+ P+ +GT Y++PE
Sbjct: 127 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 570 QSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629
+ +D+++LG ++ +L+ G + + + + E P+
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEYDFPEKFFPKA 237
Query: 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
R+ V +L D R ++
Sbjct: 238 RDL-----VEKLLV-------LDATKRLGCEEMEGYGP 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 7e-46
Identities = 61/284 (21%), Positives = 111/284 (39%), Gaps = 26/284 (9%)
Query: 386 YAELELATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE-FCSEVEV 443
+ + E + + + L G F V ++VA+K + +G + +E+ V
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 444 LSCAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAAR 503
L +H N+V L G L+ + + G L + ++ ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLD 118
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTH---DFEPLVGDFGLARWQPDGDMGVETRVLGT 560
++YLH+ IVHRD++P N+L D + ++ DFGL++ + G + + GT
Sbjct: 119 AVKYLHDL----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGT 172
Query: 561 FGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620
GY+APE ++ D +S+GV+ L+ G P + + +LK
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAE- 225
Query: 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
E P + + KDP R Q L+
Sbjct: 226 -YEFDSPYWDDISDS-----AKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 2e-45
Identities = 52/284 (18%), Positives = 95/284 (33%), Gaps = 26/284 (9%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNV 452
NR+ + G FG ++ G + G+ VA+K + E ++ Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVG 64
Query: 453 VMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC 512
+ I +C +G ++ + SL+ L+ +A + Y+H +
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 513 RVGCIVHRDMRPNNILVT---HDFEPLVGDFGLARWQPDGDMGVE------TRVLGTFGY 563
+HRD++P+N L+ + DFGLA+ D + GT Y
Sbjct: 124 ----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 564 LAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGE 623
+ + + + D+ SLG VL+ G + ++ E I
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-- 237
Query: 624 LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667
L Y E L C +P S + ++
Sbjct: 238 ---EVLCKGYPS-EFATYLNF---CRSLRFDDKPDYSYLRQLFR 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 160 bits (405), Expect = 3e-45
Identities = 65/286 (22%), Positives = 119/286 (41%), Gaps = 30/286 (10%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD---QEFCSEVEVLSCAQ 448
++R+ L GG VH L + VAVK + ++ F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 449 HRNVVMLIGFCVEDGRRL----LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARG 504
H +V + + +V EY+ +L + P+ ++ A +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQA 123
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD--MGVETRVLGTFG 562
L + H+ I+HRD++P NI+++ V DFG+AR D + V+GT
Sbjct: 124 LNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 563 YLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622
YL+PE A+ + ++DVYSLG VL E++TG + P + +H
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----------VAYQHVRE 229
Query: 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR-MSQVLRMLE 667
+ I P R+ ++ ++ + K+P +R + +++ L
Sbjct: 230 DPIPPSARHEGLSADLDAVVLK---ALAKNPENRYQTAAEMRADLV 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-43
Identities = 55/266 (20%), Positives = 95/266 (35%), Gaps = 24/266 (9%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCV 460
L G FG VHR V + K K+ + E+ +L+ A+HRN++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 461 EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHR 520
++++E+I + + L L++LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHSH----NIGHF 126
Query: 521 DMRPNNILVTHDFEPLV--GDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKA 578
D+RP NI+ + +FG AR GD + Y APE Q ++
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 579 DVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREV 638
D++SLG ++ L++G E + +++ E E
Sbjct: 185 DMWSLGTLVYVLLSGINPFL----------AETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 639 YGMLQCASLCIRKDPHSRPRMSQVLR 664
+ + K+ SR S+ L+
Sbjct: 235 MDFVDR---LLVKERKSRMTASEALQ 257
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 158 bits (400), Expect = 2e-43
Identities = 61/276 (22%), Positives = 106/276 (38%), Gaps = 31/276 (11%)
Query: 394 NRFSEANFLAEGGFGSVHRGVLPD-GQVVAVKQYK---LASSQGDQEFCSEVEVLSCAQ- 448
N FS + GGFG V+ D G++ A+K + QG+ +E +LS
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 449 --HRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLR 506
+V + + + + + G L HL + R A GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLE 121
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAP 566
++H +V+RD++P NIL+ + D GLA +GT GY+AP
Sbjct: 122 HMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAP 174
Query: 567 EYAQSGQ-ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625
E Q G AD +SLG +L +L+ G ++ + + + +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----------M 224
Query: 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQ 661
L + +S E+ +L+ +++D + R
Sbjct: 225 AVELPDSFSP-ELRSLLEG---LLQRDVNRRLGCLG 256
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-43
Identities = 60/276 (21%), Positives = 97/276 (35%), Gaps = 29/276 (10%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE---FCSEVEVLSCA-Q 448
F L +G FG V Q A+K K D + E VLS A +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 449 HRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYL 508
H + + V EY+ G L H+ + + S A GL++L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFL 119
Query: 509 HEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEY 568
H + IV+RD++ +NIL+ D + DFG+ + GD GT Y+APE
Sbjct: 120 HSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEI 174
Query: 569 AQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628
+ D +S GV+L E++ G+ P R ++
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW-----LEKE 229
Query: 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
++ + ++P R + +R
Sbjct: 230 AKDLLVK------------LFVREPEKRLGVRGDIR 253
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (386), Expect = 2e-42
Identities = 59/287 (20%), Positives = 98/287 (34%), Gaps = 38/287 (13%)
Query: 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD---------QEFCSEVEVL 444
+ L G V R + P + AVK + + EV++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 445 S-CAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAAR 503
+ H N++ L + LV++ + G L +L ++ L RKI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLE 121
Query: 504 GLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGY 563
+ LH+ IVHRD++P NIL+ D + DFG + G+ V GT Y
Sbjct: 122 VICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSY 175
Query: 564 LAPEYAQSGQ------ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK 617
LAPE + ++ D++S GV++ L+ G +L+
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW----------HRKQMLMLR 225
Query: 618 RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
G V ++ + P R + L
Sbjct: 226 MIMSGNYQFGSPEWDDYSDTVKDLVSR---FLVVQPQKRYTAEEALA 269
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (387), Expect = 2e-42
Identities = 43/298 (14%), Positives = 92/298 (30%), Gaps = 31/298 (10%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNV 452
+ + EG FG + G L + Q VA+K + E
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 453 VMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC 512
+ + + ++G ++ + G L A ++ +HE+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 513 RVGCIVHRDMRPNNILVTHDFEPLVG-----DFGLARWQPDGDMGVETR------VLGTF 561
+V+RD++P+N L+ DFG+ ++ D + GT
Sbjct: 122 ----LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 562 GYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621
Y++ + + + D+ +LG V + + G + + E + +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL--MNSKDD 677
EL E + + P + + +L +N+ +D
Sbjct: 238 REL----CAGFPEE-----FYKYMHYARNLAFDATPDYDYLQGLFS-KVLERLNTTED 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 9e-42
Identities = 59/294 (20%), Positives = 101/294 (34%), Gaps = 27/294 (9%)
Query: 392 ATNRFSEANFLAEGGFGSVHRG--VLPDGQVVAVKQYKLASSQGDQEFCSEVEV-----L 444
A ++ + EG +G V + + G+ VA+K+ ++ + + + EV L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 445 SCAQHRNVVMLIGFCVEDGRRLLVYEYI----CNGSLDSHLYGRDRDPLEWSARRKIAVG 500
+H NVV L C + + L ++L + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 501 AARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGT 560
RGL +LH +VHRD++P NILVT + + DFGLAR T V+ T
Sbjct: 125 LLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVT 178
Query: 561 FGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPR----------GQQCLTE 610
Y APE D++S+G + E+ + + G +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 611 WARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
W R + + + C+ +P R L
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (379), Expect = 2e-41
Identities = 55/285 (19%), Positives = 105/285 (36%), Gaps = 20/285 (7%)
Query: 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRN 451
++ + EG +G V++ G+ A+K+ +L E+ +L +H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEE 511
+V L R +LV+E++ LE + + G+ Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS 571
++HRD++P N+L+ + E + DFGLAR ++ + S
Sbjct: 120 R----VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 572 GQITEKADVYSLGVVLVELITGRK----------AMDLNRPRGQQCLTEWAR--PLLKRH 619
+ + D++S+G + E++ G M + R G W L K
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 620 AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
+ +P + + + S ++ DP+ R Q L
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 6e-41
Identities = 57/282 (20%), Positives = 100/282 (35%), Gaps = 32/282 (11%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD------QEFCSEVEVLSC 446
+ + L G F V + G A K K ++ ++ EV +L
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 447 AQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLR 506
QH NV+ L +L+ E + G L L +++ L + G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVY 127
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPL----VGDFGLARWQPDGDMGVETRVLGTFG 562
YLH I H D++P NI++ P + DFGLA G+ + GT
Sbjct: 128 YLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPE 181
Query: 563 YLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622
++APE + +AD++S+GV+ L++G + + L +
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----------QETLANVSAV 231
Query: 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
+ ++ + KDP R + L+
Sbjct: 232 NYEFEDEYFSNTSALAKDFIRR---LLVKDPKKRMTIQDSLQ 270
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-40
Identities = 54/285 (18%), Positives = 103/285 (36%), Gaps = 20/285 (7%)
Query: 395 RFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRN 451
F + + EG +G V++ G+VVA+K+ +L + E+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEE 511
+V L+ + + LV+E+ + L + + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQS 571
++HRD++P N+L+ + + DFGLAR V+ +
Sbjct: 122 R----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 572 GQITEKADVYSLGVVLVELITGRKAMDLNRP--------RGQQCLTEWARPLLKRHAIGE 623
+ D++SLG + E++T R + R E P + +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 624 LIDPRLRNCYSEREVYGMLQCA----SLCIRKDPHSRPRMSQVLR 664
P+ + V + + S + DP+ R L
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 58/284 (20%), Positives = 112/284 (39%), Gaps = 25/284 (8%)
Query: 400 NFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE-----FCSEVEVLSCAQHRNVV 453
+FL EG F +V++ Q+VA+K+ KL ++ E+++L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 454 MLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECR 513
L+ LV++++ + + L S + + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 514 VGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQ 573
I+HRD++PNN+L+ + + DFGLA+ T + T Y APE +
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGAR 176
Query: 574 -ITEKADVYSLGVVLVELITGRKAMDLNRPRGQ------QCLTEWARPLLKRHAIGELID 626
D++++G +L EL+ + + Q T ++ + +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 627 PRLRNCYSEREVYGML--QCASL---CIRKDPHSRPRMSQVLRM 665
+ ++ L +P +R +Q L+M
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-40
Identities = 59/292 (20%), Positives = 110/292 (37%), Gaps = 24/292 (8%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD-QEFCSEVEVLSCAQHR 450
R++ +++ EG +G V + VA+K+ Q Q E+++L +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 451 NVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGR-DRDPLEWSARRKIAVGAARGLRYLH 509
N++ + + Y+ + + LY L RGL+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR--WQPDGDMGVETRVLGTFGYLAPE 567
++HRD++P+N+L+ + + DFGLAR G T + T Y APE
Sbjct: 127 SA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 568 YAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626
+ + T+ D++S+G +L E+++ R Q + + +I+
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 627 PRLRNCYSEREVYGMLQCASL--------------CIRKDPHSRPRMSQVLR 664
+ RN + L + +PH R + Q L
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 4e-40
Identities = 54/272 (19%), Positives = 99/272 (36%), Gaps = 29/272 (10%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLS-CAQHRNVVMLIGFC 459
L G G V + + A+K + + EVE+ +Q ++V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 460 ----VEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVG 515
L+V E + G L S + R +I ++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---- 130
Query: 516 CIVHRDMRPNNILVTHDFEPLV---GDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSG 572
I HRD++P N+L T + DFG A+ + T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPE 188
Query: 573 QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632
+ + D++SLGV++ L+ G P + + R +G+ P
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
EV +++ ++ +P R +++ +
Sbjct: 243 EVSEEVKMLIRN---LLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 9e-40
Identities = 56/288 (19%), Positives = 104/288 (36%), Gaps = 54/288 (18%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE------FCSEVEVLS- 445
+++ L GGFGSV+ G+ + D VA+K + E EV +L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 446 -CAQHRNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARG 504
+ V+ L+ + +L+ E D + +R L+ R
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHD-FEPLVGDFGLARWQPDGDMGVETRVLGTFGY 563
+R+ H ++HRD++ NIL+ + E + DFG D T GT Y
Sbjct: 123 VRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVY 175
Query: 564 LAPEYAQSGQ-ITEKADVYSLGVVLVELITGR------KAMDLNRPRGQQCLTEWARPLL 616
PE+ + + A V+SLG++L +++ G + + + +Q ++ + L+
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 235
Query: 617 KRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
+ C+ P RP ++
Sbjct: 236 RW-----------------------------CLALRPSDRPTFEEIQN 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (363), Expect = 6e-39
Identities = 63/264 (23%), Positives = 107/264 (40%), Gaps = 31/264 (11%)
Query: 402 LAEGGFGSVHRGV-LPDGQVVAVKQYK---LASSQGDQEFCSEVEVLSCAQHRNVVMLIG 457
L G FG VH +G+ A+K K + + + E +LS H ++ + G
Sbjct: 12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71
Query: 458 FCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCI 517
+ + ++ +YI G L S L R P + A L YLH + I
Sbjct: 72 TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV--AKFYAAEVCLALEYLHSK----DI 125
Query: 518 VHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEK 577
++RD++P NIL+ + + DFG A++ PD V + GT Y+APE + +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 578 ADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSERE 637
D +S G+++ E++ G + ++ EL P ++E +
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMK----------TYEKILNAELRFPP---FFNE-D 227
Query: 638 VYGMLQCASLCIRKDPHSRPRMSQ 661
V +L I +D R Q
Sbjct: 228 VKDLLSR---LITRDLSQRLGNLQ 248
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 58/292 (19%), Positives = 107/292 (36%), Gaps = 32/292 (10%)
Query: 395 RFSEANFLAEGGFGSVHRGVLPD-GQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVV 453
+++ + G FG V++ L D G++VA+K+ Q + E++++ H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 454 MLIGFCVEDGRR------LLVYEYICNGSLDSHL-YGRDRDPLEWSARRKIAVGAARGLR 506
L F G + LV +Y+ Y R + L + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 507 YLHEECRVGCIVHRDMRPNNILVTHDFEPL-VGDFGLARWQPDGDMGVETRVLGTFGYLA 565
Y+H I HRD++P N+L+ D L + DFG A+ G+ + + +
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRYYRAP 191
Query: 566 PEYAQSGQITEKADVYSLGVVLVELITGR-------------KAMDLNRPRGQQCLTEWA 612
+ T DV+S G VL EL+ G+ + + + ++ + E
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM- 250
Query: 613 RPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664
P ++ + R + S + P +R +
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-37
Identities = 59/301 (19%), Positives = 106/301 (35%), Gaps = 36/301 (11%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD--QEFCSEVEVLSCAQHR 450
+++ + + +G FG V + GQ VA+K+ + + + E+++L +H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 451 NVVMLIGFCVE--------DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAA 502
NVV LI C G LV+++ + S +++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLL 127
Query: 503 RGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW---QPDGDMGVETRVLG 559
GL Y+H I+HRDM+ N+L+T D + DFGLAR + T +
Sbjct: 128 NGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 560 TFGYLAPEYAQSGQ-ITEKADVYSLGVVLVELITGRKAMDLNRP--------RGQQCLTE 610
T Y PE + D++ G ++ E+ T M N + +T
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 611 WARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASL-------CIRKDPHSRPRMSQVL 663
P + + + E ++ ++ + DP R L
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 664 R 664
Sbjct: 304 N 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 48/287 (16%), Positives = 102/287 (35%), Gaps = 22/287 (7%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHR 450
++ + + EG +G+V + ++VA+K+ +L E+ +L +H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 451 NVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHE 510
N+V L D + LV+E+ E + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI--VKSFLFQLLKGLGFCHS 119
Query: 511 ECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQ 570
++HRD++P N+L+ + E + +FGLAR V+ +
Sbjct: 120 RN----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 571 SGQITEKADVYSLGVVLVELITGRK----AMDLNRPRGQQCLTEWARPLLKRHAIGELID 626
+ + D++S G + EL + D++ + + ++ +L D
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 627 PRLRNCYSEREVYGML------QCASL---CIRKDPHSRPRMSQVLR 664
+ Y + L ++ +P R + L+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 6e-34
Identities = 58/290 (20%), Positives = 105/290 (36%), Gaps = 26/290 (8%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYK--LASSQGDQEFCSEVEVLSCAQHR 450
+ + + G +G+V V G VA+K+ S + E+ +L +H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 451 NVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGR--DRDPLEWSARRKIAVGAARGLRYL 508
NV+ L+ D ++ G+ + L + + +GLRY+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 509 HEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEY 568
H + HRD++P N+ V D E + DFGLAR Q D +M V+ +
Sbjct: 138 HAAGII----HRDLKPGNLAVNEDCELKILDFGLAR-QADSEM--TGYVVTRWYRAPEVI 190
Query: 569 AQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628
+ T+ D++S+G ++ E+ITG+ + Q + L
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 629 LRNC------YSEREVYGMLQCASL--------CIRKDPHSRPRMSQVLR 664
+N +++ +L AS + D R + L
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-33
Identities = 65/272 (23%), Positives = 95/272 (34%), Gaps = 28/272 (10%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE---FCSEVEVLSCAQH 449
N F L +G FG V G+ A+K + E +E VL +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 450 RNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLH 509
+ L R V EY G L HL R L YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLH 122
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYA 569
+V+RD++ N+++ D + DFGL + ++T GT YLAPE
Sbjct: 123 SR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177
Query: 570 QSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629
+ D + LGVV+ E++ GR + L + + E+ PR
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFY----------NQDHERLFELILMEEIRFPR- 226
Query: 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQ 661
S E +L ++KDP R
Sbjct: 227 --TLSP-EAKSLLAG---LLKKDPKQRLGGGP 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 128 bits (323), Expect = 3e-33
Identities = 54/268 (20%), Positives = 89/268 (33%), Gaps = 31/268 (11%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQE---FCSEVEVLSCAQH 449
++F L G FG V G A+K ++ +E +L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 450 RNVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLH 509
+V L ++ +V EY+ G + SHL R A YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 510 EECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYA 569
+++RD++P N+L+ V DFG A+ G + GT LAPE
Sbjct: 159 SLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEALAPEII 210
Query: 570 QSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629
S + D ++LGV++ E+ G ++P + H L
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH-----FSSDL 265
Query: 630 RNCYSEREVYGMLQCASLCIRKDPHSRP 657
++ ++ D R
Sbjct: 266 KDLLRN------------LLQVDLTKRF 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (319), Expect = 7e-33
Identities = 55/316 (17%), Positives = 108/316 (34%), Gaps = 44/316 (13%)
Query: 379 NPPRWFTYAELELAT---NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGD 434
P ++ Y + + + L G + V + + + + V VK K +
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-- 74
Query: 435 QEFCSEVEVLS-CAQHRNVVMLIGFCVEDGRRL--LVYEYICNGSLDSHLYGRDRDPLEW 491
+ E+++L N++ L + R LV+E++ N L
Sbjct: 75 -KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTD 128
Query: 492 SARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPL-VGDFGLARWQPDGD 550
R + L Y H I+HRD++P+N+++ H+ L + D+GLA + G
Sbjct: 129 YDIRFYMYEILKALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
Query: 551 MGVETRVLGTFGYLAPEYAQSGQ-ITEKADVYSLGVVLVELITGRKAMD----------- 598
+ + + PE Q D++SLG +L +I ++
Sbjct: 185 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242
Query: 599 LNRPRGQQCLTEWAR-------PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASL---C 648
+ + G + L ++ P R +SE + +
Sbjct: 243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302
Query: 649 IRKDPHSRPRMSQVLR 664
+R D SR + +
Sbjct: 303 LRYDHQSRLTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 8e-32
Identities = 59/279 (21%), Positives = 110/279 (39%), Gaps = 30/279 (10%)
Query: 394 NRFSEANFLAEGGFGSVHRGVL----PDGQVVAVKQYKLAS----SQGDQEFCSEVEVLS 445
F L G +G V G++ A+K K A+ ++ + +E +VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 446 CAQHR-NVVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARG 504
+ +V L + + L+ +YI G L +HL R+R + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEI 138
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL 564
+ L ++G I++RD++ NIL+ + ++ DFGL++ + GT Y+
Sbjct: 139 VLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 565 APEYAQSGQ--ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622
AP+ + G + D +SLGV++ EL+TG ++ + Q R L
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-SRRILKSEPPYP 256
Query: 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQ 661
+ + ++ + +L KDP R
Sbjct: 257 QEMSALAKDL-----IQRLLM-------KDPKKRLGCGP 283
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-30
Identities = 60/305 (19%), Positives = 101/305 (33%), Gaps = 45/305 (14%)
Query: 394 NRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYK--LASSQGDQEFCSEVEVLSCAQHR 450
R+ + G G V + VA+K+ + + E+ ++ C H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 451 NVVMLIGFCV------EDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARG 504
N++ L+ E LV E + D + G
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCG 131
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL 564
+++LH + HRD++P+NI+V D + DFGLAR M T + T Y
Sbjct: 132 IKHLHSAGII----HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYR 185
Query: 565 APEYAQSGQITEKADVYSLGVVLVELITGR----------------KAMDLNRPRGQQCL 608
APE E D++S+G ++ E++ + + + P + L
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 609 TEWAR------PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASL---CIRKDPHSRPRM 659
R P +L L SE Q L + DP R +
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 660 SQVLR 664
L+
Sbjct: 306 DDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 5e-28
Identities = 57/294 (19%), Positives = 102/294 (34%), Gaps = 32/294 (10%)
Query: 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYK--LASSQGDQEFCSEVEVLSCAQH 449
R+ + + G +GSV G VAVK+ S + E+ +L +H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 450 RNVVMLIGFCVE-----DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARG 504
NV+ L+ + + + ++ L++ L + + RG
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRG 133
Query: 505 LRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGVETRVLGTFGYL 564
L+Y+H + HRD++P+N+ V D E + DFGLAR D + V +
Sbjct: 134 LKYIHSADII----HRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 186
Query: 565 APEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624
+ D++S+G ++ EL+TGR Q L + ++
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 625 IDPRLRNCYSEREVYGMLQCASL--------------CIRKDPHSRPRMSQVLR 664
RN + A++ + D R +Q L
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (257), Expect = 2e-24
Identities = 49/303 (16%), Positives = 90/303 (29%), Gaps = 23/303 (7%)
Query: 391 LATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQH 449
R+ L G F +V + + VA+K + + E+++L
Sbjct: 10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVND 68
Query: 450 RNVVMLIGFCVEDGRRLLVYEYICNGSL--------------DSHLYGRDRDPLEWSARR 495
+ +LL + + + + + + +
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 496 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT-HDFEPLVGDFGLARW-QPDGDMGV 553
+I+ GL Y+H C I+H D++P N+L+ D + +A
Sbjct: 129 QISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR 613
T + T Y +PE AD++S ++ ELITG + G +
Sbjct: 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE--PDEGHSYTKDDDH 243
Query: 614 PLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMN 673
+GEL LRN R + + + D
Sbjct: 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303
Query: 674 SKD 676
D
Sbjct: 304 ISD 306
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.4 bits (213), Expect = 5e-20
Identities = 26/153 (16%), Positives = 48/153 (31%), Gaps = 20/153 (13%)
Query: 402 LAEGGFGSVHRGVLPDGQVVAVKQYKLASS----------QGDQEFCSEVEVLSCAQHRN 451
+ EG +V VK +K+ + GD F + + R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 452 VVMLIGFCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEE 511
+ L G V VY + N L + ++ + ++ + +
Sbjct: 68 LQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR 122
Query: 512 CRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544
IVH D+ N+LV + + DF +
Sbjct: 123 ----GIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 678 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.41 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 98.95 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 98.82 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 98.65 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 98.62 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 98.56 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.41 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.82 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.68 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.05 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.94 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.93 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-51 Score=430.01 Aligned_cols=266 Identities=24% Similarity=0.333 Sum_probs=223.4
Q ss_pred hhhhhhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 386 YAELELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 386 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
+.+|++..++|++.+.||+|+||.||+|.+ .+++.||||+++... ...++|.+|+.+|++++|||||+++++|.+++.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 445778889999999999999999999985 468899999987443 334679999999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+|+||||+++|+|.+++.......+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC----CcccCccccCeEEECCCCcEEEcccccee
Confidence 99999999999999999776677899999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
..............|++.|+|||++.++.|+.++|||||||++|||++|..||....... ... +.
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-----~~~----------~~ 228 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVY----------EL 228 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHH----------HH
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-----HHH----------HH
Confidence 765554444555678999999999999999999999999999999999877764322211 100 11
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
+........+..++..+.+||.+||+.||++|||+.+|++.|+..+.
T Consensus 229 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11112223444566689999999999999999999999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=417.05 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=204.2
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
.++|++.+.||+|+||.||+|++ .+|+.||||+++.... +..+.+.+|+++|++++||||+++++++.+++.+|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 35799999999999999999995 5799999999875432 334678999999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.||+|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 84 y~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~----~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc----CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999994 456799999999999999999999999 99999999999999999999999999998664332
Q ss_pred -ccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 551 -MGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 551 -~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.......+||+.|+|||++.+..+ +.++|||||||+||+|+||+.||......... ... . .. ..
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~----~-~~--------~~ 223 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD----W-KE--------KK 223 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHH----H-HT--------TC
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHH----H-hc--------CC
Confidence 223445689999999999988776 67899999999999999999999754321110 000 0 00 00
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.........+..+.+||.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001112234457889999999999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-51 Score=422.11 Aligned_cols=263 Identities=27% Similarity=0.377 Sum_probs=216.5
Q ss_pred hhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
.++++..++|++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+.++++++|||||++++++.+ +..|
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 45677889999999999999999999998888899999997433 334679999999999999999999998765 5679
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+++|+|.+++......++++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~----~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccchhheeeecccceeeccccceEEc
Confidence 999999999999988655555699999999999999999999998 9999999999999999999999999999877
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
............||+.|+|||++.++.++.++|||||||++|||+||..|+...... .+.... +..
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----~~~~~~------i~~--- 225 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQN------LER--- 225 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHH------HHT---
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----HHHHHH------HHh---
Confidence 554444444567899999999999999999999999999999999976655322211 111110 111
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
..+...+..++..+.+||.+||+.||++|||+++|++.|+..+
T Consensus 226 -~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 226 -GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1112233445668999999999999999999999999998644
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=415.64 Aligned_cols=256 Identities=26% Similarity=0.417 Sum_probs=200.3
Q ss_pred hcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEe
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYI 472 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~ 472 (678)
.++|++.+.||+|+||.||+|.+.+++.||||+++... ...++|.+|++++++++||||++++++|.+++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 35789999999999999999998888899999987432 33467999999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 552 (678)
++|+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhcc----ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999988543 34588999999999999999999999 9999999999999999999999999999876554444
Q ss_pred ceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 553 VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
......||+.|+|||++.+..|+.++|||||||++|||+|+..|+..... ..+...... . ..+..
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-----~~~~~~~i~-~---------~~~~~ 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVEDIS-T---------GFRLY 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-----HHHHHHHHH-H---------TCCCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-----HHHHHHHHH-h---------cCCCC
Confidence 44556799999999999999999999999999999999996544432211 111111111 0 11112
Q ss_pred cchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
.+..++..+.+||.+||+.||++|||+++|++.|++.
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 2334556899999999999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=418.95 Aligned_cols=250 Identities=21% Similarity=0.328 Sum_probs=209.5
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
.++|++.+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|+.+|+.++||||++++++|.+++.+|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 35799999999999999999984 57999999999866655556799999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
|.||+|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++......
T Consensus 99 ~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp CTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred cCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 999999988743 3599999999999999999999999 99999999999999999999999999998764332
Q ss_pred cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 552 GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
......+||+.|+|||++.++.|+.++|||||||++|+|+||+.||...... ......... .. + ..
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~----~~--~--~~ 236 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATN----GT--P--EL 236 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHH----CS--C--CC
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhC----CC--C--CC
Confidence 2334567999999999999999999999999999999999999999643321 101111111 00 1 11
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..+...+..+.+||.+||+.||.+|||+.|+|+
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223445568999999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-50 Score=414.43 Aligned_cols=264 Identities=28% Similarity=0.426 Sum_probs=207.1
Q ss_pred hhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
+|++..++|.+.+.||+|+||.||+|+++ ..||||+++.... ...+.|.+|+.+|++++||||+++++++.+ +.+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 35677899999999999999999999864 3599999874432 223578899999999999999999998754 568
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++||||+++|+|.+++... ..++++..+..++.||+.||+|||++ |||||||||+||||+.++.+||+|||+++.
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~----~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp EEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred EEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcC----CEeccccCHHHEEEcCCCCEEEccccceee
Confidence 9999999999999999543 34599999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCC-ccceeEEEeeecccccccccc---cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 546 QPDGD-MGVETRVLGTFGYLAPEYAQS---GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 546 ~~~~~-~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
..... ........||+.|+|||++.+ +.|+.++|||||||+||||+||+.||....+... .......
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~--- 224 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGR--- 224 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHH---
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhc---
Confidence 54322 223345679999999999864 4589999999999999999999999975432111 0111111
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
....+.+ ...+..++..+.+||.+||+.||++|||+.+|++.|+.+.
T Consensus 225 -~~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 225 -GYLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp -TSCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1112211 1233445668999999999999999999999999998543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=408.96 Aligned_cols=245 Identities=26% Similarity=0.406 Sum_probs=206.1
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++.+.||+|+||.||+|++ .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999995 578999999986432 233457889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 86 Ey~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999943 45699999999999999999999999 9999999999999999999999999999765433
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
......||+.|+|||++.+..|+.++|||||||+||+|++|+.||...... +....... . .
T Consensus 160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~----~---~--- 220 (263)
T d2j4za1 160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISR----V---E--- 220 (263)
T ss_dssp ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHT----T---C---
T ss_pred ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHHHHHHc----C---C---
Confidence 234567999999999999999999999999999999999999999643321 10010000 0 1
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..++...+..+.+||.+||+.||++|||++|+|+
T Consensus 221 -~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1233445568999999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=412.90 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=207.2
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEe
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYI 472 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~ 472 (678)
+.|++.+.||+|+||.||+|.+ .+++.||+|+++.......+.+.+|+++|+.++||||+++++++.+++.+|+||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5689999999999999999994 578999999998666666678999999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG 552 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 552 (678)
.+|+|.+++... ..++++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~----~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQ 165 (288)
T ss_dssp TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HH
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEEEeecChhheeECCCCCEEEEechhhhccCCC-cc
Confidence 999999987543 34699999999999999999999999 9999999999999999999999999999754321 11
Q ss_pred ceeEEEeeeccccccccc-----ccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCc
Q 038949 553 VETRVLGTFGYLAPEYAQ-----SGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDP 627 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~ 627 (678)
......||+.|+|||++. ...|+.++|||||||+||+|+||+.||....+... ...... .. .+
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~----~~--~~ 233 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAK----SE--PP 233 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHH----SC--CC
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHHHc----CC--CC
Confidence 223467999999999984 45689999999999999999999999975432110 011110 00 01
Q ss_pred chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 628 RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 628 ~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....+...+..+.+||.+||+.||.+|||++|+++
T Consensus 234 --~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 --TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11223445568999999999999999999999976
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=418.91 Aligned_cols=267 Identities=27% Similarity=0.372 Sum_probs=205.6
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC-CccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG-DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~-~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
++..++|++.+.||+|+||.||+|+. .+|+.||+|+++...... ...+.+|+.+|+.++|||||+++++|.+++++|+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45578999999999999999999994 579999999987543222 3568899999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+.||+|.+++.. .+.+++..++.++.||+.||.|||+.+ ||+||||||+||||+.+|.+||+|||+|+...
T Consensus 82 VmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999999953 346999999999999999999999631 89999999999999999999999999998654
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhh-HH------------
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWA-RP------------ 614 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~-~~------------ 614 (678)
.. .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||........+...... ..
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 32 234568999999999999999999999999999999999999999654321110000000 00
Q ss_pred --HHHHh--------hhhccc----CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 615 --LLKRH--------AIGELI----DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 615 --~~~~~--------~~~ell----d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..... ...+.+ ............+..+.+||.+||+.||.+|||++|+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000 000000 000000001123457889999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=417.56 Aligned_cols=261 Identities=26% Similarity=0.367 Sum_probs=210.7
Q ss_pred hhhhhhcCCcccceecccCccceeeccCCC------CcEEEEEeeehhc-ccCCccccccceeeecc-cccceEEEEeEE
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVLPD------GQVVAVKQYKLAS-SQGDQEFCSEVEVLSCA-QHRNVVMLIGFC 459 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~ 459 (678)
.|++..++|++.+.||+|+||.||+|++.. ...||+|.+.... ......+.+|+.+|+++ +|||||+++++|
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 356778899999999999999999998432 2369999886432 33445788999999988 899999999999
Q ss_pred eeCCeEEEEEEEeecCCcccccccCC---------------------CCccCccccchhhhhhccchhhhhhcceeeeEE
Q 038949 460 VEDGRRLLVYEYICNGSLDSHLYGRD---------------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIV 518 (678)
Q Consensus 460 ~~~~~~~LV~E~~~ggsL~~~l~~~~---------------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIv 518 (678)
.+.+.+|+|||||++|+|.+++..+. ...+++..++.++.||+.||+|||++ |||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~----~Ii 186 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCV 186 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEE
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----Cee
Confidence 99999999999999999999995542 23588899999999999999999999 999
Q ss_pred eccCCCCceEeeecCccccccccccccccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCcc
Q 038949 519 HRDMRPNNILVTHDFEPLVGDFGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKA 596 (678)
Q Consensus 519 HrDLKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~P 596 (678)
||||||+|||++.++.+||+|||+++...... ........||+.|+|||++.++.|+.++|||||||+||||+| |..|
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 99999999999999999999999998654433 223345678999999999999999999999999999999998 8999
Q ss_pred ccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhh
Q 038949 597 MDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLE 667 (678)
Q Consensus 597 f~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le 667 (678)
|........ + ...+. ...+...+..++..+.+||.+||+.||++|||++||++.|.
T Consensus 267 f~~~~~~~~--~----~~~~~---------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 267 YPGIPVDAN--F----YKLIQ---------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp STTCCCSHH--H----HHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHHHH--H----HHHHh---------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 965432110 1 01111 11122344556678999999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=405.02 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=213.5
Q ss_pred cCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEee
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYIC 473 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ 473 (678)
++|++.+.||+|+||.||+|++++++.||||.++... ...++|.+|+.++++++||||++++++|.+++.+++||||+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6899999999999999999998888899999997543 334679999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCccc
Q 038949 474 NGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMGV 553 (678)
Q Consensus 474 ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 553 (678)
+|+|.+++... ...+++..+++++.|+++||.|||+. ||+||||||+|||++.++.+||+|||+++.........
T Consensus 83 ~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~----~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT----TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhc----CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999987543 34588899999999999999999999 99999999999999999999999999998665544444
Q ss_pred eeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcc
Q 038949 554 ETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNC 632 (678)
Q Consensus 554 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~ 632 (678)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +.... +.. ..+..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~~~~~------i~~----~~~~~ 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEH------IAQ----GLRLY 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHH------HHT----TCCCC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------HHHHH------HHh----CCCCC
Confidence 445678999999999999999999999999999999998 89898654321 11111 111 11222
Q ss_pred cchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 633 YSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 633 ~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
.+..++..+.+||.+||+.||++|||++++++.|.+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 344556689999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=409.98 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=194.1
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEee--CCeEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVE--DGRRLL 467 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~--~~~~~L 467 (678)
.++|++.+.||+|+||.||+|+. .+|+.||+|.++..... ..+.+.+|+++|++++||||+++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36799999999999999999984 57999999998654322 23468899999999999999999999864 456899
Q ss_pred EEEEeecCCcccccccC--CCCccCccccchhhhhhccchhhhhhcce-eeeEEeccCCCCceEeeecCccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGR--DRDPLEWSARRKIAVGAARGLRYLHEECR-VGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qI~~aL~yLH~~~~-~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
|||||++|+|.+++... ....+++..++.++.||+.||.|||+... ..+|+||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998432 34579999999999999999999998710 0139999999999999999999999999998
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
...... .......||+.|+|||++.+..|+.++|||||||++|||+||+.||..... .+.... +.....
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------~~~~~~-i~~~~~--- 231 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGK-IREGKF--- 231 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHH-HHHTCC---
T ss_pred ecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH------HHHHHH-HHcCCC---
Confidence 764332 234457899999999999999999999999999999999999999964322 111111 111111
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+...+..+.+||.+||+.||.+|||++|+++
T Consensus 232 ------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1123345568999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-48 Score=411.09 Aligned_cols=258 Identities=23% Similarity=0.356 Sum_probs=195.4
Q ss_pred hhhhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 390 ELATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 390 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
+...++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+|+.++||||+++++++.+++.+||
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34568899999999999999999985 5789999999874432 233568899999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee---ecCccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT---HDFEPLVGDFGLAR 544 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~---~~~~vkL~DFGla~ 544 (678)
|||||.||+|.+++. ..+.+++..+..++.||+.||.|||++ ||+||||||+|||+. .++.+||+|||+++
T Consensus 85 vmE~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 85 IMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EECCCCSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEeccCCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhhc----eeeeEEecccceeecccCCCceEEEeccceeE
Confidence 999999999999994 345799999999999999999999999 999999999999995 47899999999998
Q ss_pred cccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
...... .....+||+.|+|||++.+..|+.++|||||||+||+|++|+.||...... +....... .
T Consensus 159 ~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~----~-- 224 (307)
T d1a06a_ 159 MEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILK----A-- 224 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHT----T--
T ss_pred EccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhc----c--
Confidence 654332 334567999999999999999999999999999999999999999643211 10010000 0
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH--Hhhc
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR--MLEG 668 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~--~Le~ 668 (678)
............+..+.+||.+||+.||++|||++|+++ ++.+
T Consensus 225 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 225 -EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp -CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred -CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 111111222345567999999999999999999999987 4544
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=411.25 Aligned_cols=264 Identities=28% Similarity=0.363 Sum_probs=211.0
Q ss_pred hhhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
.+|++..++|++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+.++++++|||||+++++|.+ +..+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 34566778999999999999999999998788889999997443 334679999999999999999999999855 5689
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+||||+++|+|..++.......+++..++.++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++..
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~----~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh----heecccccceEEEECCCCcEEEcccchhhhc
Confidence 999999999999998665556799999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 547 PDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 547 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
............||+.|+|||++..+.++.++|||||||++|||++|..|+...... .+..... ..
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~~~~~i------~~--- 229 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQV------ER--- 229 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHH------HT---
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HHHHHHH------Hh---
Confidence 554444455577999999999999999999999999999999999977665432211 1111110 11
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
..+...+..++..+.+||.+||+.||++||++++|+++|+..+.
T Consensus 230 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 230 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp -TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 11222344556689999999999999999999999999998663
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-49 Score=413.10 Aligned_cols=259 Identities=27% Similarity=0.374 Sum_probs=199.9
Q ss_pred hhcCCcccceecccCccceeeccCC-CC---cEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVLP-DG---QVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g---~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 466 (678)
..++|++.+.||+|+||.||+|.++ ++ ..||||.+..... ...+.|.+|+++|++++|||||+++++|.+++.+|
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 3467889999999999999999853 33 3688998764322 22357999999999999999999999999999999
Q ss_pred EEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccc
Q 038949 467 LVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQ 546 (678)
Q Consensus 467 LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~ 546 (678)
+|||||.+|+|.+++... ...+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++..
T Consensus 104 iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhC----CCccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999988543 44699999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCc----cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 547 PDGDM----GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 547 ~~~~~----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
..... .......||+.|+|||++.++.++.++|||||||+||||+| |+.||...... +.... +
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------~~~~~------i 246 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------DVINA------I 246 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHH------H
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------HHHHH------H
Confidence 43221 11223457899999999999999999999999999999998 89998643321 11111 0
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
. ...+...+..++..+.+||.+||+.||++|||+.+|++.|+..+.
T Consensus 247 ~----~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 247 E----QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp H----TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred H----cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1 111122344566789999999999999999999999999987654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=401.84 Aligned_cols=247 Identities=24% Similarity=0.356 Sum_probs=197.2
Q ss_pred cCC-cccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEee----CCeE
Q 038949 394 NRF-SEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE----DGRR 465 (678)
Q Consensus 394 ~~y-~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~----~~~~ 465 (678)
++| ++.+.||+|+||.||+|.+ .+++.||+|.+..... ...+.+.+|+++|++++||||++++++|.+ ...+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 344 6677899999999999984 5788999999875432 223568899999999999999999999875 3468
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeee--EEeccCCCCceEee-ecCccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILVT-HDFEPLVGDFGL 542 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g--IvHrDLKp~NILl~-~~~~vkL~DFGl 542 (678)
|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ + |+||||||+||||+ .++.+||+|||+
T Consensus 88 ~ivmE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~----~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEeCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHC----CCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 999999999999999943 45689999999999999999999998 7 99999999999997 479999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
++..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||....... .... .+.
T Consensus 162 a~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-----~~~~------~i~ 226 (270)
T d1t4ha_ 162 ATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYR------RVT 226 (270)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHH------HHT
T ss_pred ceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-----HHHH------HHH
Confidence 9854322 2345679999999999875 69999999999999999999999996432211 0000 111
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.... ...++...+..+.+||.+||+.||++|||++|+|+
T Consensus 227 ~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 227 SGVK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTCC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCC---CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111 11223334457899999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=408.20 Aligned_cols=247 Identities=20% Similarity=0.279 Sum_probs=203.2
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++|++++||||++++++|.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999985 579999999997432 233357889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.||+|.+++. ..+.+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 88 Ey~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh--ccCCCCHHHHHHHHHHHHHHHHhhccc----cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999884 345699999999999999999999999 9999999999999999999999999999876433
Q ss_pred C-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 550 D-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 550 ~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
. .......+||+.|+|||++.+..|+.++|||||||+||+|++|+.||....+. ....... .. .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~-----~~--~-- 226 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIFQKII-----KL--E-- 226 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-----TT--C--
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHHHHHH-----cC--C--
Confidence 2 22344567999999999999999999999999999999999999999743221 0000000 00 1
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVL 663 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL 663 (678)
..++...+..+.+||.+||+.||.+|||++|++
T Consensus 227 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 227 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp --CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 123344556889999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=406.64 Aligned_cols=258 Identities=24% Similarity=0.349 Sum_probs=208.3
Q ss_pred hhhcCCcccce-ecccCccceeeccCC---CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 391 LATNRFSEANF-LAEGGFGSVHRGVLP---DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 391 ~~~~~y~~~~~-LG~G~fG~Vy~a~~~---~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
+..++|.+.+. ||+|+||.||+|.++ ++..||||+++.... ...+.|.+|+++|++++|||||++++++.+ +.+
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 44567888875 999999999999742 455899999874332 233578999999999999999999999865 568
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
||||||+++|+|.+++.. .+..+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++.
T Consensus 84 ~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCcCchhheeeccCCceeeccchhhhc
Confidence 999999999999998743 335699999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCc--cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 546 QPDGDM--GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 546 ~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
...... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||...... +.... +.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~------~~~~~-i~----- 226 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAF-IE----- 226 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------HHHHH-HH-----
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH------HHHHH-HH-----
Confidence 644322 12223458899999999999999999999999999999998 89999654321 11111 11
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
...+...+..++..+.+||.+||+.||++|||+.+|++.|+..+
T Consensus 227 ----~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 227 ----QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ----TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11112334556678999999999999999999999999998655
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=403.83 Aligned_cols=261 Identities=24% Similarity=0.354 Sum_probs=202.7
Q ss_pred hhhcCCcccceecccCccceeeccCCCC-----cEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCCe
Q 038949 391 LATNRFSEANFLAEGGFGSVHRGVLPDG-----QVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 391 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g-----~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
+..+.|++.++||+|+||.||+|.+++. ..||||.++..... ...+|.+|+.++++++|||||++++++.+.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 3446788999999999999999985432 47999998643322 22468899999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.++||||+.+|++.+++... ...+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccc----ccccCccccceEEECCCCeEEEcccchhh
Confidence 99999999999998877543 35699999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCc--cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 545 WQPDGDM--GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 545 ~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
....... .......||+.|+|||++.++.++.++|||||||++|||++|..|+...... .+...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~~~~~--------- 224 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMK--------- 224 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHH---------
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----HHHHH---------
Confidence 6543321 2233456899999999999999999999999999999999976665432211 01111
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.+....+...+..++..+.+||.+||+.||++|||+.+|++.|+..+.
T Consensus 225 -~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 225 -AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 111112233445566789999999999999999999999999987553
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=400.86 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=198.4
Q ss_pred ceecccCccceeeccCC---CCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEEeec
Q 038949 400 NFLAEGGFGSVHRGVLP---DGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEYICN 474 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~---~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~g 474 (678)
+.||+|+||.||+|.++ +++.||||+++..... ..+.|.+|+.+|++++|||||+++++|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999743 4578999998643322 23578999999999999999999999865 567899999999
Q ss_pred CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCcc--
Q 038949 475 GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDMG-- 552 (678)
Q Consensus 475 gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 552 (678)
|+|.+++. ...++++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH~~----~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh--hccCCCHHHHHHHHHHHHHHHhhHHhC----CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999984 345699999999999999999999999 9999999999999999999999999999865443222
Q ss_pred ceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccCcchhc
Q 038949 553 VETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRN 631 (678)
Q Consensus 553 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~ 631 (678)
......||+.|+|||++.++.++.++|||||||++|||+| |+.||..... .+... .+. ...+.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~------~~~~~-~i~---------~~~~~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SEVTA-MLE---------KGERM 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHH-HHH---------TTCCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH------HHHHH-HHH---------cCCCC
Confidence 2234568999999999999999999999999999999998 8999964321 11111 111 11122
Q ss_pred ccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 632 CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 632 ~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
..+..++..+.+||.+||+.||++|||+++|++.|+..+
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 334556678999999999999999999999999887644
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-48 Score=410.19 Aligned_cols=246 Identities=27% Similarity=0.384 Sum_probs=201.1
Q ss_pred hcCCcccceecccCccceeecc-CCCCcEEEEEeeehhccc---CCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
..+|+.++.||+|+||.||+|+ ..+++.||||+++..... ..+.+.+|+.+|++++|||||++++++.+++.+|+|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 3469999999999999999998 457899999998744322 224688999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
||||.+|+|..++. ...++++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++.....
T Consensus 94 ~E~~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999976663 345699999999999999999999999 999999999999999999999999999986533
Q ss_pred CCccceeEEEeeecccccccccc---cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQS---GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
. ....||+.|+|||++.+ +.|+.++|||||||++|||++|..||...... ....... ...
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~------~~~ 230 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA------QNE 230 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH------HSC
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHH------hCC
Confidence 2 34579999999999864 46899999999999999999999999643221 1000000 100
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.+.+ .+...+..+.+||.+||+.||.+|||++|+|+
T Consensus 231 ~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111 12234557999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-47 Score=410.15 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=208.8
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
-++|.+.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|+.++||||+++++++.+++.+||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999984 57999999998755444456788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee--cCccccccccccccccCC
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH--DFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~--~~~vkL~DFGla~~~~~~ 549 (678)
|.||+|.+++... .+++++..++.++.||+.||.|||++ |||||||||+|||++. ++.+||+|||+++.....
T Consensus 105 ~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhc----CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999988543 34699999999999999999999999 9999999999999964 688999999999866433
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
.......||+.|+|||++.+..|+.++|||||||++|+|++|+.||..... .+....... . ....
T Consensus 180 --~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~----~---~~~~ 244 (350)
T d1koaa2 180 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKS----C---DWNM 244 (350)
T ss_dssp --SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH----T---CCCS
T ss_pred --cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHh----C---CCCC
Confidence 334567899999999999999999999999999999999999999964321 111111100 0 1111
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
........+..+.+||.+||+.||++|||++|+|+
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122334557899999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.8e-47 Score=408.84 Aligned_cols=252 Identities=20% Similarity=0.262 Sum_probs=209.0
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
.++|++.+.||+|+||.||+|.. .+|+.||||+++.........+.+|+.+|++++||||++++++|.+++.+||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999994 57999999998755444446788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEee--ecCccccccccccccccCC
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVT--HDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~--~~~~vkL~DFGla~~~~~~ 549 (678)
|.||+|.+++.. ...++++..++.++.||+.||.|||++ ||+||||||+||||+ .++.+||+|||++......
T Consensus 108 ~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999987743 334699999999999999999999999 999999999999998 5789999999999876543
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
.......||+.|+|||++.+..|+.++|||||||+||+|+||+.||...... ........ . +..+
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~----~---~~~~ 247 (352)
T d1koba_ 183 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKR----C---DWEF 247 (352)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHH----C---CCCC
T ss_pred --CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh----C---CCCC
Confidence 3345678999999999999999999999999999999999999999643321 10010000 0 1111
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
........+..+.+||.+||+.||.+|||+.|+|+
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12222344567899999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=402.55 Aligned_cols=261 Identities=25% Similarity=0.368 Sum_probs=200.9
Q ss_pred hhhhhcCCcccceecccCccceeeccCC----CCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeEEeeCC
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLP----DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG 463 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 463 (678)
+++..++|++.+.||+|+||.||+|.+. .+..||||.++..... ..+.+.+|+.+|++++||||+++++++. ++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 4667789999999999999999999843 2357889988643322 2356899999999999999999999986 46
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
.+|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred eEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhccc----CeeccccchhheeecCCCcEEEccchhh
Confidence 789999999999999887543 45689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 544 RWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 544 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
+..............||+.|+|||++.++.++.++|||||||++|||+| |.+||....... ..... .. .
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~------~~~~i-~~---~ 225 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRI-EN---G 225 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHH-HT---T
T ss_pred eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH------HHHHH-Hc---C
Confidence 8765544445556678999999999999999999999999999999988 888987543311 01100 00 0
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
.....+..++..+.+||.+||..||++|||+.+|++.|+..+.
T Consensus 226 ------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 226 ------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1112344566789999999999999999999999999987553
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=398.14 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=206.2
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC------CccccccceeeecccccceEEEEeEEeeCCe
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG------DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGR 464 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~------~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 464 (678)
..++|++.+.||+|+||.||+|.+ .+|+.||||+++...... .+.+.+|+.+|++++||||++++++|.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 357899999999999999999995 579999999986433221 2458899999999999999999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC----ccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF----EPLVGDF 540 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~----~vkL~DF 540 (678)
+|||||||+||+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~----~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhc----ceeecccccceEEEecCCCcccceEecch
Confidence 9999999999999999943 35699999999999999999999999 999999999999998776 5999999
Q ss_pred cccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .....
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i----- 228 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANV----- 228 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-----
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHHH-----
Confidence 9998664432 2344578999999999999999999999999999999999999996433210 00000
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.. .........+...+..+.+||.+||+.||++|||++|+++
T Consensus 229 -~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 229 -SA-VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -HT-TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -Hh-cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0111111222344557899999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=401.45 Aligned_cols=248 Identities=23% Similarity=0.278 Sum_probs=207.1
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehh---cccCCccccccceeeecccccceEEEEeEEeeCCeEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLA---SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
-++|++++.||+|+||.||+|+. .+|+.||||+++.. .......+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46799999999999999999994 68999999999743 233346788999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+.||+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+++....
T Consensus 84 ~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhc----CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999843 45689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|++||...... ... .......
T Consensus 158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~----~~i~~~~----- 221 (337)
T d1o6la_ 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLF----ELILMEE----- 221 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH----HHHHHCC-----
T ss_pred CC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHH----HHHhcCC-----
Confidence 22 2344578999999999999999999999999999999999999999654321 111 1100011
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCch-----HHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPR-----MSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT-----~~eVL~ 664 (678)
..++...+..+.+||.+||+.||.+||+ ++++++
T Consensus 222 --~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1233445567899999999999999995 778775
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-47 Score=400.34 Aligned_cols=264 Identities=26% Similarity=0.353 Sum_probs=213.2
Q ss_pred hhhhhhhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhccc-CCccccccceeeecccccceEEEEeE
Q 038949 386 YAELELATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCAQHRNVVMLIGF 458 (678)
Q Consensus 386 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~ 458 (678)
+.+++..+++|++.+.||+|+||.||+|+++ +++.||||+++..... ...+|.+|+.+|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4567888899999999999999999999742 4578999998744332 23579999999999999999999999
Q ss_pred EeeCCeEEEEEEEeecCCcccccccCC----------------------CCccCccccchhhhhhccchhhhhhcceeee
Q 038949 459 CVEDGRRLLVYEYICNGSLDSHLYGRD----------------------RDPLEWSARRKIAVGAARGLRYLHEECRVGC 516 (678)
Q Consensus 459 ~~~~~~~~LV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~g 516 (678)
|...+..++||||+.+|+|.+++.... ...+++..++.++.|++.||+|||++ +
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~----~ 160 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----K 160 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----T
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC----C
Confidence 999999999999999999999885322 23478889999999999999999999 9
Q ss_pred EEeccCCCCceEeeecCccccccccccccccCC-CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCC-
Q 038949 517 IVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG-DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR- 594 (678)
Q Consensus 517 IvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~- 594 (678)
||||||||+||||+.++.+||+|||+++..... .........|++.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 999999999999999999999999999855332 223334567899999999999999999999999999999999986
Q ss_pred ccccccCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 595 KAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 595 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
+||....+. +..... ... .....+..++..+.+||.+||+.||++||||.||+++|+..
T Consensus 241 ~p~~~~~~~------e~~~~v-~~~---------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 241 QPYYGMAHE------EVIYYV-RDG---------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp CTTTTSCHH------HHHHHH-HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCCHH------HHHHHH-HcC---------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 566543221 111111 111 11123445566899999999999999999999999999865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=394.18 Aligned_cols=254 Identities=27% Similarity=0.370 Sum_probs=202.9
Q ss_pred hhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEee-CCeEEE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE-DGRRLL 467 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-~~~~~L 467 (678)
|++..++|++.+.||+|+||.||+|.+ .|+.||||+++. ....+.+.+|++++++++||||++++++|.+ .+.+|+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 355677899999999999999999998 478999999863 2345679999999999999999999999865 456899
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
||||+++|+|.+++..+....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC----ceeccccchHhheecCCCCEeecccccceecC
Confidence 99999999999999665555689999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhcccC
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELID 626 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld 626 (678)
.. .....+|+.|+|||++.++.++.++|||||||++|||+| |++||....... .... +.
T Consensus 155 ~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~------~~~~------i~---- 214 (262)
T d1byga_ 155 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPR------VE---- 214 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------HHHH------HT----
T ss_pred CC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH------HHHH------HH----
Confidence 32 234567899999999999999999999999999999998 677775432211 1110 11
Q ss_pred cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 627 PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 627 ~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
...+...+...+..+.+||.+||+.||.+|||+.++++.|+..
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1122234445556899999999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=399.35 Aligned_cols=267 Identities=28% Similarity=0.393 Sum_probs=215.2
Q ss_pred hhhhhhcCCcccceecccCccceeeccC------CCCcEEEEEeeehhccc-CCccccccceeeecc-cccceEEEEeEE
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVL------PDGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCA-QHRNVVMLIGFC 459 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L-~HpnIv~l~~~~ 459 (678)
.|++..++|++.+.||+|+||.||+|++ .+++.||||+++..... ....+.+|+.+++.+ +|||||+++++|
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 4677789999999999999999999963 35679999999754332 234688999999999 699999999999
Q ss_pred eeCCeEEEEEEEeecCCcccccccCC----------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCC
Q 038949 460 VEDGRRLLVYEYICNGSLDSHLYGRD----------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMR 523 (678)
Q Consensus 460 ~~~~~~~LV~E~~~ggsL~~~l~~~~----------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLK 523 (678)
.+.+..++|||||++|+|.+++.... ...+++..+..++.||+.||+|||++ ||||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~----~ivHrDLK 172 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLA 172 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCS
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----Ceeecccc
Confidence 99999999999999999999985432 23588899999999999999999999 99999999
Q ss_pred CCceEeeecCccccccccccccccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCcc-ccccC
Q 038949 524 PNNILVTHDFEPLVGDFGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKA-MDLNR 601 (678)
Q Consensus 524 p~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~P-f~~~~ 601 (678)
|+|||++.++.++|+|||+++...... ........||+.|+|||++.++.++.++|||||||++|||+|+..| |....
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998765432 2333446789999999999999999999999999999999995544 43322
Q ss_pred CcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccccC
Q 038949 602 PRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILMN 673 (678)
Q Consensus 602 ~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~~ 673 (678)
... . ...... ...+...+...+..+.+||.+||+.||++|||+++|++.|++.+...
T Consensus 253 ~~~-----~-~~~~i~---------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 253 VDS-----K-FYKMIK---------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp SSH-----H-HHHHHH---------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHH-----H-HHHHHh---------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 211 0 011111 11122233445568999999999999999999999999999876543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.2e-46 Score=387.99 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=201.6
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc---CCccccccceeeecccccceEEEEeEEeeCC----
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ---GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG---- 463 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~---~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~---- 463 (678)
..++|++.+.||+|+||.||+|.. .+|+.||||+++..... ....+.+|+.+++.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 467899999999999999999984 68999999999744322 2246889999999999999999999987654
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
.+||||||+.||+|.+++.. .+++++..++.++.||+.||.|||++ ||+||||||+|||++.++..+|+|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~----~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCccccCcccccCccccceeehhhhh
Confidence 48999999999999998843 45699999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCC--CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 544 RWQPDG--DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 544 ~~~~~~--~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
...... ........+||+.|+|||++.+..++.++|||||||++|+|+||++||....+. +.......
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~---- 228 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVR---- 228 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH----
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHh----
Confidence 754322 223344568999999999999999999999999999999999999999653321 11111111
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCc-hHHHHHHHhhcc
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRP-RMSQVLRMLEGD 669 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RP-T~~eVL~~Le~~ 669 (678)
. ++..........+..+.++|.+||+.||.+|| |++++++.|.+.
T Consensus 229 -~--~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 229 -E--DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -C--CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -c--CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 1 11111122233456899999999999999999 899998888653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-46 Score=396.15 Aligned_cols=244 Identities=23% Similarity=0.318 Sum_probs=204.4
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++.+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5699999999999999999995 579999999997432 233457889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.||+|..++. ....+++..++.++.||+.||.|||++ ||+||||||+||||+.+|.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhccC----cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999884 345578888899999999999999999 9999999999999999999999999999876433
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
....+||+.|+|||++.+..|+.++|||||||+||+|+||+.||..... .+....... . .
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~----~---~--- 217 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILN----A---E--- 217 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH----C---C---
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHc----C---C---
Confidence 2346799999999999999999999999999999999999999964322 111111110 0 0
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
..++...+..+.+++.+||+.||.+|+ |++++++
T Consensus 218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 122334455789999999999999996 8999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=397.74 Aligned_cols=268 Identities=25% Similarity=0.308 Sum_probs=203.0
Q ss_pred ehhhhhhhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhcc-cCCccccccceeeecc-cccceEEEE
Q 038949 385 TYAELELATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCA-QHRNVVMLI 456 (678)
Q Consensus 385 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L-~HpnIv~l~ 456 (678)
...+|++..++|++.+.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|..++.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34567788899999999999999999999732 357899999864332 2234677788887776 689999999
Q ss_pred eEEeeC-CeEEEEEEEeecCCcccccccCC--------------CCccCccccchhhhhhccchhhhhhcceeeeEEecc
Q 038949 457 GFCVED-GRRLLVYEYICNGSLDSHLYGRD--------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRD 521 (678)
Q Consensus 457 ~~~~~~-~~~~LV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrD 521 (678)
+++.+. ..+++|||||++|+|.+++.... ...+++..++.++.||+.||.|||++ ||||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~----~ivHrD 159 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRD 159 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT----TCCCSC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC----CCcCCc
Confidence 987664 46899999999999999985432 23588999999999999999999999 999999
Q ss_pred CCCCceEeeecCccccccccccccccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCC-ccccc
Q 038949 522 MRPNNILVTHDFEPLVGDFGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR-KAMDL 599 (678)
Q Consensus 522 LKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~-~Pf~~ 599 (678)
|||+||||+.++.+||+|||+++...... ........||+.|+|||++.++.++.++|||||||++|||+||. +||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998654322 22334567999999999999999999999999999999999875 56753
Q ss_pred cCCcccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 600 NRPRGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 600 ~~~~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
..... .....+... .....+...+..+.+||.+||+.||++|||+.||++.|+..+.
T Consensus 240 ~~~~~------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 240 VKIDE------EFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCCSH------HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHH------HHHHHHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 32211 111111111 1112334455689999999999999999999999999987653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=395.34 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=200.9
Q ss_pred cCCcccceecccCccceeeccC-CCCc----EEEEEeeehhc-ccCCccccccceeeecccccceEEEEeEEeeCCeEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQ----VVAVKQYKLAS-SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~----~vAvK~i~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~L 467 (678)
.+|++++.||+|+||.||+|.+ .+|+ +||+|.++... ....+.|.+|+.++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 4699999999999999999984 3444 68899886432 33346799999999999999999999999864 5788
Q ss_pred EEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccccc
Q 038949 468 VYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQP 547 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~ 547 (678)
+|||+.+|+|.+++... ...+++..++.++.||+.||.|||++ |||||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~----~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc----CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999999988544 45699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCc-cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhhccc
Q 038949 548 DGDM-GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIGELI 625 (678)
Q Consensus 548 ~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ell 625 (678)
.... .......||+.|+|||++.++.|+.++|||||||+||||+| |.+||....... ... .+..
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~------~~~-~i~~------- 228 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISS-ILEK------- 228 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG------HHH-HHHH-------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH------HHH-HHHc-------
Confidence 4332 22334568999999999999999999999999999999998 788886543211 111 1111
Q ss_pred CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcc
Q 038949 626 DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGD 669 (678)
Q Consensus 626 d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~ 669 (678)
..+...+..++..+.+||.+||+.||++|||+.+|++.|+..
T Consensus 229 --~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 229 --GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 111223445666899999999999999999999999988654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=387.94 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=196.5
Q ss_pred hcCCcccceecccCccceeeccC--CCC--cEEEEEeeehhcc---cCCccccccceeeecccccceEEEEeEEeeCCeE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL--PDG--QVVAVKQYKLASS---QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~--~~g--~~vAvK~i~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
.++|++.+.||+|+||.||+|++ .++ ..||||+++.... +..++|.+|+.+|+.++||||++++++|.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 46799999999999999999984 223 3789999864432 223578999999999999999999999976 567
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
++||||+.+|+|.+++..+ ...+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhC----CEeeeeecHHHhccccccceeeccchhhhh
Confidence 8999999999999888543 34599999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCc--cceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 546 QPDGDM--GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 546 ~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
...... .......|+..|+|||++.+..++.++||||||+++|||+| |..||..... .+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------~~~~~~-------- 226 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHK-------- 226 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHH--------
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------HHHHHH--------
Confidence 644322 22334567889999999999999999999999999999998 8999964321 111111
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhc
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEG 668 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~ 668 (678)
+.....+...+...+..+.+||.+||+.||++|||+.+|++.|++
T Consensus 227 -i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 227 -IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111112222334556689999999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=393.41 Aligned_cols=252 Identities=21% Similarity=0.245 Sum_probs=200.6
Q ss_pred hcCCcccc-eecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecc-cccceEEEEeEEee----CCeE
Q 038949 393 TNRFSEAN-FLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVE----DGRR 465 (678)
Q Consensus 393 ~~~y~~~~-~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~----~~~~ 465 (678)
.++|.+.. .||+|+||.||+|.+ .+++.||||+++. ...+.+|+.++.++ +||||++++++|.+ +..+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898875 699999999999984 6799999999862 34677899887554 89999999999875 4678
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee---cCccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH---DFEPLVGDFGL 542 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~---~~~vkL~DFGl 542 (678)
|+|||||+||+|.+++..+...++++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~----~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc----CCccccccccccccccccccccccccccce
Confidence 9999999999999999766566799999999999999999999999 9999999999999985 56799999999
Q ss_pred cccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
++...... ......||+.|+|||++.+..|+.++|||||||+||+|+||+.||......... ..+.......
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~------~~~~~~i~~~ 232 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------PGMKTRIRMG 232 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------CCCSC
T ss_pred eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH------HHHHHHHhcC
Confidence 98665433 234567999999999999999999999999999999999999999754321110 0000000000
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
...+........+..+.+||.+||+.||++|||+.|+++
T Consensus 233 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 ---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 001111112234567999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=395.04 Aligned_cols=263 Identities=29% Similarity=0.373 Sum_probs=208.9
Q ss_pred hhhhhcCCcccceecccCccceeeccCC--------CCcEEEEEeeehhccc-CCccccccceeeecc-cccceEEEEeE
Q 038949 389 LELATNRFSEANFLAEGGFGSVHRGVLP--------DGQVVAVKQYKLASSQ-GDQEFCSEVEVLSCA-QHRNVVMLIGF 458 (678)
Q Consensus 389 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~i~~~~~~-~~~~~~~Ev~iL~~L-~HpnIv~l~~~ 458 (678)
+++..++|.+.+.||+|+||.||+|+.. ++..||||+++..... ...++.+|+..+.++ +||||++++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 5677899999999999999999999732 2347999998754432 235788899998888 79999999999
Q ss_pred EeeCCeEEEEEEEeecCCcccccccCC--------------CCccCccccchhhhhhccchhhhhhcceeeeEEeccCCC
Q 038949 459 CVEDGRRLLVYEYICNGSLDSHLYGRD--------------RDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRP 524 (678)
Q Consensus 459 ~~~~~~~~LV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp 524 (678)
|.+++..++||||+++|+|.+++..+. ...+++..++.++.||+.||+|||+. +||||||||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~----~ivHrDiKp 163 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAA 163 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC----CEEeeeecc
Confidence 999999999999999999999996543 24589999999999999999999999 999999999
Q ss_pred CceEeeecCccccccccccccccCCC-ccceeEEEeeecccccccccccccceecceeeeeeEEEEeee-CCccccccCC
Q 038949 525 NNILVTHDFEPLVGDFGLARWQPDGD-MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELIT-GRKAMDLNRP 602 (678)
Q Consensus 525 ~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLlt-G~~Pf~~~~~ 602 (678)
+|||++.++.+||+|||+++...... ........|++.|+|||.+.++.|+.++|||||||++|||++ |.+||.....
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 99999999999999999998664432 222334568999999999999999999999999999999998 6778754321
Q ss_pred cccchhhhhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 603 RGQQCLTEWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 603 ~~~~~l~~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
. .. ...+ ........+...+..+.+||.+||+.||.+|||+.||++.|++++.
T Consensus 244 ~------~~-~~~i---------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 E------EL-FKLL---------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp H------HH-HHHH---------HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H------HH-HHHH---------HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1 10 0111 1111222344456689999999999999999999999999987654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.7e-46 Score=396.54 Aligned_cols=244 Identities=21% Similarity=0.255 Sum_probs=204.8
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 469 (678)
++|++++.||+|+||.||+|++ .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5899999999999999999985 579999999986432 233356889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCC
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDG 549 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 549 (678)
||+.+|+|..++.. .+.+++..++.++.||+.||.|||++ |||||||||+||||+.+|.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~----~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999999844 34699999999999999999999999 9999999999999999999999999999876432
Q ss_pred CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 550 DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 550 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
.....||+.|+|||++.+..|+.++|||||||++|+|+||+.||....+. ....... .. .
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~-----~~--~--- 254 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIV-----SG--K--- 254 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-----HC--C---
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------HHHHHHh-----cC--C---
Confidence 23467999999999999999999999999999999999999999643211 1001000 00 0
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCc-----hHHHHHH
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRP-----RMSQVLR 664 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RP-----T~~eVL~ 664 (678)
...+...+..+.+||.+||+.||.+|+ |++++++
T Consensus 255 -~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 112334556899999999999999994 8999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=388.70 Aligned_cols=252 Identities=21% Similarity=0.270 Sum_probs=205.9
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
..++|.+.+.||+|+||.||+|.+ .+++.||+|+++.... ....+.+|+++|+.++||||++++++|.+++.+|||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 357899999999999999999995 5789999999975432 23467899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeec--CccccccccccccccC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHD--FEPLVGDFGLARWQPD 548 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~--~~vkL~DFGla~~~~~ 548 (678)
||.||+|.+++... ..++++..++.++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~----~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc----CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999999443 33699999999999999999999999 99999999999999854 5899999999986543
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
. .......||+.|+|||.+.+..|+.++|||||||++|+|++|..||...... +....... .. ..
T Consensus 157 ~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~----~~---~~ 221 (321)
T d1tkia_ 157 G--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMN----AE---YT 221 (321)
T ss_dssp T--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH----TC---CC
T ss_pred C--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh----CC---CC
Confidence 3 2345678999999999999999999999999999999999999999654321 11111111 00 00
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
+........+..+.+||.+||..||.+|||++|+++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111234457899999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-45 Score=397.76 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=199.6
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCcccccc---ceeeecccccceEEEEeEEeeCCeE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSE---VEVLSCAQHRNVVMLIGFCVEDGRR 465 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~E---v~iL~~L~HpnIv~l~~~~~~~~~~ 465 (678)
-++|++.+.||+|+||.||+|+. .+|+.||||++.... ......+.+| +.+++.++||||++++++|.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 36899999999999999999994 579999999986332 2222334444 6677778899999999999999999
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++ |||||||||+|||++.+|.+||+|||+++.
T Consensus 83 ~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~----~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHC----CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999943 45688999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcc
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGEL 624 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~el 624 (678)
..... .....||+.|+|||++.. ..|+.++|||||||+||+|+||+.||......... . .... .
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~----~~~~-----~ 221 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E----IDRM-----T 221 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---H----HHHH-----S
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---H----HHHh-----c
Confidence 64432 234579999999999975 56899999999999999999999999754432211 0 0000 0
Q ss_pred cCcchhcccchhhhhhhhhccceeeccCCCCCch-----HHHHHH
Q 038949 625 IDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR-----MSQVLR 664 (678)
Q Consensus 625 ld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT-----~~eVL~ 664 (678)
.. ....++...+..+.+||.+||+.||++||| ++++++
T Consensus 222 ~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 222 LT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SS--CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred cc--CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00 011123344557999999999999999999 688764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=389.24 Aligned_cols=257 Identities=27% Similarity=0.349 Sum_probs=204.8
Q ss_pred hcCCcccceecccCccceeeccCC-CCc--EEEEEeeehh-cccCCccccccceeeecc-cccceEEEEeEEeeCCeEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLP-DGQ--VVAVKQYKLA-SSQGDQEFCSEVEVLSCA-QHRNVVMLIGFCVEDGRRLL 467 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~--~vAvK~i~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~L 467 (678)
.++|++.+.||+|+||.||+|.++ ++. .||||.++.. .....+.|.+|+++|+++ +||||++++++|.+++.+++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 478999999999999999999964 444 4778877533 333456799999999998 79999999999999999999
Q ss_pred EEEEeecCCcccccccC--------------CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC
Q 038949 468 VYEYICNGSLDSHLYGR--------------DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF 533 (678)
Q Consensus 468 V~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~ 533 (678)
||||+++|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~----~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGG
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC----CccccccccceEEEcCCC
Confidence 99999999999998543 235689999999999999999999999 999999999999999999
Q ss_pred ccccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCc-cccccCCcccchhhhhh
Q 038949 534 EPLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRK-AMDLNRPRGQQCLTEWA 612 (678)
Q Consensus 534 ~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~-Pf~~~~~~~~~~l~~~~ 612 (678)
.+||+|||+++..... .......||..|+|||.+..+.++.++|||||||++|||++|.. ||..... .+..
T Consensus 165 ~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~------~~~~ 236 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELY 236 (309)
T ss_dssp CEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHH
T ss_pred ceEEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH------HHHH
Confidence 9999999999754322 22234568999999999999999999999999999999999765 5643221 1100
Q ss_pred HHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 613 RPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 613 ~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
. .+....+...+..++..+.+||.+||+.||++|||+++|++.|+..+.
T Consensus 237 ~----------~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 237 E----------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp H----------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----------HHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0 011111223344556689999999999999999999999999987664
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=386.79 Aligned_cols=275 Identities=23% Similarity=0.279 Sum_probs=205.1
Q ss_pred hcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeCC----eEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG----RRLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~----~~~LV 468 (678)
..+|.+.+.||+|+||.||+|++ +|+.||||+++..... ......|+..++.++||||+++++++.+.+ .+|+|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 35788899999999999999997 6889999998643221 122334566677889999999999998654 68999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcc----eeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEEC----RVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~----~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
|||+++|+|.+++.. .++++..++.++.|++.||.|||..+ ...||+||||||+||||+.++.+||+|||+++
T Consensus 80 ~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999954 35899999999999999999999631 11299999999999999999999999999998
Q ss_pred cccCCCcc---ceeEEEeeeccccccccccc------ccceecceeeeeeEEEEeeeCCccccccCCcccchh----hhh
Q 038949 545 WQPDGDMG---VETRVLGTFGYLAPEYAQSG------QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCL----TEW 611 (678)
Q Consensus 545 ~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l----~~~ 611 (678)
........ ......||+.|+|||++... .++.++|||||||+||||+||..||........... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76543321 23346799999999998753 378899999999999999999988865432221110 111
Q ss_pred hHHHHHHhhhhcccCcchhccc-chhhhhhhhhccceeeccCCCCCchHHHHHHHhhccccc
Q 038949 612 ARPLLKRHAIGELIDPRLRNCY-SEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDILM 672 (678)
Q Consensus 612 ~~~~~~~~~~~elld~~l~~~~-~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~~ 672 (678)
...........+.++|.+...+ +......+.+|+.+||+.||++|||+.||++.|+.....
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 1111222222233333332222 233456689999999999999999999999999866543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-45 Score=382.84 Aligned_cols=251 Identities=23% Similarity=0.295 Sum_probs=205.1
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCC---------ccccccceeeeccc-ccceEEEEeEEee
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGD---------QEFCSEVEVLSCAQ-HRNVVMLIGFCVE 461 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~---------~~~~~Ev~iL~~L~-HpnIv~l~~~~~~ 461 (678)
.++|++.+.||+|+||.||+|+. .+++.||||+++....... +.+.+|+.+++.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999994 5799999999875443221 35788999999997 9999999999999
Q ss_pred CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
++..||||||+++|+|.+++. ..+++++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~--~~~~l~e~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHc----CCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999994 345799999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCccceeEEEeeecccccccccc------cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQS------GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL 615 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 615 (678)
+++...... ......||+.|+|||++.+ ..++.++|||||||+||+|++|+.||....+. ......
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~~~~~i 227 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRMI 227 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------HHHHHH
Confidence 998765432 2344679999999999863 35688999999999999999999999743321 101111
Q ss_pred HHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 LKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 ~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. ... ...........+..+.+|+.+||+.||++|||++|+++
T Consensus 228 ~-~~~------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 M-SGN------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp H-HTC------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred H-hCC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 110 01111122345568999999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=385.55 Aligned_cols=261 Identities=23% Similarity=0.267 Sum_probs=196.8
Q ss_pred ccceecccCccceeeccC-CCCcEEEEEeeehhccc-----CCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 398 EANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ-----GDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 398 ~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~-----~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
.+++||+|+||+||+|.. .+|+.||||+++..... ....+.+|+.+|+.++||||+++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999995 57999999998644322 124688999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.++++..+. .....+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~- 154 (299)
T d1ua2a_ 82 METDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 154 (299)
T ss_dssp CSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred hcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcc----ceecccCCcceEEecCCCccccccCccccccCCCc-
Confidence 9888777666 3456699999999999999999999999 99999999999999999999999999998654432
Q ss_pred cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh------hhcc
Q 038949 552 GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA------IGEL 624 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~------~~el 624 (678)
......+||+.|+|||++.. ..|+.++|||||||++|||+||.+||....+... +..... ...... ....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--l~~i~~-~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFE-TLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-HHCCCCTTTSSSTTSS
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH--HHHHHH-hcCCCChhhccchhcc
Confidence 22334579999999999865 4679999999999999999999999964432111 000000 000000 0000
Q ss_pred cC--------cchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH--Hhhc
Q 038949 625 ID--------PRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR--MLEG 668 (678)
Q Consensus 625 ld--------~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~--~Le~ 668 (678)
.. ...........+..+.+||.+||+.||++|||++|+|+ +|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 00 00000011233457899999999999999999999986 4543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=390.68 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=202.7
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhc---ccCCccccccceeee-cccccceEEEEeEEeeCCeEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLAS---SQGDQEFCSEVEVLS-CAQHRNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~---~~~~~~~~~Ev~iL~-~L~HpnIv~l~~~~~~~~~~~LV 468 (678)
++|.+.+.||+|+||.||+|.+ .+++.||||+++... ....+.+..|..++. .++||||+++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999994 579999999997432 233345677777765 67999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccC
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPD 548 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 548 (678)
|||+++|+|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~--~~~~~~e~~~~~~~~qi~~al~ylH~~----~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999994 345689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcc
Q 038949 549 GDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPR 628 (678)
Q Consensus 549 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~ 628 (678)
.. .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||....+. ... ...... .+
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~----~~i~~~---~~- 220 (320)
T d1xjda_ 156 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELF----HSIRMD---NP- 220 (320)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH----HHHHHC---CC-
T ss_pred cc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH------HHH----HHHHcC---CC-
Confidence 22 2334467999999999999999999999999999999999999999754321 101 100001 11
Q ss_pred hhcccchhhhhhhhhccceeeccCCCCCchHH-HHHH
Q 038949 629 LRNCYSEREVYGMLQCASLCIRKDPHSRPRMS-QVLR 664 (678)
Q Consensus 629 l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~-eVL~ 664 (678)
.++...+..+.+||.+||+.||.+||++. ++++
T Consensus 221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 22334456799999999999999999996 6753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=381.18 Aligned_cols=244 Identities=23% Similarity=0.347 Sum_probs=199.7
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhccc------CCccccccceeeeccc--ccceEEEEeEEeeCC
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQ------GDQEFCSEVEVLSCAQ--HRNVVMLIGFCVEDG 463 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~------~~~~~~~Ev~iL~~L~--HpnIv~l~~~~~~~~ 463 (678)
.++|++.+.||+|+||.||+|+. .+|+.||||+++..... ...++.+|+.+|+.++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 56899999999999999999994 57999999998744322 2345788999999886 899999999999999
Q ss_pred eEEEEEEEeec-CCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-cCcccccccc
Q 038949 464 RRLLVYEYICN-GSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-DFEPLVGDFG 541 (678)
Q Consensus 464 ~~~LV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-~~~vkL~DFG 541 (678)
..|+||||+.+ +++.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC----CCccccCcccceEEecCCCeEEECccc
Confidence 99999999975 56777773 345699999999999999999999999 9999999999999995 4799999999
Q ss_pred ccccccCCCccceeEEEeeeccccccccccccc-ceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh
Q 038949 542 LARWQPDGDMGVETRVLGTFGYLAPEYAQSGQI-TEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA 620 (678)
Q Consensus 542 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 620 (678)
+++..... ......||+.|+|||++.+..+ +.++|||||||++|+|+||+.||.... .....
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~-- 219 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRG-- 219 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHC--
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhc--
Confidence 99865432 2345679999999999987665 678999999999999999999995321 00000
Q ss_pred hhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH--Hhhc
Q 038949 621 IGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR--MLEG 668 (678)
Q Consensus 621 ~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~--~Le~ 668 (678)
. ..++...+..+.+||.+||+.||++|||++|+++ +++.
T Consensus 220 --~-------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 220 --Q-------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp --C-------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred --c-------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 0 1122334557899999999999999999999987 4544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=379.40 Aligned_cols=263 Identities=22% Similarity=0.305 Sum_probs=200.1
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
++|++++.||+|+||.||+|.+ .+|+.||||+++.... .....+.+|+++|++++||||+++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999994 6799999999964432 234678899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
|+.+ .+.+++.......+++..++.++.||+.||.|||++ |||||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~----~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC----CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9854 555555555566799999999999999999999999 99999999999999999999999999998664332
Q ss_pred ccceeEEEeeecccccccccccc-cceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHh-----hhhcc
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQ-ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRH-----AIGEL 624 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-----~~~el 624 (678)
.......||+.|+|||++.... ++.++|||||||++|+|++|+.||........ +........... .....
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGS
T ss_pred -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhccccccc
Confidence 2334457999999999877655 57899999999999999999999964432110 000000000000 00000
Q ss_pred ------cCcchhc---ccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 625 ------IDPRLRN---CYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 625 ------ld~~l~~---~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
....... ......+..+.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000000 011123456889999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=386.43 Aligned_cols=265 Identities=26% Similarity=0.353 Sum_probs=212.9
Q ss_pred hhhhhhhcCCcccceecccCccceeeccCC------CCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEE
Q 038949 387 AELELATNRFSEANFLAEGGFGSVHRGVLP------DGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFC 459 (678)
Q Consensus 387 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~ 459 (678)
++|++..++|.+.+.||+|+||.||+|.+. +++.||||+++.... .....|.+|+.++++++||||++++++|
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 356788899999999999999999999753 357899999874322 2224688999999999999999999999
Q ss_pred eeCCeEEEEEEEeecCCcccccccC--------CCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee
Q 038949 460 VEDGRRLLVYEYICNGSLDSHLYGR--------DRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH 531 (678)
Q Consensus 460 ~~~~~~~LV~E~~~ggsL~~~l~~~--------~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~ 531 (678)
..++..++||||+.+|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~----~ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAE 168 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeeceEcCCceeecC
Confidence 9999999999999999999988432 223467888999999999999999999 9999999999999999
Q ss_pred cCccccccccccccccCC-CccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCC-ccccccCCcccchhh
Q 038949 532 DFEPLVGDFGLARWQPDG-DMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGR-KAMDLNRPRGQQCLT 609 (678)
Q Consensus 532 ~~~vkL~DFGla~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~-~Pf~~~~~~~~~~l~ 609 (678)
++.+||+|||+++..... .........||+.|+|||.+.++.++.++||||||+++|||+||. .||..... .
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~ 242 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------E 242 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------H
T ss_pred CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------H
Confidence 999999999999865432 222233446899999999999999999999999999999999985 56643221 1
Q ss_pred hhhHHHHHHhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 610 EWARPLLKRHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 610 ~~~~~~~~~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
++..... +. .....+..++..+.+||.+||+.||++|||+++|++.|+..+.
T Consensus 243 ~~~~~i~---------~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 243 QVLRFVM---------EG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHHH---------TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHH---------hC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111111 11 1112234455689999999999999999999999999987653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.6e-45 Score=377.76 Aligned_cols=262 Identities=22% Similarity=0.291 Sum_probs=200.3
Q ss_pred cCCcccceecccCccceeeccCCCCcEEEEEeeehhc--ccCCccccccceeeecccccceEEEEeEEeeCCeEEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLAS--SQGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYEY 471 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~--~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~ 471 (678)
++|.+.+.||+|+||.||+|++++|+.||||+++... ......+.+|+.+|+.++||||++++++|..++..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999998889999999986443 23346788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc
Q 038949 472 ICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM 551 (678)
Q Consensus 472 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 551 (678)
+.++.+..+. .....+++..++.++.||+.||+|||+. |||||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhccC----cEEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 9877776665 3456799999999999999999999998 99999999999999999999999999998654332
Q ss_pred cceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHH-----------HHHh
Q 038949 552 GVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPL-----------LKRH 619 (678)
Q Consensus 552 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~-----------~~~~ 619 (678)
.......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ +....... ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhccchhhhh
Confidence 23344568999999999865 4579999999999999999999999964432111 00000000 0000
Q ss_pred hhhc---ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 AIGE---LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 ~~~e---lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.... ...+..........+..+.+||.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00011111122234457889999999999999999999974
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=384.30 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=200.1
Q ss_pred cceecccCccceeeccCCC----CcEEEEEeeehh-cccCCccccccceeeecccccceEEEEeEEee-CCeEEEEEEEe
Q 038949 399 ANFLAEGGFGSVHRGVLPD----GQVVAVKQYKLA-SSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVE-DGRRLLVYEYI 472 (678)
Q Consensus 399 ~~~LG~G~fG~Vy~a~~~~----g~~vAvK~i~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-~~~~~LV~E~~ 472 (678)
.++||+|+||+||+|.+.. ...||||.++.. .....++|.+|+++|++++||||++++|++.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999998532 236899998632 23334679999999999999999999999875 56899999999
Q ss_pred ecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCCc-
Q 038949 473 CNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGDM- 551 (678)
Q Consensus 473 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~- 551 (678)
++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~----~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhccc----CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999988543 34477888899999999999999999 999999999999999999999999999986543321
Q ss_pred --cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhhcccCcch
Q 038949 552 --GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIGELIDPRL 629 (678)
Q Consensus 552 --~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~elld~~l 629 (678)
.......||+.|+|||.+.++.++.++||||||+++|||+||..||...... .++....... .
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-----~~~~~~i~~g----------~ 251 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVYLLQG----------R 251 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTT----------C
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcC----------C
Confidence 1222346899999999999999999999999999999999988887543211 1111111111 0
Q ss_pred hcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 630 RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 630 ~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
+...+..++..+.+||.+||+.||++||++.||++.|+....
T Consensus 252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111233455689999999999999999999999999987653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=375.64 Aligned_cols=263 Identities=22% Similarity=0.269 Sum_probs=198.0
Q ss_pred hcCCcccceecccCccceeeccC-CC-CcEEEEEeeehhccc--CCccccccceeeecc---cccceEEEEeEEee----
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PD-GQVVAVKQYKLASSQ--GDQEFCSEVEVLSCA---QHRNVVMLIGFCVE---- 461 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~-g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L---~HpnIv~l~~~~~~---- 461 (678)
.++|++++.||+|+||.||+|++ .+ ++.||||+++..... ....+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 57999999999999999999984 34 678999998754322 234567888887776 69999999999853
Q ss_pred -CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccc
Q 038949 462 -DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDF 540 (678)
Q Consensus 462 -~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DF 540 (678)
....+++|||+.++.+.... ......+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~----~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEEecCCCccEEEEcCCCCeeecch
Confidence 34689999999777665433 34455689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHH--H
Q 038949 541 GLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK--R 618 (678)
Q Consensus 541 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~--~ 618 (678)
|++...... .......||+.|+|||++.+..|+.++|||||||++|||++|++||....+... +......... .
T Consensus 161 g~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 161 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPGE 236 (305)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCG
T ss_pred hhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCch
Confidence 999754322 233456799999999999999999999999999999999999999975432110 0000000000 0
Q ss_pred hhh----------hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 619 HAI----------GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 619 ~~~----------~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
... ...........+....+..+.+||.+||+.||++|||+.|+|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000000111122334557889999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=369.98 Aligned_cols=263 Identities=23% Similarity=0.278 Sum_probs=194.2
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEee--------
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE-------- 461 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-------- 461 (678)
.++|++.+.||+|+||+||+|++ .+|+.||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47999999999999999999994 6899999999864432 233568899999999999999999998855
Q ss_pred CCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccc
Q 038949 462 DGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFG 541 (678)
Q Consensus 462 ~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFG 541 (678)
.+..|+||||+.++.+..+. .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~----~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccC----CEEecCcCchheeecCCCcEEeeecc
Confidence 34689999999887776554 3445688899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCC---ccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHH
Q 038949 542 LARWQPDGD---MGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLK 617 (678)
Q Consensus 542 la~~~~~~~---~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 617 (678)
+++...... .......+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||....+... +.... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~i~-~~~~ 239 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ--LALIS-QLCG 239 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHH-HHHC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH--HHHHH-HhcC
Confidence 997654322 1222335699999999998764 689999999999999999999999964332110 00000 0000
Q ss_pred H---hhhhc--------------ccCcchhccc-chhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 618 R---HAIGE--------------LIDPRLRNCY-SEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 618 ~---~~~~e--------------lld~~l~~~~-~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. ..... .........+ .......+.+||.+||+.||++|||++|+|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0 00000 0000000000 0011335678999999999999999999885
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-42 Score=361.63 Aligned_cols=262 Identities=18% Similarity=0.198 Sum_probs=200.3
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccc-eEEEEeEEeeCCeEEEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN-VVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~~~~~~~~LV~E 470 (678)
.++|++.+.||+|+||.||+|.+ .+|+.||||++... ....++..|+++++.++|+| |+.+.+++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh--ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 46899999999999999999984 57899999988743 23457889999999997665 5566666778888999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee---cCcccccccccccccc
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH---DFEPLVGDFGLARWQP 547 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~---~~~vkL~DFGla~~~~ 547 (678)
|+ +++|.+.+.. ....+++..+..++.|++.||+|||++ ||+||||||+|||++. +..++|+|||+++...
T Consensus 84 ~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred Ec-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 98 6677666543 345699999999999999999999999 9999999999999864 4579999999998764
Q ss_pred CCCc------cceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhh
Q 038949 548 DGDM------GVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAI 621 (678)
Q Consensus 548 ~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 621 (678)
.... .......||+.|+|||.+.+..++.++|||||||++|||+||..||................ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~----~~~~ 233 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS----EKKM 233 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH----HHHH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh----cccC
Confidence 4321 22345679999999999999999999999999999999999999997544322111110000 0000
Q ss_pred hcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhcccc
Q 038949 622 GELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDIL 671 (678)
Q Consensus 622 ~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~~ 671 (678)
. ...+. ....++..+.+++.+||+.||++||+++++.+.|+..+.
T Consensus 234 ~-~~~~~----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 234 S-TPIEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp H-SCHHH----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred C-CChhH----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0 00011 112344578999999999999999999999988886543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-43 Score=372.60 Aligned_cols=258 Identities=22% Similarity=0.289 Sum_probs=193.5
Q ss_pred CCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccccceEEEEeEEeeC------CeEEE
Q 038949 395 RFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNVVMLIGFCVED------GRRLL 467 (678)
Q Consensus 395 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~------~~~~L 467 (678)
+|+..++||+|+||+||+|++ .+|+.||||+++.. ...+.+|+++|+.++||||++++++|... .++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECcc----chHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 688889999999999999995 57999999998643 23456899999999999999999998542 35799
Q ss_pred EEEEeecCCcccccc-cCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC-cccccccccccc
Q 038949 468 VYEYICNGSLDSHLY-GRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF-EPLVGDFGLARW 545 (678)
Q Consensus 468 V~E~~~ggsL~~~l~-~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~-~vkL~DFGla~~ 545 (678)
||||+.++.+..+.. ......+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~----~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc----CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 999997664433331 23455699999999999999999999999 999999999999999775 899999999986
Q ss_pred ccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhH-------HHHH
Q 038949 546 QPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWAR-------PLLK 617 (678)
Q Consensus 546 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~-------~~~~ 617 (678)
..... ......||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||....... .+..... ....
T Consensus 173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 173 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHH
T ss_pred ccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhh
Confidence 64433 2234579999999998765 578999999999999999999999996543211 1111100 0000
Q ss_pred Hh--hhhc-----ccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 618 RH--AIGE-----LIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 618 ~~--~~~e-----lld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
.. .... ..............+..+.+||.+||+.||++|||+.|+|+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000 00000111122234557899999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.2e-42 Score=358.30 Aligned_cols=262 Identities=16% Similarity=0.174 Sum_probs=207.3
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeecccc-cceEEEEeEEeeCCeEEEEE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQH-RNVVMLIGFCVEDGRRLLVY 469 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~H-pnIv~l~~~~~~~~~~~LV~ 469 (678)
..++|++.+.||+|+||.||+|++ .+|+.||||++... .....+.+|++++..++| +|++.+++++.++...++||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 467999999999999999999994 57899999987543 234568889999999965 89999999999999999999
Q ss_pred EEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeee-----cCccccccccccc
Q 038949 470 EYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTH-----DFEPLVGDFGLAR 544 (678)
Q Consensus 470 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~-----~~~vkL~DFGla~ 544 (678)
||+ +++|.+++... ...+++..+..++.|++.||+|||++ ||+||||||+|||++. ++.++|+|||+++
T Consensus 81 e~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~----giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 81 DLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHC----CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 998 88999888543 34689999999999999999999999 9999999999999974 5789999999998
Q ss_pred cccCCC------ccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHH
Q 038949 545 WQPDGD------MGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKR 618 (678)
Q Consensus 545 ~~~~~~------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 618 (678)
...... ........||+.|+|||++.+..++.++|||||||++|||+||..||............. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~---~i~~~ 231 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE---RIGEK 231 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH---HHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH---HHHhc
Confidence 754321 122344679999999999999999999999999999999999999997544322111111 11000
Q ss_pred hhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHHHhhccc
Q 038949 619 HAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLRMLEGDI 670 (678)
Q Consensus 619 ~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~~Le~~~ 670 (678)
.. ... ........+..+.+++..|+..+|++||+++.+.+.|+..+
T Consensus 232 ~~---~~~---~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 232 KQ---STP---LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HH---HSC---HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cC---CCC---hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 00 000 01112233457899999999999999999999988887654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-43 Score=372.18 Aligned_cols=266 Identities=21% Similarity=0.266 Sum_probs=194.6
Q ss_pred hhcCCcccceecccCccceeecc-CCCCcEEEEEeeehhcc-cCCccccccceeeecccccceEEEEeEEeeCC----eE
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASS-QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG----RR 465 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~----~~ 465 (678)
.+.+|++++.||+|+||.||+|. ..+|+.||||+++.... ...+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 35689999999999999999998 46899999999864332 22357889999999999999999999987643 23
Q ss_pred EEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccccc
Q 038949 466 LLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARW 545 (678)
Q Consensus 466 ~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~ 545 (678)
+++++++.+|+|.+++.. .++++..++.++.||+.||+|||++ |||||||||+||||+.++.+||+|||++..
T Consensus 86 ~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~----~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 455566779999999943 3599999999999999999999999 999999999999999999999999999975
Q ss_pred ccCCC--ccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhh--H---HH--
Q 038949 546 QPDGD--MGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWA--R---PL-- 615 (678)
Q Consensus 546 ~~~~~--~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~--~---~~-- 615 (678)
..... .......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||............... . ..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 53321 122345679999999999854 56789999999999999999999999654321110000000 0 00
Q ss_pred ----HHHhhhhcccCcchh---cccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 616 ----LKRHAIGELIDPRLR---NCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 616 ----~~~~~~~elld~~l~---~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
............... .......+..+.+|+.+||+.||++|||++|+|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000000 0111123346889999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=359.30 Aligned_cols=259 Identities=18% Similarity=0.245 Sum_probs=202.1
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccC--CccccccceeeecccccceEEEEeEEeeCCeEEEEEE
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQG--DQEFCSEVEVLSCAQHRNVVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~--~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 470 (678)
++|++++.||+|+||+||+|++ .+++.||||+++...... ...+.+|+.+|+.++||||++++++|.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999994 688999999997543322 3578899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccccccCCC
Q 038949 471 YICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLARWQPDGD 550 (678)
Q Consensus 471 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 550 (678)
++.+++|..++. ..+.+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~----~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcC----CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999888773 445688999999999999999999999 99999999999999999999999999998664432
Q ss_pred ccceeEEEeeecccccccccccc-cceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhh---------
Q 038949 551 MGVETRVLGTFGYLAPEYAQSGQ-ITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHA--------- 620 (678)
Q Consensus 551 ~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~--------- 620 (678)
.......+++.|+|||.+.... ++.++|||||||++|||++|+.||........ ..........
T Consensus 156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-----QLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-----HHHHHHHHHCCCCTTTCTT
T ss_pred -ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH-----HHHHHHhhcCCCChhhhhh
Confidence 2233345788999999987654 68999999999999999999999743322111 1111110000
Q ss_pred hhccc---------CcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 621 IGELI---------DPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 621 ~~ell---------d~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
..... ...............+.+|+.+||+.||.+|||++|+|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 000011122233456889999999999999999999876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=370.09 Aligned_cols=260 Identities=23% Similarity=0.296 Sum_probs=192.5
Q ss_pred hhcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEeeCC-----
Q 038949 392 ATNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVEDG----- 463 (678)
Q Consensus 392 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~----- 463 (678)
..++|++++.||+|+||.||+|.+ .+|+.||||+++.... ...+.+.+|+.+|+.++||||++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 468999999999999999999994 5799999999874322 12346889999999999999999999997654
Q ss_pred -eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccc
Q 038949 464 -RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGL 542 (678)
Q Consensus 464 -~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGl 542 (678)
.+|+||||+ +.+|..++. ..++++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~----~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhC----CCcccccCcchhhcccccccccccccc
Confidence 579999998 667766652 34699999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeEEEeeecccccccccc-cccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhh-----HHHH
Q 038949 543 ARWQPDGDMGVETRVLGTFGYLAPEYAQS-GQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWA-----RPLL 616 (678)
Q Consensus 543 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~-----~~~~ 616 (678)
++..... .+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............... ....
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 9865432 234568999999999876 45689999999999999999999999654321110000000 0000
Q ss_pred H----------HhhhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 617 K----------RHAIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 617 ~----------~~~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. .....+.....+ .......+..+.+||.+||..||.+|||++|+|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 000001000001 1112233457889999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=367.38 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=202.8
Q ss_pred cCCcccceecccCccceeeccC----CCCcEEEEEeeehhc----ccCCccccccceeeecccc-cceEEEEeEEeeCCe
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL----PDGQVVAVKQYKLAS----SQGDQEFCSEVEVLSCAQH-RNVVMLIGFCVEDGR 464 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~i~~~~----~~~~~~~~~Ev~iL~~L~H-pnIv~l~~~~~~~~~ 464 (678)
++|++.+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 7799999999999999999973 258899999986432 2334678999999999976 899999999999999
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhhcC----CEEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999844 34577888999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCccceeEEEeeeccccccccccc--ccceecceeeeeeEEEEeeeCCccccccCCcccchhhhhhHHHHHHhhhh
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSG--QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEWARPLLKRHAIG 622 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 622 (678)
..............|++.|++||.+... .++.++|||||||+||+|++|..||........ ..... ... ..
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--~~~i~----~~~-~~ 250 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEIS----RRI-LK 250 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHH----HHH-HH
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH----Hhc-cc
Confidence 6654444444556789999999998754 467899999999999999999999976543221 11111 110 00
Q ss_pred cccCcchhcccchhhhhhhhhccceeeccCCCCCch-----HHHHHH
Q 038949 623 ELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPR-----MSQVLR 664 (678)
Q Consensus 623 elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT-----~~eVL~ 664 (678)
. ...++...+..+.+||.+||+.||++||| ++|+++
T Consensus 251 ~------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 S------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp C------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred C------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 11233445668999999999999999994 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.5e-42 Score=362.39 Aligned_cols=258 Identities=18% Similarity=0.258 Sum_probs=197.0
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeeccc-ccceEEEEeEEee--CCeEEEE
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVE--DGRRLLV 468 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~--~~~~~LV 468 (678)
.++|++++.||+|+||.||+|+. .+|+.||||+++.. ....+.+|+.+|+.+. ||||++++++|.. ...+++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 36899999999999999999994 67999999998633 2357889999999995 9999999999874 4569999
Q ss_pred EEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecC-cccccccccccccc
Q 038949 469 YEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDF-EPLVGDFGLARWQP 547 (678)
Q Consensus 469 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~-~vkL~DFGla~~~~ 547 (678)
|||+.+++|..+. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~----gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 111 FEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc----ccccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999997765 3589999999999999999999999 999999999999999755 69999999998654
Q ss_pred CCCccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhh--hh-----hHHHHHHh
Q 038949 548 DGDMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT--EW-----ARPLLKRH 619 (678)
Q Consensus 548 ~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~--~~-----~~~~~~~~ 619 (678)
... ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||............ .. ........
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 182 PGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 432 23445689999999998765 5799999999999999999999999654432111100 00 00000000
Q ss_pred h------hhcccCc--------chhcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 620 A------IGELIDP--------RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 620 ~------~~elld~--------~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
. ....... ..........+..+.+||.+||+.||++|||++|+|+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000000 0011111223456889999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-41 Score=359.85 Aligned_cols=261 Identities=21% Similarity=0.252 Sum_probs=187.9
Q ss_pred hcCCcccceecccCccceeeccC-CCCcEEEEEeeehhcc--cCCccccccceeeecccccceEEEEeEEee------CC
Q 038949 393 TNRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASS--QGDQEFCSEVEVLSCAQHRNVVMLIGFCVE------DG 463 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~--~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~------~~ 463 (678)
.++|++++.||+|+||+||+|.+ .+|+.||||++..... .....+.+|+.+|++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 47899999999999999999995 5799999999974322 223468899999999999999999999864 36
Q ss_pred eEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccccccccc
Q 038949 464 RRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLA 543 (678)
Q Consensus 464 ~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla 543 (678)
.+|+||||+.++.+. .+. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~----~~~~~~~i~~~~~qil~gl~~LH~~----giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHH-hhh----cCCCHHHHHHHHHHHHHHHHHhhhc----ccccccCCccccccccccceeeechhhh
Confidence 889999999665544 442 3488999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccch-hh--------h-hh-
Q 038949 544 RWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQC-LT--------E-WA- 612 (678)
Q Consensus 544 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~-l~--------~-~~- 612 (678)
+..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.......... .. + |.
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 765432 23345679999999999999999999999999999999999999996433211000 00 0 00
Q ss_pred -----HHHHHHhh------hhcccCcch---hcccchhhhhhhhhccceeeccCCCCCchHHHHHH
Q 038949 613 -----RPLLKRHA------IGELIDPRL---RNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR 664 (678)
Q Consensus 613 -----~~~~~~~~------~~elld~~l---~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~ 664 (678)
........ ......... ........+..+.+||.+||..||++|||++|+|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 000000000 00112234567899999999999999999999984
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=362.94 Aligned_cols=263 Identities=24% Similarity=0.313 Sum_probs=194.0
Q ss_pred hcCCcccceecccCccceeecc-CCCCcEEEEEeeehhccc--CCccccccceeeecccccceEEEEeEEee-----CCe
Q 038949 393 TNRFSEANFLAEGGFGSVHRGV-LPDGQVVAVKQYKLASSQ--GDQEFCSEVEVLSCAQHRNVVMLIGFCVE-----DGR 464 (678)
Q Consensus 393 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~i~~~~~~--~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~-----~~~ 464 (678)
.++|++++.||+|+||+||+|+ ..+|+.||||+++..... ....+.+|+.+|+.++||||+++++++.. +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 5789999999999999999998 468999999998743222 22468899999999999999999999864 334
Q ss_pred EEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 465 RLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 465 ~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.+++|+|+.+|+|.+++.. .++++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~----giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC----CCcccccCCccccccccccccccccchhc
Confidence 5677788889999999833 4599999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCccceeEEEeeeccccccccccc-ccceecceeeeeeEEEEeeeCCccccccCCcccchhh-hh----hHHH---
Q 038949 545 WQPDGDMGVETRVLGTFGYLAPEYAQSG-QITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLT-EW----ARPL--- 615 (678)
Q Consensus 545 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~-~~----~~~~--- 615 (678)
.... ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||............ .. ....
T Consensus 170 ~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 170 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 5432 22345689999999987665 5688999999999999999999999643321100000 00 0000
Q ss_pred ----HHHh---hhhcccCcchhcccchhhhhhhhhccceeeccCCCCCchHHHHHH--Hhh
Q 038949 616 ----LKRH---AIGELIDPRLRNCYSEREVYGMLQCASLCIRKDPHSRPRMSQVLR--MLE 667 (678)
Q Consensus 616 ----~~~~---~~~elld~~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~eVL~--~Le 667 (678)
.... .........+.. .....+..+.+||.+||+.||.+|||+.|+|+ ++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred ccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 0000 000000000000 01123456889999999999999999999987 454
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-36 Score=323.03 Aligned_cols=262 Identities=19% Similarity=0.219 Sum_probs=187.9
Q ss_pred cCCcccceecccCccceeeccC-CCCcEEEEEeeehhcccCCccccccceeeeccc-----------ccceEEEEeEEee
Q 038949 394 NRFSEANFLAEGGFGSVHRGVL-PDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-----------HRNVVMLIGFCVE 461 (678)
Q Consensus 394 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-----------HpnIv~l~~~~~~ 461 (678)
+||++++.||+|+||.||+|+. .+|+.||||+++.... ..+.+.+|+.+++.+. |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 5799999999999999999984 5899999999874322 1245667887777664 5789999988764
Q ss_pred --CCeEEEEEEEeecCCccc-ccccCCCCccCccccchhhhhhccchhhhhh-cceeeeEEeccCCCCceEeeecCc---
Q 038949 462 --DGRRLLVYEYICNGSLDS-HLYGRDRDPLEWSARRKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILVTHDFE--- 534 (678)
Q Consensus 462 --~~~~~LV~E~~~ggsL~~-~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~-~~~~~gIvHrDLKp~NILl~~~~~--- 534 (678)
....+++|+++..+.... .........+++..++.++.||+.||+|||+ . ||+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~----~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC----GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT----CEECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc----CcccccCChhHeeeeccCcccc
Confidence 345667777765544322 2333455668889999999999999999998 6 9999999999999987654
Q ss_pred ---cccccccccccccCCCccceeEEEeeecccccccccccccceecceeeeeeEEEEeeeCCccccccCCcccchhhhh
Q 038949 535 ---PLVGDFGLARWQPDGDMGVETRVLGTFGYLAPEYAQSGQITEKADVYSLGVVLVELITGRKAMDLNRPRGQQCLTEW 611 (678)
Q Consensus 535 ---vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~eLltG~~Pf~~~~~~~~~~l~~~ 611 (678)
++++|||.+...... ....+||+.|+|||++....++.++|||||||++++|++|+.||..............
T Consensus 168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 899999999755432 2345699999999999999999999999999999999999999965432111100000
Q ss_pred hHH-----------HHHHhh-hhc---------ccCc----------chhcccchhhhhhhhhccceeeccCCCCCchHH
Q 038949 612 ARP-----------LLKRHA-IGE---------LIDP----------RLRNCYSEREVYGMLQCASLCIRKDPHSRPRMS 660 (678)
Q Consensus 612 ~~~-----------~~~~~~-~~e---------lld~----------~l~~~~~~~~~~~l~~LI~~cL~~dP~~RPT~~ 660 (678)
... ...... ... .+.. ..........+..+.+||.+||..||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 000 000000 000 0000 001123345667899999999999999999999
Q ss_pred HHHH
Q 038949 661 QVLR 664 (678)
Q Consensus 661 eVL~ 664 (678)
|+|+
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=2.1e-22 Score=195.50 Aligned_cols=160 Identities=17% Similarity=0.094 Sum_probs=117.4
Q ss_pred CcccceecccCccceeeccCCCCcEEEEEeeehhcccCC------------------ccccccceeeecccccceEEEEe
Q 038949 396 FSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGD------------------QEFCSEVEVLSCAQHRNVVMLIG 457 (678)
Q Consensus 396 y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~------------------~~~~~Ev~iL~~L~HpnIv~l~~ 457 (678)
+.+.+.||+|+||.||+|...+|+.||||+++....... ..+..|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 456789999999999999977899999998763221100 11234677788888999988876
Q ss_pred EEeeCCeEEEEEEEeecCCcccccccCCCCccCccccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCcccc
Q 038949 458 FCVEDGRRLLVYEYICNGSLDSHLYGRDRDPLEWSARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLV 537 (678)
Q Consensus 458 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL 537 (678)
+.. .+++|||+.+..+.. ++...+..++.|++.+|.|||++ ||+||||||+|||++++ .++|
T Consensus 82 ~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~----giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEETT-EEEE
T ss_pred ecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC----CEEEccCChhheeeeCC-CEEE
Confidence 632 379999997755433 44566678999999999999999 99999999999999865 5889
Q ss_pred ccccccccccCCCccceeEEEeeeccccc------ccccccccceecceeee
Q 038949 538 GDFGLARWQPDGDMGVETRVLGTFGYLAP------EYAQSGQITEKADVYSL 583 (678)
Q Consensus 538 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~AP------E~l~~~~~s~ksDVwSL 583 (678)
+|||++.....+.. ..|... +++ .+.|+.++|+||.
T Consensus 144 iDFG~a~~~~~~~~---------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~ 185 (191)
T d1zara2 144 IDFPQSVEVGEEGW---------REILERDVRNIITYF-SRTYRTEKDINSA 185 (191)
T ss_dssp CCCTTCEETTSTTH---------HHHHHHHHHHHHHHH-HHHHCCCCCHHHH
T ss_pred EECCCcccCCCCCc---------HHHHHHHHHHHHHHH-cCCCCCcccHHHH
Confidence 99999975543321 112211 122 3678889999986
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.41 E-value=6.5e-14 Score=132.40 Aligned_cols=142 Identities=19% Similarity=0.252 Sum_probs=99.9
Q ss_pred ceEEEEEEeecc--------cccchhheehhhccccCCCe---EEEEEEeCCCCCCCccccccccccccccCCcccCCCC
Q 038949 13 GKVVIVAVKASK--------EIPRSALVWALTHVVQPGDY---IKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGT 81 (678)
Q Consensus 13 ~~~VvV~~das~--------~~s~~al~WaL~~v~~~gD~---i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (678)
+.||+||||.|- .-|++|+.|||+|+++.||. |+++||.+........++ ..... . +.
T Consensus 1 p~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~-----~~~~~--~----~~ 69 (171)
T d2gm3a1 1 PTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVD-----SIYAS--P----ED 69 (171)
T ss_dssp CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC---------------CCCCS--H----HH
T ss_pred CCEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEecccccccccccc-----ccccC--H----HH
Confidence 368999999873 14899999999999999996 778888775433211111 00000 0 00
Q ss_pred CCcccchhhhHHHHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhccc
Q 038949 82 SSDQKDDIVDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEE 152 (678)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~ 152 (678)
..+..++..+...+++.++.+.|+..++.+++.|..|+|...|+++|++.++++|||++|=+... .||+++
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~lGSv~~~vi~~ 149 (171)
T d2gm3a1 70 FRDMRQSNKAKGLHLLEFFVNKCHEIGVGCEAWIKTGDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKH 149 (171)
T ss_dssp HHHHTTSHHHHHHHHHHHHHHHHHHHTCEEEEEEEESCHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhcCCceEEEEEeCChHHHHHHHHhhcCCcEEEeccCCccccccCccCcHHHHHHhC
Confidence 00112334444557788888888888999999999999999999999999999999999943322 289999
Q ss_pred ccccEEEEecCCc
Q 038949 153 LQCNVVVMKRSQP 165 (678)
Q Consensus 153 l~c~i~~~~~~~~ 165 (678)
..|.|+++++..+
T Consensus 150 ~~cpVlvV~~~~~ 162 (171)
T d2gm3a1 150 AECPVMTIKRNAD 162 (171)
T ss_dssp CSSCEEEEECCGG
T ss_pred CCCCEEEEeCCCC
Confidence 9999999997754
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=98.95 E-value=9.4e-11 Score=108.47 Aligned_cols=143 Identities=18% Similarity=0.204 Sum_probs=97.0
Q ss_pred eEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchh----
Q 038949 14 KVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDI---- 89 (678)
Q Consensus 14 ~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 89 (678)
++|+|++|.| +.|.+|+.||+...-+.|..|+||||.++...... ..++.. ...........+-..++
T Consensus 4 ~~ILvavD~s-~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~-~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 75 (160)
T d1mjha_ 4 KKILYPTDFS-ETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKR-DIFSLL------LGVAGLNKSVEEFENELKNKL 75 (160)
T ss_dssp CEEEEECCSC-HHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC------------------------CHHHHHHHHHHH
T ss_pred CeEEEEECCC-HHHHHHHHHHHHHHHhcCCEEEEEEeccccccccc-cccccc------ccccccchhHHHHHHHHHHHH
Confidence 6899999988 55999999999998888899999999986543321 010000 00000011110111111
Q ss_pred hhHHHHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEE
Q 038949 90 VDSCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVM 160 (678)
Q Consensus 90 ~~~~~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~ 160 (678)
.+...+.+.++.+.++..+|.++..|..|+|...|++.|++.+|+.||++.|=+... .+++.+.+|.|.++
T Consensus 76 ~~~~~~~l~~~~~~~~~~gv~~~~~~~~G~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~GS~a~~vl~~s~~pVlvV 155 (160)
T d1mjha_ 76 TEEAKNKMENIKKELEDVGFKVKDIIVVGIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSNKPVLVV 155 (160)
T ss_dssp HHHHHHHHHHHHHHHHHTTCEEEEEEEEECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCCSCEEEE
T ss_pred HHHHHHHHHHHHHHHHhcCCeEEEEEEeccHHHHHhhhhhccccceEEeccCCCCcccccccCcHHHHHHhcCCCCEEEE
Confidence 222234455566666678999999999999999999999999999999998833222 27999999999999
Q ss_pred ecCC
Q 038949 161 KRSQ 164 (678)
Q Consensus 161 ~~~~ 164 (678)
|..+
T Consensus 156 ~~~~ 159 (160)
T d1mjha_ 156 KRKN 159 (160)
T ss_dssp CCCC
T ss_pred cCCC
Confidence 9764
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=98.82 E-value=1e-09 Score=99.57 Aligned_cols=136 Identities=12% Similarity=0.109 Sum_probs=86.9
Q ss_pred eecceEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchh
Q 038949 10 LVVGKVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDI 89 (678)
Q Consensus 10 ~~~~~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (678)
|..-++++|++|.| +.|..||.||+.-..+.|+.++++++.++........++ +.. ... ...
T Consensus 2 M~~yk~ILv~vD~s-~~s~~al~~A~~la~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~-----~~~---~~~ 63 (147)
T d1tq8a_ 2 LSAYKTVVVGTDGS-DSSMRAVDRAAQIAGADAKLIIASAYLPQHEDARAADIL---------KDE-----SYK---VTG 63 (147)
T ss_dssp CCCCCEEEEECCSS-HHHHHHHHHHHHHHTTTSEEEEEEECCC-------------------------------------
T ss_pred CcCCCEEEEEECCC-HHHHHHHHHHHHHHhcCCCEEEEEEEecccccccccccc---------hhh-----hHH---HHH
Confidence 44558899999998 569999999998554444445555555543322111110 000 111 111
Q ss_pred hhHHHHHHHHhhhcCCCCcce-EEEEEEecCCcchhhhhhhcccccEEEEccccchhhh---------hhcccccccEEE
Q 038949 90 VDSCSQMMRQLQEVYDPEKIK-VRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEKK---------CCMEELQCNVVV 159 (678)
Q Consensus 90 ~~~~~~~~~~l~~~~~~~~v~-~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~~---------~~~~~l~c~i~~ 159 (678)
.+...+.+.++.+.+...++. +++.|..|++...+++.|++.+++.||+++|-+...+ +++++.+|.|.+
T Consensus 64 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~Gs~~~~ll~~~~~pVlv 143 (147)
T d1tq8a_ 64 TAPIYEILHDAKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAKVDVLI 143 (147)
T ss_dssp CCTHHHHHHHHHHHHHTTTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTTCEEEE
T ss_pred HHHHHHHHHHHHHHHHHcCCCcEEEEEEecChHHHHHHhhhccceeEEEecCCCCCcccccccccHHHHHHHhCCCCEEE
Confidence 112234555555555554654 8999999999999999999999999999999544332 799999999999
Q ss_pred EecC
Q 038949 160 MKRS 163 (678)
Q Consensus 160 ~~~~ 163 (678)
+|.+
T Consensus 144 V~~~ 147 (147)
T d1tq8a_ 144 VHTT 147 (147)
T ss_dssp ECCC
T ss_pred EecC
Confidence 9864
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=98.65 E-value=4e-09 Score=94.36 Aligned_cols=125 Identities=14% Similarity=0.211 Sum_probs=86.2
Q ss_pred eEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhHH
Q 038949 14 KVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSC 93 (678)
Q Consensus 14 ~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (678)
++|+|++|.| +.|..|+.||+...-+.|..|+||+|+++..... +. . ...+...+..+..
T Consensus 2 k~Ilv~~D~s-~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~~---~~-----------~-----~~~~~~~~~~~~~ 61 (135)
T d2z3va1 2 KTILLAYDGS-EHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYL---GE-----------P-----FFEEALRRRLERA 61 (135)
T ss_dssp CEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEEECCCCTTC---CT-----------T-----HHHHHHHHHHHHH
T ss_pred CEEEEEECCC-HHHHHHHHHHHHHHHHcCCEEEEEEEecCCcccc---cc-----------c-----hhHHHHHHHHHHH
Confidence 5799999988 5699999999999888999999999998543221 00 0 0001112222333
Q ss_pred HHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhh---------hhhcccccccEEEE
Q 038949 94 SQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK---------KCCMEELQCNVVVM 160 (678)
Q Consensus 94 ~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~---------~~~~~~l~c~i~~~ 160 (678)
.+.+.++.+..+-. .++..+..|+|..++++.|++.+++.||++.|-+.-. .|++.+.+|.|+++
T Consensus 62 ~~~l~~~~~~~~~~--~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~ll~~~~~pVlvV 135 (135)
T d2z3va1 62 EGVLEEARALTGVP--KEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAPCPVLLV 135 (135)
T ss_dssp HHHHHHHHHHHCCC--GGGEEEEESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSCBHHHHHHHHHCSSCEEEE
T ss_pred HHHHHHHHHhcCCC--eEEEEEEcCChHHHHHHHhhhhheeeEEeccCCCCcccccccCcHHHHHHHhCCCCEEeC
Confidence 34444444333222 2356677899988999889999999999999944322 27999999999875
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=98.62 E-value=8.3e-09 Score=92.59 Aligned_cols=130 Identities=17% Similarity=0.112 Sum_probs=86.8
Q ss_pred eEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhhHH
Q 038949 14 KVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVDSC 93 (678)
Q Consensus 14 ~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (678)
++|||++|.+. .+..|+.||....-+.|+.|++|+|+++..... ++ +.... ..... ++..+..
T Consensus 3 k~ILv~vD~s~-~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~--~~------~~~~~-~~~~~-------~~~~~~~ 65 (140)
T d1jmva_ 3 KHILVAVDLSE-ESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLY--TG------LIDVN-MSSMQ-------DRISTET 65 (140)
T ss_dssp SEEEEEECCST-THHHHHHHHHHHHHHHTCEEEEEEEEECCGGGC--CC------CEEHH-HHHHT-------TCCCCHH
T ss_pred CeEEEEECCCH-HHHHHHHHHHHHHHHcCCeEEEEEEeeeccccc--cc------ccccc-hHHHH-------HHHHHHH
Confidence 68999999984 599999999999888999999999998554221 00 00000 00000 1111111
Q ss_pred HHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhh-------hhhcccccccEEEEecC
Q 038949 94 SQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEK-------KCCMEELQCNVVVMKRS 163 (678)
Q Consensus 94 ~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~-------~~~~~~l~c~i~~~~~~ 163 (678)
.+.+.++..-.+. ...+..+..|++...|++.|++.+|+.||+|+| .+.. .+++.+.+|.|.+++..
T Consensus 66 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~I~~~a~~~~~dliV~G~~-~~~~~~lgs~~~~li~~~~~pVliVp~~ 139 (140)
T d1jmva_ 66 QKALLDLAESVDY--PISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHH-QDFWSKLMSSTRQVMNTIKIDMLVVPLR 139 (140)
T ss_dssp HHHHHHHHHHSSS--CCCCEEEEEECHHHHHHHHHHHTTCCEEEEEEC-CCCHHHHHHHHHHHHTTCCSEEEEEECC
T ss_pred HHHHHHHHHhcCC--ceEEEEEEecCHHHHHHHhhhhchhhEEEeccC-CCCCCCcccHHHHHHhccCCCEEEEecC
Confidence 1233333322222 223566778999999999999999999999988 3333 27999999999999865
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=98.56 E-value=5.7e-09 Score=93.24 Aligned_cols=136 Identities=14% Similarity=0.062 Sum_probs=95.1
Q ss_pred cceEEEEEEeecccccchhheehhhccccCCCeEEEEEEeCCCCCCCccccccccccccccCCcccCCCCCCcccchhhh
Q 038949 12 VGKVVIVAVKASKEIPRSALVWALTHVVQPGDYIKLLVVMPPLSSSKKIWGFSRFTNDCATGHKSSLSGTSSDQKDDIVD 91 (678)
Q Consensus 12 ~~~~VvV~~das~~~s~~al~WaL~~v~~~gD~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (678)
..++++|++|.| +.|..||.||....-+.|..|+||||+.+..... .+ .. .... ....+..++..+
T Consensus 3 ~mk~ILv~~D~S-~~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~---~~---~~---~~~~----~~~~~~~e~~~~ 68 (138)
T d1q77a_ 3 AMKVLLVLTDAY-SDCEKAITYAVNFSEKLGAELDILAVLEDVYNLE---RA---NV---TFGL----PFPPEIKEESKK 68 (138)
T ss_dssp CCEEEEEEESTT-CCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHH---HH---HH---HHCC----CCCTHHHHHHHH
T ss_pred CCCEEEEEEeCC-HHHHHHHHHHHHhhhhccceEEEEEEccCccccc---cc---cc---cccc----chhhhhhhhhhh
Confidence 458999999999 5699999999999999999999999986322110 00 00 0000 011112233344
Q ss_pred HHHHHHHHhhhcCCCCcceEEEEEEecCCcchhhhhhhcccccEEEEccccchhhhhhcccccccEEEEe
Q 038949 92 SCSQMMRQLQEVYDPEKIKVRVKIVSGSPYGVVAVEAKKAQSNWVILDKQLKHEKKCCMEELQCNVVVMK 161 (678)
Q Consensus 92 ~~~~~~~~l~~~~~~~~v~~~i~v~~g~~~~~v~~e~k~~~a~~vVld~~~k~~~~~~~~~l~c~i~~~~ 161 (678)
.-.+.+..+.+-++..+++++..|..|+|...|+..|++.+++.||+|.|=+.--...+...+|-+.++|
T Consensus 69 ~~~~~l~~~~~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIV~Gs~g~~~l~r~l~g~~~~~livk 138 (138)
T d1q77a_ 69 RIERRLREVWEKLTGSTEIPGVEYRIGPLSEEVKKFVEGKGYELVVWACYPSAYLCKVIDGLNLASLIVK 138 (138)
T ss_dssp HHHHHHHHHHHHHHSCCCCCCEEEECSCHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHHHSSSEEEECC
T ss_pred hccccchhhcccccccceeEEEeeecchhHHHHHHhhhhccCCEEEEecCCCcHHHHHhcCCCCCEEEeC
Confidence 4445556666656667899999999999999999899999999999999965555566666666555543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.41 E-value=1.1e-07 Score=93.81 Aligned_cols=92 Identities=12% Similarity=0.013 Sum_probs=64.7
Q ss_pred hhhhhhcCCcccceecccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeeccc-ccceEEEEeEEeeCCeEE
Q 038949 388 ELELATNRFSEANFLAEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQ-HRNVVMLIGFCVEDGRRL 466 (678)
Q Consensus 388 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~ 466 (678)
++......|++.+..+-+..+.||+... +++.+++|+...........+.+|+..+..+. +--+.+++.++..++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444556777766655455578998865 56678889876555555567788888877664 333567778888888999
Q ss_pred EEEEEeecCCcccc
Q 038949 467 LVYEYICNGSLDSH 480 (678)
Q Consensus 467 LV~E~~~ggsL~~~ 480 (678)
+||++++|.++.+.
T Consensus 87 lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 87 LLMSEADGVLCSEE 100 (263)
T ss_dssp EEEECCSSEEHHHH
T ss_pred EEEEeccccccccc
Confidence 99999988776443
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.82 E-value=6.7e-06 Score=80.26 Aligned_cols=76 Identities=21% Similarity=0.114 Sum_probs=54.5
Q ss_pred eecccCc-cceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccc--cceEEEEeEEeeCCeEEEEEEEeecCCc
Q 038949 401 FLAEGGF-GSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQH--RNVVMLIGFCVEDGRRLLVYEYICNGSL 477 (678)
Q Consensus 401 ~LG~G~f-G~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~H--pnIv~l~~~~~~~~~~~LV~E~~~ggsL 477 (678)
.+..|.. +.||+....++..+++|..... ....+..|+..++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445553 5789988777888899975432 23467788888877743 2356778888888889999999988776
Q ss_pred cc
Q 038949 478 DS 479 (678)
Q Consensus 478 ~~ 479 (678)
.+
T Consensus 94 ~~ 95 (255)
T d1nd4a_ 94 LS 95 (255)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.68 E-value=0.00018 Score=75.28 Aligned_cols=75 Identities=13% Similarity=-0.013 Sum_probs=47.0
Q ss_pred ceecccCccceeeccCC-CCcEEEEEeeehh----cc---cCCccccccceeeeccc-c--cceEEEEeEEeeCCeEEEE
Q 038949 400 NFLAEGGFGSVHRGVLP-DGQVVAVKQYKLA----SS---QGDQEFCSEVEVLSCAQ-H--RNVVMLIGFCVEDGRRLLV 468 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~i~~~----~~---~~~~~~~~Ev~iL~~L~-H--pnIv~l~~~~~~~~~~~LV 468 (678)
+.||.|....||+.... +++.+++|.-... .. -...+...|+++|+.+. + ..+++++.+. ....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 35899999999999854 4678999964321 11 11234556888877663 2 3466666553 4456799
Q ss_pred EEEeecCC
Q 038949 469 YEYICNGS 476 (678)
Q Consensus 469 ~E~~~ggs 476 (678)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99996644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.05 E-value=0.00069 Score=68.68 Aligned_cols=69 Identities=14% Similarity=0.085 Sum_probs=44.9
Q ss_pred cceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccce-----EEEE--eEEeeCCeEEEEEEEeecCCc
Q 038949 408 GSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNV-----VMLI--GFCVEDGRRLLVYEYICNGSL 477 (678)
Q Consensus 408 G~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnI-----v~l~--~~~~~~~~~~LV~E~~~ggsL 477 (678)
-.||++...+|+.|++|+.+... ...+++..|...+..|...++ +..- ..+..++..+.+++++.|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 57999998899999999987442 233556777777766642222 1110 123446678899999876544
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.94 E-value=0.0052 Score=63.67 Aligned_cols=73 Identities=16% Similarity=0.175 Sum_probs=47.9
Q ss_pred ceecccCccceeeccCC--------CCcEEEEEeeehhcccCCccccccceeeecccccc-eEEEEeEEeeCCeEEEEEE
Q 038949 400 NFLAEGGFGSVHRGVLP--------DGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRN-VVMLIGFCVEDGRRLLVYE 470 (678)
Q Consensus 400 ~~LG~G~fG~Vy~a~~~--------~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~~~~~~~~LV~E 470 (678)
+.|+-|-.-.+|+...+ ..+.|.+++.. . ........+|..+++.+.-.+ ..++++++.. ++|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 45777777889987643 23567777764 2 222334567888888875333 3577887753 58999
Q ss_pred EeecCCcc
Q 038949 471 YICNGSLD 478 (678)
Q Consensus 471 ~~~ggsL~ 478 (678)
|++|..|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.93 E-value=0.003 Score=62.99 Aligned_cols=157 Identities=13% Similarity=0.010 Sum_probs=80.6
Q ss_pred ehhhhhhhhcCCccccee-----cccCccceeeccCCCCcEEEEEeeehhcccCCccccccceeeecccccce-----EE
Q 038949 385 TYAELELATNRFSEANFL-----AEGGFGSVHRGVLPDGQVVAVKQYKLASSQGDQEFCSEVEVLSCAQHRNV-----VM 454 (678)
Q Consensus 385 ~~~~~~~~~~~y~~~~~L-----G~G~fG~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~~~Ev~iL~~L~HpnI-----v~ 454 (678)
+.++++....+|.+.++. ..|---..|+....+| .+++|++... ....++..|++++..|...++ +.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccce
Confidence 445666667778775554 3455567898886555 5899988533 123445556666666643222 11
Q ss_pred EE-e--EEeeCCeEEEEEEEeecCCcccccc-----------------cCCCCc----------------------cCcc
Q 038949 455 LI-G--FCVEDGRRLLVYEYICNGSLDSHLY-----------------GRDRDP----------------------LEWS 492 (678)
Q Consensus 455 l~-~--~~~~~~~~~LV~E~~~ggsL~~~l~-----------------~~~~~~----------------------l~~~ 492 (678)
.. | +.......+.++.++.+......-. .....+ ....
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 10 0 1122345666777765544322110 000000 0000
Q ss_pred ccchhhhhhccchhhhhhcceeeeEEeccCCCCceEeeecCccccccccccc
Q 038949 493 ARRKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILVTHDFEPLVGDFGLAR 544 (678)
Q Consensus 493 ~~~~i~~qI~~aL~yLH~~~~~~gIvHrDLKp~NILl~~~~~vkL~DFGla~ 544 (678)
.....+..+...+...+...-+.|+||+|+.++||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111111122222222211122489999999999999988777899999885
|